PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sakamoto, A; Terui, Y; Uemura, T; Igarashi, K; Kashiwagi, K				Sakamoto, Akihiko; Terui, Yusuke; Uemura, Takeshi; Igarashi, Kazuei; Kashiwagi, Keiko			Polyamines regulate gene expression by stimulating translation of histone acetyltransferase mRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						polyamine; spermidine; gene expression; histone modification; histone acetyltransferase; polyamine modulon; translational regulation; histone acetyltransferase GCN5 (GCN5); histone acetyltransferase 1 (HAT1); miR-7648-5p; histone acetylase; translation regulation; miR-7648-5p	PROTEIN-SYNTHESIS; CELL-GROWTH; IN-VIVO; MODULATION; ACTIVATION; REPRESSION; COMPLEXES; PCNA	Polyamines regulate gene expression inEscherichia coliby translationally stimulating mRNAs encoding global transcription factors. In this study, we focused on histone acetylation, one of the mechanisms of epigenetic regulation of gene expression, to attempt to clarify the role of polyamines in the regulation of gene expression in eukaryotes. We found that activities of histone acetyltransferases in both the nucleus and cytoplasm decreased significantly in polyamine-reduced mouse mammary carcinoma FM3A cells. Although protein levels of histones H3 and H4 did not change in control and polyamine-reduced cells, acetylation of histones H3 and H4 was greatly decreased in the polyamine-reduced cells. Next, we used control and polyamine-reduced cells to identify histone acetyltransferases whose synthesis is stimulated by polyamines. We found that polyamines stimulate the translation of histone acetyltransferases GCN5 and HAT1. Accordingly, GCN5- and HAT1-catalyzed acetylation of specific lysine residues on histones H3 and H4 was stimulated by polyamines. Consistent with these findings, transcription of genes required for cell proliferation was enhanced by polyamines. These results indicate that polyamines regulate gene expression by enhancing the expression of the histone acetyltransferases GCN5 and HAT1 at the level of translation. Mechanistically, polyamines enhanced the interaction of microRNA-7648-5p (miR-7648-5p) with the 5?-UTR of GCN5 mRNA, resulting in stimulation of translation due to the destabilization of the double-stranded RNA (dsRNA) between the 5?-UTR and the ORF of GCN5 mRNA. Because HAT1 mRNA has a short 5?-UTR, polyamines may enhance initiation complex formation directly on this mRNA.	[Sakamoto, Akihiko; Terui, Yusuke; Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Choshi, Chiba, Japan; [Uemura, Takeshi; Igarashi, Kazuei] Amine Pharma Res Inst, Chiba, Japan; [Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan	Chiba University	Kashiwagi, K (corresponding author), Chiba Inst Sci, Fac Pharm, Choshi, Chiba, Japan.	kkashiwagi@cis.ac.jp		Sakamoto, Akihiko/0000-0002-1447-4691	Ministry of Education, Culture, Sports, Science and Technology, Japan [19K16357]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (19K16357).	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chae YB, 2014, INT J BIOL MACROMOL, V63, P56, DOI 10.1016/j.ijbiomac.2013.10.041; Di Martile M, 2016, ONCOTARGET, V7, P55789, DOI 10.18632/oncotarget.10048; Farria A, 2015, ONCOGENE, V34, P4901, DOI 10.1038/onc.2014.453; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Higashi K, 2008, BIOCHEM BIOPH RES CO, V370, P572, DOI 10.1016/j.bbrc.2008.03.137; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Igarashi K, 2019, INT J BIOCHEM CELL B, V107, P104, DOI 10.1016/j.biocel.2018.12.012; Igarashi K, 2018, J BIOL CHEM, V293, P18702, DOI 10.1074/jbc.TM118.003465; Igarashi K, 2015, IUBMB LIFE, V67, P160, DOI 10.1002/iub.1363; Imamura M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33549; Jurikova M, 2016, ACTA HISTOCHEM, V118, P544, DOI 10.1016/j.acthis.2016.05.002; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lee CY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08011-1; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Nakano S, 2004, J AM CHEM SOC, V126, P1088, DOI 10.1021/ja037314h; Narita T, 2019, NAT REV MOL CELL BIO, V20, P156, DOI 10.1038/s41580-018-0081-3; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; Nishimura K, 2009, INT J BIOCHEM CELL B, V41, P2251, DOI 10.1016/j.biocel.2009.04.021; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Parthun MR, 2007, ONCOGENE, V26, P5319, DOI 10.1038/sj.onc.1210602; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shimogori T, 1996, BIOCHEM BIOPH RES CO, V223, P544, DOI 10.1006/bbrc.1996.0931; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; SU LS, 1993, GENE DEV, V7, P735, DOI 10.1101/gad.7.5.735; Terui Y, 2015, AMINO ACIDS, V47, P345, DOI 10.1007/s00726-014-1867-z; Trisciuoglio D, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8908751; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Yamaguchi K, 2018, BIOCHEM J, V475, P3797, DOI 10.1042/BCJ20180672; Yang XH, 2013, J BIOL CHEM, V288, P18271, DOI 10.1074/jbc.M113.473199	41	10	10	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8736	8745		10.1074/jbc.RA120.013833	http://dx.doi.org/10.1074/jbc.RA120.013833			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32376690	Green Published, hybrid			2022-12-28	WOS:000546296800010
J	Hoang, VT; Nyswaner, K; Torres-Ayuso, P; Brognard, J				Hoang, Van T.; Nyswaner, Katherine; Torres-Ayuso, Pedro; Brognard, John			The protein kinase MAP3K19 phosphorylates MAP2Ks and thereby activates ERK and JNK kinases and increases viability of KRAS-mutant lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase; extracellular-signal-regulated kinase (ERK); c-Jun N-terminal kinase (JNK); oncogene; GTPase Kras (KRAS); lung cancer; cell proliferation; kinase signaling; kinome; YSK4	BRAF(V600E) INHIBITION; RESISTANCE; REVEALS	Identifying additional mitogen-activated protein kinase (MAPK) pathway regulators is invaluable in aiding our understanding of the complex signaling networks that regulate cellular processes, including cell proliferation and survival. Here, usingin vitrokinase assays and by expressing WT or kinase-dead MAPK kinase kinase 19 (MAP3K19) in the HEK293T cell line and assessing activation of the extracellular signal?regulated kinase (ERK) and JUN N-terminal kinase (JNK) signaling pathways, we defined MAP3K19 as a novel regulator of MAPK signaling. We also observed that overexpression of WT MAP3K19 activates both the ERK and JNK pathways in a panel of cancer cell lines. Furthermore, MAP3K19 sustained ERK pathway activation in the presence of inhibitors targeting the RAF proto-oncogene Ser/Thr protein kinase (RAF) and MAPK/ERK kinase, indicating that MAP3K19 activates ERK via a RAF-independent mechanism. Findings fromin vitroand in-cell kinase assays demonstrate that MAP3K19 is a kinase that directly phosphorylates both MAPK/ERK kinase (MEK) and MAPK kinase 7 (MKK7). Results from an short-hairpin RNA screen indicated that MAP3K19 is essential for maintaining survival in KRAS-mutant cancers; therefore, we depleted or inhibited MAP3K19 in KRAS-mutant cancer cell lines and observed that this reduces viability and decreases ERK and JNK pathway activation. In summary, our results reveal that MAP3K19 directly activates the ERK and JNK cascades and highlight a role for this kinase in maintaining survival of KRAS-mutant lung cancer cells.	[Hoang, Van T.; Nyswaner, Katherine; Torres-Ayuso, Pedro; Brognard, John] NCI, Lab Cell & Dev Signaling, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brognard, J (corresponding author), NCI, Lab Cell & Dev Signaling, Frederick, MD 21701 USA.	john.brognard@nih.gov	Torres-Ayuso, Pedro/AAE-6014-2021; Brognard, John/T-5099-2019	Torres-Ayuso, Pedro/0000-0003-2213-9014; Brognard, John/0000-0002-9243-6615	Intramural Research Program of NCI, National Institutes of Health [1ZIABC011691]	Intramural Research Program of NCI, National Institutes of Health	This research was supported by the Intramural Research Program of NCI, National Institutes of Health Grant 1ZIABC011691. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Arozarena I, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.09; Atay O, 2017, J CELL BIOL, V216, P317, DOI 10.1083/jcb.201609124; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bhullar KS, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0804-2; Boehme SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167169; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Durham AL, 2015, LUNG CANCER, V90, P121, DOI 10.1016/j.lungcan.2015.08.017; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Hoang VT, 2017, CANCER LETT, V392, P51, DOI 10.1016/j.canlet.2017.01.034; Knapp S, 2018, BRIT J CANCER, V118, P936, DOI 10.1038/s41416-018-0045-6; Marusiak AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4901; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Thumar J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-45; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249	25	9	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8470	8479		10.1074/jbc.RA119.012365	http://dx.doi.org/10.1074/jbc.RA119.012365			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32358059	hybrid, Green Published			2022-12-28	WOS:000546986500011
J	Balasuriya, N; Davey, NE; Johnson, JL; Liu, HD; Biggar, KK; Cantley, LC; Li, SSC; O'Donoghue, P				Balasuriya, Nileeka; Davey, Norman E.; Johnson, Jared L.; Liu, Huadong; Biggar, Kyle K.; Cantley, Lewis C.; Li, Shawn Shun-Cheng; O'Donoghue, Patrick			Phosphorylation-dependent substrate selectivity of protein kinase B (AKT1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptide array; Akt PKB; RNA metabolism; substrate specificity; protein phosphorylation; cell signaling; post-translational modification (PTM); serine; threonine protein kinase; genetic code expansion; oriented peptide array library; phosphoinositide-dependent kinase 1; phosphoseryl-tRNA synthetase; tRNASep	NF-KAPPA-B; SIGNALING PATHWAY; AKT/PKB; IDENTIFICATION; SPECIFICITY; ACTIVATION; SURVIVAL; CANCER; PREDICTION; MECHANISM	Protein kinase B (AKT1) is a central node in a signaling pathway that regulates cell survival. The diverse pathways regulated by AKT1 are communicated in the cell via the phosphorylation of perhaps more than 100 cellular substrates. AKT1 is itself activated by phosphorylation at Thr-308 and Ser-473. Despite the fact that these phosphorylation sites are biomarkers for cancers and tumor biology, their individual roles in shaping AKT1 substrate selectivity are unknown. We recently developed a method to produce AKT1 with programmed phosphorylation at either or both of its key regulatory sites. Here, we used both defined and randomized peptide libraries to map the substrate selectivity of site-specific, singly and doubly phosphorylated AKT1 variants. To globally quantitate AKT1 substrate preferences, we synthesized three AKT1 substrate peptide libraries: one based on 84 ?known? substrates and two independent and larger oriented peptide array libraries (OPALs) of ?10(11)peptides each. We found that each phospho-form of AKT1 has common and distinct substrate requirements. Compared with pAKT1(T308), the addition of Ser-473 phosphorylation increased AKT1 activities on some, but not all of its substrates. This is the first report that Ser-473 phosphorylation can positively or negatively regulate kinase activity in a substrate-dependent fashion. Bioinformatics analysis indicated that the OPAL-activity data effectively discriminate known AKT1 substrates from closely related kinase substrates. Our results also enabled predictions of novel AKT1 substrates that suggest new and expanded roles for AKT1 signaling in regulating cellular processes.	[Balasuriya, Nileeka; Liu, Huadong; Li, Shawn Shun-Cheng; O'Donoghue, Patrick] Univ Western Ontario, Dept Biochem, London, ON, Canada; [O'Donoghue, Patrick] Univ Western Ontario, Dept Chem, London, ON, Canada; [Davey, Norman E.] Inst Canc Res, Div Canc Biol, London, England; [Johnson, Jared L.; Cantley, Lewis C.] Weill Cornell Med Coll, Meyer Canc Ctr, Dept Med, New York, NY USA; [Liu, Huadong] Xi An Jiao Tong Univ, Ctr Mitochondria Biol & Med, Xian, Shanxi, Peoples R China; [Biggar, Kyle K.] Carleton Univ, Dept Biol, Ottawa, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cornell University; Xi'an Jiaotong University; Carleton University	O'Donoghue, P (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.; O'Donoghue, P (corresponding author), Univ Western Ontario, Dept Chem, London, ON, Canada.	patrick.odonoghue@uwo.ca		O'Donoghue, Patrick/0000-0002-9500-8640; Johnson, Jared/0000-0003-1802-6527; Davey, Norman/0000-0001-6988-4850	Canadian Institutes of Health Research [165985]; Natural Sciences and Engineering Research Council of Canada [04282]; Canadian Cancer Society Research Institute innovation Grant [704324]; Canada Foundation for Innovation Grant [229917]; Ontario Research Fund [229917]; Canadian Breast Cancer Foundation; Canada Research Chairs [229917, 232341]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Cancer Society Research Institute innovation Grant; Canada Foundation for Innovation Grant(Canada Foundation for Innovation); Ontario Research Fund; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canada Research Chairs(Canada Research ChairsCGIAR)	This work was supported by the Canadian Institutes of Health Research Grant 165985 (to P. O.), Natural Sciences and Engineering Research Council of Canada Grant 04282 (to P. O.), Canadian Cancer Society Research Institute innovation Grant 704324 (to P. O. and S. S.-C. L.), Canada Foundation for Innovation Grant 229917 (to P. O.), Ontario Research Fund Grant 229917 (to P. O.), Canada Research Chairs 229917 and 232341 (to P. O.), and the Canadian Breast Cancer Foundation (to S. S.-C. L.).	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Balasuriya N, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090450; Balasuriya N, 2018, J BIOL CHEM, V293, P10744, DOI 10.1074/jbc.RA118.002357; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bradley D, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000341; Chen BC, 2002, J BIOL CHEM, V277, P24169, DOI 10.1074/jbc.M106014200; Cheng J, 2014, MOL IMMUNOL, V59, P110, DOI 10.1016/j.molimm.2014.01.011; Chung CZ, 2019, RNA BIOL, V16, P1022, DOI 10.1080/15476286.2019.1608754; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Dumble M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100880; Ehrenberger T, 2015, METHODS MOL BIOL, V1278, P57, DOI 10.1007/978-1-4939-2425-7_4; Fabbro D, 1999, PROTEIN EXPRES PURIF, V17, P83, DOI 10.1006/prep.1999.1102; Freudlsperger C, 2015, INT J CANCER, V136, P2775, DOI 10.1002/ijc.29328; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; Giamas G, 2007, BIOCHEM J, V406, P389, DOI 10.1042/BJ20070091; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guan KL, 2000, J BIOL CHEM, V275, P27354; Hart JR, 2011, ONCOTARGET, V2, P467, DOI 10.18632/oncotarget.293; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Iacovides DC, 2013, MOL CELL PROTEOMICS, V12, P3210, DOI 10.1074/mcp.M112.023119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jin Y, 2019, BIOCHEM BIOPHYS REP, V18, DOI 10.1016/j.bbrep.2019.100625; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim HA, 2017, ANTICANCER RES, V37, P1409, DOI 10.21873/anticanres.11463; Krystkowiak I, 2018, NUCLEIC ACIDS RES, V46, pW235, DOI 10.1093/nar/gky426; Lee Rachel S, 2011, Enzyme Res, V2011, P720985, DOI 10.4061/2011/720985; Ma CX, 2016, CLIN CANCER RES, V22, P2650, DOI 10.1158/1078-0432.CCR-15-2160; Maiti D, 2001, J BIOL CHEM, V276, P329, DOI 10.1074/jbc.M002650200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Michell BJ, 2002, J BIOL CHEM, V277, P42344, DOI 10.1074/jbc.M205144200; Obata T, 2000, J BIOL CHEM, V275, P36108, DOI 10.1074/jbc.M005497200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Rodriguez M, 2004, J BIOL CHEM, V279, P8802, DOI 10.1074/jbc.M311886200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shi Dingding, 2012, Genes Cancer, V3, P240, DOI 10.1177/1947601912455199; Soares CD, 2017, MELANOMA RES, V27, P448, DOI 10.1097/CMR.0000000000000368; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thomsen MCF, 2012, NUCLEIC ACIDS RES, V40, pW281, DOI 10.1093/nar/gks469; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; VULLIET PR, 1989, J BIOL CHEM, V264, P16292; Wang R, 2018, BIOCHEMISTRY-US, V57, P5257, DOI 10.1021/acs.biochem.8b00677; Wei R, 2018, MOL CELL PROTEOMICS, V17, P2216, DOI 10.1074/mcp.RA117.000114; Yeh PY, 2006, J BIOL CHEM, V281, P167, DOI 10.1074/jbc.M511014200; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhang XL, 2006, J BIOL CHEM, V281, P13949, DOI 10.1074/jbc.M601384200; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	59	22	24	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8120	8134		10.1074/jbc.RA119.012425	http://dx.doi.org/10.1074/jbc.RA119.012425			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350110	Green Published, hybrid			2022-12-28	WOS:000542965700001
J	Yang, J; Zhang, H; Gong, WB; Liu, ZY; Wu, HW; Hu, WH; Chen, XX; Wang, L; Wu, S; Chen, C; Perrett, S				Yang, Jie; Zhang, Hong; Gong, Weibin; Liu, Zhenyan; Wu, Huiwen; Hu, Wanhui; Chen, Xinxin; Wang, Lei; Wu, Si; Chen, Chang; Perrett, Sarah			S-Glutathionylation of human inducible Hsp70 reveals a regulatory mechanism involving the C-terminal ?-helical lid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; oxidative stress; glutathionylation; 70-kilodalton heat shock protein (Hsp70); protein structure; cysteine modification; disulfide bond; HspA1A; protein homeostasis	SUBSTRATE-BINDING DOMAIN; OXIDATIVE STRESS; ALLOSTERIC REGULATION; CYSTEINE OXIDATION; NMR STRUCTURE; CELL BIOLOGY; DNAK; IDENTIFICATION; HEAT-SHOCK-PROTEIN-70; DYNAMICS	Heat shock protein 70 (Hsp70) proteins are a family of ancient and conserved chaperones. Cysteine modifications have been widely detected among different Hsp70 family membersin vivo, but their effects on Hsp70 structure and function are unclear. Here, we treated HeLa cells with diamide, which typically induces disulfide bond formation except in the presence of excess GSH, when glutathionylated cysteines predominate. We show that in these cells, HspA1A (hHsp70) undergoes reversible cysteine modifications, including glutathionylation, potentially at all five cysteine residues.In vitroexperiments revealed that modification of cysteines in the nucleotide-binding domain of hHsp70 is prevented by nucleotide binding but that Cys-574 and Cys-603, located in the C-terminal ?-helical lid of the substrate-binding domain, can undergo glutathionylation in both the presence and absence of nucleotide. We found that glutathionylation of these cysteine residues results in unfolding of the ?-helical lid structure. The unfolded region mimics substrate by binding to and blocking the substrate-binding site, thereby promoting intrinsic ATPase activity and competing with binding of external substrates, including heat shock transcription factor 1 (Hsf1). Thus, post-translational modification can alter the structure and regulate the function of hHsp70.	[Yang, Jie; Zhang, Hong; Gong, Weibin; Liu, Zhenyan; Wu, Huiwen; Hu, Wanhui; Chen, Xinxin; Wang, Lei; Wu, Si; Chen, Chang; Perrett, Sarah] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Yang, Jie; Zhang, Hong; Wu, Huiwen; Hu, Wanhui; Chen, Xinxin; Wang, Lei; Wu, Si; Chen, Chang; Perrett, Sarah] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Chang] Beijing Inst Brain Disorders, Beijing, Peoples R China; [Wu, Huiwen] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA USA; [Hu, Wanhui] ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Scripps Research Institute; ShanghaiTech University	Zhang, H; Chen, C; Perrett, S (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China.; Zhang, H; Chen, C; Perrett, S (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Chen, C (corresponding author), Beijing Inst Brain Disorders, Beijing, Peoples R China.	zhangh@moon.ibp.ac.cn; changchen@moon.ibp.ac.cn; sarah.perrett@cantab.net		Zhang, Hong/0000-0001-9204-2547; Wang, Lei/0000-0002-5071-5800; Gong, Weibin/0000-0001-7130-4093	Chinese Ministry of Science and Technology Grant [2017YFA-0504000]; National Natural Science Foundation of China [31570780, 31770829, 21673278, 31920103011, 31470747, 91849203, 31570857]; Beijing Natural Science Foundation [5172026]; Youth Innovation Promotion Association; Chinese Academy of Sciences (CAS); National Laboratory of Biomacromolecules; CAS Center of Excellence in Biomacromolecules	Chinese Ministry of Science and Technology Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Youth Innovation Promotion Association; Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); National Laboratory of Biomacromolecules; CAS Center of Excellence in Biomacromolecules	This work was supported by Chinese Ministry of Science and Technology Grant 2017YFA-0504000; National Natural Science Foundation of China Grants 31570780, 31770829, 21673278, 31920103011, 31470747, 91849203, and 31570857; Beijing Natural Science Foundation Grant 5172026; the Youth Innovation Promotion Association; the Chinese Academy of Sciences (CAS) (to L. W.); the National Laboratory of Biomacromolecules; and the CAS Center of Excellence in Biomacromolecules.	ABRAVAYA K, 1992, GENE DEV, V6, P1153, DOI 10.1101/gad.6.7.1153; Ansong C, 2013, P NATL ACAD SCI USA, V110, P10153, DOI 10.1073/pnas.1221210110; Azoulay I, 2013, INT J MOL SCI, V14, P12675, DOI 10.3390/ijms140612675; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Callahan MK, 2002, J BIOL CHEM, V277, P33604, DOI 10.1074/jbc.M202890200; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Duan JC, 2016, ACS NANO, V10, P524, DOI 10.1021/acsnano.5b05524; Duggan BM, 2001, J BIOMOL NMR, V19, P321, DOI 10.1023/A:1011227824104; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Filomeni G, 2005, CELL DEATH DIFFER, V12, P1555, DOI 10.1038/sj.cdd.4401754; Fratelli M, 2004, EXPERT REV PROTEOMIC, V1, P365, DOI 10.1586/14789450.1.3.365; Gao XC, 2012, J BIOL CHEM, V287, P6044, DOI 10.1074/jbc.M111.294728; Guo J, 2014, NAT PROTOC, V9, P64, DOI 10.1038/nprot.2013.161; Hassan AQ, 2015, CHEM BIOL, V22, P87, DOI 10.1016/j.chembiol.2014.11.007; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Hoppe G, 2004, EXP EYE RES, V78, P1085, DOI 10.1016/j.exer.2004.02.001; Huang B, 2009, CARDIOVASC RES, V83, P536, DOI 10.1093/cvr/cvp154; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Jakobsson ME, 2013, J BIOL CHEM, V288, P27752, DOI 10.1074/jbc.M113.483248; Je JH, 2013, SCAND J IMMUNOL, V78, P238, DOI 10.1111/sji.12078; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Konstantinidis D, 2009, CELL STRESS CHAPERON, V14, P591, DOI 10.1007/s12192-009-0110-4; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lefievre L, 2007, PROTEOMICS, V7, P3066, DOI 10.1002/pmic.200700254; Li R, 2017, METHOD ENZYMOL, V585, P269, DOI 10.1016/bs.mie.2016.10.006; Li R, 2015, J PROTEOME RES, V14, P2026, DOI 10.1021/acs.jproteome.5b00133; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; Michelet L, 2008, J BIOL CHEM, V283, P21571, DOI 10.1074/jbc.M802331200; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Miyata Y, 2012, CHEM BIOL, V19, P1391, DOI 10.1016/j.chembiol.2012.07.026; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Noguchi A, 2014, J BACTERIOL, V196, P1694, DOI 10.1128/JB.01197-13; Nordstrand K, 1999, J MOL BIOL, V286, P541, DOI 10.1006/jmbi.1998.2444; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; Penna C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00216; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Ricci Laura, 2008, Curr Chem Genomics, V2, P90, DOI 10.2174/1875397300802010090; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Schlecht R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078443; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Soss SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128240; Su D, 2014, FREE RADICAL BIO MED, V67, P460, DOI 10.1016/j.freeradbiomed.2013.12.004; Tao LM, 2004, BIOCHEMISTRY-US, V43, P4028, DOI 10.1021/bi035924o; Truman AW, 2012, CELL, V151, P1308, DOI 10.1016/j.cell.2012.10.051; Tutturen AEV, 2013, ANAL BIOANAL CHEM, V405, P9321, DOI 10.1007/s00216-013-7376-1; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; Wang H, 1998, BIOCHEMISTRY-US, V37, P7929, DOI 10.1021/bi9800855; Wang J, 2016, J BIOL CHEM, V291, P7541, DOI 10.1074/jbc.M115.694810; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wang YY, 2012, MOL BIOL CELL, V23, P3290, DOI 10.1091/mbc.E12-06-0447; Wani R, 2017, METHODS MOL BIOL, V1558, P191, DOI 10.1007/978-1-4939-6783-4_9; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang J, 2016, MOL CELL PROTEOMICS, V15, P1, DOI 10.1074/mcp.O115.056051; Yap LP, 2010, BIOCHEM J, V428, P85, DOI 10.1042/BJ20100164; Zhang H, 2016, J BIOL CHEM, V291, P6967, DOI 10.1074/jbc.M115.673608; Zhang H, 2009, MOL MICROBIOL, V71, P702, DOI 10.1111/j.1365-2958.2008.06557.x; Zhang J, 2018, FREE RADICAL BIO MED, V120, P204, DOI 10.1016/j.freeradbiomed.2018.03.038; Zhang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103518; Zhuravleva A, 2015, P NATL ACAD SCI USA, V112, pE2865, DOI 10.1073/pnas.1506692112; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108; Zylicz M, 2001, IUBMB LIFE, V51, P283	85	11	12	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8302	8324		10.1074/jbc.RA119.012372	http://dx.doi.org/10.1074/jbc.RA119.012372			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32332101	Green Published, hybrid			2022-12-28	WOS:000542965700017
J	Zhang, X; Nemeria, NS; Leandro, J; Houten, S; Lazarus, M; Gerfen, G; Ozohanics, O; Ambrus, A; Nagy, B; Brukh, R; Jordan, F				Zhang, Xu; Nemeria, Natalia S.; Leandro, Joao; Houten, Sander; Lazarus, Michael; Gerfen, Gary; Ozohanics, Oliver; Ambrus, Attila; Nagy, Balint; Brukh, Roman; Jordan, Frank			Structure?function analyses of the G729R 2-oxoadipate dehydrogenase genetic variant associated with a disorder of l-lysine metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); protein conformation; DNA damage; neurodegenerative disease; cell metabolism; 2-oxoadipate dehydrogenase; 2-oxoadipate dehydrogenase complex; H; D exchange mass spectrometry; multiple 2-oxoadipate dehydrogenase conformations; substrate channeling	EXCHANGE MASS-SPECTROMETRY; ESCHERICHIA-COLI; STRUCTURAL-ANALYSIS; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; DHTKD1 MUTATIONS; CATALYTIC DOMAIN; E1 COMPONENT; CUBIC CORE; PYRUVATE	2-Oxoadipate dehydrogenase (E1a, also known as DHTKD1, dehydrogenase E1, and transketolase domain-containing protein 1) is a thiamin diphosphate-dependent enzyme and part of the 2-oxoadipate dehydrogenase complex (OADHc) in l-lysine catabolism. Genetic findings have linked mutations in the DHTKD1 gene to several metabolic disorders. These include ?-aminoadipic and ?-ketoadipic aciduria (AMOXAD), a rare disorder of l-lysine, l-hydroxylysine, and l-tryptophan catabolism, associated with clinical presentations such as developmental delay, mild-to-severe intellectual disability, ataxia, epilepsy, and behavioral disorders that cannot currently be managed by available treatments. A heterozygous missense mutation, c.2185G?A (p.G729R), in DHTKD1 has been identified in most AMOXAD cases. Here, we report that the G729R E1a variant when assembled into OADHc in vitro displays a 50-fold decrease in catalytic efficiency for NADH production and a significantly reduced rate of glutaryl-CoA production by dihydrolipoamide succinyl-transferase (E2o). However, the G729R E1a substitution did not affect any of the three side-reactions associated solely with G729R E1a, prompting us to determine the structure?function effects of this mutation. A multipronged systematic analysis of the reaction rates in the OADHc pathway, supplemented with results from chemical cross-linking and hydrogen?deuterium exchange MS, revealed that the c.2185G?A DHTKD1 mutation affects E1a?E2o assembly, leading to impaired channeling of OADHc intermediates. Cross-linking between the C-terminal region of both E1a and G729R E1a with the E2o lipoyl and core domains suggested that correct positioning of the C-terminal E1a region is essential for the intermediate channeling. These findings may inform the development of interventions to counter the effects of pathogenic DHTKD1 mutations.	[Zhang, Xu; Nemeria, Natalia S.; Brukh, Roman; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Leandro, Joao; Houten, Sander; Lazarus, Michael] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Gerfen, Gary] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10641 USA; [Ozohanics, Oliver; Ambrus, Attila; Nagy, Balint] Semmelweis Univ, Dept Med Biochem, MTA SE Lab Neurobiochem, H-1094 Budapest, Hungary	Rutgers State University Newark; Rutgers State University New Brunswick; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; Semmelweis University	Nemeria, NS; Jordan, F (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.; Houten, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	nemerianatalia@gmail.com; sander.houten@mssm.edu; frjordan@rutgers.edu	Leandro, João T/A-8555-2014; Ambrus, Attila/O-4301-2017; ZHANG, XU/AAL-6729-2020; Ozohanics, Oliver/AAH-4449-2019; Nagy, Balint/E-6960-2017	Leandro, João T/0000-0002-0163-3235; Ambrus, Attila/0000-0001-6014-3175; Ozohanics, Oliver/0000-0002-2705-9921; Houten, Sander/0000-0002-6167-9147; Nagy, Balint/0000-0003-3669-7041	National Institutes of Health [9R15GM116077-01, R03HD092878, R21HD088775]; National Science Foundation [CHE-1402675, CHE1213550]; Hungarian Higher Education Institution Excellence Program [FIKP61826 690289 EATV]; Erasmus grant from the European Union; Rutgers-Newark Chancellor's SEED grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Hungarian Higher Education Institution Excellence Program; Erasmus grant from the European Union; Rutgers-Newark Chancellor's SEED grant	This work was supported by National Institutes of Health Grants 9R15GM116077-01 (to F. J.), R03HD092878 (to S. H.), and R21HD088775 (to S. H.); National Science Foundation Grants CHE-1402675 (to F. J.) and CHE1213550 (to G. G.); the Rutgers-Newark Chancellor's SEED grant (to F. J.); Hungarian Higher Education Institution Excellence Program FIKP61826 690289 EATV (to A. A); and an Erasmus grant from the European Union (to A. A. and F. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambrus A, 2016, BBA-MOL BASIS DIS, V1862, P2098, DOI 10.1016/j.bbadis.2016.08.013; Arjunan P, 2014, J BIOL CHEM, V289, P30161, DOI 10.1074/jbc.M114.592915; Balakrishnan A, 2013, J BIOL CHEM, V288, P21688, DOI 10.1074/jbc.M113.465419; Balakrishnan A, 2012, J AM CHEM SOC, V134, P18644, DOI 10.1021/ja3062375; Barsnes H, 2018, J PROTEOME RES, V17, P2552, DOI 10.1021/acs.jproteome.8b00175; Bezerra G. A., 2020, CRYSTAL STRUCTURE IN, DOI [10.1101/2020.01.20.912931, DOI 10.1101/2020.01.20.912931]; Biagosch C, 2017, BBA-MOL BASIS DIS, V1863, P2220, DOI 10.1016/j.bbadis.2017.05.018; Byron O, 2017, SUBCELL BIOCHEM, V83, P523, DOI 10.1007/978-3-319-46503-6_19; Chakraborty J, 2020, AICHE J, V66, DOI 10.1002/aic.16769; Chakraborty J, 2018, FEBS OPEN BIO, V8, P880, DOI 10.1002/2211-5463.12431; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Danhauser K, 2012, AM J HUM GENET, V91, P1082, DOI 10.1016/j.ajhg.2012.10.006; DeColli AA, 2019, BIOCHEMISTRY-US, V58, P4970, DOI 10.1021/acs.biochem.9b00878; DEROSIER DJ, 1971, P NATL ACAD SCI USA, V68, P1135, DOI 10.1073/pnas.68.6.1135; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Frank RAW, 2007, J MOL BIOL, V368, P639, DOI 10.1016/j.jmb.2007.01.080; Gotze M, 2015, J AM SOC MASS SPECTR, V26, P83, DOI 10.1007/s13361-014-1001-1; Grimm M, 2015, NUCLEIC ACIDS RES, V43, pW362, DOI 10.1093/nar/gkv463; Hage C, 2017, ANGEW CHEM INT EDIT, V56, P14551, DOI 10.1002/anie.201708273; Hagen J, 2015, J INHERIT METAB DIS, V38, P873, DOI 10.1007/s10545-015-9841-9; Hamuro Y, 2008, RAPID COMMUN MASS SP, V22, P1041, DOI 10.1002/rcm.3467; Jordan F, 2019, NEUROCHEM RES, V44, P2325, DOI 10.1007/s11064-019-02765-w; Knapp JE, 1998, J MOL BIOL, V280, P655, DOI 10.1006/jmbi.1998.1924; Knapp JE, 2000, PROTEIN SCI, V9, P37; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Leandro J., 2020, INHIBITION CRYSTAL S, DOI [10.1101/2020.01.20.913012, DOI 10.1101/2020.01.20.913012]; Leandro J, 2020, HUM MOL GENET, V29, P1168, DOI 10.1093/hmg/ddaa037; Murphy GE, 2005, STRUCTURE, V13, P1765, DOI 10.1016/j.str.2005.08.016; Nemeria NS, 2018, BBA-BIOENERGETICS, V1859, P932, DOI 10.1016/j.bbabio.2018.05.001; Nemeria NS, 2018, FREE RADICAL BIO MED, V115, P136, DOI 10.1016/j.freeradbiomed.2017.11.018; Nemeria NS, 2017, FREE RADICAL BIO MED, V108, P644, DOI 10.1016/j.freeradbiomed.2017.04.017; Nemeria NS, 2014, J BIOL CHEM, V289, P29859, DOI 10.1074/jbc.M114.591073; Parthasarathy A, 2011, BIOCHEMISTRY-US, V50, P3540, DOI 10.1021/bi1020056; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salisbury JP, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0403-1; Sherrill JD, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99922; Song JY, 2012, BIOCHEMISTRY-US, V51, P2795, DOI 10.1021/bi201614n; Stiles AR, 2016, JIMD REP, V25, P15, DOI 10.1007/8904_2015_462; Suzuki K, 2002, ACTA CRYSTALLOGR D, V58, P833, DOI 10.1107/S0907444902005048; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; WAGENKNECHT T, 1992, J STRUCT BIOL, V109, P70, DOI 10.1016/1047-8477(92)90069-M; WAGENKNECHT T, 1990, J BIOL CHEM, V265, P22402; Wagner T, 2014, BIOCHEM J, V457, P425, DOI 10.1042/BJ20131142; Wagner T, 2011, CHEM BIOL, V18, P1011, DOI 10.1016/j.chembiol.2011.06.004; Wang JJ, 2015, BIOCHEMISTRY-US, V54, P69, DOI 10.1021/bi5013113; Wang JJ, 2014, J BIOL CHEM, V289, P15215, DOI 10.1074/jbc.M113.544080; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Xu WY, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00085-18; Xu WY, 2012, AM J HUM GENET, V91, P1088, DOI 10.1016/j.ajhg.2012.09.018; Xu WY, 2013, FEBS LETT, V587, P3587, DOI 10.1016/j.febslet.2013.08.047; Zhou JY, 2018, J BIOL CHEM, V293, P19213, DOI 10.1074/jbc.RA118.005432; Zhou JY, 2017, P NATL ACAD SCI USA, V114, P9355, DOI 10.1073/pnas.1619981114	54	5	5	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8078	8095		10.1074/jbc.RA120.012761	http://dx.doi.org/10.1074/jbc.RA120.012761			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32303640	hybrid, Green Published			2022-12-28	WOS:000540935400020
J	Basu, U; Mishra, N; Farooqui, M; Shen, JY; Johnson, LC; Patel, SS				Basu, Urmimala; Mishra, Nandini; Farooqui, Mohammed; Shen, Jiayu; Johnson, Laura C.; Patel, Smita S.			The C-terminal tails of the mitochondrial transcription factors Mtf1 and TFB2M are part of an autoinhibitory mechanism that regulates DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; transcriptional coactivator; RNA polymerase; fluorescence anisotropy; protein?DNA interaction; autoinhibition; mitochondrial RNA polymerase; mitochondrial transcription factors; Mtf1; TFB2M	TEMPLATE STRAND; RNA-POLYMERASE; INITIATION; EVOLUTION; COMPLEX; B2	The structurally homologous Mtf1 and TFB2M proteins serve as transcription initiation factors of mitochondrial RNA polymerases in Saccharomyces cerevisiae and humans, respectively. These transcription factors directly interact with the nontemplate strand of the transcription bubble to drive promoter melting. Given the key roles of Mtf1 and TFB2M in promoter-specific transcription initiation, it can be expected that the DNA binding activity of the mitochondrial transcription factors is regulated to prevent DNA binding at inappropriate times. However, little information is available on how mitochondrial DNA transcription is regulated. While studying C-terminal (C-tail) deletion mutants of Mtf1 and TFB2M, we stumbled upon a finding that suggested that the flexible C-tail region of these factors autoregulates their DNA binding activity. Quantitative DNA binding studies with fluorescence anisotropy-based titrations revealed that Mtf1 with an intact C-tail has no affinity for DNA but deletion of the C-tail greatly increases Mtf1's DNA binding affinity. Similar observations were made with TFB2M, although autoinhibition by the C-tail of TFB2M was not as complete as in Mtf1. Analysis of available TFB2M structures disclosed that the C-tail engages in intramolecular interactions with the DNA binding groove in the free factor, which, we propose, inhibits its DNA binding activity. Further experiments showed that RNA polymerase relieves this autoinhibition by interacting with the C-tail and engaging it in complex formation. In conclusion, our biochemical and structural analyses reveal autoinhibitory and activation mechanisms of mitochondrial transcription factors that regulate their DNA binding activities and aid in specific assembly of transcription initiation complexes.	[Basu, Urmimala; Mishra, Nandini; Farooqui, Mohammed; Shen, Jiayu; Johnson, Laura C.; Patel, Smita S.] Rutgers State Univ, Dept Biochem & Mol Biol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Basu, Urmimala; Shen, Jiayu; Johnson, Laura C.] Rutgers State Univ, Grad Sch Biomed Sci, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Mishra, Nandini; Farooqui, Mohammed] Rutgers State Univ, Undergrad Honors Scholars Program, Sch Arts & Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick	Patel, SS (corresponding author), Rutgers State Univ, Dept Biochem & Mol Biol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA.	patelss@rutgers.edu		Shen, Jiayu/0000-0001-8447-9378; Basu, Urmimala/0000-0003-4035-1246; Patel, Smita S/0000-0002-2523-4933; Farooqui, Mohammed/0000-0002-1358-1751	American Heart Association [16PRE30400001]; Rutgers University; NIGMS, National Institutes of Health [GM118086]	American Heart Association(American Heart Association); Rutgers University; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant 16PRE30400001 and University and Louis Bevier dissertation completion fellowship from Rutgers University (to U. B.) and NIGMS, National Institutes of Health Grant GM118086 (to S. S. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basu U, 2020, NUCLEIC ACIDS RES, V48, P2604, DOI 10.1093/nar/gkaa040; Bird JG, 2018, ELIFE, V7, DOI 10.7554/eLife.42179; Cermakian N, 1997, J MOL EVOL, V45, P671, DOI 10.1007/PL00006271; Cotney J, 2006, J MOL EVOL, V63, P707, DOI 10.1007/s00239-006-0075-1; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Guccione E, 2019, NAT REV MOL CELL BIO, V20, P642, DOI 10.1038/s41580-019-0155-x; Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; JANG SH, 1991, J BIOL CHEM, V266, P22671; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; Marintcheva B, 2008, P NATL ACAD SCI USA, V105, P1855, DOI 10.1073/pnas.0711919105; Paratkar S, 2010, J BIOL CHEM, V285, P3949, DOI 10.1074/jbc.M109.050732; Posse V, 2017, J BIOL CHEM, V292, P2637, DOI 10.1074/jbc.M116.751008; Ramachandran A, 2017, NUCLEIC ACIDS RES, V45, P861, DOI 10.1093/nar/gkw1157; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Schwartz EC, 2008, CHEM BIOL, V15, P1091, DOI 10.1016/j.chembiol.2008.09.008; Shutt TE, 2011, TRANSCR-AUSTIN, V2, P55, DOI 10.4161/trns.2.2.14296; Tang GQ, 2011, J BIOL CHEM, V286, P38805, DOI 10.1074/jbc.M111.261966; Tang GQ, 2009, J BIOL CHEM, V284, P5514, DOI 10.1074/jbc.M807880200; Velazquez G, 2015, RNA BIOL, V12, P514, DOI 10.1080/15476286.2015.1014283	21	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6823	6830		10.1074/jbc.RA120.013338	http://dx.doi.org/10.1074/jbc.RA120.013338			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32241911	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000536212600005
J	Gorecki, L; Gerlits, O; Kong, XT; Cheng, XL; Blumenthal, DK; Taylor, P; Ballatore, C; Kovalevsky, A; Radic, Z				Gorecki, Lukas; Gerlits, Oksana; Kong, Xiaotian; Cheng, Xiaolin; Blumenthal, Donald K.; Taylor, Palmer; Ballatore, Carlo; Kovalevsky, Andrey; Radic, Zoran			Rational design, synthesis, and evaluation of uncharged, "smart" bis-oxime antidotes of organophosphate-inhibited human acetylcholinesterase (vol 295, pg 4079, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														RADIC, ZORAN/0000-0003-0806-3869				Gorecki L, 2020, J BIOL CHEM, V295, P4079, DOI 10.1074/jbc.RA119.012400	1	1	1	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6784	6784		10.1074/jbc.AAC120.013785	http://dx.doi.org/10.1074/jbc.AAC120.013785			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32385098	Green Published, hybrid			2022-12-28	WOS:000537685000044
J	Huang, C; Foster, SR; Shah, AD; Kleifeld, O; Canals, M; Schittenhelm, RB; Stone, MJ				Huang, Cheng; Foster, Simon R.; Shah, Anup D.; Kleifeld, Oded; Canals, Meritxell; Schittenhelm, Ralf B.; Stone, Martin J.			Phosphoproteomic characterization of the signaling network resulting from activation of the chemokine receptor CCR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphoproteomics; cell signaling; mass spectrometry (MS); actin; cytoskeleton; GTPase-activating protein (GAP); guanine nucleotide exchange factor (GEF); nuclear pore; chemokine; G protein-coupled receptor (GPCR); CCL2; CCR2; data-independent acquisition; C-C chemokine receptor type 2 (CCR2); C-C chemokine ligand type 2 (CCL2); signaling networks; data-independent acquisition mass spectrometry (DIA-MS)	PHOSPHOPEPTIDE ENRICHMENT; REDUCES ATHEROSCLEROSIS; CANCER-CELLS; P38 MAPK; PROTEIN; EXPRESSION; MIGRATION; PHOSPHORYLATION; PROLIFERATION; CHEMOTAXIS	Leukocyte recruitment is a universal feature of tissue inflammation and regulated by the interactions of chemokines with their G protein?coupled receptors. Activation of CC chemokine receptor 2 (CCR2) by its cognate chemokine ligands, including CC chemokine ligand 2 (CCL2), plays a central role in recruitment of monocytes in several inflammatory diseases. In this study, we used phosphoproteomics to conduct an unbiased characterization of the signaling network resulting from CCL2 activation of CCR2. Using data-independent acquisition MS analysis, we quantified both the proteome and phosphoproteome in FlpIn-HEK293T cells stably expressing CCR2 at six time points after activation with CCL2. Differential expression analysis identified 699 significantly regulated phosphorylation sites on 441 proteins. As expected, many of these proteins are known to participate in canonical signal transduction pathways and in the regulation of actin cytoskeleton dynamics, including numerous guanine nucleotide exchange factors and GTPase-activating proteins. Moreover, we identified regulated phosphorylation sites in numerous proteins that function in the nucleus, including several constituents of the nuclear pore complex. The results of this study provide an unprecedented level of detail of CCR2 signaling and identify potential targets for regulation of CCR2 function.	[Huang, Cheng; Foster, Simon R.; Shah, Anup D.; Schittenhelm, Ralf B.; Stone, Martin J.] Monash Univ, Infect & Immun Program, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Huang, Cheng; Foster, Simon R.; Shah, Anup D.; Schittenhelm, Ralf B.; Stone, Martin J.] Monash Univ, Dept Biochem & Mol Biol, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Huang, Cheng; Shah, Anup D.; Schittenhelm, Ralf B.] Monash Univ, Monash Prote & Metabol Facil, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Shah, Anup D.] Monash Univ, Mongsh Bioinformat Platform, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Kleifeld, Oded] Technion Israel Inst Technol, Fac Biol, IL-3200003 Haifa, Israel; [Canals, Meritxell] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Div Physiol Pharmacol & Neurosci, Nottingham NG7 2UH, England; [Canals, Meritxell] Univ Birmingham, Ctr Membrane Prot & Receptors, The Midlands NG7 2UH, England; [Canals, Meritxell] Univ Nottingham, Ctr Membrane Prot & Receptors, The Midlands NG7 2UH, England	Monash University; Monash University; Monash University; Monash University; Technion Israel Institute of Technology; University of Nottingham; University of Birmingham; University of Nottingham	Schittenhelm, RB (corresponding author), Monash Univ, Biomed Discovery Inst, Monash Prote & Metabol Facil, Clayton, Vic 3800, Australia.; Stone, MJ (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	schittenhelm@monash.edu; martin.stone@monash.edu	Foster, Simon R./I-1552-2014; Stone, Martin/C-2492-2012	Foster, Simon R./0000-0003-3034-1351; Shah, Anup/0000-0002-3793-1998; Canals, Meritxell/0000-0002-7942-5006; Stone, Martin/0000-0002-6468-4427; Schittenhelm, Ralf/0000-0001-8738-1878	National Health and Medical Research Council [APP1140874]; Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme; Monash University Joint Medicine-Pharmacy Grant [JMP16-18]; Office of the Vice-Provost for Research and Research Infrastructure (VPRRI) at Monash University; Bioplatforms Australia (BPA)	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme; Monash University Joint Medicine-Pharmacy Grant; Office of the Vice-Provost for Research and Research Infrastructure (VPRRI) at Monash University; Bioplatforms Australia (BPA)	This work was supported by National Health and Medical Research Council Project Grant APP1140874 (to M. J. S., M. C., and R. B. S.), the Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme (to M. C.), and Monash University Joint Medicine-Pharmacy Grant JMP16-18 (to M. J. S. and M. C.). In addition, this study was further supported by the Office of the Vice-Provost for Research and Research Infrastructure (VPRRI) at Monash University and Bioplatforms Australia (BPA). The authors declare that they have no conflicts of interest with the contents of this article.	Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Balan M, 2014, J BIOL CHEM, V289, P3126, DOI 10.1074/jbc.M113.508044; Batth TS, 2014, J PROTEOME RES, V13, P6176, DOI 10.1021/pr500893m; Bekker-Jensen DB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14609-1; Berchiche YA, 2011, MOL PHARMACOL, V79, P488, DOI 10.1124/mol.110.068486; Biswas SK, 2002, INT IMMUNOPHARMACOL, V2, P1095, DOI 10.1016/S1567-5769(02)00055-3; Bolitho C, 2010, ENDOCR-RELAT CANCER, V17, P929, DOI 10.1677/ERC-10-0107; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Brown MF, 2004, BIOORG MED CHEM LETT, V14, P2175, DOI 10.1016/j.bmcl.2004.02.022; Chen XJ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1748-1; Cheng Y, 2017, ONCOL LETT, V14, P2103, DOI 10.3892/ol.2017.6389; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; Duheron V, 2014, NUCLEUS-PHILA, V5, P601, DOI 10.4161/19491034.2014.990853; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gilbert J, 2011, AM J CARDIOL, V107, P906, DOI 10.1016/j.amjcard.2010.11.005; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hazawa M, 2018, EMBO REP, V19, P73, DOI 10.15252/embr.201744523; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huma ZE, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8529; Jensen SS, 2007, RAPID COMMUN MASS SP, V21, P3635, DOI 10.1002/rcm.3254; Jimenez-Sainz MC, 2003, MOL PHARMACOL, V64, P773, DOI 10.1124/mol.64.3.773; Kabachinski G, 2015, J CELL SCI, V128, P423, DOI 10.1242/jcs.083246; Ko J, 2007, EXP MOL MED, V39, P129, DOI 10.1038/emm.2007.15; Kodali R, 2006, CARDIOVASC RES, V69, P706, DOI 10.1016/j.cardiores.2005.09.012; Lawrence RT, 2016, NAT METHODS, V13, P431, DOI [10.1038/NMETH.3811, 10.1038/nmeth.3811]; Lee J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222559; Ludwig C, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178126; Marsigliante S, 2013, J CELL PHYSIOL, V228, P1873, DOI 10.1002/jcp.24349; McCloskey A, 2018, GENE DEV, V32, P1321, DOI 10.1101/gad.315523.118; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; O'Hayre M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011716; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Rajanala K, 2014, J CELL SCI, V127, P3505, DOI 10.1242/jcs.149112; Rohrl J, 2010, J IMMUNOL, V184, P6688, DOI 10.4049/jimmunol.0903984; Rosenberger G, 2017, NAT BIOTECHNOL, V35, P781, DOI 10.1038/nbt.3908; Russo RC, 2010, CURR OPIN DRUG DISC, V13, P414; Sandblad KG, 2015, CLIN IMMUNOL, V161, P348, DOI 10.1016/j.clim.2015.09.012; Searle BC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07454-w; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh NK, 2017, J BIOL CHEM, V292, P14080, DOI 10.1074/jbc.M117.777896; Struthers M, 2010, CURR TOP MED CHEM, V10, P1278, DOI 10.2174/156802610791561255; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Toda E, 2009, J IMMUNOL, V183, P6387, DOI 10.4049/jimmunol.0803469; Toffali L, 2017, J IMMUNOL, V198, P708, DOI 10.4049/jimmunol.1600933; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; WARD PA, 1968, J EXP MED, V128, P1201, DOI 10.1084/jem.128.5.1201; Werle M, 2002, CARDIOVASC RES, V56, P284, DOI 10.1016/S0008-6363(02)00600-4; White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; Wojcechowskyj JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024918; Yang CK, 2018, CANCER MANAG RES, V10, P679, DOI 10.2147/CMAR.S162595; Yi TF, 2014, P NATL ACAD SCI USA, V111, pE2182, DOI 10.1073/pnas.1404943111; Young K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122892	62	5	5	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6518	6531		10.1074/jbc.RA119.012026	http://dx.doi.org/10.1074/jbc.RA119.012026			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32241914	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000537685000022
J	Toto, A; Malagrino, F; Visconti, L; Troilo, F; Pagano, L; Brunori, M; Jemth, P; Gianni, S				Toto, Angelo; Malagrino, Francesca; Visconti, Lorenzo; Troilo, Francesca; Pagano, Livia; Brunori, Maurizio; Jemth, Per; Gianni, Stefano			Templated folding of intrinsically disordered proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						protein folding; protein denaturation; protein chemistry; intrinsically disordered protein; mutagenesis; folding kinetics; mutagenesis; transition state; reaction mechanism	NUCLEATION-CONDENSATION MECHANISM; LINEAGE LEUKEMIA PROTEIN; PHI-VALUE ANALYSIS; TRANSITION-STATE; CHYMOTRYPSIN INHIBITOR-2; BINDING MECHANISMS; KIX DOMAIN; C-MYB; RECOGNITION; ASSOCIATION	Much of our current knowledge of biological chemistry is founded in the structure-function relationship, whereby sequence determines structure that determines function. Thus, the discovery that a large fraction of the proteome is intrinsically disordered, while being functional, has revolutionized our understanding of proteins and raised new and interesting questions. Many intrinsically disordered proteins (IDPs) have been determined to undergo a disorder-to-order transition when recognizing their physiological partners, suggesting that their mechanisms of folding are intrinsically different from those observed in globular proteins. However, IDPs also follow some of the classic paradigms established for globular proteins, pointing to important similarities in their behavior. In this review, we compare and contrast the folding mechanisms of globular proteins with the emerging features of binding-induced folding of intrinsically disordered proteins. Specifically, whereas disorder-to-order transitions of intrinsically disordered proteins appear to follow rules of globular protein folding, such as the cooperative nature of the reaction, their folding pathways are remarkably more malleable, due to the heterogeneous nature of their folding nuclei, as probed by analysis of linear free-energy relationship plots. These insights have led to a new model for the disorder-to-order transition in IDPs termed ?templated folding,? whereby the binding partner dictates distinct structural transitions en route to product, while ensuring a cooperative folding.	[Toto, Angelo; Malagrino, Francesca; Visconti, Lorenzo; Troilo, Francesca; Pagano, Livia; Brunori, Maurizio; Gianni, Stefano] Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Toto, Angelo; Malagrino, Francesca; Visconti, Lorenzo; Troilo, Francesca; Pagano, Livia; Brunori, Maurizio; Gianni, Stefano] Sapienza Univ Roma, CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy; [Jemth, Per] Uppsala Univ, Dept Med Biochem & Microbiol, BMC Box 582, SE-75123 Uppsala, Sweden	Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Uppsala University	Gianni, S (corresponding author), Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy.; Gianni, S (corresponding author), Sapienza Univ Roma, CNR, Ist Biol & Patol Mol, I-00185 Rome, Italy.; Jemth, P (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, BMC Box 582, SE-75123 Uppsala, Sweden.	per.jemth@imbim.uu.se; Stefano.gianni@uniroma1.it	Toto, Angelo/AAV-9598-2021	Malagrino, Francesca/0000-0002-7876-2422; Toto, Angelo/0000-0002-4620-3677; Jemth, Per/0000-0003-1516-7228	Italian Ministero dell'Istruzione dell'Universitae della Ricerca (Progetto di Interesse "Invecchiamento"); Sapienza University of Rome [B52F16003410005, RP11715C34AEAC9B, RM1181641C2C24B9]; Associazione Italiana per la Ricerca sul Cancro Individual Grant MFAG 2016 [18701]; Istituto Pasteur Italia Teresa Ariaudo Research Project 2018; Swedish Research Council [2016-04965]	Italian Ministero dell'Istruzione dell'Universitae della Ricerca (Progetto di Interesse "Invecchiamento")(Ministry of Education, Universities and Research (MIUR)); Sapienza University of Rome; Associazione Italiana per la Ricerca sul Cancro Individual Grant MFAG 2016(Fondazione AIRC per la ricerca sul cancro); Istituto Pasteur Italia Teresa Ariaudo Research Project 2018; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported in part by the Italian Ministero dell'Istruzione dell'Universitae della Ricerca (Progetto di Interesse "Invecchiamento" to S. G.); Sapienza University of Rome Grants B52F16003410005, RP11715C34AEAC9B, and RM1181641C2C24B9 (to S. G); Associazione Italiana per la Ricerca sul Cancro Individual Grant MFAG 2016, 18701 (to S. G.); Istituto Pasteur Italia Teresa Ariaudo Research Project 2018 (to A. T.); and Swedish Research Council Grant 2016-04965 (to P. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Aberg E, 2018, J PHYS CHEM B, V122, P6899, DOI 10.1021/acs.jpcb.8b03876; ABKEVICH VI, 1994, BIOCHEMISTRY-US, V33, P10026, DOI 10.1021/bi00199a029; Adamski W, 2019, J AM CHEM SOC, V141, P17817, DOI 10.1021/jacs.9b09002; [Anonymous], 2005, SCIENCE, V309, P78; Arai M, 2015, P NATL ACAD SCI USA, V112, P9614, DOI 10.1073/pnas.1512799112; Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Bonetti D, 2018, BIOPHYS J, V114, P1889, DOI 10.1016/j.bpj.2018.03.017; Bonetti D, 2017, BIOCHEMISTRY-US, V56, P3780, DOI 10.1021/acs.biochem.7b00350; Borgia A, 2018, NATURE, V555, P61, DOI 10.1038/nature25762; Chemes LB, 2011, J MOL BIOL, V412, P267, DOI 10.1016/j.jmb.2011.07.015; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Cho JH, 2006, J AM CHEM SOC, V128, P16492, DOI 10.1021/ja0669878; Crabtree MD, 2018, J BIOL CHEM, V293, P9718, DOI 10.1074/jbc.RA118.002791; Crabtree MD, 2017, BIOCHEMISTRY-US, V56, P2379, DOI 10.1021/acs.biochem.7b00179; CREIGHTON TE, 1988, P NATL ACAD SCI USA, V85, P5082, DOI 10.1073/pnas.85.14.5082; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Dahal L, 2017, BIOPHYS J, V113, P2713, DOI 10.1016/j.bpj.2017.10.016; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Desfosses A, 2019, P NATL ACAD SCI USA, V116, P4256, DOI 10.1073/pnas.1816417116; Dobson CM, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a033878; Dogan J, 2014, PHYS CHEM CHEM PHYS, V16, P6323, DOI 10.1039/c3cp54226b; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dogan J, 2012, J BIOL CHEM, V287, P34316, DOI 10.1074/jbc.M112.399436; Dosnon M, 2015, ACS CHEM BIOL, V10, P795, DOI 10.1021/cb5008579; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899; Fersht A. R., 1999, STRUCTURE MECH PROTE, P325; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P14338, DOI 10.1073/pnas.0406091101; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; FERSHT AR, 1974, PROC R SOC SER B-BIO, V187, P397, DOI 10.1098/rspb.1974.0084; Frauenfelder H, 2002, BIOPHYS CHEM, V98, P35, DOI 10.1016/S0301-4622(02)00083-2; Fuxreiter M, 2019, CURR OPIN STRUC BIOL, V54, P19, DOI 10.1016/j.sbi.2018.09.008; Gianni S, 2007, BIOPHYS CHEM, V128, P105, DOI 10.1016/j.bpc.2007.04.008; Gianni S, 2016, BIOPHYS CHEM, V212, P17, DOI 10.1016/j.bpc.2016.03.001; Gianni S, 2016, CURR OPIN STRUC BIOL, V36, P18, DOI 10.1016/j.sbi.2015.11.012; Gianni S, 2014, IUBMB LIFE, V66, P449, DOI 10.1002/iub.1287; Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112; Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Iesmantavicius V, 2014, ANGEW CHEM INT EDIT, V53, P1548, DOI 10.1002/anie.201307712; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jemth P, 2014, J BIOL CHEM, V289, P5528, DOI 10.1074/jbc.M113.537068; Jensen MR, 2011, P NATL ACAD SCI USA, V108, P9839, DOI 10.1073/pnas.1103270108; Karlsson E, 2019, J BIOL CHEM, V294, P1230, DOI 10.1074/jbc.RA118.005854; Karlsson OA, 2012, J MOL BIOL, V417, P253, DOI 10.1016/j.jmb.2012.01.042; KELTON KF, 1988, PHYS REV B, V38, P10089, DOI 10.1103/PhysRevB.38.10089; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340; Lindstrom I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26213-x; Lindstrom I, 2017, BIOCHEMISTRY-US, V56, P4145, DOI 10.1021/acs.biochem.7b00428; Luchinat E, 2018, ACCOUNTS CHEM RES, V51, P1550, DOI 10.1021/acs.accounts.8b00147; Mesrouze Y, 2018, PROTEIN SCI, V27, P1810, DOI 10.1002/pro.3493; Milles S, 2015, CELL, V163, P734, DOI 10.1016/j.cell.2015.09.047; Miskei M, 2020, J MOL BIOL, V432, P2289, DOI 10.1016/j.jmb.2020.02.017; Naganathan AN, 2010, P NATL ACAD SCI USA, V107, P8611, DOI 10.1073/pnas.1000988107; Narayanan R, 2008, J AM CHEM SOC, V130, P11477, DOI 10.1021/ja803221c; Nickson AA, 2013, CURR OPIN STRUC BIOL, V23, P66, DOI 10.1016/j.sbi.2012.11.009; Nyqvist I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53067-8; O'Brien EP, 2011, J AM CHEM SOC, V133, P513, DOI 10.1021/ja107863z; Ou L, 2017, FEBS J, V284, P3381, DOI 10.1111/febs.14197; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; Robustelli P, 2018, P NATL ACAD SCI USA, V115, pE4758, DOI 10.1073/pnas.1800690115; Rogers JM, 2014, P NATL ACAD SCI USA, V111, P15420, DOI 10.1073/pnas.1409122111; Rogers JM, 2014, J AM CHEM SOC, V136, P5197, DOI 10.1021/ja4125065; Sanchez IE, 2003, J MOL BIOL, V334, P1077, DOI 10.1016/j.jmb.2003.10.016; Schuler B, 2020, CURR OPIN STRUC BIOL, V60, P66, DOI 10.1016/j.sbi.2019.12.006; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Shammas SL, 2014, P NATL ACAD SCI USA, V111, P12055, DOI 10.1073/pnas.1405815111; Shirts M, 2000, SCIENCE, V290, P1903, DOI 10.1126/science.290.5498.1903; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tompa P, 2011, CURR OPIN STRUC BIOL, V21, P419, DOI 10.1016/j.sbi.2011.03.012; Toto A, 2017, ONCOTARGET, V8, P82344, DOI 10.18632/oncotarget.19323; Toto A, 2016, BIOCHEMISTRY-US, V55, P3957, DOI 10.1021/acs.biochem.6b00505; Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994; Toto A, 2014, PROTEIN SCI, V23, P962, DOI 10.1002/pro.2480; Troilo F, 2019, ACS CHEM BIOL, V14, P337, DOI 10.1021/acschembio.8b01055; Tuttle LM, 2018, CELL REP, V22, P3251, DOI 10.1016/j.celrep.2018.02.097; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Wolynes PG, 2005, PHILOS T R SOC A, V363, P453, DOI 10.1098/rsta.2004.1502; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xiao P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11849-8	90	34	34	5	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6586	6593		10.1074/jbc.REV120.012413	http://dx.doi.org/10.1074/jbc.REV120.012413			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32253236	Green Published, hybrid			2022-12-28	WOS:000537685000027
J	Xu, FW; Zhao, F; Zhao, XX; Zhang, D; Liu, XM; Hu, SQ; Mei, S; Fan, ZL; Huang, Y; Sun, H; Wei, L; Wu, C; Li, QJ; Wang, JW; Cen, S; Liang, C; Guo, F				Xu, Fengwen; Zhao, Fei; Zhao, Xiaoxiao; Zhang, Di; Liu, Xiaoman; Hu, Siqi; Mei, Shan; Fan, Zhangling; Huang, Yu; Sun, Hong; Wei, Liang; Wu, Chao; Li, Quanjie; Wang, Jianwei; Cen, Shan; Liang, Chen; Guo, Fei			Pro-515 of the dynamin-like GTPase MxB contributes to HIV-1 inhibition by regulating MxB oligomerization and binding to HIV-1 capsid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); inhibition mechanism; infection; host-pathogen interaction; myxovirus resistance 2 (MX2); myxovirus resistance protein B (MxB); nuclear export signal (NES); virus capsid; viral infection; protein oligomerization	VIRAL DETERMINANTS; SAMHD1 RESTRICTS; INTERFERON; INFECTION; PROTEIN; VIRUS; REPLICATION; RESISTANCE; SERINC5; HOST	Interferon-regulated myxovirus resistance protein B (MxB) is an interferon-induced GTPase belonging to the dynamin superfamily. It inhibits infection with a wide range of different viruses, including HIV-1, by impairing viral DNA entry into the nucleus. Unlike the related antiviral GTPase MxA, MxB possesses an N-terminal region that contains a nuclear localization signal and is crucial for inhibiting HIV-1. Because MxB previously has been shown to reside in both the nuclear envelope and the cytoplasm, here we used bioinformatics and biochemical approaches to identify a nuclear export signal (NES) responsible for MxB's cytoplasmic location. Using the online computational tool LocNES (Locating Nuclear Export Signals or NESs), we identified five putative NES candidates in MxB and investigated whether their deletion caused nuclear localization of MxB. Our results revealed that none of the five deletion variants relocates to the nucleus, suggesting that these five predicted NES sequences do not confer NES activity. Interestingly, deletion of one sequence, encompassing amino acids 505?527, abrogated the anti-HIV-1 activity of MxB. Further mutation experiments disclosed that amino acids 515?519, and Pro-515 in particular, regulate MxB oligomerization and its binding to HIV-1 capsid, thereby playing an important role in MxB-mediated restriction of HIV-1 infection. In summary, our results indicate that none of the five predicted NES sequences in MxB appears to be required for its nuclear export. Our findings also reveal several residues in MxB, including Pro-515, critical for its oligomerization and anti-HIV-1 function.	[Xu, Fengwen; Zhao, Fei; Zhao, Xiaoxiao; Zhang, Di; Liu, Xiaoman; Hu, Siqi; Mei, Shan; Fan, Zhangling; Huang, Yu; Sun, Hong; Wei, Liang; Wu, Chao; Wang, Jianwei; Guo, Fei] Chinese Acad Med Sci & Peking Union Med Coll, NHC Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Xu, Fengwen; Zhao, Fei; Zhao, Xiaoxiao; Zhang, Di; Liu, Xiaoman; Hu, Siqi; Mei, Shan; Fan, Zhangling; Huang, Yu; Sun, Hong; Wei, Liang; Guo, Fei] Chinese Acad Med Sci & Peking Union Med Coll, Ctr AIDS Res, Beijing 100730, Peoples R China; [Li, Quanjie; Cen, Shan] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Beijing 100050, Peoples R China; [Liang, Chen] McGill Univ, AIDS Ctr, Lady Davis Inst, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Peking Union Medical College; Lady Davis Institute; McGill University	Guo, F (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Ctr AIDS Res, Beijing 100730, Peoples R China.; Guo, F (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.; Guo, F (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Pathogen Biol, Ctr AIDS Res, Beijing 100730, Peoples R China.	guofei@ipb.pumc.edu.cn		Wang, Jianwei/0000-0002-1116-4559	National Key Plan for Scientific Research and Development of China [2016YFD0500307]; Ministry of Science and Technology of China [2018ZX10301408-003, 2018ZX10731101-001-018]; CAMS Innovation Fund for Medical Sciences (CIFMS) [CIFMS 2017-I2M-1-014, CIFMS 2018-I2M-3-004]; National Natural Science Foundation of China [81401673, 81528012, 81601771, 81702451, 81371808]; Canadian Institutes of Health Research Grant [CCI-132561]; CAMS general fund [2019-RC-HL-012]; PUMC Youth Fund/Fundamental Research Funds for the Central Universities [3332018202, 3332019157]	National Key Plan for Scientific Research and Development of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); CAMS Innovation Fund for Medical Sciences (CIFMS); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); CAMS general fund; PUMC Youth Fund/Fundamental Research Funds for the Central Universities	This work was supported by National Key Plan for Scientific Research and Development of China Grant 2016YFD0500307; Ministry of Science and Technology of China Grants 2018ZX10301408-003 and 2018ZX10731101-001-018; CAMS Innovation Fund for Medical Sciences (CIFMS) Grants CIFMS 2017-I2M-1-014 and CIFMS 2018-I2M-3-004; National Natural Science Foundation of China Grants 81401673, 81528012, 81601771, 81702451, and 81371808; Canadian Institutes of Health Research Grant CCI-132561; CAMS general fund Grant 2019-RC-HL-012; and PUMC Youth Fund/Fundamental Research Funds for the Central Universities Grants 3332018202 and 3332019157. The authors declare that they have no conflicts of interest with the contents of this article.	Alvarez FJD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701264; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Buffone C, 2015, J VIROL, V89, P3285, DOI 10.1128/JVI.03730-14; Busnadiego I, 2014, J VIROL, V88, P7738, DOI 10.1128/JVI.00214-14; Crameri M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04379-2; Dicks MDJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007408; Dicks MDJ, 2016, J VIROL, V90, P22, DOI 10.1128/JVI.02247-15; Fackler OT, 2015, VIRUSES-BASEL, V7, P6730, DOI 10.3390/v7122970; Fribourgh JL, 2014, CELL HOST MICROBE, V16, P627, DOI 10.1016/j.chom.2014.09.021; Fricke T, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0068-x; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2015, J VIROL, V89, P4676, DOI 10.1128/JVI.00169-15; Goujon C, 2014, J VIROL, V88, P9017, DOI 10.1128/JVI.01269-14; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Kane M, 2018, ELIFE, V7, DOI 10.7554/eLife.35738; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lee SH, 2002, GENOME RES, V12, P527, DOI 10.1101/gr.20102; Li J, 2015, BIOCHEM J, V468, P303, DOI 10.1042/BJ20141331; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Matreyek KA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0090-z; Melen K, 1996, J BIOL CHEM, V271, P23478, DOI 10.1074/jbc.271.38.23478; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Peltekian C, 2005, J HEPATOL, V43, P965, DOI 10.1016/j.jhep.2005.06.019; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Schilling M, 2018, J VIROL, V92, DOI 10.1128/JVI.01056-18; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schulte B, 2015, J VIROL, V89, P8599, DOI 10.1128/JVI.00753-15; Shah VB, 2011, JOVE-J VIS EXP, DOI 10.3791/3384; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Staeheli P, 2018, J VIROL, V92, DOI 10.1128/JVI.00709-18; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; Wei W, 2016, EBIOMEDICINE, V8, P230, DOI 10.1016/j.ebiom.2016.04.020; Xu DR, 2015, BIOINFORMATICS, V31, P1357, DOI 10.1093/bioinformatics/btu826; Yi DR, 2019, J VIROL, V93, DOI 10.1128/JVI.01285-18; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	51	2	2	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6447	6456		10.1074/jbc.RA119.012439	http://dx.doi.org/10.1074/jbc.RA119.012439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32217692	hybrid, Green Published			2022-12-28	WOS:000537685000016
J	Gorinski, N; Wojciechowski, D; Guseva, D; Galil, DA; Mueller, FE; Wirth, A; Thiemann, S; Zeug, A; Schmidt, S; Zareba-Koziol, M; Wlodarczyk, J; Skryabin, BV; Glage, S; Fischer, M; Al-Samir, S; Kerkenberg, N; Hohoff, C; Zhang, WQ; Endeward, V; Ponimaskin, E				Gorinski, Nataliya; Wojciechowski, Daniel; Guseva, Daria; Galil, Dalia Abdel; Mueller, Franziska E.; Wirth, Alexander; Thiemann, Stefan; Zeug, Andre; Schmidt, Silke; Zareba-Koziol, Monika; Wlodarczyk, Jakub; Skryabin, Boris, V; Glage, Silke; Fischer, Martin; Al-Samir, Samer; Kerkenberg, Nicole; Hohoff, Christa; Zhang, Weiqi; Endeward, Volker; Ponimaskin, Evgeni			DHHC7-mediated palmitoylation of the accessory protein barttin critically regulates the functions of ClC-K chloride channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						post-translational modification (PTM); ion channel; enzyme; kidney metabolism; mouse genetics; Bartter syndrome type IV; barttin; chloride channel ClC-K; palmitoylation; palmitoyltransferase DHHC7; hypertension; renal dysfunction; nephropathy	S-PALMITOYLATION; IDENTIFICATION; SUBUNIT; LOCALIZATION; TRAFFICKING; MUTATIONS; DEAFNESS; RECEPTOR; VOLTAGE; SURFACE	Barttin is the accessory subunit of the human ClC-K chloride channels, which are expressed in both the kidney and inner ear. Barttin promotes trafficking of the complex it forms with ClC-K to the plasma membrane and is involved in activating this channel. Barttin undergoes post-translational palmitoylation that is essential for its functions, but the enzyme(s) catalyzing this post-translational modification is unknown. Here, we identified zinc finger DHHC-type containing 7 (DHHC7) protein as an important barttin palmitoyl acyltransferase, whose depletion affected barttin palmitoylation and ClC-K-barttin channel activation. We investigated the functional role of barttin palmitoylation in vivo in Zdhhc7(?/?) mice. Although palmitoylation of barttin in kidneys of Zdhhc7(?/?) animals was significantly decreased, it did not pathologically alter kidney structure and functions under physiological conditions. However, when Zdhhc7(?/?) mice were fed a low-salt diet, they developed hyponatremia and mild metabolic alkalosis, symptoms characteristic of human Bartter syndrome (BS) type IV. Of note, we also observed decreased palmitoylation of the disease-causing R8L barttin variant associated with human BS type IV. Our results indicate that dysregulated DHHC7-mediated barttin palmitoylation appears to play an important role in chloride channel dysfunction in certain BS variants, suggesting that targeting DHHC7 activity may offer a potential therapeutic strategy for reducing hypertension.	[Gorinski, Nataliya; Guseva, Daria; Galil, Dalia Abdel; Mueller, Franziska E.; Wirth, Alexander; Zeug, Andre; Schmidt, Silke; Ponimaskin, Evgeni] Hannover Med Sch, Dept Cellular Neurophysiol, D-30625 Hannover, Germany; [Wojciechowski, Daniel; Thiemann, Stefan; Fischer, Martin] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany; [Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, D-30625 Hannover, Germany; [Al-Samir, Samer; Endeward, Volker] Hannover Med Sch, Inst Vegetat Physiol, D-30625 Hannover, Germany; [Zareba-Koziol, Monika; Wlodarczyk, Jakub] Polish Acad Sci, Nencki Inst Expt Biol, Lab Cell Biophys, PL-02093 Warsaw, Poland; [Skryabin, Boris, V] Univ Munster, Dept Med, Core Facil Transgen Anim & Genet Engn Models TRAM, D-48149 Munster, Germany; [Kerkenberg, Nicole; Hohoff, Christa; Zhang, Weiqi] Univ Munster, Dept Psychiat & Psychotherapy, Lab Mol Psychiat, D-48149 Munster, Germany; [Kerkenberg, Nicole; Zhang, Weiqi] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, D-48149 Munster, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Munster; University of Munster; University of Munster	Ponimaskin, E (corresponding author), Hannover Med Sch, Inst Cellular Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Ponimaskin.Evgeni@mh-hannover.de	Guseva, Daria/AAW-2546-2021; Zareba-Koziol, Monika/E-1276-2015; Zeug, Andre/X-3208-2019; Skryabin, Boris/AAL-3100-2020; Wlodarczyk, Jakub/A-2253-2015	Zeug, Andre/0000-0001-9858-5841; Skryabin, Boris/0000-0002-4392-185X; Zareba-Koziol, Monika/0000-0003-3544-6259; Muller, Franziska/0000-0003-0525-0714; Kerkenberg, Nicole/0000-0003-0565-0988; Wirth, Alexander/0000-0001-6835-1200; Wlodarczyk, Jakub/0000-0001-8343-2340; Guseva, PD, PhD, Daria/0000-0002-8844-572X	Deutsche Forschungsgemeinschaft (DFG) [Po732, ZH 34/3-1]; Otto Creutzfeldt Center for Cognitive and Behavioral Neuroscience of the University of Munster; Interdisciplinary Centre for Clinical Research (IZKF) of the University of Munster Medical School [Zha3-005-14]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Otto Creutzfeldt Center for Cognitive and Behavioral Neuroscience of the University of Munster; Interdisciplinary Centre for Clinical Research (IZKF) of the University of Munster Medical School	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants Po732 (to E. P.) and ZH 34/3-1 (to A. Z.) as well as by the Otto Creutzfeldt Center for Cognitive and Behavioral Neuroscience of the University of Munster and the Interdisciplinary Centre for Clinical Research (IZKF) of the University of Munster Medical School (Zha3-005-14 and core unit PIX). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi N, 2016, J BIOL CHEM, V291, P20232, DOI 10.1074/jbc.M116.725762; Akahoshi N, 2014, AM J PHYSIOL-RENAL, V306, pF1462, DOI 10.1152/ajprenal.00623.2013; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Chen SY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08691-3; Chen SY, 2017, NATURE, V549, P399, DOI 10.1038/nature23887; Degasperi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087293; Du KY, 2017, J BIOL CHEM, V292, P2979, DOI 10.1074/jbc.M116.747139; Ernst AM, 2018, DEV CELL, V47, P479, DOI 10.1016/j.devcel.2018.10.024; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00155; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fujita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052272; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Garcia-Nieto V, 2006, PEDIATR NEPHROL, V21, P643, DOI 10.1007/s00467-006-0062-1; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hohoff C, 2019, BRAIN STRUCT FUNCT, V224, P2213, DOI 10.1007/s00429-019-01898-6; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Kilpatrick CL, 2016, J BIOL CHEM, V291, P27371, DOI 10.1074/jbc.M116.732768; McHaffie GS, 2007, BBA-BIOMEMBRANES, V1768, P2099, DOI 10.1016/j.bbamem.2007.05.017; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mukherjee A, 2014, J BIOL CHEM, V289, P14351, DOI 10.1074/jbc.M113.526020; Nomura N, 2011, AM J PHYSIOL-RENAL, V301, pF297, DOI 10.1152/ajprenal.00604.2010; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Pinelli L, 2016, J GEN PHYSIOL, V148, P213, DOI 10.1085/jgp.201611623; Rana MS, 2018, SCIENCE, V359, P176, DOI 10.1126/science.aao6326; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Roy K, 2017, J BIOL CHEM, V292, P17703, DOI 10.1074/jbc.M117.792937; Saleem AN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000985; Sands JM, 2009, SEMIN NEPHROL, V29, P178, DOI 10.1016/j.semnephrol.2009.03.008; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Steinke KV, 2015, J BIOL CHEM, V290, P17390, DOI 10.1074/jbc.M114.631705; Tagawa H, 2005, J BIOL CHEM, V280, P23876, DOI 10.1074/jbc.M501728200; Tajima M, 2007, BIOCHEM BIOPH RES CO, V362, P858, DOI 10.1016/j.bbrc.2007.08.097; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; Waldegger S, 2002, PFLUG ARCH EUR J PHY, V444, P411, DOI 10.1007/s00424-002-0819-8; Watanabe S, 2002, LANCET, V360, P692, DOI 10.1016/S0140-6736(02)09842-2; Yamamoto Y, 2007, ONCOLOGY-BASEL, V72, P132, DOI 10.1159/000111132; Yanai A, 2006, NAT NEUROSCI, V9, P824, DOI 10.1038/nn1702; Yokoi N, 2016, J NEUROSCI, V36, P6431, DOI 10.1523/JNEUROSCI.0419-16.2016; Zareba-Koziol M, 2019, MOL CELL PROTEOMICS, V18, P1916, DOI 10.1074/mcp.RA119.001581	43	6	6	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5970	5983		10.1074/jbc.RA119.011049	http://dx.doi.org/10.1074/jbc.RA119.011049			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32184353	Green Published, hybrid			2022-12-28	WOS:000531417300011
J	Zhang, RY; Yu, ZH; Chen, L; Walls, CD; Zhang, S; Wu, L; Zhang, ZY				Zhang, Ruo-Yu; Yu, Zhi-Hong; Chen, Lan; Walls, Chad D.; Zhang, Sheng; Wu, Li; Zhang, Zhong-Yin			Mechanistic insights explain the transforming potential of the T507K substitution in the protein-tyrosine phosphatase SHP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; cancer; transformation; structure?function; kinetics; signaling; mutation; SHP2	LEOPARD-SYNDROME; SH2 DOMAIN; IN-VIVO; GROWTH; INHIBITOR; ACTIVATION; BINDING; SUPPRESSOR; MUTATIONS; SPROUTY1	The protein-tyrosine phosphatase SHP2 is an allosteric enzyme critical for cellular events downstream of growth factor receptors. Mutations in the SHP2 gene have been linked to many different types of human diseases, including developmental disorders, leukemia, and solid tumors. Unlike most SHP2-activating mutations, the T507K substitution in SHP2 is unique in that it exhibits oncogenic Ras-like transforming activity. However, the biochemical basis of how the SHP2/T507K variant elicits transformation remains unclear. By combining kinetic and biophysical methods, X-ray crystallography, and molecular modeling, as well as using cell biology approaches, here we uncovered that the T507K substitution alters both SHP2 substrate specificity and its allosteric regulatory mechanism. We found that although SHP2/T507K exists in the closed, autoinhibited conformation similar to the WT enzyme, the interactions between its N-SH2 and protein-tyrosine phosphatase domains are weakened such that SHP2/T507K possesses a higher affinity for the scaffolding protein Grb2-associated binding protein 1 (Gab1). We also discovered that the T507K substitution alters the structure of the SHP2 active site, resulting in a change in SHP2 substrate preference for Sprouty1, a known negative regulator of Ras signaling and a potential tumor suppressor. Our results suggest that SHP2/T507K's shift in substrate specificity coupled with its preferential association of SHP2/T507K with Gab1 enable the mutant SHP2 to more efficiently dephosphorylate Sprouty1 at pTyr-53. This dephosphorylation hyperactivates Ras signaling, which is likely responsible for SHP2/T507K's Ras-like transforming activity.	[Zhang, Ruo-Yu; Yu, Zhi-Hong; Chen, Lan; Walls, Chad D.; Zhang, Sheng; Wu, Li; Zhang, Zhong-Yin] Purdue Univ, Ctr Canc Res, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Zhang, Ruo-Yu; Yu, Zhi-Hong; Chen, Lan; Walls, Chad D.; Zhang, Sheng; Wu, Li; Zhang, Zhong-Yin] Purdue Univ, Ctr Canc Res, Dept Chem, W Lafayette, IN 47907 USA; [Zhang, Ruo-Yu; Yu, Zhi-Hong; Chen, Lan; Walls, Chad D.; Zhang, Sheng; Wu, Li; Zhang, Zhong-Yin] Purdue Univ, Inst Drug Discovery, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhang, ZY (corresponding author), Purdue Univ, Ctr Canc Res, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	zhang-zy@purdue.edu			National Institutes of Health [RO1 CA069202, RO1 CA207288]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants RO1 CA069202 and RO1 CA207288 (to Z.-Y. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castro AF, 2005, METHODS, V37, P190, DOI 10.1016/j.ymeth.2005.05.015; Cunnick JM, 2000, J BIOL CHEM, V275, P13842, DOI 10.1074/jbc.275.18.13842; Cunnick JM, 2001, J BIOL CHEM, V276, P24380, DOI 10.1074/jbc.M010275200; Edouard T, 2010, MOL CELL BIOL, V30, P2498, DOI 10.1128/MCB.00646-09; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; Frankson R, 2017, CANCER RES, V77, P5701, DOI 10.1158/0008-5472.CAN-17-1510; Hanafusa H, 2004, J BIOL CHEM, V279, P22992, DOI 10.1074/jbc.M312498200; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Ishida M, 2007, CANCER SCI, V98, P815, DOI 10.1111/j.1349-7006.2007.00457.x; Jarvis LA, 2006, DEVELOPMENT, V133, P1133, DOI 10.1242/dev.02255; Kwabi-Addo B, 2004, CANCER RES, V64, P4728, DOI 10.1158/0008-5472.CAN-03-3759; LaRochelle JR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06823-9; LEE CH, 1994, STRUCTURE, V2, P423, DOI 10.1016/S0969-2126(00)00044-7; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Macia A, 2012, ONCOGENE, V31, P3961, DOI 10.1038/onc.2011.556; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; Miyamoto D, 2008, ONCOGENE, V27, P3508, DOI 10.1038/sj.onc.1211019; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padua RAP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06814-w; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puius YA, 1997, P NATL ACAD SCI USA, V94, P13420, DOI 10.1073/pnas.94.25.13420; Quintanar-Audelo M, 2011, J BIOL CHEM, V286, P23102, DOI 10.1074/jbc.M110.212662; Ren Y, 2004, J BIOL CHEM, V279, P8497, DOI 10.1074/jbc.M312575200; Schutzman JL, 2012, P NATL ACAD SCI USA, V109, P20023, DOI 10.1073/pnas.1217204109; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; Tajan M, 2015, EUR J MED GENET, V58, P509, DOI 10.1016/j.ejmg.2015.08.005; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Yang J, 2000, J BIOL CHEM, V275, P4066, DOI 10.1074/jbc.275.6.4066; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Yu ZH, 2018, CHEM REV, V118, P193, DOI 10.1021/acs.chemrev.7b00105; Yu ZH, 2014, BIOCHEMISTRY-US, V53, P4136, DOI 10.1021/bi5002695; Yu ZH, 2013, J BIOL CHEM, V288, P10472, DOI 10.1074/jbc.M113.450023; ZHANG ZY, 1993, ANAL BIOCHEM, V211, P7, DOI 10.1006/abio.1993.1224; Zhao Y, 1998, J BIOL CHEM, V273, P5484, DOI 10.1074/jbc.273.10.5484	48	6	6	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6187	6201		10.1074/jbc.RA119.010274	http://dx.doi.org/10.1074/jbc.RA119.010274			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32188694	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000531417300027
J	Bouchez, CL; Yoboue, ED; Vargas, LDE; Salin, B; Cuvellier, S; Rigoulet, M; Duvezin-Caubet, S; Devin, A				Bouchez, Cyrielle L.; Yoboue, Edgar D.; Vargas, Livier E. de la Rosa; Salin, Benedicte; Cuvellier, Sylvain; Rigoulet, Michel; Duvezin-Caubet, Stephane; Devin, Anne			?Labile? heme critically regulates mitochondrial biogenesis through the transcriptional co-activator Hap4p in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; heme; yeast; oxidation-reduction (redox); bioenergetics; Hap4p; labile heme; mitochondrial biogenesis; oxidative phosphorylation (OXPHOS); transcription factor; yeast; gene regulation; transcription factor; HAP complex	SKELETAL-MUSCLE; EXTINCTION COEFFICIENT; GROWTH-YIELD; CYC1 GENE; YEAST; ACTIVATION; RESPIRATION; COMPLEX; OXYGEN; HSP90	Heme (iron protoporphyrin IX) is a well-known prosthetic group for enzymes involved in metabolic pathways such as oxygen transport and electron transfer through the mitochondrial respiratory chain. However, heme has also been shown to be an important regulatory molecule (as ?labile? heme) for diverse processes such as translation, kinase activity, and transcription in mammals, yeast, and bacteria. Taking advantage of a yeast strain deficient for heme production that enabled controlled modulation and monitoring of labile heme levels, here we investigated the role of labile heme in the regulation of mitochondrial biogenesis. This process is regulated by the HAP complex in yeast. Using several biochemical assays along with EM and epifluorescence microscopy, to the best of our knowledge, we show for the first time that cellular labile heme is critical for the post-translational regulation of HAP complex activity, most likely through the stability of the transcriptional co-activator Hap4p. Consequently, we found that labile heme regulates mitochondrial biogenesis and cell growth. The findings of our work highlight a new mechanism in the regulation of mitochondrial biogenesis by cellular metabolites.	[Bouchez, Cyrielle L.; Yoboue, Edgar D.; Vargas, Livier E. de la Rosa; Salin, Benedicte; Cuvellier, Sylvain; Rigoulet, Michel; Duvezin-Caubet, Stephane; Devin, Anne] CNRS, F-33000 Bordeaux, France; [Bouchez, Cyrielle L.; Yoboue, Edgar D.; Vargas, Livier E. de la Rosa; Salin, Benedicte; Cuvellier, Sylvain; Rigoulet, Michel; Duvezin-Caubet, Stephane; Devin, Anne] Univ Bordeaux, Inst Biochim & Genet Cellulaires, UMR 5095, F-33000 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Devin, A (corresponding author), CNRS, IBGC, Bioenerget & Cell Metab Lab, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	anne.devin@ibgc.cnrs.fr		Duvezin-Caubet, Stephane/0000-0002-0243-2697; Bouchez, Cyrielle L/0000-0002-5318-3547	Ligue contre le Cancer; Agence Nationale de la Recherche; CNRS	Ligue contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Ligue contre le Cancer, the Agence Nationale de la Recherche, and CNRS. The authors declare that they have no conflicts of interest with the contents of this article.	Aquilano K, 2013, ANTIOXID REDOX SIGN, V18, P386, DOI 10.1089/ars.2012.4615; BETINA S, 1995, EUR J BIOCHEM, V229, P651, DOI 10.1111/j.1432-1033.1995.tb20510.x; Bogacka I, 2005, J CLIN ENDOCR METAB, V90, P6650, DOI 10.1210/jc.2005-1024; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bourens M, 2013, ANTIOXID REDOX SIGN, V19, P1940, DOI 10.1089/ars.2012.4847; BROWN GC, 1992, BIOCHEM J, V284, P1; Buschlen S, 2003, COMP FUNCT GENOM, V4, P37, DOI 10.1002/cfg.254; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chevtzoff C, 2010, J BIOL CHEM, V285, P1733, DOI 10.1074/jbc.M109.019570; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; Dang VD, 1996, J BACTERIOL, V178, P1842, DOI 10.1128/jb.178.7.1842-1849.1996; Dejean L, 2000, BBA-BIOENERGETICS, V1457, P45, DOI 10.1016/S0005-2728(00)00053-0; Dejean L, 2002, BBA-BIOENERGETICS, V1554, P159, DOI 10.1016/S0005-2728(02)00240-2; Devin A, 2007, AM J PHYSIOL-CELL PH, V292, pC52, DOI 10.1152/ajpcell.00208.2006; Devin A, 2006, J BIOL CHEM, V281, P26779, DOI 10.1074/jbc.M604800200; FORSBURG SL, 1989, GENE DEV, V3, P1166, DOI 10.1101/gad.3.8.1166; FORSBURG SL, 1988, MOL CELL BIOL, V8, P647, DOI 10.1128/MCB.8.2.647; GROEN AK, 1982, J BIOL CHEM, V257, P2754; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; GUARENTE L, 1984, CELL, V36, P503, DOI 10.1016/0092-8674(84)90243-5; HAHN S, 1988, MOL CELL BIOL, V8, P655, DOI 10.1128/MCB.8.2.655; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Hon T, 2005, GENETICS, V169, P1343, DOI 10.1534/genetics.104.037143; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; KIPPERT F, 1995, FEMS MICROBIOL LETT, V128, P201, DOI 10.1016/0378-1097(95)00113-J; Lan CG, 2004, J BIOL CHEM, V279, P27607, DOI 10.1074/jbc.M402777200; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lascaris R, 2003, GENOME BIOL, V4; Lee HC, 2003, MOL CELL BIOL, V23, P5857, DOI 10.1128/MCB.23.16.5857-5866.2003; Lee HC, 2002, J BIOL CHEM, V277, P7430, DOI 10.1074/jbc.M106951200; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McNabb DS, 2005, EUKARYOT CELL, V4, P1829, DOI 10.1128/EC.4.11.1829-1839.2005; MCNABB DS, 1995, GENE DEV, V9, P47, DOI 10.1101/gad.9.1.47; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Mogensen M, 2006, J PHYSIOL-LONDON, V571, P669, DOI 10.1113/jphysiol.2005.101691; OLESEN J, 1987, CELL, V51, P953, DOI 10.1016/0092-8674(87)90582-4; PINKHAM JL, 1985, MOL CELL BIOL, V5, P3410, DOI 10.1128/MCB.5.12.3410; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Rabol R, 2009, METABOLISM, V58, P1145, DOI 10.1016/j.metabol.2009.03.014; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; SCHNEIDER JC, 1991, MOL CELL BIOL, V11, P4934, DOI 10.1128/MCB.11.10.4934; Smith D. W., 1970, STRUCT BOND, V7, P1, DOI 10.1007/BFb0118898; TAGER JM, 1983, FEBS LETT, V151, P1, DOI 10.1016/0014-5793(83)80330-5; THORSNESS M, 1989, MOL CELL BIOL, V9, P5702, DOI 10.1128/MCB.9.12.5702; TRAWICK JD, 1989, J BIOL CHEM, V264, P7005; VANGELDER BF, 1962, BIOCHIM BIOPHYS ACTA, V58, P593, DOI 10.1016/0006-3002(62)90073-2; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; WANG L, 1995, GENE, V158, P163, DOI 10.1016/0378-1119(95)00126-Q; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoboue Edgar D, 2012, Int J Cell Biol, V2012, P403870, DOI 10.1155/2012/403870; Yoboue ED, 2012, J BIOL CHEM, V287, P14569, DOI 10.1074/jbc.M111.302786; Zhang TT, 2017, J BIOL CHEM, V292, P16942, DOI 10.1074/jbc.M117.790923	58	6	6	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5095	5109		10.1074/jbc.RA120.012739	http://dx.doi.org/10.1074/jbc.RA120.012739			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32075909	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000526887000029
J	Jalota, A; Singh, K; Pavithra, L; Kaul-Ghanekar, R; Jameel, S; Chattopadhyay, S				Jalota, Archana; Singh, Kamini; Pavithra, Lakshminarasimhan; Kaul-Ghanekar, Ruchika; Jameel, Shahid; Chattopadhyay, Samit			Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine-rich motif (Withdrawal of Vol 280, Pg 16019, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal																		JALOTA A, 2005, THE JOURNAL OF BIOLO, V280, P16019	1	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3390	3390		10.1074/jbc.W120.012894	http://dx.doi.org/10.1074/jbc.W120.012894			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32144153	hybrid, Green Published			2022-12-28	WOS:000519597300044
J	Trazzi, S; Steger, M; Mitrugno, VM; Bartesaghi, R; Ciani, E				Trazzi, Stefania; Steger, Martin; Mitrugno, Valentina Maria; Bartesaghi, Renata; Ciani, Elisabetta			CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/glycogen synthase kinase-3 beta/beta-catenin signaling (vol 285, pg 10098, 2010)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Ciani, Elisabetta/AAL-6462-2020					Trazzi S, 2010, J BIOL CHEM, V285, P10098, DOI 10.1074/jbc.M109.043711	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3388	3388		10.1074/jbc.AAC120.013006	http://dx.doi.org/10.1074/jbc.AAC120.013006			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32144151	Green Published, hybrid			2022-12-28	WOS:000519597300042
J	Marks, C; Deane, CM				Marks, Claire; Deane, Charlotte M.			How repertoire data are changing antibody science	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						antibody; bioinformatics; immunology; protein sequence; protein structure; adaptive immunity; B-cell receptor (BCR); observed antibody space database; structural annotation; next-generation sequencing; antibody	PROTEIN-PROTEIN DOCKING; CELL-RECEPTOR REPERTOIRE; STRUCTURE PREDICTION; MONOCLONAL-ANTIBODIES; WEB SERVER; HIV-1-NEUTRALIZING ANTIBODIES; GENE REPERTOIRE; B-CELLS; V-H; SEQUENCE	Antibodies are vital proteins of the immune system that recognize potentially harmful molecules and initiate their removal. Mammals can efficiently create vast numbers of antibodies with different sequences capable of binding to any antigen with high affinity and specificity. Because they can be developed to bind to many disease agents, antibodies can be used as therapeutics. In an organism, after antigen exposure, antibodies specific to that antigen are enriched through clonal selection, expansion, and somatic hypermutation. The antibodies present in an organism therefore report on its immune status, describe its innate ability to deal with harmful substances, and reveal how it has previously responded. Next-generation sequencing technologies are being increasingly used to query the antibody, or B-cell receptor (BCR), sequence repertoire, and the amount of BCR data in public repositories is growing. The Observed Antibody Space database, for example, currently contains over a billion sequences from 68 different studies. Repertoires are available that represent both the naive state (i.e.antigen-inexperienced) and that after immunization. This wealth of data has created opportunities to learn more about our immune system. In this review, we discuss the many ways in which BCR repertoire data have been or could be exploited. We highlight its utility for providing insights into how the naive immune repertoire is generated and how it responds to antigens. We also consider how structural information can be used to enhance these data and may lead to more accurate depictions of the sequence space and to applications in the discovery of new therapeutics.	[Marks, Claire; Deane, Charlotte M.] Univ Oxford, Dept Stat, Oxford, England	University of Oxford	Deane, CM (corresponding author), Univ Oxford, Dept Stat, Oxford, England.	deane@stats.ox.ac.uk		Deane, Charlotte/0000-0003-1388-2252				Abhinandan KR, 2007, J MOL BIOL, V369, P852, DOI 10.1016/j.jmb.2007.02.100; Adler AS, 2018, MABS-AUSTIN, V10, P431, DOI 10.1080/19420862.2018.1426422; Arora R, 2019, BIORXIV, DOI [10.1101/519108, DOI 10.1101/519108]; Bashford-Rogers RJM, 2019, NATURE, V574, P122, DOI 10.1038/s41586-019-1595-3; Berrondo M, 2014, PROTEINS, V82, P1636, DOI 10.1002/prot.24595; Bourquard T, 2018, J IMMUNOL, V201, P3096, DOI 10.4049/jimmunol.1701722; Brenke R, 2012, BIOINFORMATICS, V28, P2608, DOI 10.1093/bioinformatics/bts493; Briney B, 2019, NATURE, V566, P393, DOI 10.1038/s41586-019-0879-y; Bujotzek A, 2015, MABS-AUSTIN, V7, P838, DOI 10.1080/19420862.2015.1068492; Bujotzek A, 2015, PROTEINS, V83, P681, DOI 10.1002/prot.24756; BURNET F. M., 1960, PERSPECTIVES IN BIOL AND MED, V3, P447; Chailyan A, 2012, NUCLEIC ACIDS RES, V40, pD1230, DOI 10.1093/nar/gkr806; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; Cheung WC, 2012, NAT BIOTECHNOL, V30, P447, DOI 10.1038/nbt.2167; Choi Y, 2011, MOL BIOSYST, V7, P3327, DOI 10.1039/c1mb05223c; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Christley S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00976; Collins AM, 2018, IMMUNOGENETICS, V70, P143, DOI 10.1007/s00251-017-1049-8; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; Corcoran MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13642; Correia BE., 2019, BIORXIV, DOI 10.1101/617860; Corrie BD, 2018, IMMUNOL REV, V284, P24, DOI 10.1111/imr.12666; Daberdaku S, 2019, BIOINFORMATICS, V35, P1870, DOI 10.1093/bioinformatics/bty918; Datta-Mannan A, 2015, MABS-AUSTIN, V7, P483, DOI 10.1080/19420862.2015.1016696; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; de Vries SJ, 2015, BIOPHYS J, V108, P462, DOI 10.1016/j.bpj.2014.12.015; Deac A, 2019, J COMPUT BIOL, V26, P536, DOI 10.1089/cmb.2018.0175; DeKosky BJ, 2016, P NATL ACAD SCI USA, V113, pE2636, DOI 10.1073/pnas.1525510113; Devarajan P, 2019, CELL HOST MICROBE, V25, P354, DOI 10.1016/j.chom.2019.02.009; DeWitt WS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160853; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dunbar J, 2014, NUCLEIC ACIDS RES, V42, pD1140, DOI 10.1093/nar/gkt1043; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; Elhanati Y, 2016, BIOINFORMATICS, V32, P1943, DOI 10.1093/bioinformatics/btw112; Elhanati Y, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0243; Fasnacht M, 2014, PROTEINS, V82, P1583, DOI 10.1002/prot.24604; Feeney AJ, 2000, IMMUNOL REV, V175, P59, DOI 10.1111/j.1600-065X.2000.imr017508.x; Fowler A, 2018, BIORXIV, DOI [10.1101/464792, DOI 10.1101/464792]; Frost SDW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0240; Gadala-Maria D, 2015, P NATL ACAD SCI USA, V112, pE862, DOI 10.1073/pnas.1417683112; Galson JD, 2015, EBIOMEDICINE, V2, P2070, DOI 10.1016/j.ebiom.2015.11.034; Galson JD, 2015, IMMUNOL CELL BIOL, V93, P885, DOI 10.1038/icb.2015.57; Galson JD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00531; Galson JD, 2014, TRENDS IMMUNOL, V35, P319, DOI 10.1016/j.it.2014.04.005; Gao SH, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-55; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Ghraichy M., 2019, BIORXIV, DOI [10.1101/609651, DOI 10.1101/609651]; Gidoni M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08489-3; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Greiff V, 2017, J IMMUNOL, V199, P2985, DOI 10.4049/jimmunol.1700594; Greiff V, 2017, CELL REP, V19, P1467, DOI 10.1016/j.celrep.2017.04.054; Greiff V, 2015, TRENDS IMMUNOL, V36, P738, DOI 10.1016/j.it.2015.09.006; Greiff V, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0169-8; Gupta NT, 2017, J IMMUNOL, V198, P2489, DOI 10.4049/jimmunol.1601850; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Haberger M, 2014, MABS-AUSTIN, V6, P327, DOI 10.4161/mabs.27876; Henry C, 2019, CELL HOST MICROBE, V25, P357, DOI 10.1016/j.chom.2019.01.002; Hoehn KB, 2017, GENETICS, V206, P417, DOI 10.1534/genetics.116.196303; Hoi KH, 2013, GENES IMMUN, V14, P271, DOI 10.1038/gene.2013.10; Horns F, 2019, P NATL ACAD SCI USA, V116, P1261, DOI 10.1073/pnas.1814213116; Hua CK, 2017, ELIFE, V6, DOI 10.7554/eLife.29023; Huang KYA, 2019, NAT MICROBIOL, V4, P306, DOI 10.1038/s41564-018-0303-7; Jackson KJL, 2012, IMMUNOGENETICS, V64, P3, DOI 10.1007/s00251-011-0559-z; Jain T, 2017, BIOINFORMATICS, V33, P3758, DOI 10.1093/bioinformatics/btx519; Jarasch A, 2015, J PHARM SCI-US, V104, P1885, DOI 10.1002/jps.24430; JESKE DJ, 1984, J IMMUNOL, V133, P1090; Jespersen MC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00298; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Jimenez-Garcia B, 2013, BIOINFORMATICS, V29, P1698, DOI 10.1093/bioinformatics/btt262; Kaplon H, 2019, MABS-AUSTIN, V11, P219, DOI 10.1080/19420862.2018.1556465; Kemmish H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177923; Klausen MS, 2015, NUCLEIC ACIDS RES, V43, pW349, DOI 10.1093/nar/gkv535; Kovaltsuk A., 2019, BIORXIV, DOI [10.1101/762880, DOI 10.1101/762880]; Kovaltsuk A, 2018, J IMMUNOL, V201, P2502, DOI 10.4049/jimmunol.1800708; Kovaltsuk A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01753; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Krawczyk K, 2019, MABS-AUSTIN, V11, P1197, DOI 10.1080/19420862.2019.1633884; Krawczyk K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01698; Krawczyk K, 2014, BIOINFORMATICS, V30, P2288, DOI 10.1093/bioinformatics/btu190; Krawczyk K, 2013, PROTEIN ENG DES SEL, V26, P621, DOI 10.1093/protein/gzt043; Kunik V, 2012, NUCLEIC ACIDS RES, V40, pW521, DOI 10.1093/nar/gks480; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; Lai LS, 2019, EXP THER MED, V17, P2206, DOI 10.3892/etm.2019.7183; Lapidoth G, 2019, BIOINFORMATICS, V35, P1591, DOI 10.1093/bioinformatics/bty822; Lauer TM, 2012, J PHARM SCI-US, V101, P102, DOI 10.1002/jps.22758; Lazar GA, 2007, MOL IMMUNOL, V44, P1986, DOI 10.1016/j.molimm.2006.09.029; Lee EC, 2014, NAT BIOTECHNOL, V32, P356, DOI 10.1038/nbt.2825; Lee J, 2019, CELL HOST MICROBE, V25, P367, DOI 10.1016/j.chom.2019.01.010; Leem J, 2016, MABS-AUSTIN, V8, P1259, DOI 10.1080/19420862.2016.1205773; Li YL, 2003, NAT STRUCT BIOL, V10, P482, DOI 10.1038/nsb930; Liberis E, 2018, BIOINFORMATICS, V34, P2944, DOI 10.1093/bioinformatics/bty305; Lim CC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081861; Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213; Lopez-Santibanez-Jacome L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00899; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Maier JKX, 2014, PROTEINS, V82, P1599, DOI 10.1002/prot.24576; Mandal C, 1996, NAT BIOTECHNOL, V14, P323, DOI 10.1038/nbt0396-323; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; Marcou Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02832-w; Marks C, 2017, COMPUT STRUCT BIOTEC, V15, P222, DOI 10.1016/j.csbj.2017.01.010; Marks C, 2017, BIOINFORMATICS, V33, P1346, DOI 10.1093/bioinformatics/btw823; Messih MA, 2014, BIOINFORMATICS, V30, P2733, DOI 10.1093/bioinformatics/btu194; Miho E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09278-8; Miho E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00224; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Nowak J, 2016, MABS-AUSTIN, V8, P751, DOI 10.1080/19420862.2016.1158370; Obrezanova O, 2015, MABS-AUSTIN, V7, P352, DOI 10.1080/19420862.2015.1007828; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Olimpieri PP, 2013, BIOINFORMATICS, V29, P2285, DOI 10.1093/bioinformatics/btt369; Ostmeyer J, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1814-6; Ota M, 2010, J IMMUNOL, V185, P4128, DOI 10.4049/jimmunol.1002176; Peng HP, 2014, P NATL ACAD SCI USA, V111, pE2656, DOI 10.1073/pnas.1401131111; Popovic B, 2017, PROTEIN ENG DES SEL, V30, P303, DOI 10.1093/protein/gzx001; Prassler J, 2011, J MOL BIOL, V413, P261, DOI 10.1016/j.jmb.2011.08.012; Ramirez-Aportela E, 2016, BIOINFORMATICS, V32, P2386, DOI 10.1093/bioinformatics/btw141; Rapberger R, 2007, J MOL RECOGNIT, V20, P113, DOI 10.1002/jmr.819; Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789; Raybould MIJ, 2020, NUCLEIC ACIDS RES, V48, pD383, DOI 10.1093/nar/gkz827; Raybould MIJ, 2019, MOL SYST DES ENG, V4, P679, DOI 10.1039/c9me00034h; Raybould MIJ, 2019, P NATL ACAD SCI USA, V116, P4025, DOI 10.1073/pnas.1810576116; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Regep C, 2017, PROTEINS, V85, P1311, DOI 10.1002/prot.25291; Rosenfeld AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02107; Safdari Y, 2013, BIOTECHNOL GENET ENG, V29, P175, DOI 10.1080/02648725.2013.801235; Saggy I, 2012, PROTEIN ENG DES SEL, V25, P539, DOI 10.1093/protein/gzs060; Saper CB, 2009, J HISTOCHEM CYTOCHEM, V57, P1, DOI 10.1369/jhc.2008.952770; Sato S, 2012, NAT BIOTECHNOL, V30, P1039, DOI 10.1038/nbt.2406; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schramm CA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01876; Sela-Culang I, 2015, BIOINFORMATICS, V31, P1313, DOI 10.1093/bioinformatics/btu790; Sela-Culang I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00302; Sela-Culang I, 2014, STRUCTURE, V22, P646, DOI 10.1016/j.str.2014.02.003; Setliff I, 2018, CELL HOST MICROBE, V23, P845, DOI 10.1016/j.chom.2018.05.001; Sharma VK, 2014, P NATL ACAD SCI USA, V111, P18601, DOI 10.1073/pnas.1421779112; Sheng ZZ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00537; Shimba N, 2016, J CHEM INF MODEL, V56, P2005, DOI 10.1021/acs.jcim.6b00066; Shirai H, 2014, PROTEINS, V82, P1624, DOI 10.1002/prot.24591; Sircar A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000644; Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309; Skaggs H, 2019, REPROD TOXICOL, V89, P178, DOI 10.1016/j.reprotox.2019.06.005; Soga S, 2010, PROTEIN ENG DES SEL, V23, P441, DOI 10.1093/protein/gzq014; Soto C, 2019, NATURE, V566, P398, DOI 10.1038/s41586-019-0934-8; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; Sydow JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100736; Teplyakov A, 2014, PROTEINS, V82, P1563, DOI 10.1002/prot.24554; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Torchala M, 2013, BIOINFORMATICS, V29, P807, DOI 10.1093/bioinformatics/btt038; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Truck J, 2015, J IMMUNOL, V194, P252, DOI 10.4049/jimmunol.1401405; Vander Heiden JA, 2017, J IMMUNOL, V198, P1460, DOI 10.4049/jimmunol.1601415; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Wang B, 2016, MABS-AUSTIN, V8, P1035, DOI 10.1080/19420862.2016.1190059; Wang B, 2015, SCI REP-UK, V5, DOI 10.1038/srep13926; Wang C, 2015, P NATL ACAD SCI USA, V112, P500, DOI 10.1073/pnas.1415875112; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Weitzner BD, 2017, NAT PROTOC, V12, P401, DOI 10.1038/nprot.2016.180; Weitzner BD, 2014, PROTEINS, V82, P1611, DOI 10.1002/prot.24534; Whitelegg NRJ, 2000, PROTEIN ENG, V13, P819, DOI 10.1093/protein/13.12.819; Wollacott AM, 2019, PROTEIN ENG DES SEL, V32, P347, DOI 10.1093/protein/gzz031; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Xu YD, 2013, PROTEIN ENG DES SEL, V26, P663, DOI 10.1093/protein/gzt047; Xue HB, 2019, BIOCHEM BIOPH RES CO, V515, P481, DOI 10.1016/j.bbrc.2019.05.149; Yaari G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00358; Yaari G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks457; Yadav S, 2012, MOL PHARMACEUT, V9, P791, DOI 10.1021/mp200566k; Yamashita K, 2014, BIOINFORMATICS, V30, P3279, DOI 10.1093/bioinformatics/btu510; Yermanos A, 2017, BIOINFORMATICS, V33, P3938, DOI 10.1093/bioinformatics/btx533; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zhai WW, 2011, J MOL BIOL, V412, P55, DOI 10.1016/j.jmb.2011.07.018; Zhang W, 2020, BIOINFORMATICS, V36, P897, DOI 10.1093/bioinformatics/btz614; Zhao L, 2011, IEEE ACM T COMPUT BI, V8, P1483, DOI 10.1109/TCBB.2011.49; Zhao L, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-S1-S6; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110; Zhu K, 2014, PROTEINS, V82, P1646, DOI 10.1002/prot.24551; Zhu K, 2013, PROTEINS, V81, P1081, DOI 10.1002/prot.24240	183	14	14	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					9823	9837		10.1074/jbc.REV120.010181	http://dx.doi.org/10.1074/jbc.REV120.010181			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32409582	hybrid, Green Published			2022-12-28	WOS:000553333300005
J	Lunge, A; Gupta, R; Choudhary, E; Agarwal, N				Lunge, Ajitesh; Gupta, Radhika; Choudhary, Eira; Agarwal, Nisheeth			The unfoldase ClpC1 ofMycobacterium tuberculosisregulates the expression of a distinct subset of proteins having intrinsically disordered termini	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; caseinolytic protease; ClpC1 unfoldase; ATPase; intrinsically disordered region; Hsp20; proteolysis; protein degradation; tuberculosis; heat shock protein (HSP)	CHAPERONE; PROTEASE; DEGRADATION; BINDING	The human pathogenMycobacterium tuberculosis(Mtb) harbors a well-orchestrated Clp (caseinolytic protease) proteolytic machinery consisting of two oligomeric segments, a barrel-shaped heterotetradecameric protease core comprising the ClpP1 and ClpP2 subunits, and hexameric ring-like ATP-dependent unfoldases composed of ClpX or ClpC1. The roles of the ClpP1P2 protease subunits are well-established in Mtb, but the potential roles of the associated unfoldases, such as ClpC1, remain elusive. Using a CRISPR interference?mediated gene silencing approach, here we demonstrate thatclpC1is indispensable for the extracellular growth of Mtb and for its survival in macrophages. The results from isobaric tags for relative and absolute quantitation?based quantitative proteomic experiments withclpC1- andclpP2-depleted Mtb cells suggested that the ClpC1P1P2 complex critically maintains the homeostasis of various growth-essential proteins in Mtb, several of which contain intrinsically disordered regions at their termini. We show that the Clp machinery regulates dosage-sensitive proteins such as the small heat shock protein Hsp20, which exists in a dodecameric conformation. Further, we observed that Hsp20 is poorly expressed in WT Mtb and that its expression is greatly induced upon depletion ofclpC1orclpP2. Remarkably, high Hsp20 protein levels were detected in theclpC1(?)orclpP2(?)knockdown strains but not in the parental bacteria, despite significant induction ofhsp20transcripts. In summary, the cellular levels of oligomeric proteins such as Hsp20 are maintained post-translationally through their recognition, disassembly, and degradation by ClpC1, which requires disordered ends in its protein substrates.	[Lunge, Ajitesh; Choudhary, Eira; Agarwal, Nisheeth] Natl Capital Reg Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, Faridabad, India; [Lunge, Ajitesh] Jawaharlal Nehru Univ, New Delhi, India; [Gupta, Radhika] Univ Delhi, Daulat Ram Coll, Delhi, India; [Gupta, Radhika] Inst Genom & Integrat Biol, New Delhi, India; [Choudhary, Eira] Symbiosis Int Deemed Univ, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); Jawaharlal Nehru University, New Delhi; University of Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Symbiosis International University	Agarwal, N (corresponding author), Natl Capital Reg Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, Faridabad, India.	nisheeth@thsti.res.in		Agarwal, Nisheeth/0000-0001-9203-3026; Gupta, Radhika/0000-0002-0445-0194	Department of Biotechnology, Government of India [BT/PR19140/MED/29/1104/2016, BT/PR25690/GET/119/142/2017]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Grants BT/PR19140/MED/29/1104/2016 (to A. L. and N. A.) and BT/PR25690/GET/119/142/2017 (to N. A.) from the Department of Biotechnology, Government of India.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ahmad J, 2020, FEBS OPEN BIO, V10, P70, DOI 10.1002/2211-5463.12749; Alhuwaider AAH, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00049; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Bhandari S, 2019, PROTEINS, V87, P365, DOI 10.1002/prot.25657; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Danelishvili L, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00430-17; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Faizullin D A, 2013, Bioorg Khim, V39, P411; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Ghazaei C, 2018, J MED MICROBIOL, V67, P1203, DOI 10.1099/jmm.0.000811; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hoskins JR, 2006, P NATL ACAD SCI USA, V103, P909, DOI 10.1073/pnas.0509154103; Hoskins JR, 1998, P NATL ACAD SCI USA, V95, P12135, DOI 10.1073/pnas.95.21.12135; Kennaway CK, 2005, J BIOL CHEM, V280, P33419, DOI 10.1074/jbc.M504263200; Leodolter J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125345; Lupoli TJ, 2018, ACS INFECT DIS, V4, P478, DOI 10.1021/acsinfecdis.7b00231; Lupoli TJ, 2016, P NATL ACAD SCI USA, V113, pE7947, DOI 10.1073/pnas.1617644113; Marsee JD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113651; Pang XH, 2007, J BACTERIOL, V189, P6213, DOI 10.1128/JB.00492-07; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Raju RM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003994; Rizo AN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10150-y; Santra M, 2017, P NATL ACAD SCI USA, V114, pE2654, DOI 10.1073/pnas.1620646114; Schmitz KR, 2014, MOL MICROBIOL, V93, P617, DOI 10.1111/mmi.12694; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Thakur P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35475-4; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky Vladimir N, 2013, Intrinsically Disord Proteins, V1, pe24684, DOI 10.4161/idp.24684; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Vavouri T, 2009, CELL, V138, P198, DOI 10.1016/j.cell.2009.04.029	42	9	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9455	9473		10.1074/jbc.RA120.013456	http://dx.doi.org/10.1074/jbc.RA120.013456			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409584	Green Published, hybrid			2022-12-28	WOS:000552758600016
J	Chen, X; Gao, YQ; Zheng, YY; Wang, W; Wang, P; Liang, J; Zhao, W; Tao, T; Sun, J; Wei, LS; Li, YQ; Zhou, YW; Gan, ZJ; Zhang, XN; Chen, HQ; Zhu, MS				Chen, Xin; Gao, Yun-Qian; Zheng, Yan-Yan; Wang, Wei; Wang, Pei; Liang, Juan; Zhao, Wei; Tao, Tao; Sun, Jie; Wei, Lisha; Li, Yeqiong; Zhou, Yuwei; Gan, Zhenji; Zhang, Xuena; Chen, Hua-Qun; Zhu, Min-Sheng			The intragenic microRNA miR199A1 in the dynamin 2 gene contributes to the pathology of X-linked centronuclear myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						skeletal muscle; microRNA (miRNA); muscle physiology; cell differentiation; STAT3; dynamin 2 (Dnm2); epigenetic regulation; miR-199a-1; myotubularin 1 (Mtm1); X-linked centronuclear myopathy (XLCNM)	SKELETAL-MUSCLE; CONGENITAL MYOPATHIES; AMPHIPHYSIN-2 BIN1; PROLONGS SURVIVAL; MUTATIONS; MYOTUBULARIN; INHIBITION; EXPRESSION; IDENTIFICATION; PROLIFERATION	Mutations in the myotubularin 1 (MTM1) gene can cause the fatal disease X-linked centronuclear myopathy (XLCNM), but the underlying mechanism is incompletely understood. In this report, using anMtm1(?/y)disease model, we found that expression of the intragenic microRNA miR-199a-1 is up-regulated along with that of its host gene, dynamin 2 (Dnm2), in XLCNM skeletal muscle. To assess the role of miR-199a-1 in XLCNM, we crossedmiR-199a-1(?/?)withMtm1(?/y)mice and found that the resultantmiR-199a-1-Mtm1double-knockout mice display markers of improved health, as evidenced by lifespans prolonged by 30% and improved muscle strength and histology. Mechanistic analyses showed that miR-199a-1 directly targets nonmuscle myosin IIA (NM IIA) expression and, hence, inhibits muscle postnatal development as well as muscle maturation. Further analysis revealed that increased expression and phosphorylation of signal transducer and activator of transcription 3 (STAT3) up-regulatesDnm2/miR-199a-1expression in XLCNM muscle. Our results suggest that miR-199a-1 has a critical role in XLCNM pathology and imply that this microRNA could be targeted in therapies to manage XLCNM.	[Chen, Xin; Zheng, Yan-Yan; Wang, Wei; Wang, Pei; Liang, Juan; Zhao, Wei; Tao, Tao; Sun, Jie; Wei, Lisha; Li, Yeqiong; Zhou, Yuwei; Gan, Zhenji; Zhang, Xuena; Zhu, Min-Sheng] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Minist Educ MOE Key Lab Model Anim Dis Study, Nanjing, Peoples R China; [Chen, Xin; Zheng, Yan-Yan; Wang, Wei; Wang, Pei; Liang, Juan; Zhao, Wei; Tao, Tao; Sun, Jie; Wei, Lisha; Li, Yeqiong; Zhou, Yuwei; Gan, Zhenji; Zhang, Xuena; Zhu, Min-Sheng] Nanjing Univ, Sch Med, Nanjing, Peoples R China; [Gao, Yun-Qian] Fudan Univ, Obstet & Gynecol Hosp, State Key Lab Genet Engn, Sch Life Sci, Shanghai, Peoples R China; [Gao, Yun-Qian] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Sch Life Sci, Shanghai, Peoples R China; [Gao, Yun-Qian] Fudan Univ, Inst BioMed Sci, Shanghai Med Coll, Shanghai, Peoples R China; [Chen, Hua-Qun] Nanjing Normal Univ, Coll Life Sci, Nanjing, Peoples R China	Nanjing University; Nanjing University; Fudan University; Fudan University; Fudan University; Nanjing Normal University	Zhang, XN; Zhu, MS (corresponding author), Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Minist Educ MOE Key Lab Model Anim Dis Study, Nanjing, Peoples R China.; Zhang, XN; Zhu, MS (corresponding author), Nanjing Univ, Sch Med, Nanjing, Peoples R China.; Chen, HQ (corresponding author), Nanjing Normal Univ, Coll Life Sci, Nanjing, Peoples R China.	zhums@nju.edu.cn; chenhuaqun@njnu.edu.cn; zhangxn@nicemice.cn		Chen, Xin/0000-0003-3304-8943; Gao, Yun-Qian/0000-0003-1229-3130; Gan, Zhenji/0000-0001-5940-207X	National Natural Science Foundation of China [31330034, 31671548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China Grants 31330034 and 31671548.	Alexander MS, 2013, CELL DEATH DIFFER, V20, P1194, DOI 10.1038/cdd.2013.62; Amburgey K, 2017, NEUROLOGY, V89, P1355, DOI 10.1212/WNL.0000000000004415; Bachmann C, 2017, HUM MOL GENET, V26, P320, DOI 10.1093/hmg/ddw388; Biancalana V, 2012, EUR J HUM GENET, V20, DOI 10.1038/ejhg.2012.91; Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399; Buj-Bello A, 2008, HUM MOL GENET, V17, P2132, DOI 10.1093/hmg/ddn112; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Childers MK, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007523; Chin YH, 2015, HUM MOL GENET, V24, P5542, DOI 10.1093/hmg/ddv285; Cowling BS, 2017, J CLIN INVEST, V127, P4477, DOI 10.1172/JCI90542; Cowling BS, 2014, J CLIN INVEST, V124, P1350, DOI 10.1172/JCI71206; Cowling BS, 2012, PLOS GENET, V8, P31, DOI 10.1371/journal.pgen.1002595; Cowling BS, 2011, AM J PATHOL, V178, P2224, DOI 10.1016/j.ajpath.2011.01.054; Durieux AC, 2010, HUM MOL GENET, V19, P4820, DOI 10.1093/hmg/ddq413; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Joshi HP, 2014, P NATL ACAD SCI USA, V111, P5331, DOI 10.1073/pnas.1317242111; Jungbluth H, 2018, NAT REV NEUROL, V14, P151, DOI 10.1038/nrneurol.2017.191; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Ketel K, 2016, NATURE, V529, P408, DOI 10.1038/nature16516; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kutchukian C, 2017, J PHYSIOL-LONDON, V595, P7369, DOI 10.1113/JP274990; Kutchukian C, 2016, P NATL ACAD SCI USA, V113, P14432, DOI 10.1073/pnas.1604099113; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Sabha N, 2016, J CLIN INVEST, V126, P3613, DOI 10.1172/JCI86841; Sanger JW, 2017, HANDB EXP PHARMACOL, V235, P39, DOI 10.1007/164_2016_53; Sekine T, 2010, KIDNEY INT, V78, P207, DOI 10.1038/ki.2010.21; Shin JY, 2017, HUM MOL GENET, V26, P65, DOI 10.1093/hmg/ddw368; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Tasfaout Hichem, 2018, J Neuromuscul Dis, V5, P387, DOI 10.3233/JND-180309; Tasfaout H, 2018, MOL THER, V26, P1082, DOI 10.1016/j.ymthe.2018.02.008; Tasfaout H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15661; Tay Y, 2014, CELL REP, V8, P714, DOI 10.1016/j.celrep.2014.06.064; Verver EJJ, 2016, EAR HEARING, V37, P112, DOI 10.1097/AUD.0000000000000198; Wang L, 2010, J BIOL CHEM, V285, P22751, DOI 10.1074/jbc.C110.130013; Warnock DE, 1997, MOL BIOL CELL, V8, P2553, DOI 10.1091/mbc.8.12.2553; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119	48	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8656	8667		10.1074/jbc.RA119.010839	http://dx.doi.org/10.1074/jbc.RA119.010839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32354746	Green Published, hybrid			2022-12-28	WOS:000546296800003
J	Metcalfe, RD; Aizel, K; Zlatic, CO; Nguyen, PM; Morton, CJ; Lio, DSS; Cheng, HC; Dobson, RCJ; Parker, MW; Gooley, PR; Putoczki, TL; Griffin, MDW				Metcalfe, Riley D.; Aizel, Kaheina; Zlatic, Courtney O.; Nguyen, Paul M.; Morton, Craig J.; Lio, Daisy Sio-Seng; Cheng, Heung-Chin; Dobson, Renwick C. J.; Parker, Michael W.; Gooley, Paul R.; Putoczki, Tracy L.; Griffin, Michael D. W.			The structure of the extracellular domains of human interleukin 11? receptor reveals mechanisms of cytokine engagement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; receptor structure-function; interleukin; signaling; structural biology; inflammation; cancer; fibrosis; gp130; IL6 family cytokine	BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; MOLECULAR-CLONING; BINDING SITES; IDENTIFICATION; DYNAMICS; GP130; CRANIOSYNOSTOSIS; INTEGRATION; RECOGNITION	Interleukin (IL) 11 activates multiple intracellular signaling pathways by forming a complex with its cell surface ?-receptor, IL-11R?, and the ?-subunit receptor, gp130. Dysregulated IL-11 signaling has been implicated in several diseases, including some cancers and fibrosis. Mutations in IL-11R? that reduce signaling are also associated with hereditary cranial malformations. Here we present the first crystal structure of the extracellular domains of human IL-11R? and a structure of human IL-11 that reveals previously unresolved detail. Disease-associated mutations in IL-11R? are generally distal to putative ligand-binding sites. Molecular dynamics simulations showed that specific mutations destabilize IL-11R? and may have indirect effects on the cytokine-binding region. We show that IL-11 and IL-11R? form a 1:1 complex with nanomolar affinity and present a model of the complex. Our results suggest that the thermodynamic and structural mechanisms of complex formation between IL-11 and IL-11R? differ substantially from those previously reported for similar cytokines. This work reveals key determinants of the engagement of IL-11 by IL-11R? that may be exploited in the development of strategies to modulate formation of the IL-11?IL-11R? complex.	[Metcalfe, Riley D.; Aizel, Kaheina; Zlatic, Courtney O.; Morton, Craig J.; Lio, Daisy Sio-Seng; Cheng, Heung-Chin; Dobson, Renwick C. J.; Parker, Michael W.; Gooley, Paul R.; Griffin, Michael D. W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia; [Putoczki, Tracy L.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Putoczki, Tracy L.] Univ Melbourne, Dept Surg, Parkville, Vic, Australia; [Aizel, Kaheina; Nguyen, Paul M.; Putoczki, Tracy L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic, Australia; [Nguyen, Paul M.; Putoczki, Tracy L.] Walter & Eliza Hall Inst Med Res, Personalised Oncol Div, Parkville, Vic, Australia; [Lio, Daisy Sio-Seng] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic, Australia; [Dobson, Renwick C. J.] Univ Canterbury, Biomol Interact Ctr, Christchurch, New Zealand; [Dobson, Renwick C. J.] Univ Canterbury, Sch Biol Sci, Christchurch, New Zealand; [Parker, Michael W.] Australian Canc Res Fdn, St Vincents Inst Med Res, Rat Drug Discovery Ctr, Fitzroy, Vic, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of Canterbury; University of Canterbury; St. Vincent's Institute of Medical Research	Griffin, MDW (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia.	mgriffin@unimelb.edu.au	Parker, Michael W/F-9069-2013; Morton, Craig/GON-8638-2022; Dobson, Renwick/AAZ-7020-2021	Parker, Michael W/0000-0002-3101-1138; Morton, Craig/0000-0001-5452-5193; Dobson, Renwick/0000-0002-5506-4939; Gooley, Paul/0000-0002-0323-449X; Nguyen, Paul/0000-0003-1490-5401; Cheng, Heung-Chin/0000-0002-4965-7148; Metcalfe, Riley/0000-0002-7154-780X	National Health & Medical Research Council of Australia [APP1147621, APP1080498]; Australian Research Council [FT140100544]; Victorian Cancer Agency Fellowship [MCRF16009]; Victorian Government Operational Infrastructure Support Scheme [UOC1506]; New Zealand Royal Society Marsden Fund; National Health & Medical Research Council of Australia Research Fellowship [APP1117183]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Cancer Agency Fellowship; Victorian Government Operational Infrastructure Support Scheme; New Zealand Royal Society Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); National Health & Medical Research Council of Australia Research Fellowship	This work was supported by National Health & Medical Research Council of Australia Grants APP1147621 and APP1080498), Australian Research Council Future Fellowship Project FT140100544 (to M. D. W. G), Victorian Cancer Agency Fellowship MCRF16009 (to T. L. P.), National Health & Medical Research Council of Australia Research Fellowship APP1117183 (to M. W. P.), and Contract UOC1506 from the Victorian Government Operational Infrastructure Support Scheme to St. Vincent's Institute and the New Zealand Royal Society Marsden Fund (to R. C. J. D.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agthe M, 2018, CELL REP, V25, P10, DOI 10.1016/j.celrep.2018.09.005; Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Barton VA, 1999, J BIOL CHEM, V274, P5755, DOI 10.1074/jbc.274.9.5755; Barton VA, 2000, J BIOL CHEM, V275, P36197, DOI 10.1074/jbc.M004648200; Bobby R, 2014, FEBS J, V281, P2471, DOI 10.1111/febs.12800; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boulanger MJ, 2004, ADV PROTEIN CHEM, V68, P107; Boulanger MJ, 2003, MOL CELL, V12, P577, DOI 10.1016/S1097-2765(03)00365-4; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; Brischoux-Boucher E, 2018, CLIN GENET, V94, P373, DOI 10.1111/cge.13409; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Czupryn M, 1995, ANN NY ACAD SCI, V762, P152; Dagil R, 2012, STRUCTURE, V20, P270, DOI 10.1016/j.str.2011.12.010; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Giese B, 2005, J CELL SCI, V118, P5129, DOI 10.1242/jcs.02628; GOMEZ J, 1995, J MOL BIOL, V252, P337, DOI 10.1006/jmbi.1995.0501; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jung Y, 2011, BIOCHEM BIOPH RES CO, V405, P399, DOI 10.1016/j.bbrc.2011.01.041; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Keupp K, 2013, MOL GENET GENOM MED, V1, P223, DOI 10.1002/mgg3.28; Kirby N, 2016, ACTA CRYSTALLOGR D, V72, P1254, DOI 10.1107/S2059798316017174; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Lee CG, 2008, AM J RESP CELL MOL, V39, P739, DOI 10.1165/rcmb.2008-0053OC; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Luft JR, 1999, ACTA CRYSTALLOGR D, V55, P988, DOI 10.1107/S0907444999002085; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Matadeen R, 2007, STRUCTURE, V15, P441, DOI 10.1016/j.str.2007.02.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Morris R, 2018, PROTEIN SCI, V27, P1984, DOI 10.1002/pro.3519; MURPHY KP, 1993, PROTEINS, V15, P113, DOI 10.1002/prot.340150203; MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2; Nieminen P, 2011, AM J HUM GENET, V89, P67, DOI 10.1016/j.ajhg.2011.05.024; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Panjkovich A, 2018, BIOINFORMATICS, V34, P1944, DOI 10.1093/bioinformatics/btx846; PAUL SR, 1990, P NATL ACAD SCI USA, V87, P7512, DOI 10.1073/pnas.87.19.7512; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Putoczki TL, 2014, ACTA CRYSTALLOGR D, V70, P2277, DOI 10.1107/S1399004714012267; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Rickert M, 2004, J MOL BIOL, V339, P1115, DOI 10.1016/j.jmb.2004.04.038; Ryan TM, 2018, J APPL CRYSTALLOGR, V51, P97, DOI 10.1107/S1600576717017101; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Schleinkofer K, 2001, J MOL BIOL, V306, P263, DOI 10.1006/jmbi.2000.4387; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott DJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18045-y; Seabrook SA, 2013, ACS COMB SCI, V15, P387, DOI 10.1021/co400013v; Skiniotis G, 2008, MOL CELL, V31, P737, DOI 10.1016/j.molcel.2008.08.011; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tacken I, 1999, EUR J BIOCHEM, V265, P645, DOI 10.1046/j.1432-1327.1999.00755.x; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Varghese JN, 2002, P NATL ACAD SCI USA, V99, P15959, DOI 10.1073/pnas.232432399; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vollmer P, 1999, EUR J BIOCHEM, V263, P438, DOI 10.1046/j.1432-1327.1999.00511.x; Wang XM, 2002, EUR J BIOCHEM, V269, P61, DOI 10.1046/j.0014-2956.2002.02622.x; Widjaja AA, 2019, GASTROENTEROLOGY, V157, P777, DOI 10.1053/j.gastro.2019.05.002; Yao SG, 2000, PROTEIN SCI, V9, P671; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhao HY, 2015, ACTA CRYSTALLOGR D, V71, P3, DOI 10.1107/S1399004714010372; Zhao HY, 2014, ANAL CHEM, V86, P3181, DOI 10.1021/ac500093m; Zhao HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083439	79	9	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8285	8301		10.1074/jbc.RA119.012351	http://dx.doi.org/10.1074/jbc.RA119.012351			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32332100	hybrid, Green Published			2022-12-28	WOS:000542965700016
J	Morishita, Y; Kabil, O; Young, KZ; Kellogg, AP; Chang, A; Arvan, P				Morishita, Yoshiaki; Kabil, Omer; Young, Kelly Z.; Kellogg, Aaron P.; Chang, Amy; Arvan, Peter			Thyrocyte cell survival and adaptation to chronic endoplasmic reticulum stress due to misfolded thyroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thyroid; glycoprotein; ER quality control; proteomics; secretion; ER stress; hypothyroidism; protein misfolding; thyroglobulin; tunicamycin; secretory pathway	UNFOLDED PROTEIN RESPONSE; ER-STRESS; CONGENITAL GOITER; STORAGE DISEASE; GENE-EXPRESSION; TRANSLATION; DISORDERS; COG/COG; MFSD2A; DOMAIN	The large secretory glycoprotein thyroglobulin is the primary translation product of thyroid follicular cells. This difficult-to-fold protein is susceptible to structural alterations that disable export of the misfolded thyroglobulin from the endoplasmic reticulum (ER), which is a known cause of congenital hypothyroidism characterized by severe chronic thyrocyte ER stress. Nevertheless, individuals with this disease commonly grow a goiter, indicating thyroid cell survival and adaptation. To model these processes, here we continuously exposed rat PCCL3 thyrocytes to tunicamycin, which causes a significant degree of ER stress that is specifically attributable to thyroglobulin misfolding. We found that, in response, PCCL3 cells down-regulate expression of the ?tunicamycin transporter? (major facilitator superfamily domain containing-2A, Mfsd2a). Following CRISPR/Cas9-mediated Mfsd2a deletion, PCCL3 cells could no longer escape the chronic effects of high-dose tunicamycin, as demonstrated by persistent accumulation of unglycosylated thyroglobulin; nevertheless, these thyrocytes survived and grew. A proteomic analysis of these cells adapted to chronic ER protein misfolding revealed many hundreds of up-regulated proteins, indicating stimulation of ER chaperones, oxidoreductases, stress responses, and lipid biosynthesis pathways. Further, we noted increased phospho?AMP-kinase, suggesting up-regulated AMP-kinase activity, and decreased phospho?S6-kinase and protein translation, suggesting decreased mTOR activity. These changes are consistent with conserved cell survival/adaptation pathways. We also observed a less-differentiated thyrocyte phenotype with decreased PAX8, FOXE1, and TPO protein levels, along with decreased thyroglobulin mRNA levels. In summary, we have developed a model of thyrocyte survival and growth during chronic continuous ER stress that recapitulates features of congenital hypothyroid goiter caused by mutant thyroglobulin.	[Morishita, Yoshiaki; Kabil, Omer; Young, Kelly Z.; Kellogg, Aaron P.; Arvan, Peter] Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, 1500 E Med Ctr Dr, Ann Arbor, MI 48105 USA; [Morishita, Yoshiaki] Aichi Med Univ, Div Diabet, Dept Internal Med, Nagakute, Aichi 4801195, Japan; [Chang, Amy] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Aichi Medical University; University of Michigan System; University of Michigan	Arvan, P (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, 1500 E Med Ctr Dr, Ann Arbor, MI 48105 USA.	parvan@umich.edu	Morishita, Yoshiaki/AAX-6552-2021; Morishita, Yoshiaki/GWQ-6726-2022; Arvan, Peter/G-1759-2015	Morishita, Yoshiaki/0000-0003-4733-7981; Arvan, Peter/0000-0002-4007-8799; Young, Kelly/0000-0002-6714-7563	NIDDK, National Institutes of Health [R01 DK40344]; NIGMS, National Institutes of Health MSTP [T32 GM007863]; NIA, National Institutes of Health [R21 AG058862]; University of Michigan Protein Folding Diseases Initiative	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS, National Institutes of Health MSTP; NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Michigan Protein Folding Diseases Initiative	This work was supported by NIDDK, National Institutes of Health Grant R01 DK40344 (to P. A.); NIGMS, National Institutes of Health MSTP training Grant T32 GM007863 (to K. Z. Y.); and NIA, National Institutes of Health Grant R21 AG058862 (to A. C.). This work was also supported by the University of Michigan Protein Folding Diseases Initiative (to A. C. and P. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADKISON LR, 1990, J ENDOCRINOL, V126, P51, DOI 10.1677/joe.0.1260051; Balboa D, 2018, ELIFE, V7, DOI 10.7554/eLife.38519; Citterio CE, 2019, NAT REV ENDOCRINOL, V15, P323, DOI 10.1038/s41574-019-0184-8; Citterio CE, 2018, J BIOL CHEM, V293, P4860, DOI 10.1074/jbc.RA118.001786; Cunningham CN, 2019, MOL CELL, V75, P442, DOI 10.1016/j.molcel.2019.05.011; Di Jeso B, 2003, BIOCHEM J, V370, P449, DOI 10.1042/BJ20021257; Di Jeso B, 2016, ENDOCR REV, V37, P2, DOI 10.1210/er.2015-1090; Fregonese L, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-16; Ghosh R, 2019, MOL METAB, V27, pS60, DOI 10.1016/j.molmet.2019.06.012; Han J, 2017, GENE DEV, V31, P1417, DOI 10.1101/gad.297374.117; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hishinuma Akira, 2005, Rinsho Byori, V53, P935; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Kim PS, 1998, ENDOCR REV, V19, P173, DOI 10.1210/er.19.2.173; Knupp J, 2019, CELL DEATH DIFFER, V26, P487, DOI 10.1038/s41418-018-0133-4; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; MEDEIROSNETO G, 1993, ENDOCR REV, V14, P165, DOI 10.1210/er.14.2.165; MedeirosNeto G, 1996, J CLIN INVEST, V98, P2838, DOI 10.1172/JCI119112; Morishita Y, 2020, MOL CELL ENDOCRINOL, V499, DOI 10.1016/j.mce.2019.110613; Moritake H, 2017, HUM CELL, V30, P88, DOI 10.1007/s13577-016-0153-7; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Peters C, 2018, EUR J ENDOCRINOL, V179, pR297, DOI 10.1530/EJE-18-0383; Reiling JH, 2011, P NATL ACAD SCI USA, V108, P11756, DOI 10.1073/pnas.1018098108; Riahi Y, 2018, ELIFE, V7, DOI 10.7554/eLife.38472; Ryoo HD, 2016, FEBS J, V283, P3718, DOI 10.1111/febs.13755; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sharma RB, 2015, J CLIN INVEST, V125, P3831, DOI 10.1172/JCI79264; Shimura H, 2001, CANCER RES, V61, P3640; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Szabat M, 2016, CELL METAB, V23, P179, DOI 10.1016/j.cmet.2015.10.016; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tanjore H, 2011, J BIOL CHEM, V286, P30972, DOI 10.1074/jbc.M110.181164; Targovnik HM, 2020, MOL CELL ENDOCRINOL, V501, DOI 10.1016/j.mce.2019.110638; Tsang KY, 2010, J CELL SCI, V123, P2145, DOI 10.1242/jcs.068833; VANHERLE AJ, 1979, NEW ENGL J MED, V301, P239, DOI 10.1056/NEJM197908023010504; Wen GP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187561; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	44	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6876	6887		10.1074/jbc.RA120.012656	http://dx.doi.org/10.1074/jbc.RA120.012656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32241916	hybrid, Green Published			2022-12-28	WOS:000536212600009
J	Jmaeff, S; Sidorova, Y; Nedev, H; Saarma, M; Saragovi, HU				Jmaeff, Sean; Sidorova, Yulia; Nedev, Hinyu; Saarma, Mart; Saragovi, H. Uri			Small-molecule agonists of the RET receptor tyrosine kinase activate biased trophic signals that are influenced by the presence of GFRa1 co-receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						receptor tyrosine kinase; signal transduction; small molecule; ligand-binding protein; retinal degeneration; structure?function; biased agonist; naphthoquinone; neuroprotection; RET receptor; retinitis pigmentosa	NEUROTROPHIC FACTOR; NEURONAL SURVIVAL; GDNF; GFR-ALPHA-1; EXPRESSION; RHODOPSIN; MECHANISM; BINDING; MICE	Glial cell line?derived neurotrophic factor (GDNF) is a growth factor that regulates the health and function of neurons and other cells. GDNF binds to GDNF family receptor ?1 (GFRa1), and the resulting complex activates the RET receptor tyrosine kinase and subsequent downstream signals. This feature restricts GDNF activity to systems in which GFRa1 and RET are both present, a scenario that may constrain GDNF breadth of action. Furthermore, this co-dependence precludes the use of GDNF as a tool to study a putative functional cross-talk between GFRa1 and RET. Here, using biochemical techniques, terminal deoxynucleotidyl transferase dUTP nick end labeling staining, and immunohistochemistry in murine cells, tissues, or retinal organotypic cultures, we report that a naphthoquinone/quinolinedione family of small molecules (Q compounds) acts as RET agonists. We found that, like GDNF, signaling through the parental compound Q121 is GFRa1-dependent. Structural modifications of Q121 generated analogs that activated RET irrespective of GFRa1 expression. We used these analogs to examine RET?GFRa1 interactions and show that GFRa1 can influence RET-mediated signaling and enhance or diminish AKT Ser/Thr kinase or extracellular signal-regulated kinase signaling in a biased manner. In a genetic mutant model of retinitis pigmentosa, a lead compound, Q525, afforded sustained RET activation and prevented photoreceptor neuron loss in the retina. This work uncovers key components of the dynamic relationships between RET and its GFRa co-receptor and provides RET agonist scaffolds for drug development.	[Jmaeff, Sean; Nedev, Hinyu; Saragovi, H. Uri] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Jmaeff, Sean; Saragovi, H. Uri] McGill Univ, Dept Pharmacol, Montreal, PQ H3T 1E2, Canada; [Saragovi, H. Uri] McGill Univ, Dept Ophthalmol & Visual Sci, Montreal, PQ H3T 1E2, Canada; [Sidorova, Yulia; Saarma, Mart] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland	Lady Davis Institute; McGill University; McGill University; McGill University; University of Helsinki	Saragovi, HU (corresponding author), Jewish Gen Hosp, Lady Davis Inst, 3755 Cote St Catherine,E-535, Montreal, PQ H3T 1E2, Canada.	uri.saragovi@mcgill.ca		Sidorova, Yulia/0000-0001-8230-0530	Canada Institutes of Health Research; Canadian Consortium on Neurodegeneration and Aging; Optic Nerve Trauma Grant from the U.S. Department of Defense [W81XWH1910853]	Canada Institutes of Health Research; Canadian Consortium on Neurodegeneration and Aging; Optic Nerve Trauma Grant from the U.S. Department of Defense(United States Department of Defense)	DThis work was supported by grants from the Canada Institutes of Health Research and the Canadian Consortium on Neurodegeneration and Aging and by Optic Nerve Trauma Grant W81XWH1910853 from the U.S. Department of Defense (to H. U. S.). Patents have been filed by McGill University on behalf of the authors, covering agents reported in this work.	Afzal O, 2015, EUR J MED CHEM, V97, P871, DOI 10.1016/j.ejmech.2014.07.044; Baranov P, 2017, J OCUL PHARMACOL TH, V33, P412, DOI 10.1089/jop.2016.0121; Barcelona PF, 2016, J NEUROSCI, V36, P8826, DOI 10.1523/JNEUROSCI.4278-15.2016; Bolton JL, 2017, CHEM RES TOXICOL, V30, P13, DOI 10.1021/acs.chemrestox.6b00256; Eketjall S, 1999, EMBO J, V18, P5901, DOI 10.1093/emboj/18.21.5901; Fleming MS, 2015, ELIFE, V4, DOI 10.7554/eLife.06828; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; Galan A, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0074-8; Garcia-Caballero C, 2018, MOL VIS, V24, P733; Hedstrom KL, 2014, P NATL ACAD SCI USA, V111, P2325, DOI 10.1073/pnas.1308889111; Ibanez CF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009134; Ivanisevic L, 2003, ONCOGENE, V22, P5677, DOI 10.1038/sj.onc.1206864; Jomary C, 2004, INVEST OPHTH VIS SCI, V45, P1240, DOI 10.1167/iovs.03-1122; Josephy-Hernandez S, 2017, NEUROBIOL DIS, V97, P139, DOI 10.1016/j.nbd.2016.08.004; Klotz LO, 2014, MOLECULES, V19, P14902, DOI 10.3390/molecules190914902; Leppanen VM, 2004, EMBO J, V23, P1452, DOI 10.1038/sj.emboj.7600174; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Mikaels-Edman A, 2003, DEV DYNAM, V227, P27, DOI 10.1002/dvdy.10280; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Perron MD, 2014, MOL PHARMACOL, V85, P553, DOI 10.1124/mol.113.089847; Platon-Corchado M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.306; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Robinett RG, 2007, BIOORG MED CHEM LETT, V17, P5886, DOI 10.1016/j.bmcl.2007.07.104; Sanicola M, 1997, P NATL ACAD SCI USA, V94, P6238, DOI 10.1073/pnas.94.12.6238; Schmidt F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006215; Sidorova YA, 2010, MOL CELL NEUROSCI, V44, P223, DOI 10.1016/j.mcn.2010.03.009; Touchard E, 2012, GENE THER, V19, P886, DOI 10.1038/gt.2011.154; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Wang LN, 2014, NEUROCHEM RES, V39, P97, DOI 10.1007/s11064-013-1194-x; Whalen EJ, 2011, TRENDS MOL MED, V17, P126, DOI 10.1016/j.molmed.2010.11.004; Widhalm JR, 2016, HORTIC RES-ENGLAND, V3, DOI 10.1038/hortres.2016.46; Yang JM, 2004, FEBS LETT, V569, P267, DOI 10.1016/j.febslet.2004.06.007; Yuan JH, 2017, J PHARM PHARMACOL, V69, P896, DOI 10.1111/jphp.12681; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200; Zhang JS, 2006, J NEUROBIOL, V66, P882, DOI 10.1002/neu.20269; Zhao PS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00067	38	8	9	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6532	6542		10.1074/jbc.RA119.011802	http://dx.doi.org/10.1074/jbc.RA119.011802			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32245892	Green Published, hybrid			2022-12-28	WOS:000537685000023
J	Santos, ARS; Gerhardt, ECM; Parize, E; Pedrosa, FO; Steffens, MBR; Chubatsu, LS; Souza, EM; Passaglia, LMP; Sant'Anna, FH; de Souza, GA; Huergo, LF; Forchhammer, K				Santos, Adrian Richard Schenberger; Gerhardt, Edileusa Cristina Marques; Parize, Erick; Pedrosa, Fabio Oliveira; Steffens, Maria Berenice Reynaud; Chubatsu, Leda Satie; Souza, Emanuel Maltempi; Passaglia, Luciane Maria Pereira; Sant'Anna, Fernando Hayashi; de Souza, Gustavo Antonio; Huergo, Luciano Fernandes; Forchhammer, Karl			NAD(+) biosynthesis in bacteria is controlled by global carbon/nitrogen levels via PII signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolic regulation; nicotinamide adenine dinucleotide (NAD); protein-protein interaction; allosteric regulation; bacterial metabolism; 2-oxoglutarate (2-OG); NadE; nutrient sensing; PII protein	IN-VITRO URIDYLYLATION; P-II; AZOSPIRILLUM-BRASILENSE; TRANSDUCTION PROTEINS; DINITROGENASE REDUCTASE; MEMBRANE SEQUESTRATION; NITROGEN ASSIMILATION; PIVOTAL PLAYERS; 2-OXOGLUTARATE; BINDING	NAD(+) is a central metabolite participating in core metabolic redox reactions. The prokaryotic NAD synthetase enzyme NadE catalyzes the last step of NAD(+) biosynthesis, converting nicotinic acid adenine dinucleotide (NaAD) to NAD(+). Some members of the NadE family use l-glutamine as a nitrogen donor and are named NadE(Gln). Previous gene neighborhood analysis has indicated that the bacterial nadE gene is frequently clustered with the gene encoding the regulatory signal transduction protein PII, suggesting a functional relationship between these proteins in response to the nutritional status and the carbon/nitrogen ratio of the bacterial cell. Here, using affinity chromatography, bioinformatics analyses, NAD synthetase activity, and biolayer interferometry assays, we show that PII and NadE(Gln) physically interact in vitro, that this complex relieves NadE(Gln) negative feedback inhibition by NAD(+). This mechanism is conserved in distantly related bacteria. Of note, the PII protein allosteric effector and cellular nitrogen level indicator 2-oxoglutarate (2-OG) inhibited the formation of the PII-NadE(Gln) complex within a physiological range. These results indicate an interplay between the levels of ATP, ADP, 2-OG, PII-sensed glutamine, and NAD(+), representing a metabolic hub that may balance the levels of core nitrogen and carbon metabolites. Our findings support the notion that PII proteins act as a dissociable regulatory subunit of NadE(Gln), thereby enabling the control of NAD(+) biosynthesis according to the nutritional status of the bacterial cell.	[Santos, Adrian Richard Schenberger; Gerhardt, Edileusa Cristina Marques; Parize, Erick; Pedrosa, Fabio Oliveira; Steffens, Maria Berenice Reynaud; Chubatsu, Leda Satie; Souza, Emanuel Maltempi; Huergo, Luciano Fernandes] Univ Fed Parana UFPR, Dept Bioquim & Biol Mol, BR-81531980 Curitiba, Parana, Brazil; [Huergo, Luciano Fernandes] UFPR, Setor Litoral, BR-83260000 Matinhos, Parana, Brazil; [Santos, Adrian Richard Schenberger; Huergo, Luciano Fernandes; Forchhammer, Karl] Eberhard Karls Univ Tubingen, Interfak Inst Mikrobiol & Infekt Med, Morgenstelle 28, D-72076 Tubingen, Germany; [Passaglia, Luciane Maria Pereira; Sant'Anna, Fernando Hayashi] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, CP 15053, BR-91501970 Porto Alegre, RS, Brazil; [de Souza, Gustavo Antonio] Univ Fed Rio Grande do Norte, Dept Bioquim, BR-59072970 Natal, RN, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Eberhard Karls University of Tubingen; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Norte	Huergo, LF (corresponding author), Univ Fed Parana UFPR, Dept Bioquim & Biol Mol, BR-81531980 Curitiba, Parana, Brazil.; Huergo, LF (corresponding author), UFPR, Setor Litoral, BR-83260000 Matinhos, Parana, Brazil.; Huergo, LF; Forchhammer, K (corresponding author), Eberhard Karls Univ Tubingen, Interfak Inst Mikrobiol & Infekt Med, Morgenstelle 28, D-72076 Tubingen, Germany.	Luciano.huergo@gmail.com; karl.forchhammer@uni-tuebingen.de	; Hayashi Sant'Anna, Fernando/I-9129-2016; Souza, Emanuel/C-1920-2013	Chubatsu, Leda/0000-0002-8687-2816; Parize, Erick/0000-0002-3878-0810; Marques Gerhardt, Edileusa Cristina/0000-0001-7088-1681; Steffens, Maria Berenice Reynaud/0000-0002-7140-8455; PEDROSA, FABIO DE OLIVEIRA/0000-0003-3711-969X; Hayashi Sant'Anna, Fernando/0000-0001-7767-8168; Souza, Emanuel/0000-0003-1546-9218	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Deutsche Forschungsgemeinschaft [Fo195/9-2]; Alexander von Humboldt-Stiftung (AvH Foundation); Deutscher Akademischer Austauschdienst (DAAD); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt-Stiftung (AvH Foundation)(Alexander von Humboldt Foundation); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (to A. R. S. S., E. C. M. G., E. P., F. O. P., M. B. R. S., L. S. C., E. M. S., L. M. P. P., F. H. S., G. A. d. S., and L. F. H.), and by Deutsche Forschungsgemeinschaft Grant Fo195/9-2 (to A. R. S. S., L. F. H., and K. F.). This work was also supported by the Alexander von Humboldt-Stiftung (AvH Foundation) (to L. F. H. and K. F.), Deutscher Akademischer Austauschdienst (DAAD) (to A. R. S. S.), and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(to A. R. S. S., E. C. M. G., E. P., F. O. P., M. B. R. S., L. S. C.,E. M. S., L. M. P. P., F. H. S., G. A. d. S., and L. F. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Araujo LM, 2008, BRAZ J MED BIOL RES, V41, P289, DOI 10.1590/S0100-879X2008000400006; Araujo MS, 2004, PROTEIN EXPRES PURIF, V33, P19, DOI 10.1016/j.pep.2003.08.024; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Burckhardt RM, 2019, MOL MICROBIOL, V112, P588, DOI 10.1111/mmi.14276; Chellamuthu VR, 2014, CELL, V159, P1188, DOI 10.1016/j.cell.2014.10.015; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; da Rocha RA, 2013, BIOCHEMISTRY-US, V52, P2683, DOI 10.1021/bi301659r; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039115; de Zamaroczy M, 1998, MOL MICROBIOL, V29, P449, DOI 10.1046/j.1365-2958.1998.00938.x; Fokina O, 2010, P NATL ACAD SCI USA, V107, P19760, DOI 10.1073/pnas.1007653107; Forchhammer K, 2016, FEBS J, V283, P425, DOI 10.1111/febs.13584; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gerdes SY, 2006, J BACTERIOL, V188, P3012, DOI 10.1128/JB.188.8.3012-3023.2006; Gerhardt ECM, 2015, MOL MICROBIOL, V95, P1025, DOI 10.1111/mmi.12912; Gravina F, 2018, J PROTEOMICS, V174, P28, DOI 10.1016/j.jprot.2017.12.006; Grose JH, 2005, J BACTERIOL, V187, P2774, DOI 10.1128/JB.187.8.2774-2782.2005; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Huergo LF, 2006, MOL MICROBIOL, V59, P326, DOI 10.1111/j.1365-2958.2005.04944.x; Huergo LF, 2006, FEBS LETT, V580, P5232, DOI 10.1016/j.febslet.2006.08.054; Huergo LF, 2015, MICROBIOL MOL BIOL R, V79, P419, DOI 10.1128/MMBR.00038-15; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Huergo LF, 2012, MICROBIOL-SGM, V158, P176, DOI 10.1099/mic.0.049783-0; Jaschke A, 2016, CURR OPIN MICROBIOL, V30, P44, DOI 10.1016/j.mib.2015.12.009; Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t; Kurnasov O, 2003, CHEM BIOL, V10, P1195, DOI 10.1016/j.chembiol.2003.11.011; LaRonde-LeBlanc N, 2009, NAT STRUCT MOL BIOL, V16, P421, DOI 10.1038/nsmb.1567; Lawrence TJ, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00172; Lin H, 2007, ORG BIOMOL CHEM, V5, P2541, DOI 10.1039/b706887e; Merrick M, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00763; Moure VR, 2015, CURR TOP MICROBIOL, V384, P89, DOI 10.1007/82_2014_380; Moure VR, 2013, J BACTERIOL, V195, P279, DOI 10.1128/JB.01517-12; Moure VR, 2012, PROTEIN EXPRES PURIF, V81, P83, DOI 10.1016/j.pep.2011.09.008; Oliveira MAS, 2015, FEBS J, V282, P4797, DOI 10.1111/febs.13542; PEDROSA FO, 1984, FEMS MICROBIOL LETT, V23, P95, DOI 10.1016/0378-1097(84)90080-6; Rajendran C, 2011, P NATL ACAD SCI USA, V108, P18972, DOI 10.1073/pnas.1108038108; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Rodionova IA, 2014, MBIO, V5, DOI 10.1128/mBio.00747-13; Rodrigues TE, 2019, ARCH MICROBIOL, V201, P209, DOI 10.1007/s00203-018-1603-2; Sant'Anna F, 2009, J MOL EVOL, V68, P322, DOI 10.1007/s00239-009-9209-6; Santos ARS, 2018, J BIOL CHEM, V293, P7397, DOI 10.1074/jbc.RA118.002241; Shen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163962; Sorci L, 2014, DNA REPAIR, V23, P17, DOI 10.1016/j.dnarep.2014.07.014; Stromland O, 2019, BIOCHEM SOC T, V47, P119, DOI 10.1042/BST20180417; Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; van Heeswijk WC, 2013, MICROBIOL MOL BIOL R, V77, P628, DOI 10.1128/MMBR.00025-13; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097; Yuan J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.60; Zeth K, 2014, J BIOL CHEM, V289, P8960, DOI 10.1074/jbc.M113.536557; Zhang Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20550-7	55	8	8	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6165	6176		10.1074/jbc.RA120.012793	http://dx.doi.org/10.1074/jbc.RA120.012793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32179648	Green Published, hybrid			2022-12-28	WOS:000531417300025
J	Mardjuki, RE; Carozza, JA; Li, LY				Mardjuki, Rachel E.; Carozza, Jacqueline A.; Li, Lingyin			Development of cGAMP-Luc, a sensitive and precise coupled enzyme assay to measure cGAMP in complex biological samples	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic nucleotide; enzyme; mass spectrometry (MS); analytical chemistry; drug discovery; ATP; assay development; cancer; coupled-enzyme assay; extracellular cGAMP; STING; cyclic nucleotide	CYCLIC GMP-AMP; ATP REGENERATION; DNA SENSOR; PHOSPHOTRANSFERASE; MINERALIZATION; POLYPHOSPHATE; 2ND-MESSENGER; DINUCLEOTIDE; ADAPTER; ENPP1	2?,5?/3?,5?-cGMP-AMP (cGAMP) is a second messenger produced in response to cytosolic dsDNA that activates the stimulator of interferon genes (STING) pathway. We recently discovered that cGAMP is exported by cancer cells and that this extracellular signal is an immunotransmitter key to tumor detection and elimination by the innate immune system. The enhancement of extracellular cGAMP levels therefore holds great promise for managing cancer. However, there is still much more to understand about the basic biology of cGAMP before its full therapeutic potential can be realized. To answer these questions, we must be able to detect and quantitate cGAMP with an assay that is high-throughput, sensitive, and precise. Existing assays fall short of these needs. Here, we describe the development of cGAMP-Luc, a coupled enzyme assay that relies on the degradation of cGAMP to AMP by ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) and an optimized assay for the detection of AMP by luciferase. We also developed STING-CAP, a STING-mediated method to concentrate and purify cGAMP from any type of biological sample. We conclude that cGAMP-Luc is an economical high-throughput assay that matches the accuracy of and surpasses the detection limit of MS, the current gold standard of cGAMP quantitation. We propose that cGAMP-Luc is a powerful tool that may enable discoveries that advance insights into extracellular cGAMP levels in healthy and diseased tissues, such as cancer.	[Mardjuki, Rachel E.; Carozza, Jacqueline A.] Stanford Univ, Sch Med, Dept Chem, Stanford, CA 94306 USA; [Carozza, Jacqueline A.; Li, Lingyin] Stanford Univ, Sch Med, Stanford ChEM H, Stanford, CA 94306 USA; [Li, Lingyin] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94306 USA	Stanford University; Stanford University; Stanford University	Li, LY (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94306 USA.	lingyinl@stanford.edu		Li, Lingyin/0000-0003-4386-7926	National Science Foundation Graduate Research Fellowship Program [1656518]; National Institutes of Health [DP2CA228044]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation Graduate Research Fellowship Program Grant 1656518 (to R. E. M.) and National Institutes of Health Grant DP2CA228044 (to L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; [Anonymous], HDB STABILITY TESTIN; [Anonymous], GUIDANCE IND Q2B VAL; [Anonymous], REGARDING CGAMP UPTA; Apelbaum A, 2013, MOL CELL BIOL, V33, P800, DOI 10.1128/MCB.01430-12; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Bose D, 2016, CELL CHEM BIOL, V23, P1539, DOI 10.1016/j.chembiol.2016.10.014; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Carozza JA, 2020, NAT CANCER, V1, P184, DOI 10.1038/s43018-020-0028-4; Corrales L., 2013, J IMMUNOTHER CANC S1, V1, P015, DOI DOI 10.1186/2051-1426-1-S1-O15; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Eaglesham JB, 2019, NATURE, V566, P259, DOI 10.1038/s41586-019-0928-6; FDA, 2018, BIOAN METH VAL GUID; Gu HD, 2014, ANAL CHEM, V86, P8959, DOI 10.1021/ac5018265; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kameda A, 2001, J BIOSCI BIOENG, V91, P557, DOI 10.1263/jbb.91.557; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Kato K, 2012, ACTA CRYSTALLOGR F, V68, P778, DOI 10.1107/S1744309112019306; Li LY, 2014, NAT CHEM BIOL, V10, P1043, DOI [10.1038/NChemBio.1661, 10.1038/nchembio.1661]; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Muranaka LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072937; NODA L, 1957, J BIOL CHEM, V226, P541; Resnick SM, 2000, APPL ENVIRON MICROB, V66, P2045, DOI 10.1128/AEM.66.5.2045-2051.2000; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Shayhidin EE, 2015, BRIT J PHARMACOL, V172, P4189, DOI 10.1111/bph.13204; Shrivastava A., 2011, CHRONICLES YOUNG SCI, V2, P21, DOI [DOI 10.4103/2229-5186.79345, 10.4103/2229-5186.79345]; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	36	13	13	4	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4881	4892		10.1074/jbc.RA119.012170	http://dx.doi.org/10.1074/jbc.RA119.012170			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32127400	Green Published, hybrid			2022-12-28	WOS:000526887000012
J	Wen, YT; Yang, S; Wakabayashi, K; Svensson, MND; Stanford, SM; Santelli, E; Bottini, N				Wen, Yutao; Yang, Shen; Wakabayashi, Kuninobu; Svensson, Mattias N. D.; Stanford, Stephanie M.; Santelli, Eugenio; Bottini, Nunzio			RPTP? phosphatase activity is allosterically regulated by the membrane-distal catalytic domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein phosphatase; tyrosine-protein phosphatase (tyrosine phosphatase); protein structure; allosteric regulation; crystal structure; cell signaling; cancer; signal transduction; cancer	PROTEIN-TYROSINE-PHOSPHATASE; KINETIC-ANALYSIS; STRUCTURAL BASIS; PTP-ALPHA; INHIBITION; CD45; VISUALIZATION; MOTIONS; BINDS; SIGMA	Receptor-type protein tyrosine phosphatase ? (RPTP?) is an important positive regulator of SRC kinase activation and a known promoter of cancer growth, fibrosis, and arthritis. The domain structure of RPTPs comprises an extracellular region, a transmembrane helix, and two tandem intracellular catalytic domains referred to as D1 and D2. The D2 domain of RPTPs is believed to mostly play a regulatory function; however, no regulatory model has been established for RPTP?-D2 or other RPTP-D2 domains. Here, we solved the 1.8 ? resolution crystal structure of the cytoplasmic region of RPTP?, encompassing D1 and D2, trapped in a conformation that revealed a possible mechanism through which D2 can allosterically inhibit D1 activity. Using a D2-truncation RPTP? variant and mutational analysis of the D1/D2 interfaces, we show that D2 inhibits RPTP? phosphatase activity and identified a (PFTP408)-P-405 motif in D1 that mediates the inhibitory effect of D2. Expression of the gain-of-function F406A/T407A RPTP? variant in HEK293T cells enhanced SRC activation, supporting the relevance of our proposed D2-mediated regulation mechanism in cell signaling. There is emerging interest in the development of allosteric inhibitors of RPTPs but a scarcity of validated allosteric sites for RPTPs. The results of our study not only shed light on the regulatory role of RPTP-D2 domains, but also provide a potentially useful tool for the discovery of chemical probes targeting RPTP? and other RPTPs.	[Wen, Yutao; Yang, Shen; Wakabayashi, Kuninobu; Svensson, Mattias N. D.; Stanford, Stephanie M.; Santelli, Eugenio; Bottini, Nunzio] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA; [Wen, Yutao] Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92037 USA; [Wakabayashi, Kuninobu; Stanford, Stephanie M.; Santelli, Eugenio; Bottini, Nunzio] La Jolla Inst Immunol, Div Cellular Biol, La Jolla, CA 92037 USA; [Wakabayashi, Kuninobu] Showa Univ, Sch Med, Dept Med, Div Rheumatol, Tokyo 1428555, Japan; [Svensson, Mattias N. D.] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, S-40530 Gothenburg, Sweden	University of California System; University of California San Diego; University of California System; University of California San Diego; La Jolla Institute for Immunology; Showa University; University of Gothenburg	Bottini, N (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA.	esantelli@health.ucsd.edu; nbottini@health.ucsd.edu	Svensson, Mattias N.D./A-9827-2012	Svensson, Mattias N.D./0000-0001-8077-9824	National Institutes of Health [AR066053]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant AR066053 (to N. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Aschner Y, 2014, AM J PATHOL, V184, P1489, DOI 10.1016/j.ajpath.2014.01.016; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Blanchetot C, 2002, EMBO J, V21, P493, DOI 10.1093/emboj/21.4.493; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Choy MS, 2017, MOL CELL, V65, P644, DOI 10.1016/j.molcel.2017.01.014; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cui DS, 2017, J MOL BIOL, V429, P2360, DOI 10.1016/j.jmb.2017.06.009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Felberg J, 2004, J BIOL CHEM, V279, P3455, DOI 10.1074/jbc.M309537200; Fujikawa A, 2019, J BIOL CHEM, V294, P14953, DOI 10.1074/jbc.RA119.007878; Gu ZD, 2017, INT J ONCOL, V51, P489, DOI 10.3892/ijo.2017.4055; Hao Q, 2006, FREE RADICAL BIO MED, V41, P302, DOI 10.1016/j.freeradbiomed.2006.04.011; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; He RJ, 2014, ACTA PHARMACOL SIN, V35, P1227, DOI 10.1038/aps.2014.80; Hou L, 2011, ACTA BIOCH BIOPH SIN, V43, P977, DOI 10.1093/abbs/gmr095; Jeon TJ, 2013, MOL CELLS, V36, P55, DOI 10.1007/s10059-013-0033-x; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Kashio N, 1998, J BIOL CHEM, V273, P33856, DOI 10.1074/jbc.273.50.33856; Keedy DA, 2018, ELIFE, V7, DOI 10.7554/eLife.36307; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lim KL, 1997, EUR J BIOCHEM, V245, P693, DOI 10.1111/j.1432-1033.1997.00693.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; Nam HJ, 1999, CELL, V97, P449, DOI 10.1016/S0092-8674(00)80755-2; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sonnenburg ED, 2003, BIOCHEMISTRY-US, V42, P7904, DOI 10.1021/bi0340503; Stanford SM, 2017, TRENDS PHARMACOL SCI, V38, P524, DOI 10.1016/j.tips.2017.03.004; Stanford SM, 2016, ARTHRITIS RHEUMATOL, V68, P359, DOI 10.1002/art.39442; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Sun WC, 1998, BIOORG MED CHEM LETT, V8, P3107, DOI 10.1016/S0960-894X(98)00578-2; Toledano-Katchalski H, 2003, MOL CELL BIOL, V23, P5460, DOI 10.1128/MCB.23.15.5460-5471.2003; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tsujikawa K, 2001, MOL ENDOCRINOL, V15, P271, DOI 10.1210/me.15.2.271; Wallace MJ, 1998, MOL CELL BIOL, V18, P2608, DOI 10.1128/MCB.18.5.2608; Wang Y, 1999, J BIOL CHEM, V274, P7454, DOI 10.1074/jbc.274.11.7454; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wu L, 1997, J BIOL CHEM, V272, P6994, DOI 10.1074/jbc.272.11.6994; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; Zhang YR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11490-5; Zhang ZY, 2017, ACCOUNTS CHEM RES, V50, P122, DOI 10.1021/acs.accounts.6b00537; Zhang ZY, 2003, PROG NUCLEIC ACID RE, V73, P171, DOI 10.1016/S0079-6603(03)01006-7; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	52	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4923	4936		10.1074/jbc.RA119.011808	http://dx.doi.org/10.1074/jbc.RA119.011808			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32139509	Green Published, hybrid			2022-12-28	WOS:000526887000016
J	Hartland, EL				Hartland, Elizabeth L.			A potential new target for autoinflammatory bone disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory bone disease mediated by the inflammatory cytokine, IL-1?. Although IL-1? is known as the key driver of bone lesions in CRMO, the signaling events leading to pathogenic levels of the cytokine are not fully understood. Using a genetic mouse model of CRMO, Dasari et al. find a role for the nonreceptor spleen tyrosine kinase (SYK) in upstream signaling leading to IL-1? up-regulation. Their findings suggest that SYK may constitute a new therapeutic target for CRMO.	[Hartland, Elizabeth L.] Monash Univ, Ctr Innate Immun & Infect Dis, Hudson Inst Med Res, Clayton, Vic 3168, Australia; [Hartland, Elizabeth L.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia	Hudson Institute of Medical Research; Monash University; Monash University	Hartland, EL (corresponding author), Monash Univ, Ctr Innate Immun & Infect Dis, Hudson Inst Med Res, Clayton, Vic 3168, Australia.; Hartland, EL (corresponding author), Monash Univ, Dept Mol & Translat Sci, Clayton, Vic 3168, Australia.	elizabeth.hartland@hudson.org.au	Hartland, Elizabeth/O-2569-2014	Hartland, Elizabeth/0000-0003-4254-2863				Dasari TK, 2020, J BIOL CHEM, V295, P3394, DOI 10.1074/jbc.RA119.010623; Gringhuis SI, 2012, NAT IMMUNOL, V13, P246, DOI 10.1038/ni.2222; Gurung P, 2016, P NATL ACAD SCI USA, V113, P4452, DOI 10.1073/pnas.1601636113; Jurik AG, 2004, SEMIN MUSCULOSKEL R, V8, P243, DOI 10.1055/s-2004-835364; Mangan MSJ, 2018, NAT REV DRUG DISCOV, V17, P588, DOI [10.1038/nrd.2018.149, 10.1038/nrd.2018.97]; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Patel MN, 2017, TRENDS MOL MED, V23, P165, DOI 10.1016/j.molmed.2016.12.007; Stern SM, 2013, RHEUM DIS CLIN N AM, V39, P735, DOI 10.1016/j.rdc.2013.05.002; Van Ziffle JA, 2009, BLOOD, V114, P4871, DOI 10.1182/blood-2009-05-220806	9	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3401	3402		10.1074/jbc.H120.012867	http://dx.doi.org/10.1074/jbc.H120.012867			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32169854	hybrid, Green Published			2022-12-28	WOS:000527725300002
J	Lawrence, CM				Lawrence, C. Martin			A moonlighting nuclease puts CRISPR in its place	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HOST FACTOR	Integration of spacers into CRISPR loci requires the Cas1/Cas2 integrase complex, frequently in combination with Cas4 exonuclease. However, several CRISPR-Cas systems lack Cas4. Whether Cas4-like activity is dispensable in these systems or provided by an unidentified actor was not known. In this issue of the Journal of Biological Chemistry, Ramachandran et al. show that in subtype I-E systems, Cas4-like activity is supplied by DnaQ-superfamily exonucleases, providing a beautiful example of cellular machinery moonlighting in support of CRISPR-Cas adaptive immunity.	[Lawrence, C. Martin] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Lawrence, CM (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	lawrence@montana.edu	Lawrence, C. Martin/AAH-3420-2020	Lawrence, C. Martin/0000-0002-5398-466X	National Science Foundation [DBI-1828765]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant DBI-1828765.	Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Drabavicius G, 2018, EMBO REP, V19, DOI 10.15252/embr.201745543; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; McGinn J, 2019, NAT REV MICROBIOL, V17, P7, DOI 10.1038/s41579-018-0071-7; Nunez JK, 2016, MOL CELL, V62, P824, DOI 10.1016/j.molcel.2016.04.027; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Ramachandran A, 2020, J BIOL CHEM, V295, P3403, DOI 10.1074/jbc.RA119.012196; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Wright AV, 2017, SCIENCE, V357, P1113, DOI 10.1126/science.aao0679	10	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3415	3416		10.1074/jbc.H120.012897	http://dx.doi.org/10.1074/jbc.H120.012897			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32169855	Green Published, hybrid			2022-12-28	WOS:000527725300004
J	Sommerfeld, A; Reinehr, R; Haussinger, D				Sommerfeld, Annika; Reinehr, Roland; Haussinger, Dieter			Free fatty acids shift insulin-induced hepatocyte proliferation towards CD95-dependent apoptosis. (vol 290, pg 4398, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Sommerfeld A, 2015, J BIOL CHEM, V290, P4398, DOI 10.1074/jbc.M114.617035	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2885	2885		10.1074/jbc.AAC120.012827	http://dx.doi.org/10.1074/jbc.AAC120.012827			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	32111720	hybrid, Green Published			2022-12-28	WOS:000519969100028
J	Travis, SM; DAmico, K; Yu, IM; McMahon, C; Hamid, S; Ramirez-Arellano, G; Jeffrey, PD; Hughson, FM				Travis, Sophie M.; DAmico, Kevin; Yu, I-Mei; McMahon, Conor; Hamid, Safraz; Ramirez-Arellano, Gabriel; Jeffrey, Philip D.; Hughson, Frederick M.			Structural basis for the binding of SNAREs to the multisubunit tethering complex Dsl1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane trafficking; SNARE protein; X-ray crystallography; COPI; vesicle; yeast; multisubunit tethering complex; Dsl1 complex; CATCHR complex	N-TERMINAL DOMAIN; ENDOPLASMIC-RETICULUM; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; PROTEIN; MEMBRANE; YEAST; INTERACTS; FUSION; CONSERVATION	Multisubunit-tethering complexes (MTCs) are large (250 to >750 kDa), conserved macromolecular machines that are essential for solubleN-ethylmaleimide?sensitive factor attachment protein receptor (SNARE)?mediated membrane fusion in all eukaryotes. MTCs are thought to organize membrane trafficking by mediating the initial long-range interaction between a vesicle and its target membrane and promoting the formation of membrane-bridging SNARE complexes. Previously, we reported the structure of the yeast Dsl1 complex, the simplest known MTC, which is essential for coat protein I (COPI) mediated transport from the Golgi to the endoplasmic reticulum (ER). This structure suggests how the Dsl1 complex might tether a vesicle to its target membrane by binding at one end to the COPI coat and at the other to ER-associated SNAREs. Here, we used X-ray crystallography to investigate these Dsl1?SNARE interactions in greater detail. The Dsl1 complex comprises three subunits that together form a two-legged structure with a central hinge. We found that distal regions of each leg bind N-terminal Habc domains of the ER SNAREs Sec20 (a Qb-SNARE) and Use1 (a Qc-SNARE). The observed binding modes appear to anchor the Dsl1 complex to the ER target membrane while simultaneously ensuring that both SNAREs are in open conformations, with their SNARE motifs available for assembly. The proximity of the two SNARE motifs, and therefore their ability to enter the same SNARE complex, will depend on the relative orientation of the two Dsl1 legs. These results underscore the critical roles of SNARE N-terminal domains in mediating interactions with other elements of the vesicle docking and fusion machinery.	[Travis, Sophie M.; DAmico, Kevin; Yu, I-Mei; McMahon, Conor; Hamid, Safraz; Ramirez-Arellano, Gabriel; Jeffrey, Philip D.; Hughson, Frederick M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Yu, I-Mei] Stevenage Biosci Catalyst, Freeline Therapeut, Stevenage, Herts, England; [McMahon, Conor] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Princeton University; Harvard University; Harvard Medical School	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu		DAmico, Kevin/0000-0002-8888-0713; Travis, Sophie/0000-0002-1728-1705; McMahon, Conor/0000-0001-9971-7869; Hamid, Safraz/0000-0001-8342-7760; Jeffrey, Philip/0000-0002-4351-5341	National Institutes of Health [T32GM007388, F31GM12676, R01GM071574]; U.S. Department of Energy Office of Science User Facility [DE-SC0012704]; NIGMS, National Institutes of Health through Biomedical Technology Research Resource P41 Grant [P41GM111244]; U.S. Department of Energy Office of Biological and Environmental Research Grant [KP1605010]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy Office of Science User Facility(United States Department of Energy (DOE)); NIGMS, National Institutes of Health through Biomedical Technology Research Resource P41 Grant; U.S. Department of Energy Office of Biological and Environmental Research Grant(United States Department of Energy (DOE))	This work was supported by National Institutes of Health Grants T32GM007388 (to S. M. T. and K. D.), F31GM12676 (to S. M. T.), and R01GM071574 (to F. M. H.). This research used the AMX and FMX Beamlines of the National Synchrotron Light Source II, a U.S. Department of Energy Office of Science User Facility operated by Brookhaven National Laboratory under Contract DE-SC0012704. The Life Science Biomedical Technology Research resource, which supports AMX and FMX, is primarily supported by the NIGMS, National Institutes of Health through Biomedical Technology Research Resource P41 Grant P41GM111244, and by U.S. Department of Energy Office of Biological and Environmental Research Grant KP1605010. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abascal-Palacios G, 2013, STRUCTURE, V21, P1698, DOI 10.1016/j.str.2013.06.025; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov A, 2004, MOL CELL PROTEOMICS, V3, P934, DOI 10.1074/mcp.T400008-MCP200; Andag U, 2003, J BIOL CHEM, V278, P51722, DOI 10.1074/jbc.M308740200; Antonin W, 2002, J BIOL CHEM, V277, P36449, DOI 10.1074/jbc.M204369200; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baker RW, 2016, NAT REV MOL CELL BIO, V17, P465, DOI 10.1038/nrm.2016.65; Baker RW, 2015, SCIENCE, V349, P1111, DOI 10.1126/science.aac7906; Cheung PYP, 2015, ELIFE, V4, DOI 10.7554/eLife.12790; Chou HT, 2016, NAT STRUCT MOL BIOL, V23, P761, DOI 10.1038/nsmb.3264; Chowdhury SR, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201902114; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; D'Agostino M, 2017, NATURE, V551, P634, DOI 10.1038/nature24469; Daste F, 2015, J CELL SCI, V128, P4263, DOI 10.1242/jcs.178574; Demircioglu FE, 2014, P NATL ACAD SCI USA, V111, P13828, DOI 10.1073/pnas.1408254111; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dubuke ML, 2015, J BIOL CHEM, V290, P28245, DOI 10.1074/jbc.M115.673806; Dulubova I, 2001, NAT STRUCT BIOL, V8, P258, DOI 10.1038/85012; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fridmann-Sirkis Y, 2006, TRAFFIC, V7, P182, DOI 10.1111/j.1600-0854.2005.00374.x; Gao GB, 2020, TRAFFIC, V21, P274, DOI 10.1111/tra.12720; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gillingham AK, 2019, CURR OPIN CELL BIOL, V59, P140, DOI 10.1016/j.ceb.2019.04.010; Gillingham AK, 2016, TRENDS CELL BIOL, V26, P399, DOI 10.1016/j.tcb.2016.02.005; Ha JY, 2016, NAT STRUCT MOL BIOL, V23, P758, DOI 10.1038/nsmb.3263; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; Hsia KC, 2010, P NATL ACAD SCI USA, V107, P11271, DOI 10.1073/pnas.1006297107; Jiao JY, 2018, ELIFE, V7, DOI 10.7554/eLife.41771; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; Kraynack BA, 2005, MOL BIOL CELL, V16, P3963, DOI 10.1091/mbc.E05-01-0056; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lerman JC, 2000, BIOCHEMISTRY-US, V39, P8470, DOI 10.1021/bi0003994; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meiringer CTA, 2011, J BIOL CHEM, V286, P25039, DOI 10.1074/jbc.M110.215327; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Murray DH, 2016, NATURE, V537, P107, DOI 10.1038/nature19326; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Pei JM, 2009, J MOL BIOL, V391, P509, DOI 10.1016/j.jmb.2009.06.054; Ren Y, 2009, CELL, V139, P1119, DOI 10.1016/j.cell.2009.11.002; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song H, 2020, ELIFE, V9, DOI 10.7554/eLife.53559; Suckling RJ, 2015, P NATL ACAD SCI USA, V112, P14242, DOI 10.1073/pnas.1506186112; SWEET DJ, 1993, EMBO J, V12, P2831, DOI 10.1002/j.1460-2075.1993.tb05944.x; Travis SM, 2019, P NATL ACAD SCI USA, V116, P24031, DOI 10.1073/pnas.1909697116; Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548; Ungermann C, 2019, TRAFFIC, V20, P479, DOI 10.1111/tra.12655; Wang J, 2011, P NATL ACAD SCI USA, V108, P12277, DOI 10.1073/pnas.1013101108; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whyte JRC, 2002, J CELL SCI, V115, P2627; Yu IM, 2010, ANNU REV CELL DEV BI, V26, P137, DOI 10.1146/annurev.cellbio.042308.113327; Yue P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14236; Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012	62	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10125	10135		10.1074/jbc.RA120.013654	http://dx.doi.org/10.1074/jbc.RA120.013654			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32409579	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000556713400003
J	Hewitt, SC; Grimm, SA; Wu, SP; DeMayo, FJ; Korach, KS				Hewitt, Sylvia C.; Grimm, Sara A.; Wu, San-Pin; DeMayo, Francesco J.; Korach, Kenneth S.			Estrogen receptor ? (ER?)-binding super-enhancers drive key mediators that control uterine estrogen responses in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen receptor; gene expression; chromatin modification; transcription; reproduction; chromatin conformation capture; chromatin looping; epigenetic regulation; female reproduction; super-enhancer	RETINOIC ACID; ER-ALPHA; MOUSE; DECIDUALIZATION; CONSEQUENCES; IMPLANTATION; COACTIVATOR; DISRUPTION; PUBERTY; UTERUS	Estrogen receptor ? (ER?) modulates gene expression by interacting with chromatin regions that are frequently distal from the promoters of estrogen-regulated genes. Active chromatin-enriched ?super-enhancer? (SE) regions, mainly observed inin vitroculture systems, often control production of key cell type?determining transcription factors. Here, we defined super-enhancers that bind to ER?in vivowithin hormone-responsive uterine tissue in mice. We found that SEs are already formed prior to estrogen exposure at the onset of puberty. The genes at SEs encoded critical developmental factors, including retinoic acid receptor ? (RARA) and homeobox D (HOXD). Using high-throughput chromosome conformation capture (Hi-C) along with DNA sequence analysis, we demonstrate that most SEs are located at a chromatin loop end and that most uterine genes in loop ends associated with these SEs are regulated by estrogen. Although the SEs were formed before puberty, SE-associated genes acquired optimal ER?-dependent expression after reproductive maturity, indicating that pubertal processes that occur after SE assembly and ER? binding are needed for gene responses. Genes associated with these SEs affected key estrogen-mediated uterine functions, including transforming growth factor ? (TGF?) and LIF interleukin-6 family cytokine (LIF) signaling pathways. To the best of our knowledge, this is the first identification of SE interactions that underlie hormonal regulation of genes in uterine tissue and optimal development of estrogen responses in this tissue.	[Hewitt, Sylvia C.; Wu, San-Pin; DeMayo, Francesco J.; Korach, Kenneth S.] NIEHS, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Grimm, Sara A.] NIEHS, Integrat Bioinformat Support Grp, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hewitt, SC (corresponding author), NIEHS, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	Sylvia.Hewitt@nih.gov	, San Pin Wu/AAF-8371-2020	, San Pin Wu/0000-0001-9626-784X; Hewitt, Sylvia/0000-0001-7713-0805	Intramural Research Program of NIEHS, National Institutes of Health [1ZIAES070065, 1ZIAES103311]	Intramural Research Program of NIEHS, National Institutes of Health	This work was supported in part by the Intramural Research Program of NIEHS, National Institutes of Health, Grants 1ZIAES070065 (to K. S. K.) and 1ZIAES103311 (to F. J. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afshar Y, 2012, FASEB J, V26, P282, DOI 10.1096/fj.11-184663; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Beliakoff Jason, 2006, Nucl Recept Signal, V4, pe017; Bernard V, 2017, J CLIN ENDOCR METAB, V102, P93, DOI 10.1210/jc.2016-2749; Binder AK., 2015, KNOBIL NEILLS PHYSL, P1099, DOI [10.1016/b978-0-12-397175-3.00025-9, DOI 10.1016/B978-0-12-397175-3.00025-9]; Blackmore JK, 2014, ENDOCRINOLOGY, V155, P3251, DOI 10.1210/en.2014-1002; Bojcsuk D, 2017, NUCLEIC ACIDS RES, V45, P3693, DOI 10.1093/nar/gkw1283; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Clementi C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003863; Cunliffe VT, 2008, CURR OPIN GENET DEV, V18, P404, DOI 10.1016/j.gde.2008.10.001; Das BC, 2014, BIOORGAN MED CHEM, V22, P673, DOI 10.1016/j.bmc.2013.11.025; Du HL, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a023002; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Fisher CR, 1998, P NATL ACAD SCI USA, V95, P6965, DOI 10.1073/pnas.95.12.6965; Gao Y, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125146; Gassler J, 2017, EMBO J, V36, P3600, DOI 10.15252/embj.201798083; Grumbach MM, 1999, J CLIN ENDOCR METAB, V84, P4677, DOI 10.1210/jc.84.12.4677; Herndon CN, 2016, REPROD SCI, V23, P1289, DOI 10.1177/1933719116650758; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hewitt SC, 2019, J BIOL CHEM, V294, P9746, DOI 10.1074/jbc.RA119.008759; Hewitt SC, 2019, FASEB J, V33, P3010, DOI 10.1096/fj.201801752; Hewitt SC, 2018, ENDOCR REV, V39, P664, DOI 10.1210/er.2018-00087; Hewitt SC, 2017, ENDOCRINOLOGY, V158, P2427, DOI 10.1210/en.2017-00349; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hong SH, 2018, P NATL ACAD SCI USA, V115, P10381, DOI 10.1073/pnas.1809480115; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; KATZENELLENBOGEN BS, 1974, MOL CELL ENDOCRINOL, V2, P31, DOI 10.1016/0303-7207(74)90010-0; Kelleher AM, 2019, ENDOCR REV, V40, P1424, DOI 10.1210/er.2018-00281; Kriseman M, 2019, P NATL ACAD SCI USA, V116, P3873, DOI 10.1073/pnas.1806862116; Le Dily F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020306; Li QL, 2019, P NATL ACAD SCI USA, V116, P3367, DOI 10.1073/pnas.1821606116; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin L, 2007, J CLIN ENDOCR METAB, V92, P982, DOI 10.1210/jc.2006-1181; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Miano V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020593; Monsivais D, 2019, P NATL ACAD SCI USA, V116, P3883, DOI 10.1073/pnas.1806838116; Monsivais D, 2016, P NATL ACAD SCI USA, V113, pE387, DOI 10.1073/pnas.1523758113; Mucenski ML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40923-w; Nagashima T, 2013, J CLIN INVEST, V123, P2539, DOI 10.1172/JCI65710; Nakajima T, 2019, REPROD TOXICOL, V86, P56, DOI 10.1016/j.reprotox.2019.03.006; Nakajima T, 2019, BIOCHEM BIOPHYS REP, V17, P44, DOI 10.1016/j.bbrep.2018.10.013; Nakajima T, 2016, P NATL ACAD SCI USA, V113, P14354, DOI 10.1073/pnas.1608808113; Nanjappa MK, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125724; Panigrahi AK, 2018, MOL CELL, V70, P679, DOI 10.1016/j.molcel.2018.04.014; Pawar S, 2013, MOL ENDOCRINOL, V27, P1996, DOI 10.1210/me.2013-1206; Peng J, 2015, P NATL ACAD SCI USA, V112, pE5098, DOI 10.1073/pnas.1514498112; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; QUARMBY VE, 1984, ENDOCRINOLOGY, V114, P694, DOI 10.1210/endo-114-3-694; Quaynor SD, 2013, NEW ENGL J MED, V369, P164, DOI 10.1056/NEJMoa1303611; Raines AM, 2013, DEVELOPMENT, V140, P2942, DOI 10.1242/dev.092569; Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8; Santen RJ, 2019, ENDOCRINOLOGY, V160, P605, DOI 10.1210/en.2018-00529; Sengupta S, 2017, TRENDS CANCER, V3, P269, DOI 10.1016/j.trecan.2017.03.006; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Stewart CA, 2011, BIOL REPROD, V85, P954, DOI 10.1095/biolreprod.111.091470; Sun J, 2007, MOL ENDOCRINOL, V21, P2651, DOI 10.1210/me.2007-0082; Tasaki Hirotaka, 2013, Front Endocrinol (Lausanne), V4, P82, DOI 10.3389/fendo.2013.00082; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Walters KA, 2009, ENDOCRINOLOGY, V150, P3274, DOI 10.1210/en.2008-1750; Wang JJ, 2016, BRIEF FUNCT GENOMICS, V15, P385, DOI 10.1093/bfgp/elv062; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303	68	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8387	8400		10.1074/jbc.RA120.013666	http://dx.doi.org/10.1074/jbc.RA120.013666			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32354741	hybrid, Green Published			2022-12-28	WOS:000546986500004
J	Wang, D; Chen, YP; Liu, MW; Cao, QQ; Wang, QH; Zhou, SS; Wang, YX; Mao, SS; Gu, XS; Luo, ZG; Yu, B				Wang, Dong; Chen, Yanping; Liu, Mingwen; Cao, Qianqian; Wang, Qihui; Zhou, Shuoshuo; Wang, Yaxian; Mao, Susu; Gu, Xiaosong; Luo, Zhenge; Yu, Bin			The long noncoding RNA Arrl1 inhibits neurite outgrowth by functioning as a competing endogenous RNA during neuronal regeneration in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neuron; neurite outgrowth; neurite growth; long noncoding RNA (long ncRNA; lncRNA); regeneration; microRNA (miRNA); Arrl1; axon regeneration; competing endogenous RNA (ceRNA); long noncoding RNA; peripheral nerve injury; miR-761; cyclin-dependent kinase inhibitor 2B (Cdkn2b); RNA sponge; transcriptomics	AXON REGENERATION; INTRINSIC CONTROL; NERVOUS-SYSTEM; OVEREXPRESSION; MECHANISMS; EVOLUTION; INJURY; STAT3; PTEN; ATF3	The intrinsic regeneration ability of neurons is a pivotal factor in the repair of peripheral nerve injury. Therefore, identifying the key modulators of nerve regeneration may help improve axon regeneration and functional recovery after injury. Unlike for classical transcription factors and regeneration-associated genes, the function of long noncoding RNAs (lncRNAs) in the regulation of neuronal regeneration remains mostly unknown. In this study, we used RNA-Seq?based transcriptome profiling to analyze the expression patterns of lncRNAs and mRNAs in rat dorsal root ganglion (DRG) following sciatic nerve injury. Analyses using the lncRNA-mRNA co-expression network, gene ontology enrichment, and Kyoto Encyclopedia of Genes and Genomes pathway databases indicated that the lncRNA Arrl1 decreases neurite outgrowth after neuronal injury. shRNA-mediated Arrl1 silencing increased axon regeneration bothin vitroandin vivoand improved functional recovery of the sciatic nerve. Moreover, inhibiting an identified target gene of Arrl1, cyclin-dependent kinase inhibitor 2B (Cdkn2b), markedly promoted neurite outgrowth of DRG neurons. We also found that Arrl1 acts as a competing endogenous RNA that sponges a Cdkn2b repressor, microRNA-761 (miR-761), and thereby up-regulates Cdkn2b expression during neuron regeneration. We conclude that the lncRNA Arrl1 affects the intrinsic regeneration of DRG neurons by derepressing Cdkn2b expression. Our findings indicate a role for an lncRNA-microRNA-kinase pathway in the regulation of axon regeneration and functional recovery following peripheral nerve injury in rats.	[Wang, Dong; Chen, Yanping; Liu, Mingwen; Cao, Qianqian; Wang, Qihui; Zhou, Shuoshuo; Wang, Yaxian; Mao, Susu; Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China; [Wang, Dong; Chen, Yanping; Liu, Mingwen; Cao, Qianqian; Wang, Qihui; Zhou, Shuoshuo; Wang, Yaxian; Mao, Susu; Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Minist Educ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China; [Gu, Xiaosong; Yu, Bin] Nantong Univ, Affiliated Hosp, Jiangsu Clin Med Ctr Tissue Engn & Nerve Injury R, Nantong, Peoples R China; [Luo, Zhenge] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Nantong University; Nantong University; Nantong University; ShanghaiTech University	Yu, B (corresponding author), Nantong Univ, Affiliated Hosp, Key Lab Neuroregenerat Jiangsu, Nantong, Peoples R China.; Yu, B (corresponding author), Nantong Univ, Affiliated Hosp, Minist Educ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China.; Yu, B (corresponding author), Nantong Univ, Affiliated Hosp, Jiangsu Clin Med Ctr Tissue Engn & Nerve Injury R, Nantong, Peoples R China.	yubin@ntu.edu.cn		Wang, Dong/0000-0001-9921-8058	National Major Project of Research and Development Grant [2017YFA0104701]; National Natural Science Foundation of China [81771326, 81901257]; Natural Science Foundation of Jiangsu Province [BK20180951]; Natural Science Fund for Colleges and Universities in Jiangsu Province [19KJB180025, 18KJB180022]; Jiangsu Provincial Key Medical Center; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Major Project of Research and Development Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Fund for Colleges and Universities in Jiangsu Province; Jiangsu Provincial Key Medical Center; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Major Project of Research and Development Grant 2017YFA0104701, National Natural Science Foundation of China Grants 81771326 and 81901257, Natural Science Foundation of Jiangsu Province Grant BK20180951, Natural Science Fund for Colleges and Universities in Jiangsu Province Grants 19KJB180025 and 18KJB180022, and the Jiangsu Provincial Key Medical Center and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Afshari FT, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001288; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Bareyre FM, 2011, P NATL ACAD SCI USA, V108, P6282, DOI 10.1073/pnas.1015239108; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bunch H, 2018, MOL GENET GENOMICS, V293, P1, DOI 10.1007/s00438-017-1370-9; Chen ZQ, 2019, CANCER SCI, V110, P568, DOI 10.1111/cas.13901; Cheng C, 2008, EXP NEUROL, V212, P358, DOI 10.1016/j.expneurol.2008.04.023; Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x; Cohen JE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0509; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Fagoe ND, 2015, HUM MOL GENET, V24, P6788, DOI 10.1093/hmg/ddv383; Gong LL, 2016, BIOCHEM BIOPH RES CO, V478, P206, DOI 10.1016/j.bbrc.2016.07.067; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Jankowski MP, 2009, BRAIN RES, V1256, P43, DOI 10.1016/j.brainres.2008.12.032; Kleaveland B, 2018, CELL, V174, P350, DOI 10.1016/j.cell.2018.05.022; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Long B, 2013, FREE RADICAL BIO MED, V65, P371, DOI 10.1016/j.freeradbiomed.2013.07.009; Luo Q, 2016, CLIN INTERV AGING, V11, P867, DOI 10.2147/CIA.S107037; Mahar M, 2018, NAT REV NEUROSCI, V19, P323, DOI 10.1038/s41583-018-0001-8; Mar FM, 2014, EMBO REP, V15, P254, DOI 10.1002/embr.201337723; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; Perry RB, 2018, MOL CELL, V72, P553, DOI 10.1016/j.molcel.2018.09.021; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Rashid F, 2016, GENOM PROTEOM BIOINF, V14, P73, DOI 10.1016/j.gpb.2016.03.005; Reitz MC, 2016, PAIN, V157, P1248, DOI 10.1097/j.pain.0000000000000515; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Teotia P, 2017, STEM CELLS, V35, P2239, DOI 10.1002/stem.2675; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Weng YL, 2018, NEURON, V97, P313, DOI 10.1016/j.neuron.2017.12.036; Wu SG, 2016, MOL PAIN, V12, DOI 10.1177/1744806916629048; Yao C, 2018, J NEUROSCI, V38, P6574, DOI 10.1523/JNEUROSCI.3790-16.2018; Yao C, 2015, EUR J NEUROSCI, V42, P1718, DOI 10.1111/ejn.12966; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750; Zhao XL, 2013, NAT NEUROSCI, V16, P1024, DOI 10.1038/nn.3438	44	18	19	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8374	8386		10.1074/jbc.RA119.011917	http://dx.doi.org/10.1074/jbc.RA119.011917			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32336677	Green Published, hybrid			2022-12-28	WOS:000546986500003
J	Liu, LY; Yudin, Y; Rohacs, T				Liu, Luyu; Yudin, Yevgen; Rohacs, Tibor			Diacylglycerol kinases regulate TRPV1 channel activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transient receptor potential channels (TRP channels); dorsal root ganglia; diacylglycerol; calcium; phosphoinositide; PKC; DAGK; TRPV1	ACTIVATED ION-CHANNEL; CAPSAICIN RECEPTOR; PKC-EPSILON; PHOSPHOINOSITIDES; PHOSPHORYLATION; INHIBITION; PAIN; DESENSITIZATION; SENSITIZATION; MECHANISM	The transient receptor potential vanilloid 1 (TRPV1) channel is activated by heat and by capsaicin, the pungent compound in chili peppers. Calcium influx through TRPV1 has been shown to activate a calcium-sensitive phospholipase C (PLC) enzyme and to lead to a robust decrease in phosphatidylinositol 4,5-bisphosphate [PI(4,5)P-2] levels, which is a major contributor to channel desensitization. Diacylglycerol (DAG), the product of the PLC-catalyzed PI(4,5)P(2)hydrolysis, activates protein kinase C (PKC). PKC is known to potentiate TRPV1 activity during activation of G protein?coupled receptors, but it is not known whether DAG modulates TRPV1 during desensitization. We found here that inhibition of diacylglycerol kinase (DAGK) enzymes reduces desensitization of native TRPV1 in dorsal root ganglion neurons as well as of recombinant TRPV1 expressed in HEK293 cells. The effect of DAGK inhibition was eliminated by mutating two PKC-targeted phosphorylation sites, Ser-502 and Ser-800, indicating involvement of PKC. TRPV1 activation induced only a small and transient increase in DAG levels, unlike the robust and more sustained increase induced by muscarinic receptor activation. DAGK inhibition substantially increased the DAG signal evoked by TRPV1 activation but not that evoked by M1 muscarinic receptor activation. Our results show that Ca(2+)influx through TRPV1 activates PLC and DAGK enzymes and that the latter limits formation of DAG and negatively regulates TRPV1 channel activity. Our findings uncover a role of DAGK in ion channel regulation.	[Liu, Luyu; Yudin, Yevgen; Rohacs, Tibor] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07102 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Rohacs, T (corresponding author), Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07102 USA.	tibor.rohacs@rutgers.edu		Rohacs, Tibor/0000-0003-3580-2575	NINDS, National Institutes of Health [NS055159]; NIGMS, National Institutes of Health [GM131048, GM093290]	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NINDS, National Institutes of Health Grants NS055159 and NIGMS, National Institutes of Health Grants GM131048 and GM093290 (to T. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baldanzi G, 2010, CELL DEATH DIFFER, V17, P1059, DOI 10.1038/cdd.2009.210; Borbiro I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005667; Boroda S, 2017, BIOCHEM PHARMACOL, V123, P29, DOI 10.1016/j.bcp.2016.10.011; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Epand RM, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00112; Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0; Joseph J, 2019, J NEUROSCI, V39, P9954, DOI 10.1523/JNEUROSCI.1064-19.2019; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; Koplas PA, 1997, J NEUROSCI, V17, P3525; LEE MW, 1994, AM J PHYSIOL, V267, pC659, DOI 10.1152/ajpcell.1994.267.3.C659; Liu LY, 2019, J NEUROSCI, V39, P6067, DOI 10.1523/JNEUROSCI.2304-18.2019; Liu XL, 2017, BRIT J PHARMACOL, V174, P4464, DOI 10.1111/bph.14049; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Lukacs V, 2013, J NEUROSCI, V33, P11451, DOI 10.1523/JNEUROSCI.5637-12.2013; Lung M, 2009, J BIOL CHEM, V284, P31062, DOI 10.1074/jbc.M109.050617; Mandadi S, 2004, CELL CALCIUM, V35, P471, DOI 10.1016/j.ceca.2003.11.003; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; Numazaki M, 2002, J BIOL CHEM, V277, P13375, DOI 10.1074/jbc.C200104200; Ogasawara D, 2016, P NATL ACAD SCI USA, V113, P26, DOI 10.1073/pnas.1522364112; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Rohacs T, 2015, PFLUG ARCH EUR J PHY, V467, P1851, DOI 10.1007/s00424-015-1695-3; Sato M, 2013, PHARMACOLOGY, V92, P99, DOI 10.1159/000351849; Shirai Y, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-28; Suh BC, 2006, PFLUG ARCH EUR J PHY, V453, P293, DOI 10.1007/s00424-006-0092-3; Tewson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042791; Tewson PH, 2013, J BIOMOL SCREEN, V18, P797, DOI 10.1177/1087057113485427; Thams P, 1997, BIOCHEM PHARMACOL, V53, P1077, DOI 10.1016/S0006-2952(96)00813-1; Thirugnanam S, 2001, BIOCHEMISTRY-US, V40, P10607, DOI 10.1021/bi010609s; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Tu-Sekine Becky, 2015, Adv Biol Regul, V57, P147, DOI 10.1016/j.jbior.2014.09.010; Tu-Sekine Becky, 2013, Advances in Biological Regulation, V53, P118, DOI 10.1016/j.jbior.2012.09.007; WALSH JP, 1995, J BIOL CHEM, V270, P28647, DOI 10.1074/jbc.270.48.28647; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	36	13	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8174	8185		10.1074/jbc.RA119.012505	http://dx.doi.org/10.1074/jbc.RA119.012505			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32345612	Green Published, hybrid			2022-12-28	WOS:000542965700006
J	Altegoer, F; Weiland, P; Giammarinaro, PI; Freibert, SA; Binnebesel, L; Han, XW; Lepak, A; Kahmann, R; Lechner, M; Bange, G				Altegoer, Florian; Weiland, Paul; Giammarinaro, Pietro Ivan; Freibert, Sven-Andreas; Binnebesel, Lynn; Han, Xiaowei; Lepak, Alexander; Kahmann, Regine; Lechner, Marcus; Bange, Gert			The two paralogous kiwellin proteins KWL1 and KWL1-b from maize are structurally related and have overlapping functions in plant defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; structure-function; plant defense; fungi; carbohydrate-binding protein; chorismate mutase; KWL1-b; salicylic acid pathway; Ustilago maydis; Zea mays	PSI-BETA-BARREL; USTILAGO-MAYDIS; HUMICOLA INSOLENS; ENDOGLUCANASE V; EFFECTORS; HOST	Many plant-pathogenic bacteria and fungi deploy effector proteins that down-regulate plant defense responses and reprogram plant metabolism for colonization and survival in planta. Kiwellin (KWL) proteins are a widespread family of plant-defense proteins that target these microbial effectors. The KWL1 protein from maize (corn, Zea mays) specifically inhibits the enzymatic activity of the secreted chorismate mutase Cmu1, a virulence-promoting effector of the smut fungus Ustilago maydis. In addition to KWL1, 19 additional KWL paralogs have been identified in maize. Here, we investigated the structure and mechanism of the closest KWL1 homolog, KWL1-b (ZEAMA_GRMZM2G305329). We solved the Cmu1?KWL1-b complex to 2.75 ? resolution, revealing a highly symmetric Cmu1?KWL1-b heterotetramer in which each KWL1-b monomer interacts with a monomer of the Cmu1 homodimer. The structure also revealed that the overall architecture of the heterotetramer is highly similar to that of the previously reported Cmu1?KWL1 complex. We found that upon U. maydis infection of Z. mays, KWL1-b is expressed at significantly lower levels than KWL1 and exhibits differential tissue-specific expression patterns. We also show that KWL1-b inhibits Cmu1 activity similarly to KWL1. We conclude that KWL1 and KWL1-b are part of a redundant defense system that tissue-specifically targets Cmu1. This notion was supported by the observation that both KWL proteins are carbohydrate-binding proteins with distinct and likely tissue-related specificities. Moreover, binding by Cmu1 modulated the carbohydrate-binding properties of both KWLs. These findings indicate that KWL proteins are part of a spatiotemporally coordinated, plant-wide defense response comprising proteins with overlapping activities.	[Altegoer, Florian; Weiland, Paul; Giammarinaro, Pietro Ivan; Binnebesel, Lynn; Lepak, Alexander; Lechner, Marcus; Bange, Gert] Philipps Univ Marburg, SYNMIKRO Res Ctr, Marburg, Germany; [Altegoer, Florian; Weiland, Paul; Giammarinaro, Pietro Ivan; Binnebesel, Lynn; Lepak, Alexander; Lechner, Marcus; Bange, Gert] Philipps Univ Marburg, Dept Chem, Marburg, Germany; [Freibert, Sven-Andreas] Philipps Univ Marburg, Inst Cytobiol & Cytopathol, Marburg, Germany; [Han, Xiaowei; Kahmann, Regine] Max Planck Inst Terr Microbiol, Marburg, Germany	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Max Planck Society	Altegoer, F; Bange, G (corresponding author), Philipps Univ Marburg, SYNMIKRO Res Ctr, Marburg, Germany.; Altegoer, F; Bange, G (corresponding author), Philipps Univ Marburg, Dept Chem, Marburg, Germany.	florian.altegoer@synmikro.uni-marburg.de; gert.bange@synmikro.uni-marburg.de	Bange, Gert/AAB-3734-2021; Han, Xiaowei/AAB-7913-2022; Kahmann, Regine/AAS-1230-2021	Han, Xiaowei/0000-0002-1333-4312; Lepak, Alexander/0000-0001-8230-0004; Bange, Gert/0000-0002-7826-0932; Giammarinaro, Pietro Ivan/0000-0002-0356-8481; Weiland, Paul/0000-0003-3175-8271; Altegoer, Florian/0000-0002-6012-9047	Peter und Traudl Engelhorn Foundation; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 987]	Peter und Traudl Engelhorn Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Peter und Traudl Engelhorn Foundation (to F. A.) and the Deutsche Forschungsgemeinschaft through Sonderforschungsbereich 987 (to G. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bange Gert, 2019, Commun Integr Biol, V12, P31, DOI 10.1080/19420889.2019.1586049; Bowler MW, 2015, J SYNCHROTRON RADIAT, V22, P1540, DOI 10.1107/S1600577515016604; Castillo RM, 1999, STRUCTURE, V7, P227, DOI 10.1016/S0969-2126(99)80028-8; Davies GJ, 1996, ACTA CRYSTALLOGR D, V52, P7, DOI 10.1107/S0907444995009280; Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037; DAVIES GJ, 1993, NATURE, V365, P362, DOI 10.1038/365362a0; de Oliveira AL, 2011, J BIOL CHEM, V286, P17560, DOI 10.1074/jbc.M111.223644; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Hamiaux C, 2014, J STRUCT BIOL, V187, P276, DOI 10.1016/j.jsb.2014.07.005; Han XW, 2019, NATURE, V565, P650, DOI 10.1038/s41586-018-0857-9; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lanver D, 2017, NAT REV MICROBIOL, V15, P409, DOI 10.1038/nrmicro.2017.33; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matei A, 2018, NEW PHYTOL, V217, P1681, DOI 10.1111/nph.14960; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Pazzagli L, 2014, PLANT SCI, V228, P79, DOI 10.1016/j.plantsci.2014.02.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sampedro J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-242; Schilling L, 2014, MOL PLANT PATHOL, V15, P780, DOI 10.1111/mpp.12133; Schrodinger L. L. C., 2015, JYMOL MOL GRAPHICS D; Schuhmacher JS, 2015, P NATL ACAD SCI USA, V112, P3092, DOI 10.1073/pnas.1419388112; Skibbe DS, 2010, SCIENCE, V328, P89, DOI 10.1126/science.1185775; Tamburrini M, 2005, PROTEIN J, V24, P423, DOI 10.1007/s10930-005-7638-7; Villajuana-Bonequi M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46734-3; Walbot V, 2010, SEX PLANT REPROD, V23, P1, DOI 10.1007/s00497-009-0109-0; Zhou P, 2010, J BIOMOL NMR, V46, P23, DOI 10.1007/s10858-009-9371-6	34	2	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7816	7825		10.1074/jbc.RA119.012207	http://dx.doi.org/10.1074/jbc.RA119.012207			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32350112	Green Published, hybrid			2022-12-28	WOS:000540935400001
J	Gao, Q; Khan, R; Yu, CP; Alsheimer, M; Jiang, XH; Ma, H; Shi, QH				Gao, Qian; Khan, Ranjha; Yu, Changping; Alsheimer, Manfred; Jiang, Xiaohua; Ma, Hui; Shi, Qinghua			The testis-specific LINC component SUN3 is essential for sperm head shaping during mouse spermiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						spermatogenesis; sperm; gene knockout; reproduction; spermatozoa; infertility; LINC complex; manchette; sperm shaping; SUN3	NUCLEAR-ENVELOPE; DOMAIN PROTEINS; MANCHETTE; MICROTUBULES; COMPLEXES; ANCHORAGE; ROLES; GENE	Sperm head shaping is a key event in spermiogenesis and is tightly controlled via the acrosome?manchette network. Linker of nucleoskeleton and cytoskeleton (LINC) complexes consist of Sad1 and UNC84 domain?containing (SUN) and Klarsicht/ANC-1/Syne-1 homology (KASH) domain proteins and form conserved nuclear envelope bridges implicated in transducing mechanical forces from the manchette to sculpt sperm nuclei into a hook-like shape. However, the role of LINC complexes in sperm head shaping is still poorly understood. Here we assessed the role of SUN3, a testis-specific LINC component harboring a conserved SUN domain, in spermiogenesis. We show that CRISPR/Cas9-generated Sun3 knockout male mice are infertile, displaying drastically reduced sperm counts and a globozoospermia-like phenotype, including a missing, mislocalized, or fragmented acrosome, as well as multiple defects in sperm flagella. Further examination revealed that the sperm head abnormalities are apparent at step 9 and that the sperm nuclei fail to elongate because of the absence of manchette microtubules and perinuclear rings. These observations indicate that Sun3 deletion likely impairs the ability of the LINC complex to transduce the cytoskeletal force to the nuclear envelope, required for sperm head elongation. We also found that SUN3 interacts with SUN4 in mouse testes and that the level of SUN4 proteins is drastically reduced in Sun3-null mice. Altogether, our results indicate that SUN3 is essential for sperm head shaping and male fertility, providing molecular clues regarding the underlying pathology of the globozoospermia-like phenotype.	[Gao, Qian; Khan, Ranjha; Yu, Changping; Jiang, Xiaohua; Ma, Hui; Shi, Qinghua] Univ Sci & Technol China, Affiliated Hosp 1,Collaborat Innovat Ctr Genet &, Sch Life Sci,Chinese Acad Sci Ctr Excellence Mol, Hefei Natl Lab Phys Sci Microscale,Chinese Acad S, Hefei 230027, Peoples R China; [Alsheimer, Manfred] Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, D-97074 Wurzburg, Germany	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Wurzburg	Jiang, XH; Ma, H; Shi, QH (corresponding author), Univ Sci & Technol China, Affiliated Hosp 1,Collaborat Innovat Ctr Genet &, Sch Life Sci,Chinese Acad Sci Ctr Excellence Mol, Hefei Natl Lab Phys Sci Microscale,Chinese Acad S, Hefei 230027, Peoples R China.	biojxh@ustc.edu.cn; clsmh@ustc.edu.cn; qshi@ustc.edu.cn	Shi, Qinghua/N-2950-2013	Khan, Ranjha/0000-0002-1010-4407; Ma, Hui/0000-0002-0995-2345	National Natural Science Foundation of China (NSFC) [31890780, 31630050, 31871514]; National Key Research and Developmental Program of China [2018YFC1004700, 2016YFC1000600]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19000000]; German Research Foundation [Al 1090/4-1, Al 1090/4-2]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Developmental Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); German Research Foundation(German Research Foundation (DFG))	This work was supported by National Natural Science Foundation of China (NSFC) Grant 31890780, 31630050 (to Q. S.), and 31871514 (to X. J.); National Key Research and Developmental Program of China Grants 2018YFC1004700 (to X. J.) and 2016YFC1000600 (to Q. S.); and Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB19000000. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by German Research Foundation Grants Al 1090/4-1 and Al 1090/4-2 (to M. A.).	Akhmanova A, 2005, GENE DEV, V19, P2501, DOI 10.1101/gad.344505; Burke B, 2009, DEV CELL, V17, P587, DOI 10.1016/j.devcel.2009.10.018; Calvi A, 2015, DEV BIOL, V407, P321, DOI 10.1016/j.ydbio.2015.09.010; COURTENS JL, 1981, REPROD NUTR DEV, V21, P467, DOI 10.1051/rnd:19810312; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Dunleavy JEM, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007078; Fridkin A, 2009, CELL MOL LIFE SCI, V66, P1518, DOI 10.1007/s00018-008-8713-y; Gob E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012072; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Horn HF, 2013, J CELL BIOL, V202, P1023, DOI 10.1083/jcb.201304004; Jan SZ, 2012, BBA-MOL BASIS DIS, V1822, P1838, DOI 10.1016/j.bbadis.2012.02.008; Jiang L, 2017, CURR BIOL, V27, P1498, DOI 10.1016/j.cub.2017.04.017; Jiang XH, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.126334; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2001, MOL REPROD DEV, V59, P347, DOI 10.1002/mrd.1040; Lehti MS, 2016, REPRODUCTION, V151, pR43, DOI 10.1530/REP-15-0310; Lehti MS, 2017, DEVELOPMENT, V144, P2683, DOI 10.1242/dev.152108; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Li W, 2015, DEVELOPMENT, V142, P921, DOI 10.1242/dev.119834; Link J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004099; Liu Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005090; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Moreno RD, 2000, CELL MOTIL CYTOSKEL, V46, P235, DOI 10.1002/1097-0169(200008)46:4<235::AID-CM1>3.0.CO;2-G; Morimoto A, 2012, J CELL BIOL, V198, P165, DOI 10.1083/jcb.201204085; O'Donnell L, 2014, SEMIN CELL DEV BIOL, V30, P45, DOI 10.1016/j.semcdb.2014.01.003; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Pasch E, 2015, BIOL OPEN, V4, P1792, DOI 10.1242/bio.015768; Penkner AM, 2009, CELL, V139, P920, DOI 10.1016/j.cell.2009.10.045; Shang YL, 2017, ELIFE, V6, DOI [10.7554/eLife.28199.001, 10.7554/eLife.28199]; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622; Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003; Wang WJ, 2012, CELL RES, V22, P1440, DOI 10.1038/cr.2012.126; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yassine S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118698; Yin H, 2019, GENET MED, V21, P62, DOI 10.1038/s41436-018-0015-7; Zhang BB, 2020, J EXP MED, V217, DOI 10.1084/jem.20182365; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhou J, 2009, DEVELOPMENT, V136, P373, DOI 10.1242/dev.030858; Zhu F, 2019, J CELL MOL MED, V23, P2583, DOI 10.1111/jcmm.14149	42	24	24	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6289	6298		10.1074/jbc.RA119.012375	http://dx.doi.org/10.1074/jbc.RA119.012375			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32156700	hybrid, Green Published			2022-12-28	WOS:000537685000005
J	Jiao, WT; Fan, YF; Blackmore, NJ; Parker, EJ				Jiao, Wanting; Fan, Yifei; Blackmore, Nicola J.; Parker, Emily J.			A single amino acid substitution uncouples catalysis and allostery in an essential biosynthetic enzyme in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; molecular dynamics; protein sequence; enzyme mutation; enzyme inhibitor; enzyme structure; aromatic amino acid biosynthesis; DAH7PS; shikimate pathway; statistical coupling analysis; tuberculosis	3-DEOXY-D-ARABINO-HEPTULOSONATE-7-PHOSPHATE SYNTHASE; SYNERGISTIC ALLOSTERY; CHORISMATE MUTASE; SCATTERING; COMPLEXES; DYNAMICS; EFFICIENCY; REVEALS; PROVIDE; SYSTEM	Allostery exploits the conformational dynamics of enzymes by triggering a shift in population ensembles toward functionally distinct conformational or dynamic states. Allostery extensively regulates the activities of key enzymes within biosynthetic pathways to meet metabolic demand for their end products. Here, we have examined a critical enzyme, 3-deoxy-d-arabino-heptulosonate 7-phosphate synthase (DAH7PS), at the gateway to aromatic amino acid biosynthesis in Mycobacterium tuberculosis, which shows extremely complex dynamic allostery: three distinct aromatic amino acids jointly communicate occupancy to the active site via subtle changes in dynamics, enabling exquisite fine-tuning of delivery of these essential metabolites. Furthermore, this allosteric mechanism is co-opted by pathway branchpoint enzyme chorismate mutase upon complex formation. In this study, using statistical coupling analysis, site-directed mutagenesis, isothermal calorimetry, small-angle X-ray scattering, and X-ray crystallography analyses, we have pinpointed a critical node within the complex dynamic communication network responsible for this sophisticated allosteric machinery. Through a facile Gly to Pro substitution, we have altered backbone dynamics, completely severing the allosteric signal yet remarkably, generating a nonallosteric enzyme that retains full catalytic activity. We also identified a second residue of prime importance to the inter-enzyme communication with chorismate mutase. Our results reveal that highly complex dynamic allostery is surprisingly vulnerable and provide further insights into the intimate link between catalysis and allostery.	[Jiao, Wanting; Fan, Yifei; Blackmore, Nicola J.; Parker, Emily J.] Univ Canterbury, Maurice Wilkins Ctr Mol Biodiscovery, Biomol Interact Ctr, Christchurch 8041, New Zealand; [Jiao, Wanting; Fan, Yifei; Parker, Emily J.] Victoria Univ Wellington, Ferrier Res Inst, Wellington 6012, New Zealand	University of Canterbury; Victoria University Wellington	Parker, EJ (corresponding author), Victoria Univ Wellington, Ferrier Res Inst, Wellington 6012, New Zealand.	emily.parker@vuw.ac.nz		Jiao, Wanting/0000-0002-0234-7206; Fan, Yifei/0000-0002-4131-5573; Parker, Emily/0000-0002-9571-9987	New Zealand Marsden Fund [UOC-1105]; Maurice Wilkins Centre for Molecular Biodiscovery	New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Maurice Wilkins Centre for Molecular Biodiscovery	This work was supported by New Zealand Marsden Fund Grant UOC-1105 and The Maurice Wilkins Centre for Molecular Biodiscovery. The authors declare that they have no conflicts of interest with the contents of this article.	Ahuja LG, 2019, P NATL ACAD SCI USA, V116, P15052, DOI 10.1073/pnas.1900163116; Bahar I, 2007, CURR OPIN STRUC BIOL, V17, P633, DOI 10.1016/j.sbi.2007.09.011; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; Blackmore NJ, 2013, J MOL BIOL, V425, P1582, DOI 10.1016/j.jmb.2012.12.019; Burschowsky D, 2018, BIOCHEMISTRY-US, V57, P557, DOI 10.1021/acs.biochem.7b01018; Chinthalapudi K, 2017, ELIFE, V6, DOI 10.7554/eLife.32742; Choy MS, 2017, MOL CELL, V65, P644, DOI 10.1016/j.molcel.2017.01.014; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hartmann M, 2003, P NATL ACAD SCI USA, V100, P862, DOI 10.1073/pnas.0337566100; Holliday MJ, 2017, STRUCTURE, V25, P276, DOI 10.1016/j.str.2016.12.003; Jiao WT, 2019, BIOPHYS J, V116, P1887, DOI 10.1016/j.bpj.2019.03.040; Jiao W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180052; Jiao WT, 2012, J MOL BIOL, V415, P716, DOI 10.1016/j.jmb.2011.11.037; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kim J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600663; Kirby N, 2016, ACTA CRYSTALLOGR D, V72, P1254, DOI 10.1107/S2059798316017174; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konig V, 2004, J MOL BIOL, V337, P675, DOI 10.1016/j.jmb.2004.01.055; Lang EJM, 2016, J AM CHEM SOC, V138, P2036, DOI 10.1021/jacs.5b13134; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Modi T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123808; Munack S, 2016, J MOL BIOL, V428, P1237, DOI 10.1016/j.jmb.2016.01.001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nazmi AR, 2016, J BIOL CHEM, V291, P21836, DOI 10.1074/jbc.M116.741637; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Reichau S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152723; Rivoire O, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004817; Rosensweig C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03503-6; Saavedra HG, 2018, NATURE, V558, P324, DOI 10.1038/s41586-018-0183-2; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Shumilin IA, 1999, STRUCTURE, V7, P865, DOI 10.1016/S0969-2126(99)80109-9; Shumilin IA, 2003, BIOCHEMISTRY-US, V42, P3766, DOI 10.1021/bi027257p; Stacklies W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000574; Sterritt OW, 2018, BIOCHEMISTRY-US, V57, P2667, DOI 10.1021/acs.biochem.8b00082; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tesileanu T, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004091; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Wagner T, 2000, J MOL BIOL, V301, P389, DOI 10.1006/jmbi.2000.3957; Walker GE, 1996, MICROBIOL-SGM, V142, P1973, DOI 10.1099/13500872-142-8-1973; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; Webby CJ, 2005, ACTA CRYSTALLOGR F, V61, P403, DOI 10.1107/S1744309105007931	52	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6252	6262		10.1074/jbc.RA120.012605	http://dx.doi.org/10.1074/jbc.RA120.012605			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32217694	hybrid, Green Published			2022-12-28	WOS:000537685000001
J	Ramadoss, S; Chen, XH; Wang, CY				Ramadoss, Sivakumar; Chen, Xiaohong; Wang, Cun-Yu			Histone demethylase KDM6B promotes epithelial-mesenchymal transition (vol 287, pg 44508, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													chen, xi/GXH-3653-2022; chen, xia/GXM-5435-2022; chen, xia/GYR-3948-2022					Ramadoss S, 2012, J BIOL CHEM, V287, P44508, DOI 10.1074/jbc.M112.424903	1	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6781	6781		10.1074/jbc.AAC120.013773	http://dx.doi.org/10.1074/jbc.AAC120.013773			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32385095	Green Published, hybrid			2022-12-28	WOS:000537685000041
J	Young, T; Niks, D; Hakopian, S; Tam, TK; Yu, XJ; Hille, R; Blaha, GM				Young, Tynan; Niks, Dimitri; Hakopian, Sheron; Tam, Timothy K.; Yu, Xuejun; Hille, Russ; Blaha, Gregor M.			Crystallographic and kinetic analyses of the FdsBG subcomplex of the cytosolic formate dehydrogenase FdsABG from Cupriavidus necator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinamide adenine dinucleotide (NADH); electron transfer; enzyme kinetics; enzyme structure; flavin mononucleotide (FMN); protein crystallization; carbon assimilation; FdsABG; formate dehydrogenase	IRON-SULFUR CLUSTERS; ACYL-CARRIER PROTEIN; UBIQUINONE OXIDOREDUCTASE; MITOCHONDRIAL NADH; DIFFRACTION DATA; COMPLEX-I; REDUCTION; CO2; FLAVOPROTEINS; XANTHINE	Formate oxidation to carbon dioxide is a key reaction in one-carbon compound metabolism, and its reverse reaction represents the first step in carbon assimilation in the acetogenic and methanogenic branches of many anaerobic organisms. The molybdenum-containing dehydrogenase FdsABG is a soluble NAD(+)-dependent formate dehydrogenase and a member of the NADH dehydrogenase superfamily. Here, we present the first structure of the FdsBG subcomplex of the cytosolic FdsABG formate dehydrogenase from the hydrogen-oxidizing bacterium Cupriavidus necator H16 both with and without bound NADH. The structures revealed that the two iron-sulfur clusters, Fe4S4 in FdsB and Fe2S2 in FdsG, are closer to the FMN than they are in other NADH dehydrogenases. Rapid kinetic studies and EPR measurements of rapid freeze-quenched samples of the NADH reduction of FdsBG identified a neutral flavin semiquinone, FMNH?, not previously observed to participate in NADH-mediated reduction of the FdsABG holoenzyme. We found that this semiquinone forms through the transfer of one electron from the fully reduced FMNH?, initially formed via NADH-mediated reduction, to the Fe2S2 cluster. This Fe2S2 cluster is not part of the on-path chain of iron-sulfur clusters connecting the FMN of FdsB with the active-site molybdenum center of FdsA. According to the NADH-bound structure, the nicotinamide ring stacks onto the re-face of the FMN. However, NADH binding significantly reduced the electron density for the isoalloxazine ring of FMN and induced a conformational change in residues of the FMN-binding pocket that display peptide-bond flipping upon NAD(+) binding in proper NADH dehydrogenases.	[Young, Tynan; Niks, Dimitri; Hakopian, Sheron; Tam, Timothy K.; Yu, Xuejun; Hille, Russ] Univ Calif Riverside, Dept Biochem, 900 Univ Ave,Boyce Hall 2404, Riverside, CA 92521 USA; [Blaha, Gregor M.] Univ Calif Riverside, Dept Biochem, 900 Univ Ave,Boyce Hall 5489, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, 900 Univ Ave,Boyce Hall 2404, Riverside, CA 92521 USA.; Blaha, GM (corresponding author), Univ Calif Riverside, Dept Biochem, 900 Univ Ave,Boyce Hall 5489, Riverside, CA 92521 USA.	russ.hille@ucr.edu; gregor.blaha@ucr.edu			University of California, Riverside; United States Department of Energy [DE-SC0010666]	University of California, Riverside(University of California System); United States Department of Energy(United States Department of Energy (DOE))	This work was supported by discretionary funds of the University of California, Riverside (to G. M. B.) and by United States Department of Energy Grant DE-SC0010666 (to R. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BALLOU DP, 1974, ANAL CHEM, V46, P1248, DOI 10.1021/ac60345a034; Bliven S, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006104; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; Chanique AM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00194; Chapman S. K., 1999, FLAVOPROTEIN PROTOCO, P18; Cramm R, 2009, J MOL MICROB BIOTECH, V16, P38, DOI 10.1159/000142893; EDMONDSON DE, 1981, ARCH BIOCHEM BIOPHYS, V208, P69, DOI 10.1016/0003-9861(81)90124-7; EDMONDSON DE, 1983, TOP CURR CHEM, V108, P109; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FRIEDEBOLD J, 1993, J BACTERIOL, V175, P4719, DOI 10.1128/JB.175.15.4719-4728.1993; FRIEDEBOLD J, 1995, BIOL CHEM H-S, V376, P561, DOI 10.1515/bchm3.1995.376.9.561; Friedrich T, 1997, J THEOR BIOL, V187, P529, DOI 10.1006/jtbi.1996.0387; GALANTE YM, 1979, ARCH BIOCHEM BIOPHYS, V192, P559, DOI 10.1016/0003-9861(79)90126-7; Hartmann T, 2013, FEBS J, V280, P6083, DOI 10.1111/febs.12528; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIM JH, 1993, J BIOL CHEM, V268, P44; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Lauterbach L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025939; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Little GT, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.00814-19; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Moriarty NW, 2019, ACTA CRYSTALLOGR D, V75, P16, DOI 10.1107/S205979831801519X; Niks D, 2018, METHOD ENZYMOL, V613, P277, DOI 10.1016/bs.mie.2018.10.013; Niks D, 2016, J BIOL CHEM, V291, P1162, DOI 10.1074/jbc.M115.688457; Oh JI, 1998, J BIOL CHEM, V273, P26349, DOI 10.1074/jbc.273.41.26349; Ohnishi T, 2018, BIOL CHEM, V399, P1249, DOI 10.1515/hsz-2018-0164; OLSON JS, 1974, J BIOL CHEM, V249, P4363; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer G., 1971, FLAVINS FLAVOPROTEIN, P132; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Reda T, 2008, BIOCHEMISTRY-US, V47, P8885, DOI 10.1021/bi800437g; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; SACKMANN U, 1991, EUR J BIOCHEM, V200, P463, DOI 10.1111/j.1432-1033.1991.tb16205.x; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schulte M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10429-0; Shomura Y, 2017, SCIENCE, V357, P928, DOI 10.1126/science.aan4497; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Yano T, 1996, J BIOL CHEM, V271, P5907, DOI 10.1074/jbc.271.10.5907; Yu XJ, 2019, BIOCHEMISTRY-US, V58, P1861, DOI 10.1021/acs.biochem.8b01301; Yu XJ, 2017, J BIOL CHEM, V292, P16872, DOI 10.1074/jbc.M117.785576	52	8	8	7	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6570	6585		10.1074/jbc.RA120.013264	http://dx.doi.org/10.1074/jbc.RA120.013264			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32249211	Green Published, hybrid			2022-12-28	WOS:000537685000026
J	Ghodke, PP; Guengerich, FP				Ghodke, Pratibha P.; Guengerich, F. Peter			Impact of 1,N-6-ethenoadenosine, a damaged ribonucleotide in DNA, on translesion synthesis and repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; DNA enzyme; RNA modification; RNA processing; reverse transcription; 1; N6-ethenoadenosine (1; N6-?rA); DNA adducts; genome integrity; polymerase eta; translesion synthesis (TLS); DNA alkylation	POLYMERASE-ETA; KINETIC-ANALYSIS; VINYL-CHLORIDE; ERRONEOUS INCORPORATION; REVERSE TRANSCRIPTION; SOMATIC HYPERMUTATION; METABOLITES INVITRO; ESCHERICHIA-COLI; OXIDATIVE DAMAGE; RIBOSOMAL-RNA	Incorporation of ribonucleotides into DNA can severely diminish genome integrity. However, how ribonucleotides instigate DNA damage is poorly understood. In DNA, they can promote replication stress and genomic instability and have been implicated in several diseases. We report here the impact of the ribonucleotide rATP and of its naturally occurring damaged analog 1,N-6-ethenoadenosine (1,N-6-?rA) on translesion synthesis (TLS), mediated by human DNA polymerase ? (hpol ?), and on RNase H2?mediated incision. Mass spectral analysis revealed that 1,N-6-?rA in DNA generates extensive frameshifts during TLS, which can lead to genomic instability. Moreover, steady-state kinetic analysis of the TLS process indicated that deoxypurines (i.e. dATP and dGTP) are inserted predominantly opposite 1,N-6-?rA. We also show that hpol ? acts as a reverse transcriptase in the presence of damaged ribonucleotide 1,N-6-?rA but has poor RNA primer extension activities. Steady-state kinetic analysis of reverse transcription and RNA primer extension showed that hpol ? favors the addition of dATP and dGTP opposite 1,N-6-?rA. We also found that RNase H2 recognizes 1,N-6-?rA but has limited incision activity across from this lesion, which can lead to the persistence of this detrimental DNA adduct. We conclude that the damaged and unrepaired ribonucleotide 1,N-6-?rA in DNA exhibits mutagenic potential and can also alter the reading frame in an mRNA transcript because 1,N-6-?rA is incompletely incised by RNase H2.	[Ghodke, Pratibha P.; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37323 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		Ghodke, Pratibha P./0000-0002-8402-3933	National Institutes of Health [R01 ES026955]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01 ES026955 (to F. P. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya N, 2019, CURR GENET, V65, P649, DOI 10.1007/s00294-018-0918-5; Alenko A, 2017, BIOCHEMISTRY-US, V56, P5053, DOI 10.1021/acs.biochem.7b00730; [Anonymous], [No title captured]; Barnes RP, 2017, DNA REPAIR, V57, P1, DOI 10.1016/j.dnarep.2017.05.006; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; Berglund AK, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006628; BERGMAN K, 1982, ARCH TOXICOL, V49, P117, DOI 10.1007/BF00332359; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Betous R, 2009, MOL CARCINOGEN, V48, P369, DOI 10.1002/mc.20509; BIERNAT J, 1978, NUCLEIC ACIDS RES, V5, P789, DOI 10.1093/nar/5.3.789; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Calabretta A, 2013, BIOCHEMISTRY-US, V52, P1990, DOI 10.1021/bi400116y; Caldecott KW, 2014, SCIENCE, V343, P260, DOI 10.1126/science.1248234; Cerritelli SM, 2019, DNA REPAIR, V84, DOI 10.1016/j.dnarep.2019.102736; Cerritelli SM, 2016, TRENDS BIOCHEM SCI, V41, P434, DOI 10.1016/j.tibs.2016.02.005; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Che Y, 2010, J PSYCHIATR NEUROSCI, V35, P296, DOI 10.1503/jpn.090083; Chowdhury Goutam, 2011, Curr Protoc Nucleic Acid Chem, VChapter 7, DOI 10.1002/0471142700.nc0716s47; Clausen AR, 2013, DNA REPAIR, V12, P121, DOI 10.1016/j.dnarep.2012.11.006; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; Conover HN, 2015, GENETICS, V201, P951, DOI 10.1534/genetics.115.181149; Crespan E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10805; Cronan GE, 2019, P NATL ACAD SCI USA, V116, P1251, DOI 10.1073/pnas.1814512116; Defoiche J, 2009, CLIN CHEM, V55, P1824, DOI 10.1373/clinchem.2008.119446; DeRose EF, 2012, BIOCHEMISTRY-US, V51, P2407, DOI 10.1021/bi201710q; ELGHISSASSI F, 1995, CHEM RES TOXICOL, V8, P278, DOI 10.1021/tx00044a013; Evich M, 2016, CHEMBIOCHEM, V17, P1968, DOI 10.1002/cbic.201600385; Fiala KA, 2007, J MOL BIOL, V365, P590, DOI 10.1016/j.jmb.2006.10.008; Forslund JME, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007315; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Franklin A, 2004, IMMUNOL CELL BIOL, V82, P219, DOI 10.1046/j.0818-9641.2004.01221.x; Fu IW, 2019, DNA REPAIR, V73, P155, DOI 10.1016/j.dnarep.2018.11.012; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; Gali VK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12915-1; Garcia-Exposito L, 2016, CELL REP, V17, P1858, DOI 10.1016/j.celrep.2016.10.048; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; GUENGERICH FP, 1992, J AM CHEM SOC, V114, P1074, DOI 10.1021/ja00029a041; GUENGERICH FP, 1979, BIOCHEM PHARMACOL, V28, P589, DOI 10.1016/0006-2952(79)90140-0; Heider MR, 2017, J BIOL CHEM, V292, P8835, DOI 10.1074/jbc.M117.783472; Hofer T, 2005, BIOL CHEM, V386, P333, DOI 10.1515/bc.2005.040; Hwang HS, 2004, BIOCHEMISTRY-US, V43, P14612, DOI 10.1021/bi0489558; Hyjek M, 2019, DNA REPAIR, V84, DOI 10.1016/j.dnarep.2019.102672; Johnson KA, 2019, BEILSTEIN J ORG CHEM, V15, P16, DOI 10.3762/bjoc.15.2; Johnson MK, 2019, NUCLEIC ACIDS RES, V47, P10693, DOI 10.1093/nar/gkz792; Katafuchi A, 2010, NUCLEIC ACIDS RES, V38, P859, DOI 10.1093/nar/gkp1095; Kellner V, 2020, EMBO J, V39, DOI 10.15252/embj.2019102309; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Kim N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003924; Kreisel K, 2019, NUCLEIC ACIDS RES, V47, P2425, DOI 10.1093/nar/gky1291; LAIB RJ, 1977, TOXICOLOGY, V8, P185, DOI 10.1016/0300-483X(77)90007-5; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Li ZW, 2006, IUBMB LIFE, V58, P581, DOI 10.1080/15216540600946456; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Liu M, 2012, BIOL CHEM, V393, P123, DOI 10.1515/hsz-2011-0247; Malfatti MC, 2019, J BIOL CHEM, V294, P13061, DOI 10.1074/jbc.RA119.009493; Markkanen E, 2017, DNA REPAIR, V59, P82, DOI 10.1016/j.dnarep.2017.09.007; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Mentegari E, 2017, NUCLEIC ACIDS RES, V45, P2600, DOI 10.1093/nar/gkw1275; Meroni A, 2019, NUCLEIC ACIDS RES, V47, P4612, DOI 10.1093/nar/gkz165; Moss CF, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1009; Nawrot B, 2011, CELL MOL LIFE SCI, V68, P4023, DOI 10.1007/s00018-011-0773-8; O'Flaherty Derek K, 2014, Curr Protoc Nucleic Acid Chem, V59, DOI 10.1002/0471142700.nc0721s59; OTTENWALDER H, 1979, ARCH TOXICOL, V41, P279, DOI 10.1007/BF00296897; Pai CC, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020057; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Patra A, 2016, J BIOL CHEM, V291, P14134, DOI 10.1074/jbc.M116.732487; Potenski CJ, 2014, NUCLEIC ACIDS RES, V42, P10226, DOI 10.1093/nar/gku773; Poulsen HE, 2012, FREE RADICAL BIO MED, V52, P1353, DOI 10.1016/j.freeradbiomed.2012.01.009; Pryor JM, 2018, SCIENCE, V361, P1126, DOI 10.1126/science.aat2477; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; RANDERATH K, 1992, MUTAT RES, V275, P355, DOI 10.1016/0921-8734(92)90038-Q; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Ren MT, 2019, CHEM RES TOXICOL, V32, P926, DOI 10.1021/acs.chemrestox.9b00059; Rey L, 2009, MOL CELL BIOL, V29, P3344, DOI 10.1128/MCB.00115-09; RIBOVICH ML, 1982, CARCINOGENESIS, V3, P539, DOI 10.1093/carcin/3.5.539; Sassa A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50421-8; Sassa A, 2019, GENES ENVIRON, V41, DOI 10.1186/s41021-019-0118-7; Sassa A, 2016, J BIOL CHEM, V291, P24314, DOI 10.1074/jbc.M116.738732; Sastre-Moreno G, 2014, NUCLEIC ACIDS RES, V42, P9821, DOI 10.1093/nar/gku711; SCHULMAN LH, 1976, BIOCHEMISTRY-US, V15, P5769, DOI 10.1021/bi00671a013; SECRIST JA, 1972, BIOCHEMISTRY-US, V11, P3499, DOI 10.1021/bi00769a001; Seiffert S, 2011, ANAL BIOCHEM, V414, P47, DOI 10.1016/j.ab.2011.02.040; Shah S, 2008, NAT PROTOC, V3, P351, DOI 10.1038/nprot.2007.535; Shimizu M, 2007, BIOCHEMISTRY-US, V46, P5515, DOI 10.1021/bi062238r; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; SPENGLER S, 1981, NUCLEIC ACIDS RES, V9, P365, DOI 10.1093/nar/9.2.365; Storici F, 2007, NATURE, V447, P338, DOI 10.1038/nature05720; Su Y, 2019, J BIOL CHEM, V294, P6073, DOI 10.1074/jbc.RA119.007925; Su Y, 2017, J BIOL CHEM, V292, P18044, DOI 10.1074/jbc.M117.809723; Su Yan, 2016, Curr Protoc Nucleic Acid Chem, V65, DOI 10.1002/cpnc.2; Su Y, 2016, J BIOL CHEM, V291, P3747, DOI 10.1074/jbc.M115.706226; Su Y, 2015, J BIOL CHEM, V290, P15921, DOI 10.1074/jbc.M115.653691; Suo ZC, 1998, J BIOL CHEM, V273, P27259, DOI 10.1074/jbc.273.42.27259; Thapar R, 2019, BIOCHEMISTRY-US, V58, P312, DOI 10.1021/acs.biochem.8b00949; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Uehara R, 2018, CELL REP, V25, P1135, DOI 10.1016/j.celrep.2018.10.019; Vaisman A, 2018, CRIT REV BIOCHEM MOL, V53, P382, DOI 10.1080/10409238.2018.1483889; Vaisman A, 2017, CRIT REV BIOCHEM MOL, V52, P274, DOI 10.1080/10409238.2017.1291576; Wanrooij PH, 2019, FEBS LETT, V593, P1554, DOI 10.1002/1873-3468.13440; Willi J, 2018, NUCLEIC ACIDS RES, V46, P1945, DOI 10.1093/nar/gkx1308; Williams JS, 2014, DNA REPAIR, V19, P27, DOI 10.1016/j.dnarep.2014.03.029; Wurtmann EJ, 2009, CRIT REV BIOCHEM MOL, V44, P34, DOI [10.1080/10409230802594043, 10.1080/10409230802594043 ]; Yan LWL, 2019, J BIOL CHEM, V294, P15158, DOI 10.1074/jbc.REV119.006513; Yang W, 2018, ANNU REV BIOCHEM, V87, P239, DOI 10.1146/annurev-biochem-062917-012405; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhao Y, 2013, P NATL ACAD SCI USA, V110, P8146, DOI 10.1073/pnas.1303126110	107	6	6	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6092	6107		10.1074/jbc.RA120.012829	http://dx.doi.org/10.1074/jbc.RA120.012829			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32213600	Green Published, hybrid			2022-12-28	WOS:000531417300020
J	Klomp, J; Hyun, J; Klomp, JE; Pajcini, K; Rehman, J; Malik, AB				Klomp, Jeff; Hyun, James; Klomp, Jennifer E.; Pajcini, Kostandin; Rehman, Jalees; Malik, Asrar B.			Comprehensive transcriptomic profiling reveals SOX7 as an early regulator of angiogenesis in hypoxic human endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypoxia; endothelial cell; angiogenesis; transcriptomics; vascular	LONG NONCODING RNA; GENE-EXPRESSION; INDUCIBLE FACTOR-1; REDUNDANT ROLES; DNA-BINDING; HIF-1-ALPHA; OXYGEN; SPECIFICITY; PROTECTION; CHROMATIN	Endothelial cells (ECs) lining the vasculature of vertebrates respond to low oxygen (hypoxia) by maintaining vascular homeostasis and initiating adaptive growth of new vasculature through angiogenesis. Previous studies have uncovered the molecular underpinnings of the hypoxic response in ECs; however, there is a need for comprehensive temporal analysis of the transcriptome during hypoxia. Here, we sought to investigate the early transcriptional programs of hypoxic ECs by using RNA-Seq of primary cultured human umbilical vein ECs exposed to progressively increasing severity and duration of hypoxia. We observed that hypoxia modulates the expression levels of approximately one-third of the EC transcriptome. Intriguingly, expression of the gene encoding the developmental transcription factor SOX7 (SRY-box transcription factor 7) rapidly and transiently increased during hypoxia. Transcriptomic and functional analyses of ECs following SOX7 depletion established its critical role in regulating hypoxia-induced angiogenesis. We also observed that depletion of the hypoxia-inducible factor (HIF) genes, HIF1A (encoding HIF-1?) and endothelial PAS domain protein 1 (EPAS1 encoding HIF-2?), inhibited both distinct and overlapping transcriptional programs. Our results indicated a role for HIF-1? in down-regulating mitochondrial metabolism while concomitantly up-regulating glycolytic genes, whereas HIF-2? primarily up-regulated the angiogenesis transcriptional program. These results identify the concentration and time dependence of the endothelial transcriptomic response to hypoxia and an early key role for SOX7 in mediating angiogenesis.	[Klomp, Jeff; Hyun, James; Klomp, Jennifer E.; Pajcini, Kostandin; Rehman, Jalees; Malik, Asrar B.] Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave,Mailcode 868, Chicago, IL 60612 USA; [Rehman, Jalees] Univ Illinois, Coll Med, Dept Med, Div Cardiol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Rehman, J; Malik, AB (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave,Mailcode 868, Chicago, IL 60612 USA.	jalees@uic.edu; abmalik@uic.edu	Rehman, Jalees/GVU-1981-2022	Rehman, Jalees/0000-0002-2787-9292; Malik, Asrar/0000-0002-8205-7128; Klomp, Jeffrey/0000-0002-5243-6987; Klomp, Jennifer/0000-0003-1781-648X	National Institutes of Health T32 Training Program in Lung Biology and Pathobiology [5T32HL007829]; National Institutes of Health [R01HL126516, P01HL060678, P01HL077806, R01HL090152, R01HL118068]; Chicago Biomedical Consortium Postdoctoral Research Award [PDR-089]	National Institutes of Health T32 Training Program in Lung Biology and Pathobiology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium Postdoctoral Research Award	This work was supported by Grant 5T32HL007829 from the National Institutes of Health T32 Training Program in Lung Biology and Pathobiology (to J. K., J. H., J. E. K., and A. B. M.) and National Institutes of Health Grants R01HL126516 (to J. R.), P01HL060678 (to A. B. M. and J. R.), P01HL077806 (to A. B. M.), R01HL090152 (to A. B. M. and J. R.), and R01HL118068 (to A. B. M. and J. R.). This work was also supported by Chicago Biomedical Consortium Postdoctoral Research Award PDR-089 (to J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhtar S, 2015, HYPERTENSION, V66, P1220, DOI 10.1161/HYPERTENSIONAHA.115.05886; Andrews S., 2021, FASTQC; Behrens AN, 2014, STEM CELLS DEV, V23, P2004, DOI 10.1089/scd.2013.0525; Branco-Price C, 2012, CANCER CELL, V21, P52, DOI 10.1016/j.ccr.2011.11.017; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Chakraborty AA, 2019, SCIENCE, V363, P1217, DOI 10.1126/science.aaw1026; Chen DR, 2017, INT J MOL MED, V40, P1529, DOI 10.3892/ijmm.2017.3138; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Chesney J, 2014, ONCOTARGET, V5, P6670, DOI 10.18632/oncotarget.2213; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Cho H, 2016, NATURE, V539, P107, DOI 10.1038/nature19795; Choudhry H, 2018, CELL METAB, V27, P281, DOI 10.1016/j.cmet.2017.10.005; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Costa G, 2012, DEVELOPMENT, V139, P1587, DOI 10.1242/dev.071282; Cowburn AS, 2016, P NATL ACAD SCI USA, V113, P8801, DOI 10.1073/pnas.1602978113; Cruys B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12240; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Fuhrmann DC, 2017, REDOX BIOL, V12, P208, DOI 10.1016/j.redox.2017.02.012; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerri C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15492; Han J, 2017, SCI REP-UK, V7, P10, DOI 10.1038/s41598-017-04333-0; Hang XY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-126; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Huang YD, 2012, AM J RESP CELL MOL, V46, P224, DOI 10.1165/rcmb.2011-0024OC; Huang Y, 2012, P NATL ACAD SCI USA, V109, P17478, DOI 10.1073/pnas.1209281109; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; JANSSENS D, 1995, BIOCHEM PHARMACOL, V50, P991, DOI 10.1016/0006-2952(95)00227-Q; Kapitsinou PP, 2014, J CLIN INVEST, V124, P2396, DOI 10.1172/JCI69073; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Krueger F., 2012, TRIM GALORE; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lee CN, 2005, APOPTOSIS, V10, P887, DOI 10.1007/s10495-005-2946-0; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003230; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Lilly AJ, 2017, MECH DEVELOP, V146, P31, DOI 10.1016/j.mod.2017.05.004; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Mimura I, 2012, MOL CELL BIOL, V32, P3018, DOI 10.1128/MCB.06643-11; Mineo M, 2016, CELL REP, V15, P2500, DOI 10.1016/j.celrep.2016.05.018; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Morgan M, 2016, RSAMTOOLS BINARY ALI; Parra V, 2017, BBA-MOL BASIS DIS, V1863, P2891, DOI 10.1016/j.bbadis.2017.07.018; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Peters K, 2005, MOL CELL BIOCHEM, V270, P157, DOI 10.1007/s11010-005-4504-z; Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scheurer SB, 2004, PROTEOMICS, V4, P1737, DOI 10.1002/pmic.200300689; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Shih JW, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0358-4; Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581; Smythies JA, 2019, EMBO REP, V20, DOI 10.15252/embr.201846401; Sun P, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku201; Tang HY, 2018, AM J PHYSIOL-LUNG C, V314, pL256, DOI 10.1152/ajplung.00096.2017; Tiana M, 2018, NUCLEIC ACIDS RES, V46, P120, DOI 10.1093/nar/gkx951; Voellenkle C, 2012, RNA, V18, P472, DOI 10.1261/rna.027615.111; Wat MJ, 2012, HUM MOL GENET, V21, P4115, DOI 10.1093/hmg/dds241; Wei H, 2012, P NATL ACAD SCI USA, V109, pE841, DOI 10.1073/pnas.1202081109; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Xia XB, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r113; Zhao J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.565; Zhigalova Nadezhda, 2015, F1000Res, V4, P1518, DOI 10.12688/f1000research.7571.1; Zhou YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143650	72	7	7	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4796	4808		10.1074/jbc.RA119.011822	http://dx.doi.org/10.1074/jbc.RA119.011822			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32071080	hybrid, Green Published			2022-12-28	WOS:000526887000005
J	Mandelli, F; de Morais, MAB; de Lima, EA; Oliveira, L; Persinoti, GF; Murakami, MT				Mandelli, Fernanda; de Morais, Mariana Abrahao Bueno; de Lima, Evandro Antonio; Oliveira, Leane; Persinoti, Gabriela Felix; Murakami, Mario Tyago			Spatially remote motifs cooperatively affect substrate preference of a ruminal GH26-type endo-?-1,4-mannanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; crystal structure; glycobiology; enzyme mechanism; substrate specificity	GLYCOSIDE HYDROLASE; BIOLOGICAL MACROMOLECULES; BIOCHEMICAL ANALYSES; SOLUTION SCATTERING; BETA-MANNANASE; RESOLUTION; PROGRAM; GENOMES; PROTEIN; TOOLS	?-Mannanases from the glycoside hydrolase 26 (GH26) family are retaining hydrolases that are active on complex heteromannans and whose genes are abundant in rumen metagenomes and metatranscriptomes. These enzymes can exhibit distinct modes of substrate recognition and are often fused to carbohydrate-binding modules (CBMs), resulting in a molecular puzzle of mechanisms governing substrate preference and mode of action that has not yet been pieced together. In this study, we recovered a novel GH26 enzyme with a CBM35 module linked to its N terminus (CrMan26) from a cattle rumen metatranscriptome. CrMan26 exhibited a preference for galactomannan as substrate and the crystal structure of the full-length protein at 1.85 ? resolution revealed a unique orientation of the ancillary domain relative to the catalytic interface, strategically positioning a surface aromatic cluster of the ancillary domain as an extension of the substrate-binding cleft, contributing to galactomannan preference. Moreover, systematic investigation of nonconserved residues in the catalytic interface unveiled that residues Tyr(195) (?3 subsite) and Trp(234) (?5 subsite) from distal negative subsites have a key role in galactomannan preference. These results indicate a novel and complex mechanism for substrate recognition involving spatially remote motifs, distal negative subsites from the catalytic domain, and a surface-associated aromatic cluster from the ancillary domain. These findings expand our molecular understanding of the mechanisms of substrate binding and recognition in the GH26 family and shed light on how some CBMs and their respective orientation can contribute to substrate preference.	[Mandelli, Fernanda; de Morais, Mariana Abrahao Bueno; de Lima, Evandro Antonio; Persinoti, Gabriela Felix; Murakami, Mario Tyago] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biorenewables Natl Lab LNBR, BR-13083970 Campinas, SP, Brazil; [Oliveira, Leane] Elanco Anim Hlth, Greenfield, IN 46140 USA		Murakami, MT (corresponding author), Brazilian Ctr Res Energy & Mat, Brazilian Biorenewables Natl Lab, BR-13083970 Campinas, SP, Brazil.	mario.murakami@lnbr.cnpem.br	Persinoti, Gabriela/C-5933-2016; Murakami, Mario T/F-5640-2016; Lima, Evandro/E-4574-2017	Persinoti, Gabriela/0000-0002-0975-7283; Murakami, Mario T/0000-0002-0405-8010; Lima, Evandro/0000-0002-7412-2655; Mandelli, Fernanda/0000-0003-0891-9241	Financiadora de Estudos e Projetos (FINEP) [01.13.0225.00]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/26982-0, 2016/19995-0]	Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Financiadora de Estudos e Projetos (FINEP) Grant 01.13.0225.00 and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2015/26982-0 (to M. T. M.) and 2016/19995-0 (to M. A. B. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bagenholm V, 2019, J BIOL CHEM, V294, P9100, DOI 10.1074/jbc.RA118.007171; Bagenholm V, 2017, J BIOL CHEM, V292, P229, DOI 10.1074/jbc.M116.746438; BIELY P, 1981, EUR J BIOCHEM, V119, P559, DOI 10.1111/j.1432-1033.1981.tb05644.x; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hornung B., 2018, RUMEN METATRANSCRIPT, DOI [10.1101/275883, DOI 10.1101/275883]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Morais S, 2019, FEMS MICROBIOL REV, V43, P362, DOI 10.1093/femsre/fuz007; Nursimulu N, 2018, BIOINFORMATICS, V34, P3393, DOI 10.1093/bioinformatics/bty368; Patel AB, 2016, BIOTECHNOL APPL BIOC, V63, P257, DOI 10.1002/bab.1358; Petkun S, 2015, PEERJ, V3, DOI 10.7717/peerj.1126; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Svartstrom O, 2017, ISME J, V11, P2538, DOI 10.1038/ismej.2017.108; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Tsukagoshi H, 2014, J BIOL CHEM, V289, P10843, DOI 10.1074/jbc.M114.555383; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; von Freiesleben P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38602-x; von Freiesleben P, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1184-y; Zhang H, 2018, NUCLEIC ACIDS RES, V46, pW95, DOI 10.1093/nar/gky418	38	4	5	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5012	5021		10.1074/jbc.RA120.012583	http://dx.doi.org/10.1074/jbc.RA120.012583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32139511	hybrid, Green Published			2022-12-28	WOS:000526887000023
J	Maurya, IK; Thota, CK; Verma, SD; Sharma, J; Rawal, MK; Ravikumar, B; Sen, S; Chauhan, N; Lynn, AM; Chauhan, VS; Prasad, R				Maurya, Indresh Kumar; Thota, Chaitanya Kumar; Verma, Sachin Dev; Sharma, Jyotsna; Rawal, Manpreet Kaur; Ravikumar, Balaguru; Sen, Sobhan; Chauhan, Neeraj; Lynn, Andrew M.; Chauhan, Virander Singh; Prasad, Rajendra			RETRACTION: Withdrawal: Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans (Retraction of Vol 288, Pg 16775, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Maurya IK, 2013, J BIOL CHEM, V288, P16775, DOI 10.1074/jbc.M113.467159	1	0	0	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3393	3393		10.1074/jbc.W120.012995	http://dx.doi.org/10.1074/jbc.W120.012995			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32144156	Green Published, hybrid			2022-12-28	WOS:000519597300047
J	Wu, JB; Yuan, J; Price, NE; Wang, YS				Wu, Jiabin; Yuan, Jun; Price, Nathan E.; Wang, Yinsheng			Ada protein? and sequence context?dependent mutagenesis of alkyl phosphotriester lesions inEscherichia colicells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA alkylation; DNA replication; DNA repair; translesion synthesis; mutagenesis; replication bypass; Ada; sequence context; alkyl phosphotriester; diastereomer; mutagenesis mechanism; DNA polymerase; DNA damage	ESCHERICHIA-COLI; DNA-REPAIR; ETHYL-PHOSPHOTRIESTER; BYPASS; ALKYLPHOSPHOTRIESTERS; POLYMERASE; SITE	Alkyl phosphotriester (alkyl-PTE) lesions are frequently induced in DNA and are resistant to repair. Here, we synthesized and characterized methyl (Me)- andn-butyl (nBu)-PTEs in two diastereomeric configurations (S(p)andR(p)) at six different flanking dinucleotide sites,i.e. XT and TX(X= A, C, or G), and assessed how these lesions impact DNA replication inEscherichia colicells. When single-stranded vectors contained anS(p)-Me-PTE in the sequence contexts of 5?-AT-3?, 5?-CT-3?, or 5?-GT-3?, DNA replication was highly efficient and the replication products for all three sequence contexts contained 85?90% AT and 5?10% TG. Thus, the replication outcome was largely independent of the identity of the 5? nucleotide adjacent to anS(p)-Me-PTE. Furthermore, replication across these lesions was not dependent on the activities of DNA polymerases II, IV, or V; Ada, a protein involved in adaptive response and repair ofS(p)-Me-PTE inE. coli, however, was essential for the generation of the mutagenic products. Additionally, theR(p)diastereomer of Me-PTEs atXT sites and both diastereomers of Me-PTEs at TXsites exhibited error-free replication bypass. Moreover,S-p-nBu-PTEs atXT sites did not strongly impede DNA replication, and othernBu-PTEs displayed moderate blockage effects, with none of them being mutagenic. Taken together, these findings provide in-depth understanding of how alkyl-PTE lesions are recognized by the DNA replication machinery in prokaryotic cells and reveal that Ada contributes to mutagenesis ofS(p)-Me-PTEs inE. coli.	[Wu, Jiabin; Yuan, Jun; Wang, Yinsheng] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Price, Nathan E.; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA.; Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wu, Jiabin/AID-4204-2022; Wang, Yin/HCI-9352-2022	Wu, Jiabin/0000-0002-7380-7038; 	National Institutes of Health [R01 CA236204]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01 CA236204 (to Y. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Delaney JC, 2006, METHOD ENZYMOL, V408, P1, DOI 10.1016/S0076-6879(06)08001-3; DEMPLE B, 1985, P NATL ACAD SCI USA, V82, P2688, DOI 10.1073/pnas.82.9.2688; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Guichard Y, 2000, CANCER RES, V60, P1276; Harper M, 2012, MUTAT RES-FUND MOL M, V731, P64, DOI 10.1016/j.mrfmmm.2011.10.011; He C, 2005, MOL CELL, V20, P117, DOI 10.1016/j.molcel.2005.08.013; Hong HZ, 2007, NUCLEIC ACIDS RES, V35, P7118, DOI 10.1093/nar/gkm851; Jones GDD, 2010, MUTAGENESIS, V25, P3, DOI 10.1093/mutage/gep038; Le Pla RC, 2004, CHEM RES TOXICOL, V17, P1491, DOI 10.1021/tx049798g; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Ma B, 2018, CHEM RES TOXICOL, V31, P48, DOI 10.1021/acs.chemrestox.7b00281; MCCARTHY TV, 1985, NUCLEIC ACIDS RES, V13, P2683, DOI 10.1093/nar/13.8.2683; MYERS LC, 1993, SCIENCE, V261, P1164, DOI 10.1126/science.8395079; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; NAKAMURA T, 1988, J MOL BIOL, V202, P483, DOI 10.1016/0022-2836(88)90280-X; Neeley WL, 2007, J BIOL CHEM, V282, P12741, DOI 10.1074/jbc.M700575200; Rye PT, 2008, DNA REPAIR, V7, P170, DOI 10.1016/j.dnarep.2007.09.003; SAMSON L, 1977, NATURE, V267, P281, DOI 10.1038/267281a0; SEDGWICK B, 1988, J BIOL CHEM, V263, P4430; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; Thomason L. C., 2007, CURRENT PROTOCOLS MO, V79, P1, DOI [DOI 10.1002/0471142727.mb0117s79, 10.1002/0471142727.mb0117s79, DOI 10.1002/0471142727.MB0117S79]; Tsujikawa L, 2003, NUCLEIC ACIDS RES, V31, P4965, DOI 10.1093/nar/gkg722; Wang PC, 2019, J BIOL CHEM, V294, P3899, DOI 10.1074/jbc.RA118.007358; Wang PC, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv941; Wu JB, 2018, NUCLEIC ACIDS RES, V46, P4013, DOI 10.1093/nar/gky140; Zhai QQ, 2014, NUCLEIC ACIDS RES, V42, P10529, DOI 10.1093/nar/gku748	26	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8775	8783		10.1074/jbc.RA120.013657	http://dx.doi.org/10.1074/jbc.RA120.013657			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32381504	Green Published, hybrid			2022-12-28	WOS:000546296800013
J	Bouillet, S; Wu, T; Chen, SX; Stock, AM; Gao, R				Bouillet, Sophie; Wu, Ti; Chen, Shaoxing; Stock, Ann M.; Gao, Rong			Structural asymmetry does not indicate hemiphosphorylation in the bacterial histidine kinase CpxA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; histidine kinase; autophosphorylation; cooperativity; kinetics; asymmetric phosphorylation; environmental sensing; heterodimer; kinetic equilibrium modeling; two-component system; negative cooperativity; environmental sensing; histidine phosphotransfer	ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; SUBUNIT EXCHANGE; ATP-BINDING; AUTOPHOSPHORYLATION; INSIGHTS; CHEA; DEPHOSPHORYLATION; INHIBITION; ACTIVATION	Histidine protein kinases (HKs) are prevalent prokaryotic sensor kinases that are central to phosphotransfer in two-component signal transduction systems, regulating phosphorylation of response regulator proteins that determine the output responses. HKs typically exist as dimers and can potentially autophosphorylate at each conserved histidine residue in the individual protomers, leading to diphosphorylation. However, analyses of HK phosphorylation in biochemical assays in vitro suggest negative cooperativity, whereby phosphorylation in one protomer of the dimer inhibits phosphorylation in the second protomer, leading to ?50% phosphorylation of the available sites in dimers. This negative cooperativity is often correlated with an asymmetric domain arrangement, a common structural characteristic of autophosphorylation states in many HK structures. In this study, we engineered covalent dimers of the cytoplasmic domains of Escherichia coli CpxA, enabling us to quantify individual species: unphosphorylated, monophosphorylated, and diphosphorylated dimers. Together with mathematical modeling, we unambiguously demonstrate no cooperativity in autophosphorylation of CpxA despite its asymmetric structures, indicating that these asymmetric domain arrangements are not linked to negative cooperativity and hemiphosphorylation. Furthermore, the modeling indicated that many parameters, most notably minor amounts of ADP generated during autophosphorylation reactions or present in ATP preparations, can produce ?50% total phosphorylation that may be mistakenly attributed to negative cooperativity. This study also establishes that the engineered covalent heterodimer provides a robust experimental system for investigating cooperativity in HK autophosphorylation and offers a useful tool for testing how symmetric or asymmetric structural features influence HK functions.	[Bouillet, Sophie; Wu, Ti; Chen, Shaoxing; Stock, Ann M.; Gao, Rong] Rutgers State Univ, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Gao, R (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	rgao@cabm.rutgers.edu		Gao, Rong/0000-0002-9245-4952; Stock, Ann/0000-0002-0446-8079	National Institutes of Health [R35GM131727]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R35GM131727 (to A. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albanesi D, 2004, J BACTERIOL, V186, P2655, DOI 10.1128/JB.186.9.2655-2663.2004; Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Berntsson O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00300-5; Bhate MP, 2015, STRUCTURE, V23, P981, DOI 10.1016/j.str.2015.04.002; Buschiazzo A, 2019, ANNU REV MICROBIOL, V73, P507, DOI 10.1146/annurev-micro-091018-054627; Cai SJ, 2003, J MOL BIOL, V329, P495, DOI 10.1016/S0022-2836(03)00446-7; Cai YF, 2017, ACTA CRYSTALLOGR D, V73, P793, DOI 10.1107/S2059798317013043; Casino P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4258; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Cheung J, 2009, STRUCTURE, V17, P190, DOI 10.1016/j.str.2008.12.013; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Dikiy I, 2019, P NATL ACAD SCI USA, V116, P4963, DOI 10.1073/pnas.1813586116; Dubey BN, 2020, P NATL ACAD SCI USA, V117, P1000, DOI 10.1073/pnas.1911427117; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fisher SL, 1996, BIOCHEMISTRY-US, V35, P4732, DOI 10.1021/bi9525435; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Grimshaw CE, 1998, BIOCHEMISTRY-US, V37, P1365, DOI 10.1021/bi971917m; Gushchin I, 2017, SCIENCE, V356, DOI 10.1126/science.aah6345; Hazra S, 2015, J BIOL CHEM, V290, P24222, DOI 10.1074/jbc.M115.651745; Janiak-Spens F, 2005, BIOCHEMISTRY-US, V44, P377, DOI 10.1021/bi048433s; Jiang P, 2000, BIOCHEMISTRY-US, V39, P5057, DOI 10.1021/bi992921w; Keeble AH, 2017, ANGEW CHEM INT EDIT, V56, P16521, DOI 10.1002/anie.201707623; Mechaly AE, 2017, STRUCTURE, V25, P939, DOI 10.1016/j.str.2017.04.011; Mechaly AE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001776; Moglich A, 2019, PROTEIN SCI, V28, P1923, DOI 10.1002/pro.3705; Moore JO, 2012, STRUCTURE, V20, P729, DOI 10.1016/j.str.2012.02.021; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Noriega CE, 2008, J BACTERIOL, V190, P3869, DOI 10.1128/JB.00092-08; Park SY, 2004, BIOCHEMISTRY-US, V43, P2228, DOI 10.1021/bi0352419; Plesniak L, 2002, BIOCHEMISTRY-US, V41, P13876, DOI 10.1021/bi020331j; Potter CA, 2002, J MOL BIOL, V320, P201, DOI 10.1016/S0022-2836(02)00424-2; Surette MG, 1996, J BIOL CHEM, V271, P939, DOI 10.1074/jbc.271.2.939; TAWA P, 1994, BIOCHEMISTRY-US, V33, P7917, DOI 10.1021/bi00191a019; Trajtenberg F, 2016, ELIFE, V5, DOI 10.7554/eLife.21422; Trajtenberg F, 2010, J BIOL CHEM, V285, P24892, DOI 10.1074/jbc.M110.147843; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Ueno TB, 2015, BIOCHEM BIOPH RES CO, V465, P331, DOI 10.1016/j.bbrc.2015.07.121; Wang BY, 2014, MOL CELL, V53, P929, DOI 10.1016/j.molcel.2014.02.029; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Wilke KE, 2015, ACS CHEM BIOL, V10, P328, DOI 10.1021/cb5008019; Willett JW, 2017, MOL MICROBIOL, V103, P197, DOI 10.1111/mmi.13525; Willett JW, 2015, P NATL ACAD SCI USA, V112, pE3709, DOI 10.1073/pnas.1503118112; Wojnowska M, 2013, CHEM BIOL, V20, P1411, DOI 10.1016/j.chembiol.2013.09.008; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522; Yeo WS, 2012, MOL CELL, V45, P409, DOI 10.1016/j.molcel.2011.12.027; Young C, 2012, METHOD ENZYMOL, V511, P213, DOI 10.1016/B978-0-12-396546-2.00010-3; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	48	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8106	8117		10.1074/jbc.RA120.012757	http://dx.doi.org/10.1074/jbc.RA120.012757			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32094228	hybrid, Green Published			2022-12-28	WOS:000540935400022
J	Pederick, JL; Thompson, AP; Bell, SG; Bruning, JB				Pederick, Jordan L.; Thompson, Andrew P.; Bell, Stephen G.; Bruning, John B.			d-Alanine?d-alanine ligase as a model for the activation of ATP-grasp enzymes by monovalent cations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						structural biology; enzyme mechanism; enzyme structure; enzyme catalysis; X-ray crystallography; enzyme kinetics; metal ion?protein interaction; ATP-grasp; d-alanine?d-alanine ligase (Ddl); metal activation; monovalent cation	ALANYL-D-ALANINE; LIVER PYRUVATE-CARBOXYLASE; EFFECTIVE IONIC-RADII; AMINO-ACID LIGASE; GLUTATHIONE SYNTHETASE; ENZYMATIC SYNTHESIS; ESCHERICHIA-COLI; COA CARBOXYLASE; PURIFICATION; INHIBITION	The ATP-grasp superfamily of enzymes shares an atypical nucleotide-binding site known as the ATP-grasp fold. These enzymes are involved in many biological pathways in all domains of life. One ATP-grasp enzyme, d-alanine?d-alanine ligase (Ddl), catalyzes ATP-dependent formation of the d-alanyl?d-alanine dipeptide essential for bacterial cell wall biosynthesis and is therefore an important antibiotic drug target. Ddl is activated by the monovalent cation (MVC) K+, but despite its clinical relevance and decades of research, how this activation occurs has not been elucidated. We demonstrate here that activating MVCs bind adjacent to the active site of Ddl from Thermus thermophilus and used a combined biochemical and structural approach to characterize MVC activation. We found that TtDdl is a type II MVC-activated enzyme, retaining activity in the absence of MVCs. However, the efficiency of TtDdl increased ?20-fold in the presence of activating MVCs, and it was maximally activated by K+ and Rb+ ions. A strict dependence on ionic radius of the MVC was observed, with Li+ and Na+ providing little to no TtDdl activation. To understand the mechanism of MVC activation, we solved crystal structures of TtDdl representing distinct catalytic stages in complex with K+, Rb+, or Cs+. Comparison of these structures with apo TtDdl revealed no evident conformational change on MVC binding. Of note, the identified MVC binding site is structurally conserved within the ATP-grasp superfamily. We propose that MVCs activate Ddl by altering the charge distribution of its active site. These findings provide insight into the catalytic mechanism of ATP-grasp enzymes.	[Pederick, Jordan L.; Bruning, John B.] Univ Adelaide, Inst Photon & Adv Sensing, Adelaide, SA, Australia; [Pederick, Jordan L.; Thompson, Andrew P.; Bruning, John B.] Univ Adelaide, Dept Mol & Cellular Biol, Sch Biol Sci, Adelaide, SA, Australia; [Bell, Stephen G.] Univ Adelaide, Dept Chem, Adelaide, SA, Australia; [Thompson, Andrew P.] Univ Oxford, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England	University of Adelaide; University of Adelaide; University of Adelaide; University of Oxford	Bruning, JB (corresponding author), Univ Adelaide, Inst Photon & Adv Sensing, Adelaide, SA, Australia.; Bruning, JB (corresponding author), Univ Adelaide, Dept Mol & Cellular Biol, Sch Biol Sci, Adelaide, SA, Australia.	john.bruning@adelaide.edu.au	Bruning, John/AAW-8567-2020	Bruning, John/0000-0002-6919-1824; Pederick, Jordan/0000-0003-4048-9771; Bell, Stephen/0000-0002-7457-9727; Thompson, Andrew/0000-0002-3910-2317	Australian Government Research Training Program	Australian Government Research Training Program(Australian Government)	J. L. P. is a recipient of an Australian Government Research Training Program stipend scholarship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARGARANA CE, 1978, MOL CELL BIOCHEM, V19, P17; Bartolommei G, 2016, METHODS MOL BIOL, V1377, P111, DOI 10.1007/978-1-4939-3179-8_12; Batson S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02118-7; Chou CY, 2011, J BIOL CHEM, V286, P24417, DOI 10.1074/jbc.M111.220517; Cowan JA, 1998, CHEM REV, V98, P1067, DOI 10.1021/cr960436q; Dal Piaz F, 2009, J MED CHEM, V52, P3814, DOI 10.1021/jm801637f; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EDWARDS JB, 1968, BIOCHIM BIOPHYS ACTA, V159, P167, DOI 10.1016/0005-2744(68)90255-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS HJ, 1971, BIOCHEMISTRY-US, V10, P721; FAN C, 1994, SCIENCE, V266, P439, DOI 10.1126/science.7939684; Firestine SM, 2009, BIOORGAN MED CHEM, V17, P3317, DOI 10.1016/j.bmc.2009.03.043; Gagne OC, 2016, ACTA CRYSTALLOGR B, V72, P602, DOI 10.1107/S2052520616008507; GIORGIO AJ, 1967, BIOCHIM BIOPHYS ACTA, V139, P487, DOI 10.1016/0005-2744(67)90052-6; Gohara DW, 2016, J BIOL CHEM, V291, P20840, DOI 10.1074/jbc.R116.737833; Healy VL, 2000, CHEM BIOL, V7, P505, DOI 10.1016/S1074-5521(00)00135-6; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kino H, 2016, J BIOSCI BIOENG, V122, P155, DOI 10.1016/j.jbiosc.2016.01.014; Kino K, 2008, J BIOSCI BIOENG, V106, P313, DOI 10.1263/jbb.106.313; Kino K, 2009, BIOSCI BIOTECH BIOCH, V73, P901, DOI 10.1271/bbb.80842; Kitamura Y, 2009, ACTA CRYSTALLOGR D, V65, P1098, DOI 10.1107/S0907444909029710; Lee JH, 2006, PROTEINS, V64, P1078, DOI 10.1002/prot.20927; Liu SP, 2006, P NATL ACAD SCI USA, V103, P15178, DOI 10.1073/pnas.0604905103; MCCLURE WR, 1971, J BIOL CHEM, V246, P3569; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; MEISTER A, 1985, METHOD ENZYMOL, V113, P393; Miller JR, 2009, P NATL ACAD SCI USA, V106, P1737, DOI 10.1073/pnas.0811275106; MULLINS LS, 1990, J BIOL CHEM, V265, P8993; NEUHAUS FC, 1962, J BIOL CHEM, V237, P778; NEUHAUS FC, 1962, BIOCHEM BIOPH RES CO, V8, P377, DOI 10.1016/0006-291X(62)90011-6; NEUHAUS FC, 1962, J BIOL CHEM, V237, P3128; NIELSEN NC, 1976, BIOCHEM BIOPH RES CO, V68, P205, DOI 10.1016/0006-291X(76)90030-9; Prosser GA, 2013, ACS MED CHEM LETT, V4, P1233, DOI 10.1021/ml400349n; Prosser GA, 2013, FEBS J, V280, P1150, DOI 10.1111/febs.12108; RATHBUN WB, 1977, EXP EYE RES, V24, P145, DOI 10.1016/0014-4835(77)90255-X; ROON RJ, 1972, J BIOL CHEM, V247, P4107; RUIZAMIL M, 1965, J BIOL CHEM, V240, P3485; Sato M, 2005, J BIOSCI BIOENG, V99, P623, DOI 10.1263/jbb.99.623; Sato M, 2006, BIOSCI BIOTECH BIOCH, V70, P2790, DOI 10.1271/bbb.60307; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHASHI K, 1990, BIOCHIM BIOPHYS ACTA, V1033, P23, DOI 10.1016/0304-4165(90)90189-4; SHI Y, 1995, BIOCHEMISTRY-US, V34, P2768, DOI 10.1021/bi00009a005; Shisler KA, 2017, J AM CHEM SOC, V139, P11803, DOI 10.1021/jacs.7b04883; Sidey V, 2016, ACTA CRYSTALLOGR B, V72, P626, DOI 10.1107/S2052520616008064; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SNOKE JE, 1955, J BIOL CHEM, V213, P813; Tabata K, 2005, J BACTERIOL, V187, P5195, DOI 10.1128/JB.187.15.5195-5202.2005; Thoden JB, 1999, ACTA CRYSTALLOGR D, V55, P8, DOI 10.1107/S0907444998006234; WARREN GB, 1974, BIOCHEM J, V139, P297, DOI 10.1042/bj1390297; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; ZAWADZKE LE, 1991, BIOCHEMISTRY-US, V30, P1673, DOI 10.1021/bi00220a033; Zeczycki Tonya N, 2010, Open Enzym Inhib J, V3, P8	58	8	8	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7894	7904		10.1074/jbc.RA120.012936	http://dx.doi.org/10.1074/jbc.RA120.012936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32335509	Green Published, hybrid			2022-12-28	WOS:000540935400007
J	Subramanian, G; Popli, S; Chakravarty, S; Taylor, RT; Chakravarti, R; Chattopadhyay, S				Subramanian, Gayatri; Popli, Sonam; Chakravarty, Sukanya; Taylor, R. Travis; Chakravarti, Ritu; Chattopadhyay, Saurabh			The interferon-inducible protein TDRD7 inhibits AMP-activated protein kinase and thereby restricts autophagy-independent virus replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; interferon; AMP-activated kinase (AMPK); autophagy; herpesvirus; interferon-stimulated genes; TDRD7	HERPES-SIMPLEX-VIRUS; ANTIVIRAL DEFENSE; STIMULATED GENES; RIG-I; PATHWAY; PHOSPHORYLATION; RECOGNITION; INDUCTION; INFECTION; RELEASE	The interferon system is the first line of defense against virus infection. Recently, using a high-throughput genetic screen of a human interferon-stimulated gene short-hairpin RNA library, we identified a viral restriction factor, TDRD7 (Tudor domain?containing 7). TDRD7 inhibits the paramyxo-/pneumoviruses (e.g. Sendai virus and respiratory syncytial virus) by interfering with the virus-induced cellular autophagy pathway, which these viruses use for their replication. Here, we report that TDRD7 is a viral restriction factor against herpes simplex virus (HSV-1). Using knockdown, knockout, and ectopic expression systems, we demonstrate the anti?HSV-1 activity of TDRD7 in multiple human and mouse cell types. TDRD7 inhibited the virus-activated AMP-activated protein kinase (AMPK), which was essential for HSV-1 replication. Genetic ablation or chemical inhibition of AMPK activity suppressed HSV-1 replication in multiple human and mouse cells. Mechanistically, HSV-1 replication after viral entry depended on AMPK but not on its function in autophagy. The antiviral activity of TDRD7 depended on its ability to inhibit virus-activated AMPK. In summary, our results indicate that the newly identified viral restriction factor TDRD7 inhibits AMPK and thereby blocks HSV-1 replication independently of the autophagy pathway. These findings suggest that AMPK inhibition represents a potential strategy to manage HSV-1 infections.	[Subramanian, Gayatri; Popli, Sonam; Chakravarty, Sukanya; Taylor, R. Travis; Chattopadhyay, Saurabh] Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, Toledo, OH 43614 USA; [Chakravarti, Ritu] Univ Toledo, Coll Med & Life Sci, Dept Physiol & Pharmacol, Toledo, OH 43614 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Chattopadhyay, S (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Med Microbiol & Immunol, Toledo, OH 43614 USA.	Saurabh.Chattopadhyay@UToledo.edu	Chakravarti, Ritu/K-8928-2019; Popli, Sonam/AAR-1900-2021	Chakravarti, Ritu/0000-0003-4680-8374; Popli, Sonam/0000-0001-7450-6862; Chattopadhyay, Saurabh/0000-0002-2930-1523	American Heart Association Scientist Development [15SDG25090212, 15SDG2308025]; University of Toledo College of Medicine and Life Sciences startup funds; Medical Research Society	American Heart Association Scientist Development(American Heart Association); University of Toledo College of Medicine and Life Sciences startup funds; Medical Research Society	This work was supported by American Heart Association Scientist Development Grants 15SDG25090212 (to S. Chattopadhyay) and 15SDG2308025 (to R. C.), University of Toledo College of Medicine and Life Sciences startup funds (to S. Chattopadhyay), and funds from the Medical Research Society (to S. Chattopadhyay). The authors declare that they have no conflicts of interest with the contents of this article.	Alexander DE, 2007, J VIROL, V81, P12128, DOI 10.1128/JVI.01356-07; Anders PM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005985; [Anonymous], [No title captured]; Ashley CL, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030246; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Bravo-Santano N, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00374-18; Bruns AM, 2014, CYTOKINE GROWTH F R, V25, P507, DOI 10.1016/j.cytogfr.2014.07.006; Brunton J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003552; Buckingham EM, 2015, P NATL ACAD SCI USA, V112, P256, DOI 10.1073/pnas.1417878112; Burke JD, 2014, J VIROL, V88, P3485, DOI 10.1128/JVI.02649-13; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; Chan YK, 2015, CURR OPIN VIROL, V12, P7, DOI 10.1016/j.coviro.2015.01.004; Chattopadhyay S, 2016, IMMUNITY, V44, P1151, DOI 10.1016/j.immuni.2016.04.009; Chattopadhyay S, 2014, CYTOKINE GROWTH F R, V25, P533, DOI 10.1016/j.cytogfr.2014.06.002; Chattopadhyay S, 2014, J INTERF CYTOK RES, V34, P427, DOI 10.1089/jir.2014.0034; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Enquist LW, 2017, J VIROL, V91, DOI 10.1128/JVI.01200-16; Fensterl V, 2015, ANNU REV VIROL, V2, P549, DOI 10.1146/annurev-virology-100114-055249; Fensterl V, 2015, J VIROL, V89, P2462, DOI 10.1128/JVI.02744-14; Grose C, 2015, AUTOPHAGY, V11, P716, DOI 10.1080/15548627.2015.1017223; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003; Hardie DG, 2011, EMBO J, V30, P634, DOI 10.1038/emboj.2011.12; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Jiang YK, 2015, MBIO, V6, DOI 10.1128/mBio.01426-15; Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16; Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Koyuncu E, 2014, MBIO, V5, DOI 10.1128/mBio.02249-14; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Li M, 2018, J VIROL, V92, DOI 10.1128/JVI.02193-17; Lin SC, 2018, CELL METAB, V27, P299, DOI 10.1016/j.cmet.2017.10.009; Liu X, 2019, J VIROL, V93, DOI 10.1128/JVI.00497-19; Lv S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23130; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; Maruzuru Y, 2016, J VIROL, V90, P6738, DOI 10.1128/JVI.00846-16; McArdle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002502; McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10; Meier JL, 2017, YALE J BIOL MED, V90, P25; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Montero H, 2011, VIRUSES-BASEL, V3, P2328, DOI 10.3390/v3112328; Moreira D, 2016, CURR DRUG TARGETS, V17, P942, DOI 10.2174/1389450116666150416120559; Morizane Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199398; Moser TS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000954; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; O'Connell D, 2016, AUTOPHAGY, V12, P451, DOI 10.1080/15548627.2016.1139262; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Prantner D, 2017, J BIOL CHEM, V292, P292, DOI 10.1074/jbc.M116.763268; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Saldivia M, 2016, CELL REP, V17, P660, DOI 10.1016/j.celrep.2016.09.041; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Seo JY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003497; Silwal P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113495; Siracusano G, 2016, SCI REP-UK, V6, DOI 10.1038/srep31302; Subramanian G, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006877; Terry LJ, 2012, P NATL ACAD SCI USA, V109, P3071, DOI 10.1073/pnas.1200494109; Thomas E, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11110981; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Vink EI, 2017, J VIROL, V91, DOI 10.1128/JVI.00295-17; Waisner H, 2019, J VIROL, V93, DOI 10.1128/JVI.01258-19; Wang X, 2016, CELL HOST MICROBE, V20, P329, DOI 10.1016/j.chom.2016.08.002; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; White CL, 2009, CELLULAR SIGNALING AND INNATE IMMUNE RESPONSES TO RNA VIRUS INFECTIONS, P91; Yordy B, 2012, CELL HOST MICROBE, V12, P334, DOI 10.1016/j.chom.2012.07.013; Yu YJ, 2011, J VIROL, V85, P1573, DOI 10.1128/JVI.01967-10	78	10	10	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6811	6822		10.1074/jbc.RA120.013533	http://dx.doi.org/10.1074/jbc.RA120.013533			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32273341	hybrid, Green Published			2022-12-28	WOS:000536212600004
J	Rose, JJ; Bocian, KA; Xu, QZ; Wang, L; DeMartino, AW; Chen, XK; Corey, CG; Guimaraes, DA; Azarov, I; Huang, XYN; Tong, Q; Guo, LP; Nouraie, M; McTiernan, CF; O'Donnell, CP; Tejero, J; Shiva, S; Gladwin, MT				Rose, Jason J.; Bocian, Kaitlin A.; Xu, Qinzi; Wang, Ling; DeMartino, Anthony W.; Chen, Xiukai; Corey, Catherine G.; Guimaraes, Danielle A.; Azarov, Ivan; Huang, Xueyin N.; Tong, Qin; Guo, Lanping; Nouraie, Mehdi; McTiernan, Charles F.; O'Donnell, Christopher P.; Tejero, Jesus; Shiva, Sruti; Gladwin, Mark T.			A neuroglobin-based high-affinity ligand trap reverses carbon monoxide?induced mitochondrial poisoning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbon monoxide; nitric oxide; mitochondria; mitochondrial disease; mitochondrial respiratory chain complex; hypoxia; hypoxia-inducible factor (HIF); antidotes; CO poisoning; hemoglobin; medical toxicology; neuroglobin	CYTOCHROME-C-OXIDASE; LONG-TERM MORTALITY; NITRIC-OXIDE; OXIDATIVE STRESS; COMPLEX-I; RESPIRATORY-CHAIN; ENERGY-METABOLISM; OXYGEN; INHIBITION; HYPOXIA	Carbon monoxide (CO) remains the most common cause of human poisoning. The consequences of CO poisoning include cardiac dysfunction, brain injury, and death. CO causes toxicity by binding to hemoglobin and by inhibiting mitochondrial cytochrome c oxidase (CcO), thereby decreasing oxygen delivery and inhibiting oxidative phosphorylation. We have recently developed a CO antidote based on human neuroglobin (Ngb-H64Q-CCC). This molecule enhances clearance of CO from red blood cells in vitro and in vivo. Herein, we tested whether Ngb-H64Q-CCC can also scavenge CO from CcO and attenuate CO-induced inhibition of mitochondrial respiration. Heart tissue from mice exposed to 3% CO exhibited a 42 ? 19% reduction in tissue respiration rate and a 33 ? 38% reduction in CcO activity compared with unexposed mice. Intravenous infusion of Ngb-H64Q-CCC restored respiration rates to that of control mice correlating with higher electron transport chain CcO activity in Ngb-H64Q-CCC?treated compared with PBS-treated, CO-poisoned mice. Further, using a Clark-type oxygen electrode, we measured isolated rat liver mitochondrial respiration in the presence and absence of saturating solutions of CO (160 ?m) and nitric oxide (100 ?m). Both CO and NO inhibited respiration, and treatment with Ngb-H64Q-CCC (100 and 50 ?m, respectively) significantly reversed this inhibition. These results suggest that Ngb-H64Q-CCC mitigates CO toxicity by scavenging CO from carboxyhemoglobin, improving systemic oxygen delivery and reversing the inhibitory effects of CO on mitochondria. We conclude that Ngb-H64Q-CCC or other CO scavengers demonstrate potential as antidotes that reverse the clinical and molecular effects of CO poisoning.	[Rose, Jason J.; Bocian, Kaitlin A.; Xu, Qinzi; Wang, Ling; DeMartino, Anthony W.; Chen, Xiukai; Corey, Catherine G.; Guimaraes, Danielle A.; Azarov, Ivan; Huang, Xueyin N.; Tong, Qin; Guo, Lanping; Nouraie, Mehdi; McTiernan, Charles F.; O'Donnell, Christopher P.; Tejero, Jesus; Shiva, Sruti; Gladwin, Mark T.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Corey, Catherine G.; Guimaraes, Danielle A.; Tejero, Jesus; Shiva, Sruti] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Rose, Jason J.; Tejero, Jesus; Gladwin, Mark T.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rose, JJ (corresponding author), Univ Pittsburgh, Med Ctr, 3459 Fifth Ave, Pittsburgh, PA 15213 USA.	rosejj@upmc.edu	Guimaraes, Danielle/AAX-3556-2020; Tejero, Jesus/G-3953-2017; Rose, Jason/AAY-8921-2021; Nouraie, Seyed Mehdi/O-4071-2018	Guimaraes, Danielle/0000-0002-5187-2090; Tejero, Jesus/0000-0003-3245-9978; Nouraie, Seyed Mehdi/0000-0001-7465-0581; DeMartino, Anthony/0000-0001-5303-5758; Rose, Jason/0000-0003-1347-9148; Wang, Ling/0000-0003-4333-3158	National Institutes of Health [F32 HL132418, K08 HL136857, R01 HL111706, R01 HL125886, R01 HL098032, P01 HL103455, T32 HL110849, T32 HL007563, R01 GM113816, R21 ES027390]; National Institutes of Health, NHLBI SMARTT (Science Moving towArd Research Translation and Therapy) Program; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; Parker B. Francis Foundation; Bayer Pharmaceuticals	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NHLBI SMARTT (Science Moving towArd Research Translation and Therapy) Program; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; Parker B. Francis Foundation; Bayer Pharmaceuticals(Bayer AG)	This work was supported in part by National Institutes of Health Grants F32 HL132418 and K08 HL136857 (to J. J. R.), R01 HL111706 (to C. P. O.), R01 HL125886 (to J. T. and M. T. G.), R01 HL098032, P01 HL103455, T32 HL110849, and T32 HL007563 (to M. T. G.), R01 GM113816 (to S. S.) and R21 ES027390 (to J. T.). This work was also supported by the National Institutes of Health, NHLBI SMARTT (Science Moving towArd Research Translation and Therapy) Program, the Institute for Transfusion Medicine, the Hemophilia Center of Western Pennsylvania (to M. T. G.), and Parker B. Francis Foundation (to J. J. R.). J. J. R., L. W., C. F. M., J. T., and M. T. G. are shareholders in Globin Solutions. J. J. R., Q. X., A. W. D., J. T., and M. T. G. are coinventors of provisional, pending, and granted patents for the use of recombinant neuroglobin and other heme-based molecules as antidotes for carbon monoxide poisoning. J. J. R. and J. T. are officers and directors of Globin Solutions, Inc. M. T. G. is a director and advisor of Globin Solutions, Inc., which has licensed this technology and had an option to technology directed at using hydroxycobalamin for carbon monoxide poisoning from Virginia Commonwealth University that has expired. M. T. G. is a coinventor on patents directed to the use of nitrite salts in cardiovascular diseases licensed and exclusively optioned to Globin Solutions, Inc., which has a sponsored research agreement with the University of Pittsburgh aimed at developing carbon monoxide poisoning antidotes into therapeutics that did not support the research contained in this grant that partially supports the efforts of M. T. G., J. T., Q. X., X. C., Q. T., and X. N. H., M. T. G. is a coinvestigator in a research collaboration with Bayer Pharmaceuticals to evaluate riociguate as a treatment for patients with sickle cell disease. The financial conflicts of interest of J. J. R., J. T., Q. X., L. W., A. W. D., C. F. M., and M. T. G. were managed by the University of Pittsburgh Conflict of Interest Committee and a data stewardship committee. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Hasan YM, 2013, REPROD SCI, V20, P299, DOI 10.1177/1933719112453509; Alonso JR, 2003, PHARMACOL TOXICOL, V93, P142, DOI 10.1034/j.1600-0773.2003.930306.x; Azarov I, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aah6571; Bai YD, 2004, ANN NY ACAD SCI, V1011, P272, DOI 10.1196/annals.1293.026; Bernard C., 1857, LEONS EFFETS SUBSTAN; Brookes PS, 2003, J BIOL CHEM, V278, P31603, DOI 10.1074/jbc.M211784200; Brookes PS, 2002, METHOD ENZYMOL, V359, P305; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Brown S D, 1989, Adv Exp Med Biol, V248, P747; BROWN SD, 1990, J APPL PHYSIOL, V68, P604, DOI 10.1152/jappl.1990.68.2.604; BROWN SD, 1992, J CLIN INVEST, V89, P666, DOI 10.1172/JCI115633; Brunori M, 2001, TRENDS BIOCHEM SCI, V26, P21, DOI 10.1016/S0968-0004(00)01698-4; Cai B, 2011, EXP NEUROL, V227, P224, DOI 10.1016/j.expneurol.2010.11.009; Chambers CA, 2008, BRAIN INJURY, V22, P387, DOI 10.1080/02699050802008075; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; COBURN RF, 1973, ANNU REV MED, V24, P241, DOI 10.1146/annurev.me.24.020173.001325; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dziewierz A, 2013, J EMERG MED, V45, P831, DOI 10.1016/j.jemermed.2013.05.061; Ernst A, 1998, NEW ENGL J MED, V339, P1603, DOI 10.1056/NEJM199811263392206; Fischer GW, 2010, SEMIN THORAC CARDIOV, V22, P140, DOI 10.1053/j.semtcvs.2010.09.007; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Fordel E, 2007, GENE, V398, P114, DOI 10.1016/j.gene.2007.03.022; Gao L, 2008, VET CLIN N AM-SMALL, V38, P137, DOI 10.1016/j.cvsm.2007.10.004; Gellerich FN, 1999, SHOCK, V11, P336, DOI 10.1097/00024382-199905000-00006; Gnaiger E, 1998, J EXP BIOL, V201, P1129; GOLDBAUM L R, 1976, Annals of Clinical and Laboratory Science, V6, P372; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Hall JE, 2020, GUYTON HALL TXB MED; Hampson NB, 2008, CRIT CARE MED, V36, P2523, DOI 10.1097/CCM.0b013e31818419d8; Hampson NB, 2016, ANN AM THORAC SOC, V13, P1768, DOI 10.1513/AnnalsATS.201604-318OC; Hampson NB, 2012, AM J RESP CRIT CARE, V186, P1095, DOI 10.1164/rccm.201207-1284CI; Hampson NB, 2012, UNDERSEA HYPERBAR M, V39, P657; Hampson NB, 2009, CRIT CARE MED, V37, P1941, DOI 10.1097/CCM.0b013e3181a0064f; Handy DE, 2012, ANTIOXID REDOX SIGN, V16, P1323, DOI 10.1089/ars.2011.4123; Henry CR, 2006, JAMA-J AM MED ASSOC, V295, P398, DOI 10.1001/jama.295.4.398; Hernansanz-Agustin P, 2017, REDOX BIOL, V12, P1040, DOI 10.1016/j.redox.2017.04.025; Hopkins RO, 2008, UNDERSEA HYPERBAR M, V35, P258; Hsiao Cheng-Lung, 2004, Acta Neurol Taiwan, V13, P64; Huang CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105503; Iheagwara KN, 2007, BBA-MOL BASIS DIS, V1772, P1112, DOI 10.1016/j.bbadis.2007.06.002; Jang DH, 2018, INTENS CARE MED EXP, V6, DOI 10.1186/s40635-018-0169-2; Merino JJ, 2014, INT J MOL SCI, V15, P2475, DOI 10.3390/ijms15022475; Kamga C, 2012, NITRIC OXIDE-BIOL CH, V26, P251, DOI 10.1016/j.niox.2012.03.005; Ketteler M, 1998, KIDNEY INT, pS27; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Kumar S, 2005, TOXICOL LETT, V157, P175, DOI 10.1016/j.toxlet.2005.03.004; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Lippi G, 2012, CLIN BIOCHEM, V45, P1278, DOI 10.1016/j.clinbiochem.2012.06.004; Lo Iacono L, 2011, FREE RADICAL BIO MED, V50, P1556, DOI 10.1016/j.freeradbiomed.2011.02.033; MARAGOS CM, 1991, J MED CHEM, V34, P3242, DOI 10.1021/jm00115a013; Mimura K, 1999, Seishin Shinkeigaku Zasshi, V101, P592; Miro O, 1998, PHARMACOL TOXICOL, V82, P199, DOI 10.1111/j.1600-0773.1998.tb01425.x; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Pannala VR, 2016, J APPL PHYSIOL, V121, P1196, DOI 10.1152/japplphysiol.00524.2016; Paradies G, 2002, GENE, V286, P135, DOI 10.1016/S0378-1119(01)00814-9; Piantadosi CA, 2006, FREE RADICAL BIO MED, V40, P1332, DOI 10.1016/j.freeradbiomed.2005.11.020; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Plotnikov EY, 2009, BBA-MOL BASIS DIS, V1792, P796, DOI 10.1016/j.bbadis.2009.06.005; Powell CS, 2003, AM J PHYSIOL-LUNG C, V285, pL189, DOI 10.1152/ajplung.00253.2002; Protti A, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0762-7; Roderique JD, 2015, TOXICOLOGY, V334, P45, DOI 10.1016/j.tox.2015.05.004; Rose JJ, 2017, AM J RESP CRIT CARE, V195, P596, DOI 10.1164/rccm.201606-1275CI; Sarti P, 2003, IUBMB LIFE, V55, P605, DOI 10.1080/15216540310001628726; Sarti P, 2012, BBA-BIOENERGETICS, V1817, P610, DOI 10.1016/j.bbabio.2011.09.002; SCHEWE T, 1983, BIOMED BIOCHIM ACTA, V42, P789; SCHWERZMANN K, 1986, J CELL BIOL, V102, P97, DOI 10.1083/jcb.102.1.97; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Smithline HA, 2003, RESUSCITATION, V56, P97, DOI 10.1016/S0300-9572(02)00272-1; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Tejero J, 2014, BIOL CHEM, V395, P631, DOI 10.1515/hsz-2013-0289; Thom SR, 1997, CHEM RES TOXICOL, V10, P1023, DOI 10.1021/tx970041h; THOM SR, 1994, TOXICOL APPL PHARM, V128, P105, DOI 10.1006/taap.1994.1186; Thom SR, 2008, PHYSL MED HYPERBARIC, V321, P347; Thom SR, 2006, AM J RESP CRIT CARE, V174, P1239, DOI 10.1164/rccm.200604-557OC; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Tsai AL, 2012, BIOCHEMISTRY-US, V51, P172, DOI 10.1021/bi2015629; Turner M, 1999, J ACCID EMERG MED, V16, P92; WALD G, 1957, J GEN PHYSIOL, V40, P593, DOI 10.1085/jgp.40.4.593; Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891; Weaver LK, 2002, NEW ENGL J MED, V347, P1057, DOI 10.1056/NEJMoa013121; Weaver LK, 2008, UNDERSEA HYPERBAR M, P258; Wen JJ, 2010, ANTIOXID REDOX SIGN, V12, P27, DOI [10.1089/ars.2008.2418, 10.1089/ARS.2008.2418]; Wilson DF, 2014, J APPL PHYSIOL, V117, P1431, DOI 10.1152/japplphysiol.00737.2014; WINTER PM, 1976, JAMA-J AM MED ASSOC, V236, P1502, DOI 10.1001/jama.236.13.1502; Yang XD, 1997, J BIOL CHEM, V272, P9683; Yu Z, 2009, NEUROSCIENCE, V162, P396, DOI 10.1016/j.neuroscience.2009.04.055; ZHANG J, 1992, J CLIN INVEST, V90, P1193, DOI 10.1172/JCI115980	92	16	18	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6357	6371		10.1074/jbc.RA119.010593	http://dx.doi.org/10.1074/jbc.RA119.010593			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32205448	hybrid, Green Published			2022-12-28	WOS:000537685000010
J	Damen, MPM; Phan, TH; Ummels, R; Rubio-Canalejas, A; Bitter, W; Houben, ENG				Damen, Merel P. M.; Phan, Trang H.; Ummels, Roy; Rubio-Canalejas, Alba; Bitter, Wilbert; Houben, Edith N. G.			Modification of a PE/PPE substrate pair reroutes an Esx substrate pair from the mycobacterial ESX-1 type VII secretion system to the ESX-5 system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mycobacteria; protein secretion; substrate specificity; tuberculosis; Western blot; gene knockout; ESX-1; EsxA; PPE68; type VII secretion	VIRULENCE FACTORS; GENE-CLUSTER; TUBERCULOSIS; PROTEIN; ESAT-6; COMPLEX; MARINUM; PPE; CYTOSOL; SIGNAL	Bacterial type VII secretion systems secrete a wide range of extracellular proteins that play important roles in bacterial viability and in interactions of pathogenic mycobacteria with their hosts. Mycobacterial type VII secretion systems consist of five subtypes, ESX-1?5, and have four substrate classes, namely, Esx, PE, PPE, and Esp proteins. At least some of these substrates are secreted as heterodimers. Each ESX system mediates the secretion of a specific set of Esx, PE, and PPE proteins, raising the question of how these substrates are recognized in a system-specific fashion. For the PE/PPE heterodimers, it has been shown that they interact with their cognate EspG chaperone and that this chaperone determines the designated secretion pathway. However, both structural and pulldown analyses have suggested that EspG cannot interact with the Esx proteins. Therefore, the determining factor for system specificity of the Esx proteins remains unknown. Here, we investigated the secretion specificity of the ESX-1 substrate pair EsxB_1/EsxA_1 in Mycobacterium marinum. Although this substrate pair was hardly secreted when homologously expressed, it was secreted when co-expressed together with the PE35/PPE68_1 pair, indicating that this pair could stimulate secretion of the EsxB_1/EsxA_1 pair. Surprisingly, co-expression of EsxB_1/EsxA_1 with a modified PE35/PPE68_1 version that carried the EspG(5) chaperone-binding domain, previously shown to redirect this substrate pair to the ESX-5 system, also resulted in redirection and co-secretion of the Esx pair via ESX-5. Our results suggest a secretion model in which PE35/PPE68_1 determines the system-specific secretion of EsxB_1/EsxA_1.	[Damen, Merel P. M.; Phan, Trang H.; Rubio-Canalejas, Alba; Houben, Edith N. G.] Vrije Univ Amsterdam, Amsterdam Inst Mol & Life Sci, Sect Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [Ummels, Roy; Bitter, Wilbert] Univ Amsterdam, Med Ctr, Amsterdam Infect & Immun Inst, Dept Med Microbiol & Infect Control, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam	Houben, ENG (corresponding author), Vrije Univ Amsterdam, Amsterdam Inst Mol & Life Sci, Sect Mol Microbiol, NL-1081 HV Amsterdam, Netherlands.	e.n.g.houben@vu.nl	Bitter, Wilbert/ABG-3726-2020; Houben, Edith N.G./B-2110-2015	Bitter, Wilbert/0000-0001-8347-6511; Houben, Edith N.G./0000-0002-8805-2002; Rubio-Canalejas, Alba/0000-0003-1521-6296; Damen, Merel PM/0000-0003-4233-2671	VIDI Grant from the Netherlands Organization of Scientific Research [864.12.006]; ALW Open Grant from the Netherlands Organization of Scientific Research [ALWOP.319]	VIDI Grant from the Netherlands Organization of Scientific Research; ALW Open Grant from the Netherlands Organization of Scientific Research	This work was supported by VIDI Grant 864.12.006 (to T. H. P. and E. N. G. H.) and ALW Open Grant ALWOP.319 (to M. P. M. D.) both from the Netherlands Organization of Scientific Research. The authors declare that they have no conflicts of interest with the contents of this article.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x; Ates LS, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0011-2015; Ates LS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005190; Beckham KSH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.47; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bosserman RE, 2018, J BACTERIOL, V200, DOI [10.1128/jb.00726-17, 10.1128/JB.00726-17]; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Bunduc CM, 2020, MOL MICROBIOL, V114, P66, DOI 10.1111/mmi.14496; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Champion PAD, 2009, MOL MICROBIOL, V73, P950, DOI 10.1111/j.1365-2958.2009.06821.x; Chen JM, 2013, MOL MICROBIOL, V89, P1154, DOI 10.1111/mmi.12336; Chen X, 2017, J BIOL CHEM, V292, P16880, DOI 10.1074/jbc.M117.802645; Daleke MH, 2012, J BIOL CHEM, V287, P31939, DOI 10.1074/jbc.M112.397596; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Ekiert DC, 2014, P NATL ACAD SCI USA, V111, P14758, DOI 10.1073/pnas.1409345111; Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102; Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x; Garces A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000957; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Groschel MI, 2016, NAT REV MICROBIOL, V14, P677, DOI 10.1038/nrmicro.2016.131; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Harboe M, 1998, INFECT IMMUN, V66, P717, DOI 10.1128/IAI.66.2.717-723.1998; Houben D, 2012, CELL MICROBIOL, V14, P1287, DOI 10.1111/j.1462-5822.2012.01799.x; Houben ENG, 2014, BBA-MOL CELL RES, V1843, P1707, DOI 10.1016/j.bbamcr.2013.11.003; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Ilghari D, 2011, J BIOL CHEM, V286, P29993, DOI 10.1074/jbc.M111.248732; Korotkova N, 2015, J STRUCT BIOL, V191, P236, DOI 10.1016/j.jsb.2015.06.003; Korotkova N, 2014, MOL MICROBIOL, V94, P367, DOI 10.1111/mmi.12770; MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x; McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105; Phan TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007247; Phan TH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42704; Portaliou AG, 2016, TRENDS BIOCHEM SCI, V41, P175, DOI 10.1016/j.tibs.2015.09.005; Poulsen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089313; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Rosenberg OS, 2015, CELL, V161, P501, DOI 10.1016/j.cell.2015.03.040; Siegrist MS, 2009, P NATL ACAD SCI USA, V106, P18792, DOI 10.1073/pnas.0900589106; Simeone R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004650; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Solomonson M, 2015, STRUCTURE, V23, P571, DOI 10.1016/j.str.2015.01.002; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Tinaztepe E, 2016, INFECT IMMUN, V84, P2255, DOI 10.1128/IAI.00197-16; Tufariello JM, 2016, P NATL ACAD SCI USA, V113, pE348, DOI 10.1073/pnas.1523321113; Unnikrishnan M, 2017, TRENDS MICROBIOL, V25, P192, DOI 10.1016/j.tim.2016.11.004; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Wang SH, 2020, PROTEIN CELL, V11, P124, DOI 10.1007/s13238-019-00671-z; Weerdenburg EM, 2012, CELL MICROBIOL, V14, P728, DOI 10.1111/j.1462-5822.2012.01755.x; Xu J, 2007, MOL MICROBIOL, V66, P787, DOI 10.1111/j.1365-2958.2007.05959.x	53	12	12	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5960	5969		10.1074/jbc.RA119.011682	http://dx.doi.org/10.1074/jbc.RA119.011682			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32184351	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000531417300010
J	Singh, V; Xu, L; Boyko, S; Surewicz, K; Surewicz, WK				Singh, Virender; Xu, Ling; Boyko, Solomiia; Surewicz, Krystyna; Surewicz, Witold K.			Zinc promotes liquid?liquid phase separation of tau protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tau protein (tau); tauopathy; zinc; neurodegeneration; metal homeostasis; amyloid; Alzheimer disease; divalent transition metal; liquid-liquid phase separation; amyloid plaques; divalent transition metal	MEDIATED NEURODEGENERATION; ALZHEIMERS-DISEASE; AGGREGATION; STRESS; TRANSITION; TOXICITY; HEALTH; IONS; BETA	Tau is a microtubule-associated protein that plays a major role in Alzheimer's disease (AD) and other tauopathies. Recent reports indicate that, in the presence of crowding agents, tau can undergo liquid?liquid phase separation (LLPS), forming highly dynamic liquid droplets. Here, using recombinantly expressed proteins, turbidimetry, fluorescence microscopy imaging, and fluorescence recovery after photobleaching (FRAP) assays, we show that the divalent transition metal zinc strongly promotes this process, shifting the equilibrium phase boundary to lower protein or crowding agent concentrations. We observed no tau LLPS-promoting effect for any other divalent transition metal ions tested, including Mn2+, Fe2+, Co2+, Ni2+, and Cu2+. We also demonstrate that multiple zinc-binding sites on tau are involved in the LLPS-promoting effect and provide insights into the mechanism of this process. Zinc concentration is highly elevated in AD brains, and this metal ion is believed to be an important player in the pathogenesis of this disease. Thus, the present findings bring a new dimension to understanding the relationship between zinc homeostasis and the pathogenic process in AD and related neurodegenerative disorders.	[Singh, Virender; Xu, Ling; Boyko, Solomiia; Surewicz, Krystyna; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu	Singh, Virender/AAB-5190-2019	Singh, Virender/0000-0002-6720-8784	National Institutes of Health [RF1 AG061797]; Department of Physiology and Biophysics, Case Western Reserve University	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Physiology and Biophysics, Case Western Reserve University	This work was supported by National Institutes of Health Grant RF1 AG061797 (to W. K. S.) and the Department of Physiology and Biophysics, Case Western Reserve University, Pilot Project Grant (to W. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambadipudi S, 2019, CHEM SCI, V10, P6503, DOI 10.1039/c9sc00531e; Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Apicco DJ, 2018, NAT NEUROSCI, V21, P72, DOI 10.1038/s41593-017-0022-z; Babinchak WM, 2019, J BIOL CHEM, V294, P6306, DOI 10.1074/jbc.RA118.007222; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Boyko S, 2019, J BIOL CHEM, V294, P11054, DOI 10.1074/jbc.AC119.009198; Breydo L, 2011, METALLOMICS, V3, P1163, DOI 10.1039/c1mt00106j; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Cuajungco MP, 1997, BRAIN RES REV, V23, P219, DOI 10.1016/S0165-0173(97)00002-7; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Elbaum-Garfinkle S, 2019, J BIOL CHEM, V294, P7160, DOI 10.1074/jbc.REV118.001188; Faller P, 2014, ACCOUNTS CHEM RES, V47, P2252, DOI 10.1021/ar400293h; Fichou Y, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0682-x; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Guo T, 2017, ACTA NEUROPATHOL, V133, P665, DOI 10.1007/s00401-017-1707-9; Hernandez-Vega A, 2017, CELL REP, V20, P2304, DOI 10.1016/j.celrep.2017.08.042; Hu JY, 2017, BBA-MOL BASIS DIS, V1863, P414, DOI 10.1016/j.bbadis.2016.11.022; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Huang YP, 2014, CELL REP, V8, P831, DOI 10.1016/j.celrep.2014.06.047; Jiji AC, 2017, CHEM-EUR J, V23, P16976, DOI 10.1002/chem.201704555; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; Mo ZY, 2009, J BIOL CHEM, V284, P34648, DOI 10.1074/jbc.M109.058883; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Morris S, 2017, FIT FOR THE PRESIDENCY?: WINNERS, LOSERS, WHAT-IFS, AND ALSO-RANS, P303; Nedelsky NB, 2019, NAT REV NEUROL, V15, P272, DOI 10.1038/s41582-019-0157-5; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Peskett TR, 2018, MOL CELL, V70, P588, DOI 10.1016/j.molcel.2018.04.007; Portbury SD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122506; Rayman JB, 2018, CELL REP, V22, P59, DOI 10.1016/j.celrep.2017.12.036; Religa D, 2006, NEUROLOGY, V67, P69, DOI 10.1212/01.wnl.0000223644.08653.b5; Roman AY, 2019, J MOL BIOL, V431, P687, DOI 10.1016/j.jmb.2018.12.008; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Szewczyk B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00033; Tonnies E, 2017, J ALZHEIMERS DIS, V57, P1105, DOI 10.3233/JAD-161088; Vanderweyde T, 2016, CELL REP, V15, P1455, DOI 10.1016/j.celrep.2016.04.045; Wang YP, 2016, NAT REV NEUROSCI, V17, P5, DOI 10.1038/nrn.2015.1; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Zhang XM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002183	40	42	42	3	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5850	5856		10.1074/jbc.AC120.013166	http://dx.doi.org/10.1074/jbc.AC120.013166			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32229582	hybrid, Green Published			2022-12-28	WOS:000531417300002
J	Morimoto, K; Suzuki, N; Tanida, I; Kakuta, S; Furuta, Y; Uchiyama, Y; Hanada, K; Suzuki, Y; Yamaji, T				Morimoto, Kanta; Suzuki, Noriko; Tanida, Isei; Kakuta, Soichiro; Furuta, Yoko; Uchiyama, Yasuo; Hanada, Kentaro; Suzuki, Yusuke; Yamaji, Toshiyuki			Blood group P1 antigen?bearing glycoproteins are functional but less efficient receptors of Shiga toxin than conventional glycolipid-based receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoprotein; glycolipid; Shiga toxin; receptor; glycomics; retrograde transport; CRISPR; Cas; glycan remodeling; blood group P1 antigen; globotriaosylceramide (Gb3)	PIGEON EGG-WHITE; DIARRHEAGENIC ESCHERICHIA-COLI; N-GLYCAN STRUCTURES; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; SHIGELLA-DYSENTERIAE; MAJOR GLYCOPROTEINS; CRYSTAL-STRUCTURE; URBAN PIGEONS; HELA-CELLS	Shiga toxin (STx) is a virulence factor produced by enterohemorrhagicEscherichia coli.STx is taken up by mammalian host cells by binding to the glycosphingolipid (GSL) globotriaosylceramide (Gb3; Gal?1-4Gal?1-4Glc-ceramide) and causes cell death after its retrograde membrane transport. However, the contribution of the hydrophobic portion of Gb3 (ceramide) to STx transport remains unclear. In pigeons, blood group P1 glycan antigens (Gal?1-4Gal?1-4GlcNAc-) are expressed on glycoproteins that are synthesized by ?1,4-galactosyltransferase 2 (pA4GalT2). To examine whether these glycoproteins can also function as STx receptors, here we constructed glycan-remodeled HeLa cell variants lacking Gb3 expression but instead expressing pA4GalT2-synthesized P1 glycan antigens on glycoproteins. We compared STx binding and sensitivity of these variants with those of the parental, Gb3-expressing HeLa cells. The glycan-remodeled cells bound STx1 viaN-glycans of glycoproteins and were sensitive to STx1 even without Gb3 expression, indicating that P1-containing glycoproteins also function as STx receptors. However, these variants were significantly less sensitive to STx than the parent cells. Fluorescence microscopy and correlative light EM revealed that the STx1 B subunit accumulates to lower levels in the Golgi apparatus after glycoprotein-mediated than after Gb3-mediated uptake but instead accumulates in vacuole-like structures probably derived from early endosomes. Furthermore, coexpression of Gal?1-4Gal on both glycoproteins and GSLs reduced the sensitivity of cells to STx1 compared with those expressing Gal?1-4Gal only on GSLs, probably because of competition for STx binding or internalization. We conclude that lipid-based receptors are much more effective in STx retrograde transport and mediate greater STx cytotoxicity than protein-based receptors.	[Morimoto, Kanta; Hanada, Kentaro; Yamaji, Toshiyuki] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Morimoto, Kanta; Suzuki, Yusuke] Nihon Univ, Coll Sci & Technol, Dept Mat & Appl Chem, Tokyo, Japan; [Tanida, Isei; Kakuta, Soichiro; Furuta, Yoko; Uchiyama, Yasuo] Juntendo Univ, Dept Cellular & Mol Neuropathol, Grad Sch Med, Tokyo, Japan; [Kakuta, Soichiro] Juntendo Univ, Lab Morphol & Image Anal, Grad Sch Med, Biomed Res Ctr, Tokyo, Japan; [Suzuki, Noriko] Niigata Univ, Grad Sch Sci & Technol, Niigata, Japan	National Institute of Infectious Diseases (NIID); Nihon University; Juntendo University; Juntendo University; Niigata University	Yamaji, T (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan.; Suzuki, N (corresponding author), Niigata Univ, Grad Sch Sci & Technol, Niigata, Japan.	nrsuzuki@gs.niigata-u.ac.jp; tyamaji@nih.go.jp		Hanada, Kentaro/0000-0003-1383-2781	JSPS KAKENHI [JP17K07357]; Uchida Energy Science Promotion Foundation; MEXT KAKENHI [JP17H06417]; AMED [JP19fm0208005j0103, JP19ae0101068j0104, JP19gm0910005j0005]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uchida Energy Science Promotion Foundation(Uchida Energy Science Promotion Foundation); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED	This work was supported by the JSPS KAKENHI (No. JP17K07357 to T. Y.), the Uchida Energy Science Promotion Foundation (to N. S.), MEXT KAKENHI (No. JP17H06417 to K. H.), AMED (No. JP19fm0208005j0103 and JP19ae0101068j0104 to T. Y. and JP19gm0910005j0005 to K. H.).	Arab S, 1998, J CELL PHYSIOL, V177, P646, DOI 10.1002/(SICI)1097-4652(199812)177:4<646::AID-JCP15>3.0.CO;2-B; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borges CA, 2017, J MICROBIOL, V55, P344, DOI 10.1007/s12275-017-6523-3; Bujny MV, 2007, J CELL SCI, V120, P2010, DOI 10.1242/jcs.003111; Cherian RM, 2014, GLYCOBIOLOGY, V24, P26, DOI 10.1093/glycob/cwt086; DONOHUEROLFE A, 1989, INFECT IMMUN, V57, P3888, DOI 10.1128/IAI.57.12.3888-3893.1989; El-Sayed A, 2013, MOL THER, V21, P1118, DOI 10.1038/mt.2013.54; Elkin SR, 2016, WIEN MED WOCHENSCHR, V166, P196, DOI 10.1007/s10354-016-0432-7; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Ferreira APA, 2018, TRENDS CELL BIOL, V28, P188, DOI 10.1016/j.tcb.2017.11.004; Foster G., 2009, APPL ENVIRON MICROB, V72, P2265, DOI [10.1007/s00284-009-9434-7, DOI 10.1007/S00284-009-9434-7]; FRASER ME, 1994, NAT STRUCT BIOL, V1, P59, DOI 10.1038/nsb0194-59; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; HOLM S, 1979, SCAND J STAT, V6, P65; JACEWICZ M, 1986, J EXP MED, V163, P1391, DOI 10.1084/jem.163.6.1391; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; KIARASH A, 1994, J BIOL CHEM, V269, P11138; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; KURAYA N, 1992, J BIOCHEM, V112, P122, DOI 10.1093/oxfordjournals.jbchem.a123850; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Miyake M, 2000, ANAL BIOCHEM, V281, P202, DOI 10.1006/abio.2000.4559; Morabito S, 2001, VET MICROBIOL, V82, P275, DOI 10.1016/S0378-1135(01)00393-5; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mukhopadhyay S, 2013, MOL BIOL CELL, V24, P2311, DOI 10.1091/mbc.E13-01-0057; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Okuda T, 2006, J BIOL CHEM, V281, P10230, DOI 10.1074/jbc.M600057200; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; SANDVIG K, 1989, J CELL BIOL, V108, P1331, DOI 10.1083/jcb.108.4.1331; Selyunin AS, 2015, TRAFFIC, V16, P1270, DOI 10.1111/tra.12338; Shapiro MD, 2013, SCIENCE, V339, P1063, DOI 10.1126/science.1230422; Shimizu H, 1998, BIOCHEMISTRY-US, V37, P11078, DOI 10.1021/bi980946+; Silva VL, 2009, CURR MICROBIOL, V59, P302, DOI 10.1007/s00284-009-9434-7; Smith DC, 2006, MOL BIOL CELL, V17, P1375, DOI 10.1091/mbc.e05-11-1035; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; STEIN PE, 1992, NATURE, V355, P748, DOI 10.1038/355748a0; Stenfelt L, 2019, TRANSFUSION, V59, P1108, DOI 10.1111/trf.15115; Suzuki N, 2004, P NATL ACAD SCI USA, V101, P9023, DOI 10.1073/pnas.0402822101; Suzuki N, 2003, J BIOL CHEM, V278, P46293, DOI 10.1074/jbc.M307132200; Suzuki N, 2001, J BIOL CHEM, V276, P23221, DOI 10.1074/jbc.M101379200; Suzuki N, 2020, TRENDS GLYCOSCI GLYC, V32, pE7, DOI 10.4052/tigg.1843.1E; Suzuki N, 2019, GLYCOBIOLOGY, V29, P625, DOI 10.1093/glycob/cwz038; Suzuki N, 2019, ANAL BIOCHEM, V567, P117, DOI 10.1016/j.ab.2018.11.014; Suzuki N, 2011, GLYCOBIOLOGY, V21, P283, DOI 10.1093/glycob/cwq163; Suzuki N, 2010, J BIOL CHEM, V285, P5178, DOI 10.1074/jbc.M109.018663; Suzuki N, 2009, GLYCOBIOLOGY, V19, P693, DOI 10.1093/glycob/cwp025; Takahashi N, 2001, J BIOL CHEM, V276, P23230, DOI 10.1074/jbc.M101380200; Tomoda H, 2002, ANAL BIOCHEM, V311, P50, DOI 10.1016/S0003-2697(02)00380-9; Utskarpen A, 2007, BIOCHEM BIOPH RES CO, V358, P566, DOI 10.1016/j.bbrc.2007.04.159; Watanabe M, 2004, J INFECT DIS, V189, P360, DOI 10.1086/381124; Yahiro K, 2010, MICROB PATHOGENESIS, V49, P153, DOI 10.1016/j.micpath.2010.05.007; Yamaji T, 2005, GLYCOBIOLOGY, V15, P667, DOI 10.1093/glycob/cwi048; Yamaji T, 2019, ISCIENCE, V15, P407, DOI 10.1016/j.isci.2019.05.005; Yamaji T, 2019, ISCIENCE, V11, P409, DOI 10.1016/j.isci.2018.12.039; Yamaji T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101761; Yamaji T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088124; Yamaji T, 2010, J BIOL CHEM, V285, P35505, DOI 10.1074/jbc.M110.154229; Yu M, 2005, INFECT IMMUN, V73, P2524, DOI 10.1128/IAI.73.4.2524-2532.2005	65	7	7	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9490	9501		10.1074/jbc.RA120.013926	http://dx.doi.org/10.1074/jbc.RA120.013926			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409578	hybrid, Green Published			2022-12-28	WOS:000552758600018
J	Soysa, HSM; Aunkham, A; Schulte, A; Suginta, W				Soysa, Hannadige Sasimali Madusanka; Aunkham, Anuwat; Schulte, Albert; Suginta, Wipa			Single-channel properties, sugar specificity, and role of chitoporin in adaptive survival ofVibrio choleraetype strain O1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						black lipid membrane; chitin uptake; liposome swelling assay; outer membrane proteins; sugar transport; protein-ligand interactions; Vibrio cholerae; VcChiP; chitoporin; chitooligosaccharide; chitin; single-molecule biophysics; membrane reconstitution	BACTERIUM VIBRIO-FURNISSII; ESCHERICHIA-COLI; CRYSTAL-STRUCTURES; MOLECULAR-CLONING; CHITIN CATABOLISM; IN-VIVO; PORIN; MALTOPORIN; SURFACE; IDENTIFICATION	Vibrio choleraeis a Gram-negative, facultative anaerobic bacterial species that causes serious disease and can grow on various carbon sources, including chitin polysaccharides. In saltwater, its attachment to chitin surfaces not only serves as the initial step of nutrient recruitment but is also a crucial mechanism underlying cholera epidemics. In this study, we report the first characterization of a chitooligosaccharide-specific chitoporin,VcChiP, from the cell envelope of theV. choleraetype strain O1. We modeled the structure ofVcChiP, revealing a trimeric cylinder that forms single channels in phospholipid bilayers. The membrane-reconstitutedVcChiP channel was highly dynamic and voltage induced. Substate openings O-1?, O-2?, and O-3?, between the fully open states O-1, O-2, and O-3, were polarity selective, with nonohmic conductance profiles. Results of liposome-swelling assays suggested thatVcChiP can transport monosaccharides, as well as chitooligosaccharides, but not other oligosaccharides. Of note, an outer-membrane porin (omp)-deficient strain ofEscherichia coliexpressing heterologousVcChiP could grow on M9 minimal medium supplemented with small chitooligosaccharides. These results support a crucial role of chitoporin in the adaptive survival of bacteria on chitinous nutrients. Our findings also suggest a promising means of vaccine development based on surface-exposed outer-membrane proteins and the design of novel anticholera agents based on chitooligosaccharide-mimicking analogs.	[Soysa, Hannadige Sasimali Madusanka] Suranaree Univ Technol, Sch Chem, Inst Sci, Nakhon Ratchasima, Thailand; [Aunkham, Anuwat; Schulte, Albert; Suginta, Wipa] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn BSE, Payupnai, Rayong, Thailand; [Soysa, Hannadige Sasimali Madusanka] Sabaragamuwa Univ Sri Lanka, Fac Appl Sci, Dept Phys Sci & Technol, Belihuloya, Sri Lanka	Suranaree University of Technology; Vidyasirimedhi Institute of Science & Technology; Sabaragamuwa University of Sri Lanka	Suginta, W (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn BSE, Payupnai, Rayong, Thailand.	sasimalisoysa@gmail.com; wipa.s@vistec.ac.th		M. Soysa, H. Sasimali/0000-0003-3244-8670; Suginta, Wipa/0000-0001-5927-7192	Suranaree University of Technology [SUT1-102-5936-05]; Vidyasirimedhi Institute of Science and Technology (VISTEC) [300/111100/1711111000030]; Thailand Research Fund (TRF) through The Basic Research Grant [BRG610008]; Thailand Science Research and Innovation (TSRI) under the Global Partnership Grant	Suranaree University of Technology; Vidyasirimedhi Institute of Science and Technology (VISTEC); Thailand Research Fund (TRF) through The Basic Research Grant(Thailand Research Fund (TRF)); Thailand Science Research and Innovation (TSRI) under the Global Partnership Grant	This research was supported by Suranaree University of Technology (grant no. SUT1-102-5936-05). W. S. also received funding from Vidyasirimedhi Institute of Science and Technology (VISTEC) (grant no. 300/111100/1711111000030) and the Thailand Research Fund (TRF) through The Basic Research Grant (grant no. BRG610008). W. S. also received financial support from Thailand Science Research and Innovation (TSRI) under the Global Partnership Grant.	Almagro-Moreno S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004787; Andersen C, 2002, J BIOL CHEM, V277, P41318, DOI 10.1074/jbc.M206804200; Andersen C, 1999, MOL MICROBIOL, V32, P851, DOI 10.1046/j.1365-2958.1999.01406.x; Aunkham A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02523-y; Bartlett DH, 2005, SCIENCE, V310, P1775, DOI 10.1126/science.1122396; Blokesch M, 2012, ENVIRON MICROBIOL, V14, P1898, DOI 10.1111/j.1462-2920.2011.02689.x; Chakrabarti Sr, 1996, J BACTERIOL, V178, P524, DOI 10.1128/jb.178.2.524-530.1996; Chatterjee S, 2007, J MED MICROBIOL, V56, P824, DOI 10.1099/jmm.0.46982-0; Chen M, 2008, CHEMBIOCHEM, V9, P3029, DOI 10.1002/cbic.200800444; Chumjan W, 2015, J BIOL CHEM, V290, P19184, DOI 10.1074/jbc.M115.660530; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Conner Jenna G, 2016, Microbiol Spectr, V4, DOI 10.1128/microbiolspec.VMBF-0015-2015; Danelon C, 2003, J BIOL CHEM, V278, P35542, DOI 10.1074/jbc.M305434200; Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0; Eppens EF, 1997, FEBS LETT, V415, P317, DOI 10.1016/S0014-5793(97)01150-2; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Goulart CL, 2015, BBA-BIOMEMBRANES, V1848, P680, DOI 10.1016/j.bbamem.2014.11.009; Hunt DE, 2008, APPL ENVIRON MICROB, V74, P44, DOI 10.1128/AEM.01412-07; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Li XB, 2007, GLYCOBIOLOGY, V17, P1377, DOI 10.1093/glycob/cwm096; Liu JM, 2012, BBA-BIOMEMBRANES, V1818, P2908, DOI 10.1016/j.bbamem.2012.07.009; Lutz C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00375; Meekrathok P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149228; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Moraes TF, 2007, NAT STRUCT MOL BIOL, V14, P85, DOI 10.1038/nsmb1189; Nahar S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00260; NALIN DR, 1979, INFECT IMMUN, V25, P768, DOI 10.1128/IAI.25.2.768-770.1979; Nelson EJ, 2009, NAT REV MICROBIOL, V7, P693, DOI 10.1038/nrmicro2204; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Paliy O, 2007, APPL MICROBIOL BIOT, V73, P1169, DOI 10.1007/s00253-006-0554-8; Park JK, 2000, J BIOL CHEM, V275, P33077, DOI 10.1074/jbc.M001042200; Pathania M, 2018, STRUCTURE, V26, P708, DOI 10.1016/j.str.2018.03.010; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Sikora AE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003126; Simonet VC, 2003, J BIOL CHEM, V278, P17539, DOI 10.1074/jbc.M301202200; Soysa HSM, 2016, J BIOL CHEM, V291, P13622, DOI 10.1074/jbc.M116.728881; Stauder M, 2010, ENV MICROBIOL REP, V2, P140, DOI 10.1111/j.1758-2229.2009.00121.x; Suginta W, 2000, J APPL MICROBIOL, V89, P76, DOI 10.1046/j.1365-2672.2000.01076.x; Suginta W, 2016, INT J BIOL MACROMOL, V93, P1111, DOI 10.1016/j.ijbiomac.2016.09.066; Suginta W, 2016, BBA-BIOMEMBRANES, V1858, P3032, DOI 10.1016/j.bbamem.2016.09.007; Suginta W, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.238102; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Suginta W, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-40; Sun SY, 2015, ISME J, V9, P1812, DOI 10.1038/ismej.2014.265; Sun Y, 2013, MOL MICROBIOL, V89, P583, DOI 10.1111/mmi.12307; Tanabe M, 2010, P NATL ACAD SCI USA, V107, P6811, DOI 10.1073/pnas.0912115107; Tarsi R, 1999, APPL ENVIRON MICROB, V65, P1348; Vezzulli L, 2008, LETT APPL MICROBIOL, V46, P119, DOI 10.1111/j.1472-765X.2007.02269.x; Williams TC, 2014, APPL ENVIRON MICROB, V80, P1580, DOI 10.1128/AEM.03811-13; Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137	56	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9421	9432		10.1074/jbc.RA120.012921	http://dx.doi.org/10.1074/jbc.RA120.012921			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409576	Green Published, hybrid			2022-12-28	WOS:000552758600013
J	Yin, Y; Frank, D; Zhou, WJ; Kaur, N; French, JB; Carpino, N				Yin, Yue; Frank, David; Zhou, Weijie; Kaur, Neena; French, Jarrod B.; Carpino, Nick			An unexpected 2-histidine phosphoesterase activity of suppressor of T-cell receptor signaling protein 1 contributes to the suppression of cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; enzyme; Suppressor of TCR signaling-1 (Sts-1); 2-histidine (2H) phosphoesterase; cyclic nucleotide; 2?; 3?-cyclic nicotinamide adenine dinucleotide phosphate (NADcP); phosphodiesterase; cell signaling; signal transduction; enzyme; cyclic nucleotide; phosphodiesterases; T-cell receptor (TCR); 2H phosphoesterase; Dectin-1 receptor; NADcP; Suppressor of TCR Signaling-1; 2	PHOSPHATASE; MECHANISM; STS-1; PHOSPHODIESTERASE; ACTIVATION; TULA-2; ZAP70; SITE; SYK	The suppressor of T-cell receptor (TCR) signaling (Sts) proteins Sts-1 and Sts-2 suppress receptor-mediated signaling pathways in various immune cells, including the TCR pathway in T cells and the Dectin-1 signaling pathway in phagocytes. As multidomain enzymes, they contain an N-terminal ubiquitin-association domain, a central Src homology 3 domain, and a C-terminal histidine phosphatase domain. Recently, a 2-histidine (2H) phosphoesterase motif was identified within the N-terminal portion of Sts. The 2H phosphoesterase motif defines an evolutionarily ancient protein domain present in several enzymes that hydrolyze cyclic phosphate bonds on different substrates, including cyclic nucleotides. It is characterized by two invariant histidine residues that play a critical role in catalytic activity. Consistent with its assignment as a phosphoesterase, we demonstrate here that the Sts-1 2H phosphoesterase domain displays catalytic, saturable phosphodiesterase activity toward the dinucleotide 2?,3?-cyclic NADP. The enzyme exhibited a high degree of substrate specificity and selectively generated the 3?-nucleotide as the sole product. Sts-1 also had phosphodiesterase catalytic activity toward a 5-mer RNA oligonucleotide containing a 2?,3?-cyclic phosphate group at its 3? terminus. To investigate the functional significance of Sts-1 2H phosphoesterase activity, we generated His-to-Ala variants and examined their ability to negatively regulate cellular signaling pathways. Substitution of either conserved histidine compromised the ability of Sts-1 to suppress signaling pathways downstream of both the TCR and the Dectin-1 receptor. Our results identify a heretofore unknown cellular enzyme activity associated with Sts-1 and indicate that this catalytic activity is linked to specific cell-signaling outcomes.	[Yin, Yue; Zhou, Weijie; French, Jarrod B.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [French, Jarrod B.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Frank, David; Kaur, Neena; Carpino, Nick] SUNY Stony Brook, Med Ctr, Dept Microbiol & Immunol, Stony Brook, NY 11794 USA; [French, Jarrod B.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Minnesota System	French, JB (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.; French, JB (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.; Carpino, N (corresponding author), SUNY Stony Brook, Med Ctr, Dept Microbiol & Immunol, Stony Brook, NY 11794 USA.; French, JB (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	nicholas.carpino@stonybrook.edu; jfrench@umn.edu	French, Jarrod/K-6669-2014	French, Jarrod/0000-0002-6762-1309	NIAID, National Institutes of Health [R01AI141592, R21AI120859, R21AI133381]; NHLBI, National Institutes of Health [U01HL127522]; NIGMS, National Institutes of Health [R35GM124898]; Stony Brook University; Stony Brook University Center for Biotechnology (a New York State Center for Advanced Technology); Cold Spring Harbor Laboratory; Brookhaven National Laboratory; Feinstein Institute for Medical Research; Hormel Foundation	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stony Brook University; Stony Brook University Center for Biotechnology (a New York State Center for Advanced Technology); Cold Spring Harbor Laboratory; Brookhaven National Laboratory(United States Department of Energy (DOE)); Feinstein Institute for Medical Research; Hormel Foundation	This work was supported by NIAID, National Institutes of Health Grants R01AI141592 (to N. C. and J. B. F.), R21AI120859 (to N. C. and J. B. F.), and R21AI133381 (to N. C.), as well as by the NHLBI, National Institutes of Health Grant U01HL127522. In addition, parts of this work were supported by NIGMS, National Institutes of Health Grant R35GM124898 (to J. B. F.). Additional support was provided by Stony Brook University, the Stony Brook University Center for Biotechnology (a New York State Center for Advanced Technology), Cold Spring Harbor Laboratory, Brookhaven National Laboratory, the Feinstein Institute for Medical Research, and the Hormel Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cantrell D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018788; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Chen MJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag1796; de Castro RO, 2012, J BIOL CHEM, V287, P8194, DOI 10.1074/jbc.M111.326850; del Fresno C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00804; Diaz-Gallo LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060646; Drummond RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003417; Frank D, 2018, MBIO, V9, DOI [10.1128/mBio.00782-18, 10.1128/mbio.00782-18]; Futosi K, 2016, IMMUNOL REV, V273, P121, DOI 10.1111/imr.12455; Hofmann A, 2000, EMBO J, V19, P6207, DOI 10.1093/emboj/19.22.6207; Hu HB, 2016, J EXP MED, V213, P399, DOI 10.1084/jem.20151426; Inshaw JRJ, 2018, NAT IMMUNOL, V19, P674, DOI 10.1038/s41590-018-0129-8; Kanai A, 2009, RNA, V15, P420, DOI 10.1261/rna.1122109; Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; Kozicky LK, 2015, SEMIN IMMUNOL, V27, P276, DOI 10.1016/j.smim.2015.07.001; Lee J, 2001, J BIOL CHEM, V276, P14804, DOI 10.1074/jbc.M009434200; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Mitsutomi S, 2019, BIOCHIMIE, V165, P235, DOI 10.1016/j.biochi.2019.08.008; Motwani M, 2019, NAT REV GENET, V20, P657, DOI 10.1038/s41576-019-0151-1; Myllykoski M, 2016, BRAIN RES, V1641, P64, DOI 10.1016/j.brainres.2015.09.004; Myllykoski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032336; Naseem S, 2015, INFECT IMMUN, V83, P637, DOI 10.1128/IAI.02789-14; Ogawa S, 2019, ADV EXP MED BIOL, V1189, P85, DOI 10.1007/978-981-32-9717-3_4; Parashar K, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00406-17; Raasakka A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16520; Remus BS, 2014, RNA, V20, P1697, DOI 10.1261/rna.046797.114; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; San Luis B, 2013, BIOCHEM J, V453, P27, DOI 10.1042/BJ20121769; San Luis B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177634; Sancho D, 2012, ANNU REV IMMUNOL, V30, P491, DOI 10.1146/annurev-immunol-031210-101352; SOGIN DC, 1976, J NEUROCHEM, V27, P1333, DOI 10.1111/j.1471-4159.1976.tb02612.x; Tanaka N, 2011, J BIOL CHEM, V286, P43134, DOI 10.1074/jbc.M111.302133; Thomas DH, 2010, BLOOD, V116, P2570, DOI 10.1182/blood-2010-02-268136; Todd JA, 2018, EUR J HUM GENET, V26, P925, DOI 10.1038/s41431-018-0142-2; Tsygankov AY, 2020, CELL SIGNAL, V65, DOI 10.1016/j.cellsig.2019.109424; Wang LK, 2005, RNA, V11, P966, DOI 10.1261/rna.2170305; Yang MJ, 2015, NAT IMMUNOL, V16, P1253, DOI 10.1038/ni.3258; Zhou WJ, 2017, BIOCHEMISTRY-US, V56, P4637, DOI 10.1021/acs.biochem.7b00638	41	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8514	8523		10.1074/jbc.RA120.013482	http://dx.doi.org/10.1074/jbc.RA120.013482			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32371395	hybrid, Green Published			2022-12-28	WOS:000546986500016
J	O'Connor, KM; Das, AB; Winterbourn, CC; Hampton, MB				O'Connor, Karina M.; Das, Andrew B.; Winterbourn, Christine C.; Hampton, Mark B.			Inhibition of DNA methylation in proliferating human lymphoma cells by immune cell oxidants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidative stress; DNA methylation; neutrophil; redox signaling; epigenetics; inflammation; DNA methyltransferase (DNMT); glycine chloramine; hydrogen peroxide; tumor microenvironment	EPIGENETIC LANDSCAPE; HYPOCHLOROUS ACID; OXIDATIVE DAMAGE; REDOX REGULATION; KAPPA-B; METABOLISM; INFLAMMATION; CHLORAMINES; NEUTROPHILS; METHIONINE	Excessive generation of oxidants by immune cells results in acute tissue damage. One mechanism by which oxidant exposure could have long-term effects is modulation of epigenetic pathways. We hypothesized that methylation of newly synthesized DNA in proliferating cells can be altered by oxidants that target DNA methyltransferase activity or deplete its substrate, the methyl donor SAM. To this end, we investigated the effect of two oxidants produced by neutrophils, H2O2 and glycine chloramine, on maintenance DNA methylation in Jurkat T lymphoma cells. Using cell synchronization and MS-based analysis, we measured heavy deoxycytidine isotope incorporation into newly synthesized DNA and observed that a sublethal bolus of glycine chloramine, but not H2O2, significantly inhibited DNA methylation. Both oxidants inhibited DNA methyltransferase 1 activity, but only chloramine depleted SAM, suggesting that removal of substrate was the most effective means of inhibiting DNA methylation. These results indicate that immune cell?derived oxidants generated during inflammation have the potential to affect the epigenome of neighboring cells.	[O'Connor, Karina M.; Das, Andrew B.; Winterbourn, Christine C.; Hampton, Mark B.] Univ Otago, Dept Pathol & Biomed Sci, Ctr Free Radical Res, POB 4345, Christchurch 8140, New Zealand	University of Otago	Hampton, MB (corresponding author), Univ Otago, Dept Pathol & Biomed Sci, Ctr Free Radical Res, POB 4345, Christchurch 8140, New Zealand.	mark.hampton@otago.ac.nz	Das, Andrew/I-8352-2018; Hampton, Mark/A-8490-2008	Das, Andrew/0000-0001-6509-4886; Winterbourn, Christine/0000-0003-4160-572X; Hampton, Mark/0000-0002-7349-3729	Gravida National Centre for Growth and Development; Health Research Council of New Zealand [15/479]	Gravida National Centre for Growth and Development; Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Gravida National Centre for Growth and Development (to C. C. W. and M. B. H.) and the Health Research Council of New Zealand Grant 15/479 (to C. C. W. and M. B. H.). The authors declare that they have no conflicts of interest with the contents of this article.	COTGREAVE IA, 1986, J BIOCHEM BIOPH METH, V13, P231, DOI 10.1016/0165-022X(86)90102-8; Cyr AR, 2011, ANTIOXID REDOX SIGN, V15, P551, DOI 10.1089/ars.2010.3492; ELORANTA TO, 1976, BIOCHEM J, V160, P287, DOI 10.1042/bj1600287; Etchegaray JP, 2016, MOL CELL, V62, P695, DOI 10.1016/j.molcel.2016.05.029; Fedeles BI, 2015, P NATL ACAD SCI USA, V112, pE4571, DOI 10.1073/pnas.1507709112; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Felsenfeld G, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018200; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; Gray J W, 1979, Methods Enzymol, V58, P233; Grimes A., 1985, BIOCHEM SOC T, V13, P1259, DOI [10.1042/bst0131259, DOI 10.1042/BST0131259]; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herring JL, 2009, CHEM RES TOXICOL, V22, P1060, DOI 10.1021/tx900027w; Janke R, 2015, ANNU REV CELL DEV BI, V31, P473, DOI 10.1146/annurev-cellbio-100814-125544; Kang JI, 2008, CHEM RES TOXICOL, V21, P1211, DOI 10.1021/tx800037h; Kietzmann T, 2017, BRIT J PHARMACOL, V174, P1533, DOI 10.1111/bph.13792; Kilgore JA, 2013, J BIOL CHEM, V288, P19673, DOI 10.1074/jbc.M112.443895; Knutson CG, 2013, P NATL ACAD SCI USA, V110, pE2332, DOI 10.1073/pnas.1222669110; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lyssiotis CA, 2017, TRENDS CELL BIOL, V27, P873, DOI 10.1016/j.tcb.2017.06.003; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; Mangerich A, 2013, FREE RADICAL RES, V47, P958, DOI 10.3109/10715762.2013.832239; Midwinter RG, 2006, BIOCHEM J, V396, P71, DOI 10.1042/BJ20052026; Mikhed Y, 2015, REDOX BIOL, V5, P275, DOI 10.1016/j.redox.2015.05.008; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; Peskin AV, 2005, FREE RADICAL BIO MED, V38, P396, DOI 10.1016/j.freeradbiomed.2004.11.007; Pujadas E, 2012, CELL, V148, P1123, DOI 10.1016/j.cell.2012.02.045; Radford EJ, 2018, NAT REV ENDOCRINOL, V14, P345, DOI 10.1038/s41574-018-0005-5; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; STAAL FJT, 1995, METHOD ENZYMOL, V252, P168; Thomas E L, 1986, Methods Enzymol, V132, P569; Valinluck V, 2006, CHEM RES TOXICOL, V19, P556, DOI 10.1021/tx050341w; Valinluck V, 2007, CANCER RES, V67, P5583, DOI 10.1158/0008-5472.CAN-07-0846; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; WEITZMAN SA, 1985, SCIENCE, V227, P1231, DOI 10.1126/science.3975611; WHEATER RF, 1987, J MED GENET, V24, P113, DOI 10.1136/jmg.24.2.113; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2016, ANNU REV BIOCHEM, V85, P765, DOI 10.1146/annurev-biochem-060815-014442	43	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7839	7848		10.1074/jbc.RA120.013092	http://dx.doi.org/10.1074/jbc.RA120.013092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32312750	hybrid, Green Published			2022-12-28	WOS:000540935400003
J	Yang, YC; Li, Y; Sancar, A; Oztas, O				Yang, Yuchen; Li, Yun; Sancar, Aziz; Oztas, Onur			The circadian clock shapes the Arabidopsis transcriptome by regulating alternative splicing and alternative polyadenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian clock; alternative splicing; polyadenylation; posttranscriptional regulation; circadian rhythm	NONSENSE-MEDIATED DECAY; TEMPERATURE; GENES; IDENTIFICATION; RESPONSES; PROTEINS; SITES	The circadian clock in plants temporally coordinates biological processes throughout the day, synchronizing gene expression with diurnal environmental changes. Circadian oscillator proteins are known to regulate the expression of clock-controlled plant genes by controlling their transcription. Here, using a high-throughput RNA-Seq approach, we examined genome-wide circadian and diurnal control of the Arabidopsis transcriptome, finding that the oscillation patterns of different transcripts of multitranscript genes can exhibit substantial differences and demonstrating that the circadian clock affects posttranscriptional regulation. In parallel, we found that two major posttranscriptional mechanisms, alternative splicing (AS; especially intron retention) and alternative polyadenylation (APA), display circadian rhythmicity resulting from oscillation in the genes involved in AS and APA. Moreover, AS-related genes exhibited rhythmic AS and APA regulation, adding another layer of complexity to circadian regulation of gene expression. We conclude that the Arabidopsis circadian clock not only controls transcription of genes but also affects their posttranscriptional regulation by influencing alternative splicing and alternative polyadenylation.	[Yang, Yuchen; Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA; [Li, Yun] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA; [Sancar, Aziz; Oztas, Onur] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sancar, A; Oztas, O (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	aziz_sancar@med.unc.edu; ooztas@med.unc.edu	Yang, Yuchen/GZK-6062-2022; Oztas, Onur/AAX-5317-2021	Oztas, Onur/0000-0002-2185-6532	National Institutes of Health [ES027255, GM118102]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants ES027255 and GM118102 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barta A, 2010, PLANT CELL, V22, P2926, DOI 10.1105/tpc.110.078352; Chaudhary S, 2019, TRENDS PLANT SCI, V24, P496, DOI 10.1016/j.tplants.2019.02.006; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; El-Athman R, 2018, EBIOMEDICINE, V33, P68, DOI 10.1016/j.ebiom.2018.06.012; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Hernando CE, 2017, BBA-GENE REGUL MECH, V1860, P84, DOI 10.1016/j.bbagrm.2016.07.001; Filichkin SA, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-20; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gendreau KL, 2018, G3-GENES GENOM GENET, V8, P3539, DOI 10.1534/g3.118.200559; Guo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28060; Schlaen RG, 2015, P NATL ACAD SCI USA, V112, P9382, DOI 10.1073/pnas.1504541112; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Higashi T, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.01114, 10.3389/fpls.2016.01114]; Hong S, 2010, P NATL ACAD SCI USA, V107, P21211, DOI 10.1073/pnas.1011987107; Hsu PY, 2014, TRENDS PLANT SCI, V19, P240, DOI 10.1016/j.tplants.2013.11.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt AG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-220; Hunt AG, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00109; James AB, 2012, PLANT CELL, V24, P961, DOI 10.1105/tpc.111.093948; Jones MA, 2012, PLANT CELL, V24, P4066, DOI 10.1105/tpc.112.104828; Kersey PJ, 2018, NUCLEIC ACIDS RES, V46, pD802, DOI 10.1093/nar/gkx1011; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kim MH, 2013, CELL STRESS CHAPERON, V18, P517, DOI 10.1007/s12192-012-0398-3; Kolev NG, 2008, EMBO REP, V9, P1013, DOI 10.1038/embor.2008.146; Kwon YJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-136; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6639-4; Li Y, 2015, PLANT PHYSIOL, V169, P2409, DOI 10.1104/pp.15.00838; Lin JC, 2017, PLANT J, V91, P829, DOI 10.1111/tpj.13611; Mateos JL, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120616; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Macho AP, 2012, PLANT PHYSIOL, V159, P1845, DOI 10.1104/pp.112.199810; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; McClung CR, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010014; McGlincy NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r54; Oztas O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03922-5; Pan HR, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2015.197, 10.1038/NPLANTS.2015.197]; Park JW, 2013, METHODS MOL BIOL, V1038, P171, DOI 10.1007/978-1-62703-514-9_10; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sanchez SE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a027748; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Schoning JC, 2008, NUCLEIC ACIDS RES, V36, P6977, DOI 10.1093/nar/gkn847; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Srivastava AK, 2018, TRENDS PLANT SCI, V23, P248, DOI 10.1016/j.tplants.2017.11.003; Streitner C, 2012, NUCLEIC ACIDS RES, V40, P11240, DOI 10.1093/nar/gks873; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Wang BB, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r102; Wang QQ, 2018, ELIFE, V7, DOI 10.7554/eLife.35618; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Wu XH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00889; Yang YY, 2018, P NATL ACAD SCI USA, V115, pE4777, DOI 10.1073/pnas.1804493115; Ye CT, 2018, BIOINFORMATICS, V34, P1841, DOI 10.1093/bioinformatics/bty029; Zhou Q, 2019, PLANT J, V98, P260, DOI 10.1111/tpj.14209	57	17	17	2	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7608	7619		10.1074/jbc.RA120.013513	http://dx.doi.org/10.1074/jbc.RA120.013513			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32303634	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000538038900005
J	Ertunc, ME; Kok, BP; Parsons, WH; Wang, JG; Tan, D; Donaldson, CJ; Pinto, AFM; Vaughan, JM; Ngo, N; Lum, KM; Henry, CL; Coppola, AR; Niphakis, MJ; Cravatt, BF; Saez, E; Saghatelian, A				Erikci Ertunc, Meric; Kok, Bernard P.; Parsons, William H.; Wang, Justin G.; Tan, Dan; Donaldson, Cynthia J.; Pinto, Antonio F. M.; Vaughan, Joan M.; Ngo, Nhi; Lum, Kenneth M.; Henry, Cassandra L.; Coppola, Aundrea R.; Niphakis, Micah J.; Cravatt, Benjamin F.; Saez, Enrique; Saghatelian, Alan			AIG1 and ADTRP are endogenous hydrolases of fatty acid esters of hydroxy fatty acids (FAHFAs) in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; enzyme inhibitor; diabetes; lipid signaling; glucose metabolism; androgen induced gene 1 (AIG1); androgen-dependent TFPI-regulating protein (ADTRP); fatty acid ester of hydroxy fatty acid (FAHFA); lipid ester; threonine hydrolase	SERINE; LIBRARY; ENZYMES; LIPASE; SITE; ER	Fatty acid esters of hydroxy fatty acids (FAHFAs) are a newly discovered class of signaling lipids with anti-inflammatory and anti-diabetic properties. However, the endogenous regulation of FAHFAs remains a pressing but unanswered question. Here, using MS-based FAHFA hydrolysis assays, LC-MS?based lipidomics analyses, and activity-based protein profiling, we found that androgen-induced gene 1 (AIG1) and androgen-dependent TFPI-regulating protein (ADTRP), two threonine hydrolases, control FAHFA levels in vivo in both genetic and pharmacologic mouse models. Tissues from mice lacking ADTRP (Adtrp-KO), or both AIG1 and ADTRP (DKO) had higher concentrations of FAHFAs particularly isomers with the ester bond at the 9(th) carbon due to decreased FAHFA hydrolysis activity. The levels of other lipid classes were unaltered indicating that AIG1 and ADTRP specifically hydrolyze FAHFAs. Complementing these genetic studies, we also identified a dual AIG1/ADTRP inhibitor, ABD-110207, which is active in vivo. Acute treatment of WT mice with ABD-110207 resulted in elevated FAHFA levels, further supporting the notion that AIG1 and ADTRP activity control endogenous FAHFA levels. However, loss of AIG1/ADTRP did not mimic the changes associated with pharmacologically administered FAHFAs on extent of upregulation of FAHFA levels, glucose tolerance, or insulin sensitivity in mice, indicating that therapeutic strategies should weigh more on FAHFA administration. Together, these findings identify AIG1 and ADTRP as the first endogenous FAHFA hydrolases identified and provide critical genetic and chemical tools for further characterization of these enzymes and endogenous FAHFAs to unravel their physiological functions and roles in health and disease.	[Erikci Ertunc, Meric; Wang, Justin G.; Tan, Dan; Donaldson, Cynthia J.; Pinto, Antonio F. M.; Vaughan, Joan M.; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Kok, Bernard P.; Saez, Enrique] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Cravatt, Benjamin F.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Parsons, William H.] Oberlin Coll, Dept Chem & Biochem, Oberlin, OH 44074 USA; [Ngo, Nhi; Lum, Kenneth M.; Henry, Cassandra L.; Coppola, Aundrea R.; Niphakis, Micah J.] Lundbeck La Jolla Res Ctr Inc, San Diego, CA 92121 USA	Salk Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Oberlin College	Saghatelian, A (corresponding author), 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	asaghatelian@salk.edu		Kok, Bernard/0000-0002-9073-9700; Pinto, Antonio/0000-0002-1573-8011; Parsons, William/0000-0001-6065-2340	National Institutes of Health [DK111159, DK106210, DK114785, DA033760]; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; National Cancer Institute Cancer Center Support Grant [P30 CA014195]; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; Hewitt Foundation for Medical Research Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; Hewitt Foundation for Medical Research Fellowship	This work was supported by the National Institutes of Health Grants DK106210, DK114785, and DA033760, The Leona M. and Harry B. Helmsley Charitable Trust Grant 2012-PG-MED002 (to A. S.), National Cancer Institute Cancer Center Support Grant P30 CA014195 MASS core (to A. S.), a grant from the Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals (to A. S.), National Institutes of Health F32 postdoctoral fellowship DK111159 (to M. E. E.), and a Hewitt Foundation for Medical Research Fellowship (to W. H. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander JP, 2006, J AM CHEM SOC, V128, P9699, DOI 10.1021/ja062999h; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; He L, 2015, ANAL CHEM, V87, P11361, DOI 10.1021/acs.analchem.5b02721; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Hu T, 2018, ANAL BIOANAL CHEM, V410, P7415, DOI 10.1007/s00216-018-1350-x; Inloes JM, 2014, P NATL ACAD SCI USA, V111, P14924, DOI 10.1073/pnas.1413706111; Kisselev AF, 2000, J BIOL CHEM, V275, P14831, DOI 10.1074/jbc.275.20.14831; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Kolar MJ, 2019, J BIOL CHEM, V294, P10698, DOI 10.1074/jbc.RA118.006956; Kolar MJ, 2018, ANAL CHEM, V90, P5358, DOI 10.1021/acs.analchem.8b00503; Kuda O, 2018, DIABETES, V67, P1190, DOI 10.2337/db17-1087; Kuda O, 2016, DIABETES, V65, P2580, DOI 10.2337/db16-0385; Lee J, 2016, J BIOL CHEM, V291, P22207, DOI 10.1074/jbc.M115.703835; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lupu C, 2011, BLOOD, V118, P4463, DOI 10.1182/blood-2011-05-355370; Ma Y, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0104-4; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Nickel N, 2016, GENE, V586, P62, DOI 10.1016/j.gene.2016.03.055; Paluchova V, 2020, DIABETES, V69, P300, DOI 10.2337/db19-0494; Parsons WH, 2016, NAT CHEM BIOL, V12, P367, DOI [10.1038/NCHEMBIO.2051, 10.1038/nchembio.2051]; Patel MM, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010690; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Portolesi R, 2007, J LIPID RES, V48, P1592, DOI 10.1194/jlr.M700081-JLR200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Seo J, 2001, MOL CELLS, V11, P35; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Song P, 2018, CELL METAB, V27, P1338, DOI 10.1016/j.cmet.2018.04.001; Syed I, 2019, J CLIN INVEST, V129, P3717, DOI 10.1172/JCI122445; Syed I, 2018, CELL METAB, V27, P419, DOI 10.1016/j.cmet.2018.01.001; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tan D, 2019, J AM CHEM SOC, V141, P8798, DOI 10.1021/jacs.9b00045; Tu WC, 2010, PROSTAG LEUKOTR ESS, V83, P61, DOI 10.1016/j.plefa.2010.04.001; Wang YM, 2018, BIOCHEM BIOPH RES CO, V506, P153, DOI 10.1016/j.bbrc.2018.09.050; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wood JP, 2014, BLOOD, V123, P2934, DOI 10.1182/blood-2013-11-512764; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Zhang TJ, 2016, NAT PROTOC, V11, P747, DOI 10.1038/nprot.2016.040; Zhou P, 2019, J CLIN INVEST, V129, P4138, DOI 10.1172/JCI127092; Zhu QF, 2018, ANAL CHEM, V90, P10056, DOI 10.1021/acs.analchem.8b02839; Zvonok N, 2008, CHEM BIOL, V15, P854, DOI 10.1016/j.chembiol.2008.06.008	51	20	20	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5891	5905		10.1074/jbc.RA119.012145	http://dx.doi.org/10.1074/jbc.RA119.012145			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32152231	hybrid, Green Published			2022-12-28	WOS:000531417300005
J	Srividya, N; Lange, I; Hartmann, M; Li, QR; Mirzaei, M; Lange, BM				Srividya, Narayanan; Lange, Iris; Hartmann, Michael; Li Qunrui; Mirzaei, Maryam; Lange, Bernd Markus			Biochemical characterization of acyl activating enzymes for side chain moieties of Taxol and its analogs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						terpenoid; plant biochemistry; natural product biosynthesis; metabolism; coenzyme A (CoA); acyl-activating enzyme; CoA ligase; paclitaxel; Taxol; Taxus	COENZYME-A-SYNTHETASE; COA SYNTHETASE; ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; ANALYSIS REVEALS; BIOSYNTHESIS; ACID; IDENTIFICATION; LIGASES; GROWTH	Taxol (paclitaxel) is a very widely used anticancer drug, but its commercial sources mainly consist of stripped bark or suspension cultures of members of the plant genus Taxus. Taxol accumulates as part of a complex mixture of chemical analogs, termed taxoids, which complicates its production in pure form, highlighting the need for metabolic engineering approaches for high-level Taxol production in cell cultures or microbial hosts. Here, we report on the characterization of acyl-activating enzymes (AAEs) that catalyze the formation of CoA esters of different organic acids relevant for the N-substitution of the 3-phenylisoserine side chain of taxoids. On the basis of similarities to AAE genes of known function from other organisms, we identified candidate genes in publicly available transcriptome data sets obtained with Taxus ? media. We cloned 17 AAE genes, expressed them heterologously in Escherichia coli, purified the corresponding recombinant enzymes, and performed in vitro assays with 27 organic acids as potential substrates. We identified TmAAE1 and TmAAE5 as the most efficient enzymes for the activation of butyric acid (Taxol D side chain), TmAAE13 as the best candidate for generating a CoA ester of tiglic acid (Taxol B side chain), TmAAE3 and TmAAE13 as suitable for the activation of 4-methylbutyric acid (N-debenzoyl-N-(2-methylbutyryl)taxol side chain), TmAAE15 as a highly efficient candidate for hexanoic acid activation (Taxol C side chain), and TmAAE4 as suitable candidate for esterification of benzoic acid with CoA (Taxol side chain). This study lays important groundwork for metabolic engineering efforts aimed at improving Taxol production in cell cultures.	[Srividya, Narayanan; Lange, Iris; Lange, Bernd Markus] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Srividya, Narayanan; Lange, Iris; Hartmann, Michael; Li Qunrui; Mirzaei, Maryam; Lange, Bernd Markus] Washington State Univ, MJ Murdock Metabol Lab, Pullman, WA 99164 USA; [Hartmann, Michael] Univ Dusseldorf, Dept Mol Ecophysiol Plants, Univ Str 1, D-40225 Dusseldorf, Germany; [Li Qunrui] CP Pharmaceut Grp, Jia 3 Yongandongli, Beijing 100022, Peoples R China; [Mirzaei, Maryam] Tarbiat Modares Univ, Tehran 14115111, Iran	Washington State University; Washington State University; Heinrich Heine University Dusseldorf; Tarbiat Modares University	Lange, BM (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	lange-m@wsu.edu	Srividya, Narayanan/AAV-6936-2021	Lange, Mark/0000-0001-6565-9584; Srividya, Narayanan/0000-0001-7934-7987; Hartmann, Michael/0000-0003-4828-958X	National Institutes of Health [RC2GM092561-01, 1R01AT010593-01]; McIntire-Stennis Capacity Grant [WNP 00811]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McIntire-Stennis Capacity Grant	This work was supported by the National Institutes of Health Grants RC2GM092561-01 and 1R01AT010593-01 and McIntire-Stennis Capacity Grant WNP 00811 (to B. M. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2018, BIOTECHNOLOGY NATURA, DOI DOI 10.1007/978-3-319-67903-7_8; Arbuck S G, 1993, J Natl Cancer Inst Monogr, P11; Beuerle T, 2002, ARCH BIOCHEM BIOPHYS, V400, P258, DOI 10.1016/S0003-9861(02)00026-7; Chen H, 2011, PLANT CELL, V23, P2247, DOI 10.1105/tpc.111.086140; Cragg GM, 1998, MED RES REV, V18, P315, DOI 10.1002/(SICI)1098-1128(199809)18:5<315::AID-MED3>3.0.CO;2-W; Cuthbertson DJ, 2013, PHYTOCHEMISTRY, V91, P187, DOI 10.1016/j.phytochem.2013.02.018; Ehlting J, 1999, PLANT J, V19, P9, DOI 10.1046/j.1365-313X.1999.00491.x; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fischedick JT, 2015, PHYTOCHEMISTRY, V113, P87, DOI 10.1016/j.phytochem.2014.11.020; Foster J, 2012, PLANT CELL, V24, P1217, DOI 10.1105/tpc.112.096032; Fulda M, 2004, PLANT CELL, V16, P394, DOI 10.1105/tpc.019646; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Holton RA., 1995, TAXOL SCI APPL, P97, DOI DOI 10.1002/CHIN.199552275; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Ketchum REB, 2006, BIOTECH AGR FOREST, V57, P291; Ketchum REB, 2003, PHYTOCHEMISTRY, V62, P901, DOI 10.1016/S0031-9422(02)00711-2; Kingston DGI, 2001, CHEM COMMUN, P867, DOI 10.1039/b100070p; Klempien A, 2012, PLANT CELL, V24, P2015, DOI 10.1105/tpc.112.097519; Kliebenstein DJ, 2007, PLANT J, V51, P1062, DOI 10.1111/j.1365-313X.2007.03205.x; Koetsier MJ, 2011, FEBS LETT, V585, P893, DOI 10.1016/j.febslet.2011.02.018; Koo AJK, 2006, J BIOL CHEM, V281, P33511, DOI 10.1074/jbc.M607854200; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liu TT, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00004; Loncaric Catherine, 2007, Biotechnology Journal, V2, P266, DOI 10.1002/biot.200600194; McElroy C, 2018, BIOTECHNOLOGY NATURA, P145, DOI DOI 10.1007/978-3-319-67903-7_7; Morgan-Kiss RM, 2004, J BIOL CHEM, V279, P37324, DOI 10.1074/jbc.M405233200; Ramirez-Estrada K, 2016, PLANT BIOTECHNOL J, V14, P85, DOI 10.1111/pbi.12359; RUSSIN WA, 1995, INT J PLANT SCI, V156, P668, DOI 10.1086/297289; Sabater-Jara AB, 2010, PHYTOCHEM REV, V9, P343, DOI 10.1007/s11101-010-9167-z; SCHEPARTZ SA, 1976, CANCER TREAT REP, V60, P975; Schneider K, 2005, J BIOL CHEM, V280, P13962, DOI 10.1074/jbc.M413578200; Shockey JM, 2003, PLANT PHYSIOL, V132, P1065, DOI 10.1104/pp.103.020552; Stout JM, 2012, PLANT J, V71, P353, DOI 10.1111/j.1365-313X.2012.04949.x; Sun GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062865; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Weimar JD, 2002, J BIOL CHEM, V277, P29369, DOI 10.1074/jbc.M107022200; Xu HY, 2013, MOL PLANT, V6, P1301, DOI 10.1093/mp/sst004; Zhao LF, 2010, PLANT J, V64, P1048, DOI 10.1111/j.1365-313X.2010.04396.x; Zhou T, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1645-x	41	9	9	3	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4963	4973		10.1074/jbc.RA120.012663	http://dx.doi.org/10.1074/jbc.RA120.012663			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32086380	hybrid, Green Published			2022-12-28	WOS:000526887000019
J	Szibor, M; Gizatullina, Z; Gainutdinov, T; Endres, T; Debska-Vielhaber, G; Kunz, M; Karavasili, N; Hallmann, K; Schreiber, F; Bamberger, A; Schwarzer, M; Doenst, T; Heinze, HJ; Lemann, V; Vielhaber, S; Kunz, WS; Gellerich, FN				Szibor, Marten; Gizatullina, Zemfira; Gainutdinov, Timur; Endres, Thomas; Debska-Vielhaber, Grazyna; Kunz, Matthias; Karavasili, Niki; Hallmann, Kerstin; Schreiber, Frank; Bamberger, Alexandra; Schwarzer, Michael; Doenst, Torsten; Heinze, Hans-Jochen; Lemann, Volkmar; Vielhaber, Stephan; Kunz, Wolfram S.; Gellerich, Frank N.			Cytosolic, but not matrix, calcium is essential for adjustment of mitochondrial pyruvate supply	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mouse; mitochondria; respiratory chain; calcium; bioenergetics; malate-aspartate shuttle; mitochondrial calcium uniporter; cytosolic calcium; OXPHOS control; synaptosomes; thymocytes; fibroblasts; isolated working rat heart	MALATE-ASPARTATE SHUTTLE; OXIDATIVE-PHOSPHORYLATION; BRAIN MITOCHONDRIA; MICE LACKING; RAT-HEART; RESPIRATION; DEFICIENCY; HOMEOSTASIS; STRESS; CA2+	Mitochondrial oxidative phosphorylation (OXPHOS) and cellular workload are tightly balanced by the key cellular regulator, calcium (Ca2+). Current models assume that cytosolic Ca2+ regulates workload and that mitochondrial Ca2+ uptake precedes activation of matrix dehydrogenases, thereby matching OXPHOS substrate supply to ATP demand. Surprisingly, knockout (KO) of the mitochondrial Ca2+ uniporter (MCU) in mice results in only minimal phenotypic changes and does not alter OXPHOS. This implies that adaptive activation of mitochondrial dehydrogenases by intramitochondrial Ca2+ cannot be the exclusive mechanism for OXPHOS control. We hypothesized that cytosolic Ca2+, but not mitochondrial matrix Ca2+, may adapt OXPHOS to workload by adjusting the rate of pyruvate supply from the cytosol to the mitochondria. Here, we studied the role of malate-aspartate shuttle (MAS)-dependent substrate supply in OXPHOS responses to changing Ca2+ concentrations in isolated brain and heart mitochondria, synaptosomes, fibroblasts, and thymocytes from WT and MCU KO mice and the isolated working rat heart. Our results indicate that extramitochondrial Ca2+ controls up to 85% of maximal pyruvate-driven OXPHOS rates, mediated by the activity of the complete MAS, and that intramitochondrial Ca2+ accounts for the remaining 15%. Of note, the complete MAS, as applied here, included besides its classical NADH oxidation reaction the generation of cytosolic pyruvate. Part of this largely neglected mechanism has previously been described as the ?mitochondrial gas pedal.? Its implementation into OXPHOS control models integrates seemingly contradictory results and warrants a critical reappraisal of metabolic control mechanisms in health and disease.	[Gizatullina, Zemfira; Gainutdinov, Timur; Debska-Vielhaber, Grazyna; Kunz, Matthias; Karavasili, Niki; Schreiber, Frank; Heinze, Hans-Jochen; Vielhaber, Stephan; Gellerich, Frank N.] Otto von Guericke Univ, Dept Neurol, D-39120 Magdeburg, Germany; [Gizatullina, Zemfira; Gainutdinov, Timur; Gellerich, Frank N.] Leibniz Inst Neurobiol, D-39120 Magdeburg, Germany; [Szibor, Marten] Tampere Univ, Fac Med & Hlth Technol, FI-33520 Tampere, Finland; [Szibor, Marten; Bamberger, Alexandra; Schwarzer, Michael; Doenst, Torsten] Jena Univ Hosp, Dept Cardiothorac Surg, D-07747 Jena, Germany; [Gainutdinov, Timur] Tatarstan Acad Sci, Res Inst Problems Ecol & Mineral Wealth Use, Kazan 420087, Russia; [Endres, Thomas; Lemann, Volkmar] Otto von Guericke Univ, Inst Physiol, D-39120 Magdeburg, Germany; [Hallmann, Kerstin; Kunz, Wolfram S.] Univ Bonn, Inst Expt Epileptol & Cognit Res, D-53127 Bonn, Germany; [Schreiber, Frank; Heinze, Hans-Jochen; Vielhaber, Stephan] German Ctr Neurodegenerat Dis, D-39120 Magdeburg, Germany; [Heinze, Hans-Jochen; Lemann, Volkmar] CBBS, D-39120 Magdeburg, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Tampere University; Friedrich Schiller University of Jena; Otto von Guericke University; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Gellerich, FN (corresponding author), Otto von Guericke Univ, Dept Neurol, D-39120 Magdeburg, Germany.	Frank.Gellerich@med.ovgu.de	Schwarzer, Michael/E-4438-2013; Kunz, Wolfram/K-1232-2019; Endres, Thomas/J-9393-2012; Gainutdinov, Timur/ABC-2749-2020; Schreiber, Stefanie/S-3223-2019; Lessmann, Volkmar/E-8125-2013	Kunz, Wolfram/0000-0003-1113-3493; Endres, Thomas/0000-0003-4263-2922; Gainutdinov, Timur/0000-0003-1723-1780; Schreiber, Stefanie/0000-0003-4439-4374; Lessmann, Volkmar/0000-0002-6863-323X; Szibor, Marten/0000-0003-4029-160X	Stiftung fur Medizinische Wissenschaft (Frankfurt/M, Germany); Deutsche Forschungsgemeinschaft [KU 911/21-2]	Stiftung fur Medizinische Wissenschaft (Frankfurt/M, Germany); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Stiftung fur Medizinische Wissenschaft (Frankfurt/M, Germany) and Deutsche Forschungsgemeinschaft Grant KU 911/21-2. The authors declare that they have no conflicts of interest with the contents of this article.	Abbrescia DI, 2012, ARCH BIOCHEM BIOPHYS, V518, P157, DOI 10.1016/j.abb.2011.12.021; Amoedo ND, 2016, BBA-MOL CELL RES, V1863, P2394, DOI 10.1016/j.bbamcr.2016.04.011; Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082; Carafoli E, 2010, BBA-BIOENERGETICS, V1797, P595, DOI 10.1016/j.bbabio.2010.03.024; Colwell CS, 2000, EUR J NEUROSCI, V12, P571, DOI 10.1046/j.1460-9568.2000.00939.x; Contreras L, 2009, J BIOL CHEM, V284, P7091, DOI 10.1074/jbc.M808066200; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Doenst T, 1998, MOL CELL BIOCHEM, V180, P153, DOI 10.1023/A:1006863728395; Doenst Torsten, 1996, American Journal of Physiology, V270, pH1607; Falk MJ, 2014, JIMD REP, V14, P77, DOI 10.1007/8904_2013_287; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Frohlich C, 2016, MOL NEUROBIOL, V53, P4728, DOI 10.1007/s12035-015-9399-4; Gellerich FN, 2008, J BIOL CHEM, V283, P30715, DOI 10.1074/jbc.M709555200; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Gellerich FN, 2013, IUBMB LIFE, V65, P180, DOI 10.1002/iub.1131; Gellerich FN, 2012, BIOCHEM J, V443, P747, DOI 10.1042/BJ20110765; Gizatullina ZZ, 2003, BIOCHEM BIOPH RES CO, V304, P643, DOI 10.1016/S0006-291X(03)00654-5; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hamilton J, 2018, J BIOL CHEM, V293, P15652, DOI 10.1074/jbc.RA118.002926; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Holmstrom KM, 2015, J MOL CELL CARDIOL, V85, P178, DOI 10.1016/j.yjmcc.2015.05.022; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Juaristi I, 2017, J NEUROCHEM, V142, P132, DOI 10.1111/jnc.14047; KAUPPINEN RA, 1986, FEBS LETT, V199, P222, DOI 10.1016/0014-5793(86)80484-7; KAUPPINEN RA, 1987, BIOCHIM BIOPHYS ACTA, V930, P173, DOI 10.1016/0167-4889(87)90029-2; Keira Sidney Mamoru, 2004, Acta Cir. Bras., V19, P11, DOI 10.1590/S0102-86502004000700004; Konig T, 2016, MOL CELL, V64, P148, DOI 10.1016/j.molcel.2016.08.020; Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013; Korzeniewski B, 2017, PROG BIOPHYS MOL BIO, V125, P1, DOI 10.1016/j.pbiomolbio.2016.12.001; Koval OM, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav1439; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kwong JQ, 2015, CELL REP, V12, P15, DOI 10.1016/j.celrep.2015.06.002; Llorente-Folch I, 2013, J NEUROSCI, V33, P13957, DOI 10.1523/JNEUROSCI.0929-13.2013; Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Mazat JP, 1997, MOL CELL BIOCHEM, V174, P143, DOI 10.1023/A:1006875517267; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Monne M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184456; Nichols M, 2017, J CEREBR BLOOD F MET, V37, P3027, DOI 10.1177/0271678X16682250; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Petzold A, 2015, NEUROBIOL LEARN MEM, V120, P52, DOI 10.1016/j.nlm.2015.02.009; Psotta L, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00058; Rasmussen TP, 2015, P NATL ACAD SCI USA, V112, P9129, DOI 10.1073/pnas.1504705112; ROSENTHAL RE, 1987, J CEREBR BLOOD F MET, V7, P752, DOI 10.1038/jcbfm.1987.130; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SCHOLZ TD, 1995, PEDIATR RES, V38, P221, DOI 10.1203/00006450-199508000-00015; Schwarzer M, 2009, BASIC RES CARDIOL, V104, P547, DOI 10.1007/s00395-009-0015-5; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Tang L, 2008, AM J PHYSIOL-HEART C, V295, pH297, DOI 10.1152/ajpheart.00137.2008; Tsai CW, 2017, P NATL ACAD SCI USA, V114, P4388, DOI 10.1073/pnas.1702938114; Wang P, 2020, J PHYSIOL-LONDON, V598, P1307, DOI 10.1113/JP276636; Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591; Wu YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7081	56	28	28	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4383	4397		10.1074/jbc.RA119.011902	http://dx.doi.org/10.1074/jbc.RA119.011902			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32094224	Green Published, hybrid			2022-12-28	WOS:000524499700003
J	Tiwari, D; Singh, RK; Goswami, K; Verma, SK; Prakash, B; Nandicoori, VK				Tiwari, Divya; Singh, Rajnish Kumar; Goswami, Kasturi; Verma, Sunil Kumar; Prakash, Balaji; Nandicoori, Vinay Kumar			Key residues in Mycobacterium tuberculosis protein kinase G play a role in regulating kinase activity and survival in the host (vol 284, pg 27467, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2020	295	7					2135	2135		10.1074/jbc.AAC120.012653	http://dx.doi.org/10.1074/jbc.AAC120.012653			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KQ7VJ	32060126	hybrid, Green Published			2022-12-28	WOS:000517128200029
J	Koo, CZ; Harrison, N; Noy, PJ; Szyroka, J; Matthews, AL; Hsia, HE; Muller, SA; Tushaus, J; Goulding, J; Willis, K; Apicella, C; Cragoe, B; Davis, E; Keles, M; Malinova, A; McFarlane, TA; Morrison, PR; Nguyen, HTH; Sykes, MC; Ahmed, H; Di Maio, A; Seipold, L; Saftig, P; Cull, E; Pliotas, C; Rubinstein, E; Poulter, NS; Briddon, SJ; Holliday, ND; Lichtenthaler, SF; Tomlinson, MG				Koo, Chek Ziu; Harrison, Neale; Noy, Peter J.; Szyroka, Justyna; Matthews, Alexandra L.; Hsia, Hung-En; Mueller, Stephan A.; Tueshaus, Johanna; Goulding, Joelle; Willis, Katie; Apicella, Clara; Cragoe, Bethany; Davis, Edward; Keles, Murat; Malinova, Antonia; McFarlane, Thomas A.; Morrison, Philip R.; Nguyen, Hanh T. H.; Sykes, Michael C.; Ahmed, Haroon; Di Maio, Alessandro; Seipold, Lisa; Saftig, Paul; Cull, Eleanor; Pliotas, Christos; Rubinstein, Eric; Poulter, Natalie S.; Briddon, Stephen J.; Holliday, Nicholas D.; Lichtenthaler, Stefan F.; Tomlinson, Michael G.			The tetraspanin Tspan15 is an essential subunit of an ADAM10 scissor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tetraspanin; monoclonal antibody; shedding; membrane protein; ADAM; a disintegrin and metalloprotease; ADAM10; metalloproteinase; Tspan14; Tspan15; molecular cell biology	NOTCH ACTIVATION; CELL-ADHESION; TRAFFICKING; CLEAVAGE; ALPHA; COLOCALIZATION; CADHERIN; REVEALS; CD53	A disintegrin and metalloprotease 10 (ADAM10) is a transmembrane protein essential for embryonic development, and its dysregulation underlies disorders such as cancer, Alzheimer's disease, and inflammation. ADAM10 is a "molecular scissor" that proteolytically cleaves the extracellular region from >100 substrates, including Notch, amyloid precursor protein, cadherins, growth factors, and chemokines. ADAM10 has been recently proposed to function as six distinct scissors with different substrates, depending on its association with one of six regulatory tetraspanins, termed TspanC8s. However, it remains unclear to what degree ADAM10 function critically depends on a TspanC8 partner, and a lack of monoclonal antibodies specific for most TspanC8s has hindered investigation of this question. To address this knowledge gap, here we designed an immunogen to generate the first monoclonal antibodies targeting Tspan15, a model TspanC8. The immunogen was created in an ADAM10-knockout mouse cell line stably overexpressing human Tspan15, because we hypothesized that expression in this cell line would expose epitopes that are normally blocked by ADAM10. Following immunization of mice, this immunogen strategy generated four Tspan15 antibodies. Using these antibodies, we show that endogenous Tspan15 and ADAM10 co-localize on the cell surface, that ADAM10 is the principal Tspan15-interacting protein, that endogenous Tspan15 expression requires ADAM10 in cell lines and primary cells, and that a synthetic ADAM10/Tspan15 fusion protein is a functional scissor. Furthermore, two of the four antibodies impaired ADAM10/Tspan15 activity. These findings suggest that Tspan15 directly interacts with ADAM10 in a functional scissor complex.	[Koo, Chek Ziu; Harrison, Neale; Noy, Peter J.; Szyroka, Justyna; Matthews, Alexandra L.; Willis, Katie; Apicella, Clara; Cragoe, Bethany; Davis, Edward; Keles, Murat; Malinova, Antonia; McFarlane, Thomas A.; Morrison, Philip R.; Nguyen, Hanh T. H.; Sykes, Michael C.; Ahmed, Haroon; Di Maio, Alessandro; Cull, Eleanor; Tomlinson, Michael G.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Poulter, Natalie S.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Koo, Chek Ziu; Goulding, Joelle; Poulter, Natalie S.; Briddon, Stephen J.; Tomlinson, Michael G.] Univ Birmingham, Ctr Membrane Prot & Receptors COMPARE, Midlands B15 2TT, England; [Koo, Chek Ziu; Goulding, Joelle; Poulter, Natalie S.; Briddon, Stephen J.; Tomlinson, Michael G.] Univ Nottingham, Ctr Membrane Prot & Receptors COMPARE, Midlands B15 2TT, England; [Hsia, Hung-En; Mueller, Stephan A.; Tueshaus, Johanna; Lichtenthaler, Stefan F.] Tech Univ Munich, German Ctr Neurodegenerat Dis DZNE Munich, Neuroprote, Klinikum Rechts Isar, D-81377 Munich, Germany; [Hsia, Hung-En; Mueller, Stephan A.; Tueshaus, Johanna; Lichtenthaler, Stefan F.] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Goulding, Joelle; Briddon, Stephen J.; Holliday, Nicholas D.] Univ Nottingham, Div Physiol Pharmacol & Neurosci, Sch Life Sci, Nottingham NG7 2UH, England; [Seipold, Lisa; Saftig, Paul] Christian Albrechts Univ Kiel, Inst Biochem, D-24118 Kiel, Germany; [Pliotas, Christos] Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Rubinstein, Eric] Sorbonne Univ, INSERM, CNRS, Ctr Immunol & Malad Infect,CIMI Paris, F-75013 Paris, France	University of Birmingham; University of Birmingham; University of Birmingham; University of Nottingham; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; University of Munich; University of Nottingham; University of Kiel; University of Leeds; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Tomlinson, MG (corresponding author), Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham B15 2TT, W Midlands, England.	m.g.tomlinson@bham.ac.uk	Goulding, Joelle/AAI-1362-2021; Saftig, Paul/A-7966-2010; Rubinstein, Eric/B-4650-2019; Lichtenthaler, Stefan/B-6587-2016	Goulding, Joelle/0000-0002-6227-4483; Malinova, Antonia/0000-0003-0325-501X; KELES, MURAT/0000-0003-3420-3976; Rubinstein, Eric/0000-0001-7623-9665; Poulter, Natalie/0000-0002-3187-2130; Tomlinson, Michael/0000-0002-1189-0091; Pliotas, Christos/0000-0002-4309-4858; Muller, Stephan/0000-0003-3414-307X; Holliday, Nicholas/0000-0002-2900-828X; Koo, Chek Ziu/0000-0003-3770-2594; Lichtenthaler, Stefan/0000-0003-2211-2575; Harrison, Neale/0000-0001-6821-4089	BBSRC [BB/P00783X/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Ayling LJ, 2012, J CELL SCI, V125, P869, DOI 10.1242/jcs.091090; Brummer T, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809695; Brummer T, 2018, FASEB J, V32, P3560, DOI 10.1096/fj.201700823RR; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dahmane S, 2019, NANOSCALE, V11, P6036, DOI 10.1039/c8nr07269h; Dobos J, 2013, WEB3D 2013: 18TH INTERNATIONAL CONFERENCE ON 3D WEB TECHNOLOGY, P47; Dornier E, 2012, J CELL BIOL, V199, P481, DOI 10.1083/jcb.201201133; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Eschenbrenner E, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900444; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; Hiroshima K, 2019, EXP CELL RES, V384, DOI 10.1016/j.yexcr.2019.111622; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hughes CS, 2019, NAT PROTOC, V14, P68, DOI 10.1038/s41596-018-0082-x; Jouannet S, 2016, CELL MOL LIFE SCI, V73, P1895, DOI 10.1007/s00018-015-2111-z; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kilpatrick LE, 2012, BBA-MOL CELL RES, V1823, P1068, DOI 10.1016/j.bbamcr.2012.03.002; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Marjon KD, 2016, ONCOGENE, V35, P4132, DOI 10.1038/onc.2015.449; Matthews AL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01451; Matthews AL, 2017, BIOCHEM SOC T, V45, P719, DOI 10.1042/BST20160290; Matthews AL, 2017, PLATELETS, V28, P333, DOI 10.1080/09537104.2016.1184751; McCarty OJT, 2006, J THROMB HAEMOST, V4, P1367, DOI 10.1111/j.1538-7836.2006.01966.x; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Noy PJ, 2016, J BIOL CHEM, V291, P3145, DOI 10.1074/jbc.M115.703058; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pike JA, 2017, METHODS, V115, P42, DOI 10.1016/j.ymeth.2017.01.005; Prox J, 2012, CELL MOL LIFE SCI, V69, P2919, DOI 10.1007/s00018-012-0960-2; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reyat JS, 2017, J IMMUNOL, V199, P666, DOI 10.4049/jimmunol.1600713; Reyat JS, 2017, METHODS MOL BIOL, V1591, P155, DOI 10.1007/978-1-4939-6931-9_11; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Saint-Pol J, 2017, BIOCHEM SOC T, V45, P937, DOI 10.1042/BST20160296; Saint-Pol J, 2017, J BIOL CHEM, V292, P9551, DOI 10.1074/jbc.M116.765669; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seipold L, 2018, CELL MOL LIFE SCI, V75, P3251, DOI 10.1007/s00018-018-2791-2; Shah J, 2018, CELL REP, V25, P2132, DOI 10.1016/j.celrep.2018.10.088; Sidahmed-Adrar N, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201900025; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Termini CM, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00034; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tomlinson MG, 2007, J THROMB HAEMOST, V5, P2274, DOI 10.1111/j.1538-7836.2007.02746.x; TOMLINSON MG, 1995, EUR J IMMUNOL, V25, P2201, DOI 10.1002/eji.1830250813; TOMLINSON MG, 1993, EUR J IMMUNOL, V23, P136, DOI 10.1002/eji.1830230122; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; van Deventer SJ, 2017, BIOCHEM SOC T, V45, P741, DOI 10.1042/BST20160284; Virreira Winter S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24242; Wetzel S, 2017, BBA-MOL CELL RES, V1864, P2071, DOI 10.1016/j.bbamcr.2017.06.005; Wilson E, 2014, J CELL SCI, V127, P3039, DOI 10.1242/jcs.140434; Zhang BZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03716-9; Zhou J, 2014, CALCIFIED TISSUE INT, V95, P209, DOI 10.1007/s00223-014-9883-2; Zimmerman B, 2016, CELL, V167, P1041, DOI 10.1016/j.cell.2016.09.056; Zuidscherwoude M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12201	61	17	17	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2020	295	36					12822	12839		10.1074/jbc.RA120.012601	http://dx.doi.org/10.1074/jbc.RA120.012601			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NQ9DL	32111735	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-28	WOS:000571166700021
J	Widner, DL; Harris, KA; Corey, L; Breaker, RR				Widner, Danielle L.; Harris, Kimberly A.; Corey, Lukas; Breaker, Ronald R.			Bacillus haloduransOapB forms a high-affinity complex with the P13 region of the noncoding RNA OLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribonuclear protein (RNP); ribozyme; RNA-binding protein; RNA-protein interaction; Bacillus; Gram-positive bacteria; OapA; OLE RNA; OLE-associated protein; YbzG	SELF-SPLICING RNA; RULES	Noncoding RNAs (ncRNAs) longer than 200 nucleotides are rare in bacteria, likely because bacterial genomes are under strong evolutionary pressures to maintain a small genome size. Of the long ncRNAs unique to bacteria, the OLE (ornate, large, extremophilic) RNA class is among the largest and most structurally complex. OLE RNAs form a ribonucleoprotein (RNP) complex by partnering with at least two proteins, OapA and OapB, that directly bind OLE RNA. The biochemical functions of the OLE RNP complex remain unknown, but are required for proper adaptation to certain environmental stresses, such as cold temperatures, short chain alcohols, and high magnesium concentrations. In the current study, we used electrophoretic mobility shift assays to examine the binding of OLE RNA fragments by OapB and found that OapB recognizes a small subregion of OLE RNA, including stem P13, with a dissociation constant (K-D) of ?700 pm. Analyses with mutated RNA constructs, and the application ofin vitroselection, revealed that strong binding of OLE RNA by OapB requires a stem containing a precisely located single-nucleotide bulge and a GNRA tetraloop. Although the vast majority of bacteria with theolegene also have theoapBgene, there are many whose genomes containoapBbut lackole, suggesting that OapB has other RNA partners in some species that might exhibit similar structural features.	[Widner, Danielle L.; Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Harris, Kimberly A.; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA; [Harris, Kimberly A.; Corey, Lukas; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Breaker, RR (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06511 USA.; Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	ronald.breaker@yale.edu			National Institutes of Health [GM022778, F32GM116426]; Foundation for the National Institutes of Health [T32GM007223]; Howard Hughes Medical Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by National Institutes of Health Grant F32GM116426 (to K. A. H.), National Institutes of Health Grant GM022778 (to D. L. W., K. A. H., L. C., and R. R. B.), Foundation for the National Institutes of Health Grant T32GM007223 (to D. L. W.), and the Howard Hughes Medical Institute (to D. L. W., K. A. H., L. C., and R. R. B). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BENNER SA, 1989, P NATL ACAD SCI USA, V86, P7054, DOI 10.1073/pnas.86.18.7054; Block KF, 2011, MOL MICROBIOL, V79, P21, DOI 10.1111/j.1365-2958.2010.07439.x; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Correll CC, 2003, RNA, V9, P355, DOI 10.1261/rna.2147803; Costa M, 1997, EMBO J, V16, P3289, DOI 10.1093/emboj/16.11.3289; Fiore JL, 2013, Q REV BIOPHYS, V46, P223, DOI 10.1017/S0033583513000048; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Harris KA, 2019, MOL MICROBIOL, V112, P1552, DOI 10.1111/mmi.14379; Harris KA, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.RWR-0005-2017; Harris KA, 2018, P NATL ACAD SCI USA, V115, pE6319, DOI 10.1073/pnas.1803191115; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Koo BM, 2017, CELL SYST, V4, P291, DOI 10.1016/j.cels.2016.12.013; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Kyrpides NC, 1996, TRENDS BIOCHEM SCI, V21, P425, DOI 10.1016/S0968-0004(96)30036-4; MOLINARO M, 1995, NUCLEIC ACIDS RES, V23, P3056, DOI 10.1093/nar/23.15.3056; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; PEEBLES CL, 1986, CELL, V44, P213, DOI 10.1016/0092-8674(86)90755-5; Puerta-Fernandez E, 2006, P NATL ACAD SCI USA, V103, P19490, DOI 10.1073/pnas.0607493103; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Takami H, 1999, BIOSCI BIOTECH BIOCH, V63, P943, DOI 10.1271/bbb.63.943; Wallace JG, 2011, LETT APPL MICROBIOL, V52, P430, DOI 10.1111/j.1472-765X.2011.03017.x; Wallace JG, 2012, NUCLEIC ACIDS RES, V40, P6898, DOI 10.1093/nar/gks352; Weinberg Z, 2017, NUCLEIC ACIDS RES, V45, P10811, DOI 10.1093/nar/gkx699; Weinberg Z, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-3; Weinberg Z, 2009, NATURE, V462, P656, DOI 10.1038/nature08586	26	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9326	9334		10.1074/jbc.RA120.012676	http://dx.doi.org/10.1074/jbc.RA120.012676			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32376692	hybrid, Green Published			2022-12-28	WOS:000552758600006
J	Chen, LF; Lyons, MR; Liu, F; Green, MV; Hedrick, NG; Williams, AB; Narayanan, A; Yasuda, R; West, AE				Chen, Liang-Fu; Lyons, Michelle R.; Liu, Fang; Green, Matthew V.; Hedrick, Nathan G.; Williams, Ashley B.; Narayanan, Arthy; Yasuda, Ryohei; West, Anne E.			The NMDA receptor subunit GluN3A regulates synaptic activity-induced and myocyte enhancer factor 2C (MEF2C)-dependent transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						N?methyl?d?aspartate receptor (NMDA receptor; NMDAR); p38 MAPK; excitation-transcription coupling; neurodevelopment; brain-derived neurotrophic factor (BDNF); gene regulation; synaptic activity; mitogen-activated protein kinase (MAPK) signaling; glutamate receptor ionotropic NMDA (GluN); ionotropic glutamate receptor; MEF2 transcription factors	ACTIVATED PROTEIN-KINASE; NR3A-CONTAINING NMDARS; NUCLEAR TRANSLOCATION; BDNF TRANSCRIPTION; MAP KINASE; EXPRESSION; P38; MATURATION; PLASTICITY; MEF2	N-Methyl-d-aspartate type glutamate receptors (NMDARs) are key mediators of synaptic activity-regulated gene transcription in neurons, both during development and in the adult brain. Developmental differences in the glutamate receptor ionotropic NMDA 2 (GluN2) subunit composition of NMDARs determines whether they activate the transcription factor cAMP-responsive element-binding protein 1 (CREB). However, whether the developmentally regulated GluN3A subunit also modulates NMDAR-induced transcription is unknown. Here, using an array of techniques, including quantitative real-time PCR, immunostaining, reporter gene assays, RNA-Seq, and two-photon glutamate uncaging with calcium imaging, we show that knocking down GluN3A in rat hippocampal neurons promotes the inducible transcription of a subset of NMDAR-sensitive genes. We found that this enhancement is mediated by the accumulation of phosphorylated p38 mitogen-activated protein kinase in the nucleus, which drives the activation of the transcription factor myocyte enhancer factor 2C (MEF2C) and promotes the transcription of a subset of synaptic activity-induced genes, includingbrain-derived neurotrophic factor(Bdnf) andactivity-regulated cytoskeleton-associated protein(Arc). Our evidence that GluN3A regulates MEF2C-dependent transcription reveals a novel mechanism by which NMDAR subunit composition confers specificity to the program of synaptic activity-regulated gene transcription in developing neurons.	[Chen, Liang-Fu; Lyons, Michelle R.; Liu, Fang; Green, Matthew V.; Hedrick, Nathan G.; Williams, Ashley B.; Narayanan, Arthy; West, Anne E.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Yasuda, Ryohei] Max Planck Florida Inst Neurosci, Jupiter, FL USA	Duke University; Max Planck Society	West, AE (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	west@neuro.duke.edu			Ruth K. and Shepherd Broad Foundation; NIH [R01NS098804, DP1NS096787, R01MH080047]	Ruth K. and Shepherd Broad Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Ruth K. and Shepherd Broad Foundation and NIH grants R01NS098804 (to L. -F. C., F. L., M. V. G., A. B. W., A. N., and A. E. W.), DP1NS096787 (to N. G. H. and R. Y.) and R01MH080047 (to N. G. H. and R. Y.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Hallaq RA, 2002, MOL PHARMACOL, V62, P1119, DOI 10.1124/mol.62.5.1119; Ben-Levy R, 1998, CURR BIOL, V8, P1049, DOI 10.1016/S0960-9822(98)70442-7; Chan SF, 2001, J NEUROSCI, V21, P7985, DOI 10.1523/JNEUROSCI.21-20-07985.2001; Chen LF, 2019, CELL REP, V26, P1174, DOI 10.1016/j.celrep.2019.01.032; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; CIABARRA AM, 1995, J NEUROSCI, V15, P6498; Das S, 1998, NATURE, V393, P377, DOI 10.1038/30748; Fiuza M, 2013, P NATL ACAD SCI USA, V110, P20807, DOI 10.1073/pnas.1312211110; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gang L, 2006, J BIOL CHEM, V281, P6087, DOI 10.1074/jbc.M507610200; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gong XW, 2010, J CELL BIOCHEM, V110, P1420, DOI 10.1002/jcb.22675; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Henson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042327; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Joo JY, 2016, NAT NEUROSCI, V19, P75, DOI 10.1038/nn.4170; Kawasaki H, 1997, J BIOL CHEM, V272, P18518, DOI 10.1074/jbc.272.30.18518; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Larsen RS, 2011, NAT NEUROSCI, V14, P338, DOI 10.1038/nn.2750; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lyons MR, 2016, J NEUROCHEM, V137, P164, DOI 10.1111/jnc.13556; Lyons MR, 2012, J NEUROSCI, V32, P12780, DOI 10.1523/JNEUROSCI.0534-12.2012; Lyons MR, 2011, PROG NEUROBIOL, V94, P259, DOI 10.1016/j.pneurobio.2011.05.003; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; McDowell KA, 2010, J NEUROSCI, V30, P7453, DOI 10.1523/JNEUROSCI.3997-09.2010; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Pilli J, 2012, NEUROSCIENCE, V222, P75, DOI 10.1016/j.neuroscience.2012.07.020; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sasaki YF, 2002, J NEUROPHYSIOL, V87, P2052, DOI 10.1152/jn.00531.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUCHER NJ, 1995, J NEUROSCI, V15, P6509; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; West A E, 2014, Handb Exp Pharmacol, V220, P67, DOI 10.1007/978-3-642-45106-5_4; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Wild AR, 2019, CELL REP, V26, P3537, DOI 10.1016/j.celrep.2019.03.005; Wyllie DJA, 2013, NEUROPHARMACOLOGY, V74, P4, DOI 10.1016/j.neuropharm.2013.01.016; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Zehorai E, 2014, MOL CELL BIOL, V34, P259, DOI 10.1128/MCB.00799-13; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037	55	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8613	8627		10.1074/jbc.RA119.010266	http://dx.doi.org/10.1074/jbc.RA119.010266			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32393578	hybrid, Green Published			2022-12-28	WOS:000546986500025
J	Melville, DB; Studer, S; Schekman, R				Melville, David B.; Studer, Sean; Schekman, Randy			Small sequence variations between two mammalian paralogs of the small GTPase SAR1 underlie functional differences in coat protein complex II assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						COPII; GTPase; apolipoprotein; intracellular trafficking; membrane trafficking; secretion; SAR1A; SAR1B; SEC23; SEC31	CHYLOMICRON RETENTION DISEASE; COPII COAT; ENDOPLASMIC-RETICULUM; MEMBRANE CURVATURE; MUTATIONS; SECRETION; SEC23A; GENE; ER; MECHANISMS	Vesicles that are coated by coat protein complex II (COPII) are the primary mediators of vesicular traffic from the endoplasmic reticulum to the Golgi apparatus. Secretion-associated Ras-related GTPase 1 (SAR1) is a small GTPase that is part of COPII and, upon GTP binding, recruits the other COPII proteins to the endoplasmic reticulum membrane. Mammals have two SAR1 paralogs that genetic data suggest may have distinct physiological roles,e.g.in lipoprotein secretion in the case of SAR1B. Here we identified two amino acid clusters that have conserved SAR1 paralog?specific sequences. We observed that one cluster is adjacent to the SAR1 GTP-binding pocket and alters the kinetics of GTP exchange. The other cluster is adjacent to the binding site for two COPII components, SEC31 homolog A COPII coat complex component (SEC31) and SEC23. We found that the latter cluster confers to SAR1B a binding preference for SEC23A that is stronger than that of SAR1A for SEC23A. Unlike SAR1B, SAR1A was prone to oligomerize on a membrane surface. SAR1B knockdown caused loss of lipoprotein secretion, overexpression of SAR1B but not of SAR1A could restore secretion, and a divergent cluster adjacent to the SEC31/SEC23-binding site was critical for this SAR1B function. These results highlight that small primary sequence differences between the two mammalian SAR1 paralogs lead to pronounced biochemical differences that significantly affect COPII assembly and identify a specific function for SAR1B in lipoprotein secretion, providing insights into the mechanisms of large cargo secretion that may be relevant for COPII-related diseases.	[Melville, David B.; Studer, Sean; Schekman, Randy] Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 229 Stanley Hall, Berkeley, CA 94720 USA; [Studer, Sean] Centroid Vaccines Inc, San Diego, CA USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Schekman, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 229 Stanley Hall, Berkeley, CA 94720 USA.	schekman@berkeley.edu			NHLBI, National Institutes of Health [11287155]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	R. S. is supported as an Investigator of the Howard Hughes Medical Institute and the University of California, Berkeley, Miller Institute of Science. D. B. M. was supported in part by NHLBI, National Institutes of Health Grant 11287155. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Bianchi P, 2009, HUM MUTAT, V30, P1292, DOI 10.1002/humu.21077; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Charcosset M, 2008, MOL GENET METAB, V93, P74, DOI 10.1016/j.ymgme.2007.08.120; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; D'Arcangelo JG, 2013, BBA-MOL CELL RES, V1833, P2464, DOI 10.1016/j.bbamcr.2013.02.003; Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003; Fox RM, 2010, J CELL BIOL, V191, P479, DOI 10.1083/jcb.201004062; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Fryer LGD, 2014, J BIOL CHEM, V289, P4244, DOI 10.1074/jbc.M113.479980; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Georges A, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-1; Hanna MG, 2016, J BIOL CHEM, V291, P1014, DOI 10.1074/jbc.M115.672287; Hariri H, 2014, J MOL BIOL, V426, P3811, DOI 10.1016/j.jmb.2014.08.023; HICKE L, 1989, EMBO J, V8, P1677, DOI 10.1002/j.1460-2075.1989.tb03559.x; Hutchings J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06577-4; Jin LY, 2012, NATURE, V482, P495, DOI 10.1038/nature10822; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kanapin A, 2003, GENOME RES, V13, P1335, DOI 10.1101/gr.978703; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Kim J, 2007, CELL HOST MICROBE, V2, P160, DOI 10.1016/j.chom.2007.07.010; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Levic D, 2015, J MOL MED, V93, P165, DOI 10.1007/s00109-014-1247-x; Ma WF, 2016, P NATL ACAD SCI USA, V113, P10061, DOI 10.1073/pnas.1605916113; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Melville D, 2019, MOL BIOL CELL, V30, P387, DOI 10.1091/mbc.E18-09-0548; Melville DB, 2011, DIS MODEL MECH, V4, P763, DOI 10.1242/dmm.007625; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; NEMETH A, 1995, EUR J CLIN INVEST, V25, P271, DOI 10.1111/j.1365-2362.1995.tb01559.x; Niu XB, 2012, DEV BIOL, V367, P197, DOI 10.1016/j.ydbio.2012.05.004; Peretti N, 2009, MOL GENET METAB, V97, P136, DOI 10.1016/j.ymgme.2009.02.003; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Raote I, 2017, J CELL BIOL, V216, P901, DOI 10.1083/jcb.201608080; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Saito K, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00075; SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x; Sane A, 2019, J LIPID RES, V60, P1755, DOI 10.1194/jlr.RA119000119; Sane AT, 2017, ARTERIOSCL THROM VAS, V37, P2243, DOI 10.1161/ATVBAHA.117.310121; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schekman R., 2004, CELL, V116, pS13, DOI [10.1016/s0092-8674(03)00972-3, DOI 10.1016/S0092-8674(03)00972-3]; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silvain M, 2008, CLIN GENET, V74, P546, DOI 10.1111/j.1399-0004.2008.01069.x; Unlu G, 2014, INT J BIOCHEM CELL B, V47, P57, DOI 10.1016/j.biocel.2013.11.005; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098	49	9	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8401	8412		10.1074/jbc.RA120.012964	http://dx.doi.org/10.1074/jbc.RA120.012964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32358066	Green Published, hybrid			2022-12-28	WOS:000546986500005
J	Pandey, S; Ramsakha, N; Sharma, R; Gulia, R; Ojha, P; Lu, W; Bhattacharyya, S				Pandey, Saurabh; Ramsakha, Namrata; Sharma, Rohan; Gulia, Ravinder; Ojha, Prachi; Lu, Wei; Bhattacharyya, Samarjit			The post-synaptic scaffolding protein tamalin regulates ligand-mediated trafficking of metabotropic glutamate receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; trafficking; internalization; G-protein coupled receptor; metabotropic glutamate receptors; neurotransmitter receptors; tamalin; S-SCAM; synaptic plasticity; endocytosis	LONG-TERM DEPRESSION; FRAGILE-X; SYNAPTIC PLASTICITY; PDZ DOMAIN; DESENSITIZATION; ENDOCYTOSIS; PHOSPHORYLATION; INTERNALIZATION; UBIQUITINATION; PHARMACOLOGY	Group I metabotropic glutamate receptors (mGluRs) play important roles in various neuronal functions and have also been implicated in multiple neuropsychiatric disorders like fragile X syndrome, autism, and others. mGluR trafficking not only plays important roles in controlling the spatiotemporal localization of these receptors in the cell but also regulates the activity of these receptors. Despite this obvious significance, the cellular machineries that control the trafficking of group I metabotropic glutamate receptors in the central nervous system have not been studied in detail. The post-synaptic scaffolding protein tamalin has been shown to interact with group I mGluRs and also with many other proteins involved in protein trafficking in neurons. Using a molecular replacement approach in mouse hippocampal neurons, we show here that tamalin plays a critical role in the ligand-dependent internalization of mGluR1 and mGluR5, members of the group I mGluR family. Specifically, knockdown of endogenous tamalin inhibited the ligand-dependent internalization of these two receptors. Both N-terminal and C-terminal regions of tamalin played critical roles in mGluR1 endocytosis. Furthermore, we found that tamalin regulates mGluR1 internalization by interacting with S-SCAM, a protein that has been implicated in vesicular trafficking. Finally, we demonstrate that tamalin plays a critical role in mGluR-mediated internalization of ?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, a process believed to be the cellular correlate for mGluR-dependent synaptic plasticity. Taken together, these findings reveal a mechanistic role of tamalin in the trafficking of group I mGluRs and suggest its physiological implications in the brain.	[Pandey, Saurabh; Ramsakha, Namrata; Sharma, Rohan; Gulia, Ravinder; Ojha, Prachi; Bhattacharyya, Samarjit] Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sas Nagar, Punjab, India; [Pandey, Saurabh; Lu, Wei] NINDS, Synapse & Neural Circuit Res Unit, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Indian Institute of Science Education & Research (IISER) - Mohali; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Bhattacharyya, S (corresponding author), Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sas Nagar, Punjab, India.	samarjit@iisermohali.ac.in	Pandey, Saurabh/AHH-0237-2022; Gulia, Ravinder/AAD-3983-2021; Lu, Wei/S-5617-2018	Pandey, Saurabh/0000-0003-2340-4975; Bhattacharyya, Samarjit/0000-0002-7055-7555; Lu, Wei/0000-0001-6668-8432	Indian Institute of Science Education and Research Mohali; Department of Science and Technology, India [EMR/2016/005249]; CSIR fellowship; UGC fellowships; National Institutes of Health, NINDS intramural research program	Indian Institute of Science Education and Research Mohali; Department of Science and Technology, India(Department of Science & Technology (India)); CSIR fellowship(Council of Scientific & Industrial Research (CSIR) - India); UGC fellowships; National Institutes of Health, NINDS intramural research program	This work was supported by Indian Institute of Science Education and Research Mohali and a grant from Department of Science and Technology, India (Grant EMR/2016/005249). S.P. acknowledges receipt of a CSIR fellowship. N.R, R.S., and R.G. acknowledge receipt of UGC fellowships. P.O. acknowledges receipt of a fellowship from the Indian Institute of Science Education and Research Mohali. W.L. is supported by National Institutes of Health, NINDS intramural research program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anwyl R, 2006, PROG NEUROBIOL, V78, P17, DOI 10.1016/j.pneurobio.2005.12.001; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bhattacharyya S, 2016, INT J BIOCHEM CELL B, V77, P205, DOI 10.1016/j.biocel.2016.03.003; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Biou V, 2008, P NATL ACAD SCI USA, V105, P1038, DOI 10.1073/pnas.0711412105; Choi KY, 2011, J NEUROSCI, V31, P5921, DOI 10.1523/JNEUROSCI.6253-10.2011; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Citri A, 2010, J NEUROSCI, V30, P16437, DOI 10.1523/JNEUROSCI.4478-10.2010; Citri A, 2009, EUR J NEUROSCI, V30, P1443, DOI 10.1111/j.1460-9568.2009.06950.x; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dale LB, 2002, NEUROCHEM INT, V41, P319, DOI 10.1016/S0197-0186(02)00073-6; Dhami GK, 2006, PHARMACOL THERAPEUT, V111, P260, DOI 10.1016/j.pharmthera.2005.01.008; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Francesconi A, 2000, P NATL ACAD SCI USA, V97, P6185, DOI 10.1073/pnas.97.11.6185; Gladding CM, 2009, PHARMACOL REV, V61, P395, DOI 10.1124/pr.109.001735; Gulia R, 2017, J BIOL CHEM, V292, P1426, DOI 10.1074/jbc.M116.752105; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Kim CH, 2008, J NEUROSCI RES, V86, P1, DOI 10.1002/jnr.21437; Kitano J, 2003, J BIOL CHEM, V278, P14762, DOI 10.1074/jbc.M300184200; Kitano J, 2002, J NEUROSCI, V22, P1280, DOI 10.1523/JNEUROSCI.22-04-01280.2002; Mahato PK, 2015, NEUROSCIENCE, V306, P138, DOI 10.1016/j.neuroscience.2015.08.031; Mahato PK, 2018, ADV EXP MED BIOL, V1112, P163, DOI 10.1007/978-981-13-3065-0_12; Michalon A, 2012, NEURON, V74, P49, DOI 10.1016/j.neuron.2012.03.009; Mundell SJ, 2004, BIOCHEMISTRY-US, V43, P7541, DOI 10.1021/bi0359022; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pandey S, 2014, J NEUROCHEM, V131, P602, DOI 10.1111/jnc.12930; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Sallese M, 2000, FASEB J, V14, P2569, DOI 10.1096/fj.00-0072com; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma R, 2019, METHOD CELL BIOL, V149, P107, DOI 10.1016/bs.mcb.2018.08.008; Sharma R, 2018, J NEUROSCI, V38, P8605, DOI 10.1523/JNEUROSCI.0454-18.2018; Sugi T, 2007, EMBO J, V26, P2192, DOI 10.1038/sj.emboj.7601651; Trivedi RR, 2012, BIOCHEM BIOPH RES CO, V427, P185, DOI 10.1016/j.bbrc.2012.09.040; Wang H, 2009, SCIENCE, V326, P1554, DOI 10.1126/science.1178496	35	9	9	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8575	8588		10.1074/jbc.RA119.011979	http://dx.doi.org/10.1074/jbc.RA119.011979			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32376687	hybrid, Green Published			2022-12-28	WOS:000546986500021
J	Arrieta, A; Blackwood, EA; Stauffer, WT; Santo Domingo, M; Bilal, AS; Thuerauf, DJ; Pentoney, AN; Aivati, C; Sarakki, AV; Doroudgar, S; Glembotski, CC				Arrieta, Adrian; Blackwood, Erik A.; Stauffer, Winston T.; Santo Domingo, Michelle; Bilal, Alina S.; Thuerauf, Donna J.; Pentoney, Amber N.; Aivati, Cathrine; Sarakki, Anup V.; Doroudgar, Shirin; Glembotski, Christopher C.			Mesencephalic astrocyte?derived neurotrophic factor is an ER-resident chaperone that protects against reductive stress in the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); protein folding; cardiomyocyte; ischemia; chaperone; cardiomyocyte; heart function; ischemia; reperfusion; mesencephalic astrocyte-derived neurotrophic factor (MANF); reductive stress; unfolded protein response	ENDOPLASMIC-RETICULUM STRESS; ALPHA-B-CRYSTALLIN; CARDIAC MYOCYTES; OXIDATIVE STRESS; GENE INDUCTION; PROTEINS; ATF6; DEGRADATION; AGGREGATION; DAMAGE	We have previously demonstrated that ischemia/reperfusion (I/R) impairs endoplasmic reticulum (ER)-based protein folding in the heart and thereby activates an unfolded protein response sensor and effector, activated transcription factor 6? (ATF6). ATF6 then induces mesencephalic astrocyte-derived neurotrophic factor (MANF), an ER-resident protein with no known structural homologs and unclear ER function. To determine MANF's function in the heart in vivo, here we developed a cardiomyocyte-specific MANF-knockdown mouse model. MANF knockdown increased cardiac damage after I/R, which was reversed by AAV9-mediated ectopic MANF expression. Mechanistically, MANF knockdown in cultured neonatal rat ventricular myocytes (NRVMs) impaired protein folding in the ER and cardiomyocyte viability during simulated I/R. However, this was not due to MANF-mediated protection from reactive oxygen species generated during reperfusion. Because I/R impairs oxygen-dependent ER protein disulfide formation and such impairment can be caused by reductive stress in the ER, we examined the effects of the reductive ER stressor DTT. MANF knockdown in NRVMs increased cell death from DTT-mediated reductive ER stress, but not from nonreductive ER stresses caused by thapsigargin-mediated ER Ca2+ depletion or tunicamycin-mediated inhibition of ER protein glycosylation. In vitro, recombinant MANF exhibited chaperone activity that depended on its conserved cysteine residues. Moreover, in cells, MANF bound to a model ER protein exhibiting improper disulfide bond formation during reductive ER stress but did not bind to this protein during nonreductive ER stress. We conclude that MANF is an ER chaperone that enhances protein folding and myocyte viability during reductive ER stress.	[Arrieta, Adrian; Blackwood, Erik A.; Stauffer, Winston T.; Santo Domingo, Michelle; Bilal, Alina S.; Thuerauf, Donna J.; Pentoney, Amber N.; Aivati, Cathrine; Sarakki, Anup V.; Doroudgar, Shirin; Glembotski, Christopher C.] San Diego State Univ, Inst Heart, San Diego, CA 92182 USA; [Arrieta, Adrian; Blackwood, Erik A.; Stauffer, Winston T.; Santo Domingo, Michelle; Bilal, Alina S.; Thuerauf, Donna J.; Pentoney, Amber N.; Aivati, Cathrine; Sarakki, Anup V.; Doroudgar, Shirin; Glembotski, Christopher C.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Doroudgar, Shirin] Univ Hosp Heidelberg, Dept Cardiol Angiol & Pneumol, Innere Med 3, Heidelberg, Germany; [Doroudgar, Shirin] DZHK German Ctr Cardiovasc Res, Partner Site Heidelberg Mannheim, Heidelberg, Germany	California State University System; San Diego State University; California State University System; San Diego State University; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research	Glembotski, CC (corresponding author), San Diego State Univ, Inst Heart, San Diego, CA 92182 USA.; Glembotski, CC (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	cglembotski@sdsu.edu		Blackwood, Erik/0000-0003-0912-4133	American Heart Association [17PRE33670796]; National Institutes of Health [1F31HL140850, R01 HL135893, R01 HL141463, R01 HL149931]; San Diego State University (SDSU) Heart Institute; Inamori Foundation; ARCS Foundation, Inc., San Diego Chapter	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); San Diego State University (SDSU) Heart Institute; Inamori Foundation; ARCS Foundation, Inc., San Diego Chapter	This work was supported by American Heart Association Grant 17PRE33670796; National Institutes of Health Grant 1F31HL140850 (to E. A. B.) and Grants R01 HL135893, R01 HL141463, and R01 HL149931 (to C. C. G.); the San Diego State University (SDSU) Heart Institute (to W. T. S., A. A., E. A. B., and C. C. G.); the Inamori Foundation (to E. A. B.); and the ARCS Foundation, Inc., San Diego Chapter (to W. T. S. and E. A. B). Additionally, W. T. S., A. A., and E. A. B are Rees-Stealy Research Foundation Phillips Gausewitz, M.D., Scholars of the SDSU Heart Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Behnke J, 2016, MOL CELL, V63, P739, DOI 10.1016/j.molcel.2016.07.012; Belmont PJ, 2008, J BIOL CHEM, V283, P14012, DOI 10.1074/jbc.M709776200; Belmont PJ, 2010, CIRC RES, V106, P307, DOI 10.1161/CIRCRESAHA.109.203901; Bi XK, 2018, CIRC RES, V122, P1545, DOI 10.1161/CIRCRESAHA.117.312641; Blackwood EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08129-2; Blackwood EA, 2019, CIRC RES, V124, P79, DOI 10.1161/CIRCRESAHA.118.313854; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Chin KT, 2011, FASEB J, V25, P2583, DOI 10.1096/fj.11-184622; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; Dimmeler S, 2007, CELL, V130, P401, DOI 10.1016/j.cell.2007.07.028; Doroudgar S, 2015, CIRC RES, V117, P536, DOI 10.1161/CIRCRESAHA.115.306993; Doroudgar S, 2009, J BIOL CHEM, V284, P29735, DOI 10.1074/jbc.M109.018036; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellgaard L, 2018, TRENDS BIOCHEM SCI, V43, P32, DOI 10.1016/j.tibs.2017.10.006; Garcia-Dorado D, 2012, CARDIOVASC RES, V94, P168, DOI 10.1093/cvr/cvs116; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Glembotski CC, 2014, CIRC RES, V115, P546, DOI 10.1161/CIRCRESAHA.114.304855; Glembotski CC, 2012, PHYSIOLOGY, V27, P343, DOI 10.1152/physiol.00034.2012; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Glembotski CC, 2011, J MOL CELL CARDIOL, V51, P512, DOI 10.1016/j.yjmcc.2010.10.008; Handy DE, 2017, FREE RADICAL BIO MED, V109, P114, DOI 10.1016/j.freeradbiomed.2016.12.006; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Hoover HE, 2000, J BIOL CHEM, V275, P23825, DOI 10.1074/jbc.M003864200; Jin JK, 2017, CIRC RES, V120, P862, DOI 10.1161/CIRCRESAHA.116.310266; Koritzinsky M, 2013, J CELL BIOL, V203, P615, DOI 10.1083/jcb.201307185; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Kubota K, 2006, J NEUROCHEM, V97, P1259, DOI 10.1111/j.1471-4159.2006.03782.x; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lee CF, 2014, INT REV CEL MOL BIO, V313, P103, DOI 10.1016/B978-0-12-800177-6.00004-9; Li J, 2001, J BIOCHEM, V129, P821, DOI 10.1093/oxfordjournals.jbchem.a002925; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; LODISH HF, 1993, J BIOL CHEM, V268, P20598; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Marshall KD, 2014, AM J PHYSIOL-CELL PH, V306, pC639, DOI 10.1152/ajpcell.00167.2013; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Morrison LE, 2004, AM J PHYSIOL-HEART C, V286, pH847, DOI 10.1152/ajpheart.00715.2003; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Poet GJ, 2017, EMBO J, V36, P693, DOI 10.15252/embj.201695336; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Preissler S, 2017, ELIFE, V6, DOI 10.7554/eLife.29428; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.08961; Rainbolt TK, 2014, TRENDS ENDOCRIN MET, V25, P528, DOI 10.1016/j.tem.2014.06.007; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Stauffer WT, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031134; Tam AB, 2018, DEV CELL, V46, P327, DOI 10.1016/j.devcel.2018.04.023; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Thuerauf DJ, 2001, J BIOL CHEM, V276, P48309, DOI 10.1074/jbc.M107146200; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Tsujita Y, 2005, ECHOCARDIOGR-J CARD, V22, P245, DOI 10.1111/j.0742-2822.2005.04014.x; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vanden Hoek Terry L., 1996, American Journal of Physiology, V270, pH1334; Vekich JA, 2012, J MOL CELL CARDIOL, V53, P259, DOI 10.1016/j.yjmcc.2012.05.005; Vincenz L, 2014, CELL, V156, P1125, DOI 10.1016/j.cell.2014.02.035; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Yan YH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08450-4; Yang Q, 1997, NUCLEIC ACIDS RES, V25, P2800, DOI 10.1093/nar/25.14.2800; Yu QJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000555; Zhang GY, 2019, HYPERTENSION, V73, P390, DOI 10.1161/HYPERTENSIONAHA.118.12084; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957	67	16	17	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7566	7583		10.1074/jbc.RA120.013345	http://dx.doi.org/10.1074/jbc.RA120.013345			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32327487	hybrid, Green Published			2022-12-28	WOS:000538038900002
J	Geck, RC; Foley, JR; Stewart, TM; Asara, JM; Casero, RA; Toker, A				Geck, Renee C.; Foley, Jackson R.; Stewart, Tracy Murray; Asara, John M.; Casero, Robert A., Jr.; Toker, Alex			Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; breast cancer; metabolomics; polyamine; DNA damage; antizyme; difluoromethylornithine; ornithine decarboxylase (ODC); triple-negative breast cancer (TNBC); cell metabolism	DNA-DAMAGE; ALPHA-DIFLUOROMETHYLORNITHINE; METABOLIC VULNERABILITY; L-ARGININE; PHASE; BIOSYNTHESIS; EXPRESSION; ARGINASE; GENE; CHEMOPREVENTION	Treatment of patients with triple-negative breast cancer (TNBC) is limited by a lack of effective molecular therapies targeting this disease. Recent studies have identified metabolic alterations in cancer cells that can be targeted to improve responses to standard-of-care chemotherapy regimens. Using MDA-MB-468 and SUM-159PT TNBC cells, along with LC-MS/MS and HPLC metabolomics profiling, we found here that exposure of TNBC cells to the cytotoxic chemotherapy drugs cisplatin and doxorubicin alter arginine and polyamine metabolites. This alteration was because of a reduction in the levels and activity of a rate-limiting polyamine biosynthetic enzyme, ornithine decarboxylase (ODC). Using gene silencing and inhibitor treatments, we determined that the reduction in ODC was mediated by its negative regulator antizyme, targeting ODC to the proteasome for degradation. Treatment with the ODC inhibitor difluoromethylornithine (DFMO) sensitized TNBC cells to chemotherapy, but this was not observed in receptor-positive breast cancer cells. Moreover, TNBC cell lines had greater sensitivity to single-agent DFMO, and ODC levels were elevated in TNBC patient samples. The alterations in polyamine metabolism in response to chemotherapy, as well as DFMO-induced preferential sensitization of TNBC cells to chemotherapy, reported here suggest that ODC may be a targetable metabolic vulnerability in TNBC.	[Geck, Renee C.; Asara, John M.; Toker, Alex] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Geck, Renee C.; Toker, Alex] Harvard Med Sch, Boston, MA 02115 USA; [Foley, Jackson R.; Stewart, Tracy Murray; Casero, Robert A., Jr.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Toker, Alex] Ludwig Ctr Harvard, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine	Toker, A (corresponding author), 330 Brookline Ave,EC-CLS633A, Boston, MA 02215 USA.	atoker@bidmc.harvard.edu	Stewart, Tracy Murray/B-6137-2017	Stewart, Tracy Murray/0000-0001-8679-6414; Geck, Renee/0000-0001-7812-7675	BIDMC Research Capital Fund; Ruth L. Kirschstein Predoctoral Individual National Research Service Award [F31CA213460]	BIDMC Research Capital Fund; Ruth L. Kirschstein Predoctoral Individual National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Manning (Harvard School of Public Health) for suggestions and critical reagents; J. Brugge (Harvard Medical School), N. Kalaany (Boston Children's Hospital), and members of the Toker lab (Beth Israel Deaconess Medical Center) for discussion; M. Yuan and C. Dibble (Beth Israel Deaconess Medical Center) for assistance with MS. The BIDMC Research Capital Fund provided funds for the mass spectrometry instrumentation (QTRAP 5500 and 6500).; Supported by the Ruth L. Kirschstein Predoctoral Individual National Research Service Award F31CA213460.	Agostinelli E, 2010, AMINO ACIDS, V38, P393, DOI 10.1007/s00726-009-0396-7; ANEHUS S, 1984, MOL CELL BIOL, V4, P915, DOI 10.1128/MCB.4.5.915; Bachmann AS, 2018, J BIOL CHEM, V293, P18757, DOI 10.1074/jbc.TM118.003336; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Battaglia V, 2014, AMINO ACIDS, V46, P511, DOI 10.1007/s00726-013-1529-6; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Boyle P, 2012, ANN ONCOL, V23, P7, DOI 10.1093/annonc/mds187; Brown KK, 2017, CANCER DISCOV, V7, P391, DOI 10.1158/2159-8290.CD-16-0611; Burns MR, 2009, J MED CHEM, V52, P1983, DOI 10.1021/jm801580w; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; COURDI A, 1986, INT J CANCER, V38, P103, DOI 10.1002/ijc.2910380117; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Denkert C, 2017, LANCET, V389, P2430, DOI 10.1016/S0140-6736(16)32454-0; Dillon BJ, 2004, CANCER-AM CANCER SOC, V100, P826, DOI 10.1002/cncr.20057; Do THT, 2013, AMINO ACIDS, V44, P869, DOI 10.1007/s00726-012-1413-9; Dulloo I, 2010, P NATL ACAD SCI USA, V107, P4902, DOI 10.1073/pnas.0906782107; Fabian CJ, 2002, CLIN CANCER RES, V8, P3105; Fahrmann JF, 2020, JNCI-J NATL CANCER I, V112, P607, DOI 10.1093/jnci/djz182; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hayes CS, 2014, CANCER IMMUNOL RES, V2, P274, DOI 10.1158/2326-6066.CIR-13-0120-T; He W, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0014-1; Hoechst B, 2009, HEPATOLOGY, V50, P799, DOI 10.1002/hep.23054; Hu HY, 2005, WORLD J GASTROENTERO, V11, P2244, DOI 10.3748/wjg.v11.i15.2244; Jahani M, 2018, BIOMED PHARMACOTHER, V102, P594, DOI 10.1016/j.biopha.2018.02.109; Johansson VM, 2008, DNA CELL BIOL, V27, P511, DOI 10.1089/dna.2008.0750; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; Kahana C, 2018, J BIOL CHEM, V293, P18730, DOI 10.1074/jbc.TM118.003339; Keren-Paz A, 2007, BIOCHEM SOC T, V35, P311, DOI 10.1042/BST0350311; Kumar P, 2016, ARCH GYNECOL OBSTET, V293, P247, DOI 10.1007/s00404-015-3859-y; Lebert JM, 2018, CURR ONCOL, V25, pS142, DOI 10.3747/co.25.3954; Lee A, 2018, CANCER TREAT REV, V62, P110, DOI 10.1016/j.ctrv.2017.11.003; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lien EC, 2016, NAT CELL BIOL, V18, P572, DOI 10.1038/ncb3341; Ling YH, 1996, MOL PHARMACOL, V49, P832; Mayer IA, 2014, CLIN CANCER RES, V20, P782, DOI 10.1158/1078-0432.CCR-13-0583; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Mueller S, 2006, INT J ONCOL, V29, P471; Murray-Stewart TR, 2016, BIOCHEM J, V473, P2937, DOI 10.1042/BCJ20160383; Nayvelt I, 2010, BIOMACROMOLECULES, V11, P97, DOI 10.1021/bm900958c; Nowotarski SL, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.3; O'Shaughnessy JA, 1999, CLIN CANCER RES, V5, P3438; Oredsson SM, 2003, BIOCHEM SOC T, V31, P366, DOI 10.1042/BST0310366; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Perez-Leal O, 2012, AMINO ACIDS, V42, P611, DOI 10.1007/s00726-011-1036-6; Potter AJ, 2002, CARCINOGENESIS, V23, P389, DOI 10.1093/carcin/23.3.389; Qiu FM, 2015, CANCER LETT, V364, P1, DOI 10.1016/j.canlet.2015.04.020; Reznik E, 2018, CELL SYST, V6, P301, DOI 10.1016/j.cels.2017.12.014; Roci I, 2019, CELL REP, V26, P1691, DOI 10.1016/j.celrep.2019.01.059; Saunders LR, 2006, MOL CANCER THER, V5, P2777, DOI 10.1158/1535-7163.MCT-06-0298; SEELY JE, 1983, METHOD ENZYMOL, V94, P158; SEIDENFELD J, 1986, CANCER RES, V46, P47; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Singh R, 2000, CANCER RES, V60, P3305; Singh R, 2001, CARCINOGENESIS, V22, P1863, DOI 10.1093/carcin/22.11.1863; Stewart TM, 2018, J BIOL CHEM, V293, P18736, DOI 10.1074/jbc.TM118.003337; Szefel J, 2019, ADV MED SCI-POLAND, V64, P104, DOI 10.1016/j.advms.2018.08.018; THOMAS T, 1991, BREAST CANCER RES TR, V19, P257, DOI 10.1007/BF01961162; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Waks AG, 2019, JAMA-J AM MED ASSOC, V321, P288, DOI 10.1001/jama.2018.19323; Weicht Rebecca R, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6030065; Werner A, 2016, EUR J IMMUNOL, V46, P92, DOI 10.1002/eji.201546047; Witherspoon M, 2013, CANCER DISCOV, V3, P1072, DOI 10.1158/2159-8290.CD-12-0305; Yamashita T, 2013, INT J BIOCHEM CELL B, V45, P1042, DOI 10.1016/j.biocel.2013.02.021; Yang D, 1997, J BIOL CHEM, V272, P3376, DOI 10.1074/jbc.272.6.3376; Yao H, 2017, ONCOTARGET, V8, P1913, DOI 10.18632/oncotarget.12284; Young L, 2006, J HISTOCHEM CYTOCHEM, V54, P223, DOI 10.1369/jhc.5A6672.2005; Yuan M, 2019, NAT PROTOC, V14, P313, DOI 10.1038/s41596-018-0102-x; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006; Zhang L, 1999, CANCER LETT, V142, P129, DOI 10.1016/S0304-3835(99)00107-X	77	23	23	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6263	6277		10.1074/jbc.RA119.012376	http://dx.doi.org/10.1074/jbc.RA119.012376			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32139506	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000537685000002
J	Huet, C; Boudaba, N; Guigas, B; Viollet, B; Foretz, M				Huet, Camille; Boudaba, Nadia; Guigas, Bruno; Viollet, Benoit; Foretz, Marc			Glucose availability but not changes in pancreatic hormones sensitizes hepatic AMPK activity during nutritional transition in rodents	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); glucose; insulin; glucagon; metabolic regulation; metformin; liver; hepatocyte; energy homeostasis; nutrient sensing; nutritional transition	ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; INSULIN-RESISTANCE; MITOCHONDRIAL FISSION; PHOSPHORYLATION SITES; GLUCAGON RECEPTOR; RAT-LIVER; INHIBITION; ENERGY; IDENTIFICATION	The cellular energy sensor AMP-activated protein kinase (AMPK) is a metabolic regulator that mediates adaptation to nutritional variations to maintain a proper energy balance in cells. We show here that suckling-weaning and fasting-refeeding transitions in rodents are associated with changes in AMPK activation and the cellular energy state in the liver. These nutritional transitions were characterized by a metabolic switch from lipid to glucose utilization, orchestrated by modifications in glucose levels and the glucagon/insulin ratio in the bloodstream. We therefore investigated the respective roles of glucose and pancreatic hormones on AMPK activation in mouse primary hepatocytes. We found that glucose starvation transiently activates AMPK, whereas changes in glucagon and insulin levels had no impact on AMPK. Challenge of hepatocytes with metformin-induced metabolic stress strengthened both AMPK activation and cellular energy depletion under limited-glucose conditions, whereas neither glucagon nor insulin altered AMPK activation. Although both insulin and glucagon induced AMPK? phosphorylation at its Ser(485/491) residue, they did not affect its activity. Finally, the decrease in cellular ATP levels in response to an energy stress was additionally exacerbated under fasting conditions and by AMPK deficiency in hepatocytes, revealing metabolic inflexibility and emphasizing the importance of AMPK for maintaining hepatic energy charge. Our results suggest that nutritional changes (i.e. glucose availability), rather than the related hormonal changes (i.e. the glucagon/insulin ratio), sensitize AMPK activation to the energetic stress induced by the dietary transition during fasting. This effect is critical for preserving the cellular energy state in the liver.	[Huet, Camille; Boudaba, Nadia; Viollet, Benoit; Foretz, Marc] Univ Paris, Inst Cochin, CNRS, INSERM, F-75014 Paris, France; [Guigas, Bruno] Leiden Univ, Dept Parasitol, Med Ctr, NL-2333 ZA Leiden, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Foretz, M (corresponding author), Inst Cochin, Dept Endocrinol Metab & Diabet, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	marc.foretz@inserm.fr	Viollet, Benoit/N-2397-2019; Guigas, Bruno/M-2515-2015; Viollet, Benoit/O-6927-2017; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Guigas, Bruno/0000-0002-8856-5799; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032	INSERM, CNRS, Universite Paris Descartes, Region Ile-de-France (CORDDIM); Societe Francophone du Diabete (SFD)	INSERM, CNRS, Universite Paris Descartes, Region Ile-de-France (CORDDIM); Societe Francophone du Diabete (SFD)	This work was supported by grants from INSERM, CNRS, Universite Paris Descartes, Region Ile-de-France (CORDDIM), and the Societe Francophone du Diabete (SFD). The authors declare that they have no conflicts of interest with the contents of this article.	Allen KM, 2017, ARCH BIOCHEM BIOPHYS, V623, P49, DOI 10.1016/j.abb.2017.05.010; Assifi MM, 2005, AM J PHYSIOL-ENDOC M, V289, pE794, DOI 10.1152/ajpendo.00144.2005; ATKINSON DE, 1967, J BIOL CHEM, V242, P3239; Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Ducommun S, 2015, CELL SIGNAL, V27, P978, DOI 10.1016/j.cellsig.2015.02.008; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Esquejo RM, 2018, EBIOMEDICINE, V31, P122, DOI 10.1016/j.ebiom.2018.04.009; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; Foretz M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092826; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Garcia-Tardon N, 2018, METHODS MOL BIOL, V1732, P229, DOI 10.1007/978-1-4939-7598-3_15; Gauthier MS, 2011, BIOCHEM BIOPH RES CO, V404, P382, DOI 10.1016/j.bbrc.2010.11.127; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Ha SK, 2011, J COMP PATHOL, V145, P88, DOI 10.1016/j.jcpa.2010.11.011; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Hasenour CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170382; Hasenour CM, 2014, J BIOL CHEM, V289, P5950, DOI 10.1074/jbc.M113.528232; Hasenour CM, 2013, MOL CELL ENDOCRINOL, V366, P152, DOI 10.1016/j.mce.2012.06.018; Hawley SA, 2014, BIOCHEM J, V459, P275, DOI 10.1042/BJ20131344; Horikoshi M, 2006, DIABETES, V55, P919, DOI 10.2337/diabetes.55.04.06.db05-0727; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Keshavarz P, 2008, MOL GENET METAB, V93, P200, DOI 10.1016/j.ymgme.2007.08.125; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kraegen EW, 2006, AM J PHYSIOL-ENDOC M, V290, pE471, DOI 10.1152/ajpendo.00316.2005; Liang JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8926; Loh K, 2019, HEPATOL COMMUN, V3, P84, DOI 10.1002/hep4.1279; Longuet C, 2008, CELL METAB, V8, P359, DOI 10.1016/j.cmet.2008.09.008; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; Mount PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029887; MUNDAY MR, 1991, BIOCHEM J, V280, P733, DOI 10.1042/bj2800733; Muse ED, 2004, J CLIN INVEST, V114, P232, DOI 10.1172/JCI200421270; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PILLAY D, 1982, BIOCHIM BIOPHYS ACTA, V713, P663, DOI 10.1016/0005-2760(82)90327-7; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016; Suchankova G, 2005, BIOCHEM BIOPH RES CO, V326, P851, DOI 10.1016/j.bbrc.2004.11.114; Sun MW, 2006, DIABETES, V55, P849, DOI 10.2337/diabetes.55.03.06.db05-1418; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Willows R, 2017, BIOCHEM J, V474, P3059, DOI 10.1042/BCJ20170458; WITTERS LA, 1992, J BIOL CHEM, V267, P2864; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9; Zhang CS, 2017, NATURE, V548, P112, DOI 10.1038/nature23275; Zhang YL, 2013, CELL METAB, V18, P546, DOI 10.1016/j.cmet.2013.09.005; Zong Y, 2019, CELL RES, V29, P460, DOI 10.1038/s41422-019-0163-6	53	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5836	5849		10.1074/jbc.RA119.010244	http://dx.doi.org/10.1074/jbc.RA119.010244			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32184359	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000531417300001
J	Knights, AJ; Yang, L; Shah, M; Norton, LJ; Green, GS; Stout, ES; Vohralik, EJ; Crossley, M; Quinlan, KGR				Knights, Alexander J.; Yang, Lu; Shah, Manan; Norton, Laura J.; Green, Gamran S.; Stout, Elizabeth S.; Vohralik, Emily J.; Crossley, Merlin; Quinlan, Kate G. R.			Kr?ppel-like factor 3 (KLF3) suppresses NF-?B?driven inflammation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; endotoxin; NF-kappa B (NF-KB); NF-kB transcription factor; gene regulation; macrophage; lipopolysaccharide (LPS); transcription; Kr?ppel-like factor 3 (KLF3)	KRUPPEL-LIKE FACTORS; KAPPA-B ACTIVATION; BINDING-PROTEIN; TARGETED DISRUPTION; GENE-EXPRESSION; DNA-BINDING; KLF3/BKLF; LIPOPOLYSACCHARIDE; MACROPHAGE; REVEALS	Bacterial products such as lipopolysaccharides (or endotoxin) cause systemic inflammation, resulting in a substantial global health burden. The onset, progression, and resolution of the inflammatory response to endotoxin are usually tightly controlled to avoid chronic inflammation. Members of the NF-?B family of transcription factors are key drivers of inflammation that activate sets of genes in response to inflammatory signals. Such responses are typically short-lived and can be suppressed by proteins that act post-translationally, such as the SOCS (suppressor of cytokine signaling) family. Less is known about direct transcriptional regulation of these responses, however. Here, using a combination of in vitro approaches and in vivo animal models, we show that endotoxin treatment induced expression of the well-characterized transcriptional repressor Kr?ppel-like factor 3 (KLF3), which, in turn, directly repressed the expression of the NF-?B family member RELA/p65. We also observed that KLF3-deficient mice were hypersensitive to endotoxin and exhibited elevated levels of circulating Ly6C(+) monocytes and macrophage-derived inflammatory cytokines. These findings reveal that KLF3 is a fundamental suppressor that operates as a feedback inhibitor of RELA/p65 and may be important in facilitating the resolution of inflammation.	[Knights, Alexander J.; Yang, Lu; Shah, Manan; Norton, Laura J.; Green, Gamran S.; Stout, Elizabeth S.; Vohralik, Emily J.; Crossley, Merlin; Quinlan, Kate G. R.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia	University of New South Wales Sydney	Quinlan, KGR (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	kate.quinlan@unsw.edu.au	Knights, Alexander/AAL-1769-2021; Crossley, Merlin/D-7888-2011	Shah, Manan/0000-0003-1390-5450; Stout, Elizabeth/0000-0003-4957-5019; Crossley, Merlin/0000-0003-2057-3642; Knights, Alexander/0000-0001-8402-2212	Australian National Health and Medical Research Council (NHMRC) [APP1025873, APP1025877]; Australian Postgraduate Awards; University of New South Wales Sydney Scientia Fellowship; University of New South Wales Sydney Scientia Scholarship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Awards(Australian Government); University of New South Wales Sydney Scientia Fellowship; University of New South Wales Sydney Scientia Scholarship	This work was supported by Australian National Health and Medical Research Council (NHMRC) Grants APP1025873 and APP1025877 (to M. C.), Australian Postgraduate Awards (to A. J. K., L. J. N., M. S., and E. S. S.), a University of New South Wales Sydney Scientia Fellowship (to K. G. R. Q.), and a University of New South Wales Sydney Scientia Scholarship (to E. J. V.). The authors declare that they have no conflicts of interest with the contents of this article.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Bell-Anderson KS, 2013, DIABETES, V62, P2728, DOI 10.2337/db12-1745; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Burdach J, 2014, NUCLEIC ACIDS RES, V42, P276, DOI 10.1093/nar/gkt895; Crossley M, 1996, MOL CELL BIOL, V16, P1695; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; Dewi V, 2015, J BIOL CHEM, V290, P8591, DOI 10.1074/jbc.M115.638338; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Fan YB, 2012, ARTERIOSCL THROM VAS, V32, P2981, DOI 10.1161/ATVBAHA.112.300349; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Funnell APW, 2013, MOL CELL BIOL, V33, P2976, DOI 10.1128/MCB.00074-13; Funnell APW, 2012, MOL CELL BIOL, V32, P3281, DOI 10.1128/MCB.00173-12; Gadjeva M, 2004, J IMMUNOL, V173, P5786, DOI 10.4049/jimmunol.173.9.5786; Gajendran M, 2018, DM-DIS MON, V64, P20, DOI 10.1016/j.disamonth.2017.07.001; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Geng S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13436; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jain MK, 2014, ARTERIOSCL THROM VAS, V34, P499, DOI 10.1161/ATVBAHA.113.301925; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kim GD, 2016, J BIOL CHEM, V291, P21271, DOI 10.1074/jbc.M116.738617; Knights AJ, 2016, J BIOL CHEM, V291, P16048, DOI 10.1074/jbc.M116.715748; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lingrel JB, 2012, CIRC RES, V110, P1294, DOI 10.1161/CIRCRESAHA.112.267310; LIPTAY S, 1994, MOL CELL BIOL, V14, P7695, DOI 10.1128/MCB.14.12.7695; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Mao LF, 2017, DIABETES, V66, P407, DOI 10.2337/db16-0343; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mori N, 1996, BLOOD, V87, P3410, DOI 10.1182/blood.V87.8.3410.bloodjournal8783410; OETTGEN HF, 1980, RECENT RES CANCER, V75, P207; Perez-Cerda F., 2016, MULT SCLER DEMYELINA, V1, P9, DOI [10.1186/s40893-016-0012-0, DOI 10.1186/S40893-016-0012-0]; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Steiner AA, 2011, J PHYSIOL-LONDON, V589, P2415, DOI 10.1113/jphysiol.2010.202465; Straub RH, 2016, EVOL MED PUBLIC HLTH, P37, DOI 10.1093/emph/eow001; Sue N, 2008, MOL CELL BIOL, V28, P3967, DOI 10.1128/MCB.01942-07; Sweet DR, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00006; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Vu TT, 2011, J IMMUNOL, V187, P5032, DOI 10.4049/jimmunol.1101450; Vasseur S, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-25; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	54	9	9	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6080	6091		10.1074/jbc.RA120.013114	http://dx.doi.org/10.1074/jbc.RA120.013114			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32213596	Green Published, hybrid			2022-12-28	WOS:000531417300019
J	Manska, S; Octaviano, R; Rossetto, CC				Manska, Salom; Octaviano, Rionna; Rossetto, Cyprian C.			5-Ethynyl-2?-deoxycytidine and 5-ethynyl-2?-deoxyuridine are differentially incorporated in cells infected with HSV-1, HCMV, and KSHV viruses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleoside; nucleotide analogue; nucleoside; nucleotide metabolism; herpesvirus; DNA replication; viral replication; 5-ethynyl-2?-deoxycytidine (EdC); 5-ethynyl-2?-deoxyuridine (EdU); thymidine kinase; pulse labeling; cell proliferation; non-radioactive labeling; thymidine kinase; fluorescent reporter	URACIL-DNA GLYCOSYLASE; HERPES-SIMPLEX-VIRUS; HUMAN CYTOMEGALOVIRUS; PROTEIN-KINASE; ENDOTHELIAL ORIGIN; REPLICATION FORKS; THYMIDINE KINASE; DUTPASE; EDU; PHOSPHORYLATION	Nucleoside analogues are a valuable experimental tool. Incorporation of these molecules into newly synthesized DNA (i.e. pulse-labeling) is used to monitor cell proliferation or to isolate nascent DNA. Some of the most common nucleoside analogues used for pulse-labeling of DNA in cells are the deoxypyrimidine analogues 5-ethynyl-2?-deoxyuridine (EdU) and 5-ethynyl-2?-deoxycytidine (EdC). Click chemistry enables conjugation of an azide molecule tagged with a fluorescent dye or biotin to the alkyne of the analog, which can then be used to detect incorporation of EdU and EdC into DNA. The use of EdC is often recommended because of the potential cytotoxicity associated with EdU during longer incubations. Here, by comparing the relative incorporation efficiencies of EdU and EdC during short 30-min pulses, we demonstrate significantly lower incorporation of EdC than of EdU in noninfected human fibroblast cells or in cells infected with either human cytomegalovirus or Kaposi's sarcoma-associated herpesvirus. Interestingly, cells infected with herpes simplex virus type-1 (HSV-1) incorporated EdC and EdU at similar levels during short pulses. Of note, exogenous expression of HSV-1 thymidine kinase increased the incorporation efficiency of EdC. These results highlight the limitations when using substituted pyrimidine analogues in pulse-labeling and suggest that EdU is the preferable nucleoside analogue for short pulse-labeling experiments, resulting in increased recovery and sensitivity for downstream applications. This is an important discovery that may help to better characterize the biochemical properties of different nucleoside analogues with a given kinase, ultimately leading to significant differences in labeling efficiency of nascent DNA.	[Manska, Salom; Octaviano, Rionna; Rossetto, Cyprian C.] Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Rossetto, CC (corresponding author), Univ Nevada, Sch Med, Dept Microbiol & Immunol, Reno, NV 89557 USA.	crossetto@med.unr.edu		Octaviano, Rionna/0000-0001-7236-8240; Manska, Salome/0000-0002-6345-0880; Rossetto, Cyprian/0000-0002-4415-0196	National Institutes of Health [R01 AI045096, R56 AI106737]; University of Nevada, Reno (UNR) IDeA Network of Biomedical Research Excellence (INBRE) [P20 GM103440]; UNR startup funds	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nevada, Reno (UNR) IDeA Network of Biomedical Research Excellence (INBRE); UNR startup funds	This work was supported by National Institutes of Health Grants R01 AI045096 and R56 AI106737 (to C. C. R.); University of Nevada, Reno (UNR) IDeA Network of Biomedical Research Excellence (INBRE) Grant P20 GM103440; and UNR startup funds (to C. C. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BARR PJ, 1981, J MED CHEM, V24, P1385, DOI 10.1021/jm00144a003; BJURSELL KG, 1972, EUR J BIOCHEM, V29, P348, DOI 10.1111/j.1432-1033.1972.tb01995.x; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Cannon JS, 1999, J VIROL, V73, P4786, DOI 10.1128/JVI.73.6.4786-4793.1999; Chen RX, 2002, J GEN VIROL, V83, P2339, DOI 10.1099/0022-1317-83-10-2339; Courcelle CT, 2001, J VIROL, V75, P7592, DOI 10.1128/JVI.75.16.7592-7601.2001; Cristofoli WA, 2007, J MED CHEM, V50, P2851, DOI 10.1021/jm0701472; Davison AJ, 2005, J VIROL, V79, P12880, DOI 10.1128/JVI.79.20.12880-12892.2005; DECLERCQ E, 1982, MOL PHARMACOL, V21, P217; DECLERCQ E, 1984, PHARMACOL THERAPEUT, V26, P1, DOI 10.1016/0163-7258(84)90049-4; DECLERCQ E, 1979, P NATL ACAD SCI USA, V76, P2947, DOI 10.1073/pnas.76.6.2947; Dembowski JA, 2017, JOVE-J VIS EXP, DOI 10.3791/56374; Dembowski JA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006166; Dembowski JA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004939; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Ding P, 2010, CHEM-EUR J, V16, P14385, DOI 10.1002/chem.201001572; Dong QW, 2018, MBIO, V9, DOI 10.1128/mBio.01831-18; GRATZNER HG, 1975, EXP CELL RES, V95, P88, DOI 10.1016/0014-4827(75)90612-6; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; GREENBERG GR, 1962, P NATL ACAD SCI USA, V48, P247, DOI 10.1073/pnas.48.2.247; Guan LR, 2011, CHEMBIOCHEM, V12, P2184, DOI 10.1002/cbic.201100353; Guo HB, 2005, J AM CHEM SOC, V127, P3191, DOI 10.1021/ja0439625; GUPTA PK, 1981, CANCER RES, V41, P3133; Gustafson EA, 2000, J VIROL, V74, P684, DOI 10.1128/JVI.74.2.684-692.2000; Hocek M, 2014, J ORG CHEM, V79, P9914, DOI 10.1021/jo5020799; Jager S, 2005, J AM CHEM SOC, V127, P15071, DOI 10.1021/ja051725b; JAMIESON AT, 1974, J GEN VIROL, V24, P465, DOI 10.1099/0022-1317-24-3-465; JAMIESON AT, 1974, J GEN VIROL, V24, P481, DOI 10.1099/0022-1317-24-3-481; JONES AS, 1981, J MED CHEM, V24, P759, DOI 10.1021/jm00138a024; Kato A, 2014, J VIROL, V88, P2775, DOI 10.1128/JVI.03300-13; Kohlmeier F, 2013, CHROMOSOME RES, V21, P87, DOI 10.1007/s10577-013-9340-5; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Leung KHT, 2013, BIOTECHNIQUES, V55, P204, DOI 10.2144/000114089; Ligasova A, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150172; Ligasova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117459; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; LITTLER E, 1992, NATURE, V358, P160, DOI 10.1038/358160a0; Lu CC, 2007, J VIROL, V81, P1195, DOI 10.1128/JVI.01518-06; MAUDGAL PC, 1980, ANTIMICROB AGENTS CH, V17, P8, DOI 10.1128/AAC.17.1.8; MESSIER B, 1958, EXP CELL RES, V14, P224, DOI 10.1016/0014-4827(58)90235-0; Michel D, 2004, BBA-PROTEINS PROTEOM, V1697, P169, DOI 10.1016/j.bbapap.2003.11.022; Michel D, 1996, J VIROL, V70, P6340, DOI 10.1128/JVI.70.9.6340-6346.1996; Minkah N, 2015, J VIROL, V89, P3366, DOI 10.1128/JVI.03111-14; Myoung J, 2011, J VIROL METHODS, V174, P12, DOI 10.1016/j.jviromet.2011.03.012; Neef AB, 2012, CHEMBIOCHEM, V13, P1750, DOI 10.1002/cbic.201200253; Park J, 2000, J GEN VIROL, V81, P1067, DOI 10.1099/0022-1317-81-4-1067; Prichard MN, 1996, J VIROL, V70, P3018, DOI 10.1128/JVI.70.5.3018-3025.1996; PYLES RB, 1992, J VIROL, V66, P6706, DOI 10.1128/JVI.66.11.6706-6713.1992; Qu DZ, 2011, ANAL BIOCHEM, V417, P112, DOI 10.1016/j.ab.2011.05.037; Reyes ED, 2017, MOL CELL PROTEOMICS, V16, P2079, DOI 10.1074/mcp.M117.067116; RICHARDS RG, 1984, ADV ENZYME REGUL, V22, P157, DOI 10.1016/0065-2571(84)90013-X; Ross HH, 2011, J NEURO-ONCOL, V105, P485, DOI 10.1007/s11060-011-0621-6; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SCHECK AC, 1987, INTERVIROLOGY, V27, P121, DOI 10.1159/000149730; Schmidt N, 2015, J VIROL, V89, P11107, DOI 10.1128/JVI.01950-15; Schormann N, 2014, PROTEIN SCI, V23, P1667, DOI 10.1002/pro.2554; Senkevich TG, 2017, J VIROL, V91, DOI 10.1128/JVI.01015-17; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Strahan R, 2018, J VIROL, V92, DOI 10.1128/JVI.00739-18; Sturzl M, 2013, INT J CANCER, V132, P1954, DOI 10.1002/ijc.27849; SULLIVAN V, 1992, NATURE, V358, P162, DOI 10.1038/358162a0; TAYLOR JH, 1957, P NATL ACAD SCI USA, V43, P122, DOI 10.1073/pnas.43.1.122; TOMILIN NV, 1989, INT REV CYTOL, V114, P125; Walker R. T., 1981, NUCL ACIDS S SER, P21; Wang IH, 2013, CELL HOST MICROBE, V14, P468, DOI 10.1016/j.chom.2013.09.004; Wiest NE, 2017, METHOD ENZYMOL, V591, P1, DOI 10.1016/bs.mie.2017.03.001; Wu ZLL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023172; XEROS N, 1962, NATURE, V194, P682, DOI 10.1038/194682a0; Zhao H, 2013, CYTOM PART A, V83, P979, DOI 10.1002/cyto.a.22396	72	8	8	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5871	5890		10.1074/jbc.RA119.012378	http://dx.doi.org/10.1074/jbc.RA119.012378			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32205447	Green Published, hybrid			2022-12-28	WOS:000531417300004
J	Milton, AO; Wang, TZ; Li, WT; Guo, J; Zhang, ST				Milton, Alexandria O.; Wang, Tingzhong; Li, Wentao; Guo, Jun; Zhang, Shetuan			Mechanical stretch increases Kv1.5 current through an interaction between the S1?S2 linker and N-terminus of the channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Src kinase; potassium channel; electrophysiology; ion channel; molecular biology; patch clamp; structure-function; mechanotransduction; Kv1; 5; cell biology; voltage-gated potassium channel; mechanical stretch; Src	FOCAL ADHESION KINASE; ATRIAL-FIBRILLATION; TYROSINE KINASE; PROLINE; RECEPTORS; BINDING; HEART	The voltage-gated potassium channel Kv1.5 plays important roles in atrial repolarization and regulation of vascular tone. In the present study, we investigated the effects of mechanical stretch on Kv1.5 channels. We induced mechanical stretch by centrifuging or culturing Kv1.5-expressing HEK 293 cells and neonatal rat ventricular myocytes in low osmolarity (LO) medium and then recorded Kv1.5 current (I-Kv1.5) in a normal, isotonic solution. We observed that mechanical stretch increased I-Kv1.5, and this increase required the intact, long, proline-rich extracellular S1?S2 linker of the Kv1.5 channel. The low osmolarity?induced I-Kv1.5 increase also required an intact intracellular N terminus, which contains the binding motif for endogenous Src tyrosine kinase that constitutively inhibits I-Kv1.5. Disrupting the Src-binding motif of Kv1.5 through N-terminal truncation or mutagenesis abolished the mechanical stretch-mediated increase in I-Kv1.5. Our results further showed that the extracellular S1?S2 linker of Kv1.5 communicates with the intracellular N terminus. Although the S1?S2 linker of WT Kv1.5 could be cleaved by extracellularly applied proteinase K (PK), an N-terminal truncation up to amino acid residue 209 altered the conformation of the S1?S2 linker and made it no longer susceptible to proteinase K?mediated cleavage. In summary, the findings of our study indicate that the S1?S2 linker of Kv1.5 represents a mechanosensor that regulates the activity of this channel. By targeting the S1?S2 linker, mechanical stretch may induce a change in the N-terminal conformation of Kv1.5 that relieves Src-mediated tonic channel inhibition and results in an increase in I-Kv1.5.	[Milton, Alexandria O.; Wang, Tingzhong; Li, Wentao; Guo, Jun; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), 18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193	Natural Sciences and Engineering Research Council of Canada [RGPIN-2019-04878]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2019-04878 (to S. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Anter E, 2009, CIRCULATION, V119, P2516, DOI 10.1161/CIRCULATIONAHA.108.821306; Archer SL, 1998, J CLIN INVEST, V101, P2319, DOI 10.1172/JCI333; Bett GCL, 2012, BIOPHYS J, V103, P1440, DOI 10.1016/j.bpj.2012.08.036; Boycott HE, 2013, P NATL ACAD SCI USA, V110, pE3955, DOI 10.1073/pnas.1309896110; CHAN HC, 1992, SCIENCE, V257, P669, DOI 10.1126/science.1379742; Christophersen IE, 2013, EUR HEART J, V34, P1517, DOI 10.1093/eurheartj/ehs442; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; Dzeshka MS, 2017, HYPERTENSION, V70, P854, DOI 10.1161/HYPERTENSIONAHA.117.08934; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Fonseca PM, 2005, CIRC RES, V96, P73, DOI 10.1161/01.RES.0000152390.99806.A5; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gomis A, 2008, J PHYSIOL-LONDON, V586, P5633, DOI 10.1113/jphysiol.2008.161257; Guo W, 1998, J MOL CELL CARDIOL, V30, P157, DOI 10.1006/jmcc.1997.0584; Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hogan-Cann A, 2016, BBA-BIOMEMBRANES, V1858, P1082, DOI 10.1016/j.bbamem.2016.02.012; Holmes TC, 1996, J NEUROSCI, V16, P1581; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Hong SH, 1997, J BIOL CHEM, V272, P4166, DOI 10.1074/jbc.272.7.4166; Kaduk C, 1997, BIOPHYS J, V72, P2151, DOI 10.1016/S0006-3495(97)78858-1; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Lamothe SM, 2018, J BIOL CHEM, V293, P15347, DOI 10.1074/jbc.RA118.004065; Linz P, 2002, AM J PHYSIOL-HEART C, V282, pH1828, DOI 10.1152/ajpheart.00708.2000; MONTROSERAFIZADEH C, 1990, ANNU REV PHYSIOL, V52, P761; Noubiap JJ, 2019, AM J CARDIOL, V124, P262, DOI 10.1016/j.amjcard.2019.04.028; Ohanyan V, 2015, CIRC RES, V117, P612, DOI 10.1161/CIRCRESAHA.115.306642; Peyronnet R, 2016, CIRC RES, V118, P311, DOI 10.1161/CIRCRESAHA.115.305043; Schmidt D, 2012, P NATL ACAD SCI USA, V109, P10352, DOI 10.1073/pnas.1204700109; Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B; Tschirhart JN, 2019, MOL PHARMACOL, V95, P386, DOI 10.1124/mol.118.114751; VOLK T, 1995, P NATL ACAD SCI USA, V92, P8478, DOI 10.1073/pnas.92.18.8478; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; WESS J, 1993, EMBO J, V12, P331, DOI 10.1002/j.1460-2075.1993.tb05661.x; Yang F, 2014, ELIFE, V3, DOI 10.7554/eLife.03255; Yang T, 2010, HEART RHYTHM, V7, P1246, DOI 10.1016/j.hrthm.2010.05.032; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhang ST, 1998, J MOL CELL CARDIOL, V30, P1955, DOI 10.1006/jmcc.1998.0758	37	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4723	4732		10.1074/jbc.RA119.011302	http://dx.doi.org/10.1074/jbc.RA119.011302			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32122972	Green Published, hybrid			2022-12-28	WOS:000524499700029
J	Thoreen, CC; Kang, SA; Chang, JW; Liu, QS; Zhang, JM; Gao, Y; Reichling, LJ; Sim, T; Sabatini, DM; Gray, NS				Thoreen, Carson C.; Kang, Seong A.; Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Gao, Yi; Reichling, Laurie J.; Sim, Taebo; Sabatini, David M.; Gray, Nathanael S.			Correction: An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1 (vol 284, pg 8023, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Chang, Jae Won/AAN-4139-2020					Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200	1	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2886	2886		10.1074/jbc.AAC120.012837	http://dx.doi.org/10.1074/jbc.AAC120.012837			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	32111721	Green Published, hybrid			2022-12-28	WOS:000519969100029
J	Byun, JA; Van, K; Huang, JF; Henning, P; Franz, E; Akimoto, M; Herberg, FW; Kim, C; Melacini, G				Byun, Jung Ah; Van, Katherine; Huang, Jinfeng; Henning, Philipp; Franz, Eugen; Akimoto, Madoka; Herberg, Friedrich W.; Kim, Choel; Melacini, Giuseppe			Mechanism of allosteric inhibition in thePlasmodium falciparumcGMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); malaria; nuclear magnetic resonance (NMR); signaling; plasmodium; protein kinase G (PKG); 8-NBD-cGMP; CNB; cyclic nucleotide?binding domain (CBD); kinase signaling; PfPKG	STRUCTURAL BASIS; REGULATORY SUBUNIT; MALARIA BIOLOGY; BINDING DOMAIN; ACTIVATION; AUTOINHIBITION; SELECTIVITY; DYNAMICS; LINKERS; TARGETS	Most malaria deaths are caused by the protozoan parasitePlasmodium falciparum. Its life cycle is regulated by a cGMP-dependent protein kinase (PfPKG), whose inhibition is a promising antimalaria strategy. Allosteric kinase inhibitors, such as cGMP analogs, offer enhanced selectivity relative to competitive kinase inhibitors. However, the mechanisms underlying allostericPfPKG inhibition are incompletely understood. Here, we show that 8-NBD-cGMP is an effectivePfPKG antagonist. Using comparative NMR analyses of a key regulatory domain,PfD, in itsapo, cGMP-bound, and cGMP analog?bound states, we elucidated its inhibition mechanism of action. Using NMR chemical shift analyses, molecular dynamics simulations, and site-directed mutagenesis, we show that 8-NBD-cGMP inhibitsPfPKG not simply by reverting a two-state activeversusinactive equilibrium, but by sampling also a distinct inactive ?mixed? intermediate. Surface plasmon resonance indicates that the ability to stabilize a mixed intermediate provides a means to effectively inhibitPfPKG, without losing affinity for the cGMP analog. Our proposed model may facilitate the rational design ofPfPKG-selective inhibitors for improved management of malaria.	[Byun, Jung Ah; Van, Katherine; Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8S 4L8, Canada; [Huang, Jinfeng; Akimoto, Madoka; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, 1280 Main St W, Hamilton, ON L8S 4L8, Canada; [Henning, Philipp; Herberg, Friedrich W.] Univ Kassel, Dept Biochem, Heinrich Plett Str 40, D-34132 Kassel, Germany; [Franz, Eugen] Biaffin GmbH & Co KG, Heinrich Plett Str 40, D-34132 Kassel, Germany; [Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kim, Choel] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA	McMaster University; McMaster University; Universitat Kassel; Baylor College of Medicine; Baylor College of Medicine	Melacini, G (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8S 4L8, Canada.; Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, 1280 Main St W, Hamilton, ON L8S 4L8, Canada.	melacin@mcmaster.ca	; Herberg, Friedrich W./B-5572-2015	Huang, Jinfeng/0000-0002-6342-8536; Byun, Jung Ah/0000-0001-7814-7326; Herberg, Friedrich W./0000-0001-7117-7653; AKIMOTO, MADOKA/0000-0003-0510-5613	Canadian Institutes of Health Research Grant [389522]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2019-05990]; Deutsche Forschungsgemeinschaft (DFG) [He1818/10]; funding line Future "PhosMOrg" of the University of Kassel; Graduate School "Clocks" of the University of Kassel	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); funding line Future "PhosMOrg" of the University of Kassel; Graduate School "Clocks" of the University of Kassel	This work was supported by Canadian Institutes of Health Research Grant 389522 (to G. M.), Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2019-05990 (to G. M.), Deutsche Forschungsgemeinschaft (DFG) Grant He1818/10 (to F. W. H.), and the funding line Future "PhosMOrg" and Graduate School "Clocks" of the University of Kassel (to F. W. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimoto M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002305; Akimoto M, 2014, BIOCHEM SOC T, V42, P139, DOI 10.1042/BST20130257; Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Alam MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8285; Baker DA, 2005, FRONT BIOSCI, V10, P1229, DOI 10.2741/1615; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Boulton S, 2018, J AM CHEM SOC, V140, P9624, DOI 10.1021/jacs.8b05044; Boulton S, 2017, J BIOL CHEM, V292, P6414, DOI 10.1074/jbc.M116.773697; Boulton S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07306; Brochet M, 2016, MOL MICROBIOL, V100, P397, DOI 10.1111/mmi.13324; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Cowman AF, 2016, CELL, V167, P610, DOI 10.1016/j.cell.2016.07.055; Darden T., 2016, AMBER 2016; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng WS, 2003, BIOCHEM J, V374, P559, DOI 10.1042/BJ20030474; Diaz CA, 2006, MOL BIOCHEM PARASIT, V146, P78, DOI 10.1016/j.molbiopara.2005.10.020; Doerig C, 2005, BBA-PROTEINS PROTEOM, V1754, P132, DOI 10.1016/j.bbapap.2005.08.027; Dolgova NV, 2017, BIOCHEMISTRY-US, V56, P3129, DOI 10.1021/acs.biochem.7b00293; El Bakkouri M, 2019, P NATL ACAD SCI USA, V116, P14164, DOI 10.1073/pnas.1905558116; Fairhurst RM, 2015, CURR OPIN INFECT DIS, V28, P417, DOI 10.1097/QCO.0000000000000199; Fayos R, 2003, J BIOL CHEM, V278, P18581, DOI 10.1074/jbc.M300866200; Franz E, 2018, ACS INFECT DIS, V4, P415, DOI 10.1021/acsinfecdis.7b00222; Frisch M. J., 2016, GAUSSIAN 16 REV C01; Goddard T., 2006, SPARKY NMR ASSIGNMEN; Govindasamy K, 2016, MOL MICROBIOL, V102, P349, DOI 10.1111/mmi.13466; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hopp CS, 2012, MICROBES INFECT, V14, P831, DOI 10.1016/j.micinf.2012.04.011; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Huang JF, 2017, J CHEM INF MODEL, V57, P2273, DOI 10.1021/acs.jcim.7b00207; Kim JJ, 2016, STRUCTURE, V24, P710, DOI 10.1016/j.str.2016.03.009; Kim JJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004639; McNicholl ET, 2010, J BIOL CHEM, V285, P15523, DOI 10.1074/jbc.M110.105783; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Moon TM, 2018, J BIOL CHEM, V293, P7916, DOI 10.1074/jbc.RA117.000647; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Riniker S, 2015, J CHEM INF MODEL, V55, P2562, DOI 10.1021/acs.jcim.5b00654; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Selvaratnam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048707; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; VanSchouwen B, 2015, J BIOL CHEM, V290, P28631, DOI 10.1074/jbc.M115.685305; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; WHO, 2019, WORLD MALARIA REPORT; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	54	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8480	8491		10.1074/jbc.RA120.013070	http://dx.doi.org/10.1074/jbc.RA120.013070			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32317283	hybrid, Green Published			2022-12-28	WOS:000546986500012
J	Guerillon, C; Smedegaard, S; Hendriks, IA; Nielsen, ML; Mailand, N				Guerillon, Claire; Smedegaard, Stine; Hendriks, Ivo A.; Nielsen, Michael L.; Mailand, Niels			Multisite SUMOylation restrains DNA polymerase ? interactions with DNA damage sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sumoylation; DNA damage; DNA damage response; DNA polymerase; post-translational modification (PTM); proliferating cell nuclear antigen (PCNA); translesion DNA synthesis (TLS)	UBIQUITIN-BINDING DOMAINS; TRANSLESION SYNTHESIS; PCNA MONOUBIQUITINATION; STRUCTURAL BASIS; DVC1 C1ORF124; THYMINE DIMER; E3 LIGASE; POL-ETA; REPLICATION; RNF4	Translesion DNA synthesis (TLS) mediated by low-fidelity DNA polymerases is an essential cellular mechanism for bypassing DNA lesions that obstruct DNA replication progression. However, the access of TLS polymerases to the replication machinery must be kept tightly in check to avoid excessive mutagenesis. Recruitment of DNA polymerase ? (Pol ?) and other Y-family TLS polymerases to damaged DNA relies on proliferating cell nuclear antigen (PCNA) monoubiquitylation and is regulated at several levels. Using a microscopy-based RNAi screen, here we identified an important role of the SUMO modification pathway in limiting Pol ? interactions with DNA damage sites in human cells. We found that Pol ? undergoes DNA damage- and protein inhibitor of activated STAT 1 (PIAS1)-dependent polySUMOylation upon its association with monoubiquitylated PCNA, rendering it susceptible to extraction from DNA damage sites by SUMO-targeted ubiquitin ligase (STUbL) activity. Using proteomic profiling, we demonstrate that Pol ? is targeted for multisite SUMOylation, and that collectively these SUMO modifications are essential for PIAS1- and STUbL-mediated displacement of Pol ? from DNA damage sites. These findings suggest that a SUMO-driven feedback inhibition mechanism is an intrinsic feature of TLS-mediated lesion bypass functioning to curtail the interaction of Pol ? with PCNA at damaged DNA to prevent harmful mutagenesis.	[Guerillon, Claire; Smedegaard, Stine; Mailand, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Prot Res,Ubiquitin Signaling Grp, Novo Nordisk Fdn,Prot Signaling Program, Blegdamsvej 3B, Copenhagen, Denmark; [Hendriks, Ivo A.; Nielsen, Michael L.] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Prot Res, Novo Nordisk Fdn,Prote Program, Blegdamsvej 3B, Copenhagen, Denmark	Novo Nordisk Foundation; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Mailand, N (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Prot Res,Ubiquitin Signaling Grp, Novo Nordisk Fdn,Prot Signaling Program, Blegdamsvej 3B, Copenhagen, Denmark.	niels.mailand@cpr.ku.dk	Guérillon, Claire/I-1010-2014	Guérillon, Claire/0000-0002-1982-6596; Hendriks, Ivo/0000-0002-1439-3701; Mailand, Niels/0000-0002-6623-709X; Nielsen, Michael/0000-0002-0067-9039	Novo Nordisk Foundation [NNF14CC0001]; European Research Council [616236]; Danish Cancer Society [R146-RP11394]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council(European Research Council (ERC)European Commission); Danish Cancer Society(Danish Cancer Society)	This work was supported by Novo Nordisk Foundation Grant NNF14CC0001, European Research Council Grant 616236 (DDRegulation), and Danish Cancer Society Grant R146-RP11394.	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Bertoletti F, 2017, NUCLEIC ACIDS RES, V45, P9441, DOI 10.1093/nar/gkx619; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Bonne-Andrea C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2875; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cipolla L, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00105; Davis EJ, 2012, NAT STRUCT MOL BIOL, V19, P1093, DOI 10.1038/nsmb.2394; Despras E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13326; Despras E, 2012, ENVIRON MOL MUTAGEN, V53, P752, DOI 10.1002/em.21741; Durando M, 2013, NUCLEIC ACIDS RES, V41, P3079, DOI 10.1093/nar/gkt016; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gibbs-Seymour I, 2015, MOL CELL, V57, P150, DOI 10.1016/j.molcel.2014.12.001; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; He XY, 2017, NAT CHEM BIOL, V13, P1164, DOI [10.1038/nchembio.2463, 10.1038/NCHEMBIO.2463]; Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Itoh T, 2000, J INVEST DERMATOL, V115, P981, DOI 10.1046/j.1523-1747.2000.00154.x; Jain R, 2018, CURR OPIN STRUC BIOL, V53, P77, DOI 10.1016/j.sbi.2018.06.003; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Jung YS, 2011, MOL CELL BIOL, V31, P3997, DOI 10.1128/MCB.05808-11; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kumar R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01900-x; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Lehmann AR, 2005, FEBS LETT, V579, P873, DOI 10.1016/j.febslet.2004.11.029; Lerner LK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58180-7; Lin QC, 2006, CANCER RES, V66, P87, DOI 10.1158/0008-5472.CAN-05-1862; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Lopez-Contreras AJ, 2013, CELL REP, V3, P1105, DOI 10.1016/j.celrep.2013.03.009; Ma XL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02164-1; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; Mosbech A, 2012, NAT STRUCT MOL BIOL, V19, P1084, DOI 10.1038/nsmb.2395; Opletalova K, 2014, HUM MUTAT, V35, P117, DOI 10.1002/humu.22462; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Poulsen M, 2012, J CELL BIOL, V197, P189, DOI 10.1083/jcb.201109100; Poulsen SL, 2013, J CELL BIOL, V201, P797, DOI 10.1083/jcb.201212075; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Qian J, 2015, ONCOGENE, V34, P4791, DOI 10.1038/onc.2014.394; Sabbioneda S, 2009, P NATL ACAD SCI USA, V106, pE20, DOI 10.1073/pnas.0812744106; Sabbioneda S, 2008, MOL BIOL CELL, V19, P5193, DOI 10.1091/mbc.E08-07-0724; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Sriramachandran AM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11549-3; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Tsanov N, 2014, NUCLEIC ACIDS RES, V42, P3692, DOI 10.1093/nar/gkt1400; van Cuijk L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8499; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yang Y, 2018, CELL CYCLE, V17, P833, DOI 10.1080/15384101.2018.1456296; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yoon JH, 2019, CELL, V176, P1295, DOI 10.1016/j.cell.2019.01.023; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	65	9	9	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8350	8362		10.1074/jbc.RA120.013780	http://dx.doi.org/10.1074/jbc.RA120.013780			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32350109	Green Published, hybrid			2022-12-28	WOS:000546986500001
J	Ait-Bouziad, N; Chiki, A; Limorenko, G; Xiao, SF; Eliezer, D; Lashuel, HA				Ait-Bouziad, Nadine; Chiki, Anass; Limorenko, Galina; Xiao, Shifeng; Eliezer, David; Lashuel, Hilal A.			Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule- and lipid-binding properties of Tau	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Tau protein (Tau); tauopathy; neurodegenerative disease; phosphotyrosine; aggregation; microtubule; post-translational modification (PTM); phosphorylation; amyloid; lipid binding	PROGRESSIVE SUPRANUCLEAR PALSY; ACCOMPANIES DISEASE PROGRESSION; AMYLOID-BETA-PEPTIDE; ALZHEIMERS-DISEASE; PROTEIN-TAU; C-ABL; NEUROFIBRILLARY TANGLES; 3RD REPEAT; ABNORMAL PHOSPHORYLATION; CORE PEPTIDE	The microtubule-associated protein Tau is implicated in the pathogenesis of several neurodegenerative disorders, including Alzheimer's disease. Increasing evidence suggests that post-translational modifications play critical roles in regulating Tau's normal functions and its pathogenic properties in tauopathies. Very little is known about how phosphorylation of tyrosine residues influences the structure, aggregation, and microtubule- and lipid-binding properties of Tau. Here, we sought to determine the relative contributions of phosphorylation of one or several of the five tyrosine residues in Tau (Tyr-18, -29, -197, -310, and -394) to the regulation of its biophysical, aggregation, and functional properties. We used a combination of site-specific mutagenesis and in vitro phosphorylation by c-Abl kinase to generate Tau species phosphorylated at all five tyrosine residues, all tyrosine residues except Tyr-310 or Tyr-394 (pTau-Y310F and pTau-Y394F, respectively) and Tau phosphorylated only at Tyr-310 or Tyr-394 (4F/pTyr-310 or 4F/pTyr-394). We observed that phosphorylation of all five tyrosine residues, multiple N-terminal tyrosine residues (Tyr-18, -29, and -197), or specific phosphorylation only at residue Tyr-310 abolishes Tau aggregation and inhibits its microtubule- and lipid-binding properties. NMR experiments indicated that these effects are mediated by a local decrease in ?-sheet propensity of Tau's PHF6 domain. Our findings underscore Tyr-310 phosphorylation has a unique role in the regulation of Tau aggregation, microtubule, and lipid interactions. These results also highlight the importance of conducting further studies to elucidate the role of Tyr-310 in the regulation of Tau's normal functions and pathogenic properties.	[Ait-Bouziad, Nadine; Chiki, Anass; Limorenko, Galina; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne EPFL, Lab Mol & Chem Biol Neurodegenerat, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Xiao, Shifeng] Shenzhen Univ, Shenzhen Key Lab Marine Biotechnol & Ecol, Coll Life Sci & Oceanog, Shenzhen, Peoples R China; [Xiao, Shifeng; Eliezer, David] Weill Cornell Med Coll, Dept Biochem, New York, NY USA; [Xiao, Shifeng; Eliezer, David] Weill Cornell Med Coll, Program Struct Biol, New York, NY USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Shenzhen University; Cornell University; Cornell University	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne EPFL, Lab Mol & Chem Biol Neurodegenerat, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	Hilal.lashuel@epfl.ch	Limorenko, Galina/AAX-9584-2020; Lashuel, Hilal/M-3500-2017	Limorenko, Galina/0000-0002-6319-0257; Ait-Bouziad, Nadine/0000-0003-3182-4179; Eliezer, David/0000-0002-1311-7537	Swiss Federal Institute of Technology Lausanne; National Institutes of Health [R37AG019391]; AC Immune	Swiss Federal Institute of Technology Lausanne; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AC Immune	This work was supported by grants from the Swiss Federal Institute of Technology Lausanne (to H. A. L.), AC Immune, and National Institutes of Health Grant R37AG019391 (to D. E.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ait-Bouziad N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01575-4; Alvarez AR, 2004, NEUROBIOL DIS, V17, P326, DOI 10.1016/j.nbd.2004.06.007; Arima K, 1999, ACTA NEUROPATHOL, V97, P565, DOI 10.1007/s004010051032; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; Barbier P, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00204; Barghorn Stefan, 2005, Methods Mol Biol, V299, P35; Barre P, 2006, J MOL BIOL, V362, P312, DOI 10.1016/j.jmb.2006.07.018; Barre P, 2013, PROTEIN SCI, V22, P1037, DOI 10.1002/pro.2290; Barthelemy NR, 2016, J ALZHEIMERS DIS, V51, P1033, DOI 10.3233/JAD-150962; Bhaskar K, 2010, NEUROPATH APPL NEURO, V36, P462, DOI 10.1111/j.1365-2990.2010.01103.x; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; DELACOURTE A, 1986, CR ACAD SCI III-VIE, V303, P439; Derisbourg M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09659; Derkinderen P, 2005, J NEUROSCI, V25, P6584, DOI 10.1523/JNEUROSCI.1487-05.2005; Duka V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075025; Elbaum-Garfinkle S, 2010, BIOPHYS J, V98, P2722, DOI 10.1016/j.bpj.2010.03.013; Eliezer D, 2005, BIOCHEMISTRY-US, V44, P1026, DOI 10.1021/bi048953n; Ellmer D, 2019, ANGEW CHEM, V131, P1630, DOI [10.1002/ange.201805238, DOI 10.1002/ANGE.201805238]; Ercan E, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0229-1; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Ferrer I, 2008, BRAIN, V131, P1416, DOI 10.1093/brain/awm305; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Georgieva ER, 2014, BIOPHYS J, V107, P1441, DOI 10.1016/j.bpj.2014.07.046; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Haj-Yahya M., 2019, ANGEW CHEM, V59, P4059; Haj-Yahya M, 2018, J AM CHEM SOC, V140, P6611, DOI 10.1021/jacs.8b02668; Harbison NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034679; Hirata A, 2007, BIOORG MED CHEM LETT, V17, P2971, DOI 10.1016/j.bmcl.2007.03.071; Ho GJ, 2005, NEUROBIOL AGING, V26, P625, DOI 10.1016/j.neurobiolaging.2004.06.016; Inoue M., 2009, T MAT RES SOC JAPAN, V34, P517, DOI [10.14723/tmrsj.34.517, DOI 10.14723/TMRSJ.34.517]; Inoue M, 2008, BIOCHEMISTRY-US, V47, P11847, DOI 10.1021/bi8010994; Inoue M, 2014, BIOORGAN MED CHEM, V22, P6471, DOI 10.1016/j.bmc.2014.09.032; Jones EM, 2012, BIOCHEMISTRY-US, V51, P2539, DOI 10.1021/bi201857v; Khatri A, 2016, J CELL SCI, V129, P9, DOI 10.1242/jcs.175521; KOPKE E, 1993, J BIOL CHEM, V268, P24374; KSIEZAKREDING H, 1992, BRAIN RES, V597, P209, DOI 10.1016/0006-8993(92)91476-U; Sayas CL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210864; Lebouvier T, 2008, BBA-MOL CELL RES, V1783, P188, DOI 10.1016/j.bbamcr.2007.11.005; Lebouvier T, 2009, J ALZHEIMERS DIS, V18, P1, DOI 10.3233/JAD-2009-1116; Lee G, 2004, J NEUROSCI, V24, P2304, DOI 10.1523/JNEUROSCI.4162-03.2004; Li CZ, 2018, J ALZHEIMERS DIS, V64, P205, DOI 10.3233/JAD-180054; Li WK, 2006, BIOCHEMISTRY-US, V45, P15692, DOI 10.1021/bi061422+; Mailliot C, 1998, FEBS LETT, V433, P201, DOI 10.1016/S0014-5793(98)00910-7; MORISHIMAKAWASHIMA M, 1995, NEUROBIOL AGING, V16, P365, DOI 10.1016/0197-4580(95)00027-C; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Naruto K, 2010, FEBS LETT, V584, P4233, DOI 10.1016/j.febslet.2010.09.012; Nishiura C, 2010, J BIOCHEM, V147, P405, DOI 10.1093/jb/mvp181; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Perez M, 2001, BIOCHEMISTRY-US, V40, P5983, DOI 10.1021/bi002961w; Santa-Maria I, 2006, BBA-MOL BASIS DIS, V1762, P683, DOI 10.1016/j.bbadis.2006.06.003; Sato S, 2006, J NEUROCHEM, V98, P1573, DOI 10.1111/j.1471-4159.2006.04059.x; Scales TME, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-12; Scaramozzino F, 2006, BIOCHEMISTRY-US, V45, P3684, DOI 10.1021/bi052167g; Schlatterer SD, 2011, J MOL NEUROSCI, V45, P445, DOI 10.1007/s12031-011-9588-1; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; SHAPIRO IP, 1991, J NEUROCHEM, V56, P1154, DOI 10.1111/j.1471-4159.1991.tb11405.x; SHIRAZI SK, 1993, NEUROREPORT, V4, P435, DOI 10.1097/00001756-199304000-00024; Sogawa K, 2014, BIOPOLYMERS, V102, P288, DOI 10.1002/bip.22489; Sogawa K, 2012, J BIOCHEM, V152, P221, DOI 10.1093/jb/mvs061; Tremblay MA, 2010, J ALZHEIMERS DIS, V19, P721, DOI 10.3233/JAD-2010-1271; Vega IE, 2005, MOL BRAIN RES, V138, P135, DOI 10.1016/j.molbrainres.2005.04.015; VERMERSCH P, 1995, CR ACAD SCI III-VIE, V318, P439; Von Bergen M, 2001, ALZHEIMER'S DISEASE, P631, DOI 10.1002/0470846453.ch58; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen Martin, 2005, Methods Mol Biol, V299, P175; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WOOD JG, 1991, NEUROSCI LETT, V121, P12, DOI 10.1016/0304-3940(91)90637-9; Yu X, 2012, J BIOL CHEM, V287, P14950, DOI 10.1074/jbc.M112.340794; Zhang W, 2019, NOVEL TAU FILAMENT F, DOI [10.1101/811703, DOI 10.1101/811703]; Zhang WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.43584	77	15	15	6	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7905	7922		10.1074/jbc.RA119.012517	http://dx.doi.org/10.1074/jbc.RA119.012517			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32341125	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000540935400008
J	Yu, PF; Li, Y; Li, YL; Miao, ZJ; Peppelenbosch, MP; Pan, QW				Yu, Peifa; Li, Yang; Li, Yunlong; Miao, Zhijiang; Peppelenbosch, Maikel P.; Pan, Qiuwei			Guanylate-binding protein 2 orchestrates innate immune responses against murine norovirus and is antagonized by the viral protein NS7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral replication; host defense; host-pathogen interaction; innate immunity; GTPase; antiviral restriction factor; guanylate-binding protein 2 (GBP2); interferon-stimulated gene (ISG); murine norovirus (MNV); non-structural protein 7 (NS7)	ANTIVIRAL ACTIVITY; MGBP2 CONTROLS; RIG-I; VIRUS; INFLAMMASOME; REPLICATION; LOCALIZATION; DEGRADATION; INFECTION; EFFECTOR	Noroviruses are the main causative agents of acute viral gastroenteritis, but the host factors that restrict their replication remain poorly identified. Guanylate-binding proteins (GBPs) are interferon (IFN)-inducible GTPases that exert broad antiviral activity and are important mediators of host defenses against viral infections. Here, we show that both IFN-? stimulation and murine norovirus (MNV) infection induce GBP2 expression in murine macrophages. Results from loss- and gain-of-function assays indicated that GBP2 is important for IFN-??dependent anti-MNV activity in murine macrophages. Ectopic expression of MNV receptor (CD300lf) in human HEK293T epithelial cells conferred susceptibility to MNV infection. Importantly, GBP2 potently inhibited MNV in these human epithelial cells. Results from mechanistic dissection experiments revealed that the N-terminal G domain of GBP2 mediates these anti-MNV effects. R48A and K51A substitutions in GBP2, associated with loss of GBP2 GTPase activity, attenuated the anti-MNV effects of GBP2. Finally, we found that nonstructural protein 7 (NS7) of MNV co-localizes with GBP2 and antagonizes the anti-MNV activity of GBP2. These findings reveal that GBP2 is an important mediator of host defenses against murine norovirus.	[Yu, Peifa; Li, Yang; Li, Yunlong; Miao, Zhijiang; Peppelenbosch, Maikel P.; Pan, Qiuwei] Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Yu, PF; Pan, QW (corresponding author), Univ Med Ctr, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	p.yu@erasmusmc.nl; q.pan@erasmusmc.nl		li, yang/0000-0002-3859-5690; Yu, Peifa/0000-0003-2255-0508; Peppelenbosch, Maikel/0000-0001-9112-6028; Pan, Qiuwei/0000-0001-9982-6184	China Scholarship Council Ph.D. Fellowships [201708620177, 201703250073, 201708530243, 201708530234]; Netherlands Organization for Scientific Research VIDI Grant [91719300]	China Scholarship Council Ph.D. Fellowships(China Scholarship Council); Netherlands Organization for Scientific Research VIDI Grant	This research is supported by China Scholarship Council Ph.D. Fellowships 201708620177 (to P. Y.), 201703250073 (Yang L.), 201708530243 (Yunlong L.), and 201708530234 (Z. M.) and Netherlands Organization for Scientific Research VIDI Grant 91719300 (to Q. P.).	Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Biering SB, 2017, CELL HOST MICROBE, V22, P74, DOI 10.1016/j.chom.2017.06.005; Bok K, 2012, NEW ENGL J MED, V367, P2126, DOI 10.1056/NEJMra1207742; Braun E, 2019, CELL REP, V27, P2092, DOI 10.1016/j.celrep.2019.04.063; Dang W, 2018, ANTIVIR RES, V155, P48, DOI 10.1016/j.antiviral.2018.05.004; Davies C, 2015, J VIROL, V89, P6057, DOI 10.1128/JVI.03673-14; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Dubois H, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007709; Feng J, 2017, J INNATE IMMUN, V9, P419, DOI 10.1159/000460294; Fernandez-Vega V, 2004, J VIROL, V78, P4827, DOI 10.1128/JVI.78.9.4827-4837.2004; Fritzlar S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010047; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hogbom M, 2009, J GEN VIROL, V90, P281, DOI 10.1099/vir.0.005629-0; Hyde JL, 2010, VIROLOGY, V406, P138, DOI 10.1016/j.virol.2010.06.047; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Itsui Y, 2006, J VIRAL HEPATITIS, V13, P690, DOI 10.1111/j.1365-2893.2006.00732.x; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Krapp C, 2016, CELL HOST MICROBE, V19, P504, DOI 10.1016/j.chom.2016.02.019; Kravets E, 2012, J BIOL CHEM, V287, P27452, DOI 10.1074/jbc.M112.379636; Kresse A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-158; Lee S, 2019, CELL HOST MICROBE, V25, P845, DOI 10.1016/j.chom.2019.04.005; Li LF, 2016, J VIROL, V90, P4412, DOI 10.1128/JVI.02718-15; Li P, 2017, NATURE, V551, P378, DOI 10.1038/nature24467; Li Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060541; Maloney NS, 2012, J VIROL, V86, P12655, DOI 10.1128/JVI.01564-12; Man SM, 2017, J LEUKOCYTE BIOL, V101, P143, DOI 10.1189/jlb.4MR0516-223R; McCune BT, 2017, MBIO, V8, DOI 10.1128/mBio.00668-17; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Orchard RC, 2016, SCIENCE, V353, P933, DOI 10.1126/science.aaf1220; Pan W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-292; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Rodriguez MR, 2014, J VIROL, V88, P9277, DOI 10.1128/JVI.01422-14; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Subba-Reddy CV, 2011, J VIROL, V85, P13027, DOI 10.1128/JVI.06191-11; Wandel MP, 2017, CELL HOST MICROBE, V22, P507, DOI 10.1016/j.chom.2017.09.007; Wang PH, 2015, SCIENCE, V350, P826, DOI 10.1126/science.aab3145; Wang WS, 2017, TRENDS MICROBIOL, V25, P574, DOI 10.1016/j.tim.2017.01.001; Wang YJ, 2014, GASTROENTEROLOGY, V146, P1775, DOI 10.1053/j.gastro.2014.02.036; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wobus CE, 2006, J VIROL, V80, P5104, DOI 10.1128/JVI.02346-05; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Xu L, 2017, HEPATOLOGY, V65, P1823, DOI 10.1002/hep.29105; Xu L, 2016, FASEB J, V30, P3352, DOI 10.1096/fj.201600356R; Zhu S, 2017, NATURE, V546, P667, DOI 10.1038/nature22967; Zhu S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003592; Zhu ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055920	50	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8036	8047		10.1074/jbc.RA120.013544	http://dx.doi.org/10.1074/jbc.RA120.013544			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32354743	hybrid, Green Published			2022-12-28	WOS:000540935400017
J	Namekata, K; Guo, XL; Kimura, A; Azuchi, Y; Kitamura, Y; Harada, C; Harada, T				Namekata, Kazuhiko; Guo, Xiaoli; Kimura, Atsuko; Azuchi, Yuriko; Kitamura, Yuta; Harada, Chikako; Harada, Takayuki			Roles of the DOCK-D family proteins in a mouse model of neuroinflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						guanine nucleotide exchange factor (GEF); gene knockout; microglia; astrocyte; migration; neurodegeneration; DOCK10; DOCK11; DOCK9	IN-VITRO; EXPRESSION; CDC42; CELLS; NEURODEGENERATION; ACTIVATION; ZIZIMIN2; DELETION; REVEALS; SYSTEM	The DOCK-D (dedicator of cytokinesis D) family proteins are atypical guanine nucleotide exchange factors that regulate Rho GTPase activity. The family consists of Zizimin1 (DOCK9), Zizimin2 (DOCK11), and Zizimin3 (DOCK10). Functions of the DOCK-D family proteins are presently not well-explored, and the role of the DOCK-D family in neuroinflammation is unknown. In this study, we generated three mouse lines in which DOCK9 (DOCK9(?/?)), DOCK10 (DOCK10(?/?)), or DOCK11 (DOCK11(?/?)) had been deleted and examined the phenotypic effects of these gene deletions in MOG(35?55) peptide-induced experimental autoimmune encephalomyelitis, an animal model of the neuroinflammatory disorder multiple sclerosis. We found that all the gene knockout lines were healthy and viable. The only phenotype observed under normal conditions was a slightly smaller proportion of B cells in splenocytes in DOCK10(?/?) mice than in the other mouse lines. We also found that the migration ability of macrophages is impaired in DOCK10(?/?) and DOCK11(?/?) mice and that the severity of experimental autoimmune encephalomyelitis was ameliorated only in DOCK10(?/?) mice. No apparent phenotype was observed for DOCK9(?/?) mice. Further investigations indicated that lipopolysaccharide stimulation up-regulates DOCK10 expression in microglia and that microglial migration is decreased in DOCK10(?/?) mice. Up-regulation of C?C motif chemokine ligand 2 (CCL2) expression induced by activation of Toll-like receptor 4 or 9 signaling was reduced in DOCK10(?/?) astrocytes compared with WT astrocytes. Taken together, our findings suggest that DOCK10 plays a role in innate immunity and neuroinflammation and might represent a potential therapeutic target for managing multiple sclerosis.	[Namekata, Kazuhiko; Guo, Xiaoli; Kimura, Atsuko; Azuchi, Yuriko; Kitamura, Yuta; Harada, Chikako; Harada, Takayuki] Tokyo Metropolitan Inst Med Sci, Visual Res Project, Tokyo 1568506, Japan	Tokyo Metropolitan Institute of Medical Science	Harada, T (corresponding author), Tokyo Metropolitan Inst Med Sci, Visual Res Project, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	harada-tk@igakuken.or.jp		Harada, Takayuki/0000-0001-6167-0997	Japan Society for the Promotion of Science KAKENHI [JP20K07751, JP17K07123, JP20K09820, JP20K18404, JP19K09943, JP18K19625]; Taiju Life Social Welfare Foundation; Takeda Science Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Taiju Life Social Welfare Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants-in-Aid for Scientific Research JP20K07751 (to K. N.), JP17K07123 and JP20K09820 (to A. K.), JP20K18404 (to Y. K.), JP19K09943 (to C. H.), and JP18K19625 (to T. H.) and funds from the Taiju Life Social Welfare Foundation (to T. H.) and the Takeda Science Foundation (to T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Abraham S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8286; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Chu FN, 2018, J NEUROIMMUNOL, V318, P1, DOI 10.1016/j.jneuroim.2018.02.015; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Garcia-Serna AM, 2016, IMMUNOBIOLOGY, V221, P1343, DOI 10.1016/j.imbio.2016.07.015; Gerasimcik N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00491; Guo XL, 2017, AM J PATHOL, V187, P2876, DOI 10.1016/j.ajpath.2017.08.012; Guo XL, 2011, INVEST OPHTH VIS SCI, V52, P2696, DOI 10.1167/iovs.10-6015; Guo XL, 2010, EMBO MOL MED, V2, P504, DOI 10.1002/emmm.201000103; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Hirata E, 2012, J CELL SCI, V125, P858, DOI 10.1242/jcs.089995; Hussain NK, 2015, P NATL ACAD SCI USA, V112, pE5883, DOI 10.1073/pnas.1518382112; Alcaraz-Garcia MJ, 2011, HUM IMMUNOL, V72, P531, DOI 10.1016/j.humimm.2011.03.024; Kang MG, 2012, J BIOL CHEM, V287, P28632, DOI 10.1074/jbc.M111.336644; Karolak JA, 2015, INVEST OPHTH VIS SCI, V56, P7687, DOI 10.1167/iovs.15-17538; Kim RY, 2014, J NEUROIMMUNOL, V274, P53, DOI 10.1016/j.jneuroim.2014.06.009; Kuramoto K, 2009, J NEUROSCI RES, V87, P1794, DOI 10.1002/jnr.21997; Laurin M, 2014, GENE DEV, V28, P533, DOI 10.1101/gad.236349.113; Lee JW, 2016, EXP NEUROBIOL, V25, P262, DOI 10.5607/en.2016.25.5.262; Matsuda T, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0028-x; Mayo L, 2012, IMMUNOL REV, V248, P170, DOI 10.1111/j.1600-065X.2012.01135.x; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Mishra MK, 2016, NAT REV NEUROL, V12, P539, DOI 10.1038/nrneurol.2016.110; Namekata K, 2019, J BIOL CHEM, V294, P13421, DOI 10.1074/jbc.RA119.007645; Namekata K, 2014, PROG RETIN EYE RES, V43, P1, DOI 10.1016/j.preteyeres.2014.06.005; Nishikimi A, 2005, FEBS LETT, V579, P1039, DOI 10.1016/j.febslet.2005.01.006; Peterson PK, 1997, J INFECT DIS, V175, P478, DOI 10.1093/infdis/175.2.478; Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168; Robel S, 2011, J NEUROSCI, V31, P12471, DOI 10.1523/JNEUROSCI.2696-11.2011; Ruiz-Lafuente N, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01391; Ruiz-Lafuente N, 2015, BIOL OPEN, V4, P627, DOI 10.1242/bio.20149050; Sakabe I, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-2; Sakamoto A, 2017, INT IMMUNOL, V29, P431, DOI 10.1093/intimm/dxx054; Sutter EE, 1999, VISION RES, V39, P419, DOI 10.1016/S0042-6989(98)00161-8; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; Xu XY, 2017, J EXP MED, V214, P209, DOI 10.1084/jem.20160068; Yelo E, 2008, MOL IMMUNOL, V45, P3411, DOI 10.1016/j.molimm.2008.04.003	38	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6710	6720		10.1074/jbc.RA119.010438	http://dx.doi.org/10.1074/jbc.RA119.010438			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32241915	hybrid, Green Published			2022-12-28	WOS:000537685000036
J	Wang, YQ; Sun, ZQ; Bianco, PR; Lyubchenko, YL				Wang, Yaqing; Sun, Zhiqiang; Bianco, Piero R.; Lyubchenko, Yuri L.			Atomic force microscopy?based characterization of the interaction of PriA helicase with stalled DNA replication forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); DNA replication; single-molecule biophysics; protein translocation; protein?DNA interaction; DNA helicase	ESCHERICHIA-COLI-SSB; BINDING-PROTEIN; 2 MODES; PRIMOSOME; RECG; RECOMBINATION; ASSOCIATION; SPECIFICITY; MECHANISMS; MUTANTS	In bacteria, the restart of stalled DNA replication forks requires the DNA helicase PriA. PriA can recognize and remodel abandoned DNA replication forks, unwind DNA in the 3?-to-5? direction, and facilitate the loading of the helicase DnaB onto the DNA to restart replication. Single-stranded DNA?binding protein (SSB) is typically present at the abandoned forks, but it is unclear how SSB and PriA interact, although it has been shown that the two proteins interact both physically and functionally. Here, we used atomic force microscopy to visualize the interaction of PriA with DNA substrates with or without SSB. These experiments were done in the absence of ATP to delineate the substrate recognition pattern of PriA before its ATP-catalyzed DNA-unwinding reaction. These analyses revealed that in the absence of SSB, PriA binds preferentially to a fork substrate with a gap in the leading strand. Such a preference has not been observed for 5?- and 3?-tailed duplexes, suggesting that it is the fork structure that plays an essential role in PriA's selection of DNA substrates. Furthermore, we found that in the absence of SSB, PriA binds exclusively to the fork regions of the DNA substrates. In contrast, fork-bound SSB loads PriA onto the duplex DNA arms of forks, suggesting a remodeling of PriA by SSB. We also demonstrate that the remodeling of PriA requires a functional C-terminal domain of SSB. In summary, our atomic force microscopy analyses reveal key details in the interactions between PriA and stalled DNA replication forks with or without SSB.	[Wang, Yaqing; Sun, Zhiqiang; Lyubchenko, Yuri L.] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA; [Bianco, Piero R.] SUNY Buffalo, Ctr Single Mol Biophys, Buffalo, NY 14214 USA	University of Nebraska System; University of Nebraska Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lyubchenko, YL (corresponding author), Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA.	ylyubchenko@unmc.edu		Wang, Yaqing/0000-0002-5797-3992; Lyubchenko, Yuri/0000-0001-9721-8302	NIGMS, National Institutes of Health [R01 GM118006, R01 GM100156]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants R01 GM118006 (to Y. L. L.) and R01 GM100156 (to P. R. B. and Y. L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLEN GC, 1993, J BIOL CHEM, V268, P19204; ARAI KI, 1981, P NATL ACAD SCI-BIOL, V78, P707, DOI 10.1073/pnas.78.2.707; Bagchi D, 2018, NUCLEIC ACIDS RES, V46, P8500, DOI 10.1093/nar/gky647; Bell JC, 2015, ELIFE, V4, DOI 10.7554/eLife.08646; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; Bianco PR, 2017, PROG BIOPHYS MOL BIO, V127, P111, DOI 10.1016/j.pbiomolbio.2016.11.001; Bianco PR, 2017, PROTEIN SCI, V26, P638, DOI 10.1002/pro.3114; Bianco PR, 2017, PROTEIN SCI, V26, P227, DOI 10.1002/pro.3072; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Chen HW, 2004, J BIOL CHEM, V279, P38503, DOI 10.1074/jbc.M404769200; Costes A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001238; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Ding WF, 2020, PROTEIN SCI, V29, P1211, DOI 10.1002/pro.3855; Gabbai CB, 2010, DNA REPAIR, V9, P202, DOI 10.1016/j.dnarep.2009.12.009; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Jones JM, 2001, J MOL BIOL, V312, P935, DOI 10.1006/jmbi.2001.4930; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P3555, DOI 10.1021/bi100069s; Liu J, 2011, PROTEIN SCI, V20, P1005, DOI 10.1002/pro.633; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Marians KJ, 2000, TRENDS BIOCHEM SCI, V25, P185, DOI 10.1016/S0968-0004(00)01565-6; MASAI H, 1994, EMBO J, V13, P5338, DOI 10.1002/j.1460-2075.1994.tb06868.x; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Michel B, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00013-18; Mills M, 2017, NUCLEIC ACIDS RES, V45, P11878, DOI 10.1093/nar/gkx939; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; OUZOUNIS CA, 1991, NUCLEIC ACIDS RES, V19, P6953, DOI 10.1093/nar/19.24.6953; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Shlyakhtenko Luda S, 2013, Methods Mol Biol, V931, P295, DOI 10.1007/978-1-62703-056-4_14; Shlyakhtenko LS, 2012, BIOCHEMISTRY-US, V51, P6432, DOI 10.1021/bi300733d; Shlyakhtenko LS, 2012, BIOCHEMISTRY-US, V51, P1500, DOI 10.1021/bi201863z; Sun ZQ, 2018, BIOCHEMISTRY-US, V57, P1967, DOI 10.1021/acs.biochem.7b01235; Sun ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09625; Tan HY, 2017, PROTEIN SCI, V26, P700, DOI 10.1002/pro.3115; Tanaka T, 2003, GENES CELLS, V8, P251, DOI 10.1046/j.1365-2443.2003.00630.x; Tanaka T, 2002, J BIOL CHEM, V277, P38062, DOI 10.1074/jbc.M204397200; Tanaka T, 2007, J BIOL CHEM, V282, P19917, DOI 10.1074/jbc.M701848200; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P3342, DOI 10.1073/pnas.72.9.3342; Windgassen TA, 2019, J BIOL CHEM, V294, P2801, DOI 10.1074/jbc.RA118.006870; Windgassen TA, 2018, P NATL ACAD SCI USA, V115, pE9075, DOI 10.1073/pnas.1809842115; Windgassen TA, 2018, NUCLEIC ACIDS RES, V46, P504, DOI 10.1093/nar/gkx1203; Yu C, 2016, GENES CELLS, V21, P163, DOI 10.1111/gtc.12334; ZAVITZ KH, 1991, MOL MICROBIOL, V5, P2869, DOI 10.1111/j.1365-2958.1991.tb01846.x; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933	51	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6043	6052		10.1074/jbc.RA120.013013	http://dx.doi.org/10.1074/jbc.RA120.013013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32209655	hybrid, Green Published			2022-12-28	WOS:000531417300016
J	Gordon, DM; Neifer, KL; Hamoud, ARA; Hawk, CF; Nestor-Kalinoski, AL; Miruzzi, SA; Morran, MP; Adeosun, SO; Sarver, JG; Erhardt, PW; McCullumsmith, RE; Stec, DE; Hinds, TD				Gordon, Darren M.; Neifer, Kari L.; Hamoud, Abdul-Rizaq Ali; Hawk, Charles F.; Nestor-Kalinoski, Andrea L.; Miruzzi, Scott A.; Morran, Michael P.; Adeosun, Samuel O.; Sarver, Jeffrey G.; Erhardt, Paul W.; McCullumsmith, Robert E.; Stec, David E.; Hinds, Terry D., Jr.			Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator?activated receptor ?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hormone; PPAR?; PPAR?; PPAR?; peroxisome proliferator?activated receptor (PPAR); nuclear receptor; biliverdin; beige fat; browning; obesity; peroxisome proliferator-activated receptor (PPAR); hormone; fatty acid oxidation	INCREASES INSULIN SENSITIVITY; BILIVERDIN REDUCTASE; PPAR-GAMMA; FATTY LIVER; SERUM BILIRUBIN; METABOLIC SYNDROME; UGT1A1-ASTERISK-28 ALLELE; GLUCOCORTICOID-RECEPTOR; CARDIOVASCULAR-DISEASE; UNCOUPLING PROTEIN-1	Activation of lipid-burning pathways in the fat-storing white adipose tissue (WAT) is a promising strategy to improve metabolic health and reduce obesity, insulin resistance, and type II diabetes. For unknown reasons, bilirubin levels are negatively associated with obesity and diabetes. Here, using mice and an array of approaches, including MRI to assess body composition, biochemical assays to measure bilirubin and fatty acids, MitoTracker-based mitochondrial analysis, immunofluorescence, and high-throughput coregulator analysis, we show that bilirubin functions as a molecular switch for the nuclear receptor transcription factor peroxisome proliferator?activated receptor ? (PPAR?). Bilirubin exerted its effects by recruiting and dissociating specific coregulators in WAT, driving the expression of PPAR? target genes such as uncoupling protein 1 (Ucp1) and adrenoreceptor ? 3 (Adrb3). We also found that bilirubin is a selective ligand for PPAR? and does not affect the activities of the related proteins PPAR? and PPAR?. We further found that diet-induced obese mice with mild hyperbilirubinemia have reduced WAT size and an increased number of mitochondria, associated with a restructuring of PPAR?-binding coregulators. We conclude that bilirubin strongly affects organismal body weight by reshaping the PPAR? coregulator profile, remodeling WAT to improve metabolic function, and reducing fat accumulation.	[Gordon, Darren M.; Neifer, Kari L.; Hamoud, Abdul-Rizaq Ali; Hawk, Charles F.; Miruzzi, Scott A.; McCullumsmith, Robert E.; Hinds, Terry D., Jr.] Univ Toledo, Coll Med & Life Sci, Dept Neurosci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Gordon, Darren M.; Hinds, Terry D., Jr.] Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res CeDER, 2801 W Bancroft St, Toledo, OH 43606 USA; [Nestor-Kalinoski, Andrea L.; Morran, Michael P.] Univ Toledo, Coll Med & Life Sci, Adv Microscopy & Imaging Ctr, Dept Surg, 2801 W Bancroft St, Toledo, OH 43606 USA; [Adeosun, Samuel O.; Stec, David E.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Cardiorenal & Metab Dis Res Ctr, Jackson, MS 39216 USA; [Sarver, Jeffrey G.] Univ Toledo, Coll Pharm & Pharmaceut Sci, Ctr Drug Design & Dev CD3, Dept Pharmacol & Expt Therapeut, 2801 W Bancroft St, Toledo, OH 43606 USA; [Erhardt, Paul W.] Univ Toledo, Coll Pharm & Pharmaceut Sci, Ctr Drug Design & Dev CD3, Dept Med & Biol Chem, 2801 W Bancroft St, Toledo, OH 43606 USA; [McCullumsmith, Robert E.] ProMedica, Toledo, OH USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University of Mississippi; University of Mississippi Medical Center; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Hinds, TD (corresponding author), Univ Toledo, Coll Med & Life Sci, Dept Neurosci, 2801 W Bancroft St, Toledo, OH 43606 USA.; Hinds, TD (corresponding author), Univ Toledo, Coll Med & Life Sci, Ctr Diabet & Endocrine Res CeDER, 2801 W Bancroft St, Toledo, OH 43606 USA.	Terry.Hinds@utoledo.edu	Hamoud, Ahmed A./L-4118-2019; McCullumsmith, Robert/GYR-1547-2022; Gordon, Darren/AAE-6400-2021; HAMOUD, AHMED A./J-5568-2016; Hinds, Terry/B-8495-2015	Hamoud, Ahmed A./0000-0002-8877-7337; Gordon, Darren/0000-0002-4848-1419; HAMOUD, AHMED A./0000-0002-8877-7337; Adeosun, Samuel/0000-0002-2331-7911; Hinds, Terry/0000-0002-7599-1529; Kalinoski, Andrea/0000-0002-1475-3578; Erhardt, Paul/0000-0002-7330-0384	National Institutes of Health (NIH) [1R01DK12179701A1, 1R01DK126884-01]; NHLBI, NIH [K01HL-125445, P01 HL05197-11]; NIGMS, National Institutes of Health [P20GM104357-02]; NIGMS (NIH) as one of its Centers of Biomedical Research Excellence (COBRE) [P30GM122733]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS (NIH) as one of its Centers of Biomedical Research Excellence (COBRE)	This work was supported by the National Institutes of Health (NIH) Grants 1R01DK12179701A1 (to D. E. S.) and 1R01DK126884-01 (to D. E. S. and T. D. H.); NHLBI, NIH, Grants K01HL-125445 (to T. D. H.) and P01 HL05197-11 (to D. E. S.); and NIGMS, National Institutes of Health, Grant P20GM104357-02 (to D. E. S.). This project was supported in part by Grant P30GM122733 (Chemistry and DMPK Core Faculty) funded by NIGMS (NIH) as one of its Centers of Biomedical Research Excellence (COBRE). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8052; Adeosun SO, 2018, AM J PHYSIOL-RENAL, V315, pF323, DOI 10.1152/ajprenal.00495.2017; Adeosun Samuel O, 2018, React Oxyg Species (Apex), V5, P35, DOI 10.20455/ros.2018.809; Andersson C, 2009, METABOLISM, V58, P1109, DOI 10.1016/j.metabol.2009.04.003; AWRUCH J, 1984, BIOCHIM BIOPHYS ACTA, V787, P146, DOI 10.1016/0167-4838(84)90073-6; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; BELL JE, 1988, ARCH BIOCHEM BIOPHYS, V263, P1, DOI 10.1016/0003-9861(88)90607-8; Belo L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098467; Bosma PJ, 2003, J HEPATOL, V38, P107, DOI 10.1016/S0168-8278(02)00359-8; Bougarne N, 2018, ENDOCR REV, V39, P760, DOI 10.1210/er.2018-00064; Broekema MF, 2018, ENDOCRINOLOGY, V159, P2397, DOI 10.1210/en.2018-00149; Brunmeir R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061738; Chen WC, 2014, MED SCI SPORT EXER, V46, P1517, DOI 10.1249/MSS.0000000000000272; Cheriyath Pramil, 2010, J Clin Med Res, V2, P201, DOI 10.4021/jocmr425w; Choi SH, 2013, NUTR METAB CARDIOVAS, V23, P31, DOI 10.1016/j.numecd.2011.03.001; Christian M, 2015, ADIPOCYTE, V4, P50, DOI 10.4161/adip.29853; Croce AC, 2014, J BIOPHOTONICS, V7, P810, DOI 10.1002/jbio.201300039; Debevec D, 2007, MOL ENDOCRINOL, V21, P1581, DOI 10.1210/me.2007-0103; Defour M, 2018, MOL METAB, V10, P39, DOI 10.1016/j.molmet.2018.01.023; Gonzalez MD, 2012, PPAR RES, V2012, DOI 10.1155/2012/483536; Dong HS, 2014, ENDOCRINOLOGY, V155, P818, DOI 10.1210/en.2013-1667; Dunn FL, 2011, J DIABETES COMPLICAT, V25, P151, DOI 10.1016/j.jdiacomp.2010.06.006; Ebke LA, 2014, OBESITY, V22, P1246, DOI 10.1002/oby.20634; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Feldman PL, 2008, CURR TOP MED CHEM, V8, P728, DOI 10.2174/156802608784535084; Festuccia WT, 2008, ENDOCRINOLOGY, V149, P2121, DOI 10.1210/en.2007-1553; Festuccia WT, 2009, AM J PHYSIOL-REG I, V296, pR1327, DOI 10.1152/ajpregu.91012.2008; Forbes-Hernandez TY, 2020, FOOD FUNCT, V11, P297, DOI [10.1039/C9FO02285F, 10.1039/c9fo02285f]; Fritah A, 2010, CARDIOVASC RES, V86, P443, DOI 10.1093/cvr/cvp418; Fruchart JC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-82; FRYDMAN RB, 1987, BIOCHIM BIOPHYS ACTA, V916, P500, DOI 10.1016/0167-4838(87)90197-X; FRYDMAN RB, 1982, BIOCHEM BIOPH RES CO, V105, P752, DOI 10.1016/0006-291X(82)91498-X; Gelman L, 2005, CURR OPIN CELL BIOL, V17, P216, DOI 10.1016/j.ceb.2005.02.002; Giudici M, 2016, HANDB EXP PHARMACOL, V233, P95, DOI 10.1007/164_2015_5; Gordon DM, 2019, PHYSIOL GENOMICS, V51, P234, DOI 10.1152/physiolgenomics.00028.2019; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; GREENE BI, 1981, P NATL ACAD SCI USA, V78, P2008, DOI 10.1073/pnas.78.4.2008; Guzek Marek, 2012, Przegl Epidemiol, V66, P495; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; Haluzik M, 2004, ENDOCRINOLOGY, V145, P1662, DOI 10.1210/en.2003-1015; Hamoud AR, 2018, TRENDS ENDOCRIN MET, V29, P140, DOI 10.1016/j.tem.2018.01.002; Han SS, 2010, TOHOKU J EXP MED, V221, P133, DOI 10.1620/tjem.221.133; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Harano Y, 2006, LIVER INT, V26, P613, DOI 10.1111/j.1478-3231.2006.01265.x; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Higgins LS, 2010, AM J CLIN NUTR, V91, p267S, DOI 10.3945/ajcn.2009.28449E; Hinds TD, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0994-z; Hinds TD, 2018, HYPERTENSION, V72, P788, DOI 10.1161/HYPERTENSIONAHA.118.11130; Hinds TD, 2017, AM J PHYSIOL-ENDOC M, V312, pE291, DOI 10.1152/ajpendo.00396.2016; Hinds TD, 2016, J BIOL CHEM, V291, P25179, DOI 10.1074/jbc.M116.731703; Hinds TD, 2016, PPAR RES, V2016, DOI 10.1155/2016/6218637; Hinds TD, 2014, OBESITY, V22, P705, DOI 10.1002/oby.20559; Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Hughes MLR, 2015, J BIOL CHEM, V290, P13895, DOI 10.1074/jbc.M114.605998; Jang BK, 2012, CLIN MOL HEPATOL, V18, P357, DOI 10.3350/cmh.2012.18.4.357; Jo J, 2011, ENDOCRINE, V39, P182, DOI 10.1007/s12020-010-9417-2; John K, 2016, AM J PHYSIOL-ENDOC M, V310, pE249, DOI 10.1152/ajpendo.00478.2015; Jorgensen ME, 2014, NUTR METAB CARDIOVAS, V24, P656, DOI 10.1016/j.numecd.2013.12.009; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kim MJ, 2017, BIOMATERIALS, V133, P242, DOI 10.1016/j.biomaterials.2017.04.029; Kim SH, 2016, DIABETES METAB J, V40, P12, DOI 10.4093/dmj.2016.40.1.12; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Kwak MS, 2012, CLIN MOL HEPATOL, V18, P383, DOI 10.3350/cmh.2012.18.4.383; Kwon KM, 2011, J WOMENS HEALTH, V20, P963, DOI 10.1089/jwh.2010.2453; Lamola AA, 2014, PHOTOCHEM PHOTOBIOL, V90, P294, DOI 10.1111/php.12167; Larter CZ, 2012, J GASTROEN HEPATOL, V27, P341, DOI 10.1111/j.1440-1746.2011.06939.x; Lasar D, 2018, CELL REP, V22, P760, DOI 10.1016/j.celrep.2017.12.067; Lee Y, 2016, ANGEW CHEM INT EDIT, V55, P7460, DOI 10.1002/anie.201602525; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; LEVI AJ, 1969, J CLIN INVEST, V48, P2156, DOI 10.1172/JCI106182; LIGHTNER DA, 1979, P NATL ACAD SCI USA, V76, P29, DOI 10.1073/pnas.76.1.29; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Liu JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09886; Matsumoto K, 2007, J BIOL CHEM, V282, P17053, DOI 10.1074/jbc.M701956200; MCDONAGH AF, 1982, J AM CHEM SOC, V104, P6867, DOI 10.1021/ja00388a104; Meixiong J, 2019, ELIFE, V8, DOI 10.7554/eLife.44116; Miyata KS, 1998, MOL CELL ENDOCRINOL, V146, P69; Molzer C, 2016, SCI REP-UK, V6, DOI 10.1038/srep30051; MUSTAFA MG, 1969, J BIOL CHEM, V244, P6403; O'Brien L, 2015, TRENDS ENDOCRIN MET, V26, P212, DOI 10.1016/j.tem.2015.02.001; Pan YY, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00671; Parlee SD, 2014, METHOD ENZYMOL, V537, P93, DOI 10.1016/B978-0-12-411619-1.00006-9; Petersen CE, 2000, J BIOL CHEM, V275, P20985, DOI 10.1074/jbc.M001038200; Plavskii V. Yu, 2007, Journal of Applied Spectroscopy, V74, P120, DOI 10.1007/s10812-007-0019-6; Preidis GA, 2017, J CLIN INVEST, V127, P1193, DOI [10.1172/jci88893, 10.1172/JCI88893]; Rachid TL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191365; Rachid TL, 2015, CELL BIOCHEM FUNCT, V33, P249, DOI 10.1002/cbf.3111; Rachid TL, 2015, MOL CELL ENDOCRINOL, V402, P86, DOI 10.1016/j.mce.2014.12.027; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Ren HZ, 2010, PPAR RES, V2010, DOI 10.1155/2010/727194; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Rosell M, 2011, BBA-MOL BASIS DIS, V1812, P919, DOI 10.1016/j.bbadis.2010.12.016; Sakamoto T, 2016, AM J PHYSIOL-ENDOC M, V310, pE676, DOI 10.1152/ajpendo.00028.2015; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Schwertner HA, 2008, ATHEROSCLEROSIS, V198, P1, DOI 10.1016/j.atherosclerosis.2008.01.001; Seale P, 2015, DIABETES, V64, P2369, DOI 10.2337/db15-0203; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; Shen YC, 2020, CELL REP, V30, P3079, DOI 10.1016/j.celrep.2020.02.032; Stec DE, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030387; Stec DE, 2019, AM J PHYSIOL-REG I, V317, pR733, DOI 10.1152/ajpregu.00153.2019; Stec DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153427; Stechschulte LA, 2016, ENDOCRINOLOGY, V157, P3888, DOI 10.1210/en.2015-1996; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1254, DOI 10.1210/me.2014-1023; Stechschulte LA, 2014, MOL ENDOCRINOL, V28, P1265, DOI 10.1210/me.2014-1022; STUMPF DA, 1985, BIOCHEM MED METAB B, V34, P226, DOI 10.1016/0006-2944(85)90115-2; Sun ZL, 2017, BIOCHEM BIOPH RES CO, V492, P295, DOI 10.1016/j.bbrc.2017.08.129; Sundararaghavan VL, 2018, TRANSPLANT REV-ORLAN, V32, P234, DOI 10.1016/j.trre.2018.06.003; Takahashi A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215274; Takei R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223302; Thyagarajan B, 2017, HORM MOL BIOL CLIN I, V31, DOI 10.1515/hmbci-2017-0016; Torgerson JS, 1997, OBES RES, V5, P105, DOI 10.1002/j.1550-8528.1997.tb00650.x; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Vitek L, 2002, ATHEROSCLEROSIS, V160, P449, DOI 10.1016/S0021-9150(01)00601-3; Vitek L, 2020, MED RES REV, V40, P1335, DOI 10.1002/med.21660; Vitek L, 2019, ARCH BIOCHEM BIOPHYS, V672, DOI 10.1016/j.abb.2019.108062; Wang L, 2013, DIABETES, V62, P4122, DOI 10.2337/db13-0518; Wang S, 2019, THERANOSTICS, V9, P5122, DOI 10.7150/thno.35773; Weaver L, 2018, AM J PHYSIOL-GASTR L, V314, pG668, DOI 10.1152/ajpgi.00026.2018; Weikum ER, 2018, PROTEIN SCI, V27, P1876, DOI 10.1002/pro.3496; Wu YH, 2011, J DIABETES, V3, P217, DOI 10.1111/j.1753-0407.2011.00138.x	123	35	35	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					9804	9822		10.1074/jbc.RA120.013700	http://dx.doi.org/10.1074/jbc.RA120.013700			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32404366	Green Published, hybrid			2022-12-28	WOS:000553333300004
J	Pedersen, H; Jensen, RK; Hansen, AG; Gadeberg, TAF; Thiel, S; Laursen, NS; Andersen, GR				Pedersen, Henrik; Jensen, Rasmus K.; Hansen, Annette G.; Gadeberg, Trine A. F.; Thiel, Steffen; Laursen, Nick S.; Andersen, Gregers R.			A C3-specific nanobody that blocks all three activation pathways in the human and murine complement system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						single-domain antibody; complement system; inhibitor; innate immunity; antibody; structural biology; nanobody; C3 convertase; single-domain antibody (sdAb nanobody)	ALTERNATIVE PATHWAY; STRUCTURAL INSIGHT; MOLECULAR-BASIS; C3; RECOGNITION; COMPSTATIN; REVEALS; CRIG	The complement system is a tightly controlled proteolytic cascade in the innate immune system, which tags intruding pathogens and dying host cells for clearance. An essential protein in this process is complement component C3. Uncontrolled complement activation has been implicated in several human diseases and disorders and has spurred the development of therapeutic approaches that modulate the complement system. Here, using purified proteins and several biochemical assays and surface plasmon resonance, we report that our nanobody, hC3Nb2, inhibits C3 deposition by all complement pathways. We observe that the hC3Nb2 nanobody binds human native C3 and its degradation products with low nanomolar affinity and does not interfere with the endogenous regulation of C3b deposition mediated by Factors H and I. Using negative stain EM analysis and functional assays, we demonstrate that hC3Nb2 inhibits the substrate?convertase interaction by binding to the MG3 and MG4 domains of C3 and C3b. Furthermore, we notice that hC3Nb2 is cross-reactive and inhibits the lectin and alternative pathway in murine serum. We conclude that hC3Nb2 is a potent, general, and versatile inhibitor of the human and murine complement cascades. Its cross-reactivity suggests that this nanobody may be valuable for analysis of complement activation within animal models of both acute and chronic diseases.	[Pedersen, Henrik; Jensen, Rasmus K.; Gadeberg, Trine A. F.; Laursen, Nick S.; Andersen, Gregers R.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Hansen, Annette G.; Thiel, Steffen] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University; Aarhus University	Andersen, GR (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	gra@mbg.au.dk		Jensen, Rasmus Kjeldsen/0000-0001-5472-4862; Andersen, Gregers Rom/0000-0001-6292-3319; Pedersen, Henrik/0000-0003-4911-5119; Thiel, Steffen/0000-0002-4817-155X	Lundbeck Foundation (BRAINSTRUC) [R155-2015-2666]; Aarhus University Science and Technology	Lundbeck Foundation (BRAINSTRUC); Aarhus University Science and Technology	This work was supported by the Lundbeck Foundation (BRAINSTRUC, R155-2015-2666) and the Aarhus University Science and Technology Ph.D. School GSST.	Andersen KR, 2013, PROTEINS, V81, P1857, DOI 10.1002/prot.24364; Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Bajic G, 2013, P NATL ACAD SCI USA, V110, P16426, DOI 10.1073/pnas.1311261110; Bexborn F, 2008, MOL IMMUNOL, V45, P2370, DOI 10.1016/j.molimm.2007.11.003; Broadley SP, 2016, CELL HOST MICROBE, V20, P36, DOI 10.1016/j.chom.2016.05.023; Campagne MV, 2016, IMMUNOBIOLOGY, V221, P733, DOI 10.1016/j.imbio.2015.11.007; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Chen X, 2012, P NATL ACAD SCI USA, V109, P4586, DOI 10.1073/pnas.1202051109; Coppieters K, 2006, ARTHRITIS RHEUM-US, V54, P1856, DOI 10.1002/art.21827; Elverdi T, 2019, DRUG DES DEV THER, V13, P1251, DOI 10.2147/DDDT.S134470; Engstrom G, 2007, J HUM HYPERTENS, V21, P276, DOI 10.1038/sj.jhh.1002129; Forneris F, 2016, EMBO J, V35, P1133, DOI 10.15252/embj.201593673; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x; Harboe M, 2009, MOL IMMUNOL, V47, P373, DOI 10.1016/j.molimm.2009.09.005; Heesterbeek DAC, 2018, J INNATE IMMUN, V10, P455, DOI 10.1159/000491439; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Hill A, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.28; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jensen RK, 2018, J BIOL CHEM, V293, P6269, DOI 10.1074/jbc.RA117.001179; Kjaer TR, 2013, MOL IMMUNOL, V56, P222, DOI 10.1016/j.molimm.2013.05.220; Kojouharova M, 2010, MOL IMMUNOL, V47, P2154, DOI 10.1016/j.molimm.2010.05.011; Kotimaa J, 2016, MOL IMMUNOL, V76, P13, DOI 10.1016/j.molimm.2016.06.004; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Laursen NS, 2011, EMBO J, V30, P606, DOI 10.1038/emboj.2010.341; Laursen NS, 2010, P NATL ACAD SCI USA, V107, P3681, DOI 10.1073/pnas.0910565107; Liszewski MK, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0029-z; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lukacsi S, 2017, IMMUNOL LETT, V189, P64, DOI 10.1016/j.imlet.2017.05.014; Mastellos DC, 2019, NAT REV DRUG DISCOV, V18, P707, DOI 10.1038/s41573-019-0031-6; Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Pedersen DV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02007; Pedersen DV, 2017, EMBO J, V36, P1084, DOI 10.15252/embj.201696173; Risitano AM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01157; de Cordoba SR, 2014, SEMIN THROMB HEMOST, V40, P422, DOI 10.1055/s-0034-1375296; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Roumenina LT, 2009, BLOOD, V114, P2837, DOI 10.1182/blood-2009-01-197640; Schatz-Jakobsen JA, 2016, IMMUNOL REV, V274, P59, DOI 10.1111/imr.12465; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Smith RJH, 2019, NAT REV NEPHROL, V15, P129, DOI 10.1038/s41581-018-0107-2; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; van den Elsen JMH, 2011, SCIENCE, V332, P608, DOI 10.1126/science.1201954; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Xue XG, 2017, NAT STRUCT MOL BIOL, V24, P643, DOI 10.1038/nsmb.3427; Yatime L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02822; Zelek WM, 2019, MOL IMMUNOL, V114, P341, DOI 10.1016/j.molimm.2019.07.030	56	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8746	8758		10.1074/jbc.RA119.012339	http://dx.doi.org/10.1074/jbc.RA119.012339			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32376685	Green Published, hybrid			2022-12-28	WOS:000546296800011
J	Pham, VD; To, TA; Gagne-Thivierge, C; Couture, M; Lague, P; Yao, DQ; Picard, ME; Lortie, LA; Attere, SA; Zhu, XJ; Levesque, RC; Charette, SJ; Shi, R				Pham, Van Dung; To, Tuan Anh; Gagne-Thivierge, Cynthia; Couture, Manon; Lague, Patrick; Yao, Deqiang; Picard, Marie-Eve; Lortie, Louis-Andre; Attere, Sabrina A.; Zhu, Xiaojun; Levesque, Roger C.; Charette, Steve J.; Shi, Rong			Structural insights into the putative bacterial acetylcholinesterase ChoE and its substrate inhibition mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylcholinesterase; crystal structure; enzyme catalysis; catalytic triad; substrate inhibition; nonproductive binding; convergent evolution; acyl-enzyme; serine esterase; Pseudomonas aeruginosa; acetylcholinesterase (AChE)	PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; BACILLUS-SUBTILIS; CATALYTIC SERINE; CHOLINESTERASE; ESTERASE; ENZYME; RESIDUES; BINDING; FAMILY	Mammalian acetylcholinesterase (AChE) is well-studied, being important in both cholinergic brain synapses and the peripheral nervous systems and also a key drug target for many diseases. In contrast, little is known about the structures and molecular mechanism of prokaryotic acetylcholinesterases. We report here the structural and biochemical characterization of ChoE, a putative bacterial acetylcholinesterase fromPseudomonas aeruginosa. Analysis of WT and mutant strains indicated that ChoE is indispensable forP. aeruginosagrowth with acetylcholine as the sole carbon and nitrogen source. The crystal structure of ChoE at 1.35 ? resolution revealed that this enzyme adopts a typical fold of the SGNH hydrolase family. Although ChoE and eukaryotic AChEs catalyze the same reaction, their overall structures bear no similarities constituting an interesting example of convergent evolution. Among Ser-38, Asp-285, and His-288 of the catalytic triad residues, only Asp-285 was not essential for ChoE activity. Combined with kinetic analyses of WT and mutant proteins, multiple crystal structures of ChoE complexed with substrates, products, or reaction intermediate revealed the structural determinants for substrate recognition, snapshots of the various catalytic steps, and the molecular basis of substrate inhibition at high substrate concentrations. Our results indicate that substrate inhibition in ChoE is due to acetate release being blocked by the binding of a substrate molecule in a nonproductive mode. Because of the distinct overall folds and significant differences of the active site between ChoE and eukaryotic AChEs, these structures will serve as a prototype for other prokaryotic acetylcholinesterases.	[Pham, Van Dung; To, Tuan Anh; Gagne-Thivierge, Cynthia; Couture, Manon; Lague, Patrick; Picard, Marie-Eve; Lortie, Louis-Andre; Attere, Sabrina A.; Zhu, Xiaojun; Charette, Steve J.; Shi, Rong] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada; [Pham, Van Dung; To, Tuan Anh; Gagne-Thivierge, Cynthia; Couture, Manon; Lague, Patrick; Picard, Marie-Eve; Attere, Sabrina A.; Zhu, Xiaojun; Levesque, Roger C.; Charette, Steve J.; Shi, Rong] Univ Laval, Inst Biol Integrat & Syst IBIS, Quebec City, PQ, Canada; [Pham, Van Dung; To, Tuan Anh; Couture, Manon; Lague, Patrick; Picard, Marie-Eve; Zhu, Xiaojun; Shi, Rong] PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada; [Gagne-Thivierge, Cynthia; Attere, Sabrina A.; Charette, Steve J.] Hop Laval, Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada; [Yao, Deqiang] ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China	Laval University; Laval University; Laval University; ShanghaiTech University	Shi, R (corresponding author), Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada.; Shi, R (corresponding author), Univ Laval, Inst Biol Integrat & Syst IBIS, Quebec City, PQ, Canada.; Shi, R (corresponding author), PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada.	rong.shi@bcm.ulaval.ca	Charette, Steve/GYJ-3058-2022; Levesque, Roger C./ABD-8407-2021; Couture, Manon/F-8326-2015	ZHU, XIAOJUN/0000-0002-5409-3973; Charette, Steve/0000-0002-0199-2852; Couture, Manon/0000-0001-8296-8055; Lague, Patrick/0000-0002-5236-4979; Levesque, Roger/0000-0001-8315-5937; VAN DUNG, PHAM/0000-0002-2880-3898	Fonds de Recherche du Quebec-Nature et technologies (FRQNT) [183530];  [33092]	Fonds de Recherche du Quebec-Nature et technologies (FRQNT); 	This work was supported by Grant 183530 from the Fonds de Recherche du Quebec-Nature et technologies (FRQNT) (to R. C. L., S. J. C., and R. S.) and Canada Foundation for Innovation (CFI) John R. Evans Leaders Fund Grant 33092 (to R. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Alalouf O, 2011, J BIOL CHEM, V286, P41993, DOI 10.1074/jbc.M111.301051; Azam MW, 2019, DRUG DISCOV TODAY, V24, P350, DOI 10.1016/j.drudis.2018.07.003; Baker P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004334; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; Bourne Y, 2006, J BIOL CHEM, V281, P29256, DOI 10.1074/jbc.M603018200; Bourne Y, 2016, J AM CHEM SOC, V138, P1611, DOI 10.1021/jacs.5b11384; Bourne Y, 2015, J BIOL CHEM, V290, P1522, DOI 10.1074/jbc.M114.603902; Cavalcante SFD, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10030414; Colletier JP, 2006, EMBO J, V25, P2746, DOI 10.1038/sj.emboj.7601175; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Dimitriou PS, 2019, PROTEIN SCI, V28, P344, DOI 10.1002/pro.3527; Ding JM, 2016, J BACTERIOL, V198, P311, DOI 10.1128/JB.00471-15; DOMENECH CE, 1981, MOL CELL BIOCHEM, V34, P95, DOI 10.1007/BF02354863; DOMENECH CE, 1991, FEMS MICROBIOL LETT, V82, P131, DOI 10.1111/j.1574-6968.1991.tb04853.x; Dvir H, 2010, CHEM-BIOL INTERACT, V187, P10, DOI 10.1016/j.cbi.2010.01.042; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galperin MY, 2012, J BIOL CHEM, V287, P21, DOI 10.1074/jbc.R111.241976; GARBER N, 1980, J GEN MICROBIOL, V117, P279; Ghosh D, 2001, J BIOL CHEM, V276, P11159, DOI 10.1074/jbc.M008831200; GIBNEY G, 1990, P NATL ACAD SCI USA, V87, P7546, DOI 10.1073/pnas.87.19.7546; GOLDSTEIN DB, 1953, J GEN MICROBIOL, V8, P8, DOI 10.1099/00221287-8-1-8; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hermoso JA, 2003, STRUCTURE, V11, P1239, DOI 10.1016/j.str.2003.09.005; HOFER P, 1981, BIOPHYS STRUCT MECH, V8, P45, DOI 10.1007/BF01047105; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kawasaki K, 2002, ACTA CRYSTALLOGR D, V58, P1168, DOI 10.1107/S090744490200714X; KRUPKA RM, 1963, BIOCHEMISTRY-US, V2, P76, DOI 10.1021/bi00901a015; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazarevic-Pasti T, 2017, CURR MED CHEM, V24, P3283, DOI 10.2174/0929867324666170705123509; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LISA TA, 1994, CURR MICROBIOL, V29, P193, DOI 10.1007/BF01570153; Lo YC, 2003, J MOL BIOL, V330, P539, DOI 10.1016/S0022-2836(03)00637-5; Mazlan SNHS, 2018, INT J BIOL MACROMOL, V119, P1188, DOI 10.1016/j.ijbiomac.2018.08.022; McAuley KE, 2004, ACTA CRYSTALLOGR D, V60, P878, DOI 10.1107/S0907444904004937; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Moriarty NW, 2017, ACTA CRYSTALLOGR D, V73, P123, DOI 10.1107/S2059798316016570; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Olsen JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091232; Omelchenko MV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-31; PESIN SR, 1982, INVEST OPHTH VIS SCI, V22, P651; Pittelkow M, 2011, J MOL BIOL, V411, P53, DOI 10.1016/j.jmb.2011.05.037; QUINN DM, 1987, CHEM REV, V87, P955, DOI 10.1021/cr00081a005; RADIC Z, 1992, BIOCHEMISTRY-US, V31, P9760, DOI 10.1021/bi00155a032; Rauwerdink A, 2015, ACS CATAL, V5, P6153, DOI 10.1021/acscatal.5b01539; Reed MC, 2010, BIOESSAYS, V32, P422, DOI 10.1002/bies.200900167; Riley LM, 2013, J BIOL CHEM, V288, P22299, DOI 10.1074/jbc.M113.484931; Rochu D, 1998, BBA-PROTEIN STRUCT M, V1385, P126, DOI 10.1016/S0167-4838(98)00042-9; Rosenberry TL, 2017, MOLECULES, V22, DOI 10.3390/molecules22122098; Sanchez DG, 2012, MICROBIOL RES, V167, P317, DOI 10.1016/j.micres.2011.11.005; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SHAFFERMAN A, 1992, EMBO J, V11, P3561, DOI 10.1002/j.1460-2075.1992.tb05439.x; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; Shi R, 2007, J BIOL CHEM, V282, P13073, DOI 10.1074/jbc.M611912200; Shi R, 2011, P NATL ACAD SCI USA, V108, P1302, DOI 10.1073/pnas.1012596108; Silman I, 2017, J NEUROCHEM, V142, P19, DOI 10.1111/jnc.13992; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TAYLOR P, 1994, ANNU REV PHARMACOL, V34, P281, DOI 10.1146/annurev.pa.34.040194.001433; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tougu V., 2001, Current Medicinal Chemistry - Central Nervous System Agents, V1, P155, DOI 10.2174/1568015013358536; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; Wan Y, 2019, J BIOL CHEM, V294, P11391, DOI 10.1074/jbc.RA119.008280; Wargo MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056850; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang N, 2016, BIOORG MED CHEM LETT, V26, P3594, DOI 10.1016/j.bmcl.2016.06.013; Zhou YZ, 2010, J PHYS CHEM B, V114, P8817, DOI 10.1021/jp104258d; Zhu XY, 2003, J BIOL CHEM, V278, P2008, DOI 10.1074/jbc.M210103200	75	3	3	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8708	8724		10.1074/jbc.RA119.011809	http://dx.doi.org/10.1074/jbc.RA119.011809			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32371400	Green Published, hybrid			2022-12-28	WOS:000546296800008
J	Saha, AK; Contreras-Galindo, R; Niknafs, YS; Iyer, M; Qin, TT; Padmanabhan, K; Siddiqui, J; Palande, M; Wang, C; Qian, BA; Ward, E; Tang, T; Tomlins, SA; Gitlin, SD; Sartor, MA; Omenn, GS; Chinnaiyan, AM; Markovitz, DM				Saha, Anjan K.; Contreras-Galindo, Rafael; Niknafs, Yashar S.; Iyer, Matthew; Qin, Tingting; Padmanabhan, Karthik; Siddiqui, Javed; Palande, Monica; Wang, Claire; Qian, Brian; Ward, Elizabeth; Tang, Tara; Tomlins, Scott A.; Gitlin, Scott D.; Sartor, Maureen A.; Omenn, Gilbert S.; Chinnaiyan, Arul M.; Markovitz, David M.			The role of the histone H3 variant CENPA in prostate cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Centromere; prostate cancer; epigenetics; histone; gene expression; centromere protein A (CENPA); gene regulation; transcription; chromatin; cell proliferation; centromere	CENTROMERE PROTEIN-A; INTEGRATIVE CLINICAL GENOMICS; PROGNOSTIC VALUE; EXPRESSION; NUCLEOSOMES; GENE; CHROMATIN; MARKER; KI-67; HJURP	Overexpression of centromeric proteins has been identified in a number of human malignancies, but the functional and mechanistic contributions of these proteins to disease progression have not been characterized. The centromeric histone H3 variant centromere protein A (CENPA) is an epigenetic mark that determines centromere identity. Here, using an array of approaches, including RNA-sequencing and ChIP-sequencing analyses, immunohistochemistry-based tissue microarrays, and various cell biology assays, we demonstrate that CENPA is highly overexpressed in prostate cancer in both tissue and cell lines and that the level of CENPA expression correlates with the disease stage in a large cohort of patients. Gain-of-function and loss-of-function experiments confirmed that CENPA promotes prostate cancer cell line growth. The results from the integrated sequencing experiments suggested a previously unidentified function of CENPA as a transcriptional regulator that modulates expression of critical proliferation, cell-cycle, and centromere/kinetochore genes. Taken together, our findings show that CENPA overexpression is crucial to prostate cancer growth.	[Saha, Anjan K.; Niknafs, Yashar S.] Univ Michigan, Med Scientist Training Program, Ann Arbor, MI 48109 USA; [Saha, Anjan K.; Chinnaiyan, Arul M.; Markovitz, David M.] Univ Michigan, Program Canc Biol, Ann Arbor, MI 48109 USA; [Saha, Anjan K.; Contreras-Galindo, Rafael; Palande, Monica; Wang, Claire; Qian, Brian; Ward, Elizabeth; Tang, Tara; Gitlin, Scott D.; Omenn, Gilbert S.; Markovitz, David M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Iyer, Matthew; Qin, Tingting; Padmanabhan, Karthik; Sartor, Maureen A.; Omenn, Gilbert S.; Chinnaiyan, Arul M.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Siddiqui, Javed; Tomlins, Scott A.; Chinnaiyan, Arul M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Omenn, Gilbert S.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Niknafs, Yashar S.; Chinnaiyan, Arul M.; Markovitz, David M.] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Niknafs, Yashar S.; Iyer, Matthew; Siddiqui, Javed; Tomlins, Scott A.; Chinnaiyan, Arul M.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Markovitz, David M.] Univ Michigan, Program Immunol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Markovitz, DM (corresponding author), Univ Michigan, Program Canc Biol, Ann Arbor, MI 48109 USA.; Markovitz, DM (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.; Markovitz, DM (corresponding author), Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA.; Markovitz, DM (corresponding author), Univ Michigan, Program Immunol, Ann Arbor, MI 48109 USA.	dmarkov@umich.edu		Saha, Anjan/0000-0001-6721-1599; Tang, Tara/0000-0002-8249-458X; Contreras-Galindo, Rafael/0000-0002-6284-3359	National Institutes of Health [R01-DK109188, 5T32GM007863-34, F30-CA-210379, F30-CA-200328, R01-CA-158286-S1, RM-08-029, P30U54ES017885]; University of Michigan Cancer Biology Fellowship; Scleroderma Foundation; Prostate Cancer Foundation [17YOUN13]; Biomedical Research Core Facilities Epigenomics Core at the University of Michigan; A. Alfred Taubman Medical Research Institute; Howard Hughes Medical Institute Investigatorship; A. Alfred Taubman Scholarship; American Cancer Society Professorship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Biology Fellowship; Scleroderma Foundation; Prostate Cancer Foundation; Biomedical Research Core Facilities Epigenomics Core at the University of Michigan; A. Alfred Taubman Medical Research Institute; Howard Hughes Medical Institute Investigatorship(Howard Hughes Medical Institute); A. Alfred Taubman Scholarship; American Cancer Society Professorship(American Cancer Society)	This work was supported by National Institutes of Health Grants R01-DK109188 (to D. M. M.), 5T32GM007863-34 and F30-CA-210379 (to A. K. S.), F30-CA-200328 (to Y. S. N.), R01-DK109188 (to M. P., C. W., B. Q., E. W., and T. T.), R01-CA-158286-S1 (to M. A. S.), and RM-08-029 and P30U54ES017885 (to G. S. O.); a University of Michigan Cancer Biology Fellowship (to A. K. S.); the Scleroderma Foundation (to R. C.-G.); Prostate Cancer Foundation Grant 17YOUN13 (to Y. S. N.); the Biomedical Research Core Facilities Epigenomics Core at the University of Michigan (to T. Q. and K. P.); the A. Alfred Taubman Medical Research Institute (to S. A. T.); a Howard Hughes Medical Institute Investigatorship (to A. M. C.); an A. Alfred Taubman Scholarship (to A. M. C.); and an American Cancer Society Professorship (to A. M. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2018, AM CANC SOC CANC FAC; Athwal RK, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-2; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Bodor DL, 2014, ELIFE, V3, DOI 10.7554/eLife.02137; Bohrer LR, 2010, ENDOCRINOLOGY, V151, P5136, DOI 10.1210/en.2010-0436; Brind'Amour J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7033; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Contreras-Galindo R, 2017, GENOME RES, V27, P2040, DOI 10.1101/gr.219709.116; Cooperberg MR, 2014, NAT REV CLIN ONCOL, V11, P304, DOI 10.1038/nrclinonc.2014.58; de Oca RM, 2015, MOL ONCOL, V9, P657, DOI 10.1016/j.molonc.2014.11.002; Falk SJ, 2016, NAT STRUCT MOL BIOL, V23, P204, DOI 10.1038/nsmb.3175; Fisher G, 2013, BRIT J CANCER, V108, P271, DOI 10.1038/bjc.2012.598; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Gu XM, 2014, PATHOL RES PRACT, V210, P228, DOI 10.1016/j.prp.2013.12.007; Hasson D, 2013, NAT STRUCT MOL BIOL, V20, P687, DOI 10.1038/nsmb.2562; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hayden KE, 2012, CHROMOSOME RES, V20, P621, DOI 10.1007/s10577-012-9295-y; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kim IS, 2012, MOL CELL, V46, P260, DOI 10.1016/j.molcel.2012.03.021; Lacoste N, 2014, MOL CELL, V53, P631, DOI 10.1016/j.molcel.2014.01.018; Lee C, 2016, BIOINFORMATICS, V32, P1100, DOI 10.1093/bioinformatics/btv694; Li RL, 2004, CLIN CANCER RES, V10, P4118, DOI 10.1158/1078-0432.CCR-1052-03; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017794; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; McGovern SL, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3181; McKinley KL, 2015, MOL CELL, V60, P886, DOI 10.1016/j.molcel.2015.10.027; Niikura Y, 2015, DEV CELL, V32, P589, DOI 10.1016/j.devcel.2015.01.024; Puto LA, 2015, J BIOL CHEM, V290, P15406, DOI 10.1074/jbc.M115.658765; Qiu JJ, 2013, TUMOR BIOL, V34, P2971, DOI 10.1007/s13277-013-0860-6; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Saha A. K., 2019, GENOMIC LANDSCAPE CE, DOI [10.1101/505800, DOI 10.1101/505800]; Schleiffer A, 2012, NAT CELL BIOL, V14, P604, DOI 10.1038/ncb2493; Smith CL, 2018, NUCLEIC ACIDS RES, V46, pD836, DOI 10.1093/nar/gkx1006; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; Sun X, 2016, INT J CANCER, V139, P899, DOI 10.1002/ijc.30133; Thiru P, 2014, MOL BIOL CELL, V25, P1983, DOI 10.1091/mbc.E14-03-0837; Tomonaga T, 2005, CANCER RES, V65, P4683, DOI 10.1158/0008-5472.CAN-04-3613; Valdivia MM, 2009, CURR GENOMICS, V10, P326, DOI 10.2174/138920209788920985; Vardabasso C, 2015, MOL CELL, V59, P75, DOI 10.1016/j.molcel.2015.05.009; Vardabasso C, 2014, CELL MOL LIFE SCI, V71, P379, DOI 10.1007/s00018-013-1343-z; Viswanathan SR, 2018, CELL, V174, P433, DOI 10.1016/j.cell.2018.05.036; Welch RP, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku463; Wu Q, 2012, LUNG CANCER, V77, P407, DOI 10.1016/j.lungcan.2012.04.007; Yuen BTK, 2013, CANCER CELL, V24, P567, DOI 10.1016/j.ccr.2013.09.015; Zhang WG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12619	50	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8537	8549		10.1074/jbc.RA119.010080	http://dx.doi.org/10.1074/jbc.RA119.010080			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32371391	Green Published, hybrid			2022-12-28	WOS:000546986500018
J	Binder, BM				Binder, Brad M.			Ethylene signaling in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Arabidopsis thaliana; bioengineering; hormone receptor; phytohormone; plant hormone; signal transduction; signaling; constitutive triple response 1 (CTR1); ethylene; ethylene-insensitive 2 (EIN2)	F-BOX PROTEINS; HISTIDINE KINASE-ACTIVITY; ARABIDOPSIS HYPOCOTYL ELONGATION; SEEDLING-GROWTH-RESPONSE; PARASITIC WEEDS STRIGA; OF-FUNCTION MUTATIONS; RECEPTOR GENE FAMILY; PHASEOLUS-VULGARIS L; RAF-LIKE KINASE; SUBCELLULAR-LOCALIZATION	Ethylene is a gaseous phytohormone and the first of this hormone class to be discovered. It is the simplest olefin gas and is biosynthesized by plants to regulate plant development, growth, and stress responses via a well-studied signaling pathway. One of the earliest reported responses to ethylene is the triple response. This response is common in eudicot seedlings grown in the dark and is characterized by reduced growth of the root and hypocotyl, an exaggerated apical hook, and a thickening of the hypocotyl. This proved a useful assay for genetic screens and enabled the identification of many components of the ethylene-signaling pathway. These components include a family of ethylene receptors in the membrane of the endoplasmic reticulum (ER); a protein kinase, called constitutive triple response 1 (CTR1); an ER-localized transmembrane protein of unknown biochemical activity, called ethylene-insensitive 2 (EIN2); and transcription factors such as EIN3, EIN3-like (EIL), and ethylene response factors (ERFs). These studies led to a linear model, according to which in the absence of ethylene, its cognate receptors signal to CTR1, which inhibits EIN2 and prevents downstream signaling. Ethylene acts as an inverse agonist by inhibiting its receptors, resulting in lower CTR1 activity, which releases EIN2 inhibition. EIN2 alters transcription and translation, leading to most ethylene responses. Although this canonical pathway is the predominant signaling cascade, alternative pathways also affect ethylene responses. This review summarizes our current understanding of ethylene signaling, including these alternative pathways, and discusses how ethylene signaling has been manipulated for agricultural and horticultural applications.	[Binder, Brad M.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Binder, BM (corresponding author), Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA.	bbinder@utk.edu		Binder, Brad/0000-0002-8172-2034	National Science Foundation [MCB-1716279, MCB-1817304, IOS-1855066]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grants MCB-1716279, MCB-1817304, and IOS-1855066.	Abeles F, 1992, ETHYLENE PLANT BIOL; Allen CJ, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00950; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; An FY, 2010, PLANT CELL, V22, P2384, DOI 10.1105/tpc.110.076588; Azhar BJ, 2020, SMALL METHODS, V4, DOI 10.1002/smtd.201900452; BABIKER AGT, 1983, WEED RES, V23, P125, DOI 10.1111/j.1365-3180.1983.tb00530.x; BABIKER AGT, 1993, PHYSIOL PLANTARUM, V88, P359, DOI 10.1111/j.1399-3054.1993.tb05510.x; Bakshi A, 2018, PLANT PHYSIOL, V176, P910, DOI 10.1104/pp.17.01321; Bakshi A, 2015, J PLANT GROWTH REGUL, V34, P809, DOI 10.1007/s00344-015-9522-9; Bakshi A, 2015, PLANT PHYSIOL, V169, P219, DOI 10.1104/pp.15.00626; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Barry CS, 2006, P NATL ACAD SCI USA, V103, P7923, DOI 10.1073/pnas.0602319103; Barry CS, 2005, PLANT PHYSIOL, V138, P267, DOI 10.1104/pp.104.057745; Bayler A, 1996, J AM CHEM SOC, V118, P7006, DOI 10.1021/ja961363v; BEBAWI FF, 1985, WEED SCI, V33, P74, DOI 10.1017/S0043174500083958; BEBAWI FF, 1986, WEED SCI, V34, P694, DOI 10.1017/S0043174500067709; Berleth M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00726; Berner DK, 1999, BIOL CONTROL, V15, P274, DOI 10.1006/bcon.1999.0718; BEYER EM, 1976, PLANT PHYSIOL, V58, P268, DOI 10.1104/pp.58.3.268; Binder BM, 2003, ACTA HORTIC, P177, DOI 10.17660/ActaHortic.2003.628.21; Binder BM, 2004, PLANT PHYSIOL, V136, P2913, DOI 10.1104/pp.104.050369; Binder BM, 2004, PLANT PHYSIOL, V136, P2921, DOI 10.1104/pp.104.050393; Binder BM, 2007, FEBS LETT, V581, P5105, DOI 10.1016/j.febslet.2007.09.057; Binder BM, 2007, PLANT CELL, V19, P509, DOI 10.1105/tpc.106.048140; Binder BM, 2006, PLANT PHYSIOL, V142, P1690, DOI 10.1104/pp.106.087858; Binder BM, 2018, PLANT DIRECT, V2, DOI 10.1002/pld3.58; Binder BM, 2010, J BIOL CHEM, V285, P37263, DOI 10.1074/jbc.M110.170027; Bisson MMA, 2016, SCI REP-UK, V6, DOI 10.1038/srep30634; Bisson MMA, 2015, MOL PLANT, V8, P1165, DOI 10.1016/j.molp.2015.03.014; Bisson MMA, 2011, PLANT SIGNAL BEHAV, V6, P164, DOI [10.4161/psb.6.1.14034, 10.4161/psb.5.12.14034]; Bisson MMA, 2010, MOL PLANT, V3, P882, DOI 10.1093/mp/ssq036; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; BLANKENSHIP SM, 1993, J AM SOC HORTIC SCI, V118, P609, DOI 10.21273/JASHS.118.5.609; BLANKENSHIP SM, 1989, J PLANT GROWTH REGUL, V8, P37, DOI 10.1007/BF02024924; Blat Y, 2010, CHEM BIOL DRUG DES, V75, P535, DOI 10.1111/j.1747-0285.2010.00972.x; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Bovy AG, 1999, MOL BREEDING, V5, P301, DOI 10.1023/A:1009617804359; Bray D, 1998, NATURE, V393, P85, DOI 10.1038/30018; BURG SP, 1967, PLANT PHYSIOL, V42, P144, DOI 10.1104/pp.42.1.144; Cancel JD, 2002, PLANT PHYSIOL, V129, P1557, DOI 10.1104/pp.003780; Carlew TS, 2020, SMALL METHODS, V4, DOI 10.1002/smtd.201900266; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; CHEN QHG, 1995, PLANT PHYSIOL, V108, P597, DOI 10.1104/pp.108.2.597; Chen RQ, 2011, MOL BIOSYST, V7, P2637, DOI 10.1039/c1mb05159h; Chen T, 2009, PLANT CELL PHYSIOL, V50, P1636, DOI 10.1093/pcp/pcp107; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen Y, 2020, HORTIC RES-ENGLAND, V7, DOI 10.1038/s41438-020-0239-y; Chen Y, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01054; Chen YF, 2007, J BIOL CHEM, V282, P24752, DOI 10.1074/jbc.M704419200; Chen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008640; Christians MJ, 2007, J EXP BOT, V58, P2237, DOI 10.1093/jxb/erm086; Christians MJ, 2008, PLANT J, V55, P467, DOI 10.1111/j.1365-313X.2008.03521.x; Ciardi JA, 2000, PLANT PHYSIOL, V123, P81, DOI 10.1104/pp.123.1.81; Clark DG, 1999, PLANT PHYSIOL, V121, P53, DOI 10.1104/pp.121.1.53; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Clevenger DJ, 2004, J AM SOC HORTIC SCI, V129, P401, DOI 10.21273/JASHS.129.3.0401; Cui ML, 2004, PLANT SCI, V167, P253, DOI 10.1016/j.plantsci.2004.03.024; Das D, 2016, PLANT PHYSIOL, V172, P718, DOI 10.1104/pp.16.00725; Desikan R, 2005, PLANT PHYSIOL, V137, P831, DOI 10.1104/pp.104.056994; Deslauriers SD, 2015, NEW PHYTOL, V208, P442, DOI 10.1111/nph.13466; Dong CH, 2008, PLANT J, V53, P275, DOI 10.1111/j.1365-313X.2007.03339.x; Dong CH, 2010, J BIOL CHEM, V285, P40706, DOI 10.1074/jbc.M110.146605; EGLEY GH, 1970, WEED SCI, V18, P586, DOI 10.1017/S0043174500034263; EPLEE RE, 1975, WEED SCI, V23, P433, DOI 10.1017/S0043174500062822; EVANS DE, 1982, PLANT CELL ENVIRON, V5, P101; EVANS DE, 1982, PLANTA, V154, P48, DOI 10.1007/BF00385495; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Gagne JM, 2004, P NATL ACAD SCI USA, V101, P6803, DOI 10.1073/pnas.0401698101; Gallie DR, 2015, PLANT MOL BIOL, V87, P521, DOI 10.1007/s11103-015-0296-z; Gallie DR, 2010, PLANT PHYSIOL, V152, P1928, DOI 10.1104/pp.109.151688; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; Gao ZY, 2009, PLANT SIGNAL BEHAV, V4, P1152, DOI 10.4161/psb.4.12.9943; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; GOREN R, 1986, PLANT GROWTH REGUL, V4, P43, DOI 10.1007/BF00025348; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Gubrium EK, 2000, J AM SOC HORTIC SCI, V125, P277, DOI 10.21273/JASHS.125.3.277; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; Hall AE, 1999, PLANT PHYSIOL, V121, P291, DOI 10.1104/pp.121.1.291; Hall AE, 2003, PLANT CELL, V15, P2032, DOI 10.1105/tpc.013060; Hall AE, 2000, PLANT PHYSIOL, V123, P1449, DOI 10.1104/pp.123.4.1449; Hall BP, 2012, PLANT PHYSIOL, V159, P682, DOI 10.1104/pp.112.196790; Harkey AF, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01094; Harkey AF, 2018, PLANT PHYSIOL, V176, P2095, DOI 10.1104/pp.17.00907; He X, 2017, J INTEGR PLANT BIOL, V59, P275, DOI 10.1111/jipb.12524; Herivaux A, 2017, MBIO, V8, DOI 10.1128/mBio.01739-16; Hildreth SB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57161-9; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; Hoppen C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47185-6; Hoppen C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37571-x; Hu YM, 2014, PLANT PHYSIOL BIOCH, V75, P128, DOI 10.1016/j.plaphy.2013.12.008; Hu ZL, 2010, RUSS J PLANT PHYSL+, V57, P554, DOI 10.1134/S102144371004014X; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; HUA J, 1995, SCIENCE, V269, P1712, DOI 10.1126/science.7569898; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Hung YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160598; Hyodo H., 1991, PLANT HORMONE ETHYLE; Ju CL, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.4, 10.1038/NPLANTS.2014.4]; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; Kessenbrock M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01528; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; Kgosi RL, 2012, WEED RES, V52, P197, DOI 10.1111/j.1365-3180.2012.00912.x; Khatami F, 2020, SCI HORTIC-AMSTERDAM, V263, DOI 10.1016/j.scienta.2019.109103; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kieber JJ, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.149344; Kim H, 2011, PLANT PHYSIOL, V156, P417, DOI 10.1104/pp.110.170621; Kim HG, 2014, FEBS LETT, V588, P1652, DOI 10.1016/j.febslet.2014.02.062; Kim HG, 2013, PLANT PHYSIOL, V163, P1776, DOI 10.1104/pp.113.225649; Kim JH, 2004, PLANT CELL TISS ORG, V78, P69, DOI 10.1023/B:TICU.0000020396.64257.c1; Kim J, 2013, FEBS LETT, V587, P226, DOI 10.1016/j.febslet.2012.11.030; Kim J, 2012, PLANT PHYSIOL, V160, P1567, DOI 10.1104/pp.112.205799; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Knoester M, 1998, P NATL ACAD SCI USA, V95, P1933, DOI 10.1073/pnas.95.4.1933; Konishi M, 2008, PLANT J, V55, P821, DOI 10.1111/j.1365-313X.2008.03551.x; Kountche BA, 2019, PLANTS PEOPLE PLANET, V1, P107, DOI 10.1002/ppp3.32; Kwon SJ, 2009, PLANT J, V58, P235, DOI 10.1111/j.1365-313X.2008.03772.x; Lacey RF, 2016, PLANT PHYSIOL, V171, P2798, DOI 10.1104/pp.16.00602; Langston BJ, 2005, J EXP BOT, V56, P15, DOI 10.1093/jxb/eri002; Le J, 2005, J PLANT GROWTH REGUL, V24, P166, DOI 10.1007/s00344-005-0044-8; Li C, 2014, PLANT CELL PHYSIOL, V55, P426, DOI 10.1093/pcp/pct180; Li WB, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006703; Li WY, 2015, CELL, V163, P670, DOI 10.1016/j.cell.2015.09.037; LIAO MS, 1994, ACTA CRYSTALLOGR B, V50, P9, DOI 10.1107/S0108768193007864; Lin ZF, 2009, J EXP BOT, V60, P3697, DOI 10.1093/jxb/erp209; Lin ZF, 2008, J EXP BOT, V59, P4271, DOI 10.1093/jxb/ern276; Little HA, 2007, SEX PLANT REPROD, V20, P123, DOI 10.1007/s00497-007-0049-5; Liu MC, 2015, PLANT PHYSIOL, V169, P2380, DOI 10.1104/pp.15.01361; Liu Q, 2012, PLANT PHYSIOL, V158, P1193, DOI 10.1104/pp.111.187757; Liu Q, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-60; Liu XQ, 2017, PLANT CELL, V29, P3051, DOI 10.1105/tpc.17.00508; LOGAN DC, 1991, PLANT PHYSIOL, V97, P1435, DOI 10.1104/pp.97.4.1435; LOGAN DC, 1995, SEED SCI RES, V5, P99, DOI 10.1017/S0960258500002671; Ma B, 2006, PLANT PHYSIOL, V141, P587, DOI 10.1104/pp.106.080523; Ma B, 2018, P NATL ACAD SCI USA, V115, P2520, DOI 10.1073/pnas.1718377115; Ma B, 2013, MOL PLANT, V6, P1830, DOI 10.1093/mp/sst087; Ma BO, 2010, CHINESE SCI BULL, V55, P2204, DOI 10.1007/s11434-010-3192-2; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Mayerhofer H, 2015, J BIOL CHEM, V290, P2644, DOI 10.1074/jbc.M114.587667; Mayerhofer H, 2012, J MOL BIOL, V415, P768, DOI 10.1016/j.jmb.2011.11.046; McDaniel BK, 2012, J BIOL CHEM, V287, P26094, DOI 10.1074/jbc.M112.383034; Merchante C, 2015, CELL, V163, P684, DOI 10.1016/j.cell.2015.09.036; Milic D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21952-3; Mira-Rodado V, 2012, PLANT SIGNAL BEHAV, V7, P1467, DOI 10.4161/psb.21898; Mount SM, 2002, PLANT PHYSIOL, V130, P10, DOI 10.1104/pp.005397; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; Mubarok S, 2015, J AGR FOOD CHEM, V63, P7995, DOI [10.1021/acs.jafc.5b02, 10.1021/acs.jafc.5b02742]; Muller-Dieckmann HJ, 1999, STRUCT FOLD DES, V7, P1547, DOI 10.1016/S0969-2126(00)88345-8; Narikawa R, 2011, PLANT CELL PHYSIOL, V52, P2214, DOI 10.1093/pcp/pcr155; Nefkens GHL, 1997, J AGR FOOD CHEM, V45, P2273, DOI 10.1021/jf9604504; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; O'Malley RC, 2005, PLANT J, V41, P651, DOI [10.1111/j.1365-313X.2004.02331.x, 10.1111/j.1365-313X.2004.02331.X]; Oh K, 2017, MOLECULES, V22, DOI 10.3390/molecules22122270; Okabe Y, 2012, BREEDING SCI, V62, P202, DOI 10.1270/jsbbs.62.202; Olmedo G, 2006, P NATL ACAD SCI USA, V103, P13286, DOI 10.1073/pnas.0605528103; Papon N, 2019, TRENDS MICROBIOL, V27, P193, DOI 10.1016/j.tim.2018.12.002; Parkinson JS, 2015, TRENDS MICROBIOL, V23, P257, DOI 10.1016/j.tim.2015.03.003; Pirrung MC, 2008, CHEM BIOL, V15, P313, DOI 10.1016/j.chembiol.2008.02.018; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; Potuschak T, 2006, PLANT CELL, V18, P3047, DOI 10.1105/tpc.106.046508; Poulios S, 2016, J EXP BOT, V67, P905, DOI 10.1093/jxb/erv503; Prescott AM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01308; PYYKKO P, 1988, CHEM REV, V88, P563, DOI 10.1021/cr00085a006; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Qiu LP, 2012, PLANT PHYSIOL, V159, P1263, DOI 10.1104/pp.112.193979; Qu X, 2004, PLANT PHYSIOL, V136, P2961, DOI 10.1104/pp.104.047126; Rai MI, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0554-x; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Resnick JS, 2006, P NATL ACAD SCI USA, V103, P7917, DOI 10.1073/pnas.0602239103; Robles LM, 2007, J EXP BOT, V58, P2627, DOI 10.1093/jxb/erm080; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Runo S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006731; Rzewuski G, 2008, PLANT SCI, V175, P32, DOI 10.1016/j.plantsci.2008.01.012; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; Samejima H, 2016, PEST MANAG SCI, V72, P2035, DOI 10.1002/ps.4215; SANDERS IO, 1990, PLANT CELL PHYSIOL, V31, P1091; SANDERS IO, 1991, ANN BOT-LONDON, V68, P97, DOI 10.1093/oxfordjournals.aob.a088242; Sanikhani M, 2008, PLANT CELL REP, V27, P729, DOI 10.1007/s00299-007-0493-6; Schaller GE, 2011, CURR BIOL, V21, pR320, DOI 10.1016/j.cub.2011.02.045; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Scharein B, 2008, ANAL BIOCHEM, V377, P72, DOI 10.1016/j.ab.2008.03.015; Scharein B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024173; Schott-Verdugo S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45189-w; Seo DH, 2019, PLANT J, V98, P898, DOI 10.1111/tpj.14289; Shakeel SN, 2015, J BIOL CHEM, V290, P12415, DOI 10.1074/jbc.M115.652503; Shi JR, 2016, PLANT PHYSIOL, V171, P2783, DOI 10.1104/pp.16.00347; Shi J, 2015, PLANT PHYSIOL, V169, P266, DOI 10.1104/pp.15.00780; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; SISLER E C, 1977, Tobacco Science, V21, P43; Sisler E. C, 1996, U. S. Patent, Patent No. [5,518,988, 5518988]; Sisler EC, 1996, PLANT GROWTH REGUL, V18, P169, DOI 10.1007/BF00024378; SISLER EC, 1979, PLANT PHYSIOL, V64, P538, DOI 10.1104/pp.64.4.538; Sisler EC, 1996, PLANT GROWTH REGUL, V18, P79, DOI 10.1007/BF00028491; SISLER EC, 1986, PLANT GROWTH REGUL, V4, P213, DOI 10.1007/BF00028164; Sisler EC, 1973, TOBACCO SCI, V17, P68; SISLER EC, 1991, PLANT HORMONE ETHYLE, P81; Smalle J, 1997, P NATL ACAD SCI USA, V94, P2756, DOI 10.1073/pnas.94.6.2756; Smith A. R., 1987, Plant hormone receptors (NATO ASI Series. Series H: Cell Biology, Vol.10), P229; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Song JY, 2011, P NATL ACAD SCI USA, V108, P10780, DOI 10.1073/pnas.1104242108; Sriskandarajah S, 2007, PLANT CELL REP, V26, P805, DOI 10.1007/s00299-006-0291-6; Strader LC, 2009, PLANT CELL, V21, P3585, DOI 10.1105/tpc.108.065185; Street IH, 2015, PLANT PHYSIOL, V169, P338, DOI 10.1104/pp.15.00415; Sugimoto Y, 2003, PHYSIOL PLANTARUM, V119, P137, DOI 10.1034/j.1399-3054.2003.00162.x; Switzenberg JA, 2015, TRANSGENIC RES, V24, P497, DOI 10.1007/s11248-014-9853-5; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; THOMPSON JS, 1983, J AM CHEM SOC, V105, P3522, DOI 10.1021/ja00349a026; Tieman DV, 2000, P NATL ACAD SCI USA, V97, P5663, DOI 10.1073/pnas.090550597; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Urao T, 2000, FEBS LETT, V478, P227, DOI 10.1016/S0014-5793(00)01860-3; Van de Poel B, 2015, PLANT PHYSIOL, V169, P61, DOI 10.1104/pp.15.00724; Vandenbussche F, 2007, J EXP BOT, V58, P4269, DOI 10.1093/jxb/erm288; Voet-van-Vormizeele J, 2008, MOL PLANT, V1, P380, DOI 10.1093/mp/ssn004; Wang FF, 2017, J INTEGR PLANT BIOL, V59, P810, DOI 10.1111/jipb.12570; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065800; Wang WY, 2006, PLANT CELL, V18, P3429, DOI 10.1105/tpc.106.044537; Wang WY, 2003, P NATL ACAD SCI USA, V100, P352, DOI 10.1073/pnas.0237085100; Watkins CB, 2006, BIOTECHNOL ADV, V24, P389, DOI 10.1016/j.biotechadv.2006.01.005; Wen X, 2012, CELL RES, V22, P1613, DOI 10.1038/cr.2012.145; Wigchert SCM, 1999, J AGR FOOD CHEM, V47, P1705, DOI 10.1021/jf981006z; Wilkinson JQ, 1997, NAT BIOTECHNOL, V15, P444, DOI 10.1038/nbt0597-444; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807; Wilson RL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00433; Wilson RL, 2014, PLANT PHYSIOL, V165, P1353, DOI 10.1104/pp.114.241695; Woeste KE, 2000, PLANT CELL, V12, P443, DOI 10.1105/tpc.12.3.443; Xie F, 2006, PLANT PHYSIOL, V142, P492, DOI 10.1104/pp.106.082628; Yasumura Y, 2015, PLANT PHYSIOL, V169, P283, DOI 10.1104/pp.15.00233; Zdarska M, 2019, MOL PLANT, V12, P1338, DOI 10.1016/j.molp.2019.05.012; Zehar N, 2002, WEED RES, V42, P464, DOI 10.1046/j.1365-3180.2002.00306.x; Zhang F, 2018, PLANT CELL, V30, P153, DOI 10.1105/tpc.17.00671; Zhang F, 2017, P NATL ACAD SCI USA, V114, P10274, DOI 10.1073/pnas.1707937114; Zhang F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13018; Zhang YP, 2019, PLANT GENOME-US, V12, DOI 10.3835/plantgenome2018.11.0089; Zhao H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14313-0; Zhao XC, 2002, PLANT PHYSIOL, V130, P1983, DOI 10.1104/pp.011635; Zhong SL, 2008, J EXP BOT, V59, P965, DOI 10.1093/jxb/ern021; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514; Zhu ZQ, 2011, P NATL ACAD SCI USA, V108, P12539, DOI 10.1073/pnas.1103959108; Zwanenburg B, 2016, PEST MANAG SCI, V72, P2016, DOI 10.1002/ps.4222	249	123	126	54	185	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7710	7725		10.1074/jbc.REV120.010854	http://dx.doi.org/10.1074/jbc.REV120.010854			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32332098	hybrid, Green Published			2022-12-28	WOS:000538038900012
J	Kobayashi, A; Hirata, T; Nishikaze, T; Ninomiya, A; Maki, Y; Takada, Y; Kitamoto, T; Kinoshita, T				Kobayashi, Atsushi; Hirata, Tetsuya; Nishikaze, Takashi; Ninomiya, Akinori; Maki, Yuta; Takada, Yoko; Kitamoto, Tetsuyuki; Kinoshita, Taroh			alpha 2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylphosphatidylinositol (GPI); glycosylation; sialic acid; prion; MS; neurodegeneration; Creutzfeldt?Jakob disease; scrapie	MOLECULAR-WEIGHT ANTIGEN; TOXOPLASMA-GONDII; SCRAPIE; YEAST; PRP; GANGLIOSIDES; EXPRESSION; RESISTANT; MANNOSE; DISEASE	Prion diseases are transmissible, lethal neurodegenerative disorders caused by accumulation of the aggregated scrapie form of the prion protein (PrPSc) after conversion of the cellular prion protein (PrP(C)). The glycosylphosphatidylinositol (GPI) anchor of PrP(C) is involved in prion disease pathogenesis, and especially sialic acid in a GPI side chain reportedly affects PrP(C) conversion. Thus, it is important to define the location and structure of the GPI anchor in human PrP(C). Moreover, the sialic acid linkage type in the GPI side chain has not been determined for any GPI-anchored protein. Here we report GPI glycan structures of human PrP(C) isolated from human brains and from brains of a knock-in mouse model in which the mouse prion protein (Prnp) gene was replaced with the human PRNP gene. LC?electrospray ionization?MS analysis of human PrP(C) from both biological sources indicated that Gly(229) is the ? site in PrP(C) to which GPI is attached. Gly(229) in human PrP(C) does not correspond to Ser(231), the previously reported ? site of Syrian hamster PrP(C). We found that ?41% and 28% of GPI anchors in human PrP(C)s from human and knock-in mouse brains, respectively, have N-acetylneuraminic acid in the side chain. Using a sialic acid linkage-specific alkylamidation method to discriminate ?2,3 linkage from ?2,6 linkage, we found that N-acetylneuraminic acid in PrP(C)'s GPI side chain is linked to galactose through an ?2,3 linkage. In summary, we report the GPI glycan structure of human PrP(C), including the ?-site amino acid for GPI attachment and the sialic acid linkage type.	[Kobayashi, Atsushi] Hokkaido Univ, Fac Vet Med, Lab Comparat Pathol, Sapporo, Hokkaido, Japan; [Hirata, Tetsuya; Ninomiya, Akinori; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan; [Hirata, Tetsuya; Takada, Yoko; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Nishikaze, Takashi] Shimadzu Co Ltd, Koichi Tanaka Mass Spectrometry Res Lab, Kyoto, Japan; [Maki, Yuta] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka, Japan; [Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Dept Neurol Sci, Sendai, Miyagi, Japan; [Hirata, Tetsuya] Gifu Univ, Ctr Highly Adv Integrat Nano & Life Sci G CHAIN, Gifu, Japan	Hokkaido University; Osaka University; Osaka University; Shimadzu Corporation; Osaka University; Tohoku University; Gifu University	Kobayashi, A (corresponding author), Hokkaido Univ, Fac Vet Med, Lab Comparat Pathol, Sapporo, Hokkaido, Japan.; Kinoshita, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan.; Kinoshita, T (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan.	kobayashi@vetmed.hokudai.ac.jp; tkinoshi@biken.osaka-u.ac.jp	勇太, 真木/AAT-9449-2020; Kinoshita, Taroh/C-7353-2009	Kajihara, Yasuhiro/0000-0002-6656-2394	Japan Society for the Promotion of Science; MEXT KAKENHI [JP16H04753, 17H06422]; The Kato Memorial Trust for Nambyo Research; Japan Society for the Promotion of Science KAKENHI [18K05963]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); The Kato Memorial Trust for Nambyo Research; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science and MEXT KAKENHI grants JP16H04753 and 17H06422 (to T. Kinoshita), a grant from The Kato Memorial Trust for Nambyo Research (to A. K.), and Japan Society for the Promotion of Science KAKENHI Grant 18K05963 (to A. K.).	Aguzzit A, 2016, TRENDS CELL BIOL, V26, P40, DOI 10.1016/j.tcb.2015.08.007; Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; Asano M, 2006, BIOCHEM BIOPH RES CO, V342, P293, DOI 10.1016/j.bbrc.2006.01.149; Bate C, 2016, J BIOL CHEM, V291, P160, DOI 10.1074/jbc.M115.672394; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; Ferguson M. A. J., 2015, ESSENTIALS GLYCOBIOL, P137; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Hanamatsu H, 2018, ANAL CHEM, V90, P13193, DOI 10.1021/acs.analchem.8b02775; Hirata T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02799-0; Hizume M, 2010, BIOCHEM BIOPH RES CO, V391, P1681, DOI 10.1016/j.bbrc.2009.12.128; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Hong YJ, 1999, J BIOL CHEM, V274, P35099, DOI 10.1074/jbc.274.49.35099; Kinoshita T, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.190290; Kinoshita T, 2016, J LIPID RES, V57, P6, DOI 10.1194/jlr.R063313; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V191, P709, DOI 10.1006/bbrc.1993.1275; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; McNally KL, 2009, J VIROL, V83, P4469, DOI 10.1128/JVI.02412-08; Miyagawa-Yamaguchi A, 2015, GLYCOCONJUGATE J, V32, P531, DOI 10.1007/s10719-015-9595-5; Miyazaki H, 1997, J BIOL CHEM, V272, P24794, DOI 10.1074/jbc.272.40.24794; Nishikaze T, 2017, ANAL CHEM, V89, P2353, DOI 10.1021/acs.analchem.6b04150; Olsen ASB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170069; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Puig B, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007520; Rangel A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-8; Schnaar RL, 2016, J MOL BIOL, V428, P3325, DOI 10.1016/j.jmb.2016.05.020; Shiina T, 2000, IMMUNOGENETICS, V51, P75, DOI 10.1007/s002510050012; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; Striepen B, 1997, J MOL BIOL, V266, P797, DOI 10.1006/jmbi.1996.0806; SVENNERHOLM L, 1989, BIOCHIM BIOPHYS ACTA, V1005, P109, DOI 10.1016/0005-2760(89)90175-6; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; Taron BW, 2004, J BIOL CHEM, V279, P36083, DOI 10.1074/jbc.M405081200; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; TOMAVO S, 1994, PARASITOLOGY, V108, P139, DOI 10.1017/S0031182000068220; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang YC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14678-2; Wang YC, 2019, J BIOL CHEM, V294, P5038, DOI 10.1074/jbc.RA119.007472	44	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7789	7798		10.1074/jbc.RA120.013444	http://dx.doi.org/10.1074/jbc.RA120.013444			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32321762	hybrid, Green Published			2022-12-28	WOS:000538038900018
J	Shi, W; Ye, B; Rame, M; Wang, YJ; Cioca, D; Reibel, S; Peng, JZ; Qi, SJ; Vitale, N; Luo, HY; Wu, JP				Shi, Wei; Ye, Bei; Rame, Marion; Wang, Yujia; Cioca, Dominique; Reibel, Sophie; Peng, Junzheng; Qi, Shijie; Vitale, Nicolas; Luo, Hongyu; Wu, Jiangping			The receptor tyrosine kinase EPHB6 regulates catecholamine exocytosis in adrenal gland chromaffin cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						catecholamine; adrenal; actin; receptor tyrosine kinase; exocytosis; adrenal gland chromaffin cell; EPHB6; F-actin	F-ACTIN; PLASMA-CATECHOLAMINES; BLOOD-PRESSURE; HYPERTENSION; CONTRACTILITY; ACTIVATION; SECRETION; PROTEIN; RAT; ASSOCIATION	The erythropoietin-producing human hepatocellular receptor EPH receptor B6 (EPHB6) is a receptor tyrosine kinase that has been shown previously to control catecholamine synthesis in the adrenal gland chromaffin cells (AGCCs) in a testosterone-dependent fashion. EPHB6 also has a role in regulating blood pressure, but several facets of this regulation remain unclear. Using amperometry recordings, we now found that catecholamine secretion by AGCCs is compromised in the absence of EPHB6. AGCCs from male knockout (KO) mice displayed reduced cortical F-actin disassembly, accompanied by decreased catecholamine secretion through exocytosis. This phenotype was not observed in AGCCs from female KO mice, suggesting that testosterone, but not estrogen, contributes to this phenotype. Of note, reverse signaling from EPHB6 to ephrin B1 (EFNB1) and a 7-amino acid-long segment in the EFNB1 intracellular tail were essential for the regulation of catecholamine secretion. Further downstream, the Ras homolog family member A (RHOA) and FYN proto-oncogene Src family tyrosine kinase (FYN)?proto-oncogene c-ABL?microtubule-associated monooxygenase calponin and LIM domain containing 1 (MICAL-1) pathways mediated the signaling from EFNB1 to the defective F-actin disassembly. We discuss the implications of EPHB6's effect on catecholamine exocytosis and secretion for blood pressure regulation.	[Shi, Wei; Ye, Bei; Peng, Junzheng; Qi, Shijie; Luo, Hongyu; Wu, Jiangping] Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Montreal, PQ, Canada; [Ye, Bei; Wang, Yujia] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Rame, Marion; Vitale, Nicolas] CNRS, Inst Neurosci Cellulaires & Integrat, UPR 3212, Strasbourg, France; [Rame, Marion; Vitale, Nicolas] Univ Strasbourg, Strasbourg, France; [Cioca, Dominique; Reibel, Sophie] Chronobiotron UMS 3415, Strasbourg, France; [Wu, Jiangping] CHUM, Dept Nephrol, Montreal, PQ, Canada	Universite de Montreal; Zhejiang University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montreal	Luo, HY; Wu, JP (corresponding author), Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Montreal, PQ, Canada.; Vitale, N (corresponding author), CNRS, Inst Neurosci Cellulaires & Integrat, UPR 3212, Strasbourg, France.; Vitale, N (corresponding author), Univ Strasbourg, Strasbourg, France.; Wu, JP (corresponding author), CHUM, Dept Nephrol, Montreal, PQ, Canada.	jianping.wu@umontreal.ca; hongyu.luo@umontreal.ca; vitalen@inci-cnrs.unistra.fr	Vitale, Nicolas/G-5967-2014	Vitale, Nicolas/0000-0002-4752-4907	Fonds de recherche du Quebec-Sante; J.-Louis Levesque Foundation; Canadian Institutes of Health Research Grant [MOP272014]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-04790]; Agence Nationale de la Recherche grant; Fondation pour la Recherche Medicale [DEI20151234424]; National Natural Science Foundation of China [81700363]	Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); J.-Louis Levesque Foundation; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Agence Nationale de la Recherche grant(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Fonds de recherche du Quebec-Sante and the J.-Louis Levesque Foundation (to J. W.), Canadian Institutes of Health Research Grant MOP272014 (to J. W.) Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2017-04790 (to J. W.) and a Agence Nationale de la Recherche grant (to N. V.) and Fondation pour la Recherche Medicale grant DEI20151234424 (to N. V.), and National Natural Science Foundation of China Grant 81700363 (to Y. W.).	[Anonymous], 1997, Cell, V90, P403; AXELROD J, 1976, CLIN SCI MOL MED, V51, pS415, DOI 10.1042/cs051415s; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Borkowski K R, 1984, J Hypertens Suppl, V2, pS81; Brantley-Sieders Dana M., 2004, Angiogenesis, V7, P17, DOI 10.1023/B:AGEN.0000037340.33788.87; BUHLER FR, 1982, J CARDIOVASC PHARM, V4, pS1; Byrne CJ, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00343; Cho HJ, 2018, ONCOGENE, V37, P861, DOI 10.1038/onc.2017.386; Corssmit EPM, 1996, J CLIN ENDOCR METAB, V81, P3265, DOI 10.1210/jc.81.9.3265; Couchonnal LF, 2008, PHYSIOLOGY, V23, P151, DOI 10.1152/physiol.00043.2007; De Miguel C, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0507-z; DOMINIAK P, 1982, BRIT J CLIN PHARMACO, V13, pS381, DOI 10.1111/j.1365-2125.1982.tb01945.x; DOUGLAS WW, 1961, J PHYSIOL-LONDON, V159, P40, DOI 10.1113/jphysiol.1961.sp006791; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Esler M, 2008, ANN NY ACAD SCI, V1148, P338, DOI 10.1196/annals.1410.064; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Gasman S, 2003, CELL SIGNAL, V15, P893, DOI 10.1016/S0898-6568(03)00052-4; Gasman S, 1997, J BIOL CHEM, V272, P20564, DOI 10.1074/jbc.272.33.20564; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Ginnan R, 2013, J BIOL CHEM, V288, P29703, DOI 10.1074/jbc.M113.477257; GOLDSTEIN DS, 1983, CIRCULATION, V68, P234, DOI 10.1161/01.CIR.68.2.234; Gong LW, 2007, NAT CELL BIOL, V9, P915, DOI 10.1038/ncb1617; Gutierrez LM, 2018, PFLUG ARCH EUR J PHY, V470, P181, DOI 10.1007/s00424-017-2040-9; Han DH, 2008, J SEX MED, V5, P822, DOI 10.1111/j.1743-6109.2007.00732.x; Han Y, 2015, J NEUROCHEM, V133, P617, DOI 10.1111/jnc.13061; Hashimoto T, 2007, KIDNEY INT, V72, P954, DOI 10.1038/sj.ki.5002454; HAYCOCK JW, 1982, J BIOL CHEM, V257, P2641; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Hu Y, 2015, ARTHRITIS RHEUMATOL, V67, P1778, DOI 10.1002/art.39116; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; Jablonskis L T, 1994, Blood Press, V3, P106, DOI 10.3109/08037059409101529; Kannan H, 1996, AM J PHYSIOL-REG I, V270, pR479, DOI 10.1152/ajpregu.1996.270.2.R479; Kohno S, 2011, CELL BIOL INT, V35, P325, DOI 10.1042/CBI20090344; Kolski-Andreaco Aaron, 2007, J Vis Exp, P129, DOI 10.3791/129; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Liu YZ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00316; Luo HY, 2016, NEUROBIOL DIS, V91, P292, DOI 10.1016/j.nbd.2016.03.013; Luo HY, 2012, J BIOL CHEM, V287, P6819, DOI 10.1074/jbc.M111.293365; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Marjoram RJ, 2014, CURR MOL MED, V14, P199, DOI 10.2174/1566524014666140128104541; Martinez-Espinosa PL, 2014, J GEN PHYSIOL, V144, P275, DOI 10.1085/jgp.201411253; Mathar I, 2010, J CLIN INVEST, V120, P3267, DOI 10.1172/JCI41348; Menezes A, 1996, J NEUROCHEM, V67, P2316; Mosharov EV, 2005, NAT METHODS, V2, P651, DOI 10.1038/nmeth782; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; O'Neill AK, 2016, J CELL BIOL, V215, P217, DOI 10.1083/jcb.201604097; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Ory S, 2013, J NEUROSCI, V33, P3545, DOI 10.1523/JNEUROSCI.3654-12.2013; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; PENDE A, 1990, J BIOL REG HOMEOS AG, V4, P67; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Poea-Guyon S, 2013, J CELL BIOL, V203, P283, DOI 10.1083/jcb.201303104; RIVIER C, 1989, ENDOCRINOLOGY, V125, P3096, DOI 10.1210/endo-125-6-3096; Sala F, 2008, ACTA PHYSIOL, V192, P203, DOI 10.1111/j.1748-1716.2007.01804.x; Salvucci O, 2006, BLOOD, V108, P2914, DOI 10.1182/blood-2006-05-023341; Shi W, 2019, J BIOL CHEM, V294, P6871, DOI 10.1074/jbc.RA118.005767; SOLARO CR, 1995, J NEUROSCI, V15, P6110; Sparrenberger F, 2009, J HUM HYPERTENS, V23, P12, DOI 10.1038/jhh.2008.74; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; Tanaka M, 2010, CANCER SCI, V101, P87, DOI 10.1111/j.1349-7006.2009.01352.x; TOMLINSON A, 1987, NEUROSCIENCE, V20, P895, DOI 10.1016/0306-4522(87)90250-8; Tremblay J, 2017, SCI REP-UK, V7, DOI 10.1038/srep44114; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; VOLLMER RR, 1992, AM J PHYSIOL, V263, pR716, DOI 10.1152/ajpregu.1992.263.3.R716; Wang YJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19215-2; Wang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38976; Wang YJ, 2016, EUR J HUM GENET, V24, P1817, DOI 10.1038/ejhg.2016.105; Wang YJ, 2016, AM J PHYSIOL-HEART C, V310, pH861, DOI 10.1152/ajpheart.00873.2015; Wang YJ, 2015, J BIOL CHEM, V290, P14235, DOI 10.1074/jbc.M114.621615; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Wu T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32836-x; Wu ZH, 2012, J BIOL CHEM, V287, P15557, DOI 10.1074/jbc.M112.340869; Yoon J, 2017, DEV CELL, V42, P117, DOI 10.1016/j.devcel.2017.06.007; Zhang ZQ, 2019, J HYPERTENS, V37, P775, DOI 10.1097/HJH.0000000000001948; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	80	2	2	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7653	7668		10.1074/jbc.RA120.013251	http://dx.doi.org/10.1074/jbc.RA120.013251			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32321761	hybrid, Green Published			2022-12-28	WOS:000538038900008
J	Ray, S; Chee, L; Matson, DR; Palermo, NY; Bresnick, EH; Hewitt, KJ				Ray, Suhita; Chee, Linda; Matson, Daniel R.; Palermo, Nick Y.; Bresnick, Emery H.; Hewitt, Kyle J.			Sterile ?-motif domain requirement for cellular signaling and survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein motif; erythropoiesis; stem cell factor (SCF); stress; structure?function; hemolytic anemia; proto-oncogene c-Kit (c-Kit); receptor tyrosine kinase; sterile ?-motif; sterile ?-motif domain containing 14 (SAMD14)	C-KIT; HEMATOPOIETIC STEM; ERYTHROID PROGENITORS; CIS-ELEMENT; SAM DOMAINS; MUTATIONS; GATA2; RECEPTOR; CELLS; ACTIVATION	Hundreds of sterile ?-motif (SAM) domains have predicted structural similarities and are reported to bind proteins, lipids, or RNAs. However, the majority of these domains have not been analyzed functionally. Previously, we demonstrated that a SAM domain-containing protein, SAMD14, promotes SCF/proto-oncogene c-Kit (c-Kit) signaling, erythroid progenitor function, and erythrocyte regeneration. Deletion of a Samd14 enhancer (Samd14?Enh), occupied by GATA2 and SCL/TAL1 transcription factors, reduces SAMD14 expression in bone marrow and spleen and is lethal in a hemolytic anemia mouse model. To rigorously establish whether Samd14?Enh deletion reduces anemia-dependent c-Kit signaling by lowering SAMD14 levels, we developed a genetic rescue assay in murine Samd14?Enh(?/?) primary erythroid precursor cells. SAMD14 expression at endogenous levels rescued c-Kit signaling. The conserved SAM domain was required for SAMD14 to increase colony-forming activity, c-Kit signaling, and progenitor survival. To elucidate the molecular determinants of SAM domain function in SAMD14, we substituted its SAM domain with distinct SAM domains predicted to be structurally similar. The chimeras were less effective than SAMD14 itself in rescuing signaling, survival, and colony-forming activities. Thus, the SAMD14 SAM domain has attributes that are distinct from other SAM domains and underlie SAMD14 function as a regulator of cellular signaling and erythrocyte regeneration.	[Ray, Suhita; Chee, Linda; Hewitt, Kyle J.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA; [Matson, Daniel R.; Bresnick, Emery H.] Univ Wisconsin, Madison Blood Res Program, Dept Cell & Regenerat Biol, Sch Med & Publ Hlth,Carbone Canc Ctr, Madison, WI 53705 USA; [Palermo, Nick Y.] Univ Nebraska, Holland Comp Ctr, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Nebraska System; University of Nebraska Lincoln	Hewitt, KJ (corresponding author), Fred & Pamela Buffett Canc Ctr, Dept Genet Cell Biol & Anat, 985805 Nebraska Med Ctr, Omaha, NE 68198 USA.	kyle.hewitt@unmc.edu		Matson, Daniel/0000-0003-1430-3128; Ray, Suhita/0000-0003-0887-6640	National Institutes of Health [K01DK113117]; Nebraska Stem Cell Research Grant DHHS [2019-01, DK50107]; Cancer Center Support Grant [P30CA014520]; COBRE Nebraska Center for Molecular Target Discovery and Development [P20GM121316]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Stem Cell Research Grant DHHS; Cancer Center Support Grant; COBRE Nebraska Center for Molecular Target Discovery and Development	This work was supported by National Institutes of Health Grants K01DK113117 (to K. J. H.), Nebraska Stem Cell Research Grant DHHS 2019-01, DK50107 (to E. H. B.), Cancer Center Support Grant P30CA014520, and the COBRE Nebraska Center for Molecular Target Discovery and Development Grant P20GM121316. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agosti V, 2009, EXP HEMATOL, V37, P159, DOI 10.1016/j.exphem.2008.10.009; Ahn J, 2016, BIOL CHEM, V397, P373, DOI 10.1515/hsz-2015-0260; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Blouin MJ, 1999, BLOOD, V94, P1451, DOI 10.1182/blood.V94.4.1451.416k02_1451_1459; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bresnick EH, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.151423; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Broudy VC, 1996, BLOOD, V88, P75; BROXMEYER HE, 1991, CANCER CELL-MON REV, V3, P480; Chen DH, 2016, AM J HUM GENET, V98, P1146, DOI 10.1016/j.ajhg.2016.04.009; Dahlin JS, 2018, BLOOD, V131, pE1, DOI 10.1182/blood-2017-12-821413; Davidsson J, 2018, LEUKEMIA, V32, P1106, DOI 10.1038/s41375-018-0074-4; Di Pietro SM, 2010, EMBO J, V29, P1033, DOI 10.1038/emboj.2010.5; Dickinson RE, 2011, BLOOD, V118, P2656, DOI 10.1182/blood-2011-06-360313; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Gao X, 2013, J EXP MED, V210, P2833, DOI 10.1084/jem.20130733; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Harandi OF, 2010, J CLIN INVEST, V120, P4507, DOI 10.1172/JCI41291; HARRISON DE, 1972, BRIT J HAEMATOL, V22, P155, DOI 10.1111/j.1365-2141.1972.tb08797.x; Hewitt KJ, 2016, CURR TOP DEV BIOL, V118, P45, DOI 10.1016/bs.ctdb.2016.01.002; Hewitt KJ, 2017, DEV CELL, V42, P213, DOI 10.1016/j.devcel.2017.07.009; Hewitt KJ, 2015, MOL CELL, V59, P62, DOI 10.1016/j.molcel.2015.05.020; Ho CCM, 2017, CELL, V168, P1041, DOI 10.1016/j.cell.2017.02.011; Hong L, 2004, MOL CELL BIOL, V24, P1401, DOI 10.1128/MCB.24.3.1401-1410.2004; Hsu AP, 2013, BLOOD, V121, P3830, DOI 10.1182/blood-2012-08-452763; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; Johnson KD, 2012, J CLIN INVEST, V122, P3692, DOI 10.1172/JCI61623; Kapur R, 2001, BLOOD, V97, P1975, DOI 10.1182/blood.V97.7.1975; KELLER JR, 1995, BLOOD, V86, P1757, DOI 10.1182/blood.V86.5.1757.bloodjournal8651757; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Knight MJ, 2011, PROTEIN SCI, V20, P1697, DOI 10.1002/pro.703; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Leone M, 2008, BIOCHEMISTRY-US, V47, P12721, DOI 10.1021/bi801713f; Ma P, 2012, LEUKEMIA, V26, P1499, DOI 10.1038/leu.2012.22; McIver SC, 2014, BLOOD, V124, P2285, DOI 10.1182/blood-2014-04-571083; Mehta C, 2017, CELL REP, V20, P2966, DOI 10.1016/j.celrep.2017.08.090; Perry JM, 2007, BLOOD, V109, P4494, DOI 10.1182/blood-2006-04-016154; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Sayou C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11222; Schultz J, 1997, PROTEIN SCI, V6, P249; Soukup AA, 2019, J CLIN INVEST, V129, P1180, DOI 10.1172/JCI122694; Troster A, 2018, CHEMMEDCHEM, V13, P1629, DOI 10.1002/cmdc.201800398; von Lindern M, 1999, BLOOD, V94, P550, DOI 10.1182/blood.V94.2.550.414k39_550_559; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wandzioch E, 2004, BLOOD, V104, P51, DOI 10.1182/blood-2003-07-2554; Wang Y, 2018, ELIFE, V7, DOI 10.7554/eLife.35677; Wang Y, 2016, BIOCHEM BIOPH RES CO, V473, P1281, DOI 10.1016/j.bbrc.2016.04.059; Xiang J, 2015, BLOOD, V125, P1803, DOI 10.1182/blood-2014-07-591453; Yamazaki H, 2014, CANCER CELL, V25, P415, DOI 10.1016/j.ccr.2014.02.008	51	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7113	7125		10.1074/jbc.RA119.011895	http://dx.doi.org/10.1074/jbc.RA119.011895			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32241909	Green Published, hybrid			2022-12-28	WOS:000536212600026
J	Yang, JL; LeBlanc, ME; Cano, I; Saez-Torres, KL; Saint-Geniez, M; Ng, YS; D'Amore, PA				Yang, Jinling; LeBlanc, Michelle E.; Cano, Issahy; Saez-Torres, Kahira L.; Saint-Geniez, Magali; Ng, Yin-Shan; D'Amore, Patricia A.			ADAM10 and ADAM17 proteases mediate proinflammatory cytokine-induced and constitutive cleavage of endomucin from the endothelial surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; endothelial cell; proteolytic enzyme; leukocyte; glycoprotein; endothelium; matrix metalloproteinase (MMP); endomucin; glycocalyx	NECROSIS-FACTOR-ALPHA; ADHESION MOLECULE; REGULATED RELEASE; CELL-ADHESION; GLYCOCALYX; ECTODOMAIN; INFLAMMATION; DISINTEGRIN; PERMEABILITY; FRACTALKINE	Contact between inflammatory cells and endothelial cells (ECs) is a crucial step in vascular inflammation. Recently, we demonstrated that the cell-surface level of endomucin (EMCN), a heavily O-glycosylated single-transmembrane sialomucin, interferes with the interactions between inflammatory cells and ECs. We have also shown that, in response to an inflammatory stimulus, EMCN is cleared from the cell surface by an unknown mechanism. In this study, using adenovirus-mediated overexpression of a tagged EMCN in human umbilical vein ECs, we found that treatment with tumor necrosis factor ? (TNF-?) or the strong oxidant pervanadate leads to loss of cell-surface EMCN and increases the levels of the C-terminal fragment of EMCN 3- to 4-fold. Furthermore, treatment with the broad-spectrum matrix metalloproteinase inhibitor batimastat (BB94) or inhibition of ADAM metallopeptidase domain 10 (ADAM10) and ADAM17 with two small-molecule inhibitors, GW280264X and GI254023X, or with siRNA significantly reduced basal and TNF?-induced cell-surface EMCN cleavage. Release of the C-terminal fragment of EMCN by TNF-? treatment was blocked by chemical inhibition of ADAM10 alone or in combination with ADAM17. These results indicate that cell-surface EMCN undergoes constitutive cleavage and that TNF-? treatment dramatically increases this cleavage, which is mediated predominantly by ADAM10 and ADAM17. As endothelial cell-surface EMCN attenuates leukocyte?EC interactions during inflammation, we propose that EMCN is a potential therapeutic target to manage vascular inflammation.	[Yang, Jinling; LeBlanc, Michelle E.; Cano, Issahy; Saez-Torres, Kahira L.; Saint-Geniez, Magali; Ng, Yin-Shan; D'Amore, Patricia A.] Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA 02115 USA; [Yang, Jinling; LeBlanc, Michelle E.; Cano, Issahy; Saez-Torres, Kahira L.; Saint-Geniez, Magali; Ng, Yin-Shan; D'Amore, Patricia A.] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [D'Amore, Patricia A.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Yang, Jinling] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	D'Amore, PA (corresponding author), Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA 02115 USA.; D'Amore, PA (corresponding author), Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA.; D'Amore, PA (corresponding author), Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.	patricia_damore@meei.harvard.edu	Ng, Wing Yin/HHN-1743-2022	Yang, Jinling/0000-0003-2748-2161; Cano, Issahy/0000-0001-9994-149X	National Institutes of Health [P30 EY03790, R01EY26539, F32 EY028405]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants P30 EY03790 and R01EY26539 (to P. A. D.) and F32 EY028405 (to M. E. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Figs. S1-S6.	BAZIL V, 1993, P NATL ACAD SCI USA, V90, P3792, DOI 10.1073/pnas.90.9.3792; Dreymueller D, 2012, EMBO MOL MED, V4, P412, DOI 10.1002/emmm.201200217; Dreymueller D, 2012, EUR J CELL BIOL, V91, P472, DOI 10.1016/j.ejcb.2011.09.003; Essick E, 2008, MOL CELL BIOCHEM, V314, P151, DOI 10.1007/s11010-008-9776-7; GARDLUND B, 1995, J INFECT DIS, V172, P296, DOI 10.1093/infdis/172.1.296; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gotte M, 2002, INVEST OPHTH VIS SCI, V43, P1135; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Hayashida K, 2009, BLOOD, V114, P3033, DOI 10.1182/blood-2009-02-204966; Hikita A, 2009, BIOCHEM CELL BIOL, V87, P581, DOI [10.1139/O09-015, 10.1139/o09-015]; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Kanki Y, 2011, EMBO J, V30, P2582, DOI 10.1038/emboj.2011.173; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Koenen RR, 2009, BLOOD, V113, P4799, DOI 10.1182/blood-2008-04-152330; Kreuger J, 2016, NAT REV DRUG DISCOV, V15, P125, DOI 10.1038/nrd.2015.2; Kuhn A, 2002, J INVEST DERMATOL, V119, P1388, DOI 10.1046/j.1523-1747.2002.19647.x; Langer HF, 2009, J CELL MOL MED, V13, P1211, DOI 10.1111/j.1582-4934.2009.00811.x; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lipowsky HH, 2011, AM J PHYSIOL-HEART C, V301, pH2235, DOI 10.1152/ajpheart.00803.2011; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; Morgan SM, 1999, BLOOD, V93, P165, DOI 10.1182/blood.V93.1.165.401k25_165_175; Mulivor AW, 2009, MICROCIRCULATION, V16, P657, DOI 10.3109/10739680903133714; Mulivor AW, 2004, AM J PHYSIOL-HEART C, V286, pH1672, DOI 10.1152/ajpheart.00832.2003; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Muller WA, 2002, LAB INVEST, V82, P521, DOI 10.1038/labinvest.3780446; Pruessmeyer J, 2014, BLOOD, V123, P4077, DOI 10.1182/blood-2013-09-511543; Pruessmeyer J, 2010, J BIOL CHEM, V285, P555, DOI 10.1074/jbc.M109.059394; Ramnath R, 2014, FASEB J, V28, P4686, DOI 10.1096/fj.14-252221; Rehm M, 2007, CIRCULATION, V116, P1896, DOI 10.1161/CIRCULATIONAHA.106.684852; Reiland J, 1996, BIOCHEM J, V319, P39, DOI 10.1042/bj3190039; RIEU P, 1992, EUR J IMMUNOL, V22, P3021, DOI 10.1002/eji.1830221138; Scholz F, 2007, J INVEST DERMATOL, V127, P1444, DOI 10.1038/sj.jid.5700751; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Silveira RC, 2003, J PEDIATR-US, V143, P625, DOI 10.1067/S0022-3476(03)00531-6; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wachtel M, 1999, J CELL SCI, V112, P4347; Zahr A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10363; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	43	7	7	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6641	6651		10.1074/jbc.RA119.011192	http://dx.doi.org/10.1074/jbc.RA119.011192			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32193206	Green Published, hybrid			2022-12-28	WOS:000537685000030
J	Sehrawat, A; Shiota, C; Mohamed, N; DiNicola, J; Saleh, M; Kalsi, R; Zhang, T; Wang, Y; Prasadan, K; Gittes, GK				Sehrawat, Anuradha; Shiota, Chiyo; Mohamed, Nada; DiNicola, Julia; Saleh, Mohamed; Kalsi, Ranjeet; Zhang Ting; Wang Yan; Prasadan, Krishna; Gittes, George K.			SMAD7 enhances adult ?-cell proliferation without significantly affecting ?-cell function in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); cell proliferation; glucose metabolism; SMAD transcription factor; diabetes; SMAD7; beta cell; glucose homeostasis; cell signaling; transforming growth factor beta (TGF-beta); pancreatic islet; gene regulation; endocrine development	TGF-BETA; TRANSGENIC MICE; ENDOCRINE; EXPRESSION; RECEPTOR; HEMIPANCREATECTOMY; DIFFERENTIATION; FOLLISTATIN; INHIBITION; PANCREAS	The interplay between the transforming growth factor ? (TGF-?) signaling proteins, SMAD family member 2 (SMAD2) and 3 (SMAD3), and the TGF-??inhibiting SMAD, SMAD7, seems to play a vital role in proper pancreatic endocrine development and also in normal ?-cell function in adult pancreatic islets. Here, we generated conditional SMAD7 knockout mice by crossing insulin1(Cre) mice with SMAD7(fx/fx) mice. We also created a ? cell?specific SMAD7-overexpressing mouse line by crossing insulin1(Dre) mice with HPRT-SMAD7/RosaGFP mice. We analyzed ?-cell function in adult islets when SMAD7 was either absent or overexpressed in ? cells. Loss of SMAD7 in ? cells inhibited proliferation, and SMAD7 overexpression enhanced cell proliferation. However, alterations in basic glucose homeostasis were not detectable following either SMAD7 deletion or overexpression in ? cells. Our results show that both the absence and overexpression of SMAD7 affect TGF-? signaling and modulates ?-cell proliferation but does not appear to alter ?-cell function. Reversible SMAD7 overexpression may represent an attractive therapeutic option to enhance ?-cell proliferation without negative effects on ?-cell function.	[Sehrawat, Anuradha; Shiota, Chiyo; Mohamed, Nada; DiNicola, Julia; Saleh, Mohamed; Kalsi, Ranjeet; Zhang Ting; Wang Yan; Prasadan, Krishna; Gittes, George K.] Univ Pittsburgh, Childrens Hosp, Dept Pediat Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Shiota, Chiyo] Vanderbilt Univ, Dept Mol Physiol & Biophys, 221 Kirkland Hall, Nashville, TN 37235 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University	Gittes, GK (corresponding author), Univ Pittsburgh, Childrens Hosp, Dept Pediat Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	gittesgk@upmc.edu	wang, yan/G-3715-2018	wang, yan/0000-0001-7816-6121	National Institutes of Health [RO1DK111460]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grant RO1DK111460 (to G. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Bertera S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/856386; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; Bottinger EP, 1997, CANCER RES, V57, P5564; Bottinger EP, 1997, EMBO J, V16, P2621, DOI 10.1093/emboj/16.10.2621; Brorson M, 2001, HISTOCHEM CELL BIOL, V116, P263, DOI 10.1007/s004180100316; Chen CD, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.164913; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El-Gohary Y, 2014, DIABETES, V63, P224, DOI 10.2337/db13-0432; El-Gohary Y, 2013, DEV BIOL, V378, P83, DOI 10.1016/j.ydbio.2013.04.003; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Han B, 2011, J IMMUNOL, V186, P5833, DOI 10.4049/jimmunol.1002303; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Itkin-Ansari P, 2005, DEV DYNAM, V233, P946, DOI 10.1002/dvdy.20443; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; KENDALL DM, 1990, NEW ENGL J MED, V322, P898, DOI 10.1056/NEJM199003293221305; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; Kuang CZ, 2006, P NATL ACAD SCI USA, V103, P1858, DOI 10.1073/pnas.0508977103; Linnemann AK, 2014, ADV NUTR, V5, P278, DOI 10.3945/an.113.005488; Maldonado TS, 2000, J GASTROINTEST SURG, V4, P269, DOI 10.1016/S1091-255X(00)80075-X; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Matsuzaki K, 2013, CYTOKINE GROWTH F R, V24, P385, DOI 10.1016/j.cytogfr.2013.06.002; Meier JJ, 2012, DIABETOLOGIA, V55, P1346, DOI 10.1007/s00125-012-2466-8; Miralles F, 1998, DEVELOPMENT, V125, P1017; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; MOSES HL, 1987, J CELL PHYSIOL, P1, DOI 10.1002/jcp.1041330403; MOSES HL, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P250; Park SH, 2005, J BIOCHEM MOL BIOL, V38, P9; Prasadan K, 2016, CELL MOL LIFE SCI, V73, P3623, DOI 10.1007/s00018-016-2231-0; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SEAQUIST ER, 1992, J CLIN INVEST, V89, P1761, DOI 10.1172/JCI115779; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Szabat M, 2010, DIABETOLOGIA, V53, P1680, DOI 10.1007/s00125-010-1758-0; Tulachan SS, 2007, DEV BIOL, V305, P508, DOI 10.1016/j.ydbio.2007.02.033; Wang P, 2019, CELL METAB, V29, P638, DOI 10.1016/j.cmet.2018.12.005; WANG RN, 1994, DIABETOLOGIA, V37, P1088; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xiao XW, 2014, P NATL ACAD SCI USA, V111, pE1211, DOI 10.1073/pnas.1321347111; Xiao XW, 2013, DIABETES, V62, P1217, DOI 10.2337/db12-1428; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yang GS, 2009, GENOMICS, V93, P196, DOI 10.1016/j.ygeno.2008.09.014; Zhang YQ, 2004, DIABETES, V53, P2024, DOI 10.2337/diabetes.53.8.2024	45	7	11	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4858	4869		10.1074/jbc.RA119.011011	http://dx.doi.org/10.1074/jbc.RA119.011011			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32122971	hybrid, Green Published			2022-12-28	WOS:000526887000010
J	Tan, W; Liao, TH; Wang, J; Ye, Y; Wei, YC; Zhou, HK; Xiao, YL; Zhi, XY; Shao, ZH; Lyu, LD; Zhao, GP				Tan, Wei; Liao, Tian-Hua; Wang, Jin; Ye, Yu; Wei, Yu-Chen; Zhou, Hao-Kui; Xiao, Youli; Zhi, Xiao-Yang; Shao, Zhi-Hui; Lyu, Liang-Dong; Zhao, Guo-Ping			A recently evolved diflavin-containing monomeric nitrate reductase is responsible for highly efficient bacterial nitrate assimilation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nitrogen metabolism; Mycobacterium smegmatis; mycobacteria; reductase; protein evolution; assimilatory nitrate reductase; diflavin reductase; Mycolicibacterium smegmatis; nitrate assimilation	MYCOBACTERIUM-TUBERCULOSIS; SP NOV.; BIOCHEMICAL-CHARACTERIZATION; STREPTOMYCES-COELICOLOR; PHYLOGENETIC ANALYSIS; NITROGEN-METABOLISM; REGULATOR GLNR; BOVIS BCG; PROTEIN; IDENTIFICATION	Nitrate is one of the major inorganic nitrogen sources for microbes. Many bacterial and archaeal lineages have the capacity to express assimilatory nitrate reductase (NAS), which catalyzes the rate-limiting reduction of nitrate to nitrite. Although a nitrate assimilatory pathway in mycobacteria has been proposed and validated physiologically and genetically, the putative NAS enzyme has yet to be identified. Here, we report the characterization of a novel NAS encoded by Mycolicibacterium smegmatis Msmeg_4206, designated NasN, which differs from the canonical NASs in its structure, electron transfer mechanism, enzymatic properties, and phylogenetic distribution. Using sequence analysis and biochemical characterization, we found that NasN is an NADPH-dependent, diflavin-containing monomeric enzyme composed of a canonical molybdopterin cofactor-binding catalytic domain and an FMN?FAD/NAD-binding, electron-receiving/transferring domain, making it unique among all previously reported hetero-oligomeric NASs. Genetic studies revealed that NasN is essential for aerobic M. smegmatis growth on nitrate as the sole nitrogen source and that the global transcriptional regulator GlnR regulates nasN expression. Moreover, unlike the NADH-dependent heterodimeric NAS enzyme, NasN efficiently supports bacterial growth under nitrate-limiting conditions, likely due to its significantly greater catalytic activity and oxygen tolerance. Results from a phylogenetic analysis suggested that the nasN gene is more recently evolved than those encoding other NASs and that its distribution is limited mainly to Actinobacteria and Proteobacteria. We observed that among mycobacterial species, most fast-growing environmental mycobacteria carry nasN, but that it is largely lacking in slow-growing pathogenic mycobacteria because of multiple independent genomic deletion events along their evolution.	[Tan, Wei; Ye, Yu; Wei, Yu-Chen; Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong 999077, Peoples R China; [Tan, Wei; Ye, Yu; Wei, Yu-Chen; Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong 999077, Peoples R China; [Tan, Wei; Lyu, Liang-Dong; Zhao, Guo-Ping] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai 200032, Peoples R China; [Tan, Wei; Lyu, Liang-Dong; Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200032, Peoples R China; [Liao, Tian-Hua; Zhou, Hao-Kui; Zhao, Guo-Ping] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Synthet Biol, Shenzhen 518055, Peoples R China; [Wang, Jin] Shanghai Normal Univ, Coll Life Sci, Shanghai 200234, Peoples R China; [Xiao, Youli; Shao, Zhi-Hui; Zhao, Guo-Ping] Chinese Acad Sci, CAS Key Lab Synthet Biol, CAS Ctr Excellence Mol Plant Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; [Zhi, Xiao-Yang] Yunnan Univ, Sch Life Sci, Yunnan Inst Microbiol, Kunming 650091, Yunnan, Peoples R China; [Zhao, Guo-Ping] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol,Shanghai Inst Nutr & Hlth, Univ Chinese Acad Sci,Shanghai Inst Biol Sci,Bio, Shanghai 200031, Peoples R China; [Zhao, Guo-Ping] Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Fudan University; Fudan University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Shanghai Normal University; Chinese Academy of Sciences; Yunnan University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Max Planck Society	Zhao, GP (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong 999077, Peoples R China.; Zhao, GP (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong 999077, Peoples R China.; Lyu, LD; Zhao, GP (corresponding author), Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai 200032, Peoples R China.; Lyu, LD; Zhao, GP (corresponding author), Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200032, Peoples R China.; Zhao, GP (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Synthet Biol, Shenzhen 518055, Peoples R China.; Shao, ZH; Zhao, GP (corresponding author), Chinese Acad Sci, CAS Key Lab Synthet Biol, CAS Ctr Excellence Mol Plant Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China.; Zhi, XY (corresponding author), Yunnan Univ, Sch Life Sci, Yunnan Inst Microbiol, Kunming 650091, Yunnan, Peoples R China.; Zhao, GP (corresponding author), Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol,Shanghai Inst Nutr & Hlth, Univ Chinese Acad Sci,Shanghai Inst Biol Sci,Bio, Shanghai 200031, Peoples R China.; Zhao, GP (corresponding author), Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China.	xyzhi@ynu.edu.cn; zhshao@sibs.ac.cn; liangdong.lv@gmail.com; gpzhao@sibs.ac.cn	TAN, Wei/P-5814-2018; Lyu, Liangdong/C-6557-2014	TAN, Wei/0000-0002-7832-9338; Lyu, Liangdong/0000-0001-6391-6030; Zhao, Guo-Ping/0000-0002-7621-6620; Liao, Tianhua/0000-0002-4818-9346	National Natural Science Foundation of China [31430004, 31830002, 81671988, 91751000, 91951000, 91856112, 31970032, 81991532, 31800123]; Research Unit Fund of Li Ka Shing Institute of Health Sciences [7103506]; Hong Kong Health and Medical Research Fund [12110622]; National Key R&D Program of China [2019YFA0905100, 2018YFD0500900, 2017YFC1201200]; National Science and Technology Major Program of China [2018ZX10302301]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19040200]; Key Research Program of the Chinese Academy of Sciences [KFZD-SW-219-5]; International Partnership Program of the Chinese Academy of Sciences [153D31KYSB20170121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Unit Fund of Li Ka Shing Institute of Health Sciences; Hong Kong Health and Medical Research Fund; National Key R&D Program of China; National Science and Technology Major Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); International Partnership Program of the Chinese Academy of Sciences	This work was supported by National Natural Science Foundation of China Grants 31430004, 31830002, 81671988, 91751000, and 91951000 (to G.-P. Z.), 91856112 (to Y. X.), 31970032 and 81991532 (to L.-D. L.), and 31800123; Research Unit Fund of Li Ka Shing Institute of Health Sciences Grant 7103506 (to G.-P. Z.); Hong Kong Health and Medical Research Fund Grant 12110622 (to G.-P. Z.); National Key R&D Program of China Grants 2019YFA0905100, 2018YFD0500900, and 2017YFC1201200; National Science and Technology Major Program of China Grant 2018ZX10302301 (to L.-D. L.); Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB19040200; Key Research Program of the Chinese Academy of Sciences Grant KFZD-SW-219-5; and International Partnership Program of the Chinese Academy of Sciences Grant 153D31KYSB20170121. The authors declare that they have no conflicts of interest with the contents of this article.	Aigrain L, 2012, INT J MOL SCI, V13, P15012, DOI 10.3390/ijms131115012; Amon J, 2010, FEMS MICROBIOL REV, V34, P588, DOI 10.1111/j.1574-6976.2010.00216.x; Anderson LJ, 2001, BIOCHEMISTRY-US, V40, P11294, DOI 10.1021/bi002706b; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Case ED, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0014-2015; Chen MH, 2017, P NATL ACAD SCI USA, V114, P4954, DOI 10.1073/pnas.1615585114; Chu SH, 2017, INT J BIOL MACROMOL, V101, P1019, DOI 10.1016/j.ijbiomac.2017.04.009; Crack JC, 2015, J BIOL CHEM, V290, P12689, DOI 10.1074/jbc.M115.643072; Devulder G, 2005, INT J SYST EVOL MICR, V55, P293, DOI 10.1099/ijs.0.63222-0; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eichorst SA, 2018, ENVIRON MICROBIOL, V20, P1041, DOI 10.1111/1462-2920.14043; Flores E, 2005, PHOTOSYNTH RES, V83, P117, DOI 10.1007/s11120-004-5830-9; Fournier D, 2009, APPL ENVIRON MICROB, V75, P5088, DOI 10.1128/AEM.00418-09; Gangeswaran R, 1996, BIOCHEM J, V317, P103, DOI 10.1042/bj3170103; Gates AJ, 2008, BIOCHEM J, V409, P159, DOI 10.1042/BJ20071088; Gates AJ, 2011, BIOCHEM J, V435, P743, DOI 10.1042/BJ20101920; Gouzy A, 2014, NAT REV MICROBIOL, V12, P729, DOI 10.1038/nrmicro3349; Gray TA, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00148-13; Gupta RS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00067; Hajjar C, 2017, MBIO, V8, DOI 10.1128/mBio.01487-17; HEDGECOCK LW, 1962, J BACTERIOL, V84, P195, DOI 10.1128/JB.84.2.195-205.1962; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Iino T, 2013, J BIOSCI BIOENG, V115, P600, DOI 10.1016/j.jbiosc.2012.12.005; Jenkins VA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-301; Jessberger N., 2011, THESIS; JeSSberger Nadja, 2013, BMC Res Notes, V6, P482, DOI 10.1186/1756-0500-6-482; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawada Y, 2018, J BIOSCI BIOENG, V126, P301, DOI 10.1016/j.jbiosc.2018.03.018; Khan A, 2008, MICROB PATHOGENESIS, V44, P71, DOI 10.1016/j.micpath.2007.08.006; Khan A, 2006, MICROB PATHOGENESIS, V41, P90, DOI 10.1016/j.micpath.2006.04.006; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Koppel N, 2018, ELIFE, V7, DOI [10.7554/eLife.33953, 10.7554/elife.33953]; Kuypers MMM, 2018, NAT REV MICROBIOL, V16, P263, DOI 10.1038/nrmicro.2018.9; Lessner FH, 2012, J BIOL CHEM, V287, P18510, DOI 10.1074/jbc.M111.331199; LIN JT, 1994, J BACTERIOL, V176, P2551, DOI 10.1128/JB.176.9.2551-2559.1994; Lin W, 2014, J BIOL CHEM, V289, P15413, DOI 10.1074/jbc.M113.543504; Lombard J, 2012, NAT REV MICROBIOL, V10, P507, DOI 10.1038/nrmicro2815; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Maia LB, 2014, CHEM REV, V114, P5273, DOI 10.1021/cr400518y; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; Mannisto MK, 2012, INT J SYST EVOL MICR, V62, P2097, DOI 10.1099/ijs.0.031864-0; McGoldrick HM, 2005, J BIOL CHEM, V280, P1086, DOI 10.1074/jbc.M411884200; Mignard S, 2008, INT J SYST EVOL MICR, V58, P1432, DOI 10.1099/ijs.0.65658-0; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Morozkina EV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1151, DOI 10.1134/S0006297907100124; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Myers MR, 2016, INT J SYST EVOL MICR, V66, P5328, DOI 10.1099/ijsem.0.001516; Narrandes N. C., 2013, THESIS; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Novoa EM, 2012, CELL, V149, P202, DOI 10.1016/j.cell.2012.01.050; OGAWA KI, 1995, J BACTERIOL, V177, P1409, DOI 10.1128/jb.177.5.1409-1413.1995; Olteanu H, 2003, J BIOL CHEM, V278, P38310, DOI 10.1074/jbc.M306282200; Parte AC, 2018, INT J SYST EVOL MICR, V68, P1825, DOI 10.1099/ijsem.0.002786; PIERIK AJ, 1992, EUR J BIOCHEM, V206, P697, DOI 10.1111/j.1432-1033.1992.tb16976.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; Sahraoui N, 2011, INT J SYST EVOL MICR, V61, P1870, DOI 10.1099/ijs.0.024851-0; Schulz S, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00057; Shao ZH, 2011, ARCH MICROBIOL, V193, P463, DOI 10.1007/s00203-011-0690-0; Simtchouk S, 2013, FEBS J, V280, P6627, DOI 10.1111/febs.12567; Srivastava AP, 2017, BIOCHEMISTRY-US, V56, P5582, DOI 10.1021/acs.biochem.7b00025; Srivastava AP, 2013, BIOCHEMISTRY-US, V52, P4343, DOI 10.1021/bi400354n; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stermann M, 2004, J BACTERIOL, V186, P2856, DOI 10.1128/JB.186.9.2856-2861.2004; Suy F, 2013, J CLIN MICROBIOL, V51, P3154, DOI 10.1128/JCM.00925-13; Tortoli E, 2012, INFECT GENET EVOL, V12, P827, DOI 10.1016/j.meegid.2011.05.025; Urlacher VB, 2019, TRENDS BIOTECHNOL, V37, P882, DOI 10.1016/j.tibtech.2019.01.001; Varghese B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005288; Wang J, 2015, BIOCHEM BIOPH RES CO, V458, P605, DOI 10.1016/j.bbrc.2015.02.010; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; Weber I, 2000, MOL MICROBIOL, V35, P1017, DOI 10.1046/j.1365-2958.2000.01794.x; Willistein M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10078-3; Zhi XY, 2014, GENOME BIOL EVOL, V6, P149, DOI 10.1093/gbe/evu007	75	9	9	4	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5051	5066		10.1074/jbc.RA120.012859	http://dx.doi.org/10.1074/jbc.RA120.012859			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32111737	Green Published, hybrid			2022-12-28	WOS:000526887000026
J	Chen, JH				Chen, Jeng-Haur			Protein kinase A phosphorylation potentiates cystic fibrosis transmembrane conductance regulator gating by relieving autoinhibition on the stimulatory C terminus of the regulatory domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); chloride channel; channel activation; phosphorylation	NUCLEOTIDE-BINDING DOMAIN; CFTR CHLORIDE CHANNEL; R-DOMAIN; CONFORMATIONAL-CHANGES; ACTIVATION; SITES; IDENTIFICATION; REGION; STATE	Cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel activated by protein kinase A (PKA) phosphorylation on the regulatory (R) domain. Phosphorylation at several R domain residues stimulates ATP-dependent channel openings and closings, termed channel gating. To explore the protein segment responsible for channel potentiation and PKA-dependent activation, deletion mutations were constructed by removing one to three protein segments of the R domain including residues 708?759 (?R-708?759), R-760?783, and R-784?835, each of which contains one or two PKA phosphorylation sites. Deletion of R-708?759 or R-760?783 had little effect on CFTR gating, whereas all mutations lacking R-784?835 reduced CFTR activity by decreasing the mean burst duration and increasing the interburst interval (IBI). The data suggest that R-784?835 plays a major role in stimulating CFTR gating. For ATP-associated regulation, ?R-784?835 had minor impact on gating potentiation by 2?dATP, CaATP, and pyrophosphate. Interestingly, introducing a phosphorylated peptide matching R-809?835 shortened the IBI of ?R-708?835-CFTR. Consistently, ?R-815?835, but not ?R-784?814, enhanced IBI, whereas both reduced mean burst duration. These data suggest that the entirety of R-784?835 is required for stabilizing the open state of CFTR; however, R-815?835, through interactions with the channel, is dominant for enhancing the opening rate. Of note, PKA markedly decreased the IBI of ?R-708?783-CFTR. Conversely, the IBI of ?R-708?814?CFTR was short and PKA-independent. These data reveal that for stimulating CFTR gating, PKA phosphorylation may relieve R-784?814?mediated autoinhibition that prevents IBI shortening by R-815?835. This mechanism may elucidate how the R domain potentiates channel gating and may unveil CFTR stimulation by other protein kinases.	[Chen, Jeng-Haur] Zhejiang Normal Univ, Coll Chem & Life Sci, 688 Yingbin Rd, Jinhua 321004, Zhejiang, Peoples R China; [Chen, Jeng-Haur] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen 518057, Peoples R China; [Chen, Jeng-Haur] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Chen, Jeng-Haur] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Chen, Jeng-Haur] Univ Iowa, Howard Hughes Med Inst, Prof Michael J Welshs Lab, Iowa City, IA 52242 USA	Zhejiang Normal University; University of Hong Kong; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Chen, JH (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, 688 Yingbin Rd, Jinhua 321004, Zhejiang, Peoples R China.	jeng-haur-chen@zjnu.edu.cn	Chen, Jeng-Haur/E-1483-2011	Chen, Jeng-Haur/0000-0001-6756-6939	Hong Kong Research Grant Council [ECS HKU789713M, GRF 17106315]; National Natural Science Foundation of China [31370765, 81570001]	Hong Kong Research Grant Council(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Hong Kong Research Grant Council Grants ECS HKU789713M and GRF 17106315 and National Natural Science Foundation of China Grants 31370765 and 81570001. The author declares that he has no conflicts of interest with the contents of this article.	Aleksandrov AA, 2002, FEBS LETT, V518, P183, DOI 10.1016/S0014-5793(02)02698-4; Auerbach A, 2013, J MOL BIOL, V425, P1461, DOI 10.1016/j.jmb.2013.01.027; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Baldursson O, 2001, J BIOL CHEM, V276, P1904, DOI 10.1074/jbc.M006934200; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Billet A, 2015, FASEB J, V29, P3945, DOI 10.1096/fj.15-273151; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Burgers PP, 2016, FEBS J, V283, P2132, DOI 10.1111/febs.13726; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chappe V, 2004, P NATL ACAD SCI USA, V101, P390, DOI 10.1073/pnas.0303411101; Chen JH, 2017, J PHYSIOL-LONDON, V595, P1059, DOI 10.1113/JP273205; Chen JH, 2009, J BIOL CHEM, V284, P35495, DOI 10.1074/jbc.M109.072678; Cotten JF, 1997, J BIOL CHEM, V272, P25617, DOI 10.1074/jbc.272.41.25617; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Csanady L, 2019, PHYSIOL REV, V99, P707, DOI 10.1152/physrev.00007.2018; FRENCH PJ, 1995, J BIOL CHEM, V270, P26626, DOI 10.1074/jbc.270.44.26626; Grimard V, 2004, J BIOL CHEM, V279, P5528, DOI 10.1074/jbc.M311014200; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; Hwang TC, 2018, J GEN PHYSIOL, V150, P539, DOI 10.1085/jgp.201711946; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; Jih KY, 2012, J GEN PHYSIOL, V139, P359, DOI 10.1085/jgp.201210789; Kitchen J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-19; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Ostedgaard LS, 2001, J BIOL CHEM, V276, P7689, DOI 10.1074/jbc.R100001200; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; RICH DP, 1993, J BIOL CHEM, V268, P20259; RIORDAN JR, 1989, SCIENCE, V245, P1066; Scott-Ward TS, 2007, P NATL ACAD SCI USA, V104, P16365, DOI 10.1073/pnas.0701562104; SEIBERT FS, 1995, J BIOL CHEM, V270, P2158, DOI 10.1074/jbc.270.5.2158; Vais H, 2004, AM J PHYSIOL-CELL PH, V287, pC737, DOI 10.1152/ajpcell.00504.2003; VENGLARIK CJ, 1994, J GEN PHYSIOL, V104, P123, DOI 10.1085/jgp.104.1.123; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang GY, 2010, J BIOL CHEM, V285, P40438, DOI 10.1074/jbc.M110.161497; Wang GY, 2011, J BIOL CHEM, V286, P2171, DOI 10.1074/jbc.M110.145540; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Xie JX, 2002, J BIOL CHEM, V277, P23019, DOI 10.1074/jbc.M201661200; Zhang Z, 2018, P NATL ACAD SCI USA, V115, P12757, DOI 10.1073/pnas.1815287115; Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041	47	2	2	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4577	4590		10.1074/jbc.RA119.008427	http://dx.doi.org/10.1074/jbc.RA119.008427			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32102849	Green Published, hybrid			2022-12-28	WOS:000524499700018
J	Blaise, M; Kremer, L				Blaise, Mickael; Kremer, Laurent			Self-control of vitamin K-2 production captured in the crystal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							TUBERCULOSIS; MENAQUINONE	Menaquinone (MK) or vitamin K-2 is an important metabolite that controls the redox/energy status of Mycobacterium tuberculosis. Although the major steps of MK biosynthesis have been delineated, the regulatory mechanisms of this pathway have not been adequately explored. Bashiri et al. now demonstrate that MenD, catalyzing the first committed step of MK production, is allosterically inhibited by a downstream cytosolic metabolite in the MK biosynthesis pathway.	[Blaise, Mickael; Kremer, Laurent] Univ Montpellier, IRIM, CNRS, UMR 9004, F-34293 Montpellier, France; [Kremer, Laurent] INSERM, IRIM, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Kremer, L (corresponding author), Univ Montpellier, IRIM, CNRS, UMR 9004, F-34293 Montpellier, France.; Kremer, L (corresponding author), INSERM, IRIM, F-34293 Montpellier, France.	laurent.kremer@irim.cnrs.fr	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Blaise, Mickael/0000-0002-7860-3464				Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Bashiri G, 2020, J BIOL CHEM, V295, P3759, DOI 10.1074/jbc.RA119.012158; Berube BJ, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.02661-18, 10.1128/aac.02661-18]; Dheda K, 2017, LANCET RESP MED, V5, P269, DOI [10.1016/s2213-2600(16)30433-7, 10.1016/S2213-2600(16)30433-7]; Dhiman RK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214958; Dhiman RK, 2009, MOL MICROBIOL, V72, P85, DOI 10.1111/j.1365-2958.2009.06625.x; Jirgis ENM, 2016, STRUCTURE, V24, P1167, DOI 10.1016/j.str.2016.04.018; Kurosu M, 2009, MED CHEM, V5, P197, DOI 10.2174/157340609787582882; Sukheja P, 2017, MBIO, V8, DOI 10.1128/mBio.02022-16; Upadhyay A, 2015, ACS CENTRAL SCI, V1, P292, DOI 10.1021/acscentsci.5b00212	10	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3771	3772		10.1074/jbc.H120.013113	http://dx.doi.org/10.1074/jbc.H120.013113			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32198187	Green Published, hybrid			2022-12-28	WOS:000527704400004
J	Agarwal, S; Tiwari, SK; Seth, B; Yadav, A; Singh, A; Mudawal, A; Chauhan, LKS; Gupta, SK; Choubey, V; Tripathi, A; Kumar, A; Ray, RS; Shukla, S; Parmar, D; Chaturvedi, RK				Agarwal, Swati; Tiwari, Shashi Kant; Seth, Brashket; Yadav, Anuradha; Singh, Anshuman; Mudawal, Anubha; Chauhan, Lalit Kumar Singh; Gupta, Shailendra Kumar; Choubey, Vinay; Tripathi, Anurag; Kumar, Amit; Ray, Ratan Singh; Shukla, Shubha; Parmar, Devendra; Chaturvedi, Rajnish Kumar			RETRACTION: Withdrawal: Activation of autophagic flux against xenoestrogen bisphenol-A-Induced hippocampal neurodegeneration via AMP kinase (AMPK)/mammalian target of rapamycin (mTOR) pathways (Retraction of Vol 290, Pg 21163, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction														Gupta, Shailendra/0000-0002-3470-3260				Agarwal S, 2015, J BIOL CHEM, V290, P21163, DOI 10.1074/jbc.M115.648998	1	1	1	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2889	2889		10.1074/jbc.W120.012895	http://dx.doi.org/10.1074/jbc.W120.012895			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	32111724	hybrid, Green Published			2022-12-28	WOS:000519969100032
J	Han, ZY; Ruthel, G; Dash, S; Berry, CT; Freedman, BD; Harty, RN; Shtanko, O				Han, Ziying; Ruthel, Gordon; Dash, Shantoshini; Berry, Corbett T.; Freedman, Bruce D.; Harty, Ronald N.; Shtanko, Olena			Angiomotin regulates budding and spread of Ebola virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ebola virus; angiomotin (Amot); filovirus; budding; virus-like particle (VLP); PPxY motif; L-domain; Hippo pathway; WW-domain protein; Yes-associated protein (YAP); virology; virus; actin; angiomotin; budding; filovirus; virus-like particle (VLP)	CELL-PROLIFERATION; FAMILY-MEMBERS; HOST PROTEINS; VP40 PROTEIN; INTERACTS; DOMAINS; TSG101	The Ebola virus (EBOV) VP40 matrix protein (eVP40) orchestrates assembly and budding of virions in part by hijacking select WW-domain?bearing host proteins via its PPxY late (L)-domain motif. Angiomotin (Amot) is a multifunctional PPxY-containing adaptor protein that regulates angiogenesis, actin dynamics, and cell migration/motility. Amot also regulates the Hippo signaling pathway via interactions with the WW-domain?containing Hippo effector protein Yes-associated protein (YAP). In this report, we demonstrate that endogenous Amot is crucial for positively regulating egress of eVP40 virus-like particles (VLPs) and for egress and spread of authentic EBOV. Mechanistically, we show that ectopic YAP expression inhibits eVP40 VLP egress and that Amot co-expression rescues budding of eVP40 VLPs in a dose-dependent and PPxY-dependent manner. Moreover, results obtained with confocal and total internal reflection fluorescence microscopy suggested that Amot's role in actin organization and dynamics also contributes to promoting eVP40-mediated egress. In summary, these findings reveal a functional and competitive interplay between virus and host proteins involving the multifunctional PPxY-containing adaptor Amot, which regulates both the Hippo pathway and actin dynamics. We propose that our results have wide-ranging implications for understanding the biology and pathology of EBOV infections.	[Han, Ziying; Ruthel, Gordon; Dash, Shantoshini; Berry, Corbett T.; Freedman, Bruce D.; Harty, Ronald N.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA USA; [Shtanko, Olena] Texas Biomed Res Inst, Host Pathogen Interact, San Antonio, TX 78227 USA	University of Pennsylvania; Texas Biomedical Research Institute	Harty, RN (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA USA.; Shtanko, O (corresponding author), Texas Biomed Res Inst, Host Pathogen Interact, San Antonio, TX 78227 USA.	rharty@vet.upenn.edu; oshtanko@txbiomed.org	Ruthel, Gordon/GYU-9133-2022	Ruthel, Gordon/0000-0001-9193-5589; Shtanko, Olena/0000-0002-9848-8870	University Research Foundation Award (Penn); National Institutes of Health [AI138052, AI139392]; Texas Biomedical Research Institute	University Research Foundation Award (Penn); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Biomedical Research Institute	Funding was provided in part by a University Research Foundation Award (Penn) and National Institutes of Health Grants AI138052 and AI139392 (to R. N. H.). Biosafety level-4 live virus studies were supported by the Texas Biomedical Research Institute (to O. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Chan SW, 2013, J BIOL CHEM, V288, P37296, DOI 10.1074/jbc.M113.527598; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Han ZY, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008231; Hartlieb B, 2006, VIROLOGY, V344, P64, DOI 10.1016/j.virol.2005.09.018; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Hong WJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004573; Jasenosky LD, 2004, VIRUS RES, V106, P181, DOI 10.1016/j.virusres.2004.08.014; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Liu YJ, 2011, IEEE SYS MAN CYBERN, P2011, DOI 10.1109/ICSMC.2011.6083967; Lv M, 2017, INT J BIOL SCI, V13, P772, DOI 10.7150/ijbs.19603; Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701; Mercenne G, 2015, ELIFE, V4, DOI 10.7554/eLife.03778; Moleirinho S, 2017, ELIFE, V6, DOI 10.7554/eLife.23966; Moleirinho S, 2014, FEBS LETT, V588, P2693, DOI 10.1016/j.febslet.2014.02.006; Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099; Pei ZF, 2010, VIROLOGY, V397, P155, DOI 10.1016/j.virol.2009.11.002; Proszynski TJ, 2013, J CELL SCI, V126, P2225, DOI 10.1242/jcs.121327; Ray G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020128; Shtanko O, 2018, ANTIVIR RES, V149, P154, DOI 10.1016/j.antiviral.2017.11.016; Spadaro D, 2012, ESSAYS BIOCHEM, V53, P83, DOI [10.1042/BSE0530083, 10.1042/bse0530083]; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; van den Dries K, 2019, J CELL SCI, V132, DOI 10.1242/jcs.236828; Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003; Zeng XK, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.113; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	27	7	7	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8596	8601		10.1074/jbc.AC120.013171	http://dx.doi.org/10.1074/jbc.AC120.013171			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32381509	hybrid, Green Published			2022-12-28	WOS:000546986500023
J	Rahman, SMT; Zhou, WY; Deiters, A; Haugh, JM				Rahman, Shah Md. Toufiqur; Zhou, Wenyuan; Deiters, Alexander; Haugh, Jason M.			Optical control of MAP kinase kinase 6 (MKK6) reveals that it has divergent roles in pro-apoptotic and anti-proliferative signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						optogenetics; signal transduction; cell signaling; mitogen-activated protein kinases; apoptosis; cell death; cell stress; mitogen-activated protein kinase (MAPK)	ACTIVATED PROTEIN-KINASE; CYTOCHROME-C RELEASE; P38 MAPK; CELL-DEATH; CROSS-TALK; SPATIOTEMPORAL CONTROL; CASPASE-8 ACTIVATION; GENOTOXIC STRESS; GENE-FUNCTION; PATHWAYS	The selective pressure imposed by extrinsic death signals and stressors adds to the challenge of isolating and interpreting the roles of proteins in stress-activated signaling networks. By expressing a kinase with activating mutations and a caged lysine blocking the active site, we can rapidly switch on catalytic activity with light and monitor the ensuing dynamics. Applying this approach to MAP kinase 6 (MKK6), which activates the p38 subfamily of MAPKs, we found that decaging active MKK6 in fibroblasts is sufficient to trigger apoptosis in a p38-dependent manner. Both in fibroblasts and in a murine melanoma cell line expressing mutant B-Raf, MKK6 activation rapidly and potently inhibited the pro-proliferative extracellular signal?regulated kinase (ERK) pathway; to our surprise, this negative cross-regulation was equally robust when all p38 isoforms were inhibited. These results position MKK6 as a new pleiotropic signal transducer that promotes both pro-apoptotic and anti-proliferative signaling, and they highlight the utility of caged, light-activated kinases for dissecting stress-activated signaling networks.	[Rahman, Shah Md. Toufiqur; Haugh, Jason M.] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Zhou, Wenyuan; Deiters, Alexander] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Haugh, JM (corresponding author), North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.	jason_haugh@ncsu.edu	Deiters, Alexander/L-3722-2013; Rahman, Shah Md Toufiqur/AAP-8793-2020	Deiters, Alexander/0000-0003-0234-9209; Haugh, Jason/0000-0002-2476-4027; Rahman, Shah Md. Toufiqur/0000-0001-5419-0696	National Science Foundation [MCB-1330746, CBET-1603930]; UNC Lineberger Developmental Grant from the University Cancer Research Fund	National Science Foundation(National Science Foundation (NSF)); UNC Lineberger Developmental Grant from the University Cancer Research Fund	This work was supported by National Science Foundation Grants MCB-1330746 (to A. D. and J. M. H.) and CBET-1603930 (to A. D.) and a UNC Lineberger Developmental Grant from the University Cancer Research Fund.	Ahmed S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134708; Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Ankenbruck N, 2018, ANGEW CHEM INT EDIT, V57, P2768, DOI 10.1002/anie.201700171; Asokan SB, 2014, DEV CELL, V31, P747, DOI 10.1016/j.devcel.2014.10.024; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Belevich I, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002340; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Caunt CJ, 2013, FEBS J, V280, P489, DOI 10.1111/j.1742-4658.2012.08716.x; Chalfoun J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36984; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen Q, 2000, CELL DEATH DIFFER, V7, P227, DOI 10.1038/sj.cdd.4400629; Chou CJ, 2010, CHEMBIOCHEM, V11, P972, DOI 10.1002/cbic.201000041; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; COURTNEY T, 2019, NAT COMMUN, V10, P1, DOI DOI 10.1038/s41467-018-07882-8; Courtney T, 2018, CURR OPIN CHEM BIOL, V46, P99, DOI 10.1016/j.cbpa.2018.07.011; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Diaz-Martinez LA, 2014, EMBO J, V33, P1960, DOI 10.15252/embj.201487826; Edwards WF, 2009, ACS CHEM BIOL, V4, P441, DOI 10.1021/cb900041s; Engelke H, 2014, ACS SYNTH BIOL, V3, P731, DOI 10.1021/sb400192a; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Farley N, 2006, MOL CELL BIOL, V26, P2118, DOI 10.1128/MCB.26.6.2118-2129.2006; Finch AR, 2012, CELL SIGNAL, V24, P1002, DOI 10.1016/j.cellsig.2011.12.021; Gautier A, 2011, J AM CHEM SOC, V133, P2124, DOI 10.1021/ja1109979; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Gomez-Lazaro M, 2007, MOL PHARMACOL, V71, P736, DOI 10.1124/mol.106.030718; Graves LM, 2013, BIOCHEM J, V450, P1, DOI 10.1042/BJ20121456; Grethe S, 2006, CELL SIGNAL, V18, P531, DOI 10.1016/j.cellsig.2005.05.023; Gstaiger M, 2009, NAT REV GENET, V10, P617, DOI 10.1038/nrg2633; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hanna SC, 2013, J CLIN INVEST, V123, P2078, DOI 10.1172/JCI66715; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Hoppe J, 2002, EUR J CELL BIOL, V81, P567, DOI 10.1078/0171-9335-00276; Horgan AM, 2003, EXP CELL RES, V285, P208, DOI 10.1016/S0014-4827(03)00037-5; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Joo SS, 2009, J PINEAL RES, V47, P8, DOI 10.1111/j.1600-079X.2009.00682.x; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Lee J, 2002, BIOCHEM BIOPH RES CO, V298, P765, DOI 10.1016/S0006-291X(02)02562-7; Lee S, 2014, NAT METHODS, V11, P633, DOI [10.1038/nmeth.2940, 10.1038/NMETH.2940]; Lee SR, 2003, STROKE, V34, P2704, DOI 10.1161/01.STR.0000096540.40826.BA; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li SP, 2020, CANCER RES, V80, P364, DOI 10.1158/0008-5472.CAN-19-3320; Liaunardy-Jopeace A, 2017, NAT STRUCT MOL BIOL, V24, P1155, DOI 10.1038/nsmb.3492; Liu J, 2014, ASIAN PAC J CANCER P, V15, P4519, DOI 10.7314/APJCP.2014.15.11.4519; Liu JH, 2017, J AM CHEM SOC, V139, P9100, DOI 10.1021/jacs.7b02145; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; Liu QY, 2014, ACCOUNTS CHEM RES, V47, P45, DOI 10.1021/ar400036a; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Nakagami H, 2001, DIABETES, V50, P1472, DOI 10.2337/diabetes.50.6.1472; Nicholls SB, 2011, J BIOL CHEM, V286, P24977, DOI 10.1074/jbc.M111.221648; Pathak GP, 2013, BIOL CELL, V105, P59, DOI 10.1111/boc.201200056; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Regot S, 2014, CELL, V157, P1724, DOI 10.1016/j.cell.2014.04.039; Remy G, 2010, CELL SIGNAL, V22, P660, DOI 10.1016/j.cellsig.2009.11.020; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; She QB, 2001, CANCER RES, V61, P1604; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Shi QH, 2012, P NATL ACAD SCI USA, V109, P419, DOI 10.1073/pnas.1110865109; Shimo T, 2007, J CELL COMMUN SIGNAL, V1, P103, DOI 10.1007/s12079-007-0010-2; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Tourian L, 2004, J CELL SCI, V117, P6459, DOI 10.1242/jcs.01573; Umeda N, 2011, J AM CHEM SOC, V133, P12, DOI 10.1021/ja108258d; Underwood DC, 2000, J PHARMACOL EXP THER, V293, P281; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Yoon CH, 2009, MOL CANCER RES, V7, P361, DOI 10.1158/1541-7786.MCR-08-0069; Zhang H, 2001, J BIOL CHEM, V276, P6905, DOI 10.1074/jbc.C000917200; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	88	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8494	8504		10.1074/jbc.RA119.012079	http://dx.doi.org/10.1074/jbc.RA119.012079			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32371393	hybrid, Green Published			2022-12-28	WOS:000546986500014
J	Wu, H; Zhou, J; Zhu, TH; Cohen, I; Dictenberg, J				Wu, Hao; Zhou, Jing; Zhu, Tianhui; Cohen, Ivan; Dictenberg, Jason			A kinesin adapter directly mediates dendritic mRNA localization during neural development in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neuron; kinesin; brain-derived neurotrophic factor (BDNF); synapse; RNA interference (RNAi); BDNF; kinesin; mRNA localization; PAT1; ZBP1	MYELIN BASIC-PROTEIN; BETA-ACTIN SYNTHESIS; TUG-OF-WAR; BINDING-PROTEIN; LIGHT-CHAIN; HEAVY-CHAIN; IN-VIVO; RIBONUCLEOPROTEIN-PARTICLES; BIDIRECTIONAL TRANSPORT; SYNAPTIC PLASTICITY	Motor protein-based active transport is essential for mRNA localization and local translation in animal cells, yet how mRNA granules interact with motor proteins remains poorly understood. Using an unbiased yeast two?hybrid screen for interactions between murine RNA-binding proteins (RBPs) and motor proteins, here we identified protein interaction with APP tail-1 (PAT1) as a potential direct adapter between zipcode-binding protein 1 (ZBP1, a ?-actin RBP) and the kinesin-I motor complex. The amino acid sequence of mouse PAT1 is similar to that of the kinesin light chain (KLC), and we found that PAT1 binds to KLC directly. Studying PAT1 in mouse primary hippocampal neuronal cultures from both sexes and using structured illumination microscopic imaging of these neurons, we observed that brain-derived neurotrophic factor (BDNF) enhances co-localization of dendritic ZBP1 and PAT1 within granules that also contain kinesin-I. PAT1 is essential for BDNF-stimulated neuronal growth cone development and dendritic protrusion formation, and we noted that ZBP1 and PAT1 co-locate along with ?-actin mRNA in actively transported granules in living neurons. Acute disruption of the PAT1?ZBP1 interaction in neurons with PAT1 siRNA or a dominant-negative ZBP1 construct diminished localization of ?-actin mRNA but not of Ca2+/calmodulin-dependent protein kinase II? (CaMKII?) mRNA in dendrites. The aberrant ?-actin mRNA localization resulted in abnormal dendritic protrusions and growth cone dynamics. These results suggest a critical role for PAT1 in BDNF-induced ?-actin mRNA transport during postnatal development and reveal a new molecular mechanism for mRNA localization in vertebrates.	[Wu, Hao; Zhu, Tianhui; Cohen, Ivan] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Zhou, Jing] CUNY, Lehman Coll, Biol Dept, Bronx, NY 10468 USA; [Wu, Hao; Zhou, Jing; Zhu, Tianhui] CUNY, Grad Sch, Biol Program, New York, NY 10016 USA; [Wu, Hao; Zhou, Jing; Zhu, Tianhui] CUNY, Univ Ctr, New York, NY 10016 USA; [Dictenberg, Jason] SUNY Downstate, Cell Biol, Brooklyn, NY 11226 USA; [Dictenberg, Jason] AccelBio, Biotechnol Incubator, Brooklyn, NY 11226 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Wu, H (corresponding author), CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA.; Wu, H (corresponding author), CUNY, Grad Sch, Biol Program, New York, NY 10016 USA.; Wu, H (corresponding author), CUNY, Univ Ctr, New York, NY 10016 USA.; Dictenberg, J (corresponding author), SUNY Downstate, Cell Biol, Brooklyn, NY 11226 USA.; Dictenberg, J (corresponding author), AccelBio, Biotechnol Incubator, Brooklyn, NY 11226 USA.	haowu@genectr.hunter.cuny.edu; jason@accelbio.com	Wu, Hao/V-1303-2019	Wu, Hao/0000-0001-5648-1024	National Institutes of Health [GM084805]; National Science Foundation (NSF) [0819022, 0960367]; Hunter College of the City University of New York; Lehman College of the City University of New York; Graduate Center of the City University of New York	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Hunter College of the City University of New York; Lehman College of the City University of New York; Graduate Center of the City University of New York	This work was supported by National Institutes of Health Grants GM084805 (to J. D.). Also supported by National Science Foundation (NSF) Grants 0819022 and 0960367 (to J. D.), and by Hunter College, Lehman College, and the Graduate Center of the City University of New York. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Figs. S1-S4, Movies S1-S3, and supporting Video S1.	Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bassell GJ, 1998, J NEUROSCI, V18, P251; Berezuk MA, 2007, TRAFFIC, V8, P124, DOI 10.1111/j.1600-0854.2006.00517.x; Bianco A, 2010, CURR BIOL, V20, P1487, DOI 10.1016/j.cub.2010.07.016; Blangy A, 1997, J BIOL CHEM, V272, P19418, DOI 10.1074/jbc.272.31.19418; Blower MD, 2013, INT REV CEL MOL BIO, V302, P1, DOI 10.1016/B978-0-12-407699-0.00001-7; BONNEAU AM, 1985, J CELL BIOL, V100, P1209, DOI 10.1083/jcb.100.4.1209; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Boylan KLM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040036; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Brechbiel JL, 2008, CURR BIOL, V18, P745, DOI 10.1016/j.cub.2008.04.033; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Bullock SL, 2011, BIOCHEM SOC T, V39, P1161, DOI 10.1042/BST0391161; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Chua JJE, 2012, P NATL ACAD SCI USA, V109, P5862, DOI 10.1073/pnas.1113819109; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Dictenberg J, 2012, TRENDS BIOTECHNOL, V30, P621, DOI 10.1016/j.tibtech.2012.09.004; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dienstbier M, 2009, GENE DEV, V23, P1546, DOI 10.1101/gad.531009; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Dynes JL, 2007, J COMP NEUROL, V500, P433, DOI 10.1002/cne.21189; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Eom T, 2003, J NEUROSCI, V23, P10433; Estes PS, 2008, MOL CELL NEUROSCI, V39, P170, DOI 10.1016/j.mcn.2008.06.012; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Gagnon JA, 2011, CRIT REV BIOCHEM MOL, V46, P229, DOI 10.3109/10409238.2011.572861; Gao YZ, 2008, MOL BIOL CELL, V19, P2311, DOI 10.1091/mbc.E07-09-0914; Goetze B, 2006, J CELL BIOL, V172, P221, DOI 10.1083/jcb.200509035; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; HESKETH J, 1994, MOL BIOL REP, V19, P233, DOI 10.1007/BF00986965; Hirokawa N, 2006, J NEUROSCI, V26, P7139, DOI 10.1523/JNEUROSCI.1821-06.2006; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Iacoangeli A, 2008, P NATL ACAD SCI USA, V105, P734, DOI 10.1073/pnas.0803737105; Jeong JH, 2007, J NEUROCHEM, V102, P2073, DOI 10.1111/j.1471-4159.2007.04697.x; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kanhema T, 2006, J NEUROCHEM, V99, P1328, DOI 10.1111/j.1471-4159.2006.04158.x; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Landers SM, 2009, EUKARYOT CELL, V8, P1072, DOI 10.1128/EC.00084-09; Liao L, 2007, J PROTEOME RES, V6, P1059, DOI 10.1021/pr060358f; Libersat F, 2004, MOL NEUROBIOL, V29, P303, DOI 10.1385/MN:29:3:303; Loiseau P, 2010, DEVELOPMENT, V137, P2763, DOI 10.1242/dev.048108; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Messitt TJ, 2008, DEV CELL, V15, P426, DOI 10.1016/j.devcel.2008.06.014; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Muller M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000611; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Sasaki Y, 2010, J NEUROSCI, V30, P9349, DOI 10.1523/JNEUROSCI.0499-10.2010; Severt WL, 1999, J CELL SCI, V112, P3691; Shan JG, 2000, J BIOL CHEM, V275, P38286, DOI 10.1074/jbc.M007642200; Shan JG, 2003, J NEUROSCI, V23, P8859; Smart FM, 2003, P NATL ACAD SCI USA, V100, P14403, DOI 10.1073/pnas.2436349100; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Swanger SA, 2011, CURR OPIN GENET DEV, V21, P414, DOI 10.1016/j.gde.2011.04.002; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Tubing F, 2010, J NEUROSCI, V30, P4160, DOI 10.1523/JNEUROSCI.3537-09.2010; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI 10.1073/pnas.0804583105; Welshhans K, 2011, J NEUROSCI, V31, P9800, DOI 10.1523/JNEUROSCI.0166-11.2011; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wu XQ, 2000, BIOL REPROD, V62, P720, DOI 10.1095/biolreprod62.3.720; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	90	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6605	6628		10.1074/jbc.RA118.005616	http://dx.doi.org/10.1074/jbc.RA118.005616			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32111743	Green Published, hybrid			2022-12-28	WOS:000537685000029
J	Shepley-McTaggart, A; Fan, H; Sudol, M; Harty, RN				Shepley-McTaggart, Ariel; Fan, Hao; Sudol, Marius; Harty, Ronald N.			Viruses go modular	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						virus; microbiology; antiviral agent; E3 ubiquitin ligase; Ebola virus; budding; L domain; PPxY motif; virus-host interaction; WW domain; virus-like particle (VLP); virus budding; modular domains; host-oriented inhibitors; antiviral therapeutic; viral life cycle	ROUS-SARCOMA-VIRUS; VESICULAR STOMATITIS-VIRUS; MEMBRANE-PROTEIN 2A; EBOLA-VIRUS; WW-DOMAIN; IMMUNODEFICIENCY-VIRUS; UBIQUITIN LIGASE; MATRIX PROTEIN; HOST PROTEINS; OCULAR COMPLICATIONS	The WW domain is a modular protein structure that recognizes the proline-rich Pro-Pro-x-Tyr (PPxY) motif contained in specific target proteins. The compact modular nature of the WW domain makes it ideal for mediating interactions between proteins in complex networks and signaling pathways of the cell (e.g. the Hippo pathway). As a result, WW domains play key roles in a plethora of both normal and disease processes. Intriguingly, RNA and DNA viruses have evolved strategies to hijack cellular WW domain?containing proteins and thereby exploit the modular functions of these host proteins for various steps of the virus life cycle, including entry, replication, and egress. In this review, we summarize key findings in this rapidly expanding field, in which new virus-host interactions continue to be identified. Further unraveling of the molecular aspects of these crucial virus-host interactions will continue to enhance our fundamental understanding of the biology and pathogenesis of these viruses. We anticipate that additional insights into these interactions will help support strategies to develop a new class of small-molecule inhibitors of viral PPxY-host WW-domain interactions that could be used as antiviral therapeutics.	[Shepley-McTaggart, Ariel; Harty, Ronald N.] Univ Penn, Sch Vet Med, Dept Pathobiol, 3800 Spruce St, Philadelphia, PA 19104 USA; [Fan, Hao] ASTAR, Bioinformat Inst, 30 Biopolis St,Matrix 07-01, Singapore 138671, Singapore; [Fan, Hao] Natl Univ Singapore, Dept Biol Sci, Singapore 119077, Singapore; [Sudol, Marius] Natl Univ Singapore, Dept Physiol, Singapore 119077, Singapore; [Fan, Hao] DUKE NUS Med Sch, Ctr Computat Biol, Singapore 169857, Singapore; [Sudol, Marius] Yong Loo Li Sch Med, Lab Canc Signaling & Domainopathies, Block MD9,2 Med Dr 04-01, Singapore 117597, Singapore; [Sudol, Marius] Mechanobiol Inst, T Lab, 5A Engn Dr 1, Singapore 117411, Singapore; [Sudol, Marius] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA	University of Pennsylvania; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; National University of Singapore; National University of Singapore; Icahn School of Medicine at Mount Sinai	Harty, RN (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, 3800 Spruce St, Philadelphia, PA 19104 USA.	rharty@vet.upenn.edu			National Institutes of Health [AI102104, AI138052, AI138630, AI139392]; University Research Foundation (URF) award; National University of Singapore [R-185-000-2710-133, R-185-000-2710-733]; Mechanobiology Institute [R-714-018-006-271]; Biomedical Research Council of A*STAR	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Research Foundation (URF) award; National University of Singapore(National University of Singapore); Mechanobiology Institute; Biomedical Research Council of A*STAR(Agency for Science Technology & Research (A*STAR))	This work was supported in part by National Institutes of Health Grants AI102104, AI138052, AI138630, and AI139392 and a University Research Foundation (URF) award (to R. N. H.), by internal grants from the National University of Singapore (R-185-000-2710-133 and -733) and the Mechanobiology Institute (R-714-018-006-271) (to M. S.), and by the Biomedical Research Council of A*STAR (to H. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aki D, 2015, IMMUNOL REV, V266, P6, DOI 10.1111/imr.12301; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Barajas D, 2015, J VIROL, V89, P2064, DOI 10.1128/JVI.02719-14; Barajas D, 2009, J VIROL, V83, P11751, DOI 10.1128/JVI.00789-09; Baseler L, 2017, ANNU REV PATHOL-MECH, V12, P387, DOI 10.1146/annurev-pathol-052016-100506; Basler CF, 2017, SEMIN IMMUNOPATHOL, V39, P551, DOI 10.1007/s00281-017-0637-x; Behl C, 2016, TRENDS PHARMACOL SCI, V37, P672, DOI 10.1016/j.tips.2016.04.007; Billioux BJ, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0573-x; Blot V, 2004, J CELL SCI, V117, P2357, DOI 10.1242/jcs.01095; Bouamr F, 2003, J VIROL, V77, P11882, DOI 10.1128/JVI.77.22.11882-11895.2003; Caswell RJ, 2017, INT J STD AIDS, V28, P1352, DOI 10.1177/0956462417703572; Cen O, 2015, CURR TOP MICROBIOL, V391, P151, DOI 10.1007/978-3-319-22834-1_5; Chang NS, 2002, INT J MOL MED, V9, P19; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen Szu-Jung, 2013, Transl Respir Med, V1, P15, DOI 10.1186/2213-0802-1-15; Chen YA, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00060; Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095; Chughtai AA, 2016, EPIDEMIOL INFECT, V144, P1652, DOI 10.1017/S0950268816000054; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; Craven RC, 1999, J VIROL, V73, P3359, DOI 10.1128/JVI.73.4.3359-3365.1999; Crozier I, 2016, J INFECT DIS, V214, P1467, DOI 10.1093/infdis/jiw079; Dolnik O, 2010, J VIROL, V84, P7847, DOI 10.1128/JVI.00476-10; Dorjbal B, 2011, J BIOL CHEM, V286, P31092, DOI 10.1074/jbc.M111.259945; Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; Fuchs M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005582; Galinier R, 2002, BIOCHEMISTRY-US, V41, P14299, DOI 10.1021/bi020125b; Gamier L, 1996, NATURE, V381, P744, DOI 10.1038/381744a0; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Han ZY, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-92; Han ZY, 2017, J VIROL, V91, DOI 10.1128/JVI.00812-17; Han ZY, 2016, J VIROL, V90, P9163, DOI 10.1128/JVI.01078-16; Han ZY, 2014, J VIROL, V88, P7294, DOI 10.1128/JVI.00591-14; Hartlieb B, 2006, VIROLOGY, V344, P64, DOI 10.1016/j.virol.2005.09.018; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 1999, J VIROL, V73, P2921, DOI 10.1128/JVI.73.4.2921-2929.1999; Harty RN, 2001, J VIROL, V75, P10623, DOI 10.1128/JVI.75.22.10623-10629.2001; Harty RN, 2018, METHODS MOL BIOL, V1604, P209, DOI 10.1007/978-1-4939-6981-4_15; Harty RN, 2009, J INNATE IMMUN, V1, P397, DOI 10.1159/000226245; Heidecker G, 2004, J VIROL, V78, P6636, DOI 10.1128/JVI.78.12.6636-6648.2004; Heidecker G, 2007, J VIROL, V81, P9769, DOI 10.1128/JVI.00642-07; Hereth-Hebert E, 2017, AM J OPHTHALMOL, V175, P114, DOI 10.1016/j.ajo.2016.12.005; Hergovich A, 2012, BIOCHEM SOC T, V40, P124, DOI 10.1042/BST20110619; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Hurley JH, 2015, EMBO J, V34, P2398, DOI 10.15252/embj.201592484; Ikeda M, 2000, VIROLOGY, V268, P178, DOI 10.1006/viro.1999.0166; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Irie T, 2005, VIROLOGY, V336, P291, DOI 10.1016/j.virol.2005.03.027; Irie T, 2004, J VIROL, V78, P2657, DOI 10.1128/JVI.78.6.2657-2665.2004; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5; Jamous A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00580; Jampol LM, 2015, JAMA OPHTHALMOL, V133, P1105, DOI 10.1001/jamaophthalmol.2015.2400; Jasenosky LD, 2004, VIRUS RES, V106, P181, DOI 10.1016/j.virusres.2004.08.014; Jayakar HR, 2000, J VIROL, V74, P9818, DOI 10.1128/JVI.74.21.9818-9827.2000; Jayakar HR, 2004, VIRUS RES, V106, P117, DOI 10.1016/j.virusres.2004.08.009; Jouvenet N, 2012, CELL MOL LIFE SCI, V69, P4121, DOI 10.1007/s00018-012-1035-0; Kathage B, 2017, BBA-MOL CELL RES, V1864, P62, DOI 10.1016/j.bbamcr.2016.10.007; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Koganti P, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00295; Kuang ZZ, 2011, J VIROL, V85, P7153, DOI 10.1128/JVI.02610-10; Lan YY, 2013, BIOCHEM BIOPH RES CO, V436, P672, DOI 10.1016/j.bbrc.2013.06.014; Lata S, 2009, BIOCHEM SOC T, V37, P156, DOI 10.1042/BST0370156; Liang JJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006132; Licata JM, 2003, J VIROL, V77, P1812, DOI 10.1128/JVI.77.3.1812-1819.2003; Longnecker R, 2000, EXP CELL RES, V257, P332, DOI 10.1006/excr.2000.4900; Loughran HM, 2016, BIOORG MED CHEM LETT, V26, P3429, DOI 10.1016/j.bmcl.2016.06.053; Lu JH, 2013, J VIROL, V87, P7777, DOI 10.1128/JVI.00470-13; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2004, J VIROL, V78, P5554, DOI 10.1128/JVI.78.11.5554-5563.2004; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308; McLoughlin DM, 2008, J NEUROSCI RES, V86, P744, DOI 10.1002/jnr.21532; Medina G, 2005, TRAFFIC, V6, P880, DOI 10.1111/j.1600-0854.2005.00323.x; Mercenne G, 2015, ELIFE, V4, DOI 10.7554/eLife.03778; Montespan C, 2017, J VIROL, V91, DOI 10.1128/JVI.00581-17; Montespan C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006217; Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041; Moshirfar M, 2014, CLIN OPHTHALMOL, V8, P2355, DOI 10.2147/OPTH.S73583; Muller RU, 2020, PEDIATR NEPHROL, V35, P1143, DOI 10.1007/s00467-019-04299-3; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Noda T, 2006, PLOS PATHOG, V2, P864, DOI 10.1371/journal.ppat.0020099; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Ott DE, 2005, J VIROL, V79, P9038, DOI 10.1128/JVI.79.14.9038-9045.2005; Ott DE, 1998, J VIROL, V72, P2962, DOI 10.1128/JVI.72.4.2962-2968.1998; PARENT LJ, 1995, J VIROL, V69, P5455, DOI 10.1128/JVI.69.9.5455-5460.1995; Patnaik A, 2002, J VIROL, V76, P2789, DOI 10.1128/JVI.76.6.2789-2795.2002; Pincetic A, 2010, J VIROL, V84, P4725, DOI 10.1128/JVI.02478-09; Qin J, 2012, VIROLOGY, V426, P106, DOI 10.1016/j.virol.2012.01.020; Rasmussen AL, 2018, CURR TOP MICROBIOL, V419, P113, DOI 10.1007/82_2017_27; Rauch S, 2011, J VIROL, V85, P3546, DOI 10.1128/JVI.02045-10; Reuven N, 2015, EXP BIOL MED, V240, P375, DOI 10.1177/1535370214565991; Rogstad KE, 2015, CURR OPIN INFECT DIS, V28, P83, DOI 10.1097/QCO.0000000000000135; Rosati A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.24; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Rotin D, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S5; Sakurai A, 2004, MICROBES INFECT, V6, P150, DOI 10.1016/j.micinf.2003.10.011; Salah Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.53; Salah Z, 2012, FRONT BIOSCI-LANDMRK, V17, P331, DOI 10.2741/3930; Sang YR, 2017, BIOCHEM CELL BIOL, V95, P350, DOI 10.1139/bcb-2016-0250; Sang YR, 2017, SCI REP-UK, V7, DOI 10.1038/srep39776; Sasvari Zsuzsanna, 2014, Front Plant Sci, V5, P383, DOI 10.3389/fpls.2014.00383; Schoneberg J, 2017, NAT REV MOL CELL BIO, V18, P5, DOI 10.1038/nrm.2016.121; Scourfield EJ, 2017, BIOCHEM SOC T, V45, P613, DOI 10.1042/BST20160479; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; Seo EJ, 2012, ADV VIROL, V2012, DOI 10.1155/2012/532723; Sette P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-79; Sette P, 2010, J VIROL, V84, P8181, DOI 10.1128/JVI.00634-10; Shantha JG, 2017, CURR OPIN OPHTHALMOL, V28, P600, DOI 10.1097/ICU.0000000000000426; Shantha JG, 2016, CURR OPIN OPHTHALMOL, V27, P538, DOI 10.1097/ICU.0000000000000313; Sissoko D, 2017, CLIN INFECT DIS, V64, P513, DOI 10.1093/cid/ciw793; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Staub O, 1996, STRUCTURE, V4, P495, DOI 10.1016/S0969-2126(96)00054-8; Steptoe PJ, 2018, OPHTHALMOLOGY, V125, pE19, DOI 10.1016/j.ophtha.2017.09.009; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Sudol M, 2005, IUBMB LIFE, V57, P773, DOI 10.1080/15216540500389039; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Sudol M, 2012, SEMIN CELL DEV BIOL, V23, P827, DOI 10.1016/j.semcdb.2012.05.002; Sudol M, 2012, FEBS LETT, V586, P2571, DOI 10.1016/j.febslet.2012.06.005; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Sullivan BM, 2008, J VIROL, V82, P602, DOI 10.1128/JVI.01571-07; Sullivan BM, 2010, J VIROL, V84, P1265, DOI 10.1128/JVI.01775-09; Swedberg JE, 2018, ACS MED CHEM LETT, V9, P1258, DOI 10.1021/acsmedchemlett.8b00422; Tan BX, 2015, SCI REP-UK, V5, DOI 10.1038/srep12116; Tanna M, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00420; Tejada-Simon MV, 2003, ANN NEUROL, V53, P189, DOI 10.1002/ana.10425; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; Ulbricht A, 2015, AUTOPHAGY, V11, P538, DOI 10.1080/15548627.2015.1017186; Ulbricht Anna, 2013, Commun Integr Biol, V6, pe24925, DOI 10.4161/cib.24925; Ulbricht A, 2013, AUTOPHAGY, V9, P920, DOI 10.4161/auto.24213; Ulbricht A, 2013, CURR BIOL, V23, P430, DOI 10.1016/j.cub.2013.01.064; Urata S, 2007, J VIROL, V81, P4895, DOI 10.1128/JVI.02829-06; Urata S, 2011, ADV VIROL, V2011, DOI 10.1155/2011/180326; Urata S, 2010, J GEN VIROL, V91, P228, DOI 10.1099/vir.0.015495-0; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; Uyeki TM, 2016, CLIN INFECT DIS, V62, P1552, DOI 10.1093/cid/ciw202; Vana ML, 2004, J VIROL, V78, P13943, DOI 10.1128/JVI.78.24.13943-13953.2004; Varlet AA, 2017, CELL STRESS CHAPERON, V22, P553, DOI 10.1007/s12192-017-0780-2; Venuprasad K, 2015, IMMUNOL CELL BIOL, V93, P452, DOI 10.1038/icb.2014.118; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; Villarroya-Beltri C, 2017, J CELL SCI, V130, P2961, DOI 10.1242/jcs.205468; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Weiss ER, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001107; WILLS JW, 1994, J VIROL, V68, P6605, DOI 10.1128/JVI.68.10.6605-6618.1994; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Wirblich C, 2008, J VIROL, V82, P9730, DOI 10.1128/JVI.00889-08; Wodrich H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000808; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003; Yasuda J, 2002, EMBO REP, V3, P636, DOI 10.1093/embo-reports/kvf132; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; Zhadina M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001153; Zhang HT, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-28; Zhi X, 2012, CELL MOL LIFE SCI, V69, P1425, DOI 10.1007/s00018-011-0871-7	168	11	11	3	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4604	4616		10.1074/jbc.REV119.012414	http://dx.doi.org/10.1074/jbc.REV119.012414			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32111739	hybrid, Green Published			2022-12-28	WOS:000524499700020
J	Sarkar, S; Leaman, DW; Gupta, S; Sil, P; Young, D; Morehead, A; Mukherjee, D; Ratliff, N; Sun, YP; Rayborn, M; Hollyfield, J; Sen, S				Sarkar, Sagartirtha; Leaman, Douglas W.; Gupta, Sudhiranjan; Sil, Parames; Young, David; Morehead, Annitta; Mukherjee, Debabrata; Ratliff, Norman; Sun, Yaping; Rayborn, Mary; Hollyfield, Joe; Sen, Subha			Cardiac overexpression of myotrophin triggers myocardial hypertrophy and heart failure in transgenic mice. (Expression of Concern of Vol 279, Pg 20422, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern													Sil, Parames C./AAJ-9795-2020; Mukherjee, Debabrata/AAG-1486-2019	Mukherjee, Debabrata/0000-0002-5131-3694				Sarkar S, 2004, J BIOL CHEM, V279, P20422, DOI 10.1074/jbc.M308488200	1	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3385	3385		10.1074/jbc.EC120.012926	http://dx.doi.org/10.1074/jbc.EC120.012926			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32144148	Green Published, hybrid			2022-12-28	WOS:000519597300039
J	Sarkar, S; Chawla-Sarkar, M; Young, D; Nishiyama, K; Rayborn, ME; Hollyfield, JG; Sen, S				Sarkar, Sagartirtha; Chawla-Sarkar, Mamta; Young, David; Nishiyama, Kazutoshi; Rayborn, Mary E.; Hollyfield, Joe G.; Sen, Subha			Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure. (Expression of Concern of Vol 279, Pg 52630, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Expression of Concern																		Sarkar S, 2004, J BIOL CHEM, V279, P52630, DOI 10.1074/jbc.M402037200	1	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3386	3386		10.1074/jbc.EC120.012927	http://dx.doi.org/10.1074/jbc.EC120.012927			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32144149	hybrid, Green Published			2022-12-28	WOS:000519597300040
J	Artz, JH; Tokmina-Lukaszewska, M; Mulder, DW; Lubner, CE; Gutekunst, K; Appel, J; Bothner, B; Boehm, M; King, PW				Artz, Jacob H.; Tokmina-Lukaszewska, Monika; Mulder, David W.; Lubner, Carolyn E.; Gutekunst, Kirstin; Appel, Jens; Bothner, Brian; Boehm, Marko; King, Paul W.			The structure and reactivity of the HoxEFU complex from the cyanobacterium Synechocystis sp. PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Synechocystis; HoxEFU; diaphorase; photosynthesis; kinetics; protein cross-linking; electron paramagnetic resonance (EPR); bidirectional hydrogenase; protein-protein interaction; nickel-iron enzyme; cooperativity; hydrogenase; nickel	BIDIRECTIONAL HYDROGENASE; NEGATIVE COOPERATIVITY; KINETIC COOPERATIVITY; CATALYTIC-PROPERTIES; NADPH FLUORESCENCE; NIFE-HYDROGENASE; WILD-TYPE; PROTEIN; FERREDOXIN; BINDING	Cyanobacterial Hox is a [NiFe] hydrogenase that consists of the hydrogen (H-2)-activating subunits HoxYH, which form a complex with the HoxEFU assembly to mediate reactions with soluble electron carriers like NAD(P)H and ferredoxin (Fdx), thereby coupling photosynthetic electron transfer to energy-transforming catalytic reactions. Researchers studying the HoxEFUYH complex have observed that HoxEFU can be isolated independently of HoxYH, leading to the hypothesis that HoxEFU is a distinct functional subcomplex rather than an artifact of Hox complex isolation. Moreover, outstanding questions about the reactivity of Hox with natural substrates and the site(s) of substrate interactions and coupling of H-2, NAD(P)H, and Fdx remain to be resolved. To address these questions, here we analyzed recombinantly produced HoxEFU by electron paramagnetic resonance spectroscopy and kinetic assays with natural substrates. The purified HoxEFU subcomplex catalyzed electron transfer reactions among NAD(P)H, flavodoxin, and several ferredoxins, thus functioningin vitroas a shuttle among different cyanobacterial pools of reducing equivalents. Both Fdx1-dependent reductions of NAD(+)and NADP(+)were cooperative. HoxEFU also catalyzed the flavodoxin-dependent reduction of NAD(P)(+), Fdx2-dependent oxidation of NADH and Fdx4- and Fdx11-dependent reduction of NAD(+). MS-based mapping identified an Fdx1-binding site at the junction of HoxE and HoxF, adjacent to iron-sulfur (FeS) clusters in both subunits. Overall, the reactivity of HoxEFU observed here suggests that it functions in managing peripheral electron flow from photosynthetic electron transfer, findings that reveal detailed insights into how ubiquitous cellular components may be used to allocate energy flow into specific bioenergetic products.	[Artz, Jacob H.; Mulder, David W.; Lubner, Carolyn E.; King, Paul W.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Tokmina-Lukaszewska, Monika; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Gutekunst, Kirstin; Appel, Jens; Boehm, Marko] Univ Kiel, Bot Inst, Kiel, Germany	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; Montana State University System; Montana State University Bozeman; University of Kiel	King, PW (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA.	paul.king@nrel.gov	Mulder, David/AHC-0138-2022	Mulder, David/0000-0003-0559-0145; King, Paul/0000-0001-5039-654X; Appel, Jens/0000-0002-0658-7899; Gutekunst, Kirstin/0000-0003-4366-423X	U.S. Department of Energy Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, Photosynthetic Systems Program	U.S. Department of Energy Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, Photosynthetic Systems Program(United States Department of Energy (DOE))	Funding was provided by the U.S. Department of Energy Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences, Photosynthetic Systems Program.	Angeleri M, 2018, FEBS LETT, V592, P411, DOI 10.1002/1873-3468.12970; Appel J, 2000, ARCH MICROBIOL, V173, P333, DOI 10.1007/s002030000139; Aubert-Jousset E, 2011, FEBS J, V278, P4035, DOI 10.1111/j.1742-4658.2011.08308.x; Boehm M, 2016, PHOTOSYNTH RES, V128, P45, DOI 10.1007/s11120-015-0198-6; BOTTIN H, 1992, BIOCHIM BIOPHYS ACTA, V1101, P48, DOI 10.1016/0167-4838(92)90465-P; Buckel W, 2018, CHEM REV, V118, P3862, DOI 10.1021/acs.chemrev.7b00707; Burgdorf T, 2005, J BACTERIOL, V187, P3122, DOI 10.1128/JB.187.9.3122-3132.2005; Burroughs NJ, 2014, ENERG ENVIRON SCI, V7, P3791, DOI 10.1039/c4ee02502d; Carrieri D, 2011, BIORESOURCE TECHNOL, V102, P8368, DOI 10.1016/j.biortech.2011.03.103; Cassier-Chauvat Corinne, 2014, Life-Basel, V4, P666, DOI 10.3390/life4040666; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cornish-Bowden A, 2004, FRONT DIABETES, V16, P125; CORNISHBOWDEN A, 1987, J THEOR BIOL, V124, P1, DOI 10.1016/S0022-5193(87)80248-5; Cournac L, 2004, J BACTERIOL, V186, P1737, DOI 10.1128/JB.186.6.1737-1746.2003; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Eckert C, 2012, J BIOL CHEM, V287, P43502, DOI 10.1074/jbc.M112.392407; Fjeld CC, 2003, P NATL ACAD SCI USA, V100, P9202, DOI 10.1073/pnas.1633591100; Foyer CH, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0374; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; Gutekunst K, 2014, J BIOL CHEM, V289, P1930, DOI 10.1074/jbc.M113.526376; HAMMES GG, 1974, ANNU REV BIOPHYS BIO, V3, P1, DOI 10.1146/annurev.bb.03.060174.000245; Hanke G, 2013, PLANT CELL ENVIRON, V36, P1071, DOI 10.1111/pce.12046; Ison J, 2016, NUCLEIC ACIDS RES, V44, pD38, DOI 10.1093/nar/gkv1116; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kauny J, 2014, BBA-BIOENERGETICS, V1837, P792, DOI 10.1016/j.bbabio.2014.01.009; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khanna N, 2015, INT J MOL SCI, V16, P10537, DOI 10.3390/ijms160510537; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Lauterbach L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025939; Lauterbach L, 2011, EUR J INORG CHEM, P1067, DOI 10.1002/ejic.201001053; Ledbetter RN, 2017, BIOCHEMISTRY-US, V56, P4177, DOI 10.1021/acs.biochem.7b00389; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; Lima DB, 2015, J PROTEOMICS, V129, P51, DOI 10.1016/j.jprot.2015.01.013; Lu L, 2018, J PROTEOME RES, V17, P2370, DOI 10.1021/acs.jproteome.8b00141; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; McIntosh CL, 2011, J AM CHEM SOC, V133, P11308, DOI 10.1021/ja203376y; Mi HL, 2000, PLANT CELL PHYSIOL, V41, P1129, DOI 10.1093/pcp/pcd038; Michoux F, 2010, BIOCHEMISTRY-US, V49, P7411, DOI 10.1021/bi1011145; Motomura T, 2019, BBA-BIOENERGETICS, V1860, DOI 10.1016/j.bbabio.2019.148084; Osanai T, 2014, ENVIRON MICROBIOL, V16, P512, DOI 10.1111/1462-2920.12170; Palagyi-Meszaros LS, 2009, FEBS J, V276, P164, DOI 10.1111/j.1742-4658.2008.06770.x; Peden EA, 2013, J BIOL CHEM, V288, P35192, DOI 10.1074/jbc.M113.483727; Peters JW, 2018, CURR OPIN CHEM BIOL, V47, P32, DOI 10.1016/j.cbpa.2018.07.026; Peters JW, 2015, BBA-MOL CELL RES, V1853, P1350, DOI 10.1016/j.bbamcr.2014.11.021; Poudel S, 2016, BBA-GEN SUBJECTS, V1860, P1910, DOI 10.1016/j.bbagen.2016.05.034; Rakhely G, 2004, APPL ENVIRON MICROB, V70, P722, DOI 10.1128/AEM.70.2.722-728.2004; Roessler MM, 2018, CHEM SOC REV, V47, P2534, DOI 10.1039/c6cs00565a; Sanchez JE, 2015, BIOCHEMISTRY-US, V54, P3360, DOI 10.1021/acs.biochem.5b00174; Sanker S, 2001, J BIOL CHEM, V276, P37922; Schmitz O, 2002, BBA-BIOENERGETICS, V1554, P66, DOI 10.1016/S0005-2728(02)00214-1; Schmitz O, 1996, FEMS MICROBIOL LETT, V135, P97; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schorsch M, 2018, P NATL ACAD SCI USA, V115, pE12111, DOI 10.1073/pnas.1810379115; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Schuller JM, 2019, SCIENCE, V363, P257, DOI 10.1126/science.aau3613; Schut GJ, 2019, J BIOL CHEM, V294, P3271, DOI 10.1074/jbc.RA118.005653; Serebryakova LT, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1370, DOI 10.1134/S0006297906120133; Shomura Y, 2017, SCIENCE, V357, P928, DOI 10.1126/science.aan4497; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Takahashi H, 2008, J EXP BOT, V59, P3009, DOI 10.1093/jxb/ern157; Tamagnini P, 2002, MICROBIOL MOL BIOL R, V66, P1, DOI 10.1128/MMBR.66.1.1-20.2002; TANFORD C, 1985, P NATL ACAD SCI USA, V82, P4688, DOI 10.1073/pnas.82.14.4688; van den Heuvel RHH, 2003, J MOL BIOL, V330, P113, DOI 10.1016/S0022-2836(03)00522-9; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; WEBER J, 1993, J BIOL CHEM, V268, P20126; Yacoby I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035886; Yang ZY, 2016, BIOCHEMISTRY-US, V55, P3625, DOI 10.1021/acs.biochem.6b00421; Zhao JD, 1998, ANAL BIOCHEM, V264, P263, DOI 10.1006/abio.1998.2845	72	8	8	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9445	9454		10.1074/jbc.RA120.013136	http://dx.doi.org/10.1074/jbc.RA120.013136			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409585	hybrid, Green Published			2022-12-28	WOS:000552758600015
J	Khamaysi, A; Aharon, S; Eini-Rider, H; Ohana, E				Khamaysi, Ahlam; Aharon, Sara; Eini-Rider, Hadar; Ohana, Ehud			A dynamic anchor domain in slc13 transporters controls metabolite transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; cell metabolism; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); computer modeling; bioenergetics; citrate; NaCT; slc13; SLC26	CITRATE TRANSPORTERS; DICARBOXYLATE; OXALATE	Metabolite transport across cellular membranes is required for bioenergetic processes and metabolic signaling. The solute carrier family 13 (slc13) transporters mediate transport of the metabolites succinate and citrate and hence are of paramount physiological importance. Nevertheless, the mechanisms of slc13 transport and regulation are poorly understood. Here, a dynamic structural slc13 model suggested that an interfacial helix, H4c, which is common to all slc13s, stabilizes the stationary scaffold domain by anchoring it to the membrane, thereby facilitating movement of the SLC13 catalytic domain. Moreover, we found that intracellular determinants interact with the H4c anchor domain to modulate transport. This dual function is achieved by basic residues that alternately face either the membrane phospholipids or the intracellular milieu. This mechanism was supported by several experimental findings obtained using biochemical methods, electrophysiological measurements inXenopusoocytes, and fluorescent microscopy of mammalian cells. First, a positively charged and highly conserved H4c residue, Arg(108), was indispensable and crucial for metabolite transport. Furthermore, neutralization of other H4c basic residues inhibited slc13 transport function, thus mimicking the inhibitory effect of the slc13 inhibitor, slc26a6. Our findings suggest that the positive charge distribution across H4c domain controls slc13 transporter function and is utilized by slc13-interacting proteins in the regulation of metabolite transport.	[Khamaysi, Ahlam; Aharon, Sara; Eini-Rider, Hadar; Ohana, Ehud] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-8410501 Beer Sheva, Israel	Ben Gurion University	Ohana, E (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem & Pharmacol, IL-8410501 Beer Sheva, Israel.	ohanaeh@bgu.ac.il	Ohana, Ehud/ABB-3060-2020	Ohana, Ehud/0000-0001-8598-4042	United States-Israel Binational Science Foundation Grant [2015003]; Israel Science Foundation [271/16, 2164/16]	United States-Israel Binational Science Foundation Grant(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This work was supported by United States-Israel Binational Science Foundation Grant 2015003 (to E. O.) and by Israel Science Foundation Grants 271/16 and 2164/16 (to E. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; HARDIES K, 2015, BRAIN 11, V138, DOI DOI 10.1093/BRAIN/AWV263; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; Inoue K, 2002, BIOCHEM BIOPH RES CO, V299, P465, DOI 10.1016/S0006-291X(02)02669-4; Jiang ZR, 2006, NAT GENET, V38, P474, DOI 10.1038/ng1762; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Khamaysi A, 2019, J AM SOC NEPHROL, V30, P381, DOI 10.1681/ASN.2018030277; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542; Markovich D, 2004, PFLUG ARCH EUR J PHY, V447, P594, DOI 10.1007/s00424-003-1128-6; Markovich D, 2012, CURR TOP MEMBR, V70, P239, DOI 10.1016/B978-0-12-394316-3.00007-7; MISHRA VK, 1994, J BIOL CHEM, V269, P7185; Mulligan C, 2016, NAT STRUCT MOL BIOL, V23, P256, DOI 10.1038/nsmb.3166; Newport TD, 2019, NUCLEIC ACIDS RES, V47, pD390, DOI 10.1093/nar/gky1047; Nie RX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15009; Ohana E, 2013, J AM SOC NEPHROL, V24, P1617, DOI 10.1681/ASN.2013010080; Ohana E, 2011, J GEN PHYSIOL, V137, P239, DOI 10.1085/jgp.201010531; Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prakash S, 2003, BBA-BIOMEMBRANES, V1618, P79, DOI 10.1016/j.bbamem.2003.10.010; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schow EV, 2011, J MEMBRANE BIOL, V239, P35, DOI 10.1007/s00232-010-9330-x; Shcheynikov N, 2004, J BIOL CHEM, V279, P21857, DOI 10.1074/jbc.M313323200; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Strandberg E, 2003, FEBS LETT, V544, P69, DOI 10.1016/S0014-5793(03)00475-7; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Wright EM, 2013, MOL ASPECTS MED, V34, P183, DOI 10.1016/j.mam.2012.11.002; Zwart R, 2015, J PHARMACOL EXP THER, V355, P247, DOI 10.1124/jpet.115.226902	30	10	10	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8155	8163		10.1074/jbc.RA119.010911	http://dx.doi.org/10.1074/jbc.RA119.010911			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32152229	hybrid, Green Published			2022-12-28	WOS:000542965700004
J	Bhagdikar, D; Grundy, FJ; Henkin, TM				Bhagdikar, Divyaa; Grundy, Frank J.; Henkin, Tina M.			Transcriptional and translational S-box riboswitches differ in ligand-binding properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA structure; translation regulation; transcription regulation; aptamer; S-adenosylmethionine (SAM); gene regulation; ligand binding; riboswitch; SAM riboswitch; transcriptional S-box riboswitch; translational S-box riboswitch	MEDIATED GENE-REGULATION; SAM-I RIBOSWITCH; MESSENGER-RNA; TERMINATION CONTROL; ESCHERICHIA-COLI; SINGLE-MOLECULE; MK BOX; ADENOSYLMETHIONINE; EXPRESSION; MECHANISM	There are a number of riboswitches that utilize the same ligand-binding domain to regulate transcription or translation. S-box (SAM-I) riboswitches, including the riboswitch present in the Bacillus subtilis metI gene, which encodes cystathionine ?-synthase, regulate the expression of genes involved in methionine metabolism in response to SAM, primarily at the level of transcriptional attenuation. A rarer class of S-box riboswitches is predicted to regulate translation initiation. Here we identified and characterized a translational S-box riboswitch in the metI gene from Desulfurispirillum indicum. The regulatory mechanisms of riboswitches are influenced by the kinetics of ligand interaction. The half-life of the translational D. indicum metI RNA?SAM complex is significantly shorter than that of the transcriptional B. subtilis metI RNA. This finding suggests that, unlike the transcriptional RNA, the translational metI riboswitch can make multiple reversible regulatory decisions. Comparison of both RNAs revealed that the second internal loop of helix P3 in the transcriptional RNA usually contains an A residue, whereas the translational RNA contains a C residue that is conserved in other S-box RNAs that are predicted to regulate translation. Mutational analysis indicated that the presence of an A or C residue correlates with RNA?SAM complex stability. Biochemical analyses indicate that the internal loop sequence critically determines the stability of the RNA?SAM complex by influencing the flexibility of residues involved in SAM binding and thereby affects the molecular mechanism of riboswitch function.	[Bhagdikar, Divyaa; Grundy, Frank J.; Henkin, Tina M.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Bhagdikar, Divyaa; Grundy, Frank J.; Henkin, Tina M.] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Henkin, TM (corresponding author), Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA.	henkin.3@osu.edu	Bhagdikar, Divyaa/AAT-2107-2021		National Institutes of Health [R01GM063615]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01GM063615 (to T. M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antunes D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40875-1; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Batey RT, 2011, WIRES RNA, V2, P299, DOI 10.1002/wrna.63; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Breaker RR, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003566; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chen HY, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145794; Coppins RL, 2007, CURR OPIN MICROBIOL, V10, P176, DOI 10.1016/j.mib.2007.03.006; Fredrick K, 2002, MOL CELL, V9, P1125, DOI 10.1016/S1097-2765(02)00523-3; Fuchs RT, 2007, P NATL ACAD SCI USA, V104, P4876, DOI 10.1073/pnas.0609956104; Garst AD, 2009, BBA-GENE REGUL MECH, V1789, P584, DOI 10.1016/j.bbagrm.2009.06.004; Gong S, 2016, J PHYS CHEM B, V120, P12305, DOI 10.1021/acs.jpcb.6b09698; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Grundy FJ, 1998, MOL MICROBIOL, V30, P737, DOI 10.1046/j.1365-2958.1998.01105.x; Guedich S, 2016, RNA BIOL, V13, P373, DOI 10.1080/15476286.2016.1142040; Hall KB, 2009, METHOD ENZYMOL, V469, P269, DOI 10.1016/S0076-6879(09)69013-3; Henkin TM, 2006, COLD SPRING HARB SYM, V71, P231, DOI 10.1101/sqb.2006.71.020; Hennelly SP, 2013, NUCLEIC ACIDS RES, V41, P1922, DOI 10.1093/nar/gks978; Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Lu CR, 2010, J MOL BIOL, V404, P803, DOI 10.1016/j.jmb.2010.09.059; Lutz B, 2014, NUCLEIC ACIDS RES, V42, P2687, DOI 10.1093/nar/gkt1213; MANOR H, 1969, J MOL BIOL, V39, P1, DOI 10.1016/0022-2836(69)90329-5; McCown PJ, 2017, RNA, V23, P995, DOI 10.1261/rna.061234.117; McDaniel BA, 2005, MOL MICROBIOL, V57, P1008, DOI 10.1111/j.1365-2958.2005.04740.x; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; McGinnis JL, 2009, METHOD ENZYMOL, V468, P67, DOI 10.1016/S0076-6879(09)68004-6; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Neupane K, 2011, NUCLEIC ACIDS RES, V39, P7677, DOI 10.1093/nar/gkr305; Palmgren M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175422; Pavlova N, 2019, GENE, V708, P38, DOI 10.1016/j.gene.2019.05.036; Pradhan V., 2012, THESIS; Rauschenbach I, 2012, FEMS MICROBIOL ECOL, V81, P156, DOI 10.1111/j.1574-6941.2012.01351.x; Rauschenbach I, 2011, INT J SYST EVOL MICR, V61, P654, DOI 10.1099/ijs.0.022392-0; Rieder R, 2007, CHEMBIOCHEM, V8, P896, DOI 10.1002/cbic.200700057; Ringquist S, 1998, METH MOL B, V77, P283; Rode AB, 2015, ANGEW CHEM INT EDIT, V54, P905, DOI 10.1002/anie.201407385; ROSE JK, 1970, J MOL BIOL, V51, P541, DOI 10.1016/0022-2836(70)90007-0; Savinov A, 2014, BBA-GENE REGUL MECH, V1839, P1030, DOI 10.1016/j.bbagrm.2014.04.005; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Sherwood AV, 2016, ANNU REV MICROBIOL, V70, P361, DOI 10.1146/annurev-micro-091014-104306; Sherwood AV, 2015, P NATL ACAD SCI USA, V112, P1113, DOI 10.1073/pnas.1424175112; Smith AM, 2010, MOL MICROBIOL, V78, P1393, DOI 10.1111/j.1365-2958.2010.07410.x; Stoddard CD, 2013, J MOL BIOL, V425, P1596, DOI 10.1016/j.jmb.2013.02.023; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Suddala KC, 2013, NUCLEIC ACIDS RES, V41, P10462, DOI 10.1093/nar/gkt798; Tomsic J, 2008, J BACTERIOL, V190, P823, DOI 10.1128/JB.01034-07; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Wickiser JK, 2005, BIOCHEMISTRY-US, V44, P13404, DOI 10.1021/bi051008u; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wilson RC, 2011, J MOL BIOL, V405, P926, DOI 10.1016/j.jmb.2010.10.056; Wostenberg C, 2015, J MOL BIOL, V427, P3473, DOI 10.1016/j.jmb.2015.07.027; Zhang J, 2010, BIOCHEMISTRY-US, V49, P9123, DOI 10.1021/bi1012645	57	2	2	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6849	6860		10.1074/jbc.RA120.012853	http://dx.doi.org/10.1074/jbc.RA120.012853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32209653	hybrid, Green Published			2022-12-28	WOS:000536212600007
J	Leininger, SE; Deutsch, C; O'Brien, EP				Leininger, Sarah E.; Deutsch, Carol; O'Brien, Edward P.			Forcing the ribosome to change its message	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Mechanical forces can be generated when nascent protein segments are integrated into a membrane. These forces are then transmitted through the nascent protein to the ribosome's catalytic core, but only a few biological consequences of this process have been identified to date. In this issue, Harrington et al. present evidence that these forces form a conserved mechanism to influence the efficiency of ribosomal frameshifting during translation of viral RNA, indicating that mechanical forces may play a broader regulatory role in translation than previously appreciated.	[Leininger, Sarah E.; O'Brien, Edward P.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Deutsch, Carol] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [O'Brien, Edward P.] Penn State Univ, Bioinformat & Genom Grad Program, Inst Computat & Data Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	O'Brien, EP (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.; Deutsch, C (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.; O'Brien, EP (corresponding author), Penn State Univ, Bioinformat & Genom Grad Program, Inst Computat & Data Sci, University Pk, PA 16802 USA.	cjd@pennmedicine.upenn.edu; epo2@psu.edu		Deutsch, Carol/0000-0003-1475-5562	National Institutes of Health [R35 GM124818, R01 GM052302]; National Science Foundation [MCB-1553291]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	Supported by National Institutes of Health Grant R01 GM052302. To whom correspondence may be addressed. E-mail: cjd@pennmedicine.upenn.edu.; Supported by National Science Foundation Grant MCB-1553291 and National Institutes of Health Grant R35 GM124818. To whom correspondence may be addressed. E-mail: epo2@psu.edu.	Dinman Jonathan D, 2006, Microbe Wash DC, V1, P521, DOI 10.1128/microbe.1.521.1; Fritch B, 2018, J AM CHEM SOC, V140, P5077, DOI 10.1021/jacs.7b11044; Goldman DH, 2015, SCIENCE, V348, P457, DOI 10.1126/science.1261909; Gumbart J, 2012, BIOPHYS J, V103, P331, DOI 10.1016/j.bpj.2012.06.005; Harrington HR, 2020, J BIOL CHEM, V295, P6798, DOI 10.1074/jbc.RA120.012706; Ismail N, 2015, NAT STRUCT MOL BIOL, V22, P145, DOI 10.1038/nsmb.2940; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; Leininger SE, 2019, BIOCHEMISTRY-US, V58, P4657, DOI 10.1021/acs.biochem.9b00260; Leininger SE, 2019, P NATL ACAD SCI USA, V116, P5523, DOI 10.1073/pnas.1813003116	9	1	1	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6809	6810		10.1074/jbc.H120.013747	http://dx.doi.org/10.1074/jbc.H120.013747			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32414911	Green Published, hybrid			2022-12-28	WOS:000536212600003
J	Kapoor, A; Chen, CRG; Iozzo, RV				Kapoor, Aastha; Chen, Carolyn G.; Iozzo, Renato V.			Endorepellin evokes an angiostatic stress signaling cascade in endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; stress response; proteoglycan; endothelial cell; signal transduction; angiogenesis; eIF2; GADD45; PERK; stress signaling	UNFOLDED PROTEIN RESPONSE; SKELETAL-MUSCLE; RECEPTOR 2; SULFATE PROTEOGLYCAN; GENE-EXPRESSION; ER STRESS; PERLECAN; GROWTH; ANGIOGENESIS; AUTOPHAGY	Endorepellin, the C-terminal fragment of the heparan sulfate proteoglycan perlecan, influences various signaling pathways in endothelial cells by binding to VEGFR2. In this study, we discovered that soluble endorepellin activates the canonical stress signaling pathway consisting of PERK, eIF2?, ATF4, and GADD45?. Specifically, endorepellin evoked transient activation of VEGFR2, which, in turn, phosphorylated PERK at Thr(980). Subsequently, PERK phosphorylated eIF2? at Ser(51), upregulating its downstream effector proteins ATF4 and GADD45?. RNAi-mediated knockdown of PERK or eIF2? abrogated the endorepellin-mediated up-regulation of GADD45?, the ultimate effector protein of this stress signaling cascade. To functionally validate these findings, we utilized an ex vivo model of angiogenesis. Exposure of the aortic rings embedded in 3D fibrillar collagen to recombinant endorepellin for 2?4 h activated PERK and induced GADD45? vis ? vis vehicle-treated counterparts. Similar effects were obtained with the established cellular stress inducer tunicamycin. Notably, chronic exposure of aortic rings to endorepellin for 7?9 days markedly suppressed vessel sprouting, an angiostatic effect that was rescued by blocking PERK kinase activity. Our findings unravel a mechanism by which an extracellular matrix protein evokes stress signaling in endothelial cells, which leads to angiostasis.	[Kapoor, Aastha; Chen, Carolyn G.; Iozzo, Renato V.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; [Kapoor, Aastha; Chen, Carolyn G.; Iozzo, Renato V.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Kimmel Canc Ctr, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Kimmel Canc Ctr, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020	Kapoor, Aastha/0000-0002-7954-9113; Chen, Carolyn/0000-0003-4933-6544	National Institutes of Health [CA039481, RO1 CA047282, T32 AR052273]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants RO1 stresses such as exposure to UV light, nutrient deprivation, CA039481 and RO1 CA047282 (to R. V. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported in part by National Institutes of Health Training Grant T32 AR052273.	Adams CM, 2017, CURR OPIN CLIN NUTR, V20, P164, DOI 10.1097/MCO.0000000000000362; ALVAREZ RJ, 1992, KIDNEY INT, V41, P14, DOI 10.1038/ki.1992.3; Arab K, 2019, NAT GENET, V51, P217, DOI 10.1038/s41588-018-0306-6; Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Axten JM, 2013, ACS MED CHEM LETT, V4, P964, DOI 10.1021/ml400228e; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Benton RL, 2008, J COMP NEUROL, V507, P1031, DOI 10.1002/cne.21570; Binet F, 2015, CELL METAB, V22, P560, DOI 10.1016/j.cmet.2015.07.010; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Bretz CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197069; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Chen C, 2019, METHODS MOL BIOL, V1952, P157, DOI 10.1007/978-1-4939-9133-4_14; Chen CG, 2020, MATRIX BIOL, V90, P1, DOI 10.1016/j.matbio.2020.02.001; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; COHEN IR, 1994, CANCER RES, V54, P5771; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Ebert SM, 2020, J BIOL CHEM, V295, P2787, DOI 10.1074/jbc.RA119.012095; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Ernst C, 2006, J NEUROSCI METH, V150, P138, DOI 10.1016/j.jneumeth.2005.06.018; Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Fong TAT, 1999, CANCER RES, V59, P99; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Gao M, 2013, NUCLEIC ACIDS RES, V41, P5210, DOI 10.1093/nar/gkt223; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goyal A, 2016, J BIOL CHEM, V291, P19245, DOI 10.1074/jbc.M116.740266; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Gubbiotti MA, 2017, MATRIX BIOL, V57-58, P285, DOI 10.1016/j.matbio.2016.09.003; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008008; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Holczer M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168359; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Iqbal F, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0631-1; Ito N, 1999, Angiogenesis, V3, P159, DOI 10.1023/A:1009008926710; Kapoor Aastha, 2020, Matrix Biol Plus, V6-7, P100025, DOI 10.1016/j.mbplus.2020.100025; Karali E, 2014, MOL CELL, V54, P559, DOI 10.1016/j.molcel.2014.03.022; Karamanos NK, 2018, CHEM REV, V118, P9152, DOI 10.1021/acs.chemrev.8b00354; Kovalsky O, 2001, J BIOL CHEM, V276, P39330, DOI 10.1074/jbc.M105115200; Liebermann Dan A., 2011, Critical Reviews in Oncogenesis, V16, P129; Liebermann Dan A, 2008, J Mol Signal, V3, P15, DOI 10.1186/1750-2187-3-15; Livezey M, 2018, CELL DEATH DIFFER, V25, P1796, DOI 10.1038/s41418-018-0143-2; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Neill T, 2018, J BIOL CHEM, V293, P12137, DOI 10.1074/jbc.RA118.002934; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Poluzzi C, 2016, ADV DRUG DELIVER REV, V97, P156, DOI 10.1016/j.addr.2015.10.012; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Schaefer L, 2017, FEBS J, V284, P10, DOI 10.1111/febs.13963; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Smith AL, 2015, J MED CHEM, V58, P1426, DOI 10.1021/jm5017494; Sparro G, 1997, PROTEIN EXPRES PURIF, V10, P169, DOI 10.1006/prep.1997.0726; Su Q, 2008, J BIOL CHEM, V283, P469, DOI 10.1074/jbc.M704612200; Tameire F, 2015, SEMIN CANCER BIOL, V33, P3, DOI 10.1016/j.semcancer.2015.04.002; Theocharis AD, 2015, BBA-REV CANCER, V1855, P276, DOI 10.1016/j.bbcan.2015.03.006; Torres A, 2017, J BIOL CHEM, V292, P5055, DOI 10.1074/jbc.M116.753632; Van Valckenborgh E, 2002, BRIT J CANCER, V86, P796, DOI 10.1038/sj.bjc.6600137; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Weigel Paul H, 2015, Int J Cell Biol, V2015, P367579, DOI 10.1155/2015/367579; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Willis CD, 2013, FEBS J, V280, P2271, DOI 10.1111/febs.12164; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang F, 2013, J BIOL CHEM, V288, P6552, DOI 10.1074/jbc.M112.418335; Yang P, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0465-3; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022	79	10	10	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6344	6356		10.1074/jbc.RA120.012525	http://dx.doi.org/10.1074/jbc.RA120.012525			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32205445	Green Published, hybrid			2022-12-28	WOS:000537685000009
J	de Carvalho, JRL; Kim, HJ; Ueda, K; Zhao, J; Owji, AP; Yang, TT; Tsang, SH; Sparrow, JR				Lima de Carvalho, Jose Ronaldo, Jr.; Kim, Hye Jin; Ueda, Keiko; Zhao, Jin; Owji, Aaron P.; Yang, Tingting; Tsang, Stephen H.; Sparrow, Janet R.			Effects of deficiency in the RLBP1-encoded visual cycle protein CRALBP on visual dysfunction in humans and mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retina; retinal degeneration; retinoid; vitamin A; vision; bisretinoids; CRALBP; retinitis punctata albescens; RLBP1; visual cycle	RETINALDEHYDE-BINDING PROTEIN; QUANTITATIVE FUNDUS AUTOFLUORESCENCE; OPTICAL COHERENCE TOMOGRAPHY; RETINITIS PUNCTATA ALBESCENS; LIGHT-INDUCED DEGENERATION; BOTHNIA DYSTROPHY; RETINOID ISOMERASE; SHORT-WAVELENGTH; MUTATIONS; RPE65	Mutations in retinaldehyde-binding protein 1 (RLBP1), encoding the visual cycle protein cellular retinaldehyde-binding protein (CRALBP), cause an autosomal recessive form of retinal degeneration. By binding to 11-cis-retinoid, CRALBP augments the isomerase activity of retinoid isomerohydrolase RPE65 (RPE65) and facilitates 11-cis-retinol oxidation to 11-cis-retinal. CRALBP also maintains the 11-cis configuration and protects against unwanted retinaldehyde activity. Studying a sibling pair that is compound heterozygous for mutations in RLBP1/CRALBP, here we expand the phenotype of affected individuals, elucidate a previously unreported phenotype in RLBP1/CRALBP carriers, and demonstrate consistencies between the affected individuals and Rlbp1/Cralbp(?/?) mice. In the RLBP1/CRALBP-affected individuals, nonrecordable rod-specific electroretinogram traces were recovered after prolonged dark adaptation. In ultrawide-field fundus images, we observed radially arranged puncta typical of RLBP1/CRALBP-associated disease. Spectral domain-optical coherence tomography (SD-OCT) revealed hyperreflective aberrations within photoreceptor-associated bands. In short-wavelength fundus autofluorescence (SW-AF) images, speckled hyperautofluorescence and mottling indicated macular involvement. In both the affected individuals and their asymptomatic carrier parents, reduced SW-AF intensities, measured as quantitative fundus autofluorescence (qAF), indicated chronic impairment in 11-cis-retinal availability and provided information on mutation severity. Hypertransmission of the SD-OCT signal into the choroid together with decreased near-infrared autofluorescence (NIR-AF) provided evidence for retinal pigment epithelial cell (RPE) involvement. In Rlbp1/Cralbp(?/?) mice, reduced 11-cis-retinal levels, qAF and NIR-AF intensities, and photoreceptor loss were consistent with the clinical presentation of the affected siblings. These findings indicate that RLBP1 mutations are associated with progressive disease involving RPE atrophy and photoreceptor cell degeneration. In asymptomatic carriers, qAF disclosed previously undetected visual cycle deficiency.	[Lima de Carvalho, Jose Ronaldo, Jr.; Kim, Hye Jin; Ueda, Keiko; Zhao, Jin; Yang, Tingting; Tsang, Stephen H.; Sparrow, Janet R.] Columbia Univ, Irving Med Ctr, Dept Ophthalmol, New York, NY 10032 USA; [Owji, Aaron P.] Columbia Univ, Irving Med Ctr, Dept Pharmacol, New York, NY 10032 USA; [Tsang, Stephen H.; Sparrow, Janet R.] Columbia Univ, Irving Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Sparrow, JR (corresponding author), Columbia Univ, Dept Ophthalmol, 635 W 165th St, New York, NY 10032 USA.	jrs88@columbia.edu		Lima de Carvalho Jr, Jose Ronaldo/0000-0002-7024-1702; Zhao, Jin/0000-0002-1934-6445	National Institutes of Health [EY024091, EY012951, P30EY019007, GM127652]; Research to Prevent Blindness	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by National Institutes of Health Grants EY024091 and EY012951, P30EY019007, and GM127652 and a grant from Research to Prevent Blindness to the Department of Ophthalmology, Columbia University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrieu-Soler C, 2005, MOL VIS, V11; Bagheri Saghar, 2020, Retin Cases Brief Rep, V14, P85, DOI 10.1097/ICB.0000000000000628; Bavik C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124940; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; Bocquet B, 2013, OPHTHAL EPIDEMIOL, V20, P13, DOI 10.3109/09286586.2012.737890; Burstedt MSI, 1999, INVEST OPHTH VIS SCI, V40, P995; Burstedt MSL, 2001, ARCH OPHTHALMOL-CHIC, V119, P260; Chen L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42772-z; Choi VW, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2015.22; Dessalces E, 2013, JAMA OPHTHALMOL, V131, P1314, DOI 10.1001/jamaophthalmol.2013.4476; Dobri N, 2013, INVEST OPHTH VIS SCI, V54, P85, DOI 10.1167/iovs.12-10050; Duncker T, 2015, INVEST OPHTH VIS SCI, V56, P7274, DOI 10.1167/iovs.15-17371; Duncker T, 2015, INVEST OPHTH VIS SCI, V56, P3159, DOI 10.1167/iovs.14-16343; Duncker T, 2015, OPHTHALMOLOGY, V122, P345, DOI 10.1016/j.ophtha.2014.08.017; Duncker T, 2014, INVEST OPHTH VIS SCI, V55, P8134, DOI 10.1167/iovs.14-14848; Duncker T, 2014, INVEST OPHTH VIS SCI, V55, P1471, DOI 10.1167/iovs.13-13834; Eichers ER, 2002, AM J HUM GENET, V70, P955, DOI 10.1086/339688; Flynn E, 2014, INVEST OPHTH VIS SCI, V55, P5643, DOI 10.1167/iovs.14-14136; Genead MA, 2010, OPHTHALMIC GENET, V31, P66, DOI 10.3109/13816810903584971; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golovleva I, 2003, J BIOL CHEM, V278, P12397, DOI 10.1074/jbc.M207300200; Greenberg JP, 2013, INVEST OPHTH VIS SCI, V54, P5684, DOI 10.1167/iovs.13-12445; He XQ, 2009, P NATL ACAD SCI USA, V106, P18545, DOI 10.1073/pnas.0907454106; Hipp S, 2015, ACTA OPHTHALMOL, V93, pE281, DOI 10.1111/aos.12573; Jacobson SG, 2015, NEW ENGL J MED, V372, P1920, DOI 10.1056/NEJMoa1412965; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kaldi I, 2003, MOL VIS, V9, P337; Katsanis N, 2001, CLIN GENET, V59, P424, DOI 10.1034/j.1399-0004.2001.590607.x; Kaufman Y, 2011, J BIOL CHEM, V286, P7958, DOI 10.1074/jbc.M110.178640; Keilhauer CN, 2006, INVEST OPHTH VIS SCI, V47, P3556, DOI 10.1167/iovs.06-0122; Kellner S, 2009, AM J OPHTHALMOL, V147, P895, DOI 10.1016/j.ajo.2008.12.023; Kiser PD, 2015, NAT CHEM BIOL, V11, P409, DOI [10.1038/NCHEMBIO.1799, 10.1038/nchembio.1799]; Kumaran N, 2018, BRIT MED BULL, V126, P13, DOI 10.1093/bmb/ldy005; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Li F, 2009, MOL VIS, V15, P1185; Littink KW, 2012, OPHTHALMOLOGY, V119, P1899, DOI 10.1016/j.ophtha.2012.02.037; Ma L, 2011, J BIOL CHEM, V286, P7966, DOI 10.1074/jbc.M110.178657; MacLachlan TK, 2018, MOL THER-METH CLIN D, V8, P105, DOI 10.1016/j.omtm.2017.12.001; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Mandal MNA, 2011, J BIOL CHEM, V286, P32491, DOI 10.1074/jbc.M111.255877; Marchette LD, 2010, FREE RADICAL BIO MED, V48, P16, DOI 10.1016/j.freeradbiomed.2009.08.005; Mata NL, 2013, RETINA-J RET VIT DIS, V33, P498, DOI 10.1097/IAE.0b013e318265801d; Mata NL, 2010, CURR OPIN OPHTHALMOL, V21, P190, DOI 10.1097/ICU.0b013e32833866c8; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morimura H, 1999, INVEST OPHTH VIS SCI, V40, P1000; Paavo M, 2018, INVEST OPHTH VIS SCI, V59, P2459, DOI 10.1167/iovs.18-24213; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; Parker R, 2011, J NEUROSCI, V31, P4714, DOI 10.1523/JNEUROSCI.3722-10.2011; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Saari JC, 2005, EXP EYE RES, V81, P245, DOI 10.1016/j.exer.2005.06.015; SAARI JC, 1987, J BIOL CHEM, V262, P7618; SAARI JC, 1982, BIOCHIM BIOPHYS ACTA, V716, P266, DOI 10.1016/0304-4165(82)90277-X; Saari John C, 2016, Subcell Biochem, V81, P231; Sato S, 2016, J PHYSIOL-LONDON, V594, P6753, DOI 10.1113/JP272831; Scimone C, 2017, HUM GENOMICS, V11, DOI 10.1186/s40246-017-0114-6; Sparrow JR, 2016, P NATL ACAD SCI USA, V113, P4564, DOI 10.1073/pnas.1600474113; Sparrow JR, 2013, INVEST OPHTH VIS SCI, V54, P2812, DOI 10.1167/iovs.12-11490; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Stocker A., 2009, CRYSTAL STRUCTURE CR; Ueda K, 2016, P NATL ACAD SCI USA, V113, P6904, DOI 10.1073/pnas.1524774113; van de Kraats J, 2007, J OPT SOC AM A, V24, P1842, DOI 10.1364/JOSAA.24.001842; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wang JS, 2015, ANAL BIOCHEM, V484, P162, DOI 10.1016/j.ab.2015.05.016; Weleber RG, 2011, INVEST OPHTH VIS SCI, V52, P292, DOI 10.1167/iovs.10-6106; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wu L, 2014, INVEST OPHTH VIS SCI, V55, P1910, DOI 10.1167/iovs.14-13867; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Wu ZP, 2004, J BIOL CHEM, V279, P27357, DOI 10.1074/jbc.M401960200; Xue YL, 2015, J CLIN INVEST, V125, P727, DOI 10.1172/JCI79651; Yamamoto K, 2011, INVEST OPHTH VIS SCI, V52, P9084, DOI 10.1167/iovs.11-8632; Zhao J, 2018, J BIOL CHEM, V293, P19400, DOI 10.1074/jbc.RA118.005949	81	15	15	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6767	6780		10.1074/jbc.RA120.012695	http://dx.doi.org/10.1074/jbc.RA120.012695			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32188692	Green Published, hybrid			2022-12-28	WOS:000537685000040
J	Mekler, V; Kuznedelov, K; Severinov, K				Mekler, Vladimir; Kuznedelov, Konstantin; Severinov, Konstantin			Quantification of the affinities of CRISPR?Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding protein; DNA?protein interaction; CRISPR; Cas; fluorescence; RNA binding protein; Cas9; fluorescent Cas9 beacon; genome editing	RNA-GUIDED CAS9; CRISPR-CAS9; DNA; ENDONUCLEASE; RECOGNITION; VARIANTS; INTERROGATION; SPECIFICITY; COMPLEXES; MECHANISM	The CRISPR/Cas9 nucleases have been widely applied for genome editing in various organisms. Cas9 nucleases complexed with a guide RNA (Cas9?gRNA) find their targets by scanning and interrogating the genomic DNA for sequences complementary to the gRNA. Recognition of the DNA target sequence requires a short protospacer adjacent motif (PAM) located outside this sequence. Given that the efficiency of target location may depend on the strength of interactions that promote target recognition, here we sought to compare affinities of different Cas9 nucleases for their cognate PAM sequences. To this end, we measured affinities of Cas9 nucleases from Streptococcus pyogenes, Staphylococcus aureus, and Francisella novicida complexed with guide RNAs (gRNAs) (SpCas9?gRNA, SaCas9?gRNA, and FnCas9?gRNA, respectively) and of three engineered SpCas9?gRNA variants with altered PAM specificities for short, PAM-containing DNA probes. We used a ?beacon? assay that measures the relative affinities of DNA probes by determining their ability to competitively affect the rate of Cas9?gRNA binding to fluorescently labeled target DNA derivatives called ?Cas9 beacons.? We observed significant differences in the affinities for cognate PAM sequences among the studied Cas9 enzymes. The relative affinities of SpCas9?gRNA and its engineered variants for canonical and suboptimal PAMs correlated with previous findings on the efficiency of these PAM sequences in genome editing. These findings suggest that high affinity of a Cas9 nuclease for its cognate PAM promotes higher genome-editing efficiency.	[Mekler, Vladimir; Kuznedelov, Konstantin; Severinov, Konstantin] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow 119334, Russia	Rutgers State University New Brunswick; Russian Academy of Sciences	Mekler, V; Severinov, K (corresponding author), Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA.; Severinov, K (corresponding author), Russian Acad Sci, Inst Mol Genet, Moscow 119334, Russia.	mekler@waksman.rutgers.edu; severik@waksman.rutgers.edu			National Institutes of Health [GM104071]; Russian Science Foundation [19-14-00323]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by National Institutes of Health Grant GM104071 and Russian Science Foundation grant 19-14-00323 (to K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains supporting text, Tables S1-S3, and Figs. S1-S9.	Acharya S, 2019, P NATL ACAD SCI USA, V116, P20959, DOI 10.1073/pnas.1818461116; Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen FQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14958; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; He XB, 2019, J BIOL CHEM, V294, P9308, DOI 10.1074/jbc.RA119.007791; Hirano H, 2016, CELL, V164, P950, DOI 10.1016/j.cell.2016.01.039; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Hu XX, 2016, MOL PLANT, V9, P943, DOI 10.1016/j.molp.2016.03.003; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones DL, 2017, SCIENCE, V357, P1420, DOI 10.1126/science.aah7084; Kim HK, 2020, NAT BIOMED ENG, V4, P111, DOI 10.1038/s41551-019-0505-1; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Kuznedelov K, 2016, NUCLEIC ACIDS RES, V44, P10849, DOI 10.1093/nar/gkw914; Ma HH, 2016, J CELL BIOL, V214, P529, DOI 10.1083/jcb.201604115; Maji B, 2019, CELL, V177, P1067, DOI 10.1016/j.cell.2019.04.009; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mekler V, 2019, METHOD ENZYMOL, V616, P337, DOI 10.1016/bs.mie.2018.10.026; Mekler V, 2017, P NATL ACAD SCI USA, V114, P5443, DOI 10.1073/pnas.1619926114; Mekler V, 2016, NUCLEIC ACIDS RES, V44, P2837, DOI 10.1093/nar/gkw138; Najm FJ, 2018, NAT BIOTECHNOL, V36, P179, DOI 10.1038/nbt.4048; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Nishimasu H, 2015, CELL, V162, P1113, DOI 10.1016/j.cell.2015.08.007; Niu QF, 2020, J INTEGR PLANT BIOL, V62, P398, DOI 10.1111/jipb.12886; Pawluk A, 2018, NAT REV MICROBIOL, V16, P12, DOI 10.1038/nrmicro.2017.120; Raitskin O, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211598; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; Singh D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12778; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; Xie HH, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700561; Yourik P, 2019, RNA, V25, P35, DOI 10.1261/rna.067355.118; Zeng DC, 2020, PLANT BIOTECHNOL J, V18, P1348, DOI 10.1111/pbi.13293; Zhang F, 2019, Q REV BIOPHYS, V52, DOI 10.1017/S0033583519000052; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405; Zhong ZH, 2019, MOL PLANT, V12, P1027, DOI 10.1016/j.molp.2019.03.011	50	10	10	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6509	6517		10.1074/jbc.RA119.012239	http://dx.doi.org/10.1074/jbc.RA119.012239			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32241913	hybrid, Green Published			2022-12-28	WOS:000537685000021
J	Boursier, ME; Levin, S; Zimmerman, K; Machleidt, T; Hurst, R; Butler, BL; Eggers, CT; Kirkland, TA; Wood, KV; Ohana, RF				Boursier, Michelle E.; Levin, Sergiy; Zimmerman, Kris; Machleidt, Thomas; Hurst, Robin; Butler, Braeden L.; Eggers, Christopher T.; Kirkland, Thomas A.; Wood, Keith V.; Ohana, Rachel Friedman			The luminescent HiBiT peptide enables selective quantitation of G protein?coupled receptor ligand engagement and internalization in living cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); bioluminescence resonance energy transfer (BRET); receptor internalization; kinetics; bioluminescence; adrenergic receptor; endogenous tagging; HiBiT; ligand engagement; NanoLuc	ALLOSTERIC MODULATOR; COUPLED RECEPTOR; AGONIST BINDING; KINETICS; TIME; VALIDATION; PROTEINS; ANALOGS; POTENT; ASSAY	G protein?coupled receptors (GPCRs) are prominent targets to new therapeutics for a range of diseases. Comprehensive assessments of their cellular interactions with bioactive compounds, particularly in a kinetic format, are imperative to the development of drugs with improved efficacy. Hence, we developed complementary cellular assays that enable equilibrium and real-time analyses of GPCR ligand engagement and consequent activation, measured as receptor internalization. These assays utilize GPCRs genetically fused to an N-terminal HiBiT peptide (1.3 kDa), which produces bright luminescence upon high-affinity complementation with LgBiT, an 18-kDa subunit derived from NanoLuc. The cell impermeability of LgBiT limits signal detection to the cell surface and enables measurements of ligand-induced internalization through changes in cell-surface receptor density. In addition, bioluminescent resonance energy transfer is used to quantify dynamic interactions between ligands and their cognate HiBiT-tagged GPCRs through competitive binding with fluorescent tracers. The sensitivity and dynamic range of these assays benefit from the specificity of bioluminescent resonance energy transfer and the high signal intensity of HiBiT/LgBiT without background luminescence from receptors present in intracellular compartments. These features allow analyses of challenging interactions having low selectivity or affinity and enable studies using endogenously tagged receptors. Using the ?-adrenergic receptor family as a model, we demonstrate the versatility of these assays by utilizing the same HiBiT construct in analyses of multiple aspects of GPCR pharmacology. We anticipate that this combination of target engagement and proximal functional readout will prove useful to the study of other GPCR families and the development of new therapeutics.	[Boursier, Michelle E.; Zimmerman, Kris; Machleidt, Thomas; Hurst, Robin; Butler, Braeden L.; Eggers, Christopher T.; Wood, Keith V.; Ohana, Rachel Friedman] Promega Corp, 2800 Woods Hollow, Fitchburg, WI 53711 USA; [Levin, Sergiy; Kirkland, Thomas A.] Promega Biosci LLC, San Luis Obispo, CA 93401 USA	Promega Corporation	Ohana, RF (corresponding author), Promega Corp, 2800 Woods Hollow, Fitchburg, WI 53711 USA.	rachel.ohana@promega.com		Boursier, Michelle/0000-0002-2642-1802				Ahn KH, 2012, J BIOL CHEM, V287, P12070, DOI 10.1074/jbc.M111.316463; Ahn S, 2018, MOL PHARMACOL, V94, P850, DOI 10.1124/mol.118.111948; Algar WR, 2019, NAT METHODS, V16, P815, DOI 10.1038/s41592-019-0530-8; Alikhani V, 2004, BIOORG MED CHEM LETT, V14, P4705, DOI 10.1016/j.bmcl.2004.06.086; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Basu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070736; Beattie D, 2010, BIOORG MED CHEM LETT, V20, P5302, DOI 10.1016/j.bmcl.2010.06.136; Braadland PR, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00375; Calebiro D, 2018, BEST PRACT RES CL EN, V32, P83, DOI 10.1016/j.beem.2018.01.004; Candelore MR, 1999, J PHARMACOL EXP THER, V290, P649; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choo KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S2; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Cooper SL, 2019, BRIT J PHARMACOL, V176, P864, DOI 10.1111/bph.14575; Copeland RA, 2016, NAT REV DRUG DISCOV, V15, P87, DOI 10.1038/nrd.2015.18; Dale NC, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00056; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Flanagan CA, 2016, METHOD CELL BIOL, V132, P191, DOI 10.1016/bs.mcb.2015.11.004; Green SA, 1996, J BIOL CHEM, V271, P24029, DOI 10.1074/jbc.271.39.24029; Hoare BL, 2019, PHARMACOL RES PERSPE, V7, DOI 10.1002/prp2.513; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Isogaya M, 1999, MOL PHARMACOL, V56, P875, DOI 10.1124/mol.56.5.875; Jiang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047016; Krushinski JH, 2007, BIOORG MED CHEM LETT, V17, P5600, DOI 10.1016/j.bmcl.2007.07.086; Laprairie RB, 2015, BRIT J PHARMACOL, V172, P4790, DOI 10.1111/bph.13250; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Liu XY, 2019, SCIENCE, V364, P1283, DOI 10.1126/science.aaw8981; Machleidt T, 2015, ACS CHEM BIOL, V10, P1797, DOI 10.1021/acschembio.5b00143; Martikkala E, 2009, ANAL BIOCHEM, V392, P103, DOI 10.1016/j.ab.2009.05.022; Moore RH, 2007, AM J RESP CELL MOL, V36, P254, DOI 10.1165/rcmb.2006-0158OC; MOTULSKY HJ, 1984, MOL PHARMACOL, V25, P1; Nevins AM, 2018, METHODS MOL BIOL, V1722, P151, DOI 10.1007/978-1-4939-7553-2_10; Opekarova M, 2003, BBA-BIOMEMBRANES, V1610, P11, DOI 10.1016/S0005-2736(02)00708-3; Riching KM, 2018, ACS CHEM BIOL, V13, P2758, DOI 10.1021/acschembio.8b00692; Robers MB, 2015, ANAL BIOCHEM, V489, P1, DOI 10.1016/j.ab.2015.08.005; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Sato Y, 1996, EUR J PHARMACOL, V315, P363, DOI 10.1016/S0014-2999(96)00648-6; Schuetz DA, 2017, DRUG DISCOV TODAY, V22, P896, DOI 10.1016/j.drudis.2017.02.002; Schwinn MK, 2018, ACS CHEM BIOL, V13, P467, DOI 10.1021/acschembio.7b00549; Soave M, 2020, SLAS DISCOV, V25, P186, DOI 10.1177/2472555219880475; Soave M, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.250; Stoddart LA, 2016, BRIT J PHARMACOL, V173, P3028, DOI 10.1111/bph.13316; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/nmeth.3398, 10.1038/NMETH.3398]; Sykes DA, 2019, MOL CELL ENDOCRINOL, V485, P9, DOI 10.1016/j.mce.2019.01.018; Sykes DA, 2012, BRIT J PHARMACOL, V165, P2672, DOI 10.1111/j.1476-5381.2011.01639.x; Tsien Roger Y., 1993, Trends in Cell Biology, V3, P242, DOI 10.1016/0962-8924(93)90124-J; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Vauquelin G, 2016, BRIT J PHARMACOL, V173, P2319, DOI 10.1111/bph.13504; Walker JR, 2017, ACS CHEM BIOL, V12, P1028, DOI 10.1021/acschembio.6b01129; White CW, 2019, CELL SIGNAL, V54, P27, DOI 10.1016/j.cellsig.2018.11.018; Yeatman HR, 2014, J BIOL CHEM, V289, P15856, DOI 10.1074/jbc.M113.536672; Zhang R, 2012, ACTA PHARMACOL SIN, V33, P372, DOI 10.1038/aps.2011.173	54	16	16	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5124	5135		10.1074/jbc.RA119.011952	http://dx.doi.org/10.1074/jbc.RA119.011952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32107310	hybrid, Green Published			2022-12-28	WOS:000526887000031
J	Shi, SJ; Montalbetti, N; Wang, XQ; Rush, BM; Marciszyn, AL; Baty, CJ; Tan, RJ; Carattino, MD; Kleyman, TR				Shi, Shujie; Montalbetti, Nicolas; Wang, Xueqi; Rush, Brittney M.; Marciszyn, Allison L.; Baty, Catherine J.; Tan, Roderick J.; Carattino, Marcelo D.; Kleyman, Thomas R.			Paraoxonase 3 functions as a chaperone to decrease functional expression of the epithelial sodium channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); kidney; chaperone; hypertension; aldosterone; degenerin; MEC-6; PON3	IN-SITU HYBRIDIZATION; NA+ CHANNEL; COLLECTING DUCT; ENDOPLASMIC-RETICULUM; LIDDLES SYNDROME; GAMMA-SUBUNIT; BETA-SUBUNIT; ALPHA-ENAC; MOUSE KIDNEY; LOCALIZATION	The paraoxonase (PON) family comprises three highly conserved members: PON1, PON2, and PON3. They are orthologs of Caenorhabditis elegans MEC-6, an endoplasmic reticulum?resident chaperone that has a critical role in proper assembly and surface expression of the touch-sensing degenerin channel in nematodes. We have shown recently that MEC-6 and PON2 negatively regulate functional expression of the epithelial Na+ channel (ENaC), suggesting that the chaperone function is conserved within this family. We hypothesized that other PON family members also modulate ion channel expression. Pon3 is specifically expressed in the aldosterone-sensitive distal tubules in the mouse kidney. We found here that knocking down endogenous Pon3 in mouse cortical collecting duct cells enhanced Na+ transport, which was associated with increased ?ENaC abundance. We further examined Pon3 regulation of ENaC in two heterologous expression systems, Fisher rat thyroid cells and Xenopus oocytes. Pon3 coimmunoprecipitated with each of the three ENaC subunits in Fisher rat thyroid cells. As a result of this interaction, the whole-cell and surface abundance of ENaC ? and ? subunits was reduced by Pon3. When expressed in oocytes, Pon3 inhibited ENaC-mediated amiloride-sensitive Na+ currents, in part by reducing the surface expression of ENaC. In contrast, Pon3 did not alter the response of ENaC to chymotrypsin-mediated proteolytic activation or [2-(trimethylammonium)ethyl]methanethiosulfonate?induced activation of ??(S518C)?, suggesting that Pon3 does not affect channel open probability. Together, our results suggest that PON3 regulates ENaC expression by inhibiting its biogenesis and/or trafficking.	[Shi, Shujie; Montalbetti, Nicolas; Wang, Xueqi; Rush, Brittney M.; Marciszyn, Allison L.; Baty, Catherine J.; Tan, Roderick J.; Carattino, Marcelo D.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Carattino, Marcelo D.; Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Wang, Xueqi] Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University	Shi, SJ (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, 3550 Terrace St, Pittsburgh, PA 15261 USA.	shs117@pitt.edu	Tan, Roderick/AAQ-7678-2021; Montalbetti, Nicolas/T-4212-2019	Tan, Roderick/0000-0003-1012-1722; Montalbetti, Nicolas/0000-0003-2897-9540; , Thomas/0000-0002-2413-5415	NIDDK, National Institutes of Health [DK103834, DK119752, DK038470, DK079307]; NHLBI, National Institutes of Health [HL147818]; National Institutes of Health [S10OD021627]	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grants DK103834 and DK119752 (to S. S.), DK038470 (to T. R. K.), and DK079307 (to the Pittsburgh Center for Kidney Research); NHLBI, National Institutes of Health Grant HL147818 (to T. R. K.); and National Institutes of Health Grant S10OD021627 (to C. J. B). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bens M, 1999, J AM SOC NEPHROL, V10, P923; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Blazer-Yost BL, 1998, AM J PHYSIOL-CELL PH, V274, pC1373, DOI 10.1152/ajpcell.1998.274.5.C1373; Boscardin E, 2018, J AM SOC NEPHROL, V29, P977, DOI [10.1681/ASN.2017030345, 10.1681/asn.2017030345]; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Buck TM, 2018, CURR OPIN NEPHROL HY, V27, P364, DOI 10.1097/MNH.0000000000000438; Buck TM, 2017, BIOCHEM J, V474, P357, DOI 10.1042/BCJ20160760; Buck TM, 2013, J BIOL CHEM, V288, P18366, DOI 10.1074/jbc.M113.469882; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chanoux RA, 2013, AM J PHYSIOL-CELL PH, V305, pC776, DOI 10.1152/ajpcell.00059.2013; Chanoux RA, 2012, J BIOL CHEM, V287, P19255, DOI 10.1074/jbc.M112.357756; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Chen LH, 2017, P NATL ACAD SCI USA, V114, pE9989, DOI 10.1073/pnas.1710964114; Chen YS, 2016, MOL BIOL CELL, V27, P1272, DOI 10.1091/mbc.E15-08-0561; Christensen BM, 2010, J AM SOC NEPHROL, V21, P1942, DOI 10.1681/ASN.2009101077; CORVOL P, 1995, J ENDOCRINOL INVEST, V18, P592; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Denault DL, 1996, AM J PHYSIOL-CELL PH, V271, pC423, DOI 10.1152/ajpcell.1996.271.1.C423; Devarajan A, 2014, ADV EXP MED BIOL, V824, P33, DOI 10.1007/978-3-319-07320-0_5; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Fang X, 2002, J GEN PHYSIOL, V119, P199, DOI 10.1085/jgp.119.2.199; Frindt G, 2004, AM J PHYSIOL-RENAL, V286, pF669, DOI 10.1152/ajprenal.00381.2003; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Gamliel-Lazarovich A, 2012, ATHEROSCLEROSIS, V222, P92, DOI 10.1016/j.atherosclerosis.2012.01.047; Giraldez T, 2007, J NEUROCHEM, V102, P1304, DOI 10.1111/j.1471-4159.2007.04622.x; Grifoni SC, 2008, AM J PHYSIOL-HEART C, V294, pH2022, DOI 10.1152/ajpheart.01271.2007; Grimm PR, 2017, J AM SOC NEPHROL, V28, P2598, DOI 10.1681/ASN.2016090948; Grumbach Y, 2014, AM J PHYSIOL-CELL PH, V307, pC701, DOI 10.1152/ajpcell.00134.2014; Grunder S, 1997, CURR OPIN NEPHROL HY, V6, P35; Hadchouel J, 2010, P NATL ACAD SCI USA, V107, P18109, DOI 10.1073/pnas.1006128107; HANSSON JH, 1995, P NATL ACAD SCI USA, V92, P11495, DOI 10.1073/pnas.92.25.11495; HANSSON JH, 1995, NAT GENET, V11, P76, DOI 10.1038/ng0995-76; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Heidrich E, 2015, J BIOL CHEM, V290, P11569, DOI 10.1074/jbc.M115.640763; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; HUGHEY RP, 1986, BIOCHIM BIOPHYS ACTA, V874, P150, DOI 10.1016/0167-4838(86)90112-3; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Hummler E, 1999, J STEROID BIOCHEM, V69, P385, DOI 10.1016/S0960-0760(99)00073-4; Joyce-Brady M, 2001, J BIOL CHEM, V276, P9468, DOI 10.1074/jbc.M004352200; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Kashlan OB, 2018, AM J PHYSIOL-RENAL, V314, pF483, DOI 10.1152/ajprenal.00195.2017; Kellenberger S, 2002, J PHYSIOL-LONDON, V543, P413, DOI 10.1113/jphysiol.2002.022020; Klemens CA, 2017, J BIOL CHEM, V292, P375, DOI 10.1074/jbc.M116.753616; Kleyman TR, 2018, ANNU REV PHYSIOL, V80, P263, DOI 10.1146/annurev-physiol-021317-121143; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Li Q, 2016, HEPATOLOGY, V63, P538, DOI 10.1002/hep.28301; LIFTON RP, 1995, P NATL ACAD SCI USA, V92, P8545, DOI 10.1073/pnas.92.19.8545; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Loffing J, 2001, AM J PHYSIOL-RENAL, V280, pF675, DOI 10.1152/ajprenal.2001.280.4.F675; Loffing J, 2000, AM J PHYSIOL-RENAL, V279, pF252, DOI 10.1152/ajprenal.2000.279.2.F252; Mackness MI, 1996, CURR OPIN LIPIDOL, V7, P69, DOI 10.1097/00041433-199604000-00004; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Mall MA, 2010, J BIOL CHEM, V285, P26945, DOI 10.1074/jbc.M110.151803; Marsillach J, 2008, FREE RADICAL BIO MED, V45, P146, DOI 10.1016/j.freeradbiomed.2008.03.023; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Meyer WK, 2018, SCIENCE, V361, P591, DOI 10.1126/science.aap7714; Mick VE, 2001, MOL ENDOCRINOL, V15, P575, DOI 10.1210/me.15.4.575; Miller RL, 2005, AM J PHYSIOL-CELL PH, V288, pC1134, DOI 10.1152/ajpcell.00084.2004; Mueller GM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M707339200; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Naray-Fejes-Toth A, 2000, KIDNEY INT, V57, P1290, DOI 10.1046/j.1523-1755.2000.00964.x; Nesterov V, 2012, AM J PHYSIOL-RENAL, V303, pF1289, DOI 10.1152/ajprenal.00247.2012; Ng CJ, 2005, FREE RADICAL BIO MED, V38, P153, DOI 10.1016/j.freeradbiomed.2004.09.035; Ng CJ, 2001, J BIOL CHEM, V276, P44444, DOI 10.1074/jbc.M105660200; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; Passero CJ, 2012, AM J PHYSIOL-RENAL, V302, pF1, DOI 10.1152/ajprenal.00330.2011; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Plotkin MD, 1996, KIDNEY INT, V50, P174, DOI 10.1038/ki.1996.300; Precourt LP, 2011, ATHEROSCLEROSIS, V214, P20, DOI 10.1016/j.atherosclerosis.2010.08.076; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Rengarajan S, 2014, AM J PHYSIOL-RENAL, V306, pF1059, DOI 10.1152/ajprenal.00015.2014; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Rubera I, 2003, J CLIN INVEST, V112, P554, DOI 10.1172/JCI200316956; SCHAFER JA, 1992, KIDNEY INT, V41, P255, DOI 10.1038/ki.1992.37; Schild L, 1996, NEPHROLOGIE, V17, P395; Schild L, 2010, BBA-MOL BASIS DIS, V1802, P1159, DOI 10.1016/j.bbadis.2010.06.014; Shi SJ, 2017, J BIOL CHEM, V292, P15927, DOI 10.1074/jbc.M117.785253; Shi Shujie, 2013, Curr Mol Pharmacol, V6, P28; Shih DM, 2015, FASEB J, V29, P1185, DOI 10.1096/fj.14-260570; Shih DM, 2010, ADV EXP MED BIOL, V660, P73, DOI 10.1007/978-1-60761-350-3_8; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Strautnieks SS, 1996, HUM MOL GENET, V5, P293, DOI 10.1093/hmg/5.2.293; Strautnieks SS, 1996, NAT GENET, V13, P248, DOI 10.1038/ng0696-248; Su YR, 2001, DRUG METAB DISPOS, V29, P553; TAYLOR AN, 1982, KIDNEY INT, V21, P765, DOI 10.1038/ki.1982.95; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; WALDMANN R, 1995, J BIOL CHEM, V270, P27411, DOI 10.1074/jbc.270.46.27411; Wang XP, 2019, J BIOL CHEM, V294, P10182, DOI 10.1074/jbc.RA119.007394; Wiemuth D, 2013, CHANNELS, V7, P38, DOI 10.4161/chan.22406; Wiemuth D, 2012, FASEB J, V26, P4122, DOI 10.1096/fj.12-207043; Yang Y, 2012, FREE RADICAL BIO MED, V53, P437, DOI 10.1016/j.freeradbiomed.2012.05.015; You H, 2017, J CELL SCI, V130, P1027, DOI 10.1242/jcs.198242	106	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4950	4962		10.1074/jbc.RA119.011789	http://dx.doi.org/10.1074/jbc.RA119.011789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32079677	hybrid, Green Published			2022-12-28	WOS:000526887000018
J	Spiering, MJ				Spiering, Martin J.			Melding the best of two worlds: Cecil Pickett's work on cellular oxidative stress and in drug discovery and development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CONTROLLING INDUCIBLE EXPRESSION; ANTIOXIDANT RESPONSE ELEMENT; GLUTATHIONE S-TRANSFERASES; YA SUBUNIT GENE; NRF2; IDENTIFICATION; ACTIVATION; SEQUENCE					mspiering@asbmb.org		Spiering, Martin/0000-0002-9160-5296				Hawkins CL, 2019, J BIOL CHEM, V294, P19683, DOI 10.1074/jbc.REV119.006217; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; PAULSON KE, 1990, MOL CELL BIOL, V10, P1841, DOI 10.1128/MCB.10.5.1841; PICKETT CB, 1984, J BIOL CHEM, V259, P5182; Raghunath A, 2018, REDOX BIOL, V17, P297, DOI 10.1016/j.redox.2018.05.002; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; RUSHMORE TH, 1993, J BIOL CHEM, V268, P11475; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826	13	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3929	3931		10.1074/jbc.CL120.013048	http://dx.doi.org/10.1074/jbc.CL120.013048			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32198188	hybrid, Green Published			2022-12-28	WOS:000527704400017
J	Zhuo, Y; Yang, JY; Moremen, KW; Prestegard, JH				Zhuo, You; Yang, Jeong-Yeh; Moremen, Kelley W.; Prestegard, James H.			Glycosylation alters dimerization properties of a cell-surface signaling protein, carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) (vol 291, pg 20085, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Zhuo Y, 2016, J BIOL CHEM, V291, P20085, DOI 10.1074/jbc.M116.740050	1	3	3	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3748	3748		10.1074/jbc.AAC120.013039	http://dx.doi.org/10.1074/jbc.AAC120.013039			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32169858	Green Published, hybrid			2022-12-28	WOS:000527725300031
J	Stewart, MYY; Bush, MJ; Crack, JC; Buttner, MJ; Le Brun, NE				Stewart, Melissa Y. Y.; Bush, Matthew J.; Crack, Jason C.; Buttner, Mark J.; Le Brun, Nick E.			Interaction of the Streptomyces Wbl protein WhiD with the principal sigma factor sigma(HrdB)depends on the WhiD [Fe-4-S-4] cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron-sulfur protein; nitric oxide; protein-protein interaction; metalloprotein; microbiology; mass spectrometry (MS); sporulation; iron-sulfur cluster; sigma factor; Streptomyces; Wbl proteins; WhiD; bacterial gene regulation; protein dimerization	MYCOBACTERIUM-TUBERCULOSIS WHIB3; SENSING 4FE-4S CLUSTER; NITRIC-OXIDE; RNA-POLYMERASE; ANTIBIOTIC-RESISTANCE; NITRATE REDUCTION; COELICOLOR A3(2); DNA-BINDING; ANTI-SIGMA; EXPRESSION	The bacterial protein WhiD belongs to the Wbl family of iron-sulfur [Fe-S] proteins present only in the actinomycetes. InStreptomyces coelicolor, it is required for the late stages of sporulation, but precisely how it functions is unknown. Here, we report results fromin vitroandin vivoexperiments with WhiD fromStreptomyces venezuelae(SvWhiD), which differs fromS. coelicolorWhiD (ScWhiD) only at the C terminus. We observed that, likeScWhiD and other Wbl proteins,SvWhiD binds a [4Fe-4S] cluster that is moderately sensitive to O(2)and highly sensitive to nitric oxide (NO). However, although all previous studies have reported that Wbl proteins are monomers, we found thatSvWhiD exists in a monomer-dimer equilibrium associated with its unusual C-terminal extension. Several Wbl proteins ofMycobacterium tuberculosisare known to interact with its principal sigma factor SigA. Using bacterial two-hybrid, gel filtration, and MS analyses, we demonstrate thatSvWhiD interacts with domain 4 of the principal sigma factor ofStreptomyces, ?(HrdB)(?(HrdB)(4)). Using MS, we determined the dissociation constant (K-d) for theSvWhiD-?(HrdB)(4)complex as ?0.7 ?m, consistent with a relatively tight binding interaction. We found that complex formation was cluster dependent and that a reaction with NO, which was complete at 8?10 NO molecules per cluster, resulted in dissociation into the separate proteins. TheSvWhiD [4Fe-4S] cluster was significantly less sensitive to reaction with O(2)and NO whenSvWhiD was bound to ?(HrdB)(4), consistent with protection of the cluster in the complex.	[Stewart, Melissa Y. Y.; Crack, Jason C.; Le Brun, Nick E.] Univ East Anglia, Ctr Mol & Struct Biochem, Sch Chem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Bush, Matthew J.; Buttner, Mark J.] John Innes Ctr, Dept Mol Microbiol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Le Brun, NE (corresponding author), Univ East Anglia, Ctr Mol & Struct Biochem, Sch Chem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	n.le-brun@uea.ac.uk	Bush, Matthew/H-7849-2019	Bush, Matthew/0000-0001-8216-0152; Buttner, Mark/0000-0002-3505-2981	Biotechnology and Biological Sciences Research Council [BB/P006140/1]; Horizon 2020 Framework Programme Grant FeSBioNet COST Action [CA15133]; University of East Anglia; Biotechnology and Biological Sciences Research Council; BBSRC [BB/P006140/1, BBS/E/J/000PR9791] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Horizon 2020 Framework Programme Grant FeSBioNet COST Action; University of East Anglia; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/P006140/1 (to J. C. C. and N. E. L. B.) and Horizon 2020 Framework Programme Grant FeSBioNet COST Action CA15133. This work was also supported by the University of East Anglia through the purchase of the ESI-MS instrument and by the Biotechnology and Biological Sciences Research Council through the award of a DTP PhD studentship (to M. Y. Y. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Bassam MM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004554; Banaiee N, 2006, INFECT IMMUN, V74, P6449, DOI 10.1128/IAI.00190-06; Bibb MJ, 2012, MOL MICROBIOL, V84, P1033, DOI 10.1111/j.1365-2958.2012.08070.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN KL, 1992, MOL MICROBIOL, V6, P1133, DOI 10.1111/j.1365-2958.1992.tb01551.x; Burian J, 2013, NUCLEIC ACIDS RES, V41, P10062, DOI 10.1093/nar/gkt751; Bush MJ, 2018, MOL MICROBIOL, V110, P663, DOI 10.1111/mmi.14117; Bush MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00523-16; BUTTNER MJ, 1992, J BACTERIOL, V174, P5165, DOI 10.1128/JB.174.15.5165-5167.1992; BUTTNER MJ, 1990, J BACTERIOL, V172, P3367, DOI 10.1128/jb.172.6.3367-3378.1990; Crack JC, 2008, METHOD ENZYMOL, V437, P191, DOI 10.1016/S0076-6879(07)37011-0; Crack JC, 2006, J BIOL CHEM, V281, P18909, DOI 10.1074/jbc.C600042200; Crack JC, 2019, CHEM-EUR J, V25, P3675, DOI 10.1002/chem.201806113; Crack JC, 2018, CHEM COMMUN, V54, P5992, DOI 10.1039/c8cc01339j; Crack JC, 2017, P NATL ACAD SCI USA, V114, pE3215, DOI 10.1073/pnas.1620987114; Crack JC, 2015, J BIOL CHEM, V290, P12689, DOI 10.1074/jbc.M115.643072; Crack JC, 2014, BIOCHEM J, V463, P83, DOI 10.1042/BJ20140169; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; Crack JC, 2009, BIOCHEMISTRY-US, V48, P12252, DOI 10.1021/bi901498v; Feng LP, 2016, MICROBIOL-SGM, V162, P889, DOI 10.1099/mic.0.000257; Gallagher KA, 2020, MOL CELL, V77, P586, DOI 10.1016/j.molcel.2019.11.006; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; Johnson KA, 2000, ANAL CHEM, V72, P1410, DOI 10.1021/ac991183e; Kang SH, 2007, J BACTERIOL, V189, P4315, DOI 10.1128/JB.01789-06; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kay KL, 2016, METALLOMICS, V8, P709, DOI 10.1039/c6mt00036c; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kudhair BK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02418-y; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee DS, 2018, ANTON LEEUW INT J G, V111, P641, DOI 10.1007/s10482-017-0953-0; Molle V, 2000, J BACTERIOL, V182, P1286, DOI 10.1128/JB.182.5.1286-1295.2000; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Martinez MTP, 2017, CHEM SCI, V8, P8451, DOI 10.1039/c7sc02801f; Perez-Ruiz T, 2000, ANALYST, V125, P507, DOI 10.1039/a907780d; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Serrano PN, 2016, ANGEW CHEM INT EDIT, V55, P14575, DOI 10.1002/anie.201607033; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Wan T, 2020, NUCLEIC ACIDS RES, V48, P501, DOI 10.1093/nar/gkz1133; Yoo JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep28628	43	5	5	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9752	9765		10.1074/jbc.RA120.012708	http://dx.doi.org/10.1074/jbc.RA120.012708			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32303639	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000552758600038
J	Moilanen, A; Ruddock, LW				Moilanen, Antti; Ruddock, Lloyd W.			Non-native proteins inhibit the ER oxidoreductin 1 (Ero1)?protein disulfide-isomerase relay when protein folding capacity is exceeded	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						disulfide; unfolded protein response (UPR); protein disulfide-isomerase; protein misfolding; endoplasmic-reticulum-associated protein degradation (ERAD); ER oxidoreductin (Ero1); feedback inhibition; hyperoxidation; oxidative folding; regulation	DEGRADATION; ERO1-ALPHA; REDUCTASE; DOMAINS; PATHWAY; BINDING; PDI	Protein maturation in the endoplasmic reticulum (ER) depends on a fine balance between oxidative protein folding and quality control mechanisms, which together ensure high-capacity export of properly folded proteins from the ER. Oxidative protein folding needs to be regulated to avoid hyperoxidation. The folding capacity of the ER is regulated by the unfolded protein response (UPR) and ER-associated degradation (ERAD). The UPR is triggered by unfolded protein stress and leads to up-regulation of cellular components such as chaperones and folding catalysts. These components relieve stress by increasing folding capacity and up-regulating ERAD components that remove non-native proteins. Although oxidative protein folding and the UPR/ERAD pathways each are well-understood, very little is known about any direct cross-talk between them. In this study, we carried out comprehensivein vitroactivity and binding assays, indicating that the oxidative protein folding relay formed by ER oxidoreductin 1 (Ero1), and protein disulfide-isomerase can be inactivated by a feedback inhibition mechanism involving unfolded proteins and folding intermediates when their levels exceed the folding capacity of the system. This mechanism allows client proteins to remain mainly in the reduced state and thereby minimizes potential futile oxidation?reduction cycles and may also enhance ERAD, which requires reduced protein substrates. Relief from excess levels of non-native proteins by increasing the levels of folding factors removed the feedback inhibition. These results reveal regulatory cross-talk between the oxidative protein folding and UPR and ERAD pathways.	[Moilanen, Antti; Ruddock, Lloyd W.] Univ Oulu, Fac Biochem & Mol Med, Aapistie 7, Oulu 90220, Finland	University of Oulu	Ruddock, LW (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Aapistie 7, Oulu 90220, Finland.	lloyd.ruddock@oulu.fi		Moilanen, Antti/0000-0002-7199-3068; Ruddock, Lloyd/0000-0002-6247-686X	Academy of Finland [272573]; Biocenter Oulu	Academy of Finland(Academy of Finland); Biocenter Oulu	This work was supported by Academy of Finland Grant 272573 and by Biocenter Oulu. A patent for the production system used to make the protein for structural studies using sulfhydryl oxidases in the cytoplasm of E. coli is held by the University of Oulu:Methodforproducingnativelyfolded proteins inaprokaryotic host (Patent 9238817, January 19, 2016, inventor L. W. Ruddock).	Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Ellgaard L, 2018, TRENDS BIOCHEM SCI, V43, P32, DOI 10.1016/j.tibs.2017.10.006; Fu XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027185; Gaciarz A, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0721-x; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Guo PC, 2012, J BIOL CHEM, V287, P34961, DOI 10.1074/jbc.M112.394759; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; He KY, 2015, MOL BIOL CELL, V26, P3413, DOI 10.1091/mbc.E15-01-0034; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; Karala AR, 2007, ANTIOXID REDOX SIGN, V9, P527, DOI 10.1089/ars.2006.1473; Kim S, 2012, J CELL BIOL, V196, P713, DOI 10.1083/jcb.201110090; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Moilanen A, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800090; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Nguyen VD, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-1; Okumura M, 2014, J BIOL CHEM, V289, P27004, DOI 10.1074/jbc.M114.564104; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; TSIBRIS JCM, 1989, J BIOL CHEM, V264, P13967; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783	34	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8647	8655		10.1074/jbc.RA119.011766	http://dx.doi.org/10.1074/jbc.RA119.011766			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32102847	Green Published, hybrid			2022-12-28	WOS:000546296800002
J	Muha, V; Fenckova, M; Ferenbach, AT; Catinozzi, M; Eidhof, I; Storkebaum, E; Schenck, A; van Aalten, DMF				Muha, Villo; Fenckova, Michaela; Ferenbach, Andrew T.; Catinozzi, Marica; Eidhof, Ilse; Storkebaum, Erik; Schenck, Annette; van Aalten, Daan M. F.			O-GlcNAcase contributes to cognitive function inDrosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; O-GlcNAcylation; neuroscience; O-linked N-acetylglucosamine (O-GlcNAc); synapse; habituation; learning; NMJ; O-GlcNAcase	BETA-N-ACETYLGLUCOSAMINE; INTELLECTUAL DISABILITY; MISSENSE MUTATION; GLCNACYLATION; GLYCOSYLATION; TRANSFERASE; IDENTIFICATION; NEURONS; GENE; OGT	O-GlcNAcylation is an abundant post-translational modification in neurons. In mice, an increase inO-GlcNAcylation leads to defects in hippocampal synaptic plasticity and learning.O-GlcNAcylation is established by two opposing enzymes:O-GlcNAc transferase (OGT) andO-GlcNAcase (OGA). To investigate the role of OGA in elementary learning, we generated catalytically inactive and precise knockoutOgaalleles (Oga(D133N)andOga(KO), respectively) inDrosophila melanogaster. AdultOga(D133N)andOga(KO)flies lackingO-GlcNAcase activity showed locomotor phenotypes. Importantly, bothOgalines exhibited deficits in habituation, an evolutionarily conserved form of learning, highlighting that the requirement forO-GlcNAcase activity for cognitive function is preserved across species. Loss ofO-GlcNAcase affected a number of synaptic boutons at the axon terminals of larval neuromuscular junction. Taken together, we report behavioral and neurodevelopmental phenotypes associated withOgaalleles and show that Oga contributes to cognition and synaptic morphology inDrosophila.	[Muha, Villo; Fenckova, Michaela; Ferenbach, Andrew T.; van Aalten, Daan M. F.] Univ Dundee, Sch Life Sci, Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Fenckova, Michaela; Eidhof, Ilse; Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Catinozzi, Marica; Storkebaum, Erik] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Mol Neurobiol, NL-6525 XZ Nijmegen, Netherlands; [Catinozzi, Marica; Storkebaum, Erik] Radboud Univ Nijmegen, Fac Sci, NL-6525 XZ Nijmegen, Netherlands	University of Dundee; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Aalten, DMF (corresponding author), Univ Dundee, Sch Life Sci, Gene Regulat & Express, Dundee DD1 5EH, Scotland.	dmfvanaalten@dundee.ac.uk	Storkebaum, Erik/B-5389-2017; Fenckova, Michaela/AGY-9276-2022; Schenck, Annette/E-4514-2012; Fenckova, Michaela/H-8622-2017	Storkebaum, Erik/0000-0002-9519-5642; Fenckova, Michaela/0000-0002-5716-1652; Schenck, Annette/0000-0002-6918-3314; Fenckova, Michaela/0000-0002-5716-1652; Catinozzi, Marica/0000-0002-9211-9951; Muha, Villo/0000-0003-4156-8463; van Aalten, Daan/0000-0002-1499-6908	Netherlands Organisation for Scientific Research [912-12-109]; Wellcome Trust Senior Research Fellowship [WT087590MA]; Donders Center for Neuroscience; Muscular Dystrophy Association; European Union Joint Programme-Neurodegenerative Disease Research Grants [ZonMW 733051075, ZonMW733051073]; European Research Council Consolidator Grant [ERC-2017-COG 770244]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust Senior Research Fellowship(Wellcome Trust); Donders Center for Neuroscience; Muscular Dystrophy Association(Muscular Dystrophy Association); European Union Joint Programme-Neurodegenerative Disease Research Grants; European Research Council Consolidator Grant(European Research Council (ERC))	This work was supported in part by TOP Grant 912-12-109 from the Netherlands Organisation for Scientific Research (to A. S.) and by Wellcome Trust Senior Research Fellowship WT087590MA (to D. M. F. v. A.). This work was also supported by funds from the Donders Center for Neuroscience (to E. S.) and the Muscular Dystrophy Association (to E. S.), European Union Joint Programme-Neurodegenerative Disease Research Grants ZonMW 733051075 (TransNeuro) and ZonMW733051073 (LocalNMD) (to E. S.), and European Research Council Consolidator Grant ERC-2017-COG 770244 (to E. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Akan I, 2016, J BIOL CHEM, V291, P9906, DOI 10.1074/jbc.M115.704783; Andres LM, 2017, ACS CHEM BIOL, V12, P2030, DOI 10.1021/acschembio.7b00232; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Bouazzi H, 2015, CLIN CASE REP, V3, P604, DOI 10.1002/ccr3.301; Brent Jonathan, 2009, J Vis Exp, DOI 10.3791/1108; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castells-Nobau A, 2017, JOVE-J VIS EXP, DOI 10.3791/55395; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Constable S, 2017, GLYCOBIOLOGY, V27, P927, DOI 10.1093/glycob/cwx055; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Donelson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037250; Eidhof I, 2018, BRAIN, V141, P2592, DOI 10.1093/brain/awy198; Eidhof I, 2017, JOVE-J VIS EXP, DOI 10.3791/55892; Fenckova M, 2019, BIOL PSYCHIAT, V86, P294, DOI 10.1016/j.biopsych.2019.04.029; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Francisco H, 2009, DEV NEUROBIOL, V69, P162, DOI 10.1002/dneu.20695; Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hwang H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43017-9; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; Kochinke K, 2016, AM J HUM GENET, V98, P149, DOI 10.1016/j.ajhg.2015.11.024; Kramer JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000569; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Lagerlof O, 2017, P NATL ACAD SCI USA, V114, P1684, DOI 10.1073/pnas.1621367114; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; Mallik M, 2018, J CELL BIOL, V217, P3947, DOI 10.1083/jcb.201802151; Mariappa D, 2018, J BIOL CHEM, V293, P7209, DOI 10.1074/jbc.RA118.002580; Mariappa D, 2015, BIOCHEM J, V470, P255, DOI 10.1042/BJ20150610; McDiarmid TA, 2017, NEUROSCI BIOBEHAV R, V80, P286, DOI 10.1016/j.neubiorev.2017.05.028; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Na JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003175; Niehues S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8520; Nijhof B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004823; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Olivier-Van Stichelen S, 2017, J BIOL CHEM, V292, P6076, DOI 10.1074/jbc.M116.774042; Park S, 2011, CELL MOL LIFE SCI, V68, P3377, DOI 10.1007/s00018-011-0640-7; Peng CM, 2017, MOL CELL, V68, P591, DOI 10.1016/j.molcel.2017.10.010; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Pravata VM, 2020, FEBS LETT, V594, P717, DOI 10.1002/1873-3468.13640; Pravata VM, 2019, P NATL ACAD SCI USA, V116, P14961, DOI 10.1073/pnas.1900065116; Radermacher PT, 2014, P NATL ACAD SCI USA, V111, P5592, DOI 10.1073/pnas.1322396111; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Rao FV, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130021; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; RC Team, 2008, R LANG ENV STAT COMP; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Rigoulot S, 2017, INT J DEV NEUROSCI, V59, P52, DOI 10.1016/j.ijdevneu.2017.03.008; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Schimpl M, 2012, CHEM BIOL, V19, P173, DOI 10.1016/j.chembiol.2012.01.011; Schimpl M, 2010, BIOCHEM J, V432, P1, DOI 10.1042/BJ20101338; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt I, 2012, J NEUROSCI, V32, P7466, DOI 10.1523/JNEUROSCI.0349-12.2012; Sekine O, 2010, J BIOL CHEM, V285, P38684, DOI 10.1074/jbc.M110.155192; Selvan N, 2018, J BIOL CHEM, V293, P10810, DOI 10.1074/jbc.RA118.002583; Selvan N, 2017, NAT CHEM BIOL, V13, P882, DOI 10.1038/nchembio.2404; Skorobogatko Y, 2014, J BIOL CHEM, V289, P3602, DOI 10.1074/jbc.M113.512814; Taylor EW, 2014, J NEUROSCI, V34, P10, DOI 10.1523/JNEUROSCI.4761-12.2014; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Vaidyanathan K, 2017, J BIOL CHEM, V292, P8948, DOI 10.1074/jbc.M116.771030; van Bon BWM, 2013, HUM MOL GENET, V22, P3138, DOI 10.1093/hmg/ddt170; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wang AC, 2016, P NATL ACAD SCI USA, V113, P15120, DOI 10.1073/pnas.1606899113; Willems AP, 2017, J BIOL CHEM, V292, P12621, DOI 10.1074/jbc.M117.790097; Willemsen MH, 2013, J MED GENET, V50, P507, DOI 10.1136/jmedgenet-2012-101490; Wolman MA, 2014, CELL REP, V8, P1265, DOI 10.1016/j.celrep.2014.07.054; Yang YR, 2017, SCI REP-UK, V7, DOI 10.1038/srep44921; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Zhu YP, 2015, NAT CHEM BIOL, V11, P319, DOI [10.1038/NCHEMBIO.1774, 10.1038/nchembio.1774]	74	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8636	8646		10.1074/jbc.RA119.010312	http://dx.doi.org/10.1074/jbc.RA119.010312			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32094227	Green Published, hybrid			2022-12-28	WOS:000546296800001
J	Nasamu, AS; Polino, AJ; Istvan, ES; Goldberg, DE				Nasamu, Armiyaw S.; Polino, Alexander J.; Istvan, Eva S.; Goldberg, Daniel E.			Malaria parasite plasmepsins: More than just plain old degradative pepsins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						aspartic protease; parasitology; plasmodium; protease; protozoan; hemoglobin; malaria; maturase; digestive vacuole; transmission; antimalarial chemotherapy	SIGNAL PEPTIDE PEPTIDASE; DIGESTIVE VACUOLE PLASMEPSINS; HISTO-ASPARTIC PROTEASE; PLASMODIUM-FALCIPARUM MALARIA; ACTIVE-SITE SPECIFICITY; FOOD VACUOLE; RECOMBINANT EXPRESSION; HEMOGLOBIN DEGRADATION; CRYSTAL-STRUCTURE; ENZYMATIC CHARACTERIZATION	Plasmepsins are a group of diverse aspartic proteases in the malaria parasitePlasmodium. Their functions are strikingly multifaceted, ranging from hemoglobin degradation to secretory organelle protein processing for egress, invasion, and effector export. Some, particularly the digestive vacuole plasmepsins, have been extensively characterized, whereas others, such as the transmission-stage plasmepsins, are minimally understood. Some (e.g.plasmepsin V) have exquisite cleavage sequence specificity; others are fairly promiscuous. Some have canonical pepsin-like aspartic protease features, whereas others have unusual attributes, including the nepenthesin loop of plasmepsin V and a histidine in place of a catalytic aspartate in plasmepsin III. We have learned much about the functioning of these enzymes, but more remains to be discovered about their cellular roles and even their mechanisms of action. Their importance in many key aspects of parasite biology makes them intriguing targets for antimalarial chemotherapy. Further consideration of their characteristics suggests that some are more viable drug targets than others. Indeed, inhibitors of invasion and egress offer hope for a desperately needed new drug to combat this nefarious organism.	[Nasamu, Armiyaw S.; Polino, Alexander J.; Istvan, Eva S.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Nasamu, Armiyaw S.; Polino, Alexander J.; Istvan, Eva S.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Mol Microbiol, Div Infect Dis, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA.	dgoldberg@wustl.edu		Polino, Alexander/0000-0003-2601-3638	National Institutes of Health [AI138447, AI112508]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants AI138447 and AI112508. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu Bakar N, 2010, J CELL SCI, V123, P441, DOI 10.1242/jcs.061499; AIKAWA M, 1966, J CELL BIOL, V28, P355, DOI 10.1083/jcb.28.2.355; AISSI E, 1983, COMP BIOCHEM PHYS B, V74, P559, DOI 10.1016/0305-0491(83)90229-8; Amato R, 2017, LANCET INFECT DIS, V17, P164, DOI [10.1016/S1473-3099(16)30409-1, 10.1016/s1473-3099(16)30409-1]; Andreeva N, 2004, PROTEINS, V55, P705, DOI 10.1002/prot.20078; Asojo OA, 2003, J MOL BIOL, V327, P173, DOI 10.1016/S0022-2836(03)00036-6; Athauda SBP, 2004, BIOCHEM J, V381, P295, DOI 10.1042/BJ20031575; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; BAILLY E, 1992, J PROTOZOOL, V39, P593, DOI 10.1111/j.1550-7408.1992.tb04856.x; BAILLY E, 1991, EXP PARASITOL, V72, P278, DOI 10.1016/0014-4894(91)90147-O; Baldi DL, 2000, EMBO J, V19, P2435, DOI 10.1093/emboj/19.11.2435; Baldwin M, 2014, BIOCHEM BIOPH RES CO, V450, P1427, DOI 10.1016/j.bbrc.2014.07.013; Banerjee R, 2003, MOL BIOCHEM PARASIT, V129, P157, DOI 10.1016/S0166-6851(03)00119-1; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Bernstein NK, 2003, J MOL BIOL, V329, P505, DOI 10.1016/S0022-2836(03)00444-3; Bernstein NK, 1999, NAT STRUCT BIOL, V6, P32, DOI 10.1038/4905; Beyer BB, 2005, BIOCHEMISTRY-US, V44, P1768, DOI 10.1021/bi047886u; Bhaumik P, 2012, BBA-PROTEINS PROTEOM, V1824, P207, DOI 10.1016/j.bbapap.2011.04.008; Bhaumik P, 2011, BIOCHEMISTRY-US, V50, P8862, DOI 10.1021/bi201118z; Bhaumik P, 2011, J STRUCT BIOL, V175, P73, DOI 10.1016/j.jsb.2011.04.009; Bhaumik P, 2009, J MOL BIOL, V388, P520, DOI 10.1016/j.jmb.2009.03.011; Birnbaum J, 2020, SCIENCE, V367, P51, DOI 10.1126/science.aax4735; Bjelic S, 2004, BIOCHEMISTRY-US, V43, P14521, DOI 10.1021/bi048252q; Boddey JA, 2013, TRAFFIC, V14, P532, DOI 10.1111/tra.12053; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Bonilla JA, 2007, INT J PARASITOL, V37, P317, DOI 10.1016/j.ijpara.2006.11.008; Bonilla JA, 2007, MOL MICROBIOL, V65, P64, DOI 10.1111/j.1365-2958.2007.05768.x; Boonyalai N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207621; Boonyalai N, 2015, MOL BIOCHEM PARASIT, V201, P5, DOI 10.1016/j.molbiopara.2015.05.004; Bopp S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04104-z; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Cheuka PM, 2020, J MED CHEM, V63, P4445, DOI 10.1021/acs.jmedchem.9b01622; CHOI I, 1987, BIOCHIM BIOPHYS ACTA, V926, P170, DOI 10.1016/0304-4165(87)90234-0; Chugh M, 2013, P NATL ACAD SCI USA, V110, P5392, DOI 10.1073/pnas.1218412110; Clemente JC, 2006, ACTA CRYSTALLOGR D, V62, P246, DOI 10.1107/S0907444905041260; Coffey MJ, 2018, MBIO, V9, DOI [10.1128/mBio.01796-18, 10.1128/mbio.01796-18]; Coombs GH, 2001, TRENDS PARASITOL, V17, P532, DOI 10.1016/S1471-4922(01)02037-2; Cowman AF, 2017, CELL HOST MICROBE, V22, P232, DOI 10.1016/j.chom.2017.07.003; Curt-Varesano A, 2016, CELL MICROBIOL, V18, P151, DOI 10.1111/cmi.12498; Dame JB, 2003, MOL BIOCHEM PARASIT, V130, P1, DOI 10.1016/S0166-6851(03)00137-3; DAME JB, 1994, MOL BIOCHEM PARASIT, V64, P177, DOI 10.1016/0166-6851(94)90024-8; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Dogga SK, 2017, ELIFE, V6, DOI [10.7554/eLife.27480, 10.7554/elife.27480]; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; Ecker A, 2008, MOL MICROBIOL, V70, P209, DOI 10.1111/j.1365-2958.2008.06407.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eggleson KK, 1999, J BIOL CHEM, V274, P32411, DOI 10.1074/jbc.274.45.32411; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Favuzza P, 2020, CELL HOST MICROBE, V27, P642, DOI 10.1016/j.chom.2020.02.005; Fierro MA, 2020, MBIO, V11, DOI 10.1128/mBio.03078-19; FRANCIS SE, 1994, EMBO J, V13, P306, DOI 10.1002/j.1460-2075.1994.tb06263.x; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; Friedman R, 2007, FEBS LETT, V581, P4120, DOI 10.1016/j.febslet.2007.07.033; Gabriely G, 2008, MOL BIOL CELL, V19, P3625, DOI 10.1091/mbc.E07-05-0462; Gambini L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142509; Garten M., 2019, CONTACTING DOMAINS S, DOI [10.1101/863993, DOI 10.1101/863993]; Garten M, 2018, NAT MICROBIOL, V3, P1090, DOI 10.1038/s41564-018-0222-7; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Glushakova S, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12868; GLUZMAN IY, 1994, J CLIN INVEST, V93, P1602, DOI 10.1172/JCI117140; Gold DA, 2015, CELL HOST MICROBE, V17, P642, DOI 10.1016/j.chom.2015.04.003; Goldberg DE, 2015, NAT STRUCT MOL BIOL, V22, P647, DOI 10.1038/nsmb.3077; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; GOLDBERG DE, 1990, P NATL ACAD SCI USA, V87, P2931, DOI 10.1073/pnas.87.8.2931; GOLDBERG DE, 1991, J EXP MED, V173, P961, DOI 10.1084/jem.173.4.961; Gruring C, 2012, CELL HOST MICROBE, V12, P717, DOI 10.1016/j.chom.2012.09.010; GYANG FN, 1982, MOL BIOCHEM PARASIT, V5, P263, DOI 10.1016/0166-6851(82)90034-2; Hale VL, 2017, P NATL ACAD SCI USA, V114, P3439, DOI 10.1073/pnas.1619441114; Hammoudi PM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005211; Harbut MB, 2012, P NATL ACAD SCI USA, V109, P21486, DOI 10.1073/pnas.1216016110; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; HEMPELMANN E, 1980, PARASITOLOGY, V80, P323, DOI 10.1017/S0031182000000780; HILL J, 1994, FEBS LETT, V352, P155, DOI 10.1016/0014-5793(94)00940-6; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hirano J, 2017, P NATL ACAD SCI USA, V114, pE10782, DOI 10.1073/pnas.1712484114; Hiss JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001560; Ho CM, 2018, NATURE, V561, P70, DOI 10.1038/s41586-018-0469-4; Hodder AN, 2015, NAT STRUCT MOL BIOL, V22, P590, DOI 10.1038/nsmb.3061; Humphreys MJ, 1999, FEBS LETT, V463, P43, DOI 10.1016/S0014-5793(99)01597-5; Istvan ES, 2005, J BIOL CHEM, V280, P6890, DOI 10.1074/jbc.M412086200; Jennison C, 2019, CELL REP, V29, P3796, DOI 10.1016/j.celrep.2019.11.073; Kehrer J, 2016, MOL CELL PROTEOMICS, V15, P2852, DOI 10.1074/mcp.M116.058263; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Kolakovich KA, 1997, MOL BIOCHEM PARASIT, V87, P123, DOI 10.1016/S0166-6851(97)00062-5; Kraft TE, 2015, ANTIMICROB AGENTS CH, V59, P6203, DOI 10.1128/AAC.00899-15; Kumar S, 2018, FEBS OPEN BIO, V8, P1379, DOI 10.1002/2211-5463.12491; Lee AH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31715-9; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; LEVY MR, 1973, J PARASITOL, V59, P1064, DOI 10.2307/3278644; LEVY MR, 1974, NATURE, V247, P546, DOI 10.1038/247546a0; Lew VL, 2003, BLOOD, V101, P4189, DOI 10.1182/blood-2002-08-2654; Lewis IA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004085; Li FW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1161-5; Li T, 2004, MOL BIOCHEM PARASIT, V135, P101, DOI 10.1016/j.molbiopara.2004.01.010; Li XR, 2009, BIOCHEM BIOPH RES CO, V380, P454, DOI 10.1016/j.bbrc.2009.01.083; Li XR, 2008, MOL BIOCHEM PARASIT, V158, P22, DOI 10.1016/j.molbiopara.2007.11.007; Lin JW, 2015, J EXP MED, V212, P893, DOI 10.1084/jem.20141731; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Liu J, 2006, J BIOL CHEM, V281, P38682, DOI 10.1074/jbc.M608535200; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Liu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141758; Liu P, 2009, BIOCHEMISTRY-US, V48, P4086, DOI 10.1021/bi802059r; Loesbanluechai D, 2019, INT J PARASITOL-DRUG, V9, P16, DOI 10.1016/j.ijpddr.2018.11.004; Loymunkong C, 2019, MOL BIOCHEM PARASIT, V231, DOI 10.1016/j.molbiopara.2019.111188; Luker KE, 1996, MOL BIOCHEM PARASIT, V79, P71, DOI 10.1016/0166-6851(96)02651-5; Madabushi A, 2005, ACTA CRYSTALLOGR F, V61, P228, DOI 10.1107/S1744309105001405; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marapana DS, 2018, NAT MICROBIOL, V3, P1010, DOI 10.1038/s41564-018-0219-2; Marapana DS, 2012, TRAFFIC, V13, P1457, DOI 10.1111/j.1600-0854.2012.01402.x; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Martins TM, 2006, ACTA TROP, V97, P212, DOI 10.1016/j.actatropica.2005.11.001; Mastan BS, 2017, INT J PARASITOL, V47, P239, DOI 10.1016/j.ijpara.2016.11.009; Mastan BS, 2014, MOL BIOCHEM PARASIT, V195, P10, DOI 10.1016/j.molbiopara.2014.05.004; Matthews KM, 2019, MBIO, V10, DOI 10.1128/mBio.01106-19; Matthews KM, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13009; Meyers MJ, 2012, CURR TOP MED CHEM, V12, P445; Moon RP, 1997, EUR J BIOCHEM, V244, P552, DOI 10.1111/j.1432-1033.1997.00552.x; Moon SU, 2011, EXP PARASITOL, V128, P127, DOI 10.1016/j.exppara.2011.02.015; Mukherjee A, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02309-17, 10.1128/aac.02309-17]; Mukherjee B, 2018, EMBO J, V37, DOI 10.15252/embj.201798047; Munsamy G, 2019, PROTEIN J, V38, P616, DOI 10.1007/s10930-019-09871-2; Munsamy G, 2018, RSC ADV, V8, P21829, DOI 10.1039/c8ra04360d; Murata CE, 2003, J BIOL CHEM, V278, P38022, DOI 10.1074/jbc.M306842200; Nasamu AS, 2017, SCIENCE, V358, P518, DOI 10.1126/science.aan1478; Nessel T, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13168; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Omara-Opyene AL, 2004, J BIOL CHEM, V279, P54088, DOI 10.1074/jbc.M409605200; Onchieku NM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201556; Osborne AR, 2010, MOL BIOCHEM PARASIT, V171, P25, DOI 10.1016/j.molbiopara.2010.01.003; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Parr CL, 2008, FEBS J, V275, P1698, DOI 10.1111/j.1742-4658.2008.06325.x; Parvanova I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005078; Pino P, 2017, SCIENCE, V358, P522, DOI 10.1126/science.aaf8675; Polino AJ, 2020, ACS INFECT DIS, V6, P738, DOI 10.1021/acsinfecdis.9b00460; Ragheb D, 2011, J BIOL CHEM, V286, P27255, DOI 10.1074/jbc.M111.225318; Ragheb D, 2009, J BIOL CHEM, V284, P24806, DOI 10.1074/jbc.M109.018424; Ran Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128619; Rawat M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060077; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Recacha R, 2016, ACTA CRYSTALLOGR F, V72, P659, DOI 10.1107/S2053230X16011663; Ross LS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05652-0; RUDZINSKA MA, 1965, J PROTOZOOL, V12, P563, DOI 10.1111/j.1550-7408.1965.tb03256.x; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Sappakhaw K, 2015, MOL BIOCHEM PARASIT, V204, P51, DOI 10.1016/j.molbiopara.2016.01.003; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; SATO K, 1987, ZBL BAKT-INT J MED M, V264, P487; Schulze J, 2015, MOL MICROBIOL, V97, P301, DOI 10.1111/mmi.13024; Schwake C, 2019, BIOCHEM BIOPH RES CO, V517, P125, DOI 10.1016/j.bbrc.2019.07.031; Semenov A, 1998, ANTIMICROB AGENTS CH, V42, P2254, DOI 10.1128/AAC.42.9.2254; Shea M, 2007, TRAFFIC, V8, P1018, DOI 10.1111/j.1600-0854.2007.00589.x; Sherman I. W., 1981, The biochemistry of parasites. (Proc. Satellite Conf. of 13th Meet., Fed. Euro. Biochem. Soc. (FEBS), Jerusalem, Aug. 1980.), P137; SHERMAN IW, 1970, INT J BIOCHEM, V1, P635, DOI 10.1016/0020-711X(70)90033-9; Sigala PA, 2014, ANNU REV MICROBIOL, V68, P259, DOI 10.1146/annurev-micro-091313-103537; Sijwali PS, 2004, P NATL ACAD SCI USA, V101, P4384, DOI 10.1073/pnas.0307720101; Silva AM, 1996, P NATL ACAD SCI USA, V93, P10034, DOI 10.1073/pnas.93.19.10034; Siripurkpong P, 2002, J BIOL CHEM, V277, P41009, DOI 10.1074/jbc.M204852200; Sittikul P, 2018, BIOCHIMIE, V152, P159, DOI 10.1016/j.biochi.2018.07.002; Skinner-Adams TS, 2004, J INFECT DIS, V190, P1998, DOI 10.1086/425584; Sleebs BE, 2014, J MED CHEM, V57, P7644, DOI 10.1021/jm500797g; Sleebs BE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001897; Spaccapelo R, 2010, AM J PATHOL, V176, P205, DOI 10.2353/ajpath.2010.090504; Spillman NJ, 2015, ANNU REV BIOCHEM, V84, P813, DOI 10.1146/annurev-biochem-060614-034157; Sullivan DJ, 2017, P NATL ACAD SCI USA, V114, P7483, DOI 10.1073/pnas.1708153114; Tachibana M, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12821; Tarr SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121786; Tarr SJ, 2013, MOL MICROBIOL, V87, P835, DOI 10.1111/mmi.12133; Thomas JA, 2018, NAT MICROBIOL, V3, P447, DOI 10.1038/s41564-018-0111-0; Tyas L, 1999, FEBS LETT, V454, P210, DOI 10.1016/S0014-5793(99)00805-4; VANDERJAGT DI, 1986, MOL BIOCHEM PARASIT, V18, P389, DOI 10.1016/0166-6851(86)90095-2; VANDERJAGT DL, 1992, BIOCHIM BIOPHYS ACTA, V1122, P256, DOI 10.1016/0167-4838(92)90401-X; Wegscheid-Gerlach C, 2010, CURR TOP MED CHEM, V10, P346, DOI 10.2174/156802610790725461; Weissbach T, 2017, EXP PARASITOL, V180, P33, DOI 10.1016/j.exppara.2017.03.006; Westling J, 1997, EXP PARASITOL, V87, P185, DOI 10.1006/expr.1997.4225; Westling J, 1999, PROTEIN SCI, V8, P2001, DOI 10.1110/ps.8.10.2001; Witkowski B, 2017, LANCET INFECT DIS, V17, P174, DOI [10.1016/S1473-3099(16)30415-7, 10.1016/s1473-3099(16)30415-7]; Wyatt DM, 2002, FEBS LETT, V513, P159, DOI 10.1016/S0014-5793(02)02241-X; Xiao HG, 2007, PROTEIN ENG DES SEL, V20, P625, DOI 10.1093/protein/gzm066; Xiao HG, 2006, PROTEIN EXPRES PURIF, V49, P88, DOI 10.1016/j.pep.2006.02.022; Xiao HG, 2014, MOL BIOCHEM PARASIT, V197, P56, DOI 10.1016/j.molbiopara.2014.10.004; Xiao HG, 2010, MOL BIOCHEM PARASIT, V173, P17, DOI 10.1016/j.molbiopara.2010.04.008; Xie D, 1997, BIOCHEMISTRY-US, V36, P16166, DOI 10.1021/bi971550l; Yang T, 2019, CELL REP, V29, P2917, DOI 10.1016/j.celrep.2019.10.095; Zhang M, 2018, SCIENCE, V360, P506, DOI 10.1126/science.aap7847	189	22	22	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8425	8441		10.1074/jbc.REV120.009309	http://dx.doi.org/10.1074/jbc.REV120.009309			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32366462	Green Published, hybrid			2022-12-28	WOS:000546986500007
J	Good, NM; Fellner, M; Demirer, K; Hu, J; Hausinger, RP; Martinez-Gomez, NC				Good, Nathan M.; Fellner, Matthias; Demirer, Kemal; Hu, Jian; Hausinger, Robert P.; Martinez-Gomez, N. Cecilia			Lanthanide-dependent alcohol dehydrogenases require an essential aspartate residue for metal coordination and enzymatic function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						one-carbon metabolism; metalloprotein; alcohol dehydrogenase (ADH); crystallography; aspartate (aspartic acid); cofactor coordination; ExaF; lanthanide; methanol dehydrogenase; XoxF; ethanol dehydrogenase; pyrroloquinoline quinone	QUINOPROTEIN ETHANOL DEHYDROGENASE; METHYLOBACTERIUM-EXTORQUENS AM1; METHANOL DEHYDROGENASE; PYRROLOQUINOLINE QUINONE; TRANSPOSON MUTAGENESIS; PSEUDOMONAS-AERUGINOSA; OXIDATION; XOXF; SYSTEM; LIFE	The lanthanide elements (Ln(3+)), those with atomic numbers 57?63 (excluding promethium, Pm3+), form a cofactor complex with pyrroloquinoline quinone (PQQ) in bacterial XoxF methanol dehydrogenases (MDHs) and ExaF ethanol dehydrogenases (EDHs), expanding the range of biological elements and opening novel areas of metabolism and ecology. Other MDHs, known as MxaFIs, are related in sequence and structure to these proteins, yet they instead possess a Ca2+-PQQ cofactor. An important missing piece of the Ln(3+)puzzle is defining what features distinguish enzymes that use Ln(3+)-PQQ cofactors from those that do not. Here, using XoxF1 MDH from the model methylotrophic bacteriumMethylorubrum extorquensAM1, we investigated the functional importance of a proposed lanthanide-coordinating aspartate residue. We report two crystal structures of XoxF1, one with and another without PQQ, both with La(3+)bound in the active-site region and coordinated by Asp(320). Using constructs to produce either recombinant XoxF1 or its D320A variant, we show that Asp(320)is needed forin vivocatalytic function,in vitroactivity, and La(3+)coordination. XoxF1 and XoxF1 D320A, when produced in the absence of La3+, coordinated Ca(2+)but exhibited little or no catalytic activity. We also generated the parallel substitution in ExaF to produce ExaF D319S and found that this variant loses the capacity for efficient ethanol oxidation with La3+. These results provide evidence that a Ln(3+)-coordinating aspartate is essential for the enzymatic functions of XoxF MDHs and ExaF EDHs, supporting the notion that sequences of these enzymes, and the genes that encode them, are markers for Ln(3+)metabolism.	[Good, Nathan M.; Demirer, Kemal; Hausinger, Robert P.; Martinez-Gomez, N. Cecilia] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Fellner, Matthias; Hu, Jian; Hausinger, Robert P.] Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; [Fellner, Matthias] Univ Otago, Dept Biochem, Dunedin, Otago, New Zealand; [Demirer, Kemal] Okemos High Sch, Okemos, MI USA; [Hu, Jian] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; University of Otago; Michigan State University	Martinez-Gomez, NC (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	mart1754@msu.edu	Fellner, Matthias/AAG-6443-2022; Fellner, Matthias/AFL-6357-2022	Fellner, Matthias/0000-0003-3192-6984; Fellner, Matthias/0000-0003-3192-6984; Martinez-Gomez, Norma/0000-0002-4071-7204; Good, Nathan/0000-0002-9490-5913; Hausinger, Robert/0000-0002-3643-2054	National Science Foundation [1750003, CHE-1516126]; University of Otago Health Sciences Postdoctoral Fellowship [HSCDPD1703]	National Science Foundation(National Science Foundation (NSF)); University of Otago Health Sciences Postdoctoral Fellowship	This material is based upon work supported by the National Science Foundation under Grants 1750003 (to N. C. M.-G. and N. M. G.) and CHE-1516126 (to R. P. H. and J. H.). M. F. was supported by University of Otago Health Sciences Postdoctoral Fellowship HSCDPD1703.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ANTHONY C, 1967, BIOCHEM J, V104, P960, DOI 10.1042/bj1040960; Anthony C, 1998, PROG BIOPHYS MOL BIO, V69, P1, DOI 10.1016/S0079-6107(97)00020-5; Anthony C, 1996, BIOCHEM J, V320, P697, DOI 10.1042/bj3200697; Anthony C, 2003, BBA-PROTEINS PROTEOM, V1647, P18, DOI 10.1016/S1570-9639(03)00042-6; Anthony C, 2001, ANTIOXID REDOX SIGN, V3, P757, DOI 10.1089/15230860152664966; Anthony C., 1982, BIOCH METHYLOTROPHS; ARMSTRONG JM, 1964, BIOCHIM BIOPHYS ACTA, V86, P194; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Bogart JA, 2015, CHEM-EUR J, V21, P1743, DOI 10.1002/chem.201405159; Cao TP, 2018, J MICROBIOL, V56, P246, DOI 10.1007/s12275-018-7483-y; Chistoserdova L., 2013, PROKARYOTES, P267; Chistoserdova L, 2019, MOL MICROBIOL, V111, P1127, DOI 10.1111/mmi.14210; Chistoserdova L, 2018, TRENDS MICROBIOL, V26, P703, DOI 10.1016/j.tim.2018.01.011; Chistoserdova L, 2016, WORLD J MICROB BIOT, V32, P138, DOI 10.1007/s11274-016-2088-2; Chistoserdova L, 2011, APPL ENVIRON MICROB, V77, P4705, DOI 10.1128/AEM.00314-11; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Chistoserdova LV, 1996, MICROBIOL-UK, V142, P1459, DOI 10.1099/13500872-142-6-1459; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; Culpepper MA, 2014, BIOCHEMISTRY-US, V53, P6211, DOI 10.1021/bi500850j; Daumann LJ, 2019, ANGEW CHEM INT EDIT, V58, P12795, DOI 10.1002/anie.201904090; Delaney NF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062957; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Deng YW, 2018, J BIOL INORG CHEM, V23, P1037, DOI 10.1007/s00775-018-1604-2; Diehl A, 1998, EUR J BIOCHEM, V257, P409, DOI 10.1046/j.1432-1327.1998.2570409.x; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farhan Ul Haque M, 2015, APPL ENVIRON MICROB, V81, P7546, DOI 10.1128/AEM.02542-15; Featherston ER, 2019, CHEMBIOCHEM, V20, P2360, DOI 10.1002/cbic.201900184; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GHOSH M, 1995, STRUCTURE, V3, P177, DOI 10.1016/S0969-2126(01)00148-4; Good NM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41043-1; Good NM, 2016, J BACTERIOL, V198, P3109, DOI 10.1128/JB.00478-16; GORISCH H, 1989, A VAN LEEUW J MICROB, V56, P35, DOI 10.1007/BF00822582; Gorisch H, 2003, BBA-PROTEINS PROTEOM, V1647, P98, DOI 10.1016/S1570-9639(03)00066-9; Green PN, 2018, INT J SYST EVOL MICR, V68, P2727, DOI 10.1099/ijsem.0.002856; Hibi Y, 2011, J BIOSCI BIOENG, V111, P547, DOI 10.1016/j.jbiosc.2010.12.017; Holm L, 2019, BIOINFORMATICS, V35, P5326, DOI 10.1093/bioinformatics/btz536; Huang J, 2019, ISME J, V13, P2005, DOI 10.1038/s41396-019-0414-z; Huang JH, 2018, FORESTS, V9, DOI 10.3390/f9010009; Jacobus AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119221; Jahn B, 2018, CHEMBIOCHEM, V19, P1147, DOI 10.1002/cbic.201800130; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keitel T, 2000, J MOL BIOL, V297, P961, DOI 10.1006/jmbi.2000.3603; Keltjens JT, 2014, APPL MICROBIOL BIOT, V98, P6163, DOI 10.1007/s00253-014-5766-8; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; Lumpe H, 2018, DALTON T, V47, P10463, DOI 10.1039/c8dt01238e; Martinez-Gomez NC, 2016, INORG CHEM, V55, P10083, DOI 10.1021/acs.inorgchem.6b00919; Marx CJ, 2003, J BACTERIOL, V185, P669, DOI 10.1128/JB.185.2.669-673.2003; Matsumura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104851; Matsushita K, 2002, APPL MICROBIOL BIOT, V58, P13, DOI 10.1007/s00253-001-0851-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUTZEL A, 1991, AGR BIOL CHEM TOKYO, V55, P1721, DOI 10.1080/00021369.1991.10870854; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050480; NUNN DN, 1986, J BACTERIOL, V166, P581, DOI 10.1128/jb.166.2.581-590.1986; Ochsner AM, 2019, MOL MICROBIOL, V111, P1152, DOI 10.1111/mmi.14208; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oubrie A, 2002, J BIOL CHEM, V277, P3727, DOI 10.1074/jbc.M109403200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pol A, 2014, ENVIRON MICROBIOL, V16, P255, DOI 10.1111/1462-2920.12249; Prejano M, 2017, CHEM-EUR J, V23, P8652, DOI 10.1002/chem.201700381; RICHARDSON IW, 1992, BIOCHEM J, V287, P709, DOI 10.1042/bj2870709; Roszczenko-Jasinska P, 2020, BIORXIV, DOI [10.1101/647677., DOI 10.1101/647677]; RUPP M, 1988, BIOL CHEM H-S, V369, P431, DOI 10.1515/bchm3.1988.369.1.431; Sakuraba H, 2010, ARCH BIOCHEM BIOPHYS, V502, P81, DOI 10.1016/j.abb.2010.08.002; Schmidt S, 2010, MICROBIOL-SGM, V156, P2575, DOI 10.1099/mic.0.038570-0; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Skovran E, 2019, CURR ISSUES MOL BIOL, V33, P101, DOI 10.21775/cimb.033.101; Skovran E, 2015, SCIENCE, V348, P862, DOI 10.1126/science.aaa9091; Skovran E, 2011, J BACTERIOL, V193, P6032, DOI 10.1128/JB.05367-11; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Takeda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115722; Taubert M, 2015, ENVIRON MICROBIOL, V17, P3937, DOI 10.1111/1462-2920.12896; Toyama H, 2004, ARCH BIOCHEM BIOPHYS, V428, P10, DOI 10.1016/j.abb.2004.03.037; Toyama H, 1998, FEMS MICROBIOL LETT, V166, P1; Tsushima S, 2019, PHYS CHEM CHEM PHYS, V21, P21979, DOI 10.1039/c9cp03953h; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Vu HN, 2016, J BACTERIOL, V198, P1250, DOI 10.1128/JB.00937-15; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Wang L, 2019, ENZYME MICROB TECH, V130, DOI 10.1016/j.enzmictec.2019.109371; Wegner CE, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.01830-19; Wehrmann M, 2017, MBIO, V8, DOI 10.1128/mBio.00570-17; Williams PA, 2005, ACTA CRYSTALLOGR D, V61, P75, DOI 10.1107/S0907444904026964; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu ML, 2015, APPL ENVIRON MICROB, V81, P1442, DOI 10.1128/AEM.03292-14; XIA ZX, 1992, J BIOL CHEM, V267, P22289	88	20	21	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8272	8284		10.1074/jbc.RA120.013227	http://dx.doi.org/10.1074/jbc.RA120.013227			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32366463	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000542965700015
J	Kesavardhana, S; Malireddi, RKS; Burton, AR; Porter, SN; Vogel, P; Pruett-Miller, SM; Kanneganti, TD				Kesavardhana, Sannula; Malireddi, R. K. Subbarao; Burton, Amanda R.; Porter, Shaina N.; Vogel, Peter; Pruett-Miller, Shondra M.; Kanneganti, Thirumala-Devi			The Z?2 domain of ZBP1 is a molecular switch regulating influenza-induced PANoptosis and perinatal lethality during development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza; influenza virus; RNA virus; negative-strand RNA virus; infection; microbiology	Z-DNA; RNA; NECROPTOSIS; CASPASE-1; REVEALS; COMPLEX; RIP3	Z-DNA-binding protein 1 (ZBP1) is an innate immune sensor of nucleic acids that regulates host defense responses and development. ZBP1 activation triggers inflammation and pyroptosis, necroptosis, and apoptosis (PANoptosis) by activating receptor-interacting Ser/Thr kinase 3 (RIPK3), caspase-8, and the NLRP3 inflammasome. ZBP1 is unique among innate immune sensors because of its N-terminal Z?1 and Z?2 domains, which bind to nucleic acids in the Z-conformation. However, the specific role of these Z? domains in orchestrating ZBP1 activation and subsequent inflammation and cell death is not clear. Here we generatedZbp1(?Z?2/?Z?2)mice that express ZBP1 lacking the Z?2 domain and demonstrate that this domain is critical for influenza A virus?induced PANoptosis and underlies perinatal lethality in mice in which the RIP homotypic interaction motif domain of RIPK1 has been mutated (Ripk1(mRHIM/mRHIM)). Deletion of the Z?2 domain in ZBP1 abolished influenza A virus?induced PANoptosis and NLRP3 inflammasome activation. Furthermore, deletion of the Z?2 domain of ZBP1 was sufficient to rescueRipk1(mRHIM/mRHIM)mice from perinatal lethality caused by ZBP1-driven cell death and inflammation. Our findings identify the essential role of the Z?2 domain of ZBP1 in several physiological functions and establish a link between Z-RNA sensing via the Z?2 domain and promotion of influenza-induced PANoptosis and perinatal lethality.	[Kesavardhana, Sannula; Malireddi, R. K. Subbarao; Burton, Amanda R.; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Porter, Shaina N.; Pruett-Miller, Shondra M.] St Jude Childrens Res Hosp, Ctr Adv Genome Engn, 332 N Lauderdale St, Memphis, TN 38105 USA; [Vogel, Peter] St Jude Childrens Res Hosp, Anim Resources Ctr & Vet Pathol Core, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Thirumala-Devi.Kanneganti@StJude.org	Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443	National Institutes of Health [AR056296, CA163507, AI101935, AI124346]; American Lebanese Syrian Associated Charities	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This study was supported by National Institutes of Health Grants AR056296, CA163507, AI101935, and AI124346 and the American Lebanese Syrian Associated Charities (to T.-D. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Connelly JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40896-w; Deigendesch N, 2006, NUCLEIC ACIDS RES, V34, P5007, DOI 10.1093/nar/gkl575; Fu YN, 1999, GENE, V240, P157, DOI 10.1016/S0378-1119(99)00419-9; Ha SC, 2008, P NATL ACAD SCI USA, V105, P20671, DOI 10.1073/pnas.0810463106; Jiao HP, 2020, NATURE, V580, P391, DOI 10.1038/s41586-020-2129-8; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kesavardhana S, 2020, ANNU REV IMMUNOL, V38, P567, DOI 10.1146/annurev-immunol-073119-095439; Kesavardhana S, 2017, J EXP MED, V214, P2217, DOI 10.1084/jem.20170550; Kim K, 2011, P NATL ACAD SCI USA, V108, P6921, DOI 10.1073/pnas.1014898107; Kuriakose T, 2018, TRENDS IMMUNOL, V39, P123, DOI 10.1016/j.it.2017.11.002; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Lin J, 2016, NATURE, V540, P124, DOI 10.1038/nature20558; Maelfait J, 2017, EMBO J, V36, P2529, DOI 10.15252/embj.201796476; Malireddi RKS, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00406; Newton K, 2016, NATURE, V540, P129, DOI 10.1038/nature20559; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Placido D, 2007, STRUCTURE, V15, P395, DOI 10.1016/j.str.2007.03.001; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Wang RC, 2020, NATURE, V580, P386, DOI 10.1038/s41586-020-2127-x; Zhang T, 2020, CELL, V180, P1115, DOI 10.1016/j.cell.2020.02.050	27	49	50	10	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8325	8330		10.1074/jbc.RA120.013752	http://dx.doi.org/10.1074/jbc.RA120.013752			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350114	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000542965700018
J	Subramanian, K; Hutt, DM; Scott, SM; Gupta, V; Mao, S; Balch, WE				Subramanian, Kanagaraj; Hutt, Darren M.; Scott, Samantha M.; Gupta, Vijay; Mao, Shu; Balch, William E.			Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone deacetylase inhibitor (HDAC inhibitor) (HDI); cholesterol; lysosome; intracellular trafficking; neurodegenerative disease; cholesterol homeostasis; choloroquine; Niemann-Pick type C disease; NPC1; valproic acid	STEROL-SENSING DOMAIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; N-TERMINAL DOMAIN; LYSINE ACETYLATION; MOUSE MODEL; NPC1 PROTEIN; CHOLESTEROL ACCUMULATION; LYSOSOMAL CHOLESTEROL; ENDOPLASMIC-RETICULUM; THERAPEUTIC PARADIGM	Niemann-Pick type C (NPC) disease is primarily caused by mutations in the NPC1 gene and is characterized by the accumulation of unesterified cholesterol and lipids in the late endosomal (LE) and lysosomal (Ly) compartments. The most prevalent disease-linked mutation is the I1061T variant of NPC1, which exhibits defective folding and trafficking from the endoplasmic reticulum to the LE/Ly compartments. We now show that the FDA-approved histone deacetylase inhibitor (HDACi) valproic acid (VPA) corrects the folding and trafficking defect associated with I1061T-NPC1 leading to restoration of cholesterol homeostasis, an effect that is largely driven by a reduction in HDAC7 expression. The VPA-mediated trafficking correction is in part associated with an increase in the acetylation of lysine residues in the cysteine-rich domain of NPC1. The HDACi-mediated correction is synergistically improved by combining it with the FDA-approved anti-malarial, chloroquine, a known lysosomotropic compound, which improved the stability of the LE/Ly-localized fraction of the I1061T variant. We posit that combining the activity of VPA, to modulate epigenetically the cellular acetylome, with chloroquine, to alter the lysosomal environment to favor stability of the trafficked I1061T variant protein can have a significant therapeutic benefit in patients carrying at least one copy of the I1061T variant of NPC1, the most common disease-associated mutation leading to NPC disease. Given its ability to cross the blood-brain barrier, we posit VPA provides a potential mechanism to improve the response to 2-hydroxypropyl-?-cyclodextrin, by restoring a functional NPC1 to the cholesterol managing compartment as an adjunct therapy.	[Subramanian, Kanagaraj; Hutt, Darren M.; Scott, Samantha M.; Gupta, Vijay; Balch, William E.] Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA; [Mao, Shu] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	Scripps Research Institute; Cornell University	Balch, WE (corresponding author), Scripps Res, Dept Mol Med, La Jolla, CA 92037 USA.	webalch@scripps.edu		Gupta, Dr. Vijay/0000-0002-3613-6378; Balch, William E./0000-0003-0899-8381	National Institutes of Health [AG049665, HL095524]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants AG049665 and HL095524 (to W. E. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alam MS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9407; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Angles F, 2019, HUM MOL GENET, V28, P1982, DOI 10.1093/hmg/ddz026; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Banerjee Audreesh, 2012, Am J Respir Cell Mol Biol, V46, P132, DOI 10.1165/rcmb.2010-0276OC; Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; Bouchecareilh M, 2012, CURR MOL MED, V12, P815, DOI 10.2174/156652412801318782; Bouchecareilh M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404707; Bouchecareilh Marion, 2011, Proc Am Thorac Soc, V8, P189, DOI 10.1513/pats.201008-055MS; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Buckland Jenny, 2011, Nat Rev Rheumatol, V7, P682, DOI 10.1038/nrrheum.2011.162; Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4; Chittur SV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-507; Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Christensen DP, 2011, MOL MED, V17, P378, DOI 10.2119/molmed.2011.00021; CORNFORD EM, 1985, J NEUROCHEM, V44, P1541, DOI 10.1111/j.1471-4159.1985.tb08793.x; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Davidson J, 2019, BBA-MOL CELL BIOL L, P1545, DOI 10.1016/j.bbalip.2019.04.011; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Davies JP, 2000, SCIENCE, V290, P2295, DOI 10.1126/science.290.5500.2295; Deane CAS, 2016, CELL STRESS CHAPERON, V21, P837, DOI 10.1007/s12192-016-0708-2; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Dunmore BJ, 2013, HUM MOL GENET, V22, P3667, DOI 10.1093/hmg/ddt216; Elrick MJ, 2010, HUM MOL GENET, V19, P837, DOI 10.1093/hmg/ddp552; Eriksson I, 2013, EXP CELL RES, V319, P12, DOI 10.1016/j.yexcr.2012.10.004; Estiu G, 2013, BIOCHEMISTRY-US, V52, P6879, DOI 10.1021/bi4005478; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Farmer CA, 2019, CNS DRUGS, V33, P677, DOI 10.1007/s40263-019-00642-2; Feng HL, 2008, NEUROSCIENCE, V155, P567, DOI 10.1016/j.neuroscience.2008.06.040; Fog CK, 2019, EXPERT OPIN DRUG DIS, V14, P499, DOI 10.1080/17460441.2019.1588882; Fog CK, 2018, EBIOMEDICINE, V38, P142, DOI 10.1016/j.ebiom.2018.11.037; Frolov A, 2001, J BIOL CHEM, V276, P46414, DOI 10.1074/jbc.M108099200; Garnock-Jones KP, 2015, DRUGS, V75, P695, DOI 10.1007/s40265-015-0388-8; Gelsthorpe ME, 2008, J BIOL CHEM, V283, P8229, DOI 10.1074/jbc.M708735200; Grandjean JMD, 2019, ACS CHEM BIOL, V14, P784, DOI 10.1021/acschembio.9b00134; Halili MA, 2009, CURR TOP MED CHEM, V9, P309, DOI 10.2174/156802609788085250; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Helquist P, 2013, NEUROTHERAPEUTICS, V10, P688, DOI 10.1007/s13311-013-0217-2; Hershey LA, 2019, DRUG AGING, V36, P309, DOI 10.1007/s40266-018-00636-7; Hindorff LA, 2018, NAT REV GENET, V19, P175, DOI 10.1038/nrg.2017.89; HUSSEIN Z, 1994, J CLIN PHARMACOL, V34, P754, DOI 10.1002/j.1552-4604.1994.tb02036.x; Hutt DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106224; Hutt DM, 2011, ACS MED CHEM LETT, V2, P703, DOI 10.1021/ml200136e; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Jagannath S, 2010, LEUKEMIA RES, V34, P1111, DOI 10.1016/j.leukres.2010.04.001; Kakee A, 2002, MICROVASC RES, V63, P233, DOI 10.1006/mvre.2001.2378; Ketter TA, 1999, CELL MOL NEUROBIOL, V19, P511, DOI 10.1023/A:1006990925122; Kim SJ, 2007, BIOCHEM BIOPH RES CO, V360, P593, DOI 10.1016/j.bbrc.2007.06.116; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kirkegaard T, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9823; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; KROGSTAD DJ, 1987, AM J TROP MED HYG, V36, P213, DOI 10.4269/ajtmh.1987.36.213; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Lagace DC, 2004, J BIOL CHEM, V279, P18851, DOI 10.1074/jbc.M312795200; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Leggatt GR, 2012, IMMUNOL CELL BIOL, V90, P33, DOI 10.1038/icb.2011.94; Leng Y, 2010, NEUROSCI LETT, V476, P127, DOI 10.1016/j.neulet.2010.04.013; Li J, 2017, TRENDS CELL BIOL, V27, P895, DOI 10.1016/j.tcb.2017.08.002; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Lu SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173771; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Marks PA, 2010, EXPERT OPIN INV DRUG, V19, P1049, DOI 10.1517/13543784.2010.510514; Marwick JA, 2007, EXPERT OPIN THER TAR, V11, P745, DOI 10.1517/14728222.11.6.745; Marwick JA, 2010, DRUGS, V70, P929, DOI 10.2165/10898520-000000000-00000; McBrian MA, 2013, MOL CELL, V49, P310, DOI 10.1016/j.molcel.2012.10.025; Mengel E, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-166; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Millat G, 1999, AM J HUM GENET, V65, P1321, DOI 10.1086/302626; Millat G, 2001, AM J HUM GENET, V68, P1373, DOI 10.1086/320606; Milne JC, 2008, CURR OPIN CHEM BIOL, V12, P11, DOI 10.1016/j.cbpa.2008.01.019; Nguyen MT, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113661; Munkacsi AB, 2017, J BIOL CHEM, V292, P4395, DOI 10.1074/jbc.M116.770578; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Neufeld EB, 1996, J BIOL CHEM, V271, P21604, DOI 10.1074/jbc.271.35.21604; Nunes MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053394; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ordonez MP, 2017, BRAIN RES, V1656, P63, DOI 10.1016/j.brainres.2016.03.007; Ory DS, 2017, LANCET, V390, P1758, DOI 10.1016/S0140-6736(17)31465-4; Ory DS, 2004, TRENDS CARDIOVAS MED, V14, P66, DOI 10.1016/j.tcm.2003.12.003; Parfitt DA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.214; Park WD, 2003, HUM MUTAT, V22, P313, DOI 10.1002/humu.10255; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Pipalia NH, 2006, J LIPID RES, V47, P284, DOI 10.1194/jlr.M500388-JLR200; Pipalia NH, 2017, J LIPID RES, V58, P695, DOI 10.1194/jlr.M072140; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Poirier S, 2013, TRAFFIC, V14, P458, DOI 10.1111/tra.12046; Praggastis M, 2015, J NEUROSCI, V35, P8091, DOI 10.1523/JNEUROSCI.4173-14.2015; Pugach EK, 2018, HUM MOL GENET, V27, P2101, DOI 10.1093/hmg/ddy117; Qadri YJ, 2012, J BIOL CHEM, V287, P16781, DOI 10.1074/jbc.M111.332031; Rao R, 2012, ADV CANCER RES, V116, P239, DOI 10.1016/B978-0-12-394387-3.00007-0; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Royce SG, 2014, PHARMACOL THERAPEUT, V141, P250, DOI 10.1016/j.pharmthera.2013.10.008; Runz H, 2008, HUM MUTAT, V29, P345, DOI 10.1002/humu.20636; Schultz ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06115-2; Scott C, 2004, BBA-MOL CELL BIOL L, V1685, P8, DOI 10.1016/j.bbalip.2004.08.006; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Singh AK, 2018, PHARMACOL RES, V132, P135, DOI 10.1016/j.phrs.2018.04.014; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; Sohaebuddin Syed K, 2013, Methods Mol Biol, V991, P25, DOI 10.1007/978-1-62703-336-7_3; Sung EA, 2017, ONCOTARGET, V8, P85428, DOI 10.18632/oncotarget.19976; Suraweera A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00092; Tangemo C, 2011, J LIPID RES, V52, P813, DOI 10.1194/jlr.P013524; Taylor AM, 2012, J LIPID RES, V53, P2331, DOI 10.1194/jlr.M028241; Terasaki M, 1996, DEV BIOL, V179, P320, DOI 10.1006/dbio.1996.0263; Torres S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00982; Totenhagen JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178179; Totenhagen JW, 2013, J MAGN RESON IMAGING, V37, P1195, DOI 10.1002/jmri.23902; Totenhagen JW, 2012, J MAGN RESON IMAGING, V35, P528, DOI 10.1002/jmri.22837; VAJDA FJE, 1981, NEUROLOGY, V31, P486; van den Bosch T, 2017, EPIGENOMICS-UK, V9, P1013, DOI 10.2217/epi-2017-0027; VanderMolen KM, 2011, J ANTIBIOT, V64, P525, DOI 10.1038/ja.2011.35; Vanier MT, 2015, J INHERIT METAB DIS, V38, P187, DOI 10.1007/s10545-014-9794-4; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Venkataramani V, 2010, J BIOL CHEM, V285, P10678, DOI 10.1074/jbc.M109.057836; Verma P, 2014, J NEUROSCI, V34, P1599, DOI 10.1523/JNEUROSCI.3039-13.2014; Vite CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010101; Vivas O, 2019, CELL REP, V27, P2636, DOI 10.1016/j.celrep.2019.04.099; Wang C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12969-x; Wang C, 2018, CELL REP, V24, P2013, DOI 10.1016/j.celrep.2018.07.059; Wang C, 2017, METHODS MOL BIOL, V1639, P185, DOI 10.1007/978-1-4939-7163-3_18; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; WIESER HG, 1991, EPILEPSY RES, V9, P154, DOI 10.1016/0920-1211(91)90028-E; Xuan AG, 2015, MOL NEUROBIOL, V51, P300, DOI 10.1007/s12035-014-8751-4; Zaaraoui W, 2011, MOL GENET METAB, V103, P138, DOI 10.1016/j.ymgme.2011.02.013; Zech M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082879; Zhang M, 2001, P NATL ACAD SCI USA, V98, P4466, DOI 10.1073/pnas.081070898	136	9	9	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8017	8035		10.1074/jbc.RA119.010524	http://dx.doi.org/10.1074/jbc.RA119.010524			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32354745	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000540935400016
J	Underwood, R; Wang, B; Carico, C; Whitaker, RH; Placzek, WJ; Yacoubian, TA				Underwood, Rachel; Wang, Bing; Carico, Christine; Whitaker, Robert H.; Placzek, William J.; Yacoubian, Talene A.			The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of ?-synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						?-synuclein; Rab; Parkinson's disease; autophagy; exosome (vesicle); neurodegeneration; protein misfolding; dementia with Lewy bodies; RAS oncogene family; synucleinopathy; Lewy body	ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; LEWY BODY; UNCONVENTIONAL SECRETION; SYNAPTIC-TRANSMISSION; EXOCYTOSIS; TRANSPORT; GRANULES; RAB3A; DYSFUNCTION	?-Synuclein (?syn) is the primary component of proteinaceous aggregates termed Lewy bodies that pathologically define synucleinopathies including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). ?syn is hypothesized to spread through the brain in a prion-like fashion by misfolded protein forming a template for aggregation of endogenous ?syn. The cell-to-cell release and uptake of ?syn are considered important processes for its prion-like spread. Rab27b is one of several GTPases essential to the endosomal-lysosomal pathway and is implicated in protein secretion and clearance, but its role in ?syn spread has yet to be characterized. In this study, we used a paracrine ?syn in vitro neuronal model to test the impact of Rab27b on ?syn release, clearance, and toxicity. shRNA-mediated knockdown (KD) of Rab27b increased ?syn-mediated paracrine toxicity. Rab27b reduced ?syn release primarily through nonexosomal pathways, but the ?syn released after Rab27b KD was of higher-molecular-weight species, as determined by size-exclusion chromatography. Rab27b KD increased intracellular levels of insoluble ?syn and led to an accumulation of endogenous light chain 3 (LC3)-positive puncta. Rab27b KD also decreased LC3 turnover after treatment with an autophagosome-lysosome fusion inhibitor, chloroquine, indicating that Rab27b KD induces a defect in autophagic flux. Rab27b protein levels were increased in brain lysates obtained from postmortem tissues of individuals with PD and DLB compared with healthy controls. These data indicate a role for Rab27b in the release, clearance, and toxicity of ?syn and, ultimately, in the pathogenesis of synucleinopathies.	[Underwood, Rachel; Wang, Bing; Yacoubian, Talene A.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, UAB Stn, Birmingham, AL 35294 USA; [Carico, Christine; Whitaker, Robert H.; Placzek, William J.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Yacoubian, TA (corresponding author), Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, UAB Stn, Birmingham, AL 35294 USA.	tyacoubian@uabmc.edu		Placzek, William/0000-0003-4096-8617; Underwood, Rachel/0000-0003-3630-7007; Yacoubian, Talene/0000-0003-2227-7310; Carico, Christine/0000-0001-7426-8200; Whitaker, Robert/0000-0002-9751-0423	NIA, National Institutes of Health [P30 AG19610]; Arizona Department of Health Services [211002]; Arizona Biomedical Research Commission [4001, 0011, 05-901, 1001]; Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research; University of Alabama Birmingham High Resolution Imaging Facility	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Arizona Department of Health Services; Arizona Biomedical Research Commission; Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research; University of Alabama Birmingham High Resolution Imaging Facility	We are grateful to Drs. Geidy Serrano and Thomas Beach (Banner Sun Health Research Institute Brain and Body Donation Program, Sun City, AZ, USA) for the provision of human brain tissue. The Brain and Body Donation Program is supported by NIA, National Institutes of Health, Grant P30 AG19610 (Arizona Alzheimer's Disease Core Center); Arizona Department of Health Services Contract 211002 (Arizona Alzheimer's Research Center); Arizona Biomedical Research Commission Contracts 4001, 0011, 05-901, and 1001 to the Arizona Parkinson's Disease Consortium; and the Prescott Family Initiative of the Michael J. Fox Foundation for Parkinson's Research. Research reported in this publication was also supported by the University of Alabama Birmingham High Resolution Imaging Facility.	Alessi DR, 2018, SCIENCE, V360, P36, DOI 10.1126/science.aar5683; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Binotti B, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010007; Breda C, 2015, HUM MOL GENET, V24, P1077, DOI 10.1093/hmg/ddu521; Brozzi F, 2012, TRAFFIC, V13, P54, DOI 10.1111/j.1600-0854.2011.01301.x; Chen RHC, 2013, J BIOL CHEM, V288, P7438, DOI 10.1074/jbc.M112.439497; Chiang LL, 2011, AM J PHYSIOL-CELL PH, V301, pC507, DOI 10.1152/ajpcell.00355.2010; Chu CT, 2019, NEUROBIOL DIS, V122, P23, DOI 10.1016/j.nbd.2018.07.015; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Coune PG, 2011, J PARKINSON DIS, V1, P373, DOI 10.3233/JPD-2011-11058; Dalfo E, 2004, NEUROBIOL DIS, V16, P92, DOI 10.1016/j.nbd.2004.01.001; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Danzer KM, 2009, J NEUROCHEM, V111, P192, DOI 10.1111/j.1471-4159.2009.06324.x; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dinter E, 2016, J NEUROCHEM, V138, P758, DOI 10.1111/jnc.13712; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Ejlerskov P, 2013, J BIOL CHEM, V288, P17313, DOI 10.1074/jbc.M112.401174; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fukuda M, 2013, TRAFFIC, V14, P949, DOI 10.1111/tra.12083; Gao YJ, 2018, MOVEMENT DISORD, V33, P196, DOI 10.1002/mds.27270; Ginsberg SD, 2011, J CHEM NEUROANAT, V42, P102, DOI 10.1016/j.jchemneu.2011.05.012; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Goncalves SA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005995; Handley MTW, 2008, BIOCHEM BIOPH RES CO, V373, P275, DOI 10.1016/j.bbrc.2008.06.043; Herzfeld T, 2013, HUM MOL GENET, V22, P941, DOI 10.1093/hmg/dds499; Jae N, 2015, FEBS LETT, V589, P3182, DOI 10.1016/j.febslet.2015.08.040; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kurowska M, 2012, BLOOD, V119, P3879, DOI 10.1182/blood-2011-09-382556; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Lesage S, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000009; Lill CM, 2011, AMYOTROPH LATERAL SC, V12, P238, DOI 10.3109/17482968.2011.584629; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; Lorincz P, 2020, J MOL BIOL, V432, P2462, DOI 10.1016/j.jmb.2019.10.028; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Malik BR, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0504-x; Manzoni C, 2013, FASEB J, V27, P3424, DOI 10.1096/fj.12-223842; McFerrin MB, 2017, ANN CLIN TRANSL NEUR, V4, P466, DOI 10.1002/acn3.421; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Ngolab J, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0445-5; Nozawa Takashi, 2018, Nihon Saikingaku Zasshi, V73, P193, DOI 10.3412/jsb.73.193; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Pavlos NJ, 2010, J NEUROSCI, V30, P13441, DOI 10.1523/JNEUROSCI.0907-10.2010; Pu J, 2016, J CELL SCI, V129, P4329, DOI 10.1242/jcs.196287; Santpere G, 2018, BRAIN PATHOL, V28, P315, DOI 10.1111/bpa.12511; Shen YT, 2016, NEUROSCI BULL, V32, P331, DOI 10.1007/s12264-016-0045-6; Slone SR, 2015, NEUROBIOL DIS, V79, P1, DOI 10.1016/j.nbd.2015.02.032; Stuendl A, 2016, BRAIN, V139, P481, DOI 10.1093/brain/awv346; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Tsunemi T, 2019, J NEUROSCI, V39, P5760, DOI 10.1523/JNEUROSCI.3085-18.2019; Vidyadhara DJ, 2019, J NEUROCHEM, V150, P487, DOI 10.1111/jnc.14820; Wang B, 2018, J NEUROSCI, V38, P8211, DOI 10.1523/JNEUROSCI.1134-18.2018; Wilson GR, 2014, AM J HUM GENET, V95, P729, DOI 10.1016/j.ajhg.2014.10.015; Xilouri M, 2016, MOVEMENT DISORD, V31, P178, DOI 10.1002/mds.26477; Yi Z, 2002, MOL CELL BIOL, V22, P1858, DOI 10.1128/MCB.22.6.1858-1867.2002; Yin G, 2014, NEUROBIOL DIS, V70, P149, DOI 10.1016/j.nbd.2014.06.018; Zhao SL, 2002, ENDOCRINOLOGY, V143, P1817, DOI 10.1210/en.143.5.1817	62	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8005	8016		10.1074/jbc.RA120.013337	http://dx.doi.org/10.1074/jbc.RA120.013337			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32350025	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000540935400015
J	Liang, XH; Cui, JM; Yang, XK; Xia, NB; Li, YQ; Zhao, JL; Gupta, N; Shen, B				Liang, Xiaohan; Cui, Jianmin; Yang, Xuke; Xia, Ningbo; Li, Yaqiong; Zhao, Junlong; Gupta, Nishith; Shen, Bang			Acquisition of exogenous fatty acids renders apicoplast-based biosynthesis dispensable in tachyzoites of Toxoplasma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid; pathogenesis; Toxoplasma gondii; parasite metabolism; pyruvate dehydrogenase complex (PDC); apicoplast; FabD; FAS2; lytic cycle; virulence	PYRUVATE-DEHYDROGENASE COMPLEX; PLASMODIUM-FALCIPARUM; METABOLISM; GONDII; PARASITES; GLUCOSE	Toxoplasma gondii is a common protozoan parasite that infects a wide range of hosts, including livestock and humans. Previous studies have suggested that the type 2 fatty acid synthesis (FAS2) pathway, located in the apicoplast (a nonphotosynthetic plastid relict), is crucial for the parasite's survival. Here we examined the physiological relevance of fatty acid synthesis in T. gondii by focusing on the pyruvate dehydrogenase complex and malonyl-CoA-[acyl carrier protein] transacylase (FabD), which are located in the apicoplast to drive de novo fatty acid biosynthesis. Our results disclosed unexpected metabolic resilience of T. gondii tachyzoites, revealing that they can tolerate CRISPR/Cas9?assisted genetic deletions of three pyruvate dehydrogenase subunits or FabD. All mutants were fully viable in prolonged cultures, albeit with impaired growth and concurrent loss of the apicoplast. Even more surprisingly, these mutants displayed normal virulence in mice, suggesting an expendable role of the FAS2 pathway in vivo. Metabolic labeling of the ?pdh-e1? mutant showed reduced incorporation of glucose-derived carbon into fatty acids with medium chain lengths (C14:0 and C16:0), revealing that FAS2 activity was indeed compromised. Moreover, supplementation of exogenous C14:0 or C16:0 significantly reversed the growth defect in the ?pdh-e1? mutant, indicating salvage of these fatty acids. Together, these results demonstrate that the FAS2 pathway is dispensable during the lytic cycle of Toxoplasma because of its remarkable flexibility in acquiring fatty acids. Our findings question the long-held assumption that targeting this pathway has significant therapeutic potential for managing Toxoplasma infections.	[Liang, Xiaohan; Cui, Jianmin; Yang, Xuke; Xia, Ningbo; Li, Yaqiong; Zhao, Junlong; Gupta, Nishith; Shen, Bang] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Zhao, Junlong; Shen, Bang] Key Lab Prevent Med Hubei Prov, Wuhan, Hubei, Peoples R China; [Zhao, Junlong] Hubei Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Hubei, Peoples R China; [Gupta, Nishith] Humboldt Univ, Fac Life Sci, Inst Biol, Dept Mol Parasitol, Berlin, Germany	Huazhong Agricultural University; Humboldt University of Berlin	Gupta, N; Shen, B (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.; Shen, B (corresponding author), Key Lab Prevent Med Hubei Prov, Wuhan, Hubei, Peoples R China.; Gupta, N (corresponding author), Humboldt Univ, Fac Life Sci, Inst Biol, Dept Mol Parasitol, Berlin, Germany.	Gupta.Nishith@hu-berlin.de; shenbang@mail.hzau.edu.cn		Xia, Ningbo/0000-0002-6090-7400; Gupta, Nishith/0000-0003-1452-5126	National Key Research and Development Program of China [2017YFD0501304]; National Natural Science Foundation of China [31872463]; Fundamental Research Funds for the Central Universities in China [2662019PY079]; German Research Foundation (DFG) [GU1100/15, GU1100/16]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by National Key Research and Development Program of China Grant 2017YFD0501304, National Natural Science Foundation of China Grant 31872463, and Fundamental Research Funds for the Central Universities in China Grant 2662019PY079. The work performed by X. L. and B. S. during their visits to the Gupta laboratory was sponsored by German Research Foundation (DFG) Grants GU1100/15 and GU1100/16.	Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Cobbold SA, 2013, J BIOL CHEM, V288, P36338, DOI 10.1074/jbc.M113.503557; Coppens I, 2013, NAT REV MICROBIOL, V11, P823, DOI 10.1038/nrmicro3139; Ecker J, 2012, J CHROMATOGR B, V897, P98, DOI 10.1016/j.jchromb.2012.04.015; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Fleige T, 2007, EUKARYOT CELL, V6, P984, DOI 10.1128/EC.00061-07; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; Goodman CD, 2007, CURR DRUG TARGETS, V8, P15, DOI 10.2174/138945007779315579; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Jones JL, 2012, CLIN INFECT DIS, V55, P845, DOI 10.1093/cid/cis508; Krishnan A, 2020, CELL HOST MICROBE, V27, P290, DOI 10.1016/j.chom.2020.01.002; Long S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006379; MacRae JI, 2012, CELL HOST MICROBE, V12, P682, DOI 10.1016/j.chom.2012.09.013; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; McFadden GI, 2017, INT J PARASITOL, V47, P137, DOI 10.1016/j.ijpara.2016.08.005; McFadden GI, 2001, PLANT PHYSIOL, V125, P50, DOI 10.1104/pp.125.1.50; Misra A, 2007, CHEM BIOL, V14, P775, DOI 10.1016/j.chembiol.2007.05.013; Misra A, 2009, MOL BIOSYST, V5, P651, DOI 10.1039/b820420a; Nolan SJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006362; Oppenheim RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004263; Park S, 2018, DIABETES METAB J, V42, P270, DOI 10.4093/dmj.2018.0101; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Pei Y, 2010, MOL MICROBIOL, V75, P957, DOI 10.1111/j.1365-2958.2009.07034.x; Ramakrishnan S, 2015, MOL MICROBIOL, V97, P64, DOI 10.1111/mmi.13010; Ramakrishnan S, 2013, PROG LIPID RES, V52, P488, DOI 10.1016/j.plipres.2013.06.003; Ramakrishnan S, 2012, J BIOL CHEM, V287, P4957, DOI 10.1074/jbc.M111.310144; Shears MJ, 2015, MOL BIOCHEM PARASIT, V199, P34, DOI 10.1016/j.molbiopara.2015.03.004; Shen B, 2017, METHODS MOL BIOL, V1498, P79, DOI 10.1007/978-1-4939-6472-7_6; Shen B, 2014, MBIO, V5, DOI 10.1128/mBio.01114-14; Triana MAH, 2018, J EUKARYOT MICROBIOL, V65, P709, DOI 10.1111/jeu.12626; van Schaijk BCL, 2014, EUKARYOT CELL, V13, P550, DOI 10.1128/EC.00264-13; Vaughan AM, 2009, CELL MICROBIOL, V11, P506, DOI 10.1111/j.1462-5822.2008.01270.x; Xia NB, 2019, MBIO, V10, DOI 10.1128/mBio.00898-19; Xia NB, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12794; Ye S, 2019, PARASITOL RES, V118, P935, DOI 10.1007/s00436-018-06197-3	37	18	18	7	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7743	7752		10.1074/jbc.RA120.013004	http://dx.doi.org/10.1074/jbc.RA120.013004			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32341123	Green Published, hybrid			2022-12-28	WOS:000538038900014
J	Iwase, M; Tokiwa, S; Seno, S; Mukai, T; Yeh, YS; Takahashi, H; Nomura, W; Jheng, HF; Matsumura, S; Kusudo, T; Osato, N; Matsuda, H; Inoue, K; Kawada, T; Goto, T				Iwase, Mari; Tokiwa, Soshi; Seno, Shigeto; Mukai, Takako; Yeh, Yu-Sheng; Takahashi, Haruya; Nomura, Wataru; Jheng, Huei-Fen; Matsumura, Sigenobu; Kusudo, Tatsuya; Osato, Naoki; Matsuda, Hideo; Inoue, Kazuo; Kawada, Teruo; Goto, Tsuyoshi			Glycerol kinase stimulates uncoupling protein 1 expression by regulating fatty acid metabolism in beige adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						uncoupling protein; adipocyte; adipose tissue; lipogenesis; lipolysis; obesity; fatty acid; fatty acid metabolism; thermogenesis	BROWN ADIPOSE-TISSUE; PALMITOLEIC ACID; RECEPTOR-ALPHA; INSULIN-RESISTANCE; LIPID-METABOLISM; DEFICIENCY; MOUSE; LIPOKINE; MICE; OVEREXPRESSION	Browning of adipose tissue is induced by specific stimuli such as cold exposure and consists of up-regulation of thermogenesis in white adipose tissue. Recently, it has emerged as an attractive target for managing obesity in humans. Here, we performed a comprehensive analysis to identify genes associated with browning in murine adipose tissue. We focused on glycerol kinase (GYK) because its mRNA expression pattern is highly correlated with that of uncoupling protein 1 (UCP1), which regulates the thermogenic capacity of adipocytes. Cold exposure-induced Ucp1 up-regulation in inguinal white adipose tissue (iWAT) was partially abolished by Gyk knockdown (KD) in vivo. Consistently, the Gyk KD inhibited Ucp1 expression induced by treatment with the ?-adrenergic receptors (?AR) agonist isoproterenol (Iso) in vitro and resulted in impaired uncoupled respiration. Gyk KD also suppressed Iso- and adenylate cyclase activator-induced transcriptional activation and phosphorylation of the cAMP response element-binding protein (CREB). However, we did not observe these effects with a cAMP analog. Therefore Gyk KD related to Iso-induced cAMP products. In Iso-treated Gyk KD adipocytes, stearoyl-CoA desaturase 1 (SCD1) was up-regulated, and monounsaturated fatty acids such as palmitoleic acid (POA) accumulated. Moreover, a SCD1 inhibitor treatment recovered the Gyk KD-induced Ucp1 down-regulation and POA treatment down-regulated Iso-activated Ucp1. Our findings suggest that Gyk stimulates Ucp1 expression via a mechanism that partially depends on the ?AR-cAMP-CREB pathway and Gyk-mediated regulation of fatty acid metabolism.	[Iwase, Mari; Tokiwa, Soshi; Yeh, Yu-Sheng; Takahashi, Haruya; Nomura, Wataru; Jheng, Huei-Fen; Matsumura, Sigenobu; Inoue, Kazuo; Kawada, Teruo; Goto, Tsuyoshi] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Uji, Kyoto 6110011, Japan; [Seno, Shigeto; Osato, Naoki; Matsuda, Hideo] Osaka Univ, Dept Bioinformat Engn, Grad Sch Informat Sci & Technol, Suita, Osaka 5650871, Japan; [Mukai, Takako; Kusudo, Tatsuya] Tezukayama Gakuin Univ, Fac Human Sci, Sakai, Osaka 5900113, Japan; [Nomura, Wataru; Kawada, Teruo; Goto, Tsuyoshi] Kyoto Univ, Res Unit Physiol Chem, Ctr Promot Interdisciplinary Educ & Res, Kyoto 6068317, Japan	Kyoto University; Osaka University; Kyoto University	Goto, T (corresponding author), Kyoto Univ, Lab Mol Funct Food, Div Food Sci & Biotechnol, Grad Sch Agr, Uji 6110011, Japan.	goto.tsuyoshi.6x@kyoto-u.ac.jp	Goto, Tsuyoshi/AAY-2344-2020; Iwase, Mari/GZH-2961-2022; Yeh, Yu-Sheng/GZH-3004-2022	Goto, Tsuyoshi/0000-0003-1283-147X; Iwase, Mari/0000-0002-6494-8787; Yeh, Yu-Sheng/0000-0002-0099-2690; Matsuda, Hideo/0000-0002-4701-3779; Osato, Naoki/0000-0001-9716-6725	Japan Society for the Promotion of Science KAKENHI [JP16H02551, JP18H04124, JP19H02910]; Japan Science Society	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science Society	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants JP16H02551, JP18H04124, and JP19H02910 and a Sasakawa Scientific Research Grant from the Japan Science Society. The authors declare that they have no conflicts of interest with the contents of this article.	Beale EG, 2002, FASEB J, V16, P1695, DOI 10.1096/fj.02-0407rev; Bolsoni-Lopes A, 2013, AM J PHYSIOL-ENDOC M, V305, pE1093, DOI 10.1152/ajpendo.00082.2013; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; de Souza CO, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700504; Djousse L, 2012, CIRC-HEART FAIL, V5, P703, DOI 10.1161/CIRCHEARTFAILURE.112.967802; ENSER M, 1975, BIOCHEM J, V148, P551, DOI 10.1042/bj1480551; Festuccia WT, 2010, AM J PHYSIOL-REG I, V299, pR159, DOI 10.1152/ajpregu.00821.2009; Festuccia WTL, 2003, AM J PHYSIOL-REG I, V284, pR1536, DOI 10.1152/ajpregu.00764.2002; Frigolet ME, 2017, ADV NUTR, V8, p173S, DOI 10.3945/an.115.011130; Garcia RA, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0081-2; Goto T, 2017, J BIOL CHEM, V292, P9175, DOI 10.1074/jbc.M116.767590; Goto T, 2016, CYTOKINE, V77, P107, DOI 10.1016/j.cyto.2015.11.001; Guan HP, 2002, NAT MED, V8, P1122, DOI 10.1038/nm780; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Huq AHMM, 1997, HUM MOL GENET, V6, P1803, DOI 10.1093/hmg/6.11.1803; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Kawashita NH, 2002, AM J PHYSIOL-REG I, V282, pR1185, DOI 10.1152/ajpregu.00419.2001; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Kim M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18013; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lasar D, 2018, CELL REP, V22, P760, DOI 10.1016/j.celrep.2017.12.067; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; LEWIS B, 1994, J CHILD NEUROL, V9, P70, DOI 10.1177/088307389400900118; Linden D, 2006, FASEB J, V20, P434, DOI 10.1096/fj.05-4568com; MCCORMACK JG, 1983, PROG LIPID RES, V21, P195, DOI 10.1016/0163-7827(82)90009-1; Merino J, 2016, NUTR METAB CARDIOVAS, V26, P261, DOI 10.1016/j.numecd.2015.12.008; Miao LL, 2019, FASEB J, V33, P6736, DOI 10.1096/fj.201800945RR; Miyazaki M, 2009, BIOCHEM BIOPH RES CO, V380, P818, DOI 10.1016/j.bbrc.2009.01.183; Morgan-Bathke M, 2016, ADIPOCYTE, V5, P93, DOI 10.1080/21623945.2015.1068977; Orlicky DJ, 2001, J LIPID RES, V42, P460; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; Rahib L, 2007, EUR J HUM GENET, V15, P646, DOI 10.1038/sj.ejhg.5201801; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sakamoto T, 2013, AM J PHYSIOL-CELL PH, V304, pC729, DOI 10.1152/ajpcell.00312.2012; Sharp LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049452; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Souza CO, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/582197; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takahashi H, 2013, BIOSCI BIOTECH BIOCH, V77, P2288, DOI 10.1271/bbb.130572; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Yeh YS, 2018, ISCIENCE, V9, P175, DOI 10.1016/j.isci.2018.10.019; Yu J, 2018, NUTR DIABETES, V8, DOI 10.1038/s41387-018-0045-x; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	49	6	6	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7033	7045		10.1074/jbc.RA119.011658	http://dx.doi.org/10.1074/jbc.RA119.011658			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32273338	hybrid, Green Published			2022-12-28	WOS:000536212600021
J	Scaletti, ER; Vallin, KS; Brautigam, L; Sarno, A; Berglund, UW; Helleday, T; Stenmark, P; Jemth, AS				Scaletti, Emma Rose; Vallin, Karl S.; Brautigam, Lars; Sarno, Antonio; Berglund, Ulrika Warpman; Helleday, Thomas; Stenmark, Pal; Jemth, Ann-Sofie			MutT homologue 1 (MTH1) removes N6-methyl-dATP from the dNTP pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; X-ray crystallography; enzyme catalysis; substrate specificity; enzyme kinetics; nucleoside; nucleotide metabolism; hydrolase; epigenetics; methylation; MutT homologue 1 (MTH1); N6-methyl-dATP; nucleotide hydrolysis; Nudix hydrolase 1 (NUDT1)	PROTEIN HYDROLYZES; DNA METHYLATION; OXIDIZED FORMS; N-6-METHYLADENINE; N-6-ADENINE; EXPRESSION; INHIBITORS; DEAMINASE; CLONING; REVEAL	MutT homologue 1 (MTH1) removes oxidized nucleotides from the nucleotide pool and thereby prevents their incorporation into the genome and thereby reduces genotoxicity. We previously reported that MTH1 is an efficient catalyst of O6-methyl-dGTP hydrolysis suggesting that MTH1 may also sanitize the nucleotide pool from other methylated nucleotides. We here show that MTH1 efficiently catalyzes the hydrolysis of N6-methyl-dATP to N6-methyl-dAMP and further report that N6-methylation of dATP drastically increases the MTH1 activity. We also observed MTH1 activity with N6-methyl-ATP, albeit at a lower level. We show that N6-methyl-dATP is incorporated into DNA in vivo, as indicated by increased N6-methyl-dA DNA levels in embryos developed from MTH1 knock-out zebrafish eggs microinjected with N6-methyl-dATP compared with noninjected embryos. N6-methyl-dATP activity is present in MTH1 homologues from distantly related vertebrates, suggesting evolutionary conservation and indicating that this activity is important. Of note, N6-methyl-dATP activity is unique to MTH1 among related NUDIX hydrolases. Moreover, we present the structure of N6-methyl-dAMP?bound human MTH1, revealing that the N6-methyl group is accommodated within a hydrophobic active-site subpocket explaining why N6-methyl-dATP is a good MTH1 substrate. N6-methylation of DNA and RNA has been reported to have epigenetic roles and to affect mRNA metabolism. We propose that MTH1 acts in concert with adenosine deaminase-like protein isoform 1 (ADAL1) to prevent incorporation of N6-methyl-(d)ATP into DNA and RNA. This would hinder potential dysregulation of epigenetic control and RNA metabolism via conversion of N6-methyl-(d)ATP to N6-methyl-(d)AMP, followed by ADAL1-catalyzed deamination producing (d)IMP that can enter the nucleotide salvage pathway.	[Scaletti, Emma Rose; Stenmark, Pal] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Vallin, Karl S.; Brautigam, Lars; Berglund, Ulrika Warpman; Helleday, Thomas; Jemth, Ann-Sofie] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, S-17176 Stockholm, Sweden; [Sarno, Antonio] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, N-7491 Trondheim, Norway; [Sarno, Antonio] St Olavs Hosp, Dept Pathol, N-7006 Trondheim, Norway; [Helleday, Thomas] Univ Sheffield, Dept Oncol & Metab, Weston Pk Canc Ctr, Sheffield S10 2RX, S Yorkshire, England; [Scaletti, Emma Rose; Stenmark, Pal] Lund Univ, Dept Expt Med Sci, S-22100 Lund, Sweden	Stockholm University; Karolinska Institutet; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Sheffield; Lund University	Stenmark, P (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.; Jemth, AS (corresponding author), Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, S-17176 Stockholm, Sweden.; Stenmark, P (corresponding author), Lund Univ, Dept Expt Med Sci, S-22100 Lund, Sweden.	stenmark@dbb.su.se; annsofie.jemth@scilifelab.se		Scaletti, Emma Rose/0000-0002-8741-8981; Stenmark, Pal/0000-0003-4777-3417; Jemth, Ann-Sofie/0000-0002-7550-1833; Sarno, Antonio/0000-0002-9308-8018	Swedish Research Council [2015-00162, 2018-03406]; Knut and Alice Wallenberg Foundation NOCA; Swedish Foundation for Strategic Research [RB13-0224]; European Research Council (ERC) [TAROX-695376]; Swedish Children's Cancer Foundation [PR2018-0095]; Swedish Cancer Society [CAN 2018/0658, CAN 2017/716]; Central Norway Regional Health Authority [46056921]; Svanhild and Arne Must's Fund for Medical Research; ERC Grant [TAROX-695376]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation NOCA(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Research Council (ERC)(European Research Council (ERC)European Commission); Swedish Children's Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Central Norway Regional Health Authority; Svanhild and Arne Must's Fund for Medical Research; ERC Grant	This work was supported by Swedish Research Council Grants 2015-00162 (to T. H.) and 2018-03406 (to P. S.), a grant from Knut and Alice Wallenberg Foundation NOCA (to P. S.), Swedish Foundation for Strategic Research Grant RB13-0224 (to U. W. B.), European Research Council (ERC) Grant TAROX-695376 (to T. H.), Swedish Children's Cancer Foundation Grant PR2018-0095 (to T. H.), Swedish Cancer Society Grants CAN 2018/0658 (to T. H.) and CAN 2017/716 (to P. S.), Central Norway Regional Health Authority Grant 46056921 (to A. S.), Svanhild and Arne Must's Fund for Medical Research (to A.S.), and ERC Grant TAROX-695376 for open access funding. The authors declare that they have no conflicts of interest with the contents of this article.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balacco DL, 2019, BIOCHEMISTRY-US, V58, P363, DOI 10.1021/acs.biochem.8b01166; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Berglund UW, 2016, ANN ONCOL, V27, P2275, DOI 10.1093/annonc/mdw429; Brautigam L, 2016, CANCER RES, V76, P2366, DOI 10.1158/0008-5472.CAN-15-2380; Brautigham, 2019, MTH1 PROMOTES MITOTI, P10, DOI [10.1101/575290, DOI 10.1101/575290]; Carreras-Puigvert J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01642-w; Carter M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8871; Casadesus J, 2013, J BIOL CHEM, V288, P13929, DOI 10.1074/jbc.R113.472274; Chen MJ, 2018, PLANT CELL, V30, P1511, DOI 10.1105/tpc.18.00236; Choi JS, 2016, NUCLEIC ACIDS RES, V44, P1022, DOI 10.1093/nar/gkv1509; Chojnacki S, 2017, NUCLEIC ACIDS RES, V45, pW550, DOI 10.1093/nar/gkx273; De Luca G, 2013, AGING CELL, V12, P695, DOI 10.1111/acel.12094; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Gasmi L, 1999, BIOCHEM J, V344, P331, DOI 10.1042/0264-6021:3440331; Greer EL, 2015, CELL, V161, P868, DOI 10.1016/j.cell.2015.04.005; Hashiguchi K, 2018, MUTAT RES-FUND MOL M, V808, P10, DOI 10.1016/j.mrfmmm.2018.01.002; Heyen CA, 2009, BIOCHEM BIOPH RES CO, V390, P1414, DOI 10.1016/j.bbrc.2009.11.007; Heyn H, 2015, CELL, V161, P710, DOI 10.1016/j.cell.2015.04.021; Jemth AS, 2019, BIOCHEMISTRY-US, V58, P887, DOI 10.1021/acs.biochem.8b00950; Jemth AS, 2018, NUCLEIC ACIDS RES, V46, P10888, DOI 10.1093/nar/gky896; Kettle JG, 2016, J MED CHEM, V59, P2346, DOI 10.1021/acs.jmedchem.5b01760; Kigar SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18414-7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kumar S, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00640; Lan Q, 2019, CANCER RES, V79, P1285, DOI 10.1158/0008-5472.CAN-18-2965; Luo GZ, 2015, NAT REV MOL CELL BIO, V16, P705, DOI 10.1038/nrm4076; Maity A, 2016, FEBS J, V283, P1607, DOI 10.1111/febs.13614; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Murakami E, 2011, J MED CHEM, V54, P5902, DOI 10.1021/jm200650j; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakabeppu Y, 2001, MUTAT RES-FUND MOL M, V477, P59, DOI 10.1016/S0027-5107(01)00096-3; Narwal M, 2018, BIOCHEMISTRY-US, V57, P593, DOI 10.1021/acs.biochem.7b01163; Pacini CE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41601-7; Parkhurst JM, 2016, J APPL CRYSTALLOGR, V49, P1912, DOI 10.1107/S1600576716013595; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Schiffers S, 2017, ANGEW CHEM INT EDIT, V56, P11268, DOI 10.1002/anie.201700424; Schinkmanova M, 2006, BIOCHEM PHARMACOL, V71, P1370, DOI 10.1016/j.bcp.2006.01.013; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798; Waz S, 2017, J BIOL CHEM, V292, P2785, DOI 10.1074/jbc.M116.749713; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Wu TP, 2016, NATURE, V532, P329, DOI 10.1038/nature17640; Wu X, 2018, AM J CANCER RES, V8, P1957; Wu YS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06898-4; Xiao CL, 2018, MOL CELL, V71, P306, DOI 10.1016/j.molcel.2018.06.015; Xie Q, 2018, CELL, V175, P1228, DOI 10.1016/j.cell.2018.10.006; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200; Yang HJ, 2000, J BIOL CHEM, V275, P8844, DOI 10.1074/jbc.275.12.8844; Yao B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01195-y; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018	61	6	8	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4761	4772		10.1074/jbc.RA120.012636	http://dx.doi.org/10.1074/jbc.RA120.012636			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32144205	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000526887000001
J	Tam, TH; Chan, KL; Boroumand, P; Liu, Z; Brozinick, JT; Bui, HH; Roth, K; Wakefield, CB; Penuela, S; Bilan, PJ; Klip, A				Tam, Theresa H.; Chan, Kenny L.; Boroumand, Parastoo; Liu, Zhi; Brozinick, Joseph T.; Bui, Hai Hoang; Roth, Kenneth; Wakefield, C. Brent; Penuela, Silvia; Bilan, Philip J.; Klip, Amira			Nucleotides released from palmitate-activated murine macrophages attract neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid; nucleotide; chemotaxis; macrophage; neutrophil; inflammation; obesity; high fat diet; metabolic disorder; pannexin-1	FIND-ME SIGNAL; ATP RELEASE; INNATE IMMUNITY; PANNEXIN 1; TNF-ALPHA; INFLAMMATION; OBESITY; CHANNELS; RECRUITMENT; PYROPTOSIS	Obesity and elevation of circulating free fatty acids are associated with an accumulation and proinflammatory polarization of macrophages within metabolically active tissues, such as adipose tissue, muscle, liver, and pancreas. Beyond macrophages, neutrophils also accumulate in adipose and muscle tissues during high-fat diets and contribute to a state of local inflammation and insulin resistance. However, the mechanisms by which neutrophils are recruited to these tissues are largely unknown. Here we used a cell culture system as proof of concept to show that, upon exposure to a saturated fatty acid, palmitate, macrophages release nucleotides that attract neutrophils. Moreover, we found that palmitate up-regulates pannexin-1 channels in macrophages that mediate the attraction of neutrophils, shown previously to allow transfer of nucleotides across membranes. These findings suggest that proinflammatory macrophages release nucleotides through pannexin-1, a process that may facilitate neutrophil recruitment into metabolic tissues during obesity.	[Tam, Theresa H.; Chan, Kenny L.; Boroumand, Parastoo; Liu, Zhi; Bilan, Philip J.; Klip, Amira] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Tam, Theresa H.; Chan, Kenny L.; Klip, Amira] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Boroumand, Parastoo; Klip, Amira] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Brozinick, Joseph T.; Bui, Hai Hoang; Roth, Kenneth] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Wakefield, C. Brent; Penuela, Silvia] Western Univ, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Penuela, Silvia] Western Univ, Schulich Sch Med & Dent, Dept Oncol, London, ON N6A 5C1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Eli Lilly; Western University (University of Western Ontario); Western University (University of Western Ontario)	Klip, A (corresponding author), Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada.; Klip, A (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada.; Klip, A (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	amira@sickkids.ca	; Penuela, Silvia/A-6961-2010	boroumand, parastoo/0000-0002-9520-9303; Penuela, Silvia/0000-0003-4829-5517	Canadian Institutes of Health Research [FND-143203]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-06794]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by Foundation Grant FND-143203 (to A. K.) from the Canadian Institutes of Health Research. Panx1<SUP>-/-</SUP> mouse studies were supported by Discovery Grant RGPIN-2015-06794 (to S. P.) from the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Adamson SE, 2015, MOL METAB, V4, P610, DOI 10.1016/j.molmet.2015.06.009; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Ali M, 2018, MOL BIOL REP, V45, P1245, DOI 10.1007/s11033-018-4279-4; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Bijnen M, 2018, GUT, V67, P1317, DOI 10.1136/gutjnl-2016-313654; Boutens L, 2016, DIABETOLOGIA, V59, P879, DOI 10.1007/s00125-016-3904-9; Boyd-Tressler A, 2014, J BIOL CHEM, V289, P27246, DOI 10.1074/jbc.M114.590240; Chai WD, 2019, AM J PHYSIOL-ENDOC M, V317, pE1063, DOI 10.1152/ajpendo.00203.2019; Chan KL, 2017, CELL REP, V18, P2415, DOI 10.1016/j.celrep.2017.02.027; Chan KL, 2015, J BIOL CHEM, V290, P16979, DOI 10.1074/jbc.M115.646992; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; Corriden R, 2012, PURINERG SIGNAL, V8, P587, DOI 10.1007/s11302-012-9311-x; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Erlinge D, 2011, ADV PHARMACOL, V61, P417, DOI 10.1016/B978-0-12-385526-8.00013-8; Eugenin EA, 2003, J IMMUNOL, V170, P1320, DOI 10.4049/jimmunol.170.3.1320; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Hadad N, 2013, DIABETES, V62, P3053, DOI 10.2337/db12-1300; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Kewalramani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026947; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kukulski F, 2009, CYTOKINE, V46, P166, DOI 10.1016/j.cyto.2009.02.011; Lee VR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34234-9; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18452-1; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Makarenkova HP, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00063; Michalski K, 2016, J GEN PHYSIOL, V147, P165, DOI 10.1085/jgp.201511505; Miyatake S, 2016, AM J PHYSIOL-ENDOC M, V310, pE160, DOI 10.1152/ajpendo.00325.2015; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; PETRONE WF, 1980, P NATL ACAD SCI-BIOL, V77, P1159, DOI 10.1073/pnas.77.2.1159; Pillon NJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE825, DOI 10.1152/ajpendo.00296.2016; Pillon NJ, 2014, DIABETES, V63, P3815, DOI 10.2337/db14-0150; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Roberts HM, 2018, OBES SURG, V28, P1611, DOI 10.1007/s11695-017-3063-1; Russo L, 2018, IMMUNOLOGY, V155, P407, DOI 10.1111/imm.13002; Sahoo M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004327; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Selders GS, 2017, REGEN BIOMATER, V4, P55, DOI 10.1093/rb/rbw041; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Ubhayasekera SJKA, 2013, ANAL BIOANAL CHEM, V405, P1929, DOI 10.1007/s00216-012-6658-3; Velasquez S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00096; Vong Linda, 2013, Methods Mol Biol, V1031, P41, DOI 10.1007/978-1-62703-481-4_5; Wang QL, 2014, DIABETES, V63, P4172, DOI 10.2337/db14-0026; Wang X, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00399; Watanabe Y, 2019, FASEB J, V33, P11821, DOI 10.1096/fj.201900477RR; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022	55	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4902	4911		10.1074/jbc.RA119.010868	http://dx.doi.org/10.1074/jbc.RA119.010868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32132172	Green Published, hybrid			2022-12-28	WOS:000526887000014
J	Badarudeen, B; Gupta, R; Nair, SV; Chandrasekharan, A; Manna, TK				Badarudeen, Binshad; Gupta, Ria; Nair, Sreeja, V; Chandrasekharan, Aneesh; Manna, Tapas K.			The ubiquitin ligase FBXW7 targets the centriolar assembly protein HsSAS-6 for degradation and thereby regulates centriole duplication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell division; centriole; centrosome; mitotic spindle; E3 ubiquitin ligase; centriole; centrosome; F-Box and WD repeat domain-containing 7 (FBXW7); human SAS-6 centriolar assembly protein (HsSAS6); ubiquitin; procentriole; ubiquitin; mitosis	CENTROSOME DUPLICATION; MEDIATED DEGRADATION; SINGLE PROCENTRIOLE; TUMOR SUPPRESSION; 9-FOLD SYMMETRY; C-ELEGANS; SAS-6; PLK4; ARCHITECTURE; CARTWHEEL	Formation of a single new centriole from a pre-existing centriole is strictly controlled to maintain correct centrosome number and spindle polarity in cells. However, the mechanisms that govern this process are incompletely understood. Here, using several human cell lines, immunofluorescence and structured illumination microscopy methods, and ubiquitination assays, we show that the E3 ubiquitin ligase F-box and WD repeat domain?containing 7 (FBXW7), a subunit of the SCF ubiquitin ligase, down-regulates spindle assembly 6 homolog (HsSAS-6), a key protein required for procentriole cartwheel assembly, and thereby regulates centriole duplication. We found that FBXW7 abrogation stabilizes HsSAS-6 and increases its recruitment to the mother centriole at multiple sites, leading to supernumerary centrioles. Ultrastructural analyses revealed that FBXW7 is broadly localized on the mother centriole and that its presence is reduced at the site where the HsSAS-6?containing procentriole is formed. This observation suggested that FBXW7 restricts procentriole assembly to a specific site to generate a single new centriole. In contrast, during HsSAS-6 overexpression, FBXW7 strongly associated with HsSAS-6 at the centriole. We also found that SCFFBXW7 interacts with HsSAS-6 and targets it for ubiquitin-mediated degradation. Further, we identified putative phosphodegron sites in HsSAS-6, whose substitutions rendered it insensitive to FBXW7-mediated degradation and control of centriole number. In summary, SCFFBXW7 targets HsSAS-6 for degradation and thereby controls centriole biogenesis by restraining HsSAS-6 recruitment to the mother centriole, a molecular mechanism that controls supernumerary centrioles/centrosomes and the maintenance of bipolar spindles.	[Badarudeen, Binshad; Gupta, Ria; Nair, Sreeja, V; Manna, Tapas K.] Indian Inst Sci Educ & Res, Sch Biol, Thiruvananthapuram 695551, Kerala, India; [Chandrasekharan, Aneesh] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram 695014, Kerala, India	Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Manna, TK (corresponding author), Indian Inst Sci Educ & Res, Sch Biol, Thiruvananthapuram 695551, Kerala, India.	tmanna@iisertvm.ac.in			DST-SERB, Government of India; INSPIRE fellowship from DST, Government of India	DST-SERB, Government of India; INSPIRE fellowship from DST, Government of India	This work was supported by DST-SERB, Government of India, and by an INSPIRE fellowship from DST, Government of India (to B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Arquint C, 2014, CURR BIOL, V24, P351, DOI 10.1016/j.cub.2013.12.016; Avidor-Reiss T, 2013, CURR OPIN CELL BIOL, V25, P72, DOI 10.1016/j.ceb.2012.10.016; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Brito DA, 2012, CURR OPIN CELL BIOL, V24, P4, DOI 10.1016/j.ceb.2012.01.003; Cizmecioglu O, 2012, J CELL SCI, V125, P981, DOI 10.1242/jcs.095075; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Guichard P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14813; Guichard P, 2013, CURR BIOL, V23, P1620, DOI 10.1016/j.cub.2013.06.061; Gupta H, 2015, BIOCHEMISTRY-US, V54, P6413, DOI 10.1021/acs.biochem.5b00978; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Hilbert M, 2016, NAT CELL BIOL, V18, P393, DOI 10.1038/ncb3329; Hilbert M, 2013, P NATL ACAD SCI USA, V110, P11373, DOI 10.1073/pnas.1302721110; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Jana SC, 2014, CURR OPIN CELL BIOL, V26, P96, DOI 10.1016/j.ceb.2013.12.001; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Levine MS, 2017, DEV CELL, V40, P313, DOI 10.1016/j.devcel.2016.12.022; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Maskey D, 2015, EMBO J, V34, P2424, DOI 10.15252/embj.201490831; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2018, NAT REV MOL CELL BIO, V19, P297, DOI 10.1038/nrm.2017.127; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Ohta M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6267; Ohtake F, 2016, MOL CELL, V64, P251, DOI 10.1016/j.molcel.2016.09.014; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Skaar JR, 2008, NAT CELL BIOL, V10, P755, DOI 10.1038/ncb0708-755; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; van Breugel M, 2014, ELIFE, V3, DOI 10.7554/eLife.01812; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; Zou CZ, 2005, J CELL BIOL, V171, P437, DOI 10.1083/jcb.200506185	50	3	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4428	4437		10.1074/jbc.AC119.012178	http://dx.doi.org/10.1074/jbc.AC119.012178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32086376	hybrid, Green Published			2022-12-28	WOS:000524499700006
J	Manenda, MS; Picard, ME; Zhang, LP; Cyr, N; Zhu, XJ; Barma, J; Pascal, JM; Couture, M; Zhang, CS; Shi, R				Manenda, Mahder S.; Picard, Marie-Eve; Zhang, Liping; Cyr, Normand; Zhu, Xiaojun; Barma, Julie; Pascal, John M.; Couture, Manon; Zhang, Changsheng; Shi, Rong			Structural analyses of the Group A flavin-dependent monooxygenase PieE reveal a sliding FAD cofactor conformation bridging OUT and IN conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavin adenine dinucleotide (FAD); enzyme catalysis; enzyme mechanism; small-angle X-ray scattering (SAXS); crystal structure; flavin-dependent monooxygenase; hydroxylation; mobile flavin; piericidin; sliding conformation	CRYSTAL-STRUCTURE; 2-HYDROXYBIPHENYL 3-MONOOXYGENASE; HYDROXYBENZOATE HYDROXYLASE; SUBSTRATE; PIERICIDIN; DYNAMICS; PROTEIN; STEPS; INHIBITION; SCATTERING	Group A flavin-dependent monooxygenases catalyze the cleavage of the oxygen?oxygen bond of dioxygen, followed by the incorporation of one oxygen atom into the substrate molecule with the aid of NADPH and FAD. These flavoenzymes play an important role in many biological processes, and their most distinct structural feature is the choreographed motions of flavin, which typically adopts two distinct conformations (OUT and IN) to fulfill its function. Notably, these enzymes seem to have evolved a delicate control system to avoid the futile cycle of NADPH oxidation and FAD reduction in the absence of substrate, but the molecular basis of this system remains elusive. Using protein crystallography, size-exclusion chromatography coupled to multi-angle light scattering (SEC-MALS), and small-angle X-ray scattering (SEC-SAXS) and activity assay, we report here a structural and biochemical characterization of PieE, a member of the Group A flavin-dependent monooxygenases involved in the biosynthesis of the antibiotic piericidin A1. This analysis revealed that PieE forms a unique hexamer. Moreover, we found, to the best of our knowledge for the first time, that in addition to the classical OUT and IN conformations, FAD possesses a ?sliding? conformation that exists in between the OUT and IN conformations. This observation sheds light on the underlying mechanism of how the signal of substrate binding is transmitted to the FAD-binding site to efficiently initiate NADPH binding and FAD reduction. Our findings bridge a gap currently missing in the orchestrated order of chemical events catalyzed by this important class of enzymes.	[Manenda, Mahder S.; Picard, Marie-Eve; Zhu, Xiaojun; Barma, Julie; Couture, Manon; Shi, Rong] Univ Laval, Dept Biochim Microbiol & Bioinformat, PROTEO, Quebec City, PQ G1V 0A6, Canada; [Manenda, Mahder S.; Picard, Marie-Eve; Zhu, Xiaojun; Barma, Julie; Couture, Manon; Shi, Rong] Univ Laval, IBIS, Quebec City, PQ G1V 0A6, Canada; [Zhang, Liping; Zhang, Changsheng] Chinese Acad Sci, RNAM Ctr Marine Microbiol, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol,Guang, 164 West Xingang Rd, Guangzhou 510301, Peoples R China; [Cyr, Normand; Pascal, John M.] Univ Montreal, Dept Biochim & Med Mol, Montreal, PQ H3T 1J4, Canada	Laval University; Laval University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Universite de Montreal	Shi, R (corresponding author), Univ Laval, Dept Biochim Microbiol & Bioinformat, PROTEO, Quebec City, PQ G1V 0A6, Canada.	rong.shi@bcm.ulaval.ca	Zhang, Changsheng/B-5965-2012; Couture, Manon/F-8326-2015	Zhang, Changsheng/0000-0003-2349-3138; ZHU, XIAOJUN/0000-0002-5409-3973; Couture, Manon/0000-0001-8296-8055; Cyr, Normand/0000-0002-9024-525X	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; National Research Council Canada; Canadian Institutes of Health Research; Canada Foundation for Innovation Award [30574]	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation Award(Canada Foundation for Innovation)	We thank Dr. Bhushan Nagar and Dr. Albert Berghuis for access to the X-ray diffractometer at McGill University. We also thank Dr. Steve Charette at Universite Laval for access to scientific equipment. Part of the research described in this paper was performed using beamline 08ID-1 at the Canadian Light Source (CLS), which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, the National Research Council Canada, and the Canadian Institutes of Health Research. We thank Shaun Labiuk at CLS for X-ray data collection. SEC-MALS and SEC-SAXS data were acquired at the Structural Biology Platform of the Universite de Montreal. The Platform was funded and is currently supported by Canada Foundation for Innovation Award 30574.	Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Benitez AR, 2019, ACS CATAL, V9, P3633, DOI 10.1021/acscatal.8b04575; Fenwick RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5070; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Chen YL, 2014, ORG LETT, V16, P736, DOI 10.1021/ol4034176; Chenprakhon P, 2019, PROTEIN SCI, V28, P8, DOI 10.1002/pro.3525; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; Darrouzet E, 1998, FEBS LETT, V431, P34, DOI 10.1016/S0014-5793(98)00719-4; Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enroth C, 2003, ACTA CRYSTALLOGR D, V59, P1597, DOI 10.1107/S0907444903014902; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; GATTI DL, 1994, SCIENCE, V266, P110, DOI 10.1126/science.7939628; Greenhagen BT, 2008, BIOCHEMISTRY-US, V47, P5281, DOI 10.1021/bi702480t; HALL C, 1966, BIOCHEM BIOPH RES CO, V25, P373, DOI 10.1016/0006-291X(66)90214-2; Hicks KA, 2013, BIOCHEMISTRY-US, V52, P477, DOI 10.1021/bi301262p; Hiromoto T, 2006, J MOL BIOL, V364, P878, DOI 10.1016/j.jmb.2006.09.031; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; Hutchinson JP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15827; Jackson DR, 2016, ACS CHEM BIOL, V11, P1137, DOI 10.1021/acschembio.5b00913; Jensen CN, 2015, CHEMBIOCHEM, V16, P968, DOI 10.1002/cbic.201402701; Kallio P, 2013, BIOCHEMISTRY-US, V52, P4507, DOI 10.1021/bi400381s; Kanteev M, 2015, BBA-PROTEINS PROTEOM, V1854, P1906, DOI 10.1016/j.bbapap.2015.08.002; Kikhney AG, 2020, PROTEIN SCI, V29, P66, DOI 10.1002/pro.3731; Kobayashi J, 2017, J BIOSCI BIOENG, V123, P154, DOI 10.1016/j.jbiosc.2016.07.022; Korasick DA, 2018, PROTEIN SCI, V27, P814, DOI 10.1002/pro.3376; Koshland DE, 1998, NAT MED, V4, P1112, DOI 10.1038/2605; Koskiniemi H, 2007, J MOL BIOL, V372, P633, DOI 10.1016/j.jmb.2007.06.087; Koteva K, 2018, CELL CHEM BIOL, V25, P403, DOI 10.1016/j.chembiol.2018.01.009; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lindqvist Y, 2009, J MOL BIOL, V393, P966, DOI 10.1016/j.jmb.2009.09.003; Liu LK, 2016, J BIOL CHEM, V291, P21553, DOI 10.1074/jbc.M116.745315; Markley JL, 2019, ACS INFECT DIS, V5, P618, DOI 10.1021/acsinfecdis.8b00349; Montersino S, 2013, J BIOL CHEM, V288, P26235, DOI 10.1074/jbc.M113.479303; Montersino S, 2011, ADV SYNTH CATAL, V353, P2301, DOI 10.1002/adsc.201100384; Moriarty NW, 2017, ACTA CRYSTALLOGR D, V73, P123, DOI 10.1107/S2059798316016570; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Palfey BA, 2002, BIOCHEMISTRY-US, V41, P8438, DOI 10.1021/bi012073g; Park J, 2017, NAT CHEM BIOL, V13, P730, DOI 10.1038/nchembio.2376; Piiadov V, 2019, PROTEIN SCI, V28, P454, DOI 10.1002/pro.3528; Romero E, 2018, CHEM REV, V118, P1742, DOI 10.1021/acs.chemrev.7b00650; Ryan KS, 2007, P NATL ACAD SCI USA, V104, P15311, DOI 10.1073/pnas.0707190104; Ryan KS, 2008, BIOCHEMISTRY-US, V47, P13506, DOI 10.1021/bi801229w; Teufel R, 2016, CURR OPIN CHEM BIOL, V31, P31, DOI 10.1016/j.cbpa.2016.01.001; Treiber N, 2008, J MOL BIOL, V379, P94, DOI 10.1016/j.jmb.2008.03.032; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Berkel W. J., 2013, FLAVINS FLAVOPROTEIN, V2011, P277; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; Wang J, 2002, P NATL ACAD SCI USA, V99, P608, DOI 10.1073/pnas.022640199; Wang P, 2013, J AM CHEM SOC, V135, P7138, DOI 10.1021/ja403516u; Zheng QF, 2018, CELL CHEM BIOL, V25, P718, DOI 10.1016/j.chembiol.2018.03.007; Zhu YG, 2016, CHEM SCI, V7, P4867, DOI 10.1039/c6sc00771f	58	4	4	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4709	4722		10.1074/jbc.RA119.011212	http://dx.doi.org/10.1074/jbc.RA119.011212			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32111738	Green Published, hybrid			2022-12-28	WOS:000524499700028
J	Okamoto, Y; Saito, T; Tani, Y; Toki, T; Hasebe, A; Koido, M; Tomida, A				Okamoto, Yuka; Saito, Takuya; Tani, Yuri; Toki, Tamami; Hasebe, Akiko; Koido, Masaru; Tomida, Akihiro			The kinase PERK represses translation of the G-protein?coupled receptor LGR5 and receptor tyrosine kinase ERBB3 during ER stress in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); protein synthesis; protein stability; eukaryotic initiation factor 2 (eIF2); unfolded protein response (UPR); colon cancer; kinase signaling; leucine-rich repeat-containing G-protein?coupled receptor 5(LGR5); protein kinase R-like ER kinase (PERK)	UNCHARGED TRANSFER-RNA; WNT/BETA-CATENIN; STEM-CELLS; SMALL-INTESTINE; GRP78 PROMOTER; SELF-RENEWAL; COLON; GENE; REINITIATION; ACTIVATION	As a branch of the unfolded protein response, protein kinase R-like endoplasmic reticulum kinase (PERK) represses global translation in response to endoplasmic reticulum (ER) stress. This pathophysiological condition is associated with the tumor microenvironment in cancer. Previous findings in our lab have suggested that PERK selectively represses translation of some mRNAs, but this possibility awaits additional investigation. In this study, we show that a stem-cell marker protein, leucine-rich repeat-containing G-protein?coupled receptor 5 (LGR5), is rapidly depleted in colon cancer cells during ER stress, an effect that depended on the PERK-mediated translational repression. Indeed, the PERK inhibition led to the accumulation of premature, underglycosylated forms of LGR5, which were produced only at low levels during proper PERK activation. Unlike the mature LGR5 form, which is constitutively degraded regardless of PERK activation, the underglycosylated LGR5 exhibited a prolonged half-life and accumulated inside the cells without being expressed on the cell surface. We also found that Erb-B2 receptor tyrosine kinase 3 (ERBB3) is subjected to a similarly-regulated depletion by PERK, whereas the epidermal growth factor receptor (EGFR), stress-inducible heat-shock protein family A (Hsp70) member 5 (HSPA5), and anterior gradient 2 protein-disulfide isomerase family member (AGR2) were relatively. insensitive to the PERK-mediated repression of translation. These results indicate that LGR5 and ERBB3 are targets for PERK-mediated translational repression during ER stress	[Okamoto, Yuka; Saito, Takuya; Tani, Yuri; Toki, Tamami; Hasebe, Akiko; Koido, Masaru; Tomida, Akihiro] Japanese Fdn Canc Res, Canc Chemotherapy Ctr, Genome Res, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan	Japanese Foundation for Cancer Research	Tomida, A (corresponding author), Japanese Fdn Canc Res, Canc Chemotherapy Ctr, Genome Res, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	akihiro.tomida@jfcr.or.jp	Koido, Masaru/I-2930-2019	Koido, Masaru/0000-0002-0348-0666	Ministry of Education, Culture, Sports, Science and Technology of Japan [18K15293, 16K18465, 19H03526, 16H04717]; Nippon Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nippon Foundation(Nippon Foundation)	This work was supported in part by Grants-in-aid for Young Scientists 18K15293 and 16K18465 (to Y. O.), Grants-in-aid for Scientific Research (B) 19H03526 and 16H04717 (to A. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and in part by the Nippon Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dumartin L, 2017, ONCOGENE, V36, P3094, DOI 10.1038/onc.2016.459; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; GONCHAR NA, 1981, VOP MED KHIM, V27, P815; Gonen N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38705-5; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kraft CL, 2017, ONCOTARGET, V8, P102923, DOI 10.18632/oncotarget.22084; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Morgan RG, 2015, BRIT J CANCER, V112, P714, DOI 10.1038/bjc.2015.4; Reid DW, 2014, CELL, V158, P1362, DOI 10.1016/j.cell.2014.08.012; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato H, 2004, BIOCHEM BIOPH RES CO, V325, P109, DOI 10.1016/j.bbrc.2004.10.009; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schuldt A, 2014, NAT REV MOL CELL BIO, V15, DOI 10.1038/nrm3725; Shimokawa M, 2017, NATURE, V545, P187, DOI 10.1038/nature22081; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Trejo CL, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0018-6; Tsukumo Y, 2009, J BIOL CHEM, V284, P27500, DOI 10.1074/jbc.M109.021592; Van Hoewyk D, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0120-z; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WOODEN SK, 1991, MOL CELL BIOL, V11, P5612, DOI 10.1128/MCB.11.11.5612; Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Ye P, 2014, MOL CELL BIOL, V34, P3421, DOI 10.1128/MCB.00221-14; Zhou XL, 2017, CANCER RES, V77, P6589, DOI 10.1158/0008-5472.CAN-17-0219	48	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4591	4603		10.1074/jbc.RA119.010655	http://dx.doi.org/10.1074/jbc.RA119.010655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32107308	hybrid, Green Published			2022-12-28	WOS:000524499700019
J	Weitzel, CS; Li, L; Changyi, Z; Eilts, KK; Bretz, NM; Gatten, AL; Whitaker, RJ; Martinis, SA				Weitzel, Christopher S.; Li, Li; Changyi, Zhang; Eilts, Kristen K.; Bretz, Nicholas M.; Gatten, Alex L.; Whitaker, Rachel J.; Martinis, Susan A.			Duplication of leucyl-tRNA synthetase in an archaeal extremophile may play a role in adaptation to variable environmental conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; transfer RNA (tRNA); translation; archaea; enzyme catalysis; genetics; editing; fidelity; paralogs; Sulfolobaceae; Sulfolobus islandicus	NUCLEIC-ACID INTERACTIONS; ESCHERICHIA-COLI; SULFOLOBUS-ISLANDICUS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENETIC-CODE; AMINO-ACIDS; MICROSCALE THERMOPHORESIS; SENSITIVE METHOD; MISTRANSLATION	Aminoacyl-tRNA synthetases (aaRSs) are ancient enzymes that play a fundamental role in protein synthesis. They catalyze the esterification of specific amino acids to the 3?-end of their cognate tRNAs and therefore play a pivotal role in protein synthesis. Although previous studies suggest that aaRS-dependent errors in protein synthesis can be beneficial to some microbial species, evidence that reduced aaRS fidelity can be adaptive is limited. Using bioinformatics analyses, we identified two distinct leucyl-tRNA synthetase (LeuRS) genes within all genomes of the archaeal family Sulfolobaceae. Remarkably, one copy, designated LeuRS-I, had key amino acid substitutions within its editing domain that would be expected to disrupt hydrolytic editing of mischarged tRNA(Leu) and to result in variation within the proteome of these extremophiles. We found that another copy, LeuRS-F, contains canonical active sites for aminoacylation and editing. Biochemical and genetic analyses of the paralogs within Sulfolobus islandicus supported the hypothesis that LeuRS-F, but not LeuRS-I, functions as an essential tRNA synthetase that accurately charges leucine to tRNA(Leu) for protein translation. Although LeuRS-I was not essential, its expression clearly supported optimal S. islandicus growth. We conclude that LeuRS-I may have evolved to confer a selective advantage under the extreme and fluctuating environmental conditions characteristic of the volcanic hot springs in which these archaeal extremophiles reside.	[Weitzel, Christopher S.; Eilts, Kristen K.; Bretz, Nicholas M.] Illinois State Univ, Dept Chem, Normal, IL 61761 USA; [Li, Li; Gatten, Alex L.; Martinis, Susan A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Li, Li; Martinis, Susan A.] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Changyi, Zhang; Whitaker, Rachel J.] Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA; [Changyi, Zhang; Whitaker, Rachel J.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Li, Li] Richard B Simches Res Ctr, Ctr Computat & Integrat Res, Boston, MA 02114 USA; [Gatten, Alex L.] Univ Louisville, Sch Dent, Louisville, KY 40202 USA	Illinois State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Louisville	Weitzel, CS (corresponding author), Illinois State Univ, Dept Chem, Normal, IL 61761 USA.	csweitz@ilstu.edu		Eilts, Kristen/0000-0001-9470-3863; Martinis, Susan/0000-0001-5730-8346; Bretz, Nicholas/0000-0003-4481-7381	Illinois State University; National Science Foundation [1205373]; NASA Exobiology Program [NNX14AK23G]	Illinois State University; National Science Foundation(National Science Foundation (NSF)); NASA Exobiology Program(National Aeronautics & Space Administration (NASA))	This work was supported by laboratory startup funds from the Illinois State University (to C. S. W.), National Science Foundation Grant 1205373 (to S. A. M.), and NASA Exobiology Program Grant NNX14AK23G (to R. J. W.). The authors declare that they have no conflicts of interest with the contents of this article.	An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Andam CP, 2011, FEMS MICROBIOL REV, V35, P756, DOI 10.1111/j.1574-6976.2011.00274.x; ANEMULLER S, 1990, EUR J BIOCHEM, V191, P297, DOI 10.1111/j.1432-1033.1990.tb19123.x; Rubio MA, 2015, NUCLEIC ACIDS RES, V43, P9905, DOI 10.1093/nar/gkv1020; Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREVET A, 1995, J BIOL CHEM, V270, P14439, DOI 10.1074/jbc.270.24.14439; Campbell KM, 2017, ENVIRON MICROBIOL, V19, P2334, DOI 10.1111/1462-2920.13728; Chaliotis A, 2017, NUCLEIC ACIDS RES, V45, P1059, DOI 10.1093/nar/gkw1182; CHARLIER J, 1987, BIOCHEM J, V248, P43, DOI 10.1042/bj2480043; Colussi TM, 2014, NATURE, V511, P366, DOI 10.1038/nature13378; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Fang ZP, 2014, NUCLEIC ACIDS RES, V42, P5109, DOI 10.1093/nar/gku108; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; FIRST EA, 1995, BIOCHEMISTRY-US, V34, P5030, DOI 10.1021/bi00015a014; Fukuda W, 2008, FEMS MICROBIOL LETT, V287, P113, DOI 10.1111/j.1574-6968.2008.01303.x; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; Fukunaga R, 2007, BIOCHEMISTRY-US, V46, P4985, DOI 10.1021/bi6024935; Giege R, 2012, WIRES RNA, V3, P37, DOI 10.1002/wrna.103; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; He XD, 2018, CELL METAB, V27, P151, DOI 10.1016/j.cmet.2017.10.015; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; HIRSHFIELD IN, 1984, J BACTERIOL, V158, P615, DOI 10.1128/JB.158.2.615-620.1984; HIRSHFIELD IN, 1981, J BACTERIOL, V146, P345, DOI 10.1128/JB.146.1.345-351.1981; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Jaubert C, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130010; Karkhanis VA, 2007, J BACTERIOL, V189, P8765, DOI 10.1128/JB.01215-07; Katz A, 2016, MOL MICROBIOL, V101, P545, DOI 10.1111/mmi.13419; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee JY, 2014, J CELL SCI, V127, P4234, DOI 10.1242/jcs.152470; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Martinis S A, 1997, Nucleic Acids Symp Ser, V36, P125; Martinis SA, 2007, CHEM BIOL, V14, P1307, DOI 10.1016/j.chembiol.2007.12.001; Martinis SA, 2010, FEBS LETT, V584, P455, DOI 10.1016/j.febslet.2009.11.071; Mascarenhas A. P., 2009, V22, P155; Miranda I, 2013, MBIO, V4, DOI 10.1128/mBio.00285-13; Mohler K, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.117; Mueller AM, 2017, METHODS MOL BIOL, V1654, P151, DOI 10.1007/978-1-4939-7231-9_10; Mursinna RS, 2002, J AM CHEM SOC, V124, P7286, DOI 10.1021/ja025879s; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; NORMANLY J, 1986, P NATL ACAD SCI USA, V83, P6548, DOI 10.1073/pnas.83.17.6548; Ochsner UA, 2007, EXPERT OPIN INV DRUG, V16, P573, DOI 10.1517/13543784.16.5.573; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; RajBhandary UL, 1997, P NATL ACAD SCI USA, V94, P11761, DOI 10.1073/pnas.94.22.11761; Reader JS, 2005, SCIENCE, V309, P1533, DOI 10.1126/science.1116841; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Sakofsky CJ, 2011, ARCHAEA, V2011, DOI 10.1155/2011/864015; Samson RY, 2013, CELL REP, V3, P485, DOI 10.1016/j.celrep.2013.01.002; Santangelo TJ, 2010, APPL ENVIRON MICROB, V76, P1044, DOI 10.1128/AEM.02497-09; SANTOS MAS, 1993, EMBO J, V12, P607, DOI 10.1002/j.1460-2075.1993.tb05693.x; Sarkany Zsuzsa, 2014, Front Mol Biosci, V1, P27, DOI 10.3389/fmolb.2014.00027; Schimmel P, 2008, PROTEIN SCI, V17, P1643, DOI 10.1110/ps.037242.108; Schimmel P, 2011, PHILOS T R SOC B, V366, P2965, DOI 10.1098/rstb.2011.0158; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz MH, 2016, NUCLEIC ACIDS RES, V44, P294, DOI 10.1093/nar/gkv1379; She QX, 2009, BIOCHEM SOC T, V37, P92, DOI 10.1042/BST0370092; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Snyder JC, 2007, P NATL ACAD SCI USA, V104, P19102, DOI 10.1073/pnas.0709445104; Soma A, 1999, J MOL BIOL, V293, P1029, DOI 10.1006/jmbi.1999.3219; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tang Y, 2002, BIOCHEMISTRY-US, V41, P10635, DOI 10.1021/bi026130x; Tremblay LW, 2008, BIOCHEMISTRY-US, V47, P13326, DOI 10.1021/bi801708f; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Wagner M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00214; Wang XY, 2016, ADV NUTR, V7, p773S, DOI 10.3945/an.115.010991; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; Wiltrout E, 2012, NUCLEIC ACIDS RES, V40, P10494, DOI 10.1093/nar/gks805; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Zhai YX, 2007, BIOCHEMISTRY-US, V46, P3331, DOI 10.1021/bi061778l; Zhai YX, 2005, BIOCHEMISTRY-US, V44, P15437, DOI 10.1021/bi0514461; Zhang CY, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02167-17; Zhang CY, 2013, APPL ENVIRON MICROB, V79, P5539, DOI 10.1128/AEM.01608-13; Zhang CY, 2013, BIOCHEM SOC T, V41, P458, DOI 10.1042/BST20120338; Zhang CY, 2012, MICROBIOL-SGM, V158, P1513, DOI 10.1099/mic.0.058289-0; Zhang CY, 2010, MICROBIOL-SGM, V156, P3386, DOI 10.1099/mic.0.042523-0; Zheng T, 2012, APPL ENVIRON MICROB, V78, P568, DOI 10.1128/AEM.06095-11; Zillner K, 2012, METHODS MOL BIOL, V815, P241, DOI 10.1007/978-1-61779-424-7_18	90	3	3	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4563	4576		10.1074/jbc.RA118.006481	http://dx.doi.org/10.1074/jbc.RA118.006481			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32102848	hybrid, Green Published			2022-12-28	WOS:000524499700017
J	Kiepas, A; Voorand, E; Senecal, J; Ahn, R; Annis, MG; Jacquet, K; Tali, G; Bisson, N; Ursini-Siegel, J; Siegel, PM; Brown, CM				Kiepas, Alex; Voorand, Elena; Senecal, Julien; Ahn, Ryuhjin; Annis, Matthew G.; Jacquet, Kevin; Tali, George; Bisson, Nicolas; Ursini-Siegel, Josie; Siegel, Peter M.; Brown, Claire M.			The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; focal adhesion; cell invasion; invadopodia; microscopy; adhesion dynamics; cancer; lipoma-preferred partner (LPP); SHC adaptor protein (SHCA); transforming growth factor beta (TGF beta)	GROWTH-FACTOR-BETA; CANCER-CELL-MIGRATION; BREAST-CANCER; MESENCHYMAL TRANSITION; TYROSINE PHOSPHORYLATION; MATRIX-METALLOPROTEINASE; MAMMARY TUMORIGENESIS; ACTIN CYTOSKELETON; STATISTICAL-MODEL; INTEGRIN ADHESOME	SHC adaptor protein (SHCA) and lipoma-preferred partner (LPP) mediate transforming growth factor beta (TGF beta)-induced breast cancer cell migration and invasion. Reduced expression of either protein diminishes breast cancer lung metastasis, but the reason for this effect is unclear. Here, using total internal reflection fluorescence (TIRF) microscopy, we found that TGF beta enhanced the assembly and disassembly rates of paxillin-containing adhesions in an SHCA-dependent manner through the phosphorylation of the specific SHCA tyrosine residues Tyr-239, Tyr-240, and Tyr-313. Using a BioID proximity labeling approach, we show that SHCA exists in a complex with a variety of actin cytoskeletal proteins, including paxillin and LPP. Consistent with a functional interaction between SHCA and LPP, TGF beta-induced LPP localization to cellular adhesions depended on SHCA. Once localized to the adhesions, LPP was required for TGF beta-induced increases in cell migration and adhesion dynamics. Mutations that impaired LPP localization to adhesions (mLIM1) or impeded interactions with the actin cytoskeleton via alpha-actinin (Delta ABD) abrogated migratory responses to TGF beta. Live-cell TIRF microscopy revealed that SHCA clustering at the cell membrane preceded LPP recruitment. We therefore hypothesize that, in the presence of TGF beta, SHCA promotes the formation of small, dynamic adhesions by acting as a nucleator of focal complex formation. Finally, we defined a previously unknown function for SHCA in the formation of invadopodia, a process that also required LPP. Our results reveal that SHCA controls the formation and function of adhesions and invadopodia, two key cellular structures required for breast cancer metastasis.	[Kiepas, Alex; Tali, George; Brown, Claire M.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Voorand, Elena; Ursini-Siegel, Josie; Siegel, Peter M.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Annis, Matthew G.; Siegel, Peter M.] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Kiepas, Alex; Voorand, Elena; Senecal, Julien; Annis, Matthew G.; Siegel, Peter M.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Senecal, Julien; Ahn, Ryuhjin] McGill Univ, Div Expt Med, Montreal, PQ H4A 3J1, Canada; [Ursini-Siegel, Josie] McGill Univ, Dept Oncol, Montreal, PQ H4A 3T2, Canada; [Brown, Claire M.] McGill Univ, Adv Bioimaging Facil ABIF, Montreal, PQ H3G 0B1, Canada; [Ahn, Ryuhjin; Ursini-Siegel, Josie] Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Jacquet, Kevin; Bisson, Nicolas] Univ Laval, Ctr Hosp Univ CHU Quebec, Ctr Rech, Quebec City, PQ G1R 2J6, Canada; [Bisson, Nicolas] Univ Laval, PROTEO Network, Quebec City, PQ G1V 0A6, Canada; [Bisson, Nicolas] Univ Laval, Canc Res Ctr, Quebec City, PQ G1V 0A6, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; Laval University; Laval University; Laval University	Siegel, PM (corresponding author), 1160 Pine Ave,West,Canc Pavil,Rm 513, Montreal, PQ H3A 1A3, Canada.; Brown, CM (corresponding author), 3649 Prom Sir William Osler,Bellini Bldg Rm 137, Montreal, PQ H3G 0B1, Canada.	peter.siegel@mcgill.ca; claire.brown@mcgill.ca	Ahn, Ryuhjin/B-1141-2011; Kiepas, Alex/GVS-8491-2022; St-Pierre, Julie/AGB-3651-2022; Brown, Claire/B-1498-2008	Ahn, Ryuhjin/0000-0001-9788-4401; St-Pierre, Julie/0000-0002-2815-7099; Kiepas, Alexander/0000-0001-8169-3897; Annis, Matthew/0000-0002-8776-004X; Bisson, Nicolas/0000-0001-7752-9517; Brown, Claire/0000-0003-1622-663X	Natural Sciences and Engineering Research Council of Canada (NSERC) [493616-16, 386084-12]; Canadian Institutes of Health Research (CIHR) [CPG-146475]; Canadian Cancer Society Research Institute (CCSRI) [702060]; Canadian Cancer Society (CCS) i2I Grant [705838]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Canadian Cancer Society (CCS) i2I Grant	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grants 493616-16 and 386084-12, Canadian Institutes of Health Research (CIHR) Grant CPG-146475, Canadian Cancer Society Research Institute (CCSRI) Grant 702060, and Canadian Cancer Society (CCS) i2I Grant 705838 (to J. U.-S., P. M. S., and C. M. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn R, 2013, CANCER RES, V73, P4521, DOI 10.1158/0008-5472.CAN-12-4178; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Beaty BT, 2014, EUR J CELL BIOL, V93, P438, DOI 10.1016/j.ejcb.2014.07.003; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Blouw B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121003; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Branch KM, 2012, BIOL OPEN, V1, P711, DOI 10.1242/bio.20121867; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Chapnick DA, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-42; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Choi Hyungwon, 2012, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0815s39; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Collins LR, 1999, J CELL BIOL, V147, P1561, DOI 10.1083/jcb.147.7.1561; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Courtneidge SA, 2005, COLD SH Q B, V70, P167, DOI 10.1101/sqb.2005.70.014; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Deshmukh L, 2010, J BIOL CHEM, V285, P34875, DOI 10.1074/jbc.M110.159087; Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084; Eddy RJ, 2017, TRENDS CELL BIOL, V27, P595, DOI 10.1016/j.tcb.2017.03.003; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; Gorenne I, 2006, CIRC RES, V98, P378, DOI 10.1161/01.RES.0000202802.34727.fd; Grille SJ, 2003, CANCER RES, V63, P2172; Grunewald TGP, 2009, TRANSL ONCOL, V2, P107, DOI 10.1593/tlo.09112; Ha JR, 2018, MOL CANCER RES, V16, P894, DOI 10.1158/1541-7786.MCR-17-0623; HABIB T, 1994, J BIOL CHEM, V269, P25243; HEINO J, 1989, J BIOL CHEM, V264, P21806; HEINO J, 1989, J BIOL CHEM, V264, P380; Honda E, 2010, TOHOKU J EXP MED, V220, P319, DOI 10.1620/tjem.220.319; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Hu YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06024; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Hudson J, 2014, MOL CELL BIOL, V34, P3689, DOI 10.1128/MCB.00341-14; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Im YK, 2015, ONCOGENE, V34, P1729, DOI 10.1038/onc.2014.110; Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1; Jia DS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-364; Jin L, 2007, CIRC RES, V100, P817, DOI 10.1161/01.RES.0000261351.54147.de; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kiepas A, 2020, J CELL SCI, V133, DOI 10.1242/jcs.242834; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Lawson C, 2012, CELL ADHES MIGR, V6, P302, DOI 10.4161/cam.20488; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lewis K, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-1245-6; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Mamuya FA, 2012, J CELL MOL MED, V16, P445, DOI 10.1111/j.1582-4934.2011.01419.x; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ngan E, 2018, J CELL COMMUN SIGNAL, V12, P143, DOI 10.1007/s12079-017-0415-5; Ngan E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15059; Ngan E, 2013, J CELL SCI, V126, P1981, DOI 10.1242/jcs.118315; Northey JJ, 2008, MOL CELL BIOL, V28, P3162, DOI 10.1128/MCB.01734-07; Northey JJ, 2013, J BIOL CHEM, V288, P5210, DOI 10.1074/jbc.M112.424804; Parekh A, 2016, EXP CELL RES, V343, P89, DOI 10.1016/j.yexcr.2015.10.038; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Petit MMR, 2000, MOL BIOL CELL, V11, P117, DOI 10.1091/mbc.11.1.117; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Provenzano PP, 2009, CELL ADHES MIGR, V3, P347, DOI 10.4161/cam.3.4.9458; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Robertson J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7265; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Schmandt R, 1999, ONCOGENE, V18, P1867, DOI 10.1038/sj.onc.1202507; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shcherbakova DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12405; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Tomar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044041; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; Ursini-Siegel J, 2012, ONCOGENE, V31, P5038, DOI 10.1038/onc.2012.4; Ursini-Siegel J, 2008, CELL CYCLE, V7, P1936, DOI 10.4161/cc.7.13.6205; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Ursini-Siegel J, 2010, CANCER RES, V70, P7776, DOI 10.1158/0008-5472.CAN-10-2229; Waalkes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-503; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Wright KD, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1155-7; Wu RF, 2016, MOL CELL BIOL, V36, P2824, DOI 10.1128/MCB.00194-16; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yeh YC, 2010, AM J PATHOL, V177, P1743, DOI 10.2353/ajpath.2010.091183; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	119	8	8	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10535	10559		10.1074/jbc.RA119.011903	http://dx.doi.org/10.1074/jbc.RA119.011903			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32299913	hybrid, Green Published			2022-12-28	WOS:000560405600003
J	Stutz, C; Blein, S				Stutz, Cian; Blein, Stanislas			A single mutation increases heavy-chain heterodimer assembly of bispecific antibodies by inducing structural disorder in one homodimer species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; bispecific engagement by antibodies based on the T-cell receptor (BEAT); CH3; heterodimer; knobs-into-holes (KiH); protein engineering; protein folding; protein stability; protein structure; structural disorder	STAPHYLOCOCCAL PROTEIN-A; CRYSTAL-STRUCTURE; DOMAIN INTERFACE; IGG; COMPLEX; INFORMATION; SECRETION; FRAGMENT; ANGSTROM; KNOB	We previously reported efficient heavy-chain assembly of heterodimeric bispecific antibodies by exchanging the interdomain protein interface of the human IgG1 CH3 dimer with the protein interface of the constant ? and ? domains of the human T-cell receptor, a technology known as bispecific engagement by antibodies based on the T-cell receptor (BEAT). Efficient heterodimerization in mammalian cell transient transfections was observed, but levels were influenced by the nature of the binding arms, particularly in the Fab-scFv-Fc format. In this study, we report a single amino acid change that significantly and consistently improved the heterodimerization rate of this format (?95%) by inducing partial disorder in one homodimer species without affecting the heterodimer. Correct folding and assembly of the heterodimer were confirmed by the high-resolution (1.88?1.98 ?) crystal structure presented here. Thermal stability and 1-anilinonaphthalene-8-sulfonic acid?binding experiments, comparing original BEAT, mutated BEAT, and ?knobs-into-holes? interfaces, suggested a cooperative assembly process of heavy chains in heterodimers. The observed gain in stability of the interfaces could be classified in the following rank order: mutated BEAT > original BEAT > knobs-into-holes. We therefore propose that the superior cooperativity found in BEAT interfaces is the key driver of their greater performance. Furthermore, we show how the mutated BEAT interface can be exploited for the routine preparation of drug candidates, with minimal risk of homodimer contamination using a single Protein A chromatography step.	[Stutz, Cian; Blein, Stanislas] Ichnos Sci SA, Dept Antibody Engn, Epalinges, Switzerland		Blein, S (corresponding author), Ichnos Sci SA, Dept Antibody Engn, Epalinges, Switzerland.	stanislas.blein@ichnossciences.com						Abdiche YN, 2015, MABS-AUSTIN, V7, P331, DOI 10.1080/19420862.2015.1008353; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Brinkmann U, 2017, MABS-AUSTIN, V9, P182, DOI 10.1080/19420862.2016.1268307; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DERRICK JP, 1992, NATURE, V359, P752, DOI 10.1038/359752a0; Elliott JM, 2014, J MOL BIOL, V426, P1947, DOI 10.1016/j.jmb.2014.02.015; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; Fischer N., 2015, U. S. Patent, Patent No. [2015/0094451, 20150094451]; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; Jackman J, 2010, J BIOL CHEM, V285, P20850, DOI 10.1074/jbc.M110.113910; Kirkitadze MD, 1998, J VIROL, V72, P10066, DOI 10.1128/JVI.72.12.10066-10072.1998; Kiyoshi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7866; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Macchi FD, 2015, ANAL CHEM, V87, P10475, DOI 10.1021/acs.analchem.5b02627; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Oilier R, 2019, MABS-AUSTIN, V11, P1464, DOI 10.1080/19420862.2019.1660564; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; SASSO EH, 1991, J IMMUNOL, V147, P1877; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Skegro D, 2017, J BIOL CHEM, V292, P9745, DOI 10.1074/jbc.M117.782433; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Spiess C, 2013, NAT BIOTECHNOL, V31, P753, DOI 10.1038/nbt.2621; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strohl WR, 2018, PROTEIN CELL, V9, P86, DOI 10.1007/s13238-017-0457-8; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; VANLOGHEM E, 1982, SCAND J IMMUNOL, V15, P275; Zhang HM, 2017, ANAL CHEM, V89, P13494, DOI 10.1021/acs.analchem.7b03830	33	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9392	9408		10.1074/jbc.RA119.012335	http://dx.doi.org/10.1074/jbc.RA119.012335			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32404368	Green Published, hybrid			2022-12-28	WOS:000552758600011
J	Kalous, KS; Wynia-Smith, SL; Summers, SB; Smith, BC				Kalous, Kelsey S.; Wynia-Smith, Sarah L.; Summers, Steven B.; Smith, Brian C.			Human sirtuins are differentially sensitive to inhibition by nitrosating agents and other cysteine oxidants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sirtuin; nicotinamide adenine dinucleotide (NAD); nitric oxide; hydrogen peroxide; S-nitrosylation; glutathionylation; enzyme inactivation; protein acylation; reactive nitrogen species (RNS); redox signaling	NITRIC-OXIDE; POSTTRANSLATIONAL MODIFICATION; OXIDATIVE STRESS; S-NITROSYLATION; DEACETYLASE; MECHANISM; SIRT6; INSIGHTS; INACTIVATION; ACETYLATION	Sirtuins (e.g.human Sirt1?7) catalyze the removal of acyl groups from lysine residues in proteins in an NAD(+)-dependent manner, and loss of sirtuin deacylase activity correlates with the development of aging-related diseases. Although multiple reports suggest that sirtuin activity is regulated by oxidative post-translational modifications of cysteines during inflammation and aging, no systematic comparative study of potential direct sirtuin cysteine oxidative modifications has been performed. Here, using IC(50)andk(inact)/K(I)analyses, we quantified the ability of nitrosothiols (S-nitrosoglutathione andS-nitroso-N-acetyl-d,l-penicillamine), nitric oxide, oxidized GSH, and hydrogen peroxide to post-translationally modify and inhibit the deacylase activity of Sirt1, Sirt2, Sirt3, Sirt5, and Sirt6. The inhibition was correlated with cysteine modification and assessed with chemical-probe and blot-based assays for cysteineS-nitrosation, sulfenylation, and glutathionylation. We show that the primarily nuclear sirtuins Sirt1 and Sirt6, as well as the primarily cytosolic sirtuin Sirt2, are modified and inhibited by cysteineS-nitrosation in response to exposure to both free nitric oxide and nitrosothiols (k(inact)/K-I? 5m(?1)s(?1)), which is the first report of Sirt2 and Sirt6 inhibition byS-nitrosation. Surprisingly, the mitochondrial sirtuins Sirt3 and Sirt5 were resistant to inhibition by cysteine oxidants. Collectively, these results suggest that nitric oxide?derived oxidants may causatively link nuclear and cytosolic sirtuin inhibition to aging-related inflammatory disease development.	[Kalous, Kelsey S.; Wynia-Smith, Sarah L.; Summers, Steven B.; Smith, Brian C.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Smith, BC (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	brismith@mcw.edu	Smith, Brian C/D-9949-2013	Smith, Brian C/0000-0001-6330-2768	National Institutes of Health [R01 DK119359, F31 DK117588]; American Heart Association [15SDG25830057]; American Diabetes Association [1-18-IBS-068]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association)	This work was supported in part by National Institutes of Health Grants R01 DK119359 (to B. C. S.) and F31 DK117588 (to K. S. K. and B. C. S.), American Heart Association Grant 15SDG25830057 (to B. C. S.), and American Diabetes Association Grant 1-18-IBS-068 (to B. C. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson KA, 2017, CELL METAB, V25, P838, DOI 10.1016/j.cmet.2017.03.003; Bearne SL, 1996, J BIOL CHEM, V271, P3052; Bheda P, 2016, ANNU REV BIOCHEM, V85, P405, DOI 10.1146/annurev-biochem-060815-014537; Broniowska KA, 2013, BBA-GEN SUBJECTS, V1830, P3173, DOI 10.1016/j.bbagen.2013.02.004; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Carrico C, 2018, CELL METAB, V27, P497, DOI 10.1016/j.cmet.2018.01.016; Chen W. C., 2000, FMOC SOLID PHASE PEP; Dikalova AE, 2017, CIRC RES, V121, P564, DOI 10.1161/CIRCRESAHA.117.310933; Du CK, 2019, ANTIOXID REDOX SIGN, V30, P184, DOI 10.1089/ars.2017.7195; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Feldman JL, 2015, BIOCHEMISTRY-US, V54, P3037, DOI 10.1021/acs.biochem.5b00150; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; Girotti AW, 1998, J LIPID RES, V39, P1529; Guarente L, 2018, INTRODUCTORY REVIEW ON SIRTUINS IN BIOLOGY, AGING, AND DISEASE, P1, DOI 10.1016/B978-0-12-813499-3.00001-0; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hoth JJ, 2018, J TRAUMA ACUTE CARE, V85, P367, DOI 10.1097/TA.0000000000001951; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hu SG, 2015, FREE RADICAL BIO MED, V79, P176, DOI 10.1016/j.freeradbiomed.2014.11.011; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; KAISER E, 1970, ANAL BIOCHEM, V34, P595, DOI 10.1016/0003-2697(70)90146-6; Kalous KS, 2016, J BIOL CHEM, V291, P25398, DOI 10.1074/jbc.M116.754655; Keszler A, 2010, FREE RADICAL BIO MED, V48, P55, DOI 10.1016/j.freeradbiomed.2009.10.026; KHARITONOV VG, 1995, J BIOL CHEM, V270, P28158; Kim YM, 2018, BIOCHEM BIOPH RES CO, V501, P73, DOI 10.1016/j.bbrc.2018.04.155; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Kozhukh J, 2012, INORG CHEM, V51, P7346, DOI 10.1021/ic3007684; Li L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12235; Lim CH, 2008, CHEM RES TOXICOL, V21, P2134, DOI 10.1021/tx800213b; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Long D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11388-6; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nakazawa H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170391; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Obach RS, 2007, DRUG METAB DISPOS, V35, P246, DOI 10.1124/dmd.106.012633; Olp MD, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3513-y; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Peralta D, 2015, NAT CHEM BIOL, V11, P156, DOI [10.1038/NCHEMBIO.1720, 10.1038/nchembio.1720]; Perez H, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8561892; Rodriguez-Ortigosa CM, 2014, GASTROENTEROLOGY, V147, P1084, DOI 10.1053/j.gastro.2014.07.030; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Sen T, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6765; Shao D, 2014, J BIOL CHEM, V289, P7293, DOI 10.1074/jbc.M113.520403; Shinozaki S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005375; SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; SQUADRITO GL, 1995, CHEM-BIOL INTERACT, V96, P203, DOI 10.1016/0009-2797(94)03591-U; Strelow JM, 2017, SLAS DISCOV, V22, P3, DOI 10.1177/1087057116671509; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tong Z, 2017, ACS CHEM BIOL, V12, P300, DOI 10.1021/acschembio.6b00954; Tong Z, 2016, ACS CHEM BIOL, V11, P742, DOI 10.1021/acschembio.5b01084; Truong T., 2012, CURR PROTOC CHEM BIO, V4, P101; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5776; Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251; Zhou YY, 2012, J BIOL CHEM, V287, P28307, DOI 10.1074/jbc.M112.384511	64	10	10	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8524	8536		10.1074/jbc.RA119.011988	http://dx.doi.org/10.1074/jbc.RA119.011988			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32371394	hybrid, Green Published			2022-12-28	WOS:000546986500017
J	Dai, Y; Sweeny, EA; Schlanger, S; Ghosh, A; Stuehr, DJ				Dai, Yue; Sweeny, Elizabeth A.; Schlanger, Simon; Ghosh, Arnab; Stuehr, Dennis J.			GAPDH delivers heme to soluble guanylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						guanylate cyclase (guanylyl cyclase); cGMP; mitochondria; chaperone; NO; heme trafficking	SHOCK-PROTEIN 90; NITRIC-OXIDE; CELLULAR HEME; ACTIVATION; INSERTION; TARGET; NO; STABILIZATION; OXIDATION; DOMAIN	Soluble guanylyl cyclase (sGC) is a key component of NO?cGMP signaling in mammals. Although heme must bind in the sGC ?1 subunit (sGC?) for sGC to function, how heme is delivered to sGC? remains unknown. Given that GAPDH displays properties of a heme chaperone for inducible NO synthase, here we investigated whether heme delivery to apo-sGC? involves GAPDH. We utilized an sGC? reporter construct, tetra-Cys sGC?, whose heme insertion can be followed by fluorescence quenching in live cells, assessed how lowering cell GAPDH expression impacts heme delivery, and examined whether expressing WT GAPDH or a GAPDH variant defective in heme binding recovers heme delivery. We also studied interaction between GAPDH and sGC? in cells and their complex formation and potential heme transfer using purified proteins. We found that heme delivery to apo-sGC? correlates with cellular GAPDH expression levels and depends on the ability of GAPDH to bind intracellular heme, that apo-sGC? associates with GAPDH in cells and dissociates when heme binds sGC?, and that the purified GAPDH?heme complex binds to apo-sGC? and transfers its heme to sGC?. On the basis of these results, we propose a model where GAPDH obtains mitochondrial heme and then forms a complex with apo-sGC? to accomplish heme delivery to sGC?. Our findings illuminate a critical step in sGC maturation and uncover an additional mechanism that regulates its activity in health and disease.	[Dai, Yue; Sweeny, Elizabeth A.; Schlanger, Simon; Ghosh, Arnab; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44106 USA.	stuehrd@ccf.org		Sweeny, Elizabeth/0000-0001-7818-9112; Dai, Yue/0000-0001-9368-7769; Stuehr, Dennis/0000-0002-0960-6848; GHOSH, ARNAB/0000-0002-7498-1994	NHLBI, National Institutes of Health [P01HL081064, P01HL103453, K99HL144921]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grants P01HL081064 and P01HL103453 (to D. J. S.), and K99HL144921 (to E. A. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ben Aissa M, 2016, CURR MED CHEM, V23, P2770, DOI 10.2174/0929867323666160812145454; Beuve A, 2019, ELIFE, V8, DOI 10.7554/eLife.52418; Chakravarti R, 2012, J BIOL CHEM, V287, P16179, DOI 10.1074/jbc.M112.342758; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Childers KC, 2019, J BIOL CHEM, V294, P18451, DOI 10.1074/jbc.RA119.011010; Dai Y, 2019, J BIOL CHEM, V294, P12880, DOI 10.1074/jbc.RA119.009016; Dai Y, 2017, J BIOL CHEM, V292, P6753, DOI 10.1074/jbc.M117.777219; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Friebe A, 2020, N-S ARCH PHARMACOL, V393, P287, DOI 10.1007/s00210-019-01779-z; Fritz BG, 2011, BIOCHEMISTRY-US, V50, P5813, DOI 10.1021/bi200794c; Galmozzi A, 2019, NATURE, V576, P138, DOI 10.1038/s41586-019-1774-2; GARDNER LC, 1991, J BIOL CHEM, V266, P22010; Ghosh A, 2017, ANTIOXID REDOX SIGN, V26, P182, DOI 10.1089/ars.2016.6690; Ghosh A, 2016, P NATL ACAD SCI USA, V113, pE2355, DOI 10.1073/pnas.1524398113; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; Ghosh A, 2012, P NATL ACAD SCI USA, V109, P12998, DOI 10.1073/pnas.1205854109; Hanna DA, 2018, J BIOL CHEM, V293, P12378, DOI 10.1074/jbc.RA118.002125; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; Hannibal L, 2012, BIOCHEMISTRY-US, V51, P8514, DOI 10.1021/bi300863a; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Hoffmann LS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023596; Horst BG, 2019, ELIFE, V8, DOI 10.7554/eLife.50634; IGNARRO LJ, 1986, J BIOL CHEM, V261, P4997; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Kang YL, 2019, NATURE, V574, P206, DOI 10.1038/s41586-019-1584-6; Kim Y M, 1995, Adv Pharmacol, V34, P277; Kollau A, 2018, MOL PHARMACOL, V93, P73, DOI 10.1124/mol.117.109918; Martin E, 2005, METHOD ENZYMOL, V396, P478, DOI 10.1016/S0076-6879(05)96040-0; Montfort WR, 2017, ANTIOXID REDOX SIGN, V26, P107, DOI 10.1089/ars.2016.6693; Murad F, 2008, CAN J OPHTHALMOL, V43, P291, DOI 10.3129/i08-044; Pan J, 2017, SCI REP-UK, V7, DOI 10.1038/srep43112; Rahaman MM, 2017, CIRC RES, V121, P137, DOI 10.1161/CIRCRESAHA.117.310705; Sarkar A, 2015, J BIOL CHEM, V290, P21615, DOI 10.1074/jbc.M115.645515; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2013, HANDB EXP PHARMACOL, V218, P279, DOI 10.1007/978-3-642-38664-0_12; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Surmeli NB, 2012, CHEMBIOCHEM, V13, P977, DOI 10.1002/cbic.201100809; Sweeny EA, 2018, J BIOL CHEM, V293, P14557, DOI 10.1074/jbc.RA118.004169; Waheed SM, 2010, FREE RADICAL BIO MED, V48, P1548, DOI 10.1016/j.freeradbiomed.2010.02.038; Zhong FF, 2011, J BIOL INORG CHEM, V16, P1227, DOI 10.1007/s00775-011-0811-x	42	22	22	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8145	8154		10.1074/jbc.RA120.013802	http://dx.doi.org/10.1074/jbc.RA120.013802			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32358060	hybrid, Green Published			2022-12-28	WOS:000542965700003
J	Fu, PF; Ramchandran, R; Shaaya, M; Huang, LS; Ebenezer, DL; Jiang, Y; Komarova, Y; Vogel, SM; Malik, AB; Minshall, RD; Du, GW; Tonks, NK; Natarajan, V				Fu, Panfeng; Ramchandran, Ramaswamy; Shaaya, Mark; Huang, Longshuang; Ebenezer, David L.; Jiang, Ying; Komarova, Yulia; Vogel, Stephen M.; Malik, Asrar B.; Minshall, Richard D.; Du, Guangwei; Tonks, Nicholas K.; Natarajan, Viswanathan			Phospholipase D2 restores endothelial barrier function by promoting PTPN14-mediated VE-cadherin dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelial dysfunction; endothelial cell; cadherin; phosphotyrosine signaling; lipid signaling; endothelial barrier restoration; phosphatidic acid signaling; phospholipase D2 (PLD2); protein tyrosine phosphatase non-receptor type 14 (PTPN14); VE-cadherin	MEDIATED LAMELLIPODIA FORMATION; INDUCED VASCULAR-PERMEABILITY; PHOSPHATIDIC-ACID; ADHERENS JUNCTIONS; KINASE ACTIVATION; GROWTH-FACTOR; LEUKOCYTE EXTRAVASATION; DEPENDENT ENDOCYTOSIS; CELL PERMEABILITY; CA2+ ENTRY	Increased permeability of vascular lung tissues is a hallmark of acute lung injury and is often caused by edemagenic insults resulting in inflammation. Vascular endothelial (VE)-cadherin undergoes internalization in response to inflammatory stimuli and is recycled at cell adhesion junctions during endothelial barrier re-establishment. Here, we hypothesized that phospholipase D (PLD)-generated phosphatidic acid (PA) signaling regulates VE-cadherin recycling and promotes endothelial barrier recovery by dephosphorylating VE-cadherin. Genetic deletion of PLD2 impaired recovery from protease-activated receptor-1?activating peptide (PAR-1?AP)-induced lung vascular permeability and potentiated inflammation in vivo. In human lung microvascular endothelial cells (HLMVECs), inhibition or deletion of PLD2, but not of PLD1, delayed endothelial barrier recovery after thrombin stimulation. Thrombin stimulation of HLMVECs increased co-localization of PLD2-generated PA and VE-cadherin at cell-cell adhesion junctions. Inhibition of PLD2 activity resulted in prolonged phosphorylation of Tyr-658 in VE-cadherin during the recovery phase 3 h post-thrombin challenge. Immunoprecipitation experiments revealed that after HLMVECs are thrombin stimulated, PLD2, VE-cadherin, and protein-tyrosine phosphatase nonreceptor type 14 (PTPN14), a PLD2-dependent protein-tyrosine phosphatase, strongly associate with each other. PTPN14 depletion delayed VE-cadherin dephosphorylation, reannealing of adherens junctions, and barrier function recovery. PLD2 inhibition attenuated PTPN14 activity and reversed PTPN14-dependent VE-cadherin dephosphorylation after thrombin stimulation. Our findings indicate that PLD2 promotes PTPN14-mediated dephosphorylation of VE-cadherin and that redistribution of VE-cadherin at adherens junctions is essential for recovery of endothelial barrier function after an edemagenic insult.	[Fu, Panfeng; Ramchandran, Ramaswamy; Shaaya, Mark; Huang, Longshuang; Ebenezer, David L.; Komarova, Yulia; Vogel, Stephen M.; Malik, Asrar B.; Minshall, Richard D.; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA; [Jiang, Ying; Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, Chicago, IL USA; [Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Fu, Panfeng] Ningbo Univ, Med Sch, Affiliated Hosp, Ningbo, Peoples R China; [Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Tonks, Nicholas K.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Ningbo University; University of Texas System; University of Texas Health Science Center Houston; Cold Spring Harbor Laboratory	Natarajan, V (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA.; Natarajan, V (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	visnatar@uic.edu		Du, Guangwei/0000-0003-4193-6975; Malik, Asrar/0000-0002-8205-7128	National Institutes of Health [HLBI P01 HL060678, AR075830]; American Heart Association [19TPA34910051]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by National Institutes of Health Grants HLBI P01 HL060678 (to V. N.) and AR075830 (to G. D.), and American Heart Association Grant 19TPA34910051. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdulnour REE, 2018, J LEUKOCYTE BIOL, V103, P919, DOI 10.1002/JLB.3A0617-252RR; Adam AP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/272858; AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Au AC, 2010, AM J HUM GENET, V87, P436, DOI 10.1016/j.ajhg.2010.08.008; Barr AJ, 2006, PROTEINS, V63, P1132, DOI 10.1002/prot.20958; Benzinou M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1633; Bolomini-Vittori M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39358-0; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Ebnet K, 2008, HISTOCHEM CELL BIOL, V130, P1, DOI 10.1007/s00418-008-0418-7; Flores I, 1996, J BIOL CHEM, V271, P10334, DOI 10.1074/jbc.271.17.10334; Frye M, 2015, J EXP MED, V212, P2267, DOI 10.1084/jem.20150718; Fu PF, 2016, J BIOL CHEM, V291, P27187, DOI 10.1074/jbc.M116.758946; GARCIA JGN, 1992, BLOOD, V79, P2056; GARCIA JGN, 1992, J LAB CLIN MED, V120, P513; Gavard J, 2008, NAT CELL BIOL, V10, P883, DOI 10.1038/ncb0808-883; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gavard Julie, 2014, Cell Adh Migr, V8, P158; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Gong HX, 2014, J EXP MED, V211, P579, DOI 10.1084/jem.20131190; Han X, 2019, J CELL BIOCHEM, V120, P17723, DOI 10.1002/jcb.29038; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hu GC, 2008, CHEM-BIOL INTERACT, V171, P177, DOI 10.1016/j.cbi.2007.08.006; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Jiang Y, 2016, J BIOL CHEM, V291, P20729, DOI 10.1074/jbc.M116.752485; Juettner VV, 2019, J CELL BIOL, V218, P1725, DOI 10.1083/jcb.201807210; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Ktistakis NT, 2003, BIOCHEM SOC T, V31, P94, DOI 10.1042/bst0310094; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Lim HK, 2003, J BIOL CHEM, V278, P45117, DOI 10.1074/jbc.M303789200; Lu M, 2016, METHODS MOL BIOL, V1406, P225, DOI 10.1007/978-1-4939-3444-7_20; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nelson RK, 2015, J LIPID RES, V56, P2229, DOI 10.1194/jlr.R059220; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Pleskot R, 2013, TRENDS PLANT SCI, V18, P496, DOI 10.1016/j.tplants.2013.04.005; Ramesh M, 2015, J BIOL CHEM, V290, P9646, DOI 10.1074/jbc.M114.627968; Reeves HL, 2000, HEPATOLOGY, V31, P95, DOI 10.1002/hep.510310116; Roach AN, 2012, J LIPID RES, V53, P2598, DOI 10.1194/jlr.M028597; Rudge SA, 2009, BBA-MOL CELL BIOL L, V1791, P856, DOI 10.1016/j.bbalip.2009.04.008; Soni D, 2017, AM J PHYSIOL-LUNG C, V312, pL1003, DOI 10.1152/ajplung.00008.2017; Spring K, 2012, BLOOD, V120, P2745, DOI 10.1182/blood-2011-12-398040; Su WJ, 2017, MOL BIOL CELL, V28, P76, DOI 10.1091/mbc.E16-09-0658; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; Suryadevara V, 2019, AM J PHYSIOL-LUNG C, V317, pL175, DOI 10.1152/ajplung.00320.2018; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tian XY, 2014, J BIOL CHEM, V289, P5168, DOI 10.1074/jbc.M113.493924; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Usatyuk PV, 2014, J BIOL CHEM, V289, P13476, DOI 10.1074/jbc.M113.527556; Usatyuk PV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063007; Usatyuk PV, 2013, PULM CIRC, V3, P108, DOI 10.4103/2045-8932.109925; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; Wang ZQ, 2019, FASEB J, V33, P6713, DOI 10.1096/fj.201800390RR; Wang ZQ, 2017, DEV CELL, V43, P186, DOI 10.1016/j.devcel.2017.09.012; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Wilson KE, 2014, J BIOL CHEM, V289, P23693, DOI 10.1074/jbc.M113.534701; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537; Wu ZY, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8696481; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Zegarlinska J, 2018, ACTA BIOCHIM POL, V65, P163, DOI 10.18388/abp.2018_2592; Zeiller C, 2009, BBA-MOL CELL RES, V1793, P1236, DOI 10.1016/j.bbamcr.2009.04.001; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13	75	11	11	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7669	7685		10.1074/jbc.RA119.011801	http://dx.doi.org/10.1074/jbc.RA119.011801			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32327488	hybrid, Green Published			2022-12-28	WOS:000538038900009
J	Shima, Y; Morita, D; Mizutani, T; Mori, N; Mikami, B; Sugita, M				Shima, Yoko; Morita, Daisuke; Mizutani, Tatsuaki; Mori, Naoki; Mikami, Bunzo; Sugita, Masahiko			Crystal structures of lysophospholipid-bound MHC class I molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						major histocompatibility complex (MHC); MHC class I; lysophospholipid; antigen presentation; human immunodeficiency virus (HIV); structural biology; adaptive immunity; lipopeptide; Mamu-B; self-peptide; transporter associated with antigen processing (TAP)	PHOSPHOLIPASE A(2); RECOGNITION; PEPTIDE; SELF; EXPRESSION; PROTEIN; CD1; MEMBRANE; CALNEXIN; ANTIGENS	Newly synthesized major histocompatibility complex (MHC) class I proteins are stabilized in the endoplasmic reticulum (ER) by binding 8?10-mer-long self-peptide antigens that are provided by transporter associated with antigen processing (TAP). These MHC class I:peptide complexes then exit the ER and reach the plasma membrane, serving to sustain the steady-state MHC class I expression on the cell surface. A novel subset of MHC class I molecules that preferentially bind lipid-containing ligands rather than conventional peptides was recently identified. The primate classical MHC class I allomorphs, Mamu-B*098 and Mamu-B*05104, are capable of binding the N-myristoylated 5-mer (C14-Gly-Gly-Ala-Ile-Ser) or 4-mer (C14-Gly-Gly-Ala-Ile) lipopeptides derived from the N-myristoylated SIV Nef protein, respectively, and of activating lipopeptide antigen-specific cytotoxic T lymphocytes. We herein demonstrate that Mamu-B*098 samples lysophosphatidylethanolamine and lysophosphatidylcholine containing up to a C20 fatty acid in the ER. The X-ray crystal structures of Mamu-B*098 and Mamu-B*05104 complexed with lysophospholipids at high resolution revealed that the B and D pockets in the antigen-binding grooves of these MHC class I molecules accommodate these lipids through a monoacylglycerol moiety. Consistent with the capacity to bind cellular lipid ligands, these two MHC class I molecules did not require TAP function for cell-surface expression. Collectively, these results indicate that peptide- and lipopeptide-presenting MHC class I subsets use distinct sources of endogenous ligands.	[Shima, Yoko; Morita, Daisuke; Mizutani, Tatsuaki; Sugita, Masahiko] Kyoto Univ, Lab Cell Regulat, Inst Frontier Life & Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan; [Shima, Yoko; Morita, Daisuke; Mizutani, Tatsuaki; Sugita, Masahiko] Kyoto Univ, Lab Cell Regulat & Mol Network, Grad Sch Biostudies, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan; [Mori, Naoki] Kyoto Univ, Lab Chem Ecol, Div Appl Life Sci, Grad Sch Agr,Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan; [Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Div Appl Life Sci, Grad Sch Agr, Uji, Kyoto 6110011, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Morita, D (corresponding author), Kyoto Univ, Lab Cell Regulat, Inst Frontier Life & Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	dmorita@infront.kyoto-u.ac.jp	Mizutani, Tatsuaki/AAA-5044-2021	Mizutani, Tatsuaki/0000-0002-4323-4347; Morita, Daisuke/0000-0002-7476-7285; Sugita, Masahiko/0000-0001-5511-1304	Japan Society for the Promotion of Science KAKENHI [17H05791, 18K19563, 18H02852, 19H04805, 18K07172]; Kato Memorial Bioscience Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kato Memorial Bioscience Foundation	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 17H05791, 18K19563, 18H02852, and 19H04805 (to M. S.) and 18K07172 (to D. M.) and by a grant from the Kato Memorial Bioscience Foundation (to D. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Balboa MA, 2008, FEBS J, V275, P1915, DOI 10.1111/j.1742-4658.2008.06350.x; Bechler ME, 2012, TRENDS CELL BIOL, V22, P116, DOI 10.1016/j.tcb.2011.10.003; Birkinshaw RW, 2015, NAT IMMUNOL, V16, P258, DOI 10.1038/ni.3098; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; CROMME FV, 1994, J EXP MED, V179, P335, DOI 10.1084/jem.179.1.335; Davis B, 2008, J BIOL CHEM, V283, P6428, DOI 10.1074/jbc.M709970200; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Girardi E, 2016, J BIOL CHEM, V291, P10677, DOI 10.1074/jbc.M115.702118; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; GUO HC, 1993, P NATL ACAD SCI USA, V90, P8053, DOI 10.1073/pnas.90.17.8053; HANAU D, 1994, HUM IMMUNOL, V41, P61, DOI 10.1016/0198-8859(94)90086-8; Huang SX, 2011, P NATL ACAD SCI USA, V108, P19335, DOI 10.1073/pnas.1112969108; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Lepore M, 2014, J EXP MED, V211, P1360, DOI 10.1084/jem.20140410; Liebisch G, 2002, CLIN CHEM, V48, P2217; Lopez-Sagaseta J, 2012, EMBO J, V31, P2047, DOI 10.1038/emboj.2012.54; Markiewicz MA, 1998, P NATL ACAD SCI USA, V95, P3065, DOI 10.1073/pnas.95.6.3065; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; Morita D, 2016, IMMUNOLOGY, V149, P139, DOI 10.1111/imm.12646; Morita D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10356; Morita D, 2013, INFECT IMMUN, V81, P311, DOI 10.1128/IAI.00871-12; Morita D, 2013, J VIROL, V87, P482, DOI 10.1128/JVI.02142-12; Morita D, 2011, J IMMUNOL, V187, P608, DOI 10.4049/jimmunol.1101216; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; Oldham ML, 2016, NATURE, V529, P537, DOI 10.1038/nature16506; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAJAGOPALAN S, 1994, J EXP MED, V180, P407, DOI 10.1084/jem.180.1.407; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; SCHLAGER SI, 1980, J IMMUNOL, V125, P508; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; SUGITA M, 1994, J EXP MED, V180, P2163, DOI 10.1084/jem.180.6.2163; Thinon E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5919; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vasquez Alexis M., 2018, Advances in Biological Regulation, V67, P212, DOI 10.1016/j.jbior.2017.10.009; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto Y, 2019, J IMMUNOL, V202, P3349, DOI 10.4049/jimmunol.1900087; Yoshinaga N, 2007, J CHEM ECOL, V33, P1376, DOI 10.1007/s10886-007-9321-2	44	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6983	6991		10.1074/jbc.RA119.011932	http://dx.doi.org/10.1074/jbc.RA119.011932			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32269076	hybrid, Green Published			2022-12-28	WOS:000536212600016
J	Carey, RM; Freund, JR; Hariri, BM; Adappa, ND; Palmer, JN; Lee, RJ				Carey, Ryan M.; Freund, Jenna R.; Hariri, Benjamin M.; Adappa, Nithin D.; Palmer, James N.; Lee, Robert J.			Polarization of protease-activated receptor 2 (PAR-2) signaling is altered during airway epithelial remodeling and deciliation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC RHINOSINUSITIS; ASPERGILLUS-FUMIGATUS; RETINOIC ACID; SQUAMOUS METAPLASIA; CELL ACTIVATION; BETA-ARRESTIN; EXPRESSION; INFLAMMATION; SECRETION; PAR(2)	Protease-activated receptor 2 (PAR-2) is activated by secreted proteases from immune cells or fungi. PAR-2 is normally expressed basolaterally in differentiated nasal ciliated cells. We hypothesized that epithelial remodeling during diseases characterized by cilial loss and squamous metaplasia may alter PAR-2 polarization. Here, using a fluorescent arrestin assay, we confirmed that the common fungal airway pathogen Aspergillus fumigatus activates heterologously-expressed PAR-2. Endogenous PAR-2 activation in submerged airway RPMI 2650 or NCI-H520 squamous cells increased intracellular calcium levels and granulocyte macrophage-colony-stimulating factor, tumor necrosis factor alpha, and interleukin (IL)-6 secretion. RPMI 2650 cells cultured at an air-liquid interface (ALI) responded to apically or basolaterally applied PAR-2 agonists. However, well-differentiated primary nasal epithelial ALIs responded only to basolateral PAR-2 stimulation, indicated by calcium elevation, increased cilia beat frequency, and increased fluid and cytokine secretion. We exposed primary cells to disease-related modifiers that alter epithelial morphology, including IL-13, cigarette smoke condensate, and retinoic acid deficiency, at concentrations and times that altered epithelial morphology without causing breakdown of the epithelial barrier to model early disease states. These altered primary cultures responded to both apical and basolateral PAR-2 stimulation. Imaging nasal polyps and control middle turbinate explants, we found that nasal polyps, but not turbinates, exhibit apical calcium responses to PAR-2 stimulation. However, isolated ciliated cells from both polyps and turbinates maintained basolateral PAR-2 polarization, suggesting that the calcium responses originated from nonciliated cells. Altered PAR-2 polarization in disease-remodeled epithelia may enhance apical responses and increase sensitivity to inhaled proteases.	[Carey, Ryan M.; Freund, Jenna R.; Hariri, Benjamin M.; Adappa, Nithin D.; Palmer, James N.; Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Lee, RJ (corresponding author), Hosp Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, Ravdin Bldg,5th Fl,Ste A,3400 Spruce St, Philadelphia, PA 19104 USA.	rjl@pennmedicine.upenn.edu	Carey, Ryan/AAA-8471-2019; Lee, Robert J./L-4397-2017	Lee, Robert J./0000-0001-5826-6686; Freund, Jenna/0000-0001-8264-8318	National Institutes of Health [R01DC016309, R21AI137484]; Cystic Fibrosis Foundation [LEE19G0]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported in part by National Institutes of Health Grants R01DC016309 and R21AI137484 and Cystic Fibrosis Foundation Grant LEE19G0 (to R. J. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Chaaban MR, 2013, AM J RHINOL ALLERGY, V27, P387, DOI 10.2500/ajra.2013.27.3919; Chaudhary Neelkamal, 2011, Clin Transl Allergy, V1, P4, DOI 10.1186/2045-7022-1-4; Chen FH, 2004, J ASTHMA, V41, P631, DOI 10.1081/JAS-200026405; Chilvers MA, 2001, EUR RESPIR J, V18, P965, DOI 10.1183/09031936.01.00093001; Cho HJ, 2010, J CELL BIOCHEM, V109, P1254, DOI 10.1002/jcb.22511; CLUROE A, 1989, J CLIN PATHOL, V42, P1026, DOI 10.1136/jcp.42.10.1026; Cottrell GS, 2003, BIOCHEM SOC T, V31, P1191; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Daines MO, 2011, J ALLERGY CLIN IMMUN, V127, pAB59, DOI 10.1016/j.jaci.2010.12.246; de Boer JD, 2014, INNATE IMMUN-LONDON, V20, P618, DOI 10.1177/1753425913503387; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Dulon S, 2003, AM J RESP CELL MOL, V28, P339, DOI 10.1165/rcmb.4908; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Eichel K, 2018, TRENDS PHARMACOL SCI, V39, P200, DOI 10.1016/j.tips.2017.11.009; Freund JR, 2018, J BIOL CHEM, V293, P9824, DOI 10.1074/jbc.RA117.001005; Gieseler F, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-86; Gohy ST, 2015, EUR RESPIR J, V45, P1258, DOI 10.1183/09031936.00135814; Goncalves VSS, 2016, INT J PHARMACEUT, V515, P1, DOI 10.1016/j.ijpharm.2016.09.086; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hao YH, 2012, CELL MICROBIOL, V14, P401, DOI 10.1111/j.1462-5822.2011.01727.x; Hariri BM, 2017, J BIOL CHEM, V292, P8484, DOI [10.1074/jbc.M116.771949, 10.1074/jbc.m116.771949]; Homma T, 2016, AM J RESP CELL MOL, V54, P60, DOI 10.1165/rcmb.2015-0062OC; Hufnagl K, 2018, ALLERGO J, V27, P21, DOI 10.1007/s40629-018-0054-2; Hwang PH, 2006, LARYNGOSCOPE, V116, P1080, DOI 10.1097/01.mlg.0000224352.50256.99; JEFFERY PK, 1988, SCANNING MICROSCOPY, V2, P553; Jenkins HA, 2003, CHEST, V124, P32, DOI 10.1378/chest.124.1.32; Joo NS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116756; Joo NS, 2004, J BIOL CHEM, V279, P38854, DOI 10.1074/jbc.M407077200; Jung SR, 2016, J GEN PHYSIOL, V147, P255, DOI 10.1085/jgp.201511477; Kim SW, 2007, CANCER RES, V67, P6565, DOI 10.1158/0008-5472.CAN-06-2783; Lachowicz-Scroggins ME, 2010, AM J RESP CELL MOL, V43, P652, DOI 10.1165/rcmb.2009-0244OC; Lee RJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam7703; Lee RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33221; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2013, FASEB J, V27, P5094, DOI 10.1096/fj.13-234476; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lewandowska-Polak A, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0054-7; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Mata M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048037; Matsuwaki Y, 2012, INT ARCH ALLERGY IMM, V158, P19, DOI 10.1159/000337756; McMahon DB, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01386-2019; McMahon DB, 2018, FASEB J, V32, P155, DOI 10.1096/fj.201700114RRR; Mehta S, 2018, NAT CELL BIOL, V20, P1215, DOI 10.1038/s41556-018-0200-6; Million K, 2001, AM J RESP CELL MOL, V25, P744, DOI 10.1165/ajrcmb.25.6.4549; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; Mynatt RG, 2008, AM J RHINOL, V22, P602, DOI 10.2500/ajr.2008.22.3236; Niu YW, 2018, INVEST OPHTH VIS SCI, V59, P166, DOI 10.1167/iovs.17-21887; Palmer ML, 2006, AM J PHYSIOL-CELL PH, V290, pC1189, DOI 10.1152/ajpcell.00464.2005; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Pawankar R, 2007, CURR ALLERGY ASTHM R, V7, P202, DOI 10.1007/s11882-007-0073-4; Peters T, 2009, BRIT J PHARMACOL, V158, P1017, DOI 10.1111/j.1476-5381.2009.00449.x; Pothoven KL, 2015, J ALLERGY CLIN IMMUN, V136, P737, DOI 10.1016/j.jaci.2015.01.043; Ramachandran R, 2007, AM J PHYSIOL-LUNG C, V292, pL788, DOI 10.1152/ajplung.00226.2006; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Reed CE, 2004, J ALLERGY CLIN IMMUN, V114, P997, DOI 10.1016/j.jaci.2004.07.060; Rudack C, 2007, CLIN EXP ALLERGY, V37, P1009, DOI 10.1111/j.1365-2222.2007.02686.x; Saito A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082460; Salib RJ, 2005, CLIN EXP ALLERGY, V35, P811, DOI 10.1111/j.1365-2222.2005.02258.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SISSON JH, 1994, AM J RESP CRIT CARE, V149, P205, DOI 10.1164/ajrccm.149.1.8111584; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Son HL, 2015, ALLERGY ASTHMA IMMUN, V7, P590, DOI 10.4168/aair.2015.7.6.590; Tamashiro E, 2009, AM J RHINOL ALLERGY, V23, P117, DOI 10.2500/ajra.2009.23.3280; VOLLBERG TM, 1992, AM J RESP CELL MOL, V7, P10, DOI 10.1165/ajrcmb/7.1.10; Walker JKL, 2014, CURR OPIN PHARMACOL, V16, P142, DOI 10.1016/j.coph.2014.03.007; Wengst A, 2010, EUR J PHARM BIOPHARM, V74, P290, DOI 10.1016/j.ejpb.2009.08.008; Wu NH, 2016, SCI REP-UK, V6, DOI 10.1038/srep39668; Yaghi A, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5040040; Yee KK, 2009, TOXICOL PATHOL, V37, P594, DOI 10.1177/0192623309338055; Yoshida T, 2013, INT ARCH ALLERGY IMM, V161, P138, DOI 10.1159/000350386; Yu HM, 2010, CELL COMMUN ADHES, V17, P83, DOI 10.3109/15419061.2010.551682; Zhang Q, 2018, PROTEIN SCI, V27, P874, DOI 10.1002/pro.3385; Zhao PS, 2015, J BIOL CHEM, V290, P13875, DOI 10.1074/jbc.M115.642736; Zhao PS, 2014, J BIOL CHEM, V289, P27215, DOI 10.1074/jbc.M114.599712; Zhou J, 2013, MOL CELL BIOCHEM, V377, P75, DOI 10.1007/s11010-013-1572-3	78	8	8	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6721	6740		10.1074/jbc.RA120.012710	http://dx.doi.org/10.1074/jbc.RA120.012710			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32241907	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000537685000037
J	Pillon, MC; Goslen, KH; Gordon, J; Wells, ML; Williams, JG; Stanley, RE				Pillon, Monica C.; Goslen, Kevin H.; Gordon, Jacob; Wells, Melissa L.; Williams, Jason G.; Stanley, Robin E.			It takes two (Las1 HEPN endoribonuclease domains) to cut RNA correctly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoribonuclease; ribosome assembly; RNA degradation; RNA processing; ribosomal RNA processing (rRNA processing); higher eukaryotes and prokaryotes nucleotide-binding (HEPN); Las1; Las1L; nuclease specificity; RNA cleavage; ribosome biogenesis factor; LAS1L; RNA processing	ASP CATALYTIC DYAD; POLYNUCLEOTIDE KINASE; STRUCTURAL BASIS; WILD-TYPE; REVEALS; YEAST; HISTIDINE; D121N	The ribosome biogenesis factor Las1 is an essential endoribonuclease that is well-conserved across eukaryotes and a newly established member of the higher eukaryotes and prokaryotes nucleotide-binding (HEPN) domain-containing nuclease family. HEPN nucleases participate in diverse RNA cleavage pathways and share a short HEPN nuclease motif (R?XXXH) important for RNA cleavage. Most HEPN nucleases participate in stress-activated RNA cleavage pathways; Las1 plays a fundamental role in processing pre-rRNA. Underscoring the significance of Las1 function in the cell, mutations in the human LAS1L (LAS1-like) gene have been associated with neurological dysfunction. Two juxtaposed HEPN nuclease motifs create Las1's composite nuclease active site, but the roles of the individual HEPN motif residues are poorly defined. Here using a combination of in vivo experiments in Saccharomyces cerevisiae and in vitro assays, we show that both HEPN nuclease motifs are required for Las1 nuclease activity and fidelity. Through in-depth sequence analysis and systematic mutagenesis, we determined the consensus HEPN motif in the Las1 subfamily and uncovered its canonical and specialized elements. Using reconstituted Las1 HEPN-HEPN? chimeras, we defined the molecular requirements for RNA cleavage. Intriguingly, both copies of the Las1 HEPN motif were important for nuclease function, revealing that both HEPN motifs participate in coordinating the RNA within the Las1 active site. We also established that conformational flexibility of the two HEPN domains is important for proper nuclease function. The results of our work reveal critical information about how dual HEPN domains come together to drive Las1-mediated RNA cleavage.	[Pillon, Monica C.; Goslen, Kevin H.; Gordon, Jacob; Wells, Melissa L.; Stanley, Robin E.] NIEHS, Signal Transduct Lab, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA; [Williams, Jason G.] NIEHS, Epigenet & Stem Cell Biol Lab, NIH, US Dept HHS, POB 12233, Res Triangle Pk, NC 27709 USA; [Goslen, Kevin H.] Wake Forest Sch Med, 475 Vine St, Winston Salem, NC 27101 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Wake Forest University	Stanley, RE (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	robin.stanley@nih.gov	Stanley, Robin/M-3008-2019	Stanley, Robin/0000-0002-2106-3102; Gordon, Jacob/0000-0001-7199-7416	National Institutes of Health Intramural Research Program; NIEHS, National Institutes of Health [ZIA ES103247]; Canadian Institutes of Health Research (CIHR) [146626]	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the National Institutes of Health Intramural Research Program and NIEHS, National Institutes of Health Grant ZIA ES103247 (to R. E. S.) and by the Canadian Institutes of Health Research (CIHR) Grant 146626 (to M. C. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Anantharaman V, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-15; Bassler J, 2019, ANNU REV BIOCHEM, V88, P281, DOI 10.1146/annurev-biochem-013118-110817; Butterfield RJ, 2014, NEUROLOGY, V82, P1322, DOI 10.1212/WNL.0000000000000305; Castle CD, 2013, NUCLEIC ACIDS RES, V41, P1135, DOI 10.1093/nar/gks1086; Castle CD, 2010, MOL CELL BIOL, V30, P4404, DOI 10.1128/MCB.00358-10; Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Feldman HC, 2016, ACS CHEM BIOL, V11, P2195, DOI 10.1021/acschembio.5b00940; Fromm L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01786-9; Gasse L, 2015, MOL CELL, V60, P808, DOI 10.1016/j.molcel.2015.10.021; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Grynberg M, 2003, TRENDS BIOCHEM SCI, V28, P224, DOI 10.1016/S0968-0004(03)00060-4; Han YC, 2014, SCIENCE, V343, P1244, DOI 10.1126/science.1249845; Heindl K, 2010, EMBO J, V29, P4161, DOI 10.1038/emboj.2010.275; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Huang H, 2014, MOL CELL, V53, P221, DOI 10.1016/j.molcel.2013.12.025; Jia XY, 2018, J BIOL CHEM, V293, P6812, DOI 10.1074/jbc.RA118.002421; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kim YK, 2013, PROTEINS, V81, P261, DOI 10.1002/prot.24183; Klinge S, 2019, NAT REV MOL CELL BIO, V20, P116, DOI 10.1038/s41580-018-0078-y; Knott GJ, 2017, NAT STRUCT MOL BIOL, V24, P825, DOI 10.1038/nsmb.3466; Konermann S, 2018, CELL, V173, P665, DOI 10.1016/j.cell.2018.02.033; Korennykh AV, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-47; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Liu L, 2017, CELL, V170, P714, DOI 10.1016/j.cell.2017.06.050; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Niewoehner O, 2017, NATURE, V548, P543, DOI 10.1038/nature23467; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; O'Connell MR, 2019, J MOL BIOL, V431, P66, DOI 10.1016/j.jmb.2018.06.029; Panov KI, 1996, FEBS LETT, V398, P57, DOI 10.1016/S0014-5793(96)01173-8; Pilion MC, 2019, NAT STRUCT MOL BIOL, V26, P830, DOI 10.1038/s41594-019-0289-8; Pillon MC, 2018, RNA, V24, P721, DOI 10.1261/rna.065037.117; Pillon MC, 2018, CURR GENET, V64, P183, DOI 10.1007/s00294-017-0749-9; Pillon MC, 2017, P NATL ACAD SCI USA, V114, pE5530, DOI 10.1073/pnas.1703133114; Quirk DJ, 1998, BIOCHEMISTRY-US, V37, P17958, DOI 10.1021/bi981688j; Quirk DJ, 1999, BIOPHYS J, V76, P1571, DOI 10.1016/S0006-3495(99)77316-9; Schillewaert S, 2012, MOL CELL BIOL, V32, P430, DOI 10.1128/MCB.06019-11; Slaymaker IM, 2019, CELL REP, V26, P3741, DOI 10.1016/j.celrep.2019.02.094; Terns MP, 2018, MOL CELL, V72, P404, DOI 10.1016/j.molcel.2018.09.018; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Tomecki R, 2017, FEBS LETT, V591, P1801, DOI 10.1002/1873-3468.12682; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10507-3; Zhang B, 2018, CELL RES, V28, P1198, DOI 10.1038/s41422-018-0109-4; Zhang C, 2018, CELL, V175, P212, DOI 10.1016/j.cell.2018.09.001	51	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5857	5870		10.1074/jbc.RA119.011193	http://dx.doi.org/10.1074/jbc.RA119.011193			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32220933	hybrid, Green Published			2022-12-28	WOS:000531417300003
J	Sandmark, J; Tigerstrom, A; Akerud, T; Althage, M; Antonsson, T; Blaho, S; Bodin, C; Bostrom, J; Chen, YT; Dahlen, A; Eriksson, PO; Evertsson, E; Fex, T; Fjellstrom, O; Gustafsson, D; Herslof, M; Hicks, R; Jarkvist, E; Johansson, C; Kalies, I; Svalstedt, BK; Kartberg, F; Legnehed, A; Martinsson, S; Moberg, A; Ridderstrom, M; Rosengren, B; Sabirsh, A; Thelin, A; Vinblad, J; Wellner, AU; Xu, BZ; Ostlund-Lindqvist, AM; Knecht, W				Sandmark, Jenny; Tigerstrom, Anna; Akerud, Tomas; Althage, Magnus; Antonsson, Thomas; Blaho, Stefan; Bodin, Cristian; Bostrom, Jonas; Chen, Yantao; Dahlen, Anders; Eriksson, Per-Olof; Evertsson, Emma; Fex, Tomas; Fjellstrom, Ola; Gustafsson, David; Herslof, Margareta; Hicks, Ryan; Jarkvist, Emelie; Johansson, Carina; Kalies, Inge; Svalstedt, Birgitta Karlsson; Kartberg, Fredrik; Legnehed, Anne; Martinsson, Sofia; Moberg, Andreas; Ridderstrom, Marianne; Rosengren, Birgitta; Sabirsh, Alan; Thelin, Anders; Vinblad, Johanna; Wellner, Annika U.; Xu, Bingze; Ostlund-Lindqvist, Ann-Margret; Knecht, Wolfgang			Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; surface plasmon resonance (SPR); apolipoprotein; low-density lipoprotein (LDL); drug discovery; drug design; crystal structure; crystallography; cardiovascular disease; apo(a); apolipoprotein(a); Lp(a); small molecule inhibitor	LOW-DENSITY-LIPOPROTEIN; LYSINE-BINDING-SITE; INDUCED CONFORMATIONAL-CHANGE; ENHANCED MACROPHAGE UPTAKE; CRYSTAL-STRUCTURE; DOUBLE-BLIND; CARDIOVASCULAR-DISEASE; TRANEXAMIC ACID; RISK-FACTOR; IV TYPE-7	Increased plasma concentrations of lipoprotein(a) (Lp(a)) are associated with an increased risk for cardiovascular disease. Lp(a) is composed of apolipoprotein(a) (apo(a)) covalently bound to apolipoprotein B of low-density lipoprotein (LDL). Many of apo(a)'s potential pathological properties, such as inhibition of plasmin generation, have been attributed to its main structural domains, the kringles, and have been proposed to be mediated by their lysine-binding sites. However, available small-molecule inhibitors, such as lysine analogs, bind unselectively to kringle domains and are therefore unsuitable for functional characterization of specific kringle domains. Here, we discovered small molecules that specifically bind to the apo(a) kringle domains KIV-7, KIV-10, and KV. Chemical synthesis yielded compound AZ-05, which bound to KIV-10 with a K-d of 0.8 ?m and exhibited more than 100-fold selectivity for KIV-10, compared with the other kringle domains tested, including plasminogen kringle 1. To better understand and further improve ligand selectivity, we determined the crystal structures of KIV-7, KIV-10, and KV in complex with small-molecule ligands at 1.6?2.1 ? resolutions. Furthermore, we used these small molecules as chemical probes to characterize the roles of the different apo(a) kringle domains in in vitro assays. These assays revealed the assembly of Lp(a) from apo(a) and LDL, as well as potential pathophysiological mechanisms of Lp(a), including (i) binding to fibrin, (ii) stimulation of smooth-muscle cell proliferation, and (iii) stimulation of LDL uptake into differentiated monocytes. Our results indicate that a small-molecule inhibitor targeting the lysine-binding site of KIV-10 can combat the pathophysiological effects of Lp(a).	[Sandmark, Jenny; Akerud, Tomas; Bodin, Cristian; Eriksson, Per-Olof; Johansson, Carina; Moberg, Andreas] AstraZeneca, R&D, Discovery Sci, Struct Biophys & Fragment Based Lead Generat, S-43183 Molndal, Sweden; [Tigerstrom, Anna] AstraZeneca, R&D, Precis Med, Precis Med BioPharmaceut, S-43183 Molndal, Sweden; [Althage, Magnus] AstraZeneca, Early CVRM Biopharmaceut R&D, Translat Sci & Expt Med, S-43183 Molndal, Sweden; [Gustafsson, David; Jarkvist, Emelie; Kalies, Inge; Svalstedt, Birgitta Karlsson; Legnehed, Anne; Martinsson, Sofia; Rosengren, Birgitta; Thelin, Anders; Vinblad, Johanna; Ostlund-Lindqvist, Ann-Margret; Knecht, Wolfgang] AstraZeneca, BioPharmaceut R&D, Cardiovasc Renal & Metab, Biosci Cardiovasc, S-43183 Molndal, Sweden; [Antonsson, Thomas; Bostrom, Jonas; Chen, Yantao; Dahlen, Anders; Evertsson, Emma; Fex, Tomas; Herslof, Margareta; Wellner, Annika U.] AstraZeneca, BioPharmaceut R&D, Cardiovasc Renal & Metab, Med Chem, S-43183 Molndal, Sweden; [Blaho, Stefan; Hicks, Ryan; Kartberg, Fredrik; Xu, Bingze] AstraZeneca, R&D, Discovery Sci, Discovery Biol, S-43183 Molndal, Sweden; [Fjellstrom, Ola] AstraZeneca, Biopharmaceut R&D, Cardiovasc Renal & Metab, Res & Early Dev, S-43183 Molndal, Sweden; [Ridderstrom, Marianne] AstraZeneca, Biopharmaceut R&D, Cardiovasc Renal & Metab, Drug Metab & Pharmacokinet, S-43183 Molndal, Sweden; [Sabirsh, Alan] AstraZeneca, R&D, Pharmaceut Sci, Adv Drug Delivery, S-43183 Molndal, Sweden; [Knecht, Wolfgang] Lund Univ, Dept Biol & Lund Prot Prod Platform, Solvegatan 35, S-22362 Lund, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Lund University	Sandmark, J (corresponding author), AstraZeneca, R&D, Discovery Sci, Struct Biophys & Fragment Based Lead Generat, S-43183 Molndal, Sweden.; Knecht, W (corresponding author), AstraZeneca, BioPharmaceut R&D, Cardiovasc Renal & Metab, Biosci Cardiovasc, S-43183 Molndal, Sweden.; Knecht, W (corresponding author), Lund Univ, Dept Biol & Lund Prot Prod Platform, Solvegatan 35, S-22362 Lund, Sweden.	jenny.sandmark@astrazeneca.com; Wolfgang.Knecht@biol.lu.se	Boström, Jonas/A-3749-2009	Sabirsh, Alan/0000-0001-5310-0281; Hicks, Ryan/0000-0002-3367-6272; Bostrom, Jonas/0000-0002-9719-9137				Angelin B, 2013, J INTERN MED, V273, P3, DOI 10.1111/joim.12013; Angles-Cano E, 2001, ANN NY ACAD SCI, V936, P261; ANGLESCANO E, 1994, CHEM PHYS LIPIDS, V67-8, P369, DOI 10.1016/0009-3084(94)90159-7; Becker L, 2003, J BIOL CHEM, V278, P14074, DOI 10.1074/jbc.M212855200; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; Boonmark NW, 1997, J CLIN INVEST, V100, P558, DOI 10.1172/JCI119565; Bostrom J, 2013, J MED CHEM, V56, P3273, DOI 10.1021/jm301818g; BRUNNER C, 1993, P NATL ACAD SCI USA, V90, P11643, DOI 10.1073/pnas.90.24.11643; Burgess S, 2018, JAMA CARDIOL, V3, P619, DOI 10.1001/jamacardio.2018.1470; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; Cheng LF, 2014, ACS MED CHEM LETT, V5, P538, DOI 10.1021/ml400526d; Cho T, 2008, J BIOL CHEM, V283, P30503, DOI 10.1074/jbc.M802648200; CLAEYS H, 1976, FEBS LETT, V61, P20, DOI 10.1016/0014-5793(76)80161-5; Dalvit C, 2002, J MED CHEM, V45, P2610, DOI 10.1021/jm011122k; Dalvit C, 2008, CONCEPT MAGN RESON A, V32A, P341, DOI 10.1002/cmr.a.20121; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; Fless GM, 1996, BIOCHEMISTRY-US, V35, P2289, DOI 10.1021/bi951792q; Frank S, 1997, PROTEIN ENG, V10, P291, DOI 10.1093/protein/10.3.291; Frank S, 1999, BBA-MOL CELL BIOL L, V1438, P99, DOI 10.1016/S1388-1981(99)00044-X; FRANK S, 1995, ARTERIOSCL THROM VAS, V15, P1774, DOI 10.1161/01.ATV.15.10.1774; Gabel BR, 1998, BIOCHEMISTRY-US, V37, P7892, DOI 10.1021/bi973186w; Helmhold M, 1996, Z Gastroenterol, V34 Suppl 3, P36; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jaeger BR, 2009, NAT CLIN PRACT CARD, V6, P229, DOI 10.1038/ncpcardio1456; Kamstrup PR, 2011, SCAND J CLIN LAB INV, V71, P87, DOI 10.3109/00365513.2010.550311; KARLSSON R, 1994, ANAL BIOCHEM, V221, P142, DOI 10.1006/abio.1994.1390; KHOO JC, 1988, ARTERIOSCLEROSIS, V8, P348, DOI 10.1161/01.ATV.8.4.348; Klezovitch O, 2001, J BIOL CHEM, V276, P46864, DOI 10.1074/jbc.M107943200; Kogej T, 2006, J CHEM INF MODEL, V46, P1201, DOI 10.1021/ci0504723; Koschinsky Marlys L., 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P267; KOSCHINSKY ML, 1991, BIOCHEMISTRY-US, V30, P5044, DOI 10.1021/bi00234a029; Kostner KM, 2018, ATHEROSCLEROSIS, V274, P16, DOI 10.1016/j.atherosclerosis.2018.04.032; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Leibundgut G, 2013, J LIPID RES, V54, P2815, DOI 10.1194/jlr.M040733; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; LIU JN, 1994, BIOCHEMISTRY-US, V33, P2554, DOI 10.1021/bi00175a026; Mansson M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05318; Marcovina SM, 2003, CURR OPIN LIPIDOL, V14, P361, DOI 10.1097/00041433-200308000-00004; Mathews II, 1996, BIOCHEMISTRY-US, V35, P2567, DOI 10.1021/bi9521351; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Mochalkin I, 1999, BIOCHEMISTRY-US, V38, P1990, DOI 10.1021/bi9820558; Nikolajsen CL, 2014, J BIOL CHEM, V289, P6526, DOI 10.1074/jbc.M113.517904; Nordestgaard BG, 2011, CURR OPIN LIPIDOL, V22, P113, DOI 10.1097/MOL.0b013e32834477d2; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; O'Neil CH, 2004, J BIOL CHEM, V279, P55187, DOI 10.1074/jbc.M409860200; PALABRICA TM, 1995, NAT MED, V1, P256, DOI 10.1038/nm0395-256; Pellegrino M, 2004, J BIOL CHEM, V279, P6526, DOI 10.1074/jbc.M309705200; PHILLIPS ML, 1993, BIOCHEMISTRY-US, V32, P3722, DOI 10.1021/bi00065a026; Qian LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00316-3; Raal FJ, 2015, LANCET, V385, P341, DOI 10.1016/S0140-6736(14)61374-X; Rahman MN, 2002, BIOCHEMISTRY-US, V41, P1149, DOI 10.1021/bi010964i; Rahman MN, 2001, PROTEIN ENG, V14, P427, DOI 10.1093/protein/14.6.427; Ray KK, 2018, CIRCULATION, V138, P1304, DOI 10.1161/CIRCULATIONAHA.118.034710; REBLIN T, 1995, ATHEROSCLEROSIS, V113, P179, DOI 10.1016/0021-9150(94)05445-O; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roeseler E, 2016, ARTERIOSCL THROM VAS, V36, P2019, DOI 10.1161/ATVBAHA.116.307983; Santos RD, 2015, ARTERIOSCL THROM VAS, V35, P689, DOI 10.1161/ATVBAHA.114.304549; Tanaka S, 1998, LIPIDS, V33, P385, DOI 10.1007/s11745-998-0219-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsimikas S, 2015, LANCET, V386, P1472, DOI 10.1016/S0140-6736(15)61252-1; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; Viney NJ, 2016, LANCET, V388, P2239, DOI 10.1016/S0140-6736(16)31009-1; Virani SS, 2012, CIRCULATION, V125, P241, DOI 10.1161/CIRCULATIONAHA.111.045120; Waldmann E, 2017, ATHEROSCLEROSIS, V259, P20, DOI 10.1016/j.atherosclerosis.2017.02.019; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu SH, 1998, BIOCHEMISTRY-US, V37, P9284, DOI 10.1021/bi9729662; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x; Ye QL, 2001, PROTEIN SCI, V10, P1124, DOI 10.1110/ps.01701; Yu H, 2003, CHINESE MED J-PEKING, V116, P721	70	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5136	5151		10.1074/jbc.RA119.011251	http://dx.doi.org/10.1074/jbc.RA119.011251			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32132173	Green Published, hybrid			2022-12-28	WOS:000526887000032
J	Diaz-Coranguez, M; Lin, CM; Liebner, S; Antonetti, DA				Diaz-Coranguez, Monica; Lin, Cheng-Mao; Liebner, Stefan; Antonetti, David A.			Norrin restores blood-retinal barrier properties after vascular endothelial growth factor?induced permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vascular endothelial growth factor (VEGF); tight junction; permeability; retina; endothelium; cell signaling; tetraspanin; Wnt signaling; blood-retinal barrier; diabetic retinopathy; norrin; tetraspanin 12 (TSPAN12)	FAMILIAL EXUDATIVE VITREORETINOPATHY; TIGHT JUNCTION TRAFFICKING; PROTEIN-COUPLED RECEPTOR; BRAIN-BARRIER; WNT/BETA-CATENIN; BETA-CATENIN; CNS ANGIOGENESIS; MUTATION SPECTRUM; LRP5 MUTATIONS; DISEASE	Vascular endothelial growth factor (VEGF) contributes to blood-retinal barrier (BRB) dysfunction in several blinding eye diseases, including diabetic retinopathy. Signaling via the secreted protein norrin through the frizzled class receptor 4 (FZD4)/LDL receptor?related protein 5?6 (LRP5?6)/tetraspanin 12 (TSPAN12) receptor complex is required for developmental vascularization and BRB formation. Here, we tested the hypothesis that norrin restores BRB properties after VEGF-induced vascular permeability in diabetic rats or in animals intravitreally injected with cytokines. Intravitreal co-injection of norrin with VEGF completely ablated VEGF-induced BRB permeability to Evans Blue-albumin. Likewise, 5-month diabetic rats exhibited increased permeability of FITC-albumin, and a single norrin injection restored BRB properties. These results were corroborated in vitro, where co-stimulation of norrin with VEGF or stimulation of norrin after VEGF exposure restored barrier properties, indicated by electrical resistance or 70-kDa RITC-dextran permeability in primary endothelial cell culture. Interestingly, VEGF promoted norrin signaling by increasing the FZD4 co-receptor TSPAN12 at cell membranes in an MAPK/ERK kinase (MEK)/ERK-dependent manner. Norrin signaling through ?-catenin was required for BRB restoration, but glycogen synthase kinase 3 ?/? (GSK-3?/?) inhibition did not restore BRB properties. Moreover, levels of the tight junction protein claudin-5 were increased with norrin and VEGF or with VEGF alone, but both norrin and VEGF were required for enriched claudin-5 localization at the tight junction. These results suggest that VEGF simultaneously induces vascular permeability and promotes responsiveness to norrin. Norrin, in turn, restores tight junction complex organization and BRB properties in a ?-catenin?dependent manner.	[Diaz-Coranguez, Monica; Lin, Cheng-Mao; Antonetti, David A.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA; [Liebner, Stefan] Goethe Univ, Univ Hosp, Inst Neurol, Edinger Inst, D-60538 Frankfurt, Germany	University of Michigan System; University of Michigan; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Antonetti, DA (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA.	dantonet@med.umich.edu			National Institutes of Health [EY012021, P30EY007003, DK020572]; Jules Doris Stein Professorship from Research to Prevent Blindness; American Diabetes Association Minority Postdoctoral Fellowship Award [4-16PMF-003]; Deutsche Forschungsgemeinschaft (DFG) [FOR2325, LI 911/5-1]; Excellence Cluster Cardio-Pulmonary Institute (CPI); European Union HORIZON 2020 Grant [MSCA-ITN-2015 675619]; German Centre for Heart and Circulation Research (DZHK) [81X2800146]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jules Doris Stein Professorship from Research to Prevent Blindness; American Diabetes Association Minority Postdoctoral Fellowship Award; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Excellence Cluster Cardio-Pulmonary Institute (CPI); European Union HORIZON 2020 Grant; German Centre for Heart and Circulation Research (DZHK)	This work was supported by National Institutes of Health Grant EY012021 (to D. A. A.) and Core Grants P30EY007003 and DK020572, the Jules Doris Stein Professorship from Research to Prevent Blindness (to D. A.) American Diabetes Association Minority Postdoctoral Fellowship Award 4-16PMF-003 (to M. D.-C.) and the Deutsche Forschungsgemeinschaft (DFG) research group FOR2325, "The Neurovascular Interface Grant LI 911/5-1; the Excellence Cluster Cardio-Pulmonary Institute (CPI); the European Union HORIZON 2020 Grant MSCA-ITN-2015 675619 "BtRAIN"; and the German Centre for Heart and Circulation Research (DZHK) Grant 81X2800146 (to S. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonetti David A, 2003, Methods Mol Med, V89, P365; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Bassett EA, 2016, ELIFE, V5, DOI 10.7554/eLife.16764; Beck SC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24476-y; Berger W, 1996, HUM MOL GENET, V5, P51, DOI 10.1093/hmg/5.1.51; BERGER W, 1992, HUM MOL GENET, V1, P461, DOI 10.1093/hmg/1.7.461; Braunger BM, 2013, NEUROBIOL DIS, V50, P1, DOI 10.1016/j.nbd.2012.09.008; Bucher F, 2017, CIRCULATION, V136, P180, DOI 10.1161/CIRCULATIONAHA.116.025604; Chang JL, 2017, NAT MED, V23, P450, DOI 10.1038/nm.4309; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030203; Chen J, 2011, CIRCULATION, V124, P1871, DOI 10.1161/CIRCULATIONAHA.111.040337; Chen Q, 2017, VISION RES, V139, P47, DOI 10.1016/j.visres.2017.02.007; Chen Y, 2009, AM J PATHOL, V175, P2676, DOI 10.2353/ajpath.2009.080945; Chen YJ, 2015, STROKE, V46, P529, DOI 10.1161/STROKEAHA.114.007265; Cho C, 2017, NEURON, V95, P1056, DOI 10.1016/j.neuron.2017.07.031; Cullen M, 2011, P NATL ACAD SCI USA, V108, P5759, DOI 10.1073/pnas.1017192108; Dailey WA, 2017, EXP EYE RES, V164, P129, DOI 10.1016/j.exer.2017.08.012; Fei P, 2015, SCI REP-UK, V5, DOI 10.1038/srep16120; Fei P, 2014, MOL VIS, V20, P395; Frey T, 2011, ANTIOXID REDOX SIGN, V15, P1271, DOI 10.1089/ars.2011.3906; Gal M, 2014, AM J MED GENET A, V164, P2996, DOI 10.1002/ajmg.a.36739; Halfter W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189857; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Ke JY, 2013, GENE DEV, V27, P2305, DOI 10.1101/gad.228544.113; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Lai MB, 2017, CELL REP, V19, P2809, DOI 10.1016/j.celrep.2017.06.004; Lee H, 2013, ACTA HISTOCHEM, V115, P447, DOI 10.1016/j.acthis.2012.10.008; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lin CM, 2018, AM J PATHOL, V188, P2392, DOI 10.1016/j.ajpath.2018.06.020; Liu Yuqing, 2017, Yichuan, V39, P241, DOI 10.16288/j.yczz.16-339; Mazzoni J, 2017, NEURON, V96, P1055, DOI 10.1016/j.neuron.2017.10.025; MEINDL A, 1992, NAT GENET, V2, P139, DOI 10.1038/ng1092-139; MEITINGER T, 1993, NAT GENET, V5, P376, DOI 10.1038/ng1293-376; Murakami T, 2012, DIABETES, V61, P1573, DOI 10.2337/db11-1367; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Musada GR, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0236-y; Musada GR, 2016, MOL VIS, V22, P491; Muthusamy A, 2014, J CEREBR BLOOD F MET, V34, P522, DOI 10.1038/jcbfm.2013.230; Ngo MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158320; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Ohlmann A, 2005, J NEUROSCI, V25, P1701, DOI 10.1523/JNEUROSCI.4756-04.2005; Ohlmann A, 2010, J NEUROSCI, V30, P183, DOI 10.1523/JNEUROSCI.3210-09.2010; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Panagiotou ES, 2017, AM J HUM GENET, V100, P960, DOI 10.1016/j.ajhg.2017.05.001; Parzefall T, 2014, AUDIOL NEURO-OTOL, V19, P203, DOI 10.1159/000358866; Posokhova E, 2015, CELL REP, V10, P123, DOI 10.1016/j.celrep.2014.12.020; Rattner A, 2014, INVEST OPHTH VIS SCI, V55, P8614, DOI 10.1167/iovs.14-15693; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Roux PP, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00070-18; Rubio RG, 2016, DEV OPHTHALMOL, V55, P28, DOI 10.1159/000431129; Schafer NF, 2009, INVEST OPHTH VIS SCI, V50, P906, DOI 10.1167/iovs.08-1731; Schatz P, 2017, ACTA OPHTHALMOL, V95, P705, DOI 10.1111/aos.13411; Seitz R, 2010, J NEUROSCI, V30, P5998, DOI 10.1523/JNEUROSCI.0730-10.2010; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Ulrich F, 2016, DEVELOPMENT, V143, P147, DOI 10.1242/dev.123059; Vanhollebeke B, 2015, ELIFE, V4, DOI 10.7554/eLife.06489; Wang YS, 2018, P NATL ACAD SCI USA, V115, pE11827, DOI 10.1073/pnas.1813217115; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Wisniewska-Kruk J, 2016, AM J PATHOL, V186, P1044, DOI 10.1016/j.ajpath.2015.11.019; Wu JH, 2016, HUM MOL GENET, V25, P1637, DOI 10.1093/hmg/ddw041; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xia CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075186; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Xu Y, 2014, MOL VIS, V20, P1296; Ye X, 2011, GENE EXPR PATTERNS, V11, P151, DOI 10.1016/j.gep.2010.10.007; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zeilbeck LF, 2016, EXP EYE RES, V145, P317, DOI 10.1016/j.exer.2015.12.001; Zeilbeck LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095546; Zhang C, 2018, ARTERIOSCL THROM VAS, V38, P2691, DOI 10.1161/ATVBAHA.118.311689; Zhang L, 2016, GENET TEST MOL BIOMA, V20, P346, DOI 10.1089/gtmb.2015.0322; Zhou YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143650; Zhou YL, 2014, DEV CELL, V31, P248, DOI 10.1016/j.devcel.2014.08.018; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431; Zuercher J, 2012, HUM MOL GENET, V21, P2619, DOI 10.1093/hmg/dds087	80	16	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4647	4660		10.1074/jbc.RA119.011273	http://dx.doi.org/10.1074/jbc.RA119.011273			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32086377	hybrid, Green Published			2022-12-28	WOS:000524499700023
J	Wiechmann, S; Maisonneuve, P; Grebbin, BM; Hoffmeister, M; Kaulich, M; Clevers, H; Rajalingam, K; Kurinov, I; Farin, HF; Sicheri, F; Ernst, A				Wiechmann, Svenja; Maisonneuve, Pierre; Grebbin, Britta M.; Hoffmeister, Meike; Kaulich, Manuel; Clevers, Hans; Rajalingam, Krishnaraj; Kurinov, Igor; Farin, Henner F.; Sicheri, Frank; Ernst, Andreas			Conformation-specific inhibitors of activated Ras GTPases reveal limited Ras dependency of patient-derived cancer organoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein engineering; crystal structure; phage display; colorectal cancer; substrate specificity; GTPase; protein design; protein-protein interaction; cancer organoids; oncogenic Ras; CRAF RBD; Ras-binding domain; conformation-specific inhibitors; Ras signaling; MAPK pathway; organoids; cancer; cell signaling	MAP KINASE; MACROMOLECULAR STRUCTURES; RAS/EFFECTOR; MUTANTS; REFINEMENT; EXTRACTION; PROTEINS; DELIVERY; BINDING	The small GTPases H, K, and NRAS are molecular switches indispensable for proper regulation of cellular proliferation and growth. Several mutations in the genes encoding members of this protein family are associated with cancer and result in aberrant activation of signaling processes caused by a deregulated recruitment of downstream effector proteins. In this study, we engineered variants of the Ras-binding domain (RBD) of the C-Raf proto-oncogene, Ser/Thr kinase (CRAF). These variants bound with high affinity with the effector-binding site of Ras in an active conformation. Structural characterization disclosed how the newly identified RBD mutations cooperate and thereby enhance affinity with the effector-binding site in Ras compared with WT RBD. The engineered RBD variants closely mimicked the interaction mode of naturally occurring Ras effectors and acted as dominant-negative affinity reagents that block Ras signal transduction. Experiments with cancer cells showed that expression of these RBD variants inhibits Ras signaling, reducing cell growth and inducing apoptosis. Using these optimized RBD variants, we stratified patient-derived colorectal cancer organoids with known Ras mutational status according to their response to Ras inhibition. These results revealed that the presence of Ras mutations was insufficient to predict sensitivity to Ras inhibition, suggesting that not all of these tumors required Ras signaling for proliferation. In summary, by engineering the Ras/Raf interface of the CRAF-RBD, we identified potent and selective inhibitors of Ras in its active conformation that outcompete binding of Ras-signaling effectors.	[Wiechmann, Svenja; Hoffmeister, Meike; Kaulich, Manuel; Ernst, Andreas] Goethe Univ Frankfurt, Univ Hosp, Med Fac, Inst Biochem 2, D-60596 Frankfurt, Germany; [Wiechmann, Svenja; Ernst, Andreas] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Maisonneuve, Pierre; Sicheri, Frank] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON MSG 1X5, Canada; [Grebbin, Britta M.; Farin, Henner F.] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Grebbin, Britta M.; Farin, Henner F.] Georg Speyer Haus, Inst Tumor Biol & Expt Therapy, D-60596 Frankfurt, Germany; [Grebbin, Britta M.; Farin, Henner F.] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Hoffmeister, Meike] Brandenburg Med Sch MHB Theodor Fontane, Inst Biochem, D-14770 Brandenburg, Germany; [Kaulich, Manuel] Frankfurt Canc Inst, D-60596 Frankfurt, Germany; [Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst, NL-3584 CX Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CX Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Canc Genom Netherlands, NL-3584 CX Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Dept Genet, Ctr Mol Med, NL-3584 CX Utrecht, Netherlands; [Rajalingam, Krishnaraj] JGU Mainz, Cell Biol Unit, Univ Med Ctr Mainz, D-55131 Mainz, Germany; [Kurinov, Igor] Cornell Univ, Dept Chem & Chem Biol, NE CAT, Argonne, IL 60439 USA	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Fraunhofer Gesellschaft; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Octapharma; Helmholtz Association; German Cancer Research Center (DKFZ); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Johannes Gutenberg University of Mainz; Cornell University	Ernst, A (corresponding author), Goethe Univ Frankfurt, Univ Hosp, Med Fac, Inst Biochem 2, D-60596 Frankfurt, Germany.	ernst2001@gmail.com	Farin, Henner/AAC-2574-2021; Kaulich, Manuel/U-4523-2017	Farin, Henner/0000-0003-1558-5366; Kaulich, Manuel/0000-0002-9528-8822; Maisonneuve, Pierre/0000-0001-8292-5741	NIGMS, National Institutes of Health (NIH) [P41 GM103403]; NIH-ORIP HEI Grant [S10 RR029205]	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP HEI Grant	We thank Mani Ravichandran from the Structural and Genomic Consortium (SGC) of Toronto for providing X-ray crystallography screening kits. Diffraction work conducted at the Northeastern Collaborative Access Team beamlines was funded by NIGMS, National Institutes of Health (NIH), Grant P41 GM103403 and by NIH-ORIP HEI Grant S10 RR029205. We thank Nancy R. Gough (BioSerendipity, LLC) for constructive comments and editorial assistance. We thank Jason Moffat (University of Toronto) for donation of inducible lentiviral plasmids. We thank Georg Tascher for help in analyzing MS data, Mateusz Putyrski for cloning lentiviral gateway constructs, and Suchithra Guntur and Andrew Vorobyov for assistance during the revision.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Auger A, 2015, MOL PHARMACEUT, V12, P2962, DOI 10.1021/acs.molpharmaceut.5b00233; Burgess MR, 2017, CELL, V168, P817, DOI 10.1016/j.cell.2017.01.020; Campbell-Valois FX, 2005, P NATL ACAD SCI USA, V102, P14988, DOI 10.1073/pnas.0500465102; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erijman A, 2016, MINI-REV MED CHEM, V16, P370, DOI 10.2174/1389557515666151001141838; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Fetics SK, 2015, STRUCTURE, V23, P505, DOI 10.1016/j.str.2014.12.017; Filchtinski D, 2010, J MOL BIOL, V399, P422, DOI 10.1016/j.jmb.2010.03.046; Fridman M, 2000, J BIOL CHEM, V275, P30363, DOI 10.1074/jbc.M003193200; Fu AL, 2014, BIOCONJUGATE CHEM, V25, P1602, DOI 10.1021/bc500320j; Guillard S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16111; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karimkhani C, 2014, AM J CLIN DERMATOL, V15, P323, DOI 10.1007/s40257-014-0083-7; Kauke MJ, 2018, MOL CANCER THER, V17, P1773, DOI 10.1158/1535-7163.MCT-17-0645; Kauke MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05889-7; Khan I, 2019, ONCOGENE, V38, P2984, DOI 10.1038/s41388-018-0636-y; Kiel C, 2004, J MOL BIOL, V340, P1039, DOI 10.1016/j.jmb.2004.05.050; Kiel C, 2009, J BIOL CHEM, V284, P31893, DOI 10.1074/jbc.M109.031153; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Kovalevskiy O, 2016, ACTA CRYSTALLOGR D, V72, P1149, DOI 10.1107/S2059798316014534; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Manzano JL, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.06.07; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGee JH, 2018, J BIOL CHEM, V293, P3265, DOI 10.1074/jbc.M117.816348; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakhaeizadeh H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167145; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Roderer D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13253-8; Rudolph MG, 2001, J BIOL CHEM, V276, P23914, DOI 10.1074/jbc.M011600200; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shin SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15090; Spencer-Smith R, 2017, NAT CHEM BIOL, V13, P62, DOI [10.1038/nchembio.2231, 10.1038/NCHEMBIO.2231]; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Trinh TB, 2016, ACS COMB SCI, V18, P75, DOI 10.1021/acscombsci.5b00164; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Weber CK, 2001, CANCER RES, V61, P3595; Wiechmann S, 2017, J BIOL CHEM, V292, P15340, DOI 10.1074/jbc.M117.794255; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Yuryev A, 2000, MOL CELL BIOL, V20, P4870, DOI 10.1128/MCB.20.13.4870-4878.2000	56	10	11	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4526	4540		10.1074/jbc.RA119.011025	http://dx.doi.org/10.1074/jbc.RA119.011025			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32086379	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000524499700014
J	Agarwal, S; Yadav, A; Tiwari, SK; Seth, B; Chauhan, LKS; Khare, P; Ray, RS; Chaturvedi, RK				Agarwal, Swati; Yadav, Anuradha; Tiwari, Shashi Kant; Seth, Brashket; Chauhan, Lalit Kumar Singh; Khare, Puneet; Ray, Ratan Singh; Chaturvedi, Rajnish Kumar			Dynamin-related protein 1 inhibition mitigates bisphenol A-mediated alterations in mitochondrial dynamics and neural stem cell proliferation and differentiation (vol 291, pg 15923, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Agarwal S, 2016, J BIOL CHEM, V291, P15923, DOI 10.1074/jbc.M115.709493	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2887	2887		10.1074/jbc.AAC120.012899	http://dx.doi.org/10.1074/jbc.AAC120.012899			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	32111722	hybrid, Green Published			2022-12-28	WOS:000519969100030
J	Meriesh, HA; Lerner, AM; Chandrasekharan, MB; Strahl, BD				Meriesh, Hashem A.; Lerner, Andrew M.; Chandrasekharan, Mahesh B.; Strahl, Brian D.			The histone H4 basic patch regulates SAGA-mediated H2B deubiquitination and histone acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						histone; histone modification; gene transcription; chromatin regulation; chromatin; yeast transcription	TRANSCRIPTIONAL ACTIVATION; STRUCTURAL BASIS; GENE-EXPRESSION; UBIQUITYLATION; UBIQUITINATION; METHYLATION; PROTEIN; DYNAMICS; RAD6; H3	Histone H2B monoubiquitylation (H2Bub1) has central functions in multiple DNA-templated processes, including gene transcription, DNA repair, and replication. H2Bub1 also is required for the trans-histone regulation of H3K4 and H3K79 methylation. Although previous studies have elucidated the basic mechanisms that establish and remove H2Bub1, we have only an incomplete understanding of how H2Bub1 is regulated. We report here that the histone H4 basic patch regulates H2Bub1. Yeast cells with arginine-to-alanine mutations in the H4 basic patch (H4(2RA)) exhibited a significant loss of global H2Bub1. H4(2RA) mutant yeast strains also displayed chemotoxin sensitivities similar to, but less severe than, strains containing a complete loss of H2Bub1. We found that the H4 basic patch regulates H2Bub1 levels independently of interactions with chromatin remodelers and separately from its regulation of H3K79 methylation. To measure H2B ubiquitylation and deubiquitination kinetics in vivo, we used a rapid and reversible optogenetic tool, the light-inducible nuclear exporter, to control the subcellular location of the H2Bub1 E3 ligase, Bre1. The ability of Bre1 to ubiquitylate H2B was unaffected in the H4(2RA) mutant. In contrast, H2Bub1 deubiquitination by SAGA-associated Ubp8, but not by Ubp10, increased in the H4(2RA) mutant. Consistent with a function for the H4 basic patch in regulating SAGA deubiquitinase activity, we also detected increased SAGA-mediated histone acetylation in H4 basic patch mutants. Our findings uncover that the H4 basic patch has a regulatory function in SAGA-mediated histone modifications.	[Meriesh, Hashem A.; Lerner, Andrew M.; Strahl, Brian D.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Chandrasekharan, Mahesh B.] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Radiat Oncol, Salt Lake City, UT 84112 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Strahl, BD (corresponding author), UNC, Sch Med, 3060 Genet Med,CB 7260, Chapel Hill, NC 27599 USA.	brian_strahl@med.unc.edu	Strahl, Brian D/C-7601-2012	Strahl, Brian D/0000-0002-4947-6259; Chandrasekharan, Mahesh/0000-0002-9956-8354	National Institutes of Health [GM126900]; Cancer Cell Biology Training Program [T32CA071341]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Cell Biology Training Program	This work was supported by National Institutes of Health Grant GM126900 (to B. D. S.) and Cancer Cell Biology Training Program Grant T32CA071341 (to H. A. M.). B. D. S. acknowledges that he is a cofounder of EpiCypher, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Baptista T, 2017, MOL CELL, V68, P130, DOI 10.1016/j.molcel.2017.08.016; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Bonnet J, 2014, GENE DEV, V28, P1999, DOI 10.1101/gad.250225.114; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Chandrasekharan MB, 2010, MOL CELL BIOL, V30, P3216, DOI 10.1128/MCB.01008-09; Chandrasekharan MB, 2009, P NATL ACAD SCI USA, V106, P16686, DOI 10.1073/pnas.0907862106; Cieniewicz AM, 2014, MOL CELL PROTEOMICS, V13, P2896, DOI 10.1074/mcp.M114.038174; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Cucinotta CE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005420; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kalashnikova AA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1022; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Klucevsek KM, 2012, GENETICS, V191, P1107, DOI 10.1534/genetics.112.141713; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Koehler C, 2014, J BIOL CHEM, V289, P8989, DOI 10.1074/jbc.M113.500868; Lawrence M, 2016, TRENDS GENET, V32, P42, DOI 10.1016/j.tig.2015.10.007; Lee JS, 2012, GENE DEV, V26, P914, DOI 10.1101/gad.186841.112; Liu XY, 2017, NATURE, V544, P440, DOI 10.1038/nature22036; Livak KJ, 2013, METHODS, V59, P71, DOI 10.1016/j.ymeth.2012.10.004; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; Morgan MT, 2016, SCIENCE, V351, P725, DOI 10.1126/science.aac5681; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Nune M, 2019, ELIFE, V8, DOI 10.7554/eLife.40988; Orlandi I, 2004, J BIOL CHEM, V279, P6414, DOI 10.1074/jbc.M306464200; Racki LR, 2014, J MOL BIOL, V426, P2034, DOI 10.1016/j.jmb.2014.02.021; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Samara NL, 2012, STRUCTURE, V20, P1414, DOI 10.1016/j.str.2012.05.015; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Schulze JM, 2011, GENE DEV, V25, P2242, DOI 10.1101/gad.177220.111; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Song YH, 2010, J BIOL CHEM, V285, P2361, DOI 10.1074/jbc.M109.039255; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Sundaramoorthy R, 2018, ELIFE, V7, DOI 10.7554/eLife.35720; van Welsem T, 2018, NUCLEIC ACIDS RES, V46, P11251, DOI 10.1093/nar/gky801; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Weake VM, 2012, TRENDS CELL BIOL, V22, P177, DOI 10.1016/j.tcb.2011.11.005; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Wozniak GG, 2014, GENE DEV, V28, P1647, DOI 10.1101/gad.243121.114; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Yumerefendi H, 2016, NAT CHEM BIOL, V12, P399, DOI 10.1038/nchembio.2068	53	5	5	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6561	6569		10.1074/jbc.RA120.013196	http://dx.doi.org/10.1074/jbc.RA120.013196			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32245891	Green Published, hybrid			2022-12-28	WOS:000537685000025
J	Werner, MT; Wang, HX; Hamagami, N; Hsu, SC; Yano, JA; Stonestrom, AJ; Behera, V; Zhong, YC; Mackay, JP; Blobel, GA				Werner, Michael T.; Wang, Hongxin; Hamagami, Nicole; Hsu, Sarah C.; Yano, Jennifer A.; Stonestrom, Aaron J.; Behera, Vivek; Zhong, Yichen; Mackay, Joel P.; Blobel, Gerd A.			Comparative structure-function analysis of bromodomain and extraterminal motif (BET) proteins in a gene-complementation system (vol 295, pg 1898, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Mackay, Joel P/D-6834-2011	Mackay, Joel P/0000-0001-7508-8033; Zhong, Yichen/0000-0002-2644-5329				Werner MT, 2020, J BIOL CHEM, V295, P1898, DOI 10.1074/jbc.RA119.010679	1	0	0	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6251	6251		10.1074/jbc.AAC120.013771	http://dx.doi.org/10.1074/jbc.AAC120.013771			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32358084	hybrid, Green Published			2022-12-28	WOS:000531417300034
J	Zhao, Y; Wu, TY; Zhao, MF; Li, CJ				Zhao Yue; Wu Tian-Yu; Zhao Meng-Fei; Li Chao-Jun			The balance of protein farnesylation and geranylgeranylation during the progression of nonalcoholic fatty liver disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						protein isoprenylation; liver metabolism; glucose metabolism; lipid metabolism; cell signaling; metabolic pattern; nonalcoholic fatty liver disease; prenylation; signaling pathway; geranylgeranyl diphosphate synthase (GGPPS); posttranslational modification; lipid modification; hepatocellular carcinoma (HCC); liver fibrosis; metabolic disorder	RAS ONCOGENE ACTIVATION; ELEMENT-BINDING-PROTEIN; K-RAS; MEVALONATE PATHWAY; H-RAS; IMPROVES SURVIVAL; FEEDBACK-CONTROL; ZOLEDRONIC ACID; PRENYLATION; CANCER	Protein prenylation is an essential posttranslational modification and includes protein farnesylation and geranylgeranylation using farnesyl diphosphate or geranylgeranyl diphosphate as substrates, respectively. Geranylgeranyl diphosphate synthase is a branch point enzyme in the mevalonate pathway that affects the ratio of farnesyl diphosphate to geranylgeranyl diphosphate. Abnormal geranylgeranyl diphosphate synthase expression and activity can therefore disrupt the balance of farnesylation and geranylgeranylation and alter the ratio between farnesylated and geranylgeranylated proteins. This change is associated with the progression of nonalcoholic fatty liver disease (NAFLD), a condition characterized by hepatic fat overload. Of note, differential accumulation of farnesylated and geranylgeranylated proteins has been associated with differential stages of NAFLD and NAFLD-associated liver fibrosis. In this review, we summarize key aspects of protein prenylation as well as advances that have uncovered the regulation of associated metabolic patterns and signaling pathways, such as Ras GTPase signaling, involved in NAFLD progression. Additionally, we discuss unique opportunities for targeting prenylation in NAFLD/hepatocellular carcinoma with agents such as statins and bisphosphonates to improve clinical outcomes.	[Zhao Yue; Wu Tian-Yu; Zhao Meng-Fei; Li Chao-Jun] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Sch Med, Nanjing 210093, Peoples R China; [Zhao Yue; Wu Tian-Yu; Zhao Meng-Fei; Li Chao-Jun] Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing 210093, Peoples R China; [Zhao Yue; Li Chao-Jun] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210093, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Li, CJ (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Sch Med, Nanjing 210093, Peoples R China.; Li, CJ (corresponding author), Nanjing Univ, Jiangsu Key Lab Mol Med, Sch Med, Nanjing 210093, Peoples R China.; Li, CJ (corresponding author), Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210093, Peoples R China.	licj@nju.edu.cn		Zhao, Mengfei/0000-0002-7545-2234; Wu, Tianyu/0000-0002-5574-423X; Li, Chaojun/0000-0001-9474-7321; ZHAO, YUE/0000-0002-3236-6360	Chinese National Natural Science Foundation [31601153]; Nature Science Foundation of Jiangsu Province [BK20160619]; Fundamental Research Funds for the Central Universities [14380269, 14380343]; China Postdoctoral Science Foundation [2016M601778]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by Chinese National Natural Science Foundation Grant 31601153 (to Y. Z.), Nature Science Foundation of Jiangsu Province Grant BK20160619 (to Y. Z.), Fundamental Research Funds for the Central Universities Grants 14380269 and 14380343 (to Y. Z.), and China Postdoctoral Science Foundation Grant 2016M601778 (to Y. Z.). The authors declare	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Amin D, 1996, ARZNEIMITTEL-FORSCH, V46, P759; AMIN D, 1992, J LIPID RES, V33, P1657; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Arnaud C, 2005, ARTERIOSCL THROM VAS, V25, P1231, DOI 10.1161/01.ATV.0000163840.63685.0c; Aylon Y, 2016, GENE DEV, V30, P786, DOI 10.1101/gad.274167.115; BALL NJ, 1994, J INVEST DERMATOL, V102, P285, DOI 10.1111/1523-1747.ep12371783; Baron R, 2000, P NATL ACAD SCI USA, V97, P11626, DOI 10.1073/pnas.97.21.11626; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Bertolio R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09152-7; BOS JL, 1989, CANCER RES, V49, P4682; Buhaescu I, 2007, CLIN BIOCHEM, V40, P575, DOI 10.1016/j.clinbiochem.2007.03.016; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Cao ZW, 2011, CANCER RES, V71, P2286, DOI 10.1158/0008-5472.CAN-10-3367; CARBONI JM, 1995, ONCOGENE, V10, P1905; Chalasani N, 2005, HEPATOLOGY, V41, P690, DOI 10.1002/hep.20671; Chen MC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122690; Chen QL, 2017, DIABETES, V66, P2387, DOI 10.2337/db17-0077; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Chen Z, 2018, CARDIOVASC RES, V114, P965, DOI 10.1093/cvr/cvy042; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cox AD, 2015, CLIN CANCER RES, V21, P1819, DOI 10.1158/1078-0432.CCR-14-3214; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; Drosten M, 2017, CANCER RES, V77, P707, DOI 10.1158/0008-5472.CAN-16-2925; Elharar Y, 2017, BIOCONJUGATE CHEM, V28, P2461, DOI 10.1021/acs.bioconjchem.7b00436; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Fritz G, 2009, CURR CANCER DRUG TAR, V9, P626, DOI 10.2174/156800909789057033; Goffinet M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-60; Gong Y, 2006, CELL METAB, V3, P15, DOI 10.1016/j.cmet.2005.11.014; Graf H, 2008, DIGESTION, V78, P34, DOI 10.1159/000156702; Gruenbacher G, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00394; Haile Y, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0788-z; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Haney SL, 2019, ONCOGENE, V38, P5308, DOI 10.1038/s41388-019-0794-6; Harousseau JL, 2009, BLOOD, V114, P1166, DOI 10.1182/blood-2009-01-198093; Harrison SA, 2003, AM J GASTROENTEROL, V98, P2042, DOI 10.1016/S0002-9270(03)00622-1; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hougland JL, 2009, NAT CHEM BIOL, V5, P197, DOI 10.1038/nchembio0409-197; JAMES GL, 1995, J BIOL CHEM, V270, P6221, DOI 10.1074/jbc.270.11.6221; JANSSEN JWG, 1987, P NATL ACAD SCI USA, V84, P9228, DOI 10.1073/pnas.84.24.9228; Khan OM, 2011, J CLIN INVEST, V121, P628, DOI 10.1172/JCI43758; Kuchay S, 2019, NAT STRUCT MOL BIOL, V26, P628, DOI 10.1038/s41594-019-0249-3; Kusama T, 2002, GASTROENTEROLOGY, V122, P308, DOI 10.1053/gast.2002.31093; LEMOINE NR, 1989, ONCOGENE, V4, P159; Likus W, 2016, DRUG RESIST UPDATE, V25, P13, DOI 10.1016/j.drup.2016.02.001; Liu J, 2018, J PATHOL, V246, P277, DOI 10.1002/path.5131; Liu M, 2010, P NATL ACAD SCI USA, V107, P6471, DOI 10.1073/pnas.0908396107; Luu W, 2012, BBA-MOL CELL RES, V1823, P458, DOI 10.1016/j.bbamcr.2011.09.017; Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832; Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Mazieres J, 2005, EXP CELL RES, V304, P354, DOI 10.1016/j.yexcr.2004.10.019; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Miersch S, 2007, FREE RADICAL BIO MED, V42, P270, DOI 10.1016/j.freeradbiomed.2006.10.045; Mijimolle N, 2005, CANCER CELL, V7, P313, DOI 10.1016/j.ccr.2005.03.004; Minowa-Nozawa A, 2017, EMBO J, V36, P2790, DOI 10.15252/embj.201796463; Mullen PJ, 2016, NAT REV CANCER, V16, P718, DOI 10.1038/nrc.2016.76; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Perez-Sala D, 2007, FRONT BIOSCI-LANDMRK, V12, P4456, DOI 10.2741/2401; Polyzos SA, 2019, METABOLISM, V92, P82, DOI 10.1016/j.metabol.2018.11.014; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; Rao S, 2004, J CLIN ONCOL, V22, P3950, DOI 10.1200/JCO.2004.10.037; Reszka AA, 2004, MINI-REV MED CHEM, V4, P711; Ricoult SJH, 2016, ONCOGENE, V35, P1250, DOI 10.1038/onc.2015.179; Robert C, 2018, CELL, V175, P901, DOI 10.1016/j.cell.2018.10.032; RODENHUIS S, 1988, CANCER RES, V48, P5738; Rosenson RS, 2004, ATHEROSCLEROSIS, V173, P1, DOI 10.1016/S0021-9150(03)00239-9; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Sakaihara T, 2000, J BIOCHEM-TOKYO, V128, P1073, DOI 10.1093/oxfordjournals.jbchem.a022835; Sandoval CO, 2012, BIOCHEM SOC T, V40, P1426, DOI 10.1042/BST20120158; Santinon G, 2016, TRENDS CELL BIOL, V26, P289, DOI 10.1016/j.tcb.2015.11.004; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shen N, 2011, J BIOL CHEM, V286, P14508, DOI 10.1074/jbc.M110.190165; Shull LW, 2006, BIOORGAN MED CHEM, V14, P4130, DOI 10.1016/j.bmc.2006.02.010; Sjogren AKM, 2007, J CLIN INVEST, V117, P1294, DOI 10.1172/JCI30868; Solomon CS, 2003, INT J OBESITY, V27, P40, DOI 10.1038/sj.ijo.0802189; Sookoian S, 2014, NAT REV GASTRO HEPAT, V11, P205, DOI 10.1038/nrgastro.2014.25; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Storck EM, 2019, NAT CHEM, V11, P552, DOI 10.1038/s41557-019-0237-6; Swanson KM, 2006, CURR CANCER DRUG TAR, V6, P15, DOI 10.2174/156800906775471743; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tang QL, 2017, EUR J PHARMACOL, V814, P169, DOI 10.1016/j.ejphar.2017.08.010; Tao WW, 2015, J BIOL CHEM, V290, P20086, DOI 10.1074/jbc.M115.657742; Thompson PD, 2003, JAMA-J AM MED ASSOC, V289, P1681, DOI 10.1001/jama.289.13.1681; Tsubaki M, 2016, BIOMED PHARMACOTHER, V78, P23, DOI 10.1016/j.biopha.2015.12.017; Van Cutsem E, 2004, J CLIN ONCOL, V22, P1430, DOI 10.1200/JCO.2004.10.112; Vicent D, 2000, MOL CELL BIOL, V20, P2158, DOI 10.1128/MCB.20.6.2158-2166.2000; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001; Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016; Wang XX, 2013, J EXP MED, V210, P1559, DOI 10.1084/jem.20121806; Wasko BM, 2011, J PHARMACOL EXP THER, V337, P540, DOI 10.1124/jpet.110.175521; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Weinberger C, 1996, TRENDS ENDOCRIN MET, V7, P1, DOI 10.1016/1043-2760(95)00180-8; Weivoda MM, 2012, BONE, V50, P467, DOI 10.1016/j.bone.2011.09.056; Weivoda MM, 2011, ENDOCRINOLOGY, V152, P3113, DOI 10.1210/en.2011-0016; Weivoda MM, 2011, J CELL BIOCHEM, V112, P1506, DOI 10.1002/jcb.23087; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Wiemer AJ, 2007, BIOCHEM BIOPH RES CO, V353, P921, DOI 10.1016/j.bbrc.2006.12.094; Wild R, 2018, SCIENCE, V359, P545, DOI 10.1126/science.aar5140; Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Wu HT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7239; Xia Y, 2018, CELL, V175, P1059, DOI 10.1016/j.cell.2018.08.070; Yamauchi Y, 2011, CANCER RES, V71, P4989, DOI 10.1158/0008-5472.CAN-10-4108; Yao DW, 2017, J CELL PHYSIOL, V232, P635, DOI 10.1002/jcp.25469; Yu DC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-248; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhao Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14450-6; Zhou RH, 2004, CIRC RES, V95, P471, DOI 10.1161/01.RES.0000139956.42923.4A	118	10	11	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5152	5162		10.1074/jbc.REV119.008897	http://dx.doi.org/10.1074/jbc.REV119.008897			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32139507	Green Published, hybrid			2022-12-28	WOS:000526887000033
J	Tamura, I; Takagi, H; Doi-Tanaka, Y; Shirafuta, Y; Mihara, Y; Shinagawa, M; Maekawa, R; Taketani, T; Sato, S; Tamura, H; Sugino, N				Tamura, Isao; Takagi, Haruka; Doi-Tanaka, Yumiko; Shirafuta, Yuichiro; Mihara, Yumiko; Shinagawa, Masahiro; Maekawa, Ryo; Taketani, Toshiaki; Sato, Shun; Tamura, Hiroshi; Sugino, Norihiro			Wilms tumor 1 regulates lipid accumulation in human endometrial stromal cells during decidualization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid droplet; gene regulation; cyclic AMP (cAMP); cell differentiation; lipid metabolism; decidualization; endometrial stromal cells (ESCs); pregnancy; very low-density lipoprotein receptor (VLDLR); Wilms tumor 1 (WT1)	HISTONE ACETYLATION STATUS; PROMOTER REGION; DNA METHYLATION; GRANULOSA-CELLS; VLDL RECEPTOR; MN-SOD; EXPRESSION; WT1; PROGESTERONE; INDUCTION	We previously reported that the transcription factor Wilms tumor 1 (WT1) regulates the expression of insulin-like growth factor-binding protein-1 (IGFBP-1) and prolactin (PRL) during decidualization of human endometrial stromal cells (ESCs). However, other roles of WT1 in decidualization remain to be fully clarified. Here, we investigated how WT1 regulates the physiological functions of human ESCs during decidualization. We incubated ESCs isolated from proliferative-phase endometrium with cAMP to induce decidualization, knocked down WT1 with siRNA, and generated three types of treatments (nontreated cells, cAMP-treated cells, and cAMP-treated + WT1-knockdown cells). To identify WT1-regulated genes, we used gene microarrays and compared the transcriptome data obtained among these three treatments. We observed that WT1 up-regulates 121 genes during decidualization, including several genes involved in lipid transport. The WT1 knockdown inhibited lipid accumulation (LA) in the cAMP-induced ESCs. To examine the mechanisms by which WT1 regulates LA, we focused on very low-density lipoprotein receptor (VLDLR), which is involved in lipoprotein uptake. We found that cAMP up-regulates VLDLR and that the WT1 knockdown inhibits it. Results of ChIP assays revealed that cAMP increases the recruitment of WT1 to the promoter region of the VLDLR gene, indicating that WT1 regulates VLDLR expression. Moreover, VLDLR knockdown inhibited cAMP-induced LA, and VLDLR overexpression reverted the suppression of LA caused by the WT1 knockdown. Taken together, our results indicate that WT1 enhances lipid storage by up-regulating VLDLR expression in human ESCs during decidualization.	[Tamura, Isao; Takagi, Haruka; Doi-Tanaka, Yumiko; Shirafuta, Yuichiro; Mihara, Yumiko; Shinagawa, Masahiro; Maekawa, Ryo; Taketani, Toshiaki; Sato, Shun; Tamura, Hiroshi; Sugino, Norihiro] Yamaguchi Univ, Dept Obstet & Gynecol, Grad Sch Med, Minamikogushi 1-1-1, Ube, Yamaguchi 7558505, Japan	Yamaguchi University	Tamura, I (corresponding author), Minamikogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	isao@yamaguchi-u.ac.jp	Maekawa, Ryo/AAR-4233-2020	Maekawa, Ryo/0000-0003-0923-376X; Tamura, Isao/0000-0002-0737-5556	Japan Society for the Promotion of Science KAKENHI [16K11091, 16K20191, 16K11142, 17K11239, 18K09230, 18K16772, 18K09262, 19K09803]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 16K11091, 16K20191, 16K11142, 17K11239, 18K09230, 18K16772, 18K09262, and 19K09803. The authors declare that they have no conflicts of interest with the contents of this article.	Anthony FW, 2003, J SOC GYNECOL INVEST, V10, P509, DOI 10.1016/S1071-5576(03)00147-3; Bombail V, 2010, J CLIN ENDOCR METAB, V95, pE224, DOI 10.1210/jc.2010-0154; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Dean M, 2019, BIOL REPROD, V101, P297, DOI 10.1093/biolre/ioz102; Desarzens S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094127; Dourlen P, 2015, PROG LIPID RES, V60, P30, DOI 10.1016/j.plipres.2015.08.001; Du M, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004440; Fischbach BV, 2005, PEDIATRICS, V116, P984, DOI 10.1542/peds.2004-0467; Frolova AI, 2011, ENDOCRINOLOGY, V152, P2123, DOI 10.1210/en.2010-1266; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Jozaki K, 2019, REPRODUCTION, V157, P457, DOI 10.1530/REP-18-0393; Kajihara T, 2014, REPROD SCI, V21, P372, DOI 10.1177/1933719113497280; Klattig J, 2007, MOL CELL BIOL, V27, P4355, DOI 10.1128/MCB.01780-06; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lee Hong Jun, 2014, Ann Pediatr Endocrinol Metab, V19, P100, DOI 10.6065/apem.2014.19.2.100; Lee L, 2013, ENDOCRINOLOGY, V154, P458, DOI 10.1210/en.2012-1610; Li XL, 2013, MOL ENDOCRINOL, V27, P2041, DOI 10.1210/me.2013-1191; Maekawa R, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5695-0; Maekawa R, 2016, MOL ENDOCRINOL, V30, P335, DOI 10.1210/me.2015-1058; Maekawa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066632; Makrigiannakis A, 2001, J CLIN ENDOCR METAB, V86, P5964, DOI 10.1210/jc.86.12.5964; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; McKillop LH, 2019, CELL SIGNAL, V62, DOI 10.1016/j.cellsig.2019.06.001; Mo H, 2016, BIOCHEM BIOPH RES CO, V478, P74, DOI 10.1016/j.bbrc.2016.07.090; Motamedi FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5444; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Okada M, 2016, ENDOCRINOLOGY, V157, P3344, DOI 10.1210/en.2016-1264; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Perugorria MJ, 2009, CANCER RES, V69, P1358, DOI 10.1158/0008-5472.CAN-08-2545; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Rumman M, 2015, STEM CELLS, V33, P2903, DOI 10.1002/stem.2056; Shandilya J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5903; Shinagawa M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36566-y; Spasic M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002433; Sultana S, 2017, REPROD MED BIOL, V16, P170, DOI 10.1002/rmb2.12028; Takahashi S, 2017, J ATHEROSCLER THROMB, V24, P552, DOI 10.5551/jat.RV17004; Takazawa T, 2009, J BIOL CHEM, V284, P30049, DOI 10.1074/jbc.M109.047993; Tamura I, 2018, J BIOL CHEM, V293, P5270, DOI 10.1074/jbc.RA117.000234; Tamura I, 2017, ENDOCRINOLOGY, V158, P3696, DOI 10.1210/en.2017-00478; Tamura I, 2014, MOL ENDOCRINOL, V28, P1656, DOI 10.1210/me.2014-1117; Tamura I, 2014, ENDOCRINOLOGY, V155, P275, DOI 10.1210/en.2013-1569; Tamura I, 2012, ENDOCRINOLOGY, V153, P5612, DOI 10.1210/en.2012-1420; Tamura I, 2011, J CLIN ENDOCR METAB, V96, pE1073, DOI 10.1210/jc.2010-2489; Tatsumi T, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.161893; Wei SJ, 2018, CELL PHYSIOL BIOCHEM, V48, P2528, DOI 10.1159/000492697; Yang D, 2014, FEBS LETT, V588, P4448, DOI 10.1016/j.febslet.2014.09.046; Yoshida T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14063-y	50	8	8	5	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4673	4683		10.1074/jbc.RA120.012841	http://dx.doi.org/10.1074/jbc.RA120.012841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32098869	hybrid, Green Published			2022-12-28	WOS:000524499700025
J	Krishnan, A; Kloehn, J; Lunghi, M; Soldati-Favre, D				Krishnan, Aarti; Kloehn, Joachim; Lunghi, Matteo; Soldati-Favre, Dominique			Vitamin and cofactor acquisition in apicomplexans: Synthesis versus salvage (vol 295, pg 701, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Kloehn, Joachim/0000-0002-6366-8599				Krishnan A, 2020, J BIOL CHEM, V295, P701, DOI 10.1074/jbc.AW119.008150	1	0	0	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					4064	4064		10.1074/jbc.AAC120.013172	http://dx.doi.org/10.1074/jbc.AAC120.013172			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32198189	Green Published, hybrid			2022-12-28	WOS:000527704400029
J	Wagner, MJ; Hsiung, MS; Gish, GD; Bagshaw, RD; Doodnauth, SA; Soliman, MA; Jorgensen, C; Tucholska, M; Rottapel, R				Wagner, Melany J.; Hsiung, Marilyn S.; Gish, Gerald D.; Bagshaw, Rick D.; Doodnauth, Sasha A.; Soliman, Mohamed A.; Jorgensen, Claus; Tucholska, Monika; Rottapel, Robert			The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						receptor tyrosine kinase; signal transduction; phosphotyrosine signaling; Src homology 2 domain (SH2 domain); GTPase-activating protein (GAP); Chimaerin; EphB2; Eph receptor tyrosine kinase; Nck; p120 RasGAP; Shb	TYROSINE-KINASE; NEURONAL CIRCUITS; EPHA4; ACTIVATION; ADHESION; ALPHA-2-CHIMAERIN; MECHANISMS; EPHRIN-B3; MESODERM; REVEALS	Eph receptors are a family of receptor tyrosine kinases that control directional cell movement during various biological processes, including embryogenesis, neuronal pathfinding, and tumor formation. The biochemical pathways of Eph receptors are context-dependent in part because of the varied composition of a heterotypic, oligomeric, active Eph receptor complex. Downstream of the Eph receptors, little is known about the essential phosphorylation events that define the context and instruct cell movement. Here, we define a pathway that is required for Eph receptor B2 (EphB2)?mediated cell sorting and is conserved among multiple Eph receptors. Utilizing a HEK293 model of EphB2(+)/ephrinB1(+) cell segregation, we found that the scaffold adaptor protein SH2 domain?containing adaptor protein B (Shb) is essential for EphB2 functionality. Further characterization revealed that Shb interacts with known modulators of cytoskeletal rearrangement and cell mobility, including Nck adaptor protein (Nck), p120-Ras GTPase-activating protein (RasGAP), and the ?- and ?-Chimaerin Rac GAPs. We noted that phosphorylation of Tyr(297), Tyr(246), and Tyr(336) of Shb is required for EphB2?ephrinB1 boundary formation, as well as binding of Nck, RasGAP, and the chimaerins, respectively. Similar complexes were formed in the context of EphA4, EphA8, EphB2, and EphB4 receptor activation. These results indicate that phosphotyrosine-mediated signaling through Shb is essential in EphB2-mediated heterotypic cell segregation and suggest a conserved function for Shb downstream of multiple Eph receptors.	[Wagner, Melany J.; Doodnauth, Sasha A.; Rottapel, Robert] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5S 1A8, Canada; [Wagner, Melany J.; Hsiung, Marilyn S.; Gish, Gerald D.; Bagshaw, Rick D.; Soliman, Mohamed A.; Tucholska, Monika] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Jorgensen, Claus] Univ Manchester, Canc Res UK Manchester Inst, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England; [Rottapel, Robert] Univ Toronto, Dept Med, Toronto, ON M5S, Canada; [Rottapel, Robert] Univ Toronto, Dept Immunol, Toronto, ON M5S, Canada; [Rottapel, Robert] Univ Toronto, Dept Med Biophys, Toronto, ON M5S, Canada; [Rottapel, Robert] St Michaels Hosp, Div Rheumatol, 30 Bond St, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Cancer Research UK; University of Manchester; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Wagner, MJ; Rottapel, R (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5S 1A8, Canada.; Wagner, MJ (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.; Rottapel, R (corresponding author), Univ Toronto, PMCRT MaRS, 101 Coll St,Rm 12-704, Toronto, ON M5G 1L7, Canada.	mjdwagner@hotmail.com; rottapel@gmail.com		Bagshaw, Rick/0000-0001-5013-4291; Jorgensen, Claus/0000-0002-7841-943X	Canadian Institutes for Health Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a foundation grant from the Canadian Institutes for Health Research (to R. R.).	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Beg AA, 2007, NEURON, V55, P768, DOI 10.1016/j.neuron.2007.07.036; Bisson N, 2011, NAT BIOTECHNOL, V29, P653, DOI 10.1038/nbt.1905; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Cayuso J, 2015, DEV BIOL, V401, P122, DOI 10.1016/j.ydbio.2014.11.013; Chaki Sankar P, 2013, Bioarchitecture, V3, P57, DOI 10.4161/bioa.25744; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Fawcett JP, 2007, P NATL ACAD SCI USA, V104, P20973, DOI 10.1073/pnas.0710316105; Finger C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000547; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Holmqvist K, 2003, CELL SIGNAL, V15, P171, DOI 10.1016/S0898-6568(02)00076-1; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Janes PW, 2011, J CELL BIOL, V195, P1033, DOI 10.1083/jcb.201104037; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Kim I, 2002, FASEB J, V16, P1126, DOI 10.1096/fj.01-0805fje; Kriz V, 2006, J BIOL CHEM, V281, P34484, DOI 10.1074/jbc.M604084200; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Li W, 2001, ONCOGENE, V20, P6403, DOI 10.1038/sj.onc.1204782; Lindholm CK, 1999, J BIOL CHEM, V274, P28050, DOI 10.1074/jbc.274.39.28050; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Matskova LV, 2007, ONCOGENE, V26, P4908, DOI 10.1038/sj.onc.1210298; Noren NK, 2009, BIOCHEM J, V422, P433, DOI 10.1042/BJ20090014; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Poliakov A, 2008, J CELL BIOL, V183, P933, DOI 10.1083/jcb.200807151; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Warner N, 2008, FEBS J, V275, P2561, DOI 10.1111/j.1742-4658.2008.06405.x; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001; Xiao Z, 2012, CANCER BIOL THER, V13, P630, DOI 10.4161/cbt.20080; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zisch AH, 1997, J NEUROSCI RES, V47, P655, DOI 10.1002/(SICI)1097-4547(19970315)47:6<655::AID-JNR12>3.0.CO;2-U	46	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3932	3944		10.1074/jbc.RA119.009276	http://dx.doi.org/10.1074/jbc.RA119.009276			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32060095	hybrid, Green Published			2022-12-28	WOS:000527704400018
J	Trazzi, S; Fuchs, C; Valli, E; Perini, G; Bartesaghi, R; Ciani, E				Trazzi, Stefania; Fuchs, Claudia; Valli, Emanuele; Perini, Giovanni; Bartesaghi, Renata; Ciani, Elisabetta			RETRACTION: Withdrawal: The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for Down syndrome (Retraction of Vol 288, Pg 20817, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Ciani, Elisabetta/AAL-6462-2020					Trazzi S, 2013, J BIOL CHEM, V288, P20817, DOI 10.1074/jbc.M113.451088	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3392	3392		10.1074/jbc.W120.012956	http://dx.doi.org/10.1074/jbc.W120.012956			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32144155	hybrid, Green Published			2022-12-28	WOS:000519597300046
J	Chang, RL; Zhang, X; Qiao, AN; Dai, AT; Belousoff, MJ; Tan, QX; Shao, LJ; Zhong, L; Lin, GY; Liang, YL; Ma, LM; Han, S; Yang, DH; Danev, R; Wang, MW; Wootten, D; Wu, BL; Sexton, PM				Chang, Rulue; Zhang, Xin; Qiao, Anna; Dai, Antao; Belousoff, Matthew J.; Tan, Qiuxiang; Shao, Lijun; Zhong, Li; Lin, Guangyao; Liang, Yi-Lynn; Ma, Limin; Han, Shuo; Yang, Dehua; Danev, Radostin; Wang, Ming-Wei; Wootten, Denise; Wu, Beili; Sexton, Patrick M.			Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucagon receptor; glucagon-like peptide-1 receptor; dual agonist; cryo-electron microscopy; single particle analysis; structure-function; structural biology; peptide 15 (P15); metabolic disorder; G protein?coupled receptor (GPCR); glucagon; GLP-1 receptor	CRYO-EM STRUCTURE; BEAM-INDUCED MOTION; GLP-1 RECEPTOR; BIASED AGONISM; RECOGNITION; RESIDUES; DYNAMICS; OBESITY	Unimolecular dual agonists of the glucagon (GCG) receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R) are a new class of drugs that are potentially superior to GLP-1R?specific agonists for the management of metabolic disease. The dual-agonist, peptide 15 (P15), is a glutamic acid 16 analog of GCG with GLP-1 peptide substitutions between amino acids 17 and 24 that has potency equivalent to those of the cognate peptide agonists at the GCGR and GLP-1R. Here, we have used cryo-EM to solve the structure of an active P15-GCGR-G(s)complex and compared this structure to our recently published structure of the GCGR-G(s)complex bound to GCG. This comparison revealed that P15 has a reduced interaction with the first extracellular loop (ECL1) and the top of transmembrane segment 1 (TM1) such that there is increased mobility of the GCGR extracellular domain and at the C terminus of the peptide compared with the GCG-bound receptor. We also observed a distinct conformation of ECL3 and could infer increased mobility of the far N-terminal His-1 residue in the P15-bound structure. These regions of conformational variance in the two peptide-bound GCGR structures were also regions that were distinct between GCGR structures and previously published peptide-bound structures of the GLP-1R, suggesting that greater conformational dynamics may contribute to the increased efficacy of P15 in activation of the GLP-1R compared with GCG. The variable domains in this receptor have previously been implicated in biased agonism at the GLP-1R and could result in altered signaling of P15 at the GCGR compared with GCG.	[Chang, Rulue; Wang, Ming-Wei] Fudan Univ, Shanghai Med Coll, Sch Pharm, Shanghai, Peoples R China; [Zhang, Xin; Belousoff, Matthew J.; Liang, Yi-Lynn; Wootten, Denise; Sexton, Patrick M.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia; [Qiao, Anna; Dai, Antao; Tan, Qiuxiang; Shao, Lijun; Zhong, Li; Lin, Guangyao; Ma, Limin; Han, Shuo; Yang, Dehua; Wang, Ming-Wei; Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai, Peoples R China; [Qiao, Anna; Tan, Qiuxiang; Shao, Lijun; Zhong, Li; Lin, Guangyao; Wang, Ming-Wei; Wu, Beili] Univ Chinese Acad Sci, Beijing, Peoples R China; [Dai, Antao; Yang, Dehua; Wang, Ming-Wei] Natl Ctr Drug Screening, Shanghai, Peoples R China; [Shao, Lijun; Lin, Guangyao; Wang, Ming-Wei; Wu, Beili] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Danev, Radostin] Univ Tokyo, Grad Sch Med, Tokyo, Japan	Fudan University; Monash University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; ShanghaiTech University; University of Tokyo	Wang, MW (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Pharm, Shanghai, Peoples R China.; Wootten, D; Sexton, PM (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic, Australia.; Wang, MW; Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai, Peoples R China.; Wang, MW; Wu, BL (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Wang, MW (corresponding author), Natl Ctr Drug Screening, Shanghai, Peoples R China.; Wang, MW; Wu, BL (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.	mwwang@simm.ac.cn; denise.wootten@monash.edu; beiliwu@simm.ac.cn; Patrick.sexton@monash.edu	Wootten, Denise/ABD-5703-2021; Yang, Dehua/M-5789-2019; Belousoff, Matthew/N-4066-2017	Wootten, Denise/0000-0003-4563-1642; Zhang, Xin/0000-0001-9422-3499; Belousoff, Matthew/0000-0002-3229-474X	National Natural Science Foundation of China [81872915, 31825010, 81973373, 81773792]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program," China [2018ZX09735-001, 2018ZX09711002-002-005, 2018ZX09711002-001]; National Key R&D Program of China [2018YFA0507000]; Novo Nordisk-CAS Research Fund [NNCAS-2017-1-CC]; National Health and Medical Research Council of Australia (NHMRC) [1184726, 1126857, 1150083]; Takeda Science Foundation 2019 Medical Research Grant; Japan Science and Technology Agency (JST) [PRESTO 18069571]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program," China; National Key R&D Program of China; Novo Nordisk-CAS Research Fund; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Takeda Science Foundation 2019 Medical Research Grant; Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by the National Natural Science Foundation of China Grants 81872915 (to M.-W. W.), 31825010 (to B. W.), 81973373 (to D. Y.), and 81773792 (to D. Y.); the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program," China, Grants 2018ZX09735-001 (to M.-W. W.), 2018ZX09711002-002-005 (to D. Y.), and 2018ZX09711002-001 (to L. M.); the National Key R&D Program of China Grant 2018YFA0507000 (to M.-W. W. and B. W.); Novo Nordisk-CAS Research Fund NNCAS-2017-1-CC (to D. Y.); the National Health and Medical Research Council of Australia (NHMRC) Project Grants 1184726 and 1126857 (to D. W.) and Program Grant 1150083 (to P. M. S.); Takeda Science Foundation 2019 Medical Research Grant (to R. D.); and Japan Science and Technology Agency (JST) PRESTO 18069571 (to R. D.). P. M. S. is a Senior Principal Research Fellow and D. W. a Senior Research Fellow of the NHMRC.	Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS21, DOI 10.1111/bph.14748; Ambery P, 2018, LANCET, V391, P2607, DOI 10.1016/S0140-6736(18)30726-8; Andersson A, 2019, ENVIRON SCI-WAT RES, V5, P861, DOI 10.1039/c9ew00034h; Aroda VR, 2018, DIABETES OBES METAB, V20, P22, DOI 10.1111/dom.13162; Campbell JE, 2015, NAT REV ENDOCRINOL, V11, P329, DOI 10.1038/nrendo.2015.51; Capozzi ME, 2018, ENDOCR REV, V39, P719, DOI 10.1210/er.2018-00117; Chudleigh RA, 2020, DIABETES METAB SYNDR, V13, P433, DOI 10.2147/DMSO.S193693; Chugunov AO, 2010, MOL PHARMACOL, V78, P394, DOI 10.1124/mol.110.063578; dal Maso E, 2019, ACS PHARMACOL TRANSL, V2, P31, DOI 10.1021/acsptsci.8b00056; Day JW, 2009, NAT CHEM BIOL, V5, P749, DOI 10.1038/nchembio.209; Du XB, 2012, AM J PHYSIOL-ENDOC M, V303, pE265, DOI 10.1152/ajpendo.00142.2012; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Garcia-Nafria J, 2019, MOL CELL ENDOCRINOL, V488, P1, DOI 10.1016/j.mce.2019.02.006; Glukhova A, 2018, ACS PHARMACOL TRANSL, V1, P73, DOI 10.1021/acsptsci.8b00026; Knerr PJ, 2020, PEPTIDES, V125, DOI 10.1016/j.peptides.2019.170225; Kobayashi K, 2020, NAT STRUCT MOL BIOL, V27, P274, DOI 10.1038/s41594-020-0386-8; Kosinski JR, 2012, OBESITY, V20, P1566, DOI 10.1038/oby.2012.67; Lei SF, 2018, J BIOL CHEM, V293, P9370, DOI 10.1074/jbc.RA118.003278; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liang YL, 2020, ACS PHARMACOL TRANSL, V3, P263, DOI 10.1021/acsptsci.9b00080; Liang YL, 2020, MOL CELL, V77, P656, DOI 10.1016/j.molcel.2020.01.012; Liang YL, 2018, ACS PHARMACOL TRANSL, V1, P12, DOI 10.1021/acsptsci.8b00017; Liang YL, 2018, NATURE, V561, P492, DOI 10.1038/s41586-018-0535-y; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Ma SS, 2020, MOL CELL, V77, P669, DOI 10.1016/j.molcel.2020.01.013; Parker VER, 2020, J CLIN ENDOCR METAB, V105, P803, DOI 10.1210/clinem/dgz047; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pocai A, 2014, MOL METAB, V3, P241, DOI 10.1016/j.molmet.2013.12.001; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Qiao AN, 2020, SCIENCE, V367, P1346, DOI 10.1126/science.aaz5346; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Sanchez-Garrido MA, 2017, DIABETOLOGIA, V60, P1851, DOI 10.1007/s00125-017-4354-8; Santoprete A, 2011, J PEPT SCI, V17, P270, DOI 10.1002/psc.1328; Schorb M, 2019, NAT METHODS, V16, P471, DOI 10.1038/s41592-019-0396-9; Sekar R, 2016, INT REV CEL MOL BIO, V326, P279, DOI 10.1016/bs.ircmb.2016.05.002; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Tillner J, 2019, DIABETES OBES METAB, V21, P120, DOI 10.1111/dom.13494; Vertongen P, 2001, BRIT J PHARMACOL, V133, P1249, DOI 10.1038/sj.bjp.0704195; Visentin R, 2020, DIABETES OBES METAB, V22, P640, DOI 10.1111/dom.13939; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Wang J, 2020, CELL RES, V30, P436, DOI 10.1038/s41422-020-0280-2; Wootten D, 2017, CHEM REV, V117, P111, DOI 10.1021/acs.chemrev.6b00049; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Zhang HN, 2017, NATURE, V546, P259, DOI 10.1038/nature22363; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394; Zhao LH, 2019, SCIENCE, V364, P148, DOI 10.1126/science.aav7942; Zhao PS, 2020, NATURE, V577, P432, DOI 10.1038/s41586-019-1902-z; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	54	17	17	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9313	9325		10.1074/jbc.RA120.013793	http://dx.doi.org/10.1074/jbc.RA120.013793			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32371397	hybrid, Green Published			2022-12-28	WOS:000552758600005
J	Sitia, R; Rubartelli, A				Sitia, Roberto; Rubartelli, Anna			Evolution, role in inflammation, and redox control of leaderless secretory proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						monocyte; Toll-like receptor (TLR); stress; lysosome; reactive oxygen species (ROS); oxidation-reduction (redox); inflammation; innate immunity; interleukin 1 (IL-1); secretion; cryopyrin-associated periodic syndrome (CAPS); gasdermin D; leaderless secretory proteins; misfolding; unconventional protein secretion; secretory lysosomes; innate immune response	FIBROBLAST-GROWTH-FACTOR; MOLECULAR-PATTERN MOLECULES; MIGRATION-INHIBITORY FACTOR; THIOL-DISULFIDE EXCHANGE; UNCONVENTIONAL SECRETION; OXIDATIVE STRESS; DENDRITIC CELLS; INTERLEUKIN-1-BETA SECRETION; ALPHA-SYNUCLEIN; AUTOINFLAMMATORY DISEASES	Members of the interleukin (IL)-1 family are key determinants of inflammation. Despite their role as intercellular mediators, most lack the leader peptide typically required for protein secretion. This lack is a characteristic of dozens of other proteins that are actively and selectively secreted from living cells independently of the classical endoplasmic reticulum-Golgi exocytic route. These proteins, termed leaderless secretory proteins (LLSPs), comprise proteins directly or indirectly involved in inflammation, including cytokines such as IL-1? and IL-18, growth factors such as fibroblast growth factor 2 (FGF2), redox enzymes such as thioredoxin, and proteins most expressed in the brain, some of which participate in the pathogenesis of neurodegenerative disorders. Despite much effort, motifs that promote LLSP secretion remain to be identified. In this review, we summarize the mechanisms and pathophysiological significance of the unconventional secretory pathways that cells use to release LLSPs. We place special emphasis on redox regulation and inflammation, with a focus on IL-1?, which is secreted after processing of its biologically inactive precursor pro-IL-1? in the cytosol. Although LLSP externalization remains poorly understood, some possible mechanisms have emerged. For example, a common feature of LLSP pathways is that they become more active in response to stress and that they involve several distinct excretion mechanisms, including direct plasma membrane translocation, lysosome exocytosis, exosome formation, membrane vesiculation, autophagy, and pyroptosis. Further investigations of unconventional secretory pathways for LLSP secretion may shed light on their evolution and could help advance therapeutic avenues for managing pathological conditions, such as diseases arising from inflammation.	[Sitia, Roberto; Rubartelli, Anna] Univ Vita Salute San Raffaele, Div Genet & Cell Biol, Prot Transport & Secret Unit, IRCCS Osped San Raffaele, Milan, Italy; [Rubartelli, Anna] IRCCS Osped Policlin San Martino, Cell Biol Unit, Genoa, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Sitia, R; Rubartelli, A (corresponding author), Univ Vita Salute San Raffaele, Div Genet & Cell Biol, Prot Transport & Secret Unit, IRCCS Osped San Raffaele, Milan, Italy.; Rubartelli, A (corresponding author), IRCCS Osped Policlin San Martino, Cell Biol Unit, Genoa, Italy.	sitia.roberto@hsr.it; annarubartelli@hotmail.it	Rubartelli, Anna/AAA-1259-2021	Sitia, Roberto/0000-0001-7086-4152	AIRC [2019-IG 23285]; CARIPLO; MIURPRIN [2017XA5J5N]; Italian Ministry of Health (2017-Cinque per mille)	AIRC(Fondazione AIRC per la ricerca sul cancro); CARIPLO(Fondazione Cariplo); MIURPRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Health (2017-Cinque per mille)	This work was supported in part by grants from AIRC (2019-IG 23285), CARIPLO, and MIURPRIN (2017XA5J5N) (to R. S.) and the Italian Ministry of Health (2017-Cinque per mille) (to A. R.).	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Angelini G, 2002, P NATL ACAD SCI USA, V99, P1491, DOI 10.1073/pnas.022630299; AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; BALDARI C, 1987, EMBO J, V6, P229, DOI 10.1002/j.1460-2075.1987.tb04743.x; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Benedikter BJ, 2017, FREE RADICAL BIO MED, V108, P334, DOI 10.1016/j.freeradbiomed.2017.03.026; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; Bulau AM, 2014, P NATL ACAD SCI USA, V111, P2650, DOI 10.1073/pnas.1324140111; Carta S, 2015, P NATL ACAD SCI USA, V112, P2835, DOI 10.1073/pnas.1424741112; Carta S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00123; Carta S, 2012, ANN RHEUM DIS, V71, P1577, DOI 10.1136/annrheumdis-2012-201340; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Castellani P, 2014, ANTIOXID REDOX SIGN, V20, P1086, DOI 10.1089/ars.2012.5164; Cecchinato V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02118; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Checconi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127086; Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; Cruz-Garcia D, 2014, J CELL BIOL, V207, P695, DOI 10.1083/jcb.201407119; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; DICE JF, 1986, J BIOL CHEM, V261, P6853; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Flieger O, 2003, FEBS LETT, V551, P78, DOI 10.1016/S0014-5793(03)00900-1; Fontaine SN, 2016, EMBO J, V35, P1537, DOI 10.15252/embj.201593489; Gardella S, 2000, BLOOD, V95, P3809; Gardella S, 2000, FEBS LETT, V481, P245, DOI 10.1016/S0014-5793(00)02015-9; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Gardella S, 2001, BLOOD, V98, P2152, DOI 10.1182/blood.V98.7.2152; Garg Aarti, 2008, In Silico Biology, V8, P129; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Graziani I, 2006, BIOCHEM BIOPH RES CO, V349, P192, DOI 10.1016/j.bbrc.2006.08.021; Gross Olaf, 2012, Immunity, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Hamon Y, 1997, BLOOD, V90, P2911, DOI 10.1182/blood.V90.8.2911; Harris J, 2011, J BIOL CHEM, V286, P9587, DOI 10.1074/jbc.M110.202911; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; HOLMGREN A, 1984, METHOD ENZYMOL, V107, P295; Huang WL, 2012, J THEOR BIOL, V312, P105, DOI 10.1016/j.jtbi.2012.07.027; Jin X, 2011, J BIOL CHEM, V286, P37866, DOI 10.1074/jbc.M111.287490; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Jones SA, 2018, NAT REV IMMUNOL, V18, P773, DOI 10.1038/s41577-018-0066-7; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kandaswamy KK, 2010, BIOCHEM BIOPH RES CO, V391, P1306, DOI 10.1016/j.bbrc.2009.12.019; Katsinelos T, 2018, CELL REP, V23, P2039, DOI 10.1016/j.celrep.2018.04.056; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kovacs SB, 2017, TRENDS CELL BIOL, V27, P673, DOI 10.1016/j.tcb.2017.05.005; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; Lavieri R, 2014, J IMMUNOL, V192, P5373, DOI 10.4049/jimmunol.1303480; Lee HJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.45; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee JPW, 2016, AUTOPHAGY, V12, P907, DOI 10.1080/15548627.2016.1164358; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Lee J, 2018, J BIOL CHEM, V293, P14359, DOI 10.1074/jbc.RA118.003660; Lee YR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133178; Li X, 2012, CELL PHYSIOL BIOCHEM, V30, P815, DOI 10.1159/000341460; LIVI GP, 1991, J BIOL CHEM, V266, P15348; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lorenzen I, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8459402; Lotze MT, 2007, IMMUNOL REV, V220, P60, DOI 10.1111/j.1600-065X.2007.00579.x; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Maizel A, 2002, DEVELOPMENT, V129, P3545; Manthiram K, 2017, NAT IMMUNOL, V18, P832, DOI 10.1038/ni.3777; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; Merezhko M, 2018, CELL REP, V25, P2027, DOI 10.1016/j.celrep.2018.10.078; MIGNATTI P, 1992, J CELL PHYSIOL, V151, P81, DOI 10.1002/jcp.1041510113; MILSTEIN C, 1972, NATURE-NEW BIOL, V239, P117, DOI 10.1038/newbio239117a0; Mondola P, 1996, INT J BIOCHEM CELL B, V28, P677, DOI 10.1016/1357-2725(96)00004-0; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Mulvihill E, 2018, EMBO J, V37, DOI 10.15252/embj.201798321; Naviaux RK, 2012, J PHARMACOL EXP THER, V342, P608, DOI 10.1124/jpet.112.192120; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Nickel W, 2018, SEMIN CELL DEV BIOL, V83, P1, DOI 10.1016/j.semcdb.2018.03.007; Niinaka Y, 1998, CANCER RES, V58, P2667; PALADE GE, 1966, J AMER MED ASSOC, V198, P815, DOI 10.1001/jama.198.8.815; Park MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23015; Pernegre C, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00649; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Plugis NM, 2018, P NATL ACAD SCI USA, V115, P8781, DOI 10.1073/pnas.1805288115; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Popa SJ, 2018, SEMIN CELL DEV BIOL, V83, P42, DOI 10.1016/j.semcdb.2018.02.022; Prudovsky I, 2008, J CELL BIOCHEM, V103, P1327, DOI 10.1002/jcb.21513; Punia N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41678-0; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rammes A, 1997, J BIOL CHEM, V272, P9496; Perea JR, 2018, EXP NEUROL, V310, P14, DOI 10.1016/j.expneurol.2018.08.007; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Rodriguez L, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00344; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Rubartelli A., 1997, UNUSUAL SECRETORY PA, P87, DOI [10.1007/978-3-662-22581-3_3, DOI 10.1007/978-3-662-22581-3_3]; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Rubartelli A, 2009, ANTIOXID REDOX SIGN, V11, P2621, DOI 10.1089/ars.2009.2377; Russo HM, 2016, J IMMUNOL, V197, P1353, DOI 10.4049/jimmunol.1600699; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; SCOTT RE, 1979, J CELL SCI, V35, P229; Semino C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1121-9; SENDTNER M, 1992, J CELL BIOL, V118, P139, DOI 10.1083/jcb.118.1.139; Sharda A, 2018, EXPERT REV HEMATOL, V11, P437, DOI 10.1080/17474086.2018.1452612; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sitia R, 2018, SEMIN CELL DEV BIOL, V83, P12, DOI 10.1016/j.semcdb.2018.03.011; SLOAN IS, 1994, J BIOL CHEM, V269, P27625; Soderberg A, 2000, CANCER RES, V60, P2281; Steringer JP, 2018, SEMIN CELL DEV BIOL, V83, P3, DOI 10.1016/j.semcdb.2018.02.010; Steringer JP, 2012, J BIOL CHEM, V287, P27659, DOI 10.1074/jbc.M112.381939; Sundler R, 1997, ACTA PHYSIOL SCAND, V161, P553, DOI 10.1046/j.1365-201X.1997.00262.x; Tamboli IY, 2010, J BIOL CHEM, V285, P37405, DOI 10.1074/jbc.M110.149468; Tanudji M, 2003, AM J PHYSIOL-CELL PH, V284, pC1272, DOI 10.1152/ajpcell.00521.2002; Tanudji M, 2002, J CELL SCI, V115, P3849, DOI 10.1242/jcs.00047; Tassi S, 2010, P NATL ACAD SCI USA, V107, P9789, DOI 10.1073/pnas.1000779107; Tassi S, 2009, J IMMUNOL, V183, P1456, DOI 10.4049/jimmunol.0900578; Vene R, 2010, ANTIOXID REDOX SIGN, V13, P1145, DOI 10.1089/ars.2009.3078; Venereau E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00422; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wang H, 2004, J INTERN MED, V255, P320, DOI 10.1111/j.1365-2796.2003.01302.x; Wiedlocha A, 2004, CURR TOP MICROBIOL, V286, P45; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Xu Y, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0012-7; YAYON A, 1990, P NATL ACAD SCI USA, V87, P5346, DOI 10.1073/pnas.87.14.5346; Yi MC, 2016, ANNU REV CHEM BIOMOL, V7, P197, DOI 10.1146/annurev-chembioeng-080615-033553; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; Zhang M, 2020, CELL, V181, P637, DOI 10.1016/j.cell.2020.03.031; Zhang M, 2015, ELIFE, V4, DOI 10.7554/eLife.11205; Zhang QS, 2017, TOXICOL LETT, V265, P30, DOI 10.1016/j.toxlet.2016.11.002; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	143	19	19	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7799	7811		10.1074/jbc.REV119.008907	http://dx.doi.org/10.1074/jbc.REV119.008907			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32332096	hybrid, Green Published			2022-12-28	WOS:000538038900019
J	Feng, XY; Zhu, CL; Lee, SJ; Gao, JY; Zhu, P; Yamauchi, J; Pan, CL; Singh, S; Qu, S; Miller, R; Monga, SP; Peng, YD; Dong, HH				Feng, Xiaoyun; Zhu, Cuiling; Lee, Sojin; Gao, Jingyang; Zhu, Ping; Yamauchi, Jun; Pan, Chenglin; Singh, Sucha; Qu, Shen; Miller, Rita; Monga, Satdarshan P.; Peng, Yongde; Dong, H. Henry			Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bile acid; FOXO; gene knockout; liver; metabolic disease; bile acid metabolism; cholelithiasis; FoxO1; gallstone; mice; farnesoid X receptor (Fxr); forkhead box O1 (FoxO1); obesity; insulin resistance; metabolic disorder	CHOLESTEROL GALLSTONE DISEASE; FARNESOID X-RECEPTOR; BARIATRIC SURGERY; URSODEOXYCHOLIC ACID; NUCLEAR RECEPTORS; WEIGHT-LOSS; BILE-ACIDS; SYMPTOMATIC GALLSTONES; GASTRIC BYPASS; FOXO1	Cholelithiasis is one of the most prevalent gastroenterological diseases and is characterized by the formation of gallstones in the gallbladder. Both clinical and preclinical data indicate that obesity, along with comorbidity insulin resistance, is a predisposing factor for cholelithiasis. Forkhead box O1 (FoxO1) is a key transcription factor that integrates insulin signaling with hepatic metabolism and becomes deregulated in the insulin-resistant liver, contributing to dyslipidemia in obesity. To gain mechanistic insights into how insulin resistance is linked to cholelithiasis, here we determined FoxO1's role in bile acid homeostasis and its contribution to cholelithiasis. We hypothesized that hepatic FoxO1 deregulation links insulin resistance to impaired bile acid metabolism and cholelithiasis. To address this hypothesis, we used the FoxO1(LoxP/LoxP)-Albumin-Cre system to generate liver-specific FoxO1-knockout mice. FoxO1-knockout mice and age- and sex-matched WT littermates were fed a lithogenic diet, and bile acid metabolism and gallstone formation were assessed in these animals. We showed that FoxO1 affected bile acid homeostasis by regulating hepatic expression of key enzymes in bile acid synthesis and in biliary cholesterol and phospholipid secretion. Furthermore, FoxO1 inhibited hepatic expression of the bile acid receptor farnesoid X receptor and thereby counteracted hepatic farnesoid X receptor signaling. Nonetheless, hepatic FoxO1 depletion neither affected the onset of gallstone disease nor impacted the disease progression, as FoxO1-knockout and control mice of both sexes had similar gallstone weights and incidence rates. These results argue against the notion that FoxO1 is a link between insulin resistance and cholelithiasis.	[Feng, Xiaoyun; Zhu, Cuiling; Lee, Sojin; Gao, Jingyang; Zhu, Ping; Yamauchi, Jun; Pan, Chenglin; Miller, Rita; Dong, H. Henry] Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh, Div Endocrinol & Diabet,Dept Pediat, Pittsburgh, PA 15224 USA; [Feng, Xiaoyun; Peng, Yongde] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Endocrinol & Metab, Shanghai 200080, Peoples R China; [Zhu, Cuiling; Gao, Jingyang; Qu, Shen] Tongji Univ, Shanghai Peoples Hosp 10, Dept Endocrinol Metab, Sch Med, Shanghai 200072, Peoples R China; [Zhu, Ping] Jinan Univ, Guangzhou Red Cross Hosp, Dept Endocrinol & Metab, Med Coll, Guangzhou 510220, Peoples R China; [Pan, Chenglin] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Pediat, Shanghai 200072, Peoples R China; [Singh, Sucha; Monga, Satdarshan P.] Univ Pittsburgh, Sch Med, Dept Pathol, Div Expt Pathol, Pittsburgh, PA 15224 USA; [Singh, Sucha; Monga, Satdarshan P.; Dong, H. Henry] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh Liver Res Ctr, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shanghai Jiao Tong University; Tongji University; Jinan University; Tongji University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dong, HH (corresponding author), Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	dongh@pitt.edu		Dong, H. Henry/0000-0003-0279-5241	UPMC Children's Hospital of Pittsburgh; NIDDK, National Institutes of Health [1R01DK120310-01A1, P30DK120531]; China Scholarship Council [201806260074]	UPMC Children's Hospital of Pittsburgh; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); China Scholarship Council(China Scholarship Council)	This work was supported by UPMC Children's Hospital of Pittsburgh and NIDDK, National Institutes of Health Grant 1R01DK120310-01A1 (to H. H. D.) and P30DK120531 (to S. P. M.). C. Z. is a visiting scholar sponsored by China Scholarship Council 201806260074. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Acosta A, 2014, ANN NY ACAD SCI, V1311, P42, DOI 10.1111/nyas.12385; Al-Jiffry BO, 2003, CAN J GASTROENTEROL, V17, P169, DOI 10.1155/2003/392719; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; Bonfrate L, 2014, BEST PRACT RES CL GA, V28, P623, DOI 10.1016/j.bpg.2014.07.013; Bouchard G, 2002, J LIPID RES, V43, P1105, DOI 10.1194/jlr.M200102-JLR200; Cazzo E, 2016, OBES SURG, V26, P769, DOI 10.1007/s11695-015-1815-3; Chiang John Y. L., 2018, Gene Expression, V18, P71, DOI 10.3727/105221618X15156018385515; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Chiang JYL, 2000, J BIOL CHEM, V275, P10918, DOI 10.1074/jbc.275.15.10918; Claudel T, 2011, BBA-MOL BASIS DIS, V1812, P867, DOI 10.1016/j.bbadis.2010.12.021; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Duran-Sandoval D, 2004, DIABETES, V53, P890, DOI 10.2337/diabetes.53.4.890; Erlinger S, 2000, EUR J GASTROEN HEPAT, V12, P1347, DOI 10.1097/00042737-200012120-00015; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Ferkingstad E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07460-y; Ghoneim RH, 2015, BRIT J NUTR, V113, P507, DOI 10.1017/S0007114514003717; Haeusler RA, 2012, CELL METAB, V15, P65, DOI 10.1016/j.cmet.2011.11.010; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hirobe-Jahn S, 2015, CLIN RES HEPATOL GAS, V39, P68, DOI 10.1016/j.clinre.2014.07.002; HOLZBACH RT, 1984, HEPATOLOGY, V4, pS191, DOI 10.1002/hep.1840040836; Hyogo H, 2003, J LIPID RES, V44, P1232, DOI 10.1194/jlr.M300029-JLR200; Johansson K, 2014, INT J OBESITY, V38, P279, DOI 10.1038/ijo.2013.83; Johna S, 2016, WORLD J SURG, V40, P2911, DOI 10.1007/s00268-016-3672-1; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Katsika D, 2007, J INTERN MED, V262, P581, DOI 10.1111/j.1365-2796.2007.01860.x; Katsika D, 2010, J INTERN MED, V268, P279, DOI 10.1111/j.1365-2796.2010.02249.x; Kibbe C, 2013, J BIOL CHEM, V288, P23194, DOI 10.1074/jbc.M113.473082; Kim DH, 2011, DIABETES, V60, P2763, DOI 10.2337/db11-0548; Kovacs P, 2008, J HEPATOL, V48, P116, DOI 10.1016/j.jhep.2007.07.027; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Lammert F, 2005, NAT CLIN PRACT GASTR, V2, P423, DOI 10.1038/ncpgasthep0257; Lammert F, 2008, J HEPATOL, V48, pS124, DOI 10.1016/j.jhep.2008.01.012; Langlet F, 2017, CELL, V171, P824, DOI 10.1016/j.cell.2017.09.045; Lee S, 2017, J ENDOCRINOL, V233, pR67, DOI 10.1530/JOE-17-0002; Li TG, 2006, J BIOL CHEM, V281, P28745, DOI 10.1074/jbc.M605815200; Li TG, 2013, DRUG METAB REV, V45, P145, DOI 10.3109/03602532.2012.740048; Li VKM, 2009, SURG ENDOSC, V23, P2488, DOI 10.1007/s00464-009-0422-6; Li VKM, 2009, SURG ENDOSC, V23, P1640, DOI 10.1007/s00464-008-0204-6; Lv J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14801-2; Magouliotis DE, 2017, OBES SURG, V27, P3021, DOI 10.1007/s11695-017-2924-y; Marschall HU, 2007, J INTERN MED, V261, P529, DOI 10.1111/j.1365-2796.2007.01783.x; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Maurer KJ, 2009, GASTROENTEROLOGY, V136, P425, DOI 10.1053/j.gastro.2008.12.031; Morais M, 2016, WORLD J SURG, V40, P2904, DOI 10.1007/s00268-016-3639-2; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Park WH, 2011, EXP MOL MED, V43, P571, DOI 10.3858/emm.2011.43.10.064; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Rebholz C, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12935; Rosmorduc O, 2001, GASTROENTEROLOGY, V120, P1459, DOI 10.1053/gast.2001.23947; Sandblom G, 2015, HPB, V17, P239, DOI 10.1111/hpb.12356; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Sarr Michael G, 2006, Surg Obes Relat Dis, V2, P233, DOI 10.1016/j.soard.2006.01.011; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; SHIFFMAN ML, 1993, INT J OBESITY, V17, P153; Sparks JD, 2009, CURR OPIN LIPIDOL, V20, P217, DOI 10.1097/MOL.0b013e32832b3f4c; Stokes CS, 2014, CLIN GASTROENTEROL H, V12, P1090, DOI 10.1016/j.cgh.2013.11.031; Tung TH, 2006, WORLD J GASTROENTERO, V12, P4536, DOI 10.3748/wjg.v12.i28.4536; Teodoro JS, 2011, TRENDS ENDOCRIN MET, V22, P458, DOI 10.1016/j.tem.2011.07.002; TWISK J, 1995, HEPATOLOGY, V21, P501, DOI 10.1016/0270-9139(95)90113-2; Valenti L, 2008, DIABETES, V57, P1355, DOI 10.2337/db07-0714; Venneman NG, 2006, HEPATOLOGY, V43, P1276, DOI 10.1002/hep.21182; von Kampen O, 2013, HEPATOLOGY, V57, P2407, DOI 10.1002/hep.26009; Wang F, 2019, HEPATOLOGY, V70, P610, DOI 10.1002/hep.30403; Wang HH, 2008, GASTROENTEROLOGY, V134, P2101, DOI 10.1053/j.gastro.2008.03.011; Wang TY, 2018, CURR OPIN GASTROEN, V34, P59, DOI 10.1097/MOG.0000000000000417; Weber SN, 2019, CURR OPIN GASTROEN, V35, P82, DOI 10.1097/MOG.0000000000000511; Wittenburg H, 2010, BEST PRACT RES CL GA, V24, P747, DOI 10.1016/j.bpg.2010.07.004; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200; Zhao Y, 2015, J LIPID RES, V56, P644, DOI 10.1194/jlr.M056622; Zheng Y, 2018, J GASTROEN HEPATOL, V33, P1925, DOI 10.1111/jgh.14264	77	0	0	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7003	7017		10.1074/jbc.RA119.012272	http://dx.doi.org/10.1074/jbc.RA119.012272			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32273342	hybrid, Green Published			2022-12-28	WOS:000536212600019
J	Fu, CY; An, N; Liu, JM; Jun, A; Zhang, BT; Liu, MC; Zhang, ZQ; Fu, LY; Tian, XX; Wang, D; Dong, JT				Fu, Changying; An, Na; Liu, Jinming; Jun, A.; Zhang, Baotong; Liu, Mingcheng; Zhang, Zhiqian; Fu, Liya; Tian, Xinxin; Wang, Dan; Dong, Jin-Tang			The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1? in liver cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene regulation; gene silencing; hypoxia; hypoxia-inducible factor (HIF); liver cancer; transcription factor; transcription regulation; angiogenesis; vascular endothelial growth factor (VEGF); Hepatocellular carcinoma cells; ZFHX3	ALPHA-FETOPROTEIN GENE; FACTOR-I; ATBF1; EXPRESSION; HIF-1-ALPHA; DIFFERENTIATION; HIF1-ALPHA; DELETION; KINASES; ELEMENT	Angiogenesis is a hallmark of tumorigenesis, and hepatocellular carcinoma (HCC) is hypervascular and therefore very dependent on angiogenesis for tumor development and progression. Findings from previous studies suggest that in HCC cells, hypoxia-induced factor 1? (HIF1A) and zinc finger homeobox 3 (ZFHX3) transcription factors functionally interact in the regulation of genes in HCC cells. Here, we report that hypoxia increases the transcription of the ZFHX3 gene and enhances the binding of HIF1A to the ZFHX3 promoter in the HCC cell lines HepG2 and Huh-7. Moreover, ZFHX3, in turn, physically associated with and was functionally indispensable for HIF1A to exert its angiogenic activity, as indicated by in vitro migration and tube formation assays of human umbilical vein endothelial cells (HUVECs) and microvessel formation in xenograft tumors of HCC cells. Mechanistically, ZFHX3 was required for HIF1A to transcriptionally activate the vascular endothelial growth factor A (VEGFA) gene by binding to its promoter. Functionally, down-regulation of ZFHX3 in HCC cells slowed their tumor growth, and addition of VEGFA to conditioned medium from ZFHX3-silenced HCC cells partially rescued the inhibitory effect of this medium on HUVEC tube formation. In human HCC, ZFHX3 expression was up-regulated, and this up-regulation correlated with both HIF1A up-regulation and worse patient survival, confirming a functional association between ZFHX3 and HIF1A in human HCC. We conclude that ZFHX3 is an angiogenic transcription factor that is integral to the HIF1A/VEGFA signaling axis in HCC cells.	[Fu, Changying; An, Na; Liu, Jinming; Jun, A.; Liu, Mingcheng; Fu, Liya] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China; [Fu, Changying; An, Na; Jun, A.; Liu, Mingcheng; Zhang, Zhiqian; Tian, Xinxin; Wang, Dan; Dong, Jin-Tang] Southern Univ Sci & Technol, Sch Med, 1088 Xueyuan Rd, Shenzhen 518055, Guangdong, Peoples R China; [Zhang, Baotong] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Nankai University; Southern University of Science & Technology; Emory University	Dong, JT (corresponding author), Southern Univ Sci & Technol, Sch Med, 1088 Xueyuan Rd, Shenzhen 518055, Guangdong, Peoples R China.	dongjt@sustech.edu.cn	Zhang, Baotong/H-3482-2019; Zhang, Zhiqian/P-7746-2018	Zhang, Baotong/0000-0002-6586-4016; Zhang, Zhiqian/0000-0003-1226-4807; Tian, Xinxin/0000-0003-3504-9392	National Natural Science Foundation of China (NSFC) [81472464, 31871466]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC) Grants 81472464 and 31871466. The authors declare that they have no conflicts of interest with the contents of this article.	Ameri K, 2002, BRIT J CANCER, V87, P1173, DOI 10.1038/sj.bjc.6600576; Berra E, 2000, CANCER METAST REV, V19, P139, DOI 10.1023/A:1026506011458; Blatchley MR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7518; Bodnar RJ, 2014, ADV WOUND CARE, V3, P635, DOI 10.1089/wound.2013.0496; Carbajo-Pescador S, 2013, BRIT J CANCER, V109, P83, DOI 10.1038/bjc.2013.285; Chen DR, 2017, INT J MOL MED, V40, P1529, DOI 10.3892/ijmm.2017.3138; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Chiu DKC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00530-7; Choudhry H, 2018, CELL METAB, V27, P281, DOI 10.1016/j.cmet.2017.10.005; Diakiw SM, 2013, IUBMB LIFE, V65, P999, DOI 10.1002/iub.1233; Dong JT, 2009, CELL MOL LIFE SCI, V66, P2691, DOI 10.1007/s00018-009-0045-z; Dong XY, 2011, J BIOL CHEM, V286, P13879, DOI 10.1074/jbc.M110.187849; Dong XY, 2010, J BIOL CHEM, V285, P32801, DOI 10.1074/jbc.M110.128330; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Hu QX, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0138-y; Kataoka H, 2001, ONCOGENE, V20, P869, DOI 10.1038/sj.onc.1204160; Kim CJ, 2008, HISTOPATHOLOGY, V52, P552, DOI 10.1111/j.1365-2559.2008.02980.x; Li J, 2014, CANCER CELL, V25, P118, DOI 10.1016/j.ccr.2013.12.008; Liu LP, 2012, CLIN CANCER RES, V18, P5662, DOI 10.1158/1078-0432.CCR-12-0552; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Mas V. R., 2009, GENE EXPRESSION OMNI; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Mazure NM, 2003, CURR PHARM DESIGN, V9, P531, DOI 10.2174/1381612033391469; Mazure NM, 2002, CANCER RES, V62, P1158; MIURA K, 1995, CANCER RES, V55, P1828; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Ninomiya T, 2002, HEPATOLOGY, V35, P82, DOI 10.1053/jhep.2002.30420; Park C. K., 2012, GENE EXPRESSION OMNI; Perez-Perri JI, 2016, CELL REP, V16, P37, DOI 10.1016/j.celrep.2016.05.082; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rebouissou S, 2017, J HEPATOL, V67, P896, DOI 10.1016/j.jhep.2017.08.002; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sun XD, 2014, NEOPLASIA, V16, P377, DOI 10.1016/j.neo.2014.05.001; Sun XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092746; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Wang XW, 2010, INT C MANAGE SCI ENG, P1520, DOI 10.1109/ICMSE.2010.5719988; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Zhao D, 2016, J BIOL CHEM, V291, P12809, DOI 10.1074/jbc.M116.719377; Zhu AX, 2011, NAT REV CLIN ONCOL, V8, P292, DOI 10.1038/nrclinonc.2011.30	46	11	11	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7060	7074		10.1074/jbc.RA119.012131	http://dx.doi.org/10.1074/jbc.RA119.012131			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32277050	hybrid, Green Published			2022-12-28	WOS:000536212600023
J	Sivakumar, D; Kumar, V; Naumann, M; Stein, M				Sivakumar, Dakshinamurthy; Kumar, Vikash; Naumann, Michael; Stein, Matthias			Activation and selectivity of OTUB-1 and OTUB-2 deubiquitinylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitin thioesterase (OTUB1); deubiquitylation (deubiquitination); ovarian cancer; allosteric regulation; ubiquitin-dependent protease; cysteine protease; catalytic triad; computational analysis; molecular dynamics; OTU deubiquitinase ubiquitin aldehyde binding	CANCER; INHIBITION; CYSTEINE; ENZYME; ROLES; UBIQUITINATION; SPECIFICITY; MECHANISM; CARCINOMA; MIGRATION	The ovarian tumor domain (OTU) deubiquitinylating cysteine proteases OTUB1 and OTUB2 (OTU ubiquitin aldehyde binding 1 and 2) are representative members of the OTU subfamily of deubiquitinylases. Deubiquitinylation critically regulates a multitude of important cellular processes, such as apoptosis, cell signaling, and growth. Moreover, elevated OTUB expression has been observed in various cancers, including glioma, endometrial cancer, ovarian cancer, and breast cancer. Here, using molecular dynamics simulation approaches, we found that both OTUB1 and OTUB2 display a catalytic triad characteristic of proteases but differ in their configuration and protonation states. The OTUB1 protein had a prearranged catalytic site, with strong electrostatic interactions between the active-site residues His(265) and Asp(267). In OTUB2, however, the arrangement of the catalytic triad was different. In the absence of ubiquitin, the neutral states of the catalytic-site residues in OTUB2 were more stable, resulting in larger distances between these residues. Only upon ubiquitin binding did the catalytic triad in OTUB2 rearrange and bring the active site into a catalytically feasible state. An analysis of water access channels revealed only a few diffusion trajectories for the catalytically active form of OTUB1, whereas in OTUB2 the catalytic site was solvent-accessible, and a larger number of water molecules reached and left the binding pocket. Interestingly, in OTUB2, the catalytic residues His(224) and Asn(226) formed a stable hydrogen bond. We propose that the observed differences in activation kinetics, protonation states, water channels, and active-site accessibility between OTUB1 and OTUB2 may be relevant for the selective design of OTU inhibitors.	[Sivakumar, Dakshinamurthy; Kumar, Vikash; Stein, Matthias] Max Planck Inst Dynam Complex Tech Syst, Mol Simulat & Design Grp, D-39106 Magdeburg, Germany; [Kumar, Vikash; Naumann, Michael] Otto von Guericke Univ, Inst Expt Internal Med, Fac Med, D-39120 Magdeburg, Germany	Max Planck Society; Otto von Guericke University	Stein, M (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Mol Simulat & Design Grp, D-39106 Magdeburg, Germany.	matthias.stein@mpi-magdeburg.mpg.de	Naumann, Michael/B-5285-2011; Sivakumar, Dakshinamurthy/O-7351-2018	Naumann, Michael/0000-0002-8060-2313; Sivakumar, Dakshinamurthy/0000-0003-2130-1155	Max Planck Society for the Advancement of Science [ZS/2016/04/78155]; European Union Program European Regional Development Fund of the Ministry of Economy, Science and Digitalisation in Saxony Anhalt within the Center of Dynamic Systems	Max Planck Society for the Advancement of Science(Max Planck Society); European Union Program European Regional Development Fund of the Ministry of Economy, Science and Digitalisation in Saxony Anhalt within the Center of Dynamic Systems	This work was supported by the Max Planck Society for the Advancement of Science. The work was also supported by Grant ZS/2016/04/78155 from the European Union Program European Regional Development Fund of the Ministry of Economy, Science and Digitalisation in Saxony Anhalt within the Center of Dynamic Systems. The authors declare that they have no conflicts of interest with the contents of this article.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Altun M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115344; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; CRAIK CS, 1987, SCIENCE, V237, P909, DOI 10.1126/science.3303334; D'Arcy P, 2015, PHARMACOL THERAPEUT, V147, P32, DOI 10.1016/j.pharmthera.2014.11.002; DeLano W. L., 2017, PYMOL PYMOL MOL GRAP; Dyson PJ, 2016, CATAL SCI TECHNOL, V6, P3302, DOI 10.1039/c5cy02197a; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Elsasser B, 2017, ACS CATAL, V7, P5585, DOI 10.1021/acscatal.7b01505; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Jupin I, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006714; Karunarathna U, 2016, ONCOGENE, V35, P1433, DOI 10.1038/onc.2015.208; Kumar V, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00480; Kutzner C, 2019, J COMPUT CHEM, V40, P2418, DOI 10.1002/jcc.26011; Li H, 2016, MOL CELL, V63, P249, DOI 10.1016/j.molcel.2016.05.031; Li J, 2019, THERANOSTICS, V9, P179, DOI 10.7150/thno.29545; Liu X, 2014, PATHOL RES PRACT, V210, P770, DOI 10.1016/j.prp.2014.05.008; Magdziarz T, 2020, BIOINFORMATICS, V36, P2599, DOI 10.1093/bioinformatics/btz946; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Mitusinska K, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040143; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nanao MH, 2004, EMBO REP, V5, P783, DOI 10.1038/sj.embor.7400201; Ni QG, 2017, ACTA BIOCH BIOPH SIN, V49, P680, DOI 10.1093/abbs/gmx056; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Ozen A, 2018, STRUCTURE, V26, P72, DOI 10.1016/j.str.2017.11.010; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; Shokhen M, 2011, PROTEINS, V79, P975, DOI 10.1002/prot.22939; Shokhen M, 2009, PROTEINS, V77, P916, DOI 10.1002/prot.22516; Srivastava Mitul, 2018, Oncotarget, V9, P34289, DOI 10.18632/oncotarget.26136; Stanisic V, 2009, J BIOL CHEM, V284, P16135, DOI 10.1074/jbc.M109.007484; Stepankova V, 2013, CHEMBIOCHEM, V14, P890, DOI 10.1002/cbic.201200733; Sun JG, 2020, ONCOL LETT, V19, P30, DOI 10.3892/ol.2019.11062; VERNET T, 1995, J BIOL CHEM, V270, P16645, DOI 10.1074/jbc.270.28.16645; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wei DH, 2013, BIOCHEMISTRY-US, V52, P5145, DOI 10.1021/bi400629r; Weng WW, 2016, AM J TRANSL RES, V8, P2234; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Xu L, 2017, NEUROPATHOLOGY, V37, P217, DOI 10.1111/neup.12366; Yang L, 2004, BIOPHYS J, V87, P812, DOI 10.1529/biophysj.104.041269; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhao LL, 2018, J BIOL CHEM, V293, P4883, DOI 10.1074/jbc.M117.809533; Zhou HH, 2018, ONCOGENE, V37, P3356, DOI 10.1038/s41388-018-0224-1	51	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6972	6982		10.1074/jbc.RA120.013073	http://dx.doi.org/10.1074/jbc.RA120.013073			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32265297	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000536212600015
J	Balachandran, RC; Mukhopadhyay, S; McBride, D; Veevers, J; Harrison, FE; Aschner, M; Haynes, EN; Bowman, AB				Balachandran, Rekha C.; Mukhopadhyay, Somshuvra; McBride, Danielle; Veevers, Jennifer; Harrison, Fiona E.; Aschner, Michael; Haynes, Erin N.; Bowman, Aaron B.			Brain manganese and the balance between essential roles and neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						metal; metal homeostasis; manganese; neurodegeneration; neurodegenerative disease; neurodevelopment; homeostasis; toxicology; neurotoxin; brain; neurotransmitter	EFFLUX TRANSPORTER SLC30A10; CENTRAL-NERVOUS-SYSTEM; METAL-ION TRANSPORTER; SCHOOL-AGE-CHILDREN; SUPEROXIDE-DISMUTASE; BLOOD MANGANESE; INDUCED PARKINSONISM; OXIDATIVE STRESS; ZINC TRANSPORTER; IRON-DEFICIENCY	Manganese (Mn) is an essential micronutrient required for the normal development of many organs, including the brain. Although its roles as a cofactor in several enzymes and in maintaining optimal physiology are well-known, the overall biological functions of Mn are rather poorly understood. Alterations in body Mn status are associated with altered neuronal physiology and cognition in humans, and either overexposure or (more rarely) insufficiency can cause neurological dysfunction. The resultant balancing act can be viewed as a hormetic U-shaped relationship for biological Mn status and optimal brain health, with changes in the brain leading to physiological effects throughout the body and vice versa. This review discusses Mn homeostasis, biomarkers, molecular mechanisms of cellular transport, and neuropathological changes associated with disruptions of Mn homeostasis, especially in its excess, and identifies gaps in our understanding of the molecular and biochemical mechanisms underlying Mn homeostasis and neurotoxicity.	[Balachandran, Rekha C.; Bowman, Aaron B.] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Mukhopadhyay, Somshuvra] Univ Texas Austin, Coll Pharm, Inst Cellular & Mol Biol, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Mukhopadhyay, Somshuvra] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [McBride, Danielle; Veevers, Jennifer] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA; [Harrison, Fiona E.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Aschner, Michael] Albert Einstein Coll Med, Bronx, NY 10461 USA; [Haynes, Erin N.] Univ Kentucky, Coll Publ Hlth, Lexington, KY 40536 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University System of Ohio; University of Cincinnati; Vanderbilt University; Yeshiva University; Albert Einstein College of Medicine; University of Kentucky	Bowman, AB (corresponding author), Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA.	bowma117@purdue.edu		McBride, Danielle E./0000-0003-2965-6444; Haynes, Erin/0000-0001-9110-0477; Bowman, Aaron/0000-0001-8728-3346; aschner, michael/0000-0002-2619-1656	NIEHS, National Institutes of Health [R01 ES024812, RO1 ES016931, RO1 ES010563, R01 ES031401, R01 ES026446]; Veterans Affairs Grant [I01 CX001610-01]	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs Grant(US Department of Veterans Affairs)	This work was supported by NIEHS, National Institutes of Health, Grants R01 ES024812 (to S. M.), RO1 ES016931 (to A. B. B.), RO1 ES010563 (to A. B. B. and M. A.), R01 ES031401 (to F. E. H. and A. B. B.), and R01 ES026446 (to E. N. H.) and by Veterans Affairs Grant I01 CX001610-01 (to F. E. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amos-Kroohs RM, 2016, NEUROTOXICOL TERATOL, V56, P55, DOI 10.1016/j.ntt.2016.06.004; Anagianni S, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0942-y; Anantharaman M, 2006, AM J PATHOL, V168, P1608, DOI 10.2353/ajpath.2006.051223; Ares-Santos S, 2013, J INTERN MED, V273, P437, DOI 10.1111/joim.12049; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; Aschner JL, 2015, AM J CLIN NUTR, V102, P1482, DOI 10.3945/ajcn.115.116285; Aschner M, 2006, NEUROTOXICOLOGY, V27, P311, DOI 10.1016/j.neuro.2005.09.002; Aschner Michael, 2006, Toxicol Rev, V25, P147, DOI 10.2165/00139709-200625030-00002; Aschner M, 2007, TOXICOL APPL PHARM, V221, P131, DOI 10.1016/j.taap.2007.03.001; AUTISSIER N, 1982, TOXICOLOGY, V24, P175, DOI 10.1016/0300-483X(82)90055-5; Avila Costa M. R., 2018, DOPAMINE HLTH DIS, P59; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Babadi VY, 2014, J TOXICOL-US, V2014, DOI 10.1155/2014/946372; Bailey RA, 2019, NEUROTOX RES, V35, P606, DOI 10.1007/s12640-018-9992-1; Baker MG, 2015, J TRACE ELEM MED BIO, V29, P123, DOI 10.1016/j.jtemb.2014.05.004; Baker MG, 2014, J OCCUP ENVIRON HYG, V11, P210, DOI 10.1080/15459624.2013.852280; BALLATORI N, 1987, AM J PHYSIOL, V252, pR842, DOI 10.1152/ajpregu.1987.252.5.R842; BALY DL, 1990, J NUTR, V120, P1075, DOI 10.1093/jn/120.9.1075; BALY DL, 1984, J NUTR, V114, P1438, DOI 10.1093/jn/114.8.1438; BALY DL, 1986, BIOL TRACE ELEM RES, V11, P201, DOI 10.1007/BF02795535; BALY DL, 1988, FEBS LETT, V239, P55, DOI 10.1016/0014-5793(88)80544-1; Beaudin SA, 2017, ENVIRON HEALTH PERSP, V125, P230, DOI 10.1289/EHP258; BENDIAK B, 1987, J BIOL CHEM, V262, P5784; BERTINCHAMPS AJ, 1966, AM J PHYSIOL, V211, P217, DOI 10.1152/ajplegacy.1966.211.1.217; Betancourt O, 2015, ECOHEALTH, V12, P453, DOI 10.1007/s10393-015-1027-2; Bhang SY, 2013, ENVIRON RES, V126, P9, DOI 10.1016/j.envres.2013.05.006; Blomlie V, 2020, AM J NEURORADIOL, V41, pE3, DOI 10.3174/ajnr.A6347; Bock NA, 2008, BRAIN RES, V1198, P160, DOI 10.1016/j.brainres.2007.12.065; Bosomworth HJ, 2012, METALLOMICS, V4, P771, DOI 10.1039/c2mt20088k; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; Brna P, 2011, J CHILD NEUROL, V26, P891, DOI 10.1177/0883073810393962; Bryan MR, 2020, MOL NEUROBIOL, V57, P1570, DOI 10.1007/s12035-019-01824-1; Bryan Miles R, 2017, Adv Neurobiol, V18, P113, DOI 10.1007/978-3-319-60189-2_6; Caito Samuel, 2015, Handb Clin Neurol, V131, P169, DOI 10.1016/B978-0-444-62627-1.00011-1; Calderon-Garciduenas L, 2013, EXP TOXICOL PATHOL, V65, P503, DOI 10.1016/j.etp.2012.02.006; Calderon-Garciduenas L, 2011, INT J DEV NEUROSCI, V29, P365, DOI 10.1016/j.ijdevneu.2011.03.007; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; Carvalho CF, 2014, NEUROTOXICOLOGY, V45, P301, DOI 10.1016/j.neuro.2013.11.006; Cersosimo MG, 2006, NEUROTOXICOLOGY, V27, P340, DOI 10.1016/j.neuro.2005.10.006; Chang Y, 2010, NEUROIMAGE, V53, P1279, DOI 10.1016/j.neuroimage.2010.07.001; Chen MK, 2006, NEUROTOXICOLOGY, V27, P229, DOI 10.1016/j.neuro.2005.10.008; Chen Pan, 2015, Worm, V4, pe1042648, DOI 10.1080/21624054.2015.1042648; Chen P, 2015, TOXICOL RES-UK, V4, P191, DOI 10.1039/c4tx00127c; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Chung SE, 2015, ENVIRON HEALTH PERSP, V123, P717, DOI 10.1289/ehp.1307865; Clegg MS, 1998, P SOC EXP BIOL MED, V219, P41, DOI 10.3181/00379727-219-44314; COLLIPP PJ, 1983, ANN NUTR METAB, V27, P488, DOI 10.1159/000176724; Cordova FM, 2013, ARCH TOXICOL, V87, P1231, DOI 10.1007/s00204-013-1017-5; Criswell SR, 2011, NEUROLOGY, V76, P1296, DOI 10.1212/WNL.0b013e3182152830; Criswell SR, 2018, NEUROLOGY, V91, pE1022, DOI 10.1212/WNL.0000000000006163; Criswell SR, 2012, OCCUP ENVIRON MED, V69, P437, DOI 10.1136/oemed-2011-100119; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Das A, 2000, OSTEOARTHR CARTILAGE, V8, P343, DOI 10.1053/joca.1999.0308; DAVIS CD, 1992, AM J CLIN NUTR, V55, P747, DOI 10.1093/ajcn/55.3.747; DAVIS CD, 1993, P SOC EXP BIOL MED, V202, P103; Davis JM, 1999, NEUROTOXICOLOGY, V20, P511; Davis JM, 1998, ENVIRON HEALTH PERSP, V106, P191, DOI 10.2307/3433920; De Leo ME, 1998, NEUROSCI LETT, V250, P173, DOI 10.1016/S0304-3940(98)00469-8; Viana GFD, 2014, TOXICOL LETT, V231, P169, DOI 10.1016/j.toxlet.2014.06.018; Dorman DC, 2002, NEUROTOXICOLOGY, V23, P185, DOI 10.1016/S0161-813X(01)00075-4; Dorman DC, 2002, J TOXICOL ENV HEAL A, V65, P1493, DOI 10.1080/00984100290071630; Du K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030231; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Environmental Protection Agency, 2020, SEC DRINK WAT STAND; ERIKSSON H, 1987, ARCH TOXICOL, V61, P46, DOI 10.1007/BF00324547; ERIKSSON H, 1984, ACTA NEUROL SCAND, V70, P89; ERIKSSON H, 1992, ARCH TOXICOL, V66, P359, DOI 10.1007/BF01973632; Finkelstein MM, 2007, ENVIRON RES, V104, P420, DOI 10.1016/j.envres.2007.03.002; Finkelstein Y, 2008, ISR MED ASSOC J, V10, P793; Finley JW, 1999, AM J CLIN NUTR, V70, P37; FINLEY JW, 1994, AM J CLIN NUTR, V60, P949, DOI 10.1093/ajcn/60.6.949; Fitsanakis VA, 2006, NEUROCHEM INT, V48, P426, DOI 10.1016/j.neuint.2005.10.012; Fitsanakis VA, 2008, TOXICOL SCI, V103, P116, DOI 10.1093/toxsci/kfn019; Fitsanakis VA, 2010, NEUROTOX RES, V18, P124, DOI 10.1007/s12640-009-9130-1; Frangou S, 2004, NEUROIMAGE, V23, P800, DOI 10.1016/j.neuroimage.2004.05.027; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Ghosh Kanjaksha, 2006, Indian J Med Sci, V60, P30; GIBBONS RA, 1976, BIOCHIM BIOPHYS ACTA, V444, P1, DOI 10.1016/0304-4165(76)90218-X; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Gonzalez-Cuyar LF, 2014, NEUROTOXICOLOGY, V45, P260, DOI 10.1016/j.neuro.2013.12.008; Gonzalez-Dominguez R, 2014, BIOMETALS, V27, P539, DOI 10.1007/s10534-014-9728-5; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Gorell JM, 2004, J NEUROL SCI, V217, P169, DOI 10.1016/j.jns.2003.09.014; Gospe SM, 2000, ARCH DIS CHILD, V83, P439, DOI 10.1136/adc.83.5.439; Greenberg David M., 1943, JOUR BIOL CHEM, V147, P749; Guilarte TR, 2006, EXP NEUROL, V202, P381, DOI 10.1016/j.expneurol.2006.06.015; Guilarte TR, 2015, TOXICOL SCI, V146, P204, DOI 10.1093/toxsci/kfv099; Guilarte TR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00023; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Guilarte TR, 2008, J NEUROCHEM, V107, P1236, DOI 10.1111/j.1471-4159.2008.05695.x; Gulab S, 2018, NEUROPEDIATRICS, V49, P72, DOI 10.1055/s-0037-1608778; Gulson B, 2006, ENVIRON RES, V100, P100, DOI 10.1016/j.envres.2005.03.013; Gunier RB, 2015, ENVIRON RES, V142, P688, DOI 10.1016/j.envres.2015.09.003; Guthrie GJ, 2015, AM J PHYSIOL-GASTR L, V308, pG171, DOI 10.1152/ajpgi.00021.2014; Gwiazda RH, 2002, NEUROTOXICOLOGY, V23, P69, DOI 10.1016/S0161-813X(02)00002-5; Han JH, 2008, INHAL TOXICOL, V20, P1075, DOI [10.1080/08958370802116634, 10.1080/08958370802116634 ]; Hare DJ, 2016, METALLOMICS, V8, P628, DOI 10.1039/c6mt00019c; Hassani H, 2016, IND HEALTH, V54, P79, DOI 10.2486/indhealth.2014-0250; Haynes EN, 2015, ENVIRON HEALTH PERSP, V123, P1066, DOI 10.1289/ehp.1408993; Henn BC, 2010, EPIDEMIOLOGY, V21, P433, DOI 10.1097/EDE.0b013e3181df8e52; Hernandez-Bonilla D, 2011, NEUROTOXICOLOGY, V32, P615, DOI 10.1016/j.neuro.2011.07.010; Hisahara S, 2011, INT J MED CHEM, V2011, DOI 10.1155/2011/403039; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Hsieh CT, 2007, PEDIATR NEUROL, V36, P181, DOI 10.1016/j.pediatrneurol.2006.10.005; Huang CC, 2007, PARKINSONISM RELAT D, V13, P143, DOI 10.1016/j.parkreldis.2006.09.002; Huang CC, 2003, J NEUROL, V250, P1335, DOI 10.1007/s00415-003-0214-1; Huang Chin-Chang, 2007, Chang Gung Med J, V30, P385; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Hutchens S, 2017, J BIOL CHEM, V292, P9760, DOI 10.1074/jbc.M117.783605; Ingersoll RT, 1999, NEUROTOXICOLOGY, V20, P467; Iqbal Mudassir, 2012, J Med Case Rep, V6, P52, DOI 10.1186/1752-1947-6-52; IREGREN A, 1990, NEUROTOXICOL TERATOL, V12, P673, DOI 10.1016/0892-0362(90)90085-Q; Iwase K, 2002, DIGEST SURG, V19, P174, DOI 10.1159/000064210; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Juneja M, 2018, J GENE MED, V20, DOI 10.1002/jgm.3012; Kang J O, 2001, Clin Lab Sci, V14, P209; Keen C.L., 1990, MANGANESE, P279; Keen CL, 2000, MET IONS BIOL SYST, V37, P89; Khalid M, 2011, J NEUROSCI METH, V202, P182, DOI 10.1016/j.jneumeth.2011.06.019; Khan K, 2012, NEUROTOXICOLOGY, V33, P91, DOI 10.1016/j.neuro.2011.12.002; Kim YH, 1999, NEUROTOXICOLOGY, V20, P249; KLAASSEN CD, 1974, TOXICOL APPL PHARM, V29, P458, DOI 10.1016/0041-008X(74)90117-3; Kwakye GF, 2015, INT J ENV RES PUB HE, V12, P7519, DOI 10.3390/ijerph120707519; LAI JCK, 1992, NEUROCHEM RES, V17, P841, DOI 10.1007/BF00993259; LAI JCK, 1984, NEUROTOXICOLOGY, V5, P37; Landrigan PJ, 2011, MT SINAI J MED, V78, P1, DOI 10.1002/msj.20236; Lao Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41804; Laohaudomchok W, 2011, J OCCUP ENVIRON MED, V53, P506, DOI 10.1097/JOM.0b013e31821854da; Laohaudomchok W, 2011, NEUROTOXICOLOGY, V32, P171, DOI 10.1016/j.neuro.2010.12.014; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Lehmann T, 1999, ANN HEMATOL, V78, P483, DOI 10.1007/s002770050604; Leonhard MJ, 2019, TOXICOLOGY, V420, P46, DOI 10.1016/j.tox.2019.03.004; Lewis DA, 1997, NEUROPSYCHOPHARMACOL, V16, P385, DOI 10.1016/S0893-133X(96)00277-1; Leyva-Illades D, 2014, J NEUROSCI, V34, P14079, DOI 10.1523/JNEUROSCI.2329-14.2014; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Lin W, 2017, J CLIN INVEST, V127, P2407, DOI 10.1172/JCI90896; Liu CY, 2017, J BIOL CHEM, V292, P16605, DOI 10.1074/jbc.M117.804989; Liu YZ, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aaa749; Liuzzi JP, 2005, P NATL ACAD SCI USA, V102, P6843, DOI 10.1073/pnas.0502257102; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Ljung K, 2007, ENVIRON HEALTH PERSP, V115, P1533, DOI 10.1289/ehp.10316; Long ZY, 2014, NEUROTOXICOLOGY, V45, P285, DOI 10.1016/j.neuro.2014.03.007; Lu CL, 2018, BRAIN RES BULL, V140, P107, DOI 10.1016/j.brainresbull.2018.04.009; Lucchini RG, 2012, NEUROTOXICOLOGY, V33, P687, DOI 10.1016/j.neuro.2012.01.005; LUTZ TA, 1993, BIOL TRACE ELEM RES, V39, P221, DOI 10.1007/BF02783192; Ma RE, 2018, NEUROTOXICOLOGY, V64, P30, DOI 10.1016/j.neuro.2017.08.013; Madison JL, 2011, NEUROTOXICOLOGY, V32, P896, DOI 10.1016/j.neuro.2011.05.007; Maeda Mitsuyo, 1997, Osaka City Medical Journal, V43, P1; Marcus DL, 2006, MED SCI MONITOR, V12, pBR8; dos Santos APM, 2011, BRAIN RES, V1382, P282, DOI 10.1016/j.brainres.2011.01.047; Marti-Sanchez L, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0758-x; MCDERMOTT SD, 1987, ACS SYM SER, V354, P146; Menezes JA, 2011, ENVIRON RES, V111, P156, DOI 10.1016/j.envres.2010.09.006; Mercadante CJ, 2019, J CLIN INVEST, V129, P5442, DOI 10.1172/JCI129710; Mergler D, 1999, NEUROTOXICOLOGY, V20, P327; Molina JA, 1998, J NEURAL TRANSM, V105, P479, DOI 10.1007/s007020050071; Mora AM, 2015, ENVIRON INT, V84, P39, DOI 10.1016/j.envint.2015.07.009; Mukhopadhyay S, 2011, P NATL ACAD SCI USA, V108, P858, DOI 10.1073/pnas.1013642108; Nam H, 2013, HAEMATOLOGICA, V98, P1049, DOI 10.3324/haematol.2012.072314; National Center for Environmental Assessment, 2012, INT RISK INF SYST; Nelson M, 2018, COMP BIOCHEM PHYS C, V213, P1, DOI 10.1016/j.cbpc.2018.07.002; NEWLAND MC, 1989, EXP NEUROL, V106, P251, DOI 10.1016/0014-4886(89)90157-X; Nishito Y, 2016, J BIOL CHEM, V291, P14773, DOI 10.1074/jbc.M116.728014; O'Neal Stefanie L, 2015, Curr Environ Health Rep, V2, P315, DOI 10.1007/s40572-015-0056-x; Ohtake T, 2005, AM J KIDNEY DIS, V46, P749, DOI 10.1053/j.ajkd.2005.05.033; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Ommati MM, 2019, BIOL TRACE ELEM RES, V190, P384, DOI 10.1007/s12011-018-1552-2; Oulhote Y, 2014, ENVIRON HEALTH PERSP, V122, P1343, DOI 10.1289/ehp.1307918; Pajarillo E, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.03.002; PAPAVASILIOU PS, 1966, AM J PHYSIOL, V211, P211, DOI 10.1152/ajplegacy.1966.211.1.211; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Park JD, 2007, INHAL TOXICOL, V19, P965, DOI 10.1080/08958370701516108; Pautler RG, 2003, MAGNET RESON MED, V50, P33, DOI 10.1002/mrm.10498; Perl DP, 2007, J NEUROPATH EXP NEUR, V66, P675, DOI 10.1097/nen.0b013e31812503cf; Pfalzer Anna C, 2017, Curr Environ Health Rep, V4, P223, DOI 10.1007/s40572-017-0136-1; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Prabhakaran K, 2008, BRAIN RES BULL, V76, P361, DOI 10.1016/j.brainresbull.2008.03.004; Quadri M, 2015, MOVEMENT DISORD, V30, P996, DOI 10.1002/mds.26202; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; Racette BA, 2005, NEUROLOGY, V64, P230, DOI 10.1212/01.WNL.0000149511.19487.44; Racette BA, 2017, NEUROLOGY, V88, P344, DOI 10.1212/WNL.0000000000003533; Racette BA, 2012, NEUROTOXICOLOGY, V33, P881, DOI 10.1016/j.neuro.2011.12.010; Reaney SH, 2006, TOXICOL SCI, V93, P114, DOI 10.1093/toxsci/kfl028; REHNBERG GL, 1982, J TOXICOL ENV HEALTH, V9, P175, DOI 10.1080/15287398209530153; Revilla FJ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00202; Rink SM, 2014, ARCH ENVIRON OCCUP H, V69, P46, DOI 10.1080/19338244.2012.725229; Rivera-Mancia S, 2011, BIOMETALS, V24, P811, DOI 10.1007/s10534-011-9454-1; Robison G, 2015, METALLOMICS, V7, P748, DOI 10.1039/c5mt00023h; Rodier J, 1955, BRIT J IND MED, V12, P21; Rodrigues EG, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0127-y; ROELS H, 1987, AM J IND MED, V11, P307, DOI 10.1002/ajim.4700110308; Roh E, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.4; Rugless F, 2014, NEUROTOXICOL TERATOL, V41, P71, DOI 10.1016/j.ntt.2013.12.005; Salazar J, 2008, P NATL ACAD SCI USA, V105, P18578, DOI 10.1073/pnas.0804373105; SANDSTROM B, 1986, ACTA PHARMACOL TOX, V59, P60; SCHACHTER H, 1971, J BIOL CHEM, V246, P5321; Scheiber IF, 2019, J BIOL CHEM, V294, P9147, DOI 10.1074/jbc.RA119.008762; Schneider JS, 2006, BRAIN RES, V1118, P222, DOI 10.1016/j.brainres.2006.08.054; SCHROEDER HA, 1966, J CHRON DIS, V19, P545, DOI 10.1016/0021-9681(66)90094-4; Selikhova M, 2008, MOVEMENT DISORD, V23, P2224, DOI 10.1002/mds.22290; SETH PK, 1984, NEUROTOXICOLOGY, V5, P67; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Sikk K, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/865319; Sistrunk SC, 2007, ENVIRON TOXICOL PHAR, V23, P286, DOI 10.1016/j.etap.2006.11.004; Smith D, 2007, AM J IND MED, V50, P801, DOI 10.1002/ajim.20506; Smith MR, 2017, BIOCHEM BIOPH RES CO, V482, P388, DOI 10.1016/j.bbrc.2016.10.126; Solis-Vivanco R, 2009, ENVIRON TOXICOL PHAR, V28, P172, DOI 10.1016/j.etap.2009.04.001; Spadoni F, 2000, EXP BRAIN RES, V135, P544, DOI 10.1007/s002210000554; Standridge JS, 2008, J OCCUP ENVIRON MED, V50, P1421, DOI 10.1097/JOM.0b013e3181896936; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; Stredrick DL, 2004, NEUROTOXICOLOGY, V25, P543, DOI 10.1016/j.neuro.2003.08.006; Sulzer D, 2007, TRENDS NEUROSCI, V30, P244, DOI 10.1016/j.tins.2007.03.009; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Takeda A, 2003, BRAIN RES, V965, P279, DOI 10.1016/S0006-8993(02)04157-4; Takeda A, 2002, NEUROSCIENCE, V114, P669, DOI 10.1016/S0306-4522(02)00353-6; Takser L, 2003, NEUROTOXICOLOGY, V24, P667, DOI 10.1016/S0161-813X(03)00058-5; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Taylor CA, 2019, J BIOL CHEM, V294, P1860, DOI 10.1074/jbc.RA118.005628; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; THOMSON ABR, 1971, J LAB CLIN MED, V78, P642; Tomas-Camardiel M, 2002, MOL BRAIN RES, V103, P116, DOI 10.1016/S0169-328X(02)00192-4; Tong YW, 2014, J ALZHEIMERS DIS, V42, P865, DOI 10.3233/JAD-140534; Torres-Agustin R, 2013, ENVIRON RES, V121, P39, DOI 10.1016/j.envres.2012.10.007; Tran TT, 2002, NEUROTOXICOLOGY, V23, P635, DOI 10.1016/S0161-813X(02)00091-8; Tran TT, 2002, NEUROTOXICOLOGY, V23, P645, DOI 10.1016/S0161-813X(02)00068-2; Tuschl K, 2008, J INHERIT METAB DIS, V31, P151, DOI 10.1007/s10545-008-0813-1; Tuschl K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11601; Tuschl K, 2012, AM J HUM GENET, V90, P457, DOI 10.1016/j.ajhg.2012.01.018; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; UNDERWOOD MJ, 1993, J VASC RES, V30, P239, DOI 10.1159/000158999; Verity MA, 1999, NEUROTOXICOLOGY, V20, P489; Vezer T, 2007, AM J IND MED, V50, P841, DOI 10.1002/ajim.20485; Vollet Kaitlin, 2016, Curr Environ Health Rep, V3, P392, DOI 10.1007/s40572-016-0108-x; WAGNER RR, 1971, BIOCHEM BIOPH RES CO, V45, P57, DOI 10.1016/0006-291X(71)90049-0; Wahlberg K, 2016, TOXICOL SCI, V149, P473, DOI 10.1093/toxsci/kfv252; Wahlberg KE, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00664; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Wasserman GA, 2006, ENVIRON HEALTH PERSP, V114, P124, DOI 10.1289/ehp.8030; Weathers JD, 2012, AM J PSYCHIAT, V169, P633, DOI 10.1176/appi.ajp.2012.11081244; Wedler F C, 1993, Prog Med Chem, V30, P89, DOI 10.1016/S0079-6468(08)70376-X; Williams M., 2013, TOXICOLOGICAL PROFIL; WONG PCL, 1981, J INORG BIOCHEM, V14, P253, DOI 10.1016/S0162-0134(00)80005-7; World Health Organization, 2011, GUID INT IR FOL AC S, P5; Xia ZD, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006892; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; YAMADA M, 1986, ACTA NEUROPATHOL, V70, P273, DOI 10.1007/BF00686083; Zaki MS, 2018, CLIN GENET, V93, P905, DOI 10.1111/cge.13184; Zhang DH, 2011, TOXICOL APPL PHARM, V254, P65, DOI 10.1016/j.taap.2010.03.023; Zheng W, 2011, NEUROTOXICOLOGY, V32, P1, DOI 10.1016/j.neuro.2010.10.002; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935; Zoni S, 2007, AM J IND MED, V50, P812, DOI 10.1002/ajim.20518; Zou YF, 2014, OCCUP ENVIRON MED, V71, P189, DOI 10.1136/oemed-2013-101896; Zwingmann C, 2003, J CEREBR BLOOD F MET, V23, P756, DOI 10.1097/01.WCB.0000056062.25434.4D	259	78	79	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6312	6329		10.1074/jbc.REV119.009453	http://dx.doi.org/10.1074/jbc.REV119.009453			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32188696	Green Published, hybrid			2022-12-28	WOS:000537685000007
J	Becker, AK; Auditore, A; Pischetsrieder, M; Messlinger, K; Fleming, T; Reeh, PW; Sauer, SK				Becker, Anna K.; Auditore, Andrea; Pischetsrieder, Monika; Messlinger, Karl; Fleming, Thomas; Reeh, Peter W.; Sauer, Susanne K.			Reactive dicarbonyl compounds cause Calcitonin Gene-Related Peptide release and synergize with inflammatory conditions in mouse skin and peritoneum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; inflammation; neuropeptide; pain; transient receptor potential channels (TRP channels); 3; 4-dideoxyglucosone-3-ene; 3-deoxyglucosone; glyoxal; methylglyoxal; uremia	GLUCOSE DEGRADATION-PRODUCTS; HYPERGLYCEMIC HYPOXIA; DIABETIC-NEUROPATHY; CAPSAICIN RECEPTOR; PROSTAGLANDIN E-2; SENSORY NEURONS; DIALYSIS FLUIDS; END-PRODUCTS; METHYLGLYOXAL; TRPA1	The plasmas of diabetic or uremic patients and of those receiving peritoneal dialysis treatment have increased levels of the glucose-derived dicarbonyl metabolites like methylglyoxal (MGO), glyoxal (GO), and 3-deoxyglucosone (3-DG). The elevated dicarbonyl levels can contribute to the development of painful neuropathies. Here, we used stimulated immunoreactive Calcitonin Gene?Related Peptide (iCGRP) release as a measure of nociceptor activation, and we found that each dicarbonyl metabolite induces a concentration-, TRPA1-, and Ca2+-dependent iCGRP release. MGO, GO, and 3-DG were about equally potent in the millimolar range. We hypothesized that another dicarbonyl, 3,4-dideoxyglucosone-3-ene (3,4-DGE), which is present in peritoneal dialysis (PD) solutions after heat sterilization, activates nociceptors. We also showed that at body temperatures 3,4-DGE is formed from 3-DG and that concentrations of 3,4-DGE in the micromolar range effectively induced iCGRP release from isolated murine skin. In a novel preparation of the isolated parietal peritoneum PD fluid or 3,4-DGE alone, at concentrations found in PD solutions, stimulated iCGRP release. We also tested whether inflammatory tissue conditions synergize with dicarbonyls to induce iCGRP release from isolated skin. Application of MGO together with bradykinin or prostaglandin E-2 resulted in an overadditive effect on iCGRP release, whereas MGO applied at a pH of 5.2 resulted in reduced release, probably due to an MGO-mediated inhibition of transient receptor potential (TRP) V1 receptors. These results indicate that several reactive dicarbonyls activate nociceptors and potentiate inflammatory mediators. Our findings underline the roles of dicarbonyls and TRPA1 receptors in causing pain during diabetes or renal disease.	[Becker, Anna K.; Messlinger, Karl; Reeh, Peter W.; Sauer, Susanne K.] Friedrich Alexander Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Univ Str 17, D-91054 Erlangen, Germany; [Auditore, Andrea; Pischetsrieder, Monika] Friedrich Alexander Univ Erlangen Nurnberg, Dept Chem & Pharm, Food Chem, Nikolaus Fiebiger Str 10, D-91058 Erlangen, Germany; [Fleming, Thomas] Heidelberg Univ, Dept Med & Clin Chem & Pharmacol 1, INF 410, D-69120 Heidelberg, Germany; [Fleming, Thomas] Eberhard Karls Univ Tuebingen, German Ctr Diabet Res DZD, Otfried Muller Str 10, D-72076 Tubingen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Sauer, SK (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, Univ Str 17, D-91054 Erlangen, Germany.	Susanne.sauer@fau.de	Reeh, Peter W./J-8981-2012	Reeh, Peter W./0000-0002-4367-094X; Sauer, Susanne Katharina/0000-0002-9734-885X	Deutsche Forschungsgemeinschaft [SA 2126/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft Grant SA 2126/2-1 (to S. K. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Andersen ST, 2018, DIABETES CARE, V41, P1068, DOI 10.2337/dc17-2062; Andersson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077986; Averbeck B, 2001, NEUROPHARMACOLOGY, V40, P416, DOI 10.1016/S0028-3908(00)00171-4; Babes A, 2010, METHODS MOL BIOL, V617, P237, DOI 10.1007/978-1-60327-323-7_19; BANGSBO J, 1993, J PHYSIOL-LONDON, V462, P115, DOI 10.1113/jphysiol.1993.sp019546; Barriere DA, 2012, PAIN, V153, P553, DOI 10.1016/j.pain.2011.11.019; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; BRETAG AH, 1969, LIFE SCI PT 1 PHYSI, V8, P319, DOI 10.1016/0024-3205(69)90283-5; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Ciobanu AC, 2016, J NEUROSCI RES, V94, P282, DOI 10.1002/jnr.23700; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Davison SN, 2014, SEMIN DIALYSIS, V27, P188, DOI 10.1111/sdi.12196; de la Roche J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36740; Distler L, 2014, CHEM RES TOXICOL, V27, P1421, DOI 10.1021/tx500153n; Dull MM, 2019, PAIN, V160, P2497, DOI 10.1097/j.pain.0000000000001644; Eberhardt MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13054-3; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Roa-Coria JE, 2019, BMC NEUROSCI, V20, DOI 10.1186/s12868-018-0483-3; Erixon M, 2008, PERITON DIALYSIS INT, V28, P277; Fischer MJM, 2014, PFLUG ARCH EUR J PHY, V466, P2229, DOI 10.1007/s00424-014-1497-z; Flasar MH, 2006, PRIMARY CARE, V33, P659, DOI 10.1016/j.pop.2006.06.004; Freshwater JD, 2002, DIABETES, V51, P2249, DOI 10.2337/diabetes.51.7.2249; Fuchs D, 2010, PAIN, V151, P496, DOI 10.1016/j.pain.2010.08.010; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; Gensberger S, 2012, ANAL BIOANAL CHEM, V403, P2923, DOI 10.1007/s00216-012-5817-x; Gensberger-Reigl S, 2019, CHEM RES TOXICOL, V32, P304, DOI 10.1021/acs.chemrestox.8b00320; GRAFE P, 1994, J PHYSIOL-LONDON, V480, P297, DOI 10.1113/jphysiol.1994.sp020360; Grafe Peter, 1998, P621; Griggs RB, 2019, NEUROBIOL DIS, V127, P76, DOI 10.1016/j.nbd.2019.02.019; Griggs RB, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00679; Hansen CS, 2015, DIABETIC MED, V32, P778, DOI 10.1111/dme.12753; Hiyama H, 2018, MOL PAIN, V14, DOI 10.1177/1744806918789812; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; Hu R, 2016, CURR MED CHEM, V23, P763, DOI 10.2174/0929867323666160210125416; Kalapos MP, 2013, DIABETES RES CLIN PR, V99, P260, DOI 10.1016/j.diabres.2012.11.003; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; KATO F, 1994, J AGR FOOD CHEM, V42, P2068, DOI 10.1021/jf00045a044; Kellogg AP, 2007, DIABETES, V56, P2997, DOI 10.2337/db07-0740; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Lapolla A, 2005, ANN NY ACAD SCI, V1043, P267, DOI 10.1196/annals.1333.032; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; LEVINE JD, 1993, J NEUROSCI, V13, P2273, DOI 10.1523/JNEUROSCI.13-06-02273.1993; Linden T, 2002, KIDNEY INT, V62, P697, DOI 10.1046/j.1523-1755.2002.00490.x; LUNDBERG JM, 1992, ANN NY ACAD SCI, V657, P187, DOI 10.1111/j.1749-6632.1992.tb22767.x; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; MCLELLAN AC, 1992, ANAL CHIM ACTA, V263, P137, DOI 10.1016/0003-2670(92)85435-9; Meents JE, 2019, J NEUROPHYSIOL, V121, P427, DOI 10.1152/jn.00524.2018; Mittelmaier S, 2011, ANAL CHEM, V83, P9660, DOI 10.1021/ac2025706; Mittelmaier S, 2011, ANAL BIOANAL CHEM, V401, P1183, DOI 10.1007/s00216-011-5195-9; Mittelmaier S, 2011, ANAL BIOANAL CHEM, V399, P1689, DOI 10.1007/s00216-010-4456-3; Nagaraj RH, 1996, ARCH BIOCHEM BIOPHYS, V325, P152, DOI 10.1006/abbi.1996.0019; Nam JS, 2014, KOREAN J PAIN, V27, P326, DOI 10.3344/kjp.2014.27.4.326; Niwa T, 2001, KIDNEY INT, V59, pS37, DOI 10.1046/j.1523-1755.2001.59780037.x; Niwa T, 1999, J CHROMATOGR B, V731, P23, DOI 10.1016/S0378-4347(99)00113-9; Ohkawara S, 2012, J TOXICOL SCI, V37, P831, DOI 10.2131/jts.37.831; Ortiz A, 2006, CURR MED CHEM, V13, P2695, DOI 10.2174/092986706778201576; Petho G, 2012, PHYSIOL REV, V92, P1699, DOI 10.1152/physrev.00048.2010; Pischetsrieder M, 2016, DRUG DISCOV TODAY, V21, P1620, DOI 10.1016/j.drudis.2016.06.011; Rabbani N, 2018, KIDNEY INT, V93, P803, DOI 10.1016/j.kint.2017.11.034; Riboulet-Chavey A, 2006, DIABETES, V55, P1289, DOI 10.2337/db05-0857; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Santoro Domenico, 2013, Clin Nephrol, V79 Suppl 1, pS2; Sauer SK, 1998, LIFE SCI, V62, P2045, DOI 10.1016/S0024-3205(98)00176-3; Scheijen JLJM, 2014, CLIN CHEM LAB MED, V52, P85, DOI 10.1515/cclm-2012-0878; SCHNEIDER U, 1993, J PHYSIOL-LONDON, V465, P679, DOI 10.1113/jphysiol.1993.sp019700; STRUPP M, 1991, AM J PHYSIOL, V261, pE389, DOI 10.1152/ajpendo.1991.261.3.E389; Suzawa S, 2016, BRAIN RES BULL, V125, P181, DOI 10.1016/j.brainresbull.2016.07.005; Talbot S, 2012, EXP NEUROL, V234, P373, DOI 10.1016/j.expneurol.2011.11.032; Talbot S, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-11; Tanaka K, 2002, ANAT EMBRYOL, V205, P307, DOI 10.1007/s00429-002-0254-9; Thornalley PJ, 2009, SEMIN DIALYSIS, V22, P400, DOI 10.1111/j.1525-139X.2009.00589.x; THORNALLEY PJ, 1988, BIOCHEM J, V254, P751, DOI 10.1042/bj2540751; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Trevisan G, 2013, EUR J PHARMACOL, V714, P332, DOI 10.1016/j.ejphar.2013.07.029; Vander Jagt David L., 2008, Drug Metabolism and Drug Interactions, V23, P93; Vistoli G, 2013, FREE RADICAL RES, V47, P3, DOI 10.3109/10715762.2013.815348; Wei H, 2009, ANESTHESIOLOGY, V111, P147, DOI 10.1097/ALN.0b013e3181a1642b; Weller K, 2011, NEUROPEPTIDES, V45, P391, DOI 10.1016/j.npep.2011.07.011; Weng HJ, 2015, NEURON, V85, P833, DOI 10.1016/j.neuron.2014.12.065; Zeier M, 2003, KIDNEY INT, V63, P298, DOI 10.1046/j.1523-1755.2003.00705.x; Ziegler D, 2008, DIABETES-METAB RES, V24, pS52, DOI 10.1002/dmrr.817; Zochodne DW, 1999, J NEUROL SCI, V166, P40, DOI 10.1016/S0022-510X(99)00111-2; Zuvela J, 2018, NEPHROLOGY, V23, P718, DOI 10.1111/nep.13243	87	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6330	6343		10.1074/jbc.RA120.012890	http://dx.doi.org/10.1074/jbc.RA120.012890			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32198181	Green Published, hybrid			2022-12-28	WOS:000537685000008
J	Anderson, AC; Burnett, AJN; Hiscock, L; Maly, KE; Weadge, JT				Anderson, Alexander C.; Burnett, Alysha J. N.; Hiscock, Lana; Maly, Kenneth E.; Weadge, Joel T.			The Escherichia coli cellulose synthase subunit G (BcsG) is a Zn2+-dependent phosphoethanolamine transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biofilm; enzyme mechanism; glycobiology; cellulose; structural biology; virulence factor; bacterial cellulose synthase subunit G (BcsG); phosphoethanolamine; phosphoryl transfer; polysaccharide; surface adhesion	BIOFILM FORMATION; POLYMYXIN RESISTANCE; BIOSYNTHESIS; PROTEIN; LIPOOLIGOSACCHARIDE; IDENTIFICATION; PRODUCTS; FORM	Bacterial biofilms are cellular communities that produce an adherent matrix. Exopolysaccharides are key structural components of this matrix and are required for the assembly and architecture of biofilms produced by a wide variety of microorganisms. The human bacterial pathogens Escherichia coli and Salmonella enterica produce a biofilm matrix composed primarily of the exopolysaccharide phosphoethanolamine (pEtN) cellulose. Once thought to be composed of only underivatized cellulose, the pEtN modification present in these matrices has been implicated in the overall architecture and integrity of the biofilm. However, an understanding of the mechanism underlying pEtN derivatization of the cellulose exopolysaccharide remains elusive. The bacterial cellulose synthase subunit G (BcsG) is a predicted inner membrane?localized metalloenzyme that has been proposed to catalyze the transfer of the pEtN group from membrane phospholipids to cellulose. Here we present evidence that the C-terminal domain of BcsG from E. coli (EcBcsG(?N)) functions as a phosphoethanolamine transferase in vitro with substrate preference for cellulosic materials. Structural characterization of EcBcsG(?N) revealed that it belongs to the alkaline phosphatase superfamily, contains a Zn2+ ion at its active center, and is structurally similar to characterized enzymes that confer colistin resistance in Gram-negative bacteria. Informed by our structural studies, we present a functional complementation experiment in E. coli AR3110, indicating that the activity of the BcsG C-terminal domain is essential for integrity of the pellicular biofilm. Furthermore, our results established a similar but distinct active-site architecture and catalytic mechanism shared between BcsG and the colistin resistance enzymes.	[Anderson, Alexander C.; Burnett, Alysha J. N.; Hiscock, Lana; Weadge, Joel T.] Wilfrid Laurier Univ, Dept Biol, 75 Univ Ave W, Waterloo, ON N2L 3C5, Canada; [Hiscock, Lana; Maly, Kenneth E.] Wilfrid Laurier Univ, Dept Chem & Biochem, Waterloo, ON N2L 3C5, Canada; [Anderson, Alexander C.] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada	Wilfrid Laurier University; Wilfrid Laurier University; University of Guelph	Weadge, JT (corresponding author), Wilfrid Laurier Univ, Dept Biol, 75 Univ Ave W, Waterloo, ON N2L 3C5, Canada.	jweadge@wlu.ca	Anderson, Alexander/AAJ-7110-2021	Anderson, Alexander C./0000-0002-1870-2903; Weadge, Joel/0000-0002-8020-0015	Natural Sciences and Engineering Research Council of Canada [418310]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant 418310 (to J. T. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adcox HE, 2016, INFECT IMMUN, V84, P3243, DOI 10.1128/IAI.00532-16; Aly MA, 2019, J FOOD PROTECT, V82, P65, DOI [10.4315/0362-028X.JFP-18-036, 10.4315/0362-028x.jfp-18-036]; Bontemps-Gallo S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/371429; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P188; Cullen TW, 2010, P NATL ACAD SCI USA, V107, P5160, DOI 10.1073/pnas.0913451107; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; DIMITRIJEVIC M, 1979, H-S Z PHYSIOL CHEM, V360, P477, DOI 10.1515/bchm2.1979.360.1.477; Fage CD, 2014, ACTA CRYSTALLOGR D, V70, P2730, DOI 10.1107/S1399004714017623; Fang X, 2014, MOL MICROBIOL, V93, P439, DOI 10.1111/mmi.12672; Harper M, 2017, INFECT IMMUN, V85, DOI [10.1128/iai.00557-17, 10.1128/IAI.00557-17]; Hinchliffe P, 2017, SCI REP-UK, V7, DOI 10.1038/srep39392; Hollenbeck EC, 2018, P NATL ACAD SCI USA, V115, P10106, DOI 10.1073/pnas.1801564115; Keiski CL, 2010, STRUCTURE, V18, P265, DOI 10.1016/j.str.2009.11.015; Krasteva PV, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01523-2; Maeda K, 2018, MOL MICROBIOL, V109, P121, DOI 10.1111/mmi.13977; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Mazur O, 2011, J BIOL CHEM, V286, P17601, DOI 10.1074/jbc.M111.227660; Morgan JLW, 2016, NATURE, V531, P329, DOI 10.1038/nature16966; Morgan JLW, 2014, NAT STRUCT MOL BIOL, V21, P489, DOI 10.1038/nsmb.2803; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Omadjela O, 2013, P NATL ACAD SCI USA, V110, P17856, DOI 10.1073/pnas.1314063110; Romling U, 2015, TRENDS MICROBIOL, V23, P545, DOI 10.1016/j.tim.2015.05.005; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; SAXENA IM, 1995, J BACTERIOL, V177, P5276, DOI 10.1128/jb.177.18.5276-5283.1995; Scott NE, 2012, J BIOL CHEM, V287, P29384, DOI 10.1074/jbc.M112.380212; Singh N, 2017, VIRULENCE, V8, P275, DOI 10.1080/21505594.2016.1226713; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Stogios PJ, 2018, ACS CHEM BIOL, V13, P1322, DOI 10.1021/acschembio.8b00116; Sun L, 2018, J MOL BIOL, V430, P3170, DOI 10.1016/j.jmb.2018.07.008; Tan JQ, 2014, ACTA CRYSTALLOGR D, V70, P2054, DOI 10.1107/S1399004714001850; Thongsomboon W, 2018, SCIENCE, V359, P334, DOI 10.1126/science.aao4096; Wanty C, 2013, J MOL BIOL, V425, P3389, DOI 10.1016/j.jmb.2013.06.029; Whitfield GB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00471; Whitney JC, 2013, TRENDS MICROBIOL, V21, P63, DOI 10.1016/j.tim.2012.10.001; Wolfram F, 2012, ACTA CRYSTALLOGR F, V68, P584, DOI 10.1107/S1744309112012808; Zhao YQ, 2019, FEBS J, V286, P750, DOI 10.1111/febs.14719; Zheng HP, 2014, NAT PROTOC, V9, P156, DOI 10.1038/nprot.2013.172	39	10	10	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6225	6235		10.1074/jbc.RA119.011668	http://dx.doi.org/10.1074/jbc.RA119.011668			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32152228	hybrid, Green Published			2022-12-28	WOS:000531417300030
J	Tan, HF; Tan, SM				Tan, Hui-Foon; Tan, Suet-Mien			The focal adhesion protein kindlin-2 controls mitotic spindle assembly by inhibiting histone deacetylase 6 and maintaining ?-tubulin acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; kindlin; integrin; cell signaling; signal transduction; alpha-tubulin; cytoskeleton; histone deacetylase 6 (HDAC6); hypoxia; microtubule	PLECKSTRIN HOMOLOGY DOMAIN; STRUCTURAL BASIS; ALPHA-TUBULIN; CANCER-CELLS; 3D CULTURE; MICROTUBULES; ACTIVATION; EXPRESSION; BINDING; RESISTANCE	Kindlins are focal adhesion proteins that regulate integrin activation and outside-in signaling. The kindlin family consists of three members, kindlin-1, -2, and -3. Kindlin-2 is widely expressed in multiple cell types, except those from the hematopoietic lineage. A previous study has reported that the Drosophila Fit1 protein (an ortholog of kindlin-2) prevents abnormal spindle assembly; however, the mechanism remains unknown. Here, we show that kindlin-2 maintains spindle integrity in mitotic human cells. The human neuroblastoma SH-SY5Y cell line expresses only kindlin-2, and we found that when SH-SY5Y cells are depleted of kindlin-2, they exhibit pronounced spindle abnormalities and delayed mitosis. Of note, acetylation of ?-tubulin, which maintains microtubule flexibility and stability, was diminished in the kindlin-2?depleted cells. Mechanistically, we found that kindlin-2 maintains ?-tubulin acetylation by inhibiting the microtubule-associated deacetylase histone deacetylase 6 (HDAC6) via a signaling pathway involving AKT Ser/Thr kinase (AKT)/glycogen synthase kinase 3? (GSK3?) or paxillin. We also provide evidence that prolonged hypoxia down-regulates kindlin-2 expression, leading to spindle abnormalities not only in the SH-SY5Y cell line, but also cell lines derived from colon and breast tissues. The findings of our study highlight that kindlin-2 regulates mitotic spindle assembly and that this process is perturbed in cancer cells in a hypoxic environment.	[Tan, Hui-Foon; Tan, Suet-Mien] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, SM (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	smtan@ntu.edu.sg		Tan, Suet-Mien/0000-0003-2371-8739	Nanyang Technological University, Singapore [M4081320]; Ministry of Education, Singapore [MOE2016-T2-1-021]; National Research Foundation Singapore [MOH-000218]; Singapore Ministry of Health's National Medical Research Council	Nanyang Technological University, Singapore(Nanyang Technological University); Ministry of Education, Singapore(Ministry of Education, Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	This work was supported by Nanyang Technological University, Singapore, Grant M4081320 and Ministry of Education, Singapore, Grant MOE2016-T2-1-021. This research was also supported in part by the National Research Foundation Singapore under Open Fund -Individual Research Grant MOH-000218 (to S.-M. T.) and administered by the Singapore Ministry of Health's National Medical Research Council. The authors declare that they have no conflicts of interest with the contents of this article.	Bouaouina M, 2012, J BIOL CHEM, V287, P6979, DOI 10.1074/jbc.M111.330845; Boyault C, 2007, ONCOGENE, V26, P5468, DOI 10.1038/sj.onc.1210614; Brahme NN, 2013, J BIOL CHEM, V288, P35604, DOI 10.1074/jbc.M113.483016; Buttrick GJ, 2008, CELL CYCLE, V7, P2621, DOI 10.4161/cc.7.17.6514; Chen SG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010848; CHU DTW, 1989, DEV BIOL, V136, P104, DOI 10.1016/0012-1606(89)90134-6; Chua GL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153501; Dai W, 2002, ONCOGENE, V21, P6195, DOI 10.1038/sj.onc.1205710; Das M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026355; Deakin NO, 2014, J CELL BIOL, V206, P395, DOI 10.1083/jcb.201403039; Dix CL, 2018, DEV CELL, V45, P132, DOI 10.1016/j.devcel.2018.03.009; Dowling JJ, 2008, CIRC RES, V102, P423, DOI 10.1161/CIRCRESAHA.107.161489; Estiu G, 2008, J MED CHEM, V51, P2898, DOI 10.1021/jm7015254; Feng C, 2012, J BIOL CHEM, V287, P10714, DOI 10.1074/jbc.M111.299594; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Guo BH, 2015, CANCER LETT, V361, P271, DOI 10.1016/j.canlet.2015.03.011; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hart R, 2013, J BIOL CHEM, V288, P14852, DOI 10.1074/jbc.M112.434621; Hideshima T, 2016, P NATL ACAD SCI USA, V113, P13162, DOI 10.1073/pnas.1608067113; Kammerer P, 2017, P NATL ACAD SCI USA, V114, P9234, DOI 10.1073/pnas.1712471114; Karakose E, 2010, J CELL SCI, V123, P2353, DOI 10.1242/jcs.064600; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kozikowski AP, 2003, J AM CHEM SOC, V125, P1144, DOI 10.1021/ja0285159; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Li HD, 2017, P NATL ACAD SCI USA, V114, P9349, DOI 10.1073/pnas.1703064114; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Liu JM, 2015, NAT STRUCT MOL BIOL, V22, P383, DOI 10.1038/nsmb.2999; Liu JM, 2011, J BIOL CHEM, V286, P43334, DOI 10.1074/jbc.M111.295352; Lock MC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122628; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Moser SC, 2013, DEV CELL, V26, P381, DOI 10.1016/j.devcel.2013.06.014; Muz B, 2015, HYPOXIA, V3, P83, DOI 10.2147/HP.S93413; Nagai T, 2013, J CELL SCI, V126, P4369, DOI 10.1242/jcs.127209; Ou YW, 2016, ONCOTARGET, V7, P74872, DOI 10.18632/oncotarget.12439; Pandey R, 2007, J CELL SCI, V120, P2807, DOI 10.1242/jcs.007690; Patel H, 2016, J MOL CELL BIOL, V8, P338, DOI 10.1093/jmcb/mjw009; Patel H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3056; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Perera HD, 2011, STRUCTURE, V19, P1664, DOI 10.1016/j.str.2011.08.012; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Pluskota E, 2013, BLOOD, V122, P2491, DOI 10.1182/blood-2013-04-497669; Pluskota E, 2011, BLOOD, V117, P4978, DOI 10.1182/blood-2010-11-321182; Portran D, 2017, NAT CELL BIOL, V19, P391, DOI 10.1038/ncb3481; Qu H, 2011, J CELL SCI, V124, P879, DOI 10.1242/jcs.076976; Qu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18491; Reverte CG, 2006, J CELL BIOL, V174, P491, DOI 10.1083/jcb.200603069; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Riedl A, 2017, J CELL SCI, V130, P203, DOI 10.1242/jcs.188102; SCHATTEN G, 1988, DEV BIOL, V130, P74, DOI 10.1016/0012-1606(88)90415-0; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Sossey-Alaoui K, 2016, MOL CANCER RES, V14, P228, DOI 10.1158/1541-7786.MCR-15-0299; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Takagi A, 2007, ANTICANCER RES, V27, P45; Theodosiou M, 2016, ELIFE, V5, DOI 10.7554/eLife.10130; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Vordermark D, 2001, NEOPLASIA, V3, P527, DOI 10.1038/sj.neo.7900192; Wei XF, 2014, AM J PHYSIOL-RENAL, V306, pF271, DOI 10.1152/ajprenal.00499.2013; Wu CY, 2016, MOL CELL BIOL, V36, P1555, DOI 10.1128/MCB.00004-16; Xu ZJ, 2017, SCIENCE, V356, P328, DOI 10.1126/science.aai8764; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050; Yu Y, 2012, EMBO REP, V13, P750, DOI 10.1038/embor.2012.88	70	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5928	5943		10.1074/jbc.RA120.012954	http://dx.doi.org/10.1074/jbc.RA120.012954			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32169902	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000531417300008
J	Verma, N; Perie, L; Mueller, E				Verma, Narendra; Perie, Luce; Mueller, Elisabetta			The mRNA levels of heat shock factor 1 are regulated by thermogenic signals via the cAMP-dependent transcription factor ATF3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat shock factor protein 1 (HSF1); gene regulation; obesity; lipid metabolism; uncoupling protein; uncoupling protein 1 (UCP1); activating transcription factor 3 (ATF3); beta-adrenergic stimuli; brown fat; beige fat; thermogenesis	ACTIVATED PROTEIN-KINASE; BEIGE FAT; BROWN; OBESITY; WHITE; DYSFUNCTION; ROLES; CELLS	Heat shock factor 1 (HSF1) regulates cellular adaptation to challenges such as heat shock and oxidative and proteotoxic stresses. We have recently reported a previously unappreciated role for HSF1 in the regulation of energy metabolism in fat tissues; however, whether HSF1 is differentially expressed in adipose depots and how its levels are regulated in fat tissues remain unclear. Here, we show that HSF1 levels are higher in brown and subcutaneous fat tissues than in those in the visceral depot and that HSF1 is more abundant in differentiated, thermogenic adipocytes. Gene expression experiments indicated that HSF1 is transcriptionally regulated in fat by agents that modulate cAMP levels, by cold exposure, and by pharmacological stimulation of ?-adrenergic signaling. An in silico promoter analysis helped identify a putative response element for activating transcription factor 3 (ATF3) at ?258 to ?250 base pairs from the HSF1 transcriptional start site, and electrophoretic mobility shift and ChIP assays confirmed ATF3 binding to this sequence. Furthermore, functional assays disclosed that ATF3 is necessary and sufficient for HSF1 regulation. Detailed gene expression analysis revealed that ATF3 is one of the most highly induced ATFs in thermogenic tissues of mice exposed to cold temperatures or treated with the ?-adrenergic receptor agonist CL316,243 and that its expression is induced by modulators of cAMP levels in isolated adipocytes. To the best of our knowledge, our results show for the first time that HSF1 is transcriptionally controlled by ATF3 in response to classic stimuli that promote heat generation in thermogenic tissues.	[Verma, Narendra; Perie, Luce; Mueller, Elisabetta] NYU, Dept Med, Div Endocrinol Diabet & Metab, New Sci Bldg,Rm 612,435 E 30th St, New York, NY 10016 USA	New York University	Mueller, E (corresponding author), NYU, Dept Med, Div Endocrinol Diabet & Metab, New Sci Bldg,Rm 612,435 E 30th St, New York, NY 10016 USA.	Elisabetta.Mueller@nyumc.org		mueller, elisabetta/0000-0003-2533-2266	New York University	New York University	This work was supported by start-up funds from New York University (to E. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Allen-Jennings AE, 2001, J BIOL CHEM, V276, P29507, DOI 10.1074/jbc.M100986200; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Chen HY, 2013, PPAR RES, V2013, DOI 10.1155/2013/476049; Cheng CF, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0624-y; Dempersmier J, 2015, MOL CELL, V57, P235, DOI 10.1016/j.molcel.2014.12.005; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Jadhav Kavita, 2017, Liver Res, V1, P96, DOI 10.1016/j.livres.2017.08.001; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kim HB, 2010, BIOCHEM BIOPH RES CO, V391, P634, DOI 10.1016/j.bbrc.2009.11.111; Kim S, 2018, BIOCHEM BIOPH RES CO, V504, P903, DOI 10.1016/j.bbrc.2018.09.048; Ma XR, 2015, CELL METAB, V22, P695, DOI 10.1016/j.cmet.2015.08.005; Mottillo EP, 2011, AM J PHYSIOL-ENDOC M, V301, pE122, DOI 10.1152/ajpendo.00039.2011; Mueller E, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00019; Okamoto A, 2006, MOL CELL BIOL, V26, P1087, DOI 10.1128/MCB.26.3.1087-1097.2006; Perie L, 2019, J ENDOCR SOC, V3, P2326, DOI 10.1210/js.2019-00238; Saydah S, 2014, OBESITY, V22, P1888, DOI 10.1002/oby.20761; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Zhao J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2664-8	24	10	10	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5984	5994		10.1074/jbc.RA119.012072	http://dx.doi.org/10.1074/jbc.RA119.012072			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32184357	Green Published, hybrid			2022-12-28	WOS:000531417300012
J	Agwa, AJ; Tran, P; Mueller, A; Tran, HNT; Deuis, JR; Israel, MR; McMahon, KL; Craik, DJ; Vetter, I; Schroeder, CI				Agwa, Akello J.; Tran, Poanna; Mueller, Alexander; Tran, Hue N. T.; Deuis, Jennifer R.; Israel, Mathilde R.; McMahon, Kirsten L.; Craik, David J.; Vetter, Irina; Schroeder, Christina I.			Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pain; toxin; drug design; ion channel; electrophysiology; peptide interaction; disulfide-rich peptides; peptide?lipid membrane; regioselective oxidation; tri-molecular complex	HUWENTOXIN-IV; MEMBRANE-BINDING; DOMAIN-II; PROTX-II; NA(V)1.7; INHIBITION; SENSOR; VENOM; MUTATIONS; ANTAGONIST	Huwentoxin-IV (HwTx-IV) is a gating modifier peptide toxin from spiders that has weak affinity for the lipid bilayer. As some gating modifier toxins have affinity for model lipid bilayers, a tripartite relationship among gating modifier toxins, voltage-gated ion channels, and the lipid membrane surrounding the channels has been proposed. We previously designed an HwTx-IV analogue (gHwTx-IV) with reduced negative charge and increased hydrophobic surface profile, which displays increased lipid bilayer affinity and in vitro activity at the voltage-gated sodium channel subtype 1.7 (Na(V)1.7), a channel targeted in pain management. Here, we show that replacements of the positively-charged residues that contribute to the activity of the peptide can improve gHwTx-IV's potency and selectivity for Na(V)1.7. Using HwTx-IV, gHwTx-IV, [R26A]gHwTx-IV, [K27A]gHwTx-IV, and [R29A]gHwTx-IV variants, we examined their potency and selectivity at human Na(V)1.7 and their affinity for the lipid bilayer. [R26A]gHwTx-IV consistently displayed the most improved potency and selectivity for Na(V)1.7, examined alongside off-target Na(V)s, compared with HwTx-IV and gHwTx-IV. The lipid affinity of each of the three novel analogues was weaker than that of gHwTx-IV, but stronger than that of HwTx-IV, suggesting a possible relationship between in vitro potency at Na(V)1.7 and affinity for lipid bilayers. In a murine Na(V)1.7 engagement model, [R26A]gHwTx-IV exhibited an efficacy comparable with that of native HwTx-IV. In summary, this study reports the development of an HwTx-IV analogue with improved in vitro selectivity for the pain target Na(V)1.7 and with an in vivo efficacy similar to that of native HwTx-IV.	[Agwa, Akello J.; Tran, Poanna; Mueller, Alexander; Tran, Hue N. T.; Deuis, Jennifer R.; Israel, Mathilde R.; McMahon, Kirsten L.; Craik, David J.; Vetter, Irina; Schroeder, Christina I.] Univ Queensland, Inst Mol Biosci, Ctr Pain Res, Brisbane, Qld 4072, Australia; [Vetter, Irina] Univ Queensland, Sch Pharm, Woolloongabba, Qld 4103, Australia; [Schroeder, Christina I.] NCI, NIH, Frederick, MD 21702 USA; [Agwa, Akello J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Queensland; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bath	Schroeder, CI (corresponding author), Univ Queensland, Inst Mol Biosci, Ctr Pain Res, Brisbane, Qld 4072, Australia.; Schroeder, CI (corresponding author), NCI, NIH, Frederick, MD 21702 USA.	christina.schroeder@nih.gov	Tran, Hue/AAV-4760-2020; Craik, David/B-1695-2010; Mueller, Alexander/C-5995-2017; Vetter, Irina/A-6035-2010; Agwa, Akello/C-7999-2017; Schroeder, Christina/K-2042-2014; McMahon, Kirsten/M-8735-2017; Deuis, Jennifer/R-2440-2017; Israel, Mathilde/D-6675-2017	Tran, Hue/0000-0001-5181-1899; Craik, David/0000-0003-0007-6796; Mueller, Alexander/0000-0002-7447-1310; Vetter, Irina/0000-0002-3594-9588; Agwa, Akello/0000-0001-9295-5071; Schroeder, Christina/0000-0002-6737-6374; McMahon, Kirsten/0000-0001-8254-0235; Deuis, Jennifer/0000-0002-5107-8938; Israel, Mathilde/0000-0002-3760-6036	Australian National Health and Medical Research Council (NMHRC) [APP1080405]; ARC [FT160100055]; Australian Research Council [FL150100146]; NHMRC Early Career Fellowship [APP1139961]; University of Queensland International Research Scholarships; Australian Government Research Training Program Scholarships; NHMRC Career Development Fellowship [APP1162503]	Australian National Health and Medical Research Council (NMHRC)(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); Australian Research Council(Australian Research Council); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland International Research Scholarships; Australian Government Research Training Program Scholarships(Australian Government); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian National Health and Medical Research Council (NMHRC) Project Grant APP1080405 (to C. I. S.), Australian Research Council Future Fellow supported by ARC Grant FT160100055, ARC Australian Laureate Fellow supported by Australian Research Council Grant FL150100146, NHMRC Early Career Fellowship Grant APP1139961 (to J. R. D.), University of Queensland International Research Scholarships (to A. J. A., P. T., and H. N. T. T.), Australian Government Research Training Program Scholarships (to K. L. M., A. M., and M. R. I.), and by NHMRC Career Development Fellowship APP1162503 (to I. V.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agwa AJ, 2018, J BIOL CHEM, V293, P9041, DOI 10.1074/jbc.RA118.002553; Agwa AJ, 2017, NEUROPHARMACOLOGY, V127, P32, DOI 10.1016/j.neuropharm.2017.04.004; Agwa AJ, 2017, TOXINS, V9, DOI 10.3390/toxins9080248; Agwa AJ, 2017, BBA-BIOMEMBRANES, V1859, P835, DOI 10.1016/j.bbamem.2017.01.020; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Blesneac I, 2018, PAIN, V159, P469, DOI 10.1097/j.pain.0000000000001116; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Cai TF, 2015, PEPTIDES, V68, P148, DOI 10.1016/j.peptides.2014.09.005; Cardoso FC, 2017, BRIT J PHARMACOL, V174, P2528, DOI 10.1111/bph.13865; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chattopadhyay M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-17; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Deng MC, 2013, TOXICON, V71, P57, DOI 10.1016/j.toxicon.2013.05.015; Deplazes E, 2016, BBA-BIOMEMBRANES, V1858, P872, DOI 10.1016/j.bbamem.2016.02.002; Deuis JR, 2017, SCI REP-UK, V7, DOI 10.1038/srep40883; Deuis JR, 2016, TOXINS, V8, DOI 10.3390/toxins8030078; Deuis JR, 2016, J BIOL CHEM, V291, P11829, DOI 10.1074/jbc.M116.721662; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Durek T, 2013, ACS CHEM BIOL, V8, P1215, DOI 10.1021/cb400012k; Elia N, 2019, NEUROLOGY, V92, pE1405, DOI 10.1212/WNL.0000000000007185; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Faber CG, 2012, P NATL ACAD SCI USA, V109, P19444, DOI 10.1073/pnas.1216080109; Fischer TZ, 2009, ANN NEUROL, V65, P733, DOI 10.1002/ana.21678; Flinspach M, 2017, SCI REP-UK, V7, DOI 10.1038/srep39662; Goncalves TC, 2018, NEUROPHARMACOLOGY, V133, P404, DOI 10.1016/j.neuropharm.2018.02.016; Habbout K, 2016, NEUROLOGY, V86, P161, DOI 10.1212/WNL.0000000000002264; Han CY, 2018, MOL PHARMACOL, V94, P1256, DOI 10.1124/mol.118.113076; Henriques ST, 2017, ACS CHEM BIOL, V12, P2324, DOI 10.1021/acschembio.7b00459; Henriques ST, 2016, J BIOL CHEM, V291, P17049, DOI 10.1074/jbc.M116.729095; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Hockley JRF, 2014, PAIN, V155, P1962, DOI 10.1016/j.pain.2014.06.015; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; King GF, 2002, J TOXICOL-TOXIN REV, V21, P359, DOI 10.1081/TXR-120014409; Krafte DS, 2008, CURR OPIN PHARMACOL, V8, P50, DOI 10.1016/j.coph.2007.09.007; Lau CHY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34333; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li H, 2019, J BIOL CHEM, V294, P11892, DOI 10.1074/jbc.RA118.005511; Lin ZX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161450; Liu ZH, 2013, J BIOL CHEM, V288, P20392, DOI 10.1074/jbc.M112.426627; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; Mihailescu M, 2014, P NATL ACAD SCI USA, V111, pE5463, DOI 10.1073/pnas.1415324111; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Minassian NA, 2013, J BIOL CHEM, V288, P22707, DOI 10.1074/jbc.M113.461392; Moyer BD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196791; Mueller A, 2020, ACS PHARMACOL TRANSL, V3, P535, DOI 10.1021/acsptsci.0c00002; Mueller A, 2019, PAIN, V160, P1766, DOI 10.1097/j.pain.0000000000001567; Murray JK, 2015, J MED CHEM, V58, P2299, DOI 10.1021/jm501765v; Neff RA, 2020, J BIOL CHEM, V295, P1315, DOI 10.1074/jbc.RA119.011318; Nishizawa K, 2015, BBA-BIOMEMBRANES, V1848, P2767, DOI 10.1016/j.bbamem.2015.09.003; Okuse K, 1997, MOL CELL NEUROSCI, V10, P196, DOI 10.1006/mcne.1997.0657; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Rahnama S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173551; Remme CA, 2010, CARDIOVASC THER, V28, P287, DOI 10.1111/j.1755-5922.2010.00210.x; Revell JD, 2013, PEPTIDES, V44, P40, DOI 10.1016/j.peptides.2013.03.011; Ruiz MD, 2015, J MED CHEM, V58, P7093, DOI 10.1021/jm501981g; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Sugawara T, 2002, NEUROLOGY, V58, P1122, DOI 10.1212/WNL.58.7.1122; Tzakoniati F, 2020, CELL CHEM BIOL, V27, P306, DOI 10.1016/j.chembiol.2019.10.011; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Vetter I, 2017, PHARMACOL THERAPEUT, V172, P73, DOI 10.1016/j.pharmthera.2016.11.015; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Xu H, 2019, CELL, V176, P702, DOI 10.1016/j.cell.2018.12.018; Zhang AH, 2018, NEUROSCI LETT, V679, P35, DOI 10.1016/j.neulet.2018.04.030	74	10	10	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5067	5080		10.1074/jbc.RA119.012281	http://dx.doi.org/10.1074/jbc.RA119.012281			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32139508	Green Published, hybrid			2022-12-28	WOS:000526887000027
J	Inoue, M; Tsuji, Y; Yoshimine, C; Enomoto, S; Morita, Y; Osaki, N; Kunishige, M; Miki, M; Amano, S; Yamashita, K; Kamada, H; Tsutsumi, Y; Tsunoda, S				Inoue, Masaki; Tsuji, Yuta; Yoshimine, Chinatsu; Enomoto, Shota; Morita, Yuki; Osaki, Natsuki; Kunishige, Masahiro; Miki, Midori; Amano, Shota; Yamashita, Kanako; Kamada, Haruhiko; Tsutsumi, Yasuo; Tsunoda, Shin-ichi			Structural optimization of a TNFR1-selective antagonistic TNF alpha mutant to create new-modality TNF-regulating biologics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); cytokine; autoimmune disease; arthritis; inflammation; inhibition mechanism; protein engineering; drug design; drug delivery; forkhead box P3 (FOXP3); antagonist; single-chain	TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; T-CELLS; RECEPTOR; INFLIXIMAB; ANTIBODY; METHOTREXATE; ETANERCEPT; EXPRESSION; ADALIMUMAB	Excessive activation of the proinflammatory cytokine tumor necrosis factor-alpha (TNF alpha) is a major cause of autoimmune diseases, including rheumatoid arthritis. TNF alpha induces immune responses via TNF receptor 1 (TNFR1) and TNFR2. Signaling via TNFR1 induces proinflammatory responses, whereas TNFR2 signaling is suggested to suppress the pathophysiology of inflammatory diseases. Therefore, selective inhibition of TNFR1 signaling and preservation of TNFR2 signaling activities may be beneficial for managing autoimmune diseases. To this end, we developed a TNFR1-selective, antagonistic TNF alpha mutant (R1antTNF). Here, we developed an R1antTNF derivative, scR1antTNF-Fc, which represents a single-chain form of trimeric R1antTNF with a human IgG-Fc domain. scR1antTNF-Fc had properties similar to those of R1antTNF, including TNFR1-selective binding avidity, TNFR1 antagonistic activity, and thermal stability, and had a significantly extended plasma t(1/2) in vivo. In a murine rheumatoid arthritis model, scR1antTNF-Fc and 40-kDa PEG-scR1antTNF (a previously reported PEGylated form) delayed the onset of collagen-induced arthritis, suppressed arthritis progression in mice, and required a reduced frequency of administration. Interestingly, with these biologic treatments, we observed an increased ratio of regulatory T cells to conventional T cells in lymph nodes compared with etanercept, a commonly used TNF inhibitor. Therefore, scR1antTNF-Fc and 40-kDa PEG-scR1antTNF indirectly induced immunosuppression. These results suggest that selective TNFR1 inhibition benefits the management of autoimmune diseases and that R1antTNF derivatives hold promise as new-modality TNF-regulating biologics.	[Inoue, Masaki; Tsuji, Yuta; Yoshimine, Chinatsu; Enomoto, Shota; Morita, Yuki; Osaki, Natsuki; Kunishige, Masahiro; Miki, Midori; Amano, Shota; Yamashita, Kanako; Tsunoda, Shin-ichi] Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Cellular & Mol Physiol, Chuo Ku, Kobe, Hyogo, Japan; [Inoue, Masaki; Kamada, Haruhiko; Tsunoda, Shin-ichi] Natl Inst Biomed Innovat Hlth & Nutr, Lab Biopharmaceut Res, Ibaraki, Osaka, Japan; [Inoue, Masaki; Kamada, Haruhiko; Tsunoda, Shin-ichi] Natl Inst Biomed Innovat Hlth & Nutr, Ctr Drug Design Res, Ibaraki, Osaka, Japan; [Kamada, Haruhiko; Tsutsumi, Yasuo; Tsunoda, Shin-ichi] Osaka Univ, Global Ctr Med Engn & Informat, Suita, Osaka, Japan; [Tsutsumi, Yasuo] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Toxicol & Safety Sci, Suita, Osaka, Japan	Kobe Gakuin University; Osaka University; Osaka University	Tsunoda, S (corresponding author), Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Cellular & Mol Physiol, Chuo Ku, Kobe, Hyogo, Japan.; Tsunoda, S (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Biopharmaceut Res, Ibaraki, Osaka, Japan.; Tsunoda, S (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Ctr Drug Design Res, Ibaraki, Osaka, Japan.; Tsunoda, S (corresponding author), Osaka Univ, Global Ctr Med Engn & Informat, Suita, Osaka, Japan.	tsunoda@pharm.kobegakuin.ac.jp			JSPS KAKENHI [JP18K14877, JP18H02699, JP18K19567]; Takeda Science Foundation; Mochida Memorial Foundation forMedical and Pharmaceutical Research	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation forMedical and Pharmaceutical Research	This work was supported by JSPS KAKENHI Grants JP18K14877, JP18H02699, and JP18K19567, and the Takeda Science Foundation and Mochida Memorial Foundation forMedical and Pharmaceutical Research.	Abe Y, 2008, J IMMUNOL METHODS, V335, P71, DOI 10.1016/j.jim.2008.02.019; Biton J, 2011, J IMMUNOL, V186, P3899, DOI 10.4049/jimmunol.1003372; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chen X, 2010, CURR DIR AUTOIMMUN, V11, P119, DOI 10.1159/000289201; Dalton AC, 2014, PROTEIN SCI, V23, P517, DOI 10.1002/pro.2439; Dong Y, 2016, P NATL ACAD SCI USA, V113, P12304, DOI 10.1073/pnas.1605195113; Fischer R, 2015, ANTIBODIES, V4, P48, DOI 10.3390/antib4010048; Goel N, 2010, MABS-AUSTIN, V2, P137, DOI 10.4161/mabs.2.2.11271; Gottenberg JE, 2016, JAMA-J AM MED ASSOC, V316, P1172, DOI 10.1001/jama.2016.13512; Inoue M, 2017, J BIOL CHEM, V292, P6438, DOI 10.1074/jbc.M117.779686; Kafrouni MI, 2003, J LEUKOCYTE BIOL, V74, P564, DOI 10.1189/jlb.0103035; Kasagi S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008895; Keystone EC, 2009, ANN RHEUM DIS, V68, P789, DOI 10.1136/ard.2008.099010; Kodama S, 2005, CELL MOL LIFE SCI, V62, P1850, DOI 10.1007/s00018-005-5022-6; La Paglia GMC, 2017, CLIN EXP RHEUMATOL, V35, P551; Laas K, 2008, CLIN RHEUMATOL, V27, P927, DOI 10.1007/s10067-008-0880-6; Larsson E, 2004, RHEUMATOLOGY, V43, P428, DOI 10.1093/rheumatology/keh073; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Moreland LW, 1997, NEW ENGL J MED, V337, P141, DOI 10.1056/NEJM199707173370301; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nomura T, 2011, J CONTROL RELEASE, V149, P8, DOI 10.1016/j.jconrel.2009.12.015; Orti-Casan N, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00049; Pegoretti V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00925; Petrovic-Rackov L, 2006, CLIN RHEUMATOL, V25, P448, DOI 10.1007/s10067-005-0106-0; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200; Shibata H, 2009, BIOMATERIALS, V30, P6638, DOI 10.1016/j.biomaterials.2009.08.041; Smolen JS, 2016, LANCET, V388, P1984; Smolen JS, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.1; Tarcha EJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180762; van der Bijl AE, 2008, CLIN RHEUMATOL, V27, P1021, DOI 10.1007/s10067-008-0866-4; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Wang HL, 2008, J CLIN INVEST, V118, P2629, DOI 10.1172/JCI34916; Wiens A, 2010, RHEUMATOL INT, V30, P1063, DOI 10.1007/s00296-009-1111-4; Williams SK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31957-7; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yamamoto Y, 2003, NAT BIOTECHNOL, V21, P546, DOI 10.1038/nbt812; Yi H, 2014, MOL MED REP, V9, P2301, DOI 10.3892/mmr.2014.2127	44	2	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9379	9391		10.1074/jbc.RA120.012723	http://dx.doi.org/10.1074/jbc.RA120.012723			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32398258	Green Published, hybrid			2022-12-28	WOS:000552758600010
J	Osterlund, N; Lundqvist, M; Ilag, LL; Graslund, A; Emanuelsson, C				Osterlund, Nicklas; Lundqvist, Martin; Ilag, Leopold L.; Graslund, Astrid; Emanuelsson, Cecilia			Amyloid-? oligomers are captured by the DNAJB6 chaperone: Direct detection of interactions that can prevent primary nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (A?); Alzheimer disease; chaperone DnaJ (DnaJ); protein aggregation; proteostasis; native mass spectrometry; peptide; protein aggregation; primary nucleation	ELECTROSPRAY-IONIZATION; ALZHEIMERS-DISEASE; BETA OLIGOMERS; AGGREGATION; PEPTIDE; HAIRPIN; BINDING; TRANSTHYRETIN; STABILIZATION; PATHOGENESIS	A human molecular chaperone protein, DnaJ heat shock protein family (Hsp40) member B6 (DNAJB6), efficiently inhibits amyloid aggregation. This inhibition depends on a unique motif with conserved serine and threonine (S/T) residues that have a high capacity for hydrogen bonding. Global analysis of kinetics data has previously shown that DNAJB6 especially inhibits the primary nucleation pathways. These observations indicated that DNAJB6 achieves this remarkably effective and sub-stoichiometric inhibition by interacting not with the monomeric unfolded conformations of the amyloid-? symbol (A?) peptide but with aggregated species. However, these pre-nucleation oligomeric aggregates are transient and difficult to study experimentally. Here, we employed a native MS-based approach to directly detect oligomeric forms of A? formed in solution. We found that WT DNAJB6 considerably reduces the signals from the various forms of A? (1?40) oligomers, whereas a mutational DNAJB6 variant in which the S/T residues have been substituted with alanines does not. We also detected signals that appeared to represent DNAJB6 dimers and trimers to which varying amounts of A? are bound. These data provide direct experimental evidence that it is the oligomeric forms of A? that are captured by DNAJB6 in a manner which depends on the S/T residues. We conclude that, in agreement with the previously observed decrease in primary nucleation rate, strong binding of A? oligomers to DNAJB6 inhibits the formation of amyloid nuclei.	[Osterlund, Nicklas; Graslund, Astrid] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden; [Lundqvist, Martin; Emanuelsson, Cecilia] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden; [Ilag, Leopold L.] Stockholm Univ, Dept Mat & Environm Chem, Stockholm, Sweden	Stockholm University; Lund University; Stockholm University	Emanuelsson, C (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden.	cecilia.emanuelsson@biochemistry.lu.se		Osterlund, Nicklas/0000-0003-0905-7911; Ilag, Leopold/0000-0003-3678-7100; Lundqvist, Martin/0000-0003-1175-9103; Emanuelsson, Cecilia/0000-0001-8762-477X	Crafoord Foundation; Alzheimer Foundation; Swedish Research Council; Sven and Lilly Lawski Foundation; Olle Engkvist Byggmastare Foundation; SciLifeLab Technology Development Grant from the Faculty of Science at Stockholm University	Crafoord Foundation; Alzheimer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sven and Lilly Lawski Foundation; Olle Engkvist Byggmastare Foundation; SciLifeLab Technology Development Grant from the Faculty of Science at Stockholm University	This work was supported by the Crafoord Foundation (to C. E.), The Alzheimer Foundation (to C. E.), The Swedish Research Council (to A. G.), The Sven and Lilly Lawski Foundation (to N. O.), and the Olle Engkvist Byggmastare Foundation (to L. L. I.). The Native IM-MS infrastructure was supported by a SciLifeLab Technology Development Grant from the Faculty of Science at Stockholm University (to L. L. I.).	Abelein A, 2014, J BIOL INORG CHEM, V19, P623, DOI 10.1007/s00775-014-1131-8; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Cohen SIA, 2018, NAT CHEM, V10, P523, DOI 10.1038/s41557-018-0023-x; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; De S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09477-3; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Frimpong AK, 2010, PROTEINS, V78, P714, DOI 10.1002/prot.22604; Ghadami SA, 2020, BIOMACROMOLECULES, V21, P1112, DOI 10.1021/acs.biomac.9b01475; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Hunter PJ, 1999, DEVELOPMENT, V126, P1247; Kakkar V, 2016, MOL CELL, V62, P272, DOI 10.1016/j.molcel.2016.03.017; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Konijnenberg A, 2016, ANAL CHEM, V88, P8468, DOI 10.1021/acs.analchem.6b00731; Kreutzer AG, 2018, ACCOUNTS CHEM RES, V51, P706, DOI 10.1021/acs.accounts.7b00554; Lendel C, 2014, ANGEW CHEM INT EDIT, V53, P12756, DOI 10.1002/anie.201406357; Li JY, 2016, MASS SPECTROM REV, V35, P111, DOI 10.1002/mas.21465; Lindberg H, 2015, BIOTECHNOL J, V10, P1707, DOI 10.1002/biot.201500131; Linse Sara, 2017, Biophys Rev, V9, P329, DOI 10.1007/s12551-017-0289-z; Liu L, 2019, CHEM COMMUN, V55, P5147, DOI 10.1039/c9cc01898k; Mansson C, 2018, BIOCHEMISTRY-US, V57, P4891, DOI 10.1021/acs.biochem.8b00353; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Mansson C, 2014, CELL STRESS CHAPERON, V19, P227, DOI 10.1007/s12192-013-0448-5; Marsh JA, 2011, STRUCTURE, V19, P859, DOI 10.1016/j.str.2011.03.010; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Michaels TCT, 2020, NAT CHEM, V12, P445, DOI 10.1038/s41557-020-0452-1; Moons R, 2019, J AM CHEM SOC, V141, P10440; Pagel K, 2013, ANGEW CHEM INT EDIT, V52, P361, DOI 10.1002/anie.201203047; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Soderberg CAG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23035-9; Testa Lorenzo, 2013, Intrinsically Disord Proteins, V1, pe25068, DOI 10.4161/idp.25068; Testa L, 2011, ANAL CHEM, V83, P6459, DOI 10.1021/ac201740z; Tiiman A, 2015, BIOCHEMISTRY-US, V54, P7203, DOI 10.1021/acs.biochem.5b00976; Viola KL, 2015, ACTA NEUROPATHOL, V129, P183, DOI 10.1007/s00401-015-1386-3; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Yokoyama T, 2012, J STRUCT BIOL, V177, P283, DOI 10.1016/j.jsb.2011.12.022	44	15	15	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8135	8144		10.1074/jbc.RA120.013459	http://dx.doi.org/10.1074/jbc.RA120.013459			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350108	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000542965700002
J	Dudakovic, A; Samsonraj, RM; Paradise, CR; Galeano-Garces, C; Mol, MO; Galeano-Garces, D; Zan, PF; Galvan, ML; Hevesi, M; Pichurin, O; Thaler, R; Begun, DL; Kloen, P; Karperien, M; Larson, AN; Westendorf, JJ; Cool, SM; van Wijnen, AJ				Dudakovic, Amel; Samsonraj, Rebekah M.; Paradise, Christopher R.; Galeano-Garces, Catalina; Mol, Merel O.; Galeano-Garces, Daniela; Zan, Pengfei; Galvan, M. Lizeth; Hevesi, Mario; Pichurin, Oksana; Thaler, Roman; Begun, Dana L.; Kloen, Peter; Karperien, Marcel; Larson, A. Noelle; Westendorf, Jennifer J.; Cool, Simon M.; van Wijnen, Andre J.			Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); osteoblast; mesenchymal stem cells (MSCs); epigenetics; histone methylation; chromatin regulation; BMP2; enhancer of zeste homolog; Ezh2; methyltransferase; osteogenesis; bone development	BONE MORPHOGENETIC PROTEIN-2; ZESTE HOMOLOG 2; MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; HISTONE MODIFICATIONS; TRANSCRIPTION FACTOR; TIBIAL FRACTURES; GENE-EXPRESSION; II RECEPTOR; RUNX2	Bone-stimulatory therapeutics include bone morphogenetic proteins (e.g. BMP2), parathyroid hormone, and antibody-based suppression of WNT antagonists. Inhibition of the epigenetic enzyme enhancer of zeste homolog 2 (EZH2) is both bone anabolic and osteoprotective. EZH2 inhibition stimulates key components of bone-stimulatory signaling pathways, including the BMP2 signaling cascade. Because of high costs and adverse effects associated with BMP2 use, here we investigated whether BMP2 dosing can be reduced by co-treatment with EZH2 inhibitors. Co-administration of BMP2 with the EZH2 inhibitor GSK126 enhanced differentiation of murine (MC3T3) osteoblasts, reflected by increased alkaline phosphatase activity, Alizarin Red staining, and expression of bone-related marker genes (e.g. Bglap and Phospho1). Strikingly, co-treatment with BMP2 (10 ng/ml) and GSK126 (5 ?m) was synergistic and was as effective as 50 ng/ml BMP2 at inducing MC3T3 osteoblastogenesis. Similarly, the BMP2?GSK126 co-treatment stimulated osteogenic differentiation of human bone marrow?derived mesenchymal stem/stromal cells, reflected by induction of key osteogenic markers (e.g. Osterix/SP7 and IBSP). A combination of BMP2 (300 ng local) and GSK126 (5 ?g local and 5 days of 50 mg/kg systemic) yielded more consistent bone healing than single treatments with either compound in a mouse calvarial critical-sized defect model according to results from ?CT, histomorphometry, and surgical grading of qualitative X-rays. We conclude that EZH2 inhibition facilitates BMP2-mediated induction of osteogenic differentiation of progenitor cells and maturation of committed osteoblasts. We propose that epigenetic priming, coupled with bone anabolic agents, enhances osteogenesis and could be leveraged in therapeutic strategies to improve bone mass.	[Dudakovic, Amel; Samsonraj, Rebekah M.; Galeano-Garces, Catalina; Galeano-Garces, Daniela; Zan, Pengfei; Galvan, M. Lizeth; Hevesi, Mario; Pichurin, Oksana; Thaler, Roman; Begun, Dana L.; Larson, A. Noelle; Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Dudakovic, Amel; Westendorf, Jennifer J.; van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Paradise, Christopher R.] Mayo Clin, Mayo Clin Grad Sch Biomed Sci, Rochester, MN USA; [Paradise, Christopher R.] Mayo Clin, Ctr Regenerat Med, Rochester, MN USA; [Mol, Merel O.; Kloen, Peter] Amsterdam Univ Med Ctr, Dept Orthoped Surg, Amsterdam, Netherlands; [Zan, Pengfei] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthoped Surg, Hangzhou, Zhejiang, Peoples R China; [Zan, Pengfei] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Orthoped Surg, Shanghai, Peoples R China; [Karperien, Marcel] Univ Twente, Dept Dev BioEngn, Enschede, Netherlands; [Cool, Simon M.] ASTAR, Glycotherapeut Grp Inst Med Biol, Singapore, Singapore; [Cool, Simon M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore, Singapore	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Zhejiang University; Tongji University; University of Twente; Agency for Science Technology & Research (A*STAR); National University of Singapore	van Wijnen, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.; van Wijnen, AJ (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	vanwijnen.andre@mayo.edu	Cool, Simon McKenzie/AAG-4346-2021; van Wijnen, Andre J./AAG-3578-2019; Mol, Merel/AHA-6469-2022; Karperien, Marcel/R-3270-2018	van Wijnen, Andre J./0000-0002-4458-0946; Mol, Merel/0000-0003-2533-2530; Karperien, Marcel/0000-0003-0751-0604; Cool, Simon/0000-0001-8543-3056; Hevesi, Mario/0000-0001-6208-878X; Dudakovic, Amel/0000-0002-8850-3977	National Institutes of Health [R01 AR049069]; Career Development Award in Orthopedics Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award in Orthopedics Research	This work was supported by National Institutes of Health Grant R01 AR049069 (A. J. v. W.) and a Career Development Award in Orthopedics Research (to A. D.). We also appreciate the generous philanthropic support of William H. and Karen J. Eby and the charitable foundation in their names. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auh QS, 2016, ONCOTARGET, V7, P78320, DOI 10.18632/oncotarget.12460; Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; Baskin DS, 2003, SPINE, V28, P1219, DOI 10.1097/00007632-200306150-00003; BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309; Bouxsein ML, 2001, J BONE JOINT SURG AM, V83A, P1219, DOI 10.2106/00004623-200108000-00012; Camilleri ET, 2018, J BIOL CHEM, V293, P19001, DOI 10.1074/jbc.RA118.003909; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen YH, 2016, STEM CELLS, V34, P2183, DOI 10.1002/stem.2400; Cho YD, 2014, J BIOL CHEM, V289, P20120, DOI 10.1074/jbc.M114.558064; Cho YD, 2012, J CELL PHYSIOL, V227, P2287, DOI 10.1002/jcp.24038; Comet I, 2016, NAT REV CANCER, V16, P803, DOI 10.1038/nrc.2016.83; Dudakovic A., 2017, CURR MOL BIOL REP, V3, P94, DOI [10.1007/s40610-017-0064-8, DOI 10.1007/S40610-017-0064-8]; Dudakovic A., 2016, GENE EXPRESSION OMNI; Dudakovic A, 2018, J BIOL CHEM, V293, P12894, DOI 10.1074/jbc.RA118.002983; Dudakovic A, 2017, GENE, V609, P28, DOI 10.1016/j.gene.2017.01.019; Dudakovic A, 2016, J BIOL CHEM, V291, P24594, DOI 10.1074/jbc.M116.740571; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852; Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P1425, DOI 10.2106/00004623-200308000-00002; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Fang C, 2016, J IMMUNOL, V196, P4452, DOI 10.4049/jimmunol.1501466; Gao SM, 2017, J BIOL CHEM, V292, P12702, DOI 10.1074/jbc.M117.776278; Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1; Ge K, 2012, BBA-GENE REGUL MECH, V1819, P727, DOI 10.1016/j.bbagrm.2011.12.008; Giannoudis PV, 2011, INJURY, V42, P549, DOI 10.1016/j.injury.2011.03.037; Gordon JAR, 2015, BONE, V81, P739, DOI 10.1016/j.bone.2015.03.011; Hak DJ, 2014, INJURY, V45, pS3, DOI 10.1016/j.injury.2014.04.002; Hassan MQ, 2004, MOL CELL BIOL, V24, P9248, DOI 10.1128/MCB.24.20.9248-9261.2004; Hay E, 1999, J CELL BIOCHEM, V72, P81, DOI 10.1002/(SICI)1097-4644(19990101)72:1<81::AID-JCB9>3.0.CO;2-N; Hemming S, 2017, FASEB J, V31, P1011, DOI 10.1096/fj.201600748R; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Herberg S, 2017, J TISSUE ENG REGEN M, V11, P1806, DOI 10.1002/term.2078; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang WB, 2002, EXP CELL RES, V274, P226, DOI 10.1006/excr.2002.5483; James AW, 2016, TISSUE ENG PART B-RE, V22, P284, DOI [10.1089/ten.teb.2015.0357, 10.1089/ten.TEB.2015.0357]; Javed A, 1999, MOL CELL BIOL, V19, P7491; Javed A, 2009, CELLS TISSUES ORGANS, V189, P133, DOI 10.1159/000151719; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381; KATAGIRI T, 1990, BIOCHEM BIOPH RES CO, V172, P295, DOI 10.1016/S0006-291X(05)80208-6; Katagiri T, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021899; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Komori T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071694; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MH, 2003, J BIOL CHEM, V278, P34387, DOI 10.1074/jbc.M211386200; Lee MH, 2005, J BIOL CHEM, V280, P35579, DOI 10.1074/jbc.M502267200; Lee Zang Hee, 2015, J Bone Metab, V22, P51, DOI 10.11005/jbm.2015.22.2.51; Li KC, 2017, J TISSUE ENG REGEN M, V11, P3068, DOI 10.1002/term.2208; Liao YH, 2014, BIOMATERIALS, V35, P4901, DOI 10.1016/j.biomaterials.2014.02.055; Lu ZF, 2012, STEM CELLS DEV, V21, P2420, DOI 10.1089/scd.2011.0589; Lui JC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13685; Luppen CA, 2002, J BONE MINER RES, V17, P301, DOI 10.1359/jbmr.2002.17.2.301; Marchesi I, 2014, CELL CYCLE, V13, P516, DOI 10.4161/cc.27921; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Ong KL, 2010, SPINE, V35, P1794, DOI 10.1097/BRS.0b013e3181ecf6e4; Onishi T, 1998, BONE, V22, P605, DOI 10.1016/S8756-3282(98)00056-8; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Pike JW, 2015, BONE, V81, P757, DOI 10.1016/j.bone.2015.03.012; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reyes R, 2018, DRUG DELIV, V25, P750, DOI 10.1080/10717544.2018.1446473; Runyan CM, 2017, J CRANIOFAC SURG, V28, P1380, DOI 10.1097/SCS.0000000000003625; Russow G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010083; Ryoo HM, 1997, MOL ENDOCRINOL, V11, P1681, DOI 10.1210/me.11.11.1681; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; SAMPATH TK, 1990, J BIOL CHEM, V265, P13198; Samsonraj RM, 2018, STEM CELLS DEV, V27, P1136, DOI 10.1089/scd.2018.0037; Samsonraj RM, 2017, TISSUE ENG PART C-ME, V23, P686, DOI [10.1089/ten.tec.2017.0205, 10.1089/ten.TEC.2017.0205]; Scandura JM, 2011, BLOOD, V118, P1472, DOI 10.1182/blood-2010-11-320093; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; Sciadini MF, 2000, J ORTHOP RES, V18, P289, DOI 10.1002/jor.1100180218; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113; Sun J, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0015-x; Swiontkowski MF, 2006, J BONE JOINT SURG AM, V88A, P1258, DOI 10.2106/JBJS.E.00499; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Takazawa Y, 2000, J ENDOCRINOL, V165, P579, DOI 10.1677/joe.0.1650579; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Tzioupis C, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(07)80003-9; van Wijnen AJ, 2019, J ORTHOP RES, V37, P1465, DOI 10.1002/jor.24305; Vicente-Duenas C, 2018, TRENDS CANCER, V4, P408, DOI 10.1016/j.trecan.2018.04.007; VILLANUEVA AR, 1977, AM J MED TECHNOL, V43, P536; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; WANG EA, 1988, P NATL ACAD SCI USA, V85, P9484, DOI 10.1073/pnas.85.24.9484; Wang HR, 2016, SCI REP-UK, V6, DOI 10.1038/srep36988; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Woodhouse S, 2013, J CELL SCI, V126, P565, DOI 10.1242/jcs.114843; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Zhu XX, 2016, ONCOTARGET, V7, P63561, DOI 10.18632/oncotarget.11538; Zura R, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.2775	98	30	30	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7877	7893		10.1074/jbc.RA119.011685	http://dx.doi.org/10.1074/jbc.RA119.011685			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32332097	Green Published, hybrid			2022-12-28	WOS:000540935400006
J	Stocker, WA; Walton, KL; Richani, D; Chan, KL; Beilby, KH; Finger, BJ; Green, MP; Gilchrist, RB; Harrison, CA				Stocker, William A.; Walton, Kelly L.; Richani, Dulama; Chan, Karen L.; Beilby, Kiri H.; Finger, Bethany J.; Green, Mark P.; Gilchrist, Robert B.; Harrison, Craig A.			A variant of human growth differentiation factor-9 that improves oocyte developmental competence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						growth factor; bone morphogenetic protein (BMP); SMAD transcription factor; receptor protein serine; threonine kinase; ovary; BMP15; cumulin; GDF9; granulosa cells; oocyte maturation	BONE MORPHOGENETIC PROTEIN-15; CELL GENE-EXPRESSION; FACTOR-BETA; GRANULOSA-CELLS; I RECEPTOR; CRYSTAL-STRUCTURE; SECRETED FACTORS; MOLECULAR-BASIS; SINGLE RESIDUE; ACTIVIN	Growth differentiation factor-9 (GDF9) and bone morphogenetic protein-15 (BMP15) are co-expressed exclusively in oocytes throughout most of folliculogenesis and play central roles in controlling ovarian physiology. Although both growth factors exist as homodimers, recent evidence indicates that GDF9 and BMP15 can also heterodimerize to form the potent growth factor cumulin. Within the cumulin complex, BMP15 ?activates? latent GDF9, enabling potent signaling in granulosa cells via type I receptors (i.e. activin receptor-like kinase-4/5 (ALK4/5)) and SMAD2/3 transcription factors. In the cumulin heterodimer, two distinct type I receptor interfaces are formed compared with homodimeric GDF9 and BMP15. Previous studies have highlighted the potential of cumulin to improve treatment of female infertility, but, as a noncovalent heterodimer, cumulin is difficult to produce and purify without contaminating GDF9 and BMP15 homodimers. In this study we addressed this challenge by focusing on the cumulin interface formed by the helix of the GDF9 chain and the fingers of the BMP15 chain. We demonstrate that unique BMP15 finger residues at this site (Arg(301), Gly(304), His(307), and Met(369)) enable potent activation of the SMAD2/3 pathway. Incorporating these BMP15 residues into latent GDF9 generated a highly potent growth factor, called hereafter Super-GDF9. Super-GDF9 was >1000-fold more potent than WT human GDF9 and 4-fold more potent than cumulin in SMAD2/3-responsive transcriptional assays in granulosa cells. Our demonstration that Super-GDF9 can effectively promote mouse cumulus cell expansion and improve oocyte quality in vitro represents a potential solution to the current challenges of producing and purifying intact cumulin.	[Stocker, William A.; Walton, Kelly L.; Chan, Karen L.; Harrison, Craig A.] Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia; [Stocker, William A.; Walton, Kelly L.; Chan, Karen L.; Harrison, Craig A.] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Stocker, William A.] Swinburne Univ Technol, Dept Chem & Biotechnol, Hawthorn, Vic, Australia; [Richani, Dulama; Gilchrist, Robert B.] Univ New South Wales Sydney, Sch Womens & Childrens Hlth, Discipline Obstet & Gynaecol, Sydney, NSW, Australia; [Beilby, Kiri H.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia; [Finger, Bethany J.; Green, Mark P.] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia	Monash University; Monash University; Swinburne University of Technology; University of New South Wales Sydney; Monash University; University of Melbourne	Harrison, CA (corresponding author), Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia.; Harrison, CA (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic, Australia.	craig.harrison@monash.edu	Stocker, William/GPK-2206-2022; Richani, Dulama/H-5807-2019; Walton, Kelly/ABF-7282-2020; Gilchrist, Robert/ABE-9594-2020	Richani, Dulama/0000-0003-1886-0423; Walton, Kelly/0000-0003-0627-2958; Gilchrist, Robert/0000-0003-1611-7142; Harrison, Craig/0000-0003-1059-3682	National Institutes of Health [P41 RR-01081]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. David Mottershead (Keele University, United Kingdom) for providing the GDF9 and BMP15 expression vectors and Lesley Ritter (The University of Adelaide, Australia) for providing advice about the culture of mouse granulosa cells. The Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, CA, was supported by National Institutes of Health Grant P41 RR-01081.	Al-Musawi SL, 2013, ENDOCRINOLOGY, V154, P888, DOI 10.1210/en.2012-2015; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Attisano L, 1996, MOL CELL BIOL, V16, P1066; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; Belli M, 2018, VITAM HORM, V107, P317, DOI 10.1016/bs.vh.2017.12.003; BOYD FT, 1989, J BIOL CHEM, V264, P2272; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Cillo F, 2007, REPRODUCTION, V134, P645, DOI 10.1530/REP-07-0182; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Dragovic RA, 2007, BIOL REPROD, V76, P848, DOI 10.1095/biolreprod.106.057471; Dube JL, 1998, MOL ENDOCRINOL, V12, P1809, DOI 10.1210/me.12.12.1809; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Gilchrist RB, 2004, BIOL REPROD, V71, P732, DOI 10.1095/biolreprod.104.028852; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2006, J CELL SCI, V119, P3811, DOI 10.1242/jcs.03105; Goebel EJ, 2019, EXP BIOL MED, V244, P1530, DOI 10.1177/1535370219880894; Goebel EJ, 2019, P NATL ACAD SCI USA, V116, P15505, DOI 10.1073/pnas.1906253116; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Harrison CA, 2003, J BIOL CHEM, V278, P21129, DOI 10.1074/jbc.M302015200; Hinck AP, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022103; Hussein TS, 2006, DEV BIOL, V296, P514, DOI 10.1016/j.ydbio.2006.06.026; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kotzsch A, 2009, EMBO J, V28, P937, DOI 10.1038/emboj.2009.37; Li R, 2000, BIOL REPROD, V63, P839, DOI 10.1095/biolreprod63.3.839; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P653, DOI 10.1210/me.2003-0393; MCGRATH SA, 1995, MOL ENDOCRINOL, V9, P131, DOI 10.1210/me.9.1.131; McKenzie LJ, 2004, HUM REPROD, V19, P2869, DOI 10.1093/humrep/deh535; Moore RK, 2003, J BIOL CHEM, V278, P304, DOI 10.1074/jbc.M207362200; Mottershead DG, 2008, MOL CELL ENDOCRINOL, V283, P58, DOI 10.1016/j.mce.2007.11.007; Mottershead DG, 2015, J BIOL CHEM, V290, P24007, DOI 10.1074/jbc.M115.671487; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Nickel J, 2001, J BONE JOINT SURG AM, V83A, pS7; Otsuka F, 2000, J BIOL CHEM, V275, P39523, DOI 10.1074/jbc.M007428200; Patino LC, 2017, J CLIN ENDOCR METAB, V102, P1009, DOI 10.1210/jc.2016-3503; Peng J, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.123158; Peng J, 2013, P NATL ACAD SCI USA, V110, pE776, DOI 10.1073/pnas.1218020110; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pulkki MM, 2011, MOL CELL ENDOCRINOL, V332, P106, DOI 10.1016/j.mce.2010.10.002; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Richani D, 2013, MOL HUM REPROD, V19, P500, DOI 10.1093/molehr/gat028; Richani D, 2019, ENDOCRINOLOGY, V160, P853, DOI 10.1210/en.2018-01026; Russell DL, 2007, HUM REPROD UPDATE, V13, P289, DOI 10.1093/humupd/dml062; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simpson CM, 2012, ENDOCRINOLOGY, V153, P1301, DOI 10.1210/en.2011-1632; Su YQ, 2010, MOL ENDOCRINOL, V24, P1230, DOI 10.1210/me.2009-0497; Sudiman J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103563; Sugimura S, 2014, MOL HUM REPROD, V20, P499, DOI 10.1093/molehr/gau013; VANDERHYDEN BC, 1990, DEV BIOL, V140, P307, DOI 10.1016/0012-1606(90)90081-S; Vitt UA, 2000, BIOL REPROD, V62, P370, DOI 10.1095/biolreprod62.2.370; Vitt UA, 2002, BIOL REPROD, V67, P473, DOI 10.1095/biolreprod67.2.473; Walker RG, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0350-1; Wathlet S, 2011, HUM REPROD, V26, P1035, DOI 10.1093/humrep/der036; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yeo CX, 2008, HUM REPROD, V23, P67, DOI 10.1093/humrep/dem140	56	13	14	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7981	7991		10.1074/jbc.RA120.013050	http://dx.doi.org/10.1074/jbc.RA120.013050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32350111	Green Published, hybrid			2022-12-28	WOS:000540935400013
J	Chikazawa, M; Yoshitake, J; Lim, SY; Iwata, S; Negishi, L; Shibata, T; Uchida, K				Chikazawa, Miho; Yoshitake, Jun; Lim, Sei-Young; Iwata, Shiori; Negishi, Lumi; Shibata, Takahiro; Uchida, Koji			Glycolaldehyde is an endogenous source of lysine N-pyrrolation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein E (ApoE); atherosclerosis; polyunsaturated fatty acid (PUFA); lipid peroxidation; immunology; posttranslational modification (PTM); glucose metabolism; immunity; oxidative stress	OXIDATION-SPECIFIC EPITOPES; GLYCATION END-PRODUCTS; LIPID-PEROXIDATION; PROTEIN ADDUCTS; GA-PYRIDINE; IDENTIFICATION; BIOMARKERS; MECHANISM; PLASMA; MODEL	Lysine N-pyrrolation converts lysine residues to N-?-pyrrole-l-lysine (pyrK) in a covalent modification reaction that significantly affects the chemical properties of proteins, causing them to mimic DNA. pyrK in proteins has been detected in vivo, indicating that pyrrolation occurs as an endogenous reaction. However, the source of pyrK remains unknown. In this study, on the basis of our observation in vitro that pyrK is present in oxidized low-density lipoprotein and in modified proteins with oxidized polyunsaturated fatty acids, we used LC?electrospray ionization?MS/MS coupled with a stable isotope dilution method to perform activity-guided separation of active molecules in oxidized lipids and identified glycolaldehyde (GA) as a pyrK source. The results from mechanistic experiments to study GA-mediated lysine N-pyrrolation suggested that the reactions might include GA oxidation, generating the dialdehyde glyoxal, followed by condensation reactions of lysine amino groups with GA and glyoxal. We also studied the functional significance of GA-mediated lysine N-pyrrolation in proteins and found that GA-modified proteins are recognized by apolipoprotein E, a binding target of pyrrolated proteins. Moreover, GA-modified proteins triggered an immune response to pyrrolated proteins, and monoclonal antibodies generated from mice immunized with GA-modified proteins specifically recognized pyrrolated proteins. These findings reveal that GA is an endogenous source of DNA-mimicking pyrrolated proteins and may provide mechanistic insights relevant for innate and autoimmune responses associated with glucose metabolism and oxidative stress.	[Chikazawa, Miho; Lim, Sei-Young; Iwata, Shiori; Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Yoshitake, Jun; Shibata, Takahiro] Nagoya Univ, Inst NanoLife Syst, Inst Innovat Future Soc, Nagoya, Aichi, Japan; [Negishi, Lumi] Univ Tokyo, Inst Quantitat Biosci, Cent Lab, Bunkyo Ku, Tokyo, Japan; [Shibata, Takahiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Uchida, Koji] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	University of Tokyo; Nagoya University; University of Tokyo; Nagoya University	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	a-uchida@mail.ecc.u-tokyo.ac.jp	; Shibata, Takahiro/I-6872-2014	Chikazawa, Miho/0000-0002-7447-8387; Shibata, Takahiro/0000-0003-3194-607X; Negishi, Lumi/0000-0002-7297-0634	Ministry of Education, Sciences, Sports, Technology, Japan [17H06170, 26111011]; AMEDCREST from AMED	Ministry of Education, Sciences, Sports, Technology, Japan; AMEDCREST from AMED	This work was supported in part by Grant-in-Aid for Scientific Research (S) 17H06170 (to K. U.) and Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" 26111011 (to K. U.) of the Ministry of Education, Sciences, Sports, Technology, Japan. This research was also supported by AMEDCREST from AMED (to K. U.).	ACHARYA AS, 1983, P NATL ACAD SCI-BIOL, V80, P3590, DOI 10.1073/pnas.80.12.3590; Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Argirov OK, 2003, BBA-GEN SUBJECTS, V1620, P235, DOI 10.1016/S0304-4165(03)00002-3; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Greven WL, 2005, KIDNEY INT, V68, P595, DOI 10.1111/j.1523-1755.2005.00437.x; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; HIDALGO FJ, 1995, J LIPID RES, V36, P725; HIDALGO FJ, 1993, J BIOL CHEM, V268, P16190; Hirose S, 2019, J BIOL CHEM, V294, P11035, DOI 10.1074/jbc.RA118.006629; Ichihashi K, 2001, J BIOL CHEM, V276, P23903, DOI 10.1074/jbc.M101947200; Itakura K, 1998, J ORG CHEM, V63, P185, DOI 10.1021/jo971239+; Kaur K, 1997, CHEM RES TOXICOL, V10, P1387, DOI 10.1021/tx970112c; Milic I, 2013, ANAL CHEM, V85, P156, DOI 10.1021/ac302356z; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Miyashita H, 2014, SCI REP-UK, V4, DOI 10.1038/srep05343; Nagai R, 2002, J BIOL CHEM, V277, P48905, DOI 10.1074/jbc.M205688200; Onyango AN, 2012, CHEM PHYS LIPIDS, V165, P777, DOI 10.1016/j.chemphyslip.2012.09.004; Otaki N, 2010, J BIOL CHEM, V285, P33834, DOI 10.1074/jbc.M110.165175; Salomon RG, 2000, CHEM RES TOXICOL, V13, P557, DOI 10.1021/tx000007u; Salomon RG, 1997, CHEM RES TOXICOL, V10, P750, DOI 10.1021/tx970016b; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; Shibata T, 2017, J BIOL CHEM, V292, P8223, DOI 10.1074/jbc.M116.762609; Walsh CT, 2006, NAT PROD REP, V23, P517, DOI 10.1039/b605245m; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a	26	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7697	7709		10.1074/jbc.RA120.013179	http://dx.doi.org/10.1074/jbc.RA120.013179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32332094	Green Published, hybrid			2022-12-28	WOS:000538038900011
J	Bryant, DA; Hunter, CN; Warren, MJ				Bryant, Donald A.; Hunter, C. Neil; Warren, Martin J.			Biosynthesis of the modified tetrapyrroles?the pigments of life	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						heme; chlorophyll; biosynthesis; adenosylcobalamin (AdoCbl); photosynthesis; bacteriochlorophyll; bilin; tetrapyrrole; uroporphyrinogen III; vitamin B12; cobalamin; coenzyme F430; heme d1; 5-aminolevulinic acid; precorrin	GREEN SULFUR BACTERIA; ADENOSYL-L-METHIONINE; COBYRINIC ACID A,C-DIAMIDE; DELTA-AMINOLEVULINIC-ACID; COENZYME B-12 SYNTHESIS; CYSG GENE ENCODES; INDEPENDENT PROTOCHLOROPHYLLIDE REDUCTASE; BACTERIOCHLOROPHYLL-C BIOSYNTHESIS; GENETICALLY-ENGINEERED SYNTHESIS; PROTOPORPHYRINOGEN-IX OXIDASE	Modified tetrapyrroles are large macrocyclic compounds, consisting of diverse conjugation and metal chelation systems and imparting an array of colors to the biological structures that contain them. Tetrapyrroles represent some of the most complex small molecules synthesized by cells and are involved in many essential processes that are fundamental to life on Earth, including photosynthesis, respiration, and catalysis. These molecules are all derived from a common template through a series of enzyme-mediated transformations that alter the oxidation state of the macrocycle and also modify its size, its side-chain composition, and the nature of the centrally chelated metal ion. The different modified tetrapyrroles include chlorophylls, hemes, siroheme, corrins (including vitamin B-12), coenzyme F-430, heme d(1), and bilins. After nearly a century of study, almost all of the more than 90 different enzymes that synthesize this family of compounds are now known, and expression of reconstructed operons in heterologous hosts has confirmed that most pathways are complete. Aside from the highly diverse nature of the chemical reactions catalyzed, an interesting aspect of comparative biochemistry is to see how different enzymes and even entire pathways have evolved to perform alternative chemical reactions to produce the same end products in the presence and absence of oxygen. Although there is still much to learn, our current understanding of tetrapyrrole biogenesis represents a remarkable biochemical milestone that is summarized in this review.	[Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Warren, Martin J.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Warren, Martin J.] Quadram Inst Biosci, Norwich Res Pk, Norwich NR4 7UQ, Norfolk, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman; University of Sheffield; University of Kent; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Bryant, DA (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.; Hunter, CN (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.; Warren, MJ (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.; Warren, MJ (corresponding author), Quadram Inst Biosci, Norwich Res Pk, Norwich NR4 7UQ, Norfolk, England.	dab14@psu.edu; c.n.hunter@sheffield.ac.uk; M.J.Warren@kent.ac.uk		Warren, Martin/0000-0002-6028-6456	Biotechnology and Biological Sciences Research Council (UK) [BB/N00924X/1, BB/S002197/1]; BBSRC [BB/N00924X/1, BB/M000265/1, BB/S002197/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by Biotechnology and Biological Sciences Research Council (UK) Grant BB/M000265/1. To whom correspondence may be addressed. E-mail: c.n.hunter@sheffield.ac.uk.; Supported by Biotechnology and Biological Sciences Research Council (UK) Grants BB/N00924X/1 and BB/S002197/1. To whom correspondence may be addressed. E-mail: M.J.Warren@kent.ac.uk.	Adamczack J, 2014, J BIOL CHEM, V289, P30753, DOI 10.1074/jbc.M114.603886; Adams NBP, 2016, FEBS LETT, V590, P1687, DOI 10.1002/1873-3468.12214; Addlesee HA, 1999, J BACTERIOL, V181, P7248, DOI 10.1128/JB.181.23.7248-7255.1999; Addlesee HA, 1996, FEBS LETT, V389, P126, DOI 10.1016/0014-5793(96)00549-2; Addlesee HA, 2000, J BACTERIOL, V182, P3175, DOI 10.1128/JB.182.11.3175-3182.2000; Airs RL, 2014, FEBS LETT, V588, P3770, DOI 10.1016/j.febslet.2014.08.026; Al-Karadaghi S, 2006, TRENDS BIOCHEM SCI, V31, P135, DOI 10.1016/j.tibs.2006.01.001; Allen JWA, 2005, DALTON T, P3410, DOI 10.1039/b508139b; Alvey RM, 2011, BIOCHEMISTRY-US, V50, P4890, DOI 10.1021/bi200307s; Archipowa N, 2018, ANGEW CHEM INT EDIT, V57, P2682, DOI 10.1002/anie.201712729; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Awan SJ, 1997, BIOCHEMISTRY-US, V36, P9273, DOI 10.1021/bi9702602; Bali S, 2014, MOL MICROBIOL, V92, P153, DOI 10.1111/mmi.12542; Bali S, 2011, P NATL ACAD SCI USA, V108, P18260, DOI 10.1073/pnas.1108228108; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Barber J, 2008, PHILOS T R SOC B, V363, P2665, DOI 10.1098/rstb.2008.0047; Battersby AR, 2000, NAT PROD REP, V17, P507, DOI 10.1039/b002635m; BATTERSBY AR, 1994, SCIENCE, V264, P1551, DOI 10.1126/science.8202709; BEALE SI, 1973, BIOCHEM BIOPH RES CO, V52, P143, DOI 10.1016/0006-291X(73)90966-2; BENZ J, 1981, Z NATURFORSCH C, V36, P51; Bjorn L, 2009, PHOTOSYNTH RES, V99, P85, DOI 10.1007/s11120-008-9395-x; BLANCHE F, 1993, ANGEW CHEM INT EDIT, V32, P1651, DOI 10.1002/anie.199316511; BLANCHE F, 1989, J BACTERIOL, V171, P4222, DOI 10.1128/JB.171.8.4222-4231.1989; BLANCHE F, 1995, ANGEW CHEM INT EDIT, V34, P383, DOI 10.1002/anie.199503831; BLANCHE F, 1992, J BACTERIOL, V174, P1050, DOI 10.1128/jb.174.3.1050-1052.1992; BLANCHE F, 1991, J BACTERIOL, V173, P6052, DOI 10.1128/jb.173.19.6052-6057.1991; Blanche F, 1996, ADV INORG BIOCHEM, P99; Boldareva-Nuianzina EN, 2013, APPL ENVIRON MICROB, V79, P2596, DOI 10.1128/AEM.00104-13; BOLLIVAR DW, 1994, BIOCHEMISTRY-US, V33, P12763, DOI 10.1021/bi00209a006; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Boss L, 2017, FEBS J, V284, P4314, DOI 10.1111/febs.14307; Boynton TO, 2011, APPL ENVIRON MICROB, V77, P4795, DOI 10.1128/AEM.00171-11; Boynton TO, 2009, BIOCHEMISTRY-US, V48, P6705, DOI 10.1021/bi900850y; Branzanic AMV, 2019, CHEM COMMUN, V55, P14047, DOI 10.1039/c9cc05271b; Bridwell-Rabb J, 2017, CURR OPIN CHEM BIOL, V37, P63, DOI 10.1016/j.cbpa.2017.01.013; Brindley AA, 2003, J BIOL CHEM, V278, P22388, DOI 10.1074/jbc.M302468200; Brindley AA, 2010, FEBS LETT, V584, P2461, DOI 10.1016/j.febslet.2010.04.053; BROGLIE RM, 1980, P NATL ACAD SCI-BIOL, V77, P87, DOI 10.1073/pnas.77.1.87; Brushaber KR, 1998, J BIOL CHEM, V273, P2684, DOI 10.1074/jbc.273.5.2684; Bryant DA, 2020, PHOTOSYNTH RES, V143, P81, DOI 10.1007/s11120-019-00689-8; Bryant DA, 2018, J PHYS B-AT MOL OPT, V51, DOI 10.1088/1361-6455/aa9c3c; Bryant DA, 2013, ADV BOT RES, V66, P99, DOI 10.1016/B978-0-12-397923-0.00004-7; Buan NR, 2004, J BACTERIOL, V186, P5708, DOI 10.1128/JB.186.17.5708-5714.2004; BURKE DH, 1993, J BACTERIOL, V175, P2414, DOI 10.1128/JB.175.8.2414-2422.1993; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; BURKE DH, 1993, J BACTERIOL, V175, P2407, DOI 10.1128/JB.175.8.2407-2413.1993; BYSTROVA MI, 1979, MOL BIOL+, V13, P440; CAMERON B, 1991, J BACTERIOL, V173, P6066, DOI 10.1128/jb.173.19.6066-6073.1991; CAMERON B, 1989, J BACTERIOL, V171, P547, DOI 10.1128/jb.171.1.547-557.1989; Canniffe DP, 2018, J BIOL CHEM, V293, P15233, DOI 10.1074/jbc.RA118.004672; Canniffe DP, 2014, BIOCHEM J, V462, P433, DOI 10.1042/BJ20140163; Canniffe DP, 2013, BIOCHEM J, V450, P397, DOI 10.1042/BJ20121723; Celis AI, 2017, J AM CHEM SOC, V139, P1900, DOI 10.1021/jacs.6b11324; Chao A, 2019, BIOCHEMISTRY-US, V58, P4610, DOI 10.1021/acs.biochem.9b00726; Chao A, 2019, BIOCHEMISTRY-US, V58, P489, DOI 10.1021/acs.biochem.8b01198; Charles P, 2020, PHYS CHEM CHEM PHYS, V22, P6457, DOI 10.1039/c9cp06556c; Chen GYE, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq1407; Chen GE, 2017, P NATL ACAD SCI USA, V114, P6280, DOI 10.1073/pnas.1701687114; Chen GE, 2016, J BACTERIOL, V198, P1393, DOI 10.1128/JB.00925-15; Chen M, 2014, ANNU REV BIOCHEM, V83, P317, DOI 10.1146/annurev-biochem-072711-162943; Chen M, 2012, FEBS LETT, V586, P3249, DOI 10.1016/j.febslet.2012.06.045; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; Chen XM, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.125, 10.1038/NPLANTS.2015.125]; Chen XM, 2015, MOL PLANT, V8, P1125, DOI 10.1016/j.molp.2015.04.013; Chen XM, 2014, J BIOL CHEM, V289, P25690, DOI 10.1074/jbc.M114.584920; Chen YR, 2012, P NATL ACAD SCI USA, V109, P8310, DOI 10.1073/pnas.1201744109; Cheong CG, 2002, BIOCHEMISTRY-US, V41, P4798, DOI 10.1021/bi012111w; Cheong CG, 1999, BIOCHEMISTRY-US, V38, P16125, DOI 10.1021/bi991752c; Chew A. Gomez Maqueo, 2005, PHOTOSYNTHESIS FUNDA, P875; Chew AGM, 2008, J BACTERIOL, V190, P747, DOI 10.1128/JB.01430-07; Chew AGM, 2007, J BACTERIOL, V189, P6176, DOI 10.1128/JB.00519-07; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; Chidgey JW, 2017, MOL MICROBIOL, V106, P961, DOI 10.1111/mmi.13861; Chidgey JW, 2014, PLANT CELL, V26, P1267, DOI 10.1105/tpc.114.124495; Chowdhury C, 2014, MICROBIOL MOL BIOL R, V78, P438, DOI 10.1128/MMBR.00009-14; COOMBER SA, 1990, MOL MICROBIOL, V4, P977, DOI 10.1111/j.1365-2958.1990.tb00670.x; Corradi HR, 2006, J BIOL CHEM, V281, P38625, DOI 10.1074/jbc.M606640200; Crane BR, 1996, CURR OPIN STRUC BIOL, V6, P744, DOI 10.1016/S0959-440X(96)80003-0; CROUZET J, 1991, J BACTERIOL, V173, P6074, DOI 10.1128/jb.173.19.6074-6087.1991; Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672; Dailey HA, 1996, J BIOL CHEM, V271, P8714, DOI 10.1074/jbc.271.15.8714; Dailey HA, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00048-16; Dailey HA, 2015, P NATL ACAD SCI USA, V112, P2210, DOI 10.1073/pnas.1416285112; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dammeyer T, 2006, J BIOL CHEM, V281, P27081, DOI 10.1074/jbc.M605154200; Davison PA, 2005, BIOCHEMISTRY-US, V44, P7603, DOI 10.1021/bi050240x; DEBUSSCHE L, 1990, J BACTERIOL, V172, P6239, DOI 10.1128/jb.172.11.6239-6244.1990; DEBUSSCHE L, 1993, J CHEM SOC CHEM COMM, P1100, DOI 10.1039/c39930001100; DEBUSSCHE L, 1993, J BACTERIOL, V175, P7430, DOI 10.1128/JB.175.22.7430-7440.1993; DEBUSSCHE L, 1991, J BACTERIOL, V173, P6300, DOI 10.1128/jb.173.19.6300-6302.1991; DEBUSSCHE L, 1992, J BACTERIOL, V174, P7445, DOI 10.1128/jb.174.22.7445-7451.1992; Deery E, 2012, NAT CHEM BIOL, V8, P933, DOI [10.1038/NCHEMBIO.1086, 10.1038/nchembio.1086]; Degnan PH, 2014, CELL METAB, V20, P769, DOI 10.1016/j.cmet.2014.10.002; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Erskine PT, 1997, NAT STRUCT BIOL, V4, P1025, DOI 10.1038/nsb1297-1025; ESCALANTESEMERENA JC, 1990, J BACTERIOL, V172, P273, DOI 10.1128/JB.172.1.273-280.1990; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; Fan CG, 2008, J BIOL CHEM, V283, P11322, DOI 10.1074/jbc.M800287200; Farmer DA, 2019, BIOCHEM J, V476, P1875, DOI 10.1042/BCJ20190095; Ferlez B, 2015, J PHYS CHEM B, V119, P13714, DOI 10.1021/acs.jpcb.5b03339; Fiedor L, 2008, BBA-BIOENERGETICS, V1777, P1491, DOI 10.1016/j.bbabio.2008.09.005; Frankenberg N, 2003, J BIOL CHEM, V278, P9219, DOI 10.1074/jbc.M211643200; Fresquet V, 2004, BIOCHEMISTRY-US, V43, P10619, DOI 10.1021/bi048972x; Frigaard N-U., 2006, COMPLEX INTRACELLULA, V2, P79, DOI [10.1007/7171_021, DOI 10.1007/7171_021]; Frigaard NU, 2003, PHOTOSYNTH RES, V78, P93, DOI 10.1023/B:PRES.0000004310.96189.b4; Frigaard NU, 2002, J BACTERIOL, V184, P3368, DOI 10.1128/JB.184.12.3368-3376.2002; Fukusumi T, 2012, FEBS LETT, V586, P2338, DOI 10.1016/j.febslet.2012.05.036; Fushimi K, 2019, CURR OPIN STRUC BIOL, V57, P39, DOI 10.1016/j.sbi.2019.01.018; Gan Fei, 2015, Life-Basel, V5, P4, DOI 10.3390/life5010004; Gan F, 2014, SCIENCE, V345, P1312, DOI 10.1126/science.1256963; Ganapathy S, 2012, BIOCHEMISTRY-US, V51, P4488, DOI 10.1021/bi201817x; Ganapathy S, 2009, P NATL ACAD SCI USA, V106, P8525, DOI 10.1073/pnas.0903534106; Garg H, 2017, J BIOL CHEM, V292, P19279, DOI 10.1074/jbc.M117.814756; GAUBIER P, 1995, MOL GEN GENET, V249, P58, DOI 10.1007/BF00290236; Ge HH, 2010, BIOCHEM BIOPH RES CO, V402, P356, DOI 10.1016/j.bbrc.2010.10.033; GIBSON KD, 1958, BIOCHEM J, V70, P71, DOI 10.1042/bj0700071; Gisriel C, 2017, SCIENCE, V357, P1021, DOI 10.1126/science.aan5611; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GRANICK S, 1949, HARVEY LECT, V44, P220; GRANICK S, 1957, ANN NY ACAD SCI, V69, P292, DOI 10.1111/j.1749-6632.1957.tb49665.x; GRANICK S., 1965, P67; Gu S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16943; Gunther LM, 2018, J PHYS CHEM B, V122, P6712, DOI 10.1021/acs.jpcb.8b02875; Gunther LM, 2016, J PHYS CHEM B, V120, P5367, DOI 10.1021/acs.jpcb.6b03718; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Harada J, 2008, PHOTOCH PHOTOBIO SCI, V7, P1179, DOI 10.1039/b802435a; Harada J, 2015, MOL MICROBIOL, V98, P1184, DOI 10.1111/mmi.13208; Harada J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060026; Harada J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00671; Hartzler DA, 2014, J PHYS CHEM B, V118, P7221, DOI 10.1021/jp500539w; Hazra AB, 2015, P NATL ACAD SCI USA, V112, P10792, DOI 10.1073/pnas.1509132112; He ZH, 2019, PHOTOSYNTH RES, V142, P87, DOI 10.1007/s11120-019-00650-9; Hennig M, 1997, P NATL ACAD SCI USA, V94, P4866, DOI 10.1073/pnas.94.10.4866; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Hitchcock A, 2016, ACS SYNTH BIOL, V5, P948, DOI 10.1021/acssynbio.6b00069; Ho MY, 2016, SCIENCE, V353, DOI 10.1126/science.aaf9178; Hofbauer S, 2016, FEBS J, V283, P4386, DOI 10.1111/febs.13930; Holliday GL, 2007, NAT PROD REP, V24, P972, DOI 10.1039/b703107f; Hollingshead S, 2012, J BIOL CHEM, V287, P27823, DOI 10.1074/jbc.M112.352526; HUANG DD, 1984, SCIENCE, V225, P1482, DOI 10.1126/science.6206568; HUNTER CN, 1988, J GEN MICROBIOL, V134, P1491; Ishida T, 1998, P NATL ACAD SCI USA, V95, P4853, DOI 10.1073/pnas.95.9.4853; Islam MR, 2008, PLANT PHYSIOL, V148, P1068, DOI 10.1104/pp.108.123117; Ito H, 2008, J BIOL CHEM, V283, P9002, DOI 10.1074/jbc.M708369200; Jaffe EK, 2000, ACTA CRYSTALLOGR D, V56, P115, DOI 10.1107/S0907444999014894; Jia T, 2016, PLANTA, V244, P1041, DOI 10.1007/s00425-016-2568-5; JORDAN PM, 1987, FEBS LETT, V225, P87, DOI 10.1016/0014-5793(87)81136-5; JORDAN PM, 1988, FEBS LETT, V235, P189, DOI 10.1016/0014-5793(88)81260-2; JORDAN PM, 1980, J CHEM SOC CHEM COMM, P240, DOI 10.1039/c39800000240; Jost M, 2015, BIOCHEMISTRY-US, V54, P3231, DOI 10.1021/acs.biochem.5b00416; Kajiwara Y, 2006, J AM CHEM SOC, V128, P9971, DOI 10.1021/ja062940a; Karger GA, 2001, BIOCHEMISTRY-US, V40, P9291, DOI 10.1021/bi010562a; Kato K, 2010, P NATL ACAD SCI USA, V107, P16649, DOI 10.1073/pnas.1000771107; Keller JP, 2002, STRUCTURE, V10, P1475, DOI 10.1016/S0969-2126(02)00876-6; Keller Y, 1998, EUR J BIOCHEM, V251, P413, DOI 10.1046/j.1432-1327.1998.2510413.x; Kieninger C, 2019, ANGEW CHEM INT EDIT, V58, P10756, DOI 10.1002/anie.201904713; Kiesel S, 2015, J BIOL CHEM, V290, P1141, DOI 10.1074/jbc.M114.617761; KIKUCHI G, 1958, J BIOL CHEM, V233, P1214; Kim EJ, 2016, J MICROBIOL BIOTECHN, V26, P959, DOI 10.4014/jmb.1601.01019; Kim EJ, 2010, J BACTERIOL, V192, P198, DOI 10.1128/JB.01271-09; KIUCHI F, 1992, J CHEM SOC CHEM COMM, P306, DOI 10.1039/c39920000306; Klunemann T, 2019, J MOL BIOL, V431, P3246, DOI 10.1016/j.jmb.2019.05.046; Kobayashi M., 2007, ADV PHOTOSYNTHESIS R, V25, P39; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; Kohchi T, 2001, PLANT CELL, V13, P425, DOI 10.1105/tpc.13.2.425; Koizumi H, 2005, SCI TECHNOL ADV MAT, V6, P551, DOI 10.1016/j.stam.2005.06.022; Kronfel CM, 2013, BIOCHEMISTRY-US, V52, P8663, DOI 10.1021/bi401192z; LaMattina JW, 2016, P NATL ACAD SCI USA, V113, P12138, DOI 10.1073/pnas.1603209113; Lange C, 2015, J BIOL CHEM, V290, P19697, DOI 10.1074/jbc.M115.660555; Larkin RM, 2003, SCIENCE, V299, P902, DOI 10.1126/science.1079978; Larkum AWD, 2005, TRENDS PLANT SCI, V10, P355, DOI 10.1016/j.tplants.2005.06.005; LARSEN KL, 1995, ARCH MICROBIOL, V163, P119, DOI 10.1007/s002030050180; Lash TD, 2005, BIOORG MED CHEM LETT, V15, P4506, DOI 10.1016/j.bmcl.2005.07.010; Lawrence AD, 2008, J BIOL CHEM, V283, P10813, DOI 10.1074/jbc.M710431200; Lawrence AD, 2014, BIOSCIENCE REP, V34, P345, DOI 10.1042/BSR20140060; Layer G, 2002, J BIOL CHEM, V277, P34136, DOI 10.1074/jbc.M205247200; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Layer G, 2006, J BIOL CHEM, V281, P15727, DOI 10.1074/jbc.M512628200; Ledermann B., 2017, MODERN TOPICS PHOTOT, P305, DOI DOI 10.1007/978-3-319-51365-2_9; Ledermann B, 2016, ENVIRON MICROBIOL, V18, P4337, DOI 10.1111/1462-2920.13290; Leech HK, 2003, J BIOL CHEM, V278, P41900, DOI 10.1074/jbc.M306112200; Leech HK, 2002, BIOCHEM SOC T, V30, P610, DOI 10.1042/bst0300610; Lewis CA, 2008, P NATL ACAD SCI USA, V105, P17328, DOI 10.1073/pnas.0809838105; Li YQ, 2013, J PHYS CHEM B, V117, P11309, DOI 10.1021/jp402413d; Li YQ, 2012, BBA-BIOENERGETICS, V1817, P1292, DOI 10.1016/j.bbabio.2012.02.026; Liu X, 2012, INT C MANAGE SCI ENG, P108, DOI 10.1109/ICMSE.2012.6414169; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Liu ZF, 2011, J BACTERIOL, V193, P4996, DOI 10.1128/JB.05520-11; Liu ZF, 2011, J BIOL CHEM, V286, P22393, DOI 10.1074/jbc.M111.249433; Llorens-Mares T, 2017, ISME J, V11, P201, DOI 10.1038/ismej.2016.93; Lojek LJ, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00176-17; LOUIE GV, 1992, NATURE, V359, P33, DOI 10.1038/359033a0; Ludwig M, 2014, J BIOL CHEM, V289, P16624, DOI 10.1074/jbc.M114.561233; Luer C, 2005, J BIOL CHEM, V280, P18568, DOI 10.1074/jbc.M500440200; Lundqvist J, 2009, J STRUCT BIOL, V167, P227, DOI 10.1016/j.jsb.2009.06.013; Lyles KV, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00198; Maggio-Hall LA, 1999, P NATL ACAD SCI USA, V96, P11798, DOI 10.1073/pnas.96.21.11798; Maggio-Hall LA, 2004, MICROBIOL-SGM, V150, P1385, DOI 10.1099/mic.0.26952-0; Mahmoud RM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00243; Maines MD, 2005, PHYSIOLOGY, V20, P382, DOI 10.1152/physiol.00029.2005; Manning WM, 1943, J BIOL CHEM, V151, P1; Manske AK, 2005, APPL ENVIRON MICROB, V71, P8049, DOI 10.1128/AEM.71.12.8049-8060.2005; Maresca J. A., 2007, THESIS; Maresca JA, 2004, J BACTERIOL, V186, P2558, DOI 10.1128/JB.186.9.2558-2566.2004; Marschall E, 2010, ENVIRON MICROBIOL, V12, P1348, DOI 10.1111/j.1462-2920.2010.02178.x; Martens JH, 2002, APPL MICROBIOL BIOT, V58, P275, DOI 10.1007/s00253-001-0902-7; Martin WF, 2018, FEMS MICROBIOL REV, V42, P205, DOI 10.1093/femsre/fux056; Mattes T. A., 2017, ENCY INORGANIC BIOIN, P1; MCGLYNN P, 1993, MOL GEN GENET, V236, P227, DOI 10.1007/BF00277117; McGoldrick HM, 2005, J BIOL CHEM, V280, P1086, DOI 10.1074/jbc.M411884200; Medlock A, 2007, P NATL ACAD SCI USA, V104, P1789, DOI 10.1073/pnas.0606144104; Mera PE, 2007, BIOCHEMISTRY-US, V46, P13829, DOI 10.1021/bi701622j; Mera PE, 2010, APPL MICROBIOL BIOT, V88, P41, DOI 10.1007/s00253-010-2773-2; MIN CH, 1993, J AM CHEM SOC, V115, P10380, DOI 10.1021/ja00075a072; Minamizaki K, 2008, J BIOL CHEM, V283, P2684, DOI 10.1074/jbc.M708954200; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Miyashita H., 2014, J PHYS CHEM BIOPHYS, V4, P149, DOI [10.4172/2161- 0398.1000149, DOI 10.4172/2161-0398.1000149]; Mobius K, 2010, P NATL ACAD SCI USA, V107, P10436, DOI 10.1073/pnas.1000956107; Moore SJ, 2017, NATURE, V543, P78, DOI 10.1038/nature21427; Moore SJ, 2013, P NATL ACAD SCI USA, V110, P14906, DOI 10.1073/pnas.1308098110; Moore SJ, 2013, J BIOL CHEM, V288, P297, DOI 10.1074/jbc.M112.422535; Moseley J, 2000, EMBO J, V19, P2139, DOI 10.1093/emboj/19.10.2139; Moseley JL, 2002, PLANT CELL, V14, P673, DOI 10.1105/tpc.010420; Moser J, 2001, EMBO J, V20, P6583, DOI 10.1093/emboj/20.23.6583; Moser J, 2019, METHODS MOL BIOL, V1876, P25, DOI 10.1007/978-1-4939-8864-8_2; Moser J, 2013, P NATL ACAD SCI USA, V110, P2094, DOI 10.1073/pnas.1218303110; Mothersole DJ, 2016, MOL MICROBIOL, V99, P307, DOI 10.1111/mmi.13235; MUCHA H, 1985, FEBS LETT, V190, P169, DOI 10.1016/0014-5793(85)80451-8; Murakami A, 2004, SCIENCE, V303, P1633, DOI 10.1126/science.1095459; Muraki N, 2010, NATURE, V465, P110, DOI 10.1038/nature08950; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Nakanishi H, 2005, PLANT CELL PHYSIOL, V46, P467, DOI 10.1093/pcp/pci053; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Niedzwiedzki DM, 2014, J PHYS CHEM B, V118, P2295, DOI 10.1021/jp409495m; Nishimori R, 2011, BIOCHEMISTRY-US, V50, P7756, DOI 10.1021/bi200994h; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Nurnberg DJ, 2018, SCIENCE, V360, P1210, DOI 10.1126/science.aar8313; Orf GS, 2013, PHOTOSYNTH RES, V116, P315, DOI 10.1007/s11120-013-9869-3; Orf GS, 2013, BBA-BIOENERGETICS, V1827, P493, DOI 10.1016/j.bbabio.2013.01.006; Ortega-Ramos M, 2018, BBA-BIOENERGETICS, V1859, P501, DOI 10.1016/j.bbabio.2018.02.006; Osman D, 2019, NAT CHEM BIOL, V15, P241, DOI 10.1038/s41589-018-0211-4; Oster U, 1997, BOT ACTA, V110, P420, DOI 10.1111/j.1438-8677.1997.tb00658.x; Oster U, 1997, J BIOL CHEM, V272, P9671; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; OTOOLE GA, 1994, J BIOL CHEM, V269, P26503; OTOOLE GA, 1995, J BIOL CHEM, V270, P23560, DOI 10.1074/jbc.270.40.23560; Ouchane S, 2004, J BIOL CHEM, V279, P6385, DOI 10.1074/jbc.M309851200; OZAKI SI, 1993, J AM CHEM SOC, V115, P7935, DOI 10.1021/ja00071a001; Palmer DJ, 2014, MOL MICROBIOL, V93, P247, DOI 10.1111/mmi.12656; Payne KAP, 2015, NATURE, V517, P513, DOI 10.1038/nature13901; Peter E, 2009, BBA-BIOENERGETICS, V1787, P1458, DOI 10.1016/j.bbabio.2009.06.006; PFALTZ A, 1987, EUR J BIOCHEM, V170, P459, DOI 10.1111/j.1432-1033.1987.tb13722.x; Phillips JD, 2004, J BIOL CHEM, V279, P38960, DOI 10.1074/jbc.M406050200; Phillips JD, 2003, EMBO J, V22, P6225, DOI 10.1093/emboj/cdg606; Pinta V, 2002, J BACTERIOL, V184, P746, DOI 10.1128/JB.184.3.746-753.2002; Porra RJ, 1996, EUR J BIOCHEM, V239, P85, DOI 10.1111/j.1432-1033.1996.0085u.x; PUDEK MR, 1975, BIOCHEMISTRY-US, V14, P3132, DOI 10.1021/bi00685a015; Qian P, 2018, NATURE, V556, P203, DOI 10.1038/s41586-018-0014-5; Ragsdale SW, 2014, METAL IONS LIFE SCI, V14, P125, DOI 10.1007/978-94-017-9269-1_6; Raux E, 1997, J BACTERIOL, V179, P3202, DOI 10.1128/jb.179.10.3202-3212.1997; Raux E, 2003, BIOCHEM J, V370, P505, DOI 10.1042/BJ20021443; Reinbothe C, 2010, TRENDS PLANT SCI, V15, P614, DOI 10.1016/j.tplants.2010.07.002; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Rockwell NC, 2017, CURR OPIN PLANT BIOL, V37, P87, DOI 10.1016/j.pbi.2017.04.003; Rockwell NC, 2009, P NATL ACAD SCI USA, V106, P6123, DOI 10.1073/pnas.0902370106; Roessner CA, 2005, J BIOL CHEM, V280, P16748, DOI 10.1074/jbc.M501805200; Roessner CA, 2002, FEBS LETT, V525, P25, DOI 10.1016/S0014-5793(02)03056-9; ROESSNER CA, 1992, FEBS LETT, V301, P73, DOI 10.1016/0014-5793(92)80213-Z; Roessner CA, 2006, J BACTERIOL, V188, P7331, DOI 10.1128/JB.00918-06; Romao CV, 2011, P NATL ACAD SCI USA, V108, P97, DOI 10.1073/pnas.1014298108; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Ruediger Wolfhart, 2006, V25, P189; Rzeznicka K, 2005, P NATL ACAD SCI USA, V102, P5886, DOI 10.1073/pnas.0501784102; Saga Y, 2016, BIOORGAN MED CHEM, V24, P4165, DOI 10.1016/j.bmc.2016.07.004; Saga Y, 2015, BIOCHEMISTRY-US, V54, P4998, DOI 10.1021/acs.biochem.5b00311; Saga Y, 2014, J BIOSCI BIOENG, V118, P82, DOI 10.1016/j.jbiosc.2013.12.023; Santander PJ, 1997, CHEM BIOL, V4, P659, DOI 10.1016/S1074-5521(97)90221-0; Sarma R, 2008, BIOCHEMISTRY-US, V47, P13004, DOI 10.1021/bi801058r; Saunders AH, 2013, BIOCHEMISTRY-US, V52, P8442, DOI 10.1021/bi401172b; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; Schliep M, 2010, J BIOL CHEM, V285, P28450, DOI 10.1074/jbc.M110.146753; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; Schmid HC, 2001, BIOL CHEM, V382, P903, DOI 10.1515/BC.2001.112; Schmid HC, 2002, BIOL CHEM, V383, P1769, DOI 10.1515/BC.2002.198; SCHNEEGURT MA, 1992, BIOCHEMISTRY-US, V31, P11677, DOI 10.1021/bi00162a002; Schoch S, 1999, NATO ASI 3 HIGH TECH, V64, P213; Schroeder S, 2009, J BIOL CHEM, V284, P4796, DOI 10.1074/jbc.M807184200; Schubert HL, 2008, BIOCHEM J, V415, P257, DOI 10.1042/BJ20080785; Schubert HL, 2008, BIOCHEMISTRY-US, V47, P8648, DOI 10.1021/bi800635y; Schubert HL, 1999, BIOCHEMISTRY-US, V38, P10660, DOI 10.1021/bi9906773; Schubert HL, 2002, EMBO J, V21, P2068, DOI 10.1093/emboj/21.9.2068; Schubert HL, 1998, NAT STRUCT BIOL, V5, P585, DOI 10.1038/846; Schulze JO, 2006, J MOL BIOL, V358, P1212, DOI 10.1016/j.jmb.2006.02.064; SCOTT AI, 1993, FEBS LETT, V331, P105, DOI 10.1016/0014-5793(93)80306-F; Scott AI, 2003, J ORG CHEM, V68, P2529, DOI 10.1021/jo020728t; Shelton AN, 2019, ISME J, V13, P789, DOI 10.1038/s41396-018-0304-9; SHEMIN D, 1946, J BIOL CHEM, V166, P621; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Shen GZ, 2019, PHOTOSYNTH RES, V140, P77, DOI 10.1007/s11120-018-00610-9; Shepherd M, 2005, FEBS J, V272, P4532, DOI 10.1111/j.1742-4658.2005.04873.x; Shepherd M, 2004, BIOCHEM J, V382, P1009, DOI 10.1042/BJ20040661; Shepherd M, 2003, BIOCHEM J, V371, P351, DOI 10.1042/BJ20021394; Shipman LW, 2001, STRUCTURE, V9, P587, DOI 10.1016/S0969-2126(01)00618-9; Shukla A, 2012, P NATL ACAD SCI USA, V109, P20136, DOI 10.1073/pnas.1211777109; Sirijovski N, 2007, ARCH MICROBIOL, V188, P599, DOI 10.1007/s00203-007-0282-1; Smith CA, 1996, PLANT MOL BIOL, V30, P1307, DOI 10.1007/BF00019561; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; Sobotka R, 2011, PLANT PHYSIOL, V155, P1735, DOI 10.1104/pp.110.167528; SOLL J, 1983, PLANT PHYSIOL, V71, P849, DOI 10.1104/pp.71.4.849; SPENCER JB, 1993, J AM CHEM SOC, V115, P11610, DOI 10.1021/ja00077a075; SPENCER JB, 1993, FEBS LETT, V335, P57, DOI 10.1016/0014-5793(93)80438-Z; Spencer P, 1998, BIOCHEMISTRY-US, V37, P14917, DOI 10.1021/bi981366f; STARK WM, 1993, J CHEM SOC PERK T 1, P2875, DOI 10.1039/p19930002875; Steensgaard DB, 1996, PHOTOSYNTH RES, V48, P385, DOI 10.1007/BF00029471; Stephenson JR, 2007, PROTEIN SCI, V16, P401, DOI 10.1110/ps.062636907; STOCKER R, 1990, METHOD ENZYMOL, V186, P301; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; Stolowich NJ, 1996, J AM CHEM SOC, V118, P1657, DOI 10.1021/ja952739s; Storbeck S, 2010, ARCHAEA, V2010, DOI 10.1155/2010/175050; Storbeck S, 2011, J BIOL CHEM, V286, P26754, DOI 10.1074/jbc.M111.239855; Stroupe ME, 2003, NAT STRUCT BIOL, V10, P1064, DOI 10.1038/nsb1007; SUZUKI JY, 1995, J BIOL CHEM, V270, P3732, DOI 10.1074/jbc.270.8.3732; SWANSON RV, 1992, J BIOL CHEM, V267, P16146; Sytina OA, 2008, NATURE, V456, P1001, DOI 10.1038/nature07354; Tabrizi ST, 2016, J BIOL CHEM, V291, P8978, DOI 10.1074/jbc.C116.719989; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tavares NK, 2018, MOL MICROBIOL, V110, P239, DOI 10.1111/mmi.14100; Teramura M, 2019, PHOTOSYNTH RES, V139, P163, DOI 10.1007/s11120-018-0573-1; Teramura M, 2018, PHOTOSYNTH RES, V135, P319, DOI 10.1007/s11120-017-0415-6; Teramura M, 2016, PHOTOSYNTH RES, V130, P33, DOI 10.1007/s11120-016-0220-7; Teramura M, 2016, PLANT CELL PHYSIOL, V57, P1048, DOI 10.1093/pcp/pcw045; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; THIBAUT D, 1990, J BACTERIOL, V172, P6245, DOI 10.1128/jb.172.11.6245-6251.1990; THIBAUT D, 1990, P NATL ACAD SCI USA, V87, P8800, DOI 10.1073/pnas.87.22.8800; THIBAUT D, 1990, P NATL ACAD SCI USA, V87, P8795, DOI 10.1073/pnas.87.22.8795; THIBAUT D, 1992, J BACTERIOL, V174, P1043, DOI 10.1128/jb.174.3.1043-1049.1992; THIBAUT D, 1992, J CHEM SOC CHEM COMM, P139, DOI 10.1039/c39920000139; THIBAUT D, 1993, J CHEM SOC CHEM COMM, P513, DOI 10.1039/c39930000513; THIBAUT D, 1992, J CHEM SOC CHEM COMM, P982, DOI 10.1039/c39920000982; Thweatt JL, 2019, ADV BOT RES, V90, P35, DOI 10.1016/bs.abr.2019.03.002; Thweatt JL, 2017, J BIOL CHEM, V292, P1361, DOI 10.1074/jbc.M116.767665; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; TRZEBIATOWSKI JR, 1994, J BACTERIOL, V176, P3568, DOI 10.1128/JB.176.12.3568-3575.1994; Tsukatani Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01217; UZAR HC, 1987, J CHEM SOC PERK T 1, P1689, DOI 10.1039/p19870001689; Verdecia MA, 2005, PLOS BIOL, V3, P777, DOI 10.1371/journal.pbio.0030151; Vevodova J, 2004, J MOL BIOL, V344, P419, DOI 10.1016/j.jmb.2004.09.020; VISHWAKARMA RA, 1993, J CHEM SOC PERK T 1, P2893, DOI 10.1039/p19930002893; Vogl K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00298; Wada K, 2006, J MOL BIOL, V360, P839, DOI 10.1016/j.jmb.2006.05.057; Wakao N, 1996, PLANT CELL PHYSIOL, V37, P889, DOI 10.1093/oxfordjournals.pcp.a029029; WALKER CJ, 1989, BIOCHEM J, V257, P599, DOI 10.1042/bj2570599; Wang JJ, 1996, P NATL ACAD SCI USA, V93, P14320, DOI 10.1073/pnas.93.25.14320; Wang PR, 2010, PLANT PHYSIOL, V153, P994, DOI 10.1104/pp.110.158477; Wang SC, 2018, NAT PROD REP, V35, P707, DOI 10.1039/c7np00059f; WARREN MJ, 1988, BIOCHEMISTRY-US, V27, P9020, DOI 10.1021/bi00425a021; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; WARREN MJ, 1990, BIOCHEM J, V265, P725, DOI 10.1042/bj2650725; WARREN MJ, 1994, BIOCHEM J, V302, P837, DOI 10.1042/bj3020837; Warren MJ, 1998, TRENDS BIOCHEM SCI, V23, P217, DOI 10.1016/S0968-0004(98)01219-5; WARREN MJ, 1992, BIOCHEMISTRY-US, V31, P603, DOI 10.1021/bi00117a043; WARREN MJ, 1990, TRENDS BIOCHEM SCI, V15, P486, DOI 10.1016/0968-0004(90)90304-T; WEAVER GW, 1991, J CHEM SOC CHEM COMM, P976, DOI 10.1039/c39910000976; WELLINGTON CL, 1989, GENE, V83, P251, DOI 10.1016/0378-1119(89)90111-X; Whitby FG, 1998, EMBO J, V17, P2463, DOI 10.1093/emboj/17.9.2463; Widner FJ, 2016, ANGEW CHEM INT EDIT, V55, P11281, DOI 10.1002/anie.201603738; Wilks A, 2014, ACCOUNTS CHEM RES, V47, P2291, DOI 10.1021/ar500028n; Wilks A, 2014, ARCH BIOCHEM BIOPHYS, V544, P87, DOI 10.1016/j.abb.2013.10.013; Williams L, 2007, J AM CHEM SOC, V129, P294, DOI 10.1021/ja067962b; Woodson JD, 2003, J BACTERIOL, V185, P311, DOI 10.1128/JB.185.1.311-316.2003; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Yamamoto H, 2009, PLANT CELL PHYSIOL, V50, P1663, DOI 10.1093/pcp/pcp111; Yamanashi K, 2015, BIOCHEM BIOPH RES CO, V463, P1328, DOI 10.1016/j.bbrc.2015.06.124; Yamazaki S, 2006, PLANT PHYSIOL, V142, P911, DOI 10.1104/pp.106.086090; Zapata Manuel, 2006, V25, P39; Zayas CL, 2007, J BACTERIOL, V189, P7697, DOI 10.1128/JB.01090-07; Zayas CL, 2007, J BACTERIOL, V189, P2210, DOI 10.1128/JB.01665-06; Zhang SW, 2019, NATURE, V574, P722, DOI 10.1038/s41586-019-1685-2; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zheng KY, 2016, SCIENCE, V354, P339, DOI 10.1126/science.aag2947; ZHOU JH, 1992, J BIOL CHEM, V267, P16138; Zill JC, 2018, PHOTOSYNTH RES, V137, P295, DOI 10.1007/s11120-018-0504-1	386	90	91	27	81	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6888	6925		10.1074/jbc.REV120.006194	http://dx.doi.org/10.1074/jbc.REV120.006194			38	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32241908	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000536212600010
J	Nayak, A; Wang, TB; Franz, P; Steffen, W; Chizhov, I; Tsiavaliaris, G; Amrute-Nayak, M				Nayak, Arnab; Wang, Tianbang; Franz, Peter; Steffen, Walter; Chizhov, Igor; Tsiavaliaris, Georgios; Amrute-Nayak, Mamta			Single-molecule analysis reveals that regulatory light chains fine-tune skeletal myosin II function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; myosin; molecular imaging; optical tweezers; single-molecule biophysics; actin filament gliding assay; myosin II; regulatory light chain; solution kinetics; optical trapping; single-molecule analysis; molecular motor; muscle contraction	LOAD-DEPENDENT KINETICS; RATE-LIMITING STEP; MUSCLE MYOSIN; SHORTENING VELOCITY; ACTIN-FILAMENT; PHOSPHATE RELEASE; MECHANICAL EVENTS; SLIDING VELOCITY; SMOOTH; RABBIT	Myosin II is the main force-generating motor during muscle contraction. Myosin II exists as different isoforms that are involved in diverse physiological functions. One outstanding question is whether the myosin heavy chain (MHC) isoforms alone account for these distinct physiological properties. Unique sets of essential and regulatory light chains (RLCs) are known to assemble with specific MHCs, raising the intriguing possibility that light chains contribute to specialized myosin functions. Here, we asked whether different RLCs contribute to this functional diversification. To this end, we generated chimeric motors by reconstituting the MHC fast isoform (MyHC-IId) and slow isoform (MHC-I) with different light-chain variants. As a result of the RLC swapping, actin filament sliding velocity increased by ?10-fold for the slow myosin and decreased by >3-fold for the fast myosin. Results from ensemble molecule solution kinetics and single-molecule optical trapping measurements provided in-depth insights into altered chemo-mechanical properties of the myosin motors that affect the sliding speed. Notably, we found that the mechanical output of both slow and fast myosins is sensitive to the RLC isoform. We therefore propose that RLCs are crucial for fine-tuning the myosin function.	[Nayak, Arnab; Wang, Tianbang; Steffen, Walter; Amrute-Nayak, Mamta] Hannover Med Sch, Inst Mol & Cell Physiol, D-30625 Hannover, Germany; [Franz, Peter; Chizhov, Igor; Tsiavaliaris, Georgios] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany	Hannover Medical School; Hannover Medical School	Amrute-Nayak, M (corresponding author), Hannover Med Sch, Inst Mol & Cell Physiol, D-30625 Hannover, Germany.	amrute.mamta@MH-Hannover.de		Nayak, Arnab/0000-0003-0888-1888; Wang, Tianbang/0000-0002-4150-9546; Franz, Peter/0000-0001-9770-743X	Deutsche Forschungsgemeinschaft (DFG) [AM/507/1-1]; Fritz Thyssen Stiftung [10.19.1.009MN]; DFG [TS 169/5-1, STE 1697/1-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fritz Thyssen Stiftung; DFG(German Research Foundation (DFG))	This research was supported by Deutsche Forschungsgemeinschaft (DFG) Grant AM/507/1-1 (to M. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Fritz Thyssen Stiftung Grant 10.19.1.009MN (to M. A.).; Supported in part by DFG Grant STE 1697/1-2.; Supported by the DFG Grant TS 169/5-1.	Amrute-Nayak M, 2008, J BIOL CHEM, V283, P3773, DOI 10.1074/jbc.M706779200; Amrute-Nayak M, 2019, SMALL, V15, DOI 10.1002/smll.201804313; Andruchov O, 2006, J PHYSIOL-LONDON, V571, P231, DOI 10.1113/jphysiol.2005.099770; Batters C, 2011, METHODS MOL BIOL, V778, P97, DOI 10.1007/978-1-61779-261-8_7; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Capitanio M, 2006, P NATL ACAD SCI USA, V103, P87, DOI 10.1073/pnas.0506830102; Cuda G, 1997, BIOPHYS J, V72, P1767, DOI 10.1016/S0006-3495(97)78823-4; Haithcock J, 2011, J BIOL CHEM, V286, P8819, DOI 10.1074/jbc.M110.163592; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; HARRIS DE, 1993, CIRC RES, V72, P219, DOI 10.1161/01.RES.72.1.219; HUXLEY AF, 1971, NATURE, V233, P533, DOI 10.1038/233533a0; Iorga B, 2007, J BIOL CHEM, V282, P3559, DOI 10.1074/jbc.M608191200; Iorga B, 2018, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01111; Ishijima A, 1998, CELL, V92, P161, DOI 10.1016/S0092-8674(00)80911-3; Iwane AH, 1997, BIOCHEM BIOPH RES CO, V230, P76, DOI 10.1006/bbrc.1996.5861; Kampourakis T, 2016, P NATL ACAD SCI USA, V113, pE3039, DOI 10.1073/pnas.1602776113; Kampourakis T, 2015, J MOL CELL CARDIOL, V85, P199, DOI 10.1016/j.yjmcc.2015.06.002; Karatzaferi C, 2017, AM J PHYSIOL-CELL PH, V313, pC644, DOI 10.1152/ajpcell.00023.2017; KATOH T, 1989, J CELL BIOL, V109, P1549, DOI 10.1083/jcb.109.4.1549; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; Lewalle A, 2008, BIOPHYS J, V94, P2160, DOI 10.1529/biophysj.107.119396; Liao WQ, 2010, J BIOL CHEM, V285, P24933, DOI 10.1074/jbc.M110.101105; Lionne C, 2002, BIOCHEMISTRY-US, V41, P13297, DOI 10.1021/bi0260278; LOWEY S, 1995, BIOPHYS J, V68, pS120; LOWEY S, 1971, NATURE, V234, P81, DOI 10.1038/234081a0; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; MORANO I, 1992, BASIC RES CARDIOL, V87, P129; Muretta JM, 2015, P NATL ACAD SCI USA, V112, P14272, DOI 10.1073/pnas.1514859112; Percario V, 2018, J PHYSIOL-LONDON, V596, P1243, DOI 10.1113/JP275404; PERSECHINI A, 1985, J BIOL CHEM, V260, P7951; RAJASEKHARAN KN, 1991, ARCH BIOCHEM BIOPHYS, V288, P584, DOI 10.1016/0003-9861(91)90240-J; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Reconditi M, 2004, NATURE, V428, P578, DOI 10.1038/nature02380; REISER PJ, 1985, J BIOL CHEM, V260, P9077; Risal D, 2004, P NATL ACAD SCI USA, V101, P8930, DOI 10.1073/pnas.0403002101; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Ruppel KM, 1996, MOL BIOL CELL, V7, P1123, DOI 10.1091/mbc.7.7.1123; SALVIATI G, 1982, BIOCHEM J, V207, P261, DOI 10.1042/bj2070261; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Scruggs SB, 2011, ARCH BIOCHEM BIOPHYS, V510, P129, DOI 10.1016/j.abb.2011.02.013; Sheikh F, 2015, GENE, V569, P14, DOI 10.1016/j.gene.2015.06.027; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; Smith DA, 2001, BIOPHYS J, V81, P2795, DOI 10.1016/S0006-3495(01)75922-X; STARON RS, 1987, PFLUG ARCH EUR J PHY, V409, P67, DOI 10.1007/BF00584751; Steffen W, 2001, P NATL ACAD SCI USA, V98, P14949, DOI 10.1073/pnas.261560698; Steffen W. L. A., 2006, CELL BIOL, V3, P37; STEIN LA, 1985, BIOCHEMISTRY-US, V24, P1357, DOI 10.1021/bi00327a013; Stephenson GM, 2001, CLIN EXP PHARMACOL P, V28, P692, DOI 10.1046/j.1440-1681.2001.03505.x; SWEENEY HL, 1986, AM J PHYSIOL, V250, pC657, DOI 10.1152/ajpcell.1986.250.4.C657; Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200; Thedinga E, 1999, J MUSCLE RES CELL M, V20, P785, DOI 10.1023/A:1005658825375; TRYBUS KM, 1993, J BIOL CHEM, V268, P4412; Tsiavaliaris G, 2002, EMBO REP, V3, P1099, DOI 10.1093/embo-reports/kvf214; Uyeda TQP, 1996, P NATL ACAD SCI USA, V93, P4459, DOI 10.1073/pnas.93.9.4459; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; WARSHAW DM, 1990, J CELL BIOL, V111, P453, DOI 10.1083/jcb.111.2.453; Weiss S, 2001, J BIOL CHEM, V276, P45902, DOI 10.1074/jbc.M107434200; Woody MS, 2019, ELIFE, V8, DOI 10.7554/eLife.49266	62	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7046	7059		10.1074/jbc.RA120.012774	http://dx.doi.org/10.1074/jbc.RA120.012774			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32273340	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000536212600022
J	Lee, FFY; Davidson, K; Harris, C; McClendon, J; Janssen, WJ; Alper, S				Lee, Frank Fang-Yao; Davidson, Kevin; Harris, Chelsea; McClendon, Jazalle; Janssen, William J.; Alper, Scott			NF-?B mediates lipopolysaccharide-induced alternative pre-mRNA splicing of MyD88 in mouse macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myeloid differentiation primary response gene 88 (MyD88); Toll-like receptor 4 (TLR4); alternative pre-mRNA splicing; macrophage; inflammation; gene regulation; NF-kappaB (NF-KB); TRIF; lipopolysaccharide	TOLL-LIKE RECEPTOR; PATTERN-RECOGNITION RECEPTORS; KAPPA-B; NEGATIVE REGULATION; UP-REGULATION; IMMUNITY; VARIANT; TRANSCRIPTION; ACTIVATION; PROTEIN	Although a robust inflammatory response is needed to combat infection, this response must ultimately be terminated to prevent chronic inflammation. One mechanism that terminates inflammatory signaling is the production of alternative mRNA splice forms in the Toll-like receptor (TLR) signaling pathway. Whereas most genes in the TLR pathway encode positive mediators of inflammatory signaling, several, including that encoding the MyD88 signaling adaptor, also produce alternative spliced mRNA isoforms that encode dominant-negative inhibitors of the response. Production of these negatively acting alternatively spliced isoforms is induced by stimulation with the TLR4 agonist lipopolysaccharide (LPS); thus, this alternative pre-mRNA splicing represents a negative feedback loop that terminates TLR signaling and prevents chronic inflammation. In the current study, we investigated the mechanisms regulating the LPS-induced alternative pre-mRNA splicing of the MyD88 transcript in murine macrophages. We found that 1) the induction of the alternatively spliced MyD88 form is due to alternative pre-mRNA splicing and not caused by another RNA regulatory mechanism, 2) MyD88 splicing is regulated by both the MyD88- and TRIF-dependent arms of the TLR signaling pathway, 3) MyD88 splicing is regulated by the NF-?B transcription factor, and 4) NF-?B likely regulates MyD88 alternative pre-mRNA splicing per se rather than regulating splicing indirectly by altering MyD88 transcription. We conclude that alternative splicing of MyD88 may provide a sensitive mechanism that ensures robust termination of inflammation for tissue repair and restoration of normal tissue homeostasis once an infection is controlled.	[Lee, Frank Fang-Yao; Harris, Chelsea; Alper, Scott] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [McClendon, Jazalle; Janssen, William J.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Lee, Frank Fang-Yao; Harris, Chelsea; Alper, Scott] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA; [Lee, Frank Fang-Yao; Harris, Chelsea; Alper, Scott] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA; [Janssen, William J.] Univ Colorado, Sch Med, Dept Med, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA; [Davidson, Kevin] WakeMed Hosp, Pulm & Crit Care, Raleigh, NC 27610 USA	National Jewish Health; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Alper, S (corresponding author), Natl Jewish Hlth, 1400 Jackson St, Denver, CO 80206 USA.	alpers@njhealth.org		Harris, Chelsea/0000-0002-1471-8764; janssen, william/0000-0002-6397-3454	National Institutes of Health [R01ES025161, R01HL148335, R21AI132827, R35HL140039, T32HL007085]; Wendy Siegel Fund for Leukemia and Cancer Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wendy Siegel Fund for Leukemia and Cancer Research	This study was supported by National Institutes of Health Grants R01ES025161, R01HL148335, R21AI132827, R35HL140039, and T32HL007085 and the Wendy Siegel Fund for Leukemia and Cancer Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Andrews CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144840; Biasin M, 2010, J IMMUNOL, V184, P2710, DOI 10.4049/jimmunol.0902463; Bigger JW, 1944, LANCET, V2, P497; Blumhagen RZ, 2017, AM J PHYSIOL-LUNG C, V313, pL930, DOI 10.1152/ajplung.00247.2017; Burke B., 2002, MACROPHAGE; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Collins LJ, 2009, J HERED, V100, P597, DOI 10.1093/jhered/esp064; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; De Arras L, 2014, GENETICS, V197, P485, DOI 10.1534/genetics.113.160499; De Arras L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003855; De Arras L, 2013, J BIOL CHEM, V288, P1967, DOI 10.1074/jbc.M112.407205; De Arras L, 2012, J IMMUNOL, V188, P2905, DOI 10.4049/jimmunol.1102595; Deng WW, 2008, J BIOL CHEM, V283, P35590, DOI 10.1074/jbc.M805775200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Frans G, 2014, CRIT REV CL LAB SCI, V51, P112, DOI 10.3109/10408363.2014.881317; Gasparian AV, 2009, CELL CYCLE, V8, P1559, DOI 10.4161/cc.8.10.8415; Giulietti M, 2013, NUCLEIC ACIDS RES, V41, pD125, DOI 10.1093/nar/gks997; Gray P, 2010, J IMMUNOL, V184, P6359, DOI 10.4049/jimmunol.0903543; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hardy MP, 2004, J BIOL CHEM, V279, P27699, DOI 10.1074/jbc.M403068200; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hoogerwerf JJ, 2010, AM J RESP CELL MOL, V42, P349, DOI 10.1165/rcmb.2008-0362OC; Hosseini AM, 2015, ADV PHARM BULL, V5, P605, DOI 10.15171/apb.2015.082; Hung YY, 2018, NEUROIMMUNOMODULAT, V25, P42, DOI 10.1159/000489562; Iwami K, 2000, J IMMUNOL, V165, P6682, DOI 10.4049/jimmunol.165.12.6682; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knobloch J, 2011, AM J RESP CRIT CARE, V183, P204, DOI 10.1164/rccm.201002-0199OC; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Koop A, 2011, EUR J IMMUNOL, V41, P224, DOI 10.1002/eji.201040814; Lee FFY, 2018, METHODS MOL BIOL, V1809, P289, DOI 10.1007/978-1-4939-8570-8_18; Liew CW, 2018, COMPUT BIOL MED, V93, P56, DOI 10.1016/j.compbiomed.2017.12.013; Lu JW, 2013, J IMMUNOL, V190, P6570, DOI 10.4049/jimmunol.1102487; Ma YY, 2005, J BIOL CHEM, V280, P41827, DOI 10.1074/jbc.M510849200; Mallory MJ, 2015, P NATL ACAD SCI USA, V112, pE2139, DOI 10.1073/pnas.1423695112; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nelson AM, 2018, J IMMUNOL, V201, P3073, DOI 10.4049/jimmunol.1800557; O'Connor BP, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004932; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Pineda JMB, 2018, GENE DEV, V32, P577, DOI 10.1101/gad.312058.118; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Pollyea DA, 2019, HAEMATOLOGICA, V104, DOI 10.3324/haematol.2018.214155; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rao N, 2005, MOL CELL BIOL, V25, P6521, DOI 10.1128/MCB.25.15.6521-6532.2005; Rino J, 2009, TRENDS CELL BIOL, V19, P375, DOI 10.1016/j.tcb.2009.05.004; Rosadini CV, 2017, CURR OPIN IMMUNOL, V44, P14, DOI 10.1016/j.coi.2016.10.005; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; Rosenstiel P, 2006, P NATL ACAD SCI USA, V103, P3280, DOI 10.1073/pnas.0505423103; Saldi T, 2016, J MOL BIOL, V428, P2623, DOI 10.1016/j.jmb.2016.04.017; Schappe MS, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2926; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Sperling J, 2008, STRUCTURE, V16, P1605, DOI 10.1016/j.str.2008.08.011; Stamm S, 2012, ALTERNATIVE PRE MRNA; Taggart AJ, 2012, NAT STRUCT MOL BIOL, V19, P719, DOI 10.1038/nsmb.2327; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tartey S, 2017, INT REV IMMUNOL, V36, P57, DOI 10.1080/08830185.2016.1261318; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Wells CA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r10; Wiersinga WJ, 2009, CRIT CARE MED, V37, P569, DOI 10.1097/CCM.0b013e318194b1bf; Zuo L, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00312	72	5	6	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6236	6248		10.1074/jbc.RA119.011495	http://dx.doi.org/10.1074/jbc.RA119.011495			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32179652	Green Published, hybrid			2022-12-28	WOS:000531417300031
J	Wang, HY; Wang, X; Chen, GN; Zhang, XM; Tang, XB; Park, D; Cucinotta, FA; Yu, DS; Deng, XM; Dynan, WS; Doetsch, PW; Wang, Y				Wang, Hongyan; Wang, Xiang; Chen, Guangnan; Zhang, Xiangming; Tang, Xiaobing; Park, Dongkyoo; Cucinotta, Francis A.; Yu, David S.; Deng, Xingming; Dynan, William S.; Doetsch, Paul W.; Wang, Ya			RETRACTION: Withdrawal: Distinct roles of Ape1 protein, an enzyme involved in DNA repair, in high or low linear energy transfer ionizing radiation-induced cell killing (vol 289, pg 30635, 2014) (Retraction of Vol 289, Pg 30635, 2014)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Cucinotta, Francis/AAZ-5941-2020					Wang HY, 2014, J BIOL CHEM, V289, P30635, DOI 10.1074/jbc.M114.604959	1	0	0	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6249	6249		10.1074/jbc.W120.013724	http://dx.doi.org/10.1074/jbc.W120.013724			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32358082	Green Published, hybrid			2022-12-28	WOS:000531417300032
J	Futamata, R; Ogasawara, F; Ichikawa, T; Kodan, A; Kimura, Y; Kioka, N; Ueda, K				Futamata, Ryota; Ogasawara, Fumihiko; Ichikawa, Takafumi; Kodan, Atsushi; Kimura, Yasuhisa; Kioka, Noriyuki; Ueda, Kazumitsu			In vivo FRET analyses reveal a role of ATP hydrolysis?associated conformational changes in human P-glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; ATPase; multidrug transporter; membrane protein; fluorescence resonance energy transfer (FRET); conformational change; ABCB1; MDR1; P-glycoprotein	NUCLEOTIDE-BINDING DOMAINS; MULTIDRUG-RESISTANCE; ENERGY-TRANSFER; GENE; TRANSPORTER; SITE; MODULATION; MUTATIONS; MECHANISM; PROTEINS	P-glycoprotein (P-gp; also known as MDR1 or ABCB1) is an ATP-driven multidrug transporter that extrudes various hydrophobic toxic compounds to the extracellular space. P-gp consists of two transmembrane domains (TMDs) that form the substrate translocation pathway and two nucleotide-binding domains (NBDs) that bind and hydrolyze ATP. At least two P-gp states are required for transport. In the inward-facing (pre-drug transport) conformation, the two NBDs are separated, and the two TMDs are open to the intracellular side; in the outward-facing (post-drug transport) conformation, the NBDs are dimerized, and the TMDs are slightly open to the extracellular side. ATP binding and hydrolysis cause conformational changes between the inward-facing and the outward-facing conformations, and these changes help translocate substrates across the membrane. However, how ATP hydrolysis is coupled to these conformational changes remains unclear. In this study, we used a new FRET sensor that detects conformational changes in P-gp to investigate the role of ATP binding and hydrolysis during the conformational changes of human P-gp in living HEK293 cells. We show that ATP binding causes the conformational change to the outward-facing state and that ATP hydrolysis and subsequent release of ?-phosphate from both NBDs allow the outward-facing state to return to the original inward-facing state. The findings of our study underscore the utility of using FRET analysis in living cells to elucidate the function of membrane proteins such as multidrug transporters.	[Futamata, Ryota; Ichikawa, Takafumi; Kimura, Yasuhisa; Kioka, Noriyuki] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan; [Ogasawara, Fumihiko; Kodan, Atsushi; Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, KUIAS, Kyoto 6068501, Japan; [Ichikawa, Takafumi] EMBL, Dev Biol Unit, D-69117 Heidelberg, Germany	Kyoto University; Kyoto University; European Molecular Biology Laboratory (EMBL)	Ueda, K (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, KUIAS, Kyoto 6068501, Japan.	uedak@kais.kyoto-u.ac.jp		Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X; Ichikawa, Takafumi/0000-0002-0490-4176; Ogasawara, Fumihiko/0000-0001-8127-1504; Kimura, Yasuhisa/0000-0001-6466-1324	JSPS KAKENHI [18H05269, 18K19176]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants 18H05269 (to K. U.) and 18K19176 (to Y. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Alam A, 2018, P NATL ACAD SCI USA, V115, pE1973, DOI 10.1073/pnas.1717044115; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Barsony O, 2016, SCI REP-UK, V6, DOI 10.1038/srep24810; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Dastvan R, 2019, SCIENCE, V364, P689, DOI 10.1126/science.aav9406; Druley TE, 2001, BIOCHEMISTRY-US, V40, P4312, DOI 10.1021/bi001371v; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Hofmann S, 2019, NATURE, V571, P580, DOI 10.1038/s41586-019-1391-0; Iram SH, 2015, MOL PHARMACOL, V88, P84, DOI 10.1124/mol.114.096792; Ishigami M, 2013, BBA-MOL CELL BIOL L, V1831, P683, DOI 10.1016/j.bbalip.2012.12.016; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kim Y, 2018, SCIENCE, V359, P915, DOI 10.1126/science.aar7389; Kimura Y, 2004, ANAL BIOCHEM, V326, P262, DOI 10.1016/j.ab.2003.12.012; Kimura Y, 2004, CURR DRUG METAB, V5, P1, DOI 10.2174/1389200043489090; Kimura Y, 2007, BIOCHEM J, V401, P597, DOI 10.1042/BJ20060632; Kodan A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08007-x; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; Muller M, 1996, J BIOL CHEM, V271, P1877; Ogasawara F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39973-x; Qu Q, 2001, BIOCHEMISTRY-US, V40, P1413, DOI 10.1021/bi002035h; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Stewart SE, 2015, BBA-BIOMEMBRANES, V1848, P115, DOI 10.1016/j.bbamem.2014.10.012; Szabo K, 1998, J BIOL CHEM, V273, P10132, DOI 10.1074/jbc.273.17.10132; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; UEDA K, 1986, BIOCHEM BIOPH RES CO, V141, P956, DOI 10.1016/S0006-291X(86)80136-X; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Verhalen B, 2017, NATURE, V543, P738, DOI 10.1038/nature21414; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Zoghbi ME, 2017, J BIOL CHEM, V292, P20412, DOI 10.1074/jbc.M117.814186	39	10	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5002	5011		10.1074/jbc.RA119.012042	http://dx.doi.org/10.1074/jbc.RA119.012042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32111736	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000526887000022
J	Murakami, K; Obata, Y; Sekikawa, A; Ueda, H; Izuo, N; Awano, T; Takabe, K; Shimizu, T; Irie, K				Murakami, Kazuma; Obata, Yayoi; Sekikawa, Asa; Ueda, Haruka; Izuo, Naotaka; Awano, Tatsuya; Takabe, Keiji; Shimizu, Takahiko; Irie, Kazuhiro			An RNA aptamer with potent affinity for a toxic dimer of amyloid?42 has potential utility for histochemical studies of Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid-beta (AB); aggregation; aptamer; circular dichroism (CD); immunohistochemistry; G-quadruplex; oligomer; transgenic mice; RNA	BETA-PROTEIN; SECONDARY STRUCTURE; OXIDATIVE STRESS; OLIGOMERS; NEUROTOXICITY; AGGREGATION; MECHANISM; SELECTION; SEQUENCE; ANTIBODY	Oligomers of ?-amyloid 42 (A?42), rather than fibrils, drive the pathogenesis of Alzheimer's disease (AD). In particular, toxic oligomeric species called protofibrils (PFs) have attracted significant attention. Herein, we report RNA aptamers with higher affinity toward PFs derived from a toxic A?42 dimer than toward fibrils produced from WT A?42 or from a toxic, conformationally constrained A?42 variant, E22P?A?42. We obtained these RNA aptamers by using the preincubated dimer model of E22P?A?42, which dimerized via a linker located at Val-40, as the target of in vitro selection. This dimer formed PFs during incubation. Several physicochemical characteristics of an identified aptamer, E22P?AbD43, suggested that preferential affinity of this aptamer toward PFs is due to its higher affinity for the toxic dimer unit (K-D = 20 ? 6.0 nm) of A?42 than for less-toxic A?40 aggregates. Comparison of CD data from the full-length and random regions of E22P?AbD43 suggested that the preferential binding of E22P?AbD43 toward the dimer might be related to the formation of a G-quadruplex structure. E22P?AbD43 significantly inhibited the nucleation phase of the dimer and its associated neurotoxicity in SH-SY5Y human neuroblastoma cells. Of note, E22P?AbD43 also significantly protected against the neurotoxicity of WT A?42 and E22P?A?42. Furthermore, in an AD mouse model, E22P?AbD43 preferentially recognized diffuse aggregates, which likely originated from PFs or higher-order oligomers with curvilinear structures, compared with senile plaques formed from fibrils. We conclude that the E22P?AbD43 aptamer is a promising research and diagnostic tool for further studies of AD etiology.	[Murakami, Kazuma; Obata, Yayoi; Sekikawa, Asa; Ueda, Haruka; Irie, Kazuhiro] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan; [Awano, Tatsuya; Takabe, Keiji] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Kyoto 6068502, Japan; [Izuo, Naotaka; Shimizu, Takahiko] Chiba Univ, Grad Sch Med, Dept Endocrinol Hematol & Gerontol, Chiba 2608670, Japan; [Izuo, Naotaka] Univ Toyama, Fac Pharmaceut Sci, Lab Pharmaceut Therapy & Neuropharmacol, Toyama 9300194, Japan; [Shimizu, Takahiko] Natl Ctr Geriatr & Gerontol, Aging Stress Response Res Project Team, Obu 4748511, Japan	Kyoto University; Kyoto University; Chiba University; University of Toyama; National Center for Geriatrics & Gerontology	Murakami, K; Irie, K (corresponding author), Kitashirakawa Oiwake Cho,Sakyo Ku, Kyoto 6068502, Japan.	murakami.kazuma.4v@kyoto-u.ac.jp; irie.kazuhiro.2z@kyoto-u.ac.jp	Awano, Tatsuya/GSN-5165-2022; Irie, Kazuhiro/A-6121-2014; Murakami, Kazuma/GQA-7062-2022	Awano, Tatsuya/0000-0002-4735-4506; Irie, Kazuhiro/0000-0001-7109-8568; Murakami, Kazuma/0000-0003-3152-1784	Japan Society for the Promotion of Science KAKENHI [26221202, 16H06194, 22603006]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 26221202 (to K. I. and K. M.) 16H06194 (to K. M.), and 22603006 (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Andrushchenko V, 2011, J AM CHEM SOC, V133, P15055, DOI 10.1021/ja204630k; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chakravarthy M, 2018, CHEM COMMUN, V54, P4593, DOI 10.1039/c8cc02256a; Farrar CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089901; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hanaki M, 2016, BIOORGAN MED CHEM, V24, P304, DOI 10.1016/j.bmc.2015.12.021; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V325, P384, DOI 10.1016/j.bbrc.2004.10.039; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Irie K, 2007, MINI-REV MED CHEM, V7, P1001, DOI 10.2174/138955707782110187; Irie Y, 2017, ACS CHEM NEUROSCI, V8, P807, DOI 10.1021/acschemneuro.6b00390; Kageyama Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35004-3; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Masuda Y, 2009, CHEMBIOCHEM, V10, P287, DOI 10.1002/cbic.200800411; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; Murakami K, 2005, J AM CHEM SOC, V127, P15168, DOI 10.1021/ja054041c; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Murakami K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29038; Murakami K, 2010, ACS CHEM NEUROSCI, V1, P747, DOI 10.1021/cn100072e; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Rahimi F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007694; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Sato M, 2013, J BIOL CHEM, V288, P23212, DOI 10.1074/jbc.M113.464222; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sugimoto S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv338; Takahashi T, 2009, MOL BIOSYST, V5, P986, DOI 10.1039/b903391b; Toda T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/617974; Tsukakoshi K, 2016, CHEM COMMUN, V52, P12646, DOI 10.1039/c6cc07552e; Tsukakoshi K, 2012, ANAL CHEM, V84, P5542, DOI 10.1021/ac300330g; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Watanabe-Nakayama T, 2016, P NATL ACAD SCI USA, V113, P5835, DOI 10.1073/pnas.1524807113; Ylera F, 2002, BIOCHEM BIOPH RES CO, V290, P1583, DOI 10.1006/bbrc.2002.6354; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199	45	12	13	1	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4870	4880		10.1074/jbc.RA119.010955	http://dx.doi.org/10.1074/jbc.RA119.010955			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32127399	Green Published, hybrid			2022-12-28	WOS:000526887000011
J	Sun, R; Cheng, ED; Velasquez, C; Chang, Y; Moore, PS				Sun, Rui; Cheng, Erdong; Velasquez, Celestino; Chang, Yuan; Moore, Patrick S.			Mitosis-related phosphorylation of the eukaryotic translation suppressor 4E-BP1 and its interaction with eukaryotic translation initiation factor 4E (eIF4E) (vol 294, pg 11840, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Moore, Patrick/GVR-8294-2022					Sun R, 2019, J BIOL CHEM, V294, P11840, DOI 10.1074/jbc.RA119.008512	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4760	4760		10.1074/jbc.AAC120.013398	http://dx.doi.org/10.1074/jbc.AAC120.013398			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32245903	Green Published, hybrid			2022-12-28	WOS:000524499700032
J	Tomida, S; Takata, M; Hirata, T; Nagae, M; Nakano, M; Kizuka, Y				Tomida, Seita; Takata, Misaki; Hirata, Tetsuya; Nagae, Masamichi; Nakano, Miyako; Kizuka, Yasuhiko			The SH3 domain in the fucosyltransferase FUT8 controls FUT8 activity and localization and is essential for core fucosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Src homology 3 domain (SH3 domain); glycosyltransferase; N-linked glycosylation; glycosylation; fucosyltransferase; ?1; 6-fucosyltransferase; core fucosylation; ribophorin I; posttranslational modification; protein-protein interaction; glycan	RIBOPHORIN-I; MAMMALIAN ALPHA-1,6-FUCOSYL-TRANSFERASE; N-ACETYLGLUCOSAMINE; CDNA CLONING; COMPLEX; GLYCOSYLATION; ASSOCIATION; BINDING; SPERM; ALPHA-2,6-SIALYLTRANSFERASE	Core fucose is an N-glycan structure synthesized by ?1,6-fucosyltransferase 8 (FUT8) localized to the Golgi apparatus and critically regulates the functions of various glycoproteins. However, how FUT8 activity is regulated in cells remains largely unclear. At the luminal side and uncommon for Golgi proteins, FUT8 has an Src homology 3 (SH3) domain, which is usually found in cytosolic signal transduction molecules and generally mediates protein-protein interactions in the cytosol. However, the SH3 domain has not been identified in other glycosyltransferases, suggesting that FUT8's functions are selectively regulated by this domain. In this study, using truncated FUT8 constructs, immunofluorescence staining, FACS analysis, cell-surface biotinylation, proteomics, and LC-electrospray ionization MS analyses, we reveal that the SH3 domain is essential for FUT8 activity both in cells and in vitro and identified His-535 in the SH3 domain as the critical residue for enzymatic activity of FUT8. Furthermore, we found that although FUT8 is mainly localized to the Golgi, it also partially localizes to the cell surface in an SH3-dependent manner, indicating that the SH3 domain is also involved in FUT8 trafficking. Finally, we identified ribophorin I (RPN1), a subunit of the oligosaccharyltransferase complex, as an SH3-dependent binding protein of FUT8. RPN1 knockdown decreased both FUT8 activity and core fucose levels, indicating that RPN1 stimulates FUT8 activity. Our findings indicate that the SH3 domain critically controls FUT8 catalytic activity and localization and is required for binding by RPN1, which promotes FUT8 activity and core fucosylation.	[Tomida, Seita; Hirata, Tetsuya; Kizuka, Yasuhiko] Gifu Univ, Ctr Highly Adv Integrat Nano & Life Sci G CHAIN, Gifu, Japan; [Tomida, Seita] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan; [Takata, Misaki; Nakano, Miyako] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Japan; [Nagae, Masamichi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka, Japan; [Nagae, Masamichi] Osaka Univ, Lab Mol Immunol, Immunol Frontier Res Ctr IFReC, Suita, Osaka, Japan; [Kizuka, Yasuhiko] Tokai Natl Higher Educ & Res Syst, Inst Glycocore Res iGCORE, Gifu, Japan	Gifu University; Gifu University; Hiroshima University; Osaka University; Osaka University	Kizuka, Y (corresponding author), Gifu Univ, Ctr Highly Adv Integrat Nano & Life Sci G CHAIN, Gifu, Japan.; Kizuka, Y (corresponding author), Tokai Natl Higher Educ & Res Syst, Inst Glycocore Res iGCORE, Gifu, Japan.	kizuka@gifu-u.ac.jp		Nagae, Masamichi/0000-0002-5470-3807; Kizuka, Yasuhiko/0000-0002-3181-9743; Hirata, Tetsuya/0000-0003-1965-5405	Leading Initiative for Excellent Young Researchers (LEADER) project from the Japan Society for the Promotion of Science (JSPS); CREST Grant from the Japan Science and Technology Agency (JST) [18070267]; Takeda Science Foundation; Uehara Memorial Foundation;  [17K07356]	Leading Initiative for Excellent Young Researchers (LEADER) project from the Japan Society for the Promotion of Science (JSPS); CREST Grant from the Japan Science and Technology Agency (JST); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); 	This work was supported in part by Grant-in-Aid for Scientific Research (C) 17K07356 (to Y. K.), a Leading Initiative for Excellent Young Researchers (LEADER) project (to Y. K.) from the Japan Society for the Promotion of Science (JSPS), CREST Grant 18070267 (to Y. K.) from the Japan Science and Technology Agency (JST), grants from the Takeda Science Foundation (to Y. K.), and a grant from the Uehara Memorial Foundation (to Y. K.).	Agrawal P, 2017, CANCER CELL, V31, P804, DOI 10.1016/j.ccell.2017.05.007; Banfield DK, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005264; BEGOVAC PC, 1991, J CELL BIOL, V113, P637, DOI 10.1083/jcb.113.3.637; Braunger K, 2018, SCIENCE, V360, P215, DOI 10.1126/science.aar7899; Breton C, 2001, BIOCHIMIE, V83, P713, DOI 10.1016/S0300-9084(01)01298-6; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; EVANS SC, 1995, BIOESSAYS, V17, P261, DOI 10.1002/bies.950170313; Fujii H, 2016, GASTROENTEROLOGY, V150, P1620, DOI 10.1053/j.gastro.2016.03.002; Garcia-Basteiro Alberto L, 2020, Nat Commun, V11, P3500, DOI 10.1038/s41467-020-17318-x; Granovsky M, 2000, NAT MED, V6, P306; Gu W, 2015, J BIOL CHEM, V290, P17566, DOI 10.1074/jbc.M114.579938; Harada Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236074; Harada Y, 2009, P NATL ACAD SCI USA, V106, P6945, DOI 10.1073/pnas.0812489106; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hathaway HJ, 2003, J CELL SCI, V116, P4319, DOI 10.1242/jcs.00720; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Ihara H, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2020.129596; Jarva MA, 2020, J BIOL CHEM, V295, P6677, DOI 10.1074/jbc.RA120.013291; Kawamoto S, 2011, INT J ONCOL, V39, P203, DOI 10.3892/ijo.2011.1005; Khoder-Agha F, 2019, J BIOL CHEM, V294, P14383, DOI 10.1074/jbc.RA119.009539; Kizuka Y, 2006, J BIOL CHEM, V281, P13644, DOI 10.1074/jbc.M601453200; Kizuka Y, 2017, CELL CHEM BIOL, V24, P1467, DOI 10.1016/j.chembiol.2017.08.023; Kizuka Y, 2016, PROTEOMICS, V16, P2854, DOI 10.1002/pmic.201600053; Kizuka Y, 2016, CELL CHEM BIOL, V23, P782, DOI 10.1016/j.chembiol.2016.06.010; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Kotzler MP, 2013, ACS CHEM BIOL, V8, P1830, DOI 10.1021/cb400140u; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lu QX, 1997, DEVELOPMENT, V124, P4121; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; MILLER DJ, 1992, NATURE, V357, P589, DOI 10.1038/357589a0; Moremen KW, 2019, NAT CHEM BIOL, V15, P853, DOI 10.1038/s41589-019-0350-2; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; MUNRO S, 1995, EMBO J, V14, P4695, DOI 10.1002/j.1460-2075.1995.tb00151.x; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Nakano M, 2019, MOL CELL PROTEOMICS, V18, P2044, DOI 10.1074/mcp.RA119.001534; Nakano M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009001; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Qin SY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394288; RAM PA, 1989, GAMETE RES, V22, P321, DOI 10.1002/mrd.1120220309; Ramakrishnan B, 2004, CURR OPIN STRUC BIOL, V14, P593, DOI 10.1016/j.sbi.2004.09.006; Ramirez AS, 2019, SCIENCE, V366, P1372, DOI 10.1126/science.aaz3505; Rocha J, 2016, PLANT CELL, V28, P2352, DOI 10.1105/tpc.16.00519; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Seko A, 2005, GLYCOBIOLOGY, V15, P943, DOI 10.1093/glycob/cwi082; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Shrimal S, 2019, GLYCOBIOLOGY, V29, P288, DOI 10.1093/glycob/cwy093; Stanley P., 2017, ESSENTIALS GLYCOBIOL; Sun SS, 2019, CLIN PROTEOM, V16, DOI 10.1186/s12014-019-9254-0; Takeda K, 2014, BIOCHEM BIOPH RES CO, V454, P436, DOI 10.1016/j.bbrc.2014.10.102; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Uozumi N, 1996, J BIOCHEM, V120, P385; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Vilcaes AA, 2011, J BIOL CHEM, V286, P31437, DOI 10.1074/jbc.M111.257196; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; Yang Q, 2017, J BIOL CHEM, V292, P14796, DOI 10.1074/jbc.M117.804070; Zafra-Ruano A, 2012, FEBS LETT, V586, P2619, DOI 10.1016/j.febslet.2012.04.057; Zhao YY, 2008, CANCER SCI, V99, P1304, DOI 10.1111/j.1349-7006.2008.00839.x	64	13	13	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7992	8004		10.1074/jbc.RA120.013079	http://dx.doi.org/10.1074/jbc.RA120.013079			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32350116	hybrid, Green Published			2022-12-28	WOS:000540935400014
J	Endo, M; Druso, JE; Cerione, RA				Endo, Makoto; Druso, Joseph E.; Cerione, Richard A.			The two splice variant forms of Cdc42 exert distinct and essential functions in neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						small GTPase; CDC42; stem cells; mTOR complex (mTORC); differentiation; ACK; CDC42b; CDC42u; neurogenesis; splice variant	BINDING PROTEINS RHOA; MOLECULAR-CLONING; TYROSINE KINASE; HUMAN HOMOLOG; EXPRESSION; IDENTIFICATION; GTPASES; MTOR; GENE; LOCALIZATION	The small GTPase cell division cycle 42 (CDC42) plays essential roles in neurogenesis and brain development. Previously, using murine embryonic P19 cells as a model system, we showed that CDC42 stimulates mTOR complex 1 (mTORC1) activity and thereby up-regulates transcription factors required for the formation of neural progenitor cells. However, paradoxically, although endogenous CDC42 is required for both the initial transition of undifferentiated P19 cells to neural progenitors and their ultimate terminal differentiation into neurons, ectopic CDC42 overexpression promotes only the first stage of neurogenesis (i.e. the formation of neuroprogenitors) and not the second phase (differentiation into neurons). Here, using both P19 cells and mouse embryonic stem cells, we resolve this paradox, demonstrating that two splice variants of CDC42, differing only in nine amino acid residues in their very C-terminal regions, play distinct roles in neurogenesis. We found that a CDC42 splice variant that has a ubiquitous tissue distribution, termed here as CDC42u, specifically drives the formation of neuroprogenitor cells, whereas a brain-specific CDC42 variant, CDC42b, is essential for promoting the transition of neuroprogenitor cells to neurons. We further show that the specific roles of CDC42u and CDC42b in neurogenesis are due to their opposing effects on mTORC1 activity. Specifically, CDC42u stimulated mTORC1 activity and thereby induced neuroprogenitor formation, whereas CDC42b worked together with activated CDC42-associated kinase (ACK) in down-regulating mTOR expression and promoting neuronal differentiation. These findings highlight the remarkable functional specificities of two highly similar CDC42 splice variants in regulating distinct stages of neurogenesis.	[Endo, Makoto; Druso, Joseph E.; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Coll Vet Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA; [Druso, Joseph E.] Univ Vermont, Robert Lamer Coll Med, Burlington, VT 05405 USA	Cornell University; Cornell University; University of Vermont	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Coll Vet Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			NIGMS, National Institutes of Health [R35 GM122575]; NCI, National Institutes of Health [R01 CA201402]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIGMS, National Institutes of Health, Grant R35 GM122575 and NCI, National Institutes of Health, Grant R01 CA201402 (to R. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Chen F, 2000, CURR BIOL, V10, P758, DOI 10.1016/S0960-9822(00)00571-6; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Dharmaiah S, 2016, P NATL ACAD SCI USA, V113, pE6766, DOI 10.1073/pnas.1615316113; Endo M, 2009, J BIOL CHEM, V284, P5107, DOI 10.1074/jbc.M807745200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fang YM, 2003, CURR BIOL, V13, P2037, DOI 10.1016/j.cub.2003.11.021; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; HART MJ, 1991, J BIOL CHEM, V266, P20840; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Lam B Daniel, 2013, Small GTPases, V4, P78, DOI 10.4161/sgtp.23310; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Maxwell KN, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00186-18; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Moutin E, 2017, CEREB CORTEX, V27, P3618, DOI 10.1093/cercor/bhw183; MUNEMITSU S, 1990, MOL CELL BIOL, V10, P5977, DOI 10.1128/MCB.10.11.5977; Nishimura A, 2013, MOL CELL BIOL, V33, P1417, DOI 10.1128/MCB.01398-12; Olenik C, 1999, MOL BRAIN RES, V70, P9, DOI 10.1016/S0169-328X(99)00121-7; Olenik C, 1997, MOL BRAIN RES, V52, P263, DOI 10.1016/S0169-328X(97)00270-2; Peng X, 2013, PROTEIN CELL, V4, P231, DOI 10.1007/s13238-012-2098-2; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; Swiech L, 2008, BBA-PROTEINS PROTEOM, V1784, P116, DOI 10.1016/j.bbapap.2007.08.015; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Urena JM, 2005, J COMP NEUROL, V490, P119, DOI 10.1002/cne.20656; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Wang C, 2015, DEV BIOL, V398, P11, DOI 10.1016/j.ydbio.2014.11.010; Wang JB, 2009, J CELL SCI, V122, P2024, DOI 10.1242/jcs.044644; Wirth A, 2013, BIOCHEM J, V456, P311, DOI 10.1042/BJ20130788; Yap K, 2016, CELL REP, V15, P1316, DOI 10.1016/j.celrep.2016.04.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	7	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4498	4512		10.1074/jbc.RA119.011837	http://dx.doi.org/10.1074/jbc.RA119.011837			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32071086	hybrid, Green Published			2022-12-28	WOS:000524499700012
J	Takahashi, S; Luo, YH; Ranjit, S; Xie, C; Libby, AE; Orlicky, DJ; Dvornikov, A; Wang, XXX; Myakala, K; Jones, BA; Bhasin, K; Wang, D; McManaman, JL; Krausz, KW; Gratton, E; Ir, D; Robertson, CE; Frank, DN; Gonzalez, FJ; Levi, M				Takahashi, Shogo; Luo, Yuhuan; Ranjit, Suman; Xie, Cen; Libby, Andrew E.; Orlicky, David J.; Dvornikov, Alexander; Wang, Xiaoxin X.; Myakala, Komuraiah; Jones, Bryce A.; Bhasin, Kanchan; Wang, Dong; McManaman, James L.; Krausz, Kristopher W.; Gratton, Enrico; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.; Gonzalez, Frank J.; Levi, Moshe			Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet?fed mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver injury; liver metabolism; bile acid; metabolomics; lipid metabolism; bile acid sequestrants; microbiome; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis	GUT MICROBIOTA; CHOLESTEROL CRYSTALS; LIPID-ACCUMULATION; OBESITY; SEVELAMER; DYSBIOSIS; METABOLISM; DISEASE; BINDING; SENSITIVITY	Nonalcoholic fatty liver disease is a rapidly rising problem in the 21st century and is a leading cause of chronic liver disease that can lead to end-stage liver diseases, including cirrhosis and hepatocellular cancer. Despite this rising epidemic, no pharmacological treatment has yet been established to treat this disease. The rapidly increasing prevalence of nonalcoholic fatty liver disease and its aggressive form, nonalcoholic steatohepatitis (NASH), requires novel therapeutic approaches to prevent disease progression. Alterations in microbiome dynamics and dysbiosis play an important role in liver disease and may represent targetable pathways to treat liver disorders. Improving microbiome properties or restoring normal bile acid metabolism may prevent or slow the progression of liver diseases such as NASH. Importantly, aberrant systemic circulation of bile acids can greatly disrupt metabolic homeostasis. Bile acid sequestrants are orally administered polymers that bind bile acids in the intestine, forming nonabsorbable complexes. Bile acid sequestrants interrupt intestinal reabsorption of bile acids, decreasing their circulating levels. We determined that treatment with the bile acid sequestrant sevelamer reversed the liver injury and prevented the progression of NASH, including steatosis, inflammation, and fibrosis in a Western diet?induced NASH mouse model. Metabolomics and microbiome analysis revealed that this beneficial effect is associated with changes in the microbiota population and bile acid composition, including reversing microbiota complexity in cecum by increasing Lactobacillus and decreased Desulfovibrio. The net effect of these changes was improvement in liver function and markers of liver injury and the positive effects of reversal of insulin resistance.	[Takahashi, Shogo; Ranjit, Suman; Libby, Andrew E.; Wang, Xiaoxin X.; Myakala, Komuraiah; Jones, Bryce A.; Bhasin, Kanchan; Levi, Moshe] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Jones, Bryce A.] Georgetown Univ, Dept Pharmacol & Physiol, Washington, DC 20057 USA; [Orlicky, David J.] Univ Colorado, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA; [Luo, Yuhuan; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [McManaman, James L.] Univ Colorado, Div Reprod Sci, Anschutz Med Campus, Aurora, CO 80045 USA; [McManaman, James L.] Univ Colorado, Grad Program Integrated Physiol, Anschutz Med Campus, Aurora, CO 80045 USA; [Ranjit, Suman; Dvornikov, Alexander; Wang, Dong; Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Lab Fluorescence Dynam, Irvine, CA 92697 USA; [Takahashi, Shogo; Xie, Cen; Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, NIH, Bethesda, MD 20892 USA	Georgetown University; Georgetown University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Levi, M (corresponding author), Georgetown Univ, Biochem & Mol & Cellular Biol, 3900 Reservoir Rd,Basic Sci 353, Washington, DC 20057 USA.	Moshe.Levi@georgetown.edu	Komuraiah, Myakala/AAQ-9961-2021; Takahashi, Shogo/GVS-9010-2022	Komuraiah, Myakala/0000-0003-3233-047X; Takahashi, Shogo/0000-0002-3831-5353; Libby, Andrew/0000-0003-3726-2170; Ranjit, Suman/0000-0003-3058-6332; Orlicky, David/0000-0002-0417-1400; Jones, Bryce/0000-0002-6950-8414; ROBERTSON, CHARLES/0000-0002-4136-4121	National Institute of Aging [AG049493]; National Institute of Diabetes and Digestive and Kidney Diseases [116567]; National Institutes of Health [2R01HD45965, R01-HD075285, P50GM076516, P41GM103540]; Colorado Clinical and Translational Sciences Institute/National Institutes of Health [TL1-TR001081]; Gastrointestinal and Liver Innate Immunity Program of the University of Colorado School of Medicine; American Heart Association Postdoctoral Fellowships [19POST34430001, 19POST34381041]	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Clinical and Translational Sciences Institute/National Institutes of Health; Gastrointestinal and Liver Innate Immunity Program of the University of Colorado School of Medicine; American Heart Association Postdoctoral Fellowships(American Heart Association)	This work was supported by National Institute of Aging Grant AG049493 (to M. L.), National Institute of Diabetes and Digestive and Kidney Diseases Grant 116567 (to M. L.), National Institutes of Health Grants 2R01HD45965 and R01-HD075285 (to J. L. M.), Colorado Clinical and Translational Sciences Institute/National Institutes of Health Grant TL1-TR001081 (to A. E. L.), and National Institutes of Health Grants P50GM076516 and P41GM103540 (to S. R., A. D., and E. G.). This work was also supported by funds from the Gastrointestinal and Liver Innate Immunity Program of the University of Colorado School of Medicine (to D. N. F., D. I., and C. E. R.) and American Heart Association Postdoctoral Fellowships 19POST34430001 (to A. E. L.) and 19POST34381041 (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Arab JP, 2017, HEPATOLOGY, V65, P350, DOI 10.1002/hep.28709; Betrapally NS, 2016, GASTROENTEROLOGY, V150, P1745, DOI 10.1053/j.gastro.2016.02.073; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; Braunlin W, 2002, KIDNEY INT, V62, P611, DOI 10.1046/j.1523-1755.2002.00459.x; Bronden A, 2015, DIABETES OBES METAB, V17, P116, DOI 10.1111/dom.12355; Caussy C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09455-9; Chiang John Y. L., 2018, Gene Expression, V18, P71, DOI 10.3727/105221618X15156018385515; Dawson PA, 2015, J LIPID RES, V56, P1085, DOI 10.1194/jlr.R054114; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ferslew BC, 2015, DIGEST DIS SCI, V60, P3318, DOI 10.1007/s10620-015-3776-8; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Friedman JE, 2018, HEPATOL COMMUN, V2, P313, DOI 10.1002/hep4.1139; Hendrikx T, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0652-0; Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Jiang T, 2007, DIABETES, V56, P2485, DOI 10.2337/db06-1642; Jonscher KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152877; Kapil S, 2016, J GASTROEN HEPATOL, V31, P213, DOI 10.1111/jgh.13058; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kolodziejczyk AA, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809302; Kraus Daniel, 2015, Bio Protoc, V5; Lanaspa MA, 2018, J CLIN INVEST, V128, P2226, DOI 10.1172/JCI94427; Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Leung C, 2016, NAT REV GASTRO HEPAT, V13, P412, DOI 10.1038/nrgastro.2016.85; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Libby AE, 2016, J BIOL CHEM, V291, P24231, DOI 10.1074/jbc.M116.759795; Lim RS, 2011, J LIPID RES, V52, P2177, DOI 10.1194/jlr.M018077; Lim RS, 2010, J LIPID RES, V51, P1729, DOI 10.1194/jlr.M003616; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001; McGettigan BM, 2016, J BIOL CHEM, V291, P23058, DOI 10.1074/jbc.M116.731042; Mehal WZ, 2013, NAT REV GASTRO HEPAT, V10, P637, DOI 10.1038/nrgastro.2013.146; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Molinaro A, 2018, TRENDS ENDOCRIN MET, V29, P31, DOI 10.1016/j.tem.2017.11.002; Nycz BT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191232; Orlicky DJ, 2019, J PHYSIOL-LONDON, V597, P1565, DOI 10.1113/JP277140; Pathak P, 2018, HEPATOLOGY, V68, P1574, DOI 10.1002/hep.29857; Ponziani FR, 2019, HEPATOLOGY, V69, P107, DOI 10.1002/hep.30036; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramakrishnan VR, 2015, J ALLERGY CLIN IMMUN, V136, P334, DOI 10.1016/j.jaci.2015.02.008; Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Russell KN, 2007, JAVMA-J AM VET MED A, V230, P1329, DOI 10.2460/javma.230.9.1329; Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Shapiro H, 2018, J EXP MED, V215, P383, DOI 10.1084/jem.20171965; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Suhalim JL, 2012, BIOPHYS J, V102, P1988, DOI 10.1016/j.bpj.2012.03.016; Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729; Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010; Utzschneider KM, 2016, J CLIN ENDOCR METAB, V101, P2622, DOI 10.1210/jc.2015-4251; Vlassara H, 2012, CLIN J AM SOC NEPHRO, V7, P934, DOI 10.2215/CJN.12891211; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99; Wang XXX, 2016, J AM SOC NEPHROL, V27, P1362, DOI 10.1681/ASN.2014121271; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wieland A, 2015, ALIMENT PHARM THER, V42, P1051, DOI 10.1111/apt.13376	69	23	24	5	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4733	4747		10.1074/jbc.RA119.011913	http://dx.doi.org/10.1074/jbc.RA119.011913			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32075905	hybrid, Green Published			2022-12-28	WOS:000524499700030
J	Goldfine, H				Goldfine, Howard			Life without air	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						lipid; acyl carrier protein (ACP); plasmalogen; anaerobiosis; Clostridium; cyclopropane fatty acids; lipidomes; Listeria	MEMBRANE-LIPID-COMPOSITION; CYCLOPROPANE FATTY-ACIDS; LISTERIA-MONOCYTOGENES; PHOSPHOLIPASE-C; CLOSTRIDIUM-BUTYRICUM; ESCHERICHIA-COLI; OUTER-MEMBRANE; CRYSTAL-STRUCTURE; PHASE-BEHAVIOR; BIOSYNTHESIS	An early exposure to lipid biochemistry in the laboratory of Konrad Bloch resulted in a fascination with the biosynthesis, structures, and functions of bacterial lipids. The discovery of plasmalogens (1-alk-1?-enyl, 2-acyl phospholipids) in anaerobic Gram-positive bacteria led to studies on the physical chemistry of these lipids and the cellular regulation of membrane lipid polymorphism in bacteria. Later studies in several laboratories showed that the formation of the alk-1-enyl ether bond involves an aerobic process in animal cells and thus is fundamentally different from that in anaerobic organisms. Our work provides evidence for an anaerobic process in which plasmalogens are formed from their corresponding diacyl lipids. Studies on the roles of phospholipases in Listeria monocytogenes revealed distinctions between its phospholipases and those previously discovered in other bacteria and showed how the Listeria enzymes are uniquely fitted to the intracellular lifestyle of this significant human pathogen.	[Goldfine, Howard] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Goldfine, H (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	goldfinh@pennmedicine.upenn.edu						AMES GF, 1974, J BACTERIOL, V117, P406, DOI 10.1128/JB.117.2.406-416.1974; Bannam T, 1999, INFECT IMMUN, V67, P182, DOI 10.1128/IAI.67.1.182-186.1999; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BAUMANN NA, 1965, J BIOL CHEM, V240, P1559; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; BROQUIST HP, 1951, J BIOL CHEM, V188, P431; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; Dowhan W, 2017, J BIOL CHEM, V292, P10755, DOI 10.1074/jbc.X117.794891; GANDHI AJ, 1993, J BACTERIOL, V175, P8014, DOI 10.1128/JB.175.24.8014-8017.1993; GEOFFROY C, 1991, INFECT IMMUN, V59, P2382, DOI 10.1128/IAI.59.7.2382-2388.1991; GOLDFINE H, 1971, J LIPID RES, V12, P214; GOLDFINE H, 1987, BIOCHEMISTRY-US, V26, P2814, DOI 10.1021/bi00384a024; GOLDFINE H, 1960, J BIOL CHEM, V235, P2238; GOLDFINE H, 1995, P NATL ACAD SCI USA, V92, P2979, DOI 10.1073/pnas.92.7.2979; GOLDFINE H, 1993, J BACTERIOL, V175, P4298, DOI 10.1128/JB.175.14.4298-4306.1993; GOLDFINE H, 1992, INFECT IMMUN, V60, P4059, DOI 10.1128/IAI.60.10.4059-4067.1992; GOLDFINE H, 1987, BIOCHIM BIOPHYS ACTA, V904, P283, DOI 10.1016/0005-2736(87)90377-4; GOLDFINE H, 1958, J BIOL CHEM, V232, P577; GOLDFINE H, 1961, J BIOL CHEM, V236, P2596; Goldfine H, 2017, FEBS LETT, V591, P2714, DOI 10.1002/1873-3468.12714; Guan ZQ, 2019, LIPIDS, V54, P423, DOI 10.1002/lipd.12181; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P186, DOI 10.1016/j.bbalip.2010.12.010; HAGEN PO, 1967, J BIOL CHEM, V242, P5700; HARLEY JB, 1978, J BACTERIOL, V134, P808, DOI 10.1128/JB.134.3.808-820.1978; HECHEMY K, 1971, BIOCHEM BIOPH RES CO, V42, P245, DOI 10.1016/0006-291X(71)90094-5; Heine A, 2014, PROTEINS, V82, P2041, DOI 10.1002/prot.24557; ISRAELACHVILI JN, 1980, Q REV BIOPHYS, V13, P121, DOI 10.1017/S0033583500001645; JOHNSTON NC, 1985, BIOCHIM BIOPHYS ACTA, V813, P10, DOI 10.1016/0005-2736(85)90339-6; Johnston NC, 2010, J LIPID RES, V51, P1953, DOI 10.1194/jlr.M004788; KAUFMAN AE, 1988, J BACTERIOL, V170, P2770, DOI 10.1128/jb.170.6.2770-2774.1988; KOGA Y, 1984, J BACTERIOL, V159, P597, DOI 10.1128/JB.159.2.597-604.1984; Konovalova A, 2017, ANNU REV MICROBIOL, V71, P539, DOI 10.1146/annurev-micro-090816-093754; KOPLOW J, 1974, J BACTERIOL, V117, P527, DOI 10.1128/JB.117.2.527-543.1974; LOHNER K, 1984, CHEM PHYS LIPIDS, V34, P163, DOI 10.1016/0009-3084(84)90041-0; LUEKING DR, 1975, J BIOL CHEM, V250, P8530; MALTHANER M, 1987, BIOCHEMISTRY-US, V26, P5826, DOI 10.1021/bi00392a037; MALTHANER M, 1987, BIOCHIM BIOPHYS ACTA, V900, P191, DOI 10.1016/0005-2736(87)90333-6; MARINARI LA, 1974, BIOCHEMISTRY-US, V13, P1978, DOI 10.1021/bi00706a030; McIntyre TM, 2008, N COMP BIOC, P245, DOI 10.1016/B978-044453219-0.50011-8; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Moser J, 1997, J MOL BIOL, V273, P269, DOI 10.1006/jmbi.1997.1290; Poussin MA, 2009, MICROB PATHOGENESIS, V46, P1, DOI 10.1016/j.micpath.2008.09.008; Rilfors L, 2002, COLLOID SURFACE B, V26, P112, DOI 10.1016/S0927-7765(01)00310-1; Rilfors L, 1993, Subcell Biochem, V20, P109; ROONEY SA, 1972, J BACTERIOL, V111, P531, DOI 10.1128/JB.111.2.531-541.1972; SCHEUERBRANDT G, 1961, J BIOL CHEM, V236, pPC70; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Spiering MJ, 2019, J BIOL CHEM, V294, P14876, DOI 10.1074/jbc.CL119.010972; Tian B, 2013, BBA-MOL CELL BIOL L, V1831, P1185, DOI 10.1016/j.bbalip.2013.03.005; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770; Wadsworth SJ, 2002, INFECT IMMUN, V70, P4650, DOI 10.1128/IAI.70.8.4650-4660.2002; Wei ZY, 2005, INFECT IMMUN, V73, P6639, DOI 10.1128/IAI.73.10.6639-6646.2005; Wei ZY, 2005, P NATL ACAD SCI USA, V102, P12927, DOI 10.1073/pnas.0501725102; WIESLANDER A, 1986, BIOCHEMISTRY-US, V25, P7511, DOI 10.1021/bi00371a038; ZALKIN H, 1963, J BIOL CHEM, V238, P1242; Zhang YM, 2008, J LIPID RES, V49, P1867, DOI 10.1194/jlr.R800005-JLR200; Zuckert WR, 1998, INFECT IMMUN, V66, P4823	59	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 27	2020	295	13					4124	4133		10.1074/jbc.X120.013022	http://dx.doi.org/10.1074/jbc.X120.013022			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KZ7MI	32221031	Green Published, hybrid			2022-12-28	WOS:000523442500006
J	Cinar, B; Al-Mathkour, MM; Khan, SA; Moreno, CS				Cinar, Bekir; Al-Mathkour, Marwah M.; Khan, Shafiq A.; Moreno, Carlos S.			Androgen attenuates the inactivating phospho?Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						signal transduction; androgens; androgen receptor; YAP1; Hippo; MST1; STK4; protein phosphatase PP2A; protein?protein interaction; post-translational modification; phosphorylation; nuclear translocation; gene transcription; androgen; cell signaling; Hippo pathway; yes-associated protein (YAP); protein phosphorylation; protein serine; threonine phosphatase (PSP); gene transcription; androgen; AR signaling; YAP1 nuclear localization	HIPPO PATHWAY; CELL-GROWTH; PHOSPHORYLATION; DOMAIN; MST2; LOCALIZATION; REGULATORS; TEAD; NLK	The transcriptional coactivator YAP1 (yes-associated protein 1) regulates cell proliferation, cell?cell interactions, organ size, and tumorigenesis. Post-transcriptional modifications and nuclear translocation of YAP1 are crucial for its nuclear activity. The objective of this study was to elucidate the mechanism by which the steroid hormone androgen regulates YAP1 nuclear entry and functions in several human prostate cancer cell lines. We demonstrate that androgen exposure suppresses the inactivating post-translational modification phospho?Ser-127 in YAP1, coinciding with increased YAP1 nuclear accumulation and activity. Pharmacological and genetic experiments revealed that intact androgen receptor signaling is necessary for androgen's inactivating effect on phospho?Ser-127 levels and increased YAP1 nuclear entry. We also found that androgen exposure antagonizes Ser/Thr kinase 4 (STK4/MST1) signaling, stimulates the activity of protein phosphatase 2A, and thereby attenuates the phospho?Ser-127 modification and promotes YAP1 nuclear localization. Results from quantitative RT-PCR and CRISPR/Cas9?aided gene knockout experiments indicated that androgen differentially regulates YAP1-dependent gene expression. Furthermore, an unbiased computational analysis of the prostate cancer data from The Cancer Genome Atlas revealed that YAP1 and androgen receptor transcript levels correlate with each other in prostate cancer tissues. These findings indicate that androgen regulates YAP1 nuclear localization and its transcriptional activity through the androgen receptor?STK4/MST1?protein phosphatase 2A axis, which may have important implications for human diseases such as prostate cancer.	[Cinar, Bekir; Al-Mathkour, Marwah M.; Khan, Shafiq A.] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Dept Biol Sci, Atlanta, GA 30314 USA; [Cinar, Bekir; Khan, Shafiq A.; Moreno, Carlos S.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Moreno, Carlos S.] Emory Univ, Dept Pathol & Lab Med & Biomed Informat, Atlanta, GA 30322 USA	Clark Atlanta University; Emory University; Emory University	Cinar, B (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Dept Biol Sci, Atlanta, GA 30314 USA.; Cinar, B (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.	bcinar@cau.edu	CİNAR, BEKIR MURAT/AAL-4474-2021; Moreno, Carlos S/B-3863-2009	CİNAR, BEKIR MURAT/0000-0002-7906-5039; Moreno, Carlos S/0000-0002-5582-0028	National Science Foundation-Division of Molecular and Cellular Biosciences Grant [1832022]; NIMHD, National Institutes of Health [2U54MD007590-32]	National Science Foundation-Division of Molecular and Cellular Biosciences Grant(National Science Foundation (NSF)); NIMHD, National Institutes of Health	This work was supported in part by National Science Foundation-Division of Molecular and Cellular Biosciences Grant 1832022 (to B. C.) and by NIMHD, National Institutes of Health Grant 2U54MD007590-32 (to the Center for Cancer Research and Therapeutic Program, Clark Atlanta University). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Chen YA, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00060; Cinar B, 2011, CANCER RES, V71, P4303, DOI 10.1158/0008-5472.CAN-10-4532; Cochrane DR, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3599; Collak FK, 2012, J BIOL CHEM, V287, P23698, DOI 10.1074/jbc.M112.358713; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Ege N, 2018, CELL SYST, V6, P692, DOI 10.1016/j.cels.2018.05.006; Elbediwy A, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221788; Elosegui-Artola A, 2017, CELL, V171, P1397, DOI 10.1016/j.cell.2017.10.008; Elosegui-Artola A, 2016, NAT CELL BIOL, V18, P540, DOI 10.1038/ncb3336; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hata Y, 2013, MAR DRUGS, V11, P896, DOI 10.3390/md11030896; He MJ, 2016, CELL DIV, V11, DOI 10.1186/s13008-016-0013-6; Hein AL, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0172-9; Hong AW, 2017, EMBO REP, V18, P72, DOI 10.15252/embr.201642681; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kofler M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07450-0; Kuser-Abali G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9126; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lin KC, 2017, NAT CELL BIOL, V19, P996, DOI 10.1038/ncb3581; Liu AM, 2012, BBA-REV CANCER, V1826, P357, DOI 10.1016/j.bbcan.2012.05.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma SH, 2019, ANNU REV BIOCHEM, V88, P577, DOI 10.1146/annurev-biochem-013118-111829; Macedo LF, 2006, CANCER RES, V66, P7775, DOI 10.1158/0008-5472.CAN-05-3984; Manning SA, 2018, CURR BIOL, V28, P1651, DOI 10.1016/j.cub.2018.04.018; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Moon S, 2017, EMBO REP, V18, P61, DOI 10.15252/embr.201642683; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; SUDOL M, 1994, ONCOGENE, V9, P2145; THALMANN GN, 1994, CANCER RES, V54, P2577; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang KC, 2016, P NATL ACAD SCI USA, V113, P11525, DOI 10.1073/pnas.1613121113; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024288; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	47	4	4	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8550	8559		10.1074/jbc.RA120.013794	http://dx.doi.org/10.1074/jbc.RA120.013794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32376689	Green Published, hybrid			2022-12-28	WOS:000546986500019
J	Singh, V; Gowda, CP; Singh, V; Ganapathy, AS; Karamchandani, DM; Eshelman, MA; Yochum, GS; Nighot, P; Spiegelman, VS				Singh, Vikash; Gowda, Chethana P.; Singh, Vishal; Ganapathy, Ashwinkumar S.; Karamchandani, Dipti M.; Eshelman, Melanie A.; Yochum, Gregory S.; Nighot, Prashant; Spiegelman, Vladimir S.			The mRNA-binding protein IGF2BP1 maintains intestinal barrier function by up-regulating occludin expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1); occludin; intestinal epithelium; permeability; mRNA decay; RNA-binding proteins; inflammatory bowel disease (IBD); colitis; epithelial barrier; intestinal mucosa; RNA-binding protein; intestinal mucosa	TIGHT JUNCTION BARRIER; C-MYC; CRD-BP; CODING REGION; CELL-ADHESION; IMP1 PROMOTES; STEM-CELLS; HOMEOSTASIS; PHENOTYPE; FAMILY	Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an mRNA-binding protein that has an oncofetal pattern of expression. It is also expressed in intestinal tissue, suggesting that it has a possible role in intestinal homeostasis. To investigate this possibility, here we generated Villin CreERT2:Igf2bp1flox/flox mice, which enabled induction of an IGF2BP1 knockout specifically in intestinal epithelial cells (IECs) of adult mice. Using gut barrier and epithelial permeability assays and several biochemical approaches, we found that IGF2BP1 ablation in the adult intestinal epithelium causes mild active colitis and mild-to-moderate active enteritis. Moreover, the IGF2BP1 deletion aggravated dextran sodium sulfate?induced colitis. We also found that IGF2BP1 removal compromises barrier function of the intestinal epithelium, resulting from altered protein expression at tight junctions. Mechanistically, IGF2BP1 interacted with the mRNA of the tight-junction protein occludin (Ocln), stabilizing Ocln mRNA and inducing expression of occludin in IECs. Furthermore, ectopic occludin expression in IGF2BP1-knockdown cells restored barrier function. We conclude that IGF2BP1-dependent regulation of occludin expression is an important mechanism in intestinal barrier function maintenance and in the prevention of colitis.	[Singh, Vikash; Gowda, Chethana P.; Spiegelman, Vladimir S.] Penn State Coll Med, Div Hematol & Oncol, Pediat Dept, Hershey, PA 17033 USA; [Ganapathy, Ashwinkumar S.; Nighot, Prashant] Penn State Coll Med, Dept Med, Hershey, PA USA; [Karamchandani, Dipti M.] Penn State Coll Med, Dept Pathol, Hershey, PA USA; [Eshelman, Melanie A.; Yochum, Gregory S.] Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA; [Yochum, Gregory S.] Penn State Coll Med, Dept Surg, Hershey, PA USA; [Singh, Vishal] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Spiegelman, VS (corresponding author), Penn State Coll Med, Div Hematol & Oncol, Pediat Dept, Hershey, PA 17033 USA.	vspiegelman@pennstatehealth.psu.edu	Ganapathy, Ashwinkumar Subramenium/AAA-8198-2022; Singh, Vikash/HCI-9902-2022	Singh, Vikash/0000-0002-5325-1386; Spiegelman, Vladimir S/0000-0003-4847-155X; Ganapathy, Ashwinkumar Subramenium/0000-0001-5254-9431	NCI, National Institutes of Health [CA191550, CA243167]; NIDDK, National Institutes of Health [DK114024]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by NCI, National Institutes of Health, Grants CA191550 and CA243167 (to V. S. S.). This work was also supported in part by NIDDK, National Institutes of Health, Grant DK114024 (to P. N.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Al-Sadi R, 2011, AM J PHYSIOL-GASTR L, V300, pG1054, DOI 10.1152/ajpgi.00055.2011; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; Buschmann MM, 2013, MOL BIOL CELL, V24, P3056, DOI 10.1091/mbc.E12-09-0688; Catalioto RM, 2011, CURR MED CHEM, V18, P398, DOI 10.2174/092986711794839179; Chatterji P, 2019, EMBO REP, V20, DOI 10.15252/embr.201847074; Chen Y, 2015, J BIOL CHEM, V290, P20580, DOI 10.1074/jbc.M115.653584; Conway AE, 2016, CELL REP, V15, P666, DOI 10.1016/j.celrep.2016.03.052; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Degrauwe N, 2016, GENE DEV, V30, P2459, DOI 10.1101/gad.287540.116; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Franklin CL, 2017, LAB ANIMAL, V46, P114, DOI 10.1038/laban.1222; Gehart H, 2019, NAT REV GASTRO HEPAT, V16, P19, DOI 10.1038/s41575-018-0081-y; Goswami S, 2015, J BIOL CHEM, V290, P384, DOI 10.1074/jbc.M114.590158; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hamilton KE, 2015, MOL CANCER RES, V13, P1478, DOI 10.1158/1541-7786.MCR-15-0224; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Harlow E, 1988, ANTIBODIES LABORATOR, P471; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Kanarek N, 2014, P NATL ACAD SCI USA, V111, pE702, DOI 10.1073/pnas.1322691111; Kim DH, 2017, IMMUNE NETW, V17, P25, DOI 10.4110/in.2017.17.1.25; Knuckles P, 2012, NAT NEUROSCI, V15, P962, DOI 10.1038/nn.3139; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Manieri NA, 2012, GASTROENTEROLOGY, V143, P110, DOI 10.1053/j.gastro.2012.03.037; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Martinez C, 2017, GUT, V66, P1597, DOI 10.1136/gutjnl-2016-311477; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Muller S, 2019, NUCLEIC ACIDS RES, V47, P375, DOI 10.1093/nar/gky1012; Muller S, 2018, NUCLEIC ACIDS RES, V46, P6285, DOI 10.1093/nar/gky229; Nighot PK, 2015, J BIOL CHEM, V290, P7234, DOI 10.1074/jbc.M114.597492; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Rath E, 2012, GUT, V61, P1269, DOI 10.1136/gutjnl-2011-300767; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Rutgeerts P, 2009, GASTROENTEROLOGY, V136, P1182, DOI 10.1053/j.gastro.2009.02.001; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Tambuwala MM, 2010, GASTROENTEROLOGY, V139, P2093, DOI 10.1053/j.gastro.2010.06.068; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Van Itallie CM, 2010, J CELL SCI, V123, P2844, DOI 10.1242/jcs.065581; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Vogt M., 2013, BIO-PROTOCOL, V3, pe398, DOI DOI 10.21769/BioProtoc.398; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xiao L, 2014, CURR OPIN PHARMACOL, V19, P46, DOI 10.1016/j.coph.2014.07.006; Yisraeli JK, 2005, BIOL CELL, V97, P87; Yu T, 2016, CELL TISSUE RES, V366, P341, DOI 10.1007/s00441-016-2435-5; Yu TX, 2013, MOL BIOL CELL, V24, P85, DOI 10.1091/mbc.E12-07-0531; Ziegler TR, 2008, AM J PHYSIOL-REG I, V294, pR402, DOI 10.1152/ajpregu.00650.2007	59	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8602	8612		10.1074/jbc.AC120.013646	http://dx.doi.org/10.1074/jbc.AC120.013646			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32385106	hybrid, Green Published			2022-12-28	WOS:000546986500024
J	Wang, ZJ; Blanco, I; Hayoz, S; Brelidze, TI				Wang, Ze-Jun; Blanco, Ismary; Hayoz, Sebastien; Brelidze, Tinatin I.			The HCN domain is required for HCN channel cell-surface expression and couples voltage- and cAMP-dependent gating mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; TRANSMEMBRANE PROTEINS; PACEMAKER CHANNELS; HYPERPOLARIZATION; ACTIVATION; IDENTIFICATION; MUTATION; DEACTIVATION; DYSFUNCTION; MODULATION	Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are major regulators of synaptic plasticity and rhythmic activity in the heart and brain. Opening of HCN channels requires membrane hyperpolarization and is further facilitated by intracellular cyclic nucleotides (cNMPs). In HCN channels, membrane hyperpolarization is sensed by the membrane-spanning voltage sensor domain (VSD), and the cNMP-dependent gating is mediated by the intracellular cyclic nucleotide-binding domain (CNBD) connected to the pore-forming S6 transmembrane segment via the C-linker. Previous functional analysis of HCN channels has suggested a direct or allosteric coupling between the voltage- and cNMP-dependent activation mechanisms. However, the specifics of this coupling remain unclear. The first cryo-EM structure of an HCN1 channel revealed that a novel structural element, dubbed the HCN domain (HCND), forms a direct structural link between the VSD and C-linker-CNBD. In this study, we investigated the functional significance of the HCND. Deletion of the HCND prevented surface expression of HCN2 channels. Based on the HCN1 structure analysis, we identified Arg(237)and Gly(239)residues on the S2 of the VSD that form direct interactions with Ile(135)on the HCND. Disrupting these interactions abolished HCN2 currents. We also identified three residues on the C-linker?CNBD (Glu(478), Gln(482), and His(559)) that form direct interactions with residues Arg(154)and Ser(158)on the HCND. Disrupting these interactions affected both voltage- and cAMP-dependent gating of HCN2 channels. These findings indicate that the HCND is necessary for the cell-surface expression of HCN channels and provides a functional link between voltage- and cAMP-dependent mechanisms of HCN channel gating.	[Wang, Ze-Jun; Hayoz, Sebastien; Brelidze, Tinatin I.] Georgetown Univ, Med Ctr, Dept Pharmacol & Physiol, Washington, DC 20007 USA; [Blanco, Ismary; Brelidze, Tinatin I.] Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA; [Hayoz, Sebastien] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	Georgetown University; Georgetown University; California Institute of Technology	Brelidze, TI (corresponding author), Georgetown Univ, Med Ctr, Dept Pharmacol & Physiol, Washington, DC 20007 USA.; Brelidze, TI (corresponding author), Georgetown Univ, Med Ctr, Interdisciplinary Program Neurosci, Washington, DC 20007 USA.	tib5@georgetown.edu		Blanco, Ismary/0000-0003-4499-1427; Brelidze, Tinatin/0000-0003-3046-8184	NIGMS, National Institutes of Health [R01GM124020]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01GM124020 (to T. I. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Chiavegatto S, 2001, P NATL ACAD SCI USA, V98, P1277, DOI 10.1073/pnas.031487198; Cowgill J, 2019, P NATL ACAD SCI USA, V116, P670, DOI 10.1073/pnas.1816724116; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Dai GC, 2019, NAT STRUCT MOL BIOL, V26, P686, DOI 10.1038/s41594-019-0259-1; Dibbens LM, 2010, ANN NEUROL, V67, P542, DOI 10.1002/ana.21909; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DiFrancesco D, 2010, CIRC RES, V106, P434, DOI 10.1161/CIRCRESAHA.109.208041; DiFrancesco JC, 2011, J NEUROSCI, V31, P17327, DOI 10.1523/JNEUROSCI.3727-11.2011; Flynn GE, 2018, P NATL ACAD SCI USA, V115, pE8086, DOI 10.1073/pnas.1805596115; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Hummert S, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006045; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kasimova MA, 2019, ELIFE, V8, DOI 10.7554/eLife.53400; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; King BR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r68; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; Kwan DCH, 2012, J GEN PHYSIOL, V140, P279, DOI 10.1085/jgp.201210838; Lee CH, 2019, CELL, V179, P1582, DOI 10.1016/j.cell.2019.11.006; Lee CH, 2017, CELL, V168, P111, DOI 10.1016/j.cell.2016.12.023; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Moller M, 2018, CELL PHYSIOL BIOCHEM, V49, P1238, DOI 10.1159/000493301; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080376; Nava C, 2014, NAT GENET, V46, P640, DOI 10.1038/ng.2952; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; Pan Y, 2015, INVEST OPHTH VIS SCI, V56, P3514, DOI 10.1167/iovs.15-16902; Porro A, 2019, ELIFE, V8, DOI 10.7554/eLife.49672; Proenza C, 2002, J BIOL CHEM, V277, P29634, DOI 10.1074/jbc.M200504200; Puljung MC, 2014, P NATL ACAD SCI USA, V111, P9816, DOI 10.1073/pnas.1405371111; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Schulze-Bahr E, 2003, J CLIN INVEST, V111, P1537, DOI 10.1172/JCI200316387; Shi WM, 1999, CIRC RES, V85, pE1; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Tang B, 2008, NEUROBIOL DIS, V29, P59, DOI 10.1016/j.nbd.2007.08.006; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang ZJ, 2019, BIOPHYS J, V116, p103A, DOI 10.1016/j.bpj.2018.11.592; Wicks NL, 2009, PFLUG ARCH EUR J PHY, V458, P877, DOI 10.1007/s00424-009-0687-6; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	42	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8164	8173		10.1074/jbc.RA120.013281	http://dx.doi.org/10.1074/jbc.RA120.013281			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32341127	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000542965700005
J	Kiatpakdee, B; Sato, K; Otsuka, Y; Arashiki, N; Chen, YQ; Tsumita, T; Otsu, W; Yamamoto, A; Kawata, R; Yamazaki, J; Sugimoto, Y; Takada, K; Mohandas, N; Inaba, M				Kiatpakdee, Benjaporn; Sato, Kota; Otsuka, Yayoi; Arashiki, Nobuto; Chen, Yuqi; Tsumita, Takuya; Otsu, Wataru; Yamamoto, Akito; Kawata, Reo; Yamazaki, Jumpei; Sugimoto, Yoshikazu; Takada, Kensuke; Mohandas, Narla; Inaba, Mutsumi			Cholesterol-binding protein TSPO2 coordinates maturation and proliferation of terminally differentiating erythroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; cytokinesis; cell cycle; erythropoiesis; erythrocyte; Na plus; K plus -ATPase; erythroblast; TSPO2	CELL-CYCLE; METHYLTRANSFERASE SETD8; 18 KDA; ERYTHROCYTE; EXPRESSION; APOPTOSIS; MICE; HYPOCHOLESTEROLEMIA; ACCUMULATION; DEGRADATION	TSPO2 (translocator protein 2) is a transmembrane protein specifically expressed in late erythroblasts and has been postulated to mediate intracellular redistribution of cholesterol. We identified TSPO2 as the causative gene for the HK (high-K+) trait with immature red cell phenotypes in dogs and investigated the effects of the TSPO2 defects on erythropoiesis in HK dogs with the TSPO2 mutation and Tspo2 knockout (Tspo2(?/?)) mouse models. Bone marrow?derived erythroblasts from HK dogs showed increased binucleated and apoptotic cells at various stages of maturation and shed large nuclei with incomplete condensation when cultured in the presence of erythropoietin, indicating impaired maturation and cytokinesis. The canine TSPO2 induces cholesterol accumulation in the endoplasmic reticulum and could thereby regulate cholesterol availability by changing intracellular cholesterol distribution in erythroblasts. Tspo2(?/?) mice consistently showed impaired cytokinesis with increased binucleated erythroblasts, resulting in compensated anemia, and their red cell membranes had increased Na,K-ATPase, resembling the HK phenotype in dogs. Tspo2-deficient mouse embryonic stem cell?derived erythroid progenitor (MEDEP) cells exhibited similar morphological defects associated with a cell-cycle arrest at the G(2)/M phase, resulting in decreased cell proliferation and had a depletion in intracellular unesterified and esterified cholesterol. When the terminal maturation was induced, Tspo2(?/?) MEDEP cells showed delays in hemoglobinization; maturation-associated phenotypic changes in CD44, CD71, and TER119 expression; and cell-cycle progression. Taken together, these findings imply that TSPO2 is essential for coordination of maturation and proliferation of erythroblasts during normal erythropoiesis.	[Kiatpakdee, Benjaporn; Sato, Kota; Otsuka, Yayoi; Arashiki, Nobuto; Chen, Yuqi; Tsumita, Takuya; Otsu, Wataru; Yamamoto, Akito; Kawata, Reo; Yamazaki, Jumpei; Takada, Kensuke; Inaba, Mutsumi] Hokkaido Univ, Lab Mol Med, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Sugimoto, Yoshikazu] Shirakawa Inst Anim Genet, Shirakawa, Japan; [Mohandas, Narla] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10021 USA; [Sato, Kota] Natl Vet Assay Lab, Tokyo, Japan; [Otsuka, Yayoi] Iwate Univ, Cooperat Dept Vet Med, Fac Agr, Morioka, Iwate, Japan; [Arashiki, Nobuto] Tokyo Womens Med Univ, Dept Biochem, Tokyo, Japan; [Otsu, Wataru] Gifu Pharmaceut Univ, Biomed Res Lab, Gifu, Japan; [Kawata, Reo] Otsuka Pharmaceut Tokushima Res Inst, Tokushima, Japan	Hokkaido University; New York Blood Center; Iwate University; Tokyo Women's Medical University; Gifu Pharmaceutical University	Inaba, M (corresponding author), Hokkaido Univ, Lab Mol Med, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	inazo@vetmed.hokudai.ac.jp	Arashiki, Nobuto/AAH-6776-2019	Arashiki, Nobuto/0000-0001-5306-9405; Otsu, Wataru/0000-0002-5930-1954	Japan Society for Promotion of Science [19208027, 25282177, 15K14861, 16H05031, 20H03138]; NCI, National Institutes of Health [DK32094]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by Grants-in-aid for Scientific Research 19208027, 25282177, 15K14861, 16H05031, and 20H03138 from the Japan Society for Promotion of Science (to M. I.). N. M. was supported in part by NCI, National Institutes of Health, Grant DK32094. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; CHAN PC, 1964, BIOCHIM BIOPHYS ACTA, V79, P242; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; CIOE L, 1981, CANCER RES, V41, P237; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; De Maria R, 1999, BLOOD, V93, P796, DOI 10.1182/blood.V93.3.796.403k23_796_803; Dzierzak E, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011601; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Fan JJ, 2009, J BIOL CHEM, V284, P30484, DOI 10.1074/jbc.M109.029876; Fernandez C, 2005, J LIPID RES, V46, P920, DOI 10.1194/jlr.M400407-JLR200; Fernandez C, 2004, EXP CELL RES, V300, P109, DOI 10.1016/j.yexcr.2004.06.029; Gautier EF, 2020, BLOOD ADV, V4, P1464, DOI 10.1182/bloodadvances.2020001652; Gnanapragasam MN, 2016, BLOOD, V128, P1631, DOI 10.1182/blood-2016-03-706671; HANSPAL M, 1987, J CELL BIOL, V105, P1417, DOI 10.1083/jcb.105.3.1417; Hiroyama T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001544; Holm TM, 2002, BLOOD, V99, P1817, DOI 10.1182/blood.V99.5.1817; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; INABA M, 1989, COMP BIOCHEM PHYS B, V92, P151, DOI 10.1016/0305-0491(89)90328-3; INABA M, 1986, J BIOL CHEM, V261, P6099; Inaba M., 2010, SCHALMS VET HEMATOLO, P187; Ito D, 2006, J CELL SCI, V119, P3602, DOI 10.1242/jcs.03101; Keerthivasan G, 2010, BLOOD, V116, P3331, DOI 10.1182/blood-2010-03-277426; Kettle E, 2015, TRAFFIC, V16, P1174, DOI 10.1111/tra.12328; Komatsu T, 2010, J VET MED SCI, V72, P893, DOI 10.1292/jvms.10-0030; Konstantinidis DG, 2015, BLOOD, V126, P1473, DOI 10.1182/blood-2014-12-616169; Konstantinidis DG, 2012, BLOOD, V119, P6118, DOI 10.1182/blood-2011-09-379263; LAZARIDES E, 1984, CELL, V37, P354, DOI 10.1016/0092-8674(84)90364-7; Liu J, 2013, BLOOD, V121, pE43, DOI 10.1182/blood-2012-09-456079; MAEDE Y, 1985, J BIOL CHEM, V260, P3337; MAEDE Y, 1983, BLOOD, V61, P493; MAEDE Y, 1987, AM J VET RES, V48, P114; Malik J, 2017, CELL REP, V21, P2376, DOI 10.1016/j.celrep.2017.11.011; Malik J, 2015, MOL CELL BIOL, V35, P2059, DOI 10.1128/MCB.01413-14; Marginedas-Freixa I, 2016, SCI REP-UK, V6, DOI 10.1038/srep33516; Marginedas-Freixa I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29885-7; Martinez-Botas J, 1999, FASEB J, V13, P1359, DOI 10.1096/fasebj.13.11.1359; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Minami R, 2003, EXP HEMATOL, V31, P355, DOI 10.1016/S0301-472X(03)00040-7; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Ng MM, 2005, DEV CELL, V9, P781, DOI 10.1016/j.devcel.2005.11.002; Ohene-Abuakwa Y, 2005, BLOOD, V105, P838, DOI 10.1182/blood-2004-03-1016; Otsu W, 2013, J BIOL CHEM, V288, P18521, DOI 10.1074/jbc.M112.443325; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Papayannopoulou T., 2017, HEMATOLOGY BASIC PRI; Peller S, 2003, ONCOGENE, V22, P4648, DOI 10.1038/sj.onc.1206541; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson MS, 2015, TRAFFIC, V16, P1210, DOI 10.1111/tra.12335; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Runz H, 2006, EMBO J, V25, P2953, DOI 10.1038/sj.emboj.7601205; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Sankaran VG, 2012, GENE DEV, V26, P2075, DOI 10.1101/gad.197020.112; Shalev H, 2007, AM J HEMATOL, V82, P199, DOI 10.1002/ajh.20804; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; VITOLS S, 1985, LANCET, V2, P1150; Wang CC, 2012, J VET MED SCI, V74, P17, DOI 10.1292/jvms.11-0345; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Zamai L, 2000, BLOOD, V95, P3716; Zhang SY, 2017, HUM MOL GENET, V26, P3823, DOI 10.1093/hmg/ddx269; Zhao BB, 2016, DEV CELL, V36, P498, DOI 10.1016/j.devcel.2016.02.001	61	6	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8048	8063		10.1074/jbc.RA119.011679	http://dx.doi.org/10.1074/jbc.RA119.011679			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32358067	Green Published, hybrid			2022-12-28	WOS:000540935400018
J	Lee, CAA; Banerjee, P; Wilson, BJ; Wu, SY; Guo, Q; Berg, G; Karpova, S; Mishra, A; Lian, JW; Tran, J; Emmerich, M; Murphy, GF; Frank, MH; Frank, NY				Lee, Catherine A. A.; Banerjee, Pallavi; Wilson, Brian J.; Wu, Siyuan; Guo, Qin; Berg, Gretchen; Karpova, Svetlana; Mishra, Ananda; Lian, John W.; Tran, Johnathan; Emmerich, Max; Murphy, George F.; Frank, Markus H.; Frank, Natasha Y.			Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glioblastoma; cancer stem cells; chemoresistance; anticancer drug; cell cycle; apoptosis; tumor marker; temozolomide; ATP-binding cassette subfamily B member 5 (ABCB5); glioblastoma multiforme; CD133	CANCER STEM-CELL; ELEVATED EXPRESSION; P-GLYCOPROTEIN; CHEMORESISTANCE; IDENTIFICATION; RESISTANCE; DENSITY; ARREST; GROWTH; NORMALIZATION	Glioblastoma multiforme (GBM) is a malignant brain tumor with a poor prognosis resulting from tumor resistance to anticancer therapy and a high recurrence rate. Compelling evidence suggests that this is driven by subpopulations of cancer stem cells (CSCs) with tumor-initiating potential. ABC subfamily B member 5 (ABCB5) has been identified as a molecular marker for distinct subsets of chemoresistant tumor-initiating cell populations in diverse human malignancies. In the current study, we examined the potential role of ABCB5 in growth and chemoresistance of GBM. We found that ABCB5 is expressed in primary GBM tumors, in which its expression was significantly correlated with the CSC marker protein CD133 and with overall poor survival. Moreover, ABCB5 was also expressed by CD133-positive CSCs in the established human U-87 MG, LN-18, and LN-229 GBM cell lines. Antibody- or shRNA-mediated functional ABCB5 blockade inhibited proliferation and survival of GBM cells and sensitized them to temozolomide (TMZ)-induced apoptosis in vitro. Likewise, in in vivo human GBM xenograft experiments with immunodeficient mice, mAb treatment inhibited growth of mutant TP53, WT PTEN LN-229 tumors, and sensitized LN-229 tumors to TMZ therapy. Mechanistically, we demonstrate that ABCB5 blockade inhibits TMZ-induced G(2)/M arrest and augments TMZ-mediated cell death. Our results identify ABCB5 as a GBM chemoresistance marker and point to the potential utility of targeting ABCB5 to improve current GBM therapies.	[Lee, Catherine A. A.; Wu, Siyuan; Guo, Qin; Karpova, Svetlana; Mishra, Ananda; Tran, Johnathan; Frank, Natasha Y.] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Lian, John W.; Murphy, George F.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Frank, Markus H.] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Lee, Catherine A. A.; Banerjee, Pallavi; Wilson, Brian J.; Guo, Qin; Berg, Gretchen; Mishra, Ananda; Tran, Johnathan; Emmerich, Max; Frank, Markus H.; Frank, Natasha Y.] Harvard Med Sch, Boston Childrens Hosp, Transplant Res Program, Boston, MA 02115 USA; [Banerjee, Pallavi; Guo, Qin; Berg, Gretchen; Karpova, Svetlana; Frank, Natasha Y.] Vet Affairs Boston Healthcare Syst, Dept Med, Boston, MA 02132 USA; [Wilson, Brian J.; Murphy, George F.; Frank, Markus H.; Frank, Natasha Y.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Frank, Markus H.] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA 6027, Australia	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Edith Cowan University	Frank, NY (corresponding author), Brigham & Womens Hosp, 77 Ave Louis Pasteur,168F, Boston, MA 02115 USA.	nyfrank@bwh.harvard.edu	; Frank, Markus/O-1625-2014	Tran, Johnathan/0000-0002-0769-4848; Frank, Markus/0000-0002-1312-0488; Emmerich, Max/0000-0002-2026-974X	National Institutes of Health [T32 EB016652-05]; Vetarans Affairs BLRD Grant [1I01BX000516]; Vetarans Affairs RRDGrant [1I01RX000989]; Merit Review Awards; Department of Defense translational team science award; NCI, National Institutes of Health [R01CA113796, R01CA158467, R01CA138231]; NEI, National Institutes of Health [1RO1EY025794, R24EY028767]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vetarans Affairs BLRD Grant; Vetarans Affairs RRDGrant; Merit Review Awards; Department of Defense translational team science award; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant T32 EB016652-05 (to C. A. A. L.); Vetarans Affairs BLR&D Grant 1I01BX000516 andRR&DGrant 1I01RX000989, Merit Review Awards, and a Department of Defense translational team science award (to N. Y. F.); NCI, National Institutes of Health, Grants R01CA113796, R01CA158467, and R01CA138231 (to M. H. F.); and NEI, National Institutes of Health, Grants 1RO1EY025794 and R24EY028767 (to M. H. F. and N. Y. F.). N. Y. F. and M. H. F. are co-inventors of the ABCB5-related United States Patent 7,928,202 (Targeting ABCB5 for cancer therapy) assigned to Brigham and Women's Hospital, Boston, Massachusetts, and licensed to Ticeba GmbH (Heidelberg, Germany) and Rheacell GmbH & Co. KG (Heidelberg, Germany). M. H. F. serves as a scientific advisor to Ticeba GmbH and Rheacell GmbH & Co. KG. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso MM, 2007, CANCER RES, V67, P11499, DOI 10.1158/0008-5472.CAN-07-5312; Auffinger B, 2014, CELL DEATH DIFFER, V21, P1119, DOI 10.1038/cdd.2014.31; Back M, 2018, CLIN ONCOL-UK, V30, P556, DOI 10.1016/j.clon.2018.06.005; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Behnan J, 2019, BRAIN, V142, P847, DOI 10.1093/brain/awz044; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheung ST, 2011, GASTROENTEROLOGY, V140, P344, DOI 10.1053/j.gastro.2010.07.049; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; El-Khattouti A, 2015, CANCER LETT, V357, P83, DOI 10.1016/j.canlet.2014.10.043; Filippi-Chiela EC, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-147; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Gazzaniga P, 2010, EJSO-EUR J SURG ONC, V36, P1211, DOI 10.1016/j.ejso.2010.05.001; Grimm M, 2012, EUR J CANCER, V48, P3186, DOI 10.1016/j.ejca.2012.05.027; Guo Q, 2018, J BIOL CHEM, V293, P11166, DOI 10.1074/jbc.RA118.003187; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hirose Y, 2001, CANCER RES, V61, P5843; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson JR, 2000, CANCER RES, V60, P566; Jongkhajornpong P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20541; Kleffel S, 2016, J INVEST DERMATOL, V136, P838, DOI 10.1016/j.jid.2015.12.038; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Ksander BR, 2014, NATURE, V511, P353, DOI 10.1038/nature13426; Lai CY, 2012, CANCER RES, V72, P5111, DOI 10.1158/0008-5472.CAN-12-0624; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lin F, 2014, CLIN CANCER RES, V20, P2703, DOI 10.1158/1078-0432.CCR-14-0084; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Luna JI, 2019, CANCERS, V11, DOI 10.3390/cancers11010085; Munoz JL, 2015, CANCER LETT, V367, P69, DOI 10.1016/j.canlet.2015.07.013; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Olar A, 2014, J PATHOL, V232, P165, DOI 10.1002/path.4282; Pore N, 2003, CANCER RES, V63, P236; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Scherer HJ, 1940, J NEUROL PSYCHIATRY, V3, P147, DOI 10.1136/jnnp.3.2.147; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Sherr CJ, 2000, CANCER RES, V60, P3689; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tyagi AK, 2002, CLIN CANCER RES, V8, P3512; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wei LH, 2008, CLIN CANCER RES, V14, P3416, DOI 10.1158/1078-0432.CCR-07-1824; Wijaya J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122544; Wilson BJ, 2011, CANCER RES, V71, P5307, DOI 10.1158/0008-5472.CAN-11-0221; Woo JY, 2015, J KOREAN NEUROSURG S, V58, P426, DOI 10.3340/jkns.2015.58.5.426; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.182	53	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7774	7788		10.1074/jbc.RA120.013778	http://dx.doi.org/10.1074/jbc.RA120.013778			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32317280	hybrid, Green Published			2022-12-28	WOS:000538038900017
J	Harrington, HR; Zimmer, MH; Chamness, LM; Nash, V; Penn, WD; Miller, TF; Mukhopadhyay, S; Schlebach, JP				Harrington, Haley R.; Zimmer, Matthew H.; Chamness, Laura M.; Nash, Veronica; Penn, Wesley D.; Miller, Thomas F., III; Mukhopadhyay, Suchetana; Schlebach, Jonathan P.			Cotranslational folding stimulates programmed ribosomal frameshifting in the alphavirus structural polyprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; membrane protein; transmembrane domain; translocation; translation control; ribosome; alphavirus; programmed ribosomal frameshifting; topology; Sindbis virus; translocon; membrane protein folding; cotranslational folding	SITE-DIRECTED MUTATIONS; TRANSMEMBRANE HELICES; MEMBRANE-PROTEINS; INNER MEMBRANE; MESSENGER-RNA; VIRUS; RECOGNITION; EXPRESSION; CYSTEINES; TOPOLOGY	Viruses maximize their genetic coding capacity through a variety of biochemical mechanisms, including programmed ribosomal frameshifting (PRF), which facilitates the production of multiple proteins from a single mRNA transcript. PRF is typically stimulated by structural elements within the mRNA that generate mechanical tension between the transcript and ribosome. However, in this work, we show that the forces generated by the cotranslational folding of the nascent polypeptide chain can also enhance PRF. Using an array of biochemical, cellular, and computational techniques, we first demonstrate that the Sindbis virus structural polyprotein forms two competing topological isomers during its biosynthesis at the ribosome-translocon complex. We then show that the formation of one of these topological isomers is linked to PRF. Coarse-grained molecular dynamics simulations reveal that the translocon-mediated membrane integration of a transmembrane domain upstream from the ribosomal slip site generates a force on the nascent polypeptide chain that scales with observed frameshifting. Together, our results indicate that cotranslational folding of this viral protein generates a tension that stimulates PRF. To our knowledge, this constitutes the first example in which the conformational state of the nascent polypeptide chain has been linked to PRF. These findings raise the possibility that, in addition to RNA-mediated translational recoding, a variety of cotranslational folding or binding events may also stimulate PRF.	[Harrington, Haley R.; Chamness, Laura M.; Nash, Veronica; Penn, Wesley D.; Schlebach, Jonathan P.] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Mukhopadhyay, Suchetana] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Zimmer, Matthew H.; Miller, Thomas F., III] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; California Institute of Technology	Schlebach, JP (corresponding author), Indiana Univ, Dept Chem, Bloomington, IN 47405 USA.; Mukhopadhyay, S (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.; Miller, TF (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	tfm@caltech.edu; jschleba@indiana.edu; sumukhop@indiana.edu			NIAID, National Institutes of Health [R21AI142383]; NIGMS, National Institutes of Health [R01GM125063]	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by NIAID, National Institutes of Health, Grant R21AI142383 (to J. P. S. and S. M.) as well as NIGMS, National Institutes of Health, Grant R01GM125063 (to T. F. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belew AT, 2014, NATURE, V512, P265, DOI 10.1038/nature13429; Bock LV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12648-x; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Brown RS, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020089; Caliskan N, 2015, TRENDS BIOCHEM SCI, V40, P265, DOI 10.1016/j.tibs.2015.03.006; Caliskan N, 2014, CELL, V157, P1619, DOI 10.1016/j.cell.2014.04.041; Chen J, 2014, NATURE, V512, P328, DOI 10.1038/nature13428; Chen LH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07704-x; CHENG RH, 1995, CELL, V80, P621; Choi J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax6969; Chung BYW, 2010, J MOL BIOL, V397, P448, DOI 10.1016/j.jmb.2010.01.044; Cymer F, 2014, FEBS LETT, V588, P1930, DOI 10.1016/j.febslet.2014.03.050; Cymer F, 2013, P NATL ACAD SCI USA, V110, P14640, DOI 10.1073/pnas.1306787110; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-108; GAEDIGKNITSCHKO K, 1990, VIROLOGY, V175, P274, DOI 10.1016/0042-6822(90)90209-A; GAFVELIN G, 1994, CELL, V77, P401, DOI 10.1016/0092-8674(94)90155-4; Goldman DH, 2015, SCIENCE, V348, P457, DOI 10.1126/science.1261909; Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13; Halma MTJ, 2019, P NATL ACAD SCI USA, V116, P19500, DOI 10.1073/pnas.1905258116; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Ismail N, 2012, NAT STRUCT MOL BIOL, V19, P1018, DOI 10.1038/nsmb.2376; IVANOVA L, 1993, J VIROL, V67, P2546, DOI 10.1128/JVI.67.5.2546-2551.1993; Kendra JA, 2018, J BIOL CHEM, V293, P17536, DOI 10.1074/jbc.RA118.005606; Khan Y. A., 2019, CONTESTING EVIDENCE, DOI [10.1101/513333, DOI 10.1101/513333]; Kim HK, 2014, P NATL ACAD SCI USA, V111, P5538, DOI 10.1073/pnas.1403457111; Korniy N, 2019, FEBS LETT, V593, P1468, DOI 10.1002/1873-3468.13478; Lee H, 2012, BIOCHEM BIOPH RES CO, V427, P780, DOI 10.1016/j.bbrc.2012.09.138; Leininger SE, 2019, BIOCHEMISTRY-US, V58, P4657, DOI 10.1021/acs.biochem.9b00260; LILJESTROM P, 1991, J VIROL, V65, P147; LOBIGS M, 1990, J VIROL, V64, P4346, DOI 10.1128/JVI.64.9.4346-4355.1990; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Muldoon-Jacobs KL, 2006, EUKARYOT CELL, V5, P762, DOI 10.1128/EC.5.4.762-770.2006; Mulvey M, 1996, VIROLOGY, V219, P125, DOI 10.1006/viro.1996.0229; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Napthine S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15582; Niesen MJM, 2018, BIOPHYS J, V115, P1885, DOI 10.1016/j.bpj.2018.10.002; Niesen MJM, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005427; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Ramsey J, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080228; Ramsey J, 2017, J VIROL, V91, DOI 10.1128/JVI.02000-16; Rogers KJ, 2020, VIROLOGY, V542, P63, DOI 10.1016/j.virol.2020.01.001; Roushar FJ, 2019, J AM CHEM SOC, V141, P204, DOI 10.1021/jacs.8b08243; Ruch TR, 2012, VIRUSES-BASEL, V4, P363, DOI 10.3390/v4030363; Ryan C, 1998, VIROLOGY, V249, P62, DOI 10.1006/viro.1998.9281; Snyder AJ, 2012, J VIROL, V86, P3100, DOI 10.1128/JVI.06615-11; Snyder JE, 2013, J VIROL, V87, P8511, DOI 10.1128/JVI.00449-13; Taylor A, 2016, J VIROL, V90, P4150, DOI 10.1128/JVI.03192-15; Van Lehn RC, 2015, ELIFE, V4, DOI 10.7554/eLife.08697; Virkki MT, 2014, PROTEIN SCI, V23, P981, DOI 10.1002/pro.2483; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Wang XL, 2019, CELL, V176, P625, DOI 10.1016/j.cell.2018.12.030; Wu S, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4967956; Zhang B, 2012, CELL REP, V2, P927, DOI 10.1016/j.celrep.2012.08.039	55	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6798	6808		10.1074/jbc.RA120.012706	http://dx.doi.org/10.1074/jbc.RA120.012706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32169904	hybrid, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000536212600002
J	Pilquil, C; Alvandi, Z; Opas, M				Pilquil, Carlos; Alvandi, Zahra; Opas, Michal			Calreticulin regulates a switch between osteoblast and chondrocyte lineages derived from murine embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell (ESC); glycogen synthase kinase 3 (GSK-3); Wnt signaling; chondrogenesis; NFAT transcription factor; calreticulin; osteogenesis; nuclear factor of activated T cells 1 (NFATC1); gene regulation; cell fate decision; development	ENDOPLASMIC-RETICULUM; BONE-FORMATION; CALCINEURIN; CALCIUM; NFAT; DIFFERENTIATION; DICKKOPF-1; UPSTREAM; CA2+; DKK1	Calreticulin is a highly conserved, ubiquitous Ca2+-buffering protein in the endoplasmic reticulum that controls transcriptional activity of various developmental programs and also of embryonic stem cell (ESC) differentiation. Calreticulin activates calcineurin, which dephosphorylates and induces the nuclear import of the osteogenic transcription regulator nuclear factor of activated T cells 1 (NFATC1). We investigated whether calreticulin controls a switch between osteogenesis and chondrogenesis in mouse ESCs through NFATC1. We found that in the absence of calreticulin, intranuclear transport of NFATC1 is blocked and that differentiation switches from osteogenic to chondrogenic, a process that could be mimicked by chemical inhibition of NFAT translocation. Glycogen synthase kinase 3? (GSK3?) deactivation and nuclear localization of ?-catenin critical to osteogenesis were abrogated by calreticulin deficiency or NFAT blockade. Chemically induced GSK3? inhibition bypassed the calreticulin/calcineurin axis and increased osteoblast output from both control and calreticulin-deficient ESCs, while suppressing chondrogenesis. Calreticulin-deficient ESCs or cells treated with an NFAT blocker had enhanced expression of dickkopf WNT-signaling pathway inhibitor 1 (Dkk1), a canonical Wnt pathway antagonist that blocks GSK3? deactivation. The addition of recombinant mDKK1 switched osteogenic ESC differentiation toward chondrogenic differentiation. The results of our study indicate a role for endoplasmic reticulum calcium signaling via calreticulin in the differentiation of ESCs to closely associated osteoblast or chondrocyte lineages.	[Pilquil, Carlos; Alvandi, Zahra; Opas, Michal] Univ Toronto, Dept Lab Med & Pathobiol, 1 Kings Coll Circle,Med Sci Bldg,Rm 6326, Toronto, ON M5S 1A8, Canada	University of Toronto	Pilquil, C (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, 1 Kings Coll Circle,Med Sci Bldg,Rm 6326, Toronto, ON M5S 1A8, Canada.	cs2.pilquil@gmail.com		Pilquil, Carlos/0000-0002-4033-5054; Alvandi, Zahra/0000-0003-0097-4713	Canadian Institutes of Health Research (CIHR) [MOP-106461, MOP-130551]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Grants MOP-106461 and MOP-130551 (to M. O.). The authors declare that they have no conflicts of interest with the contents of this article.	BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Craft AM, 2013, DEVELOPMENT, V140, P2597, DOI 10.1242/dev.087890; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Djuric SW, 2000, J MED CHEM, V43, P2975, DOI 10.1021/jm990615a; FRUMAN DA, 1992, EUR J IMMUNOL, V22, P2513, DOI 10.1002/eji.1830221008; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Groenendyk J, 2004, MOL CELLS, V17, P383; Guo L, 2002, J BIOL CHEM, V277, P50776, DOI 10.1074/jbc.M209900200; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Kugimiya F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000837; Kumar D, 2014, CELL REP, V8, P1419, DOI 10.1016/j.celrep.2014.07.038; Lerner UH, 2015, J INTERN MED, V277, P630, DOI 10.1111/joim.12368; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Lynch J, 2005, J CELL BIOL, V170, P37, DOI 10.1083/jcb.200412156; Lynch J, 2003, BIOCHEM BIOPH RES CO, V311, P1173, DOI 10.1016/j.bbrc.2003.08.040; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; MICHAYLOVA V, 1971, ANAL CHIM ACTA, V53, P194, DOI 10.1016/S0003-2670(01)80088-X; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Papp S, 2003, J CELL BIOL, V160, P475, DOI 10.1083/jcb.200207136; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6; Sitara D, 2010, IMMUNOL REV, V233, P286, DOI 10.1111/j.0105-2896.2009.00849.x; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Tonelli FMP, 2012, ADV EXP MED BIOL, V740, P891, DOI 10.1007/978-94-007-2888-2_40; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Yu YH, 2016, METHODS MOL BIOL, V1341, P425, DOI 10.1007/7651_2014_126; Yu YH, 2015, DIFFERENTIATION, V89, P1, DOI 10.1016/j.diff.2014.12.003; Zhong L, 2016, STEM CELLS DEV, V25, P1808, DOI 10.1089/scd.2016.0222; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	41	6	6	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6861	6875		10.1074/jbc.RA119.011029	http://dx.doi.org/10.1074/jbc.RA119.011029			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32220932	Green Published, hybrid			2022-12-28	WOS:000536212600008
J	Lavenus, SB; Tudor, SM; Ullo, MF; Vosatka, KW; Logue, JS				Lavenus, Sandrine B.; Tudor, Sara M.; Ullo, Maria F.; Vosatka, Karl W.; Logue, Jeremy S.			A flexible network of vimentin intermediate filaments promotes migration of amoeboid cancer cells through confined environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; metastasis; epithelial-to-mesenchymal transition (EMT); cell migration; cytoskeleton; vimentin; amoeboid; bleb; bundling; simvastatin	MOTILITY; CHOLESTEROL; PERSISTENCE; PROTEIN	Tumor cells can spread to distant sites through their ability to switch between mesenchymal and amoeboid (bleb-based) migration. Because of this difference, inhibitors of metastasis must account for each migration mode. However, the role of vimentin in amoeboid migration has not been determined. Because amoeboid leader bleb?based migration (LBBM) occurs in confined spaces and vimentin is known to strongly influence cell-mechanical properties, we hypothesized that a flexible vimentin network is required for fast amoeboid migration. To this end, here we determined the precise role of the vimentin intermediate filament system in regulating the migration of amoeboid human cancer cells. Vimentin is a classic marker of epithelial-to-mesenchymal transition and is therefore an ideal target for a metastasis inhibitor. Using a previously developed polydimethylsiloxane slab?based approach to confine cells, RNAi-based vimentin silencing, vimentin overexpression, pharmacological treatments, and measurements of cell stiffness, we found that RNAi-mediated depletion of vimentin increases LBBM by ?50% compared with control cells and that vimentin overexpression and simvastatin-induced vimentin bundling inhibit fast amoeboid migration and proliferation. Importantly, these effects were independent of changes in actomyosin contractility. Our results indicate that a flexible vimentin intermediate filament network promotes LBBM of amoeboid cancer cells in confined environments and that vimentin bundling perturbs cell-mechanical properties and inhibits the invasive properties of cancer cells.	[Lavenus, Sandrine B.; Tudor, Sara M.; Ullo, Maria F.; Vosatka, Karl W.; Logue, Jeremy S.] Albany Med Coll, Dept Regenerat & Canc Cell Biol, 47 New Scotland Ave,Bldg Med Sci MS,Rm MS420, Albany, NY 12208 USA	Albany Medical College	Logue, JS (corresponding author), Albany Med Coll, Dept Regenerat & Canc Cell Biol, 47 New Scotland Ave,Bldg Med Sci MS,Rm MS420, Albany, NY 12208 USA.	loguej@mail.amc.edu			Albany Medical College	Albany Medical College	This work was supported by start-up funds provided by Albany Medical College. The authors declare that they have no conflicts of interest with the contents of this article.	Benn M, 2011, JNCI-J NATL CANCER I, V103, P508, DOI 10.1093/jnci/djr008; Bergert M, 2015, NAT CELL BIOL, V17, P524, DOI 10.1038/ncb3134; CHOU YH, 1991, J BIOL CHEM, V266, P7325; Costigliola N, 2017, P NATL ACAD SCI USA, V114, P5195, DOI 10.1073/pnas.1614610114; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; DEGRELLA RF, 1982, J BIOL CHEM, V257, P4256; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Eckes B, 2000, J CELL SCI, V113, P2455; Elmen J, 2005, NUCLEIC ACIDS RES, V33, P439, DOI 10.1093/nar/gki193; Fiorenza AM, 2000, INT J CLIN LAB RES, V30, P141, DOI 10.1007/s005990070013; Galou M, 1996, J CELL BIOL, V133, P853, DOI 10.1083/jcb.133.4.853; Gan Z, 2016, CELL SYST, V3, P252, DOI 10.1016/j.cels.2016.08.007; GEORGATOS SD, 1987, J CELL BIOL, V105, P117, DOI 10.1083/jcb.105.1.117; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Henrion D, 1997, J CLIN INVEST, V100, P2909, DOI 10.1172/JCI119840; Jiu YM, 2015, CELL REP, V11, P1511, DOI 10.1016/j.celrep.2015.05.008; Leduc C, 2017, J CELL BIOL, V216, P1689, DOI 10.1083/jcb.201607045; Li M, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-109; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Logue J., 2018, PROTOC EXCH, DOI [10.1038/protex.2018.033, DOI 10.1038/PROTEX.2018.033]; Logue JS, 2018, ONCOGENE, V37, P2104, DOI 10.1038/s41388-017-0071-5; Logue JS, 2015, ELIFE, V4, DOI 10.7554/eLife.08314; Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145; Makise M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4454-y; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mendez MG, 2014, BIOPHYS J, V107, P314, DOI 10.1016/j.bpj.2014.04.050; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Mostajeran Z, 2019, VIMENTIN PROVIDES TH, DOI [10.1101/720946., DOI 10.1101/720946]; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Patteson A, VIMENTIN PROTECTS ST, DOI [10.1101/566174., DOI 10.1101/566174, 10.1101/566174]; Paul CD, 2017, NAT REV CANCER, V17, P131, DOI 10.1038/nrc.2016.123; Petrie RJ, 2014, SCIENCE, V345, P1062, DOI 10.1126/science.1256965; Phua DCY, 2009, MOL BIOL CELL, V20, P2841, DOI 10.1091/mbc.E08-02-0199; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Trogden KP, 2018, FASEB J, V32, P2841, DOI 10.1096/fj.201700663R; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yamada KM, 2019, NAT REV MOL CELL BIO, V20, P738, DOI 10.1038/s41580-019-0172-9	45	18	18	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6700	6709		10.1074/jbc.RA119.011537	http://dx.doi.org/10.1074/jbc.RA119.011537			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32234762	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000537685000035
J	Lim, KS; Yong, ZWE; Wang, HJ; Tan, TZ; Huang, RYJ; Yamamoto, D; Inaki, N; Hazawa, M; Wong, RW; Oshima, H; Oshima, M; Ito, Y; Voon, DCC				Lim, Kee Siang; Yong, Zachary Wei Ern; Wang, Huajing; Tan, Tuan Zea; Huang, Ruby Yun-Ju; Yamamoto, Daisuke; Inaki, Noriyuki; Hazawa, Masaharu; Wong, Richard W.; Oshima, Hiroko; Oshima, Masanobu; Ito, Yoshiaki; Voon, Dominic Chih-Cheng			Inflammatory and mitogenic signals drive interleukin 23 subunit alpha (IL23A) secretion independent of IL12B in intestinal epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine induction; inflammation; colorectal cancer; intestinal epithelium; mitogen-activated protein kinase (MAPK); IL23A; MAPK; NF-?B; RUNX; IL23A secretion; intestinal epithelial cells; mitogenic signal; carcinogenesis; non-canonical IL-23; innate immunity; cytokine signaling	NF-KAPPA-B; LYMPHOTOXIN-BETA; IL-23 P19; IN-VITRO; GENE-EXPRESSION; HUMAN COLON; C-REL; ACTIVATION; RUNX3; DABRAFENIB	The heterodimeric cytokine interleukin-23 (IL-23 or IL23A/IL12B) is produced by dendritic cells and macrophages and promotes the proinflammatory and regenerative activities of T helper 17 (Th17) and innate lymphoid cells. A recent study has reported that IL-23 is also secreted by lung adenoma cells and generates an inflammatory and immune-suppressed stroma. Here, we observed that proinflammatory tumor necrosis factor (TNF)/NF-?B and mitogen-activated protein kinase (MAPK) signaling strongly induce IL23A expression in intestinal epithelial cells. Moreover, we identified a strong crosstalk between the NF-?B and MAPK/ERK kinase (MEK) pathways, involving the formation of a transcriptional enhancer complex consisting of proto-oncogene c-Jun (c-Jun), RELA proto-oncogene NF-?B subunit (RelA), RUNX family transcription factor 1 (RUNX1), and RUNX3. Collectively, these proteins induced IL23A secretion, confirmed by immunoprecipitation of endogenous IL23A from activated human colorectal cancer (CRC) cell culture supernatants. Interestingly, IL23A was likely secreted in a noncanonical form, as it was not detected by an ELISA specific for heterodimeric IL-23 likely because IL12B expression is absent in CRC cells. Given recent evidence that IL23A promotes tumor formation, we evaluated the efficacy of MAPK/NF-?B inhibitors in attenuating IL23A expression and found that the MEK inhibitor trametinib and BAY 11?7082 (an IKK?/I?B inhibitor) effectively inhibited IL23A in a subset of human CRC lines with mutant KRAS or BRAFV600E mutations. Together, these results indicate that proinflammatory and mitogenic signals dynamically regulate IL23A in epithelial cells. They further reveal its secretion in a noncanonical form independent of IL12B and that small-molecule inhibitors can attenuate IL23A secretion.	[Lim, Kee Siang; Tan, Tuan Zea; Huang, Ruby Yun-Ju; Ito, Yoshiaki] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Lim, Kee Siang; Wong, Richard W.; Oshima, Hiroko; Oshima, Masanobu] Kanazawa Univ, WPI Nanolife Sci Inst NanoLSI, Kanazawa, Ishikawa 9201192, Japan; [Yong, Zachary Wei Ern; Yamamoto, Daisuke; Oshima, Hiroko; Oshima, Masanobu; Voon, Dominic Chih-Cheng] Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan; [Wang, Huajing] Agcy Sci Technol & Res, Inst Bioengn & Nanotechnol, Singapore 138669, Singapore; [Huang, Ruby Yun-Ju] Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore 119228, Singapore; [Yamamoto, Daisuke] Ishikawa Prefectural Cent Hosp, Dept Gastroenterol Surg, Kanazawa, Ishikawa 9208530, Japan; [Inaki, Noriyuki] Juntendo Univ, Dept Digest & Gen Surg, Urayasu Hosp, Chiba 2790021, Japan; [Hazawa, Masaharu; Wong, Richard W.] Kanazawa Univ, Inst Nat Sci & Technol, Fac Nat Syst, Kanazawa, Ishikawa 9201192, Japan; [Hazawa, Masaharu; Wong, Richard W.; Voon, Dominic Chih-Cheng] Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa 9201192, Japan	National University of Singapore; Kanazawa University; Kanazawa University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore; Ishikawa Prefectural Central Hospital; Juntendo University; Kanazawa University; Kanazawa University	Ito, Y (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore.; Voon, DCC (corresponding author), Kanazawa Univ, Canc Res Inst, Div Genet, Kanazawa, Ishikawa 9201192, Japan.; Voon, DCC (corresponding author), Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa 9201192, Japan.	yoshi_ito@nus.edu.sg; dvoon@staff.kanazawa-u.ac.jp	HAZAWA, Masaharu/A-6520-2016; Tan, Tuan Zea/I-9227-2019; Lim, Kee Siang/AAH-1407-2019; Wong, Richard W./E-9155-2011; Inaki, Noriyuki/B-4361-2018; Hazawa, M/AAA-2712-2021	Tan, Tuan Zea/0000-0001-6624-1593; Inaki, Noriyuki/0000-0002-4241-5015; Huang, Ruby Yun-Ju/0000-0001-6376-3185; Oshima, Hiroko/0000-0001-6855-4008; Voon, Dominic Chih-Cheng/0000-0002-2963-9305; Wong, Richard/0000-0002-2131-6595	Ministry of Education Academic Research Fund (AcRF) Tier 2 Grant [MOE2014-T2-2-143]; Ministry of Education, Culture, Sports, Science and Technology of Japan [JP18K07228]; Institute for Frontier Science Initiative, Kanazawa University, inter-disciplinary research grant	Ministry of Education Academic Research Fund (AcRF) Tier 2 Grant; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute for Frontier Science Initiative, Kanazawa University, inter-disciplinary research grant	This work was supported by Ministry of Education Academic Research Fund (AcRF) Tier 2 Grant MOE2014-T2-2-143 (to Y. I.); a Ministry of Education, Culture, Sports, Science and Technology of Japan Grant-in-Aid for Scientific Research JP18K07228 (to D. C.-C. V.); and an Institute for Frontier Science Initiative, Kanazawa University, inter-disciplinary research grant. The authors declare that they have no conflicts of interest with the contents of this article.	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Al-Sammak F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075192; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Broad Institute TCGA Genome Data Analysis Center, 2016, AN READ STAND TCGA D; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Corcoran RB, 2018, CANCER DISCOV, V8, P428, DOI 10.1158/2159-8290.CD-17-1226; Corcoran RB, 2015, J CLIN ONCOL, V33, P4023, DOI 10.1200/JCO.2015.63.2471; Croxford AL, 2014, CYTOKINE GROWTH F R, V25, P415, DOI 10.1016/j.cytogfr.2014.07.017; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Deng ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036739; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Floss DM, 2015, CYTOKINE GROWTH F R, V26, P569, DOI 10.1016/j.cytogfr.2015.07.005; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hamelin V, 2006, BLOOD, V107, P3106, DOI 10.1182/blood-2005-07-2953; Hasegawa H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00479; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hor YT, 2014, CELL REP, V8, P50, DOI 10.1016/j.celrep.2014.06.003; Imai Y, 2004, MOL CELL BIOL, V24, P1033, DOI 10.1128/MCB.24.3.1033-1043.2004; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kopp T, 2003, J IMMUNOL, V170, P5438, DOI 10.4049/jimmunol.170.11.5438; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Kortlever RM, 2017, CELL, V171, P1301, DOI 10.1016/j.cell.2017.11.013; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leppa S, 1998, EMBO J, V17, P4404, DOI 10.1093/emboj/17.15.4404; LI YC, 1991, MOL CELL BIOL, V11, P1883, DOI 10.1128/MCB.11.4.1883; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; Liu L, 2015, CLIN CANCER RES, V21, P1639, DOI 10.1158/1078-0432.CCR-14-2339; Macho-Fernandez E, 2015, MUCOSAL IMMUNOL, V8, P403, DOI 10.1038/mi.2014.78; McGeachy MJ, 2007, SEMIN IMMUNOL, V19, P372, DOI 10.1016/j.smim.2007.10.012; Michaud J, 2002, BLOOD, V99, P1364, DOI 10.1182/blood.V99.4.1364; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Morrison PJ, 2011, IMMUNOLOGY, V133, P397, DOI 10.1111/j.1365-2567.2011.03454.x; Moscat J, 2003, EMBO REP, V4, P31, DOI 10.1038/sj.embor.embor704; Mouradov D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oh YS, 2013, CELL, V152, P831, DOI 10.1016/j.cell.2013.01.014; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Ramnath D, 2015, IMMUNOL CELL BIOL, V93, P771, DOI 10.1038/icb.2015.77; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Subrata LS, 2012, CYTOKINE, V60, P498, DOI 10.1016/j.cyto.2012.05.029; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tanaka T, 1996, MOL CELL BIOL, V16, P3967; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Utsugi M, 2006, J IMMUNOL, V177, P4550, DOI 10.4049/jimmunol.177.7.4550; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; Voon DC, 2004, J IMMUNOL, V172, P4332, DOI 10.4049/jimmunol.172.7.4332; Voon DC, 2001, J INTERF CYTOK RES, V21, P921, DOI 10.1089/107999001753289532; Voon DCC, 2012, STEM CELLS, V30, P2088, DOI 10.1002/stem.1183; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Yao WL, 2016, J BIOL CHEM, V291, P21694, DOI 10.1074/jbc.M116.738302	59	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6387	6400		10.1074/jbc.RA120.012943	http://dx.doi.org/10.1074/jbc.RA120.012943			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32209656	hybrid, Green Published			2022-12-28	WOS:000537685000012
J	Sweeney, C				Sweeney, Colleen			Targeting the polyamine pathway??a means? to overcome chemoresistance in triple-negative breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ORNITHINE-DECARBOXYLASE	Triple-negative breast cancer (TNBC) is characterized by its aggressive biology, early metastatic spread, and poor survival outcomes. TNBC lacks expression of the targetable receptors found in other breast cancer subtypes, mandating use of cytotoxic chemotherapy. However, resistance to chemotherapy is a significant problem, encountered in about two-thirds of TNBC patients, and new strategies are needed to mitigate resistance. In this issue of the Journal of Biological Chemistry, Geck et al. report that TNBC cells are highly sensitive to inhibition of the de novo polyamine synthesis pathway and that inhibition of this pathway sensitizes cells to TNBC-relevant chemotherapy, uncovering new opportunities for addressing chemoresistance.	[Sweeney, Colleen] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Sweeney, C (corresponding author), Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA.	casweeney@ucdavis.edu		Sweeney, Colleen/0000-0002-9924-4421				Bae DH, 2018, BBA-GEN SUBJECTS, V1862, P2053, DOI 10.1016/j.bbagen.2018.06.004; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3; Chaudhary LN, 2018, SURG ONCOL CLIN N AM, V27, P141, DOI 10.1016/j.soc.2017.08.004; Geck RC, 2020, J BIOL CHEM, V295, P6263, DOI 10.1074/jbc.RA119.012376; Lin NU, 2012, CANCER-AM CANCER SOC, V118, P5463, DOI 10.1002/cncr.27581; Lyons TG, 2019, CURR TREAT OPTION ON, V20, DOI 10.1007/s11864-019-0682-x; PRAKASH NJ, 1978, CANCER RES, V38, P3059; RUSSELL DH, 1971, CANCER RES, V31, P1555; Symmans WF, 2017, J CLIN ONCOL, V35, P1049, DOI 10.1200/JCO.2015.63.1010	10	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6278	6279		10.1074/jbc.H120.013736	http://dx.doi.org/10.1074/jbc.H120.013736			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32385094	Green Published, hybrid			2022-12-28	WOS:000537685000003
J	Hu, BC; Wang, X; Hu, SF; Ying, XM; Wang, P; Zhang, XM; Wang, J; Wang, HY; Wang, Y				Hu, Baocheng; Wang, Xiang; Hu, Shuofeng; Ying, Xiaomin; Wang, Ping; Zhang, Xiangming; Wang, Jian; Wang, Hongyan; Wang, Ya			RETRACTION: Withdrawal: miR-21-mediated radioresistance occurs via promoting repair of DNA double strand breaks. (Retraction of Vol 292, Pg 3531, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Hu BC, 2017, J BIOL CHEM, V292, P3531, DOI 10.1074/jbc.M116.772392	1	1	1	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6250	6250		10.1074/jbc.W120.013725	http://dx.doi.org/10.1074/jbc.W120.013725			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32358083	Green Published, hybrid			2022-12-28	WOS:000531417300033
J	Kirchdoerfer, RN				Kirchdoerfer, Robert N.			Halting coronavirus polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The nucleotide analogue remdesivir is an investigational drug for the treatment of human coronavirus infection. Remdesivir is a phosphoramidate prodrug and is known to target viral RNA-dependent RNA polymerases. In this issue, Gordon et al. identify that remdesivir acts as a delayed RNA chain terminator for MERS-CoV polymerase complexes.	[Kirchdoerfer, Robert N.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Kirchdoerfer, RN (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	rnkirchdoerf@wisc.edu		Kirchdoerfer, Robert/0000-0002-5974-2709	NIAID, National Institutes of Health [AI123498]	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health, Grant AI123498 (to R. N. K.). The author declares that he has no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18; Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056; Jordan Paul C., 2018, Antiviral Chemistry & Chemotherapy, V26, p2040206618764483, DOI 10.1177/2040206618764483; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395; Posthuma CC, 2017, VIRUS RES, V234, P58, DOI 10.1016/j.virusres.2017.01.023; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Subissi L, 2014, P NATL ACAD SCI USA, V111, pE3900, DOI 10.1073/pnas.1323705111; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180	10	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4780	4781		10.1074/jbc.H120.013397	http://dx.doi.org/10.1074/jbc.H120.013397			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32277065	Green Published, hybrid			2022-12-28	WOS:000526887000003
J	Lopez-Sanchez, U; Tury, S; Nicolas, G; Wilson, MS; Jurici, S; Ayrignac, X; Courgnaud, V; Saiardi, A; Sitbon, M; Battini, JL				Lopez-Sanchez, Uriel; Tury, Sandrine; Nicolas, Gael; Wilson, Miranda S.; Jurici, Snejana; Ayrignac, Xavier; Courgnaud, Valerie; Saiardi, Adolfo; Sitbon, Marc; Battini, Jean-Luc			Interplay between primary familial brain calcification-associated SLC20A2 and XPR1 phosphate transporters requires inositol polyphosphates for control of cellular phosphate homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						xenotropic and polytropic retrovirus receptor 1 (XPR1); phosphate transporter; primary familial brain calcification (PFBC); phosphate homeostasis; ATP; inositol pyrophosphate; metabolic regulation; SPX domain; efflux transporter; cell metabolism; energy metabolism; anion transport; inositol phosphate	BASAL GANGLIA CALCIFICATION; APE LEUKEMIA-VIRUS; INORGANIC-PHOSPHATE; CEREBROSPINAL-FLUID; MURINE RETROVIRUS; SURFACE RECEPTOR; GENE; MUTATIONS; PYROPHOSPHATES; CLONING	Solute carrier family 20 member 2 (SLC20A2) and xenotropic and polytropic retrovirus receptor 1 (XPR1) are transporters with phosphate uptake and efflux functions, respectively. Both are associated with primary familial brain calcification (PFBC), a genetic disease characterized by cerebral calcium-phosphate deposition and associated with neuropsychiatric symptoms. The association of the two transporters with the same disease suggests that they jointly regulate phosphate fluxes and cellular homeostasis, but direct evidence is missing. Here, we found that cross-talk between SLC20A2 and XPR1 regulates phosphate homeostasis, and we identified XPR1 as a key inositol polyphosphate (IP)-dependent regulator of this process. We found that overexpression of WT SLC20A2 increased phosphate uptake, as expected, but also unexpectedly increased phosphate efflux, whereas PFBC-associated SLC20A2 variants did not. Conversely, SLC20A2 depletion decreased phosphate uptake only slightly, most likely compensated for by the related SLC20A1 transporter, but strongly decreased XPR1-mediated phosphate efflux. The SLC20A2-XPR1 axis maintained constant intracellular phosphate and ATP levels, which both increased in XPR1 KO cells. Elevated ATP levels are a hallmark of altered inositol pyrophosphate (PP-IP) synthesis, and basal ATP levels were restored after phosphate efflux rescue with WT XPR1 but not with XPR1 harboring a mutated PP-IP?binding pocket. Accordingly, inositol hexakisphosphate kinase 1-2 (IP6K1-2) gene inactivation or IP6K inhibitor treatment abolished XPR1-mediated phosphate efflux regulation and homeostasis. Our findings unveil an SLC20A2-XPR1 interplay that depends on IPs such as PP-IPs and controls cellular phosphate homeostasis via the efflux route, and alteration of this interplay likely contributes to PFBC.	[Lopez-Sanchez, Uriel; Tury, Sandrine; Battini, Jean-Luc] Univ Montpellier, Inst Rech Infectiol Montpellier IRIM, CNRS, Montpellier, France; [Lopez-Sanchez, Uriel; Courgnaud, Valerie; Sitbon, Marc; Battini, Jean-Luc] Univ Montpellier, Inst Genet Mol Montpellier IGMM, CNRS, Montpellier, France; [Nicolas, Gael] Normandie Univ, UNIROUEN, Inserm U1245, Rouen, France; [Nicolas, Gael] Normandie Univ, Rouen Univ Hosp, Dept Genet, Rouen, France; [Nicolas, Gael] Normandie Univ, CNR MAJ, Normandy Ctr Genom & Personalized Med, Rouen, France; [Wilson, Miranda S.; Saiardi, Adolfo] UCL, MRC Lab Mol Cell Biol, London, England; [Jurici, Snejana] Perpignan Hosp, Dept Neurol, Perpignan, France; [Ayrignac, Xavier] Montpellier Univ Hosp, Dept Neurol, Montpellier, France; [Lopez-Sanchez, Uriel] Univ Grenoble Alpes, Inst Biol Struct, CEA, CNRS,UMR 5075, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; MRC Laboratory Molecular Biology; University of London; University College London; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Battini, JL (corresponding author), Univ Montpellier, Inst Rech Infectiol Montpellier IRIM, CNRS, Montpellier, France.; Sitbon, M; Battini, JL (corresponding author), Univ Montpellier, Inst Genet Mol Montpellier IGMM, CNRS, Montpellier, France.	marc.sitbon@igmm.cnrs.fr; jean-luc.battini@irim.cnrs.fr	Sitbon, Marc/A-6771-2010	Sitbon, Marc/0000-0003-3616-2338; ayrignac, xavier/0000-0003-3834-2981; Courgnaud, Valerie/0000-0003-1000-0322; Saiardi, Adolfo/0000-0002-4351-0081; TURY, Sandrine/0000-0001-9291-734X; Lopez-Sanchez, Uriel/0000-0003-4937-7055; Nicolas, Gael/0000-0001-9391-7800; Battini, Jean-Luc/0000-0002-5884-9934	Labex EpiGenMed [ANR-10-LABX-12-01]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [243449/440597]; Fondation pour la Recherche Medicale (FRM) [FDT20170436884]; ANR [ANR-17-CE14-0008, ANR-17-CE14-0008-01]; FRM [DBI201312285579]; NIH [DK32094]; Labex GR-Ex [ANR-11-LABX-0051]; European Union; Region Normandie through the Recherche Innovation Normandie (RIN 2018); Inserm; MRC [MR/T028904/1] Funding Source: UKRI	Labex EpiGenMed; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Labex GR-Ex; European Union(European Commission); Region Normandie through the Recherche Innovation Normandie (RIN 2018); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	U. L.-S. was supported successively by the Labex EpiGenMed (Grant ANR-10-LABX-12-01), Consejo Nacional de Ciencia y Tecnologia (CONACYT Grant 243449/440597), the Fondation pour la Recherche Medicale (FRM) (Grant FDT20170436884), and ANR (CALCIPHOS Grant ANR-17-CE14-0008-01); S. T. was supported by ANR (CALCIPHOS Grant ANR-17-CE14-0008-01). This work was supported by grants from FRM grant DBI201312285579 (to M. S.) and NIH grant DK32094 (to M. S.), from ANR (CALCIPHOS Grant ANR-17-CE14-0008 to J.-L. B., G. N., and M. S.), and from Labex GR-Ex (Grant ANR-11-LABX-0051). This study was co-supported by the European Union and Region Normandie, more specifically through the Recherche Innovation Normandie (RIN 2018). Europe gets involved in Normandie with the European Regional Development Fund (ERDF). G. N., M. S., and J.-L. B. are supported by Inserm. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anheim M, 2016, J NEUROL, V263, P1559, DOI 10.1007/s00415-016-8166-4; Azevedo C, 2006, NAT PROTOC, V1, P2416, DOI 10.1038/nprot.2006.337; Azevedo C, 2017, TRENDS BIOCHEM SCI, V42, P219, DOI 10.1016/j.tibs.2016.10.008; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Beck-Cormier S, 2019, J BONE MINER RES, V34, P1101, DOI 10.1002/jbmr.3691; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Bon N, 2018, J BIOL CHEM, V293, P2102, DOI 10.1074/jbc.M117.807339; Bugnicourt JM, 2013, J AM SOC NEPHROL, V24, P353, DOI 10.1681/ASN.2012050536; Cen ZD, 2020, BRAIN, V143, P491, DOI 10.1093/brain/awz392; Collins JF, 2004, PFLUG ARCH EUR J PHY, V447, P647, DOI 10.1007/s00424-003-1088-x; Crouthamel MH, 2013, ARTERIOSCL THROM VAS, V33, P2625, DOI 10.1161/ATVBAHA.113.302249; David S, 2016, EUR J HUM GENET, V24, P1630, DOI 10.1038/ejhg.2016.50; Dong JS, 2019, MOL PLANT, V12, P1463, DOI 10.1016/j.molp.2019.08.002; Durham AL, 2018, CARDIOVASC RES, V114, P590, DOI 10.1093/cvr/cvy010; Giovannini D, 2013, CELL REP, V3, P1866, DOI 10.1016/j.celrep.2013.05.035; Grangeon L, 2019, BRAIN, V142, P1573, DOI 10.1093/brain/awz095; Gu CF, 2017, P NATL ACAD SCI USA, V114, P11968, DOI 10.1073/pnas.1702370114; Gu CF, 2017, J BIOL CHEM, V292, P4544, DOI 10.1074/jbc.M116.765743; Guerreiro PM, 2014, AM J PHYSIOL-RENAL, V306, pF1275, DOI 10.1152/ajprenal.00458.2013; Hilfiker H, 1998, P NATL ACAD SCI USA, V95, P14564, DOI 10.1073/pnas.95.24.14564; Hozumi I, 2018, J NEUROL SCI, V388, P150, DOI 10.1016/j.jns.2018.03.014; Jensen N, 2016, NEUROGENETICS, V17, P125, DOI 10.1007/s10048-015-0469-6; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jung JY, 2018, CURR OPIN BIOTECH, V49, P156, DOI 10.1016/j.copbio.2017.08.012; Kavanaugh MP, 1996, KIDNEY INT, V49, P959, DOI 10.1038/ki.1996.135; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723; Khoshniat S, 2011, CELL MOL LIFE SCI, V68, P205, DOI 10.1007/s00018-010-0527-z; Larsen FT, 2017, J MOL NEUROSCI, V61, P215, DOI 10.1007/s12031-016-0868-7; Lassaux A, 2005, J VIROL, V79, P6560, DOI 10.1128/JVI.79.10.6560-6564.2005; Legati A, 2015, NAT GENET, V47, P579, DOI 10.1038/ng.3289; Li XY, 2020, P NATL ACAD SCI USA, V117, P3568, DOI 10.1073/pnas.1908830117; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Lopez-Sanchez U, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43255-x; Mamede JI, 2017, SCI REP-UK, V7, DOI 10.1038/srep45214; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Miklossy J, 2005, ACTA NEUROPATHOL, V109, P643, DOI 10.1007/s00401-005-1007-7; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; Nicolas G, 2015, AM J MED GENET B, V168, P586, DOI 10.1002/ajmg.b.32336; Nicolas G, 2013, BRAIN, V136, P3395, DOI 10.1093/brain/awt255; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Paucar M, 2017, J NEUROL SCI, V375, P245, DOI 10.1016/j.jns.2017.02.007; Prie D, 2010, NEW ENGL J MED, V362, P2399, DOI 10.1056/NEJMra0904186; Ramos E.M., 1993, GENEREVIEWS R; Ramos EM, 2018, EUR J HUM GENET, V26, P1462, DOI 10.1038/s41431-018-0185-4; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Suzuki A, 2010, J BONE MINER METAB, V28, P139, DOI 10.1007/s00774-009-0121-3; Szijgyarto Z, 2011, SCIENCE, V334, P802, DOI 10.1126/science.1211908; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; Vaughan AE, 2012, J VIROL, V86, P1661, DOI 10.1128/JVI.06073-11; Villa-Bellosta R, 2009, PFLUG ARCH EUR J PHY, V458, P1151, DOI 10.1007/s00424-009-0688-5; Wallingford MC, 2017, BRAIN PATHOL, V27, P64, DOI 10.1111/bpa.12362; Wang C, 2012, NAT GENET, V44, P254, DOI 10.1038/ng.1077; Wege S, 2014, FEBS LETT, V588, P482, DOI 10.1016/j.febslet.2013.12.013; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; Wilson MS, 2019, J BIOL CHEM, V294, P11597, DOI 10.1074/jbc.RA119.007848; Wilson MSC, 2013, BIOCHEM J, V452, P369, DOI 10.1042/BJ20130118; Xu H, 1999, GENOMICS, V62, P281, DOI 10.1006/geno.1999.6009; Yang YL, 1999, NAT GENET, V21, P216, DOI 10.1038/6005; Yao XP, 2018, NEURON, V98, P1116, DOI 10.1016/j.neuron.2018.05.037	63	16	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9366	9378		10.1074/jbc.RA119.011376	http://dx.doi.org/10.1074/jbc.RA119.011376			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32393577	Green Published, hybrid			2022-12-28	WOS:000552758600009
J	Yu, T; Kuang, HY; Chen, JH; Lin, X; Wu, Y; Chen, KY; Zhang, MJ; Zhang, WQ; Wen, ZL				Yu, Tao; Kuang, Haoyue; Chen, Jiahao; Lin, Xi; Wu, Yi; Chen, Keyu; Zhang, Mingjie; Zhang, Wenqing; Wen, Zilong			Tripartite-motif family protein 35-28 regulates microglia development by preventing necrotic death of microglial precursors in zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Trim; zebrafish; microglia; development; cell death; macrophage; immune system; central nervous system (CNS; ); genetic screen; neuronal inflammation	PROGRAMMED CELL-DEATH; MYELOID CELLS; ADULT MICROGLIA; B-BOX; ORIGINS; BRAIN; MACROPHAGES; MUTATIONS; ABLATION; REVEALS	Microglia are tissue-resident macrophages in the central nervous system (CNS) that play essential roles in the regulation of CNS development and homeostasis. Yet, the genetic networks governing microglia development remain incompletely defined. Here, we report the identification and characterization of a microglia-defective zebrafish mutantwulong(hkz12)(wul(hkz12)) isolated from an ethylnitrosourea (ENU)-based genetic screen. We show thatwul(hkz12)mutants harbors a missense point mutation in the gene region encoding the PRY/SPRY domain of the tripartite-motif family protein 35-28 (trim35-28) gene. Time-lapse imaging revealed that the loss of Trim35-28 function causes lytic necrosis of microglial precursors/peripheral macrophages, as indicated by cytoplasmic swelling and membrane rupture of these precursors and accompanied by neutrophil infiltration and systemic inflammation. Intriguingly, the lytic necrosis of microglial precursors intrim35-28?deficient mutants appeared to depend neither on the canonical pyroptotic nor necroptotic pathways, as inhibition of the key component in each pathway could not rescue the microglia phenotype intrim35-28?deficient mutants. Finally, results from tissue-specific rescue experiments suggested that Trim35-28 acts cell-autonomously in the survival of microglial precursors. Taken together, the findings of our study reveal Trim35-28 as a regulatory protein essential for microglia development.	[Yu, Tao; Kuang, Haoyue; Wu, Yi; Zhang, Mingjie; Wen, Zilong] Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Biomed Res Inst, Shenzhen Key Lab Neuronal Struct Biol, Shenzhen, Peoples R China; [Chen, Jiahao; Zhang, Wenqing] South China Univ Technol, Sch Med, Dept Cell Dev & Integrat Biol, Guangzhou, Guangdong, Peoples R China; [Lin, Xi; Chen, Keyu; Zhang, Mingjie; Wen, Zilong] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, State Key Lab Mol Neurosci, Div Life Sci,Kowloon, Clear Water Bay, Hong Kong, Peoples R China; [Chen, Keyu; Zhang, Mingjie; Wen, Zilong] Shenzhen Bay Lab, Greater Bay Biomed Innoctr, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; South China University of Technology; Hong Kong University of Science & Technology; Shenzhen Bay Laboratory	Wen, ZL (corresponding author), Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Biomed Res Inst, Shenzhen Key Lab Neuronal Struct Biol, Shenzhen, Peoples R China.; Zhang, WQ (corresponding author), South China Univ Technol, Sch Med, Dept Cell Dev & Integrat Biol, Guangzhou, Guangdong, Peoples R China.; Wen, ZL (corresponding author), Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, State Key Lab Mol Neurosci, Div Life Sci,Kowloon, Clear Water Bay, Hong Kong, Peoples R China.; Wen, ZL (corresponding author), Shenzhen Bay Lab, Greater Bay Biomed Innoctr, Shenzhen, Peoples R China.	mczhangwq@scut.edu.cn; zilong@ust.hk	YU, TAO/HGU-2328-2022; zhang, wenqing/GYA-0786-2022	YU, TAO/0000-0001-6017-4852; Lin, Xi/0000-0003-2526-5163; CHEN, Jiahao/0000-0002-9754-5626	Natural Science Foundation of Guangdong Province [2018A030313149]; Shenzhen Science and Technology Innovation Committee [JCYJ20180223181227269]; China Postdoctoral Science Foundation [2017M620379]; National Natural Science Foundation of China [31801211]; Research Grants Council of the Hong Kong Special Administrative Region [16131916, 16103718, N_HKUST621/17, C6002-17GF, AoE/M-09/12, T13-605/18-W]; Innovation and Technology Commission of the Hong Kong Special Administrative Region [ITCPD/17-9]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Innovation Committee; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); Innovation and Technology Commission of the Hong Kong Special Administrative Region	This work was supported by Natural Science Foundation of Guangdong Province Grant 2018A030313149 (to T. Y.), Shenzhen Science and Technology Innovation Committee Grant JCYJ20180223181227269 (to T. Y.), China Postdoctoral Science Foundation Grant 2017M620379 (to T. Y.), National Natural Science Foundation of China Grant 31801211 (to T. Y.), Research Grants Council of the Hong Kong Special Administrative Region Grants 16131916, 16103718, N_HKUST621/17 (to Z. W.), C6002-17GF (to Z. W.), AoE/M-09/12, and T13-605/18-W, and Innovation and Technology Commission of the Hong Kong Special Administrative Region (ITCPD/17-9).	Ah-Young C., 2013, MOL CELLS, V36, P82, DOI [10.1007/s10059-013-0087-9, DOI 10.1007/S10059-013-0087-9]; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Felmer RN, 2004, BIOL RES, V37, P449, DOI 10.4067/S0716-97602004000300009; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gomez-Nicola D, 2015, NEUROSCIENTIST, V21, P169, DOI 10.1177/1073858414530512; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; He SC, 2018, ELIFE, V7, DOI 10.7554/eLife.36131; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; Hristovska I, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00073; Jin H, 2012, BLOOD, V119, P5239, DOI 10.1182/blood-2011-12-398362; Khan R, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2028; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kimura F, 2003, J BIOL CHEM, V278, P25046, DOI 10.1074/jbc.M303438200; Kitaguchi T, 2009, MECH DEVELOP, V126, P314, DOI 10.1016/j.mod.2009.02.007; Kristiansen M, 2014, CELL DEATH DIFFER, V21, P1025, DOI 10.1038/cdd.2014.47; Lalonde JP, 2004, J BIOL CHEM, V279, P8181, DOI 10.1074/jbc.M306751200; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Li DR, 2017, ELIFE, V6, DOI 10.7554/eLife.27692.001; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Li XL, 2012, DEVELOPMENT, V139, P4321, DOI 10.1242/dev.081869; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Ma ZP, 2019, NATURE, V568, P259, DOI 10.1038/s41586-019-1057-y; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Perez-Garijo A, 2015, DEVELOPMENT, V142, P3253, DOI 10.1242/dev.127878; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shiau CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117513; Shiau CE, 2013, CELL REP, V5, P1342, DOI 10.1016/j.celrep.2013.11.004; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun YH, 2020, GENOME RES, V30, P118, DOI 10.1101/gr.248559.119; van der Vaart M, 2013, DIS MODEL MECH, V6, P841, DOI 10.1242/dmm.010843; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wallach D, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2154; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wang TN, 2019, J GENET GENOMICS, V46, P291, DOI 10.1016/j.jgg.2019.06.002; Wang YM, 2015, FEBS LETT, V589, P1322, DOI 10.1016/j.febslet.2015.04.019; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Wu ST, 2018, DEV CELL, V46, P552, DOI 10.1016/j.devcel.2018.08.005; Xu J, 2016, DEV CELL, V38, P214, DOI 10.1016/j.devcel.2016.06.018; Xu J, 2015, DEV CELL, V34, P632, DOI 10.1016/j.devcel.2015.08.018; Yu T, 2017, BLOOD, V129, P509, DOI 10.1182/blood-2016-07-727651; Zhen FH, 2013, DEVELOPMENT, V140, P3977, DOI 10.1242/dev.097071; Zhou Y, 2011, METHOD CELL BIOL, V104, P287, DOI 10.1016/B978-0-12-374814-0.00016-1	61	4	4	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8846	8856		10.1074/jbc.RA119.012043	http://dx.doi.org/10.1074/jbc.RA119.012043			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32398256	hybrid, Green Published			2022-12-28	WOS:000546296800019
J	Alam, SMD; Tsukamoto, Y; Ogawa, M; Senoo, Y; Ikeda, K; Tashima, Y; Takeuchi, H; Okajima, T				Alam, Sayad Md. Didarul; Tsukamoto, Yohei; Ogawa, Mitsutaka; Senoo, Yuya; Ikeda, Kazutaka; Tashima, Yuko; Takeuchi, Hideyuki; Okajima, Tetsuya			N-Glycans on EGF domain-specificO-GlcNAc transferase (EOGT) facilitate EOGT maturation and peripheral endoplasmic reticulum localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAc; EGF domain-specific O-GlcNAc transferase (EOGT); Notch receptor; endoplasmic reticulum; N-linked glycosylation; posttranslational modification; protein folding; oligomannose glycan; protein maturation; glycoprotein; O-linked N-acetylglucosamine (O-GlcNAc); endoplasmic reticulum (ER); EOGT	O-GLCNAC; EXTRACELLULAR DOMAIN; LINKED GLYCOSYLATION; ENZYME-ACTIVITY; NOTCH; GROWTH; ACETYLGLUCOSAMINE; CANCER; GLYCOSYLTRANSFERASE; REPEATS	Epidermal growth factor (EGF) domain-specificO-GlcNAc transferase (EOGT) is an endoplasmic reticulum (ER)-resident protein that modifies EGF repeats of Notch receptors and thereby regulates Delta-like ligand-mediated Notch signaling. SeveralEOGTmutations that may affect putativeN-glycosylation consensus sites are recorded in the cancer database, but the presence and function ofN-glycans in EOGT have not yet been characterized. Here, we identifiedN-glycosylation sites in mouse EOGT and elucidated their molecular functions. Three predictedN-glycosylation consensus sequences on EOGT are highly conserved among mammalian species. Within these sites, we found that Asn-263 and Asn-354, but not Asn-493, are modified withN-glycans. Lectin blotting, endoglycosidase H digestion, and MS analysis revealed that both residues are modified with oligomannoseN-glycans. Loss of an individualN-glycan on EOGT did not affect its endoplasmic reticulum (ER) localization, enzyme activity, and ability toO-GlcNAcylate Notch1 in HEK293T cells. However, simultaneous substitution of bothN-glycosylation sites affected both EOGT maturation and expression levels without an apparent change in enzymatic activity, suggesting thatN-glycosylation at a single site is sufficient for EOGT maturation and expression. Accordingly, a decrease inO-GlcNAc stoichiometry was observed in Notch1 co-expressed with an N263Q/N354Q variant compared with WT EOGT. Moreover, the N263Q/N354Q variant exhibited altered subcellular distribution within the ER in HEK293T cells, indicating thatN-glycosylation of EOGT is required for its ER localization at the cell periphery. These results suggest critical roles ofN-glycans in sustainingO-GlcNAc transferase function both by maintaining EOGT levels and by ensuring its proper subcellular localization in the ER.	[Alam, Sayad Md. Didarul; Tsukamoto, Yohei; Ogawa, Mitsutaka; Senoo, Yuya; Ikeda, Kazutaka; Tashima, Yuko; Takeuchi, Hideyuki; Okajima, Tetsuya] Nagoya Univ, Dept Mol Biochem, Grad Sch Med, Nagoya, Aichi, Japan; [Ikeda, Kazutaka] RIKEN, Ctr Integrat Med Sci, Tsurumi Ku, Suehiro Cho, Yokohama, Kanagawa, Japan	Nagoya University; RIKEN	Okajima, T (corresponding author), Nagoya Univ, Dept Mol Biochem, Grad Sch Med, Nagoya, Aichi, Japan.	tokajima@med.nagoya-u.ac.jp	Takeuchi, Hideyuki/AAZ-9210-2020; Okajima, Tetsuya/I-7332-2014	mitsutaka, ogawa/0000-0001-5808-169X; Alam, Sayad Md. Didarul/0000-0002-2877-2059; Okajima, Tetsuya/0000-0002-3677-648X	JSPS KAKENHI [JP19H03416, JP19H03176, JP19K16073]; Mitsubishi Foundation; Japan Foundation for Applied Enzymology; Takeda Science Foundation; Hori Sciences and Arts foundation; Foundation for Promotion of Cancer Research	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mitsubishi Foundation; Japan Foundation for Applied Enzymology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Hori Sciences and Arts foundation; Foundation for Promotion of Cancer Research	This work was supported by JSPS KAKENHI Grant JP19H03416 (to T. O.), JP19H03176 (to H. T.), and JP19K16073 (to M. O.), and grants from the Mitsubishi Foundation (to T. O.), the Japan Foundation for Applied Enzymology (to T. O.), Takeda Science Foundation (to M. O. and H. T.), The Hori Sciences and Arts foundation (M. O.), and Foundation for Promotion of Cancer Research (M. O.).	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Allam H, 2017, J BIOL CHEM, V292, P16351, DOI 10.1074/jbc.M117.783936; Cohen I, 2014, EUR J HUM GENET, V22, P374, DOI 10.1038/ejhg.2013.159; Contessa JN, 2010, CLIN CANCER RES, V16, P3205, DOI 10.1158/1078-0432.CCR-09-3331; Ellgaard L, 2016, TRAFFIC, V17, P615, DOI 10.1111/tra.12392; FAST DG, 1993, BIOCHIM BIOPHYS ACTA, V1202, P325, DOI 10.1016/0167-4838(93)90023-K; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gao G, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000355; HARAGUCHI M, 1995, BIOCHEM J, V312, P273, DOI 10.1042/bj3120273; Hebert DN, 2014, NAT CHEM BIOL, V10, P902, DOI 10.1038/nchembio.1651; Holcman D, 2018, NAT CELL BIOL, V20, P1118, DOI 10.1038/s41556-018-0192-2; Hou XH, 2012, J BIOL CHEM, V287, P474, DOI 10.1074/jbc.M111.317578; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Liu G, 2017, MOL CELL PROTEOMICS, V16, P2032, DOI 10.1074/mcp.M117.068239; Liu Y, 2015, ONCOTARGET, V6, P20650, DOI 10.18632/oncotarget.4115; Lopez-Sambrooks C, 2016, NAT CHEM BIOL, V12, P1023, DOI 10.1038/nchembio.2194; Loriol C, 2007, FEBS J, V274, P1202, DOI 10.1111/j.1742-4658.2007.05663.x; Manya H, 2010, J BIOCHEM, V147, P337, DOI 10.1093/jb/mvp170; Martina JA, 1998, J BIOL CHEM, V273, P3725, DOI 10.1074/jbc.273.6.3725; Martina JA, 2000, NEUROCHEM RES, V25, P725, DOI 10.1023/A:1007527523734; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Nagai K, 1997, GLYCOBIOLOGY, V7, P769, DOI 10.1093/glycob/7.6.769; Nixon-Abell J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf3928; Ogawa M, 2020, BIOCHEM BIOPH RES CO, V526, P184, DOI 10.1016/j.bbrc.2020.03.066; Ogawa M, 2018, MOLECULES, V23, DOI 10.3390/molecules23071745; Ogawa M, 2015, J BIOL CHEM, V290, P2137, DOI 10.1074/jbc.M114.598821; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sawaguchi S, 2017, ELIFE, V6, DOI 10.7554/eLife.24419; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Shaheen R, 2013, AM J HUM GENET, V92, P598, DOI 10.1016/j.ajhg.2013.02.012; Shrimal S, 2013, J CELL BIOL, V201, P81, DOI 10.1083/jcb.201301031; St-Pierre P, 2012, J CELL SCI, V125, P1727, DOI 10.1242/jcs.096396; Takeuchi H, 2018, P NATL ACAD SCI USA, V115, pE8395, DOI 10.1073/pnas.1804005115; Takeuchi H, 2018, GLYCOBIOLOGY, V28, P276, DOI 10.1093/glycob/cwy014; Takeuchi H, 2012, J BIOL CHEM, V287, P33934, DOI 10.1074/jbc.M112.401315; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; Tashima Y, 2014, J BIOL CHEM, V289, P11132, DOI 10.1074/jbc.M113.492512; Uemura S, 2006, GLYCOBIOLOGY, V16, P258, DOI 10.1093/glycob/cwj060; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X	43	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8560	8574		10.1074/jbc.RA119.012280	http://dx.doi.org/10.1074/jbc.RA119.012280			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32376684	Green Published, hybrid			2022-12-28	WOS:000546986500020
J	Uchigashima, M; Leung, M; Watanabe, T; Cheung, A; Le, T; Pallat, S; Dinis, ALM; Watanabe, M; Kawasawa, YI; Futai, K				Uchigashima, Motokazu; Leung, Ming; Watanabe, Takuya; Cheung, Amy; Le, Timmy; Pallat, Sabine; Dinis, Alexandre Luis Marques; Watanabe, Masahiko; Kawasawa, Yuka Imamura; Futai, Kensuke			Neuroligin3 splice isoforms shape inhibitory synaptic function in the mouse hippocampus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurobiology; neuron; neurotransmitter receptor; synapse; GABA receptor; glutamate receptor; hippocampus; CA1 pyramidal neuron; excitatory and inhibitory balance; neuroligin 3 (NLGN3); splice variants; trans-synaptic cell adhesion; synaptic transmission	SYNAPSES; MUTATIONS; RECEPTOR; CODE	Synapse formation is a dynamic process essential for the development and maturation of the neuronal circuitry in the brain. At the synaptic cleft, trans-synaptic protein?protein interactions are major biological determinants of proper synapse efficacy. The balance of excitatory and inhibitory synaptic transmission (E-I balance) stabilizes synaptic activity, and dysregulation of the E-I balance has been implicated in neurodevelopmental disorders, including autism spectrum disorders. However, the molecular mechanisms underlying the E-I balance remain to be elucidated. Here, using single-cell transcriptomics, immunohistochemistry, and electrophysiology approaches to murine CA1 pyramidal neurons obtained from organotypic hippocampal slice cultures, we investigate neuroligin (Nlgn) genes that encode a family of postsynaptic adhesion molecules known to shape excitatory and inhibitory synaptic function. We demonstrate that the NLGN3 protein differentially regulates inhibitory synaptic transmission in a splice isoform?dependent manner at hippocampal CA1 synapses. We also found that distinct subcellular localizations of the NLGN3 isoforms contribute to the functional differences observed among these isoforms. Finally, results from single-cell RNA-Seq analyses revealed thatNlgn1andNlgn3are the major murineNlgngenes and that the expression levels of theNlgnsplice isoforms are highly diverse in CA1 pyramidal neurons. Our results delineate isoform-specific effects ofNlgngenes on the E-I balance in the murine hippocampus.	[Uchigashima, Motokazu; Watanabe, Takuya; Cheung, Amy; Le, Timmy; Pallat, Sabine; Dinis, Alexandre Luis Marques; Futai, Kensuke] Univ Massachusetts, Sch Med, Dept Neurobiol, Brudnick Neuropsychiat Res Inst, Worcester, MA 01605 USA; [Uchigashima, Motokazu; Watanabe, Masahiko] Hokkaido Univ, Dept Anat, Grad Sch Med, Sapporo, Hokkaido, Japan; [Leung, Ming; Kawasawa, Yuka Imamura] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Leung, Ming; Kawasawa, Yuka Imamura] Penn State Univ, Coll Med, Inst Personalized Med, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Univ Coll Med, Dept Pharmacol, Hershey, PA USA	University of Massachusetts System; University of Massachusetts Worcester; Hokkaido University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Futai, K (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Brudnick Neuropsychiat Res Inst, Worcester, MA 01605 USA.; Kawasawa, YI (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.; Kawasawa, YI (corresponding author), Penn State Univ, Coll Med, Inst Personalized Med, Hershey, PA 17033 USA.; Kawasawa, YI (corresponding author), Penn State Univ Coll Med, Dept Pharmacol, Hershey, PA USA.	yimamura@pennstatehealth.psu.edu; Kensuke.Futai@umassmed.edu	Watanabe, Masahiko/S-3614-2019	Watanabe, Masahiko/0000-0001-5037-7138; Imamura Kawasawa, Yuka/0000-0002-8638-6738; Le, Timmy/0000-0001-9274-3570; Dinis, Alexandre/0000-0002-6813-6380; Uchigashima, Motokazu/0000-0002-0878-2233	National Institutes of Health [R01NS085215, T32 GM107000, 15K06732]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01NS085215 (to K. F.) and T32 GM107000 (to A. C.) and Grant-in-Aid for Scientific Research 15K06732 (to M. U.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baudouin SJ, 2012, SCIENCE, V338, P128, DOI 10.1126/science.1224159; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Budreck EC, 2007, EUR J NEUROSCI, V26, P1738, DOI 10.1111/j.1460-9568.2007.05842.x; Budreck EC, 2013, P NATL ACAD SCI USA, V110, P725, DOI 10.1073/pnas.1214718110; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Etherton M, 2011, P NATL ACAD SCI USA, V108, P13764, DOI 10.1073/pnas.1111093108; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837; Futai K, 2013, J NEUROSCI, V33, P3612, DOI 10.1523/JNEUROSCI.1811-12.2013; Hasegawa Y, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0186-17.2017; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jiang M, 2017, MOL PSYCHIATR, V22, P375, DOI 10.1038/mp.2016.80; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Mao WJ, 2018, CELL REP, V23, P3209, DOI 10.1016/j.celrep.2018.05.028; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Nelson SB, 2015, NEURON, V87, P684, DOI 10.1016/j.neuron.2015.07.033; Nguyen QA, 2016, ELIFE, V5, DOI 10.7554/eLife.19236; Shipman SL, 2012, P NATL ACAD SCI USA, V109, P19432, DOI 10.1073/pnas.1217633109; Shipman SL, 2012, NEURON, V76, P309, DOI 10.1016/j.neuron.2012.07.024; Shipman SL, 2011, NAT NEUROSCI, V14, P718, DOI 10.1038/nn.2825; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sudhof TC, 2017, CELL, V171, P745, DOI 10.1016/j.cell.2017.10.024; Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020; Uchigashima M, 2016, P NATL ACAD SCI USA, V113, P4206, DOI 10.1073/pnas.1514074113; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410	30	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8589	8595		10.1074/jbc.AC120.012571	http://dx.doi.org/10.1074/jbc.AC120.012571			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32381505	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000546986500022
J	Verhaegh, R; Becker, KA; Edwards, MJ; Gulbins, E				Verhaegh, Rabea; Becker, Katrin Anne; Edwards, Michael J.; Gulbins, Erich			Sphingosine kills bacteria by binding to cardiolipin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; Pseudomonas aeruginosa (P; aeruginosa); Staphylococcus aureus (S; aureus); sphingolipid; innate immunity; bactericidal activity; lung pathogen; membrane permeabilization; sphingoid base; sphingosine	PSEUDOMONAS-AERUGINOSA BACTEREMIA; CYSTIC-FIBROSIS GENE; STAPHYLOCOCCUS-AUREUS; HOST-DEFENSE; EPIDEMIOLOGY; INFLAMMATION; INFECTION; SUSCEPTIBILITY; IDENTIFICATION; BASES	Sphingosine is a long-chain sphingoid base that has been shown to have bactericidal activity against many pathogens, including Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli. We have previously demonstrated that sphingosine is present in nasal, tracheal, and bronchial epithelial cells and constitutes a central element of the defense of the airways against bacterial pathogens. Here, using assorted lipid-binding and cell biology assays, we demonstrate that exposing P. aeruginosa and S. aureus cells to sphingosine results in a very rapid, i.e. within minutes, permeabilization of the bacterial plasma membrane, resulting in leakiness of the bacterial cells, loss of ATP, and loss of bacterial metabolic activity. These alterations rapidly induced bacterial death. Mechanistically, we demonstrate that the presence of the protonated NH2 group in sphingosine, which is an amino-alcohol, is required for sphingosine's bactericidal activity. We also show that the protonated NH2 group of sphingosine binds to the highly negatively?charged lipid cardiolipin in bacterial plasma membranes. Of note, this binding was required for bacterial killing by sphingosine, as revealed by genetic experiments indicating that E. coli or P. aeruginosa strains that lack cardiolipin synthase are resistant to sphingosine, both in vitro and in vivo. We propose that binding of sphingosine to cardiolipin clusters cardiolipin molecules in the plasma membrane of bacteria. This clustering results in the formation of gel-like or even crystal-like structures in the bacterial plasma membrane and thereby promotes rapid permeabilization of the plasma membrane and bacterial cell death.	[Verhaegh, Rabea; Becker, Katrin Anne; Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Univ Clin, Essen, Germany; [Edwards, Michael J.; Gulbins, Erich] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45221 USA	University of Duisburg Essen; University System of Ohio; University of Cincinnati	Gulbins, E (corresponding author), Univ Duisburg Essen, Dept Mol Biol, Univ Clin, Essen, Germany.; Gulbins, E (corresponding author), Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45221 USA.	erich.gulbins@uni-due.de			Deutsche Forschungsgemeinschaft [GU 335/35-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GU 335/35-1.	Azuma MM, 2018, BIOCHEM BIOPH RES CO, V495, P2383, DOI 10.1016/j.bbrc.2017.12.137; Bhagirath AY, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0339-5; BIBEL DJ, 1992, J INVEST DERMATOL, V98, P269, DOI 10.1111/1523-1747.ep12497842; Brewer C, 1996, CHEST, V109, P1019; Carstens Henning, 2019, Cell Physiol Biochem, V53, P1015, DOI 10.33594/000000194; Currie AJ, 2003, SEM RESP CRIT CARE M, V24, P671, DOI 10.1055/s-2004-815663; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; El Khoury M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10543-3; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Fischer CL, 2013, SKIN PHARMACOL PHYS, V26, P36, DOI 10.1159/000343175; FORBES AR, 1977, ANESTHESIOLOGY, V46, P319, DOI 10.1097/00000542-197705000-00002; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2017, CELL HOST MICROBE, V21, P707, DOI 10.1016/j.chom.2017.05.001; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LaBauve AE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003889; Martin GE, 2017, BIOCHIMIE, V141, P91, DOI 10.1016/j.biochi.2017.03.014; MCMANUS AT, 1985, EUR J CLIN MICROBIOL, V4, P219, DOI 10.1007/BF02013601; MORRISON AJ, 1984, REV INFECT DIS, V6, pS627; Muraglia KA, 2019, NATURE, V567, P405, DOI 10.1038/s41586-019-1018-5; Parsons JB, 2012, J BACTERIOL, V194, P5294, DOI 10.1128/JB.00743-12; Pewzner-Jung Y, 2014, EMBO MOL MED, V6, P1205, DOI 10.15252/emmm.201404075; Rao S, 2006, ARCH DIS CHILD, V91, P786, DOI 10.1136/adc.2004.069419; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schaffer K, 2015, J HOSP INFECT, V89, P309, DOI 10.1016/j.jhin.2015.02.005; Tabazavareh ST, 2016, CELL PHYSIOL BIOCHEM, V38, P2094, DOI 10.1159/000445567; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Vidal F, 1996, ARCH INTERN MED, V156, P2121, DOI 10.1001/archinte.156.18.2121	28	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7686	7696		10.1074/jbc.RA119.012325	http://dx.doi.org/10.1074/jbc.RA119.012325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32327486	Green Published, hybrid			2022-12-28	WOS:000538038900010
J	Fang, GB; Fu, Y; Li, SX; Qiu, JX; Kuang, MY; Lin, SP; Li, CC; Ding, Y				Fang, Guibin; Fu, Yuan; Li, Shixun; Qiu, Junxiong; Kuang, Manyuan; Lin, Sipeng; Li, Changchuan; Ding, Yue			The USP14?NLRC5 pathway inhibits titanium particle?induced osteolysis in mice by suppressing NF-?B and PI3K/AKT activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; NF-?B; osteoclast; cytokine; tumor necrosis factor (TNF); NLRC5; total hip arthroplasty; USP14; wear particles	FACTOR-ALPHA PRODUCTION; KAPPA-B; SIGNALING PATHWAY; CELLULAR-RESPONSE; BONE LOSS; IN-VITRO; ACTIVATION; OSTEOCLASTOGENESIS; POLARIZATION; ARTHROPLASTY	Total hip arthroplasty (THA) is a widely-used surgical intervention for treating patients with end-stage degenerative and inflammatory osteoarthropathy. However, wear particles from the artificial titanium joint can induce osteolysis, limiting the long-term survivorship of THA. Monocyte/macrophage lineage cells are the key players in the response to wear particles, and the proinflammatory NF-?B and phosphoinositide 3-kinase (PI3K)?AKT Ser/Thr kinase (AKT)-signaling pathways have been shown to be the most important contributors to wear particle?induced osteolysis. In contrast, ubiquitin-specific protease 14 (USP14) specifically removes the polyubiquitin chains from the nucleotide-binding and oligomerization domain (NOD)-like receptor family Caspase recruitment domain (CARD)?containing 5 (NLRC5) and thereby enhances the NLRC5-mediated inhibition of NF-?B signaling. In this study, we aimed to clarify the role of the USP14?NLRC5 pathway in wear particle?induced osteolysis in vitro and in vivo. We found that NLRC5 or USP14 overexpression inhibits titanium particle?induced proinflammatory tumor necrosis factor ? (TNF?) production and NF-?B pathway activation, and it also decreases M1 macrophage polarization and PI3K/AKT pathway activation. Of note, NLRC5 and USP14 overexpression attenuated titanium particle?induced cranial osteolysis in mice. In conclusion, the findings of our study indicate that the USP14?NLRC5 pathway inhibits titanium particle?induced osteolysis by suppressing the NF-?B and PI3K/AKT pathways both in vitro and in vivo.	[Fang, Guibin; Fu, Yuan; Li, Shixun; Qiu, Junxiong; Kuang, Manyuan; Lin, Sipeng; Li, Changchuan; Ding, Yue] Sun Yat Sen Univ, Dept Orthopaed Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Peoples R China	Sun Yat Sen University	Ding, Y (corresponding author), Sun Yat Sen Univ, Dept Orthopaed Surg, Sun Yat Sen Mem Hosp, Guangzhou 510120, Peoples R China.	dingyue@mail.sysu.edu.cn	Li, Changchuan/GPX-7405-2022	Lin, Sipeng/0000-0001-8395-8561	Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology, National Natural Science Fund [81672186]; Natural Science Foundation of Guangdong Province Grant [2017B030311016]	Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology, National Natural Science Fund; Natural Science Foundation of Guangdong Province Grant(National Natural Science Foundation of Guangdong Province)	This work was supported by the Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology, National Natural Science Fund Grant 81672186, and Natural Science Foundation of Guangdong Province Grant 2017B030311016. The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An SB, 2018, CELL PHYSIOL BIOCHEM, V50, P1100, DOI 10.1159/000494537; Benko S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00150; Bresalier RS, 1996, GASTROENTEROLOGY, V110, P1354, DOI 10.1053/gast.1996.v110.pm8613039; Chelbi ST, 2017, ADV IMMUNOL, V133, P89, DOI 10.1016/bs.ai.2016.11.003; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Eger M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02963; Feng WY, 2018, BIOCHEM BIOPH RES CO, V503, P62, DOI 10.1016/j.bbrc.2018.05.177; Gu QL, 2017, J ORTHOP TRANSL, V10, P86, DOI 10.1016/j.jot.2017.05.002; Han F, 2018, BIOMED PHARMACOTHER, V103, P222, DOI 10.1016/j.biopha.2018.04.040; Holding CA, 2006, BIOMATERIALS, V27, P5212, DOI 10.1016/j.biomaterials.2006.05.054; Horwood NJ, 2016, CLIN REV ALLERG IMMU, V51, P79, DOI 10.1007/s12016-015-8519-2; Huang JB, 2013, INFLAMMATION, V36, P1041, DOI 10.1007/s10753-013-9636-9; Huang JB, 2013, ARTIF ORGANS, V37, P298, DOI 10.1111/j.1525-1594.2012.01568.x; Li B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00055; Li MG, 2019, LIFE SCI, V218, P147, DOI 10.1016/j.lfs.2018.12.014; [李儒军 Li Rujun], 2018, [中国矫形外科杂志, Orthopedic Journal of China], V26, P1729; Li SX, 2019, BIOMATER SCI-UK, V7, P2702, DOI 10.1039/c9bm00306a; Lin TH, 2014, ACTA BIOMATER, V10, P1, DOI 10.1016/j.actbio.2013.09.034; Linton MF, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112703; Man K, 2017, J FUNCT BIOMATER, V8, DOI 10.3390/jfb8030033; Massin P., 2017, Morphologie, V101, P1, DOI 10.1016/j.morpho.2016.06.001; Meng QC, 2015, J CELL BIOL, V211, P1025, DOI 10.1083/jcb.201505091; Mialki RK, 2013, J BIOL CHEM, V288, P15437, DOI 10.1074/jbc.C112.446682; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nabeshima A, 2017, BIOMATERIALS, V117, P1, DOI 10.1016/j.biomaterials.2016.11.039; Negroni A, 2018, J INFLAMM RES, V11, P49, DOI 10.2147/JIR.S137606; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Pajarinen J, 2017, J BIOMED MATER RES A, V105, P1195, DOI 10.1002/jbm.a.35978; Qi WZ, 2019, CHEM-BIOL INTERACT, V306, P19, DOI 10.1016/j.cbi.2019.04.002; Sadoghi P, 2013, J ARTHROPLASTY, V28, P1329, DOI 10.1016/j.arth.2013.01.012; Tong YZ, 2012, CELL RES, V22, P822, DOI 10.1038/cr.2012.53; Vaden JH, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-3; Vijayan S, 2019, IMMUNOGENETICS, V71, P273, DOI 10.1007/s00251-019-01106-z; von Knoch M, 2004, BIOMATERIALS, V25, P4675, DOI 10.1016/j.biomaterials.2004.02.069; Wang MZ, 2019, J CELL PHYSIOL, V234, P19990, DOI 10.1002/jcp.28596; Wang SY, 2019, CANCER LETT, V452, P14, DOI 10.1016/j.canlet.2019.03.015; Wang X, 2019, J PERIODONTAL RES, V54, P329, DOI 10.1111/jre.12633; Wu LC, 2017, J CELL BIOCHEM, V118, P1308, DOI 10.1002/jcb.25672; Yang HL, 2016, BIOMATERIALS, V80, P1, DOI 10.1016/j.biomaterials.2015.11.046; Zhang C, 2018, J BIOMED NANOTECHNOL, V14, P609, DOI 10.1166/jbn.2018.2533; Zhou CH, 2018, BRIT J PHARMACOL, V175, P859, DOI 10.1111/bph.14092	42	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7018	7032		10.1074/jbc.RA119.012495	http://dx.doi.org/10.1074/jbc.RA119.012495			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32273344	hybrid, Green Published			2022-12-28	WOS:000536212600020
J	Ilie, A; Boucher, A; Park, J; Berghuis, AM; McKinney, RA; Orlowski, J				Ilie, Alina; Boucher, Annie; Park, Jaeok; Berghuis, Albert Marinus; McKinney, R. Anne; Orlowski, John			Assorted dysfunctions of endosomal alkali cation/proton exchanger SLC9A6 variants linked to Christianson syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; endosome; endocytosis; membrane transport; neurological disease; pH regulation; protein sorting; sodium-proton exchange; structure?function	ENDOPLASMIC-RETICULUM STRESS; MENTAL-RETARDATION; TRANSMEMBRANE SEGMENT; QUALITY-CONTROL; FUNCTIONAL-CHARACTERIZATION; INTELLECTUAL DISABILITY; SODIUM/PROTON EXCHANGER; PHENOTYPIC SPECTRUM; HIPPOCAMPAL-NEURONS; RAT HEPATOCYTES	Genetic screening has identified numerous variants of the endosomal solute carrier family 9 member A6 (SLC9A6)/(Na+,K+)/H+ exchanger 6 (NHE6) gene that cause Christianson syndrome, a debilitating X-linked developmental disorder associated with a range of neurological, somatic, and behavioral symptoms. Many of these variants cause complete loss of NHE6 expression, but how subtler missense substitutions or nonsense mutations that partially truncate its C-terminal cytoplasmic regulatory domain impair NHE6 activity and endosomal function are poorly understood. Here, we describe the molecular and cellular consequences of six unique mutations located in the N-terminal cytoplasmic segment (A9S), the membrane ion translocation domain (L188P and G383D), and the C-terminal regulatory domain (E547*, R568Q, and W570*) of human NHE6 that purportedly cause disease. Using a heterologous NHE6-deficient cell expression system, we show that the biochemical, catalytic, and cellular properties of the A9S and R568Q variants were largely indistinguishable from those of the WT transporter, which obscured their disease significance. By contrast, the L188P, G383D, E547*, and W570* mutants exhibited variable deficiencies in biosynthetic post-translational maturation, membrane sorting, pH homeostasis in recycling endosomes, and cargo trafficking, and they also triggered apoptosis. These findings broaden our understanding of the molecular dysfunctions of distinct NHE6 variants associated with Christianson syndrome.	[Ilie, Alina; Boucher, Annie; Orlowski, John] McGill Univ, Dept Physiol, Bellini Pavil,Rm 166, Montreal, PQ H3G 0B1, Canada; [Park, Jaeok; Berghuis, Albert Marinus] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [McKinney, R. Anne] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University; McGill University	Orlowski, J (corresponding author), McGill Univ, Dept Physiol, Bellini Pavil,Rm 166, Montreal, PQ H3G 0B1, Canada.	john.orlowski@mcgill.ca	, WaNgtJ/AAR-7045-2020		Canadian Foundation for Innovation	Canadian Foundation for Innovation(Canada Foundation for Innovation)	We are grateful for the services provided by the McGill Life Sciences Advanced BioImaging Facility and the Flow Cytometry Facility and by Genome Quebec for DNA sequencing. The platforms were supported by funding from the Canadian Foundation for Innovation.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Barlowe C, 2016, ANNU REV CELL DEV BI, V32, P197, DOI 10.1146/annurev-cellbio-111315-125016; Barriere Herve, 2008, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1513s40; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bosemani T, 2014, NEUROPEDIATRICS, V45, P247, DOI 10.1055/s-0033-1363091; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; Bredesen DE, 2005, CELL DEATH DIFFER, V12, P1031, DOI 10.1038/sj.cdd.4401680; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2002, AM J PHYSIOL-CELL PH, V282, pC1031, DOI 10.1152/ajpcell.00420.2001; Brewster JL, 2006, MOL CELL NEUROSCI, V32, P242, DOI 10.1016/j.mcn.2006.04.006; Cardon M, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000062; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Christianson AL, 1999, J MED GENET, V36, P759, DOI 10.1136/jmg.36.10.759; Coincon M, 2016, NAT STRUCT MOL BIOL, V23, P248, DOI 10.1038/nsmb.3164; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Coorg R, 2015, PEDIATR NEUROL, V53, P527, DOI 10.1016/j.pediatrneurol.2015.07.007; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Counillon L, 1997, BIOCHEMISTRY-US, V36, P2951, DOI 10.1021/bi9615405; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; Deane EC, 2013, J NEUROSCI, V33, P595, DOI 10.1523/JNEUROSCI.2583-12.2013; Ding J, 2007, CAN J PHYSIOL PHARM, V85, P319, DOI 10.1139/Y06-081; Doyle KM, 2011, J CELL MOL MED, V15, P2025, DOI 10.1111/j.1582-4934.2011.01374.x; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fichou Y, 2009, EUR J HUM GENET, V17, P1378, DOI 10.1038/ejhg.2009.82; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; Gao AYL, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104490; Garbern JY, 2010, BRAIN, V133, P1391, DOI 10.1093/brain/awq071; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Gomez-Navarro N, 2016, J CELL BIOL, V215, P769, DOI 10.1083/jcb.201610031; GRADY EF, 1995, MOL BIOL CELL, V6, P509, DOI 10.1091/mbc.6.5.509; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; HARFORD J, 1983, J BIOL CHEM, V258, P3191; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hu Hao, 2009, Hugo J, V3, P41, DOI 10.1007/s11568-010-9137-y; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang SH, 2013, J NEUROSCI, V33, P9214, DOI 10.1523/JNEUROSCI.3256-12.2013; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Ilie A, 2019, NEUROBIOL DIS, V121, P187, DOI 10.1016/j.nbd.2018.10.002; Ilie A, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0129-9; Ilie A, 2014, NEUROCHEM INT, V73, P192, DOI 10.1016/j.neuint.2013.09.020; Jentsch TJ, 2018, PHYSIOL REV, V98, P1493, DOI 10.1152/physrev.00047.2017; Jinadasa T, 2015, J BIOL CHEM, V290, P18173, DOI 10.1074/jbc.M115.642199; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Karim MA, 2018, MOL BIOL CELL, V29, P317, DOI 10.1091/mbc.E17-08-0496; Khadilkar A, 2001, J BIOL CHEM, V276, P43792, DOI 10.1074/jbc.M106659200; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Kincaid MM, 2007, MOL BIOL CELL, V18, P455, DOI 10.1091/mbc.E06-08-0696; Krueger KM, 1997, J BIOL CHEM, V272, P5; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; Leal G, 2015, BRAIN RES, V1621, P82, DOI 10.1016/j.brainres.2014.10.019; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Liu J, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0392-5; Lou XH, 2011, AM J PHYSIOL-CELL PH, V301, pC1431, DOI 10.1152/ajpcell.00154.2011; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Mahon Matthew J, 2011, Adv Biosci Biotechnol, V2, P132; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Markunas CA, 2010, PSYCHIAT GENET, V20, P73, DOI 10.1097/YPG.0b013e3283351209; Masurel-Paulet A, 2016, AM J MED GENET A, V170, P2103, DOI 10.1002/ajmg.a.37765; MAXFIELD FR, 1982, J CELL BIOL, V95, P676, DOI 10.1083/jcb.95.2.676; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MELLMAN I, 1992, J EXP BIOL, V172, P39; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; Mercimek-Mahmutoglu S, 2015, EPILEPSIA, V56, P707, DOI 10.1111/epi.12954; Merkulova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14827; Merkulova M, 2010, BBA-BIOENERGETICS, V1797, P1398, DOI 10.1016/j.bbabio.2010.02.009; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mick E, 2010, J AM ACAD CHILD PSY, V49, P898, DOI 10.1016/j.jaac.2010.02.014; Mignot C, 2013, BRAIN DEV-JPN, V35, P172, DOI 10.1016/j.braindev.2012.03.010; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nygaard EB, 2011, J BIOL CHEM, V286, P634, DOI 10.1074/jbc.M110.159202; Ohgaki R, 2010, MOL BIOL CELL, V21, P1293, DOI 10.1091/mbc.E09-09-0767; Ouyang Q, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0046-19.2019; Ouyang Q, 2013, NEURON, V80, P97, DOI 10.1016/j.neuron.2013.07.043; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Padmanabha Hansashree, 2017, BMJ Case Rep, V2017, DOI 10.1136/bcr-2017-222050; Pescosolido Matthew F, 2019, Mol Neuropsychiatry, V5, P98, DOI 10.1159/000496341; Pescosolido MF, 2014, ANN NEUROL, V76, P581, DOI 10.1002/ana.24225; Piton A, 2011, MOL PSYCHIATR, V16, P867, DOI 10.1038/mp.2010.54; Pokkuluri PR, 2013, MICROBIOLOGYOPEN, V2, P766, DOI 10.1002/mbo3.112; Prasad H, 2018, P NATL ACAD SCI USA, V115, pE6640, DOI 10.1073/pnas.1801612115; Prasad H, 2015, J BIOL CHEM, V290, P5311, DOI 10.1074/jbc.M114.602219; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rai R, 2006, J AM CHEM SOC, V128, P7916, DOI 10.1021/ja060674v; Redin C, 2014, J MED GENET, V51, P724, DOI 10.1136/jmedgenet-2014-102554; Riess A, 2013, CLIN GENET, V83, P596, DOI 10.1111/j.1399-0004.2012.01948.x; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Roxrud I, 2009, EXP CELL RES, V315, P3014, DOI 10.1016/j.yexcr.2009.07.012; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Santoni FA, 2014, GENOME RES, V24, P349, DOI 10.1101/gr.163832.113; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schroer RJ, 2010, AM J MED GENET A, V152A, P2775, DOI 10.1002/ajmg.a.33093; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Schuurs-Hoeijmakers JHM, 2013, J MED GENET, V50, P802, DOI 10.1136/jmedgenet-2013-101644; Schwede M, 2014, MOL PSYCHIATR, V19, P277, DOI 10.1038/mp.2013.28; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Sikora J, 2016, DIS MODEL MECH, V9, P13, DOI 10.1242/dmm.022780; Sinajon P, 2016, HUM GENET, V135, P841, DOI 10.1007/s00439-016-1675-5; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Stromme P, 2011, BRAIN, V134, P3369, DOI 10.1093/brain/awr250; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Takahashi Y, 2011, AM J MED GENET B, V156B, P799, DOI 10.1002/ajmg.b.31221; TANAKA K, 1981, ARCH BIOCHEM BIOPHYS, V208, P296, DOI 10.1016/0003-9861(81)90152-1; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Thibert C, 2010, CELL CYCLE, V9, P2085, DOI 10.4161/cc.9.11.11809; Tilot AK, 2018, P NATL ACAD SCI USA, V115, P3168, DOI 10.1073/pnas.1715492115; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; Trump N, 2016, J MED GENET, V53, P310, DOI 10.1136/jmedgenet-2015-103263; Tzschach A, 2015, EUR J HUM GENET, V23, P1513, DOI 10.1038/ejhg.2015.5; Tzschach A, 2011, AM J MED GENET A, V155A, P2771, DOI 10.1002/ajmg.a.34230; Ullman JC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02716-5; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; VANWEERT AWM, 1995, J CELL BIOL, V130, P821, DOI 10.1083/jcb.130.4.821; Viana RJS, 2012, MOL NEUROBIOL, V46, P522, DOI 10.1007/s12035-012-8301-x; Weisz OA, 2003, INT REV CYTOL, V226, P259, DOI 10.1016/S0074-7696(03)01005-2; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Xu Meiyu, 2017, eNeuro, V4, DOI 10.1523/ENEURO.0388-17.2017; YAMASHIRO DJ, 1984, J CELL BIOCHEM, V26, P231, DOI 10.1002/jcb.240260404; YAMASHIRO DJ, 1988, TRENDS PHARMACOL SCI, V9, P190, DOI 10.1016/0165-6147(88)90078-8; Yang LN, 2016, AM J MED GENET B, V171, P363, DOI 10.1002/ajmg.b.32415; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zanni G, 2014, EPILEPSY RES, V108, P811, DOI 10.1016/j.eplepsyres.2014.02.009	136	7	7	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7075	7095		10.1074/jbc.RA120.012614	http://dx.doi.org/10.1074/jbc.RA120.012614			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32277048	Green Published, hybrid			2022-12-28	WOS:000536212600024
J	Strobel, EJ; Lis, JT; Lucks, JB				Strobel, Eric J.; Lis, John T.; Lucks, Julius B.			Chemical roadblocking of DNA transcription for nascent RNA display	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription; RNA polymerase; RNA; RNA folding; biotin; desthiobiotin; etheno-dA; RNAP roadblocking; site-specific transcription arrest; translesion synthesis	QUANTITATIVE-ANALYSIS; PROTEIN INTERACTIONS; POLYMERASE BYPASS; STRAND BREAKS; ABASIC SITES; MUTAGENESIS; ELONGATION; RIBOSWITCH; MECHANISM	Site-specific arrest of RNA polymerases (RNAPs) is fundamental to several technologies that assess RNA structure and function. Current in vitro transcription ?roadblocking? approaches inhibit transcription elongation by blocking RNAP with a protein bound to the DNA template. One limitation of protein-mediated transcription roadblocking is that it requires inclusion of a protein factor extrinsic to the minimal in vitro transcription reaction. In this work, we developed a chemical approach for halting transcription by Escherichia coli RNAP. We first established a sequence-independent method for site-specific incorporation of chemical lesions into dsDNA templates by sequential PCR and translesion synthesis. We then show that interrupting the transcribed DNA strand with an internal desthiobiotin-triethylene glycol modification or 1,N-6-etheno-2?-deoxyadenosine base efficiently and stably halts Escherichia coli RNAP transcription. By encoding an intrinsic stall site within the template DNA, our chemical transcription roadblocking approach enables display of nascent RNA molecules from RNAP in a minimal in vitro transcription reaction.	[Strobel, Eric J.; Lucks, Julius B.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Lucks, Julius B.] Northwestern Univ, Ctr Synthet Biol, Evanston, IL 60208 USA; [Strobel, Eric J.; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Northwestern University; Northwestern University; Cornell University	Strobel, EJ (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.; Strobel, EJ (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	eric.strobel@northwestern.edu	Lucks, Julius/L-2801-2016	Lis, John/0000-0003-1201-9406; Lucks, Julius/0000-0002-0619-6505; Strobel, Eric/0000-0002-7082-2881	Arnold O. Beckman postdoctoral fellowship; NIGMS, National Institutes of Health [GM025232]; Searle Funds at The Chicago Community Trust	Arnold O. Beckman postdoctoral fellowship; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Searle Funds at The Chicago Community Trust	This work was supported by an Arnold O. Beckman postdoctoral fellowship (to E. J. S.), NIGMS, National Institutes of Health Grant GM025232 (to J. T. L.)., and Searle Funds at The Chicago Community Trust (to J. B. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Buenrostro JD, 2014, NAT BIOTECHNOL, V32, P562, DOI 10.1038/nbt.2880; Chauvier A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13892; Clauson CL, 2010, P NATL ACAD SCI USA, V107, P3657, DOI 10.1073/pnas.0913191107; Fiala KA, 2007, J MOL BIOL, V365, P590, DOI 10.1016/j.jmb.2006.10.008; Frieda KL, 2012, SCIENCE, V338, P397, DOI 10.1126/science.1225722; Landick R, 1996, METHOD ENZYMOL, V274, P334; Luzzietti N, 2012, NAT PROTOC, V7, P643, DOI 10.1038/nprot.2012.008; Luzzietti N, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1004; McDonald JP, 2006, NUCLEIC ACIDS RES, V34, P1102, DOI 10.1093/nar/gkj512; METZGER W, 1989, EMBO J, V8, P2745, DOI 10.1002/j.1460-2075.1989.tb08416.x; PAVCO PA, 1990, J BIOL CHEM, V265, P9960; Pupov D, 2019, BIOCHEM BIOPH RES CO, V510, P122, DOI 10.1016/j.bbrc.2019.01.062; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; STRAUSS BS, 1991, BIOESSAYS, V13, P79, DOI 10.1002/bies.950130206; Strobel EJ, 2019, NAT CHEM BIOL, V15, P1067, DOI 10.1038/s41589-019-0382-7; Strobel EJ, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx233; Strobel EJ, 2015, P NATL ACAD SCI USA, V112, pE4374, DOI 10.1073/pnas.1512986112; Tome JM, 2014, NAT METHODS, V11, P683, DOI [10.1038/NMETH.2970, 10.1038/nmeth.2970]; VANHOUTEN B, 1987, J BIOL CHEM, V262, P13180; Viswanathan A, 1998, J BIOL CHEM, V273, P21276, DOI 10.1074/jbc.273.33.21276; Viswanathan A, 1999, ANN NY ACAD SCI, V870, P386, DOI 10.1111/j.1749-6632.1999.tb08909.x; Wang HX, 2001, MOL BIOTECHNOL, V19, P133, DOI 10.1385/MB:19:2:133; Watters KE, 2016, NAT STRUCT MOL BIOL, V23, P1124, DOI 10.1038/nsmb.3316; Widom JR, 2019, RNA, V25, P1457, DOI 10.1261/rna.071613.119; ZHOU W, 1993, P NATL ACAD SCI USA, V90, P6601, DOI 10.1073/pnas.90.14.6601	26	7	7	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6401	6412		10.1074/jbc.RA120.012641	http://dx.doi.org/10.1074/jbc.RA120.012641			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32209658	Green Published, hybrid			2022-12-28	WOS:000537685000013
J	Rainczuk, AK; Klatt, S; Yamaryo-Botte, Y; Brammananth, R; McConville, MJ; Coppel, RL; Crellin, PK				Rainczuk, Arek K.; Klatt, Stephan; Yamaryo-Botte, Yoshiki; Brammananth, Rajini; McConville, Malcolm J.; Coppel, Ross L.; Crellin, Paul K.			MtrP, a putative methyltransferase in Corynebacteria, is required for optimal membrane transport of trehalose mycolates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; cell wall; lipid bilayer; fatty acid; microbiology; Corynebacterium; glutamicum	MYCOLIC ACID BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS; CLONING VECTORS; IDENTIFICATION; MMPL3; MONOMYCOLATE; METHYLATION; GLUTAMICUM; TARGETS; GENE	Pathogenic bacteria of the genera Mycobacterium and Corynebacterium cause severe human diseases such as tuberculosis (Mycobacterium tuberculosis) and diphtheria (Corynebacterium diphtheriae). The cells of these species are surrounded by protective cell walls rich in long-chain mycolic acids. These fatty acids are conjugated to the disaccharide trehalose on the cytoplasmic side of the bacterial cell membrane. They are then transported across the membrane to the periplasm where they act as donors for other reactions. We have previously shown that transient acetylation of the glycolipid trehalose monohydroxycorynomycolate (hTMCM) enables its efficient transport to the periplasm in Corynebacterium glutamicum and that acetylation is mediated by the membrane protein TmaT. Here, we show that a putative methyltransferase, encoded at the same genetic locus as TmaT, is also required for optimal hTMCM transport. Deletion of the C. glutamicum gene NCgl2764 (Rv0224c in M. tuberculosis) abolished acetyltrehalose monocorynomycolate (AcTMCM) synthesis, leading to accumulation of hTMCM in the inner membrane and delaying its conversion to trehalose dihydroxycorynomycolate (h2TDCM). Complementation with NCgl2764 normalized turnover of hTMCM to h2TDCM. In contrast, complementation with NCgl2764 derivatives mutated at residues essential for methyltransferase activity failed to rectify the defect, suggesting that NCgl2764/Rv0224c encodes a methyltransferase, designated here as MtrP. Comprehensive analyses of the individual mtrP and tmaT mutants and of a double mutant revealed strikingly similar changes across several lipid classes compared with WT bacteria. These findings indicate that both MtrP and TmaT have nonredundant roles in regulating AcTMCM synthesis, revealing additional complexity in the regulation of trehalose mycolate transport in the Corynebacterineae.	[Rainczuk, Arek K.; Brammananth, Rajini; Coppel, Ross L.; Crellin, Paul K.] Monash Univ, Infect & Immun Program, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Rainczuk, Arek K.; Brammananth, Rajini; Coppel, Ross L.; Crellin, Paul K.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Klatt, Stephan; Yamaryo-Botte, Yoshiki; McConville, Malcolm J.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Inst Mol Sci & Biotechnol, Parkville, Vic 3010, Australia; [Klatt, Stephan] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne Dementia Res Ctr, 30 Royal Parade, Parkville, Vic 3052, Australia; [Yamaryo-Botte, Yoshiki] Univ Grenoble Alpes, ApicoLipid Team, Inst Adv Biosci, CNRS,UMR5309,INSERM,U1209, Grenoble, France	Monash University; Monash University; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Crellin, PK (corresponding author), Monash Univ, Infect & Immun Program, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia.; Crellin, PK (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	paul.crellin@monash.edu		Crellin, Paul K/0000-0002-2017-4935; Klatt, Stephan/0000-0003-0064-3367; McConville, Malcolm/0000-0002-7107-7887	National Health and Medical Research Council of Australia [1064466]; Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics Grant [COE562063]; Australian Research Council [180102463]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics Grant(Australian Research Council); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council of Australia Project Grant 1064466 (to P. K. C., R. L. C., and M. J. M.), Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics Grant COE562063 (to R. L. C.), and Australian Research Council Discovery Grant 180102463 (to R. L. C. and M. J. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; Alsayed SSR, 2019, CURR MOL PHARMACOL, V12, P27, DOI 10.2174/1874467211666181025141114; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Belardinelli JM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47159-8; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Bhatt A, 2007, MOL MICROBIOL, V64, P1442, DOI 10.1111/j.1365-2958.2007.05761.x; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cashmore TJ, 2017, J BIOL CHEM, V292, P4976, DOI 10.1074/jbc.M116.772202; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; DeJesus MA, 2017, MBIO, V8, DOI 10.1128/mBio.02133-16; Druszczynska M, 2017, CURR MED CHEM, V24, P4267, DOI 10.2174/0929867324666170823130445; Dupont C, 2019, J BIOL CHEM, V294, P17512, DOI 10.1074/jbc.RA119.010135; Fernandes ND, 1996, GENE, V170, P95, DOI 10.1016/0378-1119(95)00842-X; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; Hattori Y, 2011, BIOCHEM BIOPH RES CO, V409, P304, DOI 10.1016/j.bbrc.2011.04.146; Jankute M, 2015, ANNU REV MICROBIOL, V69, P405, DOI 10.1146/annurev-micro-091014-104121; Keller JP, 2002, STRUCTURE, V10, P1475, DOI 10.1016/S0969-2126(02)00876-6; Klatt S, 2018, J LIPID RES, V59, P1190, DOI 10.1194/jlr.M082784; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Li W, 2019, ACS INFECT DIS, V5, P1001, DOI 10.1021/acsinfecdis.9b00048; Li W, 2014, ANTIMICROB AGENTS CH, V58, P6413, DOI 10.1128/AAC.03229-14; Liao HW, 2015, J CLIN INVEST, V125, P4529, DOI 10.1172/JCI82826; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Rainczuk AK, 2012, J BIOL CHEM, V287, P42726, DOI 10.1074/jbc.M112.373415; Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Su CC, 2019, P NATL ACAD SCI USA, V116, P11241, DOI 10.1073/pnas.1901346116; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Williams JT, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00547-19; Xu ZJ, 2017, P NATL ACAD SCI USA, V114, P7993, DOI 10.1073/pnas.1700062114; Yamaryo-Botte Y, 2015, ACS CHEM BIOL, V10, P734, DOI 10.1021/cb5007689; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6	50	8	8	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6108	6119		10.1074/jbc.RA119.011688	http://dx.doi.org/10.1074/jbc.RA119.011688			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32217691	Green Published, hybrid			2022-12-28	WOS:000531417300021
J	Yoon, JH; Johnson, RE; Prakash, L; Prakash, S				Yoon, Jung-Hoon; Johnson, Robert E.; Prakash, Louise; Prakash, Satya			Genetic evidence for reconfiguration of DNA polymerase ? active site for error-free translesion synthesis in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; DNA replication; mutagenesis; mutagenesis mechanism; active site reconfiguration; DNA polymerase theta; Hoogsteen base pairing; syn conformation; translesion synthesis; error-free translesion synthesis	REPLICATIVE BYPASS; YEAST; IOTA; ZETA; MOUSE; THETA	The action mechanisms revealed by the biochemical and structural analyses of replicative and translesion synthesis (TLS) DNA polymerases (Pols) are retained in their cellular roles. In this regard, DNA polymerase ? differs from other Pols in that whereas purified Pol? misincorporates an A opposite 1,N-6-ethenodeoxyadenosine (?dA) using an abasic-like mode, Pol? performs predominantly error-free TLS in human cells. To test the hypothesis that Pol? adopts a different mechanism for replicating through ?dA in human cells than in the purified Pol, here we analyze the effects of mutations in the two highly conserved tyrosine residues, Tyr-2387 and Tyr-2391, in the Pol? active site. Our findings that these residues are indispensable for TLS by the purified Pol but are not required in human cells, as well as other findings, provide strong evidence that the Pol? active site is reconfigured in human cells to stabilize ?dA in the syn conformation for Hoogsteen base pairing with the correct nucleotide. The evidence that a DNA polymerase can configure its active site entirely differently in human cells than in the purified Pol establishes a new paradigm for DNA polymerase function.	[Yoon, Jung-Hoon; Johnson, Robert E.; Prakash, Louise; Prakash, Satya] Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, S (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.	saprakas@utmb.edu		Prakash, Satya/0000-0001-7228-1444	National Institutes of Health [ES022948, GM126087]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health Grants ES022948 and GM126087. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Chung FL, 1999, IARC SCI PUBL, P45; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P10466, DOI 10.1073/pnas.0503859102; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Luczaj W, 2003, CELL MOL BIOL LETT, V8, P391; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Yoon JH, 2019, GENE DEV, V33, P282, DOI 10.1101/gad.320531.118; Yoon JH, 2019, CELL, V176, P1295, DOI 10.1016/j.cell.2019.01.023; Yoon JH, 2018, J BIOL CHEM, V293, P2949, DOI 10.1074/jbc.RA117.000962; Yoon JH, 2017, J BIOL CHEM, V292, P18682, DOI 10.1074/jbc.M117.808659; Yoon JH, 2014, J BIOL CHEM, V289, P13177, DOI 10.1074/jbc.M114.556977; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Zahn KE, 2015, NAT STRUCT MOL BIOL, V22, P304, DOI 10.1038/nsmb.2993	23	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5918	5927		10.1074/jbc.RA120.012816	http://dx.doi.org/10.1074/jbc.RA120.012816			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32169903	hybrid, Green Published			2022-12-28	WOS:000531417300007
J	Jegouzo, SAF; Nelson, C; Hardwick, T; Wong, STA; Lau, NKK; Neoh, GKE; Castellanos-Rueda, R; Huang, ZY; Mignot, B; Hirdaramani, A; Howitt, A; Frewin, K; Shen, Z; Fox, RJ; Wong, R; Ando, M; Emony, L; Zhu, H; Holder, A; Werling, D; Krishnan, N; Robertson, BD; Clements, A; Taylor, ME; Drickamer, K				Jegouzo, Sabine A. F.; Nelson, Conor; Hardwick, Thomas; Wong, S. T. Angel; Lau, Noel Kuan Kiat; Neoh, Gaik Kin Emily; Castellanos-Rueda, Rocio; Huang, Zhiyao; Mignot, Benjamin; Hirdaramani, Aanya; Howitt, Annie; Frewin, Kathryn; Shen, Zheng; Fox, Rhys J.; Wong, Rachel; Ando, Momoko; Emony, Lauren; Zhu, Henderson; Holder, Angela; Werling, Dirk; Krishnan, Nitya; Robertson, Brian D.; Clements, Abigail; Taylor, Maureen E.; Drickamer, Kurt			Mammalian lectin arrays for screening host?microbe interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; lectin; carbohydrate-binding protein; carbohydrate function; lipopolysaccharide (LPS); array screening; glycan-binding receptors; innate immune system; ligand binding; pathogen	C-TYPE LECTIN; CARBOHYDRATE-RECOGNITION; MOLECULAR-BASIS; BINDING; RECEPTOR; EXPRESSION; IDENTIFICATION; MECHANISM; LIPOPOLYSACCHARIDES; POLYSACCHARIDE	Many members of the C-type lectin family of glycan-binding receptors have been ascribed roles in the recognition of microorganisms and serve as key receptors in the innate immune response to pathogens. Other mammalian receptors have become targets through which pathogens enter target cells. These receptor roles have often been documented with binding studies involving individual pairs of receptors and microorganisms. To provide a systematic overview of interactions between microbes and the large complement of C-type lectins, here we developed a lectin array and suitable protocols for labeling of microbes that could be used to probe this array. The array contains C-type lectins from cow, chosen as a model organism of agricultural interest for which the relevant pathogen?receptor interactions have not been previously investigated in detail. Screening with yeast cells and various strains of both Gram-positive and -negative bacteria revealed distinct binding patterns, which in some cases could be explained by binding to lipopolysaccharides or capsular polysaccharides, but in other cases they suggested the presence of novel glycan targets on many of the microorganisms. These results are consistent with interactions previously ascribed to the receptors, but they also highlight binding to additional sugar targets that have not previously been recognized. Our findings indicate that mammalian lectin arrays represent unique discovery tools for identifying both novel ligands and new receptor functions.	[Jegouzo, Sabine A. F.; Nelson, Conor; Hardwick, Thomas; Wong, S. T. Angel; Lau, Noel Kuan Kiat; Neoh, Gaik Kin Emily; Castellanos-Rueda, Rocio; Huang, Zhiyao; Mignot, Benjamin; Hirdaramani, Aanya; Howitt, Annie; Frewin, Kathryn; Shen, Zheng; Fox, Rhys J.; Wong, Rachel; Ando, Momoko; Emony, Lauren; Zhu, Henderson; Clements, Abigail; Taylor, Maureen E.; Drickamer, Kurt] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Holder, Angela; Werling, Dirk] Royal Vet Coll, Dept Pathobiol & Populat Sci, Hatfield AL9 7TA, Herts, England; [Krishnan, Nitya; Robertson, Brian D.] Imperial Coll London, Dept Infect Dis, London SW7 2AZ, England; [Clements, Abigail] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England	Imperial College London; University of London; University of London Royal Veterinary College; Imperial College London; Imperial College London	Drickamer, K (corresponding author), Imperial Coll London, Dept Life Sci, London SW7 2AZ, England.; Drickamer, K (corresponding author), Imperial Coll, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.	k.drickamer@imperial.ac.uk	Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044; Zhu, Henderson/0000-0002-5547-6669; Lau, Noel Kuan Kiat/0000-0002-9560-504X; Howitt, Annie/0000-0003-0388-0990; Wong, Rachel/0000-0003-0701-4563; Hardwick, Tom/0000-0003-1018-511X; Jegouzo, Sabine/0000-0001-7768-0102; Neoh, Emily/0000-0002-4802-3135; Mignot, Benjamin/0000-0002-0283-3108; Fox, Rhys/0000-0002-7433-0331	Biotechnology and Biological Sciences Research Council [BB/P005659/1, BB/P008461/1]; Bill and Melinda Gates Foundation [37882]; Aeras grant; BBSRC [BB/P005659/1, BB/P008461/1] Funding Source: UKRI; MRC [MR/P028225/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Aeras grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/P005659/1 (to K. D. and M. E. T.) and BB/P008461/1 (to D. W.), Bill and Melinda Gates Foundation Grant 37882 (to B. D. R.), and an Aeras grant (to B. D. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Arthur CM, 2015, METHODS MOL BIOL, V1207, P115, DOI 10.1007/978-1-4939-1396-1_8; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; Chatterjee D, 2001, CELL MOL LIFE SCI, V58, P2018, DOI 10.1007/PL00000834; Clements A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003817; Coombs PJ, 2005, J BIOL CHEM, V280, P22993, DOI 10.1074/jbc.M504197200; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Fadden AJ, 2003, GLYCOBIOLOGY, V13, P529, DOI 10.1093/glycob/cwg068; Feinberg H, 2017, J BIOL CHEM, V292, P13402, DOI 10.1074/jbc.M117.799080; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Fuller ME, 2000, APPL ENVIRON MICROB, V66, P4486, DOI 10.1128/AEM.66.10.4486-4496.2000; Fulton KM, 2018, EXPERT REV PROTEOMIC, V15, P203, DOI 10.1080/14789450.2018.1435276; Geissner A, 2019, P NATL ACAD SCI USA, V116, P1958, DOI 10.1073/pnas.1800853116; Gibson AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00124; Gjerstorff M, 2004, ANIM GENET, V35, P333, DOI 10.1111/j.1365-2052.2004.01167.x; Guzman E, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00307; Hansen S, 2002, J IMMUNOL, V169, P5726, DOI 10.4049/jimmunol.169.10.5726; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; Hirabayashi J, 2015, TOP CURR CHEM, V367, P105, DOI 10.1007/128_2014_612; Howard M, 2018, SEMIN IMMUNOPATHOL, V40, P75, DOI 10.1007/s00281-017-0642-0; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jang S, 2009, J BIOL CHEM, V284, P3956, DOI 10.1074/jbc.M807477200; Killick KE, 2013, CELL MICROBIOL, V15, P1484, DOI 10.1111/cmi.12161; Klein G, 2011, J BIOL CHEM, V286, P42787, DOI 10.1074/jbc.M111.291799; KUHN HM, 1988, FEMS MICROBIOL LETT, V54, P195, DOI 10.1111/j.1574-6968.1988.tb02743.x; Lang R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00005; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mavridou DAI, 2016, PLASMID, V87-88, P65, DOI 10.1016/j.plasmid.2016.09.005; Mistretta N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39929-1; Ng KKS, 1996, J BIOL CHEM, V271, P663, DOI 10.1074/jbc.271.2.663; Ng S, 2015, J AM CHEM SOC, V137, P5248, DOI 10.1021/ja511237n; Nishiuchi Y, 2000, FEMS IMMUNOL MED MIC, V28, P163, DOI 10.1111/j.1574-695X.2000.tb01472.x; Pant SD, 2014, GENE, V537, P302, DOI 10.1016/j.gene.2013.12.020; Pilobello KT, 2005, CHEMBIOCHEM, V6, P985, DOI 10.1002/cbic.200400403; Plato A, 2013, INT REV IMMUNOL, V32, P134, DOI 10.3109/08830185.2013.777065; Powlesland AS, 2008, J BIOL CHEM, V283, P593, DOI 10.1074/jbc.M706292200; Propster JM, 2015, PROTEIN EXPRES PURIF, V109, P14, DOI 10.1016/j.pep.2015.01.005; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Stowell SR, 2014, NAT CHEM BIOL, V10, P470, DOI [10.1038/nchembio.1525, 10.1038/NCHEMBIO.1525]; Taylor ME, 2019, FEBS J, V286, P1800, DOI 10.1111/febs.14759; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; Valdivia RH, 2006, METHOD BIOCHEM ANAL, V47, P163; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Whitfield C., 2015, ECOLOGICAL IMPORTANC, P265, DOI DOI 10.1016/B978-0-12-802749-3.00009-8; WIDMALM G, 1993, CARBOHYD RES, V247, P255, DOI 10.1016/0008-6215(93)84258-8; Willcocks S, 2006, VET IMMUNOL IMMUNOP, V113, P234, DOI 10.1016/j.vetimm.2006.04.007; Yamakawa Y, 2008, J LEUKOCYTE BIOL, V83, P1396, DOI 10.1189/jlb.0807523; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005; Young JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6887; Zhen L, 2018, FEBS LETT, V592, P3976, DOI 10.1002/1873-3468.13217; Zheng RB, 2017, ACS CHEM BIOL, V12, P2990, DOI 10.1021/acschembio.7b00797	60	5	5	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4541	4555		10.1074/jbc.RA120.012783	http://dx.doi.org/10.1074/jbc.RA120.012783			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32094229	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000524499700015
J	Poli, M; Anower-E-Khuda, F; Asperti, M; Ruzzenenti, P; Gryzik, M; Denardo, A; Gordts, PLSM; Arosio, P; Esko, JD				Poli, Maura; Anower-E-Khuda, Ferdous; Asperti, Michela; Ruzzenenti, Paola; Gryzik, Magdalena; Denardo, Andrea; Gordts, Philip L. S. M.; Arosio, Paolo; Esko, Jeffrey D.			Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice (vol 294, pg 13292, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction									[Esko, Jeffrey D.] TEGA Therapeut, La Jolla, CA 92093 USA; [Esko, Jeffrey D.] Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Esko, JD (corresponding author), TEGA Therapeut, La Jolla, CA 92093 USA.; Esko, JD (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.			arosio, paolo/0000-0002-5343-8992				Poli M, 2019, J BIOL CHEM, V294, P13292, DOI 10.1074/jbc.RA118.007213	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3747	3747		10.1074/jbc.AAC120.013026	http://dx.doi.org/10.1074/jbc.AAC120.013026			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32169857	hybrid, Green Published			2022-12-28	WOS:000527725300030
J	Stammers, M; Ivanova, IM; Niewczas, IS; Segonds-Pichon, A; Streeter, M; Spiegel, DA; Clark, J				Stammers, Melanie; Ivanova, Irina M.; Niewczas, Izabella S.; Segonds-Pichon, Anne; Streeter, Matthew; Spiegel, David A.; Clark, Jonathan			Age-related changes in the physical properties, cross-linking, and glycation of collagen from mouse tail tendon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tendon; collagen; cross-links; lysine glycation; aging; physical strain; chemistry; diabetes; mechanical stress; connective tissue; tendon; protein cross-linking		Collagen is a structural protein whose internal cross-linking critically determines the properties and functions of connective tissue. Knowing how the cross-linking of collagen changes with age is key to understanding why the mechanical properties of tissues change over a lifetime. The current scientific consensus is that collagen cross-linking increases with age and that this increase leads to tendon stiffening. Here, we show that this view should be reconsidered. Using MS-based analyses, we demonstrated that during aging of healthy C57BL/6 mice, the overall levels of collagen cross-linking in tail tendon decreased with age. However, the levels of lysine glycation in collagen, which is not considered a cross-link, increased dramatically with age. We found that in 16-week-old diabetic db/db mice, glycation reaches levels similar to those observed in 98-week-old C57BL/6 mice, while the other cross-links typical of tendon collagen either decreased or remained the same as those observed in 20-week-old WT mice. These results, combined with findings from mechanical testing of tendons from these mice, indicate that overall collagen cross-linking in mouse tendon decreases with age. Our findings also reveal that lysine glycation appears to be an important factor that contributes to tendon stiffening with age and in diabetes.	[Stammers, Melanie; Ivanova, Irina M.; Niewczas, Izabella S.; Segonds-Pichon, Anne; Clark, Jonathan] Babraham Inst, Cambridge, England; [Ivanova, Irina M.] John Innes Ctr, Norwich, Norfolk, England; [Streeter, Matthew; Spiegel, David A.] Yale Univ, Dept Chem, New Haven, CT USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Yale University	Clark, J (corresponding author), Babraham Inst, Cambridge, England.	jonathan.clark@babraham.ac.uk			SENS Research Foundation; Babraham Institute's Core Capability Grant from the BBSRC	SENS Research Foundation; Babraham Institute's Core Capability Grant from the BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	M. Stammers was funded by SENS Research Foundation. Imagining, chemistry, mass spectroscopy, and statistical analysis were carried out in Babraham Institute facilities which are funded in part by Babraham Institute's Core Capability Grant from the BBSRC.	BAILEY AJ, 1968, BIOCHEM BIOPH RES CO, V33, P812, DOI 10.1016/0006-291X(68)90233-7; Bawazeer S, 2012, J CHROMATOGR A, V1263, P61, DOI 10.1016/j.chroma.2012.09.005; BERNSTEIN PH, 1980, J BIOL CHEM, V255, P414; DAVISON PF, 1989, CONNECT TISSUE RES, V18, P293, DOI 10.3109/03008208909019078; Davison PF., 1972, CONNECT TISSUE RES, V1, P205, DOI [10.3109/03008207209152076, DOI 10.3109/03008207209152076]; Draghici C, 2015, SCIENCE, V350, P294, DOI 10.1126/science.aac9655; Eyre DR, 2019, J BIOL CHEM, V294, P6578, DOI 10.1074/jbc.RA118.007202; Fratzl P, 2008, COLLAGEN STRUCTURE M; Hudson DM, 2018, J BIOL CHEM, V293, P15620, DOI 10.1074/jbc.RA118.004829; LEITER EH, 1988, FASEB J, V2, P2807, DOI 10.1096/fasebj.2.12.3044905; Li QR, 2013, TETRAHEDRON, V69, P10384, DOI 10.1016/j.tet.2013.09.098; Monnier VM, 2014, CLIN CHEM LAB MED, V52, P21, DOI 10.1515/cclm-2013-0174; Monnier VM, 1999, DIABETES, V48, P870, DOI 10.2337/diabetes.48.4.870; Naffa R, 2016, J CHROMATOGR A, V1478, P60, DOI 10.1016/j.chroma.2016.11.060; Nash Anthony, 2019, Matrix Biol Plus, V4, P100013, DOI 10.1016/j.mbplus.2019.100013; ROBINS SP, 1973, BIOCHEM J, V131, P771, DOI 10.1042/bj1310771; Saito M, 2010, OSTEOPOROSIS INT, V21, P195, DOI 10.1007/s00198-009-1066-z; Sricholpech M, 2012, J BIOL CHEM, V287, P22998, DOI 10.1074/jbc.M112.343954; Stammer M., 2020, J BIOL CHEM, V295; TANZER ML, 1973, J BIOL CHEM, V248, P393; TANZER ML, 1970, BIOCHIM BIOPHYS ACTA, V207, P548; Terajima M, 2016, J BIOL CHEM, V291, P9501, DOI 10.1074/jbc.M115.699470	22	11	11	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10562	10571		10.1074/jbc.RA119.011031	http://dx.doi.org/10.1074/jbc.RA119.011031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32381510	hybrid, Green Published			2022-12-28	WOS:000560405600005
J	Rodriguez-Berdini, L; Ferrero, GO; Plonka, FB; Gizzi, AMC; Prucca, CG; Quiroga, S; Caputto, BL				Rodriguez-Berdini, Lucia; Ferrero, Gabriel Orlando; Bustos Plonka, Florentyna; Cardozo Gizzi, Andres Mauricio; Prucca, Cesar German; Quiroga, Santiago; Caputto, Beatriz Leonor			The moonlighting protein c-Fos activates lipid synthesis in neurons, an activity that is critical for cellular differentiation and cortical development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neurodifferentiation; neurodevelopment; c-Fos; lipid synthesis; phospholipid metabolism; hippocampus; AP-1; central nervous system; oncogene; neurodifferentiation; neurodevelopment; phospholipid metabolism; lipid synthesis; AP1 transcription factor (AP-1); central nervous system (CNS); oncogene	SMOOTH ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE EXPANSION; SQUID GIANT-AXON; PHOSPHOLIPID-SYNTHESIS; HIPPOCAMPAL-NEURONS; ENDOMEMBRANE SYSTEM; PHOSPHATIDIC-ACID; GENE-EXPRESSION; NERVOUS-SYSTEM; BRAIN	Differentiation of neuronal cells is crucial for the development and function of the nervous system. This process involves high rates of membrane expansion, during which the synthesis of membrane lipids must be tightly regulated. In this work, using a variety of molecular and biochemical assays and approaches, including immunofluorescence microscopy and FRET analyses, we demonstrate that the proto-oncogene c-Fos (c-Fos) activates cytoplasmic lipid synthesis in the central nervous system and thereby supports neuronal differentiation. Specifically, in hippocampal primary cultures, blocking c-Fos expression or its activity impairs neuronal differentiation. When examining its subcellular localization, we found that c-Fos co-localizes with endoplasmic reticulum markers and strongly interacts with lipid-synthesizing enzymes, whose activities were markedly increasedin vitroin the presence of recombinant c-Fos. Of note, the expression of c-Fos dominant-negative variants capable of blocking its lipid synthesis?activating activity impaired neuronal differentiation. Moreover, using anin uteroelectroporation model, we observed that neurons with blocked c-Fos expression or lacking its AP-1?independent activity fail to initiate cortical development. These results highlight the importance of c-Fos?mediated activation of lipid synthesis for proper nervous system development.	[Rodriguez-Berdini, Lucia; Ferrero, Gabriel Orlando; Bustos Plonka, Florentyna; Cardozo Gizzi, Andres Mauricio; Prucca, Cesar German; Quiroga, Santiago; Caputto, Beatriz Leonor] Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Ctr Invest Quim Biol Cordoba, Dept Quim Biol Ranwel Caputto,Fac Ciencias Quim, Cordoba, Argentina; [Ferrero, Gabriel Orlando] Univ Tecnol Nacl, Consejo Nacl Invest Cient & Tecn, Ctr Invest & Tecnol Quim Prof Dr Oscar A Orio, Fac Reg Cordoba, Ciudad Univ, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Caputto, BL (corresponding author), Univ Nacl Cordoba, Consejo Nacl Invest Cient & Tecn, Ctr Invest Quim Biol Cordoba, Dept Quim Biol Ranwel Caputto,Fac Ciencias Quim, Cordoba, Argentina.	bcaputto@fcq.unc.edu.ar	Prucca, César Germán/AAC-4630-2021	Prucca, César Germán/0000-0003-4165-4660; Rodriguez-Berdini, Lucia/0000-0003-0542-0461; Cardozo Gizzi, Andres Mauricio/0000-0003-3894-1845	Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba; Fondo para la Investigacion Cientifica y Tecnologica, Ministerio de Ciencia, Tecnologia e Innovacion, Argentina [PICT 2017-2761, PICT 2012-2797, PICT 2013-2996, PICT 2015-3702]; Instituto Nacional del Cancer, Ministerio de Salud, Argentina	Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); Fondo para la Investigacion Cientifica y Tecnologica, Ministerio de Ciencia, Tecnologia e Innovacion, Argentina; Instituto Nacional del Cancer, Ministerio de Salud, Argentina	This work was supported by the Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba; the Fondo para la Investigacion Cientifica y Tecnologica, Ministerio de Ciencia, Tecnologia e Innovacion, Argentina (Grants PICT 2017-2761, PICT 2012-2797, PICT 2013-2996, and PICT 2015-3702); and the Instituto Nacional del Cancer, Ministerio de Salud, Argentina. Gabriel Orlando Ferrero, Cesar German Prucca, Santiago Quiroga, and Beatriz Leonor Caputto are members of and Lucia Rodriguez Berdini, Florentyna Bustos Plonka, and Andres Mauricio Cardozo Gizzi are fellows of CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnologicas), Ministerio de Ciencia, Tecnologia e Innovacion, Argentina.	Pecchio ARA, 2011, MOL BIOL CELL, V22, P4716, DOI 10.1091/mbc.E11-03-0259; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Armijo-Weingart L, 2017, MOL CELL NEUROSCI, V84, P36, DOI 10.1016/j.mcn.2017.03.007; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Borioli GA, 2001, BIOCHEM BIOPH RES CO, V280, P9, DOI 10.1006/bbrc.2000.4081; BROADWELL RD, 1983, J HISTOCHEM CYTOCHEM, V31, P1077, DOI 10.1177/31.9.6309951; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bussolino DF, 2001, FASEB J, V15, P556; Bussolino DF, 1998, MOL BRAIN RES, V58, P10, DOI 10.1016/S0169-328X(98)00065-5; Caceres A, 2012, CURR OPIN CELL BIOL, V24, P547, DOI 10.1016/j.ceb.2012.05.011; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Gizzi AMC, 2015, J BIOL CHEM, V290, P29578, DOI 10.1074/jbc.M115.678821; CAUBET JF, 1989, MOL CELL BIOL, V9, P2269, DOI 10.1128/MCB.9.5.2269; Racca AC, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00544; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; DECHAVES EP, 1995, J CELL BIOL, V128, P913, DOI 10.1083/jcb.128.5.913; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DRAGUNOW M, 1987, NEUROSCI LETT, V82, P157, DOI 10.1016/0304-3940(87)90121-2; DRAGUNOW M, 1987, EUR J PHARMACOL, V135, P113, DOI 10.1016/0014-2999(87)90767-9; DROZ B, 1975, BRAIN RES, V93, P1, DOI 10.1016/0006-8993(75)90282-6; Ferrero GO, 2012, ONCOGENE, V31, P3381, DOI 10.1038/onc.2011.510; Ferrero GO, 2014, BIOCHEM J, V461, P521, DOI 10.1042/BJ20131376; GALLIARD T, 1965, BIOCHIM BIOPHYS ACTA, V106, P551, DOI 10.1016/0005-2760(65)90071-8; Gallo FT, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00079; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Gil GA, 2012, NEUROCHEM RES, V37, P1364, DOI 10.1007/s11064-012-0763-8; Gonzalez C, 2014, SEMIN CELL DEV BIOL, V27, P23, DOI 10.1016/j.semcdb.2013.12.004; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; GOULD RM, 1983, J NEUROCHEM, V40, P1293, DOI 10.1111/j.1471-4159.1983.tb13569.x; GOULD RM, 1983, J NEUROCHEM, V40, P1300, DOI 10.1111/j.1471-4159.1983.tb13570.x; Guido ME, 1996, J NEUROSCI RES, V43, P93, DOI 10.1002/jnr.490430112; Hatten ME, 1999, NEURON, V22, P2, DOI 10.1016/S0896-6273(00)80668-6; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HAYASHI K, 1967, J BIOCHEM-TOKYO, V62, P15, DOI 10.1093/oxfordjournals.jbchem.a128630; HUGHES P, 1995, PHARMACOL REV, V47, P133; Valenzuela JI, 2011, MOL CELL NEUROSCI, V48, P269, DOI 10.1016/j.mcn.2011.07.001; KUMARASIRI MH, 1980, BRAIN RES, V186, P315, DOI 10.1016/0006-8993(80)90978-6; Kwan AC, 2012, CURR BIOL, V22, P1459, DOI 10.1016/j.cub.2012.06.007; Ledeen R. W., 1985, TRANSPORT EXCHANGE T, P135; LINDSEY JD, 1985, J NEUROSCI, V5, P3135; Luarte A, 2018, DEV NEUROBIOL, V78, P181, DOI 10.1002/dneu.22560; Lykidis A, 1997, J BIOL CHEM, V272, P33402, DOI 10.1074/jbc.272.52.33402; Merianda T, 2013, NEUROSCI BULL, V29, P493, DOI 10.1007/s12264-013-1360-9; Millet Larry J., 2012, Yale Journal of Biology and Medicine, V85, P501; MORGAN JI, 1988, CELL CALCIUM, V9, P303, DOI 10.1016/0143-4160(88)90011-5; Nadarajah B, 2002, NAT REV NEUROSCI, V3, P423, DOI 10.1038/nrn845; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; PALAY S L, 1958, Exp Cell Res, V14, P275; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Portal MM, 2007, ONCOGENE, V26, P3551, DOI 10.1038/sj.onc.1210137; Quiroga S, 2018, DEV NEUROBIOL, V78, P170, DOI 10.1002/dneu.22553; RAMBOURG A, 1980, J NEUROCHEM, V35, P16, DOI 10.1111/j.1471-4159.1980.tb12484.x; Rao K, 2016, MOL BIOL CELL, V27, P3245, DOI 10.1091/mbc.E16-05-0287; Rodriguez-Berdini L., 2016, BIO-PROTOCOL, V6, DOI [10.21769/BioProtoc.1705, DOI 10.21769/BIOPROTOC.1705]; SAGAR SM, 1988, SCIENCE, V240, P1328, DOI 10.1126/science.3131879; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Schelski M, 2017, MOL CELL NEUROSCI, V84, P11, DOI 10.1016/j.mcn.2017.03.008; SCHIBECI A, 1977, BIOCHEM PHARMACOL, V26, P1769, DOI 10.1016/0006-2952(77)90344-6; Silvestre DC, 2009, J NEUROSCI RES, V87, P857, DOI 10.1002/jnr.21915; Spillane Mirela, 2014, Small GTPases, V5, pe27974, DOI 10.4161/sgtp.27974; Stipursky J, 2012, DEV NEUROSCI-BASEL, V34, P68, DOI 10.1159/000338108; SUN GY, 1989, LIFE SCI, V44, P689, DOI 10.1016/0024-3205(89)90475-X; Tabata H, 2003, J NEUROSCI, V23, P9996; TANAKA T, 1987, BIOCHIM BIOPHYS ACTA, V922, P85, DOI 10.1016/0005-2760(87)90248-7; TONG W, 1994, LIPIDS, V29, P385, DOI 10.1007/BF02537306; Tracey TJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00010; TSUKITA S, 1976, J ELECTRON MICROSC, V25, P141; VANCE JE, 1994, J NEUROCHEM, V62, P329; VANCE JE, 1991, J CELL BIOL, V115, P1061, DOI 10.1083/jcb.115.4.1061; Vance JE, 2000, BBA-MOL CELL BIOL L, V1486, P84, DOI 10.1016/S1388-1981(00)00050-0; Velazquez FN, 2015, ONCOTARGET, V6, P16883, DOI 10.18632/oncotarget.4527; WEISS P, 1948, J EXP ZOOL, V107, P315, DOI 10.1002/jez.1401070302; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Winkle CC, 2016, INT REV CEL MOL BIO, V322, P247, DOI 10.1016/bs.ircmb.2015.10.003; WISSING JB, 1993, FEBS LETT, V315, P95, DOI 10.1016/0014-5793(93)81141-L; Zerpa GAD, 1999, J NEUROCHEM, V73, P1228, DOI 10.1046/j.1471-4159.1999.0731228.x	77	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8808	8818		10.1074/jbc.RA119.010129	http://dx.doi.org/10.1074/jbc.RA119.010129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32385110	Green Published, hybrid			2022-12-28	WOS:000546296800016
J	Yamashita, K; Shibata, T; Takahashi, T; Kobayashi, Y; Kawabata, S				Yamashita, Keisuke; Shibata, Toshio; Takahashi, Toshiaki; Kobayashi, Yuki; Kawabata, Shun-ichiro			Roles of the clip domains of two protease zymogens in the coagulation cascade in horseshoe crabs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serine protease; coagulation cascade; lipopolysaccharide (LPS); enzyme mutation; recombinant protein expression; endotoxin; enzyme processing; clip domain; prochelicerase B (proB); proclotting enzyme (proCE); coagulation factor	SERINE-PROTEASE; CRYSTAL-STRUCTURE; TACHYPLEUS-TRIDENTATUS; PROCLOTTING ENZYME; STRUCTURAL BASIS; FACTOR-B; FACTOR-C; LIPOPOLYSACCHARIDE; HEMOCYTES; RECOGNITION	The lipopolysaccharide (LPS)-triggered coagulation cascade in horseshoe crabs comprises three protease zymogens: prochelicerase C (proC), prochelicerase B (proB), and the proclotting enzyme (proCE). The presence of LPS results in autocatalytic activation of proC to ?-chelicerase C, which, in turn, activates proB to chelicerase B, converting proCE to the clotting enzyme (CE). ProB and proCE contain an N-terminal clip domain, but the roles of these domains in this coagulation cascade remain unknown. Here, using recombinant proteins and kinetics and binding assays, we found that five basic residues in the clip domain of proB are required to maintain its LPS-binding activity and activation by ?-chelicerase C. Moreover, an amino acid substitution at a potential hydrophobic cavity in proB's clip domain (V55A-proB) reduced both its LPS-binding activity and activation rate. WT proCE exhibited no LPS-binding activity, and the WT chelicerase B-mediated activation of a proCE variant with a substitution at a potential hydrophobic cavity (V53A-proCE) was ?4-fold slower than that of WT proCE. Thek(cat)/K(m)value of the interaction of WT chelicerase B with V53A-proCE was 7-fold lower than that of the WT chelicerase B-WT proCE interaction. The enzymatic activities of V55A-chelicerase B and V53A-CE against specific peptide substrates were indistinguishable from those of the corresponding WT proteases. In conclusion, the clip domain of proB recruits it to a reaction center composed of ?-chelicerase C and LPS, where ?-chelicerase C is ready to activate proB, leading to chelicerase B?mediated activation of proCE via its clip domain.	[Yamashita, Keisuke; Shibata, Toshio; Takahashi, Toshiaki; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Grad Sch Syst Life Sci, Fukuoka, Japan; [Shibata, Toshio; Kawabata, Shun-ichiro] Kyushu Univ, Dept Biol, Fac Sci, Fukuoka, Japan; [Kobayashi, Yuki] Seikagaku Corp, Cent Res Lab, LAL Res, Tokyo, Japan	Kyushu University; Kyushu University; Seikagaku Corporation	Kawabata, S (corresponding author), Kyushu Univ, Fac Sci, Grad Sch Syst Life Sci, Fukuoka, Japan.; Kawabata, S (corresponding author), Kyushu Univ, Dept Biol, Fac Sci, Fukuoka, Japan.	sskawascb@kyudai.jp		Yamashita, Keisuke/0000-0002-4748-2516	Seikagaku Corporation	Seikagaku Corporation	This study was supported by the joint research fund of the Seikagaku Corporation.	AKETAGAWA J, 1986, J BIOL CHEM, V261, P7357; Anderson KV, 1998, CELL, V95, P439, DOI 10.1016/S0092-8674(00)81610-4; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Ariki S, 2004, P NATL ACAD SCI USA, V101, P953, DOI 10.1073/pnas.0306904101; Armstrong Peter B., 2003, P288; Ashida M., 1997, MOL MECH IMMUNE RESP, P135; BODE W, 1976, FEBS LETT, V68, P231, DOI 10.1016/0014-5793(76)80443-7; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; CORNISHBOWDEN A, 1978, BIOCHIM BIOPHYS ACTA, V523, P268, DOI 10.1016/0005-2744(78)90030-X; Hashiguchi T, 2007, P NATL ACAD SCI USA, V104, P19535, DOI 10.1073/pnas.0707830104; HOESS A, 1993, EMBO J, V12, P3351, DOI 10.1002/j.1460-2075.1993.tb06008.x; Huang RD, 2007, BIOCHEMISTRY-US, V46, P11431, DOI 10.1021/bi7010724; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Jiang HB, 2000, INSECT BIOCHEM MOLEC, V30, P95, DOI 10.1016/S0965-1748(99)00113-7; Kawabata S, 2010, ADV EXP MED BIOL, V708, P122; Kawabata S, 2010, J BIOCHEM, V147, P611, DOI 10.1093/jb/mvq026; KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x; Kellenberger C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182741; Kobayashi Y, 2015, J BIOL CHEM, V290, P19379, DOI 10.1074/jbc.M115.653196; Kobayashi Y, 2014, J BIOL CHEM, V289, P25987, DOI 10.1074/jbc.M114.586933; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; Levin Jack, 2003, P310; MARRA MN, 1990, J IMMUNOL, V144, P662; Mizumura H, 2017, INNATE IMMUN-LONDON, V23, P136, DOI 10.1177/1753425916681074; MUTA T, 1993, METHOD ENZYMOL, V223, P352; MUTA T, 1993, J BIOL CHEM, V268, P21384; MUTA T, 1990, J BIOL CHEM, V265, P22426; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; NAKAMURA T, 1985, J BIOCHEM, V97, P1561, DOI 10.1093/oxfordjournals.jbchem.a135213; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Piao S, 2005, EMBO J, V24, P4404, DOI 10.1038/sj.emboj.7600891; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Segel I. H., 1975, ENZYME KINETICS, P41; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Shibata T, 2018, J BIOL CHEM, V293, P11589, DOI 10.1074/jbc.RA118.002311; TOH Y, 1991, CELL TISSUE RES, V266, P137, DOI 10.1007/BF00678720; Veillard F, 2016, BIOCHIMIE, V122, P255, DOI 10.1016/j.biochi.2015.10.007; Volz J, 2005, J BIOL CHEM, V280, P40161, DOI 10.1074/jbc.M506191200	42	4	4	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8857	8866		10.1074/jbc.RA119.012452	http://dx.doi.org/10.1074/jbc.RA119.012452			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32409575	hybrid, Green Published			2022-12-28	WOS:000546296800020
J	Licon, MH; Yates, PA				Licon, M. Haley; Yates, Phillip A.			Purine-responsive expression of theLeishmania donovaniNT3 purine nucleobase transporter is mediated by a conserved RNA stem?loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Leishmania; posttranscriptional regulation; purine; mRNA; parasitology; stress response; transporter; adaptation; starvation	GENE-EXPRESSION; LEISHMANIA; CULTIVATION; STARVATION; METABOLISM; PARASITE; PROTEINS; SYSTEM; FLY	The ability to modulate gene expression in response to changes in the host environment is essential for survival of the kinetoplastid parasiteLeishmania. Unlike most eukaryotes, gene expression in kinetoplastids is predominately regulated posttranscriptionally. Consequently, RNA-binding proteins and mRNA-encoded sequence elements serve as primary determinants of gene regulation in these organisms; however, few have defined roles in specific stress response pathways.Leishmaniaspecies cannot synthesize purinesde novoand must scavenge these essential nutrients from the host.Leishmaniahave evolved a robust stress response to withstand sustained periods of purine scarcity during their life cycle. The purine nucleobase transporter LdNT3 is among the most substantially up-regulated proteins in purine-starvedLeishmania donovaniparasites. Here we report that the posttranslational stability of the LdNT3 protein is unchanged in response to purine starvation. Instead, LdNT3 up-regulation is primarily mediated by a 33-nucleotide-long sequence in theLdNT3mRNA 3? UTR that is predicted to adopt a stem?loop structure. Although this sequence is highly conserved within the mRNAs of orthologous transporters in multiple kinetoplastid species, putative stem?loops fromL. donovaniandTrypanosoma bruceinucleobase transporter mRNAs were not functionally interchangeable for purine-responsive regulation. Through mutational analysis of the element, we demonstrate that species specificity is attributable to just three variant bases within the predicted loop. Finally, we provide evidence that the abundance of thetrans-acting factor that binds theLdNT3stem?loopin vivois substantially higher than required for regulation of LdNT3 alone, implying a potential role in regulating other purine-responsive genes.	[Licon, M. Haley] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Yates, Phillip A.] Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Yates, PA (corresponding author), Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA.	yatesp@ohsu.edu			NIAID, National Institutes of Health [R03 AI137636, T32 AI007472-22]	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant R03 AI137636 (to P. A. Y.). A select few reagents were purchased with funds available through NIAID, National Institutes of Health Grant T32 AI007472-22 (to M. H. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BATES PA, 1993, EXP PARASITOL, V76, P412, DOI 10.1006/expr.1993.1050; Boitz JM, 2012, TRENDS PARASITOL, V28, P345, DOI 10.1016/j.pt.2012.05.005; Carter NS, 2010, MOL MICROBIOL, V78, P92, DOI 10.1111/j.1365-2958.2010.07327.x; Clayton C, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190072; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dillon LAL, 2015, NUCLEIC ACIDS RES, V43, P6799, DOI 10.1093/nar/gkv656; Dominguez D, 2018, MOL CELL, V70, P854, DOI 10.1016/j.molcel.2018.05.001; Droll D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003286; Fernandez-Moya SM, 2014, NUCLEIC ACIDS RES, V42, P7201, DOI 10.1093/nar/gku358; Fulwiler AL, 2011, MOL BIOCHEM PARASIT, V175, P209, DOI 10.1016/j.molbiopara.2010.10.008; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jolma A, 2019, BINDING SPECIFICITIE, P317909, DOI [10.1101/317909, DOI 10.1101/317909]; Louradour I, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12755; Martin JL, 2016, MOL MICROBIOL, V101, P299, DOI 10.1111/mmi.13390; Martin JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003938; Opperdoes FR, 2016, J EUKARYOT MICROBIOL, V63, P657, DOI 10.1111/jeu.12315; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rosenzweig D, 2008, FASEB J, V22, P590, DOI 10.1096/fj.07-9254com; Serafim TD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001833; Somanna A, 2002, ACTA TROP, V83, P37, DOI 10.1016/S0001-706X(02)00054-2; Soysa R, 2015, MOL BIOCHEM PARASIT, V204, P89, DOI 10.1016/j.molbiopara.2016.01.008; Soysa R, 2014, MOL BIOCHEM PARASIT, V195, P1, DOI 10.1016/j.molbiopara.2014.05.002; Subota I, 2011, MOL BIOL CELL, V22, P4205, DOI 10.1091/mbc.E11-06-0511; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; 2010, WHO TECH REP SER, V949, pXII	29	2	3	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8449	8459		10.1074/jbc.RA120.012696	http://dx.doi.org/10.1074/jbc.RA120.012696			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32354744	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000546986500009
J	Liang, FS; Miller, AS; Tang, C; Maranon, D; Williamson, EA; Hromas, R; Wiese, C; Zhao, WX; Sung, P; Kupfer, GM				Liang, Fengshan; Miller, Adam S.; Tang, Caroline; Maranon, David; Williamson, Elizabeth A.; Hromas, Robert; Wiese, Claudia; Zhao, Weixing; Sung, Patrick; Kupfer, Gary M.			The DNA-binding activity of USP1-associated factor 1 is required for efficient RAD51-mediated homologous DNA pairing and homology-directed DNA repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; homologous recombination; DNA-binding protein; DNA damage response; DNA damage; deubiquitination; Fanconi anemia; interstrand cross-linking (ICL); UAF1?RAD51AP1; ubiquitin-specific peptidase 1 (USP1)	STRAND BREAK REPAIR; FANCONI-ANEMIA; DAMAGE RESPONSE; FANCD2; RAD51AP1; COMPLEX; BRCA2; MONOUBIQUITINATION; RECOMBINATION; INACTIVATION	USP1-associated factor 1 (UAF1) is an integral component of the RAD51-associated protein 1 (RAD51AP1)?UAF1-ubiquitin-specific peptidase 1 (USP1) trimeric deubiquitinase complex. This complex acts on DNA-bound, monoubiquitinated Fanconi anemia complementation group D2 (FANCD2) protein in the Fanconi anemia pathway of the DNA damage response. Moreover, RAD51AP1 and UAF1 cooperate to enhance homologous DNA pairing mediated by the recombinase RAD51 in DNA repair via the homologous recombination (HR) pathway. However, whereas the DNA-binding activity of RAD51AP1 has been shown to be important for RAD51-mediated homologous DNA pairing and HR-mediated DNA repair, the role of DNA binding by UAF1 in these processes is unclear. We have isolated mutant UAF1 variants that are impaired in DNA binding and tested them together with RAD51AP1 in RAD51-mediated HR. This biochemical analysis revealed that the DNA-binding activity of UAF1 is indispensable for enhanced RAD51 recombinase activity within the context of the UAF1?RAD51AP1 complex. In cells, DNA-binding deficiency of UAF1 increased DNA damage sensitivity and impaired HR efficiency, suggesting that UAF1 and RAD51AP1 have coordinated roles in DNA binding during HR and DNA damage repair. Our findings show that even though UAF1's DNA-binding activity is redundant with that of RAD51AP1 in FANCD2 deubiquitination, it is required for efficient HR-mediated chromosome damage repair.	[Liang, Fengshan; Miller, Adam S.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; [Liang, Fengshan; Tang, Caroline; Kupfer, Gary M.] Yale Univ, Sch Med, Dept Pediat, Sect Hematol Oncol, New Haven, CT 06510 USA; [Tang, Caroline; Kupfer, Gary M.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Maranon, David; Wiese, Claudia] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Williamson, Elizabeth A.; Hromas, Robert] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Zhao, Weixing; Sung, Patrick] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA	Yale University; Yale University; Yale University; Colorado State University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Kupfer, GM (corresponding author), Yale Univ, Sch Med, Dept Pediat, Sect Hematol Oncol, New Haven, CT 06510 USA.; Kupfer, GM (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.; Sung, P (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA.	sungp@uthscsa.edu; gary.kupfer@yale.edu	Classen, Scott/AAY-8176-2020	Hromas, Robert/0000-0002-1916-6276	CPRIT REI Award [RR180029]; Gray Foundation Team Science Grant; National Institutes of Health [RO1 CA168635, R35 CA241801, U54 DK106857, RO1 CA205224, RO1 ES007061, RO1 GM109645, PO1 CA92584, P30 CA054174]; Robert A. Welch Distinguished Chair in Chemistry Grant [AQ-0012]; V Foundation Scholarship	CPRIT REI Award; Gray Foundation Team Science Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Distinguished Chair in Chemistry Grant; V Foundation Scholarship	This work was supported by CPRIT REI Award RR180029 (to P. S.), a Gray Foundation Team Science Grant, and National Institutes of Health Grants RO1 CA168635, R35 CA241801, U54 DK106857, RO1 CA205224, RO1 ES007061, RO1 GM109645, PO1 CA92584, and P30 CA054174 (to P. S. and G. M. K.). This work was also supported in part by a Robert A. Welch Distinguished Chair in Chemistry Grant AQ-0012 (to P. S.) and a V Foundation Scholarship (to W. Z.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barroso-Gonzalez J, 2019, MOL CELL, V76, P11, DOI 10.1016/j.molcel.2019.06.043; Bhatia V, 2014, NATURE, V511, P362, DOI 10.1038/nature13374; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Daniel JA, 2013, MOL CELL, V50, P309, DOI 10.1016/j.molcel.2013.04.017; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Dunlop MH, 2012, J BIOL CHEM, V287, P12343, DOI 10.1074/jbc.C112.352161; Duxin JP, 2015, CURR OPIN CELL BIOL, V37, P49, DOI 10.1016/j.ceb.2015.09.002; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Garcia-Rubio ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005674; Hamperl S, 2014, DNA REPAIR, V19, P84, DOI 10.1016/j.dnarep.2014.03.023; Hashimoto S, 2016, GENES ENVIRON, V38, DOI 10.1186/s41021-016-0037-9; Hussain S, 2004, HUM MOL GENET, V13, P1241, DOI 10.1093/hmg/ddh135; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Knies K, 2017, J CLIN INVEST, V127, P3013, DOI 10.1172/JCI92069; Liang FS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10408-5; Liang FS, 2016, CELL REP, V15, P2118, DOI 10.1016/j.celrep.2016.05.007; Liang ZB, 2019, CELL REP, V26, P564, DOI 10.1016/j.celrep.2018.12.084; Lim KS, 2018, MOL CELL, V72, P925, DOI 10.1016/j.molcel.2018.10.045; Longerich S, 2014, NUCLEIC ACIDS RES, V42, P5657, DOI 10.1093/nar/gku198; Mladenova V, 2006, FEBS LETT, V580, P1631, DOI 10.1016/j.febslet.2006.02.009; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Morita Eiji, 2012, Biotechniques, V0, P1, DOI 10.2144/000113909; Murai J, 2011, MOL CELL BIOL, V31, P2462, DOI 10.1128/MCB.05058-11; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niraj J, 2019, ANNU REV CANC BIOL, V3, P457, DOI 10.1146/annurev-cancerbio-030617-050422; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Park E, 2013, MOL CELL BIOL, V33, P4360, DOI 10.1128/MCB.00870-13; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Sato K, 2012, NUCLEIC ACIDS RES, V40, P4553, DOI 10.1093/nar/gks053; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sollier J, 2014, MOL CELL, V56, P777, DOI 10.1016/j.molcel.2014.10.020; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Wang AT, 2015, MOL CELL, V59, P478, DOI 10.1016/j.molcel.2015.07.009; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Wimberly H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3115; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	38	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8186	8194		10.1074/jbc.RA120.013714	http://dx.doi.org/10.1074/jbc.RA120.013714			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350107	hybrid, Green Published			2022-12-28	WOS:000542965700007
J	Rowe, JB; Taghon, GJ; Kapolka, NJ; Morgan, WM; Isom, DG				Rowe, Jacob B.; Taghon, Geoffrey J.; Kapolka, Nicholas J.; Morgan, William M.; Isom, Daniel G.			CRISPR-addressable yeast strains with applications in human G protein?coupled receptor profiling and synthetic biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; G protein?coupled receptor (GPCR); Saccharomyces cerevisiae; synthetic biology; bioengineering; DNA payloads; genome barcoding; landing pad; pathway engineering; safe harbor locus	ASSAYS	Genome stability is essential for engineering cell-based devices and reporter systems. With the advent of CRISPR technology, it is now possible to build such systems by installing the necessary genetic parts directly into an organism's genome. Here, we used this approach to build a set of 10 versatile yeast-based reporter strains for studying human G protein?coupled receptors (GPCRs), the largest class of membrane receptors in humans. These reporter strains contain the necessary genetically encoded parts for studying human GPCR signaling in yeast, as well as four CRISPR-addressable expression cassettes,i.e.landing pads, installed at known safe-harbor sites in the yeast genome. We showcase the utility of these strains in two applications. First, we demonstrate that increasing GPCR expression by incrementally increasing GPCR gene copy number potentiates G? coupling of the pharmacologically dark receptor GPR68. Second, we used two CRISPR-addressable landing pads for autocrine activation of a GPCR (the somatostatin receptor SSTR5) with its peptide agonist SRIF-14. The utility of these reporter strains can be extended far beyond these select examples to include applications such as nanobody development, mutational analysis, drug discovery, and studies of GPCR chaperoning. Additionally, we present a BY4741 yeast strain created for broad applications in the yeast and synthetic biology communities that contains only the four CRISPR-addressable landing pads. The general utility of these yeast strains provides an inexpensive, scalable, and easy means of installing and expressing genes directly from the yeast genome to build genome-barcoded sensors, reporter systems, and cell-based factories.	[Rowe, Jacob B.; Taghon, Geoffrey J.; Kapolka, Nicholas J.; Morgan, William M.; Isom, Daniel G.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Isom, Daniel G.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33146 USA; [Isom, Daniel G.] Univ Miami, Ctr Computat Sci, Miami, FL 33146 USA	University of Miami; University of Miami; University of Miami	Isom, DG (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.; Isom, DG (corresponding author), Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL 33146 USA.; Isom, DG (corresponding author), Univ Miami, Ctr Computat Sci, Miami, FL 33146 USA.	disom@miami.edu	Taghon, Geoffrey/GON-5639-2022	Rowe, Jacob/0000-0001-7147-5407; Kapolka, Nicholas/0000-0003-2223-8207; Taghon, Geoffrey/0000-0002-5350-5075	NIGMS, National Institutes of Health [R35GM119518]; Common Fund for Illuminating the Druggable Genome through National Institutes of Health [R03TR002908]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Common Fund for Illuminating the Druggable Genome through National Institutes of Health	This work was supported by NIGMS, National Institutes of Health Grant R35GM119518 and by the Common Fund for Illuminating the Druggable Genome through National Institutes of Health Grant R03TR002908 (to D. G. I.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bajar BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20889; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Besada-Lombana PB, 2018, CURR OPIN BIOTECH, V53, P39, DOI 10.1016/j.copbio.2017.12.002; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dowell SJ, 2009, METHODS MOL BIOL, V552, P213, DOI 10.1007/978-1-60327-317-6_15; Dowell SJ, 2002, RECEPTOR CHANNEL, V8, P343, DOI 10.1080/10606820214647; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Horwitz AA, 2015, CELL SYST, V1, P88, DOI 10.1016/j.cels.2015.02.001; Huang XP, 2015, NATURE, V527, P477, DOI 10.1038/nature15699; Ishii J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037136; Kapolka N., 2020, DCYFIR HIGH THROUGHP, DOI [10.1101/2020.01.16.909325, DOI 10.1101/2020.01.16.909325]; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Laughery MF, 2015, YEAST, V32, P711, DOI 10.1002/yea.3098; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nielsen J, 2013, BIOENGINEERED, V4, P207, DOI 10.4161/bioe.22856; OCARROLL AM, 1994, MOL PHARMACOL, V46, P291; Ronda C, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0288-3; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; Tran TNT, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0751-y; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Voth WP, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e59; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Wu XL, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0872-3	25	6	7	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8262	8271		10.1074/jbc.RA120.013066	http://dx.doi.org/10.1074/jbc.RA120.013066			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32358068	Green Published, hybrid			2022-12-28	WOS:000542965700014
J	Brewitz, L; Tumber, A; Schofield, CJ				Brewitz, Lennart; Tumber, Anthony; Schofield, Christopher J.			Kinetic parameters of human aspartate/asparagine??-hydroxylase suggest that it has a possible function in oxygen sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; enzyme kinetics; hypoxia; mass spectrometry (MS); hypoxia-inducible factor (HIF); 2-oxoglutarate; alpha-ketoglutarate; 2OG-dependent dioxygenase; aspartate; asparagine?beta-hydroxylase; AspH; BAH; HAAH; enzyme assays; epidermal growth factor?like domain; epidermal growth factor?like protein 7; EGFL7	HYPOXIA-INDUCIBLE-FACTOR; FACTOR-LIKE DOMAIN; ASPARAGINYL BETA-HYDROXYLASE; HISTONE LYSINE DEMETHYLASES; SITE-DIRECTED MUTAGENESIS; FACTOR-INHIBITING-HIF; GROWTH-FACTOR-DOMAIN; AMINO-ACID-SEQUENCE; EGF-LIKE DOMAIN; HEPATOCELLULAR-CARCINOMA	Human aspartate/asparagine??-hydroxylase (AspH) is a 2-oxoglutarate (2OG)?dependent oxygenase that catalyzes the post-translational hydroxylation of Asp and Asn residues in epidermal growth factor?like domains (EGFDs). Despite its biomedical significance, studies on AspH have long been limited by a lack of assays for its isolated form. Recent structural work has revealed that AspH accepts substrates with a noncanonical EGFD disulfide connectivity (i.e. the Cys 1?2, 3?4, 5?6 disulfide pattern). We developed stable cyclic thioether analogues of the noncanonical EGFD AspH substrates to avoid disulfide shuffling. We monitored their hydroxylation by solid-phase extraction coupled to MS. The extent of recombinant AspH-catalyzed cyclic peptide hydroxylation appears to reflect levels of EGFD hydroxylation observed in vivo, which vary considerably. We applied the assay to determine the kinetic parameters of human AspH with respect to 2OG, Fe(II), l-ascorbic acid, and substrate and found that these parameters are in the typical ranges for 2OG oxygenases. Of note, a relatively high K-m for O-2 suggested that O-2 availability may regulate AspH activity in a biologically relevant manner. We anticipate that the assay will enable the development of selective small-molecule inhibitors for AspH and other human 2OG oxygenases.	[Brewitz, Lennart; Tumber, Anthony; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England	University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk		Tumber, Anthony/0000-0003-1958-8353	Wellcome Trust [106244/Z/14/Z]; Cancer Research UK [C8717/A18245]; Biotechnology and Biological Sciences Research Council [BB/J003018/1]; Deutsche Forschungsgemeinschaft [BR 5486/2-1]; BBSRC [BB/L009846/1, BB/J003018/1, BB/L000121/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grant 106244/Z/14/Z, Cancer Research UK Grant C8717/A18245, and Biotechnology and Biological Sciences Research Council Grant BB/J003018/1. This work was also supported by Deutsche Forschungsgemeinschaft Fellowship BR 5486/2-1 (to L. B.) The authors declare that they have no conflicts of interest with the contents of this article.	Barriga HHA, 2018, AM J MED GENET A, V176, P2494, DOI 10.1002/ajmg.a.40508; Aihara A, 2014, HEPATOLOGY, V60, P1302, DOI 10.1002/hep.27275; ARLAUD GJ, 1987, FEBS LETT, V222, P129, DOI 10.1016/0014-5793(87)80205-3; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Cascella B, 2012, BIOCHEMISTRY-US, V51, P8699, DOI 10.1021/bi3012466; Chakraborty AA, 2019, SCIENCE, V363, P1217, DOI 10.1126/science.aaw1026; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chevreux G, 2015, PROTEIN SCI, V24, P1640, DOI 10.1002/pro.2756; Chillakuri CR, 2012, SEMIN CELL DEV BIOL, V23, P421, DOI 10.1016/j.semcdb.2012.01.009; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Dao JH, 2009, ANAL BIOCHEM, V384, P213, DOI 10.1016/j.ab.2008.09.052; de la Monte SM, 2006, J HEPATOL, V44, P971, DOI 10.1016/j.jhep.2006.01.038; DERIAN CK, 1989, J BIOL CHEM, V264, P6615; Dilley DR, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt031; Dinchuk JE, 2002, J BIOL CHEM, V277, P12970, DOI 10.1074/jbc.M110389200; DRAKENBERG T, 1983, P NATL ACAD SCI-BIOL, V80, P1802, DOI 10.1073/pnas.80.7.1802; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FERNLUND P, 1983, J BIOL CHEM, V258, P2509; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Flashman E, 2010, FEBS J, V277, P4089, DOI 10.1111/j.1742-4658.2010.07804.x; Flashman E, 2010, BIOCHEM J, V427, P135, DOI 10.1042/BJ20091609; Gerken PA, 2017, ANGEW CHEM INT EDIT, V56, P15555, DOI 10.1002/anie.201706788; GLANVILLE RW, 1994, J BIOL CHEM, V269, P26630; GRADY JK, 1988, ANAL BIOCHEM, V173, P111, DOI 10.1016/0003-2697(88)90167-4; GRONKE RS, 1989, P NATL ACAD SCI USA, V86, P3609, DOI 10.1073/pnas.86.10.3609; GRONKE RS, 1990, J BIOL CHEM, V265, P8558; Hancock RL, 2017, ACS CHEM BIOL, V12, P1011, DOI 10.1021/acschembio.6b00958; HARRIS RJ, 1992, J BIOL CHEM, V267, P5102; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Holt-Martyn JP, 2019, MEDCHEMCOMM, V10, P500, DOI 10.1039/c8md00548f; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150336; Huergo LF, 2015, MICROBIOL MOL BIOL R, V79, P419, DOI 10.1128/MMBR.00038-15; Hutchinson SE, 2012, J BIOMOL SCREEN, V17, P39, DOI 10.1177/1087057111416660; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Ince N, 2000, CANCER RES, V60, P1261; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; Kawamura A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14773; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; KORIOTH F, 1994, GENE, V150, P395, DOI 10.1016/0378-1119(94)90460-X; Koury MJ, 2015, NAT REV NEPHROL, V11, P394, DOI 10.1038/nrneph.2015.82; Lavaissiere L, 1996, J CLIN INVEST, V98, P1313, DOI 10.1172/JCI118918; Lawton M, 2010, OXID MED CELL LONGEV, V3, P347, DOI 10.4161/oxim.3.5.13296; Liu YS, 2015, POSTGRAD MED, V127, P144, DOI 10.1080/00325481.2015.996503; Luo BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099922; Ma LB, 2017, INT J CLIN EXP PATHO, V10, P5359; McGinnis K, 1996, BIOCHEMISTRY-US, V35, P3957, DOI 10.1021/bi951520n; McKeown SR, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130676; MCMULLEN BA, 1983, BIOCHEMISTRY-US, V22, P2875, DOI 10.1021/bi00281a016; McNeill LA, 2005, MOL BIOSYST, V1, P321, DOI 10.1039/b511249b; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Mulji A, 2012, J BIOMOL SCREEN, V17, P108, DOI 10.1177/1087057111418229; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; Nichol D, 2010, BLOOD, V116, P6133, DOI 10.1182/blood-2010-03-274860; Osipyants AI, 2018, BIOCHIMIE, V147, P46, DOI 10.1016/j.biochi.2017.12.011; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Patel N, 2014, AM J HUM GENET, V94, P755, DOI 10.1016/j.ajhg.2014.04.002; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pfeffer I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12711-7; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; PRZYSIECKI CT, 1987, P NATL ACAD SCI USA, V84, P7856, DOI 10.1073/pnas.84.22.7856; Rabinowitz MH, 2013, J MED CHEM, V56, P9369, DOI 10.1021/jm400386j; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Rydzik AM, 2012, CHEMBIOCHEM, V13, P1559, DOI 10.1002/cbic.201200256; Schofield CJ, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, pV; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Seo YS, 2004, BIOCHEM J, V380, P339, DOI 10.1042/BJ20031762; Siggs OM, 2019, OPHTHALMIC GENET, V40, P12, DOI 10.1080/13816810.2018.1561904; Sjakste N, 2005, CNS DRUG REV, V11, P151; STENFLO J, 1991, BLOOD, V78, P1637; STENFLO J, 1989, P NATL ACAD SCI USA, V86, P444, DOI 10.1073/pnas.86.2.444; Sturla LM, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00203; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tarhonskaya H, 2015, J BIOL CHEM, V290, P19726, DOI 10.1074/jbc.M115.653014; THIELENS NM, 1990, BIOCHEMISTRY-US, V29, P3570, DOI 10.1021/bi00466a021; THIM L, 1988, BIOCHEMISTRY-US, V27, P7785, DOI 10.1021/bi00420a030; WANG QP, 1991, J BIOL CHEM, V266, P14004; Westaway SM, 2016, J MED CHEM, V59, P1357, DOI 10.1021/acs.jmedchem.5b01537; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Wu F, 2009, HEPATOLOGY, V50, P1839, DOI 10.1002/hep.23197; Xue JH, 2019, NATURE, V569, P581, DOI 10.1038/s41586-019-1160-0; Yang H, 2010, ONCOL REP, V24, P1257, DOI 10.3892/or_00000980; Yang M, 2013, ANGEW CHEM INT EDIT, V52, P1700, DOI 10.1002/anie.201208046; Yang M, 2011, J BIOL CHEM, V286, P7648, DOI 10.1074/jbc.M110.193540; Zou QF, 2018, EBIOMEDICINE, V31, P287, DOI 10.1016/j.ebiom.2018.05.004	94	10	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7826	7838		10.1074/jbc.RA119.012202	http://dx.doi.org/10.1074/jbc.RA119.012202			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32107312	hybrid, Green Published			2022-12-28	WOS:000540935400002
J	Fujita, H; Oikawa, R; Hayakawa, M; Tomoike, F; Kimura, Y; Okuno, H; Hatashita, Y; Oliveros, CF; Bito, H; Ohshima, T; Tsuneda, S; Abe, H; Inoue, T				Fujita, Hirotaka; Oikawa, Ryota; Hayakawa, Mayu; Tomoike, Fumiaki; Kimura, Yasuaki; Okuno, Hiroyuki; Hatashita, Yoshiki; Fiallos Oliveros, Carolina; Bito, Haruhiko; Ohshima, Toshio; Tsuneda, Satoshi; Abe, Hiroshi; Inoue, Takafumi			Quantification of native mRNA dynamics in living neurons using fluorescence correlation spectroscopy and reduction-triggered fluorescent probes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fluorescence correlation spectroscopy (FCS); mRNA; neuron; RNA transport; live-cell imaging; reduction-triggered fluorescence (RETF); transcription; gene regulation; hippocampus; cellular dynamics	IMMEDIATE-EARLY GENE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; LOCAL TRANSLATION; MICE LACKING; GAG PROTEIN; TRANSPORT; ARC; LOCALIZATION; DIFFUSION; VISUALIZATION	RNA localization in subcellular compartments is essential for spatial and temporal regulation of protein expression in neurons. Several techniques have been developed to visualize mRNAs inside cells, but the study of the behavior of endogenous and nonengineered mRNAs in living neurons has just started. In this study, we combined reduction-triggered fluorescent (RETF) probes and fluorescence correlation spectroscopy (FCS) to investigate the diffusion properties of activity-regulated cytoskeleton-associated protein (Arc) and inositol 1,4,5-trisphosphate receptor type 1 (Ip3r1) mRNAs. This approach enabled us to discriminate between RNA-bound and unbound fluorescent probes and to quantify mRNA diffusion parameters and concentrations in living rat primary hippocampal neurons. Specifically, we detected the induction of Arc mRNA production after neuronal activation in real time. Results from computer simulations with mRNA diffusion coefficients obtained in these analyses supported the idea that free diffusion is incapable of transporting mRNA of sizes close to those of Arc or Ip3r1 to distal dendrites. In conclusion, the combined RETF-FCS approach reported here enables analyses of the dynamics of endogenous, unmodified mRNAs in living neurons, affording a glimpse into the intracellular dynamics of RNA in live cells.	[Fujita, Hirotaka; Hatashita, Yoshiki; Fiallos Oliveros, Carolina; Ohshima, Toshio; Tsuneda, Satoshi; Inoue, Takafumi] Waseda Univ, Dept Life Sci & Med Biosci, Sch Adv Sci & Engn, Tokyo, Japan; [Oikawa, Ryota; Hayakawa, Mayu; Tomoike, Fumiaki; Kimura, Yasuaki; Abe, Hiroshi] Nagoya Univ, Dept Chem, Grad Sch Sci, Nagoya, Aichi, Japan; [Okuno, Hiroyuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima, Japan; [Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Dept Neurochem, Tokyo, Japan	Waseda University; Nagoya University; Kagoshima University; University of Tokyo	Inoue, T (corresponding author), Waseda Univ, Dept Life Sci & Med Biosci, Sch Adv Sci & Engn, Tokyo, Japan.	inoue.t@waseda.jp	ABE, Hiroshi/CAG-4088-2022; Inoue, Takafumi/AAM-9533-2020; Bito, Haruhiko/A-8635-2008	ABE, Hiroshi/0000-0003-0048-3789; Inoue, Takafumi/0000-0002-2728-0060; Hatashita, Yoshiki/0000-0002-5108-5986; Kimura, Yasuaki/0000-0002-3609-602X; OKUNO, HIROYUKI/0000-0001-6237-6503; Bito, Haruhiko/0000-0001-6315-9594	Japan Society for the Promotion of Science (JSPS) [23300121, 26640016]; Private University Research Branding Project (MEXT, Japan); Waseda University	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Private University Research Branding Project (MEXT, Japan); Waseda University	This work was supported by Grants-in-Aid for Scientific Research 23300121 and 26640016 from the Japan Society for the Promotion of Science (JSPS) (to T. I.), the Private University Research Branding Project (MEXT, Japan) (to T. I.), and Waseda University Grants for Special Research Projects.	Abe H, 2008, BIOCONJUGATE CHEM, V19, P1219, DOI 10.1021/bc800014d; Ashley J, 2018, CELL, V172, P262, DOI 10.1016/j.cell.2017.12.022; Bannai H, 2004, J BIOL CHEM, V279, P53427, DOI 10.1074/jbc.M409732200; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Carson JH, 2001, CURR OPIN NEUROBIOL, V11, P558, DOI 10.1016/S0959-4388(00)00249-X; Chen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128241; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Das S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar3448; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Dynes JL, 2012, J COMP NEUROL, V520, P3105, DOI 10.1002/cne.23073; Dynes JL, 2007, J COMP NEUROL, V500, P433, DOI 10.1002/cne.21189; Eliscovich C, 2013, J BIOL CHEM, V288, P20361, DOI 10.1074/jbc.R113.452094; Farris S, 2014, J NEUROSCI, V34, P4481, DOI 10.1523/JNEUROSCI.4944-13.2014; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Fujii S, 2000, LEARN MEMORY, V7, P312, DOI 10.1101/lm.34100; FURUICHI T, 1993, RECEPTOR CHANNEL, V1, P11; Furukawa K, 2011, ANGEW CHEM INT EDIT, V50, P12020, DOI 10.1002/anie.201104425; Furukawa K, 2009, BIOCONJUGATE CHEM, V20, P1026, DOI 10.1021/bc900040t; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Gennerich A, 2000, BIOPHYS J, V79, P3294, DOI 10.1016/S0006-3495(00)76561-1; Gennerich A, 2002, BIOPHYS J, V83, P510, DOI 10.1016/S0006-3495(02)75187-4; Glock C, 2017, CURR OPIN NEUROBIOL, V45, P169, DOI 10.1016/j.conb.2017.05.005; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Heidarinejad M, 2018, NEUROSCI RES, V136, P13, DOI 10.1016/j.neures.2018.01.003; Hirokawa N, 2006, J NEUROSCI, V26, P7139, DOI 10.1523/JNEUROSCI.1821-06.2006; Holt CE, 2019, NAT STRUCT MOL BIOL, V26, P557, DOI 10.1038/s41594-019-0263-5; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Inoue T, 2018, MICROSCOPY-JPN, V67, P129, DOI 10.1093/jmicro/dfy015; Itoh S, 2001, BRAIN RES, V901, P237, DOI 10.1016/S0006-8993(01)02373-3; Jacobs M. H., 1967, DIFFUSION PROCESSES, P67; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kinjo M., 2010, LIVE CELL IMAGING LA, P229; Lifland AW, 2011, TRAFFIC, V12, P1000, DOI 10.1111/j.1600-0854.2011.01209.x; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Marras SAE, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf121; Medioni C, 2012, DEVELOPMENT, V139, P3263, DOI 10.1242/dev.078626; Mikl M, 2011, EMBO REP, V12, P1077, DOI 10.1038/embor.2011.149; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Nelles DA, 2016, CELL, V165, P488, DOI 10.1016/j.cell.2016.02.054; Ozawa T, 2007, NAT METHODS, V4, P413, DOI 10.1038/NMETH1030; Pack C, 2006, BIOPHYS J, V91, P3921, DOI 10.1529/biophysj.106.079467; Park HY, 2014, SCIENCE, V343, P422, DOI 10.1126/science.1239200; Pastuzyn ED, 2018, CELL, V172, P275, DOI 10.1016/j.cell.2017.12.024; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; RALL W, 1959, EXP NEUROL, V1, P491, DOI 10.1016/0014-4886(59)90046-9; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Savas JN, 2010, J BIOL CHEM, V285, P13142, DOI 10.1074/jbc.M110.114561; Shin HS, 2013, J PHYS CHEM A, V117, P27, DOI 10.1021/jp307018k; Turner-Bridger B, 2018, P NATL ACAD SCI USA, V115, pE9697, DOI 10.1073/pnas.1806189115; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Urbanek MO, 2014, RNA BIOL, V11, P1083, DOI 10.4161/rna.35506; Vargas DY, 2005, P NATL ACAD SCI USA, V102, P17008, DOI 10.1073/pnas.0505580102; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wallace CS, 1998, J NEUROSCI, V18, P26; Walton SP, 2002, BIOPHYS J, V82, P366, DOI 10.1016/S0006-3495(02)75401-5; WIDENGREN J, 1995, J PHYS CHEM-US, V99, P13368, DOI 10.1021/j100036a009; Wohland T, 2001, BIOPHYS J, V80, P2987, DOI 10.1016/S0006-3495(01)76264-9; Wu B, 2015, CELL, V162, P211, DOI 10.1016/j.cell.2015.05.054; Wu B, 2012, BIOPHYS J, V102, P2936, DOI 10.1016/j.bpj.2012.05.017; Yamada T, 2016, SCI REP-UK, V6, DOI 10.1038/srep38910	67	2	2	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7923	7940		10.1074/jbc.RA119.010921	http://dx.doi.org/10.1074/jbc.RA119.010921			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32341124	hybrid, Green Published			2022-12-28	WOS:000540935400009
J	Bizard, AH; Hickson, ID				Bizard, Anna H.; Hickson, Ian D.			The many lives of type IA topoisomerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						DNA topology; protein translocation; DNA replication; chromosomes; DNA transcription; BLM; PICH; reverse gyrase; TOP3A; TOP3B; translocases; chromosome segregation; DNA supercoiling	COLI DNA TOPOISOMERASE; HOLLIDAY-JUNCTION DISSOLUTION; TOPO III-ALPHA; REVERSE GYRASE; CRYSTAL-STRUCTURE; SUPERCOILED DNA; RECQ HELICASE; RNA TOPOISOMERASE; FANCONI-ANEMIA; MICE LACKING	The double-helical structure of genomic DNA is both elegant and functional in that it serves both to protect vulnerable DNA bases and to facilitate DNA replication and compaction. However, these design advantages come at the cost of having to evolve and maintain a cellular machinery that can manipulate a long polymeric molecule that readily becomes topologically entangled whenever it has to be opened for translation, replication, or repair. If such a machinery fails to eliminate detrimental topological entanglements, utilization of the information stored in the DNA double helix is compromised. As a consequence, the use of B-form DNA as the carrier of genetic information must have co-evolved with a means to manipulate its complex topology. This duty is performed by DNA topoisomerases, which therefore are, unsurprisingly, ubiquitous in all kingdoms of life. In this review, we focus on how DNA topoisomerases catalyze their impressive range of DNA-conjuring tricks, with a particular emphasis on DNA topoisomerase III (TOP3). Once thought to be the most unremarkable of topoisomerases, the many lives of these type IA topoisomerases are now being progressively revealed. This research interest is driven by a realization that their substrate versatility and their ability to engage in intimate collaborations with translocases and other DNA-processing enzymes are far more extensive and impressive than was thought hitherto. This, coupled with the recent associations of TOP3s with developmental and neurological pathologies in humans, is clearly making us reconsider their undeserved reputation as being unexceptional enzymes.	[Bizard, Anna H.; Hickson, Ian D.] Univ Copenhagen, Ctr Chromosome Stabil, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark; Univ Copenhagen, Ctr Hlth Aging, Dept Cellular & Mol Med, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen	Bizard, AH; Hickson, ID (corresponding author), Univ Copenhagen, Ctr Chromosome Stabil, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.	ahb@sund.ku.dk; iandh@sund.ku.dk		Hickson, Ian/0000-0002-0583-566X	Danish National Research Foundation [DNRF115]; Nordea Foundation; Novo Nordisk Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); Nordea Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work is supported by Danish National Research Foundation Grant DNRF115, the Nordea Foundation, and the Novo Nordisk Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad F, 2005, MOL GENET GENOMICS, V273, P102, DOI 10.1007/s00438-005-1111-3; Ahmad M, 2018, METHODS MOL BIOL, V1703, P161, DOI 10.1007/978-1-4939-7459-7_12; Ahmad M, 2017, RNA BIOL, V14, P854, DOI 10.1080/15476286.2017.1330741; Ahmad M, 2017, NUCLEIC ACIDS RES, V45, P2704, DOI 10.1093/nar/gkw1293; Ahumada A, 1998, BIOCHEM BIOPH RES CO, V251, P509, DOI 10.1006/bbrc.1998.9500; Ahumada A, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-13; Alberts B., 1980, MECH STUDIES DNA REP, P809, DOI DOI 10.1016/B978-0-12-048850-6.50072-7; Alemany S, 2015, AM J MED GENET B, V168, P459, DOI 10.1002/ajmg.b.32341; Austin CA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092765; Aze A, 2016, NAT CELL BIOL, V18, P684, DOI 10.1038/ncb3344; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; Baranello L, 2016, CELL, V165, P357, DOI 10.1016/j.cell.2016.02.036; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Baxter J, 2011, SCIENCE, V331, P1328, DOI 10.1126/science.1201538; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; BERANSTEED RK, 1989, PROTEINS, V6, P249, DOI 10.1002/prot.340060307; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; Bizard A, 2011, J MOL BIOL, V408, P839, DOI 10.1016/j.jmb.2011.03.030; Bizard AH, 2019, NAT STRUCT MOL BIOL, V26, P267, DOI 10.1038/s41594-019-0201-6; Bizard AH, 2018, CURR OPIN CELL BIOL, V52, P112, DOI 10.1016/j.ceb.2018.02.012; Bizard AH, 2018, NUCLEIC ACIDS RES, V46, P861, DOI 10.1093/nar/gkx1247; Bizard AH, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016477; Bocquet N, 2014, NAT STRUCT MOL BIOL, V21, P261, DOI 10.1038/nsmb.2775; BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; Bugreev DV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1467, DOI 10.1134/S0006297909130045; Cai LP, 2001, NUCLEIC ACIDS RES, V29, P1389, DOI 10.1093/nar/29.6.1389; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Capranico G, 2017, J MED CHEM, V60, P2169, DOI 10.1021/acs.jmedchem.6b00966; Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Chan YW, 2018, NAT CELL BIOL, V20, P92, DOI 10.1038/s41556-017-0011-1; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Changela A, 2007, J MOL BIOL, V368, P105, DOI 10.1016/j.jmb.2007.01.065; Chaudhury I, 2013, NUCLEIC ACIDS RES, V41, P6444, DOI 10.1093/nar/gkt348; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Chen SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083582; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Chen SH, 2012, J BIOL CHEM, V287, P19346, DOI 10.1074/jbc.M112.363044; Corless Samuel, 2016, Biophys Rev, V8, P245, DOI [10.1007/s12551-016-0242-6, 10.1007/s12551-016-0210-1]; Daghsni M, 2018, CYTOGENET GENOME RES, V154, P1, DOI 10.1159/000486945; Dekker NH, 2002, P NATL ACAD SCI USA, V99, P12126, DOI 10.1073/pnas.132378799; Dewar JM, 2015, NATURE, V525, P345, DOI 10.1038/nature14887; Diaz-Ingelmo O, 2015, CELL REP, V13, P667, DOI 10.1016/j.celrep.2015.09.039; DIGATE RJ, 1992, J BIOL CHEM, V267, P20532; DIGATE RJ, 1988, J BIOL CHEM, V263, P13366; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorn A, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007674; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Fasching CL, 2015, MOL CELL, V57, P595, DOI 10.1016/j.molcel.2015.01.022; Feinberg H, 1999, NAT STRUCT BIOL, V6, P918; Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Fulconis R, 2004, BIOPHYS J, V87, P2552, DOI 10.1529/biophysj.104.043059; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gangloff S, 1999, EMBO J, V18, P1701, DOI 10.1093/emboj/18.6.1701; Garcia-Muse T, 2019, CELL, V179, P604, DOI 10.1016/j.cell.2019.08.055; Garnier F, 2018, METHODS MOL BIOL, V1703, P1, DOI 10.1007/978-1-4939-7459-7_1; GARTENBERG MR, 1992, P NATL ACAD SCI USA, V89, P11461, DOI 10.1073/pnas.89.23.11461; GIAEVER GN, 1988, CELL, V55, P849, DOI 10.1016/0092-8674(88)90140-7; Gomez-Gonzalez B, 2019, GENE DEV, V33, P1008, DOI 10.1101/gad.324517.119; Goodwin A, 1999, NUCLEIC ACIDS RES, V27, P4050, DOI 10.1093/nar/27.20.4050; Goto-Ito S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42123; Goulaouic H, 1999, NUCLEIC ACIDS RES, V27, P2443, DOI 10.1093/nar/27.12.2443; Hansen G, 2006, J MOL BIOL, V358, P1328, DOI 10.1016/j.jmb.2006.03.012; Harmon FG, 1999, MOL CELL, V3, P611, DOI 10.1016/S1097-2765(00)80354-8; Harmon FG, 2003, J BIOL CHEM, V278, P42668, DOI 10.1074/jbc.M302994200; Hartung F, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000285; Heintzman DR, 2019, CELL REP, V29, P422, DOI 10.1016/j.celrep.2019.08.097; Hemphill AW, 2009, CYTOGENET GENOME RES, V125, P165, DOI 10.1159/000230001; HIASA H, 1994, J BIOL CHEM, V269, P32655; Hoadley KA, 2012, P NATL ACAD SCI USA, V109, P4437, DOI 10.1073/pnas.1117279109; Hoadley KA, 2010, STRUCTURE, V18, P1149, DOI 10.1016/j.str.2010.06.009; Hotoda N, 2000, J BIOCHEM, V127, P1109, DOI 10.1093/oxfordjournals.jbchem.a022705; Huang LF, 2018, NUCLEIC ACIDS RES, V46, P3061, DOI 10.1093/nar/gky103; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Joshi RS, 2010, EMBO J, V29, P740, DOI 10.1038/emboj.2009.391; Kaufman CS, 2016, CYTOGENET GENOME RES, V150, P106, DOI 10.1159/000452815; Kaur H, 2015, MOL CELL, V57, P583, DOI 10.1016/j.molcel.2015.01.020; Keszthelyi A, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120134; Kim N, 2017, DNA REPAIR, V56, P33, DOI 10.1016/j.dnarep.2017.06.005; KIM RA, 1995, P NATL ACAD SCI USA, V92, P2667, DOI 10.1073/pnas.92.7.2667; KIM RA, 1992, J BIOL CHEM, V267, P17178; Kim YC, 2000, NUCLEIC ACIDS RES, V28, P2012, DOI 10.1093/nar/28.9.2012; Kim YC, 2002, GENES CELLS, V7, P19, DOI 10.1046/j.1356-9597.2001.00496.x; KIRKEGAARD K, 1985, J MOL BIOL, V185, P625, DOI 10.1016/0022-2836(85)90075-0; Knoll A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00033; Kobayashi M, 2001, BIOCHEM BIOPH RES CO, V287, P282, DOI 10.1006/bbrc.2001.5580; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Kwan KY, 2007, P NATL ACAD SCI USA, V104, P9242, DOI 10.1073/pnas.0703587104; Kwan KY, 2003, P NATL ACAD SCI USA, V100, P2526, DOI 10.1073/pnas.0437998100; Kwan KY, 2001, P NATL ACAD SCI USA, V98, P5717, DOI 10.1073/pnas.101132498; Lai MS, 2007, EMBO REP, V8, P685, DOI 10.1038/sj.embor.7401000; Lai MS, 2012, BIOCHEM BIOPH RES CO, V427, P682, DOI 10.1016/j.bbrc.2012.09.124; Le TT, 2019, CELL, V179, P619, DOI 10.1016/j.cell.2019.09.034; Lee CM, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00563-18; Lee JH, 2019, GENES-BASEL, V10, DOI 10.3390/genes10110859; Lee SK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07101-4; Lee SH, 2013, P NATL ACAD SCI USA, V110, pE3587, DOI 10.1073/pnas.1304103110; Li W, 1998, P NATL ACAD SCI USA, V95, P1010, DOI 10.1073/pnas.95.3.1010; Li ZY, 2001, MOL CELL, V7, P301, DOI 10.1016/S1097-2765(01)00178-2; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Lu R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10180-6; Lulchev P, 2014, NUCLEIC ACIDS RES, V42, P8200, DOI 10.1093/nar/gku589; Ma Jie, 2016, Biophys Rev, V8, P75, DOI 10.1007/s12551-016-0215-9; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Mankouri HW, 2007, TRENDS BIOCHEM SCI, V32, P538, DOI 10.1016/j.tibs.2007.09.009; Manthei KA, 2013, CELL MOL LIFE SCI, V70, P4067, DOI 10.1007/s00018-013-1325-1; Marko JF, 1999, PHYS REV E, V59, P900, DOI 10.1103/PhysRevE.59.900; Martin CA, 2018, AM J HUM GENET, V103, P221, DOI 10.1016/j.ajhg.2018.07.001; McKinnon PJ, 2016, NAT REV NEUROSCI, V17, P673, DOI 10.1038/nrn.2016.101; Medves S, 2016, BRIT J HAEMATOL, V174, P57, DOI 10.1111/bjh.13995; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Mills M, 2018, NAT STRUCT MOL BIOL, V25, P1111, DOI 10.1038/s41594-018-0158-x; Mohanty S, 2008, P NATL ACAD SCI USA, V105, P5063, DOI 10.1073/pnas.0801235105; Mondragon A, 1999, STRUCTURE, V7, P1373, DOI 10.1016/S0969-2126(00)80027-1; Mundbjerg K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005697; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Nicholls TJ, 2018, MOL CELL, V69, P9, DOI 10.1016/j.molcel.2017.11.033; Nielsen CF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9962; Nurse P, 2003, J BIOL CHEM, V278, P8653, DOI 10.1074/jbc.M211211200; Oakley TJ, 2002, DNA REPAIR, V1, P463, DOI 10.1016/S1568-7864(02)00032-0; Perez-Cheeks BA, 2012, MOL MICROBIOL, V86, P1007, DOI 10.1111/mmi.12039; Perugino G, 2009, BIOCHEM SOC T, V37, P69, DOI 10.1042/BST0370069; Pires R, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0115-6; Plank JL, 2005, J BIOL CHEM, V280, P3564, DOI 10.1074/jbc.M411337200; Plank J, 2009, J BIOL CHEM, V284, P30737, DOI 10.1074/jbc.R109.051268; Plank JL, 2006, P NATL ACAD SCI USA, V103, P11118, DOI 10.1073/pnas.0604873103; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Postow L, 2001, J BIOL CHEM, V276, P2790, DOI 10.1074/jbc.M006736200; Reckinger AR, 2007, NUCLEIC ACIDS RES, V35, P79, DOI 10.1093/nar/gkl981; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Roca J, 2011, TRANSCR-AUSTIN, V2, P82, DOI 10.4161/trns.2.2.14807; Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418; Rosato M, 2021, MOL PSYCHIATR, V26, P784, DOI 10.1038/s41380-019-0436-y; Sarlos K, 2018, NAT STRUCT MOL BIOL, V25, P868, DOI 10.1038/s41594-018-0123-8; Schalbetter SA, 2015, P NATL ACAD SCI USA, V112, pE4565, DOI 10.1073/pnas.1505356112; Schvartzman JB, 2004, EMBO REP, V5, P256, DOI 10.1038/sj.embor.7400101; Seguela-Arnaud M, 2015, P NATL ACAD SCI USA, V112, P4713, DOI 10.1073/pnas.1423107112; Seki M, 2006, MOL CELL BIOL, V26, P6299, DOI 10.1128/MCB.00702-06; Seki T, 1998, J BIOL CHEM, V273, P28553, DOI 10.1074/jbc.273.44.28553; Siaw GEL, 2016, P NATL ACAD SCI USA, V113, pE5544, DOI 10.1073/pnas.1605517113; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Sobinoff AP, 2017, EMBO J, V36, P2907, DOI 10.15252/embj.201796889; Sollier J, 2015, TRENDS CELL BIOL, V25, P514, DOI 10.1016/j.tcb.2015.05.003; Sorensen KM, 2010, J MOL DIAGN, V12, P147, DOI 10.2353/jmoldx.2010.090099; SRIVENUGOPAL KS, 1984, BIOCHEMISTRY-US, V23, P1899, DOI 10.1021/bi00304a002; d'Alcontres MS, 2014, CELL CYCLE, V13, P1463, DOI 10.4161/cc.28419; Stoll G, 2013, NAT NEUROSCI, V16, P1228, DOI 10.1038/nn.3484; Stolz R, 2019, P NATL ACAD SCI USA, V116, P6260, DOI 10.1073/pnas.1819476116; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; Suski C, 2008, MOL CELL, V30, P779, DOI 10.1016/j.molcel.2008.04.020; Tang SM, 2015, MOL CELL, V57, P607, DOI 10.1016/j.molcel.2015.01.021; Tarsitano M, 2014, GENE, V536, P213, DOI 10.1016/j.gene.2013.11.051; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Temime-Smaali N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006919; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; Tsai HZ, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0255-2; Tsai HJ, 2006, J BIOL CHEM, V281, P13717, DOI 10.1074/jbc.M600649200; Viard T, 2007, BIOCHIMIE, V89, P456, DOI 10.1016/j.biochi.2006.10.013; Vologodskii A, 2011, BIOPHYS J, V101, P1403, DOI 10.1016/j.bpj.2011.08.011; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6; Wang F, 2010, STRUCTURE, V18, P1159, DOI 10.1016/j.str.2010.06.008; Wang H, 1996, P NATL ACAD SCI USA, V93, P9477, DOI 10.1073/pnas.93.18.9477; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Wang TF, 2002, BIOCHEM BIOPH RES CO, V296, P949, DOI 10.1016/S0006-291X(02)02034-X; Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; Wilson TM, 2000, J BIOL CHEM, V275, P1533, DOI 10.1074/jbc.275.3.1533; Wilson-Sali T, 2002, P NATL ACAD SCI USA, V99, P7974, DOI 10.1073/pnas.122007999; Wong BC, 1998, J BIOL CHEM, V273, P12120, DOI 10.1074/jbc.273.20.12120; Wu DD, 2019, J GENET, V98, DOI 10.1007/s12041-019-1090-5; Wu JH, 2010, P NATL ACAD SCI USA, V107, P6228, DOI 10.1073/pnas.1001855107; Wu L, 2002, NUCLEIC ACIDS RES, V30, P4823, DOI 10.1093/nar/gkf611; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xiong B, 2008, PROTEINS, V71, P1984, DOI 10.1002/prot.21876; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Xu DY, 2013, NAT NEUROSCI, V16, P1238, DOI 10.1038/nn.3479; Xue XY, 2013, J BIOL CHEM, V288, P14221, DOI 10.1074/jbc.M113.465609; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041208; Yang J, 2012, MOL CELL BIOL, V32, P3054, DOI 10.1128/MCB.00255-12; Yang J, 2010, J BIOL CHEM, V285, P21426, DOI 10.1074/jbc.M110.123216; Yang YZ, 2014, MOL CELL, V53, P484, DOI 10.1016/j.molcel.2014.01.011; Zhang HL, 1996, J BIOL CHEM, V271, P9039, DOI 10.1074/jbc.271.15.9039; Zhang T, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190222; Zhang ZT, 2011, P NATL ACAD SCI USA, V108, P6939, DOI 10.1073/pnas.1100300108	193	23	23	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7138	7153		10.1074/jbc.REV120.008286	http://dx.doi.org/10.1074/jbc.REV120.008286			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32277049	Green Published, hybrid			2022-12-28	WOS:000536212600028
J	Mohan, MK; Abraham, N; Rajesh, RP; Jayaseelan, BF; Ragnarsson, L; Lewis, RJ; Sarma, SP				Mohan, Madhan Kumar; Abraham, Nikita; Rajesh, R. P.; Jayaseelan, Benjamin Franklin; Ragnarsson, Lotten; Lewis, Richard J.; Sarma, Siddhartha P.			Structure and allosteric activity of a single-disulfide conopeptide from Conus zonatus at human?3?4 and?7 nicotinic acetylcholine receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptors (nAChR); allosteric regulation; nuclear magnetic resonance (NMR); disulfide; neuropeptide; peptide conformation; molecular pharmacology; allosteric modulation; conformational exchange; nAChR receptor antagonists; proline cis; trans isomerism; single-disulfide conopeptides	ALPHA-CONOTOXIN; PROTEIN STRUCTURES; MASS-SPECTROMETRY; MARINE SNAIL; XPLOR-NIH; NMR; VENOM; PEPTIDES; IDENTIFICATION; SPECTROSCOPY	Conopeptides are neurotoxic peptides in the venom of marine cone snails and have broad therapeutic potential for managing pain and other conditions. Here, we identified the single-disulfide peptides Czon1107 and Cca1669 from the venoms of Conus zonatus and Conus caracteristicus, respectively. We observed that Czon1107 strongly inhibits the human ?3?4 (IC50 15.7 ? 3.0 ?m) and ?7 (IC50 77.1 ? 0.05 ?m) nicotinic acetylcholine receptor (nAChR) subtypes, but the activity of Cca1669 remains to be identified. Czon1107 acted at a site distinct from the orthosteric receptor site. Solution NMR experiments revealed that Czon1107 exists in equilibrium between conformational states that are the result of a key Ser(4)?Pro(5) cis-trans isomerization. Moreover, we found that the X-Pro amide bonds in the inter-cysteine loop are rigidly constrained to cis conformations. Structure-activity experiments of Czon1107 and its variants at positions P5 and P7 revealed that the conformation around the X-Pro bonds (cis-trans) plays an important role in receptor subtype selectivity. The cis conformation at the Cys(6)?Pro(7) peptide bond was essential for ?3?4 nAChR subtype allosteric selectivity. In summary, we have identified a unique single-disulfide conopeptide with a noncompetitive, potentially allosteric inhibitory mechanism at the nAChRs. The small size and rigidity of the Czon1107 peptide could provide a scaffold for rational drug design strategies for allosteric nAChR modulation. This new paradigm in the ?conotoxinomic? structure-function space provides an impetus to screen venom from other Conus species for similar, short bioactive peptides that allosterically modulate ligand-gated receptor function.	[Mohan, Madhan Kumar; Sarma, Siddhartha P.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Abraham, Nikita; Ragnarsson, Lotten; Lewis, Richard J.] Univ Queensland, Inst Mol Biosci, Queensland Biosci Precinct, 306 Carmody Rd, St Lucia, Qld 4072, Australia; [Rajesh, R. P.] Sathyabama Inst Sci & Technol, Chennai 600119, Tamil Nadu, India; [Jayaseelan, Benjamin Franklin] Bombay Nat Hist Soc, Hornbill House, Mumbai 400001, Maharashtra, India	Indian Institute of Science (IISC) - Bangalore; University of Queensland; Sathyabama Institute of Science & Technology	Sarma, SP (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.; Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, Queensland Biosci Precinct, 306 Carmody Rd, St Lucia, Qld 4072, Australia.	r.lewis@uq.edu.au; sidd@iisc.ac.in	R P, Rajesh/AAA-3266-2022; Ragnarsson, Lotten/A-8632-2012; Lewis, Richard J./E-8674-2013	Sarma, Siddhartha/0000-0001-7619-8904; Ragnarsson, Lotten/0000-0002-7137-1656; Mohan, Madhan Kumar/0000-0002-5498-7280; R P, Rajesh/0000-0003-0058-247X; Lewis, Richard J./0000-0003-3470-923X	DBT-IISc Partnership Program; NHMRC [APP1072113]; ARC [DP170104792]	DBT-IISc Partnership Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council)	We (M. M. K., R. R. P., B. F. J. and S. P. S.) thank the Department of Science and Technology and the Department of Biotechnology, Government of India for the NMR and Mass spectrometric Facilities at the Indian Institute of Science. S. P. S. thanks the DBT-IISc Partnership Program for funds to defray costs of the project. R. J. L. acknowledges support from the NHMRC Program Grant APP1072113 and ARC Dicovery Grant DP170104792.	Abraham N, 2018, MAR DRUGS, V16, DOI 10.3390/md16060208; Aguilar MB, 2006, PEPTIDES, V27, P500, DOI 10.1016/j.peptides.2005.07.020; Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; [Anonymous], 1995, MANUAL LIVING CONIDA; Balaji RA, 2000, J BIOL CHEM, V275, P39516, DOI 10.1074/jbc.M006354200; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BIEMANN K, 1990, METHOD ENZYMOL, V193, P455, DOI 10.1016/0076-6879(90)93433-L; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BOTHNERBY AA, 1984, J AM CHEM SOC, V106, P811, DOI 10.1021/ja00315a069; CAVANAGH J, 1992, J MAGN RESON, V96, P670, DOI 10.1016/0022-2364(92)90357-D; Chhabra S, 2014, J MED CHEM, V57, P9933, DOI 10.1021/jm501126u; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; DORMAN DE, 1973, J ORG CHEM, V38, P2379, DOI 10.1021/jo00953a021; Dutertre S, 2008, J BIOL CHEM, V283, P7100, DOI 10.1074/jbc.M706477200; Dutertre S, 2014, TOXICON, V91, P135, DOI 10.1016/j.toxicon.2014.09.011; Franklin JB, 2009, ZOOTAXA, P1; Franklin JB, 2017, TOXICON, V132, P50, DOI [10.1016/j.toxicon.2017.04.003, 10.1016/j.toxicon.2017.04]; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; GRAY WR, 1983, J BIOL CHEM, V258, P2247; GRAY WR, 1981, J BIOL CHEM, V256, P4734; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Haber-Pohlmeier S, 2007, BIOPHYS J, V92, P3207, DOI 10.1529/biophysj.106.094847; HILLYARD DR, 1992, NEURON, V9, P69, DOI 10.1016/0896-6273(92)90221-X; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jacobsen R, 1998, J PEPT RES, V51, P173; JOHNSON CE, 1958, J CHEM PHYS, V29, P1012, DOI 10.1063/1.1744645; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; Kaas Q, 2010, TOXICON, V55, P1491, DOI 10.1016/j.toxicon.2010.03.002; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kumar GS, 2005, BIOCHEM BIOPH RES CO, V335, P965, DOI 10.1016/j.bbrc.2005.08.002; Lamthanh H, 1999, FEBS LETT, V454, P293, DOI 10.1016/S0014-5793(99)00831-5; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lebbe EKM, 2016, J VENOM ANIM TOXINS, V22, DOI 10.1186/s40409-016-0083-6; Mandal AK, 2007, J AM SOC MASS SPECTR, V18, P1396, DOI 10.1016/j.jasms.2007.04.009; MCINTOSH JM, 1994, J BIOL CHEM, V269, P16733; MCINTOSH JM, 1984, J BIOL CHEM, V259, P4343; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; NIELSEN DB, 1994, TOXICON, V32, P845, DOI 10.1016/0041-0101(94)90009-4; Olivera BM, 2008, CHANNELS, V2, P143, DOI 10.4161/chan.2.2.6276; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; Olivera BM, 2014, ANNU REV ANIM BIOSCI, V2, P487, DOI 10.1146/annurev-animal-022513-114124; Olivera Baldomero M., 2000, P74, DOI 10.1159/000062483; Pennington MW, 2018, BIOORGAN MED CHEM, V26, P2738, DOI 10.1016/j.bmc.2017.09.029; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; RAMILO CA, 1992, BIOCHEMISTRY-US, V31, P9919, DOI 10.1021/bi00156a009; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Sabareesh V, 2006, PEPTIDES, V27, P2647, DOI 10.1016/j.peptides.2006.07.009; Schrodinger LLC, 2015, JYMOL MOL GRAPH DEV; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; SHON KJ, 1995, BIOCHEMISTRY-US, V34, P4913, DOI 10.1021/bi00015a002; Skinner SP, 2016, J BIOMOL NMR, V66, P111, DOI 10.1007/s10858-016-0060-y; Steiner AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078456; Sudarslal S, 2004, BIOCHEM BIOPH RES CO, V317, P682, DOI 10.1016/j.bbrc.2004.03.100; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Terrat Y, 2012, TOXICON, V59, P34, DOI 10.1016/j.toxicon.2011.10.001; Thakur SS, 2007, RAPID COMMUN MASS SP, V21, P3420, DOI 10.1002/rcm.3225; Vijayasarathy M, 2017, J PROTEOME RES, V16, P763, DOI 10.1021/acs.jproteome.6b00776; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WAGNER G, 1987, J MOL BIOL, V196, P611, DOI 10.1016/0022-2836(87)90037-4; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P1; ZAFARALLA GC, 1988, BIOCHEMISTRY-US, V27, P7102, DOI 10.1021/bi00418a065	68	5	7	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7096	7112		10.1074/jbc.RA119.012098	http://dx.doi.org/10.1074/jbc.RA119.012098			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32234761	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000536212600025
J	Sreelatha, A; Nolan, C; Park, BC; Pawlowski, K; Tomchick, DR; Tagliabracci, VS				Sreelatha, Anju; Nolan, Christine; Park, Brenden C.; Pawlowski, Krzysztof; Tomchick, Diana R.; Tagliabracci, Vincent S.			A Legionella effector kinase is activated by host inositol hexakisphosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial protein kinase; bacterial pathogenesis; inositol phosphate; enzyme structure; allosteric regulation; effector; inositol hexikisphosphate; Legionella	PROTEIN DRRA; X-RAY; FEATURES; PATHWAY; FAMILY; DOMAIN; SERVER; MODEL; IP6; CK2	The transfer of a phosphate from ATP to a protein substrate, a modification known as protein phosphorylation, is catalyzed by protein kinases. Protein kinases play a crucial role in virtually every cellular activity. Recent studies of atypical protein kinases have highlighted the structural similarity of the kinase superfamily despite notable differences in primary amino acid sequence. Here, using a bioinformatics screen, we searched for putative protein kinases in the intracellular bacterial pathogen Legionella pneumophila and identified the type 4 secretion system effector Lpg2603 as a remote member of the protein kinase superfamily. Employing an array of biochemical and structural biology approaches, including in vitro kinase assays and isothermal titration calorimetry, we show that Lpg2603 is an active protein kinase with several atypical structural features. Importantly, we found that the eukaryote-specific host signaling molecule inositol hexakisphosphate (IP6) is required for Lpg2603 kinase activity. Crystal structures of Lpg2603 in the apo-form and when bound to IP6 revealed an active-site rearrangement that allows for ATP binding and catalysis. Our results on the structure and activity of Lpg2603 reveal a unique mode of regulation of a protein kinase, provide the first example of a bacterial kinase that requires IP6 for its activation, and may aid future work on the function of this effector during Legionella pathogenesis.	[Sreelatha, Anju] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Nolan, Christine; Park, Brenden C.; Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Tomchick, Diana R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Tomchick, Diana R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Pawlowski, Krzysztof] Warsaw Univ Life Sci, Inst Biol, PL-02787 Warsaw, Poland	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Warsaw University of Life Sciences	Sreelatha, A (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	anju.sreelatha@utsouthwestern.edu; vincent.tagliabracci@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022; Pawlowski, Krzysztof/C-2949-2013	Tomchick, Diana/0000-0002-7529-4643; Pawlowski, Krzysztof/0000-0002-5367-0935; Sreelatha, Anju/0000-0001-9485-0214; Tagliabracci, Vincent/0000-0002-9735-4678	National Institutes of Health [R00DK099254, DP2GM137419, T32DK007257-37]; Welch Foundation [I-1911]; Polish National Agency for Scientific Exchange Scholarship [PPN/BEK/2018/1/00431]; Office of the Director, National Institutes of Health [S10OD025018]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Polish National Agency for Scientific Exchange Scholarship; Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R00DK099254 and DP2GM137419 (to V. S. T.) and T32DK007257-37 (to A. S.), Welch Foundation Grants I-1911 (to V. S. T.), Polish National Agency for Scientific Exchange Scholarship PPN/BEK/2018/1/00431 (to K. P.), and Award S10OD025018 (D. R. T.) from the Office of the Director, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; Anderson DM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004944; Beyrakhova K, 2018, J BIOL CHEM, V293, P13044, DOI 10.1074/jbc.RA118.003845; Bhogaraju S, 2019, NATURE, V572, P382, DOI 10.1038/s41586-019-1440-8; Black MH, 2019, SCIENCE, V364, P787, DOI 10.1126/science.aaw7446; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doolittle LK, 2013, METHODS MOL BIOL, V1046, P273, DOI 10.1007/978-1-62703-538-5_16; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fischer EH, 2013, BIOCHEM BIOPH RES CO, V430, P865, DOI 10.1016/j.bbrc.2012.10.024; Gan NH, 2019, NATURE, V572, P387, DOI 10.1038/s41586-019-1439-1; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; Haenssler E, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00064; Hervet E, 2011, INFECT IMMUN, V79, P1936, DOI 10.1128/IAI.00805-10; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hubber A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004222; Hubber A, 2010, ANNU REV CELL DEV BI, V26, P261, DOI 10.1146/annurev-cellbio-100109-104034; Hyvonen M, 1997, EMBO J, V16, P3396, DOI 10.1093/emboj/16.12.3396; Kanev GK, 2019, TRENDS PHARMACOL SCI, V40, P818, DOI 10.1016/j.tips.2019.09.002; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lee PC, 2018, CELL HOST MICROBE, V24, P429, DOI 10.1016/j.chom.2018.08.004; Lee WK, 2013, P NATL ACAD SCI USA, V110, P19360, DOI 10.1073/pnas.1304670110; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu YC, 2007, INFECT IMMUN, V75, P592, DOI 10.1128/IAI.01278-06; Lopez VA, 2019, CELL, V179, P205, DOI 10.1016/j.cell.2019.08.020; Losick VP, 2010, CELL MICROBIOL, V12, P1083, DOI 10.1111/j.1462-5822.2010.01452.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michard C, 2015, MBIO, V6, DOI 10.1128/mBio.00354-15; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moss SM, 2019, CELL HOST MICROBE, V25, P454, DOI 10.1016/j.chom.2019.01.006; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nguyen KB, 2016, P NATL ACAD SCI USA, V113, pE3482, DOI 10.1073/pnas.1605917113; Park BC, 2019, IUBMB LIFE, V71, P749, DOI 10.1002/iub.2040; Salomon D, 2013, CELL HOST MICROBE, V14, P269, DOI 10.1016/j.chom.2013.07.008; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shamsuddin AK, 2012, CURR SIGNAL TRANSD T, V7, P289; Shamsuddin AM, 1999, ANTICANCER RES, V19, P3733; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Sreelatha A, 2018, CELL, V175, P809, DOI 10.1016/j.cell.2018.08.046; Sulpizio A, 2019, ELIFE, V8, DOI 10.7554/eLife.51162; Tagliabracci VS, 2015, CELL, V161, P1619, DOI 10.1016/j.cell.2015.05.028; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Wang Q, 2015, ELIFE, V4, DOI 10.7554/eLife.06074; Weber ANR, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01454; Xu D, 2015, BIOINFORMATICS, V31, P2098, DOI 10.1093/bioinformatics/btv092; Xu D, 2014, BIOINFORMATICS, V30, P660, DOI 10.1093/bioinformatics/btt578; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430	54	10	10	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6214	6224		10.1074/jbc.RA120.013067	http://dx.doi.org/10.1074/jbc.RA120.013067			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32229585	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000531417300029
J	Li, WF; Aryal, M; Shu, ST; Smithgall, TE				Li Wing Fai; Aryal, Manish; Shu, Sherry T.; Smithgall, Thomas E.			HIV-1 Nef dimers short-circuit immune receptor signaling by activating Tec-family kinases at the host cell membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); protein kinase; dimerization; signal transduction; protein?protein interaction; T-cell receptor (TCR); infectious disease; bimolecular fluorescence complementation (BiFC); Bruton's tyrosine kinase (BTK); HIV-1 Nef; interleukin-2-inducible kinase (ITK); Tec-family kinase	CRYSTAL-STRUCTURE; SRC; PROTEIN; HCK; TRANSFORMATION; INFECTIVITY; ENDOCYTOSIS; RESISTANCE; SERINC5; COMPLEX	The HIV-1 virulence factor Nef promotes high-titer viral replication, immune escape, and pathogenicity. Nef interacts with interleukin-2?inducible T-cell kinase (Itk) and Bruton's tyrosine kinase (Btk), two Tec-family kinases expressed in HIV-1 target cells (CD4 T cells and macrophages, respectively). Using a cell-based bimolecular fluorescence complementation assay, here we demonstrate that Nef recruits both Itk and Btk to the cell membrane and induces constitutive kinase activation in transfected 293T cells. Nef homodimerization-defective mutants retained their interaction with both kinases but failed to induce activation, supporting a role for Nef homodimer formation in the activation mechanism. HIV-1 infection up-regulates endogenous Itk activity in SupT1 T cells and donor-derived peripheral blood mononuclear cells. However, HIV-1 strains expressing Nef variants with mutations in the dimerization interface replicated poorly and were significantly attenuated in Itk activation. We conclude that direct activation of Itk and Btk by Nef at the membrane in HIV-infected cells may override normal immune receptor control of Tec-family kinase activity to enhance the viral life cycle.	[Li Wing Fai; Aryal, Manish; Shu, Sherry T.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Bridgeside Point 2,Suite 523,450 Technol Dr, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Bridgeside Point 2,Suite 523,450 Technol Dr, Pittsburgh, PA 15219 USA.	tsmithga@pitt.edu			National Institutes of Health [AI057083, AI126617]; China Scholarship Council award through the Tsinghua University School of Medicine	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council award through the Tsinghua University School of Medicine	This work was supported by National Institutes of Health Grants AI057083 and AI126617 (to T. E. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Figs. S1-S4.; Supported by a China Scholarship Council award through the Tsinghua University School of Medicine. Present address: Tsinghua University School of Medicine, Beijing 100084, China.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Alvarado JJ, 2014, J BIOL CHEM, V289, P28539, DOI 10.1074/jbc.M114.600031; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Basmaciogullari S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00232; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Chung JK, 2019, P NATL ACAD SCI USA, V116, P10798, DOI 10.1073/pnas.1819309116; Collette Y, 2000, J BIOL CHEM, V275, P4171, DOI 10.1074/jbc.275.6.4171; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Courtney AH, 2018, TRENDS BIOCHEM SCI, V43, P108, DOI 10.1016/j.tibs.2017.11.008; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Devkota S, 2017, BIOCHEMISTRY-US, V56, P2938, DOI 10.1021/acs.biochem.6b01182; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Emert-Sedlak LA, 2016, BIOORG MED CHEM LETT, V26, P1480, DOI 10.1016/j.bmcl.2016.01.043; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Gaud G, 2018, NAT REV IMMUNOL, V18, P485, DOI 10.1038/s41577-018-0020-8; Heusinger E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00198; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lin TA, 2004, BIOCHEMISTRY-US, V43, P11056, DOI 10.1021/bi049428r; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; Manninen A, 2000, J BIOL CHEM, V275, P16513, DOI 10.1074/jbc.M910032199; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Moroco JA, 2018, J MOL BIOL, V430, P310, DOI 10.1016/j.jmb.2017.12.008; Mujib S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93684; Narute PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032561; Pawlak EN, 2015, BBA-GEN SUBJECTS, V1850, P733, DOI 10.1016/j.bbagen.2015.01.003; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Readinger JA, 2008, P NATL ACAD SCI USA, V105, P6684, DOI 10.1073/pnas.0709659105; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Roskoski R, 2016, PHARMACOL RES, V113, P395, DOI 10.1016/j.phrs.2016.09.011; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shi HB, 2020, ACS INFECT DIS, V6, P302, DOI 10.1021/acsinfecdis.9b00382; Sloan RD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-44; Tarafdar S, 2014, J BIOL CHEM, V289, P15718, DOI 10.1074/jbc.M114.572099; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Veillette M, 2014, J VIROL, V88, P2633, DOI 10.1128/JVI.03230-13; Venzke S, 2006, J VIROL, V80, P11141, DOI 10.1128/JVI.01556-06; Wang TJ, 2017, CLIN CANCER RES, V23, P2506, DOI 10.1158/1078-0432.CCR-16-1996; Wu MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192512; Wu YF, 2019, MBIO, V10, DOI 10.1128/mBio.01071-19	46	8	8	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5163	5174		10.1074/jbc.RA120.012536	http://dx.doi.org/10.1074/jbc.RA120.012536			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32144207	Green Published, hybrid			2022-12-28	WOS:000526887000034
J	Velasquez, CD; Kim, C; Haldiman, T; Kim, C; Herbst, A; Aiken, J; Safar, JG; McKenzie, D				Velasquez, Camilo Duque; Kim, Chae; Haldiman, Tracy; Kim, Chiye; Herbst, Allen; Aiken, Judd; Safar, Jiri G.; McKenzie, Debbie			Chronic wasting disease (CWD) prion strains evolve via adaptive diversification of conformers in hosts expressing prion protein polymorphisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion; genetic polymorphism; conformational change; oligomer; prion disease; host?pathogen interaction; evolution; host range; strains	CREUTZFELDT-JAKOB-DISEASE; CONFORMATIONAL TRANSITIONS; PRP POLYMORPHISMS; SCRAPIE; DEER; TRANSMISSION; STABILITY; ENCEPHALOPATHY; SUSCEPTIBILITY; INFECTIVITY	Chronic wasting disease (CWD) is caused by an unknown spectrum of prions and has become enzootic in populations of cervid species that express cellular prion protein (PrP (c)) molecules varying in amino acid composition. These PrP (c) polymorphisms can affect prion transmission, disease progression, neuropathology, and emergence of new prion strains, but the mechanistic steps in prion evolution are not understood. Here, using conformation-dependent immunoassay, conformation stability assay, and protein-misfolding cyclic amplification, we monitored the conformational and phenotypic characteristics of CWD prions passaged through deer and transgenic mice expressing different cervid PrP (c) polymorphisms. We observed that transmission through hosts with distinct PrP (c) sequences diversifies the PrPCWD conformations and causes a shift toward oligomers with defined structural organization, replication rate, and host range. When passaged in host environments that restrict prion replication, distinct co-existing PrPCWD conformers underwent competitive selection, stabilizing a new prion strain. Nonadaptive conformers exhibited unstable replication and accumulated only to low levels. These results suggest a continuously evolving diversity of CWD conformers and imply a critical interplay between CWD prion plasticity and PrP (c) polymorphisms during prion strain evolution.	[Velasquez, Camilo Duque; Kim, Chiye; McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2R3, Canada; [Kim, Chae; Haldiman, Tracy; Safar, Jiri G.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Safar, Jiri G.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Herbst, Allen; Aiken, Judd] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada; [Velasquez, Camilo Duque; Kim, Chiye; Herbst, Allen; Aiken, Judd; McKenzie, Debbie] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada	University of Alberta; Case Western Reserve University; Case Western Reserve University; University of Alberta; University of Alberta	McKenzie, D (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2R3, Canada.; McKenzie, D (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada.	Debbie.McKenzie@ualberta.ca		Herbst, Allen/0000-0001-6601-1245	Alberta Prion Research Institute (APRI) [PEX15023]; Genome Canada; Genome Alberta; APRI; University of Alberta; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-05539]; Alberta Innovates Biosolutions [FP00204477]; National Institutes of Health [1R01NS103848]	Alberta Prion Research Institute (APRI); Genome Canada(Genome Canada); Genome Alberta; APRI; University of Alberta(University of Alberta); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Biosolutions; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Alberta Prion Research Institute (APRI) Grant PEX15023, Genome Canada, Genome Alberta, APRI, the University of Alberta in support of Systems Biology and Molecular Ecology, Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2017-05539, Alberta Innovates Biosolutions Grant FP00204477, and National Institutes of Health Grant 1R01NS103848. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angers R, 2014, P NATL ACAD SCI USA, V111, P11169, DOI 10.1073/pnas.1404739111; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Asante EA, 2015, NATURE, V522, P478, DOI 10.1038/nature14510; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Choi YP, 2011, J GEN VIROL, V92, P727, DOI 10.1099/vir.0.026948-0; Choi YP, 2010, J VIROL, V84, P12030, DOI 10.1128/JVI.01057-10; Cinar MU, 2018, VET J, V233, P19, DOI 10.1016/j.tvjl.2017.12.019; Cohen ML, 2015, BRAIN, V138, P1009, DOI 10.1093/brain/awv006; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Gonzalez L, 2003, J GEN VIROL, V84, P1339, DOI 10.1099/vir.0.18800-0; Haldiman T, 2013, J BIOL CHEM, V288, P29846, DOI 10.1074/jbc.M113.500108; Hannaoui S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006553; Henderson DM, 2015, J VIROL, V89, P9338, DOI 10.1128/JVI.01118-15; Herbst A, 2017, EMERG INFECT DIS, V23, P1598, DOI [10.3201/eid2309.161474, 10.3201/eid2309.161747]; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Johnson CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035383; Johnson CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017450; KASCSAK RJ, 1985, J GEN VIROL, V66, P1715, DOI 10.1099/0022-1317-66-8-1715; Kim C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04584-z; Kim C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002835; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Laferriere F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003702; Langeveld JPM, 2016, J VIROL, V90, P805, DOI 10.1128/JVI.02316-15; Lau A, 2015, EMBO MOL MED, V7, P339, DOI 10.15252/emmm.201404588; Le Dur A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14170; Li QY, 2018, J BIOL CHEM, V293, P18494, DOI [10.1074/jbc.RA118.005622, 10.1074/jbc.ra118.005622]; Makarava N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003759; Mays CE, 2015, J VIROL, V89, P12418, DOI 10.1128/JVI.02142-15; Mays CE, 2014, J CLIN INVEST, V124, P847, DOI 10.1172/JCI72241; Meade-White K, 2007, J VIROL, V81, P4533, DOI 10.1128/JVI.02762-06; Miller MW, 2012, J WILDLIFE DIS, V48, P526, DOI 10.7589/0090-3558-48.2.526; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Moore RA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005416; Moore SJ, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1400-9; Oelschlegel AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003158; Otero A, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1794-z; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Perucchini M, 2008, J GEN VIROL, V89, P1324, DOI 10.1099/vir.0.83424-0; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; Race B, 2011, J VIROL, V85, P9235, DOI 10.1128/JVI.00790-11; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Robinson SJ, 2012, ECOL APPL, V22, P1050, DOI 10.1890/11-0907.1; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; SAFAR J, 1994, BIOCHEMISTRY-US, V33, P8375, DOI 10.1021/bi00193a027; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAFAR J, 1993, BIOPOLYMERS, V33, P1461, DOI 10.1002/bip.360330915; Safar JG, 2005, J VIROL, V79, P10796, DOI 10.1128/JVI.79.16.10796-10806.2005; Safar JG, 2005, J GEN VIROL, V86, P2913, DOI 10.1099/vir.0.80947-0; Safar JG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004832; Safar JG, 2012, PRION, V6, P108, DOI 10.4161/pri.18666; Silva CJ, 2018, ANAL CHEM, V90, P1255, DOI 10.1021/acs.analchem.7b03985; Silva CJ, 2017, ANAL CHEM, V89, P854, DOI 10.1021/acs.analchem.6b03822; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Uro-Coste E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000029; Velasquez CD, 2015, J VIROL, V89, P12362, DOI 10.1128/JVI.02010-15; Weissmann C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002582	70	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4985	5001		10.1074/jbc.RA120.012546	http://dx.doi.org/10.1074/jbc.RA120.012546			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32111742	Green Published, hybrid			2022-12-28	WOS:000526887000021
J	Massa, D; Baran, M; Bengoechea, JA; Bowie, AG				Massa, Davide; Baran, Marcin; Bengoechea, Jose A.; Bowie, Andrew G.			PYHIN1 regulates pro-inflammatory cytokine induction rather than innate immune DNA sensing in airway epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; pattern recognition receptor (PRR); DNA viruses; interleukin 6 (IL-6); tumor necrosis factor (TNF); airway epithelial cells; cGAS; DNA sensing; PYHIN proteins; STING	CYCLIC DINUCLEOTIDE; IFI16; SENSOR; AIM2; ADAPTER; GENE; INFLAMMASOMES; REPLICATION; ACTIVATION; INFECTION	Animal cells use pattern-recognition receptors (PRRs) to detect specific pathogens. Pathogen detection mounts an appropriate immune response, including interferon and cytokine induction. The intracellular PRR-signaling pathways that detect DNA viruses have been characterized, particularly in myeloid cells. In these pathways, cGMP-AMP synthase (cGAS) and the pyrin and HIN domain family member (PYHIN) protein interferon-??inducible protein 16 (IFI16) detect DNA and signal via stimulator of interferon genes protein (STING). However, although airway epithelial cells are frontline sentinels in detecting pathogens, information on how they respond to DNA viruses is limited, and the roles of PYHIN proteins in these cells are unknown. Here, we examined expression and activities of cGAS, STING, and PYHINs in human lung epithelial cells. A549 epithelial cells, commonly used for RNA-sensing studies, failed to respond to DNA because they lacked STING expression, and ectopic STING expression restored a cGAS-dependent DNA response in these cells. In contrast, NuLi-1 immortalized human bronchial epithelial cells did express STING, which was activated after DNA stimulation and mediated DNA-dependent gene induction. PYHIN1, which like IFI16 has been proposed to be a viral DNA sensor, was the only PYHIN protein expressed in both airway epithelial cell types. However, rather than having a role in DNA sensing, PYHIN1 induced proinflammatory cytokines in response to interleukin-1 (IL-1) or tumor necrosis factor ? (TNF?) stimulation. Of note, PYHIN1, via its HIN domain, directly induced IL-6 and TNF? transcription, revealing that PYHIN proteins play a role in proinflammatory gene induction in airway epithelial cells.	[Massa, Davide; Baran, Marcin; Bowie, Andrew G.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Bengoechea, Jose A.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast BT9 7BL, Antrim, North Ireland	Trinity College Dublin; Queens University Belfast	Bowie, AG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland.	agbowie@tcd.ie		Bengoechea, Jose/0000-0002-9677-8751; Bowie, Andrew/0000-0001-5316-4373	Science Foundation Ireland [11/PI/1056, 16/IA/4376]; European Union Seventh Framework Programme Marie Curie Initial Training Networks (FP7-PEOPLE-2012-ITN) [PITN-GA-2012316682]; Marie Curie Career Integration Grant [PCIG13-GA-2013-618162]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L007223/1, BB/P020194/1]; BBSRC [BB/P020194/1, BB/L007223/1, BB/P006078/1] Funding Source: UKRI	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union Seventh Framework Programme Marie Curie Initial Training Networks (FP7-PEOPLE-2012-ITN); Marie Curie Career Integration Grant; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Science Foundation Ireland Grants 11/PI/1056 and 16/IA/4376 (to A. G. B.) and by the European Union Seventh Framework Programme Marie Curie Initial Training Networks (FP7-PEOPLE-2012-ITN) for the project INBIONET under grant agreement PITN-GA-2012316682 (to D. M.). This work was also supported by Marie Curie Career Integration Grant PCIG13-GA-2013-618162 (U-KARE) and by Biotechnology and Biological Sciences Research Council (BBSRC) Grants BB/L007223/1 and BB/P020194/1 (to J. A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Andreoletti G, 2015, INFLAMM BOWEL DIS, V21, P1229, DOI 10.1097/MIB.0000000000000381; Antiochos B, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120179; BALIS JU, 1984, EXP LUNG RES, V6, P197, DOI 10.3109/01902148409109248; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Caneparo V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01180; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Connolly DJ, 2014, BIOCHEM PHARMACOL, V92, P405, DOI 10.1016/j.bcp.2014.08.031; Cooksley C, 2015, MOL IMMUNOL, V68, P476, DOI 10.1016/j.molimm.2015.09.024; Crow MS, 2017, MOL CELL PROTEOMICS, V16, pS200, DOI 10.1074/mcp.M116.064741; Diner BA, 2016, MBIO, V7, DOI 10.1128/mBio.01553-16; Diner BA, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145808; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Ding Y, 2006, MOL CELL BIOL, V26, P1979, DOI 10.1128/MCB.26.5.1979-1996.2006; Ding Y, 2004, ONCOGENE, V23, P4556, DOI 10.1038/sj.onc.1207592; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Ghosh S, 2017, J IMMUNOL, V199, P3249, DOI 10.4049/jimmunol.1700823; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hauenstein AV, 2015, CURR OPIN STRUC BIOL, V31, P75, DOI 10.1016/j.sbi.2015.03.014; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hotter D, 2019, CELL HOST MICROBE, V25, P858, DOI 10.1016/j.chom.2019.05.002; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Jin L, 2011, GENES IMMUN, V12, P263, DOI 10.1038/gene.2010.75; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Jonsson KL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14391; Kantor DB, 2013, HUM GENET, V132, P1039, DOI 10.1007/s00439-013-1310-7; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Knipe DM, 2015, VIROLOGY, V479, P153, DOI 10.1016/j.virol.2015.02.009; Konno H, 2018, ONCOGENE, V37, P2037, DOI 10.1038/s41388-017-0120-0; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Li Y, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0159-2; Liao JCC, 2011, STRUCTURE, V19, P418, DOI 10.1016/j.str.2010.12.015; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Lo Cigno I, 2015, J VIROL, V89, P7506, DOI 10.1128/JVI.00013-15; Lukens JR, 2015, IMMUNITY, V42, P654, DOI 10.1016/j.immuni.2015.03.006; Merkl PE, 2019, MBIO, V10, DOI 10.1128/mBio.02621-18; Mishra R, 2016, AM J RESP CELL MOL, V54, P853, DOI 10.1165/rcmb.2014-0437OC; Morrone SR, 2014, P NATL ACAD SCI USA, V111, pE62, DOI 10.1073/pnas.1313577111; Ng KW, 2018, TRENDS IMMUNOL, V39, P44, DOI 10.1016/j.it.2017.07.013; Olagnier D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05861-7; Orzalli MH, 2013, P NATL ACAD SCI USA, V110, pE4492, DOI 10.1073/pnas.1316194110; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; Sharma BR, 2019, EUR J IMMUNOL, V49, P1998, DOI 10.1002/eji.201848070; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tang A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037689; Thompson MR, 2014, J BIOL CHEM, V289, P23568, DOI 10.1074/jbc.M114.554147; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vanhove W, 2015, INFLAMM BOWEL DIS, V21, P2673, DOI 10.1097/MIB.0000000000000535; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Yamaguchi H, 2008, MOL CARCINOGEN, V47, P739, DOI 10.1002/mc.20423; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	65	7	8	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4438	4450		10.1074/jbc.RA119.011400	http://dx.doi.org/10.1074/jbc.RA119.011400			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32102850	Green Published, hybrid			2022-12-28	WOS:000524499700007
J	Ticho, AL; Malhotra, P; Manzella, C; Dudeja, PK; Saksena, S; Gill, RK; Alrefai, WA				Ticho, Alexander L.; Malhotra, Pooja; Manzella, Christopher; Dudeja, Pradeep K.; Saksena, Seema; Gill, Ravinder K.; Alrefai, Waddah A.			S-acylation modulates the function of the apical sodium-dependent bile acid transporter in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bile acid; membrane transport; intestinal epithelium; protein acylation; intestine; apical sodium-dependent bile acid transporter (ASBT); bile acid transport; intestinal epithelial cells; posttranslational modification (PTM); S-acylation; ileum; lipid modification	PROTEIN PALMITOYLATION; ZDHHC FAMILY; FATTY-ACIDS; CSS-PALM; ASBT; NA+; LOCALIZATION; DEGRADATION; SELECTIVITY; SUBUNIT	The ileal apical sodium-dependent bile acid transporter (ASBT) is crucial for the enterohepatic circulation of bile acids. ASBT function is rapidly regulated by several posttranslational modifications. One reversible posttranslational modification is S-acylation, involving the covalent attachment of fatty acids to cysteine residues in proteins. However, whether S-acylation affects ASBT function and membrane expression has not been determined. Using the acyl resin-assisted capture method, we found that the majority of ASBT (?80%) was S-acylated in ileal brush border membrane vesicles from human organ donors, as well as in HEK293 cells stably transfected with ASBT (2BT cells). Metabolic labeling with alkyne?palmitic acid (100 ?m for 15 h) also showed that ASBT is S-acylated in 2BT cells. Incubation with the acyltransferase inhibitor 2-bromopalmitate (25 ?m for 15 h) significantly reduced ASBT S-acylation, function, and levels on the plasma membrane. Treatment of 2BT cells with saturated palmitic acid (100 ?m for 15 h) increased ASBT function, whereas treatment with unsaturated oleic acid significantly reduced ASBT function. Metabolic labeling with alkyne?oleic acid (100 ?m for 15 h) revealed that oleic acid attaches to ASBT, suggesting that unsaturated fatty acids may decrease ASBT's function via a direct covalent interaction with ASBT. We also identified Cys-314 as a potential S-acylation site. In conclusion, these results provide evidence that S-acylation is involved in the modulation of ASBT function. These findings underscore the potential for unsaturated fatty acids to reduce ASBT function, which may be useful in disorders in which bile acid toxicity is implicated.	[Malhotra, Pooja; Dudeja, Pradeep K.; Saksena, Seema; Gill, Ravinder K.; Alrefai, Waddah A.] Univ Illinois, Coll Med, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60612 USA; [Ticho, Alexander L.; Manzella, Christopher] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Dudeja, Pradeep K.; Saksena, Seema; Alrefai, Waddah A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Alrefai, WA (corresponding author), Univ Illinois, Coll Med, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60612 USA.; Alrefai, WA (corresponding author), Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA.	walrefai@uic.edu		Gill, Ravinder/0000-0002-5337-2567; Ticho, Alexander/0000-0002-2115-010X	Veterans Affairs [BX000152]; NIDDK, National Institutes of Health [DK109709, F30 DK113703, F30 DK117535, DK054016, DK98170]; Veterans Affairs Merit Award [BX002867]; Veteran Affairs Merit Award [BX002011]; Veterans Affairs Senior Research Career Scientist Award	Veterans Affairs(US Department of Veterans Affairs); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs Merit Award(US Department of Veterans Affairs); Veteran Affairs Merit Award; Veterans Affairs Senior Research Career Scientist Award	This work was supported by the Veterans Affairs Research Career Scientist Award and Merit Award BX000152 (to W. A. A.). This work was also supported by NIDDK, National Institutes of Health, Grants DK109709 (to W. A. A.), F30 DK113703 (to C. R. M.), F30 DK117535 (to A. L. T.), DK054016 (to P. K. D.), DK98170 (to R. K. G.); by Veterans Affairs Merit Award BX002867 (to S. S.) and Veteran Affairs Merit Award BX002011 (to P. K. D.); and by a Veterans Affairs Senior Research Career Scientist Award (to P. K. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or reflect the position or policy of the Department of Veterans Affairs or the United States government.	Annaba F, 2008, AM J PHYSIOL-GASTR L, V294, pG489, DOI 10.1152/ajpgi.00237.2007; Annaba F, 2012, AM J PHYSIOL-GASTR L, V302, pG1216, DOI 10.1152/ajpgi.00017.2012; Annaba F, 2010, AM J PHYSIOL-GASTR L, V299, pG898, DOI 10.1152/ajpgi.00139.2010; Banerjee A, 2005, BIOCHEMISTRY-US, V44, P8908, DOI 10.1021/bi050553s; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASEY WM, 1994, J BIOL CHEM, V269, P2082; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Chavda B, 2014, EXPERT OPIN DRUG DIS, V9, P1005, DOI 10.1517/17460441.2014.933802; Chen LH, 2012, AM J PHYSIOL-ENDOC M, V302, pE68, DOI 10.1152/ajpendo.00323.2011; Chothe PP, 2018, BBA-BIOMEMBRANES, V1860, P645, DOI 10.1016/j.bbamem.2017.11.016; Dawson PA, 2003, J BIOL CHEM, V278, P33920, DOI 10.1074/jbc.M306370200; DUDEJA PK, 1994, BBA-BIOMEMBRANES, V1193, P67, DOI 10.1016/0005-2736(94)90334-4; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Foster JD, 2011, J BIOL CHEM, V286, P5175, DOI 10.1074/jbc.M110.187872; Fritz KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075868; Gaebler A, 2013, J LIPID RES, V54, P2282, DOI 10.1194/jlr.D038653; Gill RK, 2005, AM J PHYSIOL-CELL PH, V289, pC846, DOI 10.1152/ajpcell.00112.2005; Greaves J, 2017, P NATL ACAD SCI USA, V114, pE1365, DOI 10.1073/pnas.1612254114; HARIG JM, 1990, BIOCHEM BIOPH RES CO, V167, P438, DOI 10.1016/0006-291X(90)92042-X; Hong V, 2010, BIOCONJUGATE CHEM, V21, P1912, DOI 10.1021/bc100272z; Hu LL, 2011, BIOCHIMIE, V93, P489, DOI 10.1016/j.biochi.2010.10.022; Hussainzada N, 2006, MOL PHARMACOL, V70, P1565, DOI 10.1124/mol.106.028647; Jang D, 2015, J CELL SCI, V128, P2179, DOI 10.1242/jcs.169409; Jiang H, 2018, CHEM REV, V118, P43, DOI 10.1021/acs.chemrev.6b00750; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Lemonidis K, 2017, BIOCHEM SOC T, V45, P751, DOI 10.1042/BST20160309; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; McClure M, 2012, PROTEIN ENG DES SEL, V25, P7, DOI 10.1093/protein/gzr054; McClure ML, 2014, BIOCHEM J, V459, P417, DOI 10.1042/BJ20131037; Miyata M, 2013, EUR J PHARMACOL, V714, P507, DOI 10.1016/j.ejphar.2013.06.036; Moore RH, 2013, BIOCHEMISTRY-US, V52, P5117, DOI 10.1021/bi400028q; Moritz AE, 2015, J BIOL CHEM, V290, P29095, DOI 10.1074/jbc.M115.667055; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; Mukherjee A, 2014, J BIOL CHEM, V289, P14351, DOI 10.1074/jbc.M113.526020; Muszbek L, 1999, LIPIDS, V34, pS331, DOI 10.1007/BF02562334; Muthusamy S, 2015, AM J PHYSIOL-CELL PH, V308, pC964, DOI 10.1152/ajpcell.00023.2015; Oelkers P, 1997, J CLIN INVEST, V99, P1880, DOI 10.1172/JCI119355; Rao A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4823; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Ren WY, 2013, ADIPOCYTE, V2, P17, DOI 10.4161/adip.22117; Sanders SS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004405; Sarwar Z, 2009, AM J PHYSIOL-GASTR L, V297, pG532, DOI 10.1152/ajpgi.00052.2009; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Spinelli M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123820; Spinelli M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02221-9; Sun AQ, 2003, J BIOL CHEM, V278, P4000, DOI 10.1074/jbc.M207163200; Tabaczar S, 2017, EXP BIOL MED, V242, P1150, DOI 10.1177/1535370217707732; Thorne RF, 2010, BBA-MOL CELL RES, V1803, P1298, DOI 10.1016/j.bbamcr.2010.07.002; Ticho AL, 2018, AM J PHYSIOL-GASTR L, V315, pG529, DOI 10.1152/ajpgi.00133.2018; Tiessen RG, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-017-0736-0; Werno MW, 2015, SCI REP-UK, V5, DOI 10.1038/srep12413; Wu YL, 2013, J MED CHEM, V56, P5094, DOI 10.1021/jm400459m; Xia XF, 2004, J BIOL CHEM, V279, P44931, DOI 10.1074/jbc.M400969200; Xie YB, 2016, SCI REP-UK, V6, DOI 10.1038/srep28249; Xu ZY, 2015, BIOCHEM BIOPH RES CO, V460, P949, DOI 10.1016/j.bbrc.2015.03.132; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Zhao L, 2018, J HEPATOL, V69, P705, DOI 10.1016/j.jhep.2018.04.006; Zhou Bo, 2014, J Proteomics Bioinform, V7, P256; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	60	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4488	4497		10.1074/jbc.RA119.011032	http://dx.doi.org/10.1074/jbc.RA119.011032			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32071081	hybrid, Green Published			2022-12-28	WOS:000524499700011
J	Drake, S; Fournier, A				Drake, Sienna; Fournier, Alyson			Nogo BACE jumps on the exosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The protein Nogo-A has been widely studied for its role in inhibiting axonal regeneration following injury to the central nervous system, but the mechanism by which the membrane-bound Nogo-A is presented intercellularly is not fully understood. New research suggests that a highly inhibitory fragment of Nogo-A is generated by the amyloid precursor protein protease BACE1 and presented on the membranes of exosomes following spinal cord injury. This finding represents a new mode through which Nogo-A may exert its effects in the central nervous system.	[Drake, Sienna; Fournier, Alyson] Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University	Fournier, A (corresponding author), Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada.	alyson.fournier@mcgill.ca		Fournier, Alyson/0000-0002-1859-7015				Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Lopez-Verrilli MA, 2013, GLIA, V61, P1795, DOI 10.1002/glia.22558; Frohlich D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0510; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9; Korkut C, 2013, NEURON, V77, P1039, DOI 10.1016/j.neuron.2013.01.013; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Sekine Y, 2020, J BIOL CHEM, V295, P2175, DOI 10.1074/jbc.RA119.009896; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Zagrebelsky M, 2010, J NEUROSCI, V30, P13220, DOI 10.1523/JNEUROSCI.1044-10.2010	10	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2184	2185		10.1074/jbc.H120.012745	http://dx.doi.org/10.1074/jbc.H120.012745			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	32086246	Green Published, hybrid			2022-12-28	WOS:000517330200003
J	Pore, D; Mahata, N; Chakrabarti, MK				Pore, Debasis; Mahata, Nibedita; Chakrabarti, Manoj K.			RETRACTION: Outer membrane protein A (OmpA) of Shigella flexneri 2a links innate and adaptive immunity in a TLR2-dependent manner and involvement of IL-12 and nitric oxide (Retraction of Vol 287, Pg 12589, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction																		Pore D, 2012, J BIOL CHEM, V287, P12589, DOI 10.1074/jbc.M111.335554	1	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2543	2543		10.1074/jbc.W120.012819	http://dx.doi.org/10.1074/jbc.W120.012819			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	32090978	Green Published, hybrid			2022-12-28	WOS:000517330200034
J	Du, QD; Chan, LY; Gilding, EK; Henriques, ST; Condon, ND; Ravipati, AS; Kaas, Q; Huang, YH; Craik, DJ				Du, Qingdan; Chan, Lai Y.; Gilding, Edward K.; Henriques, Sonia Troeira; Condon, Nicholas D.; Ravipati, Anjaneya S.; Kaas, Quentin; Huang, Yen-Hua; Craik, David J.			Discovery and mechanistic studies of cytotoxic cyclotides from the medicinal herbHybanthus enneaspermus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic peptide; peptide chemical synthesis; cyclotide; nuclear magnetic resonance (NMR); cancer cell cytotoxicity; peptide-membrane interaction; anticancer property; surface plasmon resonance (SPR); flow cytometry; microscopy; cancer cell cytoxicity	GC-MS ANALYSIS; KALATA B1; CYCLOVIOLACIN O2; HYBANTHUS-ENNEASPERMUS; PLANT CYCLOTIDES; MEMBRANE-BINDING; KNOTTED PROTEINS; SCANNING MUTAGENESIS; CIRCULAR PROTEINS; VIOLA-ODORATA	Cyclotides are plant-derived peptides characterized by an similar to 30-amino acid-long cyclic backbone and a cystine knot motif. Cyclotides have diverse bioactivities, and their cytotoxicity has attracted significant attention for its potential anticancer applications.Hybanthus enneaspermus(Linn) F. Muell is a medicinal herb widely used in India as a libido enhancer, and a previous study has reported that it may contain cyclotides. In the current study, we isolated 11 novel cyclotides and 1 known cyclotide (cycloviolacin O2) fromH. enneaspermusand used tandem MS to determine their amino acid sequences. We found that among these cyclotides, hyen C comprises a unique sequence in loops 1, 2, 3, 4, and 6 compared with known cyclotides. The most abundant cyclotide in this plant, hyen D, had anticancer activity comparable to that of cycloviolacin O2, one of the most cytotoxic known cyclotides. We also provide mechanistic insights into how these novel cyclotides interact with and permeabilize cell membranes. Results from surface plasmon resonance experiments revealed that hyen D, E, L, and M and cycloviolacin O2 preferentially interact with model lipid membranes that contain phospholipids with phosphatidyl-ethanolamine headgroups. The results of a lactate dehydrogenase assay indicated that exposure to these cyclotides compromises cell membrane integrity. Using live-cell imaging, we show that hyen D induces rapid membrane blebbing and cell necrosis. Cyclotide-membrane interactions correlated with the observed cytotoxicity, suggesting that membrane permeabilization and disintegration underpin cyclotide cytotoxicity. These findings broaden our knowledge on the indigenous Indian herbH. enneaspermusand have uncovered cyclotides with potential anticancer activity.	[Du, Qingdan; Chan, Lai Y.; Gilding, Edward K.; Henriques, Sonia Troeira; Condon, Nicholas D.; Ravipati, Anjaneya S.; Kaas, Quentin; Huang, Yen-Hua; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Henriques, Sonia Troeira] Queensland Univ Technol, Sch Biomed Sci, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Henriques, Sonia Troeira] Queensland Univ Technol, Translat Res Inst, Brisbane, Qld, Australia	University of Queensland; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	d.craik@imb.uq.edu.au	Craik, David/B-1695-2010; CHAN, LAI YUE/C-6489-2014; Huang, Yen-Hua/J-9056-2014; Kaas, Quentin/J-8727-2014; Troeira Henriques, Sonia/J-3500-2016	Craik, David/0000-0003-0007-6796; CHAN, LAI YUE/0000-0002-9346-2487; Huang, Yen-Hua/0000-0001-6937-2660; Kaas, Quentin/0000-0001-9988-6152; Troeira Henriques, Sonia/0000-0001-9564-9651; Gilding, Edward Kalani/0000-0003-1720-1282; Du, Qingdan/0000-0002-1165-3766	Australian government; ARC [LE160100218]; ACRF	Australian government(Australian GovernmentCGIAR); ARC(Australian Research Council); ACRF	The Translational Research Institute is supported by a grant from the Australian government. S. T. H. is an ARC Future Fellow (FT150100398). D. J. C. is an ARC Australian Laureate Fellow (FL150100146). The work was facilitated using infrastructure provided by the Australian Government through the National Collaborative Research Infrastructure strategy (NCRIS). We thank Alun Jones and Institute for Molecular Bioscience Mass Spectrometry Facility (The University of Queensland) for technical support and access to MS equipment. We thank Gregoire J.-B. Philippe for experimental help and suggestions on the biological assays. We also acknowledge Dr. Peta Harvey for help in NMR and the Queensland NMR facility for access to NMR equipment and an ARC grant (LE160100218). Microscopy was performed at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Cancer Biology Imaging Facility, which was established with the support of the ACRF.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Annie, 2007, PHARMACOLOGYONLINE, V1, P152; Bhanu H. S., 2011, INT J PHARM PHARM SC, V3, P90; Bobey AF, 2018, PLANTA MED, V84, P947, DOI 10.1055/a-0632-2204; Broussalis AM, 2001, PHYTOCHEMISTRY, V58, P47, DOI 10.1016/S0031-9422(01)00173-X; Burman R, 2011, BBA-BIOMEMBRANES, V1808, P2665, DOI 10.1016/j.bbamem.2011.07.004; Burman R, 2011, ORG BIOMOL CHEM, V9, P4306, DOI 10.1039/c0ob00966k; Chan LY, 2013, CHEMBIOCHEM, V14, P617, DOI 10.1002/cbic.201300034; Cheneval O, 2014, J ORG CHEM, V79, P5538, DOI 10.1021/jo500699m; Chiche L, 2004, CURR PROTEIN PEPT SC, V5, P341, DOI 10.2174/1389203043379477; Cierpicki T, 2001, J BIOMOL NMR, V21, P249, DOI 10.1023/A:1012911329730; Colgrave ML, 2008, CHEMBIOCHEM, V9, P1939, DOI 10.1002/cbic.200800174; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2017, CURR OPIN CHEM BIOL, V38, P8, DOI 10.1016/j.cbpa.2017.01.018; Craik DJ, 2013, CURR OPIN CHEM BIOL, V17, P546, DOI 10.1016/j.cbpa.2013.05.033; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; de Veer SJ, 2019, CHEM REV, V119, P12375, DOI 10.1021/acs.chemrev.9b00402; Gerlach SL, 2010, BIOPOLYMERS, V94, P617, DOI 10.1002/bip.21435; Gerlach SL, 2010, J NAT PROD, V73, P1207, DOI 10.1021/np9007365; Goransson U, 2004, J NAT PROD, V67, P1287, DOI 10.1021/np0499719; Goransson U, 2012, J BIOL CHEM, V287, P27001, DOI 10.1074/jbc.R111.300129; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gruber CW, 2008, PLANT CELL, V20, P2471, DOI 10.1105/tpc.108.062331; Grundemann C, 2019, INT J PEPT RES THER, V25, P9, DOI 10.1007/s10989-018-9701-1; Hall K, 2012, BBA-BIOMEMBRANES, V1818, P2354, DOI 10.1016/j.bbamem.2012.04.007; He WJ, 2011, PEPTIDES, V32, P1719, DOI 10.1016/j.peptides.2011.06.016; Heitz A, 2001, BIOCHEMISTRY-US, V40, P7973, DOI 10.1021/bi0106639; Hemalatha S., 2003, INDIAN J TRADIT KNOW, V2, P383; Henriques ST, 2008, BIOPHYS J, V95, P1877, DOI 10.1529/biophysj.108.131458; Henriques ST, 2017, BIOCHEMISTRY-US, V56, P669, DOI 10.1021/acs.biochem.6b01212; Henriques ST, 2014, CHEMBIOCHEM, V15, P1956, DOI 10.1002/cbic.201402144; Henriques ST, 2012, J BIOL CHEM, V287, P33629, DOI 10.1074/jbc.M112.372011; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Herrmann A, 2006, CELL MOL LIFE SCI, V63, P235, DOI 10.1007/s00018-005-5486-4; Herrmann A, 2008, PHYTOCHEMISTRY, V69, P939, DOI 10.1016/j.phytochem.2007.10.023; Hu EP, 2015, INT J CLIN EXP MED, V8, P4059; Huang YH, 2019, TOXICON, V172, P33, DOI 10.1016/j.toxicon.2019.10.244; Huang YH, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00017; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886; Ivanova A, 2002, Z NATURFORSCH C, V57, P624; Jackson MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04669-9; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Koehbach J, 2013, P NATL ACAD SCI USA, V110, P21183, DOI 10.1073/pnas.1311183110; Koehbach J, 2013, BIOPOLYMERS, V100, P438, DOI 10.1002/bip.22328; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Lindholm P, 2002, MOL CANCER THER, V1, P365; Mulvenna JP, 2006, NUCLEIC ACIDS RES, V34, pD192, DOI 10.1093/nar/gkj005; Oguis GK, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00645; Park S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091430; Patel D. K., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P316, DOI 10.1016/S2221-1691(11)60051-8; Philippe GJB, 2019, ACS CHEM BIOL, V14, P2071, DOI 10.1021/acschembio.9b00593; Pinto MEF, 2018, J NAT PROD, V81, P1203, DOI 10.1021/acs.jnatprod.7b00969; Plan MRR, 2008, J AGR FOOD CHEM, V56, P5237, DOI 10.1021/jf800302f; Pranting M, 2010, J ANTIMICROB CHEMOTH, V65, P1964, DOI 10.1093/jac/dkq220; Quimbar P, 2013, J BIOL CHEM, V288, P13885, DOI 10.1074/jbc.M113.460030; Ravipati AS, 2015, ACS CHEM BIOL, V10, P2491, DOI 10.1021/acschembio.5b00454; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; Sampath B., 2016, THESIS; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Setty M, 2007, F MUELL PHARMACOLOGY, V2, P158; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Simonsen SM, 2005, PLANT CELL, V17, P3176, DOI 10.1105/tpc.105.034678; Skjeldal L, 2002, ARCH BIOCHEM BIOPHYS, V399, P142, DOI 10.1006/abbi.2002.2769; Suman TY, 2016, ENVIRON SCI POLLUT R, V23, P2705, DOI 10.1007/s11356-015-5468-5; Svangard E, 2004, J NAT PROD, V67, P144, DOI 10.1021/np030101l; Svangard E, 2007, J NAT PROD, V70, P643, DOI 10.1021/np070007v; Tang J, 2010, HELV CHIM ACTA, V93, P2287, DOI 10.1002/hlca.201000115; Tang J, 2010, PEPTIDES, V31, P1434, DOI 10.1016/j.peptides.2010.05.004; Thell K, 2014, DRUG DISCOV TODAY, V19, P645, DOI 10.1016/j.drudis.2013.12.002; Tripathy S, 2009, AFR J PHARM PHARMACO, V3, P611; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vuda M, 2012, EXP TOXICOL PATHOL, V64, P855, DOI 10.1016/j.etp.2011.03.006; Wang CK, 2009, BIOPHYS J, V97, P1471, DOI 10.1016/j.bpj.2009.06.032; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471	82	17	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2020	295	32					10911	10925		10.1074/jbc.RA120.012627	http://dx.doi.org/10.1074/jbc.RA120.012627			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NE7BV	32414842	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000562757100004
J	Gur-Arie, L; Eitan-Wexler, M; Weinberger, N; Rosenshine, I; Livnah, O				Gur-Arie, Lihi; Eitan-Wexler, Maayan; Weinberger, Nina; Rosenshine, Ilan; Livnah, Oded			The bacterial metalloprotease NleD selectively cleaves mitogen-activated protein kinases that have high flexibility in their activation loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitogen-activated protein kinase (MAPK); extracellular signal-regulated kinase (ERK); p38; Jun N-terminal kinase (JNK); NleD; metalloprotease; effector protein; type III secretion system (T3SS); bacterial pathogen; protein structure; crystallography; bacterial pathogenesis; structural biology; proteolysis	P38 MAP KINASE; KAPPA-B; IMMUNE; BINDING; ACETYLATION; MECHANISM; EFFECTOR; INSIGHTS; INSERT; ERK2	Microbial pathogens often target the host mitogen-activated protein kinase (MAPK) network to suppress host immune responses. We previously identified a bacterial type III secretion system effector, termed NleD, a metalloprotease that inactivates MAPKs by specifically cleaving their activation loop. Here, we show that NleDs form a growing family of virulence factors harbored by human and plant pathogens as well as insect symbionts. These NleDs disable specifically Jun N-terminal kinases (JNKs) and p38s that are required for host immune response, whereas extracellular signal-regulated kinase (ERK), which is essential for host cell viability, remains intact. We investigated the mechanism that makes ERK resistant to NleD cleavage. Biochemical and structural analyses revealed that NleD exclusively targets activation loops with high conformational flexibility. Accordingly, NleD cleaved the flexible loops of JNK and p38 but not the rigid loop of ERK. Our findings elucidate a compelling mechanism of native substrate proteolysis that is promoted by entropy-driven specificity. We propose that such entropy-based selectivity is a general attribute of proteolytic enzymes.	[Gur-Arie, Lihi; Rosenshine, Ilan] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, IMRIC, Fac Med, Edmond J Safra Campus, Jerusalem, Israel; [Eitan-Wexler, Maayan; Weinberger, Nina; Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Alexander Silverman Inst Life Sci, Dept Biol Chem, Edmond J Safra Campus, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rosenshine, I (corresponding author), Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, IMRIC, Fac Med, Edmond J Safra Campus, Jerusalem, Israel.; Livnah, O (corresponding author), Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Alexander Silverman Inst Life Sci, Dept Biol Chem, Edmond J Safra Campus, Jerusalem, Israel.	ilanr@ekmd.huji.ac.il; oded.livnah@huji.ac.il			Israel Science Foundation - Israel Academy of Science and Humanities [617/15, 1422/16]; European Research Council [810186]	Israel Science Foundation - Israel Academy of Science and Humanities; European Research Council(European Research Council (ERC)European Commission)	Work in the I. R. and O. L. laboratories was supported by grants from the Israel Science Foundation, funded by the Israel Academy of Science and Humanities, grants 617/15 and 1422/16, respectively, and in the I. R. laboratory also by a grant from the European Research Council (810186).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Baruch K, 2011, EMBO J, V30, P221, DOI 10.1038/emboj.2010.297; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Creuzburg K, 2011, APPL ENVIRON MICROB, V77, P8705, DOI 10.1128/AEM.06492-11; Diskin R, 2008, J MOL BIOL, V375, P70, DOI 10.1016/j.jmb.2007.09.002; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Guerin ME, 2018, P NATL ACAD SCI USA, V115, P11525, DOI 10.1073/pnas.1803872115; Hutter D, 2000, BIOCHEM J, V352, P155, DOI 10.1042/0264-6021:3520155; Incardona MF, 2009, J SYNCHROTRON RADIAT, V16, P872, DOI 10.1107/S0909049509036681; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kayode O, 2016, J BIOL CHEM, V291, P26304, DOI 10.1074/jbc.M116.758417; Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021; Kumar GS, 2018, P NATL ACAD SCI USA, V115, P4655, DOI 10.1073/pnas.1721441115; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mooney LM, 2004, J BIOL CHEM, V279, P11843, DOI 10.1074/jbc.M311841200; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pearson JS, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0012-2013; Peti W, 2013, PROTEIN SCI, V22, P1698, DOI 10.1002/pro.2374; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Reddick LE, 2014, MOL CELL, V54, P321, DOI 10.1016/j.molcel.2014.03.010; Salomon D, 2013, CURR OPIN MICROBIOL, V16, P213, DOI 10.1016/j.mib.2013.01.013; Shaw D, 2008, J MOL BIOL, V383, P885, DOI 10.1016/j.jmb.2008.08.086; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stofega MR, 1997, CELL GROWTH DIFFER, V8, P113; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tesker M, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160020; Trosky JE, 2007, J BIOL CHEM, V282, P34299, DOI 10.1074/jbc.M706970200; Tzarum N, 2013, J BIOL CHEM, V288, P19537, DOI 10.1074/jbc.M113.464511; Tzarum N, 2012, J MOL BIOL, V424, P339, DOI 10.1016/j.jmb.2012.10.007; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; WILSON IA, 1991, METHOD ENZYMOL, V203, P153; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhang L, 2012, NATURE, V481, P204, DOI 10.1038/nature10690; Zhang YY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203786; Zhu YQ, 2007, MOL CELL, V28, P899, DOI 10.1016/j.molcel.2007.11.011	51	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9409	9420		10.1074/jbc.RA120.013590	http://dx.doi.org/10.1074/jbc.RA120.013590			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32404367	Green Published, hybrid			2022-12-28	WOS:000552758600012
J	Catlin, DS; Yang, XH; Bennett, B; Holz, RC; Liu, DL				Catlin, Daniel S.; Yang, Xinhang; Bennett, Brian; Holz, Richard C.; Liu, Dali			Structural basis for the hydrolytic dehalogenation of the fungicide chlorothalonil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; zinc; enzyme catalysis; enzyme mechanism; enzyme kinetics; bioremediation; Chd; chlorothalonil; dechlorination; dehalogenase	METALLO-BETA-LACTAMASES; MECHANISM; ALKYLSULFATASE; PURIFICATION; DEGRADATION; DOCKING; ENZYMES; ZINC	Cleavage of aromatic carbon?chlorine bonds is critical for the degradation of toxic industrial compounds. Here, we solved the X-ray crystal structure of chlorothalonil dehalogenase (Chd) fromPseudomonassp. CTN-3, with 15 of its N-terminal residues truncated (Chd(T)), using single-wavelength anomalous dispersion refined to 1.96 ? resolution. Chd has low sequence identity (<15%) compared with all other proteins whose structures are currently available, and to the best of our knowledge, we present the first structure of a Zn(II)-dependent aromatic dehalogenase that does not require a coenzyme. Chd(T)forms a ?head-to-tail? homodimer, formed between two ?-helices from each monomer, with three Zn(II)-binding sites, two of which occupy the active sites, whereas the third anchors a structural site at the homodimer interface. The catalytic Zn(II) ions are solvent-accessible via a large hydrophobic (8.5 ? 17.8 ?) opening to bulk solvent and two hydrophilic branched channels. Each active-site Zn(II) ion resides in a distorted trigonal bipyramid geometry with His(117), His(257), Asp(116), Asn(216), and a water/hydroxide as ligands. A conserved His residue, His(114), is hydrogen-bonded to the Zn(II)-bound water/hydroxide and likely functions as the general acid-base. We examined substrate binding by docking chlorothalonil (2,4,5,6-tetrachloroisophtalonitrile, TPN) into the hydrophobic channel and observed that the most energetically favorable pose includes a TPN orientation that coordinates to the active-site Zn(II) ions via a CN and that maximizes a ??? interaction with Trp(227). On the basis of these results, along with previously reported kinetics data, we propose a refined catalytic mechanism for Chd-mediated TPN dehalogenation.	[Yang, Xinhang; Holz, Richard C.] Marquette Univ, Dept Chem, Milwaukee, WI 53233 USA; [Bennett, Brian] Marquette Univ, Dept Phys, Milwaukee, WI 53233 USA; [Catlin, Daniel S.; Liu, Dali] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA; [Holz, Richard C.] Colorado Sch Mines, Dept Chem, Golden, CO 80401 USA	Marquette University; Marquette University; Loyola University Chicago; Colorado School of Mines	Holz, RC (corresponding author), Marquette Univ, Dept Chem, Milwaukee, WI 53233 USA.; Liu, DL (corresponding author), Loyola Univ, Dept Chem & Biochem, Chicago, IL 60611 USA.; Holz, RC (corresponding author), Colorado Sch Mines, Dept Chem, Golden, CO 80401 USA.	rholz@mines.edu; dliu@luc.edu	; Liu, Dali/D-2571-2014	Holz, Richard/0000-0001-6093-2799; Liu, Dali/0000-0002-7587-703X	National Science Foundation [CHE-1808711]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant CHE-1808711 (to B. B. and R. C. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ang TF, 2018, MOLECULES, V23, DOI 10.3390/molecules23051100; Arora PK, 2014, J CHEM-NY, V2014, P1, DOI 10.1155/2014/265140; Baier F, 2014, J MOL BIOL, V426, P2442, DOI 10.1016/j.jmb.2014.04.013; Baxter J, 2006, ANTON LEEUW INT J G, V90, P1, DOI 10.1007/s10482-006-9057-y; Beil S, 1998, J BACTERIOL, V180, P5520, DOI 10.1128/JB.180.21.5520-5528.1998; Bunge M, 2003, NATURE, V421, P357, DOI 10.1038/nature01237; Carlo-Rojas Z, 2004, WATER AIR SOIL POLL, V151, P397, DOI 10.1023/B:WATE.0000009918.70113.c5; Caux PY, 1996, CRIT REV ENV SCI TEC, V26, P45, DOI 10.1080/10643389609388486; Christianson DW, 1999, ANNU REV BIOCHEM, V68, P33, DOI 10.1146/annurev.biochem.68.1.33; Copley SD, 1998, CURR OPIN CHEM BIOL, V2, P613, DOI 10.1016/S1367-5931(98)80092-6; Cosper NJ, 2003, J AM CHEM SOC, V125, P14654, DOI 10.1021/ja036650v; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; de Jong RM, 2003, CURR OPIN STRUC BIOL, V13, P722, DOI 10.1016/j.sbi.2003.10.009; Desmarais W, 2006, J BIOL INORG CHEM, V11, P398, DOI 10.1007/s00775-006-0093-x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fryszczyn BG, 2014, PROTEIN SCI, V23, P1235, DOI 10.1002/pro.2505; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; Hagelueken G, 2006, P NATL ACAD SCI USA, V103, P7631, DOI 10.1073/pnas.0510501103; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu JM, 2019, PROTEIN SCI, V28, P68, DOI 10.1002/pro.3479; Janssen DB, 2001, CURR OPIN BIOTECH, V12, P254, DOI 10.1016/S0958-1669(00)00208-1; Knaus T, 2012, FEBS J, V279, P4374, DOI 10.1111/febs.12027; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Kussmann M, 2000, METH MOL B, V146, P405, DOI 10.1385/1-59259-045-4:405; Leisinger Thomas, 1994, Biodegradation, V5, P237, DOI 10.1007/BF00696462; Liang B, 2011, APPL ENVIRON MICROB, V77, P4268, DOI 10.1128/AEM.02457-10; Mozzachio AM, 2008, ENVIRON RES, V108, P400, DOI 10.1016/j.envres.2008.07.018; ORSER CS, 1993, J BACTERIOL, V175, P2640, DOI 10.1128/JB.175.9.2640-2644.1993; Peat TS, 2015, ACTA CRYSTALLOGR D, V71, P710, DOI 10.1107/S1399004715000619; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quiroga R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155183; Reddy GVB, 2000, MICROBIOL-UK, V146, P405, DOI 10.1099/00221287-146-2-405; Ren XJ, 2011, CURR MICROBIOL, V62, P1068, DOI 10.1007/s00284-010-9824-x; Sakkas VA, 2002, CHEMOSPHERE, V48, P939, DOI 10.1016/S0045-6535(02)00121-2; Sakurai M, 1995, J PHYS CHEM-US, V99, P17789, DOI 10.1021/j100050a019; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Signor L, 2013, JOVE-J VIS EXP, DOI 10.3791/50635; Sims J. L., 1991, REDUCTIVE DEHALOGENA; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Viciu MS, 2001, ORGANOMETALLICS, V20, P3607, DOI 10.1021/om010332s; VICKERS AEM, 1985, ENVIRON HEALTH PERSP, V59, P121, DOI 10.2307/3429884; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang GL, 2010, J BACTERIOL, V192, P2737, DOI 10.1128/JB.01547-09; XUN LY, 1992, J BACTERIOL, V174, P8003, DOI 10.1128/JB.174.24.8003-8007.1992; Yang XH, 2019, J BIOL CHEM, V294, P13411, DOI 10.1074/jbc.RA119.009094; Yang XH, 2018, ARCH BIOCHEM BIOPHYS, V657, P1, DOI 10.1016/j.abb.2018.08.013; YOKOTA T, 1986, AGR BIOL CHEM TOKYO, V50, P453, DOI 10.1080/00021369.1986.10867402; Yue WL, 2015, J BIOSCI BIOENG, V120, P544, DOI 10.1016/j.jbiosc.2015.03.013	51	2	2	4	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8668	8677		10.1074/jbc.RA120.013150	http://dx.doi.org/10.1074/jbc.RA120.013150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32358058	Green Published, hybrid			2022-12-28	WOS:000546296800004
J	McDonald, IM; Graves, LM				McDonald, Ian M.; Graves, Lee M.			Enigmatic MELK: The controversy surrounding its complex role in cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						RNA interference (RNAi); inhibitor; CRISPR; Cas; cancer; cell proliferation; serine; threonine protein kinase; drug target; maternal embryonic leucine zipper kinase (MELK); OTS167; target specificity	LEUCINE-ZIPPER KINASE; THERAPEUTIC TARGET; HEPATOCELLULAR-CARCINOMA; GROWTH; PROLIFERATION; EXPRESSION; CELLS; INHIBITOR; DISCOVERY; PHOSPHORYLATION	The Ser/Thr protein kinase MELK (maternal embryonic leucine zipper kinase) has been considered an attractive therapeutic target for managing cancer since 2005. Studies using expression analysis have indicated that MELK expression is higher in numerous cancer cells and tissues than in their normal, nonneoplastic counterparts. Further, RNAi-mediated MELK depletion impairs proliferation of multiple cancers, including triple-negative breast cancer (TNBC), and these growth defects can be rescued with exogenous WT MELK, but not kinase-dead MELK complementation. Pharmacological MELK inhibition with OTS167 (alternatively called OTSSP167) and NVS-MELK8a, among other small molecules, also impairs cancer cell growth. These collective results led to MELK being classified as essential for cancer proliferation. More recently, in 2017, the proliferation of TNBC and other cancer cell lines was reported to be unaffected by genetic CRISPR/Cas9-mediated MELK deletion, calling into question the essentiality of this kinase in cancer. To date, the requirement of MELK in cancer remains controversial, and mechanisms underlying the disparate growth effects observed with RNAi, pharmacological inhibition, and CRISPR remain unclear. Our objective with this review is to highlight the evidence on both sides of this controversy, to provide commentary on the purported requirement of MELK in cancer, and to emphasize the need for continued elucidation of the functions of MELK.	[McDonald, Ian M.; Graves, Lee M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; [McDonald, Ian M.; Graves, Lee M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Graves, Lee M.] Univ N Carolina, UNC Michael Hooker Prote Core Facil, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Graves, LM (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.; Graves, LM (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Graves, LM (corresponding author), Univ N Carolina, UNC Michael Hooker Prote Core Facil, Chapel Hill, NC 27515 USA.	lmg@med.unc.edu	Graves, Lee/AAG-5470-2021		National Institutes of Health [R01 CA199064]; UNC dissertation completion fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC dissertation completion fellowship	This work was supported by National Institutes of Health Grant R01 CA199064 (to L. M. G.). This work was also supported, in part, by a UNC dissertation completion fellowship (to I. M. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal R, 2017, CANCER GENET-NY, V216, P37, DOI 10.1016/j.cancergen.2017.06.002; Alachkar H, 2014, ONCOTARGET, V5, P12371, DOI 10.18632/oncotarget.2642; Allegretti PA, 2020, BIOORGAN MED CHEM, V28, DOI 10.1016/j.bmc.2019.115193; Badouel C, 2010, EXP CELL RES, V316, P2166, DOI 10.1016/j.yexcr.2010.04.019; Beke L, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150194; Blot J, 2002, DEV BIOL, V241, P327, DOI 10.1006/dbio.2001.0525; Bolomsky A, 2018, HAEMATOLOGICA, V103, P325, DOI 10.3324/haematol.2017.172973; Chen S, 2020, J CELL MOL MED, V24, P1804, DOI 10.1111/jcmm.14878; Chlenski A, 2019, MOL CANCER THER, V18, P507, DOI 10.1158/1535-7163.MCT-18-0819; Choi S, 2011, BIOCHEM BIOPH RES CO, V412, P207, DOI 10.1016/j.bbrc.2011.07.060; Chung SY, 2012, ONCOTARGET, V3, P1629; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deng JL, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00695; Du T, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-100; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Edupuganti R, 2017, BIOORGAN MED CHEM, V25, P2609, DOI 10.1016/j.bmc.2017.03.018; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Giuliano CJ, 2018, ELIFE, V7, DOI 10.7554/eLife.32838; Grant GD, 2013, MOL BIOL CELL, V24, P3634, DOI 10.1091/mbc.E13-05-0264; Graves LM, 2013, BIOCHEM J, V450, P1, DOI 10.1042/BJ20121456; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Gu CY, 2013, STEM CELLS, V31, P870, DOI 10.1002/stem.1322; Guan S, 2018, ONCOTARGET, V9, P2591, DOI 10.18632/oncotarget.23515; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Huang HT, 2017, ELIFE, V6, DOI 10.7554/eLife.26693; Inoue H, 2016, ONCOTARGET, V7, P13621, DOI 10.18632/oncotarget.7297; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Janostiak R, 2017, CELL REP, V21, P2829, DOI 10.1016/j.celrep.2017.11.033; Ji WB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153518; Johnson CN, 2015, ACS MED CHEM LETT, V6, P25, DOI 10.1021/ml5001245; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Kim SH, 2015, STEM CELL REP, V4, P226, DOI 10.1016/j.stemcr.2014.12.006; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Kuner R, 2013, J MOL MED, V91, P237, DOI 10.1007/s00109-012-0949-1; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Li S, 2016, ONCOTARGET, V7, P6266, DOI 10.18632/oncotarget.6673; Lin A, 2017, ELIFE, V6, DOI 10.7554/eLife.24179; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Marie SKN, 2008, INT J CANCER, V122, P807, DOI 10.1002/ijc.23189; McDonald IM, 2020, J BIOL CHEM, V295, P2359, DOI 10.1074/jbc.RA119.011083; Meraldi P, 2019, EMBO J, V38, DOI 10.15252/embj.2019101912; Minata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092546; Nakano I, 2008, J NEUROSCI RES, V86, P48, DOI 10.1002/jnr.21471; Pickard MR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2350; Pitner MK, 2017, EXPERT OPIN THER TAR, V21, P849, DOI 10.1080/14728222.2017.1363183; Rodriguez-Rodriguez JA, 2018, CURR BIOL, V28, P3422, DOI 10.1016/j.cub.2018.10.006; Seok H, 2018, CELL MOL LIFE SCI, V75, P797, DOI 10.1007/s00018-017-2656-0; Settleman J, 2018, ELIFE, V7, DOI 10.7554/eLife.32402; Speers C, 2016, CLIN CANCER RES, V22, P5864, DOI 10.1158/1078-0432.CCR-15-2711; Stefka AT, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.71; Sun CT, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181293; Toure BB, 2016, J MED CHEM, V59, P4711, DOI 10.1021/acs.jmedchem.6b00052; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Wang YB, 2018, ISCIENCE, V9, P149, DOI 10.1016/j.isci.2018.10.015; Wang YB, 2014, ELIFE, V3, DOI 10.7554/eLife.01763; Wittrup A, 2015, NAT REV GENET, V16, P543, DOI 10.1038/nrg3978; Xia HP, 2016, CANCER LETT, V383, P85, DOI 10.1016/j.canlet.2016.09.017; Xu QY, 2020, EBIOMEDICINE, V51, DOI 10.1016/j.ebiom.2019.102609; Zhang G, 2019, EMBO J, V38, DOI 10.15252/embj.2018100977; Zhang Y, 2018, ONCOGENE, V37, P5520, DOI 10.1038/s41388-018-0333-x; Zou YF, 2019, ONCOL LETT, V18, P4593, DOI 10.3892/ol.2019.10804	63	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8195	8203		10.1074/jbc.REV120.013433	http://dx.doi.org/10.1074/jbc.REV120.013433			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350113	hybrid, Green Published			2022-12-28	WOS:000542965700008
J	Ruben, EA; Gandhi, PS; Chen, ZW; Koester, SK; DeKoster, GT; Frieden, C; Di Cera, E				Ruben, Eliza A.; Gandhi, Prafull S.; Chen, Zhiwei; Koester, Sarah K.; DeKoster, Gregory T.; Frieden, Carl; Di Cera, Enrico			F-19 NMR reveals the conformational properties of free thrombin and its zymogen precursor prethrombin-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); X-ray crystallography; thrombin; serine protease; protein conformation; blood coagulation; ligand binding; protein dynamics; zymogen	RAY CRYSTAL-STRUCTURE; NA+ BINDING; BOVINE TRYPSINOGEN; PROTEIN-STRUCTURE; STRUCTURAL BASIS; LIGAND-BINDING; RAPID KINETICS; INDUCED FIT; SPECIFICITY; MECHANISM	The conformational properties of trypsin-like proteases and their zymogen forms remain controversial because of a lack of sufficient information on their free forms. Specifically, it is unclear whether the free protease is zymogen-like and shifts to its mature form upon a ligand-induced fit or exists in multiple conformations in equilibrium from which the ligand selects the optimal fit via conformational selection. Here we report the results of(19)F NMR measurements that reveal the conformational properties of a protease and its zymogen precursor in the free form. Using the trypsin-like, clotting protease thrombin as a relevant model system, we show that its conformation is quite different from that of its direct zymogen precursor prethrombin-2 and more similar to that of its fully active Na+-bound form. The results cast doubts on recent hypotheses that free thrombin is zymogen-like and transitions to protease-like forms upon ligand binding. Rather, they validate the scenario emerged from previous findings of X-ray crystallography and rapid kinetics supporting a pre-existing equilibrium between open (E) and closed (E*) forms of the active site. In this scenario, prethrombin-2 is more dynamic and exists predominantly in the E* form, whereas thrombin is more rigid and exists predominantly in the E form. Ligand binding to thrombin takes place exclusively in the E form without significant changes in the overall conformation. In summary, these results disclose the structural architecture of the free forms of thrombin and prethrombin-2, consistent with an E*?E equilibrium and providing no evidence that free thrombin is zymogen-like.	[Ruben, Eliza A.; Chen, Zhiwei; Koester, Sarah K.; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Gandhi, Prafull S.] Novo Nordisk, Global Res, Malov, Denmark; [DeKoster, Gregory T.; Frieden, Carl] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Saint Louis University; Novo Nordisk; Washington University (WUSTL)	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu		DeKoster, Gregory/0000-0001-9928-8195; Koester, Sarah/0000-0003-4626-504X	National Institutes of Health [HL049413, HL139554, HL147821]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants HL049413, HL139554, and HL147821 (to E. D. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aramini JM, 2014, STRUCTURE, V22, P515, DOI 10.1016/j.str.2014.01.010; Arosio D, 2000, BIOCHEMISTRY-US, V39, P8095, DOI 10.1021/bi0006215; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; Bann JG, 2002, P NATL ACAD SCI USA, V99, P709, DOI 10.1073/pnas.022649599; BODE W, 1976, J MOL BIOL, V106, P325, DOI 10.1016/0022-2836(76)90089-9; BODE W, 1978, FEBS LETT, V90, P265, DOI 10.1016/0014-5793(78)80382-2; BODE W, 1978, J MOL BIOL, V118, P99, DOI 10.1016/0022-2836(78)90246-2; BODE W, 1992, PROTEIN SCI, V1, P426; CARR HY, 1954, PHYS REV, V94, P630, DOI 10.1103/PhysRev.94.630; Chakraborty P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21728-9; Chakraborty P, 2017, BIOCHEMISTRY-US, V56, P2853, DOI 10.1021/acs.biochem.7b00340; Danielson MA, 1996, ANNU REV BIOPH BIOM, V25, P163, DOI 10.1146/annurev.bb.25.060196.001115; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frieden C, 2004, METHOD ENZYMOL, V380, P400; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Fuglestad B, 2012, BIOPHYS J, V103, P79, DOI 10.1016/j.bpj.2012.05.047; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; Handley LD, 2017, SCI REP-UK, V7, DOI 10.1038/srep39575; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Huntington JA, 2009, J THROMB HAEMOST, V7, P159, DOI 10.1111/j.1538-7836.2009.03365.x; Kahler U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57822-0; Kamath P, 2010, J BIOL CHEM, V285, P28651, DOI 10.1074/jbc.M110.154914; Landgraf KE, 2014, NAT CHEM BIOL, V10, P567, DOI [10.1038/nchembio.1533, 10.1038/NCHEMBIO.1533]; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Marino F, 2010, J BIOL CHEM, V285, P19145, DOI 10.1074/jbc.M110.119875; Mazur A, 2013, BIOINFORMATICS, V29, P1819, DOI 10.1093/bioinformatics/btt286; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Pelc LA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48839-1; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pineda AO, 2004, J BIOL CHEM, V279, P39824, DOI 10.1074/jbc.M407272200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Pozzi N, 2011, BIOCHEMISTRY-US, V50, P10195, DOI 10.1021/bi2015019; Pozzi N, 2011, BIOPHYS CHEM, V159, P6, DOI 10.1016/j.bpc.2011.04.003; Renatus M, 1997, EMBO J, V16, P4797, DOI 10.1093/emboj/16.16.4797; Renatus M, 1997, J BIOL CHEM, V272, P21713, DOI 10.1074/jbc.272.35.21713; Rohr KB, 2006, J MOL BIOL, V357, P195, DOI 10.1016/j.jmb.2005.12.037; Stojanovski BM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54564-6; Vogt AD, 2015, J BIOL CHEM, V290, P22435, DOI 10.1074/jbc.M115.675538; Vogt AD, 2014, BIOPHYS CHEM, V186, P13, DOI 10.1016/j.bpc.2013.09.003; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Vogt AD, 2010, J PHYS CHEM B, V114, P16125, DOI 10.1021/jp105502c; Wakeham N, 2002, PROTEIN ENG, V15, P753, DOI 10.1093/protein/15.9.753; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008	53	2	2	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8227	8235		10.1074/jbc.RA120.013419	http://dx.doi.org/10.1074/jbc.RA120.013419			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32358061	hybrid, Green Published			2022-12-28	WOS:000542965700011
J	Traughber, CA; Opoku, E; Brubaker, G; Major, J; Lu, HX; Lorkowski, SW; Neumann, C; Hardaway, A; Chung, YM; Gulshan, K; Sharifi, N; Brown, JM; Smith, JD				Traughber, C. Alicia; Opoku, Emmanuel; Brubaker, Gregory; Major, Jennifer; Lu, Hanxu; Lorkowski, Shuhui Wang; Neumann, Chase; Hardaway, Aimalie; Chung, Yoon-Mi; Gulshan, Kailash; Sharifi, Nima; Brown, J. Mark; Smith, Jonathan D.			Uptake of high-density lipoprotein by scavenger receptor class B type 1 is associated with prostate cancer proliferation and tumor progression in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; high-density lipoprotein (HDL); lipoprotein metabolism; lipoprotein receptor; prostate cancer; scavenger receptor; CRISPR; Cas; SCARB1; scavenger receptor class B; type 1	CHOLESTERYL ESTER ACCUMULATION; APOLIPOPROTEIN-A-I; SR-BI; STEROIDOGENIC CELLS; STATIN USE; RISK; HDL; EXPRESSION; CARCINOMA; BLOOD	High-density lipoprotein (HDL) metabolism is facilitated in part by scavenger receptor class B, type 1 (SR-B1) that mediates HDL uptake into cells. Higher levels of HDL have been associated with protection in other diseases, however, its role in prostate cancer is not definitive. SR-B1 is up-regulated in prostate cancer tissue, suggesting a possible role of this receptor in tumor progression. Here, we report that knockout (KO) of SR-B1 in both human and mouse prostate cancer cell lines through CRISPR/Cas9-mediated genome editing reduces HDL uptake into the prostate cancer cells and reduces their proliferation in response to HDL.In vivostudies using syngeneic SR-B1 WT (SR-B1(+/+)) and SR-B1 KO (SR-B1(?/?)) prostate cancer cells in WT and apolipoprotein-AI KO (apoA1-KO) C57BL/6J mice revealed that WT hosts, containing higher levels of total and HDL-cholesterol, grew larger tumors than apoA1-KO hosts with lower levels of total and HDL-cholesterol. Furthermore, SR-B1(?/?)prostate cancer cells formed smaller tumors in WT hosts than SR-B1(+/+)cells in the same host model. Increased tumor volume was overall associated with reduced survival. We conclude that knocking out SR-B1 in prostate cancer tumors reduces HDL-associated increases in prostate cancer cell proliferation and disease progression.	[Traughber, C. Alicia; Opoku, Emmanuel; Brubaker, Gregory; Major, Jennifer; Lu, Hanxu; Lorkowski, Shuhui Wang; Neumann, Chase; Gulshan, Kailash; Brown, J. Mark; Smith, Jonathan D.] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA; [Hardaway, Aimalie; Chung, Yoon-Mi; Sharifi, Nima] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Traughber, C. Alicia; Neumann, Chase; Brown, J. Mark; Smith, Jonathan D.] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Brown, J. Mark] Case Western Reserve Univ, Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Brown, J. Mark] Cleveland Clin Fdn, Ctr Microbiome & Human Hlth, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Major, Jennifer] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Smith, JD (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA.; Smith, JD (corresponding author), Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	smithj4@ccf.org		Opoku, Emmanuel/0000-0003-2816-7761	National Institutes of Health [R01HL128628, R01DK120679, P50AA024333, P01HL147823, R01CA172382, R01CA190289, R01CA236780, F31HL134231, R01HL148158]; American Heart Association [SDG25710128]; Case Comprehensive Cancer Center pilot Grant [RES511106]; VeloSano Foundation; NCI National Institutes of Health [P30CA043703]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Case Comprehensive Cancer Center pilot Grant; VeloSano Foundation; NCI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01HL128628 (to J. D. S.), R01DK120679 (to J. M. B.), P50AA024333 (to J. M. B.), P01HL147823 (to J. M. B.), R01CA172382 (to N. S.), R01CA190289 (to N. S.), R01CA236780 (to N. S.), and F31HL134231 (to C. A. T.), American Heart Association Grant SDG25710128 (to K. G.), the Case Comprehensive Cancer Center pilot Grant RES511106 (to J. D. S.), the VeloSano Foundation (to J. D. S.), National Institutes of Health Grant R01HL148158 (to K. G.), and Case Comprehensive Cancer Center pilot grant program supported by NCI National Institutes of Health Grant P30CA043703. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Bull CJ, 2016, CANCER MED-US, V5, P1125, DOI 10.1002/cam4.695; CALVO D, 1993, J BIOL CHEM, V268, P18929; Calvo D, 1997, ARTERIOSCL THROM VAS, V17, P2341, DOI 10.1161/01.ATV.17.11.2341; Davis CE, 1996, AM J EPIDEMIOL, V143, P1100; de la Llera-Moya M, 1999, J LIPID RES, V40, P575; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Eissa MA, 2016, J PEDIATR-US, V170, P199, DOI 10.1016/j.jpeds.2015.11.018; Gillotte-Taylor K, 2001, J LIPID RES, V42, P1474; Gordon JA, 2019, CANCER RES, V79, P3320, DOI 10.1158/0008-5472.CAN-18-2529; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hammarsten J, 2004, BLOOD PRESSURE, V13, P47, DOI 10.1080/08037050310025735; Huggins C, 1941, CANCER RES, V1, P293; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; Jacobs EJ, 2012, CANCER CAUSE CONTROL, V23, P1289, DOI 10.1007/s10552-012-0006-y; Jafri H, 2010, J AM COLL CARDIOL, V55, P2846, DOI 10.1016/j.jacc.2009.12.069; Jamnagerwalla J, 2018, PROSTATE CANCER P D, V21, P252, DOI 10.1038/s41391-017-0030-9; Kim J, 2019, BBA-MOL CELL BIOL L, V1864, DOI 10.1016/j.bbalip.2019.158525; KIRKLAND RT, 1987, JAMA-J AM MED ASSOC, V257, P502, DOI 10.1001/jama.257.4.502; Kok DEG, 2011, PROSTATE CANCER P D, V14, P340, DOI 10.1038/pcan.2011.30; Langer C, 2002, BIOCHEM BIOPH RES CO, V296, P1051, DOI 10.1016/S0006-291X(02)02038-7; Lee BH, 2013, CANCER RES, V73, P1211, DOI 10.1158/0008-5472.CAN-12-3128; Li K, 2018, METHODS MOL BIOL, V1740, P139, DOI 10.1007/978-1-4939-7652-2_11; Liu YP, 2015, CANCER EPIDEM BIOMAR, V24, P1086, DOI 10.1158/1055-9965.EPI-14-1329; Llaverias G, 2010, AM J PATHOL, V177, P3180, DOI 10.2353/ajpath.2010.100568; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACHIDA T, 1981, HORM BEHAV, V15, P238, DOI 10.1016/0018-506X(81)90013-1; Machiela MJ, 2018, BIOINFORMATICS, V34, P887, DOI 10.1093/bioinformatics/btx561; Martin RM, 2009, CANCER CAUSE CONTROL, V20, P1181, DOI 10.1007/s10552-009-9319-x; Mary Goldman B. C., 2019, BIORXIV, DOI [DOI 10.1101/326470, 10.1101/326470]; Meng Y, 2016, ONCOTARGETS THER, V9, P1689, DOI 10.2147/OTT.S97993; Murtola TJ, 2017, EUR UROL FOCUS, V3, P212, DOI 10.1016/j.euf.2016.05.004; Oka R, 2016, INT J CLIN ONCOL, V21, P389, DOI 10.1007/s10147-015-0891-7; Petryszak R, 2016, NUCLEIC ACIDS RES, V44, pD746, DOI 10.1093/nar/gkv1045; Pirro M, 2018, PROG LIPID RES, V71, P54, DOI 10.1016/j.plipres.2018.06.001; Plump AS, 1996, J CLIN INVEST, V97, P2660, DOI 10.1172/JCI118716; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Raval AD, 2016, PROSTATE CANCER P D, V19, P151, DOI 10.1038/pcan.2015.58; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1996, J BIOL CHEM, V271, P33545, DOI 10.1074/jbc.271.52.33545; Robinet P, 2010, J LIPID RES, V51, P3364, DOI 10.1194/jlr.D007336; Schorghofer D, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0087-z; Sekine Y, 2010, MOL CANCER RES, V8, P1284, DOI 10.1158/1541-7786.MCR-10-0008; Shen WJ, 2018, ANNU REV PHYSIOL, V80, P95, DOI 10.1146/annurev-physiol-021317-121550; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sivaprasad U, 2006, MOL CANCER THER, V5, P2310, DOI 10.1158/1535-7163.MCT-06-0175; Tan P, 2017, ASIAN J ANDROL, V19, P666, DOI 10.4103/1008-682X.190327; Tilly-Kiesi M, 1997, ARTERIOSCL THROM VAS, V17, P3513, DOI 10.1161/01.ATV.17.12.3513; Van Hemelrijck M, 2011, CANCER CAUSE CONTROL, V22, P1011, DOI 10.1007/s10552-011-9774-z; Velagapudi S, 2018, J LIPID RES, V59, P2188, DOI 10.1194/jlr.M083311; Wang SH, 2014, BIOFACTORS, V40, P547, DOI 10.1002/biof.1187; Williamson CM, 2017, PHYSIOL BEHAV, V171, P110, DOI 10.1016/j.physbeh.2016.12.038; Witt W, 2000, J LIPID RES, V41, P2009; Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025; Xu GH, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3761-z; Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019; Zamanian-Daryoush M, 2017, ONCOTARGET, V8, P71965, DOI 10.18632/oncotarget.18666; Zamanian-Daryoush M, 2013, J BIOL CHEM, V288, P21237, DOI 10.1074/jbc.M113.468967	60	9	9	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8252	8261		10.1074/jbc.RA120.013694	http://dx.doi.org/10.1074/jbc.RA120.013694			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32358065	Green Published, hybrid			2022-12-28	WOS:000542965700013
J	Morel, M; Shah, KN; Long, WW				Morel, Marion; Shah, Krushangi N.; Long, Weiwen			The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Myc (c-Myc); E3 ubiquitin ligase; protein stability; ubiquitylation (ubiquitination); cancer; cell migration; F-box and leucine-rich repeat protein 16 (FBXL16); F-box protein; F-box; WD repeat-containing protein 7 (FBW7); protein homeostasis; proto-oncogene C-Myc (C-MYC)	UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; STRUCTURAL BASIS; STEM-CELLS; CANCER; MECHANISMS; RECOGNITION; DEGRADATION; COMPLEX; GROWTH	F-box proteins, such as F-box/WD repeat-containing protein 7 (FBW7), are essential components of the SKP1-CUL1-F-box (SCF) E3 ubiquitin ligases. They bind to S-phase kinase-associated protein 1 (SKP1) through the F-box motif and deliver their protein substrate to the E3 ligase complex for ubiquitination and subsequent degradation. F-box and leucine-rich repeat protein 16 (FBXL16) is a poorly studied F-box protein. Because it does not interact with the scaffold protein cullin 1 (CUL1), we hypothesized that FBXL16 might not form a functional SCF-E3 ligase complex. In the present study, we found that FBXL16 up-regulates the levels of proteins targeted by SCF-E3 ligases, such as C-MYC, ?-catenin, and steroid receptor coactivator 3 (SRC-3). Focusing on C-MYC, a well-known oncoprotein overexpressed in most human cancers, we show that FBXL16 stabilizes C-MYC by antagonizing FBW7-mediated C-MYC ubiquitination and degradation. Further, we found that, although FBXL16 does not interact with CUL1, it interacts with SKP1 via its N-terminal F-box domain and with its substrate C-MYC via its C-terminal leucine-rich repeats (LRRs) domain. We found that both the F-box domain and the LRR domain are important for FBXL16-mediated C-MYC stabilization. In line with its role in up-regulating the levels of the C-MYC and SRC-3 oncoproteins, FBXL16 promoted cancer cell growth and migration and colony formation in soft agar. Our findings reveal that FBXL16 is an F-box protein that antagonizes the activity of another F-box protein, FBW7, and thereby increases C-MYC stability, resulting in increased cancer cell growth and invasiveness.	[Morel, Marion; Shah, Krushangi N.; Long, Weiwen] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Long, WW (corresponding author), Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	weiwen.long@wright.edu	Shah, Krushangi N/AAL-9331-2020; Morel, Marion/X-4104-2019	Shah, Krushangi N/0000-0002-7908-6462; Morel, Marion/0000-0002-1439-5360	NCI, National Institutes of Health [1R01CA193264-01]; Wright State University	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wright State University	This work was supported by NCI, National Institutes of Health Grant 1R01CA193264-01 (to W. L.). This work was also supported by a start-up fund of Wright State University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cremona CA, 2016, SEMIN CANCER BIOL, V36, P52, DOI 10.1016/j.semcancer.2015.09.006; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Elkhadragy L, 2018, J BIOL CHEM, V293, P16193, DOI 10.1074/jbc.RA118.003699; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Heo JH, 2016, SEMIN CANCER BIOL, V36, P33, DOI 10.1016/j.semcancer.2015.09.015; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Honarpour N, 2014, MOL CELL PROTEOMICS, V13, P780, DOI 10.1074/mcp.M113.031765; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Li C, 2007, MOL CELL BIOL, V27, P1296, DOI 10.1128/MCB.00336-06; Liu X, 2018, MOL CELL, V69, P773, DOI 10.1016/j.molcel.2018.01.038; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Roworth AP, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970480; Sato K, 2010, INT J ONCOL, V36, P479, DOI 10.3892/ijo_00000522; Shimizu K, 2018, CELL SIGNAL, V46, P15, DOI 10.1016/j.cellsig.2018.02.009; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Tan MKM, 2013, MOL CELL, V52, P9, DOI 10.1016/j.molcel.2013.08.018; Vo BT, 2016, CANCER CELL, V29, P5, DOI 10.1016/j.ccell.2015.12.003; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	37	9	9	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7970	7980		10.1074/jbc.RA120.012658	http://dx.doi.org/10.1074/jbc.RA120.012658			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32345600	Green Published, hybrid			2022-12-28	WOS:000540935400012
J	Bujnowska, M; Zhang, JC; Dai, Q; Heideman, EM; Fei, JY				Bujnowska, Magda; Zhang, Jiacheng; Dai, Qing; Heideman, Emily M.; Fei, Jingyi			Deoxyribozyme-based method for absolute quantification of N-6-methyladenosine fractions at specific sites of RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA methylation; RNA modification; DNA enzyme; reverse transcription; polymerase chain reaction (PCR); deoxyribozymes; N6-methyladenosine	SINGLE-NUCLEOTIDE-RESOLUTION; MESSENGER-RNA; NUCLEAR-RNA; N6-METHYLADENOSINE; IDENTIFICATION; PSEUDOURIDINE; SUBSTRATE	N-6-Methyladenosine (m(6)A) is the most prevalent modified base in eukaryotic mRNA and long noncoding RNA. Although candidate sites for the m(6)A modification are identified at the transcriptomic level, methods for site-specific quantification of absolute m(6)A modification levels are still limited. Herein, we present a facile method implementing a deoxyribozyme, VMC10, which preferentially cleaves the unmodified RNA. We leveraged reverse transcription and real-time quantitative PCR along with key control experiments to quantify the methylation fraction of specific m(6)A sites. We validated the accuracy of this method with synthetic RNA in which methylation fractions ranged from 0 to 100% and applied our method to several endogenous sites that were previously identified in sequencing-based studies. This method provides a time- and cost-effective approach for absolute quantification of the m(6)A fraction at specific loci, with the potential for multiplexed quantifications, expanding the current toolkit for studying RNA modifications.	[Bujnowska, Magda; Heideman, Emily M.; Fei, Jingyi] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Dai, Qing] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA; [Zhang, Jiacheng; Fei, Jingyi] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Fei, JY (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.; Fei, JY (corresponding author), Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA.	jingyifei@uchicago.edu	Dai, Qing/ABD-8444-2021	Heideman, Emily/0000-0001-6563-8097; Fei, Jingyi/0000-0002-9775-3820; Bujnowska, Magda/0000-0003-0794-383X	Searle Scholars Program, National Institutes of Health Director's New Innovator Award [1DP2GM128185-01]; National Institutes of Health Center for the Dynamic RNA Epitranscriptomes at the University of Chicago	Searle Scholars Program, National Institutes of Health Director's New Innovator Award; National Institutes of Health Center for the Dynamic RNA Epitranscriptomes at the University of Chicago(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funds from the Searle Scholars Program, National Institutes of Health Director's New Innovator Award 1DP2GM128185-01, and a pilot grant from the National Institutes of Health Center for the Dynamic RNA Epitranscriptomes at the University of Chicago (to J. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Chen K, 2015, ANGEW CHEM INT EDIT, V54, P1587, DOI 10.1002/anie.201410647; Dai Q, 2007, NUCLEIC ACIDS RES, V35, P6322, DOI 10.1093/nar/gkm657; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Garcia-Campos MA, 2019, CELL, V178, P731, DOI 10.1016/j.cell.2019.06.013; HARADA K, 1993, NUCLEIC ACIDS RES, V21, P2287, DOI 10.1093/nar/21.10.2287; Harcourt EM, 2013, J AM CHEM SOC, V135, P19079, DOI 10.1021/ja4105792; Helm M, 2017, NAT REV GENET, V18, P275, DOI 10.1038/nrg.2016.169; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kasowitz SD, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007412; Ke SD, 2017, GENE DEV, V31, P990, DOI 10.1101/gad.301036.117; Lei ZX, 2017, ANGEW CHEM INT EDIT, V56, P14878, DOI 10.1002/anie.201708276; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Liu WL, 2018, CHEM SCI, V9, P3354, DOI 10.1039/c7sc05233b; Maity A, 2016, FEBS J, V283, P1607, DOI 10.1111/febs.13614; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Nachtergaele S, 2018, ANNU REV GENET, V52, P349, DOI 10.1146/annurev-genet-120417-031522; Potapov V, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky303; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Sednev MV, 2018, ANGEW CHEM INT EDIT, V57, P15117, DOI 10.1002/anie.201808745; Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025; Tserovski L, 2016, METHODS, V107, P110, DOI 10.1016/j.ymeth.2016.02.012; Wang SR, 2016, CHEM SCI, V7, P1440, DOI 10.1039/c5sc02902c; Warda AS, 2017, EMBO REP, V18, P2004, DOI 10.15252/embr.201744940; Xiao Y, 2018, ANGEW CHEM INT EDIT, V57, P15995, DOI 10.1002/anie.201807942; Zhang Z, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0250; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	30	8	8	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6992	7000		10.1074/jbc.RA120.013359	http://dx.doi.org/10.1074/jbc.RA120.013359			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32269077	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000536212600017
J	Majumdar, A; Trinh, V; Moore, KJ; Smallwood, CR; Kumar, A; Yang, TH; Scott, DC; Long, NJ; Newton, SM; Klebba, PE				Majumdar, Aritri; Trinh, Vy; Moore, Kyle J.; Smallwood, Chuck R.; Kumar, Ashish; Yang, Taihao; Scott, Daniel C.; Long, Noah J.; Newton, Salete M.; Klebba, Phillip E.			Conformational rearrangements in the N-domain of Escherichia coli FepA during ferric enterobactin transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; iron; outer membrane; disulfide; site-directed mutagenesis; siderophore; FepA; fluorescent sensor	LOW-COPY-NUMBER; OUTER-MEMBRANE; CRYSTAL-STRUCTURE; RECEPTOR PROTEIN; PSEUDOMONAS-AERUGINOSA; DEPENDENT TRANSPORT; STRUCTURAL BASIS; IRON TRANSPORT; TONB; CHANNELS	The Escherichia coli outer membrane receptor FepA transports ferric enterobactin (FeEnt) by an energy- and TonB-dependent, but otherwise a mechanistically undetermined process involving its internal 150-residue N-terminal globular domain (N-domain). We genetically introduced pairs of Cys residues in different regions of the FepA tertiary structure, with the potential to form disulfide bonds. These included Cys pairs on adjacent ?-strands of the N-domain (intra-N) and Cys pairs that bridged the external surface of the N-domain to the interior of the C-terminal transmembrane ?-barrel (inter-N?C). We characterized FeEnt uptake by these mutants with siderophore nutrition tests, [Fe-59]Ent binding and uptake experiments, and fluorescence decoy sensor assays. The three methods consistently showed that the intra-N disulfide bonds, which restrict conformational motion within the N-domain, prevented FeEnt uptake, whereas most inter-N?C disulfide bonds did not prevent FeEnt uptake. These outcomes indicate that conformational rearrangements must occur in the N terminus of FepA during FeEnt transport. They also argue against disengagement of the N-domain out of the channel as a rigid body and suggest instead that it remains within the transmembrane pore as FeEnt enters the periplasm.	[Majumdar, Aritri; Kumar, Ashish; Yang, Taihao; Long, Noah J.; Newton, Salete M.; Klebba, Phillip E.] Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66506 USA; [Trinh, Vy] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Moore, Kyle J.] Cameron Univ, Dept Chem Phys & Engn, Lawton, OK 73505 USA; [Smallwood, Chuck R.] Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA; [Scott, Daniel C.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA	Kansas State University; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Sandia National Laboratories; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Klebba, PE (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66506 USA.	peklebba@ksu.edu	Smallwood, Chuck/P-5421-2017	Smallwood, Chuck/0000-0003-2221-5726	National Science Foundation [MCB09522999]; National Institutes of Health [GM53836, AI115187]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Science Foundation Grant MCB09522999 and National Institutes of Health Grants GM53836 and AI115187. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annamalai R, 2004, J BACTERIOL, V186, P3578, DOI 10.1128/JB.186.11.3578-3589.2004; BARDWELL JCA, 1994, MOL MICROBIOL, V14, P199, DOI 10.1111/j.1365-2958.1994.tb01281.x; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; Cao Z, 2002, BIOCHIMIE, V84, P399, DOI 10.1016/S0300-9084(02)01455-4; Cao ZH, 2000, MOL MICROBIOL, V37, P1306, DOI 10.1046/j.1365-2958.2000.02093.x; Cao ZH, 2003, J BIOL CHEM, V278, P1022, DOI 10.1074/jbc.M210360200; Chakravorty S, 2019, J BIOL CHEM, V294, P4682, DOI 10.1074/jbc.RA118.006921; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Cobessi D, 2005, J MOL BIOL, V352, P893, DOI 10.1016/j.jmb.2005.08.004; Cobessi D, 2005, J MOL BIOL, V347, P121, DOI 10.1016/j.jmb.2005.01.021; Cornelissen CN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00117; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Dhople AM, 1996, MICROBIOS, V87, P77; DIMASI DR, 1973, J BACTERIOL, V115, P506, DOI 10.1128/JB.115.2.506-513.1973; Eisenbeis S, 2008, J BACTERIOL, V190, P5230, DOI 10.1128/JB.00194-08; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Fetherston JD, 2010, INFECT IMMUN, V78, P2045, DOI 10.1128/IAI.01236-09; FURMAN M, 1994, INFECT IMMUN, V62, P4091, DOI 10.1128/IAI.62.9.4091-4094.1994; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; Goldstone D, 2001, P NATL ACAD SCI USA, V98, P9551, DOI 10.1073/pnas.171315498; Gumbart J, 2007, BIOPHYS J, V93, P496, DOI 10.1529/biophysj.107.104158; HANCOCK REW, 1976, FEBS LETT, V65, P208, DOI 10.1016/0014-5793(76)80481-4; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; HOLLIFIELD WC, 1978, BIOCHEM BIOPH RES CO, V83, P739, DOI 10.1016/0006-291X(78)91051-3; Jordan LD, 2013, P NATL ACAD SCI USA, V110, P11553, DOI 10.1073/pnas.1304243110; Josts I, 2019, ELIFE, V8, DOI 10.7554/eLife.48528; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; KLEBBA PE, 1994, EMBO J, V13, P4670, DOI 10.1002/j.1460-2075.1994.tb06790.x; Konings AF, 2013, INFECT IMMUN, V81, P2697, DOI 10.1128/IAI.00418-13; Larson JA, 2002, INFECT IMMUN, V70, P1461, DOI 10.1128/IAI.70.3.1461-1467.2002; le Coutret J, 2000, BIOPOLYMERS, V55, P297, DOI 10.1002/1097-0282(2000)55:4<297::AID-BIP1003>3.0.CO;2-H; LIU J, 1994, BIOCHEMISTRY-US, V33, P13274, DOI 10.1021/bi00249a014; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Lohmiller S, 2008, MICROBIOL-SGM, V154, P1748, DOI 10.1099/mic.0.2008/017350-0; LUCKEY M, 1980, BIOCHEM BIOPH RES CO, V93, P166, DOI 10.1016/S0006-291X(80)80261-0; LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; Lukacik P, 2012, P NATL ACAD SCI USA, V109, P9857, DOI 10.1073/pnas.1203472109; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; Mainathambika BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI 10.1146/annurev.cellbio.24.110707.175333; Mortensen BL, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00095; Moynie L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11508-y; MURPHY CK, 1990, J BACTERIOL, V172, P2736, DOI 10.1128/jb.172.5.2736-2746.1990; Nairn BL, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00889-16; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Newton SM, 2010, J BIOL CHEM, V285, P17488, DOI 10.1074/jbc.M109.100206; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NOEL D, 1979, BIOCHEMISTRY-US, V18, P4159, DOI 10.1021/bi00586a017; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Payne MA, 1997, J BIOL CHEM, V272, P21950, DOI 10.1074/jbc.272.35.21950; RUTZ JM, 1992, SCIENCE, V258, P471, DOI 10.1126/science.1411544; Saier MH, 2000, J MEMBRANE BIOL, V175, P165, DOI 10.1007/s00232001065; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoolnik GK, 2002, ADV MICROB PHYSIOL, V46, P1, DOI 10.1016/S0065-2911(02)46001-8; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Smallwood CR, 2014, J GEN PHYSIOL, V144, P69, DOI 10.1085/jgp.201311159; Smallwood CR, 2009, MOL MICROBIOL, V72, P1171, DOI 10.1111/j.1365-2958.2009.06715.x; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Smith KD, 2007, INT J BIOCHEM CELL B, V39, P1776, DOI 10.1016/j.biocel.2007.07.003; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Tapley TL, 2007, J BIOL CHEM, V282, P10263, DOI 10.1074/jbc.M611541200; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; WAYNE R, 1976, J BACTERIOL, V126, P7, DOI 10.1128/JB.126.1.7-12.1976; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; Zhai YF, 2003, BBA-BIOMEMBRANES, V1614, P201, DOI 10.1016/S0005-2736(03)00176-7	76	5	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4974	4984		10.1074/jbc.RA119.011850	http://dx.doi.org/10.1074/jbc.RA119.011850			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32098871	hybrid, Green Published			2022-12-28	WOS:000526887000020
J	Ariana, A; Alturki, NA; Hajjar, S; Stumpo, DJ; Tiedje, C; Alnemri, ES; Gaestel, M; Blackshear, PJ; Sad, S				Ariana, Ardeshir; Alturki, Norah A.; Hajjar, Stephanie; Stumpo, Deborah J.; Tiedje, Christopher; Alnemri, Emad S.; Gaestel, Matthias; Blackshear, Perry J.; Sad, Subash			Tristetraprolin regulates necroptosis during tonic Toll-like receptor 4 (TLR4) signaling in murine macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; cell death; Toll-like receptor 4 (TLR4); necrosis; necrotic death; cytokine; tristetraprolin; ZFP36 ring finger protein (ZFP36); necrosome	TUMOR-NECROSIS-FACTOR; CELL-DEATH; TNF-ALPHA; PROGRAMMED NECROSIS; RIPK1; INFLAMMATION; BINDING; PHOSPHORYLATION; INHIBITOR; CASPASE-8	The necrosome is a protein complex required for signaling in cells that results in necroptosis, which is also dependent on tumor necrosis factor receptor (TNF-R) signaling. TNF? promotes necroptosis, and its expression is facilitated by mitogen-activated protein (MAP) kinase?activated protein kinase 2 (MK2) but is inhibited by the RNA-binding protein tristetraprolin (TTP, encoded by the Zfp36 gene). We have stimulated murine macrophages from WT, MyD88(?/?), Trif(?/?), MyD88(?/?)Trif(?/?), MK2(?/?), and Zfp36(?/?) mice with graded doses of lipopolysaccharide (LPS) and various inhibitors to evaluate the role of various genes in Toll-like receptor 4 (TLR4)?induced necroptosis. Necrosome signaling, cytokine production, and cell death were evaluated by immunoblotting, ELISA, and cell death assays, respectively. We observed that during TLR4 signaling, necrosome activation is mediated through the adaptor proteins MyD88 and TRIF, and this is inhibited by MK2. In the absence of MK2-mediated necrosome activation, lipopolysaccharide-induced TNF? expression was drastically reduced, but MK2-deficient cells became highly sensitive to necroptosis even at low TNF? levels. In contrast, during tonic TLR4 signaling, WT cells did not undergo necroptosis, even when MK2 was disabled. Of note, necroptosis occurred only in the absence of TTP and was mediated by the expression of TNF? and activation of JUN N-terminal kinase (JNK). These results reveal that TTP plays an important role in inhibiting TNF?/JNK-induced necrosome signaling and resultant cytotoxicity.	[Ariana, Ardeshir; Alturki, Norah A.; Hajjar, Stephanie; Sad, Subash] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Stumpo, Deborah J.] NIEHS, Signal Transduct Lab, Res Triangle Pk, NC 27709 USA; [Tiedje, Christopher; Blackshear, Perry J.] Univ Copenhagen, Dept Cellular & Mol Med, Maersk Tower 7-3,Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Tiedje, Christopher; Gaestel, Matthias] Hannover Med Sch, Inst Cell Biochem, D-30623 Hannover, Germany; [Alnemri, Emad S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Sad, Subash] Univ Ottawa, Ctr Infect Immun & Inflammat, Ottawa, ON K1H 8M5, Canada	University of Ottawa; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Copenhagen; Hannover Medical School; Jefferson University; University of Ottawa	Sad, S (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.; Sad, S (corresponding author), Univ Ottawa, Ctr Infect Immun & Inflammat, Ottawa, ON K1H 8M5, Canada.	subash.sad@uottawa.ca	Gaestel, Matthias/A-6560-2013; Blackshear, Perry/C-6206-2019	Gaestel, Matthias/0000-0002-4944-4652; Tiedje, Christopher/0000-0002-3013-6967; Blackshear, Perry/0000-0002-9561-8529; alturki, Norah/0000-0003-0608-4797; Sad, Subash/0000-0002-2462-7137; Ariana, Ardeshir/0000-0003-2206-9829	Natural Sciences and Engineering Research Council (NSERC) [RGPIN-2017-03836]; Canadian Institutes of Health Research (CIHR) [375862]; Intramural Research Program of the NIEHS, National Institutes of Health	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Natural Sciences and Engineering Research Council (NSERC) Grant RGPIN-2017-03836 and by Canadian Institutes of Health Research (CIHR) Grant 375862 (to S. S.). This work was also supported by the Intramural Research Program of the NIEHS, National Institutes of Health (to P. J. B. and D. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alturki NA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0672-0; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Brodsky IE, 2009, NAT CELL BIOL, V11, P521, DOI 10.1038/ncb0509-521; Brumatti G, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3099; Cao MT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1189-2; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Dondelinger Y, 2017, NAT CELL BIOL, V19, P1237, DOI 10.1038/ncb3608; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Eckmann L, 2001, MICROBES INFECT, V3, P1191, DOI 10.1016/S1286-4579(01)01479-4; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Geng JF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00406-w; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Haneklaus M, 2017, J BIOL CHEM, V292, P6869, DOI 10.1074/jbc.M116.772947; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hughes MA, 2016, MOL CELL, V61, P834, DOI 10.1016/j.molcel.2016.02.023; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Jaco I, 2017, MOL CELL, V66, P698, DOI 10.1016/j.molcel.2017.05.003; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Karunakaran D, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600224; Kearney CJ, 2014, FEBS J, V281, P4921, DOI 10.1111/febs.13034; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lalaoui N, 2016, CANCER CELL, V29, P145, DOI 10.1016/j.ccell.2016.01.006; Legarda D, 2016, CELL REP, V15, P2449, DOI 10.1016/j.celrep.2016.05.032; McComb S, 2012, CELL DEATH DIFFER, V19, P1791, DOI 10.1038/cdd.2012.59; McComb S, 2014, P NATL ACAD SCI USA, V111, pE3206, DOI 10.1073/pnas.1407068111; McComb S, 2014, J IMMUNOL, V192, P5671, DOI 10.4049/jimmunol.1303380; Menon MB, 2017, NAT CELL BIOL, V19, P1248, DOI 10.1038/ncb3614; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Rijal D, 2018, J BIOL CHEM, V293, P11913, DOI 10.1074/jbc.RA118.003614; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Selmi T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1388-5; Shutinoski B, 2016, CELL DEATH DIFFER, V23, P1628, DOI 10.1038/cdd.2016.51; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tiedje C, 2016, NUCLEIC ACIDS RES, V44, P7418, DOI 10.1093/nar/gkw474; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang W, 2018, CANCER CELL, V34, P757, DOI 10.1016/j.ccell.2018.10.006	57	5	5	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4661	4672		10.1074/jbc.RA119.011633	http://dx.doi.org/10.1074/jbc.RA119.011633			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32094226	hybrid, Green Published			2022-12-28	WOS:000524499700024
J	Tempelhagen, L; Ayer, A; Culham, DE; Stocker, R; Wood, JM				Tempelhagen, Laura; Ayer, Anita; Culham, Doreen E.; Stocker, Roland; Wood, Janet M.			Cultivation at high osmotic pressure confers ubiquinone 8?independent protection of respiration on Escherichia coli (vol 295, pg 981, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Stocker, Roland/AAV-4489-2021					Tempelhagen L, 2020, J BIOL CHEM, V295, P981, DOI 10.1074/jbc.RA119.011549	1	2	2	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2542	2542		10.1074/jbc.AAC120.012815	http://dx.doi.org/10.1074/jbc.AAC120.012815			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	32090977	Green Published			2022-12-28	WOS:000517330200033
J	Hori, N; Okada, K; Takakura, Y; Takano, H; Yamaguchi, N; Yamaguchi, N				Hori, Naoto; Okada, Kazuyuki; Takakura, Yuki; Takano, Hiroyuki; Yamaguchi, Naoto; Yamaguchi, Noritaka			Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell proliferation; cell signaling; Hippo pathway; transcription coactivator; Yes-associated protein (YAP); TEA domain?containing transcription factor (TEAD); vestigial-like 3 (VGLL3); transcriptional coactivator with PDZ-binding motif (TAZ); cancer; cell proliferation; cell signaling	YAP; TUMOR; EXPRESSION; INDUCTION; GROWTH; GENE; TAZ	Vestigial-like 3 (VGLL3) is a member of the VGLL family, whose members serve as cofactors for TEA domain?containing transcription factors (TEADs). TEADs promote tissue and tumor development together with the cofactors Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ). Although VGLL3 is involved in tumor cell proliferation, its relationship with TEADs and YAP/TAZ remains largely unknown. To close this research gap, here we established tumor cells stably expressing VGLL3 and found that they exhibit enhanced proliferation. Notably, YAP and TAZ were inactivated in the VGLL3-expressing cells, coinciding with activation of the Hippo pathway, which suppresses YAP/TAZ activities. VGLL3 in combination with TEADs promoted expression of the Hippo pathway components large tumor suppressor kinase (LATS2) and angiomotin-like 2 (AMOTL2). VGLL3 was highly expressed in malignant breast tumor cells and osteosarcoma cells, and VGLL3 knockdown increased nuclear localization of YAP and TAZ. Knockdown of LATS2 or AMOTL2, as well as VGLL3 knockdown, repressed proliferation of breast tumor cells. Together, these results suggest that VGLL3 together with TEADs promotes cell proliferation by activating the Hippo pathway through LATS2 and AMOTL2, leading to YAP/TAZ inactivation.	[Hori, Naoto; Okada, Kazuyuki; Takakura, Yuki; Yamaguchi, Naoto; Yamaguchi, Noritaka] Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chiba, Japan; [Takano, Hiroyuki; Yamaguchi, Noritaka] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cardiovasc Pharmacol, Chiba, Japan	Chiba University; Chiba University	Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Lab Mol Cell Biol, Chiba, Japan.; Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cardiovasc Pharmacol, Chiba, Japan.	yamaguchinoritaka@chiba-u.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [19K22482]; Takeda Science Foundation; Foundation for Promotion of Cancer Research in Japan; Chiba Foundation for Health Promotion and Disease Prevention; Daiichi Sankyo Co., Ltd.	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Foundation for Promotion of Cancer Research in Japan; Chiba Foundation for Health Promotion and Disease Prevention; Daiichi Sankyo Co., Ltd.(Daiichi Sankyo Company Limited)	This work was supported in part by Grant-in-aid for Challenging Research (Exploratory) 19K22482 (to Noritaka Yamaguchi) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; grants from the Takeda Science Foundation (to Noritaka Yamaguchi), the Foundation for Promotion of Cancer Research in Japan (to Noritaka Yamaguchi), and the Chiba Foundation for Health Promotion and Disease Prevention (to Naoto Yamaguchi); and a scholarship donation from the Daiichi Sankyo Co., Ltd. (to Naoto Yamaguchi).	Antonescu CR, 2011, GENE CHROMOSOME CANC, V50, P757, DOI 10.1002/gcc.20897; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; Calses PC, 2019, TRENDS CANCER, V5, P297, DOI 10.1016/j.trecan.2019.04.001; Cody NAL, 2007, ONCOGENE, V26, P618, DOI 10.1038/sj.onc.1209821; Cody NAL, 2009, MOL CARCINOGEN, V48, P1077, DOI 10.1002/mc.20535; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Figeac N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.225946; Gambaro K, 2013, MOL ONCOL, V7, P513, DOI 10.1016/j.molonc.2012.12.006; Hallor KH, 2009, J PATHOL, V217, P716, DOI 10.1002/path.2513; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Helias-Rodzewicz Z, 2010, GENE CHROMOSOME CANC, V49, P1161, DOI 10.1002/gcc.20825; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Li CZ, 2013, BIOCHEM BIOPH RES CO, V438, P607, DOI 10.1016/j.bbrc.2013.08.008; Lin KC, 2017, TRENDS BIOCHEM SCI, V42, P862, DOI 10.1016/j.tibs.2017.09.003; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Pobbati AV, 2015, STRUCTURE, V23, P2076, DOI 10.1016/j.str.2015.09.009; Simon E, 2016, DEV GENES EVOL, V226, P297, DOI 10.1007/s00427-016-0546-3; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Yamaguchi N, 2017, J BIOL CHEM, V292, P8136, DOI 10.1074/jbc.M116.763276; Yuki R, 2019, ONCOGENE, V38, P637, DOI 10.1038/s41388-018-0481-z; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang LH, 2019, WORLD J CLIN CASES, V7, P1954, DOI 10.12998/wjcc.v7.i15.1954; Zhang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05856-2; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zheng YG, 2019, DEV CELL, V50, P264, DOI 10.1016/j.devcel.2019.06.003	28	18	18	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8798	8807		10.1074/jbc.RA120.012781	http://dx.doi.org/10.1074/jbc.RA120.012781			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32385107	hybrid, Green Published			2022-12-28	WOS:000546296800015
J	Koiwai, K; Inaba, K; Morohashi, K; Enya, S; Arai, R; Kojima, H; Okabe, T; Fujikawa, Y; Inoue, H; Yoshino, R; Hirokawa, T; Kato, K; Fukuzawa, K; Shimada-Niwa, Y; Nakamura, A; Yumoto, F; Senda, T; Niwa, R				Koiwai, Kotaro; Inaba, Kazue; Morohashi, Kana; Enya, Sora; Arai, Reina; Kojima, Hirotatsu; Okabe, Takayoshi; Fujikawa, Yuuta; Inoue, Hideshi; Yoshino, Ryunosuke; Hirokawa, Takatsugu; Kato, Koichiro; Fukuzawa, Kaori; Shimada-Niwa, Yuko; Nakamura, Akira; Yumoto, Fumiaki; Senda, Toshiya; Niwa, Ryusuke			An integrated approach to unravel a crucial structural property required for the function of the insect steroidogenic Halloween protein Noppera-bo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; molecular dynamics; Drosophila; steroid hormone; estrogen; lipid metabolism; 17?-estradiol; ecdysone; glutathione S-transferase; GSTE14; insecticide; ecdysteroid	GLUTATHIONE-S-TRANSFERASE; ECDYSONE BIOSYNTHETIC-PATHWAY; ECDYSTEROID BIOSYNTHESIS; DROSOPHILA-MELANOGASTER; CYTOCHROME-P450 ENZYME; ESTROGEN-RECEPTOR; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; P450 ENZYMES; BLACK-BOX	Ecdysteroids are the principal steroid hormones essential for insect development and physiology. In the last 18 years, several enzymes responsible for ecdysteroid biosynthesis encoded by Halloween genes were identified and genetically and biochemically characterized. However, the tertiary structures of these proteins have not yet been characterized. Here, we report the results of an integrated series of in silico, in vitro, and in vivo analyses of the Halloween GST protein Noppera-bo (Nobo). We determined crystal structures of Drosophila melanogaster Nobo (DmNobo) complexed with GSH and 17?-estradiol, a DmNobo inhibitor. 17?-Estradiol almost fully occupied the putative ligand-binding pocket and a prominent hydrogen bond formed between 17?-estradiol and Asp-113 of DmNobo. We found that Asp-113 is essential for 17?-estradiol?mediated inhibition of DmNobo enzymatic activity, as 17?-estradiol did not inhibit and physically interacted less with the D113A DmNobo variant. Asp-113 is highly conserved among Nobo proteins, but not among other GSTs, implying that this residue is important for endogenous Nobo function. Indeed, a homozygous nobo allele with the D113A substitution exhibited embryonic lethality and an undifferentiated cuticle structure, a phenocopy of complete loss-of-function nobo homozygotes. These results suggest that the nobo family of GST proteins has acquired a unique amino acid residue that appears to be essential for binding an endogenous sterol substrate to regulate ecdysteroid biosynthesis. To the best of our knowledge, ours is the first study describing the structural characteristics of insect steroidogenic Halloween proteins. Our findings provide insights relevant for applied entomology to develop insecticides that specifically inhibit ecdysteroid biosynthesis.	[Koiwai, Kotaro; Inaba, Kazue; Yumoto, Fumiaki; Senda, Toshiya; Niwa, Ryusuke] High Energy Accelerator Res Org, Inst Mat Struct Sci, Struct Biol Res Ctr, Photon Factory, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan; [Inaba, Kazue; Morohashi, Kana; Enya, Sora; Arai, Reina] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan; [Kojima, Hirotatsu; Okabe, Takayoshi] Univ Tokyo, Drug Discovery Initiat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan; [Fujikawa, Yuuta; Inoue, Hideshi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan; [Yoshino, Ryunosuke] Univ Tsukuba, Grad Sch Comprehens Human Sci Majors Med Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Hirokawa, Takatsugu] Univ Tsukuba, Transborder Med Res Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Hirokawa, Takatsugu] Univ Tsukuba, Div Biomed Sci, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Hirokawa, Takatsugu] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Koto Ku, 2-4-7 Aomi, Tokyo 1350064, Japan; [Kato, Koichiro] Mizuho Informat Res Inst Inc, Chiyoda Ku, 2-3 Kanda Nishiki Cho, Tokyo 1018443, Japan; [Fukuzawa, Kaori] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan; [Shimada-Niwa, Yuko; Niwa, Ryusuke] Univ Tsukuba, Tsukuba Adv Res Alliance TARA, Life Sci Ctr Survival Dynam, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan; [Nakamura, Akira] Kumamoto Univ, Inst Mol Embryol & Genet, Chuo Ku, 2-2-1 Honjo, Kumamoto 8600811, Japan; [Senda, Toshiya] Sokendai Univ, Sch High Energy Accelerator Sci, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan; [Senda, Toshiya] Univ Tsukuba, Fac Pure & Appl Sci, 1-1-1 Tennodai, Ibaraki 3058571, Japan; [Enya, Sora] Tokyo Med & Dent Univ, Grad Sch Med & Dent, Dept Environm Parasitol, Sci,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan	High Energy Accelerator Research Organization (KEK); University of Tsukuba; University of Tokyo; Tokyo University of Pharmacy & Life Sciences; University of Tsukuba; University of Tsukuba; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); Mizuho Research & Technologies, Ltd.; Hoshi University; University of Tsukuba; Kumamoto University; University of Tsukuba; Tokyo Medical & Dental University (TMDU)	Niwa, R (corresponding author), High Energy Accelerator Res Org, Inst Mat Struct Sci, Struct Biol Res Ctr, Photon Factory, 1-1 Oho, Tsukuba, Ibaraki 3050801, Japan.; Niwa, R (corresponding author), Univ Tsukuba, Tsukuba Adv Res Alliance TARA, Life Sci Ctr Survival Dynam, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	ryusuke-niwa@tara.tsukuba.ac.jp	Nakamura, Akira/V-6869-2019	Nakamura, Akira/0000-0001-6506-9146; Koiwai, Kotaro/0000-0002-9684-3699; Yoshino, Ryunosuke/0000-0002-5123-1349; Niwa, Ryusuke/0000-0002-1716-455X; Kato, Koichiro/0000-0003-4392-8741; Kojima, Hirotatsu/0000-0002-5480-3189; Fujikawa, Yuuta/0000-0002-5872-8462; Inoue, Hideshi/0000-0001-9806-9660; Senda, Toshiya/0000-0002-5153-928X	KAKENHI [15K14719, 18K19163]; Basis for Supporting Innovative Drug Discovery and Life Science Research from Japan Agency for Medical Research and Development (AMED) [18am0101113j0002]; Private University Research Branding Project; Japan Agency for Medical Research and Development	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Basis for Supporting Innovative Drug Discovery and Life Science Research from Japan Agency for Medical Research and Development (AMED); Private University Research Branding Project; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by KAKENHI Grants 15K14719 and 18K19163 (to R. N.) and by the Basis for Supporting Innovative Drug Discovery and Life Science Research from Japan Agency for Medical Research and Development (AMED) Grant Number 18am0101113j0002 (to R. N.). In addition, this work was supported by the Private University Research Branding Project (to Y. F.), and the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from Japan Agency for Medical Research and Development. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Avvakumov GV, 2002, J BIOL CHEM, V277, P45219, DOI 10.1074/jbc.M207762200; Ayres C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029237; Bier E, 2018, GENETICS, V208, P1, DOI 10.1534/genetics.117.1113; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chanut-Delalande H, 2014, NAT CELL BIOL, V16, P1035, DOI 10.1038/ncb3052; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enya S, 2017, GENETICS, V207, P1519, DOI 10.1534/genetics.117.300391; Enya S, 2015, INSECT BIOCHEM MOLEC, V61, P1, DOI 10.1016/j.ibmb.2015.04.001; Enya S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06586; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fedorov DG, 2009, FRAGMENT MOLECULAR ORBITAL METHOD: PRACTICAL APPLICATIONS TO LARGE MOLECULAR SYSTEMS, P1, DOI 10.1201/9781420078497; Fedorov DG, 2012, PHYS CHEM CHEM PHYS, V14, P7562, DOI 10.1039/c2cp23784a; Fedorov DG, 2007, J COMPUT CHEM, V28, P222, DOI 10.1002/jcc.20496; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Fujikawa Y, 2015, CHEM COMMUN, V51, P11459, DOI 10.1039/c5cc02067k; Fukuzawa K, 2006, J PHYS CHEM B, V110, P16102, DOI 10.1021/jp060770i; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Gokcezade J, 2014, G3-GENES GENOM GENET, V4, P2279, DOI 10.1534/g3.114.014126; Gonze X, 2009, COMPUT PHYS COMMUN, V180, P2582, DOI 10.1016/j.cpc.2009.07.007; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Hiraki M, 2006, ACTA CRYSTALLOGR D, V62, P1058, DOI 10.1107/S0907444906023821; Imura E, 2017, JOVE-J VIS EXP, DOI 10.3791/55519; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kina H, 2019, DEV GROWTH DIFFER, V61, P265, DOI 10.1111/dgd.12607; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel Evgeny, 2012, J Mol Biochem, V1, P76; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Low WY, 2010, J MOL BIOL, V399, P358, DOI 10.1016/j.jmb.2010.04.020; Mashiyama ST, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001843; Mochizuki Y, 2004, THEOR CHEM ACC, V112, P442, DOI 10.1007/s00214-004-0602-3; Mochizuki Y, 2004, CHEM PHYS LETT, V396, P473, DOI 10.1016/j.cplett.2004.08.082; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Nakano T., 2006, MODERN METHODS THEOR, P39; Namiki T, 2005, BIOCHEM BIOPH RES CO, V337, P367, DOI 10.1016/j.bbrc.2005.09.043; Niwa R, 2004, J BIOL CHEM, V279, P35942, DOI 10.1074/jbc.M404514200; Niwa R, 2014, BIOSCI BIOTECH BIOCH, V78, P1283, DOI 10.1080/09168451.2014.942250; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Ou QX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001160; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pedersen LC, 2002, J BIOL CHEM, V277, P17928, DOI 10.1074/jbc.M111651200; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608; Pinto PIS, 2014, MAR DRUGS, V12, P4474, DOI 10.3390/md12084474; Riveron JM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r27; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Saito J, 2016, J INSECT PHYSIOL, V93-94, P94, DOI 10.1016/j.jinsphys.2016.09.012; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Scian M, 2015, ACTA CRYSTALLOGR D, V71, P2089, DOI 10.1107/S1399004715013929; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Shimada-Niwa Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6778; SIMONS PC, 1980, J BIOL CHEM, V255, P4740; Tanaka S, 2014, PHYS CHEM CHEM PHYS, V16, P10310, DOI 10.1039/c4cp00316k; Tsukamoto T., 2015, J COMP CHEM, V14, P1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wieschaus E., 1986, P199; WILLIAMS CM, 1967, SCI AM, V217, P13, DOI 10.1038/scientificamerican0767-13; Wu BJ, 2012, TRENDS PHARMACOL SCI, V33, P656, DOI 10.1016/j.tips.2012.09.007; Yamada Y., 2013, Journal of Physics: Conference Series, V425, DOI 10.1088/1742-6596/425/1/012017; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; Yoshiyama-Yanagawa T, 2011, J BIOL CHEM, V286, P25756, DOI 10.1074/jbc.M111.244384; Yu QY, 2008, INSECT BIOCHEM MOLEC, V38, P1158, DOI 10.1016/j.ibmb.2008.08.002; Zhan S, 2013, NUCLEIC ACIDS RES, V41, pD758, DOI 10.1093/nar/gks1057	76	8	9	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7154	7167		10.1074/jbc.RA119.011463	http://dx.doi.org/10.1074/jbc.RA119.011463			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32241910	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000536212600029
J	Jaremko, W; Huang, Z; Karl, N; Pierce, VD; Lynch, J; Niu, L				Jaremko, William; Huang, Zhen; Karl, Nicholas; Pierce, Vincen D.; Lynch, Janet; Niu, Li			A kainate receptor?selective RNA aptamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aptamer; RNA; RNA modification; drug development; ionotropic glutamate receptor; inhibitor; neurological disease; 2?-fluoro?modified RNAs; AMPA receptors; kainate receptors; selective antagonist; SELEX	RECEPTOR SUBUNIT; AMPA RECEPTOR; SELECTIVE-INHIBITION; CRYSTAL-STRUCTURES; ION CHANNELS; ANTAGONISTS; EXCITABILITY; ACTIVATION; EXPRESSION; BINDING	Kainate and ?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors are two major, closely related receptor subtypes in the glutamate ion channel family. Excessive activities of these receptors have been implicated in a number of central nervous system diseases. Designing potent and selective antagonists of these receptors, especially of kainate receptors, is useful for developing potential treatment strategies for these neurological diseases. Here, we report on two RNA aptamers designed to individually inhibit kainate and AMPA receptors. To improve the biostability of these aptamers, we also chemically modified these aptamers by substituting their 2?-OH group with 2?-fluorine. These 2?-fluoro aptamers, FB9s-b and FB9s-r, were markedly resistant to RNase-catalyzed degradation, with a half-life of ?5 days in rat cerebrospinal fluid or serum-containing medium. Furthermore, FB9s-r blocked AMPA receptor activity. Aptamer FB9s-b selectively inhibited GluK1 and GluK2 kainate receptor subunits, and also GluK1/GluK5 and GluK2/GluK5 heteromeric kainate receptors with equal potency. This inhibitory profile makes FB9s-b a powerful template for developing tool molecules and drug candidates for treatment of neurological diseases involving excessive activities of the GluK1 and GluK2 subunits.	[Jaremko, William; Huang, Zhen; Karl, Nicholas; Pierce, Vincen D.; Lynch, Janet; Niu, Li] SUNY Albany, Dept Chem, LSRB 1060, Albany, NY 12222 USA; [Jaremko, William; Huang, Zhen; Karl, Nicholas; Pierce, Vincen D.; Lynch, Janet; Niu, Li] SUNY Albany, Ctr Neurosci Res, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Niu, L (corresponding author), SUNY Albany, Dept Chem, LSRB 1060, Albany, NY 12222 USA.	lniu@albany.edu			National Institutes of Health/NINDS Grant [R01 NS060812, R21 NS106392]	National Institutes of Health/NINDS Grant	This work was supported by National Institutes of Health/NINDS Grant R01 NS060812 and R21 NS106392 (to L. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alt A, 2004, NEUROPHARMACOLOGY, V46, P793, DOI 10.1016/j.neuropharm.2003.11.026; AURUP H, 1992, BIOCHEMISTRY-US, V31, P9636, DOI 10.1021/bi00155a016; BAHN S, 1994, J NEUROSCI, V14, P5525; Bell C, 1999, IN VITRO CELL DEV-AN, V35, P533; Ben-Ari Y., 2012, JASPERS BASIC MECH E; Benussi A, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00304; Bhangoo SK, 2013, MOL PHARMACOL, V83, P307, DOI 10.1124/mol.112.081398; Bonnet CS, 2015, ANN RHEUM DIS, V74, P242, DOI 10.1136/annrheumdis-2013-203670; Borbely S, 2015, NEUROTOX RES, V27, P441, DOI 10.1007/s12640-014-9515-7; Braga MFM, 2009, J PHARMACOL EXP THER, V330, P558, DOI 10.1124/jpet.109.153908; Breslow R, 1996, P NATL ACAD SCI USA, V93, P10018, DOI 10.1073/pnas.93.19.10018; Carta M, 2014, EUR J NEUROSCI, V39, P1835, DOI 10.1111/ejn.12590; CAZENAVE C, 1994, P NATL ACAD SCI USA, V91, P6972, DOI 10.1073/pnas.91.15.6972; Contractor A, 2011, TRENDS NEUROSCI, V34, P154, DOI 10.1016/j.tins.2010.12.002; CUMMINS LL, 1995, NUCLEIC ACIDS RES, V23, P2019, DOI 10.1093/nar/23.11.2019; Das A, 2012, NEUROSCIENCE, V220, P237, DOI 10.1016/j.neuroscience.2012.06.002; Dingledine R, 1999, PHARMACOL REV, V51, P7; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Evans AJ, 2019, NEUROCHEM RES, V44, P572, DOI 10.1007/s11064-017-2450-2; Fattal E., 2006, Arch Soc Esp Oftalmol, V81, P03; GILL R, 1994, CEREBROVAS BRAIN MET, V6, P225; Gratacos M, 2009, AM J MED GENET B, V150B, P808, DOI 10.1002/ajmg.b.30902; Greenwood TA, 2016, SCHIZOPHR RES, V170, P30, DOI 10.1016/j.schres.2015.11.008; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Huang Z, 2007, BIOCHEMISTRY-US, V46, P12648, DOI 10.1021/bi701036p; Huang Z, 2019, FUTURE MED CHEM, V11, P551, DOI 10.4155/fmc-2018-0364; Huang Z, 2013, ANAL BIOCHEM, V435, P35, DOI 10.1016/j.ab.2012.12.011; Huang Z, 2010, BIOCHEMISTRY-US, V49, P5790, DOI 10.1021/bi100690k; Jane DE, 2009, NEUROPHARMACOLOGY, V56, P90, DOI 10.1016/j.neuropharm.2008.08.023; Jaremko WJ, 2017, J BIOL CHEM, V292, P7338, DOI 10.1074/jbc.M116.774752; Kaur H, 2018, THERANOSTICS, V8, P4016, DOI 10.7150/thno.25958; Lauri SE, 2006, NEURON, V50, P415, DOI 10.1016/j.neuron.2006.03.020; Lauri SE, 2005, J NEUROSCI, V25, P4473, DOI 10.1523/JNEUROSCI.4050-04.2005; Lemoine D, 2012, CHEM REV, V112, P6285, DOI 10.1021/cr3000829; Lerma J, 2013, NEURON, V80, P292, DOI 10.1016/j.neuron.2013.09.045; Li G, 2004, J BIOL CHEM, V279, P3990, DOI 10.1074/jbc.M310410200; Low SJ, 2004, INT J CLIN PHARM TH, V42, P1; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Melyan Z, 2004, J NEUROSCI, V24, P4530, DOI 10.1523/JNEUROSCI.5356-03.2004; Mollerud S, 2017, NEUROPHARMACOLOGY, V112, P16, DOI 10.1016/j.neuropharm.2016.05.014; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Nussinov R, 2012, CURR PHARM DESIGN, V18, P1311; O'Neill MJ, 2000, NEUROPHARMACOLOGY, V39, P1575, DOI 10.1016/S0028-3908(99)00250-6; Pallesen J, 2019, ACS CHEM NEUROSCI, V10, P1841, DOI 10.1021/acschemneuro.8b00726; Park JS, 2011, J BIOL CHEM, V286, P15608, DOI 10.1074/jbc.M111.229559; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; Perrais D, 2009, NEUROPHARMACOLOGY, V56, P131, DOI 10.1016/j.neuropharm.2008.08.002; PIEKEN WA, 1991, SCIENCE, V253, P314, DOI 10.1126/science.1857967; Porter RHP, 1997, BRAIN RES, V751, P217, DOI 10.1016/S0006-8993(96)01404-7; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; SCHIEVEN GL, 1982, BIOCHEMISTRY-US, V21, P5148, DOI 10.1021/bi00264a007; Schiffer HH, 1997, NEURON, V19, P1141, DOI 10.1016/S0896-6273(00)80404-3; Smolders I, 2002, NAT NEUROSCI, V5, P796, DOI 10.1038/nn880; Sutula TP, 2007, PROG BRAIN RES, V163, P541, DOI 10.1016/S0079-6123(07)63029-5; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tucker CE, 1999, J CHROMATOGR B, V732, P203, DOI 10.1016/S0378-4347(99)00285-6; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vesikansa A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00310; Waterhouse Rikki N, 2003, Mol Imaging Biol, V5, P376, DOI 10.1016/j.mibio.2003.09.014; Weiser T, 2005, CNS NEUROL DISORD-DR, V4, P153, DOI 10.2174/1568007053544129; WERNER P, 1991, NATURE, V351, P742, DOI 10.1038/351742a0; Zhang Y, 2019, MOLECULES, V24, DOI 10.3390/molecules24050941; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199; Zhuo M, 2017, NEUROPHARMACOLOGY, V112, P228, DOI 10.1016/j.neuropharm.2016.08.014; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	68	0	1	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6280	6288		10.1074/jbc.RA119.011649	http://dx.doi.org/10.1074/jbc.RA119.011649			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32161119	Green Published, hybrid			2022-12-28	WOS:000537685000004
J	Reardon, PN; Jara, KA; Rolland, AD; Smith, DA; Hoang, HTM; Prell, JS; Barbar, EJ				Reardon, Patrick N.; Jara, Kayla A.; Rolland, Amber D.; Smith, Delaney A.; Hoang, Hanh T. M.; Prell, James S.; Barbar, Elisar J.			The dynein light chain 8 (LC8) binds predominantly ?in-register? to a multivalent intrinsically disordered partner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intrinsically disordered protein; nuclear magnetic resonance (NMR); analytical ultracentrifugation; protein dynamic; protein assembly; LC8; multivalency; native mass spectrometry	INTERMEDIATE CHAIN; STRUCTURAL BASIS; RECOGNITION; DYNLL1; MOTIF; DIMERIZATION; SYSTEM; ASCIZ; C-13	Dynein light chain 8 (LC8) interacts with intrinsically disordered proteins (IDPs) and influences a wide range of biological processes. It is becoming apparent that among the numerous IDPs that interact with LC8, many contain multiple LC8-binding sites. Although it is established that LC8 forms parallel IDP duplexes with some partners, such as nucleoporin Nup159 and dynein intermediate chain, the molecular details of these interactions and LC8's interactions with other diverse partners remain largely uncharacterized. LC8 dimers could bind in either a paired ?in-register? or a heterogeneous off-register manner to any of the available sites on a multivalent partner. Here, using NMR chemical shift perturbation, analytical ultracentrifugation, and native electrospray ionization MS, we show that LC8 forms a predominantly in-register complex when bound to an IDP domain of the multivalent regulatory protein ASCIZ. Using saturation transfer difference NMR, we demonstrate that at substoichiometric LC8 concentrations, the IDP domain preferentially binds to one of the three LC8 recognition motifs. Further, the differential dynamic behavior for the three sites and the size of the fully bound complex confirmed an in-register complex. Dynamics measurements also revealed that coupling between sites depends on the linker length separating these sites. These results identify linker length and motif specificity as drivers of in-register binding in the multivalent LC8?IDP complex assembly and the degree of compositional and conformational heterogeneity as a promising emerging mechanism for tuning of binding and regulation.	[Reardon, Patrick N.] Oregon State Univ, NMR Facil, Corvallis, OR 97331 USA; [Jara, Kayla A.; Smith, Delaney A.; Hoang, Hanh T. M.; Barbar, Elisar J.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Rolland, Amber D.; Prell, James S.] Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA; [Rolland, Amber D.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Prell, James S.] Univ Oregon, Mat Sci Inst, Eugene, OR 97403 USA	Oregon State University; Oregon State University; University of Oregon; University of Oregon; University of Oregon	Barbar, EJ (corresponding author), Dept Biochem & Biophys, 2011 Agr & Life Sci Bldg,2900 SW Campus Way, Corvallis, OR 97331 USA.	Elisar.Barbar@oregonstate.edu	Smith, Delaney/AAD-3412-2021	Rolland, Amber/0000-0002-7905-8250; Jara, Kayla/0000-0003-0406-2957; Barbar, Elisar/0000-0003-4892-5259; Reardon, Patrick/0000-0002-6858-0086	National Science Foundation [1617019]; National Institutes of Health [T32 GM007759]; National Institutes of Health, HEI [1S10OD018518]; M. J. Murdock Charitable Trust [2014162]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, HEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust	This work was supported by National Science Foundation Award 1617019. This work was also supported by a National Institutes of Health Grant T32 GM007759 (to A. D. R.). The Oregon State University NMR Facility is supported in part by the National Institutes of Health, HEI Grant 1S10OD018518 (to E. J. B.) and by M. J. Murdock Charitable Trust Grant 2014162 (to E. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Benison G, 2009, METHOD ENZYMOL, V455, P237, DOI 10.1016/S0076-6879(08)04209-2; Bodor A, 2014, BIOCHEMISTRY-US, V53, P7107, DOI 10.1021/bi500574z; Clark S, 2018, ELIFE, V7, DOI 10.7554/eLife.36258; Clark S, 2016, BIOCHEMISTRY-US, V55, P199, DOI 10.1021/acs.biochem.5b01099; Clark SA, 2015, FEBS LETT, V589, P2543, DOI 10.1016/j.febslet.2015.07.032; Coggins BE, 2012, J AM CHEM SOC, V134, P18619, DOI 10.1021/ja307445y; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunsch AK, 2012, J CELL BIOL, V198, P1039, DOI 10.1083/jcb.201202112; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Gaik M, 2015, J CELL BIOL, V208, P283, DOI 10.1083/jcb.201411003; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Jespersen N., 2020, TRENDS BIOCH SCI; Jespersen N, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900366; Jespersen NE, 2019, J MOL BIOL, V431, P4959, DOI 10.1016/j.jmb.2019.10.011; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jurado S, 2012, J EXP MED, V209, P1629, DOI 10.1084/jem.20120785; Jurado S, 2012, J BIOL CHEM, V287, P3156, DOI 10.1074/jbc.M111.306019; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Nyarko A, 2013, J BIOL CHEM, V288, P2614, DOI 10.1074/jbc.M112.432831; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rapali P, 2011, BIOCHEM BIOPH RES CO, V414, P493, DOI 10.1016/j.bbrc.2011.09.093; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; Slevin LK, 2014, J BIOL CHEM, V289, P20727, DOI 10.1074/jbc.M114.576041; Sorensen CS, 2019, P NATL ACAD SCI USA, V116, P23124, DOI 10.1073/pnas.1904813116; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Toropova K, 2019, NAT STRUCT MOL BIOL, V26, P823, DOI 10.1038/s41594-019-0286-y; Venters RA, 1996, J MOL BIOL, V264, P1101, DOI 10.1006/jmbi.1996.0699; Wheeler LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164740; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Zaytseva O, 2014, GENETICS, V196, P443, DOI 10.1534/genetics.113.159541	41	8	8	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4912	4922		10.1074/jbc.RA119.011653	http://dx.doi.org/10.1074/jbc.RA119.011653			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32139510	hybrid, Green Published			2022-12-28	WOS:000526887000015
J	Bao, Y; Zheng, J; Han, CF; Jin, J; Han, HX; Liu, YP; Lau, YL; Tu, WW; Cao, XT				Bao, Yan; Zheng, Jian; Han, Chaofeng; Jin, Jing; Han, Huanxing; Liu, Yinping; Lau, Yu-Lung; Tu, Wenwei; Cao, Xuetao			Tyrosine kinase Btk is required for NK cell activation (vol 290, pg 23769, 2012)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Bao Y, 2012, J BIOL CHEM, V287, P23769, DOI 10.1074/jbc.M112.372425	1	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3389	3389		10.1074/jbc.AAC120.012994	http://dx.doi.org/10.1074/jbc.AAC120.012994			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32144152	Green Published, hybrid			2022-12-28	WOS:000519597300043
J	Ruppert, PMM; Kersten, S				Ruppert, Philip M. M.; Kersten, Sander			A lipase fusion feasts on fat	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The enzyme lipoprotein lipase (LPL) is responsible for breaking down triglycerides in the blood. Mutations in LPL cause a rare but debilitating disorder characterized by excessive plasma triglyceride levels for which treatment options are limited. Nimonkar et al. now present a fusion protein between LPL and its physiological transporter GBIHBP1 that is highly active and largely resistant to physiological inhibitors of LPL. Injecting this fusion protein effectively lowers plasma triglycerides in mice and represents a promising new approach for lowering triglycerides in patients with familial chylomicronemia syndrome.	[Ruppert, Philip M. M.; Kersten, Sander] Wageningen Univ, Nutr Metab & Genom Grp, Div Human Nutr & Hlth, Stippeneng 4, NL-6708 WE Wageningen, Netherlands	Wageningen University & Research	Kersten, S (corresponding author), Wageningen Univ, Nutr Metab & Genom Grp, Div Human Nutr & Hlth, Stippeneng 4, NL-6708 WE Wageningen, Netherlands.	sander.kersten@wur.nl	Ruppert, Philip/AAO-5002-2021; Kersten, Sander/A-1116-2011	Ruppert, Philip/0000-0002-4028-8200; Kersten, Sander/0000-0003-4488-7734				Arora R, 2019, P NATL ACAD SCI USA, V116, P10360, DOI 10.1073/pnas.1820171116; Beigneux AP, 2019, P NATL ACAD SCI USA, V116, P6319, DOI 10.1073/pnas.1900983116; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Morrison C, 2015, NAT BIOTECHNOL, V33, P217, DOI 10.1038/nbt0315-217; Nimonkar AV, 2020, J BIOL CHEM, V295, P2900, DOI 10.1074/jbc.RA119.011079	6	3	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					2913	2914		10.1074/jbc.H120.012744	http://dx.doi.org/10.1074/jbc.H120.012744			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32144145	Green Published, hybrid			2022-12-28	WOS:000519597300003
J	Levy, DR; Udgata, A; Tourlomousis, P; Symmons, MF; Hopkins, LJ; Bryant, CE; Gay, NJ				Levy, Daniel R.; Udgata, Atul; Tourlomousis, Panagiotis; Symmons, Martyn F.; Hopkins, Lee J.; Bryant, Clare E.; Gay, Nicholas J.			The Parkinson's disease-associated kinase LRRK2 regulates genes required for cell adhesion, polarization, and chemotaxis in activated murine macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcriptomics; Parkinson's disease; macrophage; protein kinase; guanine nucleotide exchange factor (GEF)	NICOTINIC-ACID; EXPRESSION; CHEMOKINES; MUTATION; GPR109A; SYSTEM; TARGET; LIVER; LPS; MYC	Leucine-rich repeat kinase 2 (LRRK2) encodes a complex protein that includes kinase and GTPase domains. Genome-wide association studies have identified dominantLRRK2alleles that predispose their carriers to late-onset idiotypic Parkinson's disease (PD) and also to autoimmune disorders such as Crohn's disease. Considerable evidence indicates that PD initiation and progression involve activation of innate immune functions in microglia, which are brain-resident macrophages. Here we asked whether LRRK2 modifies inflammatory signaling and how this modification might contribute to PD and Crohn's disease. We used RNA-Seq-based high-resolution transcriptomics to compare gene expression in activated primary macrophages derived from WT andLrrk2knockout mice. Remarkably, expression of a single gene, Rap guanine nucleotide exchange factor 3 (Rapgef3), was strongly up-regulated in the absence of LRRK2 and down-regulated in its presence. We observed similar regulation ofRapgef3expression in cells treated with a highly specific inhibitor of LRRK2 protein kinase activity.Rapgef3encodes an exchange protein, activated by cAMP 1 (EPAC-1), a guanine nucleotide exchange factor that activates the small GTPase Rap-1. Rap-1 mediates cell adhesion, polarization, and directional motility, and our results indicate that LRRK2 modulates chemotaxis of microglia and macrophages. Dominant PD-associatedLRRK2alleles may suppress EPAC-1 activity, further restricting motility and preventing efficient migration of microglia to sites of neuronal damage. Functional analysisin vivoin a subclinical infection model also indicated that Lrrk2 subtly modifies the inflammatory response. These results indicate that LRRK2 modulates the expression of genes involved in murine immune cell chemotaxis.	[Levy, Daniel R.; Udgata, Atul; Symmons, Martyn F.; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England; [Tourlomousis, Panagiotis; Hopkins, Lee J.; Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England	University of Cambridge; University of Cambridge	Gay, NJ (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	njg11@cam.ac.uk		Levy, Daniel/0000-0002-4660-8615; Bryant, Clare Elizabeth/0000-0002-2924-0038	Wellcome Trust [WT100321/z/12/Z, 108045/Z/15/Z]	Wellcome Trust(Wellcome Trust)	This work was supported by Wellcome Trust Investigator awards WT100321/z/12/Z and 108045/Z/15/Z (to C. E. B. and N. J. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Akagi K, 2008, GENOME RES, V18, P869, DOI 10.1101/gr.075770.107; Akram IG, 2016, TUMOR BIOL, V37, P2461, DOI 10.1007/s13277-015-4089-4; Banerjee U, 2015, GENE, V570, P157, DOI 10.1016/j.gene.2015.06.063; Cascon A, 2012, CANCER RES, V72, P3119, DOI 10.1158/0008-5472.CAN-11-3891; Castano A, 2002, J NEUROCHEM, V81, P150, DOI 10.1046/j.1471-4159.2002.00799.x; Choi I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9255; Devine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022489; Di Fonzo A, 2005, LANCET, V365, P412; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Dzamko N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039132; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gingras S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000808; Greggio E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-94; Iravani MM, 2005, EUR J NEUROSCI, V22, P317, DOI 10.1111/j.1460-9568.2005.04220.x; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; Jang H, 2009, BBA-MOL BASIS DIS, V1792, P714, DOI 10.1016/j.bbadis.2008.08.001; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Linde L, 2007, EUR J HUM GENET, V15, P1156, DOI 10.1038/sj.ejhg.5201889; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Lorenowicz MJ, 2006, J LEUKOCYTE BIOL, V80, P1542, DOI 10.1189/jlb.0506357; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luerman GC, 2014, J NEUROCHEM, V128, P561, DOI 10.1111/jnc.12483; Lukasova M, 2011, TRENDS PHARMACOL SCI, V32, P700, DOI 10.1016/j.tips.2011.08.002; Ma B, 2016, HUM MOL GENET, V25, P3515, DOI 10.1093/hmg/ddw194; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Migeotte I, 2002, EUR J IMMUNOL, V32, P494, DOI 10.1002/1521-4141(200202)32:2<494::AID-IMMU494>3.0.CO;2-Y; Mills RD, 2014, HUM MUTAT, V35, P395, DOI 10.1002/humu.22515; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Niehaus I, 2003, OCCUP ENVIRON MED, V60, P378, DOI 10.1136/oem.60.5.378; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Reith AD, 2012, BIOORG MED CHEM LETT, V22, P5625, DOI 10.1016/j.bmcl.2012.06.104; Robichaux WG, 2018, PHYSIOL REV, V98, P919, DOI 10.1152/physrev.00025.2017; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roy A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22067; Russo I, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0449-7; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Wakade C, 2014, J NEUROL SCI, V347, P34, DOI 10.1016/j.jns.2014.10.024; Wakade C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109818; Yi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030404; Yoshimura T, 2011, EXP CELL RES, V317, P674, DOI 10.1016/j.yexcr.2010.10.023; Zandi-Nejad K, 2013, FASEB J, V27, P4366, DOI 10.1096/fj.12-223933; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	51	6	6	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10857	10867		10.1074/jbc.RA119.011842	http://dx.doi.org/10.1074/jbc.RA119.011842			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32111741	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000560405600027
J	Lautenschlager, J; Wagner-Valladolid, S; Stephens, AD; Fernandez-Villegas, A; Hockings, C; Mishra, A; Manton, JD; Fantham, MJ; Lu, M; Rees, EJ; Kaminski, CF; Schierle, GSK				Lautenschlager, Janin; Wagner-Valladolid, Sara; Stephens, Amberley D.; Fernandez-Villegas, Ana; Hockings, Colin; Mishra, Ajay; Manton, James D.; Fantham, Marcus J.; Lu, Meng; Rees, Eric J.; Kaminski, Clemens F.; Schierle, Gabriele S. Kaminski			Intramitochondrial proteostasis is directly coupled to ?-synuclein and amyloid?1-42 pathologies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						?-synuclein; amyloid-? (A?; ); mitochondria; neurodegeneration; HtrA2; Omi; HtrA serine peptidase 2; Parkinson disease; protein aggregation; protein homeostasis; Lon protease; Lon peptidase 1 mitochondrial; ?-synuclein (a-synuclein); amyloid-? (AB); mitochondria; neurodegenerative disease; neurodegeneration; HtrA serine peptidase 2; HtrA2; Omi; protein homeostasis	CALCIUM-DEPENDENT PROTEASES; ALPHA-SYNUCLEIN; PRECURSOR PROTEIN; BETA-PEPTIDE; MITOCHONDRIAL DYSFUNCTION; DOPAMINERGIC-NEURONS; ESSENTIAL TREMOR; COMPLEX-I; GENE; PINK1	Mitochondrial dysfunction has long been implicated in the neurodegenerative disorder Parkinson's disease (PD); however, it is unclear how mitochondrial impairment and ?-synuclein pathology are coupled. Using specific mitochondrial inhibitors, EM analysis, and biochemical assays, we report here that intramitochondrial protein homeostasis plays a major role in ?-synuclein aggregation. We found that interference with intramitochondrial proteases, such as HtrA2 and Lon protease, and mitochondrial protein import significantly aggravates ?-synuclein seeding. In contrast, direct inhibition of mitochondrial complex I, an increase in intracellular calcium concentration, or formation of reactive oxygen species, all of which have been associated with mitochondrial stress, did not affect ?-synuclein pathology. We further demonstrate that similar mechanisms are involved in amyloid-? 1-42 (A?42) aggregation. Our results suggest that, in addition to other protein quality control pathways, such as the ubiquitin?proteasome system, mitochondriaper secan influence protein homeostasis of cytosolic aggregation-prone proteins. We propose that approaches that seek to maintain mitochondrial fitness, rather than target downstream mitochondrial dysfunction, may aid in the search for therapeutic strategies to manage PD and related neuropathologies.	[Lautenschlager, Janin; Wagner-Valladolid, Sara; Stephens, Amberley D.; Fernandez-Villegas, Ana; Hockings, Colin; Mishra, Ajay; Lu, Meng; Schierle, Gabriele S. Kaminski] Univ Cambridge, Dept Chem Engn & Biotechnol, Mol Neurosci Grp, West Cambridge Site,Philippa Fawcett Dr, Cambridge, England; [Manton, James D.; Rees, Eric J.] Univ Cambridge, Dept Chem Engn & Biotechnol, Quantitat Imaging Grp, West Cambridge Site,Philippa Fawcett Dr, Cambridge, England; [Fantham, Marcus J.; Kaminski, Clemens F.] Univ Cambridge, Dept Chem Engn & Biotechnol, Laser Analyt Grp, West Cambridge Site,Philippa Fawcett Dr, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Lautenschlager, J; Schierle, GSK (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Mol Neurosci Grp, West Cambridge Site,Philippa Fawcett Dr, Cambridge, England.	janin.lautenschlaeger@gmail.com; gsk20@cam.ac.uk	; Kaminski, Clemens/G-7488-2016	mishra, ajay/0000-0001-8201-4067; Manton, James/0000-0001-9260-3156; Kaminski, Clemens/0000-0002-5194-0962	Deutsche Forschungsgemeinschaft (DFG) [LA 3609/2-1]; Wellcome Trust [065807/Z/01/Z, 203249/Z/16/Z]; UK Medical Research Council (MRC) [MR/K02292X/1]; Alzheimer Research UK (ARUK) [ARUK-PG013-14]; Michael J Fox Foundation [16238]; Infinitus China Ltd.; UK Engineering and Physical Sciences Research Council (EPSRC); MRC [MC_U105184326, MR/N012453/1, MR/K02292X/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wellcome Trust(Wellcome Trust); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer Research UK (ARUK)(Alzheimer's Research UK (ARUK)); Michael J Fox Foundation; Infinitus China Ltd.; UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) research fellowship award LA 3609/2-1 (to J. L.), the Wellcome Trust Grants 065807/Z/01/Z and 203249/Z/16/Z (to G. S. K. S.), UK Medical Research Council (MRC) Grant MR/K02292X/1 (to G. S. K. S.), Alzheimer Research UK (ARUK) Grant ARUK-PG013-14 (to G. S. K. S.), Michael J Fox Foundation (16238 to G. S. K. S.), Infinitus China Ltd. (to G. S. K. S. and C. F. K.), the UK Engineering and Physical Sciences Research Council (EPSRC) (to C. F. K.), and Alzheimer Research UK (ARUK) travel grants (to J. L. and A. D. S.).	Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; [Anonymous], 2019, FRONT NEUROSCI SWITZ; [Anonymous], 2017, BMC BIOL; [Anonymous], 2017, JOVE J VIS EXP JAN; Arai K., 2007, REPORTS FAC SCI ENG, V36, P36; Bajar BT, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091488; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bogaerts V, 2008, HUM MUTAT, V29, P832, DOI 10.1002/humu.20713; BURNS RS, 1983, P NATL ACAD SCI-BIOL, V80, P4546, DOI 10.1073/pnas.80.14.4546; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Cenini G, 2016, MOL BIOL CELL, V27, P3257, DOI 10.1091/mbc.E16-05-0313; Chao YX, 2015, NEUROGENETICS, V16, P241, DOI 10.1007/s10048-015-0443-3; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen WY, 2017, NANO LETT, V17, P143, DOI 10.1021/acs.nanolett.6b03686; Chen WY, 2015, BIOPHYS J, V108, P999, DOI 10.1016/j.bpj.2015.01.012; Chung SY, 2016, STEM CELL REP, V7, P664, DOI 10.1016/j.stemcr.2016.08.012; Cilenti L, 2003, J BIOL CHEM, V278, P11489, DOI 10.1074/jbc.M212819200; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; da Cruz LN, 2011, INT J PARASITOL, V41, P363, DOI 10.1016/j.ijpara.2010.10.009; Dabir DV, 2013, DEV CELL, V25, P81, DOI 10.1016/j.devcel.2013.03.006; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dehvari N, 2012, NEUROCHEM INT, V60, P533, DOI 10.1016/j.neuint.2012.02.012; DEMARTINO GN, 1982, J NEUROCHEM, V38, P1642, DOI 10.1111/j.1471-4159.1982.tb06645.x; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Di Maio R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3634; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Edelstein Arthur D, 2014, J Biol Methods, V1; Falkevall A, 2006, J BIOL CHEM, V281, P29096, DOI 10.1074/jbc.M602532200; Fang D, 2015, HUM MOL GENET, V24, P5198, DOI 10.1093/hmg/ddv241; Follett J, 2013, NEUROTOX RES, V23, P378, DOI 10.1007/s12640-012-9366-z; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gibellini L, 2015, ONCOTARGET, V6, P25466, DOI 10.18632/oncotarget.4510; Gispert S, 2015, HUM MOL GENET, V24, P1061, DOI 10.1093/hmg/ddu520; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Gulsuner HU, 2014, P NATL ACAD SCI USA, V111, P18285, DOI 10.1073/pnas.1419581111; GURTUBAY JIG, 1980, J BIOENERG BIOMEMBR, V12, P47, DOI 10.1007/BF00745012; Guzman JN, 2018, J CLIN INVEST, V128, P2266, DOI 10.1172/JCI95898; Herbert S., 2014, P IWBBIO APR 4 9 GRA; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Kotera I, 2010, ACS CHEM BIOL, V5, P215, DOI 10.1021/cb900263z; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lautenschager J, 2019, PROG NEUROBIOL, V181, DOI 10.1016/j.pneurobio.2019.101660; Lautenschlager J, 2015, MITOCHONDRION, V25, P49, DOI 10.1016/j.mito.2015.10.003; Lautenschlager J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03111-4; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lu M, 2019, J BIOL CHEM, V294, P1478, DOI 10.1074/jbc.RA118.004511; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Marchenko Steven, 2007, J Vis Exp, P267, DOI 10.3791/267; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; MELLGREN RL, 1987, FASEB J, V1, P110, DOI 10.1096/fasebj.1.2.2886390; Mossmann D, 2014, CELL METAB, V20, P662, DOI 10.1016/j.cmet.2014.07.024; Muller M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10980; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Oliveras-Salva M, 2014, NEUROBIOL AGING, V35, P2625, DOI 10.1016/j.neurobiolaging.2014.04.032; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Pinotsi D, 2016, P NATL ACAD SCI USA, V113, P3815, DOI 10.1073/pnas.1516546113; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ray P, 2002, J APPL TOXICOL, V22, P139, DOI 10.1002/jat.829; Ruan LH, 2017, NATURE, V543, P443, DOI 10.1038/nature21695; Rui YF, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0261-z; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schierle GSK, 2011, CHEMPHYSCHEM, V12, P673, DOI 10.1002/cphc.201000996; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitz A, 2004, TRAFFIC, V5, P89, DOI 10.1111/j.1600-0854.2004.00159.x; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Subramaniam SR, 2014, NEUROBIOL DIS, V70, P204, DOI 10.1016/j.nbd.2014.06.017; Sum TH, 2016, MOLECULES, V21, DOI 10.3390/molecules21091230; Thakur P, 2017, P NATL ACAD SCI USA, V114, pE8284, DOI 10.1073/pnas.1710442114; Todd AM, 2012, GENET MOL RES, V11, P1497, DOI 10.4238/2012.May.21.6; Todd AM, 2008, GENOME, V51, P1040, DOI 10.1139/G08-085; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang L, 2001, INVEST OPHTH VIS SCI, V42, P194; Warren SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070687; Westerlund M, 2011, FASEB J, V25, P1345, DOI 10.1096/fj.10-163402; Wu HQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109438; Young LJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53988	94	12	12	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2020	295	30					10138	10152		10.1074/jbc.RA119.011650	http://dx.doi.org/10.1074/jbc.RA119.011650			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MW0BV	32385113	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000556713400005
J	Collins, MP; Stransky, LA; Forgac, M				Collins, Michael P.; Stransky, Laura A.; Forgac, Michael			AKT Ser/Thr kinase increases V-ATPase?dependent lysosomal acidification in response to amino acid starvation in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase; proton transport; lysosomal acidification; Akt PKB; CRISPR; Cas; amino acid homeostasis; nutrient sensing; kinase signaling; pH regulation; MK2206	ATPASE; GLUCOSE; PH; ACTIVATION; MTORC1; COMPARTMENTS; INHIBITORS; MECHANISM; SUBUNIT; AMPK	The vacuolar H+-ATPase (V-ATPase) is an ATP-dependent proton pump that is essential for cellular homeostasis. V-ATPase activity is controlled by the regulated assembly of the enzyme from its component V(1)and V(0)domains. We previously reported that amino acid starvation rapidly increases V-ATPase assembly and activity in mammalian lysosomes, but the signaling pathways controlling this effect are unknown. In testing inhibitors of pathways important for controlling cellular metabolism, we found here that the cAMP-dependent protein kinase (PKA) inhibitor H89 increases lysosomal V-ATPase activity and blocks any further change upon starvation. The AMP-activated protein kinase (AMPK) inhibitor dorsomorphin decreased lysosomal V-ATPase activity and also blocked any increase upon starvation. However, CRISPR-mediated gene editing revealed that PKA and AMPK are not required for the starvation-dependent increase in lysosomal V-ATPase activity, indicating that H89 and dorsomorphin modify V-ATPase activity through other cellular targets. We next found that the AKT Ser/Thr kinase (AKT) inhibitor MK2206 blocks the starvation-dependent increase in lysosomal V-ATPase activity without altering basal activity. Expression of AKT1 or AKT3, but not AKT2, was required for increased lysosomal V-ATPase activity in response to amino acid starvation in mouse fibroblasts. Finally, HEK293T cells expressing only AKT1 responded normally to starvation, whereas cells expressing only AKT2 displayed a significantly reduced increase in V-ATPase activity and assembly upon starvation. These results show that AKT is required for controlling the rapid response of lysosomal V-ATPase activity to changes in amino acid availability and that this response depends on specific AKT isoforms.	[Collins, Michael P.; Forgac, Michael] Tufts Univ, Grad Sch Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA; [Stransky, Laura A.; Forgac, Michael] Tufts Univ, Grad Sch Biomed Sci, Program Cellular & Mol Physiol, Boston, MA 02111 USA; [Forgac, Michael] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Stransky, Laura A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Tufts University; Tufts University; Tufts University; Harvard University; Dana-Farber Cancer Institute	Forgac, M (corresponding author), Tufts Univ, Grad Sch Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA.; Forgac, M (corresponding author), Tufts Univ, Grad Sch Biomed Sci, Program Cellular & Mol Physiol, Boston, MA 02111 USA.; Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	michael.forgac@tufts.edu		Collins, Michael/0000-0002-1806-6775; Stransky, Laura/0000-0001-8834-936X	Tufts Collaborative Cancer Biology Awards; National Institutes of Health [CA189321, GM34478]	Tufts Collaborative Cancer Biology Awards; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by Tufts Collaborative Cancer Biology Awards to M. P. C. and L. A. S., as well as National Institutes of Health Grants CA189321 to L. A. S. and GM34478 to M. F. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Collins MP, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00902; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Daniel S, 1996, J BIOL CHEM, V271, P1385, DOI 10.1074/jbc.271.3.1385; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; Hallows KR, 2009, AM J PHYSIOL-CELL PH, V296, pC672, DOI 10.1152/ajpcell.00004.2009; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hirata N, 2018, ONCOGENE, V37, P5367, DOI 10.1038/s41388-018-0330-0; HORSTRUP K, 1994, EUR J BIOCHEM, V225, P21, DOI 10.1111/j.1432-1033.1994.00021.x; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Inoue H, 2013, EUR J PHARMACOL, V714, P170, DOI 10.1016/j.ejphar.2013.06.018; Kane PM, 2007, J BIOENERG BIOMEMBR, V39, P415, DOI 10.1007/s10863-007-9112-z; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Li DL, 2016, CIRCULATION, V133, P1668, DOI 10.1161/CIRCULATIONAHA.115.017443; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Marjuki H, 2011, CELL MICROBIOL, V13, P587, DOI 10.1111/j.1462-5822.2010.01556.x; Matsuda-Lennikov M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0079795; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McGuire CM, 2018, J BIOL CHEM, V293, P9113, DOI 10.1074/jbc.RA117.001327; NEZU J, 1992, J BIOCHEM, V112, P212, DOI 10.1093/oxfordjournals.jbchem.a123879; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao VK, 2019, J CELL PHYSIOL, V234, P8683, DOI 10.1002/jcp.27528; Rein J, 2008, AM J PHYSIOL-CELL PH, V294, pC56, DOI 10.1152/ajpcell.00041.2007; Sanidas I, 2014, MOL CELL, V53, P577, DOI 10.1016/j.molcel.2013.12.018; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Soliman M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006820; Stransky LA, 2015, J BIOL CHEM, V290, P27360, DOI 10.1074/jbc.M115.659128; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Turnham RE, 2016, GENE, V577, P101, DOI 10.1016/j.gene.2015.11.052; Vogt J, 2011, CELL SIGNAL, V23, P1831, DOI 10.1016/j.cellsig.2011.06.019; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Zhang CS, 2014, CELL METAB, V20, P526, DOI 10.1016/j.cmet.2014.06.014; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	42	8	8	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9433	9444		10.1074/jbc.RA120.013223	http://dx.doi.org/10.1074/jbc.RA120.013223			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409581	Green Published, hybrid			2022-12-28	WOS:000552758600014
J	Oosterheert, W; Gros, P				Oosterheert, Wout; Gros, Piet			Cryo-electron microscopy structure and potential enzymatic function of human six-transmembrane epithelial antigen of the prostate 1 (STEAP1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						six-transmembrane epithelial antigen of the prostate 1 (STEAP1); membrane protein; metalloenzyme; cryo-electron microscopy; cancer; cancer therapy; antibody; enzyme structure; protein chimera	MOLECULAR-CLONING; TUMOR-GROWTH; PROTEIN; CANCER; MODEL; FERRIREDUCTASE; IMMUNOTHERAPY; STAMP2; DOMAIN; ASSAY	Six-transmembrane epithelial antigen of the prostate 1 (STEAP1) is an integral membrane protein that is highly up-regulated on the cell surface of several human cancers, making it a promising therapeutic target to manage these diseases. It shares sequence homology with three enzymes (STEAP2?STEAP4) that catalyze the NADPH-dependent reduction of iron(III). However, STEAP1 lacks an intracellular NADPH-binding domain and does not exhibit cellular ferric reductase activity. Thus, both the molecular function of STEAP1 and its role in cancer progression remain elusive. Here, we present a ?3.0-? cryo-EM structure of trimeric human STEAP1 bound to three antigen-binding fragments (Fabs) of the clinically used antibody mAb120.545. The structure revealed that STEAP1 adopts a reductase-like conformation and interacts with the Fabs through its extracellular helices. Enzymatic assays in human cells revealed that STEAP1 promotes iron(III) reduction when fused to the intracellular NADPH-binding domain of its family member STEAP4, suggesting that STEAP1 functions as a ferric reductase in STEAP heterotrimers. Our work provides a foundation for deciphering the molecular mechanisms of STEAP1 and may be useful in the design of new therapeutic strategies to target STEAP1 in cancer.	[Oosterheert, Wout; Gros, Piet] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Chem, Fac Sci,Crystal & Struct Chem, Utrecht, Netherlands	Utrecht University	Oosterheert, W; Gros, P (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Dept Chem, Fac Sci,Crystal & Struct Chem, Utrecht, Netherlands.	w.oosterheert@uu.nl; p.gros@uu.nl		Oosterheert, Wout/0000-0003-1189-6044	Netherlands Organization for Scientific Research (NWO), Fund NCI Technology Area [731.015.201]	Netherlands Organization for Scientific Research (NWO), Fund NCI Technology Area	This work has been supported by the Netherlands Organization for Scientific Research (NWO), Fund NCI Technology Area (Project 731.015.201).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alves PMS, 2006, CANCER IMMUNOL IMMUN, V55, P1515, DOI 10.1007/s00262-006-0165-3; Barroca-Ferreira J, 2018, CURR CANCER DRUG TAR, V18, P222, DOI 10.2174/1568009617666170427103732; Boswell CA, 2011, BIOCONJUGATE CHEM, V22, P1994, DOI 10.1021/bc200212a; Cappuccini F, 2016, CANCER IMMUNOL IMMUN, V65, P701, DOI 10.1007/s00262-016-1831-8; Carrasquillo JA, 2019, J NUCL MED, V60, P1517, DOI 10.2967/jnumed.118.222844; Challita-Eid PM, 2007, CANCER RES, V67, P5798, DOI 10.1158/0008-5472.CAN-06-3849; Chen X, 2019, BIOMED PHARMACOTHER, V111, P1124, DOI 10.1016/j.biopha.2019.01.012; Danila DC, 2019, J CLIN ONCOL, V37, P3518, DOI 10.1200/JCO.19.00646; Doran MG, 2014, J NUCL MED, V55, P2045, DOI 10.2967/jnumed.114.145185; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gauss GH, 2013, J BIOL CHEM, V288, P20668, DOI 10.1074/jbc.M113.479154; Genentech Inc, 2015, U.S. Patent, Patent No. [EP2502938B1, 2502938]; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gomes IM, 2012, MOL CANCER RES, V10, P573, DOI 10.1158/1541-7786.MCR-11-0281; Grunewald TGP, 2012, BIOL CELL, V104, P641, DOI 10.1111/boc.201200027; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Herrmann VL, 2016, PROSTATE, V76, P456, DOI 10.1002/pros.23136; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; Isobe T, 2011, EXP CELL RES, V317, P2582, DOI 10.1016/j.yexcr.2011.07.022; Jin Y, 2015, EMBO MOL MED, V7, P315, DOI 10.15252/emmm.201404181; Kim K, 2016, BIOCHEMISTRY-US, V55, P6673, DOI 10.1021/acs.biochem.6b00610; Kleven MD, 2015, J BIOL CHEM, V290, P22558, DOI 10.1074/jbc.M115.664565; Korkmaz CG, 2005, ONCOGENE, V24, P4934, DOI 10.1038/sj.onc.1208677; Korkmaz KS, 2002, J BIOL CHEM, V277, P36689, DOI 10.1074/jbc.M202414200; Mancusso R, 2011, METHODS, V55, P324, DOI 10.1016/j.ymeth.2011.07.008; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; Moreaux J, 2012, BIOCHEM BIOPH RES CO, V429, P148, DOI 10.1016/j.bbrc.2012.10.123; O'Donoghue JA, 2019, MOL PHARMACEUT, V16, P3083, DOI 10.1021/acs.molpharmaceut.9b00326; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Oosterheert W, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06817-7; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Rouge L, 2020, SCIENCE, V367, P1224, DOI 10.1126/science.aaz9356; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schirmer D, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1175795; Sendamarai AK, 2008, P NATL ACAD SCI USA, V105, P7410, DOI 10.1073/pnas.0801318105; Sikkeland J, 2016, MOL CELL ENDOCRINOL, V425, P26, DOI 10.1016/j.mce.2016.02.013; Sukumaran S, 2017, AAPS J, V19, P130, DOI 10.1208/s12248-016-9993-z; Whiteland H, 2014, CLIN EXP METASTAS, V31, P909, DOI 10.1007/s10585-014-9679-9; Yamamoto T, 2013, EXP CELL RES, V319, P2617, DOI 10.1016/j.yexcr.2013.07.025; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081	47	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9502	9512		10.1074/jbc.RA120.013690	http://dx.doi.org/10.1074/jbc.RA120.013690			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409586	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000552758600019
J	Ruskamo, S; Krokengen, OC; Kowal, J; Nieminen, T; Lehtimaki, M; Raasakka, A; Dandey, VP; Vattulainen, I; Stahlberg, H; Kursula, P				Ruskamo, Salla; Krokengen, Oda C.; Kowal, Julia; Nieminen, Tuomo; Lehtimaki, Mari; Raasakka, Arne; Dandey, Venkata P.; Vattulainen, Ilpo; Stahlberg, Henning; Kursula, Petri			Cryo-EM, X-ray diffraction, and atomistic simulations reveal determinants for the formation of a supramolecular myelin-like proteolipid lattice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane structure; protein structure; myelin; molecular dynamics; membrane biophysics; membrane protein; membrane bilayer; Charcot-Marie-Tooth disease; neuropathy; proteolipid	ACID-BINDING PROTEIN; PO PROTEIN; PHOSPHOLIPID-MEMBRANES; FATTY-ACIDS; RESOLUTION; CRYSTALLIZATION; LOCALIZATION; P2-PROTEIN; SCATTERING; ADHESION	Myelin protein P2 is a peripheral membrane protein of the fatty acid?binding protein family that functions in the formation and maintenance of the peripheral nerve myelin sheath. Several P2 gene mutations cause human Charcot-Marie-Tooth neuropathy, but the mature myelin sheath assembly mechanism is unclear. Here, cryo-EM of myelin-like proteolipid multilayers revealed an ordered three-dimensional (3D) lattice of P2 molecules between stacked lipid bilayers, visualizing supramolecular assembly at the myelin major dense line. The data disclosed that a single P2 layer is inserted between two bilayers in a tight intermembrane space of ?3 nm, implying direct interactions between P2 and two membrane surfaces. X-ray diffraction from P2-stacked bicelle multilayers revealed lateral protein organization, and surface mutagenesis of P2 coupled with structure-function experiments revealed a role for both the portal region of P2 and its opposite face in membrane interactions. Atomistic molecular dynamics simulations of P2 on model membrane surfaces suggested that Arg-88 is critical for P2-membrane interactions, in addition to the helical lid domain. Negatively charged lipid headgroups stably anchored P2 on the myelin-like bilayer surface. Membrane binding may be accompanied by opening of the P2 ?-barrel structure and ligand exchange with the apposing bilayer. Our results provide an unprecedented view into an ordered, multilayered biomolecular membrane system induced by the presence of a peripheral membrane protein from human myelin. This is an important step toward deciphering the 3D assembly of a mature myelin sheath at the molecular level.	[Ruskamo, Salla; Lehtimaki, Mari; Kursula, Petri] Univ Oulu, Fac Biochem & Mol Med, Oulu 90014, Finland; [Ruskamo, Salla; Kursula, Petri] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Krokengen, Oda C.; Raasakka, Arne; Kursula, Petri] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway; [Kowal, Julia; Dandey, Venkata P.; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt C CINA, Biozentrum, CH-4058 Basel, Switzerland; [Vattulainen, Ilpo] Tampere Univ, Computat Phys Lab, Tampere 33014, Finland; [Vattulainen, Ilpo] Univ Helsinki, Dept Phys, Helsinki 00014, Finland; [Kowal, Julia] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Nieminen, Tuomo] Tampere Univ Appl Sci, Tampere 33014, Finland; [Lehtimaki, Mari] US FDA, Rockville, MD 20852 USA; [Dandey, Venkata P.] New York Struct Biol Ctr, Natl Resource Automated Mol Microscopy, Simons Electron Microscopy Ctr, New York, NY 10027 USA	University of Oulu; University of Oulu; University of Bergen; University of Basel; Tampere University; University of Helsinki; Swiss Federal Institutes of Technology Domain; ETH Zurich; Tampere University; Tampere University of Applied Sciences TAMK; US Food & Drug Administration (FDA)	Kursula, P (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu 90014, Finland.; Kursula, P (corresponding author), Univ Oulu, Bioctr Oulu, Oulu 90014, Finland.; Kursula, P (corresponding author), Univ Bergen, Dept Biomed, N-5020 Bergen, Norway.	petri.kursula@uib.no	Raasakka, Arne/AAA-5251-2020; Stahlberg, Henning/H-1868-2011; Kursula, Petri/K-1058-2012	Raasakka, Arne/0000-0002-9443-9959; Stahlberg, Henning/0000-0002-1185-4592; Nieminen, Tuomo/0000-0003-2641-9929; Ruskamo, Salla/0000-0002-9740-9077; Kursula, Petri/0000-0001-8529-3751; Vattulainen, Ilpo/0000-0001-7408-3214; Kowal, Julia/0000-0003-4694-1896	Norwegian Research Council (SYNKNOYT Project) [247669]; European Union [653706, 730872]	Norwegian Research Council (SYNKNOYT Project); European Union(European Commission)	Beamtime and user support at EMBL/DESY and ISA are gratefully acknowledged. Travel to synchrotrons was supported by the Norwegian Research Council (SYNKNOYT Project 247669) and the European Union Horizon 2020 programs iNEXT (Grant 653706) and CALIPSOplus (Grant 730872).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Belin S, 2019, HUM MOL GENET, V28, P1260, DOI 10.1093/hmg/ddy420; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davies JK, 1999, BIOCHEMISTRY-US, V38, P16932, DOI 10.1021/bi991926q; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Gonzaga-Jauregui C, 2015, CELL REP, V12, P1169, DOI 10.1016/j.celrep.2015.07.023; Gould RM, 2008, NEURON GLIA BIOL, V4, P137, DOI 10.1017/S1740925X09990238; Graf SA, 2019, PIGM CELL MELANOMA R, V32, P424, DOI 10.1111/pcmr.12760; Guo Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143476; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hong YB, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005829; INOUYE H, 1988, BIOPHYS J, V53, P247, DOI 10.1016/S0006-3495(88)83086-8; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JONES TA, 1988, EMBO J, V7, P1597, DOI 10.1002/j.1460-2075.1988.tb02985.x; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIM HK, 1992, J BIOL CHEM, V267, P20051; Knoll W, 2010, SPECTROSC-INT J, V24, P585, DOI 10.1155/2010/317525; Kursula P., 2004, J APPL CRYSTALLOGR, V37, P347; Laulumaa S, 2019, J PHYS CHEM B, V123, P8178, DOI 10.1021/acs.jpcb.9b05320; Laulumaa S, 2019, MOLECULES, V24, DOI 10.3390/molecules24173044; Laulumaa S, 2018, BMC STRUCT BIOL, V18, DOI 10.1186/s12900-018-0087-2; Laulumaa S, 2015, ACTA CRYSTALLOGR F, V71, P1391, DOI 10.1107/S2053230X15017902; Laulumaa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128954; Lehtimaki M, 2012, ACTA CRYSTALLOGR F, V68, P1359, DOI 10.1107/S1744309112039036; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Majava V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010300; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mittendorf KF, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700220; Motley WW, 2016, BRAIN, V139, P1649, DOI 10.1093/brain/aww055; Palaima P, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1162-x; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patil R, 2014, ACS CHEM BIOL, V9, P2526, DOI 10.1021/cb5005178; Punetha J, 2018, MOL GENET METAB, V125, P302, DOI 10.1016/j.ymgme.2018.08.005; Raasakka A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37009-4; Raasakka A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05364-3; Ruskamo S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06781-0; Ruskamo S, 2014, ACTA CRYSTALLOGR D, V70, P165, DOI 10.1107/S1399004713027910; Saher G, 2015, BBA-MOL CELL BIOL L, V1851, P1083, DOI 10.1016/j.bbalip.2015.02.010; Scherer S, 2014, J STRUCT BIOL, V186, P302, DOI 10.1016/j.jsb.2014.03.016; SCHMITT F.0., 1935, SCIENCE, V82, P44, DOI 10.1126/science.82.2115.44; SEDZIK J, 1985, J NEUROCHEM, V45, P844, DOI 10.1111/j.1471-4159.1985.tb04071.x; Simpson MA, 1998, BIOCHEMISTRY-US, V37, P10980, DOI 10.1021/bi980507a; Stettner M, 2018, CELL MOL NEUROBIOL, V38, P487, DOI 10.1007/s10571-017-0494-0; STORCH J, 1993, MOL CELL BIOCHEM, V123, P45, DOI 10.1007/BF01076474; Suresh S, 2010, BIOCHEMISTRY-US, V49, P3456, DOI 10.1021/bi100128h; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thumser AEA, 2000, J LIPID RES, V41, P647; Thumser AEA, 2001, J MOL NEUROSCI, V16, P143, DOI 10.1385/JMN:16:2-3:143; TRAPP BD, 1979, P NATL ACAD SCI USA, V76, P3552, DOI 10.1073/pnas.76.7.3552; TRAPP BD, 1984, J NEUROCHEM, V43, P944, DOI 10.1111/j.1471-4159.1984.tb12828.x; Wong MH, 1996, J CELL BIOL, V134, P1531, DOI 10.1083/jcb.134.6.1531; WONG MH, 1994, J CELL BIOL, V126, P1089, DOI 10.1083/jcb.126.4.1089; YOUNG ACM, 1994, STRUCTURE, V2, P523, DOI 10.1016/S0969-2126(00)00052-6; Zamarreno F, 2018, J BIOMOL STRUCT DYN, V36, P861, DOI 10.1080/07391102.2017.1301271; Zenker J, 2014, GLIA, V62, P1502, DOI 10.1002/glia.22696	65	10	10	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8692	8705		10.1074/jbc.RA120.013087	http://dx.doi.org/10.1074/jbc.RA120.013087			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32265298	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000546296800006
J	Gordon, CJ; Tchesnokov, EP; Woolner, E; Perry, JK; Feng, JY; Porter, DP; Gotte, M				Gordon, Calvin J.; Tchesnokov, Egor P.; Woolner, Emma; Perry, Jason K.; Feng, Joy Y.; Porter, Danielle P.; Gotte, Matthias			Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase; plus-stranded RNA virus; drug action; drug development; drug discovery; COVID-19; coronavirus (CoV); MERS; SARS; SARS-CoV-2; Ebola virus; Lassa virus; RNA-dependent RNA polymerase (RdRp); replication; remdesivir; sofosbuvir; favipiravir; ribavirin	THERAPEUTIC-EFFICACY; STRUCTURAL BASIS; EBOLA-VIRUS; INTERFERON; RIBAVIRIN; EXCISION; GS-5734; EXORIBONUCLEASE; REPLICATION; DISCOVERY	Effective treatments for coronavirus disease 2019 (COVID-19) are urgently needed to control this current pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Replication of SARS-CoV-2 depends on the viral RNA-dependent RNA polymerase (RdRp), which is the likely target of the investigational nucleotide analogue remdesivir (RDV). RDV shows broad-spectrum antiviral activity against RNA viruses, and previous studies with RdRps from Ebola virus and Middle East respiratory syndrome coronavirus (MERS-CoV) have revealed that delayed chain termination is RDV's plausible mechanism of action. Here, we expressed and purified active SARS-CoV-2 RdRp composed of the nonstructural proteins nsp8 and nsp12. Enzyme kinetics indicated that this RdRp efficiently incorporates the active triphosphate form of RDV (RDV-TP) into RNA. Incorporation of RDV-TP at position i caused termination of RNA synthesis at position i+3. We obtained almost identical results with SARS-CoV, MERS-CoV, and SARS-CoV-2 RdRps. A unique property of RDV-TP is its high selectivity over incorporation of its natural nucleotide counterpart ATP. In this regard, the triphosphate forms of 2?-C-methylated compounds, including sofosbuvir, approved for the management of hepatitis C virus infection, and the broad-acting antivirals favipiravir and ribavirin, exhibited significant deficits. Furthermore, we provide evidence for the target specificity of RDV, as RDV-TP was less efficiently incorporated by the distantly related Lassa virus RdRp, and termination of RNA synthesis was not observed. These results collectively provide a unifying, refined mechanism of RDV-mediated RNA synthesis inhibition in coronaviruses and define this nucleotide analogue as a direct-acting antiviral.	[Gordon, Calvin J.; Tchesnokov, Egor P.; Woolner, Emma; Gotte, Matthias] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2R3, Canada; [Gotte, Matthias] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB T6G 2R3, Canada; [Perry, Jason K.; Feng, Joy Y.; Porter, Danielle P.] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	University of Alberta; University of Alberta; Gilead Sciences	Gotte, M (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada.	gotte@ualberta.ca		Gordon, Calvin/0000-0002-8259-6201; Woolner, Emma/0000-0002-8697-7802; Tchesnokov, Egor Petrovitch/0000-0003-1698-2961; Perry, Jason/0000-0001-5492-0652	Canadian Institutes of Health Research (CIHR) [170343]; Gilead Sciences; Alberta Ministry of Economic Development, Trade, and Tourism Major Innovation Fund Program for the AMR-One Health Consortium	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Gilead Sciences(Gilead Sciences); Alberta Ministry of Economic Development, Trade, and Tourism Major Innovation Fund Program for the AMR-One Health Consortium	This study was supported by Canadian Institutes of Health Research (CIHR) Grant 170343, Gilead Sciences, and the Alberta Ministry of Economic Development, Trade, and Tourism Major Innovation Fund Program for the AMR-One Health Consortium (to M. G.). M. G. has previously received funding from Gilead Sciences in support of the study of EBOV RdRp inhibition by RDV. This study is also sponsored in part by a grant from Gilead Sciences to M. G., J. K. P., J. Y. F., and D. P. P. are Gilead employees.	Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18; [Anonymous], 2002, Bull World Health Organ, V80, P983; Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Bouvet M, 2012, P NATL ACAD SCI USA, V109, P9372, DOI 10.1073/pnas.1201130109; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117; Delang L, 2018, ANTIVIR RES, V153, P85, DOI 10.1016/j.antiviral.2018.03.003; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Ferron F, 2018, P NATL ACAD SCI USA, V115, pE162, DOI 10.1073/pnas.1718806115; Furuta Y, 2017, P JPN ACAD B-PHYS, V93, P449, DOI 10.2183/pjab.93.027; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056; Hawman DW, 2018, ANTIVIR RES, V157, P18, DOI 10.1016/j.antiviral.2018.06.013; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jin ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068347; Jordan PC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006889; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Kumaki Y, 2011, ANTIVIR RES, V92, P329, DOI 10.1016/j.antiviral.2011.09.001; Li HO, 2020, ANTIMICROB AGENTS CH, V64, DOI [10.1128/AAC.00483-20, 10.1128/AAC.00483-20.]; Lo MK, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau9242; Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Oestereich L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002804; Posthuma CC, 2017, VIRUS RES, V234, P58, DOI 10.1016/j.virusres.2017.01.023; Pruijssers AJ, 2019, CURR OPIN VIROL, V35, P57, DOI 10.1016/j.coviro.2019.04.002; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Siegel D, 2017, J MED CHEM, V60, P1648, DOI 10.1021/acs.jmedchem.6b01594; Stuyver LJ, 2004, ANTIMICROB AGENTS CH, V48, P651, DOI 10.1128/AAC.48.2.651-654.2004; Subissi L, 2014, P NATL ACAD SCI USA, V111, pE3900, DOI 10.1073/pnas.1323705111; Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326; Tchesnokov EP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22328-3; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Uebelhoer LS, 2014, ANTIVIR RES, V106, P86, DOI 10.1016/j.antiviral.2014.03.018; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; Welch SR, 2017, ANTIVIR RES, V147, P91, DOI 10.1016/j.antiviral.2017.10.008; Welch SR, 2016, ANTIVIR RES, V136, P9, DOI 10.1016/j.antiviral.2016.10.007; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	50	488	500	12	114	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6785	6797		10.1074/jbc.RA120.013679	http://dx.doi.org/10.1074/jbc.RA120.013679			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32284326	Green Published, hybrid			2022-12-28	WOS:000536212600001
J	Back, CR; Higman, VA; Le Vay, K; Patel, VV; Parnell, AE; Frankel, D; Jenkinson, HF; Burston, SG; Crump, MP; Nobbs, AH; Race, PR				Back, Catherine R.; Higman, Victoria A.; Le Vay, Kristian; Patel, Viren V.; Parnell, Alice E.; Frankel, Daniel; Jenkinson, Howard F.; Burston, Steven G.; Crump, Matthew P.; Nobbs, Angela H.; Race, Paul R.			The streptococcal multidomain fibrillar adhesin CshA has an elongated polymeric architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); small-angle X-ray scattering (SAXS); adhesin; protein folding; fibril; microbiology; virulence factor; biofilm; bacterial pathogenicity; CshA	FIMBRIAE-ASSOCIATED ADHESIN; MUTANS ANTIGEN-I/II; CRYSTAL-STRUCTURE; CELL-SURFACE; MICROBIAL BIOGEOGRAPHY; STRUCTURE VALIDATION; ISOPEPTIDE BONDS; GORDONII; PROTEIN; BINDING	The cell surfaces of many bacteria carry filamentous polypeptides termed adhesins that enable binding to both biotic and abiotic surfaces. Surface adherence is facilitated by the exquisite selectivity of the adhesins for their cognate ligands or receptors and is a key step in niche or host colonization and pathogenicity. Streptococcus gordonii is a primary colonizer of the human oral cavity and an opportunistic pathogen, as well as a leading cause of infective endocarditis in humans. The fibrillar adhesin CshA is an important determinant of S. gordonii adherence, forming peritrichous fibrils on its surface that bind host cells and other microorganisms. CshA possesses a distinctive multidomain architecture comprising an N-terminal target-binding region fused to 17 repeat domains (RDs) that are each ?100 amino acids long. Here, using structural and biophysical methods, we demonstrate that the intact CshA repeat region (CshA_RD1?17, domains 1?17) forms an extended polymeric monomer in solution. We recombinantly produced a subset of CshA RDs and found that they differ in stability and unfolding behavior. The NMR structure of CshA_RD13 revealed a hitherto unreported all ?-fold, flanked by disordered interdomain linkers. These findings, in tandem with complementary hydrodynamic studies of CshA_RD1?17, indicate that this polypeptide possesses a highly unusual dynamic transitory structure characterized by alternating regions of order and disorder. This architecture provides flexibility for the adhesive tip of the CshA fibril to maintain bacterial attachment that withstands shear forces within the human host. It may also help mitigate deleterious folding events between neighboring RDs that share significant structural identity without compromising mechanical stability.	[Back, Catherine R.; Jenkinson, Howard F.; Nobbs, Angela H.] Univ Bristol, Bristol Dent Sch, Lower Maudlin St, Bristol BS1 2LY, Avon, England; [Back, Catherine R.; Le Vay, Kristian; Patel, Viren V.; Parnell, Alice E.; Burston, Steven G.; Race, Paul R.] Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Back, Catherine R.; Parnell, Alice E.; Burston, Steven G.; Crump, Matthew P.; Race, Paul R.] Univ Bristol, BrisSynBio Synthet Biol Res Ctr, Bristol BS8 1TQ, Avon, England; [Higman, Victoria A.; Crump, Matthew P.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Le Vay, Kristian] Univ Bristol, Bristol Ctr Funct Nanomat, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; [Frankel, Daniel] Newcastle Univ, Sch Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Bristol; University of Bristol; University of Bristol; University of Bristol; University of Bristol; Newcastle University - UK	Nobbs, AH (corresponding author), Univ Bristol, Bristol Dent Sch, Lower Maudlin St, Bristol BS1 2LY, Avon, England.; Race, PR (corresponding author), Univ Bristol, Sch Biochem, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.	Angela.Nobbs@bristol.ac.uk; Paul.Race@bristol.ac.uk	Nobbs, Angela/AAS-3926-2020; Jenkinson, Howard/AAD-9282-2022; Jenkinson, Howard/ABI-1842-2020; Le Vay, Kristian/AAN-1269-2020	Le Vay, Kristian/0000-0003-2455-8706; Crump, Matthew/0000-0002-7868-5818; Frankel, Daniel/0000-0002-9891-2942; Jenkinson, Howard/0000-0002-9195-7945; Burston, Steven/0000-0003-1848-1853; Nobbs, Angela/0000-0003-3813-4410	National Institutes of Health [DE016690]; Biotechnology and Biological Sciences Research Council [BB/L01386X/1, BB/M025624/1]; Royal Society University Research Fellowship [UF080534]; Engineering and Physical Sciences Research Council Bristol Centre for Functional Nanomaterials Ph.D. studentship [EP/G036780/1]; BBSRC [BB/L01386X/1, BB/M025624/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society University Research Fellowship(Royal Society of London); Engineering and Physical Sciences Research Council Bristol Centre for Functional Nanomaterials Ph.D. studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by National Institutes of Health Grant DE016690 (to H. F. J.), by Biotechnology and Biological Sciences Research Council Grants BB/L01386X/1 and BB/M025624/1, and through the award of Royal Society University Research Fellowship UF080534 (to P. R. R.) and Engineering and Physical Sciences Research Council Bristol Centre for Functional Nanomaterials Ph.D. studentship EP/G036780/1 (to K. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen WJ, 2012, CURR OPIN STRUC BIOL, V22, P500, DOI 10.1016/j.sbi.2012.02.001; Back CR, 2017, J BIOL CHEM, V292, P1538, DOI 10.1074/jbc.M116.760975; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doreleijers JF, 2012, J BIOMOL NMR, V54, P267, DOI 10.1007/s10858-012-9669-7; Forster S, 2010, J APPL CRYSTALLOGR, V43, P639, DOI 10.1107/S0021889810008289; Formosa-Dague C, 2016, P NATL ACAD SCI USA, V113, P410, DOI 10.1073/pnas.1519265113; Forsgren N, 2010, J MOL BIOL, V397, P740, DOI 10.1016/j.jmb.2010.01.065; Forsgren N, 2009, PROTEIN SCI, V18, P1896, DOI 10.1002/pro.200; Froeliger EH, 2001, INFECT IMMUN, V69, P2512, DOI 10.1128/IAI.69.4.2512-2519.2001; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Gruszka DT, 2016, P NATL ACAD SCI USA, V113, P11841, DOI 10.1073/pnas.1608762113; Gruszka DT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8271; Gruszka DT, 2012, P NATL ACAD SCI USA, V109, pE1011, DOI 10.1073/pnas.1119456109; Holmes AR, 1996, INFECT IMMUN, V64, P4680, DOI 10.1128/IAI.64.11.4680-4685.1996; Jakubovics NS, 2009, MICROBIOL-SGM, V155, P3572, DOI 10.1099/mic.0.032078-0; JAMESON MW, 1995, MICROBIOL-UK, V141, P2729, DOI 10.1099/13500872-141-10-2729; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Klemm P, 2010, APPL MICROBIOL BIOT, V88, P451, DOI 10.1007/s00253-010-2805-y; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Larson MR, 2011, J BIOL CHEM, V286, P21657, DOI 10.1074/jbc.M111.231100; Larson MR, 2010, P NATL ACAD SCI USA, V107, P5983, DOI 10.1073/pnas.0912293107; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Linge JP, 2004, J MAGN RESON, V167, P334, DOI 10.1016/j.jmr.2004.01.010; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Macintosh RL, 2009, J BACTERIOL, V191, P7007, DOI 10.1128/JB.00764-09; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McNab R, 1996, INFECT IMMUN, V64, P4204, DOI 10.1128/IAI.64.10.4204-4210.1996; McNab R, 1999, J BACTERIOL, V181, P3087, DOI 10.1128/JB.181.10.3087-3095.1999; PAKULA R, 1963, J GEN MICROBIOL, V31, P125, DOI 10.1099/00221287-31-1-125; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rego S, 2016, J BIOL CHEM, V291, P15985, DOI 10.1074/jbc.M116.726562; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smith BO, 2006, J BIOL CHEM, V281, P5821, DOI 10.1074/jbc.M510868200; Troffer-Charlier N, 2002, J MOL BIOL, V318, P179, DOI 10.1016/S0022-2836(02)00025-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wizemann TM, 1999, EMERG INFECT DIS, V5, P395, DOI 10.3201/eid0503.990310; Wu H, 1999, MOL MICROBIOL, V34, P1070, DOI 10.1046/j.1365-2958.1999.01670.x; Wu H, 1998, MOL MICROBIOL, V28, P487, DOI 10.1046/j.1365-2958.1998.00805.x	45	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6689	6699		10.1074/jbc.RA119.011719	http://dx.doi.org/10.1074/jbc.RA119.011719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32229583	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000537685000034
J	Ward, R; Kaylor, JJ; Cobice, DF; Pepe, DA; McGarrigle, EM; Brockerhoff, SE; Hurley, JB; Travis, GH; Kennedy, BN				Ward, Rebecca; Kaylor, Joanna J.; Cobice, Diego F.; Pepe, Dionissia A.; McGarrigle, Eoghan M.; Brockerhoff, Susan E.; Hurley, James B.; Travis, Gabriel H.; Kennedy, Breandan N.			Non-photopic and photopic visual cycles differentially regulate immediate, early, and late phases of cone photoreceptor-mediated vision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vitamin A; vision; zebrafish; retina; pharmacology; chemical biology; cone-based visual behavior; Rpe65; visual cycle; zebrafish	RETINAL-PIGMENT EPITHELIUM; BINDING-PROTEIN; DIHYDROCERAMIDE DESATURASE; MOUSE MODEL; VITAMIN-A; RPE65; ISOMEROHYDROLASE; IDENTIFICATION; ISOMERASE; CRALBP	Cone photoreceptors in the retina enable vision over a wide range of light intensities. However, the processes enabling cone vision in bright light (i.e. photopic vision) are not adequately understood. Chromophore regeneration of cone photopigments may require the retinal pigment epithelium (RPE) and/or retinal M?ller glia. In the RPE, isomerization of all-trans-retinyl esters to 11-cis-retinol is mediated by the retinoid isomerohydrolase Rpe65. A putative alternative retinoid isomerase, dihydroceramide desaturase-1 (DES1), is expressed in RPE and M?ller cells. The retinol-isomerase activities of Rpe65 and Des1 are inhibited by emixustat and fenretinide, respectively. Here, we tested the effects of these visual cycle inhibitors on immediate, early, and late phases of cone photopic vision. In zebrafish larvae raised under cyclic light conditions, fenretinide impaired late cone photopic vision, while the emixustat-treated zebrafish unexpectedly had normal vision. In contrast, emixustat-treated larvae raised under extensive dark-adaptation displayed significantly attenuated immediate photopic vision concomitant with significantly reduced 11-cis-retinaldehyde (11cRAL). Following 30 min of light, early photopic vision was recovered, despite 11cRAL levels remaining significantly reduced. Defects in immediate cone photopic vision were rescued in emixustat- or fenretinide-treated larvae following exogenous 9-cis-retinaldehyde supplementation. Genetic knockout of Des1 (degs1) or retinaldehyde-binding protein 1b (rlbp1b) did not eliminate photopic vision in zebrafish. Our findings define molecular and temporal requirements of the nonphotopic or photopic visual cycles for mediating vision in bright light.	[Ward, Rebecca; Kennedy, Breandan N.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, UCD Conway Inst, Dublin D04 V1W8, Ireland; [Kaylor, Joanna J.; Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Cobice, Diego F.] Ulster Univ, Biomed Sci Res Inst, Sch Biomed Sci, Mass Spectrometry Ctr, Coleraine BT52 1SA, Londonderry, North Ireland; [Pepe, Dionissia A.; McGarrigle, Eoghan M.] Univ Coll Dublin, UCD Sch Chem, Ctr Synth & Chem Biol, Dublin D04 V1W8, Ireland; [Brockerhoff, Susan E.; Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98109 USA; [Brockerhoff, Susan E.; Hurley, James B.] Univ Washington, Dept Ophthalmol, Seattle, WA 98109 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Travis, Gabriel H.] Univ Calif Los Angeles, Ophthalmol, Los Angeles, CA 90024 USA	University College Dublin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Ulster University; University College Dublin; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Kennedy, BN (corresponding author), Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, UCD Conway Inst, Dublin D04 V1W8, Ireland.	brendan.kennedy@ucd.ie	kennedy, Breandan/H-5643-2019; Travis, Gabriel Harvey/AIF-1062-2022	kennedy, Breandan/0000-0001-7991-4689; Travis, Gabriel Harvey/0000-0003-4020-9493; Pepe, Dionissia Barbara/0000-0001-5401-8407; Ward, Rebecca/0000-0003-2957-8642; Cobice, Diego/0000-0001-5283-2931; McGarrigle, Eoghan/0000-0001-8160-6431; Kaylor, Joanna/0000-0002-4535-2574	Research to Prevent Blindness	Research to Prevent Blindness(Research to Prevent Blindness (RPB))	We thank the UCD Biomedical Facility technicians for zebrafish maintenance and the UCD Conway Institute Imaging Core, with particular thanks to Dr. Dimitri Scholz and Dr. Niamh Stephens. We wish to acknowledge our Public and Patient Involvement panel and Fighting Blindness for providing meaningful insights into this project and Research to Prevent Blindness unrestricted grant (to the Jules Stein Eye Institute). We thank Prof. Jack Saari for helpful discussions surrounding this project and Dr. Ross Collery for proof-reading the manuscript.	Babino D, 2015, FASEB J, V29, P216, DOI 10.1096/fj.14-261693; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bilotta J, 2001, DEV DYNAM, V222, P564, DOI 10.1002/dvdy.1188; Boyer NP, 2012, J BIOL CHEM, V287, P22276, DOI 10.1074/jbc.M111.329235; Brockerhoff SE, 1998, VISION RES, V38, P1335, DOI 10.1016/S0042-6989(97)00227-7; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Collery R, 2008, INVEST OPHTH VIS SCI, V49, P3812, DOI 10.1167/iovs.08-1957; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; Crowley R., 2019, PROTOCOLSIO, DOI [10.17504/protocols.io.3jggkjw, DOI 10.17504/PROTOCOLS.IO.3JGGKJW]; Daly C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11513-5; Dobri N, 2013, INVEST OPHTH VIS SCI, V54, P85, DOI 10.1167/iovs.12-10050; Fan J, 2003, P NATL ACAD SCI USA, V100, P13662, DOI 10.1073/pnas.2234461100; Fan J, 2008, INVEST OPHTH VIS SCI, V49, P2384, DOI 10.1167/iovs.08-1727; Fleisch VC, 2008, J NEUROSCI, V28, P8208, DOI 10.1523/JNEUROSCI.2367-08.2008; Gearhart PM, 2010, ARCH OPHTHALMOL-CHIC, V128, P1442, DOI 10.1001/archophthalmol.2010.210; Gloriani AH, 2019, CURR BIOL, V29, P1206, DOI 10.1016/j.cub.2019.02.023; GOLDSTEI.EB, 1970, VISION RES, V10, P1065, DOI 10.1016/0042-6989(70)90082-9; HOOD DC, 1973, VISION RES, V13, P1943, DOI 10.1016/0042-6989(73)90065-5; Hussain RM, 2018, EXPERT OPIN BIOL TH, V18, P1049, DOI 10.1080/14712598.2018.1513486; Kaylor JJ, 2013, NAT CHEM BIOL, V9, P30, DOI [10.1038/nchembio.1114, 10.1038/NCHEMBIO.1114]; Kiser PD, 2019, FASEB J, V33, P5782, DOI 10.1096/fj.201802493R; Kiser PD, 2018, J GEN PHYSIOL, V150, P571, DOI 10.1085/jgp.201711815; Kolesnikov A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32667-w; Mata NL, 2013, RETINA-J RET VIT DIS, V33, P498, DOI 10.1097/IAE.0b013e318265801d; Mata NL, 2005, BIOCHEMISTRY-US, V44, P11715, DOI 10.1021/bi050942m; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morshedian A, 2019, NEURON, V102, P1172, DOI 10.1016/j.neuron.2019.04.004; Motani A, 2009, J BIOL CHEM, V284, P7673, DOI 10.1074/jbc.M809654200; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Rahmaniyan M, 2011, J BIOL CHEM, V286, P24754, DOI 10.1074/jbc.M111.250779; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; RODRIGUEZ KA, 1989, AM J PHYSIOL, V256, pR255, DOI 10.1152/ajpregu.1989.256.1.R255; Rosenfeld PJ, 2018, OPHTHALMOLOGY, V125, P1556, DOI 10.1016/j.ophtha.2018.03.059; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Saari JC, 2002, INVEST OPHTH VIS SCI, V43, P1730; Saari John C, 2016, Subcell Biochem, V81, P231; Saszik S, 1999, VISUAL NEUROSCI, V16, P881, DOI 10.1017/S0952523899165076; Schonthaler HB, 2007, EUR J NEUROSCI, V26, P1940, DOI 10.1111/j.1460-9568.2007.05801.x; Siddique MM, 2013, MOL CELL BIOL, V33, P2353, DOI 10.1128/MCB.00226-13; Takahashi Y, 2011, FEBS J, V278, P2913, DOI 10.1111/j.1742-4658.2011.08216.x; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297; Van Hooser JP, 2002, J BIOL CHEM, V277, P19173, DOI 10.1074/jbc.M112384200; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Wang JS, 2009, CURR BIOL, V19, P1665, DOI 10.1016/j.cub.2009.07.054; Ward R, 2020, DEV BIOL, V457, P226, DOI 10.1016/j.ydbio.2019.02.008; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Xue YL, 2015, J CLIN INVEST, V125, P727, DOI 10.1172/JCI79651; Zhang JY, 2015, J CLIN INVEST, V125, P2781, DOI 10.1172/JCI80950	54	10	10	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6482	6497		10.1074/jbc.RA119.011374	http://dx.doi.org/10.1074/jbc.RA119.011374			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32238432	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000537685000019
J	Cairns, L; Patterson, A; Weingartner, KA; Koehler, TJ; DeAngelis, DR; Tripp, KW; Bothner, B; Kavran, JM				Cairns, Leah; Patterson, Angela; Weingartner, Kyler A.; Koehler, T. J.; DeAngelis, Daniel R.; Tripp, Katherine W.; Bothner, Brian; Kavran, Jennifer M.			Biophysical characterization of SARAH domain?mediated multimerization of Hippo pathway complexes in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; Hippo pathway; Salvador (sav); structure-function; MST2 (mammalian sterile 20-like kinase 2); SARAH domain; Sav; RassF; Hpo domain; protein-protein interaction; cell proliferation	PROTEIN-PROTEIN INTERACTIONS; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; MST1 KINASE; ORGAN SIZE; STRUCTURAL BASIS; APOPTOSIS; GROWTH; SALVADOR; PHOSPHORYLATION	Hippo pathway signaling limits cell growth and proliferation and maintains the stem-cell niche. These cellular events result from the coordinated activity of a core kinase cassette that is regulated, in part, by interactions involving Hippo, Salvador, and dRassF. These interactions are mediated by a conserved coiled-coil domain, termed SARAH, in each of these proteins. SARAH domain?mediated homodimerization of Hippo kinase leads to autophosphorylation and activation. Paradoxically, SARAH domain?mediated heterodimerization between Hippo and Salvador enhances Hippo kinase activity in cells, whereas complex formation with dRassF inhibits it. To better understand the mechanism by which each complex distinctly modulates Hippo kinase and pathway activity, here we biophysically characterized the entire suite of SARAH domain?mediated complexes. We purified the three SARAH domains from Drosophila melanogaster and performed an unbiased pulldown assay to identify all possible interactions, revealing that isolated SARAH domains are sufficient to recapitulate the cellular assemblies and that Hippo is a universal binding partner. Additionally, we found that the Salvador SARAH domain homodimerizes and demonstrate that this interaction is conserved in Salvador's mammalian homolog. Using native MS, we show that each of these complexes is dimeric in solution. We also measured the stability of each SARAH domain complex, finding that despite similarities at both the sequence and structural levels, SARAH domain complexes differ in stability. The identity, stoichiometry, and stability of these interactions characterized here comprehensively reveal the nature of SARAH domain?mediated complex formation and provide mechanistic insights into how SARAH domain?mediated interactions influence Hippo pathway activity.	[Cairns, Leah; Weingartner, Kyler A.; Koehler, T. J.; DeAngelis, Daniel R.; Kavran, Jennifer M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 20215 USA; [Patterson, Angela; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Tripp, Katherine W.] Johns Hopkins Univ, Krieger Sch Arts & Sci, TC Jenkins Dept Biophys, Baltimore, MD 20121 USA; [Kavran, Jennifer M.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 20215 USA; [Kavran, Jennifer M.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 20215 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Montana State University System; Montana State University Bozeman; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kavran, JM (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	jkavran@jhu.edu		Cairns, Leah/0000-0002-3907-001X	National Institutes of Health [R01GM134000, T32 GM007445, T32 GM080189, T32CA009110]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by National Institutes of Health Grants R01GM134000 (to J. M. K.), T32 GM007445 (to L. C.), T32 GM080189 (to T. J. K.), and T32CA009110 (to K. W. and D. D. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aruxandei DC, 2011, BIOCHEMISTRY-US, V50, P10990, DOI [10.1021/bi20111oh, 10.1021/bi201110h]; Bae SJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30278.001, 10.7554/eLife.30278]; Bitra A, 2017, SCI REP-UK, V7, DOI 10.1038/srep45020; Boggiano JC, 2011, DEV CELL, V21, P888, DOI 10.1016/j.devcel.2011.08.028; Cairns L, 2018, J BIOL CHEM, V293, P5532, DOI 10.1074/jbc.RA117.000923; Callus BA, 2006, FEBS J, V273, P4264, DOI 10.1111/j.1742-4658.2006.05427.x; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chaikuad A., 2014, CRYSTAL STRUCTURE ST; Chaikuad A., 2013, CRYSTAL STRUCTURE ST; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Colombani J, 2006, CURR BIOL, V16, P1453, DOI 10.1016/j.cub.2006.05.059; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Deng YT, 2013, DEV BIOL, V375, P152, DOI 10.1016/j.ydbio.2012.12.017; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Gloss LM, 1997, BIOCHEMISTRY-US, V36, P5612, DOI 10.1021/bi970056e; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hauri S, 2013, MOL SYST BIOL, V9, DOI 10.1002/msb.201304750; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Hwang E, 2007, P NATL ACAD SCI USA, V104, P9236, DOI 10.1073/pnas.0610716104; Hwang E, 2014, ACTA CRYSTALLOGR D, V70, P1944, DOI 10.1107/S139900471400947X; Jain A, 2014, P NATL ACAD SCI USA, V111, P17833, DOI 10.1073/pnas.1419425111; Jin YY, 2012, J BIOL CHEM, V287, P5784, DOI 10.1074/jbc.M111.310334; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Liu G. G., 2013, CRYSTAL STRUCTURE HU; Luo ML, 2016, NUCLEIC ACIDS RES, V44, P7385, DOI 10.1093/nar/gkw421; Makbul C, 2013, BIOCHEMISTRY-US, V52, P1045, DOI 10.1021/bi3014642; Margineanu A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28186; Millward TA, 1999, J BIOL CHEM, V274, P33847, DOI 10.1074/jbc.274.48.33847; Mok YK, 1996, PROTEIN SCI, V5, P310; Ni LS, 2013, STRUCTURE, V21, P1757, DOI 10.1016/j.str.2013.07.008; Ohnishi S, 2007, FEBS LETT, V581, P462, DOI 10.1016/j.febslet.2007.01.008; Pace C N, 1986, Methods Enzymol, V131, P266; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Poon CLC, 2011, DEV CELL, V21, P896, DOI 10.1016/j.devcel.2011.09.012; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Sanchez-Sanz G, 2016, BRIEF BIOINFORM, V17, P593, DOI 10.1093/bib/bbv070; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Stegert MR, 2005, MOL CELL BIOL, V25, P11019, DOI 10.1128/MCB.25.24.11019-11029.2005; Street TO, 2008, METHOD CELL BIOL, V84, P295, DOI 10.1016/S0091-679X(07)84011-8; Szimler T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41972-x; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Wingfield P T, 2001, Curr Protoc Protein Sci, VAppendix 3, p3A, DOI 10.1002/0471140864.psa03as00; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053	56	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6202	6213		10.1074/jbc.RA120.012679	http://dx.doi.org/10.1074/jbc.RA120.012679			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32213597	Green Published, hybrid			2022-12-28	WOS:000531417300028
J	Huang, DY; Shi, S; Liang, C; Zhang, XY; Du, XN; An, HL; Peers, C; Zhang, HL; Gamper, N				Huang, Dongyang; Shi, Sai; Liang, Ce; Zhang, Xiaoyu; Du, Xiaona; An, Hailong; Peers, Chris; Zhang, Hailin; Gamper, Nikita			Delineating an extracellular redox-sensitive module in T-type Ca2+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium channel; oxidation?reduction (redox); zinc; electrophysiology; homology modeling; neuropeptide	GATED CALCIUM-CHANNELS; SENSORY NEURONS; MOLECULAR-MECHANISMS; MODULATION; CAV3.2; RAT; INHIBITION; PAIN; ACTIVATION; EXPRESSION	T-type (Cav3) Ca2+ channels are important regulators of excitability and rhythmic activity of excitable cells. Among other voltage-gated Ca2+ channels, Cav3 channels are uniquely sensitive to oxidation and zinc. Using recombinant protein expression in HEK293 cells, patch clamp electrophysiology, site-directed mutagenesis, and homology modeling, we report here that modulation of Cav3.2 by redox agents and zinc is mediated by a unique extracellular module containing a high-affinity metal-binding site formed by the extracellular IS1?IS2 and IS3?IS4 loops of domain I and a cluster of extracellular cysteines in the IS1?IS2 loop. Patch clamp recording of recombinant Cav3.2 currents revealed that two cysteine-modifying agents, sodium (2-sulfonatoethyl) methanethiosulfonate (MTSES) and N-ethylmaleimide, as well as a reactive oxygen species?producing neuropeptide, substance P (SP), inhibit Cav3.2 current to similar degrees and that this inhibition is reversed by a reducing agent and a zinc chelator. Pre-application of MTSES prevented further SP-mediated current inhibition. Substitution of the zinc-binding residue His(191) in Cav3.2 reduced the channel's sensitivity to MTSES, and introduction of the corresponding histidine into Cav3.1 sensitized it to MTSES. Removal of extracellular cysteines from the IS1?IS2 loop of Cav3.2 reduced its sensitivity to MTSES and SP. We hypothesize that oxidative modification of IS1?IS2 loop cysteines induces allosteric changes in the zinc-binding site of Cav3.2 so that it becomes sensitive to ambient zinc.	[Huang, Dongyang; Liang, Ce; Zhang, Xiaoyu; Du, Xiaona; Zhang, Hailin; Gamper, Nikita] Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050000, Hebei, Peoples R China; [Huang, Dongyang] Hebei Med Univ, Inst Chinese Integrat Med, Shijiazhuang 050000, Hebei, Peoples R China; [Shi, Sai; An, Hailong] Hebei Univ Technol, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin 300401, Peoples R China; [Shi, Sai; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys, Tianjin 300401, Peoples R China; [Peers, Chris] Univ Leeds, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Gamper, Nikita] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England	Hebei Medical University; Hebei Medical University; Hebei University of Technology; Hebei University of Technology; University of Leeds; University of Leeds	Zhang, HL; Gamper, N (corresponding author), Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050000, Hebei, Peoples R China.; Gamper, N (corresponding author), Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.	zhanghl@hebmu.edu.cn; n.gamper@leeds.ac.uk	Zhang, xiaoyu/GXA-3206-2022	Gamper, Nikita/0000-0001-5806-0207	Biotechnology and Biological Sciences Research Council [BB/R003068/1, BB/R02104X/1]; 100 Foreign Experts of Hebei Province Award; National Natural Science Foundation of China [81701113, 81871075, 91732108]; Excellent Youth Fund of Natural Science Foundation of Hebei Grant [C2018206222]; Hebei Province Department of Education Grant [BJ2017004]; BBSRC [BB/R003068/1, BB/R02104X/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 100 Foreign Experts of Hebei Province Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Fund of Natural Science Foundation of Hebei Grant; Hebei Province Department of Education Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/R003068/1 and BB/R02104X/1 (to N. G.), the 100 Foreign Experts of Hebei Province Award (to N. G.), National Natural Science Foundation of China Grants 81701113 (to D. H.) and 81871075 and 91732108 (to H. Z.), and Excellent Youth Fund of Natural Science Foundation of Hebei Grant C2018206222 and Hebei Province Department of Education Grant BJ2017004 (to D. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Beurrier C, 1999, J NEUROSCI, V19, P599, DOI 10.1523/jneurosci.19-02-00599.1999; Blesneac I, 2015, P NATL ACAD SCI USA, V112, P13705, DOI 10.1073/pnas.1511740112; Bourinet E, 2005, EMBO J, V24, P315, DOI 10.1038/sj.emboj.7600515; Boycott HE, 2013, FASEB J, V27, P3395, DOI 10.1096/fj.13-227249; Crandall SR, 2010, J NEUROSCI, V30, P15419, DOI 10.1523/JNEUROSCI.3636-10.2010; Elies J, 2016, J PHYSIOL-LONDON, V594, P4119, DOI 10.1113/JP270963; Elies J, 2014, FASEB J, V28, P5376, DOI 10.1096/fj.14-257113; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Francois A, 2015, CELL REP, V10, P370, DOI 10.1016/j.celrep.2014.12.042; Gamper N, 2015, ANTIOXID REDOX SIGN, V22, P486, DOI 10.1089/ars.2014.5884; Garcia-Caballero A, 2014, NEURON, V83, P1144, DOI 10.1016/j.neuron.2014.07.036; Huang DY, 2016, ANTIOXID REDOX SIGN, V25, P233, DOI 10.1089/ars.2015.6560; Huang DY, 2016, BIOCHEM BIOPH RES CO, V473, P396, DOI 10.1016/j.bbrc.2016.02.118; Huang DY, 2015, BIOCHEM BIOPH RES CO, V465, P188, DOI 10.1016/j.bbrc.2015.07.137; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; Jagodic MM, 2008, J NEUROPHYSIOL, V99, P3151, DOI 10.1152/jn.01031.2007; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; Jevtovic-Todorovic V, 2006, CELL CALCIUM, V40, P197, DOI 10.1016/j.ceca.2006.04.024; Kang HW, 2010, J BIOL CHEM, V285, P3271, DOI 10.1074/jbc.M109.067660; Kang HW, 2006, J BIOL CHEM, V281, P4823, DOI 10.1074/jbc.M510197200; Lee J, 2013, MOL NEUROBIOL, V48, P274, DOI 10.1007/s12035-013-8493-8; Lee WY, 2009, J NEUROSCI, V29, P9500, DOI 10.1523/JNEUROSCI.5803-08.2009; Linley JE, 2012, P NATL ACAD SCI USA, V109, pE1578, DOI 10.1073/pnas.1201544109; Marger F, 2011, P NATL ACAD SCI USA, V108, P11268, DOI 10.1073/pnas.1100869108; Messinger RB, 2009, PAIN, V145, P184, DOI 10.1016/j.pain.2009.06.012; Moran VH, 2012, NUTRIENTS, V4, P841, DOI 10.3390/nu4080841; Nelson MT, 2007, J NEUROSCI, V27, P12577, DOI 10.1523/JNEUROSCI.2206-07.2007; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Nelson MT, 2005, J NEUROSCI, V25, P8766, DOI 10.1523/JNEUROSCI.2527-05.2005; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; Orestes P, 2013, DIABETES, V62, P3828, DOI 10.2337/db13-0813; Orestes P, 2011, J PHYSIOL-LONDON, V589, P135, DOI 10.1113/jphysiol.2010.196220; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; Rose KE, 2013, NEUROSCIENCE, V250, P263, DOI 10.1016/j.neuroscience.2013.07.005; Springer J, 2007, CLIN EXP ALLERGY, V37, P1788, DOI 10.1111/j.1365-2222.2007.02851.x; Springer J, 2005, REGUL PEPTIDES, V124, P99, DOI 10.1016/j.regpep.2004.07.004; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; Tanabe T, 1996, EUR J PHARMACOL, V299, P187, DOI 10.1016/0014-2999(95)00816-0; Todorovic SM, 2001, NEURON, V31, P75, DOI 10.1016/S0896-6273(01)00338-5; Traboulsie A, 2007, J PHYSIOL-LONDON, V578, P159, DOI 10.1113/jphysiol.2006.114496; Voisin T, 2016, J PHYSIOL-LONDON, V594, P3561, DOI 10.1113/JP271925; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weiss N, 2020, J MED GENET, V57, P1, DOI 10.1136/jmedgenet-2019-106163; Weiss N, 2013, PFLUG ARCH EUR J PHY, V465, P1159, DOI 10.1007/s00424-013-1259-3; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Zamponi GW, 2016, NAT REV DRUG DISCOV, V15, P19, DOI 10.1038/nrd.2015.5; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; Zhao YY, 2019, NATURE, V576, P492, DOI 10.1038/s41586-019-1801-3	49	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6177	6186		10.1074/jbc.RA120.012668	http://dx.doi.org/10.1074/jbc.RA120.012668			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32188693	Green Published, hybrid			2022-12-28	WOS:000531417300026
J	Liu, J; Kozhaya, L; Torres, VJ; Unutmaz, D; Lu, M				Liu, Jie; Kozhaya, Lina; Torres, Victor J.; Unutmaz, Derya; Lu, Min			Structure-based discovery of a small-molecule inhibitor of methicillin-resistant Staphylococcus aureus virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						methicillin-resistant Staphylococcus aureus (MRSA); toxin; virulence factor; structural biology; drug discovery; antivirulence therapy; MRSA; pore-forming toxin; structure-based drug design; virulence factor; phosphatidylcholine; Panton-Valentine leukocidin (PVL); alpha-toxin; leukocidin ED (LukED)	PANTON-VALENTINE LEUKOCIDIN; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; ALPHA-HEMOLYSIN; GAMMA-HEMOLYSIN; CRYSTAL-STRUCTURE; PORE-FORMATION; KEY RESIDUES; S-COMPONENT; N-TERMINUS	The rapid emergence and dissemination of methicillin-resistant Staphylococcus aureus (MRSA) strains poses a major threat to public health. MRSA possesses an arsenal of secreted host-damaging virulence factors that mediate pathogenicity and blunt immune defenses. Panton?Valentine leukocidin (PVL) and ?-toxin are exotoxins that create lytic pores in the host cell membrane. They are recognized as being important for the development of invasive MRSA infections and are thus potential targets for antivirulence therapies. Here, we report the high-resolution X-ray crystal structures of both PVL and ?-toxin in their soluble, monomeric, and oligomeric membrane-inserted pore states in complex with n-tetradecylphosphocholine (C14PC). The structures revealed two evolutionarily conserved phosphatidylcholine-binding mechanisms and their roles in modulating host cell attachment, oligomer assembly, and membrane perforation. Moreover, we demonstrate that the soluble C14PC compound protects primary human immune cells in vitro against cytolysis by PVL and ?-toxin and hence may serve as the basis for the development of an antivirulence agent for managing MRSA infections.	[Liu, Jie; Lu, Min] Rutgers State Univ, Publ Hlth Res Inst, Dept Microbiol Biochem & Mol Genet, New Jersey Med Sch, Newark, NJ 07103 USA; [Kozhaya, Lina; Unutmaz, Derya] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Torres, Victor J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Jackson Laboratory; New York University	Lu, M (corresponding author), Univ Med & Dent New Jersey, Dept Microbiol Biochem & Mol Genet, Publ Hlth Res Inst, Newark, NJ 07103 USA.	lum1@njms.rutgers.edu		Torres, Victor/0000-0002-7126-0489	National Institutes of Health [AI094599]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant AI094599 (to M. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonzo F, 2014, MICROBIOL MOL BIOL R, V78, P199, DOI 10.1128/MMBR.00055-13; Alonzo F, 2013, NATURE, V493, P51, DOI 10.1038/nature11724; Alonzo F, 2012, MOL MICROBIOL, V83, P423, DOI 10.1111/j.1365-2958.2011.07942.x; Anderson MJ, 2018, TOXINS, V10, DOI 10.3390/toxins10040157; Badarau A, 2015, J BIOL CHEM, V290, P142, DOI 10.1074/jbc.M114.598110; Berube BJ, 2013, TOXINS, V5, P1140, DOI 10.3390/toxins5061140; Bhattacharya M, 2018, P NATL ACAD SCI USA, V115, P7416, DOI 10.1073/pnas.1721949115; Bowler PG, 2018, J WOUND CARE, V27, P273, DOI 10.12968/jowc.2018.27.5.273; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; DeLeo FR, 2011, P NATL ACAD SCI USA, V108, P18091, DOI 10.1073/pnas.1111084108; Diekema DJ, 2014, INFECT CONT HOSP EP, V35, P285, DOI 10.1086/675283; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2010, P NATL ACAD SCI USA, V107, P5587, DOI 10.1073/pnas.0912403107; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; DuMont AL, 2014, INFECT IMMUN, V82, P1268, DOI 10.1128/IAI.01444-13; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreras M, 1998, BBA-BIOMEMBRANES, V1414, P108, DOI 10.1016/S0005-2736(98)00160-6; Galdiero S, 2004, PROTEIN SCI, V13, P1503, DOI 10.1110/ps.03561104; Gauduchon V, 2001, INFECT IMMUN, V69, P2390, DOI 10.1128/IAI.69.4.2390-2395.2001; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gouaux E, 1997, PROTEIN SCI, V6, P2631; Guillet V, 2004, J BIOL CHEM, V279, P41028, DOI 10.1074/jbc.M406904200; Han LL, 2007, J CLIN MICROBIOL, V45, P1350, DOI 10.1128/JCM.02274-06; Hua L, 2015, ANTIMICROB AGENTS CH, V59, P4526, DOI 10.1128/AAC.00510-15; Jones SM, 2001, LANCET, V357, P40, DOI 10.1016/S0140-6736(00)03572-8; JURSCH R, 1994, INFECT IMMUN, V62, P2249, DOI 10.1128/IAI.62.6.2249-2256.1994; Kawate T, 2003, PROTEIN SCI, V12, P997, DOI 10.1110/ps.0231203; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; KRISHNASASTRY M, 1994, FEBS LETT, V356, P66, DOI 10.1016/0014-5793(94)01240-7; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le VTM, 2016, ANTIMICROB AGENTS CH, V60, P5640, DOI 10.1128/AAC.00710-16; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liang XD, 2009, INFECT IMMUN, V77, P977, DOI 10.1128/IAI.00920-08; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Mangili A, 2005, CLIN INFECT DIS, V40, P1058, DOI 10.1086/428616; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendes RE, 2010, J CLIN MICROBIOL, V48, P568, DOI 10.1128/JCM.01384-09; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Monma N, 2004, J BIOCHEM, V136, P427, DOI 10.1093/jb/mvh140; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagle JF, 2000, CURR OPIN STRUC BIOL, V10, P474, DOI 10.1016/S0959-440X(00)00117-2; Nocadello S, 2016, ACTA CRYSTALLOGR D, V72, P113, DOI 10.1107/S2059798315023207; NODA M, 1980, INFECT IMMUN, V29, P678; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pedelacq JD, 1999, STRUCTURE, V7, P277, DOI 10.1016/S0969-2126(99)80038-0; Potrich C, 2009, J MEMBRANE BIOL, V227, P13, DOI 10.1007/s00232-008-9140-6; Prince A, 2017, J INFECT DIS, V215, P1386, DOI 10.1093/infdis/jiw425; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Reyes-Robles T, 2013, CELL HOST MICROBE, V14, P453, DOI 10.1016/j.chom.2013.09.005; Sause WE, 2016, TRENDS PHARMACOL SCI, V37, P231, DOI 10.1016/j.tips.2015.11.008; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Spaan AN, 2017, NAT REV MICROBIOL, V15, P435, DOI 10.1038/nrmicro.2017.27; Spaan AN, 2013, CELL HOST MICROBE, V13, P584, DOI 10.1016/j.chom.2013.04.006; Sugawara T, 2015, TOXICON, V108, P226, DOI 10.1016/j.toxicon.2015.09.033; Tseng CW, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005292; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Valeva A, 1997, BBA-BIOMEMBRANES, V1325, P281, DOI 10.1016/S0005-2736(96)00266-0; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; WALKER B, 1995, J BIOL CHEM, V270, P23065, DOI 10.1074/jbc.270.39.23065; WARD PD, 1980, INFECT IMMUN, V28, P393; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; WATANABE M, 1987, BIOCHIM BIOPHYS ACTA, V898, P257, DOI 10.1016/0005-2736(87)90065-4; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Willyard C, 2017, NATURE, V543, P15, DOI 10.1038/nature.2017.21550; Wilson P, 2003, J ANTIMICROB CHEMOTH, V51, P186, DOI 10.1093/jac/dkg104; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WOODIN AM, 1960, BIOCHEM J, V75, P158, DOI 10.1042/bj0750158; Yamashita D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5897; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108; Yokota K, 2000, BIOSCI BIOTECH BIOCH, V64, P2744, DOI 10.1271/bbb.64.2744; Yu XQ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01020-16, 10.1128/aac.01020-16]	83	10	10	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5944	5959		10.1074/jbc.RA120.012697	http://dx.doi.org/10.1074/jbc.RA120.012697			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32179646	Green Published, hybrid			2022-12-28	WOS:000531417300009
J	Yamashita-Sugahara, Y; Tokuzawa, Y; Nakachi, Y; Kanesaki-Yatsuka, Y; Matsumoto, M; Mizuno, Y; Okazaki, Y				Yamashita-Sugahara, Yzumi; Tokuzawa, Yoshimi; Nakachi, Yutaka; Kanesaki-Yatsuka, Yukiko; Matsumoto, Masahito; Mizuno, Yosuke; Okazaki, Yasushi			Fam57b (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor ? target gene that regulates adipogenesis through ceramide synthesis (vol 288, pg 4522, 2013)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Matsumoto, Masahito/AGS-0755-2022	Okazaki, Yasushi/0000-0003-3241-5502				Yamashita-Sugahara Y, 2013, J BIOL CHEM, V288, P4522, DOI 10.1074/jbc.M112.440792	1	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5176	5176		10.1074/jbc.AAC120.013475	http://dx.doi.org/10.1074/jbc.AAC120.013475			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32277067	Green Published, hybrid			2022-12-28	WOS:000526887000036
J	Zamanian-Daryoush, M; Gogonea, V; DiDonato, AJ; Buffa, JA; Choucair, I; Levison, BS; Hughes, RA; Ellington, AD; Huang, Y; Li, XMS; DiDonato, JA; Hazen, SL				Zamanian-Daryoush, Maryam; Gogonea, Valentin; DiDonato, Anthony J.; Buffa, Jennifer A.; Choucair, Ibrahim; Levison, Bruce S.; Hughes, Randall A.; Ellington, Andrew D.; Huang, Ying; Li, Xinmin S.; DiDonato, Joseph A.; Hazen, Stanley L.			Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; cholesterol; recombinant protein expression; atherosclerosis; synthetic biology; tryptophan; apolipoprotein A-I dysfunction; genetic code expansion; non-canonical amino acids; orthogonal translation; posttranslational modification; cardiovascular disease; high-density lipoprotein (HDL); coronary artery disease	MYELOPEROXIDASE-CATALYZED OXIDATION; HYPOCHLOROUS ACID; ARTERY WALL; LIPID RAFTS; MOUSE MODEL; APOA-I; HDL; ATHEROSCLEROSIS; DISEASE; ABCA1	Apolipoprotein A-I (apoA-I) is the major protein constituent of high-density lipoprotein (HDL) and a target of myeloperoxidase-dependent oxidation in the artery wall. In atherosclerotic lesions, apoA-I exhibits marked oxidative modifications at multiple sites, including Trp(72). Site-specific mutagenesis studies have suggested, but have not conclusively shown, that oxidative modification of Trp(72) of apoA-I impairs many atheroprotective properties of this lipoprotein. Herein, we used genetic code expansion technology with an engineered Saccharomyces cerevisiae tryptophanyl tRNA-synthetase (Trp-RS):suppressor tRNA pair to insert the noncanonical amino acid 5-hydroxytryptophan (5-OHTrp) at position 72 in recombinant human apoA-I and confirmed site-specific incorporation utilizing MS. In functional characterization studies, 5-OHTrp(72) apoA-I (compared with WT apoA-I) exhibited reduced ABC subfamily A member 1 (ABCA1)-dependent cholesterol acceptor activity in vitro (41.73 ? 6.57% inhibition; p < 0.01). Additionally, 5-OHTrp(72) apoA-I displayed increased activation and stabilization of paraoxonase 1 (PON1) activity (?mol/min/mg) when compared with WT apoA-I and comparable PON1 activation/stabilization compared with reconstituted HDL (WT apoA-I, 1.92 ? 0.04; 5-OHTrp(72) apoA-I, 2.35 ? 0.0; and HDL, 2.33 ? 0.1; p < 0.001, p < 0.001, and p < 0.001, respectively). Following injection into apoA-I?deficient mice, 5-OHTrp(72) apoA-I reached plasma levels comparable with those of native apoA-I yet exhibited significantly reduced (48%; p < 0.01) lipidation and evidence of HDL biogenesis. Collectively, these findings unequivocally reveal that site-specific oxidative modification of apoA-I via 5-OHTrp at Trp(72) impairs cholesterol efflux and the rate-limiting step of HDL biogenesis both in vitro and in vivo.	[Zamanian-Daryoush, Maryam; Gogonea, Valentin; DiDonato, Anthony J.; Buffa, Jennifer A.; Choucair, Ibrahim; Levison, Bruce S.; Huang, Ying; Li, Xinmin S.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, NC10,9500 Euclid Ave, Cleveland, OH 44195 USA; [Zamanian-Daryoush, Maryam; Gogonea, Valentin; DiDonato, Anthony J.; Buffa, Jennifer A.; Choucair, Ibrahim; Huang, Ying; Li, Xinmin S.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Microbiome & Human Hlth, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44195 USA; [Gogonea, Valentin; Choucair, Ibrahim] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Hughes, Randall A.] Univ Texas Austin, US Army, Res Lab South, Austin, TX 78712 USA; [Ellington, Andrew D.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Hazen, SL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, NC10,9500 Euclid Ave, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021	Choucair, Ibrahim/0000-0003-3540-2811; Levison, Bruce/0000-0002-1816-368X	National Institutes of Health [R01 HL128300, R01 HL103866, P01 H147823, S10OD016346]; Astra Zeneca; PG; Roche Diagnostics; Pfizer Inc.	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Astra Zeneca(AstraZeneca); PG; Roche Diagnostics; Pfizer Inc.(Pfizer)	This work was supported by National Institutes of Health Grants R01 HL128300, R01 HL103866, and P01 H147823 (to S. L. H.) and S10OD016346 (to J. A. D.). S. L. H. is named as an inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics or therapeutics. S. L. H. reports having the right to receive royalty payment for inventions or discoveries related to cardiovascular diagnostics from Cleveland Heart Lab, Inc. S. L. H. also reports having been paid as a consultant for P&G and receiving research funds from Astra Zeneca, P&G, Pfizer Inc., and Roche Diagnostics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Arciello A, 2016, FEBS LETT, V590, P4171, DOI 10.1002/1873-3468.12468; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Beck WHJ, 2013, BBA-BIOMEMBRANES, V1828, P1503, DOI 10.1016/j.bbamem.2013.02.009; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Black LL, 2015, J IMMUNOL, V195, P4685, DOI 10.4049/jimmunol.1500806; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Catapano AL, 2014, CARDIOVASC RES, V103, P372, DOI 10.1093/cvr/cvu150; Das M, 2016, J MOL BIOL, V428, P449, DOI 10.1016/j.jmb.2015.10.029; Das M, 2014, FEBS J, V281, P2525, DOI 10.1111/febs.12809; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; de Souza JA, 2010, J CELL MOL MED, V14, P608, DOI 10.1111/j.1582-4934.2009.00713.x; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Ellefson JW, 2014, NAT BIOTECHNOL, V32, P97, DOI 10.1038/nbt.2714; Feig JE, 2014, ANN GLOB HEALTH, V80, P13, DOI 10.1016/j.aogh.2013.12.001; Feig JE, 2014, CIRC RES, V114, P205, DOI 10.1161/CIRCRESAHA.114.300760; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Fuhrman B, 2010, ATHEROSCLEROSIS, V211, P61, DOI 10.1016/j.atherosclerosis.2010.01.025; Gaddis DE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03493-5; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gross E, 2006, BIOPHYS J, V90, P1362, DOI 10.1529/biophysj.105.075069; Guo L, 2013, J BIOL CHEM, V288, P17947, DOI 10.1074/jbc.M112.442699; Hammill JT, 2007, NAT PROTOC, V2, P2601, DOI 10.1038/nprot.2007.379; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hewing B, 2014, ARTERIOSCL THROM VAS, V34, P779, DOI 10.1161/ATVBAHA.113.303044; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Huang Y, 2013, J CLIN INVEST, V123, P3815, DOI 10.1172/JCI67478; Italia JS, 2017, NAT CHEM BIOL, V13, P446, DOI 10.1038/nchembio.2312; Kaul S, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004401; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kim KD, 2005, BIOCHEM BIOPH RES CO, V338, P1126, DOI 10.1016/j.bbrc.2005.10.065; Kontush A, 2015, HANDB EXP PHARMACOL, V224, P3, DOI 10.1007/978-3-319-09665-0_1; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lewis TL, 2010, J BIOL CHEM, V285, P36958, DOI 10.1074/jbc.M110.127829; Ma J, 2004, ACTA BIOCH BIOPH SIN, V36, P419, DOI 10.1093/abbs/36.6.419; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Melchior JT, 2017, NAT STRUCT MOL BIOL, V24, P1093, DOI 10.1038/nsmb.3501; Miyake-Stoner SJ, 2010, BIOCHEMISTRY-US, V49, P1667, DOI 10.1021/bi901947r; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Ouimet M, 2019, CIRC RES, V124, P1505, DOI 10.1161/CIRCRESAHA.119.312617; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Pollard RD, 2016, BIOCHEMISTRY-US, V55, P4971, DOI 10.1021/acs.biochem.6b00347; Porter JJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7607463; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Shao BH, 2014, CIRC RES, V114, P1733, DOI 10.1161/CIRCRESAHA.114.303454; Shao BH, 2010, J LIPID RES, V51, P1849, DOI 10.1194/jlr.M004085; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Shao BH, 2005, J BIOL CHEM, V280, P29311, DOI 10.1074/jbc.M504040200; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Su F, 2010, P NATL ACAD SCI USA, V107, P19997, DOI 10.1073/pnas.1009010107; Sultana A, 2016, FASEB J, V30, P2324, DOI 10.1096/fj.201500026R; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P2803, DOI 10.1161/ATVBAHA.112.253930; Tavori H, 2015, J LIPID RES, V56, P635, DOI 10.1194/jlr.M056408; Thacker SG, 2016, IMMUNOLOGY, V149, P306, DOI 10.1111/imm.12638; Todorovski T, 2011, J PEPT SCI, V17, P256, DOI 10.1002/psc.1322; Umemoto T, 2013, CIRC RES, V112, P1345, DOI 10.1161/CIRCRESAHA.111.300581; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Yamada H, 2017, BIOCHEM BIOPH RES CO, V484, P403, DOI 10.1016/j.bbrc.2017.01.138; Zamanian-Daryoush M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00265; Zamanian-Daryoush M, 2013, J BIOL CHEM, V288, P21237, DOI 10.1074/jbc.M113.468967; Zhang ZW, 2004, P NATL ACAD SCI USA, V101, P8882, DOI 10.1073/pnas.0307029101; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109; Zhou L, 2016, AMINO ACIDS, V48, P1309, DOI 10.1007/s00726-016-2186-3	83	11	15	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4836	4848		10.1074/jbc.RA119.012092	http://dx.doi.org/10.1074/jbc.RA119.012092			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32098873	Green Published, hybrid			2022-12-28	WOS:000526887000008
J	Rouaud, F; Tessaro, F; Aimaretti, L; Scapozza, L; Citi, S				Rouaud, Florian; Tessaro, Francesca; Aimaretti, Laura; Scapozza, Leonardo; Citi, Sandra			Cooperative binding of the tandem WW domains of PLEKHA7 to PDZD11 promotes conformation-dependent interaction with tetraspanin 33	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pleckstrin homology domain containing A7 (PLEKHA7); PDZ domain containing 11 (PDZD11); tetraspanin 33; WW domain; polyproline; cooperativity; cell-cell junction; ?-toxin; ADAM metallopeptidase domain 10 (ADAM10); adherens junction; membrane protein; molecular docking; protein complex; PDZD11; PLEKHA7; polyproline; tetraspanin33	GENOME-WIDE ASSOCIATION; ADHERENS JUNCTIONS; PROTEIN; SUSCEPTIBILITY; MOTIF	Pleckstrin homology domain?containing A7 (PLEKHA7) is a cytoplasmic protein at adherens junctions that has been implicated in hypertension, glaucoma, and responses toStaphylococcus aureus?-toxin. Complex formation between PLEKHA7, PDZ domain?containing 11 (PDZD11), tetraspanin 33, and the ?-toxin receptor ADAM metallopeptidase domain 10 (ADAM10) promotes junctional clustering of ADAM10 and ?-toxin?mediated pore formation. However, how the N-terminal region of PDZD11 interacts with the N-terminal tandem WW domains of PLEKHA7 and how this interaction promotes tetraspanin 33 binding to the WW1 domain is unclear. Here, we used site-directed mutagenesis, glutathioneS-transferase pulldown experiments, immunofluorescence, molecular modeling, and docking experiments to characterize the mechanisms driving these interactions. We found that Asp-30 of WW1 and His-75 of WW2 interact through a hydrogen bond and, together with Thr-35 of WW1, form a binding pocket that accommodates a polyproline stretch within the N-terminal PDZD11 region. By strengthening the interactions of the ternary complex, the WW2 domain stabilized the WW1 domain and cooperatively promoted the interaction with PDZD11. Modeling results indicated that, in turn, PDZD11 binding induces a conformational rearrangement, which strengthens the ternary complex, and contributes to enlarging a ?hydrophobic hot spot? region on the WW1 domain. The last two lipophilic residues of tetraspanin 33, Trp-283 and Tyr-282, were required for its interaction with PLEKHA7. Docking of the tetraspanin 33 C terminus revealed that it fits into the hydrophobic hot spot region of the accessible surface of WW1. We conclude that communication between the two tandem WW domains of PLEKHA7 and the PLEKHA7?PDZD11 interaction modulate the ligand-binding properties of PLEKHA7.	[Rouaud, Florian; Citi, Sandra] Univ Geneva, Fac Sci, Dept Cell Biol, Geneva, Switzerland; [Rouaud, Florian; Citi, Sandra] Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland; [Tessaro, Francesca; Aimaretti, Laura; Scapozza, Leonardo] Univ Geneva, Sch Pharmaceut Sci, Pharmaceut Biochem Grp, Geneva, Switzerland; [Tessaro, Francesca; Aimaretti, Laura; Scapozza, Leonardo] Univ Geneva, Inst Pharmaceut Sci Western Switzerland, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva	Citi, S (corresponding author), Univ Geneva, Fac Sci, Dept Cell Biol, Geneva, Switzerland.; Citi, S (corresponding author), Univ Geneva, Inst Genet & Genom Geneva iGE3, Geneva, Switzerland.	sandra.citi@unige.ch	Tessaro, Francesca/AAQ-9441-2020	Tessaro, Francesca/0000-0001-8672-885X; Scapozza, Leonardo/0000-0003-1079-648X	Swiss National Fund [31003A_172809]	Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Fund Grant 31003A_172809 (to S. C.).	Bhattacharya S, 2008, INT J BIOCHEM CELL B, V40, P147, DOI 10.1016/j.biocel.2007.07.007; Case D. A., 2016, AMBER 2016; Chang HT, 2014, ONCOTARGET, V5, P11792, DOI 10.18632/oncotarget.2961; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Dodson EJ, 2015, EXP BIOL MED, V240, P351, DOI 10.1177/1535370214566558; Endres BT, 2014, P NATL ACAD SCI USA, V111, P12817, DOI 10.1073/pnas.1410745111; Fedoroff OY, 2004, J BIOL CHEM, V279, P34991, DOI 10.1074/jbc.M404987200; Goellner GM, 2003, ANN NY ACAD SCI, V986, P461, DOI 10.1111/j.1749-6632.2003.tb07230.x; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Guerrera D, 2016, J BIOL CHEM, V291, P11016, DOI 10.1074/jbc.M115.712935; Huang XJ, 2009, J BIOL CHEM, V284, P25375, DOI 10.1074/jbc.M109.024828; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kourtidis A, 2016, CELL CYCLE, V15, P498, DOI 10.1080/15384101.2016.1141840; Kourtidis A, 2015, NAT CELL BIOL, V17, P1145, DOI 10.1038/ncb3227; Kurita S, 2013, J BIOL CHEM, V288, P29356, DOI 10.1074/jbc.M113.453464; Lee MC, 2017, HUM MOL GENET, V26, P4011, DOI 10.1093/hmg/ddx292; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li Y, 2009, ONCOGENE, V28, P2948, DOI 10.1038/onc.2009.162; Macias MJ, 2000, NAT STRUCT BIOL, V7, P375, DOI 10.1038/75144; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Nabokina SM, 2011, AM J PHYSIOL-GASTR L, V301, pG808, DOI 10.1152/ajpgi.00269.2011; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Popov LM, 2015, P NATL ACAD SCI USA, V112, P14337, DOI 10.1073/pnas.1510265112; Pulimeno P, 2011, J BIOL CHEM, V286, P16743, DOI 10.1074/jbc.M111.230862; Pulimeno P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012207; Ramirez-Espain X, 2007, J MOL BIOL, V373, P1255, DOI 10.1016/j.jmb.2007.08.052; Shah J, 2018, CELL REP, V25, P2132, DOI 10.1016/j.celrep.2018.10.088; Stephenson SEM, 2005, J BIOL CHEM, V280, P33270, DOI 10.1074/jbc.M505889200; Sudol M, 2005, IUBMB LIFE, V57, P773, DOI 10.1080/15216540500389039; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Tavano S, 2018, NEURON, V97, P1299, DOI 10.1016/j.neuron.2018.01.052; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wythe JD, 2011, DIS MODEL MECH, V4, P607, DOI 10.1242/dmm.002204; YOUNG L, 1994, PROTEIN SCI, V3, P717; Zweifel ME, 2005, STRUCTURE, V13, P1599, DOI 10.1016/j.str.2005.07.015	38	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9299	9312		10.1074/jbc.RA120.012987	http://dx.doi.org/10.1074/jbc.RA120.012987			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32371390	hybrid, Green Published			2022-12-28	WOS:000552758600004
J	Safgren, SL; Olson, RLO; Vrabel, AM; Almada, LL; Marks, DL; Hernandez-Alvarado, N; Gaspar-Maia, A; Fernandez-Zapico, ME				Safgren, Stephanie L.; Olson, Rachel L. O.; Vrabel, Anne M.; Almada, Luciana L.; Marks, David L.; Hernandez-Alvarado, Nelmary; Gaspar-Maia, Alexandre; Fernandez-Zapico, Martin E.			The transcription factor GLI1 cooperates with the chromatin remodeler SMARCA2 to regulate chromatin accessibility at distal DNA regulatory elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GLI family zinc finger 1 (GLI1); SWI; SNF related; matrix associated; actin dependent regulator of chromatin; subfamily A; member 2 (SMARCA2); enhancer; gene transcription; cancer cells; chromatin; epigenetic regulation; transcriptomics; ATAC-seq; chromatin; cancer; transcription enhancer; chromatin remodeling	SONIC HEDGEHOG; GENE-EXPRESSION; ACTIVATION; ONCOGENE; PROMOTER; PATHWAY; PCAF; BRG1; BRM	The transcription factor GLI1 (GLI family zinc finger 1) plays a key role in the development and progression of multiple malignancies. To date, regulation of transcriptional activity at target gene promoters is the only molecular event known to underlie the oncogenic function of GLI1. Here, we provide evidence that GLI1 controls chromatin accessibility at distal regulatory regions by modulating the recruitment of SMARCA2 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 2) to these elements. We demonstrate that SMARCA2 endogenously interacts with GLI1 and enhances its transcriptional activity. Mapping experiments indicated that the C-terminal transcriptional activation domain of GLI1 and SMARCA2's central domains, including its ATPase motif, are required for this interaction. Interestingly, similar to SMARCA2, GLI1 overexpression increased chromatin accessibility, as indicated by results of the micrococcal nuclease assay. Further, results of assays for transposase-accessible chromatin with sequencing (ATAC-seq) after GLI1 knockdown supported these findings, revealing that GLI1 regulates chromatin accessibility at several regions distal to gene promoters. Integrated RNA-seq and ATAC-seq data analyses identified a subset of differentially expressed genes located incisto these regulated chromatin sites. Finally, using the GLI1-regulated geneHHIP(Hedgehog-interacting protein) as a model, we demonstrate that GLI1 and SMARCA2 co-occupy a distal chromatin peak and that SMARCA2 recruitment to this HHIP putative enhancer requires intact GLI1. These findings provide insights into how GLI1 controls gene expression in cancer cells and may inform approaches targeting this oncogenic transcription factor to manage malignancies.	[Safgren, Stephanie L.; Olson, Rachel L. O.; Vrabel, Anne M.; Almada, Luciana L.; Marks, David L.; Hernandez-Alvarado, Nelmary; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Gaspar-Maia, Alexandre] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Hernandez-Alvarado, Nelmary] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	fernandez-zapico.martin@mayo.edu	Gaspar-Maia, Alexandre/AAY-5416-2020	Gaspar-Maia, Alexandre/0000-0001-8528-5575	NCI, National Institutes of Health [CA136526]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grant CA136526 (to M. E. F.-Z.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Bosco-Clement G, 2014, ONCOGENE, V33, P2087, DOI 10.1038/onc.2013.164; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Carr RM, 2020, J BIOL CHEM, V295, P2698, DOI 10.1074/jbc.RA119.011146; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Diao YM, 2018, MOL ONCOL, V12, P1718, DOI 10.1002/1878-0261.12366; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Fiaschi M, 2009, CANCER RES, V69, P4810, DOI 10.1158/0008-5472.CAN-08-3938; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Jiang H, 2014, INT J CLIN EXP PATHO, V7, P4531; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malatesta M, 2013, CANCER RES, V73, P6323, DOI 10.1158/0008-5472.CAN-12-4660; Marechal R, 2015, CLIN CANCER RES, V21, P1215, DOI 10.1158/1078-0432.CCR-14-0667; Mazza D, 2013, CELL DEATH DIFFER, V20, P1688, DOI 10.1038/cdd.2013.120; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Nye MD, 2014, J BIOL CHEM, V289, P15495, DOI 10.1074/jbc.M113.545194; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reisman DN, 2005, APPL IMMUNOHISTO M M, V13, P66, DOI 10.1097/00129039-200503000-00011; Stark R., 2016, DIFFBIND DIFFERENTIA; Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5; Wu M, 2016, J BIOL CHEM, V291, P25749, DOI 10.1074/jbc.M116.753129; Xu LS, 2010, BREAST CANCER RES TR, V123, P59, DOI 10.1007/s10549-009-0617-5; Yoon JW, 2015, DNA REPAIR, V34, P9, DOI 10.1016/j.dnarep.2015.06.006; Yoon JW, 1998, J BIOL CHEM, V273, P3496, DOI 10.1074/jbc.273.6.3496; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108	38	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8725	8735		10.1074/jbc.RA120.013268	http://dx.doi.org/10.1074/jbc.RA120.013268			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32376693	Green Published, hybrid			2022-12-28	WOS:000546296800009
J	Xu, B; Qin, TT; Yu, JC; Giordano, TJ; Sartor, MA; Koenig, RJ				Xu, Bin; Qin, Tingting; Yu, Jingcheng; Giordano, Thomas J.; Sartor, Maureen A.; Koenig, Ronald J.			Novel role of ASH1L histone methyltransferase in anaplastic thyroid carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thyroid; cancer; gene expression; histone methylation; long noncoding RNA (lncRNA); microRNA; CCAT1; anaplastic thyroid cancer; ASH1-like histone lysine methyltransferase (ASH1L); epigenetics; miR-200b-3p; microRNA (miRNA)	RNA-SEQ; MUTATIONAL LANDSCAPE; DOWN-REGULATION; CANCER; GENE; PROTEIN; TUMORIGENESIS; CATENIN; CCAT1	Anaplastic thyroid cancer (ATC) is one of the most aggressive human malignancies, with an average life expectancy of ?6 months from the time of diagnosis. The genetic and epigenetic changes that underlie this malignancy are incompletely understood. We found that ASH1-like histone lysine methyltransferase (ASH1L) is overexpressed in ATC relative to the much less aggressive and more common differentiated thyroid cancer. This increased expression was due at least in part to reduced levels of microRNA-200b-3p (miR-200b-3p), which represses ASH1L expression, in ATC. Genetic knockout of ASH1L protein expression in ATC cell lines decreased cell growth both in culture and in mouse xenografts. RNA-Seq analysis of ASH1L knockoutversusWT ATC cell lines revealed that ASH1L is involved in the regulation of numerous cancer-related genes and gene sets. The pro-oncogenic long noncoding RNA colon cancer-associated transcript 1 (CCAT1) was one of the most highly (approximately 68-fold) down-regulated transcripts in ASH1L knockout cells. Therefore, we investigated CCAT1 as a potential mediator of the growth-inducing activity of ASH1L. Supporting this hypothesis, CCAT1 knockdown in ATC cells decreased their growth rate, and ChIP-Seq data indicated that CCAT1 is likely a direct target of ASH1L's histone methyltransferase activity. These results indicate that ASH1L contributes to the aggressiveness of ATC and suggest that ASH1L, along with its upstream regulator miR-200b-3p and its downstream mediator CCAT1, represents a potential therapeutic target in ATC.	[Xu, Bin; Yu, Jingcheng; Koenig, Ronald J.] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Qin, Tingting; Sartor, Maureen A.] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI USA; [Giordano, Thomas J.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, B; Koenig, RJ (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	bxu@umich.edu; rkoenig@umich.edu		Giordano, Thomas/0000-0003-0641-8873	National Cancer Institute of the National Institutes of Health [P30CA046592]; Rogel Cancer Center Tissue and Molecular Pathology Shared Resource	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rogel Cancer Center Tissue and Molecular Pathology Shared Resource	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number P30CA046592 (to T. J. G.) by the use of the Rogel Cancer Center Tissue and Molecular Pathology Shared Resource. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2019, MICROB BIOTECHNOL, DOI DOI 10.1093/jb/mvz107; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonhomme B, 2017, THYROID, V27, P682, DOI 10.1089/thy.2016.0254; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Caillou B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022567; Cavalcante RG, 2017, BIOINFORMATICS, V33, P2381, DOI 10.1093/bioinformatics/btx183; Chen S, 2019, ONCOTARGETS THER, V12, P9215, DOI 10.2147/OTT.S216718; Chen YH, 2020, NUCLEIC ACIDS RES, V48, pD127, DOI 10.1093/nar/gkz757; Colamaio M, 2015, J CLIN ENDOCR METAB, V100, pE59, DOI 10.1210/jc.2014-2280; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DONGHI R, 1993, J CLIN INVEST, V91, P1753, DOI 10.1172/JCI116385; Enomoto K, 2017, J CLIN ENDOCR METAB, V102, P2268, DOI 10.1210/jc.2016-3771; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Feichtinger J, 2012, ONCOTARGET, V3, P843; Fujimoto A, 2016, NAT GENET, V48, P500, DOI 10.1038/ng.3547; Garcia-Rostan G, 1999, CANCER RES, V59, P1811; Ghafouri-Fard S, 2019, J CELL PHYSIOL, V234, P14581, DOI 10.1002/jcp.28176; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Guo XQ, 2017, J CANCER RES CLIN, V143, P555, DOI 10.1007/s00432-016-2268-3; Hebrant A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103871; Hough Soren H, 2016, Per Med, V13, P517, DOI 10.2217/pme-2016-0068; Hua F, 2019, GASTROENTEROLOGY, V156, P708, DOI 10.1053/j.gastro.2018.10.031; Ivanova AV, 2009, CLIN CANCER RES, V15, P2602, DOI 10.1158/1078-0432.CCR-08-2755; Jih G, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-117367; Jones M, 2015, J CLIN INVEST, V125, P2007, DOI 10.1172/JCI78124; Kebebew E, 2005, CANCER-AM CANCER SOC, V103, P1330, DOI 10.1002/cncr.20936; Kitamura Y, 1999, J CLIN ENDOCR METAB, V84, P4043, DOI 10.1210/jc.84.11.4043; Kumari N, 2016, TUMOR BIOL, V37, P11553, DOI 10.1007/s13277-016-5098-7; Kunstman JW, 2015, HUM MOL GENET, V24, P2318, DOI 10.1093/hmg/ddu749; Lancia I, 2016, J CLIN INVEST, V126, P1052, DOI 10.1172/JCI85271; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee C, 2016, BIOINFORMATICS, V32, P1100, DOI 10.1093/bioinformatics/btv694; Liu LX, 2015, ONCOTARGET, V6, P2466, DOI 10.18632/oncotarget.2967; Lu XM, 2018, NEOPLASMA, V65, P656, DOI 10.4149/neo_2018_171024N680; Mebarki S, 2016, ONCOTARGET, V7, P39026, DOI 10.18632/oncotarget.9346; Molinaro E, 2017, NAT REV ENDOCRINOL, V13, P644, DOI 10.1038/nrendo.2017.76; Nakamura T, 2000, P NATL ACAD SCI USA, V97, P7284, DOI 10.1073/pnas.97.13.7284; NAKAMURA T, 1992, JPN J CANCER RES, V83, P1293, DOI 10.1111/j.1349-7006.1992.tb02761.x; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P5399, DOI 10.1210/jc.2003-030838; Pallante P, 2014, NAT REV ENDOCRINOL, V10, P88, DOI 10.1038/nrendo.2013.223; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Sato T, 2000, THYROID, V10, P1113, DOI 10.1089/thy.2000.10.1113; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Shen W, 2019, EUR J MED GENET, V62, P55, DOI 10.1016/j.ejmg.2018.05.003; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Skawran B, 2008, MODERN PATHOL, V21, P505, DOI 10.1038/modpathol.3800998; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Tang TT, 2019, THERANOSTICS, V9, P7384, DOI 10.7150/thno.37892; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trissal MC, 2018, CANCER RES, V78, P3510, DOI 10.1158/0008-5472.CAN-17-3592; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Xia SJ, 2017, J CANCER, V8, P2816, DOI 10.7150/jca.18482; Xu B, 2016, J BIOL CHEM, V291, P19274, DOI 10.1074/jbc.M116.740324; Xu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014199; Yang Z, 2019, J CELL BIOCHEM, V120, P4634, DOI 10.1002/jcb.27751; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Zhu L, 2016, CANCER DISCOV, V6, P770, DOI 10.1158/2159-8290.CD-16-0058	67	14	14	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8834	8845		10.1074/jbc.RA120.013530	http://dx.doi.org/10.1074/jbc.RA120.013530			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32398261	Green Published, hybrid			2022-12-28	WOS:000546296800018
J	Esmaili, M; Tancowny, BP; Wang, XY; Moses, A; Cortez, LM; Sim, VL; Wille, H; Overduin, M				Esmaili, Mansoore; Tancowny, Brian P.; Wang, Xiongyao; Moses, Audric; Cortez, Leonardo M.; Sim, Valerie L.; Wille, Holger; Overduin, Michael			Native nanodiscs formed by styrene maleic acid copolymer derivatives help recover infectious prion multimers bound to brain-derived lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; nanotechnology; prion; lipid; lipid binding protein; neurodegenerative disease; lipid-protein interaction; protein misfolding; native nanodisc; SMALP; styrene maleic acid copolymer; styrene?maleic acid lipid particle (SMALP)	BRANCHED POLYAMINES; PROTEIN; SMA; EXTRACTION; RAFTS	Prions are lipidated proteins that interact with endogenous lipids and metal ions. They also assemble into multimers and propagate into the infectious scrapie form known as PrPSc. The high-resolution structure of the infectious PrP(Sc)state remains unknown, and its analysis largely relies on detergent-based preparations devoid of endogenous ligands. Here we designed polymers that allow isolation of endogenous membrane:protein assemblies in native nanodiscs without exposure to conventional detergents that destabilize protein structures and induce fibrillization. A set of styrene?maleic acid (SMA) polymers including a methylamine derivative facilitated gentle release of the infectious complexes for resolution of multimers, and a thiol-containing version promoted crystallization. Polymer extraction from brain homogenates from Syrian hamsters infected with Hyper prions and WT mice infected with Rocky Mountain Laboratories prions yielded infectious prion nanoparticles including oligomers and microfilaments bound to lipid vesicles. Lipid analysis revealed the brain phospholipids that associate with prion protofilaments, as well as those that are specifically enriched in prion assemblies captured by the methylamine-modified copolymer. A comparison of the infectivity of PrP(Sc)attached to SMA lipid particles in mice and hamsters indicated that these amphipathic polymers offer a valuable tool for high-yield production of intact, detergent-free prions that retainin vivoactivity. This native prion isolation method provides an avenue for producing relevant prion:lipid targets and potentially other proteins that form multimeric assemblies and fibrils on membranes.	[Esmaili, Mansoore; Tancowny, Brian P.; Wang, Xiongyao; Wille, Holger; Overduin, Michael] Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB, Canada; [Tancowny, Brian P.; Wang, Xiongyao; Cortez, Leonardo M.; Sim, Valerie L.; Wille, Holger] Univ Alberta, Ctr Prions & Prot Folding Dis, Fac Med & Dent, Edmonton, AB, Canada; [Moses, Audric] Univ Alberta, Fac Med & Dent, Lipid Core Facil, Edmonton, AB, Canada; [Cortez, Leonardo M.; Sim, Valerie L.] Univ Alberta, Ctr Prions & Prot Folding Dis, Dept Med, Div Neurol, Edmonton, AB, Canada; [Cortez, Leonardo M.; Sim, Valerie L.] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta; University of Alberta	Wille, H; Overduin, M (corresponding author), Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB, Canada.; Wille, H (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Fac Med & Dent, Edmonton, AB, Canada.	overduin@ualberta.ca; wille@ualberta.ca	Wille, Holger/C-2280-2008	Wille, Holger/0000-0001-5102-8706; Overduin, Michael/0000-0002-3114-6585; Cortez, Leonardo/0000-0003-4080-8728	Alberta Prion Research Institute Exploration Grant [201600018]; NSERC [RGPIN-2018-04994]; Campus Alberta Innovates Program Grant [RCP-12-002C]; Alberta Prion Research Institute Team Program Award [201600029]	Alberta Prion Research Institute Exploration Grant; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Campus Alberta Innovates Program Grant; Alberta Prion Research Institute Team Program Award	This work was supported by Alberta Prion Research Institute Exploration Grant 201600018 (to M. O.), NSERC Discovery Grant RGPIN-2018-04994 (to M. O.), Campus Alberta Innovates Program Grant RCP-12-002C (to M. O.), and Alberta Prion Research Institute Team Program Award 201600029 (to H. W.).	Angelisova P, 2019, BBA-BIOMEMBRANES, V1861, P130, DOI 10.1016/j.bbamem.2018.08.006; Bode DC, 2019, J BIOL CHEM, V294, P7566, DOI 10.1074/jbc.AC118.007195; Botsios S, 2015, VIRULENCE, V6, P787, DOI 10.1080/21505594.2015.1098804; Breyer J, 2012, VET MICROBIOL, V157, P23, DOI 10.1016/j.vetmic.2011.12.008; Camargo M, 2013, HUM REPROD, V28, P33, DOI 10.1093/humrep/des357; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Dorr JM, 2016, EUR BIOPHYS J BIOPHY, V45, P3, DOI 10.1007/s00249-015-1093-y; Dorr JM, 2014, P NATL ACAD SCI USA, V111, P18607, DOI 10.1073/pnas.1416205112; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Fischer M, 2010, BIOMACROMOLECULES, V11, P1314, DOI 10.1021/bm100101s; Giles K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023499; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Graeve M, 2009, J CHROMATOGR B, V877, P1815, DOI 10.1016/j.jchromb.2009.05.004; Grethen A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11616-z; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Gursky O, 2015, ADV EXP MED BIOL, V855, pV; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Klein TR, 1998, BIOL CHEM, V379, P655, DOI 10.1515/bchm.1998.379.6.655; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Korotych O, 2019, EUR POLYM J, V114, P485, DOI 10.1016/j.eurpolymj.2018.10.035; Korshavn KJ, 2017, J BIOL CHEM, V292, P4638, DOI 10.1074/jbc.M116.764092; Lee SC, 2016, NAT PROTOC, V11, P1149, DOI 10.1038/nprot.2016.070; Levine DJ, 2015, ACS CHEM BIOL, V10, P1269, DOI 10.1021/cb5006239; Lim YB, 2010, BIOMATERIALS, V31, P2025, DOI 10.1016/j.biomaterials.2009.11.085; Lindhoud S, 2016, BIOMACROMOLECULES, V17, P1516, DOI 10.1021/acs.biomac.6b00140; McCarthy JM, 2013, BIOMACROMOLECULES, V14, P27, DOI 10.1021/bm301165u; MCKINLEY MP, 1991, LAB INVEST, V65, P622; Morrison KA, 2016, BIOCHEM J, V473, P4349, DOI 10.1042/BCJ20160723; Overduin M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9061230; Overduin M, 2019, CHEM PHYS LIPIDS, V218, P73, DOI 10.1016/j.chemphyslip.2018.11.008; Priola SA, 2009, PRION, V3, P134, DOI 10.4161/pri.3.3.9771; Qiu WH, 2018, P NATL ACAD SCI USA, V115, P12985, DOI 10.1073/pnas.1812526115; Riesner D, 2003, BRIT MED BULL, V66, P21, DOI 10.1093/bmb/66.1.21; Sciacca MFM, 2018, BBA-BIOMEMBRANES, V1860, P1625, DOI 10.1016/j.bbamem.2018.02.022; Shaked Y, 2002, J NEUROCHEM, V82, P1, DOI 10.1046/j.1471-4159.2002.00995.x; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sun C, 2018, NATURE, V557, P123, DOI 10.1038/s41586-018-0061-y; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Taylor DR, 2006, MOL MEMBR BIOL, V23, P89, DOI 10.1080/09687860500449994; Terry C, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160035; Teruya K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006045; Thody SA, 2018, BBA-BIOMEMBRANES, V1860, P1927, DOI 10.1016/j.bbamem.2018.02.031; Tonge SR, 2001, ADV DRUG DELIVER REV, V53, P109, DOI 10.1016/S0169-409X(01)00223-X; Tsukigawa K, 2015, CANCER SCI, V106, P270, DOI 10.1111/cas.12592; Wang F, 2013, ACTA BIOCH BIOPH SIN, V45, P485, DOI 10.1093/abbs/gmt038; Wenborn A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10062; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; Wille H, 1999, BIOPHYS J, V76, P1048, DOI 10.1016/S0006-3495(99)77270-X; Wille H, 2009, P NATL ACAD SCI USA, V106, P3740, DOI 10.1073/pnas.0812770106	52	9	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8460	8469		10.1074/jbc.RA119.012348	http://dx.doi.org/10.1074/jbc.RA119.012348			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32358064	hybrid, Green Published			2022-12-28	WOS:000546986500010
J	Garcia, PAA; Lovejoy, CM; Nagarajan, P; Park, D; Popova, LV; Freitas, MA; Parthun, MR				Garcia, Paula A. Agudelo; Lovejoy, Callie M.; Nagarajan, Prabakaran; Park, Dongju; Popova, Liudmila V.; Freitas, Michael A.; Parthun, Mark R.			Histone acetyltransferase 1 is required for DNA replication fork function and stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyltransferase; acetylation; DNA replication; histone acetylase; chromatin; chromatin assembly; HAT1; replication fork; replication fork stalling; replication stress	CHAPERONE ASF1; NASCENT DNA; CHROMATIN; H3; ACETYLATION; LYSINE-56; H3-H4; BINDING; H4; INHERITANCE	The replisome is a protein complex on the DNA replication fork and functions in a dynamic environment at the intersection of parental and nascent chromatin. Parental nucleosomes are disrupted in front of the replication fork. The daughter DNA duplexes are packaged with an equal amount of parental and newly synthesized histones in the wake of the replication fork through the activity of the replication-coupled chromatin assembly pathway. Histone acetyltransferase 1 (HAT1) is responsible for the cytosolic diacetylation of newly synthesized histone H4 on lysines 5 and 12, which accompanies replication-coupled chromatin assembly. Here, using proximity ligation assay-based chromatin assembly assays and DNA fiber analysis, we analyzed the role of murine HAT1 in replication-coupled chromatin assembly. We demonstrate that HAT1 physically associates with chromatin near DNA replication sites. We found that the association of HAT1 with newly replicated DNA is transient, but can be stabilized by replication fork stalling. The association of HAT1 with nascent chromatin may be functionally relevant, as HAT1 loss decreased replication fork progression and increased replication fork stalling. Moreover, in the absence of HAT1, stalled replication forks were unstable, and newly synthesized DNA became susceptible to MRE11-dependent degradation. These results suggest that HAT1 links replication fork function to the proper processing and assembly of newly synthesized histones.	[Garcia, Paula A. Agudelo; Lovejoy, Callie M.; Nagarajan, Prabakaran; Popova, Liudmila V.; Parthun, Mark R.] Ohio State Univ, Dept Biol Chem, Columbus, OH 43210 USA; [Park, Dongju] Ohio State Univ, Dept Pharmacol, Columbus, OH 43210 USA; [Freitas, Michael A.] Ohio State Univ, Dept Canc Biol & Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Parthun, MR (corresponding author), Ohio State Univ, Dept Biol Chem, Columbus, OH 43210 USA.	parthun.1@osu.edu	NAGARAJAN, PRABAKARAN/AAA-2881-2020	NAGARAJAN, PRABAKARAN/0000-0001-6124-3274	National Institutes of Health NINDS [P30 NS104177]	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Microscopy was supported by a grant from the National Institutes of Health NINDS Grant P30 NS104177.	Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; Alvarez F, 2011, J BIOL CHEM, V286, P17714, DOI 10.1074/jbc.M111.223453; Annunziato AT, 2012, BBA-GENE REGUL MECH, V1819, P196, DOI 10.1016/j.bbagrm.2011.07.005; Barman HK, 2008, BIOCHEM BIOPH RES CO, V373, P624, DOI 10.1016/j.bbrc.2008.06.100; Bellelli R, 2018, MOL CELL, V72, P112, DOI 10.1016/j.molcel.2018.08.043; Bhaskara S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-27; Bhat KP, 2018, NAT STRUCT MOL BIOL, V25, P446, DOI 10.1038/s41594-018-0075-z; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Campos EI, 2010, NAT STRUCT MOL BIOL, V17, P1343, DOI 10.1038/nsmb.1911; Chang L, 1997, BIOCHEMISTRY-US, V36, P469, DOI 10.1021/bi962069i; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Clement C, 2015, NAT STRUCT MOL BIOL, V22, P587, DOI 10.1038/nsmb.3067; Clemente-Ruiz M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002376; Clemente-Ruiz M, 2009, EMBO REP, V10, P790, DOI 10.1038/embor.2009.67; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Ejlassi-Lassallette A, 2011, MOL BIOL CELL, V22, P245, DOI 10.1091/mbc.E10-07-0633; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Finn RM, 2008, BIOPHYS J, V95, P1314, DOI 10.1529/biophysj.108.130021; Foltman M, 2013, CELL REP, V3, P892, DOI 10.1016/j.celrep.2013.02.028; Franco AA, 2005, GENE DEV, V19, P1365, DOI 10.1101/gad.1305005; Garcia PAA, 2020, J PROTEOME RES, V19, P1663, DOI 10.1021/acs.jproteome.9b00843; Garcia PAA, 2017, NUCLEIC ACIDS RES, V45, P9319, DOI 10.1093/nar/gkx545; Ge ZQ, 2013, MOL CELL BIOL, V33, P3286, DOI 10.1128/MCB.00460-13; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, J BIOL CHEM, V282, P14158, DOI 10.1074/jbc.M700611200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Huang HD, 2015, NAT STRUCT MOL BIOL, V22, P618, DOI 10.1038/nsmb.3055; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Jasencakova Z, 2010, SEMIN CELL DEV BIOL, V21, P231, DOI 10.1016/j.semcdb.2009.09.018; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Kehrli K, 2016, J BIOL CHEM, V291, P24487, DOI 10.1074/jbc.M115.708594; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; Kolinjivadi AM, 2017, MOL CELL, V67, P867, DOI 10.1016/j.molcel.2017.07.001; Lazarchuk P, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00421-19; Lazarchuk P, 2019, METHODS MOL BIOL, V1983, P29, DOI 10.1007/978-1-4939-9434-2_3; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Liu SF, 2017, SCIENCE, V355, P415, DOI 10.1126/science.aah4712; Liu WH, 2012, NUCLEIC ACIDS RES, V40, P11229, DOI 10.1093/nar/gks906; Malay AD, 2008, J BIOL CHEM, V283, P14022, DOI 10.1074/jbc.M800594200; Mejlvang J, 2014, J CELL BIOL, V204, P29, DOI 10.1083/jcb.201305017; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Milutinovic S, 2002, J BIOL CHEM, V277, P20974, DOI 10.1074/jbc.M202504200; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Nagarajan P, 2019, AGING CELL, V18, DOI 10.1111/acel.12992; Nagarajan P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003518; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Petruk S, 2017, MOL CELL, V66, P247, DOI 10.1016/j.molcel.2017.03.006; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; Qin S, 2006, MOL CELL BIOL, V26, P3649, DOI 10.1128/MCB.26.9.3649-3658.2006; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Richet N, 2015, NUCLEIC ACIDS RES, V43, P1905, DOI 10.1093/nar/gkv021; Ridgway P, 2000, J CELL SCI, V113, P2647; Rivera C, 2015, NUCLEIC ACIDS RES, V43, P9097, DOI 10.1093/nar/gkv929; Roy S, 2018, J CELL BIOL, V217, P1553, DOI 10.1083/JCB.20170912103212018c; Saade E, 2009, PROTEOMICS, V9, P4934, DOI 10.1002/pmic.200900206; SEALE RL, 1975, J MOL BIOL, V94, P479, DOI 10.1016/0022-2836(75)90216-8; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Suter B, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-38; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Tyler JK, 2001, MOL CELL BIOL, V21, P6574, DOI 10.1128/MCB.21.19.6574-6584.2001; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Wang H, 2015, PROTEIN CELL, V6, P693, DOI 10.1007/s13238-015-0190-0; Wang HY, 2008, NUCLEIC ACIDS RES, V36, P5763, DOI 10.1093/nar/gkn574; Wang HY, 2012, NUCLEIC ACIDS RES, V40, P660, DOI 10.1093/nar/gkr781; WEINTRAU.H, 1972, NATURE, V240, P449, DOI 10.1038/240449a0; WEINTRAUB H, 1972, J MOL BIOL, V66, P13, DOI 10.1016/S0022-2836(72)80003-2; Wessel SR, 2019, CELL REP, V28, P3497, DOI 10.1016/j.celrep.2019.08.051; Yang JY, 2016, CELL REP, V16, P3414, DOI 10.1016/j.celrep.2016.08.070; Yang XH, 2013, J BIOL CHEM, V288, P18271, DOI 10.1074/jbc.M113.473199	80	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8363	8373		10.1074/jbc.RA120.013496	http://dx.doi.org/10.1074/jbc.RA120.013496			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32366460	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000546986500002
J	Khan, MA; Srivastava, SK; Zubair, H; Patel, GK; Arora, S; Khushman, M; Carter, JE; Gorman, GS; Singh, S; Singh, AP				Khan, Mohammad Aslam; Srivastava, Sanjeev Kumar; Zubair, Haseeb; Patel, Girijesh Kumar; Arora, Sumit; Khushman, Moh'd; Carter, James Elliot; Gorman, Gregory Stephen; Singh, Seema; Singh, Ajay Pratap			Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreatic cancer; chemoresistance; sonic hedgehog (SHH); C-X-C chemokine receptor type 4 (CXCR-4); stromal cell; cancer stemness; chemotherapy; pancreatic stellate cell (PSC); paracrine signaling; cancer stemness	GEMCITABINE-METABOLIZING ENZYME; SONIC HEDGEHOG; MOUSE MODEL; PROMOTES DESMOPLASIA; CELLS; EXPRESSION; CHEMORESISTANCE; RESISTANCE; SURVIVAL; ADENOCARCINOMA	Pancreatic cancer (PC) remains a therapeutic challenge because of its intrinsic and extrinsic chemoresistance mechanisms. Here, we report that C-X-C motif chemokine receptor 4 (CXCR4) and hedgehog pathways cooperate in PC chemoresistance via bidirectional tumor-stromal crosstalk. We show that when PC cells are co-cultured with pancreatic stellate cells (PSCs) they are significantly more resistant to gemcitabine toxicity than those grown in monoculture. We also demonstrate that this co-culture?induced chemoresistance is abrogated by inhibition of the CXCR4 and hedgehog pathways. Similarly, the co-culture?induced altered expression of genes in PC cells associated with gemcitabine metabolism, antioxidant defense, and cancer stemness is also reversed upon CXCR4 and hedgehog inhibition. We have confirmed the functional impact of these genetic alterations by measuring gemcitabine metabolites, reactive oxygen species production, and sphere formation in vehicle- or gemcitabine-treated monocultures and co-cultured PC cells. Treatment of orthotopic pancreatic tumor?bearing mice with gemcitabine alone or in combination with a CXCR4 antagonist (AMD3100) or hedgehog inhibitor (GDC-0449) displays reduced tumor growth. Notably, we show that the triple combination treatment is the most effective, resulting in nearly complete suppression of tumor growth. Immunohistochemical analysis of Ki67 and cleaved caspase-3 confirm these findings fromin vivoimaging and tumor measurements. Our findings provide preclinical and mechanistic evidence that a combination of gemcitabine treatment with targeted inhibition of both the CXCR4 and hedgehog pathways improves outcomes in a PC mouse model.	[Khan, Mohammad Aslam; Srivastava, Sanjeev Kumar; Zubair, Haseeb; Carter, James Elliot; Singh, Seema; Singh, Ajay Pratap] Univ S Alabama, Coll Med, Dept Pathol, Mobile, AL 36688 USA; [Khan, Mohammad Aslam; Srivastava, Sanjeev Kumar; Zubair, Haseeb; Patel, Girijesh Kumar; Arora, Sumit; Singh, Seema; Singh, Ajay Pratap] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36688 USA; [Khushman, Moh'd] Univ S Alabama, Mitchell Canc Inst, Dept Med Oncol, Mobile, AL USA; [Gorman, Gregory Stephen] Samford Univ, Pharmaceut Sci Res Inst, Birmingham, AL USA; [Singh, Seema; Singh, Ajay Pratap] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama; Samford University; University of South Alabama	Singh, AP (corresponding author), Univ S Alabama, Coll Med, Dept Pathol, Mobile, AL 36688 USA.; Singh, AP (corresponding author), Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36688 USA.; Singh, AP (corresponding author), Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA.	asingh@health.southalabama.edu		Singh, Ajay/0000-0003-3492-6330	NCI, National Institutes of Health [R01CA175772, R01CA224306]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI, National Institutes of Health Grants R01CA175772 and R01CA224306 (to A. P. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aiello Nicole M, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot078360; Aier I, 2019, CANCER EPIDEMIOL, V58, P104, DOI 10.1016/j.canep.2018.12.001; Allison Malorye, 2012, Nat Biotechnol, V30, P203, DOI 10.1038/nbt0312-203; Amrutkar M, 2017, CANCERS, V9, DOI 10.3390/cancers9110157; Ansari D, 2019, ANTICANCER RES, V39, P3317, DOI 10.21873/anticanres.13474; Arora S, 2013, J BIOL CHEM, V288, P21197, DOI 10.1074/jbc.M113.484576; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bhardwaj A, 2016, J BIOL CHEM, V291, P16263, DOI 10.1074/jbc.M116.732651; Chen F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06860-4; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Costantino CL, 2009, CANCER RES, V69, P4567, DOI 10.1158/0008-5472.CAN-09-0371; Deshmukh SK, 2017, CANCER LETT, V396, P21, DOI 10.1016/j.canlet.2017.03.010; Ene-Obong A, 2013, GASTROENTEROLOGY, V145, P1121, DOI 10.1053/j.gastro.2013.07.025; Fiorini C, 2015, BBA-MOL CELL RES, V1853, P549, DOI 10.1016/j.bbamcr.2014.12.016; Fiorini C, 2015, BBA-MOL CELL RES, V1853, P89, DOI 10.1016/j.bbamcr.2014.10.003; Frese KK, 2012, CANCER DISCOV, V2, P260, DOI 10.1158/2159-8290.CD-11-0242; Fu JS, 2013, CANCER LETT, V330, P22, DOI 10.1016/j.canlet.2012.11.018; Herreros-Villanueva M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.23; Herreros-Villanueva M, 2014, WORLD J GASTROENTERO, V20, P2247, DOI 10.3748/wjg.v20.i9.2247; Hu QS, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12456; Hunsucker SA, 2001, J BIOL CHEM, V276, P10498, DOI 10.1074/jbc.M011218200; Ju HQ, 2015, MOL CANCER THER, V14, P788, DOI 10.1158/1535-7163.MCT-14-0420; Khan MA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040779; Khan MA, 2015, ONCOTARGET, V6, P39140, DOI 10.18632/oncotarget.3784; Khan MA, 2012, MOL CANCER THER, V11, P1873, DOI 10.1158/1535-7163.MCT-12-0141; Kumari S, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271918755391; Li XQ, 2014, CLIN CANCER RES, V20, P4326, DOI 10.1158/1078-0432.CCR-13-3426; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Lu YH, 2013, CANCER LETT, V340, P113, DOI 10.1016/j.canlet.2013.07.009; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Meng QC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1244-z; Meng QC, 2018, ONCOGENE, V37, P5843, DOI 10.1038/s41388-018-0392-z; Miyamoto H, 2004, PANCREAS, V28, P38, DOI 10.1097/00006676-200401000-00006; Neesse A, 2019, GUT, V68, P159, DOI 10.1136/gutjnl-2018-316451; Nikitovic D, 2013, FOOD CHEM TOXICOL, V61, P178, DOI 10.1016/j.fct.2013.06.013; Nunes T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124036; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Patel GK, 2017, BRIT J CANCER, V116, P609, DOI 10.1038/bjc.2017.18; Patzak MS, 2019, EBIOMEDICINE, V40, P394, DOI 10.1016/j.ebiom.2019.01.037; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Saiki Y, 2012, BIOCHEM BIOPH RES CO, V421, P98, DOI 10.1016/j.bbrc.2012.03.122; Saur D, 2005, GASTROENTEROLOGY, V129, P1237, DOI 10.1053/j.gastro.2005.06.056; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Singh A. P., 2016, STEM CELLS TOXICOLOG, P375; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; Singh BN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027306; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Soini Y, 2014, PATHOL RES PRACT, V210, P35, DOI 10.1016/j.prp.2013.10.001; Thomas D, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0927-5; Tu YM, 2017, SCI REP-UK, V7, DOI 10.1038/srep42630; von Ahrens D, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0448-5; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang Z, 2013, ANTICANCER RES, V33, P4103; Wang-Gillam A, 2016, LANCET, V387, P545, DOI 10.1016/S0140-6736(15)00986-1; Weizman N, 2014, ONCOGENE, V33, P3812, DOI 10.1038/onc.2013.357; Xiao GF, 2017, CELL PHYSIOL BIOCHEM, V43, P840, DOI 10.1159/000481610; Xiong JJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002936; Zhang JB, 2018, ONCOL LETT, V15, P1771, DOI 10.3892/ol.2017.7512; Zubair H, 2016, CANCER RES, V76, P7254, DOI 10.1158/0008-5472.CAN-16-1666	62	19	20	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8413	8424		10.1074/jbc.RA119.011748	http://dx.doi.org/10.1074/jbc.RA119.011748			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32358063	Green Published, hybrid			2022-12-28	WOS:000546986500006
J	Zoltner, M; Campagnaro, GD; Taleva, G; Burrell, A; Cerone, M; Leung, KF; Achcar, F; Horn, D; Vaughan, S; Gadelha, C; Zikova, A; Barrett, MP; de Koning, HP; Field, MC				Zoltner, Martin; Campagnaro, Gustavo D.; Taleva, Gergana; Burrell, Alana; Cerone, Michela; Leung, Ka-Fai; Achcar, Fiona; Horn, David; Vaughan, Sue; Gadelha, Catarina; Zikova, Alena; Barrett, Michael P.; de Koning, Harry P.; Field, Mark C.			Suramin exposure alters cellular metabolism and mitochondrial energy production in African trypanosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						drug action; trypanosome; Trypanosoma brucei; parasite metabolism; metabolomics; suramin; glycosomes; polypharmacology; proteomics; differentiation; drug mechanisms; energy homeostasis; sleeping sickness	TRYPANOCIDAL DRUG SURAMIN; WEB-BASED TOOL; PROLINE METABOLISM; MASS-SPECTROMETRY; BRUCEI; IDENTIFICATION; MEMBRANE; RESISTANCE; INHIBITORS; EXPRESSION	Introduced about a century ago, suramin remains a frontline drug for the management of early-stage East African trypanosomiasis (sleeping sickness). Cellular entry into the causative agent, the protozoan parasiteTrypanosoma brucei, occurs through receptor-mediated endocytosis involving the parasite's invariant surface glycoprotein 75 (ISG75), followed by transport into the cytosol via a lysosomal transporter. The molecular basis of the trypanocidal activity of suramin remains unclear, but some evidence suggests broad, but specific, impacts on trypanosome metabolism (i.e.polypharmacology). Here we observed that suramin is rapidly accumulated in trypanosome cells proportionally to ISG75 abundance. Although we found little evidence that suramin disrupts glycolytic or glycosomal pathways, we noted increased mitochondrial ATP production, but a net decrease in cellular ATP levels. Metabolomics highlighted additional impacts on mitochondrial metabolism, including partial Krebs' cycle activation and significant accumulation of pyruvate, corroborated by increased expression of mitochondrial enzymes and transporters. Significantly, the vast majority of suramin-induced proteins were normally more abundant in the insect forms compared with the blood stage of the parasite, including several proteins associated with differentiation. We conclude that suramin has multiple and complex effects on trypanosomes, but unexpectedly partially activates mitochondrial ATP-generating activity. We propose that despite apparent compensatory mechanisms in drug-challenged cells, the suramin-induced collapse of cellular ATP ultimately leads to trypanosome cell death.	[Zoltner, Martin; Horn, David; Field, Mark C.] Univ Dundee, Sch Life Sci, Dundee, Scotland; [Campagnaro, Gustavo D.; Cerone, Michela; de Koning, Harry P.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Achcar, Fiona; Barrett, Michael P.] Univ Glasgow, Wellcome Ctr Integrat Parasitol & Glasgow Poly, Glasgow, Lanark, Scotland; [Taleva, Gergana; Zikova, Alena; Field, Mark C.] Univ South Bohemia, Czech Acad Sci, Inst Parasitol, Fac Sci,Biol Ctr, Ceske Budejovice, Czech Republic; [Burrell, Alana; Vaughan, Sue] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford, England; [Leung, Ka-Fai] Univ Cambridge, Dept Pathol, Cambridge, England; [Gadelha, Catarina] Univ Nottingham, Sch Life Sci, Nottingham, England; [Zoltner, Martin] Charles Univ Prague, Fac Sci, Dept Parasitol, BIOCEV, Vestec, Czech Republic	University of Dundee; University of Glasgow; University of Glasgow; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Oxford Brookes University; University of Cambridge; University of Nottingham; Charles University Prague	Field, MC (corresponding author), Univ Dundee, Sch Life Sci, Dundee, Scotland.; Field, MC (corresponding author), Univ South Bohemia, Czech Acad Sci, Inst Parasitol, Fac Sci,Biol Ctr, Ceske Budejovice, Czech Republic.	mfield@mac.com	Gadelha, Catarina/ABD-5623-2021; Zikova, Alena/G-7855-2014; Field, Mark/AAD-6455-2021	Gadelha, Catarina/0000-0001-5016-3682; Zikova, Alena/0000-0002-8686-0225; Horn, David/0000-0001-5173-9284; Campagnaro, Gustavo/0000-0001-6542-0485; Cerone, Michela/0000-0003-0535-3983; Burrell, Alana/0000-0002-6067-5160; De Koning, Harry/0000-0002-9963-1827; Achcar, Fiona/0000-0001-8792-7615	Wellcome Trust [104111/Z/14/Z, 204697/Z/16/Z]; Medical Research Council [MR/P009018/1]; Leverhulme Trust Early Career Fellowship [ECF-2015-392]; University of Bologna, Italy; Science Without Borders (CNPq, Brazil) [206385/2014-5]; Czech Academy of Science [CZ.02.1.01/0.0/0.0/16_019/0000759];  [17-22248S]; MRC [MR/N010558/1, MR/N01037X/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leverhulme Trust Early Career Fellowship(Leverhulme Trust); University of Bologna, Italy; Science Without Borders (CNPq, Brazil); Czech Academy of Science(Czech Academy of Sciences); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Grant 204697/Z/16/Z (to M. C. F.) and Medical Research Council Grant MR/P009018/1 (to M. C. F.). M. C. F. and D. H. are Wellcome Trust investigators. F. A. was supported by Leverhulme Trust Early Career Fellowship ECF-2015-392. M. P. B. was supported by Wellcome Trust Grant 104111/Z/14/Z. M. C. was supported by a post-lauream fellowship from the University of Bologna, Italy. G. D. C. received a Ph.D. scholarship from Science Without Borders (206385/2014-5, CNPq, Brazil). A. Z. was supported by Grant 17-22248S and ERD Fund Grant CZ.02.1.01/0.0/0.0/16_019/0000759 Czech Academy of Science.	ABEBE G, 1983, TROP ANIM HEALTH PRO, V15, P151, DOI 10.1007/BF02239924; Akama T, 2018, BIOORG MED CHEM LETT, V28, P6, DOI 10.1016/j.bmcl.2017.11.028; Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016; Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Alsford S, 2008, MOL BIOCHEM PARASIT, V161, P76, DOI 10.1016/j.molbiopara.2008.05.006; Alsford S, 2013, TRENDS PARASITOL, V29, P207, DOI 10.1016/j.pt.2013.03.004; Alsford S, 2012, NATURE, V482, P232, DOI 10.1038/nature10771; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Barrett MP, 2011, FUTURE MICROBIOL, V6, P1037, DOI [10.2217/FMB.11.88, 10.2217/fmb.11.88]; Begolo D, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007315; BRINGAUD F, 1993, MOL CELL BIOL, V13, P1146, DOI 10.1128/MCB.13.2.1146; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; Chokkathukalam A, 2013, BIOINFORMATICS, V29, P281, DOI 10.1093/bioinformatics/bts674; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Chung WL, 2008, TRAFFIC, V9, P1681, DOI 10.1111/j.1600-0854.2008.00785.x; Colasante C, 2018, MOL BIOCHEM PARASIT, V221, P36, DOI 10.1016/j.molbiopara.2018.03.003; Colasante C, 2009, MOL BIOCHEM PARASIT, V167, P104, DOI 10.1016/j.molbiopara.2009.05.004; COLLINS JM, 1986, J CLIN PHARMACOL, V26, P22; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croci R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091765; CROSS GAM, 1975, PARASITOLOGY, V71, P311, DOI 10.1017/S0031182000046758; Dejung M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005439; Deramchia K, 2014, J BIOL CHEM, V289, P17365, DOI 10.1074/jbc.M114.567230; Fairlamb AH, 2018, TRENDS PARASITOL, V34, P481, DOI 10.1016/j.pt.2018.04.002; FANG Y, 1994, ACTA TROP, V58, P79, DOI 10.1016/0001-706X(94)90123-6; Field MC, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.193; Gadelha C, 2009, P NATL ACAD SCI USA, V106, P17425, DOI 10.1073/pnas.0909289106; Giordani F, 2016, PARASITOLOGY, V143, P1862, DOI 10.1017/S0031182016001268; Gloaguen Y, 2017, BIOINFORMATICS, V33, P4007, DOI 10.1093/bioinformatics/btx499; Haanstra JR, 2016, BBA-MOL CELL RES, V1863, P1038, DOI 10.1016/j.bbamcr.2015.09.015; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; HIRUMI H, 1994, PARASITOL TODAY, V10, P80, DOI 10.1016/0169-4758(94)90402-2; Kerkhoven EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003371; Koeller CM, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12980; Kovarova J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006953; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Leung KF, 2011, EUKARYOT CELL, V10, P916, DOI 10.1128/EC.05012-11; Lingnau A, 1999, J CELL SCI, V112, P3061; Mantilla BS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006158; Mazet M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002587; McCain DF, 2004, J BIOL CHEM, V279, P14713, DOI 10.1074/jbc.M312488200; Mesu VKBK, 2018, LANCET, V391, P144, DOI 10.1016/S0140-6736(17)32758-7; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Mony BM, 2015, MOL MICROBIOL, V96, P220, DOI 10.1111/mmi.12949; Mony BM, 2014, NATURE, V505, P681, DOI 10.1038/nature12864; Morgan HP, 2011, J BIOL CHEM, V286, P31232, DOI 10.1074/jbc.M110.212613; Natesan Senthil Ka, 2010, BMC Res Notes, V3, P63, DOI 10.1186/1756-0500-3-63; Naviaux RK, 2017, ANN CLIN TRANSL NEUR, V4, P491, DOI 10.1002/acn3.424; Ong HB, 2015, MOL MICROBIOL, V95, P143, DOI 10.1111/mmi.12853; Opoku-Temeng C, 2016, CHEM COMMUN, V52, P3754, DOI 10.1039/c5cc10446g; Pal A, 2002, MOL BIOCHEM PARASIT, V122, P217, DOI 10.1016/S0166-6851(02)00096-8; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rattigan KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194126; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Rico E, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00078; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Riviere L, 2009, P NATL ACAD SCI USA, V106, P12694, DOI 10.1073/pnas.0903355106; Rotureau B, 2011, CELL MICROBIOL, V13, P705, DOI 10.1111/j.1462-5822.2010.01566.x; Saldivia M, 2016, CELL REP, V17, P660, DOI 10.1016/j.celrep.2016.09.041; Salvador GHM, 2015, ACTA CRYSTALLOGR D, V71, P2066, DOI 10.1107/S1399004715014443; Sanchez MA, 2013, J BIOL CHEM, V288, P14428, DOI 10.1074/jbc.M113.473157; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Scott AG, 1996, ACTA TROP, V60, P251, DOI 10.1016/0001-706X(96)00131-3; Seed John Richard, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated, DOI 10.1186/1475-9292-2-3; Silvester E, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6030029; Sonoiki E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14574; Spitznagel D, 2009, FEBS J, V276, P7187, DOI 10.1111/j.1742-4658.2009.07432.x; St Aubin CN, 2007, MOL PHARMACOL, V71, P1360, DOI 10.1124/mol.106.031732; Stafkova J, 2016, MOL MICROBIOL, V100, P442, DOI 10.1111/mmi.13325; STEIN CA, 1989, J CLIN ONCOL, V7, P499, DOI 10.1200/JCO.1989.7.4.499; Stoffel SA, 2011, MOL BIOCHEM PARASIT, V179, P1, DOI 10.1016/j.molbiopara.2011.04.006; Subrtova K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004660; Szoor B, 2010, GENE DEV, V24, P1306, DOI 10.1101/gad.570310; Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017; Thomas J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006980; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; Vanderheyden N, 2000, BIOCHEM J, V346, P53, DOI 10.1042/0264-6021:3460053; VANSTERKENBURG ELM, 1993, ACTA TROP, V54, P237, DOI 10.1016/0001-706X(93)90096-T; Veitch NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-124; VICKERMAN K, 1989, PARASITOLOGY, V99, pS37, DOI 10.1017/S0031182000083402; Wall RJ, 2018, P NATL ACAD SCI USA, V115, P9616, DOI 10.1073/pnas.1807915115; Wallace LJM, 2002, J BIOL CHEM, V277, P26149, DOI 10.1074/jbc.M202835200; Wenzler T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22451; Wiedemar N, 2019, FASEB BIOADV, V1, P595, DOI 10.1096/fba.2019-00033; Wiedemar N, 2018, MOL MICROBIOL, V107, P57, DOI 10.1111/mmi.13854; WIEMER EAC, 1995, BIOCHEM J, V312, P479, DOI 10.1042/bj3120479; WILLSON M, 1993, MOL BIOCHEM PARASIT, V59, P201, DOI 10.1016/0166-6851(93)90218-M; Wu K, 2016, P NATL ACAD SCI USA, V113, pE2011, DOI 10.1073/pnas.1601089113; Zhang N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006850; Zikova A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006679; Zoltner M, 2016, CURR OPIN MICROBIOL, V34, P97, DOI 10.1016/j.mib.2016.08.005; Zoltner M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005236	96	16	16	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8331	8347		10.1074/jbc.RA120.012355	http://dx.doi.org/10.1074/jbc.RA120.012355			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32354742	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000542965700019
J	Huang, W; Ray, P; Ji, WB; Wang, ZW; Nancarrow, D; Chen, GA; Galban, S; Lawrence, TS; Beer, DG; Rehemtulla, A; Ramnath, N; Ray, D				Huang, Wei; Ray, Paramita; Ji, Wenbin; Wang, Zhuwen; Nancarrow, Derek; Chen, Guoan; Galban, Stefanie; Lawrence, Theodore S.; Beer, David G.; Rehemtulla, Alnawaz; Ramnath, Nithya; Ray, Dipankar			The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; ubiquitylation (ubiquitination); cell cycle; ubiquitin ligase; lung cancer; anaphase promoting complex (APC); CDC20-homologue 1 (CDH1); cell division cycle 20 (CDC20); RAS GTPase; lung adenocarcinoma; cancer; cell cycle regulation; destruction box (D-box)	ANAPHASE-PROMOTING COMPLEX; PROSTATE-CANCER; BREAST-CANCER; DEGRADATION; EXPRESSION; PROGRESSION; CALCITRIOL; ACTIVATORS; INHIBITOR; BATTLE	We previously reported that overexpression of cytochrome P450 family 24 subfamily A member 1 (CYP24A1) increases lung cancer cell proliferation by activating RAS signaling and that CYP24A1 knockdown inhibits tumor growth. However, the mechanism of CYP24A1-mediated cancer cell proliferation remains unclear. Here, we conducted cell synchronization and biochemical experiments in lung adenocarcinoma cells, revealing a link between CYP24A1 and anaphase-promoting complex (APC), a key cell cycle regulator. We demonstrate that CYP24A1 expression is cell cycle?dependent; it was higher in the G(2)-M phase and diminished upon G(1) entry. CYP24A1 has a functional destruction box (D-box) motif that allows binding with two APC adaptors, CDC20-homologue 1 (CDH1) and cell division cycle 20 (CDC20). Unlike other APC substrates, however, CYP24A1 acted as a pseudo-substrate, inhibiting CDH1 activity and promoting mitotic progression. Conversely, overexpression of a CYP24A1 D-box mutant compromised CDH1 binding, allowing CDH1 hyperactivation, thereby hastening degradation of its substrates cyclin B1 and CDC20, and accumulation of the CDC20 substrate p21, prolonging mitotic exit. These activities also occurred with a CYP24A1 isoform 2 lacking the catalytic cysteine (Cys-462), suggesting that CYP24A1's oncogenic potential is independent of its catalytic activity. CYP24A1 degradation reduced clonogenic survival of mutant KRAS-driven lung cancer cells, and calcitriol treatment increased CYP24A1 levels and tumor burden in Lsl-KRAS(G12D) mice. These results disclose a catalytic activity-independent growth-promoting role of CYP24A1 in mutant KRAS-driven lung cancer. This suggests that CYP24A1 could be therapeutically targeted in lung cancers in which its expression is high.	[Ray, Paramita; Ji, Wenbin; Lawrence, Theodore S.; Beer, David G.; Rehemtulla, Alnawaz; Ray, Dipankar] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Huang, Wei; Ramnath, Nithya] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wang, Zhuwen; Nancarrow, Derek; Chen, Guoan; Beer, David G.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Galban, Stefanie] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI 48109 USA; [Ramnath, Nithya] Ann Arbor Healthcare Syst, Vet Adm, Ann Arbor, MI 48105 USA; [Ji, Wenbin] Arbor Res Collaborat Hlth, Ann Arbor, MI 48105 USA; [Chen, Guoan] Southern Univ Sci & Technol, Sch Med, Shenzhen 518055, Peoples R China	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Arbor Research Collaborative for Health; Southern University of Science & Technology	Ramnath, N (corresponding author), 1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA.; Ray, D (corresponding author), Med Sci Bldg 1, Ann Arbor, MI 48109 USA.	nithyar@umich.edu; dipray@umich.edu	Chen, Guoan/J-9140-2018	Chen, Guoan/0000-0001-5608-6761	NCI, National Institutes of Health [R01CA160981]; Veterans Administration Merit Award [I01CX000333-02]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Administration Merit Award	This work was supported by NCI, National Institutes of Health Grant R01CA160981 (to D. R.) and Veterans Administration Merit Award I01CX000333-02 (to N. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albertson DG, 2003, BREAST CANCER RES TR, V78, P289, DOI 10.1023/A:1023025506386; Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Annalora AJ, 2017, DRUG METAB DISPOS, V45, P375, DOI 10.1124/dmd.116.073254; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bowman BM, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005607; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Cappell SD, 2018, NATURE, V558, P313, DOI 10.1038/s41586-018-0199-7; Chen GA, 2011, CLIN CANCER RES, V17, P817, DOI 10.1158/1078-0432.CCR-10-1789; Delbaldo C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004569.pub2; Di Fiore B, 2015, DEV CELL, V32, P358, DOI 10.1016/j.devcel.2015.01.003; Fang GW, 1999, PHILOS T ROY SOC B, V354, P1583, DOI 10.1098/rstb.1999.0502; Gadagkar SR, 2015, J PHARMACOL TOX MET, V71, P68, DOI 10.1016/j.vascn.2014.08.006; Gold KA, 2011, CANCER PREV RES, V4, P962, DOI 10.1158/1940-6207.CAPR-11-0232; Gross AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142618; Hamasaki M, 2014, CHEM BIOL, V21, P1707, DOI 10.1016/j.chembiol.2014.11.005; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Horvath HC, 2010, J STEROID BIOCHEM, V121, P76, DOI 10.1016/j.jsbmb.2010.03.080; Hyun SY, 2013, BIOCHEM BIOPH RES CO, V436, P12, DOI 10.1016/j.bbrc.2013.04.073; Iizuka-Ohashi Mahiro, 2018, Oncotarget, V9, P19597, DOI 10.18632/oncotarget.24696; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Mimori K, 2004, ANN ONCOL, V15, P236, DOI 10.1093/annonc/mdh056; Muindi JR, 2007, J STEROID BIOCHEM, V103, P334, DOI 10.1016/j.jsbmb.2006.12.060; Ostapenko D, 2008, MOL CELL BIOL, V28, P4653, DOI 10.1128/MCB.00055-08; Patel V, 2018, NAT REV UROL, V15, P643, DOI 10.1038/s41585-018-0077-y; Peng L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13413; Ramnath N, 2013, CANCER CHEMOTH PHARM, V71, P1173, DOI 10.1007/s00280-013-2109-x; Rodriguez M, 2013, MOL CANCER RES, V11, P780, DOI 10.1158/1541-7786.MCR-12-0675; Sakaki T, 2014, ANTI-CANCER AGENT ME, V14, P97, DOI 10.2174/18715206113139990307; Shiratsuchi H, 2017, J THORAC ONCOL, V12, P269, DOI 10.1016/j.jtho.2016.10.010; Sivakumar S, 2015, NAT REV MOL CELL BIO, V16, P82, DOI 10.1038/nrm3934; Tannour-Louet M, 2014, FASEB J, V28, P364, DOI 10.1096/fj.13-236109; Tipton AR, 2011, CELL CYCLE, V10, P3740, DOI 10.4161/cc.10.21.17919; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wan LX, 2017, CANCER DISCOV, V7, P424, DOI 10.1158/2159-8290.CD-16-0647; Zhang QH, 2013, J STEROID BIOCHEM, V136, P264, DOI 10.1016/j.jsbmb.2012.09.022; Zou MJ, 2017, CANCER RES, V77, P2161, DOI 10.1158/0008-5472.CAN-16-2066; Zou MJ, 2014, CLIN ENDOCRINOL, V81, P109, DOI 10.1111/cen.12396	41	1	1	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5906	5917		10.1074/jbc.RA119.011869	http://dx.doi.org/10.1074/jbc.RA119.011869			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32165494	Green Published, hybrid			2022-12-28	WOS:000531417300006
J	Joszai, J; Thamm, K; Karbanova, J; Janich, P; Fargeas, CA; Huttner, WB; Corbeil, D				Joszai, Jazsef; Thamm, Kristina; Karbanova, Jana; Janich, Peggy; Fargeas, Christine A.; Huttner, Wieland B.; Corbeil, Denis			Prominins control ciliary length throughout the animal kingdom: New lessons from human prominin-1 and zebrafish prominin-3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prominin-1 (PROM1); cilia; zebrafish; membrane protein; ADP-ribosylation factor (ARF); development; CD133; left-right asymmetry; MDCK; membrane polarity; ADP-ribosylation factor-like protein 13B (Arl13b); cilium; Kupffer's vesicle; ciliopathy; development	CELL MARKER CD133; POLYTOPIC MEMBRANE-PROTEIN; EPITHELIAL-CELLS; PLASMA-MEMBRANE; INTRAFLAGELLAR TRANSPORT; NEURAL PROGENITORS; PRIMARY CILIUM; STEM-CELLS; ARL13B; CHOLESTEROL	Prominins (proms) are transmembrane glycoproteins conserved throughout the animal kingdom. They are associated with plasma membrane protrusions, such as primary cilia, as well as extracellular vesicles derived thereof. Primary cilia host numerous signaling pathways affected in diseases known as ciliopathies. Human PROM1 (CD133) is detected in both somatic and cancer stem cells and is also expressed in terminally differentiated epithelial and photoreceptor cells. Genetic mutations in the PROM1 gene result in retinal degeneration by impairing the proper formation of the outer segment of photoreceptors, a modified cilium. Here, we investigated the impact of proms on two distinct examples of ciliogenesis. First, we demonstrate that the overexpression of a dominant-negative mutant variant of human PROM1 (i.e. mutation Y819F/Y828F) significantly decreases ciliary length in Madin?Darby canine kidney cells. These results contrast strongly to the previously observed enhancing effect of WT PROM1 on ciliary length. Mechanistically, the mutation impeded the interaction of PROM1 with ADP-ribosylation factor?like protein 13B, a key regulator of ciliary length. Second, we observed that in vivo knockdown of prom3 in zebrafish alters the number and length of monocilia in the Kupffer's vesicle, resulting in molecular and anatomical defects in the left-right asymmetry. These distinct loss-of-function approaches in two biological systems reveal that prom proteins are critical for the integrity and function of cilia. Our data provide new insights into ciliogenesis and might be of particular interest for investigations of the etiologies of ciliopathies.	[Joszai, Jazsef; Thamm, Kristina; Karbanova, Jana; Janich, Peggy; Fargeas, Christine A.; Corbeil, Denis] Tech Univ Dresden, Tissue Engn Labs, Biotechnol Ctr BIOTEC, Tatzberg 47-49, D-01307 Dresden, Germany; [Joszai, Jazsef; Thamm, Kristina; Karbanova, Jana; Janich, Peggy; Fargeas, Christine A.; Corbeil, Denis] Tech Univ Dresden, Ctr Mol & Cellular Bioengn, Tatzberg 47-49, D-01307 Dresden, Germany; [Joszai, Jazsef] Techn Univ Dresden, Fak Med, Inst Anat, Fiedlerstr 42, D-01307 Dresden, Germany; [Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Thamm, Kristina] DenovoMATRIX GmbH, Tatzberg 47, D-01307 Dresden, Germany; [Janich, Peggy] Swiss Canc League, Effingerstr 40, CH-3001 Bern, Switzerland	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society	Joszai, J; Corbeil, D (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-49, D-01307 Dresden, Germany.	jozsef.jaszai@tu-dresden.de; denis.corbeil@tu-dresden.de	Corbeil, Denis/L-2340-2019; Corbeil, Denis/AFL-1008-2022	Corbeil, Denis/0000-0003-1181-3659; Karbanova, Jana/0000-0001-7687-0983	Intramural Funds of the Medical Faculty of TU Dresden (MeDDrive grant); Deutsche Forschungsgemeinschaft (DFG) [CO298/5-1]; DFG [CO298/5-1, SFB655]	Intramural Funds of the Medical Faculty of TU Dresden (MeDDrive grant); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by Intramural Funds of the Medical Faculty of TU Dresden (MeDDrive grant) and Deutsche Forschungsgemeinschaft (DFG) Grant CO298/5-1 (to J. J.), DFG Grant SFB655 A2 (to W. B. H.), and DFG Grants SFB655 B3 and CO298/5-1 (to D. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Amack Jeffrey D, 2014, Bioarchitecture, V4, P6, DOI 10.4161/bioa.28014; Bachor TP, 2017, NEUROBIOL DIS, V108, P13, DOI 10.1016/j.nbd.2017.07.010; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Bae YK, 2009, CURR BIOL, V19, P1599, DOI 10.1016/j.cub.2009.08.045; Bauer N, 2011, EMBO MOL MED, V3, P398, DOI 10.1002/emmm.201100147; Bhattacharya S, 2017, INVEST OPHTH VIS SCI, V58, P2366, DOI 10.1167/iovs.16-21162; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Copeland J, 2020, SEMIN CELL DEV BIOL, V102, P132, DOI 10.1016/j.semcdb.2019.12.005; Copeland SJ, 2018, MOL BIOL CELL, V29, P1611, DOI 10.1091/mbc.E18-02-0088; Corbeil D, 1999, J CELL SCI, V112, P1023; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Corbeil D, 2019, J BIOL CHEM, V294, P17166, DOI 10.1074/jbc.L119.011198; Corbeil D, 2013, ADV EXP MED BIOL, V777, P3, DOI 10.1007/978-1-4614-5894-4_1; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dilan TL, 2019, J NEUROSCI, V39, P1347, DOI 10.1523/JNEUROSCI.1761-18.2018; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Drummond ML, 2018, J CELL BIOL, V217, P3255, DOI 10.1083/jcb.201703196; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Fargeas CA, 2003, J BIOL CHEM, V278, P8586, DOI 10.1074/jbc.M210640200; Fargeas CA, 2006, FUTURE LIPIDOL, V1, P213, DOI 10.2217/17460875.1.2.213; Fargeas CA, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00091; Fargeas CA, 2013, ADV EXP MED BIOL, V777, P25, DOI 10.1007/978-1-4614-5894-4_2; Florek M, 2007, CELL TISSUE RES, V328, P31, DOI 10.1007/s00441-006-0324-z; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; Garcia-Gonzalo FR, 2015, DEV CELL, V34, P400, DOI 10.1016/j.devcel.2015.08.001; Goldberg AFX, 2016, PROG RETIN EYE RES, V55, P52, DOI 10.1016/j.preteyeres.2016.05.003; Grosse-Gehling P, 2013, J PATHOL, V229, P355, DOI 10.1002/path.4086; Gurudev N, 2013, ADV EXP MED BIOL, V777, P55, DOI 10.1007/978-1-4614-5894-4_4; Han Z, 2012, INVEST OPHTH VIS SCI, V53, P361, DOI 10.1167/iovs.11-8635; Hanke-Gogokhia C, 2017, J BIOL CHEM, V292, P21442, DOI 10.1074/jbc.RA117.000141; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hsiao Yi-Chun, 2012, Cilia, V1, P4, DOI 10.1186/2046-2530-1-4; Ivanova AA, 2017, J BIOL CHEM, V292, P11091, DOI 10.1074/jbc.M117.784025; Izumi H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39229-8; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Jaszai J, 2003, DEVELOPMENT, V130, P6611, DOI 10.1242/dev.00899; Jaszai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063457; Jaszai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017590; Jaszai J, 2010, HISTOCHEM CELL BIOL, V133, P527, DOI 10.1007/s00418-010-0690-1; Jensen V, 2015, EMBO J, V34, P2537, DOI 10.15252/embj.201488044; Jones AT, 1998, J BIOL CHEM, V273, P25301, DOI 10.1074/jbc.273.39.25301; Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Karbanova J, 2018, STEM CELL TRANSL MED, V7, P155, DOI 10.1002/sctm.17-0223; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Lee S, 2018, J CELL BIOL, V217, P2831, DOI 10.1083/jcb.201711104; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; Liu CJ, 2016, J BIOL CHEM, V291, P15540, DOI 10.1074/jbc.M115.712976; Lu H, 2015, DEV BIOL, V397, P225, DOI 10.1016/j.ydbio.2014.11.009; Lu ZJ, 2019, J BIOL CHEM, V294, P17167, DOI 10.1074/jbc.RL119.011224; Lu ZJ, 2019, J BIOL CHEM, V294, P13953, DOI 10.1074/jbc.RA119.008618; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Malicki J, 2014, ORGANOGENESIS, V10, P138, DOI 10.4161/org.29055; Marzesco AM, 2005, J CELL SCI, V118, P2849, DOI 10.1242/jcs.02439; Marzesco AM, 2013, ADV EXP MED BIOL, V777, P41, DOI 10.1007/978-1-4614-5894-4_3; Marzesco AM, 2009, FEBS LETT, V583, P897, DOI 10.1016/j.febslet.2009.01.048; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; May-Simera Helen L, 2012, Cilia, V1, P7, DOI 10.1186/2046-2530-1-7; McGrail M, 2010, DEV DYNAM, V239, P1849, DOI 10.1002/dvdy.22307; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Morleo M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080905; Nager AR, 2017, CELL, V168, P252, DOI 10.1016/j.cell.2016.11.036; Nozaki S, 2017, J CELL SCI, V130, P563, DOI 10.1242/jcs.197004; Orhon I, 2016, AUTOPHAGY, V12, P2258, DOI 10.1080/15548627.2016.1212790; Pintado P, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161102; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Roy K, 2017, J BIOL CHEM, V292, P17703, DOI 10.1074/jbc.M117.792937; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Singer D, 2019, EMBO J, V38, DOI 10.15252/embj.201899845; Spencer WJ, 2019, P NATL ACAD SCI USA, V116, P27043, DOI 10.1073/pnas.1913518117; Steiner AB, 2014, P NATL ACAD SCI USA, V111, pE1393, DOI 10.1073/pnas.1318692111; Sullivan-Brown J, 2008, DEV BIOL, V314, P261, DOI 10.1016/j.ydbio.2007.11.025; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Taieb N, 2009, CANCER LETT, V278, P164, DOI 10.1016/j.canlet.2009.01.013; Thamm K, 2019, TRAFFIC, V20, P39, DOI 10.1111/tra.12618; Thamm K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164079; Tuscher O, 1997, FEBS LETT, V419, P271, DOI 10.1016/S0014-5793(97)01471-3; Walker TL, 2013, J NEUROSCI, V33, P3010, DOI 10.1523/JNEUROSCI.3363-12.2013; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wotton KR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-171; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yeyati PL, 2017, J CELL BIOL, V216, P999, DOI 10.1083/jcb.201607032; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128	96	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6007	6022		10.1074/jbc.RA119.011253	http://dx.doi.org/10.1074/jbc.RA119.011253			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32201384	Green Published, hybrid			2022-12-28	WOS:000531417300014
J	Shikha, S; Schneider, A				Shikha, Shikha; Schneider, Andre			The single CCA-adding enzyme of T. brucei has distinct functions in the cytosol and in mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Trypanosoma brucei; transfer RNA (tRNA); mitochondria; RNA processing; RNA interference (RNAi); mitochondrial tRNA import	TRANSFER-RNA NUCLEOTIDYLTRANSFERASE; TRYPANOSOMA-BRUCEI; IMPORT; GENE; IDENTIFICATION; CONSEQUENCES; TRANSLATION; TRANSLOCASE; MECHANISMS; EXPRESSION	tRNAs universally carry a CCA nucleotide triplet at their 3?-ends. In eukaryotes, the CCA is added post-transcriptionally by the CCA-adding enzyme (CAE). The mitochondrion of the parasitic protozoan Trypanosoma brucei lacks tRNA genes and therefore imports all of its tRNAs from the cytosol. This has generated interest in the tRNA modifications and their distribution in this organism, including how CCA is added to tRNAs. Here, using a BLAST search for genes encoding putative CAE proteins in T. brucei, we identified a single ORF, Tb927.9.8780, as a potential candidate. Knockdown of this putative protein, termed TbCAE, resulted in the accumulation of truncated tRNAs, abolished translation, and inhibited both total and mitochondrial CCA-adding activities, indicating that TbCAE is located both in the cytosol and mitochondrion. However, mitochondrially localized tRNAs were much less affected by the TbCAE ablation than the other tRNAs. Complementation assays revealed that the N-terminal 10 amino acids of TbCAE are dispensable for its activity and mitochondrial localization and that deletion of 10 further amino acids abolishes both. A growth arrest caused by the TbCAE knockdown was rescued by the expression of the cytosolic isoform of yeast CAE, even though it was not imported into mitochondria. This finding indicated that the yeast enzyme complements the essential function of TbCAE by adding CCA to the primary tRNA transcripts. Of note, ablation of the mitochondrial TbCAE activity, which likely has a repair function, only marginally affected growth.	[Shikha, Shikha; Schneider, Andre] Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland	University of Bern	Schneider, A (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	andre.schneider@dcb.unibe.ch		Schneider, Andre/0000-0001-5421-0909; , Shikha/0000-0002-7878-1463	NCCR "RNA Disease" [175563]; Swiss National Science Foundation	NCCR "RNA Disease"; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by NCCR "RNA & Disease" and Grant 175563 from the Swiss National Science Foundation.	Aeby E, 2010, NUCLEIC ACIDS RES, V38, P5833, DOI 10.1093/nar/gkq345; Aeby E, 2009, MOL BIOCHEM PARASIT, V168, P191, DOI 10.1016/j.molbiopara.2009.08.007; Aeby E, 2009, P NATL ACAD SCI USA, V106, P5088, DOI 10.1073/pnas.0901575106; Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056; Alfonzo JD, 2009, BIOL CHEM, V390, P717, DOI 10.1515/BC.2009.101; BEJA O, 1993, MOL BIOCHEM PARASIT, V57, P223, DOI 10.1016/0166-6851(93)90198-7; Betat H, 2015, BIOESSAYS, V37, P975, DOI 10.1002/bies.201500043; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; Charriere F, 2009, J BIOL CHEM, V284, P16210, DOI 10.1074/jbc.M109.005348; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Crain PF, 2002, RNA, V8, P752, DOI 10.1017/S1355838202022045; Cristodero M, 2010, MOL MICROBIOL, V78, P757, DOI 10.1111/j.1365-2958.2010.07368.x; HANCOCK K, 1992, J BIOL CHEM, V267, P23963; Harsman A, 2012, J BIOL CHEM, V287, P31437, DOI 10.1074/jbc.M112.392118; Hartmann RK, 2009, PROG MOL BIOL TRANSL, V85, P319, DOI 10.1016/S0079-6603(08)00808-8; Huot JL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47268-4; HURT EC, 1987, NATURE, V325, P499, DOI 10.1038/325499a0; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Leibovitch M, 2013, BIOCHEM J, V453, P401, DOI 10.1042/BJ20121577; Mani J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7646; Maraia RJ, 2011, WIRES RNA, V2, P362, DOI 10.1002/wrna.64; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Morl M, 2001, EMBO REP, V2, P17, DOI 10.1093/embo-reports/kve006; Niemann M, 2017, P NATL ACAD SCI USA, V114, pE7679, DOI 10.1073/pnas.1711430114; Niemann M, 2013, MOL CELL PROTEOMICS, V12, P515, DOI 10.1074/mcp.M112.023093; Niemann M, 2011, TRENDS PARASITOL, V27, P429, DOI 10.1016/j.pt.2011.03.011; Paris Z, 2018, IUBMB LIFE, V70, P1207, DOI 10.1002/iub.1957; Peikert CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15272; Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060; Regev-Rudzki N, 2008, J CELL SCI, V121, P2423, DOI 10.1242/jcs.029207; Rettig J, 2012, NUCLEIC ACIDS RES, V40, P1299, DOI 10.1093/nar/gkr794; Reuven NB, 1997, J BIOL CHEM, V272, P33255, DOI 10.1074/jbc.272.52.33255; RIBEIRO S, 1995, ANAL BIOCHEM, V228, P330, DOI 10.1006/abio.1995.1359; Roggy JL, 1999, MOL BIOCHEM PARASIT, V98, P1, DOI 10.1016/S0166-6851(98)00114-5; Rossmanith W, 2012, BBA-GENE REGUL MECH, V1819, P1017, DOI 10.1016/j.bbagrm.2011.11.003; Salavati R, 2001, MOL BIOCHEM PARASIT, V115, P109, DOI 10.1016/S0166-6851(01)00273-0; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Seidman D, 2012, J BIOL CHEM, V287, P8892, DOI 10.1074/jbc.M111.300186; Shikha S, 2019, CHIMIA, V73, P395, DOI 10.2533/chimia.2019.395; Sieber F, 2011, INT REV CEL MOL BIO, V287, P145, DOI 10.1016/B978-0-12-386043-9.00004-9; Tan THP, 2002, MOL CELL BIOL, V22, P3707, DOI 10.1128/MCB.22.11.3707-3716.2002; TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x; Taschner A, 2012, CELL REP, V2, P19, DOI 10.1016/j.celrep.2012.05.021; Tschopp F, 2011, EMBO REP, V12, P825, DOI 10.1038/embor.2011.111; von Braun SS, 2007, J EXP BOT, V58, P4083, DOI 10.1093/jxb/erm267; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wohlgamuth-Benedum JM, 2009, J BIOL CHEM, V284, P23947, DOI 10.1074/jbc.M109.029421; Wolfe CL, 1996, J BIOL CHEM, V271, P4679; WOLFE CL, 1994, J BIOL CHEM, V269, P13361; ZHU LQ, 1987, EMBO J, V6, P2473, DOI 10.1002/j.1460-2075.1987.tb02528.x	54	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6138	6150		10.1074/jbc.RA119.011877	http://dx.doi.org/10.1074/jbc.RA119.011877			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32234763	hybrid, Green Published			2022-12-28	WOS:000531417300023
J	Chedin, F; Benham, CJ				Chedin, Frederic; Benham, Craig J.			Emerging roles for R-loop structures in the management of topological stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						DNA structure; DNA topology; DNA transcription; DNA topoisomerase; chromosomes; gene transcription; genome stability; R-loop; supercoiling; superhelicity; topological stress	CLOSED CIRCULAR DNA; RNA-POLYMERASE-II; ESCHERICHIA-COLI; TOPOISOMERASE-I; TRANSCRIPTION ELONGATION; SWITCH REGIONS; DUPLEX DESTABILIZATION; RECA PROTEIN; REPLICATION; CHROMATIN	R-loop structures are a prevalent class of alternative non-B DNA structures that form during transcription upon invasion of the DNA template by the nascent RNA. R-loops form universally in the genomes of organisms ranging from bacteriophages, bacteria, and yeasts to plants and animals, including mammals. A growing body of work has linked these structures to both physiological and pathological processes, in particular to genome instability. The rising interest in R-loops is placing new emphasis on understanding the fundamental physicochemical forces driving their formation and stability. Pioneering work in Escherichia coli revealed that DNA topology, in particular negative DNA superhelicity, plays a key role in driving R-loops. A clear role for DNA sequence was later uncovered. Here, we review and synthesize available evidence on the roles of DNA sequence and DNA topology in controlling R-loop formation and stability. Factoring in recent developments in R-loop modeling and single-molecule profiling, we propose a coherent model accounting for the interplay between DNA sequence and DNA topology in driving R-loop structure formation. This model reveals R-loops in a new light as powerful and reversible topological stress relievers, an insight that significantly expands the repertoire of R-loops' potential biological roles under both normal and aberrant conditions.	[Chedin, Frederic] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Chedin, Frederic; Benham, Craig J.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Benham, Craig J.] Univ Calif Davis, Dept Math, Davis, CA 95616 USA; [Benham, Craig J.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Chedin, F (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.; Chedin, F; Benham, CJ (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Benham, CJ (corresponding author), Univ Calif Davis, Dept Math, Davis, CA 95616 USA.; Benham, CJ (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	flchedin@ucdavis.edu; cjbenham@ucdavis.edu	Benham, Craig J/G-1512-2013	Chedin, Frederic/0000-0002-1306-5335	National Institutes of Health [R01-GM120607]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01-GM120607 (to F. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baaklini I, 2004, MOL MICROBIOL, V54, P198, DOI 10.1111/j.1365-2958.2004.04258.x; Baaklini I, 2008, J BACTERIOL, V190, P7346, DOI 10.1128/JB.00680-08; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Baranello L, 2016, CELL, V165, P357, DOI 10.1016/j.cell.2016.02.036; Baranello L, 2012, BBA-GENE REGUL MECH, V1819, P632, DOI 10.1016/j.bbagrm.2011.12.007; BAUER W, 1970, Journal of Molecular Biology, V47, P419, DOI 10.1016/0022-2836(70)90312-8; BAUER WR, 1993, J MOL BIOL, V234, P1184, DOI 10.1006/jmbi.1993.1669; Belotserkovskii BP, 2017, NUCLEIC ACIDS RES, V45, P6589, DOI 10.1093/nar/gkx403; Belotserkovskii BP, 2011, BIOPHYS J, V100, P675, DOI 10.1016/j.bpj.2010.12.3709; Belotserkovskii BP, 2010, P NATL ACAD SCI USA, V107, P12816, DOI 10.1073/pnas.1007580107; Benedetti F, 2017, NUCLEIC ACIDS RES, V45, P9850, DOI 10.1093/nar/gkx716; Benedetti F, 2014, NUCLEIC ACIDS RES, V42, P10425, DOI 10.1093/nar/gku759; Benedetti F, 2014, NUCLEIC ACIDS RES, V42, P2848, DOI 10.1093/nar/gkt1353; BENHAM CJ, 1987, CELL BIOPHYS, V10, P193, DOI 10.1007/BF02797340; BENHAM CJ, 1979, P NATL ACAD SCI USA, V76, P3870, DOI 10.1073/pnas.76.8.3870; Benham CJ, 1996, J MOL BIOL, V255, P425, DOI 10.1006/jmbi.1996.0035; BOLES TC, 1990, J MOL BIOL, V213, P931, DOI 10.1016/S0022-2836(05)80272-4; Bunch H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10191; Chan YJA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004288; Chedin F, 2016, TRENDS GENET, V32, P828, DOI 10.1016/j.tig.2016.10.002; Chen L, 2017, MOL CELL, V68, P745, DOI 10.1016/j.molcel.2017.10.008; Cohen S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02894-w; Corless Samuel, 2016, Biophys Rev, V8, P245, DOI [10.1007/s12551-016-0242-6, 10.1007/s12551-016-0210-1]; Costantino L, 2015, CURR OPIN CELL BIOL, V34, P39, DOI 10.1016/j.ceb.2015.04.008; Cozzarelli NR, 2006, NAT REV MOL CELL BIO, V7, P580, DOI 10.1038/nrm1982; COZZARELLI NR, 1980, SCIENCE, V207, P953, DOI 10.1126/science.6243420; Crossley MP, 2019, MOL CELL, V73, P398, DOI 10.1016/j.molcel.2019.01.024; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; De Magis A, 2019, P NATL ACAD SCI USA, V116, P816, DOI 10.1073/pnas.1810409116; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Dekker J, 2015, FEBS LETT, V589, P2877, DOI 10.1016/j.febslet.2015.08.044; Ding Y, 2014, P NATL ACAD SCI USA, V111, P15402, DOI 10.1073/pnas.1320644111; Donczew R, 2014, J MOL BIOL, V426, P2769, DOI 10.1016/j.jmb.2014.05.018; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; DROLET M, 1995, P NATL ACAD SCI USA, V92, P3526, DOI 10.1073/pnas.92.8.3526; Drolet M, 2006, MOL MICROBIOL, V59, P723, DOI 10.1111/j.1365-2958.2005.05006.x; DROLET M, 1994, J BIOL CHEM, V269, P2068; DUNN K, 1980, NUCLEIC ACIDS RES, V8, P555, DOI 10.1093/nar/8.3.555; El Hage A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004716; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; FINCH JT, 1977, NATURE, V269, P29, DOI 10.1038/269029a0; Forth S, 2013, ANNU REV BIOPHYS, V42, P583, DOI 10.1146/annurev-biophys-083012-130412; FULLER RS, 1983, P NATL ACAD SCI-BIOL, V80, P5817, DOI 10.1073/pnas.80.19.5817; Gilbert N, 2014, CURR OPIN GENET DEV, V25, P15, DOI 10.1016/j.gde.2013.10.013; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Gu B, 2018, SCIENCE, V359, P1050, DOI 10.1126/science.aao3136; Hartono SR, 2018, J MOL BIOL, V430, P272, DOI 10.1016/j.jmb.2017.12.016; Hartono SR, 2015, NUCLEIC ACIDS RES, V43, P9729, DOI 10.1093/nar/gkv811; Hatfield GW, 2002, ANNU REV GENET, V36, P175, DOI 10.1146/annurev.genet.36.032902.111815; Holt IJ, 2019, NUCLEIC ACIDS RES, V47, P5480, DOI 10.1093/nar/gkz277; Hraiky C, 2000, J BIOL CHEM, V275, P11257, DOI 10.1074/jbc.275.15.11257; Huang FT, 2007, MOL CELL BIOL, V27, P5921, DOI 10.1128/MCB.00702-07; Huang FT, 2006, P NATL ACAD SCI USA, V103, P5030, DOI 10.1073/pnas.0506548103; Huppert JL, 2008, MOL BIOSYST, V4, P686, DOI 10.1039/b800354h; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kao YP, 2013, MOL IMMUNOL, V54, P208, DOI 10.1016/j.molimm.2012.11.009; Kasahara M, 2000, GENE DEV, V14, P360; Kasho K, 2017, J BIOL CHEM, V292, P1251, DOI 10.1074/jbc.M116.762815; Kim S, 2019, CELL, V179, P106, DOI 10.1016/j.cell.2019.08.033; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Kobryn K, 1999, J MOL BIOL, V289, P777, DOI 10.1006/jmbi.1999.2805; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Kouzine F, 2017, CELL SYST, V4, P344, DOI 10.1016/j.cels.2017.01.013; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Kreuzer KN, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-358; Lang KS, 2017, CELL, V170, P787, DOI 10.1016/j.cell.2017.07.044; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; LEBOWITZ J, 1990, TRENDS BIOCHEM SCI, V15, P202, DOI 10.1016/0968-0004(90)90163-6; Leela JK, 2013, P NATL ACAD SCI USA, V110, P258, DOI 10.1073/pnas.1213123110; Leng FF, 2011, P NATL ACAD SCI USA, V108, P19973, DOI 10.1073/pnas.1109854108; Levens D, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035011; Lim YW, 2015, ELIFE, V4, DOI 10.7554/eLife.08007; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Ma Jie, 2016, Biophys Rev, V8, P75, DOI 10.1007/s12551-016-0215-9; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Malig M, 2020, J MOL BIOL, V432, P2271, DOI 10.1016/j.jmb.2020.02.014; Manzo SG, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1478-1; Masse E, 1999, J BIOL CHEM, V274, P16659, DOI 10.1074/jbc.274.23.16659; Masse E, 1997, J BIOL CHEM, V272, P12816, DOI 10.1074/jbc.272.19.12816; Michelini F, 2017, NAT CELL BIOL, V19, P1400, DOI 10.1038/ncb3643; MIZUTANI M, 1991, P NATL ACAD SCI USA, V88, P718, DOI 10.1073/pnas.88.3.718; Mondal N, 2001, NATURE, V413, P435, DOI 10.1038/35096590; Mondal N, 2003, NUCLEIC ACIDS RES, V31, P5016, DOI 10.1093/nar/gkg705; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Nguyen HD, 2017, MOL CELL, V65, P832, DOI 10.1016/j.molcel.2017.01.029; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; PATTERTON HG, 1993, J MOL BIOL, V229, P623, DOI 10.1006/jmbi.1993.1068; PECK LJ, 1983, P NATL ACAD SCI-BIOL, V80, P6206, DOI 10.1073/pnas.80.20.6206; Peter BJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r87; Petryk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10208; PFAFFLE P, 1990, J BIOL CHEM, V265, P16830; PFAFFLE P, 1990, J BIOL CHEM, V265, P16821; Phoenix P, 1997, J BIOL CHEM, V272, P1473, DOI 10.1074/jbc.272.3.1473; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Postow L, 2004, GENE DEV, V18, P1766, DOI 10.1101/gad.1207504; Prioleau MN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000454; PRUSS GJ, 1989, CELL, V56, P521, DOI 10.1016/0092-8674(89)90574-6; Puget N, 2019, DNA REPAIR, V81, DOI 10.1016/j.dnarep.2019.102661; PULLEYBLANK DE, 1975, P NATL ACAD SCI USA, V72, P4280, DOI 10.1073/pnas.72.11.4280; Racko D, 2019, NUCLEIC ACIDS RES, V47, P521, DOI 10.1093/nar/gky1091; Racko D, 2018, NUCLEIC ACIDS RES, V46, P1648, DOI 10.1093/nar/gkx1123; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; Remus D, 2004, EMBO J, V23, P897, DOI 10.1038/sj.emboj.7600077; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Roca J, 2011, CHROMOSOMA, V120, P323, DOI 10.1007/s00412-011-0324-y; Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8; Roy D, 2008, MOL CELL BIOL, V28, P50, DOI 10.1128/MCB.01251-07; Roy D, 2010, MOL CELL BIOL, V30, P146, DOI 10.1128/MCB.00897-09; Roy D, 2009, MOL CELL BIOL, V29, P3124, DOI 10.1128/MCB.00139-09; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Sanz LA, 2016, MOL CELL, V63, P167, DOI 10.1016/j.molcel.2016.05.032; SINDEN RR, 1981, P NATL ACAD SCI-BIOL, V78, P224, DOI 10.1073/pnas.78.1.224; Skourti-Stathaki K, 2014, GENE DEV, V28, P1384, DOI 10.1101/gad.242990.114; Solier S, 2013, CANCER RES, V73, P4830, DOI 10.1158/0008-5472.CAN-12-3504; Sollier J, 2015, TRENDS CELL BIOL, V25, P514, DOI 10.1016/j.tcb.2015.05.003; Stoll G, 2013, NAT NEUROSCI, V16, P1228, DOI 10.1038/nn.3484; Stolz R, 2019, P NATL ACAD SCI USA, V116, P6260, DOI 10.1073/pnas.1819476116; Stork CT, 2016, ELIFE, V5, DOI 10.7554/eLife.17548; Teves SS, 2014, NUCLEUS-AUSTIN, V5, P211, DOI 10.4161/nucl.29086; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; VINOGRAD J, 1968, J MOL BIOL, V33, P173, DOI 10.1016/0022-2836(68)90287-8; VINOGRAD J, 1965, P NATL ACAD SCI USA, V53, P1104, DOI 10.1073/pnas.53.5.1104; VINOGRAD J, 1966, J GEN PHYSIOL, V49, P103, DOI 10.1085/jgp.49.6.103; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wahba L, 2016, GENE DEV, V30, P1327, DOI 10.1101/gad.280834.116; Wang HQ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-248; Wang HQ, 2006, NUCLEIC ACIDS RES, V34, pD373, DOI 10.1093/nar/gkj007; Wang H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040017; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Wilson-Sali T, 2002, P NATL ACAD SCI USA, V99, P7974, DOI 10.1073/pnas.122007999; Xu DY, 2013, NAT NEUROSCI, V16, P1238, DOI 10.1038/nn.3479; Xu W, 2017, NAT PLANTS, V3, P704, DOI 10.1038/s41477-017-0004-x; Yan Y, 2018, NUCLEIC ACIDS RES, V46, P4417, DOI 10.1093/nar/gky153; Yan Y, 2018, NUCLEIC ACIDS RES, V46, P2370, DOI 10.1093/nar/gky021; Yanez-Cuna JO, 2017, CURR OPIN GENET DEV, V43, P67, DOI 10.1016/j.gde.2016.12.005; Yang YZ, 2014, MOL CELL, V53, P484, DOI 10.1016/j.molcel.2014.01.011; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zaitsev EN, 2000, GENE DEV, V14, P740; Zhabinskaya D, 2013, NUCLEIC ACIDS RES, V41, P9610, DOI 10.1093/nar/gkt733; Zhabinskaya D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002484; Zhabinskaya D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001051; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	148	29	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4684	4695		10.1074/jbc.REV119.006364	http://dx.doi.org/10.1074/jbc.REV119.006364			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32107311	Green Published, hybrid			2022-12-28	WOS:000524499700026
J	Bansal, K; Balaji, KN				Bansal, Kushagra; Balaji, Kithiganahalli N.			Intracellular pathogen sensor NOD2 programs macrophages to trigger Notch1 activation (vol 286, pg 5823, 2011)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Bansal K, 2011, J BIOL CHEM, V286, P5823, DOI 10.1074/jbc.M110.192393	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2020	295	8					2541	2541		10.1074/jbc.AAC120.012812	http://dx.doi.org/10.1074/jbc.AAC120.012812			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KR0SI	32090976	Green Published, hybrid			2022-12-28	WOS:000517330200032
J	Lange, MJP; Szperlinski, M; Kalix, L; Lange, T				Lange, Maria Joao Pimenta; Szperlinski, Manuela; Kalix, Leon; Lange, Theo			Cucumber gibberellin 1-oxidase/desaturase initiates novel gibberellin catabolic pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; recombinant protein expression; development; dioxygenase; enzyme; metabolism; oxidase; plant physiology; plant molecular biology; phytohormone; anabolism; catabolism; cucumber; gibberellins; seed development	EXPRESSION; BIOSYNTHESIS; 20-OXIDASE; OXIDASES; IDENTIFICATION; SATIVUS; EMBRYOS; CLONING; GENES	Bioactive gibberellins (GAs) are central regulators of plant growth and development, including seed development. GA homeostasis is achieved via complex biosynthetic and catabolic pathways, whose exact activities remain to be elucidated. Here, we isolated two cDNAs from mature or imbibed cucumber seeds with high sequence similarity to known GA 3-oxidases. We found that one enzyme (designated here CsGA3ox5) has GA 3-oxidation activity. However, the second enzyme (designated CsGA1ox/ds) performed multiple reactions, including 1?-oxidation and 9,11-desaturation of GAs, but was lacking the 3-oxidation activity. CsGA1ox/ds overexpression inArabidopsisplants resulted in severely dwarfed plants that could be rescued by the exogenous application of bioactive GA(4), confirming that CsGA1ox/ds catabolizes GAs. Substitution of three amino acids in CsGA1ox/ds, Phe(93), Pro(106), and Ser(202), with those typically conserved among GA 3-oxidases, Tyr(93), Met(106), and Thr(202), respectively, conferred GA 3-oxidase activity to CsGA1ox/ds and thereby augmented its potential to form bioactive GAs in addition to catabolic products. Accordingly, overexpression of this amino acid?modified GA1ox/ds variant inArabidopsisaccelerated plant growth and development, indicating that this enzyme variant can produce bioactive GAsin planta. Furthermore, a genetically modified GA3ox5 variant in which these three canonical GA 3-oxidase amino acids were changed to the ones present in CsGA1ox/ds was unable to convert GA(9)to GA(4), highlighting the importance of these three conserved amino acids for GA 3-oxidase activity.	[Lange, Maria Joao Pimenta; Szperlinski, Manuela; Kalix, Leon; Lange, Theo] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pflanzenbiol, Braunschweig, Germany	Braunschweig University of Technology	Lange, MJP; Lange, T (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Pflanzenbiol, Braunschweig, Germany.	m.pimenta@tu-bs.de; theo.lange@tu-bs.de	Lange, Theo/H-6148-2018	Lange, Theo/0000-0003-1294-2647	Volkswagen Foundation [Az. 95475]	Volkswagen Foundation(Volkswagen)	This work was supported in part by the Volkswagen Foundation Az. 95475 (to M. J. P. L.).	Achard P, 2008, PLANT CELL, V20, P2117, DOI 10.1105/tpc.108.058941; Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colebrook EH, 2014, J EXP BIOL, V217, P67, DOI 10.1242/jeb.089938; Curtis IS, 2000, PLANT J, V23, P329, DOI 10.1046/j.1365-313x.2000.00784.x; Frisse A, 2003, PLANT PHYSIOL, V131, P1220, DOI 10.1104/pp.015206; Gaskin P., 1992, GC MS GIBBERELLINS R; He J, 2019, NAT PLANTS, V5, P1057, DOI 10.1038/s41477-019-0511-z; Hedden P, 2016, ANNU PLANT REV, V49, P37, DOI 10.1002/9781119210436.ch2; HEMPHILL DD, 1972, PLANTA, V103, P241, DOI 10.1007/BF00386846; Hu YL, 2018, NAT PLANTS, V4, P289, DOI 10.1038/s41477-018-0143-8; Huang Y, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0490-2; Lange MJP, 2006, PLANT BIOLOGY, V8, P281, DOI 10.1055/s-2006-923882; Lange MJP, 2016, DEVELOPMENT, V143, P4425, DOI 10.1242/dev.135947; Lange MJP, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.25, 10.1038/NPLANTS.2014.25]; Lange MJP, 2013, PHYTOCHEMISTRY, V90, P62, DOI 10.1016/j.phytochem.2013.02.006; Lange T, 1997, P NATL ACAD SCI USA, V94, P6553, DOI 10.1073/pnas.94.12.6553; Lange T, 2005, PLANT PHYSIOL, V139, P213, DOI 10.1104/pp.105.064162; LANGE T, 1994, P NATL ACAD SCI USA, V91, P8552, DOI 10.1073/pnas.91.18.8552; LANGE T, 1993, PLANTA, V189, P350, DOI 10.1007/BF00194431; Magome H, 2016, ANNU PLANT REV, V49, P73, DOI 10.1002/9781119210436.ch3; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Niki T, 2001, PLANT PHYSIOL, V126, P965, DOI 10.1104/pp.126.3.965; Pearce S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0520-7; Radi A, 2006, PLANT PHYSIOL, V140, P528, DOI 10.1104/pp.105.073668; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Varbanova M, 2007, PLANT CELL, V19, P32, DOI 10.1105/tpc.106.044602; Ward DA, 2010, PHYTOCHEMISTRY, V71, P2010, DOI 10.1016/j.phytochem.2010.09.015; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	30	2	2	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8442	8448		10.1074/jbc.RA120.013708	http://dx.doi.org/10.1074/jbc.RA120.013708			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32345611	hybrid, Green Published			2022-12-28	WOS:000546986500008
J	Cattley, RT; Lee, M; Boggess, WC; Hawse, WF				Cattley, Richard T.; Lee, Mijoon; Boggess, William C.; Hawse, William F.			Transforming growth factor ? (TGF-?) receptor signaling regulates kinase networks and phosphatidylinositol metabolism during T-cell activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T-cell receptor (TCR); phosphatidylinositide 3-kinase (PI 3-kinase); computer modeling; phosphatidylinositol; phosphatidylinositol kinase (PI kinase); T cell; T-cell biology; phosphatase and tensin homolog (PTEN); protein kinase A (PKA); phosphatidylinositol signaling; C-terminal Src kinase (CSK); immunity; transforming growth factor ? (TGF-?); cytokine; phosphoinositide 3-kinase (PI3K); phospholipid signaling	FOCAL ADHESION KINASE; FACTOR-BETA; PROTEIN-KINASE; PHOSPHORYLATION; TYROSINE; 3-KINASE; BINDING; INHIBITION; DOMAIN; PTEN	The cytokine content in tissue microenvironments shapes the functional capacity of a T cell. This capacity depends on the integration of extracellular signaling through multiple receptors, including the T-cell receptor (TCR), co-receptors, and cytokine receptors. Transforming growth factor ? (TGF-?) signals through its cognate receptor, TGF?R, to SMAD family member proteins and contributes to the generation of a transcriptional program that promotes regulatory T-cell differentiation. In addition to transcription, here we identified specific signaling networks that are regulated by TGF?R. Using an array of biochemical approaches, including immunoblotting, kinase assays, immunoprecipitation, and flow cytometry, we found that TGF?R signaling promotes the formation of a SMAD3/4-protein kinase A (PKA) complex that activates C-terminal Src kinase (CSK) and thereby down-regulates kinases involved in proximal TCR activation. Additionally, TGF?R signaling potentiated CSK phosphorylation of the P85 subunit in the P85?P110 phosphoinositide 3-kinase (PI3K) heterodimer, which reduced PI3K activity and down-regulated the activation of proteins that require phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3) for their activation. Moreover, TGF?R-mediated disruption of the P85?P110 interaction enabled P85 binding to a lipid phosphatase, phosphatase and tensin homolog (PTEN), aiding in the maintenance of PTEN abundance and thereby promoting elevated PtdIns(4,5)P2 levels in response to TGF?R signaling. Taken together, these results highlight that TGF-? influences the trajectory of early T-cell activation by altering PI3K activity and PtdIns levels.	[Cattley, Richard T.; Hawse, William F.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA; [Lee, Mijoon; Boggess, William C.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Notre Dame	Hawse, WF (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.	whawse@pitt.edu	Lee, Mijoon/AFK-1543-2022	Lee, Mijoon/0000-0001-7432-0427	Competitive Medical Research Fund Grant from the University of Pittsburgh Medical Center; University of Pittsburgh Department of Immunology; National Institutes of Health [1R21AI144558-01A1]	Competitive Medical Research Fund Grant from the University of Pittsburgh Medical Center; University of Pittsburgh Department of Immunology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Competitive Medical Research Fund Grant from the University of Pittsburgh Medical Center (to W. F. H.), startup funds generously provided by the University of Pittsburgh Department of Immunology (to W. F. H.) and by the National Institutes of Health Grant 1R21AI144558-01A1 (to W. F. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; August A, 1997, P NATL ACAD SCI USA, V94, P11227, DOI 10.1073/pnas.94.21.11227; BERGMAN M, 1992, EMBO J, V11, P2919, DOI 10.1002/j.1460-2075.1992.tb05361.x; CAI YC, 1995, IMMUNITY, V3, P417, DOI 10.1016/1074-7613(95)90171-X; Chagpar RB, 2010, P NATL ACAD SCI USA, V107, P5471, DOI 10.1073/pnas.0908899107; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chemnitz JM, 2006, CANCER RES, V66, P1114, DOI 10.1158/0008-5472.CAN-05-3252; Chen CH, 2003, J EXP MED, V197, P1689, DOI 10.1084/jem.20021170; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Cheung LWT, 2015, ELIFE, V4, DOI 10.7554/eLife.06866; Ching KA, 2000, J IMMUNOL, V165, P256, DOI 10.4049/jimmunol.165.1.256; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Dimeloe S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3334; Girod A, 1996, FEBS LETT, V391, P121, DOI 10.1016/0014-5793(96)00717-X; Gokhale NA, 2013, BIOCHEM J, V453, P413, DOI 10.1042/BJ20121528; Goni GM, 2014, P NATL ACAD SCI USA, V111, pE3177, DOI 10.1073/pnas.1317022111; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Hawse WF, 2019, J IMMUNOL, V203, P2771, DOI 10.4049/jimmunol.1900749; Hawse WF, 2019, J BIOL CHEM, V294, P4793, DOI 10.1074/jbc.RA118.006524; Hawse WF, 2017, J IMMUNOL, V199, P589, DOI 10.4049/jimmunol.1700369; Hawse WF, 2015, J IMMUNOL, V194, P4615, DOI 10.4049/jimmunol.1402554; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Horwitz DA, 2003, J LEUKOCYTE BIOL, V74, P471, DOI 10.1189/jlb.0503228; Howden AJM, 2019, NAT IMMUNOL, V20, P1542, DOI 10.1038/s41590-019-0495-x; Huynh A, 2015, NAT IMMUNOL, V16, P188, DOI 10.1038/ni.3077; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Lucas PJ, 2000, J EXP MED, V191, P1187, DOI 10.1084/jem.191.7.1187; Luo W, 2019, NAT IMMUNOL, V20, P736, DOI 10.1038/s41590-019-0376-3; MCFARLAND EDC, 1993, P NATL ACAD SCI USA, V90, P1402, DOI 10.1073/pnas.90.4.1402; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oudart JB, 2016, ONCOTARGET, V7, P1516, DOI 10.18632/oncotarget.6399; Pages F, 1996, J BIOL CHEM, V271, P9403, DOI 10.1074/jbc.271.16.9403; Piccirillo AR, 2019, J BIOL CHEM, V294, P2397, DOI 10.1074/jbc.RA118.006977; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SIEH M, 1993, EMBO J, V12, P315, DOI 10.1002/j.1460-2075.1993.tb05659.x; Souchelnytskyi S, 1997, J BIOL CHEM, V272, P28107, DOI 10.1074/jbc.272.44.28107; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yang WC, 2001, J IMMUNOL, V166, P387, DOI 10.4049/jimmunol.166.1.387; Yaqub S, 2003, BIOCHEM J, V372, P271, DOI 10.1042/BJ20030021; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004; Zhou J, 2015, BIOPHYS J, V108, P698, DOI 10.1016/j.bpj.2014.11.3454; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	52	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8236	8251		10.1074/jbc.RA120.012572	http://dx.doi.org/10.1074/jbc.RA120.012572			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32358062	Green Published, hybrid			2022-12-28	WOS:000542965700012
J	Jones, CS; Sychantha, D; Howell, PL; Clarke, AJ				Jones, Carys S.; Sychantha, David; Howell, P. Lynne; Clarke, Anthony J.			Structural basis for theO-acetyltransferase function of the extracytoplasmic domain of OatA fromStaphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptidoglycan; virulence factor; Staphylococcus aureus (S; aureus); methicillin-resistant Staphylococcus aureus (MRSA); cell wall; bacterial cell wall; O-acetylation; O-acetyltransferase; OatA; X-ray crystal structure	PEPTIDOGLYCAN O-ACETYLTRANSFERASE; STAPHYLOCOCCUS-AUREUS; LYSOZYME RESISTANCE; NEISSERIA-GONORRHOEAE; ENTEROCOCCUS-FAECALIS; MUREIN BIOSYNTHESIS; PROTEUS-MIRABILIS; ACETYLATION; MODEL; PATHOGENESIS	Many bacteria possess enzymes that modify the essential cell-wall polymer peptidoglycan byO-acetylation. This modification occurs in numerous Gram-positive pathogens, including methicillin-resistantStaphylococcus aureus, a common cause of human infections.O-Acetylation of peptidoglycan protects bacteria from the lytic activity of lysozyme, a mammalian innate immune enzyme, and as such is important for bacterial virulence. TheO-acetylating enzyme in Gram-positive bacteria,O-acetyltransferase A (OatA), is a two-domain protein consisting of an N-terminal integral membrane domain and a C-terminal extracytoplasmic domain. Here, we present the X-ray crystal structure at 1.71 ? resolution and the biochemical characterization of the C-terminal domain ofS. aureusOatA. The structure revealed that this OatA domain adopts an SGNH-hydrolase fold and possesses a canonical catalytic triad. Site-specific replacement of active-site amino acids revealed the presence of a water-coordinating aspartate residue that limits esterase activity. This residue, although conserved in staphyloccocal OatA and most other homologs, is not present in the previously characterized streptococcal OatA. These results provide insights into the mechanism of acetyl transfer in the SGNH/GDSL hydrolase family and highlight important evolutionary differences between homologous OatA enzymes. Furthermore, this study enhances our understanding of PGO-acetyltransferases, which could guide the development of novel antibacterial drugs to combat infections with multidrug-resistant bacterial pathogens.	[Jones, Carys S.; Sychantha, David; Clarke, Anthony J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Howell, P. Lynne] Hosp Sick Children, Program Mol Med, Toronto, ON, Canada; [Howell, P. Lynne] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON, Canada; [Clarke, Anthony J.] Wilfrid Laurier Univ, Dept Chem & Biochem, Waterloo, ON, Canada; [Sychantha, David] McMaster Univ, David Braley Ctr Antibiot Discovery, Michael G DeGroote Inst Infect Dis Res, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	University of Guelph; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Wilfrid Laurier University; McMaster University	Clarke, AJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.; Clarke, AJ (corresponding author), Wilfrid Laurier Univ, Dept Chem & Biochem, Waterloo, ON, Canada.	ajclarke@wlu.ca		Jones, Carys/0000-0003-0591-0815	Canadian Institutes of Health Research Operating Grant [PJT156353]; Canadian Glycomics Network; National Centre of Excellence; Natural Sciences and Engineering Research Council; Province of Ontario; Canadian Research Chair	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Canadian Glycomics Network; National Centre of Excellence; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Province of Ontario; Canadian Research Chair(Canada Research Chairs)	This work was supported by Canadian Institutes of Health Research Operating Grant PJT156353 (to A. J. C.); an operating grant from the Canadian Glycomics Network, a National Centre of Excellence (to A. J. C.); postgraduate scholarships from the Natural Sciences and Engineering Research Council and the Province of Ontario (to C. S. J.); and a Canadian Research Chair (to P. L. H.).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Aubry C, 2011, J INFECT DIS, V204, P731, DOI 10.1093/infdis/jir396; Baranwal G, 2017, INT J MED MICROBIOL, V307, P388, DOI 10.1016/j.ijmm.2017.08.002; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bera A, 2006, INFECT IMMUN, V74, P4598, DOI 10.1128/IAI.00301-06; Bernard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047893; BLUNDELL JK, 1980, FEMS MICROBIOL LETT, V9, P259, DOI 10.1111/j.1574-6968.1980.tb05648.x; Brott AS, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8020065; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; CLARKE AJ, 1993, J BACTERIOL, V175, P4550, DOI 10.1128/JB.175.14.4550-4553.1993; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; DUPONT C, 1991, EUR J BIOCHEM, V195, P763, DOI 10.1111/j.1432-1033.1991.tb15764.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLEMING TJ, 1986, INFECT IMMUN, V52, P600, DOI 10.1128/IAI.52.2.600-608.1986; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; GMEINER J, 1987, EUR J BIOCHEM, V163, P389, DOI 10.1111/j.1432-1033.1987.tb10811.x; GMEINER J, 1981, EUR J BIOCHEM, V117, P171; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Hebert L, 2007, INFECT IMMUN, V75, P5390, DOI 10.1128/IAI.00571-07; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; JOHANNSEN L, 1983, FEMS MICROBIOL LETT, V16, P313; Kell L. F., 2015, THESIS; Laaberki MH, 2011, J BIOL CHEM, V286, P5278, DOI 10.1074/jbc.M110.183236; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAR AL, 1986, J GEN MICROBIOL, V132, P2413; Moynihan PJ, 2014, BIOCHEMISTRY-US, V53, P6243, DOI 10.1021/bi501002d; Moynihan PJ, 2011, INT J BIOCHEM CELL B, V43, P1655, DOI 10.1016/j.biocel.2011.08.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; Pushkaran AC, 2015, J CHEM INF MODEL, V55, P760, DOI 10.1021/ci500734k; Review on Antimicrobial Resistance, 2014, ANTIMICROBIAL RESIST; Rex JH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11303-9; Sanchez M, 2017, CELL HOST MICROBE, V22, P543, DOI 10.1016/j.chom.2017.08.008; Schallenberger MA, 2012, J BACTERIOL, V194, P2677, DOI 10.1128/JB.00064-12; SNOWDEN MA, 1989, J GEN MICROBIOL, V135, P3015; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; SWIM SC, 1983, INFECT IMMUN, V42, P446, DOI 10.1128/IAI.42.2.446-452.1983; Sychantha D, 2018, BIOCHEMISTRY-US, V57, P2394, DOI 10.1021/acs.biochem.8b00301; Sychantha D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006667; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Veyrier FJ, 2013, MOL MICROBIOL, V87, P1100, DOI 10.1111/mmi.12153; Wang G, 2012, MBIO, V3, DOI 10.1128/mBio.00409-12; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; Williams AH, 2014, ACTA CRYSTALLOGR D, V70, P2631, DOI 10.1107/S1399004714016770	48	10	10	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8204	8213		10.1074/jbc.RA120.013108	http://dx.doi.org/10.1074/jbc.RA120.013108			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350117	hybrid, Green Published			2022-12-28	WOS:000542965700009
J	Torii, S; Orba, Y; Sasaki, M; Tabata, K; Wada, Y; Carr, M; Hobson-Peters, J; Hall, RA; Takada, A; Fukuhara, T; Matsuura, Y; Hall, WW; Sawa, H				Torii, Shiho; Orba, Yasuko; Sasaki, Michihito; Tabata, Koshiro; Wada, Yuji; Carr, Michael; Hobson-Peters, Jody; Hall, Roy A.; Takada, Ayato; Fukuhara, Takasuke; Matsuura, Yoshiharu; Hall, William W.; Sawa, Hirofumi			Host ESCRT factors are recruited during chikungunya virus infection and are required for the intracellular viral replication cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chikungunya virus; endosomal sorting complexes required for transport (ESCRT); alphavirus; trafficking; viral replication; hepatocyte growth factor-regulated tyrosine kinase substrate (HGS); viral release; host factor; siRNA screen; particle release; host-pathogen interaction	MONOCLONAL-ANTIBODIES; CYTOPLASMIC SURFACE; PROTEIN; MEMBRANE; ASSOCIATION; DISSECTION; TRANSPORT; OUTBREAK; BINDING; TSG101	Chikungunya fever is a re-emerging zoonotic disease caused by chikungunya virus (CHIKV), a member of the Alphavirus genus in the Togaviridae family. Only a few studies have reported on the host factors required for intracellular CHIKV trafficking. Here, we conducted an imaging-based siRNA screen to identify human host factors for intracellular trafficking that are involved in CHIKV infection, examined their interactions with CHIKV proteins, and investigated the contributions of these proteins to CHIKV infection. The results of the siRNA screen revealed that host endosomal sorting complexes required for transport (ESCRT) proteins are recruited during CHIKV infection. Co-immunoprecipitation analyses revealed that both structural and nonstructural CHIKV proteins interact with hepatocyte growth factor?regulated tyrosine kinase substrate (HGS), a component of the ESCRT-0 complex. We also observed that HGS co-localizes with the E2 protein of CHIKV and with dsRNA, a marker of the replicated CHIKV genome. Results from gene knockdown analyses indicated that, along with other ESCRT factors, HGS facilitates both genome replication and post-translational steps during CHIKV infection. Moreover, we show that ESCRT factors are also required for infections with other alphaviruses. We conclude that during CHIKV infection, several ESCRT factors are recruited via HGS and are involved in viral genome replication and post-translational processing of viral proteins.	[Torii, Shiho; Orba, Yasuko; Sasaki, Michihito; Tabata, Koshiro; Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido, Japan; [Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan; [Carr, Michael; Takada, Ayato; Hall, William W.; Sawa, Hirofumi] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido, Japan; [Wada, Yuji] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Carr, Michael; Hall, William W.] Univ Coll Dublin, Sch Med, Natl Virus Reference Lab, Dublin, Ireland; [Hall, William W.] Univ Coll Dublin, Sch Med, Ctr Res Infect Dis, Dublin, Ireland; [Hobson-Peters, Jody; Hall, Roy A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Fukuhara, Takasuke; Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Suita, Osaka, Japan; [Hall, William W.; Sawa, Hirofumi] Global Virus Network, Baltimore, MD 21201 USA	Hokkaido University; Hokkaido University; Hokkaido University; National Institute of Infectious Diseases (NIID); University College Dublin; University College Dublin; University of Queensland; Osaka University	Sawa, H (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido, Japan.; Sawa, H (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido, Japan.; Sawa, H (corresponding author), Global Virus Network, Baltimore, MD 21201 USA.	h-sawa@czc.hokudai.ac.jp	Sawa, Hirofumi/F-6954-2012; Sawa, Hirofumi/AAW-8816-2021; Sasaki, Michihito/AAY-1900-2021	Sawa, Hirofumi/0000-0003-2569-2755; Sasaki, Michihito/0000-0003-1607-2175; Carr, Michael/0000-0003-0011-6209; Torii, Shiho/0000-0003-4584-1199	MEXT/JSPS KAKENHI [JP16H06431, JP16H06429, JP16K21723]; Japan Initiative for Global Research Network on Infectious Diseases, from the Japan Agency for Medical Research and Development [JP19fm0108008]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Initiative for Global Research Network on Infectious Diseases, from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was supported by grants for Scientific Research on Innovative Areas and International Group from the MEXT/JSPS KAKENHI (JP16H06431, JP16H06429, JP16K21723), and the Japan Initiative for Global Research Network on Infectious Diseases, from the Japan Agency for Medical Research and Development (JP19fm0108008).	Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; Andriamandimby SF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002339; Arii J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05889-9; Barajas D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004087; Barajas D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000705; Barouch-Bentov R, 2016, MBIO, V7, DOI 10.1128/mBio.01456-16; Bernard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011479; Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; Calistri A, 2007, J VIROL, V81, P11468, DOI 10.1128/JVI.01364-07; Chen KC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-169; Chen RB, 2018, J GEN VIROL, V99, P761, DOI 10.1099/jgv.0.001072; Chiou CT, 2003, J GEN VIROL, V84, P2795, DOI 10.1099/vir.0.19201-0; Chou SF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005123; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; Couderc T, 2015, ANTIVIR RES, V121, P120, DOI 10.1016/j.antiviral.2015.07.002; Crump CA, 2007, J VIROL, V81, P7380, DOI 10.1128/JVI.00222-07; DECURTIS I, 1988, P NATL ACAD SCI USA, V85, P8052, DOI 10.1073/pnas.85.21.8052; Dejarnac O, 2018, CELL REP, V23, P1779, DOI 10.1016/j.celrep.2018.04.013; Diaz A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004742; FROSHAUER S, 1988, J CELL BIOL, V107, P2075, DOI 10.1083/jcb.107.6.2075; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; GEIGENMULLERGNIRKE U, 1993, J VIROL, V67, P1620; Goh LYH, 2015, J GEN VIROL, V96, P507, DOI 10.1099/jgv.0.000002; Goh LYH, 2013, CLIN IMMUNOL, V149, P487, DOI 10.1016/j.clim.2013.10.004; Gordon TB, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010025; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Howley PM., 2013, FIELDS VIROLOGY, V6, P651; Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; Kumar S, 2019, CELL REP, V26, P1800, DOI 10.1016/j.celrep.2019.01.075; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Lim CK, 2009, AM J TROP MED HYG, V81, P865, DOI 10.4269/ajtmh.2009.09-0009; Liu Y, 2010, FUTURE VIROL, V5, P481, DOI 10.2217/FVL.10.33; Masrinoul P, 2014, VIROLOGY, V464, P111, DOI 10.1016/j.virol.2014.05.038; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nobori H, 2018, ANTIVIR RES, V155, P60, DOI 10.1016/j.antiviral.2018.05.003; Pattanakitsakul SN, 2010, J PROTEOME RES, V9, P4640, DOI 10.1021/pr100357f; Pawliczek T, 2009, J VIROL, V83, P11254, DOI 10.1128/JVI.00574-09; Perera R, 2001, J VIROL, V75, P1, DOI 10.1128/JVI.75.1.1-10.2001; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Rauch S, 2011, J VIROL, V85, P3546, DOI 10.1128/JVI.02045-10; Remenyi R, 2018, J VIROL, V92, DOI [10.1128/JVI.00477-18, 10.1128/jvi.00477-18]; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rupp JC, 2015, J GEN VIROL, V96, P2483, DOI 10.1099/jgv.0.000249; Sasaki M, 2011, GENES CELLS, V16, P343, DOI 10.1111/j.1365-2443.2011.01491.x; Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068; Taylor GM, 2007, J VIROL, V81, P13631, DOI 10.1128/JVI.01688-07; Thomas S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-269; van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Wada Y, 2017, VIROLOGY, V505, P102, DOI 10.1016/j.virol.2017.02.014; Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016; Zhang N, 2017, BIOCHEM BIOPH RES CO, V493, P1190, DOI 10.1016/j.bbrc.2017.09.142; Zhang R, 2018, NATURE, V557, P570, DOI 10.1038/s41586-018-0121-3	63	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7941	7957		10.1074/jbc.RA119.012303	http://dx.doi.org/10.1074/jbc.RA119.012303			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32341071	Green Published, hybrid			2022-12-28	WOS:000540935400010
J	Holt, C; Hamborg, L; Lau, K; Brohus, M; Sorensen, AB; Larsen, KT; Sommer, C; Van Petegem, F; Overgaard, MT; Wimmer, R				Holt, Christian; Hamborg, Louise; Lau, Kelvin; Brohus, Malene; Sorensen, Anders Bundgaard; Larsen, Kamilla Taunsig; Sommer, Cordula; Van Petegem, Filip; Overgaard, Michael Toft; Wimmer, Reinhard			The arrhythmogenic N53I variant subtly changes the structure and dynamics in the calmodulin N-terminal domain, altering its interaction with the cardiac ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calmodulin (CaM); calcium-binding protein; ryanodine receptor; protein structure; protein-protein interaction; structure-function; CaM-N53I; cardiac arrhythmia; CPVT; NMR; X-ray crystallography	LONG QT SYNDROME; VENTRICULAR-TACHYCARDIA; MUTATIONS; BINDING; PROTEIN; INACTIVATION; INHIBITION; CALM1; GENE	Mutations in the genes encoding the highly conserved Ca2+-sensing protein calmodulin (CaM) cause severe cardiac arrhythmias, including catecholaminergic polymorphic ventricular tachycardia or long QT syndrome and sudden cardiac death. Most of the identified arrhythmogenic mutations reside in the C-terminal domain of CaM and mostly affect Ca2+-coordinating residues. One exception is the catecholaminergic polymorphic ventricular tachycardia?causing N53I substitution, which resides in the N-terminal domain (N-domain). It does not affect Ca2+ coordination and has only a minor impact on binding affinity toward Ca2+ and on other biophysical properties. Nevertheless, the N53I substitution dramatically affects CaM's ability to reduce the open probability of the cardiac ryanodine receptor (RyR2) while having no effect on the regulation of the plasmalemmal voltage-gated Ca2+ channel, Ca(v)1.2. To gain more insight into the molecular disease mechanism of this mutant, we used NMR to investigate the structures and dynamics of both apo- and Ca2+-bound CaM-N53I in solution. We also solved the crystal structures of WT and N53I CaM in complex with the primary calmodulin-binding domain (CaMBD2) from RyR2 at 1.84?2.13 ? resolutions. We found that all structures of the arrhythmogenic CaM-N53I variant are highly similar to those of WT CaM. However, we noted that the N53I substitution exposes an additional hydrophobic surface and that the intramolecular dynamics of the protein are significantly altered such that they destabilize the CaM N-domain. We conclude that the N53I-induced changes alter the interaction of the CaM N-domain with RyR2 and thereby likely cause the arrhythmogenic phenotype of this mutation.	[Holt, Christian; Hamborg, Louise; Brohus, Malene; Sorensen, Anders Bundgaard; Larsen, Kamilla Taunsig; Sommer, Cordula; Overgaard, Michael Toft; Wimmer, Reinhard] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark; [Lau, Kelvin; Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	Aalborg University; University of British Columbia	Overgaard, MT; Wimmer, R (corresponding author), Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark.; Van Petegem, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	petegem@mail.ubc.ca; mto@bio.aau.dk; rw@bio.aau.dk	Wimmer, Reinhard/A-7901-2012; Wimmer, Reinhard/M-2346-2019	Wimmer, Reinhard/0000-0001-6942-5056; Lau, Kelvin/0000-0002-9040-7597; Holt, Christian/0000-0003-2604-0695; Overgaard, Michael Toft/0000-0002-1423-2481; Hamborg Nielsen, Louise/0000-0002-8580-9751	Danish Council for Independent Research Grant [DFF-1323-00344]; Novo Nordisk Foundation [NNF18OC0053032, NNF16OC0023344]; Obel Family Foundation; SparNord Foundation; Carlsberg Foundation; Canadian Institutes of Health Research [PJT-148632]	Danish Council for Independent Research Grant; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Obel Family Foundation; SparNord Foundation; Carlsberg Foundation(Carlsberg Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Danish Council for Independent Research Grant DFF-1323-00344 and Novo Nordisk Foundation Grants NNF18OC0053032 and NNF16OC0023344. The medical biotechnology group at Aalborg University is supported by the Obel Family Foundation, the SparNord Foundation, and the Carlsberg Foundation. This work is also supported by Operating Grant PJT-148632 from the Canadian Institutes of Health Research (to F. V. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Balshaw DM, 2001, J BIOL CHEM, V276, P20144, DOI 10.1074/jbc.M010771200; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Boczek NJ, 2016, CIRC-CARDIOVASC GENE, V9, P136, DOI 10.1161/CIRCGENETICS.115.001323; Brohus M, 2019, BIOCHEM J, V476, P193, DOI 10.1042/BCJ20180545; Burnley BT, 2012, ELIFE, V1, DOI 10.7554/eLife.00311; Burnley BT., 2013, COMPUT CRYSTALLOGR N, V4, P51; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Coumel P., 1978, BRIT HEART J, V40, P28; Crotti L, 2019, EUR HEART J, V40, P2964, DOI 10.1093/eurheartj/ehz311; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FISCHER R, 1988, J BIOL CHEM, V263, P17055; Friedberg F, 2001, IUBMB LIFE, V51, P215; Gomez-Hurtado N, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004161; Gong DS, 2019, NATURE, V572, P347, DOI 10.1038/s41586-019-1377-y; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert P, 1997, Methods Mol Biol, V60, P157; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hwang HS, 2014, CIRC RES, V114, P1114, DOI 10.1161/CIRCRESAHA.114.303391; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Keller R., 2004, COMPUTER AIDED RESON, V1; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; Lau K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6397; Lau K, 2014, BIOCHEMISTRY-US, V53, P932, DOI 10.1021/bi401502x; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; Liu B, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008155; Makita N, 2014, CIRC-CARDIOVASC GENE, V7, P466, DOI 10.1161/CIRCGENETICS.113.000459; Marsman RF, 2014, J AM COLL CARDIOL, V63, P259, DOI 10.1016/j.jacc.2013.07.091; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Priori SG, 2001, CIRCULATION, V103, P196; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Rezacova P, 2008, PROTEINS, V70, P311, DOI 10.1002/prot.21511; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sondergaard MT, 2020, FEBS J, V287, P2256, DOI 10.1111/febs.15147; Sondergaard MT, 2015, J BIOL CHEM, V290, P26151, DOI 10.1074/jbc.M115.676627; Sondergaard MT, 2015, FEBS J, V282, P803, DOI 10.1111/febs.13184; Sondergaard MT, 2017, J BIOL CHEM, V292, P1385, DOI 10.1074/jbc.M116.766253; Sorensen AB, 2013, FEBS J, V280, P5511, DOI 10.1111/febs.12337; Sorensen BR, 1998, BIOCHEMISTRY-US, V37, P4244, DOI 10.1021/bi9718200; Tian XX, 2013, BIOCHEM J, V455, P367, DOI 10.1042/BJ20130805; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; TSALKOVA TN, 1985, J MOL BIOL, V181, P533, DOI 10.1016/0022-2836(85)90425-5; Vassilakopoulou V, 2015, BBA-GEN SUBJECTS, V1850, P2168, DOI 10.1016/j.bbagen.2015.07.001; Wang KQ, 2020, J PHYSIOL-LONDON, V598, P1169, DOI 10.1113/JP279307; Wang KQ, 2018, P NATL ACAD SCI USA, V115, pE10556, DOI 10.1073/pnas.1808733115; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yin G, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000996; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	68	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7620	7634		10.1074/jbc.RA120.013430	http://dx.doi.org/10.1074/jbc.RA120.013430			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32317284	hybrid, Green Published			2022-12-28	WOS:000538038900006
J	Liao, CY; Cai, BX; Feng, YF; Chen, JM; Wu, YP; Zhuang, JB; Liu, ZG; Wu, YL				Liao, Chunyan; Cai, Binxiang; Feng, Yufeng; Chen, Jingmeng; Wu, Yiping; Zhuang, Jingbin; Liu, Zuguo; Wu, Yalin			Activation of JNK signaling promotes all-trans-retinal?induced photoreceptor apoptosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						retina; retinal metabolism; photoreceptor; apoptosis; DNA damage	CYTOCHROME-C; VISUAL CYCLE; DNA-DAMAGE; CASPASE-9 ACTIVATION; INDUCED RETINOPATHY; NUCLEOTIDE-BINDING; STARGARDT DISEASE; PROTEIN-KINASE; OUTER SEGMENTS; CELL-DEATH	Disrupted clearance of all-trans-retinal (atRAL), a component of the visual (retinoid) cycle in the retina, may cause photoreceptor atrophy in autosomal recessive Stargardt disease (STGD1) and dry age-related macular degeneration (AMD). However, the mechanisms underlying atRAL-induced photoreceptor loss remain elusive. Here, we report that atRAL activates c-Jun N-terminal kinase (JNK) signaling at least partially through reactive oxygen species production, which promoted mitochondria-mediated caspase- and DNA damage-dependent apoptosis in photoreceptor cells. Damage to mitochondria in atRAL-exposed photoreceptor cells resulted from JNK activation, leading to decreased expression of Bcl2 apoptosis regulator (Bcl2), increased Bcl2 antagonist/killer (Bak) levels, and cytochrome c (Cyt c) release into the cytosol. Cytosolic Cyt c specifically provoked caspase-9 and caspase-3 activation and thereby initiated apoptosis. Phosphorylation of JNK in atRAL-loaded photoreceptor cells induced the appearance of ?H2AX, a sensitive marker for DNA damage, and was also associated with apoptosis onset. Suppression of JNK signaling protected photoreceptor cells against atRAL-induced apoptosis. Moreover, photoreceptor cells lacking Jnk1 and Jnk2 genes were more resistant to atRAL-associated cytotoxicity. The Abca4(?/?) Rdh8(?/?) mouse model displays defects in atRAL clearance that are characteristic of STGD1 and dry AMD. We found that JNK signaling was activated in the neural retina of light-exposed Abca4(?/?)Rdh8(?/?) mice. Of note, intraperitoneal administration of JNK?IN-8, which inhibits JNK signaling, effectively ameliorated photoreceptor degeneration and apoptosis in light-exposed Abca4(?/?)Rdh8(?/?) mice. We propose that pharmacological inhibition of JNK signaling may represent a therapeutic strategy for preventing photoreceptor loss in retinopathies arising from atRAL overload.	[Liao, Chunyan; Cai, Binxiang; Wu, Yiping; Zhuang, Jingbin; Liu, Zuguo; Wu, Yalin] Xiamen Univ, Sch Med, Fujian Prov Key Lab Ophthalmol & Visual Sci, Dept Ophthalmol Xiangan Hosp,Eye Inst, Xiamen 361102, FJ, Peoples R China; [Feng, Yufeng] Xiamen Univ, Affiliated Hosp 1, Dept Anesthesiol, Xiamen 361003, FJ, Peoples R China; [Chen, Jingmeng] Xiamen Univ, Sch Med, Xiamen 361102, FJ, Peoples R China; [Wu, Yalin] Xiamen Univ, Xiamen Eye Ctr, Wutong West Rd, Xiamen 361001, FJ, Peoples R China; [Wu, Yalin] Xiamen Univ, Shenzhen Res Inst, Shenzhen 518063, GD, Peoples R China	Xiamen University; Xiamen University; Xiamen University; Xiamen University; Xiamen University	Wu, YL (corresponding author), Xiamen Univ, Xiamen Eye Ctr, Wutong West Rd, Xiamen 361001, FJ, Peoples R China.; Wu, YL (corresponding author), Xiamen Univ, Sch Med, Xiangan Hosp, Inst Eye, Xiangan South Rd, Xiamen, FJ, Peoples R China.	yalinw@xmu.edu.cn			China National Natural Science Foundation [81870671, 81570857]; Basic Research Program of Shenzhen Grant [JCYJ20180306173025004]; Natural Science Foundation of Fujian Province [2017J01148]; Sanming Project of Medicine in Shenzhen Grant [SZSM201612022]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Basic Research Program of Shenzhen Grant; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Sanming Project of Medicine in Shenzhen Grant	This work was supported in part by China National Natural Science Foundation Grants 81870671 and 81570857 (to Yalin Wu), Basic Research Program of Shenzhen Grant JCYJ20180306173025004 (to Yalin Wu), Natural Science Foundation of Fujian Province Grant 2017J01148 (to Yalin Wu), and Sanming Project of Medicine in Shenzhen Grant SZSM201612022 (to Z. L. and Yalin Wu). The authors declare that they have no conflicts of interest with the contents of this article.	Adler L, 2014, J BIOL CHEM, V289, P1519, DOI 10.1074/jbc.M113.511295; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Biswas-Fiss EE, 2012, J BIOL CHEM, V287, P44097, DOI 10.1074/jbc.M112.409623; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Chen YR, 1996, J BIOL CHEM, V271, P31929, DOI 10.1074/jbc.271.50.31929; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Du HJ, 2013, P NATL ACAD SCI USA, V110, P2377, DOI 10.1073/pnas.1221729110; FUTTERMAN S, 1970, J NEUROCHEM, V17, P149, DOI 10.1111/j.1471-4159.1970.tb02195.x; Guma M, 2009, P NATL ACAD SCI USA, V106, P8760, DOI 10.1073/pnas.0902659106; Heibein JA, 1999, J IMMUNOL, V163, P4683; Hill MM, 2004, EMBO J, V23, P2134, DOI 10.1038/sj.emboj.7600210; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Johnson-Cadwell LI, 2007, J NEUROCHEM, V101, P1619, DOI 10.1111/j.1471-4159.2007.04516.x; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Kulkarni AD, 2005, ADV DRUG DELIVER REV, V57, P1994, DOI 10.1016/j.addr.2005.09.003; Li J, 2016, TOXICOLOGY, V371, P41, DOI 10.1016/j.tox.2016.10.005; Li J, 2015, TOXICOL SCI, V143, P196, DOI 10.1093/toxsci/kfu223; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li YN, 2017, P NATL ACAD SCI USA, V114, P1542, DOI 10.1073/pnas.1620626114; Liao Y, 2019, INVEST OPHTH VIS SCI, V60, P3034, DOI 10.1167/iovs.18-26360; Lin AN, 2002, AGING CELL, V1, P112, DOI 10.1046/j.1474-9728.2002.00014.x; Liu X, 2016, INVEST OPHTH VIS SCI, V57, P1017, DOI 10.1167/iovs.15-18429; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maeda T, 2012, PHOTOCHEM PHOTOBIOL, V88, P1309, DOI 10.1111/j.1751-1097.2012.01143.x; Mao X, 2008, CELL RES, V18, P879, DOI 10.1038/cr.2008.86; Masse H, 2016, J FR OPHTALMOL, V39, P40, DOI 10.1016/j.jfo.2015.10.001; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Modesti M, 2001, CURR BIOL, V11, pR229, DOI 10.1016/S0960-9822(01)00112-9; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; Panaretakis T, 2002, J BIOL CHEM, V277, P44317, DOI 10.1074/jbc.M205273200; Perez AR, 2017, NAT BIOTECHNOL, V35, P347, DOI 10.1038/nbt.3804; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sawada O, 2014, EXP EYE RES, V123, P27, DOI 10.1016/j.exer.2014.04.003; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Wu L, 2010, ADV EXP MED BIOL, V664, P533, DOI 10.1007/978-1-4419-1399-9_61; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhao JL, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20734; Zhu XW, 2001, J NEUROCHEM, V76, P435, DOI 10.1046/j.1471-4159.2001.00046.x	56	4	5	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6958	6971		10.1074/jbc.RA120.013189	http://dx.doi.org/10.1074/jbc.RA120.013189			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32265302	Green Published, hybrid			2022-12-28	WOS:000536212600014
J	Lee, H; Smith, SB; Sheu, SS; Yoon, Y				Lee, Hakjoo; Smith, Sylvia B.; Sheu, Shey-Shing; Yoon, Yisang			The short variant of optic atrophy 1 (OPA1) improves cell survival under oxidative stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; mitochondrial permeability transition (MPT); necrosis (necrotic death); reactive oxygen species (ROS); oxidative stress; mitochondrial dynamics; OPA1; optic atrophy 1 (OPA1); OMA1 zinc metallopeptidase; apoptosis	MITOCHONDRIAL PERMEABILITY TRANSITION; DYNAMIN-RELATED PROTEIN; CYTOCHROME-C; PROTEOLYTIC CLEAVAGE; OMA1 PROTEASE; CYCLOPHILIN-D; ATP SYNTHASE; APOPTOSIS; FUSION; DEATH	Optic atrophy 1 (OPA1) is a dynamin protein that mediates mitochondrial fusion at the inner membrane. OPA1 is also necessary for maintaining the cristae and thus essential for supporting cellular energetics. OPA1 exists as membrane-anchored long form (L-OPA1) and short form (S-OPA1) that lacks the transmembrane region and is generated by cleavage of L-OPA1. Mitochondrial dysfunction and cellular stresses activate the inner membrane?associated zinc metallopeptidase OMA1 that cleaves L-OPA1, causing S-OPA1 accumulation. The prevailing notion has been that L-OPA1 is the functional form, whereas S-OPA1 is an inactive cleavage product in mammals, and that stress-induced OPA1 cleavage causes mitochondrial fragmentation and sensitizes cells to death. However, S-OPA1 contains all functional domains of dynamin proteins, suggesting that it has a physiological role. Indeed, we recently demonstrated that S-OPA1 can maintain cristae and energetics through its GTPase activity, despite lacking fusion activity. Here, applying oxidant insult that induces OPA1 cleavage, we show that cells unable to generate S-OPA1 are more sensitive to this stress under obligatory respiratory conditions, leading to necrotic death. These findings indicate that L-OPA1 and S-OPA1 differ in maintaining mitochondrial function. Mechanistically, we found that cells that exclusively express L-OPA1 generate more superoxide and are more sensitive to Ca2+-induced mitochondrial permeability transition, suggesting that S-OPA1, and not L-OPA1, protects against cellular stress. Importantly, silencing of OMA1 expression increased oxidant-induced cell death, indicating that stress-induced OPA1 cleavage supports cell survival. Our findings suggest that S-OPA1 generation by OPA1 cleavage is a survival mechanism in stressed cells.	[Lee, Hakjoo; Yoon, Yisang] Augusta Univ, Med Coll Georgia, Dept Physiol, 1120 15th St, Augusta, GA 30912 USA; [Smith, Sylvia B.] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Smith, Sylvia B.] Augusta Univ, Med Coll Georgia, Culver Vis Discovery Inst, Augusta, GA 30912 USA; [Sheu, Shey-Shing] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Jefferson University	Yoon, Y (corresponding author), Augusta Univ, Med Coll Georgia, Dept Physiol, 1120 15th St, Augusta, GA 30912 USA.	yyoon@augusta.edu	Sheu, Shey-Shing/Y-4009-2019	Sheu, Shey-Shing/0000-0003-3838-3601; Yoon, Yisang/0000-0002-1618-5439	American Heart Association [16GRNT31170032, 19TPA34890037]; National Institutes of Health [R01HL093671, R01EY028103, R01EY012830, R01HL137266]	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by American Heart Association Grants 16GRNT31170032 and 19TPA34890037 (to Y. Y.) and National Institutes of Health Grants R01HL093671 (to Y. Y. and S.-S. S.), R01EY028103 and R01EY012830 (to S. B. S.), and R01HL137266 (to S.-S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acin-Perez R, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan4935; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2008, BRAIN, V131, P338, DOI 10.1093/brain/awm298; Anand R, 2014, J CELL BIOL, V204, P919, DOI 10.1083/jcb.201308006; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baker MJ, 2014, EMBO J, V33, P578, DOI 10.1002/embj.201386474; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bobba A, 1999, FEBS LETT, V457, P126, DOI 10.1016/S0014-5793(99)01018-2; Bohovych I, 2015, SCI REP-UK, V5, DOI 10.1038/srep13989; Brookes PS, 2000, J BIOL CHEM, V275, P20474, DOI 10.1074/jbc.M001077200; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Consolato F, 2018, J CELL SCI, V131, DOI 10.1242/jcs.213546; Del Dotto V, 2017, CELL REP, V19, P2557, DOI 10.1016/j.celrep.2017.05.073; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Delettre C, 2001, HUM GENET, V109, P584, DOI 10.1007/s00439-001-0633-y; Desmurs M, 2015, MOL CELL BIOL, V35, P1139, DOI 10.1128/MCB.01047-14; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Ehses S, 2009, J CELL BIOL, V187, P1023, DOI 10.1083/jcb.200906084; Filipovic DM, 1999, AM J PHYSIOL-RENAL, V277, pF428, DOI 10.1152/ajprenal.1999.277.3.F428; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Ganapathy PS, 2011, INVEST OPHTH VIS SCI, V52, P5551, DOI 10.1167/iovs.11-7256; Ganapathy PS, 2009, INVEST OPHTH VIS SCI, V50, P4460, DOI 10.1167/iovs.09-3402; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Griparic L, 2007, J CELL BIOL, V178, P757, DOI 10.1083/jcb.200704112; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; He JY, 2017, P NATL ACAD SCI USA, V114, P9086, DOI 10.1073/pnas.1711201114; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; Head B, 2009, J CELL BIOL, V187, P959, DOI 10.1083/jcb.200906083; Hurst S, 2019, J BIOL CHEM, V294, P10807, DOI 10.1074/jbc.RA118.006443; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Jemmerson R, 2002, CELL DEATH DIFFER, V9, P538, DOI 10.1038/sj.cdd.4400981; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; Khalimonchuk O, 2012, J BIOL CHEM, V287, P7289, DOI 10.1074/jbc.M111.313148; Konig T, 2016, MOL CELL, V64, P148, DOI 10.1016/j.molcel.2016.08.020; Kong DJ, 2005, MOL CELL BIOCHEM, V272, P187, DOI 10.1007/s11010-005-7323-3; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Kushnareva YE, 2013, CELL DEATH DIFFER, V20, P353, DOI 10.1038/cdd.2012.128; Landes T, 2010, SEMIN CELL DEV BIOL, V21, P593, DOI 10.1016/j.semcdb.2009.12.012; Larson EM, 1997, INVEST OPHTH VIS SCI, V38, P1929; Lee H, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7120186; Lee H, 2017, J BIOL CHEM, V292, P7115, DOI 10.1074/jbc.M116.762567; Lee Y, 1999, J BIOL CHEM, V274, P19792, DOI 10.1074/jbc.274.28.19792; MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nadtochiy SM, 2007, J MOL CELL CARDIOL, V42, P812, DOI 10.1016/j.yjmcc.2007.01.010; Neame SJ, 1998, J CELL BIOL, V142, P1583, DOI 10.1083/jcb.142.6.1583; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Olichon A, 2007, CELL DEATH DIFFER, V14, P682, DOI 10.1038/sj.cdd.4402048; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; PAGE B, 1993, INT J ONCOL, V3, P473; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Scorrano L, 1999, J BIOL CHEM, V274, P22581, DOI 10.1074/jbc.274.32.22581; Shanmughapriya S, 2015, MOL CELL, V60, P47, DOI 10.1016/j.molcel.2015.08.009; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Sun Y, 2016, J MOL MED, V94, P335, DOI 10.1007/s00109-015-1359-y; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tokunaga H, 2000, HYPERTENS RES, V23, P39, DOI 10.1291/hypres.23.39; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; Troyano A, 2003, CELL DEATH DIFFER, V10, P889, DOI 10.1038/sj.cdd.4401249; Vercesi AE, 1997, BIOSCIENCE REP, V17, P43, DOI 10.1023/A:1027335217774; Wai T, 2016, TRENDS ENDOCRIN MET, V27, P105, DOI 10.1016/j.tem.2015.12.001; Wai T, 2015, SCIENCE, V350, DOI 10.1126/science.aad0116; Walisser JA, 1999, EXP CELL RES, V251, P401, DOI 10.1006/excr.1999.4589; Xiao X, 2014, AM J PHYSIOL-RENAL, V306, pF1318, DOI 10.1152/ajprenal.00036.2014; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007	78	16	16	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6543	6560		10.1074/jbc.RA119.010983	http://dx.doi.org/10.1074/jbc.RA119.010983			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32245890	hybrid, Green Published			2022-12-28	WOS:000537685000024
J	Miranda, CJ; Fernandez, N; Kamel, N; Turner, D; Benzenhafer, D; Bolch, SN; Andring, JT; McKenna, R; Smith, WC				Miranda, Connie Jaqueline; Fernandez, Nicole; Kamel, Nader; Turner, Daniel; Benzenhafer, Del; Bolch, Susan N.; Andring, Jacob T.; McKenna, Robert; Smith, W. Clay			An arrestin-1 surface opposite of its interface with photoactivated rhodopsin engages with enolase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arrestin; glycolysis; photoreceptor; phototransduction; protein complex; G protein-coupled receptor (GPCR); protein conformation; enolase; fluorescence quench protection; light sensing	VISUAL ARRESTIN; CRYSTAL-STRUCTURE; S-ANTIGEN; BINDING; PROTEIN; ROD; MECHANISM; MOVEMENT; PHOSPHORYLATION; TRANSLOCATION	Arrestin-1 is the arrestin family member responsible for inactivation of the G protein?coupled receptor rhodopsin in photoreceptors. Arrestin-1 is also well-known to interact with additional protein partners and to affect other signaling cascades beyond phototransduction. In this study, we investigated one of these alternative arrestin-1 binding partners, the glycolysis enzyme enolase-1, to map the molecular contact sites between these two proteins and investigate how the binding of arrestin-1 affects the catalytic activity of enolase-1. Using fluorescence quench protection of strategically placed fluorophores on the arrestin-1 surface, we observed that arrestin-1 primarily engages enolase-1 along a surface that is opposite of the side of arrestin-1 that binds photoactivated rhodopsin. Using this information, we developed a molecular model of the arrestin-1?enolase-1 complex, which was validated by targeted substitutions of charge-pair interactions. Finally, we identified the likely source of arrestin's modulation of enolase-1 catalysis, showing that selective substitution of two amino acids in arrestin-1 can completely remove its effect on enolase-1 activity while still remaining bound to enolase-1. These findings open up opportunities for examining the functional effects of arrestin-1 on enolase-1 activity in photoreceptors and their surrounding cells.	[Miranda, Connie Jaqueline; Fernandez, Nicole; Kamel, Nader; Turner, Daniel; Benzenhafer, Del; Bolch, Susan N.; Smith, W. Clay] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Andring, Jacob T.; McKenna, Robert] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Turner, Daniel] Duke Univ, Dept Med, Durham, NC 27710 USA; [Benzenhafer, Del] Univ Colorado, Dept Radiol, Denver, CO 80204 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Duke University; University of Colorado System; University of Colorado Denver	Smith, WC (corresponding author), Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA.	wcsmith@ufl.edu	Smith, W. Clay/AAQ-1589-2021	Andring, Jacob/0000-0002-6632-6391	Research to Prevent Blindness; Oxnard Foundation; Foundation Fighting Blindness Grant [TA-NMT-0619-0770-UFL]	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Oxnard Foundation; Foundation Fighting Blindness Grant	This research was supported by Research to Prevent Blindness, the Oxnard Foundation, and Foundation Fighting Blindness Grant TA-NMT-0619-0770-UFL. The authors declare that they have no conflicts of interest with the contents of this article.	BROEKHUYSE RM, 1985, CURR EYE RES, V4, P613, DOI 10.3109/02713688508999993; DONOSO LA, 1990, CURR EYE RES, V9, P343, DOI 10.3109/02713689008999622; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Gurevich VV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00125; Gurevich VV, 1997, MOL PHARMACOL, V51, P161, DOI 10.1124/mol.51.1.161; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Haque A, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8020033; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; HSU SC, 1991, J BIOL CHEM, V266, P21745; Huang SP, 2010, J NEUROSCI, V30, P9381, DOI 10.1523/JNEUROSCI.1207-10.2010; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Kang HJ, 2008, ACTA CRYSTALLOGR D, V64, P651, DOI 10.1107/S0907444908008561; Kang YY, 2016, FEBS J, V283, P816, DOI 10.1111/febs.13561; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; McDowell J. H., 1993, PHOTORECEPTOR CELLS, V15, P123; McDowell JH, 1999, BIOCHEMISTRY-US, V38, P6119, DOI 10.1021/bi990175p; Mookerjee SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152016; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Ostermaier MK, 2014, P NATL ACAD SCI USA, V111, P1825, DOI 10.1073/pnas.1319402111; Peterson YK, 2017, PHARMACOL REV, V69, P256, DOI 10.1124/pr.116.013367; PHILP NJ, 1987, FEBS LETT, V225, P127, DOI 10.1016/0014-5793(87)81144-4; Schreier B, 2010, BIOCHEMISTRY-US, V49, P7582, DOI 10.1021/bi100954f; Sente A, 2018, NAT STRUCT MOL BIOL, V25, P541, DOI 10.1038/s41594-018-0071-3; Smith WC, 2011, INVEST OPHTH VIS SCI, V52, P1832, DOI 10.1167/iovs.10-5724; Sommer ME, 2007, J BIOL CHEM, V282, P25560, DOI 10.1074/jbc.M702155200; Vajda S, 2017, PROTEINS, V85, P435, DOI 10.1002/prot.25219; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2013, J BIOL CHEM, V288, P3394, DOI 10.1074/jbc.M112.445437; WHELAN JP, 1988, J NEUROSCI RES, V20, P263, DOI 10.1002/jnr.490200216; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; Wold F., 1971, ENZYMES, P499; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075; Zhou XE, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.21; Zhu XM, 2002, MOL VIS, V8, P462	44	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6498	6508		10.1074/jbc.RA120.013043	http://dx.doi.org/10.1074/jbc.RA120.013043			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32238431	Green Published, hybrid			2022-12-28	WOS:000537685000020
J	Rios, N; Radi, R; Kalyanaraman, B; Zielonka, J				Rios, Natalia; Radi, Rafael; Kalyanaraman, Balaraman; Zielonka, Jacek			Tracking isotopically labeled oxidants using boronate-based redox probes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen peroxide; superoxide ion; reactive oxygen species (ROS); reactive nitrogen species (RNS); oxygen radicals; isotopic tracer; mass spectrometry (MS); oxygen-18; peroxymonocarbonate; peroxynitrite; reaction mechanism; redox probes; hypochlorous acid; superoxide radical anion; isotope tracing	IMAGING HYDROGEN-PEROXIDE; REACTIVE OXYGEN; NITRIC-OXIDE; IN-VIVO; FLUORESCENT-PROBES; INTRACELLULAR SUPEROXIDE; MYELOPEROXIDASE ACTIVITY; PEROXYNITRITE FORMATION; BIOLOGICAL-SYSTEMS; FLUOROGENIC PROBES	Reactive oxygen and nitrogen species have been implicated in many biological processes and diseases, including immune responses, cardiovascular dysfunction, neurodegeneration, and cancer. These chemical species are short-lived in biological settings, and detecting them in these conditions and diseases requires the use of molecular probes that form stable, easily detectable, products. The chemical mechanisms and limitations of many of the currently used probes are not well-understood, hampering their effective applications. Boronates have emerged as a class of probes for the detection of nucleophilic two-electron oxidants. Here, we report the results of an oxygen-18?labeling MS study to identify the origin of oxygen atoms in the oxidation products of phenylboronate targeted to mitochondria. We demonstrate that boronate oxidation by hydrogen peroxide, peroxymonocarbonate, hypochlorite, or peroxynitrite involves the incorporation of oxygen atoms from these oxidants. We therefore conclude that boronates can be used as probes to track isotopically labeled oxidants. This suggests that the detection of specific products formed from these redox probes could enable precise identification of oxidants formed in biological systems. We discuss the implications of these results for understanding the mechanism of conversion of the boronate-based redox probes to oxidant-specific products.	[Rios, Natalia; Radi, Rafael] Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay; [Rios, Natalia; Radi, Rafael] Univ Republica, Fac Med, Ctr Invest Biomed CEINBIO, Montevideo 11800, Uruguay; [Kalyanaraman, Balaraman; Zielonka, Jacek] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Medical College of Wisconsin	Zielonka, J (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jzielonk@mcw.edu	Zielonka, Jacek/N-9546-2014	Zielonka, Jacek/0000-0002-2524-0145; Rios, Natalia/0000-0001-5114-3130	NCI, National Institutes of Health [U01CA178960, R01CA208648]; Espacio Interdisciplinario 2015, Universidad de la Republica, Uruguay; CSIC Grupos 2018, Universidad de la Republica, Uruguay; American Cancer Society [IRG 16-183-31]; MCW Cancer Center; Agencia Nacional de Investigacion e Innovacion (ANII); Universidad de la Republica; Programa de Desarrollo de Ciencias Basicas (PEDECIBA, Uruguay)	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Espacio Interdisciplinario 2015, Universidad de la Republica, Uruguay; CSIC Grupos 2018, Universidad de la Republica, Uruguay; American Cancer Society(American Cancer Society); MCW Cancer Center; Agencia Nacional de Investigacion e Innovacion (ANII); Universidad de la Republica; Programa de Desarrollo de Ciencias Basicas (PEDECIBA, Uruguay)	This work was supported by NCI, National Institutes of Health Grants U01CA178960 and R01CA208648 (to B. K.) and by Espacio Interdisciplinario 2015 and CSIC Grupos 2018, Universidad de la Republica, Uruguay (to R. R.). This work was also supported by American Cancer Society Institutional Research Grant IRG 16-183-31 and the MCW Cancer Center (to J. Z.); by Agencia Nacional de Investigacion e Innovacion (ANII) and Universidad de la Republica fellowships (to N. R.); and by Programa de Desarrollo de Ciencias Basicas (PEDECIBA, Uruguay) (to R. R. and N. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Fig. S1.	Alvarez MN, 2002, METHOD ENZYMOL, V359, P353; Bakhmutova-Albert EV, 2010, INORG CHEM, V49, P11287, DOI 10.1021/ic1007389; Bennett DA, 2001, INORG CHEM, V40, P2996, DOI 10.1021/ic000910h; Cairns Andrew G, 2015, Methods Mol Biol, V1265, P25, DOI 10.1007/978-1-4939-2288-8_3; Carroll V, 2014, J AM CHEM SOC, V136, P14742, DOI 10.1021/ja509198w; Cheng G, 2018, J BIOL CHEM, V293, P10363, DOI 10.1074/jbc.RA118.003044; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Cocheme HM, 2012, NAT PROTOC, V7, P946, DOI 10.1038/nprot.2012.035; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; Dagnell M, 2019, J BIOL CHEM, V294, P12330, DOI 10.1074/jbc.RA119.009001; Debowska K, 2015, PHARMACOL REP, V67, P756, DOI 10.1016/j.pharep.2015.03.016; Dickinson BC, 2013, NAT PROTOC, V8, P1249, DOI 10.1038/nprot.2013.064; Dickinson BC, 2010, J AM CHEM SOC, V132, P5906, DOI 10.1021/ja1014103; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Ferrer-Sueta G, 2018, CHEM REV, V118, P462, DOI 10.1021/acs.chemrev.7b00568; Forman HJ, 2014, J MOL CELL CARDIOL, V73, P2, DOI 10.1016/j.yjmcc.2014.01.018; Hardy M, 2018, ANTIOXID REDOX SIGN, V28, P1416, DOI 10.1089/ars.2017.7398; Hawkins CL, 2019, J BIOL CHEM, V294, P19683, DOI 10.1074/jbc.REV119.006217; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; Kabeya LM, 2013, ANAL BIOCHEM, V437, P130, DOI 10.1016/j.ab.2013.02.020; Kalyanaraman B, 2017, ARCH BIOCHEM BIOPHYS, V617, P38, DOI 10.1016/j.abb.2016.08.021; Kalyanaraman B, 2014, BBA-GEN SUBJECTS, V1840, P739, DOI 10.1016/j.bbagen.2013.05.008; Koto T, 2014, FREE RADICAL RES, V48, P478, DOI 10.3109/10715762.2014.886774; Lehmann WD, 2017, MASS SPECTROM REV, V36, P58, DOI 10.1002/mas.21497; Lin VS, 2013, METHOD ENZYMOL, V526, P19, DOI 10.1016/B978-0-12-405883-5.00002-8; Lippert AR, 2011, ACCOUNTS CHEM RES, V44, P793, DOI 10.1021/ar200126t; Lippert AR, 2010, CHEM COMMUN, V46, P7510, DOI 10.1039/c0cc01560a; Maghzal GJ, 2014, J BIOL CHEM, V289, P5580, DOI 10.1074/jbc.M113.539486; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; Michalski R, 2014, J BIOL CHEM, V289, P22536, DOI 10.1074/jbc.M114.553727; Michalski R, 2014, FREE RADICAL BIO MED, V67, P278, DOI 10.1016/j.freeradbiomed.2013.10.816; Michalski R, 2013, FREE RADICAL BIO MED, V54, P135, DOI 10.1016/j.freeradbiomed.2012.09.018; MOTTLEY C, 1986, BIOCHEM BIOPH RES CO, V141, P622, DOI 10.1016/S0006-291X(86)80218-2; Pattison DI, 2012, FREE RADICAL RES, V46, P975, DOI 10.3109/10715762.2012.667566; Peskin AV, 2019, FREE RADICAL BIO MED, V145, P1, DOI 10.1016/j.freeradbiomed.2019.09.010; Prolo C, 2018, FREE RADICAL BIO MED, V128, P59, DOI 10.1016/j.freeradbiomed.2018.02.017; Prolo C, 2015, FREE RADICAL BIO MED, V87, P346, DOI 10.1016/j.freeradbiomed.2015.06.027; Proniewski B, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7838406; Reczek CR, 2015, CURR OPIN CELL BIOL, V33, P8, DOI 10.1016/j.ceb.2014.09.010; Richardson DE, 2000, J AM CHEM SOC, V122, P1729, DOI 10.1021/ja9927467; Rinkel J, 2015, BEILSTEIN J ORG CHEM, V11, P2493, DOI 10.3762/bjoc.11.271; Rios N, 2016, FREE RADICAL BIO MED, V101, P284, DOI 10.1016/j.freeradbiomed.2016.08.033; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Sedgwick AC, 2018, J AM CHEM SOC, V140, P14267, DOI 10.1021/jacs.8b08457; Seredenina T, 2016, FREE RADICAL BIO MED, V97, P95, DOI 10.1016/j.freeradbiomed.2016.05.016; Seven O, 2017, SENSOR ACTUAT B-CHEM, V239, P1318, DOI 10.1016/j.snb.2016.09.120; Shan XP, 2006, J INORG BIOCHEM, V100, P421, DOI 10.1016/j.jinorgbio.2006.01.014; Shchepinova MM, 2017, CELL CHEM BIOL, V24, P1285, DOI 10.1016/j.chembiol.2017.08.003; Sikora A, 2011, CHEM RES TOXICOL, V24, P687, DOI 10.1021/tx100439a; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Smulik R, 2014, J BIOL CHEM, V289, P35570, DOI 10.1074/jbc.M114.597740; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Talib J, 2016, FREE RADICAL BIO MED, V97, P124, DOI 10.1016/j.freeradbiomed.2016.05.004; Thomas DD, 2002, METHOD ENZYMOL, V359, P84; Truzzi DR, 2019, J BIOL CHEM, V294, P14055, DOI 10.1074/jbc.RA119.008825; Truzzi DR, 2017, HYDROGEN PEROXIDE ME, P81, DOI [10.1201/9781315154831-4, DOI 10.1201/9781315154831-4]; Van de Bittner GC, 2010, P NATL ACAD SCI USA, V107, P21316, DOI 10.1073/pnas.1012864107; VISSERS MC, 2017, HYDROGEN PEROXIDE ME; Wardman P, 2008, METHOD ENZYMOL, V441, P261, DOI 10.1016/S0076-6879(08)01214-7; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Winterbourn CC, 2020, CHEMTEXTS, V6, DOI 10.1007/s40828-019-0101-8; Winterbourn CC, 2018, ANTIOXID REDOX SIGN, V29, P541, DOI 10.1089/ars.2017.7425; Xiao HB, 2016, CHEM SCI, V7, P6153, DOI 10.1039/c6sc01793b; Xiao Y, 2019, ANTIOXID REDOX SIGN, V31, P359, DOI 10.1089/ars.2018.7535; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhou HY, 2011, J AM CHEM SOC, V133, P15803, DOI 10.1021/ja2077137; Zielonka J, 2005, FREE RADICAL BIO MED, V39, P853, DOI 10.1016/j.freeradbiomed.2005.05.001; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2006, ARCH BIOCHEM BIOPHYS, V456, P39, DOI 10.1016/j.abb.2006.09.031; Zielonka J, 2018, FREE RADICAL BIO MED, V128, P3, DOI 10.1016/j.freeradbiomed.2018.03.032; Zielonka J, 2017, CELL BIOCHEM BIOPHYS, V75, P335, DOI 10.1007/s12013-017-0813-6; Zielonka J, 2016, FREE RADICAL BIO MED, V99, P32, DOI 10.1016/j.freeradbiomed.2016.07.023; Zielonka J, 2016, J BIOL CHEM, V291, P7029, DOI 10.1074/jbc.M115.702787; Zielonka Jacek, 2015, Methods Mol Biol, V1264, P171, DOI 10.1007/978-1-4939-2257-4_16; Zielonka J, 2014, J BIOL CHEM, V289, P16176, DOI 10.1074/jbc.M114.548693; Zielonka J, 2013, METHOD ENZYMOL, V526, P145, DOI 10.1016/B978-0-12-405883-5.00009-0; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j; Zielonka J, 2012, J BIOL CHEM, V287, P2984, DOI 10.1074/jbc.M111.309062; Zielonka J, 2010, J BIOL CHEM, V285, P14210, DOI 10.1074/jbc.M110.110080; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	86	9	9	5	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6665	6676		10.1074/jbc.RA120.013402	http://dx.doi.org/10.1074/jbc.RA120.013402			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32217693	Green Published, hybrid			2022-12-28	WOS:000537685000032
J	Salustiano, EJ; da Costa, KM; Freire-de-Lima, L; Mendonca-Previato, L; Previato, JO				Salustiano, Eduardo J.; da Costa, Kelli M.; Freire-de-Lima, Leonardo; Mendonca-Previato, Lucia; Previato, Jose O.			Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; glycosyltransferase; ganglioside; multidrug transporter; chronic myelogenous leukemia; lipid metabolism; cancer; active transport; multifactorial drug resistance; neoplasia	P-GLYCOPROTEIN; GLUCOSYLCERAMIDE SYNTHASE; INDUCED APOPTOSIS; DRUG-RESISTANCE; COLLATERAL SENSITIVITY; PERIPHERAL-BLOOD; PROTEIN-1 MRP1; CELL-LINES; CERAMIDE; EXPRESSION	Multidrug resistance (MDR) in cancer arises from cross-resistance to structurally- and functionally-divergent chemotherapeutic drugs. In particular, MDR is characterized by increased expression and activity of ATP-binding cassette (ABC) superfamily transporters. Sphingolipids are substrates of ABC proteins in cell signaling, membrane biosynthesis, and inflammation, for example, and their products can favor cancer progression. Glucosylceramide (GlcCer) is a ubiquitous glycosphingolipid (GSL) generated by glucosylceramide synthase, a key regulatory enzyme encoded by the UDP-glucose ceramide glucosyltransferase (UGCG) gene. Stressed cells increase de novo biosynthesis of ceramides, which return to sub-toxic levels after UGCG mediates incorporation into GlcCer. Given that cancer cells seem to mobilize UGCG and have increased GSL content for ceramide clearance, which ultimately contributes to chemotherapy failure, here we investigated how inhibition of GSL biosynthesis affects the MDR phenotype of chronic myeloid leukemias. We found that MDR is associated with higher UGCG expression and with a complex GSL profile. UGCG inhibition with the ceramide analog d-threo-1-(3,4,-ethylenedioxy)phenyl-2-palmitoylamino-3-pyrrolidino-1-propanol (EtDO-P4) greatly reduced GSL and monosialotetrahexosylganglioside levels, and co-treatment with standard chemotherapeutics sensitized cells to mitochondrial membrane potential loss and apoptosis. ABC subfamily B member 1 (ABCB1) expression was reduced, and ABCC-mediated efflux activity was modulated by competition with nonglycosylated ceramides. Consistently, inhibition of ABCC-mediated transport reduced the efflux of exogenous C-6-ceramide. Overall, UGCG inhibition impaired the malignant glycophenotype of MDR leukemias, which typically overcomes drug resistance through distinct mechanisms. This work sheds light on the involvement of GSL in chemotherapy failure, and its findings suggest that targeted GSL modulation could help manage MDR leukemias.	[Salustiano, Eduardo J.; da Costa, Kelli M.; Freire-de-Lima, Leonardo; Mendonca-Previato, Lucia; Previato, Jose O.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude C1 042, Inst Biofis Carlos Chagas Filho, Lab Glicobiol, Ave Carlos Chagas Filho 373,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Salustiano, EJ; Mendonca-Previato, L (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude C1 042, Inst Biofis Carlos Chagas Filho, Lab Glicobiol, Ave Carlos Chagas Filho 373,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.	salustiano@bioqmed.ufrj.br; luciamp@biof.ufrj.br	dos Santos, Eduardo Salustiano Jesus/G-6666-2012	dos Santos, Eduardo Salustiano Jesus/0000-0001-5572-6130; da Costa, Kelli/0000-0001-6178-0942; Mendonca Previato, Lucia/0000-0003-3927-3244; Freire-de-Lima, Leonardo/0000-0003-3013-3173	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq; Financiadora de Estudos e Projetos, FINEP; Fundacao do Cancer; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos, FINEP(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao do Cancer; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq; Financiadora de Estudos e Projetos, FINEP; Fundacao do Cancer; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES. The authors declare that they have no conflicts of interest with the contents of this article.	ABBASZADEGAN MR, 1994, CANCER RES, V54, P4676; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Bixby D, 2011, LEUKEMIA, V25, P7, DOI 10.1038/leu.2010.238; Carrett-Dias M, 2016, LEUKEMIA RES, V42, P13, DOI 10.1016/j.leukres.2016.01.008; Cebo C, 2006, J IMMUNOL, V176, P864, DOI 10.4049/jimmunol.176.2.864; Chang KT, 2015, BBA-BIOMEMBRANES, V1848, P2374, DOI 10.1016/j.bbamem.2015.07.013; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2014, J BIOL CHEM, V289, P30880, DOI 10.1074/jbc.R114.609248; Da Costa KM, 2018, AN ACAD BRAS CIENC, V90, P3081, DOI 10.1590/0001-3765201820180364; Daflon-Yunes N, 2013, MOL CELL BIOCHEM, V383, P123, DOI 10.1007/s11010-013-1761-0; Davis MA, 2000, TOXICOL SCI, V53, P48, DOI 10.1093/toxsci/53.1.48; Dijkhuis AJ, 2006, J LIPID RES, V47, P1187, DOI 10.1194/jlr.M500518-JLR200; Dogan AL, 2004, LEUKEMIA RES, V28, P619, DOI 10.1016/j.leukres.2003.10.015; DRACH D, 1992, BLOOD, V80, P2729; Dyatlovitskaya EV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P10, DOI 10.1134/S0006297906010020; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Evseenko DA, 2007, DRUG METAB DISPOS, V35, P595, DOI 10.1124/dmd.106.011478; Freire-De-Lima L, 2011, P NATL ACAD SCI USA, V108, P17690, DOI 10.1073/pnas.1115191108; Gazzin S, 2008, J COMP NEUROL, V510, P497, DOI 10.1002/cne.21808; Gencer EB, 2011, ANN HEMATOL, V90, P1265, DOI 10.1007/s00277-011-1212-5; Grazide S, 2004, J BIOL CHEM, V279, P18256, DOI 10.1074/jbc.M314105200; Guan F, 2010, FASEB J, V24, P4889, DOI 10.1096/fj.10-162107; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Huang M, 2007, ANN BIOMED ENG, V35, P1276, DOI 10.1007/s10439-007-9265-2; Hummel I, 2011, MOL PHARMACOL, V79, P229, DOI 10.1124/mol.110.069013; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-71; Jiang YX, 2013, BIOMOLECULES, V3, P435, DOI 10.3390/biom3030435; Klappe K, 2004, INT J CANCER, V110, P511, DOI 10.1002/ijc.20140; Knapp P, 2017, GYNECOL ONCOL, V147, P139, DOI 10.1016/j.ygyno.2017.07.143; Kok JW, 1998, J CELL BIOL, V142, P25, DOI 10.1083/jcb.142.1.25; Krusch M, 2011, CURR MED CHEM, V18, P5174, DOI 10.2174/092986711798184271; Kyle-Cezar F, 2007, IMMUNOLOGY, V121, P122, DOI 10.1111/j.1365-2567.2007.02547.x; Lee L, 1999, J BIOL CHEM, V274, P14662, DOI 10.1074/jbc.274.21.14662; Legrand O, 1999, ADV EXP MED BIOL, V457, P161; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; Liu Y, 2010, CANCER CHEMOTH PHARM, V66, P433, DOI 10.1007/s00280-009-1177-4; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Liu YY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-145; Lorendeau D, 2017, CURR MED CHEM, V24, P1186, DOI 10.2174/0929867324666161118130238; Daniotti JL, 2016, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00300; Madigan JP, 2020, EXP CELL RES, V388, DOI 10.1016/j.yexcr.2020.111860; Maia RC, 2018, MOLECULES, V23, DOI 10.3390/molecules23010119; Maia RC, 2011, INVEST NEW DRUG, V29, P1143, DOI 10.1007/s10637-010-9453-z; MARKS DC, 1993, BRIT J HAEMATOL, V84, P83, DOI 10.1111/j.1365-2141.1993.tb03028.x; Marques-Santos LF, 2003, BIOSCIENCE REP, V23, P199, DOI 10.1023/B:BIRE.0000007693.33521.18; Moreira MAM, 2014, LEUKEMIA RES, V38, P983, DOI 10.1016/j.leukres.2014.06.001; Meszaros P, 2013, BBA-BIOMEMBRANES, V1828, P340, DOI 10.1016/j.bbamem.2012.10.007; Moro Kazuki, 2018, Oncotarget, V9, P19874, DOI 10.18632/oncotarget.24903; NAKAMURA M, 1991, CANCER RES, V51, P1940; Pallis M, 2000, BLOOD, V95, P2897, DOI 10.1182/blood.V95.9.2897.009k14_2897_2904; Park JW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228848; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pluchino KM, 2012, DRUG RESIST UPDATE, V15, P98, DOI 10.1016/j.drup.2012.03.002; Raggers RJ, 1999, J CELL SCI, V112, P415; RAMU A, 1984, CANCER TREAT REP, V68, P637; Rumjanek VM, 2001, AN ACAD BRAS CIENC, V73, P57, DOI 10.1590/S0001-37652001000100007; Saddoughi SA, 2013, ADV CANCER RES, V117, P37, DOI 10.1016/B978-0-12-394274-6.00002-9; Salas A, 2011, BLOOD, V117, P5941, DOI 10.1182/blood-2010-08-300772; Salustiano EJS, 2010, INVEST NEW DRUG, V28, P139, DOI 10.1007/s10637-009-9231-y; Sanchenkov A, 2001, JNCI-J NATL CANCER I, V93, P347, DOI 10.1093/jnci/93.5.347; Sharom FJ, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00041; Stefanovic M, 2016, ONCOTARGET, V7, P8253, DOI 10.18632/oncotarget.6982; Strouse JJ, 2013, ANAL BIOCHEM, V437, P77, DOI 10.1016/j.ab.2013.02.018; Sun YL, 2006, NEOPLASMA, V53, P1; van der Kolk DM, 1998, CLIN CANCER RES, V4, P1727; Vasconcelos FC, 2007, LEUKEMIA RES, V31, P445, DOI 10.1016/j.leukres.2006.07.016; von Haefen C, 2002, ONCOGENE, V21, P4009, DOI 10.1038/sj.onc.1205497; Ween MP, 2015, CRIT REV ONCOL HEMAT, V96, P220, DOI 10.1016/j.critrevonc.2015.05.012; Wegner MS, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4084-4; Wu CP, 2011, MOL PHARMACEUT, V8, P1996, DOI 10.1021/mp200261n; Yamada A, 2018, MOL CANCER RES, V16, P1059, DOI 10.1158/1541-7786.MCR-17-0353; Yandim MK, 2013, CANCER CHEMOTH PHARM, V71, P13, DOI 10.1007/s00280-012-1984-x; YUSA K, 1989, CANCER RES, V49, P5002; Zhao S, 2004, J CELL PHYSIOL, V199, P47, DOI 10.1002/jcp.10453	75	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6457	6471		10.1074/jbc.RA120.013090	http://dx.doi.org/10.1074/jbc.RA120.013090			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32229586	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000537685000017
J	Chaudhuri, E; Dash, S; Balasubramaniam, M; Padron, A; Holland, J; Sowd, GA; Villalta, F; Engelman, AN; Pandhare, J; Dash, C				Chaudhuri, Evan; Dash, Sabyasachi; Balasubramaniam, Muthukumar; Padron, Adrian; Holland, Joseph; Sowd, Gregory A.; Villalta, Fernando; Engelman, Alan N.; Pandhare, Jui; Dash, Chandravanu			The HIV-1 capsid-binding host factor CPSF6 is post-transcriptionally regulated by the cellular microRNA miR-125b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); microRNA (miRNA); post-transcriptional regulation; epigenetics; RNA binding protein; host-pathogen interaction; 3?UTR; cleavage and polyadenylation specificity factor 6 (CPSF6); HIV; miR-125b; miRNA biogenesis	FACTOR-I-M; MOLECULAR-MECHANISMS; NUCLEAR IMPORT; CLEAVAGE; RECOGNITION; INTEGRATION; INFECTION; GENES; DNA; IDENTIFICATION	Cleavage and polyadenylation specificity factor 6 (CPSF6) is a cellular protein involved in mRNA processing. Emerging evidence suggests that CPSF6 also plays key roles in HIV-1 infection, specifically during nuclear import and integration targeting. However, the cellular and molecular mechanisms that regulate CPSF6 expression are largely unknown. In this study, we report a post-transcriptional mechanism that regulates CPSF6 via the cellular microRNA miR-125b. An in silico analysis revealed that the 3?UTR of CPSF6 contains a miR-125b?binding site that is conserved across several mammalian species. Because miRNAs repress protein expression, we tested the effects of miR-125b expression on CPSF6 levels in miR-125b knockdown and over-expression experiments, revealing that miR-125b and CPSF6 levels are inversely correlated. To determine whether miR-125b post-transcriptionally regulates CPSF6, we introduced the 3?UTR of CPSF6 mRNA into a luciferase reporter and found that miR-125b negatively regulates CPSF6 3?UTR-driven luciferase activity. Accordingly, mutations in the miR-125b seed sequence abrogated the regulatory effect of the miRNA on the CPSF6 3?UTR. Finally, pulldown experiments demonstrated that miR-125b physically interacts with CPSF6 3?UTR. Interestingly, HIV-1 infection down-regulated miR-125b expression concurrent with up-regulation of CPSF6. Notably, miR-125b down-regulation in infected cells was not due to reduced pri-miRNA or pre-miRNA levels. However, miR-125b down-regulation depended on HIV-1 reverse transcription but not viral DNA integration. These findings establish a post-transcriptional mechanism that controls CPSF6 expression and highlight a novel function of miR-125b during HIV-host interaction.	[Chaudhuri, Evan; Dash, Sabyasachi; Balasubramaniam, Muthukumar; Holland, Joseph; Villalta, Fernando; Pandhare, Jui; Dash, Chandravanu] Meharry Med Coll, Ctr AIDS Hlth Dispar Res, Nashville, TN 37208 USA; [Chaudhuri, Evan; Dash, Sabyasachi; Balasubramaniam, Muthukumar; Padron, Adrian; Holland, Joseph; Dash, Chandravanu] Meharry Med Coll, Dept Biochem Canc Biol Pharmacol & Neurosci, Nashville, TN 37208 USA; [Padron, Adrian; Holland, Joseph; Villalta, Fernando; Pandhare, Jui] Meharry Med Coll, Dept Microbiol Immunol & Physiol, Nashville, TN 37208 USA; [Padron, Adrian; Pandhare, Jui] Meharry Med Coll, Sch Grad Studies & Res, Nashville, TN 37208 USA; [Dash, Sabyasachi] KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Odisha, India; [Dash, Sabyasachi] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10065 USA; [Sowd, Gregory A.; Engelman, Alan N.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA; [Sowd, Gregory A.; Engelman, Alan N.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Meharry Medical College; Meharry Medical College; Meharry Medical College; Meharry Medical College; Kalinga Institute of Industrial Technology (KIIT); Cornell University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Dash, C (corresponding author), CAHDR, Old Hosp Bldg,Rm 5027,1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA.	cdash@mmc.edu	Padron, Adrian/P-5225-2019; Dash, Sabyasachi/ABG-1337-2020	Padron, Adrian/0000-0002-2142-0501; Dash, Sabyasachi/0000-0003-3966-9396; Dash, Chandravanu/0000-0003-4466-8355; Holland, Joseph/0000-0003-2512-8783; Villalta, Fernando/0000-0002-6232-0574	National Institutes of Health [R01 AI136740, R56 AI122960, R24 DA036420, U54 MD007593, R01 AI052014, P50 AI150481, T32 AI007245]; Research Centers in Minority Institutions (RCMI) [U54MD007586-01]; Meharry Translational Research Center (MeTRC) [5U54MD007593-10]; Tennessee CFAR Grant from the National Institutes of Health [P30 AI110527]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Centers in Minority Institutions (RCMI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Meharry Translational Research Center (MeTRC); Tennessee CFAR Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 AI136740, R56 AI122960, R24 DA036420, and U54 MD007593 (to C. D.), R01 AI052014 and P50 AI150481 (to A. N. E.), and T32 AI007245 (to G. A. S.), and the Research Centers in Minority Institutions (RCMI) U54MD007586-01 (to J. P.). This work is also in part supported by the Meharry Translational Research Center (MeTRC) Grant 5U54MD007593-10 and Tennessee CFAR Grant P30 AI110527 from the National Institutes of Health (to C. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achuthan V, 2018, CELL HOST MICROBE, V24, P392, DOI 10.1016/j.chom.2018.08.002; Aiken Christopher, 2009, V485, P41, DOI 10.1007/978-1-59745-170-3_4; Ambrose Z, 2012, J VIROL, V86, P4708, DOI 10.1128/JVI.05887-11; Arhel N, 2010, BBA-MOL BASIS DIS, V1802, P313, DOI 10.1016/j.bbadis.2009.12.003; Baker A, 1997, GENE THER, V4, P773, DOI 10.1038/sj.gt.3300471; Balasubramaniam M, 2019, J VIROL, V93, DOI 10.1128/JVI.01741-18; Balasubramaniam M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030110; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bejarano DA, 2019, ELIFE, V8, DOI 10.7554/eLife.41800; Bhattacharya A, 2014, P NATL ACAD SCI USA, V111, P18625, DOI 10.1073/pnas.1419945112; Binothman N, 2017, EBIOMEDICINE, V21, P65, DOI 10.1016/j.ebiom.2017.06.023; Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chiang K, 2011, FUTURE VIROL, V6, P209, DOI 10.2217/FVL.10.92; Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Craigie R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006890; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Dash S, 2018, JOVE-J VIS EXP, DOI 10.3791/57786; Dash S, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0089-17.2017; De Iaco A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-11; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; Di Nunzio F, 2013, VIROLOGY, V440, P8, DOI 10.1016/j.virol.2013.02.008; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Gruber AR, 2012, RNA BIOL, V9, P1405, DOI 10.4161/rna.22570; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hardy JG, 2016, BIOCHEM SOC T, V44, P1051, DOI 10.1042/BST20160078; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jang S, 2019, NUCLEIC ACIDS RES, V47, P4663, DOI 10.1093/nar/gkz206; Koh Y, 2013, J VIROL, V87, P648, DOI 10.1128/JVI.01148-12; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee K, 2012, J VIROL, V86, P3851, DOI 10.1128/JVI.06607-11; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lee S, 2013, CELL HOST MICROBE, V13, P678, DOI 10.1016/j.chom.2013.05.007; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li SB, 2013, CELL, V153, P562, DOI 10.1016/j.cell.2013.04.005; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Mantri CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051387; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Pan DL, 2019, MBIO, V10, DOI 10.1128/mBio.02856-18; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Ruegsegger U, 1996, J BIOL CHEM, V271, P6107; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shaham L, 2012, LEUKEMIA, V26, P2011, DOI 10.1038/leu.2012.90; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sowd GA, 2016, P NATL ACAD SCI USA, V113, pE1054, DOI 10.1073/pnas.1524213113; Sun YM, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-6; Swanstrom R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007443; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; UNAIDS, 2020, GLOB HIV AIDS STAT F; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhang RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015620; Zhu Y, 2018, MOL CELL, V69, P62, DOI 10.1016/j.molcel.2017.11.031	74	8	8	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5081	5094		10.1074/jbc.RA119.010534	http://dx.doi.org/10.1074/jbc.RA119.010534			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32152226	Green Published, hybrid			2022-12-28	WOS:000526887000028
J	Chi, YL; Youn, DY; Xiaoli, AM; Liu, L; Pessin, JB; Yang, FJ; Pessin, JE				Chi, Yuling; Youn, Dou Yeon; Xiaoli, Alus M.; Liu, Li; Pessin, Jacob B.; Yang, Fajun; Pessin, Jeffrey E.			Regulation of gene expression during the fasting-feeding cycle of the liver displays mouse strain specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver; gene regulation; lipid metabolism; transcriptomics; nutrition; BALB; cJ; C57BL; 6J; mRNA-Seq; nutrient signaling; transcriptome	HIGH-FAT DIET; HOMEOSTASIS; RESPONSES; OBESITY; MICE	The liver maintains metabolic homeostasis by integrating the regulation of nutrient status with both hormonal and neural signals. Many studies on hepatic signaling in response to nutrients have been conducted in mice. However, no in-depth study is currently available that has investigated genome-wide changes in gene expression during the normal physiological fasting-feeding cycle in nutrient-sensitive and -insensitive mice. Using two strains of mice, C57BL/6J and BALB/cJ, and deploying deep RNA-Seq complemented with quantitative RT-PCR, we found that feeding causes substantial and transient changes in gene expression in the livers of both mouse strains. The majority of significantly changed transcripts fell within the areas of biological regulation and cellular and metabolic processes. Among the metabolisms of three major types of macronutrients (i.e. carbohydrates, proteins, and lipids), feeding affected lipid metabolism the most. We also noted that the C57BL/6J and BALB/cJ mice significantly differed in gene expression and in changes in gene expression in response to feeding. In both fasted and fed states, both mouse strains shared common expression patterns for about 10,200 genes, and an additional 400?600 genes were differentially regulated in one strain but not the other. Among the shared genes, more lipogenic genes were induced upon feeding in BABL/cJ than in C57BL/6J mice. In contrast, in the population of differentially enriched genes, C57BL/6J mice expressed more genes involved in lipid metabolism than BALB/cJ mice. In summary, these results reveal that the two mouse strains used here exhibit several differences in feeding-induced hepatic responses in gene expression, especially in lipogenic genes.	[Chi, Yuling; Youn, Dou Yeon; Xiaoli, Alus M.; Liu, Li; Pessin, Jacob B.; Yang, Fajun; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, 1301 Morris Pk Ave, Bronx, NY 10461 USA; [Chi, Yuling; Youn, Dou Yeon; Xiaoli, Alus M.; Liu, Li; Pessin, Jacob B.; Yang, Fajun; Pessin, Jeffrey E.] Albert Einstein Coll Med, Fleischer Inst Diabet & Metab, Bronx, NY 10461 USA; [Xiaoli, Alus M.; Yang, Fajun] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chi, YL; Pessin, JE (corresponding author), Albert Einstein Coll Med, Dept Med, 1301 Morris Pk Ave, Bronx, NY 10461 USA.	yuling.chi@einsteinmed.org; Jeffrey.Pessin@einsteinmed.org			NIDDK, National Institutes of Health [DK110063, DK020541, DK076169]	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by NIDDK, National Institutes of Health, Grants DK110063, DK020541, and DK076169 (to F. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Chan MY, 2008, OBESITY, V16, P972, DOI 10.1038/oby.2008.32; Cheng AA, 2018, PHYSIOL GENOMICS, V50, P1059, DOI 10.1152/physiolgenomics.00052.2018; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Flower DR, 1996, BIOCHEM J, V318, P1; Gazzana G, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-35; Geisler CE, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0122-x; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Kim EJ, 2010, J MED FOOD, V13, P743, DOI 10.1089/jmf.2009.1350; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Swindell WR, 2018, AGING-US, V10, P701, DOI 10.18632/aging.101424; Waller-Evans H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082825; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	18	7	7	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4809	4821		10.1074/jbc.RA119.012349	http://dx.doi.org/10.1074/jbc.RA119.012349			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32075912	Green Published, hybrid			2022-12-28	WOS:000526887000006
J	Shen, L; Viljoen, A; Villaume, S; Joe, M; Halloum, I; Chene, L; Mery, A; Fabre, E; Takegawa, K; Lowary, TL; Vincent, SP; Kremer, L; Guerardel, Y; Mariller, C				Shen, Lin; Viljoen, Albertus; Villaume, Sydney; Joe, Maju; Halloum, Iman; Chene, Loic; Mery, Alexandre; Fabre, Emeline; Takegawa, Kaoru; Lowary, Todd L.; Vincent, Stephane P.; Kremer, Laurent; Guerardel, Yann; Mariller, Christophe			The endogenous galactofuranosidase GlfH1 hydrolyzes mycobacterial arabinogalactan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; mycobacteria; polysaccharide; glycosidase; galactofuranose; arabinogalactan; catabolism; cell envelope; galactofuranosidase; Rv3096	SUBSTRATE-SPECIFICITY; TUBERCULOSIS; KINETICS; INSIGHTS; CALCIUM	Despite impressive progress made over the past 20 years in our understanding of mycolylarabinogalactan-peptidoglycan (mAGP) biogenesis, the mechanisms by which the tubercle bacillus Mycobacterium tuberculosis adapts its cell wall structure and composition to various environmental conditions, especially during infection, remain poorly understood. Being the central portion of the mAGP complex, arabinogalactan (AG) is believed to be the constituent of the mycobacterial cell envelope that undergoes the least structural changes, but no reports exist supporting this assumption. Herein, using recombinantly expressed mycobacterial protein, bioinformatics analyses, and kinetic and biochemical assays, we demonstrate that the AG can be remodeled by a mycobacterial endogenous enzyme. In particular, we found that the mycobacterial GlfH1 (Rv3096) protein exhibits exo-?-d-galactofuranose hydrolase activity and is capable of hydrolyzing the galactan chain of AG by recurrent cleavage of the terminal ?-(1,5) and ?-(1,6)-Galf linkages. The characterization of this galactosidase represents a first step toward understanding the remodeling of mycobacterial AG.	[Shen, Lin; Mery, Alexandre; Fabre, Emeline; Guerardel, Yann; Mariller, Christophe] Univ Lille, CNRS, UMR8576, UGSF, F-59000 Lille, France; [Viljoen, Albertus; Halloum, Iman; Kremer, Laurent] UM, CNRS, UMR9004, IRIM, 1919 Route Mende, F-34293 Montpellier 5, France; [Villaume, Sydney; Chene, Loic; Vincent, Stephane P.] Univ Namur, Lab Chim Bioorgan CBO, Rue Bruxelles 61, B-5000 Namur, Belgium; [Joe, Maju; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Joe, Maju; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Takegawa, Kaoru] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan; [Kremer, Laurent] INSERM, Inst Rech Infectiol Montpellier, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); University of Namur; University of Alberta; University of Alberta; Kyushu University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Mariller, C (corresponding author), Univ Lille, CNRS, UMR8576, UGSF, F-59000 Lille, France.	christophe.mariller@univ-lille.fr	Viljoen, Albertus/O-6794-2019; Lowary, Todd L/F-9608-2019; Kremer, Laurent/M-4935-2017	Viljoen, Albertus/0000-0001-8949-7401; Lowary, Todd L/0000-0002-8331-8211; Kremer, Laurent/0000-0002-6604-4458; Guerardel, Yann/0000-0003-4967-9512; CHENE, Loic P./0000-0002-7574-3816; JOE, MAJU/0000-0003-0664-5275	Centre National de La Recherche Scientifique (CNRS); Agence Nationale de la Recherche (project MyCat) [ANR-15-CE18-0007-01]; Fondation pour la Recherche Medicale (FRM) [DEQ20150331719]	Centre National de La Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (project MyCat)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de La Recherche Scientifique (CNRS), the Agence Nationale de la Recherche (project MyCat) Grant ANR-15-CE18-0007-01 (to L. S., Y. G., and C. M.), and the Fondation pour la Recherche Medicale (FRM) Grant DEQ20150331719 (to I. H. and L. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Alderwick LJ, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021113; ANGYAL SJ, 1984, ADV CARBOHYD CHEM BI, V42, P15, DOI 10.1016/S0065-2318(08)60122-5; [Anonymous], 2015, REACTION PATHWAYS ME, DOI DOI 10.1007/978-981-287-688-1; [Anonymous], [No title captured]; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Besra GS, 1998, METH MOL B, V101, P91, DOI 10.1385/0-89603-471-2:91; Bhamidi S, 2011, J BIOL CHEM, V286, P23168, DOI 10.1074/jbc.M110.210534; Bordoni A, 2008, CARBOHYD RES, V343, P1863, DOI 10.1016/j.carres.2008.02.019; Carrere-Kremer S, 2015, MOL MICROBIOL, V96, P1085, DOI 10.1111/mmi.12992; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Daffe M, 2015, TUBERCULOSIS, V95, pS155, DOI 10.1016/j.tube.2015.02.024; de Sanctis D, 2010, FEBS J, V277, P4562, DOI 10.1111/j.1742-4658.2010.07870.x; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038134; Goncalves AMD, 2012, ACTA CRYSTALLOGR D, V68, P1468, DOI 10.1107/S0907444912034646; Goodsmith N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004645; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta RS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00067; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Hong X, 2004, BIOMACROMOLECULES, V5, P1052, DOI 10.1021/bm034514c; Joe M, 2016, CAN J CHEM, V94, P976, DOI 10.1139/cjc-2016-0416; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kieser KJ, 2014, NAT REV MICROBIOL, V12, P550, DOI 10.1038/nrmicro3299; Lee REB, 2005, GLYCOBIOLOGY, V15, P139, DOI 10.1093/glycob/cwh150; LIVINGSTONE G, 1977, J SOLUTION CHEM, V6, P203, DOI 10.1007/BF00646739; MargollesClark E, 1996, APPL ENVIRON MICROB, V62, P3840, DOI 10.1128/AEM.62.10.3840-3846.1996; Marino C, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2017-0030; Matsunaga E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137230; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Moynihan PJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10586-2; Naumoff DG, 1999, FEBS LETT, V448, P177, DOI 10.1016/S0014-5793(99)00369-5; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Okuyama M, 2014, FEBS LETT, V588, P3213, DOI 10.1016/j.febslet.2014.07.002; Ota R, 2019, CARBOHYD RES, V473, P99, DOI 10.1016/j.carres.2019.01.005; Puffal J, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty027; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rombouts Y, 2012, J BIOL CHEM, V287, P11060, DOI 10.1074/jbc.M111.327387; Saha BC, 2000, BIOTECHNOL ADV, V18, P403, DOI 10.1016/S0734-9750(00)00044-6; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Santucci P, 2019, FEBS J, V286, P3164, DOI 10.1111/febs.14864; Santucci P, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00394-18; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tefsen B, 2012, BIOL CHEM, V393, P767, DOI 10.1515/hsz-2012-0134; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; VARELA O, 1986, CARBOHYD RES, V155, P247, DOI 10.1016/S0008-6215(00)90153-8; Wadood A, 2018, INT J BIOL MACROMOL, V111, P82, DOI 10.1016/j.ijbiomac.2017.12.148; Wheat WH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003405; Wu M, 2015, SCIENCE, V350, DOI 10.1126/science.aac5992; Xin Y, 1999, BBA-GEN SUBJECTS, V1473, P267, DOI 10.1016/S0304-4165(99)00204-4; Zhou P, 2014, ACTA CRYSTALLOGR D, V70, P2970, DOI 10.1107/S1399004714019762	52	7	7	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5110	5123		10.1074/jbc.RA119.011817	http://dx.doi.org/10.1074/jbc.RA119.011817			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32107309	hybrid, Green Published			2022-12-28	WOS:000526887000030
J	Masin, J; Osickova, A; Jurnecka, D; Klimova, N; Khaliq, H; Sebo, P; Osicka, R				Masin, Jiri; Osickova, Adriana; Jurnecka, David; Klimova, Nela; Khaliq, Humaira; Sebo, Peter; Osicka, Radim			Retargeting from the CR3 to the LFA-1 receptor uncovers the adenylyl cyclase enzyme-translocating segment of Bordetella adenylate cyclase toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AC domain translocation; acylation; acyltransferase; fatty acyl; integrin; RTX toxin; complement receptor 3 (CR3; ); CyaA; HlyA; AC translocon; protein translocation; protein acylation; fatty acid; bacterial toxin; Bordetella pertussis; Escherichia coli (E; coli)	ESCHERICHIA-COLI HEMOLYSIN; PERTUSSIS CYAA-HEMOLYSIN; ALPHA-HEMOLYSIN; FATTY-ACYLATION; MEMBRANE TRANSLOCATION; COMPLEMENT RECEPTOR-3; BACILLUS-ANTHRACIS; LIPID-BILAYERS; TARGET-CELLS; RTX PROTEINS	TheBordetellaadenylate cyclase toxin-hemolysin (CyaA) and the ?-hemolysin (HlyA) ofEscherichia colibelong to the family of cytolytic pore-forming Repeats in ToXin (RTX) cytotoxins. HlyA preferentially binds the ?(L)?(2)integrin LFA-1 (CD11a/CD18) of leukocytes and can promiscuously bind and also permeabilize many other cells. CyaA bears an N-terminal adenylyl cyclase (AC) domain linked to a pore-forming RTX cytolysin (Hly) moiety, binds the complement receptor 3 (CR3, ?(M)?(2), CD11b/CD18, or Mac-1) of myeloid phagocytes, penetrates their plasma membrane, and delivers the AC enzyme into the cytosol. We constructed a set of CyaA/HlyA chimeras and show that the CyaC-acylated segment and the CR3-binding RTX domain of CyaA can be functionally replaced by the HlyC-acylated segment and the much shorter RTX domain of HlyA. Instead of binding CR3, a CyaA(1-710)/HlyA(411-1024)chimera bound the LFA-1 receptor and effectively delivered AC into Jurkat T cells. At high chimera concentrations (25 nm), the interaction with LFA-1 was not required for CyaA(1-710)/HlyA(411-1024)binding to CHO cells. However, interaction with the LFA-1 receptor strongly enhanced the specific capacity of the bound CyaA(1-710)/HlyA(411-1024)chimera to penetrate cells and deliver the AC enzyme into their cytosol. Hence, interaction of the acylated segment and/or the RTX domain of HlyA with LFA-1 promoted a productive membrane interaction of the chimera. These results help delimit residues 400?710 of CyaA as an ?AC translocon? sufficient for translocation of the AC polypeptide across the plasma membrane of target cells.	[Masin, Jiri; Osickova, Adriana; Jurnecka, David; Klimova, Nela; Khaliq, Humaira; Sebo, Peter; Osicka, Radim] Czech Acad Sci, Inst Microbiol, Prague, Czech Republic; [Osickova, Adriana; Jurnecka, David; Klimova, Nela] Charles Univ Prague, Fac Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Masin, J; Osicka, R (corresponding author), Czech Acad Sci, Inst Microbiol, Prague, Czech Republic.	masin@biomed.cas.cz; osicka@biomed.cas.cz	Masin, Jiri/H-3125-2014; Jurnečka, David/ABA-2334-2021; SEBO, Peter/N-2043-2019; Osicka, Radim/H-6776-2014; Jurnečka, David/L-7246-2017; Osickova, Adriana/H-6841-2014; SEBO, Peter/F-7423-2011	Jurnečka, David/0000-0002-1690-8908; SEBO, Peter/0000-0002-9755-7715; Osicka, Radim/0000-0003-2626-5456; Jurnečka, David/0000-0002-1690-8908; Osickova, Adriana/0000-0002-5739-1183; SEBO, Peter/0000-0002-9755-7715; Masin, Jiri/0000-0001-6258-4599; Klimova, Nela/0000-0002-9425-6386	Grant Agency of the Czech Republic [19-04607S, 18-18079S, 19-12695S, 18-20621S]; Ministry of Education, Youth and Sports of the Czech Republic [LM2018133]; Charles University project GA UK [507116]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University project GA UK	This work was supported by Grants 19-04607S (to J. M.), 18-18079S (to R. O.), 19-12695S (to R. O.), and 18-20621S (to P. S.) from the Grant Agency of the Czech Republic, Project LM2018133 (to R. O.) from the Ministry of Education, Youth and Sports of the Czech Republic, and Charles University project GA UK number 507116 (to N. K.).	Ahmad JN, 2016, CELL MICROBIOL, V18, P384, DOI 10.1111/cmi.12519; Basar T, 1999, J BIOL CHEM, V274, P10777, DOI 10.1074/jbc.274.16.10777; Basar T, 2001, J BIOL CHEM, V276, P348, DOI 10.1074/jbc.M006463200; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Basler M, 2007, J BIOL CHEM, V282, P12419, DOI 10.1074/jbc.M611226200; BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1994, J BIOL CHEM, V269, P27231; Benz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112248; BETSOU F, 1993, INFECT IMMUN, V61, P3583, DOI 10.1128/IAI.61.9.3583-3589.1993; BHAKDI S, 1989, J EXP MED, V169, P737, DOI 10.1084/jem.169.3.737; BHAKDI S, 1990, J CLIN INVEST, V85, P1746, DOI 10.1172/JCI114631; Bumba L, 2018, TOXINS, V10, DOI 10.3390/toxins10060245; Bumba L, 2016, MOL CELL, V62, P47, DOI 10.1016/j.molcel.2016.03.018; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; Cerny O, 2017, J IMMUNOL, V198, P1285, DOI 10.4049/jimmunol.1601309; Cerny O, 2015, J IMMUNOL, V194, P4901, DOI 10.4049/jimmunol.1402941; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; Cortajarena AL, 2003, J BIOL CHEM, V278, P19159, DOI 10.1074/jbc.M208552200; Cortajarena AL, 2001, J BIOL CHEM, V276, P12513, DOI 10.1074/jbc.M006792200; Dobereiner A, 1996, EUR J BIOCHEM, V240, P454, DOI 10.1111/j.1432-1033.1996.0454h.x; EHRMANN IE, 1991, FEBS LETT, V278, P79, DOI 10.1016/0014-5793(91)80088-K; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; Franken KLMC, 2000, PROTEIN EXPRES PURIF, V18, P95, DOI 10.1006/prep.1999.1162; GADEBERG OV, 1984, INFECT IMMUN, V45, P255, DOI 10.1128/IAI.45.1.255-260.1984; Gmira S, 2001, RES MICROBIOL, V152, P889, DOI 10.1016/S0923-2508(01)01272-4; Gonzalez-Bullon D, 2017, P NATL ACAD SCI USA, V114, pE6784, DOI 10.1073/pnas.1701783114; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; GORDON VM, 1989, J BIOL CHEM, V264, P14792; Gray M, 1998, J BIOL CHEM, V273, P18260, DOI 10.1074/jbc.273.29.18260; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; HACKETT M, 1995, J BIOL CHEM, V270, P20250, DOI 10.1074/jbc.270.35.20250; HANSKI E, 1989, TRENDS BIOCHEM SCI, V14, P459, DOI 10.1016/0968-0004(89)90106-0; Hasan S, 2015, FEBS LETT, V589, P374, DOI 10.1016/j.febslet.2014.12.023; Holubova J, 2012, INFECT IMMUN, V80, P1181, DOI 10.1128/IAI.05711-11; Hyland C, 2001, J BACTERIOL, V183, P5364, DOI 10.1128/JB.183.18.5364-5370.2001; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Johnsen N, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13017; Juntapremjit S, 2015, TOXICON, V106, P14, DOI 10.1016/j.toxicon.2015.09.006; Kamanova J, 2008, J IMMUNOL, V181, P5587, DOI 10.4049/jimmunol.181.8.5587; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karst JC, 2014, J BIOL CHEM, V289, P30702, DOI 10.1074/jbc.M114.580852; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; KEANE WF, 1987, AM J PATHOL, V126, P350; Khan F, 2006, ANAL CHEM, V78, P3072, DOI 10.1021/ac060184l; LADANT D, 1988, J BIOL CHEM, V263, P2612; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Lim KB, 2000, J BIOL CHEM, V275, P36698, DOI 10.1074/jbc.C000544200; Linhartova I, 2010, FEMS MICROBIOL REV, V34, P1076, DOI 10.1111/j.1574-6976.2010.00231.x; Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b; Masin J, 2004, BBA-BIOMEMBRANES, V1660, P144, DOI 10.1016/j.bbamem.2003.11.008; Masin J, 2018, P NATL ACAD SCI USA, V115, pE2489, DOI 10.1073/pnas.1722588115; Masin J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09575-6; Masin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29137; Masin J, 2013, INFECT IMMUN, V81, P4571, DOI 10.1128/IAI.00711-13; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Novak J, 2017, TOXINS, V9, DOI 10.3390/toxins9100300; O'Brien DP, 2019, FASEB J, V33, P10065, DOI 10.1096/fj.201802442RR; Osicka R, 2000, INFECT IMMUN, V68, P247; Osicka R, 2015, ELIFE, V4, DOI 10.7554/eLife.10766; Osickova A, 1999, J BIOL CHEM, V274, P37644; Osickova A, 2010, MOL MICROBIOL, V75, P1550, DOI 10.1111/j.1365-2958.2010.07077.x; PEARSON RD, 1987, J IMMUNOL, V139, P2749; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Powthongchin B, 2009, ARCH MICROBIOL, V191, P1, DOI 10.1007/s00203-008-0421-3; Prangkio P, 2018, PROTEIN PEPTIDE LETT, V25, P236, DOI 10.2174/0929866525666171201120456; Ristow LC, 2019, MBIO, V10, DOI 10.1128/mBio.01459-19; Ristow LC, 2016, BBA-BIOMEMBRANES, V1858, P538, DOI 10.1016/j.bbamem.2015.08.015; Roderova J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42200-2; ROGEL A, 1989, EMBO J, V8, P2755, DOI 10.1002/j.1460-2075.1989.tb08417.x; ROGEL A, 1992, J BIOL CHEM, V267, P22599; ROSE T, 1995, J BIOL CHEM, V270, P26370, DOI 10.1074/jbc.270.44.26370; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; Schwidder M, 2019, TOXINS, V11, DOI 10.3390/toxins11090502; Sebo P, 2014, EXPERT REV VACCINES, V13, P1215, DOI 10.1586/14760584.2014.944900; Soloaga A, 1999, MOL MICROBIOL, V31, P1013, DOI 10.1046/j.1365-2958.1999.01225.x; Soloaga A, 1996, EUR J BIOCHEM, V238, P418, DOI 10.1111/j.1432-1033.1996.0418z.x; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; STANLEY P, 1994, SCIENCE, V266, P1992, DOI 10.1126/science.7801126; Subrini O, 2013, J BIOL CHEM, V288, P32585, DOI 10.1074/jbc.M113.508838; SUTTORP N, 1990, INFECT IMMUN, V58, P3796, DOI 10.1128/IAI.58.11.3796-3801.1990; SZABO G, 1994, J BIOL CHEM, V269, P22496; Valeva A, 2005, J BIOL CHEM, V280, P36657, DOI 10.1074/jbc.M507690200; Voegele A, 2019, TOXINS, V11, DOI 10.3390/toxins11020111; Voegele A, 2017, TOXINS, V9, DOI 10.3390/toxins9110369; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; Wagner C, 2001, EUR J IMMUNOL, V31, P1173, DOI 10.1002/1521-4141(200104)31:4<1173::AID-IMMU1173>3.0.CO;2-9; Wald T, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw008; Wang XZ, 2017, BIOCHEMISTRY-US, V56, P1324, DOI 10.1021/acs.biochem.6b01163; Wang XZ, 2015, J BIOL CHEM, V290, P3576, DOI 10.1074/jbc.M114.585281; Westrop G, 1997, J BACTERIOL, V179, P871, DOI 10.1128/jb.179.3.871-879.1997; Wiles TJ, 2013, FUTURE MICROBIOL, V8, P73, DOI [10.2217/fmb.12.131, 10.2217/FMB.12.131]; WOLFF J, 1980, P NATL ACAD SCI-BIOL, V77, P3841, DOI 10.1073/pnas.77.7.3841	96	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9349	9365		10.1074/jbc.RA120.013630	http://dx.doi.org/10.1074/jbc.RA120.013630			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32393579	hybrid, Green Published			2022-12-28	WOS:000552758600008
J	Wesslowski, J; Kozielewicz, P; Wang, XX; Cui, HJ; Schihada, H; Kranz, D; Karuna, MP; Levkin, P; Gross, JC; Boutros, M; Schulte, G; Davidson, G				Wesslowski, Janine; Kozielewicz, Pawel; Wang, Xianxian; Cui, Haijun; Schihada, Hannes; Kranz, Dominique; Karuna, Pradhipa M.; Levkin, Pavel; Gross, Julia Christina; Boutros, Michael; Schulte, Gunnar; Davidson, Gary			eGFP-tagged Wnt-3a enables functional analysis of Wnt trafficking and signaling and kinetic assessment of Wnt binding to full-length Frizzled	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Wnt signaling; G protein?coupled receptor (GPCR); bioluminescence resonance energy transfer (BRET); fusion protein; membrane protein; trafficking; Frizzled; ligand binding; NanoBRET; NanoBiT	SECRETION; PROTEINS; EXPRESSION; RECOGNITION; ORGANIZER; GRADIENT; PLATFORM; PATHWAY; COMPLEX; FAMILY	The Wingless/Int1 (Wnt) signaling system plays multiple, essential roles in embryonic development, tissue homeostasis, and human diseases. Although many of the underlying signaling mechanisms are becoming clearer, the binding mode, kinetics, and selectivity of 19 mammalian WNTs to their receptors of the class Frizzled (FZD(1?10)) remain obscure. Attempts to investigate Wnt-FZD interactions are hampered by the difficulties in working with Wnt proteins and their recalcitrance to epitope tagging. Here, we used a fluorescently tagged version of mouse Wnt-3a for studying Wnt-FZD interactions. We observed that the enhanced GFP (eGFP)-tagged Wnt-3a maintains properties akin to wild-type (WT) Wnt-3a in several biologically relevant contexts. The eGFP-tagged Wnt-3a was secreted in an evenness interrupted (EVI)/Wntless-dependent manner, activated Wnt/?-catenin signaling in 2D and 3D cell culture experiments, promoted axis duplication inXenopusembryos, stimulated low-density lipoprotein receptor-related protein 6 (LRP6) phosphorylation in cells, and associated with exosomes. Further, we used conditioned medium containing eGFP-Wnt-3a to visualize its binding to FZD and to quantify Wnt-FZD interactions in real time in live cells, utilizing a recently established NanoBRET-based ligand binding assay. In summary, the development of a biologically active, fluorescent Wnt-3a reported here opens up the technical possibilities to unravel the intricate biology of Wnt signaling and Wnt-receptor selectivity.	[Wesslowski, Janine; Wang, Xianxian; Cui, Haijun; Levkin, Pavel; Davidson, Gary] Karlsruhe Inst Technol KIT, Inst Biol & Chem Syst Funct Mol Syst IBCS FMS, Karlsruhe, Germany; [Kozielewicz, Pawel; Schihada, Hannes; Schulte, Gunnar] Karolinska Inst, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, Stockholm, Sweden; [Kranz, Dominique; Boutros, Michael] German Canc Res Ctr, Div Signaling & Funct Genom, Heidelberg, Germany; [Kranz, Dominique; Boutros, Michael] Heidelberg Univ, Heidelberg, Germany; [Karuna, Pradhipa M.; Gross, Julia Christina] Univ Med Ctr Goettingen, Hematol & Oncol Dev Biochem, Gottingen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Karolinska Institutet; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Gottingen	Davidson, G (corresponding author), Karlsruhe Inst Technol KIT, Inst Biol & Chem Syst Funct Mol Syst IBCS FMS, Karlsruhe, Germany.; Schulte, G (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Receptor Biol & Signaling, Stockholm, Sweden.	gary.davidson@kit.edu; gunnar.schulte@ki.se	Kozielewicz, Pawel/ABE-3624-2020; Davidson, Gary/AAA-7321-2021; Gross, Julia Christina/AAN-5730-2020; Levkin, Pavel A/E-5804-2011; Schihada, Hannes/AAB-6440-2022	Davidson, Gary/0000-0002-2264-5518; Gross, Julia Christina/0000-0002-8939-5664; Levkin, Pavel A/0000-0002-5975-948X; Kranz, Dominique/0000-0003-3604-7647; Schihada, Hannes/0000-0002-1889-1636; Boutros, Michael/0000-0002-9458-817X; Cui, Haijun/0000-0003-2065-9542; Schulte, Gunnar/0000-0002-2700-7013; Kozielewicz, Pawel/0000-0003-1414-3566	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [331351713-SFB 1324]; Karolinska Institutet [2018-01520]; Lars Hierta Memorial Foundation [FO2019-0086]; Alex and Eva Wallstrom Foundation for Scientific Research and Education [2020-00228]; Swedish Society of Medical Research [P19-0055]; China Scholar Council; KIT in the context of the Helmholtz program BioInterfaces in Technology and Medicine (BIFTM); Deutsche Forschungsgemeinschaft (DFG) [427840891]; Swedish Research Council [2017-04676]; Swedish Cancer Society [CAN2017/561]; Novo Nordisk Foundation [NNF17OC0026940]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Karolinska Institutet(Karolinska Institutet); Lars Hierta Memorial Foundation; Alex and Eva Wallstrom Foundation for Scientific Research and Education; Swedish Society of Medical Research; China Scholar Council; KIT in the context of the Helmholtz program BioInterfaces in Technology and Medicine (BIFTM); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), project number 331351713-SFB 1324 (project A06 to G. D., Z03 to M. B., and A03 to J. C. G.). P. K. acknowledges funding from Karolinska Institutet (2018-01520), The Lars Hierta Memorial Foundation (FO2019-0086), The Alex and Eva Wallstrom Foundation for Scientific Research and Education (2020-00228), and The Swedish Society of Medical Research (P19-0055). X. W. acknowledges funding from the China Scholar Council. G. D. and P. L. also acknowledge funding by the KIT in the context of the Helmholtz program BioInterfaces in Technology and Medicine (BIFTM). H. S. acknowledges funding from Deutsche Forschungsgemeinschaft (DFG; project 427840891). G. S. acknowledges funding from Karolinska Institutet, the Swedish Research Council (2017-04676), the Swedish Cancer Society (CAN2017/561), and the Novo Nordisk Foundation (NNF17OC0026940).	Arthofer E, 2016, MOL PHARMACOL, V90, P447, DOI 10.1124/mol.116.104919; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Chu MLH, 2013, STRUCTURE, V21, P1235, DOI 10.1016/j.str.2013.05.006; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Demir K, 2013, CELL REP, V4, P1224, DOI 10.1016/j.celrep.2013.08.008; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Eubelen M, 2018, SCIENCE, V361, P663, DOI 10.1126/science.aat1178; Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Galli LM, 2018, DEV BIOL, V439, P53, DOI 10.1016/j.ydbio.2018.04.025; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Gerlach JP, 2018, P NATL ACAD SCI USA, V115, pE3996, DOI 10.1073/pnas.1721321115; Glaeser K, 2018, EMBO J, V37, DOI 10.15252/embj.201797311; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hirai H, 2019, NAT STRUCT MOL BIOL, V26, P372, DOI 10.1038/s41594-019-0216-z; Holzer T, 2012, FEBS LETT, V586, P1638, DOI 10.1016/j.febslet.2012.04.035; Hoppler Stefan, 2008, V469, P319, DOI 10.1007/978-1-60327-469-2_21; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kozielewicz P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14149-3; Kozielewicz P, 2020, MOL PHARMACOL, V97, P23, DOI 10.1124/mol.119.118158; Kozielewicz P, 2020, MOL PHARMACOL, V97, P62, DOI 10.1124/mol.119.117986; Mattes B, 2018, ELIFE, V7, DOI 10.7554/eLife.36953; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Menck K, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1378056; Mihara E, 2016, ELIFE, V5, DOI 10.7554/eLife.11621; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Pani AM, 2018, ELIFE, V7, DOI 10.7554/eLife.38325; PARR BA, 1993, DEVELOPMENT, V119, P247; Petersen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00253-9; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Rodriguez EA, 2017, TRENDS BIOCHEM SCI, V42, P111, DOI 10.1016/j.tibs.2016.09.010; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulte G, 2018, TRENDS PHARMACOL SCI, V39, P828, DOI 10.1016/j.tips.2018.07.001; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/nmeth.3398, 10.1038/NMETH.3398]; Takada R, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0172-x; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Voloshanenko O, 2017, FASEB J, V31, P4832, DOI 10.1096/fj.201700144R; Wallkamm V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109428; Wang YS, 2016, CURR TOP DEV BIOL, V117, P113, DOI 10.1016/bs.ctdb.2015.11.028; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wiese KE, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.165902; Winn RA, 2002, ONCOGENE, V21, P7497, DOI 10.1038/sj.onc.1205963; Wright SC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08630-2; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang L, 2014, CURR OPIN GENET DEV, V27, P14, DOI 10.1016/j.gde.2014.03.006	65	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8759	8774		10.1074/jbc.RA120.012892	http://dx.doi.org/10.1074/jbc.RA120.012892			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32381507	Green Published, hybrid			2022-12-28	WOS:000546296800012
J	Justilien, V; Lewis, KC; Meneses, KM; Jamieson, L; Murray, NR; Fields, AP				Justilien, Verline; Lewis, Kayla C.; Meneses, Kayleah M.; Jamieson, Lee; Murray, Nicole R.; Fields, Alan P.			Protein kinase C? promotes UBF1?ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell proliferation; protein-protein interaction; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); tumor cell biology; epithelial cell transforming protein 2 (ECT2); non-small cell lung cancer; protein kinase C ? (PKC?); ribosomal DNA transcription; upstream binding factor 1 (UBF1); gene regulation; ribosome biogenesis	POLYMERASE-I TRANSCRIPTION; CYTOKINESIS REGULATOR ECT2; RDNA TRANSCRIPTION; GENE-EXPRESSION; BRCT DOMAINS; PHOSPHORYLATION; ACTIVATION; PRKCI; PROTOONCOGENE; ONCOGENES	Epithelial cell?transforming sequence 2 (ECT2) is a guanine nucleotide exchange factor for Rho GTPases that is overexpressed in many cancers and involved in signal transduction pathways that promote cancer cell proliferation, invasion, and tumorigenesis. Recently, we demonstrated that a significant pool of ECT2 localizes to the nucleolus of non-small-cell lung cancer (NSCLC) cells, where it binds the transcription factor upstream binding factor 1 (UBF1) on the promoter regions of ribosomal DNA (rDNA) and activates rDNA transcription, transformed cell growth, and tumor formation. Here, we investigated the mechanism by which ECT2 engages UBF1 on rDNA promoters. Results from ECT2 mutagenesis indicated that the tandem BRCT domain of ECT2 mediates binding to UBF1. Biochemical and MS-based analyses revealed that protein kinase C? (PKC?) directly phosphorylates UBF1 at Ser-412, thereby generating a phosphopeptide-binding epitope that binds the ECT2 BRCT domain. Lentiviral shRNA knockdown and reconstitution experiments revealed that both a functional ECT2 BRCT domain and the UBF1 Ser-412 phosphorylation site are required for UBF1-mediated ECT2 recruitment to rDNA, elevated rRNA synthesis, and transformed growth. Our findings provide critical molecular insight into ECT2-mediated regulation of rDNA transcription in cancer cells and offer a rationale for therapeutic targeting of UBF1- and ECT2-stimulated rDNA transcription for the management of NSCLC.	[Justilien, Verline; Lewis, Kayla C.; Meneses, Kayleah M.; Jamieson, Lee; Murray, Nicole R.; Fields, Alan P.] Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Justilien, V; Fields, AP (corresponding author), Mayo Clin, Ctr Comprehens Canc, Dept Canc Biol, Jacksonville, FL 32224 USA.	justilien.verline@mayo.edu; fields.alan@mayo.edu			NCI, National Institutes of Health [R01 CA081436-22, R01 CA206267-04, R01 CA140290-05, R21 CA204938]; Mayo Clinic Center for Biomedical Discovery Career Development Award; American Cancer Society Research Scholar Award [RSG-18-201-01]	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mayo Clinic Center for Biomedical Discovery Career Development Award; American Cancer Society Research Scholar Award(American Cancer Society)	This work was supported by NCI, National Institutes of Health, Grants R01 CA081436-22 and R01 CA206267-04 (to A. P. F.), R01 CA140290-05 (to N. R. M.), and R21 CA204938 (to V. J.). A. P. F. is the Monica Flynn Jacoby Professor of Cancer Research, an endowment fund that provides partial support for the investigator's research program. V. J. was supported in part by a Mayo Clinic Center for Biomedical Discovery Career Development Award and an American Cancer Society Research Scholar Award (RSG-18-201-01). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali SA, 2016, CANCER CELL, V29, P367, DOI 10.1016/j.ccell.2016.02.012; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Boohaker Rebecca J, 2014, Biomed J, V37, P3, DOI 10.4103/2319-4170.125655; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Chen JX, 2015, J HEPATOL, V62, P1287, DOI 10.1016/j.jhep.2015.01.014; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Fields Alan P, 2017, Small GTPases, V8, P58, DOI 10.1080/21541248.2016.1194953; Fields Alan P., 2015, Advances in Biological Regulation, V60, P47, DOI 10.1016/j.jbior.2015.10.009; Fields AP, 2010, ADV ENZYME REGUL, V50, P190, DOI 10.1016/j.advenzreg.2009.10.010; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gerloff DL, 2012, FEBS LETT, V586, P2711, DOI 10.1016/j.febslet.2012.05.005; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hannan R, 1999, NUCLEIC ACIDS RES, V27, P1205, DOI 10.1093/nar/27.4.1205; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Hirata D, 2009, CLIN CANCER RES, V15, P256, DOI 10.1158/1078-0432.CCR-08-1672; Huff Lauren P, 2013, Genes Cancer, V4, P460, DOI 10.1177/1947601913514851; Jamieson L, 1999, J BIOL CHEM, V274, P3927, DOI 10.1074/jbc.274.7.3927; JANTZEN HM, 1992, GENE DEV, V6, P1950, DOI 10.1101/gad.6.10.1950; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Justilien Verline, 2019, Small GTPases, V10, P388, DOI 10.1080/21541248.2017.1335274; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Kanada M, 2008, MOL BIOL CELL, V19, P8, DOI 10.1091/mbc.E07-04-0370; Khot A, 2019, CANCER DISCOV, V9, P1036, DOI 10.1158/2159-8290.CD-18-1455; Kim H, 2014, CELL CYCLE, V13, P2952, DOI 10.4161/15384101.2014.947201; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; Kusnadi EP, 2015, GENE, V556, P27, DOI 10.1016/j.gene.2014.11.010; Kwong LN, 2012, NAT MED, V18, P1503, DOI 10.1038/nm.2941; Nguyen LXT, 2015, J CELL PHYSIOL, V230, P1181, DOI 10.1002/jcp.24854; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Liu Y, 2020, CELL REP, V30, P771, DOI 10.1016/j.celrep.2019.12.071; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Parker PJ, 2014, BIOCHEM PHARMACOL, V88, P1, DOI 10.1016/j.bcp.2013.10.023; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Reina-Campos M, 2019, CANCER CELL, V36, P218, DOI 10.1016/j.ccell.2019.07.010; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sano M, 2006, ONCOL REP, V16, P1093; Stallings-Mann M, 2006, CANCER RES, V66, P1767, DOI 10.1158/0008-5472.CAN-05-3405; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; TAKAI S, 1995, GENOMICS, V27, P220, DOI 10.1006/geno.1995.1033; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Tokinaga-Uchiyama A, 2019, INT J GYNECOL PATHOL, V38, P301, DOI 10.1097/PGP.0000000000000539; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Yang YL, 2008, GENE CHROMOSOME CANC, V47, P127, DOI 10.1002/gcc.20514; Yin N, 2019, CANCER CELL, V36, P156, DOI 10.1016/j.ccell.2019.07.002; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000; Zhang C, 2005, MOL CELL BIOL, V25, P6899, DOI 10.1128/MCB.25.16.6899-6911.2005; Zhang ML, 2008, HEPATOB PANCREAT DIS, V7, P533; Zhou HJ, 2013, J PROTEOME RES, V12, P260, DOI 10.1021/pr300630k; Zou Y, 2014, FEBS LETT, V588, P2911, DOI 10.1016/j.febslet.2014.07.019	62	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2020	295	24					8214	8226		10.1074/jbc.RA120.013175	http://dx.doi.org/10.1074/jbc.RA120.013175			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MC0CT	32350115	Green Published, hybrid			2022-12-28	WOS:000542965700010
J	Verma, M; Zhu, JH; Wang, KZQ; Chu, CT				Verma, Manish; Zhu, Jianhui; Wang, Kent Z. Q.; Chu, Charleen T.			Chronic treatment with the complex I inhibitor MPP+ depletes endogenous PTEN-induced kinase 1 (PINK1) via up-regulation of Bcl-2?associated athanogene 6 (BAG6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						PTEN-induced putative kinase 1 (PINK1); mitochondria; Parkinson disease; neurodegeneration; protein degradation; BAG6; mitochondrial complex I inhibition; mitochondrial dysfunction; MPP+; neuron injury	OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; DENDRITIC MITOCHONDRIA; PARKINSONS-DISEASE; MITOFUSIN 2; APOPTOSIS; 1-METHYL-4-PHENYLPYRIDINIUM; MITOPHAGY; MUTATIONS; AUTOPHAGY	Mitochondrial dysfunction is implicated in sporadic and familial Parkinson's disease (PD). However, the mechanisms that impair homeostatic responses to mitochondrial dysfunction remain unclear. Previously, we found that chronic, low-dose administration of the mitochondrial complex I inhibitor 1-methyl-4-phenylpyridinium (MPP+) dysregulates mitochondrial fission?fusion, mitophagy, and mitochondrial biogenesis. Given that PTEN-induced kinase 1 (PINK1) regulates mitochondrial function, dynamics, and turnover, we hypothesized that alterations in endogenous PINK1 levels contribute to depletion of mitochondria during chronic complex I injury. Here we found that chronic MPP+ treatment of differentiated SH-SY5Y neuronal cells significantly decreases PINK1 expression prior to reductions in other mitochondrial components. Furthermore, Bcl2-associated athanogene 6 (BAG6, BAT3, or Scythe), a protein involved in protein quality control and degradation, was highly up-regulated during the chronic MPP+ treatment. BAG6 interacted with PINK1, and BAG6 overexpression decreased the half-life of PINK1. Conversely, siRNA-mediated BAG6 knockdown prevented chronic MPP+ stress-induced loss of PINK1, reversed MPP+-provoked mitochondrial changes, increased cell viability, and prevented MPP+-induced dendrite shrinkage in primary neurons. These results indicate that BAG6 up-regulation during chronic complex I inhibition contributes to mitochondrial pathology by decreasing the levels of endogenous PINK1. Given that recessive mutations in PINK1 cause familial PD, the finding of accelerated PINK1 degradation in the chronic MPP+ model suggests that PINK1 loss of function represents a point of convergence between the neurotoxic and genetic causes of PD.	[Verma, Manish; Zhu, Jianhui; Wang, Kent Z. Q.; Chu, Charleen T.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Chu, Charleen T.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; [Chu, Charleen T.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA; [Chu, Charleen T.] Univ Pittsburgh, Ctr Prot Conformat Dis, Pittsburgh, PA 15260 USA; [Chu, Charleen T.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chu, CT (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.; Chu, CT (corresponding author), Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA.; Chu, CT (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.; Chu, CT (corresponding author), Univ Pittsburgh, Ctr Prot Conformat Dis, Pittsburgh, PA 15260 USA.; Chu, CT (corresponding author), Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA.	ctc4@pitt.edu	Chu, Charleen/B-1601-2008	Chu, Charleen/0000-0002-5052-8271	National Institutes of Health [R01-AG026389, R01-NS065789, R01-NS101628]; (NINDS/NIA)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); (NINDS/NIA)	This work was supported in part by National Institutes of Health Grants R01-AG026389, R01-NS065789, and R01-NS101628 (co-funded by NINDS/NIA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ando M, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0174-z; BATES TE, 1994, J NEUROCHEM, V63, P640; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Binici J, 2014, CELL MOL LIFE SCI, V71, P1829, DOI 10.1007/s00018-013-1522-y; Bogaerts V, 2008, GENES BRAIN BEHAV, V7, P129, DOI 10.1111/j.1601-183X.2007.00342.x; Cao YL, 2017, NEUROBIOL AGING, V60, P104, DOI 10.1016/j.neurobiolaging.2017.08.023; Che XQ, 2013, BIOCHEM BIOPH RES CO, V441, P488, DOI 10.1016/j.bbrc.2013.10.086; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cherra SJ, 2013, AM J PATHOL, V182, P474, DOI 10.1016/j.ajpath.2012.10.027; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Chien WL, 2013, FREE RADICAL BIO MED, V58, P160, DOI 10.1016/j.freeradbiomed.2012.12.008; Chien WL, 2011, J NEUROCHEM, V117, P643, DOI 10.1111/j.1471-4159.2011.07229.x; Choi JW, 2014, MOL BIOSYST, V10, P1940, DOI 10.1039/c4mb00026a; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Chu CT, 2005, J NEUROCHEM, V94, P1685, DOI 10.1111/j.1471-4159.2005.03329.x; Dagda RK, 2011, CELL DEATH DIFFER, V18, P1914, DOI 10.1038/cdd.2011.74; Dagda RK, 2014, J NEUROCHEM, V128, P864, DOI 10.1111/jnc.12494; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Fall CP, 1999, J NEUROSCI RES, V55, P620, DOI 10.1002/(SICI)1097-4547(19990301)55:5<620::AID-JNR9>3.0.CO;2-S; Fedorowicz MA, 2014, EMBO REP, V15, P86, DOI 10.1002/embr.201337294; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Guo JF, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0103-7; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hayashishita M, 2019, FEBS OPEN BIO, V9, P1281, DOI 10.1002/2211-5463.12677; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kermer P, 2015, J MOL NEUROSCI, V55, P587, DOI 10.1007/s12031-014-0396-2; Kostic M, 2015, CELL REP, V13, P376, DOI 10.1016/j.celrep.2015.08.079; Krug AK, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.166; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Moriwaki Y, 2008, NEUROSCI RES, V61, P43, DOI 10.1016/j.neures.2008.01.006; Murata H, 2011, J BIOL CHEM, V286, P7182, DOI 10.1074/jbc.M110.179390; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Qu DB, 2015, J BIOL CHEM, V290, P30441, DOI 10.1074/jbc.M115.677815; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Stephans SE, 2002, NEUROTOXICOLOGY, V23, P569, DOI 10.1016/S0161-813X(02)00060-8; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Thress K, 2001, EMBO J, V20, P1033, DOI 10.1093/emboj/20.5.1033; TORTOSA A, 1994, J NEUROCHEM, V62, P1913; Trancikova A, 2012, ANTIOXID REDOX SIGN, V16, P896, DOI 10.1089/ars.2011.4200; Um JW, 2010, BIOCHEM BIOPH RES CO, V393, P824, DOI 10.1016/j.bbrc.2010.02.090; Verma M, 2017, J NEUROSCI, V37, P11151, DOI 10.1523/JNEUROSCI.3791-16.2017; Vives-Bauza C, 2010, AUTOPHAGY, V6, P674, DOI 10.4161/auto.6.5.12068; Wang KJ, 2018, J MANUF SYST, V47, P1, DOI 10.1016/j.jmsy.2018.01.009; WANG XX, 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/journal.pone.0086276; Weihofen A, 2008, HUM MOL GENET, V17, P602, DOI 10.1093/hmg/ddm334; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Zhu JH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.46; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524; Zhu JH, 2010, J ALZHEIMERS DIS, V20, pS325, DOI 10.3233/JAD-2010-100363	74	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7865	7876		10.1074/jbc.RA119.010474	http://dx.doi.org/10.1074/jbc.RA119.010474			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32332095	hybrid, Green Published			2022-12-28	WOS:000540935400005
J	Herdendorf, TJ; Stapels, DAC; Rooijakkers, SHM; Geisbrecht, BV				Herdendorf, Timothy J.; Stapels, Daphne A. C.; Rooijakkers, Suzan H. M.; Geisbrecht, Brian V.			Local structural plasticity of the Staphylococcus aureus evasion protein EapH1 enables engagement with multiple neutrophil serine proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neutrophil; protease; protease inhibitor; protein?protein interaction; Staphylococcus aureus (S; aureus)	IMMUNE EVASION; CRYSTAL-STRUCTURE; CATHEPSIN-G; ELASTASE; MECHANISMS; MYELOPEROXIDASE; RECOGNITION; INHIBITOR; COMPLEX; REVEAL	Members of the EAP family of Staphylococcus aureus immune evasion proteins potently inhibit the neutrophil serine proteases (NSPs) neutrophil elastase, cathepsin-G, and proteinase-3. Previously, we determined a 1.8 ? resolution crystal structure of the EAP family member EapH1 bound to neutrophil elastase. This structure revealed that EapH1 blocks access to the enzyme's active site by forming a noncovalent complex with this host protease. To determine how EapH1 inhibits other NSPs, we studied here the effects of EapH1 on cathepsin-G. We found that EapH1 inhibits cathepsin-G with a K-i of 9.8 ? 4.7 nm. Although this K-i value is ?466-fold weaker than the K-i for EapH1 inhibition of neutrophil elastase, the time dependence of inhibition was maintained. To define the physical basis for EapH1's inhibition of cathepsin-G, we crystallized EapH1 bound to this protease, solved the structure at 1.6 ? resolution, and refined the model to R-work and R-free values of 17.4% and 20.9%, respectively. This structure revealed a protease-binding mode for EapH1 with cathepsin-G that was globally similar to that seen in the previously determined EapH1?neutrophil elastase structure. The nature of the intermolecular interactions formed by EapH1 with cathepsin-G differed considerably from that with neutrophil elastase, however, with far greater contributions from the inhibitor backbone in the cathepsin-G?bound form. Together, these results reveal that EapH1's ability to form high-affinity interactions with multiple NSP targets is due to its remarkable level of local structural plasticity.	[Herdendorf, Timothy J.; Geisbrecht, Brian V.] Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall,1711 Claflin Rd, Manhattan, KS 66506 USA; [Stapels, Daphne A. C.; Rooijakkers, Suzan H. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands	Kansas State University; Utrecht University; Utrecht University Medical Center	Geisbrecht, BV (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall,1711 Claflin Rd, Manhattan, KS 66506 USA.	GeisbrechtB@ksu.edu		Stapels, Daphne/0000-0001-7058-541X	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	X-ray diffraction data were collected at Southeast Regional Collaborative Access Team 22-ID Beamline at the Advanced Photon Source, Argonne National Laboratory. A list of supporting institutions will be provided upon request. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; de Jong NWM, 2017, P NATL ACAD SCI USA, V114, P9439, DOI 10.1073/pnas.1707032114; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Fujinaga M, 1996, J MOL BIOL, V261, P267, DOI 10.1006/jmbi.1996.0458; Garcia BL, 2016, J IMMUNOL, V197, P2051, DOI 10.4049/jimmunol.1600863; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Geisbrecht BV, 2005, J BIOL CHEM, V280, P17243, DOI 10.1074/jbc.M412311200; Hellman L, 2014, BIOL CHEM, V395, P15, DOI 10.1515/hsz-2013-0211; Herdendorf TJ, 2019, ARCH BIOCHEM BIOPHYS, V676, DOI 10.1016/j.abb.2019.108140; Herdendorf TJ, 2018, BIOCHEMISTRY-US, V57, P6888, DOI 10.1021/acs.biochem.8b01134; Hof P, 1996, EMBO J, V15, P5481, DOI 10.1002/j.1460-2075.1996.tb00933.x; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; JONSSON K, 1995, J BIOL CHEM, V270, P21457, DOI 10.1074/jbc.270.37.21457; Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lin SJ, 2014, STRUCTURE, V22, P1333, DOI 10.1016/j.str.2014.07.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nauseef WM, 2014, CELL MICROBIOL, V16, P1146, DOI 10.1111/cmi.12312; NAVIA MA, 1989, P NATL ACAD SCI USA, V86, P7, DOI 10.1073/pnas.86.1.7; ODEBERG H, 1976, INFECT IMMUN, V14, P1276; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Stapels DAC, 2018, PROTEIN SCI, V27, P509, DOI 10.1002/pro.3342; Stapels DAC, 2015, CURR OPIN MICROBIOL, V23, P42, DOI 10.1016/j.mib.2014.11.002; Stapels DAC, 2014, P NATL ACAD SCI USA, V111, P13187, DOI 10.1073/pnas.1407616111; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wright CD, 1999, BIOCHEM BIOPH RES CO, V254, P614, DOI 10.1006/bbrc.1998.0108	37	3	3	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7753	7762		10.1074/jbc.RA120.013601	http://dx.doi.org/10.1074/jbc.RA120.013601			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32303641	Green Published, hybrid			2022-12-28	WOS:000538038900015
J	Guo, L; Zhu, ZM; Wang, GY; Cui, S; Shen, M; Song, ZH; Wang, JH				Guo, Li; Zhu, Zhaoming; Wang, Guangyan; Cui, Shan; Shen, Meng; Song, Zhenhua; Wang, Jin-Hui			microRNA-15b contributes to depression-like behavior in mice by affecting synaptic protein levels and function in the nucleus accumbens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neuroscience; microRNA (miRNA); stress; synapse; fusion protein	MEDIAL PREFRONTAL CORTEX; GAMMA-AMINOBUTYRIC-ACID; VENTRAL TEGMENTAL AREA; CHRONIC MILD STRESS; MESSENGER-RNA; GABAERGIC NEURONS; SIGNALING PATHWAY; MAJOR DEPRESSION; INHIBITORY DEFICITS; GENE-EXPRESSION	Major depression is a prevalent affective disorder characterized by recurrent low mood. It presumably results from stress-induced deteriorations of molecular networks and synaptic functions in brain reward circuits of genetically-susceptible individuals through epigenetic processes. Epigenetic regulator microRNA-15b inhibits neuronal progenitor proliferation and is up-regulated in the medial prefrontal cortex of mice that demonstrate depression-like behavior, indicating the contribution of microRNA-15 to major depression. Using a mouse model of major depression induced by chronic unpredictable mild stress (CUMS), here we examined the effects of microRNA-15b on synapses and synaptic proteins in the nucleus accumbens of these mice. The application of a microRNA-15b antagomir into the nucleus accumbens significantly reduced the incidence of CUMS-induced depression and reversed the attenuations of excitatory synapse and syntaxin-binding protein 3 (STXBP3A)/vesicle-associated protein 1 (VAMP1) expression. In contrast, the injection of a microRNA-15b analog into the nucleus accumbens induced depression-like behavior as well as attenuated excitatory synapses and STXBP3A/VAMP1 expression similar to the down-regulation of these processes induced by the CUMS. We conclude that microRNA-15b-5p may play a critical role in chronic stress-induced depression by decreasing synaptic proteins, innervations, and activities in the nucleus accumbens. We propose that the treatment of anti-microRNA-15b-5p may convert stress-induced depression into resilience.	[Guo, Li; Cui, Shan; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Guo, Li; Wang, Jin-Hui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhu, Zhaoming; Wang, Guangyan; Shen, Meng; Song, Zhenhua] Qingdao Univ, Sch Pharm, Qingdao 266021, Shandong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao University	Wang, JH (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.; Wang, JH (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.	wangjinhui@ucas.ac.cn			National Key R&D Program of China [2016YFC1307101]; Natural Science Foundation of China [81971027, 81930033, 81671071]	National Key R&D Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key R&D Program of China Grant 2016YFC1307101 and Natural Science Foundation of China Grants 81971027, 81930033, and 81671071 (to J.-H. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonso-Grunz F, 2015, CELL MOL LIFE SCI, V72, P3127, DOI 10.1007/s00018-015-1922-2; [Anonymous], [No title captured]; Bai M, 2014, PHYSIOL BEHAV, V129, P135, DOI 10.1016/j.physbeh.2014.02.035; Bajbouj M, 2006, BIOL PSYCHIAT, V59, P395, DOI 10.1016/j.biopsych.2005.07.036; Banasr M, 2011, CURR OPIN CELL BIOL, V23, P730, DOI 10.1016/j.ceb.2011.09.002; Basar K, 2010, PROG NEUROBIOL, V92, P533, DOI 10.1016/j.pneurobio.2010.08.007; Beilharz TH, 2010, PROG MOL SUBCELL BIO, V50, P99, DOI 10.1007/978-3-642-03103-8_7; Bennett Paul, 2008, J Genet Couns, V17, P234, DOI 10.1007/s10897-007-9136-x; Bergstrom A, 2007, J MOL NEUROSCI, V33, P201, DOI 10.1007/s12031-007-0065-9; Bosch-Bouju M, 2016, CELL REP, V16, P1237, DOI 10.1016/j.celrep.2016.06.082; Camp NJ, 2005, TRENDS MOL MED, V11, P138, DOI 10.1016/j.molmed.2005.01.002; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Croarkin PE, 2011, NEUROSCI BIOBEHAV R, V35, P818, DOI 10.1016/j.neubiorev.2010.10.002; Dalmay T, 2013, ESSAYS BIOCHEM, V54, P29, DOI [10.1042/BSE0540029, 10.1042/bse0540029]; Day JJ, 2007, NEUROSCIENTIST, V13, P148, DOI 10.1177/1073858406295854; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dias C, 2014, NATURE, V516, P51, DOI 10.1038/nature13976; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Elizalde N, 2008, PSYCHOPHARMACOLOGY, V199, P1, DOI 10.1007/s00213-007-1035-1; Fadok JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012751; Feng J, 2017, NEUROPSYCHOPHARMACOL, V42, P1657, DOI 10.1038/npp.2017.6; Feng J, 2017, CEREB CORTEX, V27, P5858, DOI 10.1093/cercor/bhx292; Floresco SB, 2015, ANNU REV PSYCHOL, V66, P25, DOI 10.1146/annurev-psych-010213-115159; Francis TC, 2017, BIOL PSYCHIAT, V81, P645, DOI 10.1016/j.biopsych.2016.09.007; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gao ZL, 2019, BRAIN RES, V1721, DOI 10.1016/j.brainres.2019.146333; Gao ZL, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00285; Ge RJ, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-26; Ge RJ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-19; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hamilton JP, 2013, NEUROBIOL DIS, V52, P4, DOI 10.1016/j.nbd.2012.01.015; Hammels C, 2015, NEUROSCI BIOBEHAV R, V59, P111, DOI 10.1016/j.neubiorev.2015.10.006; Haruno M, 2014, J COGNITIVE NEUROSCI, V26, P1861, DOI 10.1162/jocn_a_00589; Hettema JM, 2006, MOL PSYCHIATR, V11, P752, DOI 10.1038/sj.mp.4001845; Higuchi F, 2016, J NEUROSCI, V36, P7253, DOI 10.1523/JNEUROSCI.0319-16.2016; Hikida T, 2016, NEUROSCI RES, V108, P1, DOI 10.1016/j.neures.2016.01.004; Huang YH, 2011, BEHAV BRAIN RES, V216, P9, DOI 10.1016/j.bbr.2010.07.039; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jabbi M, 2008, ANN NY ACAD SCI, V1148, P42, DOI 10.1196/annals.1410.018; Karolewicz B, 2010, INT J NEUROPSYCHOPH, V13, P411, DOI 10.1017/S1461145709990587; Keers R, 2012, CURR PSYCHIAT REP, V14, P129, DOI 10.1007/s11920-011-0251-x; Khundakar A, 2011, INT PSYCHOGERIATR, V23, P644, DOI 10.1017/S1041610210001444; Kim KS, 2008, J NEUROCHEM, V107, P105, DOI 10.1111/j.1471-4159.2008.05592.x; Klengel T, 2013, CAN J PSYCHIAT, V58, P76, DOI 10.1177/070674371305800203; Kochenborger L, 2012, NEUROPHARMACOLOGY, V62, P427, DOI 10.1016/j.neuropharm.2011.08.019; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lei ZF, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00316; Levinson AJ, 2010, BIOL PSYCHIAT, V67, P458, DOI 10.1016/j.biopsych.2009.09.025; Li JZ, 2013, P NATL ACAD SCI USA, V110, P9950, DOI 10.1073/pnas.1305814110; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lin LC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00110; Liu BB, 2015, PSYCHOPHARMACOLOGY, V232, P541, DOI 10.1007/s00213-014-3690-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohoff FW, 2010, CURR PSYCHIAT REP, V12, P539, DOI 10.1007/s11920-010-0150-6; Lu W, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-38; Lv XH, 2014, EMBO REP, V15, P1305, DOI 10.15252/embr.201438923; Ma K, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.181; Ma K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159093; Maciag D, 2010, BIOL PSYCHIAT, V67, P465, DOI 10.1016/j.biopsych.2009.10.027; Manji HK, 2003, BIOL PSYCHIAT, V53, P707, DOI 10.1016/S0006-3223(03)00117-3; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Monk CS, 2008, AM J PSYCHIAT, V165, P90, DOI 10.1176/appi.ajp.2007.06111917; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Moylan S, 2013, MOL PSYCHIATR, V18, P595, DOI 10.1038/mp.2012.33; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607; Oruc L, 1997, NEUROPSYCHOBIOLOGY, V36, P62; Overstreet DH, 2012, METHODS MOL BIOL, V829, P125, DOI 10.1007/978-1-61779-458-2_7; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Plante DT, 2012, NEUROPSYCHOPHARMACOL, V37, P1548, DOI 10.1038/npp.2012.4; Price RB, 2009, BIOL PSYCHIAT, V65, P792, DOI 10.1016/j.biopsych.2008.10.025; Pujara M, 2014, NEUROSCIENTIST, V20, P82, DOI 10.1177/1073858413499407; Rajkowska G, 2007, NEUROPSYCHOPHARMACOL, V32, P471, DOI 10.1038/sj.npp.1301234; Rajkowska G, 2015, J PSYCHIATR RES, V65, P53, DOI 10.1016/j.jpsychires.2015.04.010; Ravichandran V, 1997, J MOL NEUROSCI, V8, P159, DOI 10.1007/BF02736780; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Sandi C, 2015, NAT REV NEUROSCI, V16, P290, DOI 10.1038/nrn3918; Shen MM, 2019, PSYCHOPHARMACOLOGY, V236, P2119, DOI 10.1007/s00213-019-05209-z; Si YW, 2018, AM J MED GENET B, V177, P563, DOI 10.1002/ajmg.b.32651; Smalheiser NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033201; Smalheiser NR, 2011, INT J NEUROPSYCHOPH, V14, P1315, DOI 10.1017/S1461145710001628; Southwick SM, 2012, SCIENCE, V338, P79, DOI 10.1126/science.1222942; Sun XY, 2018, PROG NEURO-PSYCHOPH, V86, P150, DOI 10.1016/j.pnpbp.2018.05.023; Sun Y, 2019, J NEUROPHYSIOL, V122, P1002, DOI 10.1152/jn.00215.2019; Thomas KL, 2002, EUR J NEUROSCI, V16, P1789, DOI 10.1046/j.1460-9568.2002.02247.x; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Tzschentke TM, 2000, CRIT REV NEUROBIOL, V14, P131; Veeraiah P, 2014, BIOL PSYCHIAT, V76, P231, DOI 10.1016/j.biopsych.2013.09.024; Vialou V, 2010, NAT NEUROSCI, V13, P745, DOI 10.1038/nn.2551; Volk N, 2016, CELL REP, V17, P1882, DOI 10.1016/j.celrep.2016.10.038; Volk N, 2014, J NEUROSCI, V34, P15070, DOI 10.1523/JNEUROSCI.0855-14.2014; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang JL, 2018, INT SYM COMPUT INTEL, P7, DOI 10.1109/ISCID.2018.00008; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Wang Jin-Hui, 2019, F1000Res, V8, P457, DOI 10.12688/f1000research.18771.1; Wang Jin-Hui, 2017, F1000Res, V6, P283, DOI 10.12688/f1000research.11096.2; Wang JX, 2019, ANTIOXID REDOX SIGN, V31, P369, DOI 10.1089/ars.2018.7688; Wang W, 2010, NEUROPSYCHOPHARMACOL, V35, P2249, DOI 10.1038/npp.2010.99; Wang X, 2010, J NEUROSCI, V30, P12632, DOI 10.1523/JNEUROSCI.1264-10.2010; Waraczynski MA, 2006, NEUROSCI BIOBEHAV R, V30, P472, DOI 10.1016/j.neubiorev.2005.09.001; Wei J, 2004, NEUROSCIENCE, V127, P637, DOI 10.1016/j.neuroscience.2004.05.056; Wilde A, 2013, DEPRESS ANXIETY, V30, P267, DOI 10.1002/da.22000; Xu AP, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv122; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Yan FX, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5648390; Yang FC, 2014, NEUROBIOL LEARN MEM, V112, P186, DOI 10.1016/j.nlm.2013.07.017; Yang ZL, 2017, ONCOTARGET, V8, P72424, DOI 10.18632/oncotarget.19770; Yang ZL, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-1; Yu JD, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-26; Zhang FY, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-20; Zhang GJ, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-2; Zhu ZM, 2017, ONCOTARGET, V8, P35933, DOI 10.18632/oncotarget.16411	120	10	10	2	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6831	6848		10.1074/jbc.RA119.012047	http://dx.doi.org/10.1074/jbc.RA119.012047			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32209659	hybrid, Green Published			2022-12-28	WOS:000536212600006
J	Jarva, MA; Dramicanin, M; Lingford, JP; Mao, RY; John, A; Jarman, KE; Grinter, R; Goddard-Borger, ED				Jarva, Michael A.; Dramicanin, Marija; Lingford, James P.; Mao, Runyu; John, Alan; Jarman, Kate E.; Grinter, Rhys; Goddard-Borger, Ethan D.			Structural basis of substrate recognition and catalysis by fucosyltransferase 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; fucosyltransferase; glycosyltransferase; substrate specificity; glycosylation; N-linked glycosylation; structural biology; enzyme mechanism; core fucose; enzyme evolution; fucosyltransferase 8 (FUT8); protein maturation	CORE FUCOSYLATION; MAMMALIAN ALPHA-1,6-FUCOSYL-TRANSFERASE; CELL-RECEPTOR; BINDING; FUT8; SPECIFICITY; MECHANISM; ACTIVATION; EXPRESSION; PHENOTYPE	Fucosylation of the innermost GlcNAc of N-glycans by fucosyltransferase 8 (FUT8) is an important step in the maturation of complex and hybrid N-glycans. This simple modification can dramatically affect the activities and half-lives of glycoproteins, effects that are relevant to understanding the invasiveness of some cancers, development of mAb therapeutics, and the etiology of a congenital glycosylation disorder. The acceptor substrate preferences of FUT8 are well-characterized and provide a framework for understanding N-glycan maturation in the Golgi; however, the structural basis of these substrate preferences and the mechanism through which catalysis is achieved remain unknown. Here we describe several structures of mouse and human FUT8 in the apo state and in complex with GDP, a mimic of the donor substrate, and with a glycopeptide acceptor substrate at 1.80?2.50 ? resolution. These structures provide insights into a unique conformational change associated with donor substrate binding, common strategies employed by fucosyltransferases to coordinate GDP, features that define acceptor substrate preferences, and a likely mechanism for enzyme catalysis. Together with molecular dynamics simulations, the structures also revealed how FUT8 dimerization plays an important role in defining the acceptor substrate-binding site. Collectively, this information significantly builds on our understanding of the core fucosylation process.	[Jarva, Michael A.; Dramicanin, Marija; Lingford, James P.; Mao, Runyu; John, Alan; Jarman, Kate E.; Goddard-Borger, Ethan D.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Jarva, Michael A.; Dramicanin, Marija; Lingford, James P.; Mao, Runyu; John, Alan; Jarman, Kate E.; Goddard-Borger, Ethan D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Grinter, Rhys] Monash Univ, Monash Biomed Discovery Inst, Dept Microbiol, Clayton, Vic 3800, Australia	Walter & Eliza Hall Institute; University of Melbourne; Monash University	Goddard-Borger, ED (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.; Goddard-Borger, ED (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.	goddard-borger.e@wehi.edu.au	John, Alan/AAX-1829-2020	John, Alan/0000-0002-6855-5470; Lingford, James/0000-0003-1980-3949; Dramicanin, Marija/0000-0003-3677-4019; Grinter, Rhys/0000-0002-8195-5348; Goddard-Borger, Ethan/0000-0002-8181-9733; Mao, Runyu/0000-0001-5267-3328; Jarva, Michael Antonio/0000-0002-8519-5622	Walter and Eliza Hall Institute of Medical Research; National Health and Medical Research Council of Australia [GNT1139549]; Australian Cancer Research Fund; Victorian State Government Operational Infrastructure support grant	Walter and Eliza Hall Institute of Medical Research; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Fund; Victorian State Government Operational Infrastructure support grant	This work was supported by The Walter and Eliza Hall Institute of Medical Research, National Health and Medical Research Council of Australia Project Grant GNT1139549, the Australian Cancer Research Fund, and a Victorian State Government Operational Infrastructure support grant. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agrawal P, 2017, CANCER CELL, V31, P804, DOI 10.1016/j.ccell.2017.05.007; AOYAGI Y, 1985, LANCET, V2, P1353; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Brzezinski K, 2012, ACTA CRYSTALLOGR D, V68, P160, DOI 10.1107/S0907444911053157; Calderon AD, 2016, ORG BIOMOL CHEM, V14, P4027, DOI 10.1039/c6ob00586a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujii H, 2016, GASTROENTEROLOGY, V150, P1620, DOI 10.1053/j.gastro.2016.03.002; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; Garcia-Garcia A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14794-z; Herrera H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102528; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ihara H, 2006, GLYCOBIOLOGY, V16, P333, DOI 10.1093/glycob/cwj068; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Iijima J, 2017, GLYCOBIOLOGY, V27, P1006, DOI 10.1093/glycob/cwx075; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaminska J, 1998, GLYCOCONJUGATE J, V15, P783, DOI 10.1023/A:1006959915435; Kirby N, 2016, ACTA CRYSTALLOGR D, V72, P1254, DOI 10.1107/S2059798316017174; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Kotzler MP, 2013, ACS CHEM BIOL, V8, P1830, DOI 10.1021/cb400140u; Kotzler MP, 2012, BBA-GEN SUBJECTS, V1820, P1915, DOI 10.1016/j.bbagen.2012.08.018; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Li WZ, 2015, J IMMUNOL, V194, P2596, DOI 10.4049/jimmunol.1402678; Li ZJ, 2017, NAT CHEM BIOL, V13, P757, DOI 10.1038/nchembio.2381; Liang W, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00078; Lin HL, 2011, AM J PHYSIOL-RENAL, V300, pF1017, DOI 10.1152/ajprenal.00426.2010; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Manabe Y, 2019, ANGEW CHEM INT EDIT, V58, P18697, DOI 10.1002/anie.201911875; Matsumoto K, 2008, CANCER SCI, V99, P1611, DOI 10.1111/j.1349-7006.2008.00847.x; Nakayama K, 2019, J BIOCHEM, V165, P227, DOI 10.1093/jb/mvy098; Ng BG, 2018, AM J HUM GENET, V102, P188, DOI 10.1016/j.ajhg.2017.12.009; Niwa R, 2005, J IMMUNOL METHODS, V306, P151, DOI 10.1016/j.jim.2005.08.009; Okada M, 2017, CELL REP, V20, P1017, DOI 10.1016/j.celrep.2017.07.027; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Takahashi T, 2000, GLYCOBIOLOGY, V10, P503, DOI 10.1093/glycob/10.5.503; Thaysen-Andersen M, 2012, GLYCOBIOLOGY, V22, P1440, DOI 10.1093/glycob/cws110; Tseng TH, 2017, J AM CHEM SOC, V139, P9431, DOI 10.1021/jacs.7b03729; Tu CF, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0904-8; Urbanowicz BR, 2017, PLANT J, V91, P931, DOI 10.1111/tpj.13628; Valero-Gonzalez J, 2016, NAT CHEM BIOL, V12, P240, DOI [10.1038/NCHEMBIO.2019, 10.1038/nchembio.2019]; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Wang XC, 2009, J BIOCHEM, V145, P643, DOI 10.1093/jb/mvp022; Yang Q, 2017, J BIOL CHEM, V292, P14796, DOI 10.1074/jbc.M117.804070	48	11	11	5	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6677	6688		10.1074/jbc.RA120.013291	http://dx.doi.org/10.1074/jbc.RA120.013291			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32220931	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000537685000033
J	Morgan, SA; Lavenir, I; Fan, J; Masuda-Suzukake, M; Passarella, D; DeTure, MA; Dickson, DW; Ghetti, B; Goedert, M				Morgan, Sophie A.; Lavenir, Isabelle; Fan, Juan; Masuda-Suzukake, Masami; Passarella, Daniela; DeTure, Michael A.; Dickson, Dennis W.; Ghetti, Bernardino; Goedert, Michel			?-Synuclein filaments from transgenic mouse and human synucleinopathy-containing brains are major seed-competent species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-synuclein (?-synuclein); oligomer; neurodegeneration; Parkinson disease; fibril; brain disease; Lewy body; multiple system atrophy; seeded aggregation; synucleinopathy	MULTIPLE SYSTEM ATROPHY; PATHOLOGICAL ALPHA-SYNUCLEIN; GLIAL CYTOPLASMIC INCLUSIONS; PARKINSONS-DISEASE; LEWY BODIES; OLIVOPONTOCEREBELLAR ATROPHY; MUTATION; TRANSMISSION; NEURONS; PRIONS	Assembled ?-synuclein in nerve cells and glial cells is the defining pathological feature of neurodegenerative diseases called synucleinopathies. Seeds of ?-synuclein can induce the assembly of monomeric protein. Here, we used sucrose gradient centrifugation and transiently transfected HEK 293T cells to identify the species of ?-synuclein from the brains of homozygous, symptomatic mice transgenic for human mutant A53T ?-synuclein (line M83) that seed aggregation. The most potent fractions contained Sarkosyl-insoluble assemblies enriched in filaments. We also analyzed six cases of idiopathic Parkinson's disease (PD), one case of familial PD, and six cases of multiple system atrophy (MSA) for their ability to induce ?-synuclein aggregation. The MSA samples were more potent than those of idiopathic PD in seeding aggregation. We found that following sucrose gradient centrifugation, the most seed-competent fractions from PD and MSA brains are those that contain Sarkosyl-insoluble ?-synuclein. The fractions differed between PD and MSA, consistent with the presence of distinct conformers of assembled ?-synuclein in these different samples. We conclude that ?-synuclein filaments are the main driving force for amplification and propagation of pathology in synucleinopathies.	[Morgan, Sophie A.; Lavenir, Isabelle; Fan, Juan; Masuda-Suzukake, Masami; Passarella, Daniela; Goedert, Michel] MRC, Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [DeTure, Michael A.; Dickson, Dennis W.] Mayo Clin, Jacksonville, FL 32224 USA; [Ghetti, Bernardino] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Goedert, Michel] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	MRC Laboratory Molecular Biology; Mayo Clinic; Indiana University System; Indiana University Bloomington; University of Cambridge	Goedert, M (corresponding author), MRC, Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	mg@mrc-lmb.cam.ac.uk		Passarella, Daniela/0000-0002-6145-2874; Masuda-Suzukake, Masami/0000-0001-6760-1669; Morgan, Sophie/0000-0002-5542-4324	United Kingdom Medical Research Council [MC_U105184291]; National Institutes of Health NIA [PHS P30 AG01033]; MRC [MC_U105184291] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the United Kingdom Medical Research Council Grant MC_U105184291 (to M. G.) and National Institutes of Health NIA Grant PHS P30 AG01033 (to B. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Aulic S, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-69; Ayers JI, 2017, J VIROL, V91, DOI 10.1128/JVI.02095-16; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2017, J PARKINSON DIS, V7, pS73, DOI 10.3233/JPD-179001; Breid S, 2016, J VIROL, V90, P9182, DOI 10.1128/JVI.01399-16; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Corriveau RA, 2017, NEUROLOGY, V89, P2381, DOI 10.1212/WNL.0000000000004717; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Crowther RA, 2000, NEUROSCI LETT, V292, P128, DOI 10.1016/S0304-3940(00)01440-3; Cykowski MD, 2015, BRAIN, V138, P2293, DOI 10.1093/brain/awv114; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Fanciulli A, 2015, NEW ENGL J MED, V372, P249, DOI 10.1056/NEJMra1311488; Froula JM, 2019, J BIOL CHEM, V294, P10392, DOI 10.1074/jbc.RA119.007743; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Goedert M, 2017, J PARKINSON DIS, V7, pS53, DOI 10.3233/JPD-179005; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; Jellinger KA, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1016-8; Karpowicz RJ, 2019, LAB INVEST, V99, P971, DOI 10.1038/s41374-019-0195-z; KATO S, 1990, ACTA NEUROPATHOL, V79, P584, DOI 10.1007/BF00294235; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Kim S, 2019, NEURON, V103, P627, DOI 10.1016/j.neuron.2019.05.035; Klingstedt T, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0840-1; Konno T, 2016, PARKINSONISM RELAT D, V22, pS1, DOI 10.1016/j.parkreldis.2015.09.007; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; KOSAKA K, 1978, ACTA NEUROPATHOL, V42, P127, DOI 10.1007/BF00690978; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lavenir I, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0804-5; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Logan T, 2017, NAT NEUROSCI, V20, P681, DOI 10.1038/nn.4529; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Mirbaha H, 2018, ELIFE, V7, DOI 10.7554/eLife.36584; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Osterberg VR, 2015, CELL REP, V10, P1252, DOI 10.1016/j.celrep.2015.01.060; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Peelaerts W, 2018, CELL TISSUE RES, V373, P195, DOI 10.1007/s00441-018-2839-5; Peng C, 2018, NATURE, V557, P558, DOI 10.1038/s41586-018-0104-4; Perrin RJ, 2003, NEUROSCI LETT, V349, P133, DOI 10.1016/S0304-3940(03)00781-X; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Tarutani A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0532-2; Tarutani A, 2016, J BIOL CHEM, V291, P18675, DOI 10.1074/jbc.M116.734707; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Woerman AL, 2018, ACTA NEUROPATHOL, V135, P49, DOI 10.1007/s00401-017-1762-2; Woerman AL, 2015, P NATL ACAD SCI USA, V112, pE4949, DOI 10.1073/pnas.1513426112; Yamasaki TR, 2019, J BIOL CHEM, V294, P1045, DOI 10.1074/jbc.RA118.004471; Yoshino H, 2017, NEUROBIOL AGING, V57, DOI 10.1016/j.neurobiolaging.2017.05.022; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	74	13	13	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6652	6664		10.1074/jbc.RA119.012179	http://dx.doi.org/10.1074/jbc.RA119.012179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32209651	Green Published, hybrid			2022-12-28	WOS:000537685000031
J	Poston, RG; Murphy, L; Rejepova, A; Ghaninejad-Esfahani, M; Segales, J; Mulligan, K; Saha, RN				Poston, Robert G.; Murphy, Lillian; Rejepova, Ayna; Ghaninejad-Esfahani, Mina; Segales, Joshua; Mulligan, Kimberly; Saha, Ramendra N.			Certain ortho-hydroxylated brominated ethers are promiscuous kinase inhibitors that impair neuronal signaling and neurodevelopmental processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						toxin; toxicology; axon; Drosophila; signal transduction; 6-OH?BDE-47; environmental toxins; MEK?ERK; neurodevelopmental toxicity; PBDE	POLYBROMINATED DIPHENYL ETHERS; ENDOCRINE-DISRUPTING CHEMICALS; ACTIVATED PROTEIN-KINASE; MAP KINASE; ANTIMICROBIAL SUBSTANCES; PRESYNAPTIC PLASTICITY; CALCIUM HOMEOSTASIS; CRYSTAL-STRUCTURES; FLAME RETARDANTS; HUMAN EXPOSURE	The developing nervous system is remarkably sensitive to environmental signals, including disruptive toxins, such as polybrominated diphenyl ethers (PBDEs). PBDEs are an environmentally pervasive class of brominated flame retardants whose neurodevelopmental toxicity mechanisms remain largely unclear. Using dissociated cortical neurons from embryonic Rattus norvegicus, we found here that chronic exposure to 6-OH?BDE-47, one of the most prevalent hydroxylated PBDE metabolites, suppresses both spontaneous and evoked neuronal electrical activity. On the basis of our previous work on mitogen-activated protein kinase (MAPK)/extracellular signal-related kinase (ERK) (MEK) biology and our observation that 6-OH?BDE-47 is structurally similar to kinase inhibitors, we hypothesized that certain hydroxylated PBDEs mediate neurotoxicity, at least in part, by impairing the MEK?ERK axis of MAPK signal transduction. We tested this hypothesis on three experimental platforms: 1) in silico, where modeling ligand?protein docking suggested that 6-OH?BDE-47 is a promiscuous ATP-competitive kinase inhibitor; 2) in vitro in dissociated neurons, where 6-OH?BDE-47 and another specific hydroxylated BDE metabolite similarly impaired phosphorylation of MEK/ERK1/2 and activity-induced transcription of a neuronal immediate early gene; and 3) in vivo in Drosophila melanogaster, where developmental exposures to 6-OH?BDE-47 and a MAPK inhibitor resulted in offspring displaying similarly increased frequency of mushroom-body ??lobe midline crossing, a metric of axonal guidance. Taken together, our results support that certain ortho-hydroxylated PBDE metabolites are promiscuous kinase inhibitors and can cause disruptions of critical neurodevelopmental processes, including neuronal electrical activity, pre-synaptic functions, MEK?ERK signaling, and axonal guidance.	[Poston, Robert G.; Rejepova, Ayna; Ghaninejad-Esfahani, Mina; Segales, Joshua; Saha, Ramendra N.] Univ Calif Merced, Sch Nat Sci, Mol & Cell Biol Dept, Merced, CA 95343 USA; [Murphy, Lillian; Mulligan, Kimberly] Calif State Univ Sacramento, Dept Biol Sci, Ctr Interdisciplinary Mol Biol Educ Res & Adv CIM, Sacramento, CA 95819 USA	University of California System; University of California Merced; California State University System; California State University Sacramento	Saha, RN (corresponding author), Univ Calif Merced, Rm 346,S&E Bldg 1,5200 North Lake Rd, Merced, CA 95343 USA.	rsaha3@ucmerced.edu	Saha, Ramendra/C-7000-2014	Saha, Ramendra/0000-0002-5494-2584; Murphy, Lillian/0000-0003-3015-808X	National Institutes of Health NIGMS-RISE Grant [R25GM122667]; NIEHS [R01ES028738]	National Institutes of Health NIGMS-RISE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health NIGMS-RISE Grant R25GM122667 for the Drosophila portion of the study and by NIEHS Grant R01ES028738 (to R. N. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarwal V, 2017, NAT CHEM BIOL, V13, P537, DOI [10.1038/NCHEMBIO.2330, 10.1038/nchembio.2330]; Agarwal V, 2014, NAT CHEM BIOL, V10, P640, DOI 10.1038/nchembio.1564; Ageta-Ishihara N, 2009, J NEUROSCI, V29, P13720, DOI 10.1523/JNEUROSCI.3018-09.2009; Agnew C, 2019, J BIOL CHEM, V294, P13545, DOI 10.1074/jbc.RA119.009725; [Anonymous], ERK1 2 SIGNALLING DY; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112; Barf T, 2011, BIOORG MED CHEM LETT, V21, P3818, DOI 10.1016/j.bmcl.2011.04.018; Bramwell L, 2016, ENVIRON INT, V92-93, P680, DOI 10.1016/j.envint.2016.02.017; Braun JM, 2014, ENVIRON HEALTH PERSP, V122, P513, DOI 10.1289/ehp.1307261; Brown JP, 2016, TOXICOL SCI, V154, P126, DOI 10.1093/toxsci/kfw147; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Burkholder P. R, 1969, Lloydia, V32, P466; BUSSAU LJ, 1993, CLIN EXP PHARMACOL P, V20, P697, DOI 10.1111/j.1440-1681.1993.tb01654.x; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Charlesworth P, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-014-0028-0; Chen HX, 2015, P NATL ACAD SCI USA, V112, pE5936, DOI 10.1073/pnas.1516319112; Chen H, 2017, TOXICOL SCI, V156, P375, DOI 10.1093/toxsci/kfw259; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Costa LG, 2014, TOXICOL LETT, V230, P282, DOI 10.1016/j.toxlet.2013.11.011; Dingemans MML, 2008, ENVIRON HEALTH PERSP, V116, P637, DOI 10.1289/ehp.11059; Dingemans MML, 2011, ENVIRON HEALTH PERSP, V119, P900, DOI 10.1289/ehp.1003035; Dorman DC, 2018, J TOXICOL ENV HEAL B, V21, P269, DOI 10.1080/10937404.2018.1514829; Erratico CA, 2013, CHEM RES TOXICOL, V26, P721, DOI 10.1021/tx300522u; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051; Frank CL, 2017, TOXICOL SCI, V160, P121, DOI 10.1093/toxsci/kfx169; Frederiksen M, 2009, INT J HYG ENVIR HEAL, V212, P109, DOI 10.1016/j.ijheh.2008.04.005; Fu ZQ, 2016, ENVIRON SCI TECHNOL, V50, P8155, DOI 10.1021/acs.est.6b00524; Gassmann K, 2014, ARCH TOXICOL, V88, P1537, DOI 10.1007/s00204-014-1217-7; Giachello CNG, 2010, J CELL SCI, V123, P881, DOI 10.1242/jcs.056846; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Heald RA, 2012, J MED CHEM, V55, P4594, DOI 10.1021/jm2017094; Hertz-Picciotto I, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-1; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang SPC, 2010, TOXICOL SCI, V114, P124, DOI 10.1093/toxsci/kfp296; Igarashi M, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0476-x; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Kim K, 2018, J MOL BIOL, V430, P1521, DOI 10.1016/j.jmb.2018.04.001; Kumar A, 2005, J MOL BIOL, V348, P183, DOI 10.1016/j.jmb.2005.02.039; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Lake D, 2016, CELL MOL LIFE SCI, V73, P4397, DOI 10.1007/s00018-016-2297-8; Lam J, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1632; Li T, 2013, TOXICOL SCI, V134, P111, DOI 10.1093/toxsci/kft083; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Li ZG, 2006, DEV GROWTH DIFFER, V48, P513, DOI 10.1111/j.1440-169x.2006.00889.x; Linares V, 2015, ARCH TOXICOL, V89, P335, DOI 10.1007/s00204-015-1457-1; Feo ML, 2013, ENVIRON HEALTH PERSP, V121, P440, DOI 10.1289/ehp.1205446; Lupton SJ, 2009, CHEM RES TOXICOL, V22, P1802, DOI 10.1021/tx900215u; Lyall K, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/ehp1079; Lyons MR, 2011, PROG NEUROBIOL, V94, P259, DOI 10.1016/j.pneurobio.2011.05.003; Malmberg T, 2005, ENVIRON SCI TECHNOL, V39, P5342, DOI 10.1021/es050574+; Malmvarn A, 2005, ENVIRON SCI TECHNOL, V39, P2990, DOI 10.1021/es0482886; Malmvarn A, 2008, CHEMOSPHERE, V72, P910, DOI 10.1016/j.chemosphere.2008.03.036; Mao LM, 2016, MOL NEUROBIOL, V53, P6309, DOI 10.1007/s12035-015-9535-1; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; Messer A, 2010, PHYSIOL BEHAV, V100, P245, DOI 10.1016/j.physbeh.2010.01.011; Michel CI, 2004, J NEUROSCI, V24, P5798, DOI 10.1523/JNEUROSCI.1102-04.2004; Miksys S, 2004, DRUG METAB REV, V36, P313, DOI 10.1081/DMR-120034149; Millan MJ, 2013, NEUROPHARMACOLOGY, V68, P2, DOI 10.1016/j.neuropharm.2012.11.015; Mitchell MM, 2012, ENVIRON MOL MUTAGEN, V53, P589, DOI 10.1002/em.21722; Napoli E, 2013, TOXICOL SCI, V132, P196, DOI 10.1093/toxsci/kfs339; National Academies of Sciences Engineering and Medicine, 2017, APPL SYST REV METH O; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Pacyniak EK, 2007, TOXICOL SCI, V97, P94, DOI 10.1093/toxsci/kfm025; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Poston RG, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152703; Poston RG, 2018, ENVIRON EPIGENETICS, V4, DOI 10.1093/eep/dvx020; Rauen KA, 2013, ANNU REV GENOM HUM G, V14, P355, DOI 10.1146/annurev-genom-091212-153523; Rhim JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26547; Samuels IS, 2009, NEURON, V61, P160, DOI 10.1016/j.neuron.2009.01.001; Schenk U, 2005, J NEUROSCI, V25, P1654, DOI 10.1523/JNEUROSCI.3074-04.2005; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Shafer TJ, 2019, TOXICOL SCI, V169, P436, DOI 10.1093/toxsci/kfz052; SHARMA GM, 1967, TETRAHEDRON LETT, P4147; SHARMA GM, 1970, J ORG CHEM, V35, P2823, DOI 10.1021/jo00833a084; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Sueyoshi T, 2014, TOXICOL SCI, V137, P292, DOI 10.1093/toxsci/kft243; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Tang FJ, 2005, J NEUROSCI, V25, P6702, DOI 10.1523/JNEUROSCI.0871-05.2005; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Traglia M, 2017, G3-GENES GENOM GENET, V7, P1287, DOI 10.1534/g3.117.039784; Trasande L, 2015, J CLIN ENDOCR METAB, V100, P1245, DOI 10.1210/jc.2014-4324; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tyssowski KM, 2018, NEURON, V98, P530, DOI 10.1016/j.neuron.2018.04.001; U. S. Environmental Protection Agency Office of Research and Development National Center for Environmental Assessment, 2010, EPA600R08086F; UNSON MD, 1994, MAR BIOL, V119, P1, DOI 10.1007/BF00350100; Van Boxtel AL, 2008, ENVIRON SCI TECHNOL, V42, P1773, DOI 10.1021/es0720863; Vara H, 2009, P NATL ACAD SCI USA, V106, P9872, DOI 10.1073/pnas.0900077106; Vuong AM, 2018, HORM BEHAV, V101, P94, DOI 10.1016/j.yhbeh.2017.11.008; Wahl M, 2010, TOXICOL LETT, V198, P119, DOI 10.1016/j.toxlet.2010.06.001; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Wong S, 2016, CNS NEUROL DISORD-DR, V15, P614, DOI 10.2174/1871527315666160413122624; Woods R, 2012, HUM MOL GENET, V21, P2399, DOI 10.1093/hmg/dds046; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Xing L, 2016, ELIFE, V5, DOI 10.7554/elite.11123; Yang JH, 2017, MOL NEUROBIOL, V54, P7156, DOI 10.1007/s12035-016-0225-4; Ye BS, 2017, ENVIRON POLLUT, V227, P234, DOI 10.1016/j.envpol.2017.04.039; Zha MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044828; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhao Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179936; Zhou FQ, 2006, PHILOS T R SOC B, V361, P1575, DOI 10.1098/rstb.2006.1882	111	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6120	6137		10.1074/jbc.RA119.011138	http://dx.doi.org/10.1074/jbc.RA119.011138			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32229587	Green Published, hybrid			2022-12-28	WOS:000531417300022
J	Eddington, C; Titus, MA				Eddington, Casey; Titus, Margaret A.			Putting the brakes on a myosin motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							INSULIN; MEMBRANE; BINDING	Insulin-stimulated trafficking of GLUT4 requires the myosin motor Myo1C and signaling adaptor 14-3-3?. Originally, it was thought that 14-3-3? promotes GLUT4 transport by binding the Myo1C lever arm and activating the Myo1C motor. New work by Ji and Ostap using in vitro assays reveals that 14-3-3? binding actually inhibits Myo1C motility, prompting reconsideration of the functional relationship between 14-3-3? and Myo1C and the regulatory potential of atypical light chains.	[Eddington, Casey; Titus, Margaret A.] Univ Minnesota, Dept Genet Cell Biol & Dev, 6-160 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Titus, MA (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 6-160 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	titus004@umn.edu			National Institutes of Health [R01GM122917, R01GM122917-01S1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by National Institutes of Health Grants R01GM122917 and R01GM122917-01S1. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boguslavsky S, 2012, MOL BIOL CELL, V23, P4065, DOI 10.1091/mbc.E12-04-0263; Bose A, 2002, NATURE, V420, P821, DOI 10.1038/nature01246; Bose A, 2004, MOL CELL BIOL, V24, P5447, DOI 10.1128/MCB.24.12.5447-5458.2004; Chen XW, 2007, DEV CELL, V13, P391, DOI 10.1016/j.devcel.2007.07.007; Heissler Sarah M, 2014, Bioarchitecture, V4, P169, DOI 10.1080/19490992.2015.1054092; Ji HH, 2020, J BIOL CHEM, V295, P3749, DOI 10.1074/jbc.RA119.011227; Manceva S, 2007, BIOCHEMISTRY-US, V46, P11718, DOI 10.1021/bi700894h; Munnich S, 2014, J MOL BIOL, V426, P2070, DOI 10.1016/j.jmb.2014.03.004; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Tang N, 2007, J MUSCLE RES CELL M, V28, P285, DOI 10.1007/s10974-007-9124-7; Yip MF, 2008, CELL METAB, V8, P384, DOI 10.1016/j.cmet.2008.09.011	11	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3757	3758		10.1074/jbc.H120.013153	http://dx.doi.org/10.1074/jbc.H120.013153			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32198186	hybrid, Green Published			2022-12-28	WOS:000527704400002
J	Anderson, EM; Sychantha, D; Brewer, D; Clarke, AJ; Geddes-McAlister, J; Khursigara, CM				Anderson, Erin M.; Sychantha, David; Brewer, Dyanne; Clarke, Anthony J.; Geddes-McAlister, Jennifer; Khursigara, Cezar M.			Peptidoglycomics reveals compositional changes in peptidoglycan between biofilm- and planktonic-derived Pseudomonas aeruginosa (vol 295, pg 504, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Anderson EM, 2020, J BIOL CHEM, V295, P504, DOI 10.1074/jbc.RA119.010505	1	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3387	3387		10.1074/jbc.AAC120.012947	http://dx.doi.org/10.1074/jbc.AAC120.012947			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32144150	Green Published, hybrid			2022-12-28	WOS:000519597300041
J	Chen, H; Shi, ZN; Guo, JJ; Chang, KJ; Chen, QQ; Yao, CH; Haigis, MC; Shi, Y				Chen, Hao; Shi, Zhennan; Guo, Jiaojiao; Chang, Kao-jung; Chen, Qianqian; Yao, Cong-Hui; Haigis, Marcia C.; Shi, Yang			The human mitochondrial 12S rRNA m(4)C methyltransferase METTL15 is required for mitochondrial function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						m4C methylation; 12S mt-rRNA; mitochondrial translation; mitoribosome biogenesis; methyltransferase-like 15 (METTL15); rsmH; post-transcriptional modification; RNA methylation; RNA methyltransferase; RNA modification; mitochondria; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); m4C methylation; mitochondrial translation	GENE-EXPRESSION; METHYLATION; TRANSCRIPTION; TRANSLATION; GENOME	Mitochondrial DNA gene expression is coordinately regulated both pre- and post-transcriptionally, and its perturbation can lead to human pathologies. Mitochondrial rRNAs (mt-rRNAs) undergo a series of nucleotide modifications after release from polycistronic mitochondrial RNA precursors, which is essential for mitochondrial ribosomal biogenesis. CytosineN(4)-methylation (m(4)C) at position 839 (m(4)C839) of the 12S small subunit mt-rRNA was identified decades ago; however, its biogenesis and function have not been elucidated in detail. Here, using several approaches, including immunofluorescence, RNA immunoprecipitation and methylation assays, and bisulfite mapping, we demonstrate that human methyltransferase-like 15 (METTL15), encoded by a nuclear gene, is responsible for 12S mt-rRNA methylation at m(4)C839 bothin vivoandin vitro. We tracked the evolutionary history of RNA m(4)C methyltransferases and identified a difference in substrate preference between METTL15 and its bacterial ortholog rsmH. Additionally, unlike the very modest impact of a loss of m(4)C methylation in bacterial small subunit rRNA on the ribosome, we found that METTL15 depletion results in impaired translation of mitochondrial protein-coding mRNAs and decreases mitochondrial respiration capacity. Our findings reveal that human METTL15 is required for mitochondrial function, delineate the evolution of methyltransferase substrate specificities and modification patterns in rRNA, and highlight a differential impact of m(4)C methylation on prokaryotic ribosomes and eukaryotic mitochondrial ribosomes.	[Chen, Hao; Shi, Zhennan; Chang, Kao-jung; Chen, Qianqian; Shi, Yang] Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; [Chen, Hao; Shi, Zhennan; Chang, Kao-jung; Chen, Qianqian; Shi, Yang] Boston Childrens Hosp, Dept Med, Epigenet Program, Boston, MA 02115 USA; [Chen, Hao; Shi, Zhennan; Chang, Kao-jung; Chen, Qianqian; Yao, Cong-Hui; Haigis, Marcia C.; Shi, Yang] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Guo, Jiaojiao] Northeastern Univ, Coll Sci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Northeastern University	Shi, Y (corresponding author), Boston Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA.; Shi, Y (corresponding author), Boston Childrens Hosp, Dept Med, Epigenet Program, Boston, MA 02115 USA.; Shi, Y (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	Yang.Shi@childrens.harvard.edu		Chang, Kao-Jung/0000-0002-2238-7387; CHEN, HAO/0000-0002-2534-9650; Yao, Conghui/0000-0003-3922-1874	Boston Children's Hospital funds	Boston Children's Hospital funds	This work was supported by Boston Children's Hospital funds. Y. S. is an American Cancer Society Research Professor.	Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6; Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026; Bradfield JP, 2019, HUM MOL GENET, V28, P3327, DOI 10.1093/hmg/ddz161; COSTANZO MC, 1990, ANNU REV GENET, V24, P91; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; DUBIN DT, 1974, J MOL BIOL, V84, P257, DOI 10.1016/0022-2836(74)90584-1; DUBIN DT, 1978, NUCLEIC ACIDS RES, V5, P4385, DOI 10.1093/nar/5.11.4385; Fernandez-Vizarra E, 2007, J MED GENET, V44, P173, DOI 10.1136/jmg.2006.045252; Fukasawa Y, 2015, MOL CELL PROTEOMICS, V14, P1113, DOI 10.1074/mcp.M114.043083; Garone C, 2017, HUM MOL GENET, V26, P4257, DOI 10.1093/hmg/ddx314; Kehrein K, 2015, CELL REP, V10, P843, DOI 10.1016/j.celrep.2015.01.012; Kimura S, 2010, NUCLEIC ACIDS RES, V38, P1341, DOI 10.1093/nar/gkp1073; Klinge S, 2019, NAT REV MOL CELL BIO, V20, P116, DOI 10.1038/s41580-018-0078-y; Kozbial PZ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-19; Ma HH, 2019, NAT CHEM BIOL, V15, P88, DOI 10.1038/s41589-018-0184-3; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003; Popova AM, 2014, J AM CHEM SOC, V136, P2058, DOI 10.1021/ja412084b; Rieder D, 2016, BIOINFORMATICS, V32, P782, DOI 10.1093/bioinformatics/btv647; Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schulz TJ, 2013, BIOCHEM J, V453, P167, DOI 10.1042/BJ20130457; Seidel-Rogol BL, 2003, NAT GENET, V33, P23, DOI 10.1038/ng1064; Sergiev PV, 2018, NAT CHEM BIOL, V14, P226, DOI [10.1038/nchembio.2569, 10.1038/NCHEMBIO.2569]; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharoyko VV, 2014, HUM MOL GENET, V23, P5733, DOI 10.1093/hmg/ddu288; Shi ZN, 2019, FASEB J, V33, P13040, DOI 10.1096/fj.201901331R; Shinawi M, 2011, AM J MED GENET A, V155A, P1272, DOI 10.1002/ajmg.a.33878; Spahr H, 2012, P NATL ACAD SCI USA, V109, P15253, DOI 10.1073/pnas.1210688109; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Van Haute L, 2019, NUCLEIC ACIDS RES, V47, P10267, DOI 10.1093/nar/gkz735; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wei Y, 2012, J STRUCT BIOL, V179, P29, DOI 10.1016/j.jsb.2012.04.011	37	25	25	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8505	8513		10.1074/jbc.RA119.012127	http://dx.doi.org/10.1074/jbc.RA119.012127			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32371392	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000546986500015
J	Richter, K; Rufer, AC; Muller, M; Burger, D; Casagrande, F; Grossenbacher, T; Huber, S; Hug, MN; Koldewey, P; D'Osualdo, A; Schlatter, D; Stoll, T; Rudolph, MG				Richter, Kirsten; Rufer, Arne C.; Muller, Magali; Burger, Dominique; Casagrande, Fabio; Grossenbacher, Tabea; Huber, Sylwia; Hug, Melanie N.; Koldewey, Philipp; D'Osualdo, Andrea; Schlatter, Daniel; Stoll, Theodor; Rudolph, Markus G.			Small molecule AX-024 reduces T cell proliferation independently of CD3?/Nck1 interaction, which is governed by a domain swap in the Nck1-SH3.1 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; crystal structure; T-cell receptor (TCR); protein drug interaction; cell proliferation; structure-function; protein structure; nuclear magnetic resonance (NMR); analytical ultracentrifugation; surface plasmon resonance (SPR)	TERMINAL SH3 DOMAIN; CRYSTAL-STRUCTURE; PROTEIN INTERACTIONS; BINDING; ACTIVATION; PHOSPHORYLATION; CD3-EPSILON; MECHANISM; ADAPTERS; DIMER	Activation of the T cell receptor (TCR) results in binding of the adapter protein Nck (noncatalytic region of tyrosine kinase) to the CD3? subunit of the TCR. The interaction was suggested to be important for the amplification of TCR signals and is governed by a proline-rich sequence (PRS) in CD3? that binds to the first Src homology 3 (SH3) domain of Nck (Nck-SH3.1). Inhibition of this protein/protein interaction ameliorated inflammatory symptoms in mouse models of multiple sclerosis, psoriasis, and asthma. A small molecule, AX-024, was reported to inhibit the Nck/CD3? interaction by physically binding to the Nck1-SH3.1 domain, suggesting a route to develop an inhibitor of the Nck1/CD3? interaction for modulating TCR activity in autoimmune and inflammatory diseases. We show here that AX-024 reduces T cell proliferation upon weak TCR stimulation but does not significantly affect phosphorylation of Zap70 (? chain of T cell receptor?associated protein kinase 70). We also find that AX-024 is likely not involved in modulating the Nck/TCR interaction but probably has other targets in T cells. An array of biophysical techniques did not detect a direct interaction between AX-024 and Nck-SH3.1 in vitro. Crystal structures of the Nck-SH3.1 domain revealed its binding mode to the PRS in CD3?. The SH3 domain tends to generate homodimers through a domain swap. Domain swaps observed previously in other SH3 domains indicate a general propensity of this protein fold to exchange structural elements. The swapped form of Nck-SH3.1 is unable to bind CD3?, possibly representing an inactive form of Nck in cells.	[Richter, Kirsten; Muller, Magali; D'Osualdo, Andrea] F Hoffmann La Roche Ltd, I2O Dis Translat Area, Grenzacherstr 124, CH-4070 Basel, Switzerland; [Rufer, Arne C.; Burger, Dominique; Casagrande, Fabio; Grossenbacher, Tabea; Huber, Sylwia; Hug, Melanie N.; Koldewey, Philipp; Schlatter, Daniel; Stoll, Theodor; Rudolph, Markus G.] F Hoffmann La Roche Ltd, PRED Pharma Res & Early Dev, Roche Innovat Ctr Basel, Therapeut Modal,Discovery & Med Chem, Grenzacherstr 124, CH-4070 Basel, Switzerland; [Hug, Melanie N.] Univ Appl Sci Northwestern Switzerland FHNW, Sch Life Sci, Inst Chem & Bioanalyt, Hofackerstr 30, CH-4132 Muttenz, Switzerland	Roche Holding; Roche Holding; FHNW University of Applied Sciences & Arts Northwestern Switzerland	Rudolph, MG (corresponding author), F Hoffmann La Roche Ltd, PRED Pharma Res & Early Dev, Therapeut Modal, CH-4070 Basel, Switzerland.	markus.rudolph@roche.com						Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bacarizo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113224; Baker MAB, 2016, NAT STRUCT MOL BIOL, V23, P197, DOI 10.1038/nsmb.3172; Banjade S, 2015, P NATL ACAD SCI USA, V112, pE6426, DOI 10.1073/pnas.1508778112; Baxter EL, 2012, P NATL ACAD SCI USA, V109, P1955, DOI 10.1073/pnas.1116369109; Benfield AP, 2007, ARCH BIOCHEM BIOPHYS, V462, P47, DOI 10.1016/j.abb.2007.03.010; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Borroto A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2140; Borroto A, 2014, IMMUNOL LETT, V161, P113, DOI 10.1016/j.imlet.2014.05.007; Borroto A, 2014, J IMMUNOL, V192, P2042, DOI 10.4049/jimmunol.1203414; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Camara-Artigas A, 2016, ARCH BIOCHEM BIOPHYS, V602, P116, DOI 10.1016/j.abb.2016.02.024; Camara-Artigas A, 2009, FEBS LETT, V583, P749, DOI 10.1016/j.febslet.2009.01.036; Concordet JP, 2018, NUCLEIC ACIDS RES, V46, pW242, DOI 10.1093/nar/gky354; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Ding F, 2002, J MOL BIOL, V324, P851, DOI 10.1016/S0022-2836(02)01112-9; Ehler A, 2014, ACTA CRYSTALLOGR D, V70, P2163, DOI 10.1107/S1399004714012917; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank MK, 2002, NAT STRUCT BIOL, V9, P877, DOI 10.1038/nsb854; Frese S, 2006, J BIOL CHEM, V281, P18236, DOI 10.1074/jbc.M512917200; GREEN SM, 1995, NAT STRUCT BIOL, V2, P746, DOI 10.1038/nsb0995-746; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Harkiolaki M, 2006, STRUCTURE, V14, P1741, DOI 10.1016/j.str.2006.09.013; Hosoe Y, 2019, BIOPHYS PHYSICOBIOL, V16, P80, DOI 10.2142/biophysico.16.0_80; Huculeci R, 2017, METHODS MOL BIOL, V1555, P257, DOI 10.1007/978-1-4939-6762-9_14; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; Kishan KVR, 1997, NAT STRUCT BIOL, V4, P739; Lettau M, 2010, PROTEIN SCI, V19, P658, DOI 10.1002/pro.334; Lettau M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-1; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Love PE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002485; Lucas LH, 2004, CONCEPT MAGN RESON A, V20A, P24, DOI 10.1002/cmr.a.10094; Matsumura Y, 2013, BIOPHYS CHEM, V175, P39, DOI 10.1016/j.bpc.2013.02.005; MAZZARELLA L, 1993, ACTA CRYSTALLOGR D, V49, P389, DOI 10.1107/S0907444993003403; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ngoenkam J, 2018, IMMUNOLOGY, V153, P42, DOI 10.1111/imm.12809; Ngoenkam J, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-21; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Paensuwan P, 2016, J IMMUNOL, V196, P448, DOI 10.4049/jimmunol.1500958; Pei XY, 1997, P NATL ACAD SCI USA, V94, P9637, DOI 10.1073/pnas.94.18.9637; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; Rousseau F, 2012, ADV EXP MED BIOL, V747, P137, DOI 10.1007/978-1-4614-3229-6_9; Roy E, 2010, P NATL ACAD SCI USA, V107, P15529, DOI 10.1073/pnas.1009743107; Rufer AC, 2018, ACTA CRYSTALLOGR D, V74, P450, DOI 10.1107/S2059798318004813; Saint-Jean AP, 1998, BIOCHEMISTRY-US, V37, P10345, DOI 10.1021/bi980868q; Santiveri CM, 2009, BBA-PROTEINS PROTEOM, V1794, P110, DOI 10.1016/j.bbapap.2008.09.016; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schymkowitz JWH, 2001, NAT STRUCT BIOL, V8, P888, DOI 10.1038/nsb1001-888; Spinelli S, 2004, FEBS LETT, V564, P35, DOI 10.1016/S0014-5793(04)00304-7; Tailor P, 2008, J IMMUNOL, V181, P243, DOI 10.4049/jimmunol.181.1.243; Takeuchi K, 2008, J MOL BIOL, V380, P704, DOI 10.1016/j.jmb.2008.05.037; Teyra J, 2017, STRUCTURE, V25, P1598, DOI 10.1016/j.str.2017.07.017; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yiemwattana I, 2012, CLIN EXP IMMUNOL, V167, P99, DOI 10.1111/j.1365-2249.2011.04494.x; Yuzawa S, 2004, GENES CELLS, V9, P443, DOI 10.1111/j.1356-9597.2004.00733.x	61	9	9	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7849	7864		10.1074/jbc.RA120.012788	http://dx.doi.org/10.1074/jbc.RA120.012788			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32317279	Green Published, hybrid			2022-12-28	WOS:000540935400004
J	Singh, G; Fritz, SE; Seufzer, B; Boris-Lawrie, K				Singh, Gatikrushna; Fritz, Sarah E.; Seufzer, Bradley; Boris-Lawrie, Kathleen			The mRNA encoding the JUND tumor suppressor detains nuclear RNA-binding proteins to assemble polysomes that are unaffected by mTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mammalian target of rapamycin (mTOR); tumor suppressor gene; eukaryotic translation initiation factor 4E (eIF4E); RNA helicase; RNA binding protein; complex 5'-UTR; mTOR; non-canonical cap-binding complex; polyribosome; post-transcriptional control element (PCE)	NONSENSE-MEDIATED DECAY; TRANSLATION INITIATION; FXR1A-ASSOCIATED MICRORNP; HELICASE-A; CAP; GENE; CANCER; HIV-1; EIF4E; CELLS	One long-standing knowledge gap is the role of nuclear proteins in mRNA translation. Nuclear RNA helicase A (DHX9/RHA) is necessary for the translation of the mRNAs of JUND (JunD proto-oncogene AP-1 transcription factor subunit) and HIV-1 genes, and nuclear cap-binding protein 1 (NCBP1)/CBP80 is a component of HIV-1 polysomes. The protein kinase mTOR activates canonical messenger ribonucleoproteins by post-translationally down-regulating the eIF4E inhibitory protein 4E-BP1. We posited here that NCBP1 and DHX9/RHA (RHA) support a translation pathway of JUND RNA that is independent of mTOR. We present evidence from reciprocal immunoprecipitation experiments indicating that NCBP1 and RHA both are components of messenger ribonucleoproteins in several cell types. Moreover, tandem affinity and RT?quantitative PCR results revealed that JUND mRNA is a component of a previously unknown ribonucleoprotein complex. Results from the tandem IP indicated that another component of the JUND-containing ribonucleoprotein complex is NCBP3, a recently identified ortholog of NCBP2/CBP20. We also found that NCBP1, NCBP3, and RHA, but not NCBP2, are components of JUND-containing polysomes. Mutational analysis uncovered two dsRNA-binding domains of RHA that are necessary to tether JUND?NCBP1/NCBP3 to polysomes. We also found that JUND translation is unaffected by inhibition of mTOR, unless RHA was down-regulated by siRNA. These findings uncover a noncanonical cap-binding complex consisting of NCBP1/NCBP3 and RHA substitutes for the eukaryotic translation initiation factors 4E and 4G and activates mTOR-independent translation of the mRNA encoding the tumor suppressor JUND.	[Singh, Gatikrushna; Seufzer, Bradley; Boris-Lawrie, Kathleen] Univ Minnesota, Dept Vet & Biomed Sci, 1971 Commonwealth Ave, St Paul, MN 55108 USA; [Fritz, Sarah E.; Boris-Lawrie, Kathleen] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Fritz, Sarah E.] NIH, Biochem & Biophys Ctr, Bldg 10, Bethesda, MD 20892 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA	Boris-Lawrie, K (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, 1971 Commonwealth Ave, St Paul, MN 55108 USA.	kbl@umn.edu	Fritz, Sarah/AAR-9924-2021	Fritz, Sarah/0000-0001-6318-4319; Boris-Lawrie, Kathleen/0000-0001-6366-6270	National Institutes of Health [P50 NIGMS0103297, T32GM068412, U54AI50470]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants P50 NIGMS0103297, T32GM068412, and U54AI50470. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atsaves V, 2019, CANCERS, V11, DOI 10.3390/cancers11071037; Boeras I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06883-9; Boeras I, 2016, J MOL BIOL, V428, P2418, DOI 10.1016/j.jmb.2016.04.011; Bolinger C, 2007, NUCLEIC ACIDS RES, V35, P2629, DOI 10.1093/nar/gkm124; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; BRADDOCK M, 1994, NUCLEIC ACIDS RES, V22, P5255, DOI 10.1093/nar/22.24.5255; Brady S, 2019, J BIOL CHEM, V294, P11473, DOI 10.1074/jbc.RA119.007679; Bukhari SIA, 2017, RNA BIOL, V14, P137, DOI 10.1080/15476286.2016.1265197; Bukhari SIA, 2016, MOL CELL, V61, P760, DOI 10.1016/j.molcel.2016.02.013; Cao SG, 2017, AM J TRANSL RES, V9, P674; Cheng DD, 2017, ONCOTARGET, V8, P26380, DOI 10.18632/oncotarget.15474; Childs-Disney JL, 2018, CHEM-US, V4, P2384, DOI 10.1016/j.chempr.2018.08.003; Choe J, 2014, P NATL ACAD SCI USA, V111, pE4577, DOI 10.1073/pnas.1409695111; Choe J, 2013, NUCLEIC ACIDS RES, V41, P1307, DOI 10.1093/nar/gks1196; Gebhardt A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008155; Gebhardt A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9192; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Henis-Korenblit S, 2000, MOL CELL BIOL, V20, P496, DOI 10.1128/MCB.20.2.496-506.2000; Hernandez JM, 2008, ONCOGENE, V27, P4757, DOI 10.1038/onc.2008.120; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Jeong SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09086-0; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lee ASY, 2016, NATURE, V536, P96, DOI 10.1038/nature18954; Lee CG, 1999, SOMAT CELL MOLEC GEN, V25, P33, DOI 10.1023/B:SCAM.0000007138.44216.3a; Lee T, 2016, ONCOGENE, V35, P5093, DOI 10.1038/onc.2016.52; Lee T, 2016, ONCOTARGET, V7, P42716, DOI 10.18632/oncotarget.8446; Lewis SM, 2008, NUCLEIC ACIDS RES, V36, P168, DOI 10.1093/nar/gkm1007; Lu SH, 2003, RNA, V9, P618, DOI 10.1261/rna.5260303; Matsumoto K, 1998, EMBO J, V17, P2107, DOI 10.1093/emboj/17.7.2107; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nevins TA, 2003, J BIOL CHEM, V278, P3572, DOI 10.1074/jbc.M206781200; Ng YC, 2018, NUCLEIC ACIDS RES, V46, P9011, DOI 10.1093/nar/gky742; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Nousch M, 2007, RNA, V13, P374, DOI 10.1261/rna.372307; Ranji A, 2011, J BIOL CHEM, V286, P5328, DOI 10.1074/jbc.M110.176339; Roberts TM, 2000, J VIROL, V74, P8111, DOI 10.1128/JVI.74.17.8111-8118.2000; Roberts TM, 2003, J VIROL, V77, P11973, DOI 10.1128/JVI.77.22.11973-11984.2003; Ryu I, 2017, BMB REP, V50, P186, DOI 10.5483/BMBRep.2017.50.4.007; Santulli G, 2013, PHARMACOGENOMICS, V14, P1517, DOI 10.2217/pgs.13.143; Sharma A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002612; Shen BC, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13148; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Short JD, 2002, J BIOL CHEM, V277, P32697, DOI 10.1074/jbc.M204553200; Singh G, 2018, NUCLEIC ACIDS RES, V46, P7366, DOI 10.1093/nar/gky369; Singh G, 2017, JOVE-J VIS EXP, DOI 10.3791/54391; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soto-Rifo R, 2013, NUCLEIC ACIDS RES, V41, P6286, DOI 10.1093/nar/gkt306; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Toro-Ascuy D, 2018, NUCLEIC ACIDS RES, V46, P11539, DOI 10.1093/nar/gky851; Yoffe Y, 2016, GENE DEV, V30, P1991, DOI 10.1101/gad.285239.116	58	8	8	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7763	7773		10.1074/jbc.RA119.012005	http://dx.doi.org/10.1074/jbc.RA119.012005			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32312751	hybrid, Green Published			2022-12-28	WOS:000538038900016
J	Schonfeld, M; Zhao, J; Komatz, A; Weinman, SA; Tikhanovich, I				Schonfeld, Michael; Zhao, Jie; Komatz, Amberly; Weinman, Steven A.; Tikhanovich, Irina			The polymorphism rs975484 in the protein arginine methyltransferase 1 gene modulates expression of immune checkpoint genes in hepatocellular carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; CCAAT-enhancer-binding protein (C; EBP); macrophage; checkpoint control; tumor immunology; PD-L2; programmed cell death 1 ligand 1 (PD-L1); protein arginine methyltransferase 1 (PRMT1); rs975484; SNP	METHYLATION; CANCER; RECRUITMENT; RESPONSES; CARM1; PRMT1	Protein arginine methyltransferase 1 (PRMT1) is a key regulator of hepatic immune responses. Recently, we reported that PRMT1 regulates the tumor immune response in hepatocellular carcinoma (HCC). Here we found that PRMT1 expression in human HCC correlates with that of programmed cell death 1 ligand 1 (PD-L1), PD-L2, and other checkpoint genes. PRMT1 deletion in mice reduced PD-L1 and PD-L2 expression in tumors and reduced the efficiency of PD-1 antibody treatment in a diethylnitrosamine-induced HCC mouse model, suggesting that PRMT1 regulates the hepatic immune checkpoint. Mice had reduced PD-L1 and PD-L2 expression when PRMT1 was specifically deleted in tumor cells or macrophages, but PRMT1 deletion in dendritic cells did not alter PD-L1 and PD-L2 expression. rs975484 is a common polymorphism in the human PRMT1 gene promoter, and we found that it alters PRMT1 expression in blood monocytes and tumor-associated macrophages in human HCC. PRMT1 expression was higher in individuals with a GG genotype than in individuals with a CC genotype, and heterozygous carriers had intermediate expression. Luciferase reporter assays indicated that this differential expression is due to an extra C/EBP?-binding site in the PRMT1 promoter of individuals carrying the minor G allele. The rs975484 genotype also correlated with PRMT1 target expression in HCC. Individuals with the GG genotype had significantly higher levels of the PRMT1 targets PD-L1, PD-L2, and VISTA than those with the CC genotype. We conclude that PRMT1 critically controls immune checkpoints in mice and humans and that the PRMT1 polymorphism rs975484 affects checkpoint gene expression in HCC.	[Schonfeld, Michael; Zhao, Jie; Weinman, Steven A.; Tikhanovich, Irina] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA; [Komatz, Amberly; Weinman, Steven A.] Univ Kansas, Med Ctr, Ctr Liver, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Tikhanovich, I (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA.	itikhanovich@kumc.edu	Tikhanovich, Irina/GOK-0267-2022		National Institute on Alcoholism and Alcohol Abuse [AA027586]; American Association for the Study of Liver Diseases	National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Association for the Study of Liver Diseases	This study was supported by grant AA027586 from the National Institute on Alcoholism and Alcohol Abuse and the 2016 Pinnacle Award from the American Association for the Study of Liver Diseases. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11; An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Chittka A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013807; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Gao YH, 2018, CANCER IMMUNOL RES, V6, P1352, DOI 10.1158/2326-6066.CIR-18-0108; Hassa PO, 2008, J MOL BIOL, V377, P668, DOI 10.1016/j.jmb.2008.01.044; He L, 2002, J BIOL CHEM, V277, P43572, DOI 10.1074/jbc.M204535200; Lee KH, 2016, RENAL FAILURE, V38, P228, DOI 10.3109/0886022X.2015.1120096; Li Z, 2016, CELL DEATH DIFFER, V23, P583, DOI 10.1038/cdd.2015.125; Lin H, 2018, J CLIN INVEST, V128, P1708, DOI 10.1172/JCI120803; McPeak MB, 2017, J LEUKOCYTE BIOL, V102, P191, DOI 10.1189/jlb.4HI1216-537R; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Siu EHL, 2018, TRANSL GASTROENT HEP, V3, DOI 10.21037/tgh.2018.10.16; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tikhanovich I, 2017, J BIOL CHEM, V292, P13333, DOI 10.1074/jbc.M117.797928; Tikhanovich I, 2017, J BIOL CHEM, V292, P6882, DOI 10.1074/jbc.M117.778761; Tikhanovich I, 2015, HEPATOLOGY, V62, p846A; Tikhanovich I, 2015, J BIOL CHEM, V290, P22236, DOI 10.1074/jbc.M115.653543; Yang YZ, 2014, MOL CELL, V53, P484, DOI 10.1016/j.molcel.2014.01.011; Yi M, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0864-3; Yin ZY, 2020, CANCER LETT, V470, P8, DOI 10.1016/j.canlet.2019.12.002; Zhao Jie, 2019, Gene Expression, V19, P137, DOI 10.3727/105221618X15372014086197; Zhao J, 2018, HEPATOLOGY, V67, P1109, DOI 10.1002/hep.29587	28	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7126	7137		10.1074/jbc.RA120.013401	http://dx.doi.org/10.1074/jbc.RA120.013401			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32245889	hybrid, Green Published			2022-12-28	WOS:000536212600027
J	Pan, YL; Xiao, YC; Pei, ZF; Cummins, TR				Pan, Yanling; Xiao, Yucheng; Pei, Zifan; Cummins, Theodore R.			S-Palmitoylation of the sodium channel Nav1.6 regulates its activity and neuronal excitability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						sodium channel; patch clamp; protein palmitoylation; post-translational modification (PTM); neurophysiology; dorsal root ganglia; Nav1; 6; neurological disorder; neuronal excitability	AXON INITIAL SEGMENTS; PROTEIN PALMITOYLATION; POSTTRANSLATIONAL MODIFICATION; PURKINJE NEURONS; NA(V)1.6; CURRENTS; IDENTIFICATION; EXPRESSION; RECOGNITION; SUBUNIT	S-Palmitoylation is a reversible post-translational lipid modification that dynamically regulates protein functions. Voltage-gated sodium channels are subjected to S-palmitoylation and exhibit altered functions in different S-palmitoylation states. Our aim was to investigate whether and how S-palmitoylation regulates Nav1.6 channel function and to identify S-palmitoylation sites that can potentially be pharmacologically targeted. Acyl-biotin exchange assay showed that Nav1.6 is modified by S-palmitoylation in the mouse brain and in a Nav1.6 stable HEK 293 cell line. Using whole-cell voltage clamp, we discovered that enhancing S-palmitoylation with palmitic acid increases Nav1.6 current, whereas blocking S-palmitoylation with 2-bromopalmitate reduces Nav1.6 current and shifts the steady-state inactivation in the hyperpolarizing direction. Three S-palmitoylation sites (Cys(1169), Cys(1170), and Cys(1978)) were identified. These sites differentially modulate distinct Nav1.6 properties. Interestingly, Cys(1978) is exclusive to Nav1.6 among all Nav isoforms and is evolutionally conserved in Nav1.6 among most species. Cys(1978) S-palmitoylation regulates current amplitude uniquely in Nav1.6. Furthermore, we showed that eliminating S-palmitoylation at specific sites alters Nav1.6-mediated excitability in dorsal root ganglion neurons. Therefore, our study reveals S-palmitoylation as a potential isoform-specific mechanism to modulate Nav activity and neuronal excitability in physiological and diseased conditions.	[Pan, Yanling; Cummins, Theodore R.] Indiana Univ Sch Med, Program Med Neurosci, Paul & Carole Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Pei, Zifan; Cummins, Theodore R.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Xiao, Yucheng; Cummins, Theodore R.] Indiana Univ Purdue Univ, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Cummins, TR (corresponding author), Indiana Univ Purdue Univ, Sch Sci, Dept Biol, Indianapolis, IN 46202 USA.	trcummin@iu.edu		Pan, Yanling/0000-0002-0915-2639	NINDS, National Institutes of Health [NS053422]	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NINDS, National Institutes of Health Grant NS053422 (to T. R. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bagal SK, 2015, CHANNELS, V9, P360, DOI 10.1080/19336950.2015.1079674; Barbosa C, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0063-9; Bosmans F, 2011, P NATL ACAD SCI USA, V108, P20213, DOI 10.1073/pnas.1108497108; Brigidi GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9200; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chen LB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22216-w; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Cummins T R, 2000, Prog Brain Res, V129, P3; Cummins TR, 2009, NAT PROTOC, V4, P1103, DOI 10.1038/nprot.2009.91; Do MTH, 2004, J NEUROPHYSIOL, V92, P726, DOI 10.1152/jn.00186.2004; Enomoto A, 2007, J NEUROPHYSIOL, V98, P710, DOI 10.1152/jn.00292.2007; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fredericks GJ, 2014, P NATL ACAD SCI USA, V111, P16478, DOI 10.1073/pnas.1417176111; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gasser A, 2012, J NEUROSCI, V32, P7232, DOI 10.1523/JNEUROSCI.5434-11.2012; Globa AK, 2017, CURR OPIN NEUROBIOL, V45, P210, DOI 10.1016/j.conb.2017.02.016; Gorleku OA, 2011, J BIOL CHEM, V286, P39573, DOI 10.1074/jbc.M111.272369; Greaves J, 2011, MOL BIOL CELL, V22, P1887, DOI 10.1091/mbc.E10-11-0924; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Herzog RI, 2003, J NEUROSCI, V23, P8261; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Howie J, 2014, P NATL ACAD SCI USA, V111, P17534, DOI 10.1073/pnas.1413627111; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Itoh Masayuki, 2019, Neuropsychopharmacology Reports, V39, P61, DOI 10.1002/npr2.12044; Itoh M, 2018, J NEUROSCI, V38, P10220, DOI 10.1523/JNEUROSCI.1590-18.2018; Jarecki BW, 2010, J CLIN INVEST, V120, P369, DOI 10.1172/JCI40801; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Khaliq ZM, 2003, J NEUROSCI, V23, P4899, DOI 10.1523/jneurosci.23-12-04899.2003; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lemonidis K, 2015, J BIOL CHEM, V290, P21939, DOI 10.1074/jbc.M115.657668; Li Y, 2010, J BIOL CHEM, V285, P13022, DOI 10.1074/jbc.M109.079426; Lievens PMJ, 2016, MOL CELL BIOL, V36, P2208, DOI 10.1128/MCB.00144-16; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; Mercer JN, 2007, J NEUROSCI, V27, P13552, DOI 10.1523/JNEUROSCI.3430-07.2007; Mill P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000748; Nadolski MJ, 2009, J BIOL CHEM, V284, P17720, DOI 10.1074/jbc.M109.005447; Naumenko VS, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/5701348; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Osorio N, 2010, J PHYSIOL-LONDON, V588, P651, DOI 10.1113/jphysiol.2010.183798; Pan XJ, 2019, SCIENCE, V363, P1309, DOI 10.1126/science.aaw2999; Pan YL, 2020, J PHYSIOL-LONDON, V598, P381, DOI 10.1113/JP278952; Pankow S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aan7984; Pei ZF, 2018, HANDB EXP PHARMACOL, V246, P101, DOI 10.1007/164_2017_69; Pei ZF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12035; Plain F, 2017, J BIOL CHEM, V292, P10745, DOI 10.1074/jbc.M116.773945; Ponimaskin E, 2008, J NEUROSCI, V28, P8897, DOI 10.1523/JNEUROSCI.2171-08.2008; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rogers M, 2016, ASSAY DRUG DEV TECHN, V14, P109, DOI 10.1089/adt.2016.704; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493; Shipston MJ, 2014, J GEN PHYSIOL, V143, P659, DOI 10.1085/jgp.201411176; Smith MR, 1998, J NEUROSCI, V18, P6093; Summers DW, 2018, P NATL ACAD SCI USA, V115, pE8746, DOI 10.1073/pnas.1806933115; Thomas GM, 2012, NEURON, V73, P482, DOI 10.1016/j.neuron.2011.11.021; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Van Wart A, 2006, J NEUROSCI, V26, P7172, DOI 10.1523/JNEUROSCI.1101-06.2006; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Woolfrey KM, 2018, J BIOL CHEM, V293, P1551, DOI 10.1074/jbc.M117.813808	68	6	6	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6151	6164		10.1074/jbc.RA119.012423	http://dx.doi.org/10.1074/jbc.RA119.012423			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32161114	Green Published, hybrid			2022-12-28	WOS:000531417300024
J	Abbadi, A; Loftis, J; Wang, AM; Yu, MJ; Wang, Y; Shakya, S; Li, XX; Maytin, E; Hascall, V				Abbadi, Amina; Loftis, Jacqueline; Wang Aimin; Yu Minjia; Wang Yan; Shakya, Sajina; Li Xiaoxia; Maytin, Edward; Hascall, Vincent			Heparin inhibits proinflammatory and promotes anti-inflammatory macrophage polarization under hyperglycemic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; monocyte; hyaluronan; inflammation; heparin	ALTERNATIVE ACTIVATION; ENDOPLASMIC-RETICULUM; HYALURONAN STRUCTURES; MESANGIAL CELLS; MONOCYTE; EXPRESSION; MECHANISM; ADHESIVE; MATRIX	Monocytes are rapidly recruited to sites of diabetic complications and differentiate into macrophages. Previously, we showed that rat kidney mesangial cells dividing during hyperglycemic stress abnormally synthesize hyaluronan (HA) in intracellular compartments. This initiates a stress response, resulting in an extracellular HA matrix after division that recruits inflammatory cells. Cell?cell communication among macrophages that are recruited into the glomeruli and the damaged rat mesangial cells leads to diabetic nephropathy, fibrosis, and proteinurea, which are inhibited in heparin-treated diabetic rats. In this study, we found that murine bone marrow?derived macrophages (BMDMs) and a human leukemic cell line, U937 cells, dividing in hyperglycemia also accumulate intracellular HA and that heparin inhibits the HA accumulation. Both cell types expressed increased levels of proinflammatory markers: inducible nitric-oxide synthase and tumor necrosis factor-?, when cultured under hyperglycemic stress, which was inhibited by heparin. Furthermore, the abnormal intracellular HA was also observed in peripheral blood monocytes derived from three different hyperglycemic diabetic mouse models: streptozotocin-treated, high-fat fed, and Ins2Akita. Moreover, peripheral blood monocytes in humans with type 2 diabetes and poorly controlled blood glucose levels (hemoglobin A1c (HbA1c) levels of >7) also had intracellular HA, whereas those with HbA1c of <7, did not. Of note, heparin increased the anti-inflammatory markers arginase 1 and interleukin-10 in murine BMDMs. We conclude that heparin treatment of high glucose?exposed dividing BMDMs promotes an anti-inflammatory tissue-repair phenotype in these cells.	[Abbadi, Amina; Loftis, Jacqueline; Wang Aimin; Wang Yan; Shakya, Sajina; Maytin, Edward; Hascall, Vincent] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Yu Minjia; Li Xiaoxia] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA; [Yu Minjia] Harvard Med Sch, Mt Auburn Hosp, Cambridge, MA 02472 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Mount Auburn Hospital	Hascall, V (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA.	hascalv@ccf.org		Shakya, Sajina/0000-0002-9400-4250	NHLBI, National Institutes of Health [P01HL107147, 1K12HL141952]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grants P01HL107147 and 1K12HL141952 from the NHLBI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Cipolletta C, 2005, DIABETES, V54, P2779, DOI 10.2337/diabetes.54.9.2779; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Eguchi J, 2013, DIABETES, V62, P3394, DOI 10.2337/db12-1327; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P821, DOI 10.1016/j.imbio.2010.05.031; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gerhardt T, 2015, CARDIOVASC RES, V107, P321, DOI 10.1093/cvr/cvv147; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liu LP, 2004, ATHEROSCLEROSIS, V175, P39, DOI 10.1016/j.atherosclerosis.2004.01.044; Mathews CE, 2002, TRANSPLANTATION, V73, P1333, DOI 10.1097/00007890-200204270-00024; Mills CD, 2001, CRIT REV IMMUNOL, V21, P399, DOI 10.1615/critrevimmunol.v21.i5.10; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Parsa R, 2012, DIABETES, V61, P2881, DOI 10.2337/db11-1635; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; Sica A, 2015, CELL MOL LIFE SCI, V72, P4111, DOI 10.1007/s00018-015-1995-y; Stempin CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/683485; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Szablewski L, 2017, BIOL CHEM, V398, P411, DOI 10.1515/hsz-2016-0196; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Wang AM, 2014, J BIOL CHEM, V289, P11410, DOI 10.1074/jbc.M113.541458; Wang AM, 2014, J BIOL CHEM, V289, P9418, DOI 10.1074/jbc.M113.541441; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	38	8	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4849	4857		10.1074/jbc.RA119.012419	http://dx.doi.org/10.1074/jbc.RA119.012419			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32107314	hybrid, Green Published			2022-12-28	WOS:000526887000009
J	Sander, M; Wu, ZD; Strasburger, CJ				Sander, Max; Wu Zida; Strasburger, Christian J.			Short stature explained by dimerization of human growth hormone induced by a p.C53S point mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						growth hormone; disulfide; dimerization; pituitary gland; protein folding; c; 705G>C; cysteine; GH-C53S; growth hormone deficiency	FULL-LENGTH RECEPTOR; DISULFIDE BONDS; ENDOPLASMIC-RETICULUM; EXTRACELLULAR DOMAIN; PITUITARY; PROLACTIN; SERUM; HGH; GH; ACTIVATION	A homozygous mutation in growth hormone 1 (GH1) was recently identified in an individual with growth failure. This mutation, c.705G>C, causes replacement of cysteine at position 53 of the 191-amino-acid sequence of 22 kDa human GH (hGH) with serine (p.C53S). This hGH molecule (hereafter referred to as GH-C53S) lacks the disulfide bond between p.Cys-53 and p.Cys-165, which is highly conserved among species. It has been reported previously that monomeric GH-C53S has reduced bioactivity compared with WT GH (GH-WT) because of its decreased ability to bind and activate the GH receptor in vitro. In this study, we discovered that substitution of p.Cys-53 in hGH significantly increased formation of hGH dimers in pituitary cells. We expressed His-tagged hGH variants in the cytoplasm of genetically modified Rosetta-gami B DE3 Escherichia coli cells, facilitating high-yield production. We observed that the bioactivity of monomeric GH-C53S is 25.2% of that of GH-WT and that dimeric GH-C53S?His has no significant bioactivity in cell proliferation assays. We also found that the expression of GH-C53S in pituitary cells deviates from that of GH-WT. GH-C53S was exclusively stained in the Golgi apparatus, and no secretory granules formed for this variant, impairing its stimulated release. In summary, the unpaired Cys-165 in GH-C53S forms a disulfide bond linking two hGH molecules in pituitary cells. We conclude that the GH-C53S dimer is inactive and responsible for the growth failure in the affected individual.	[Sander, Max; Wu Zida; Strasburger, Christian J.] Univ Med Berlin, Dept Endocrinol Diabet & Nutr Med, Campus Charite Mitte,Charitepl 1, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sander, M (corresponding author), Charite Univ Med Berlin, Dept Endocrinol Diabet & Nutr Med, Sauerbruchweg 5, D-10117 Berlin, Germany.	max.sander@charite.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a research fellowship of the Deutsche Forschungsgemeinschaft-funded Graduate College 1208 "Hormonal Regulation of Energy Metabolism, Body Weight, and Growth" (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abkevich VI, 2000, J MOL BIOL, V300, P975, DOI 10.1006/jmbi.2000.3893; Anderson LL, 2012, EXP BIOL MED, V237, P126, DOI 10.1258/ebm.2011.011306; Ariyasu D, 2013, ENDOCRINOLOGY, V154, P3228, DOI 10.1210/en.2013-1249; BANCROFT FC, 1973, ENDOCRINOLOGY, V92, P1014, DOI 10.1210/endo-92-4-1014; BANCROFT FC, 1973, EXP CELL RES, V79, P275, DOI 10.1016/0014-4827(73)90445-X; BAUMANN G, 1986, ENDOCRINOLOGY, V119, P1497, DOI 10.1210/endo-119-4-1497; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Besson A, 2005, J CLIN ENDOCR METAB, V90, P2493, DOI 10.1210/jc.2004-1838; BEWLEY TA, 1969, BIOCHEMISTRY-US, V8, P4701, DOI 10.1021/bi00840a007; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Bustamante JJ, 2009, PROTEOMICS, V9, P3474, DOI 10.1002/pmic.200800989; CHEN XZ, 1992, MOL ENDOCRINOL, V6, P598, DOI 10.1210/me.6.4.598; CUNNINGHAM BC, 1991, SCIENCE, V253, P545, DOI 10.1126/science.1907025; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dannies PS, 2002, MOL GENET METAB, V76, P6, DOI 10.1016/S1096-7192(02)00011-2; DATTANI MT, 1995, J CLIN ENDOCR METAB, V80, P2675, DOI 10.1210/jc.80.9.2675; DEFELIPPIS MR, 1993, BIOCHEMISTRY-US, V32, P1555, DOI 10.1021/bi00057a021; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DIXON JS, 1966, SCIENCE, V154, P785, DOI 10.1126/science.154.3750.785; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Forsyth IA, 2002, J MAMMARY GLAND BIOL, V7, P291, DOI 10.1023/A:1022804817104; Gertler A, 1996, J BIOL CHEM, V271, P24482, DOI 10.1074/jbc.271.40.24482; GRAF L, 1976, FEBS LETT, V66, P233, DOI 10.1016/0014-5793(76)80511-X; Haro LS, 1996, BIOCHEM BIOPH RES CO, V228, P549, DOI 10.1006/bbrc.1996.1697; Jensen MR, 2008, PROTEINS, V73, P161, DOI 10.1002/prot.22039; KOPCHICK JJ, 1990, J REPROD FERTIL, P25; KOWARSKI AA, 1978, J CLIN ENDOCR METAB, V47, P461, DOI 10.1210/jcem-47-2-461; LEWIS UJ, 1977, J BIOL CHEM, V252, P3697; MOORE HPH, 1985, J CELL BIOL, V101, P1773, DOI 10.1083/jcb.101.5.1773; NECESSARY PC, 1985, MOL CELL ENDOCRINOL, V39, P247, DOI 10.1016/0303-7207(85)90068-1; NIALL HD, 1971, P NATL ACAD SCI USA, V68, P866, DOI 10.1073/pnas.68.4.866; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; Petkovic V, 2012, ENDOCR DEV, V23, P96, DOI 10.1159/000341763; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Ross RJM, 1997, MOL ENDOCRINOL, V11, P265, DOI 10.1210/me.11.3.265; Rowland JE, 2002, CLIN ENDOCRINOL, V56, P475, DOI 10.1046/j.1365-2265.2002.01507.x; Rowlinson SW, 1998, J BIOL CHEM, V273, P5307, DOI 10.1074/jbc.273.9.5307; Sockolosky JT, 2013, PROTEIN EXPRES PURIF, V87, P129, DOI 10.1016/j.pep.2012.11.002; St-Amand Jonny, 2011, Front Endocrinol (Lausanne), V2, P111, DOI 10.3389/fendo.2011.00111; Strasburger CJ, 1996, J CLIN ENDOCR METAB, V81, P2613, DOI 10.1210/jc.81.7.2613; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Walsh STR, 2003, PROTEIN SCI, V12, P1960, DOI 10.1110/ps.03133903; Wang JH, 2005, HUM GENE THER, V16, P571, DOI 10.1089/hum.2005.16.571; Waters Michael J, 2014, JAKSTAT, V3, pe29569, DOI 10.4161/jkst.29569; Woycechowsky KJ, 2000, CURR OPIN CHEM BIOL, V4, P533, DOI 10.1016/S1367-5931(00)00128-9; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200	47	2	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4893	4901		10.1074/jbc.RA119.009101	http://dx.doi.org/10.1074/jbc.RA119.009101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32132170	Green Published, hybrid			2022-12-28	WOS:000526887000013
J	Chin, HG; Esteve, PO; Ruse, C; Lee, J; Schaus, SE; Pradhan, S; Hansen, U				Chin, Hang Gyeong; Esteve, Pierre-Olivier; Ruse, Cristian; Lee, Jiyoung; Schaus, Scott E.; Pradhan, Sriharsa; Hansen, Ulla			The microtubule-associated histone methyltransferase SET8, facilitated by transcription factor LSF, methylates ?-tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tubulin; posttranslational modification (PTM); protein methylation; cytoskeleton; cancer; lysine methyltransferase 5A (KMT5A); mammalian cells; SET8; transcription factor CP2 (TFCP2); transcription factor LSF	LATE SV40 FACTOR; SMALL-MOLECULE INHIBITORS; POSTTRANSLATIONAL MODIFICATIONS; GENE-EXPRESSION; CELL-CYCLE; C-MYC; PR-SET7; H4; DNA; RESISTANCE	Microtubules are cytoskeletal structures critical for mitosis, cell motility, and protein and organelle transport and are a validated target for anticancer drugs. However, how tubulins are regulated and recruited to support these distinct cellular processes is incompletely understood. Posttranslational modifications of tubulins are proposed to regulate microtubule function and dynamics. Although many of these modifications have been investigated, only one prior study reports tubulin methylation and an enzyme responsible for this methylation. Here we used in vitro radiolabeling, MS, and immunoblotting approaches to monitor protein methylation and immunoprecipitation, immunofluorescence, and pulldown approaches to measure protein?protein interactions. We demonstrate that N-lysine methyltransferase 5A (KMT5A or SET8/PR-Set7), which methylates lysine 20 in histone H4, bound ?-tubulin and methylated it at a specific lysine residue, Lys(311). Furthermore, late SV40 factor (LSF)/CP2, a known transcription factor, bound both ?-tubulin and SET8 and enhanced SET8-mediated ?-tubulin methylation in vitro. In addition, we found that the ability of LSF to facilitate this methylation is countered by factor quinolinone inhibitor 1 (FQI1), a specific small-molecule inhibitor of LSF. These findings suggest the general model that microtubule-associated proteins, including transcription factors, recruit or stimulate protein-modifying enzymes to target tubulins. Moreover, our results point to dual functions for SET8 and LSF not only in chromatin regulation but also in cytoskeletal modification.	[Chin, Hang Gyeong; Esteve, Pierre-Olivier; Ruse, Cristian; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA; [Chin, Hang Gyeong; Hansen, Ulla] Boston Univ, Grad Sch Arts & Sci, MCBB Grad Program, Boston, MA 02215 USA; [Schaus, Scott E.] Boston Univ, Ctr Mol Discovery, Boston, MA 02215 USA; [Hansen, Ulla] Boston Univ, Dept Biol, 5 Cummington Mall, Boston, MA 02215 USA; [Lee, Jiyoung] Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Jeongeup Si 56212, Jeollabuk Do, South Korea	New England Biolabs; Boston University; Boston University; Boston University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Hansen, U (corresponding author), Boston Univ, Dept Biol, 5 Cummington Mall, Boston, MA 02215 USA.	uhansen@bu.edu		Hansen, Ulla/0000-0001-9803-4185	New England Biolabs, Inc.; National Institutes of Health [R01 GM078240, R24 GM111625]; Boston University; Johnson & Johnson Clinical Innovation Award through Boston University	New England Biolabs, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University; Johnson & Johnson Clinical Innovation Award through Boston University	Supported by New England Biolabs, Inc.; Supported by National Institutes of Health Grants R01 GM078240 and R24 GM111625.; Supported by Ignition Awards from Boston University and a Johnson & Johnson Clinical Innovation Award through Boston University.	Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; ALEXANDROVA N, 1995, MOL CELL BIOL, V15, P5188; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chen XY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1541-1; Chin HG, 2016, ONCOTARGET, V7, P83627, DOI 10.18632/oncotarget.13271; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fan RH, 2011, WORLD J GASTROENTERO, V17, P3420, DOI 10.3748/wjg.v17.i29.3420; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Grant TJ, 2012, P NATL ACAD SCI USA, V109, P4503, DOI 10.1073/pnas.1121601109; Gu YJ, 2015, ONCOTARGET, V6, P33658, DOI 10.18632/oncotarget.5603; Hansen U, 2009, CELL CYCLE, V8, P2146, DOI 10.4161/cc.8.14.9089; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2017, CURR BIOL, V27, pR1287, DOI 10.1016/j.cub.2017.10.044; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kim JS, 2017, ONCOTARGET, V8, P24389, DOI 10.18632/oncotarget.15462; Komlodi-Pasztor E, 2012, CLIN CANCER RES, V18, P51, DOI 10.1158/1078-0432.CCR-11-0999; Kotarba G, 2018, CANCER LETT, V420, P72, DOI 10.1016/j.canlet.2018.01.078; Laursen Lucas, 2014, Nature, V516, pS2, DOI 10.1038/516S2a; Lee J, 2010, MOL CELL, V40, P345, DOI 10.1016/j.molcel.2010.10.033; Lu CH, 2013, DIGEST DIS SCI, V58, P2713, DOI 10.1007/s10620-013-2692-z; MAXWELL SA, 1991, CELL GROWTH DIFFER, V2, P115; McKay DJ, 2015, DEV CELL, V32, P373, DOI 10.1016/j.devcel.2014.12.025; Milite C, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0268-4; Niklinski J, 2000, MOL CELL BIOL, V20, P5276, DOI 10.1128/MCB.20.14.5276-5284.2000; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Park IY, 2016, CELL, V166, P950, DOI 10.1016/j.cell.2016.07.005; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Powell CMH, 2000, EMBO J, V19, P4665, DOI 10.1093/emboj/19.17.4665; Rajasekaran D, 2015, ONCOTARGET, V6, P26266, DOI 10.18632/oncotarget.4656; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Sakaguchi A, 2007, J CELL BIOL, V176, P155, DOI 10.1083/jcb.200607178; Seol HS, 2016, CANCER LETT, V372, P24, DOI 10.1016/j.canlet.2015.12.005; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Song YY, 2015, TRENDS CELL BIOL, V25, P125, DOI 10.1016/j.tcb.2014.10.004; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Takawa M, 2012, CANCER RES, V72, P3217, DOI 10.1158/0008-5472.CAN-11-3701; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Willoughby J. L. S., 2019, LSF SMALL MOL INHIBI, DOI [10.1101/665570, DOI 10.1101/665570]; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Wu SM, 2011, CELL CYCLE, V10, P68, DOI 10.4161/cc.10.1.14363; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Xu ZJ, 2017, SCIENCE, V356, P328, DOI 10.1126/science.aai8764; Yin Y, 2008, CELL CYCLE, V7, P1423, DOI 10.4161/cc.7.10.5867; Yoo BK, 2010, P NATL ACAD SCI USA, V107, P8357, DOI 10.1073/pnas.1000374107; Zhang HF, 2019, NUCLEIC ACIDS RES, V47, P9053, DOI 10.1093/nar/gkz626; Zhang X, 2017, CELL REP, V21, P1227, DOI 10.1016/j.celrep.2017.10.017; Ziegelbauer J, 2001, MOL CELL, V8, P339, DOI 10.1016/S1097-2765(01)00313-6	65	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4748	4759		10.1074/jbc.RA119.010951	http://dx.doi.org/10.1074/jbc.RA119.010951			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32111740	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000524499700031
J	Kierzek, E; Kierzek, R				Kierzek, Elzbieta; Kierzek, Ryszard			Conscious uncoupling of riboswitch functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Riboswitches alter gene expression in response to ligand binding, coupling sensing and regulatory functions to help bacteria respond to their environment. The structural determinants of ligand binding in the prequeuosine (7-aminomethyl-7-deazaguanine, preQ(1)) bacterial riboswitches have been studied, but the functional consequences of structural perturbations are less known. A new article combining biophysical and cell-based readouts of 15 mutants of the preQ(1)-II riboswitch from Lactobacillus rhamnosus demonstrates that ligand binding does not ensure successful gene regulation, providing new insights into these shapeshifting sequences.	[Kierzek, Elzbieta; Kierzek, Ryszard] Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland	Polish Academy of Sciences	Kierzek, R (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	rkierzek@ibch.poznan.pl		Kierzek, Ryszard/0000-0002-7644-0016; Kierzek, Elzbieta/0000-0002-5563-003X				Batey RT, 2012, Q REV BIOPHYS, V45, P345, DOI 10.1017/S0033583512000078; Deigan KE, 2011, ACCOUNTS CHEM RES, V44, P1329, DOI 10.1021/ar200039b; Dutta D, 2020, J BIOL CHEM, V295, P2555, DOI 10.1074/jbc.RA119.010755; Eichhorn CD, 2014, BBA-GENE REGUL MECH, V1839, P939, DOI 10.1016/j.bbagrm.2014.04.019; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Kang MJ, 2014, P NATL ACAD SCI USA, V111, pE663, DOI 10.1073/pnas.1400126111; Liberman JA, 2013, NAT CHEM BIOL, V9, P353, DOI 10.1038/nchembio.1231	7	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2568	2569		10.1074/jbc.H120.012787	http://dx.doi.org/10.1074/jbc.H120.012787			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	32111719	hybrid, Green Published			2022-12-28	WOS:000519969100003
J	Lockhart, DEA; Stanley, M; Raimi, OG; Robinson, DA; Boldovjakova, D; Squair, DR; Ferenbach, AT; Fang, WX; van Aalten, DMF				Lockhart, Deborah E. A.; Stanley, Mathew; Raimi, Olawale G.; Robinson, David A.; Boldovjakova, Dominika; Squair, Daniel R.; Ferenbach, Andrew T.; Fang, Wenxia; van Aalten, Daan M. F.			Targeting a critical step in fungal hexosamine biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fungi; cell wall; protein-protein interaction; X-ray crystallography; virulence factor; chitin; antifungal drug development; fragment; glucosamine 6-phosphate N-acetyltransferase (Gna1); resistance; Aspergillus fumigatus	INFECTIOUS-DISEASES SOCIETY; GALLERIA-MELLONELLA LARVAE; ASPERGILLUS-FUMIGATUS; CELL-WALL; STRUCTURAL VALIDATION; PRACTICE GUIDELINES; STRESS-RESPONSE; MURINE MODEL; NIKKOMYCIN-Z; INHIBITORS	Aspergillus fumigatusis a human opportunistic fungal pathogen whose cell wall protects it from the extracellular environment including host defenses. Chitin, an essential component of the fungal cell wall, is synthesized from UDP-GlcNAc produced in the hexosamine biosynthetic pathway. As this pathway is critical for fungal cell wall integrity, the hexosamine biosynthesis enzymes represent potential targets of antifungal drugs. Here, we provide genetic and chemical evidence that glucosamine 6-phosphateN-acetyltransferase (Gna1), a key enzyme in this pathway, is an exploitable antifungal drug target.GNA1deletion resulted in loss of fungal viability and disruption of the cell wall, phenotypes that could be rescued by exogenous GlcNAc, the product of the Gna1 enzyme. In a murine model of aspergillosis, the ?gna1mutant strain exhibited attenuated virulence. Using a fragment-based approach, we discovered a small heterocyclic scaffold that binds proximal to the Gna1 active site and can be optimized to a selective submicromolar binder. Taken together, we have provided genetic, structural, and chemical evidence that Gna1 is an antifungal target inA. fumigatus.	[Lockhart, Deborah E. A.; Stanley, Mathew; Raimi, Olawale G.; Squair, Daniel R.; Ferenbach, Andrew T.; Fang, Wenxia; van Aalten, Daan M. F.] Univ Dundee, Sch Life Sci, Dundee, Scotland; [Lockhart, Deborah E. A.; Boldovjakova, Dominika] Univ Aberdeen, Inst Med Sci, Foresterhill, Aberdeen, Scotland; [Robinson, David A.] Univ Dundee, Sch Life Sci, Wellcome Ctr Antiinfect Res, Drug Discovery Unit, Dundee, Scotland	University of Dundee; University of Aberdeen; University of Dundee	Lockhart, DEA; van Aalten, DMF (corresponding author), Univ Dundee, Sch Life Sci, Dundee, Scotland.; Lockhart, DEA (corresponding author), Univ Aberdeen, Inst Med Sci, Foresterhill, Aberdeen, Scotland.	deborah.lockhart@abdn.ac.uk; dmfvanaalten@dundee.ac.uk		Robinson, David/0000-0003-1979-5918; Fang, Wenxia/0000-0001-8055-2072; van Aalten, Daan/0000-0002-1499-6908; Ferenbach, Andrew/0000-0002-1562-7987; Raimi, Olawale G./0000-0003-2782-7318	Wellcome Trust [WT105772/A/14/Z, WT105772/Z/14/Z]; MRC Programme Grant [MR/M004139/1]; University of Aberdeen; MRC [MR/M004139/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Aberdeen; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust Postdoctoral Research Training Fellowship for Clinicians WT105772/A/14/Z and WT105772/Z/14/Z (to D. L.) and MRC Programme Grant MR/M004139/1 (to D. M. F. v. A). This work was also supported by a University of Aberdeen Summer Research Scholarship (to D. B).	Agarwal R, 2013, CLIN EXP ALLERGY, V43, P850, DOI 10.1111/cea.12141; Allen D, 2015, EXPERT REV ANTI-INFE, V13, P787, DOI 10.1586/14787210.2015.1032939; Becker JM, 2010, P NATL ACAD SCI USA, V107, P22044, DOI 10.1073/pnas.1009845107; Boehmelt G, 2000, EMBO J, V19, P5092, DOI 10.1093/emboj/19.19.5092; Boehmelt G, 2000, J BIOL CHEM, V275, P12821, DOI 10.1074/jbc.275.17.12821; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Buil JB, 2018, J ANTIMICROB CHEMOTH, V73, P134, DOI [10.1093/jac/dkx354, 10.1093/jac/dkx425]; Campitelli Marco, 2017, J Clin Med Res, V9, P451, DOI 10.14740/jocmr2992w; Cardinale D, 2010, CURR MED CHEM, V17, P826, DOI 10.2174/092986710790712156; Centers for Disease Control and Prevention, 2019, ICML; Chowdhary A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003633; Cova M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22441-3; Da Silva F, 2019, J MED CHEM, V62, P9732, DOI 10.1021/acs.jmedchem.9b01184; dEnfert C, 1996, CURR GENET, V30, P76, DOI 10.1007/s002940050103; DEnfert C, 1996, INFECT IMMUN, V64, P4401, DOI 10.1128/IAI.64.10.4401-4405.1996; Denning DW, 2013, MYCOSES, V56, P13; Drwal MN, 2018, J MED CHEM, V61, P5963, DOI 10.1021/acs.jmedchem.8b00256; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109; Falci Diego R, 2013, Infect Drug Resist, V6, P163, DOI 10.2147/IDR.S51340; Fallon JP, 2011, VIRULENCE, V2, P413, DOI 10.4161/viru.2.5.17811; Fang WX, 2013, BIOSCIENCE REP, V33, P689, DOI 10.1042/BSR20130053; Fang WX, 2013, MOL MICROBIOL, V89, P479, DOI 10.1111/mmi.12290; Feher VA, 1996, NAT STRUCT BIOL, V3, P516, DOI 10.1038/nsb0696-516; Fisher MC, 2018, SCIENCE, V360, P739, DOI 10.1126/science.aap7999; Gao CD, 2014, SCI REP-UK, V4, DOI 10.1038/srep04712; Gao F, 2006, J MED CHEM, V49, P5273, DOI 10.1021/jm060732n; Gastebois A, 2009, FUTURE MICROBIOL, V4, P583, DOI 10.2217/FMB.09.29; GAUGHRAN JP, 1994, J BACTERIOL, V176, P5857, DOI 10.1128/JB.176.18.5857-5860.1994; Golus J, 2016, J APPL MICROBIOL, V121, P1291, DOI 10.1111/jam.13253; Haiduven D, 2009, MED MYCOL, V47, pS210, DOI 10.1080/13693780802247694; Hamill R, 2013, DRUGS, V73, P919, DOI 10.1007/s40265-013-0069-4; Head MG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004129; Holt SL, 2011, AM J HEALTH-SYST PH, V68, P1207, DOI 10.2146/ajhp100456; Hu WQ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030024; Huang MY, 2019, EUR J MED CHEM, V178, P259, DOI 10.1016/j.ejmech.2019.05.078; Hurtado-Guerrero R., 2008, STRUCTURAL COMP ASPE; Hurtado-Guerrero R., 2009, AFGNA1 CRYSTAL STRUC; Hurtado-Guerrero R, 2008, BIOCHEM J, V415, P217, DOI 10.1042/BJ20081000; Hurtado-Guerrero R, 2007, FEBS LETT, V581, P5597, DOI 10.1016/j.febslet.2007.10.065; Ichihara O, 2011, MOL INFORM, V30, P298, DOI 10.1002/minf.201000174; Jain R, 2011, MOL MICROBIOL, V82, P39, DOI 10.1111/j.1365-2958.2011.07778.x; Jiang HC, 2014, FUNGAL GENET BIOL, V62, P62, DOI 10.1016/j.fgb.2013.11.003; Kovalevsky AY, 2008, J MOL BIOL, V384, P178, DOI 10.1016/j.jmb.2008.09.031; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; Lenardon MD, 2010, CURR OPIN MICROBIOL, V13, P416, DOI 10.1016/j.mib.2010.05.002; Lopata A, 2016, J BIOL CHEM, V291, P26320, DOI 10.1074/jbc.M116.734012; Maertens JA, 2016, LANCET, V387, P760, DOI 10.1016/S0140-6736(15)01159-9; Milewski S, 2006, YEAST, V23, P1, DOI 10.1002/yea.1337; Min J, 2006, CRYSTAL STRUCTURE GN; Mio T, 1999, J BIOL CHEM, V274, P424, DOI 10.1074/jbc.274.1.424; Mio T, 2000, MICROBIOL-SGM, V146, P1753, DOI 10.1099/00221287-146-7-1753; Mondal J, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006180; Mowlds P, 2008, MYCOPATHOLOGIA, V165, P5, DOI 10.1007/s11046-007-9069-9; Ngo L, 2019, CHEM BIOL DRUG DES, V93, P865, DOI 10.1111/cbdd.13476; NIAID, NIHNIAIDN01AI30041; Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326; Peneff C, 2001, J BIOL CHEM, V276, P16328, DOI 10.1074/jbc.M009988200; Perfect JR, 2017, NAT REV DRUG DISCOV, V16, P603, DOI 10.1038/nrd.2017.46; Perlin DS, 2017, LANCET INFECT DIS, V17, pE383, DOI 10.1016/S1473-3099(17)30316-X; Prakash O, 2019, MOLECULES, V24, DOI 10.3390/molecules24050996; Ram AFJ, 2004, MICROBIOL-SGM, V150, P3315, DOI 10.1099/mic.0.27249-0; Renwick J, 2006, MYCOPATHOLOGIA, V161, P377, DOI 10.1007/s11046-006-0021-1; Roemer T, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019703; Schauwvlieghe AFAD, 2018, LANCET RESP MED, V6, P782, DOI 10.1016/S2213-2600(18)30274-1; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott DE, 2012, BIOCHEMISTRY-US, V51, P4990, DOI 10.1021/bi3005126; SELITRENNIKOFF CP, 1976, P NATL ACAD SCI USA, V73, P534, DOI 10.1073/pnas.73.2.534; Shah NB, 2014, JOVE-J VIS EXP, DOI 10.3791/51383; Sheppard DC, 2004, ANTIMICROB AGENTS CH, V48, P1908, DOI 10.1128/AAC.48.5.1908-1911.2004; Sheppard DC, 2006, ANTIMICROB AGENTS CH, V50, P3501, DOI 10.1128/AAC.00787-06; Slater JL, 2011, MED MYCOL, V49, pS107, DOI 10.3109/13693786.2010.523852; Steinbach WJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003642; Tada R, 2013, CURR PHARM DESIGN, V19, P3738, DOI 10.2174/1381612811319200012; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Verwer PEB, 2012, ANTIMICROB AGENTS CH, V56, P1595, DOI 10.1128/AAC.05323-11; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Wang J, 2008, FEBS LETT, V582, P2973, DOI 10.1016/j.febslet.2008.07.040; Wang Y, 2016, ELIFE, V5, DOI [10.7554/elife.17505, 10.7554/eLife.17505]; Wapenaar H, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0225-2; Wartchow CA, 2011, J COMPUT AID MOL DES, V25, P669, DOI 10.1007/s10822-011-9439-8; Williams V, 2011, EUKARYOT CELL, V10, P293, DOI 10.1128/EC.00252-10; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wyatt PG, 2011, CURR TOP MED CHEM, V11, P1275; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; Zhang D, 1999, CURR PHARM DESIGN, V5, P73; Zheng YJ, 2004, METHOD ENZYMOL, V376, P188	91	7	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8678	8691		10.1074/jbc.RA120.012985	http://dx.doi.org/10.1074/jbc.RA120.012985			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32341126	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000546296800005
J	Archer, CR; Enslow, BT; Carver, CM; Stockand, JD				Archer, Crystal R.; Enslow, Benjamin T.; Carver, Chase M.; Stockand, James D.			Phosphatidylinositol 4,5-bisphosphate directly interacts with the ? and ? subunits of the sodium channel ENaC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hypertension; phosphoinositide; epithelial sodium channel (ENaC); ion channel; transport; epithelial ion transport; microscale thermophoresis; phospholipid signaling; sodium excretion; steady state intrinsic spectroscopy	K+ CHANNEL; POTASSIUM CHANNELS; PIP2 ACTIVATION; PROTEINS; SEGREGATION; PI(4,5)P-2; CALMODULIN	The plasma membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) regulates the activity of diverse ion channels to include the epithelial Na+ channel ENaC. Whether PIP2 regulation of ENaC is due to a direct phospholipid-protein interaction, remains obscure. To date, possible interaction of PIP2 with ENaC primarily has been tested indirectly through assays of channel function. A fragment-based biochemical analysis approach is used here to directly quantify possible PIP2-ENaC interactions. We find using the CIBN-CRY2 optogenetic dimerization system that the phosphoryl group positioned at carbon 5 of PIP2 is necessary for interaction with ENaC. Previous studies have implicated conserved basic residues in the cytosolic portions of ?- and ?-ENaC subunits as being important for PIP2-ENaC interactions. To test this, we used synthetic peptides of these regions of ?- and ?-ENaC. Steady-state intrinsic fluorescence spectroscopy demonstrated that phosphoinositides change the local conformation of the N terminus of ?-ENaC, and two sites of ?-ENaC adjacent to the plasma membrane, suggesting direct interactions of PIP2 with these three regions. Microscale thermophoresis elaborated PIP2 interactions with the N termini of ?- (K-d ?5.2 ?m) and ?-ENaC (K-d ?13 ?m). A weaker interaction site within the carboxyl terminus of ?-ENaC (K-d ?800 ?m) was also observed. These results support that PIP2 regulates ENaC activity by directly interacting with at least three distinct regions within the cytoplasmic domains of the channel that contain conserved basic residues. These interactions are probably electrostatic in nature, and are likely to bear a key structural role in support of channel activity.	[Archer, Crystal R.; Carver, Chase M.; Stockand, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA; [Enslow, Benjamin T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Archer, CR (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA.	ArcherC@uthscsa.edu		Archer, Crystal/0000-0002-2377-643X	American Heart Association [20POST35210746]; National Institutes of Health, NHLBI Grant [T32 HL007446]; NCATS Grant [TL1 TR002647]; NIGMS Grant [K12 GM11726]; NIDDK Grant [R01 DK113816]	American Heart Association(American Heart Association); National Institutes of Health, NHLBI Grant; NCATS Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIGMS Grant; NIDDK Grant	This work was supported by American Heart Association Grant 20POST35210746 and National Institutes of Health, NHLBI Grant T32 HL007446 (to C. R. A.), NCATS Grant TL1 TR002647 and NIGMS Grant K12 GM11726 (to B. T. E.), and NIDDK Grant R01 DK113816 (to J. D. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the American Heart Association or National Institutes of Health.	Alli AA, 2015, AM J PHYSIOL-RENAL, V309, pF456, DOI 10.1152/ajprenal.00631.2014; Balla Tamas, 2009, Curr Protoc Cell Biol, VChapter 24, DOI 10.1002/0471143030.cb2404s42; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Butterworth MB, 2008, J BIOL CHEM, V283, P35305, DOI 10.1074/jbc.R800044200; Carroll K, 2004, NAT REV MOL CELL BIO, V5, P55, DOI 10.1038/nrm1278; CHU A, 1991, J BIOL CHEM, V266, P7699; Eaton Douglas C, 2010, Proc Am Thorac Soc, V7, P54, DOI 10.1513/pats.200909-096JS; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; Everett J.K., 2008, SPARSE CONSTRAINT SO; Feng SJ, 2019, CELL REP, V28, P567, DOI 10.1016/j.celrep.2019.06.023; Furukawa T, 1996, PFLUG ARCH EUR J PHY, V431, P504, DOI 10.1007/s004240050028; Han B, 2016, SCI REP-UK, V6, DOI 10.1038/srep23417; Hansen SB, 2015, BBA-MOL CELL BIOL L, V1851, P620, DOI 10.1016/j.bbalip.2015.01.011; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hanukoglu I, 2016, GENE, V579, P95, DOI 10.1016/j.gene.2015.12.061; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kasuya G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00887-9; Klemens CA, 2017, J BIOL CHEM, V292, P375, DOI 10.1074/jbc.M116.753616; Kota P, 2014, J BIOL CHEM, V289, P23029, DOI 10.1074/jbc.M114.570952; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, P278; Mahon MJ, 2011, CELL SIGNAL, V23, P1659, DOI 10.1016/j.cellsig.2011.05.020; Martin-Belmonte F, 2007, CELL CYCLE, V6, P1957, DOI 10.4161/cc.6.16.4583; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mironova E, 2015, ACTA PHYSIOL, V213, P213, DOI 10.1111/apha.12372; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; Pavlov TS, 2017, AM J PHYSIOL-RENAL, V313, pF135, DOI 10.1152/ajprenal.00427.2016; Pochynyuk O, 2006, AM J PHYSIOL-RENAL, V290, pF949, DOI 10.1152/ajprenal.00386.2005; Pochynyuk O, 2008, CURR OPIN NEPHROL HY, V17, P533, DOI 10.1097/MNH.0b013e328308fff3; Pochynyuk O, 2008, AM J PHYSIOL-RENAL, V294, pF38, DOI 10.1152/ajprenal.00403.2007; Pochynyuk O, 2007, J GEN PHYSIOL, V130, P399, DOI 10.1085/jgp.200709800; Scheuermann TH, 2016, ANAL BIOCHEM, V496, P79, DOI 10.1016/j.ab.2015.12.013; Shei RJ, 2018, CURR OPIN PHARMACOL, V43, P152, DOI 10.1016/j.coph.2018.09.007; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Tong QS, 2006, AM J PHYSIOL-RENAL, V290, pF821, DOI 10.1152/ajprenal.00312.2005; Tu P, 2009, J NEUROCHEM, V108, P126, DOI 10.1111/j.1471-4159.2008.05752.x; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Weixel KM, 2007, J BIOL CHEM, V282, P36534, DOI 10.1074/jbc.M703970200; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Yin Y, 2019, SCIENCE, V363, P945, DOI 10.1126/science.aav9334; Yue G, 2002, J BIOL CHEM, V277, P11965, DOI 10.1074/jbc.M108951200; Zhou-Suckow Z, 2017, CELL TISSUE RES, V367, P537, DOI 10.1007/s00441-016-2562-z	48	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7958	7969		10.1074/jbc.RA120.012606	http://dx.doi.org/10.1074/jbc.RA120.012606			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32341072	Green Published, hybrid			2022-12-28	WOS:000540935400011
J	Li, T; Zhang, YM; Liu, Y; Li, XD; Hao, GL; Han, QH; Dirk, LMA; Downie, AB; Ruan, YL; Wang, JM; Wang, GY; Zhao, TY				Li, Tao; Zhang, Yumin; Liu, Ying; Li, Xudong; Hao, Guanglong; Han, Qinghui; Dirk, Lynnette M. A.; Downie, A. Bruce; Ruan, Yong-Ling; Wang, Jianmin; Wang, Guoying; Zhao, Tianyong			Raffinose synthase enhances drought tolerance through raffinose synthesis or galactinol hydrolysis in maize and Arabidopsis plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; carbohydrate metabolism; carbohydrate biosynthesis; carbohydrate function; galactosyltransferase; drought stress; galactinol hydrolysis; maize; raffinose synthase; raffinose synthesis	INOSITOL 1-PHOSPHATE SYNTHASE; COARCTATA ROXB. TATEOKA; FAMILY OLIGOSACCHARIDES; MOLECULAR-CLONING; STRESS TOLERANCE; ABIOTIC STRESS; EXPRESSION; SEEDS; GENE; OVEREXPRESSION	Raffinose and its precursor galactinol accumulate in plant leaves during abiotic stress. RAFFINOSE SYNTHASE (RAFS) catalyzes raffinose formation by transferring a galactosyl group of galactinol to sucrose. However, whether RAFS contributes to plant drought tolerance and, if so, by what mechanism remains unclear. In this study, we report that expression of RAFS from maize (or corn, Zea mays) (ZmRAFS) is induced by drought, heat, cold, and salinity stresses. We found that zmrafs mutant maize plants completely lack raffinose and hyper-accumulate galactinol and are more sensitive to drought stress than the corresponding null-segregant (NS) plants. This indicated that ZmRAFS and its product raffinose contribute to plant drought tolerance. ZmRAFS overexpression in Arabidopsis enhanced drought stress tolerance by increasing myo-inositol levels via ZmRAFS-mediated galactinol hydrolysis in the leaves due to sucrose insufficiency in leaf cells and also enhanced raffinose synthesis in the seeds. Supplementation of sucrose to detached leaves converted ZmRAFS from hydrolyzing galactinol to synthesizing raffinose. Taken together, we demonstrate that ZmRAFS enhances plant drought tolerance through either raffinose synthesis or galactinol hydrolysis, depending on sucrose availability in plant cells. These results provide new avenues to improve plant drought stress tolerance through manipulation of the raffinose anabolic pathway.	[Li, Tao; Zhang, Yumin; Liu, Ying; Li, Xudong; Hao, Guanglong; Han, Qinghui; Zhao, Tianyong] Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Li, Tao; Zhang, Yumin; Liu, Ying; Li, Xudong; Hao, Guanglong; Han, Qinghui; Zhao, Tianyong] Northwest A&F Univ, Key Lab Biol & Genet Improvement Maize Arid Area, Minist Agr, Yangling, Shaanxi, Peoples R China; [Li, Tao] Henan Agr Univ, Collaborat Innovat Ctr Henan Grain Crops, Coll Life Sci, State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Henan, Peoples R China; [Dirk, Lynnette M. A.; Downie, A. Bruce] Univ Kentucky, Dept Hort, Coll Agr Food & Environm, Seed Biol, Lexington, KY USA; [Ruan, Yong-Ling] Univ Newcastle, Australia China Res Ctr Crop Improvement, Callaghan, NSW, Australia; [Ruan, Yong-Ling] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia; [Wang, Jianmin; Wang, Guoying] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Henan Agricultural University; University of Kentucky; University of Newcastle; University of Newcastle; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhao, TY (corresponding author), Northwest A&F Univ, Coll Life Sci, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Zhao, TY (corresponding author), Northwest A&F Univ, Key Lab Biol & Genet Improvement Maize Arid Area, Minist Agr, Yangling, Shaanxi, Peoples R China.; Wang, GY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China.	wangguoying@caas.cn; tzhao2@nwafu.edu.cn	wang, jian/GVS-0711-2022; Ruan, Yong-Ling/AAU-7244-2021	Ruan, Yong-Ling/0000-0002-8394-4474; li, tao/0000-0002-6422-608X	NSFC (National Science Foundation in China) [31671776]; Ministry of Agriculture in China [2014ZX0800920B]	NSFC (National Science Foundation in China); Ministry of Agriculture in China(Ministry of Agriculture & Rural Affairs)	This work was supported by NSFC (National Science Foundation in China) Grant 31671776 and the Special fund for transgenic research from Ministry of Agriculture in China Grant 2014ZX0800920B (to T. Z.).	BARNETT JEG, 1970, BIOCHEM J, V119, P183, DOI 10.1042/bj1190183; Cacela C, 2006, BBA-BIOMEMBRANES, V1758, P680, DOI 10.1016/j.bbamem.2006.04.005; Cao T, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00263; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Dos Santos TB, 2015, GENET MOL BIOL, V38, P182, DOI 10.1590/S1415-475738220140171; Downie B, 2003, PLANT PHYSIOL, V131, P1347, DOI 10.1104/pp.016386; Egert A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00206; Egert A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-218; Gangl R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01115; Gangl R, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00789; Gangola MP, 2016, PHYTOCHEMISTRY, V125, P88, DOI 10.1016/j.phytochem.2016.02.009; Selvaraj MG, 2017, PLANT BIOTECHNOL J, V15, P1465, DOI 10.1111/pbi.12731; Goswami L, 2014, J PLANT BIOCHEM BIOT, V23, P316, DOI 10.1007/s13562-013-0217-7; Gu L, 2016, PLANT MOL BIOL, V90, P157, DOI 10.1007/s11103-015-0403-1; Gu L, 2013, PLANT SCI, V213, P38, DOI 10.1016/j.plantsci.2013.09.002; Himuro Y, 2014, J PLANT PHYSIOL, V171, P1127, DOI 10.1016/j.jplph.2014.04.007; Joshi R, 2013, PLANT PHYSIOL BIOCH, V65, P61, DOI 10.1016/j.plaphy.2013.01.009; Kaur H, 2013, PLANTA, V237, P321, DOI 10.1007/s00425-012-1781-0; KOSTER KL, 1988, PLANT PHYSIOL, V88, P829, DOI 10.1104/pp.88.3.829; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lahuta LB, 2014, J PLANT PHYSIOL, V171, P1306, DOI 10.1016/j.jplph.2014.04.012; Lahuta LB, 2011, ACTA PHYSIOL PLANT, V33, P725, DOI 10.1007/s11738-010-0597-4; Li SH, 2007, BIOTECHNOL LETT, V29, P635, DOI 10.1007/s10529-006-9268-3; Li T, 2017, MOL PLANT, V10, P1540, DOI 10.1016/j.molp.2017.10.014; Li ZH, 2013, PLANT CELL, V25, P3311, DOI 10.1105/tpc.113.113340; LINEBERGER RD, 1980, PLANT PHYSIOL, V65, P298, DOI 10.1104/pp.65.2.298; Majee M, 2004, J BIOL CHEM, V279, P28539, DOI 10.1074/jbc.M310138200; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Peterbauer T, 2002, PLANTA, V215, P839, DOI 10.1007/s00425-002-0804-7; SARAVITZ DM, 1987, PLANT PHYSIOL, V83, P185, DOI 10.1104/pp.83.1.185; Schneider T, 2009, PLANT CELL PHYSIOL, V50, P2174, DOI 10.1093/pcp/pcp151; Shimosaka E, 2015, BREEDING SCI, V65, P363, DOI 10.1270/jsbbs.65.363; Sivitz AB, 2007, PLANT PHYSIOL, V143, P188, DOI 10.1104/pp.106.089003; Sui XL, 2012, J PLANT PHYSIOL, V169, P1883, DOI 10.1016/j.jplph.2012.07.019; Sun ZB, 2013, PLANT PHYSIOL BIOCH, V69, P82, DOI 10.1016/j.plaphy.2013.04.009; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tan JL, 2013, PLANT CELL ENVIRON, V36, P288, DOI 10.1111/j.1365-3040.2012.02573.x; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhao TY, 2006, SEED SCI RES, V16, P107, DOI 10.1079/SSR2006243; Zhou ML, 2012, GLYCOBIOLOGY, V22, P1775, DOI 10.1093/glycob/cws121; Zhou Y, 2017, J AGR FOOD CHEM, V65, P2751, DOI 10.1021/acs.jafc.7b00377	41	28	30	13	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8064	8077		10.1074/jbc.RA120.013948	http://dx.doi.org/10.1074/jbc.RA120.013948			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32366461	Green Published, hybrid			2022-12-28	WOS:000540935400019
J	Vaughn, CM; Selby, CP; Yang, YY; Hsu, DS; Sancar, A				Vaughn, Courtney M.; Selby, Christopher P.; Yang, Yanyan; Hsu, David S.; Sancar, Aziz			Genome-wide single-nucleotide resolution of oxaliplatin?DNA adduct repair in drug-sensitive and -resistant colorectal cancer cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleotide excision repair; DNA damage; chemoresistance; colorectal cancer; DNA repair; genomics; drug resistance; chemotherapy; cytotoxicity; excision repair sequencing (XR-seq); oxaliplatin resistance	EXCISION-REPAIR; DNA-REPAIR; COLON-CANCER; ACQUIRED-RESISTANCE; GENE-EXPRESSION; POOR-PROGNOSIS; CISPLATIN; RNA; CYTOTOXICITY; ASSOCIATION	Platinum-based chemotherapies, including oxaliplatin, are a mainstay in the management of solid tumors and induce cell death by forming intrastrand dinucleotide DNA adducts. Despite their common use, they are highly toxic, and approximately half of cancer patients have tumors that are either intrinsically resistant or develop resistance. Previous studies suggest that this resistance is mediated by variations in DNA repair levels or net drug influx. Here, we aimed to better define the roles of nucleotide excision repair and DNA damage in platinum chemotherapy resistance by profiling DNA damage and repair efficiency in seven oxaliplatin-sensitive and three oxaliplatin-resistant colorectal cancer cell lines. We assayed DNA repair indirectly as toxicity and directly measured bulky adduct formation and removal from the genome by slot blot and repair capacity in an excision assay, and used excision repair sequencing (XR-seq) to map repair events genome-wide at single-nucleotide resolution. Using this combinatorial approach and proxies for oxaliplatin?DNA damage, we observed no significant differences in repair efficiency that could explain the relative sensitivities and chemotherapy resistances of these cell lines. In contrast, the levels of oxaliplatin-induced DNA damage were significantly lower in the resistant cells, indicating that decreased damage formation, rather than increased damage repair, is a major determinant of oxaliplatin resistance in these cell lines. XR-seq?based analysis of gene expression revealed up-regulation of membrane transport pathways in the resistant cells, and these pathways may contribute to resistance. In conclusion, additional research is needed to characterize the factors mitigating cellular DNA damage formation by platinum compounds.	[Vaughn, Courtney M.; Selby, Christopher P.; Yang, Yanyan; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Hsu, David S.] Duke Univ, Med Ctr, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu			National Institutes of Health [GM118102, ES027255]; National Institute of General Medical Sciences [5T32 GM007092]; National Cancer Institute [F30CA225060]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants GM118102 and ES027255 (to A. S.) and National Institute of General Medical Sciences award 5T32 GM007092 and National Cancer Institute fellowship F30CA225060 (to C. M. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Barckhausen C, 2014, ONCOGENE, V33, P1964, DOI 10.1038/onc.2013.141; Benson AB, 2017, J NATL COMPR CANC NE, V15, P370, DOI 10.6004/jnccn.2017.0036; Bowden NA, 2014, CANCER LETT, V346, P163, DOI 10.1016/j.canlet.2014.01.005; Chen SF, 2016, BIOMED PHARMACOTHER, V82, P583, DOI 10.1016/j.biopha.2016.05.017; de Gramont A, 2003, Colorectal Dis, V5 Suppl 3, P10, DOI 10.1046/j.1463-1318.5.s3.3.x; Deger N, 2019, J BIOL CHEM, V294, P18092, DOI 10.1074/jbc.AC119.011448; Di Francia R, 2015, EUR REV MED PHARMACO, V19, P4443; Fang C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40384; Fang YN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170609; Gong WJ, 2016, TUMOR BIOL, V37, P8349, DOI 10.1007/s13277-015-4497-5; Guffanti Federica, 2018, Oncotarget, V9, P24707, DOI 10.18632/oncotarget.25185; Hahne JC, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00226; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Ho GY, 2016, CRIT REV ONCOL HEMAT, V102, P37, DOI 10.1016/j.critrevonc.2016.03.014; Howell SB, 2010, MOL PHARMACOL, V77, P887, DOI 10.1124/mol.109.063172; Hu JC, 2019, NAT PROTOC, V14, P248, DOI 10.1038/s41596-018-0093-7; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; Huang YX, 2017, MOL CARCINOGEN, V56, P447, DOI 10.1002/mc.22507; JOHNSON SW, 1994, BIOCHEM PHARMACOL, V47, P689, DOI 10.1016/0006-2952(94)90132-5; Katano K, 2002, CANCER RES, V62, P6559; Kemp MG, 2012, J BIOL CHEM, V287, P22889, DOI 10.1074/jbc.M112.374447; Kim ES, 2012, J CLIN ONCOL, V30, P3345, DOI 10.1200/JCO.2011.40.8120; Li WT, 2018, P NATL ACAD SCI USA, V115, pE3408, DOI 10.1073/pnas.1801687115; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Massari F, 2015, CRIT REV ONCOL HEMAT, V96, P81, DOI 10.1016/j.critrevonc.2015.05.005; MASUDA H, 1988, CANCER RES, V48, P5713; Meynard D, 2007, ONCOL REP, V17, P1213; Mezencev R, 2016, CANCER GENE THER, V23, P446, DOI 10.1038/cgt.2016.71; Modi S, 2016, J GASTROINTEST SURG, V20, P13, DOI 10.1007/s11605-015-3000-3; Novakovic P, 2006, CARCINOGENESIS, V27, P916, DOI 10.1093/carcin/bgi312; Ozawa T, 2017, ANN ONCOL, V28, P1882, DOI 10.1093/annonc/mdx248; Oztas O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03922-5; Preston TJ, 2009, MOL CANCER THER, V8, P2015, DOI 10.1158/1535-7163.MCT-08-0929; Riou L, 2004, CANCER RES, V64, P889, DOI 10.1158/0008-5472.CAN-03-2070; Saintas E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172140; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Unger FT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-359; Veal GJ, 2001, CLIN CANCER RES, V7, P2205; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang SS, 2018, CHEM RES TOXICOL, V31, P1293, DOI 10.1021/acs.chemrestox.8b00170; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Wu XM, 2003, CLIN CANCER RES, V9, P5874; Yang YY, 2019, J BIOL CHEM, V294, P11960, DOI 10.1074/jbc.RA119.009579; Yu WK, 2017, BRIT J PHARMACOL, V174, P302, DOI 10.1111/bph.13690; Zhang JL, 2017, ONCOL LETT, V14, P6907, DOI 10.3892/ol.2017.7049	53	7	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7584	7594		10.1074/jbc.RA120.013347	http://dx.doi.org/10.1074/jbc.RA120.013347			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32299912	Green Published, hybrid			2022-12-28	WOS:000538038900003
J	Rout, SS; Singh, M; Shindler, KS; Das Sarma, J				Rout, Saurav Saswat; Singh, Manmeet; Shindler, Kenneth S.; Das Sarma, Jayasri			One proline deletion in the fusion peptide of neurotropic mouse hepatitis virus (MHV) restricts retrograde axonal transport and neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fusion protein; neurodegeneration; plus-stranded RNA virus; neuroinflammation; membrane fusion; mouse hepatitis virus; murine coronavirus (M-CoV); optic neuritis; retrograde axonal transport; spike protein	SPIKE GLYCOPROTEIN; CORONAVIRUS; DEMYELINATION; REGIONS; SPREAD; MODEL; GENE	Mouse hepatitis virus (MHV; murine coronavirus) causes meningoencephalitis, myelitis, and optic neuritis followed by axonal loss and demyelination. This murine virus is used as a common model to study acute and chronic virus-induced demyelination in the central nervous system. Studies with recombinant MHV strains that differ in the gene encoding the spike protein have demonstrated that the spike has a role in MHV pathogenesis and retrograde axonal transport. Fusion peptides (FPs) in the spike protein play a key role in MHV pathogenesis. In a previous study of the effect of deleting a single proline residue in the FP of a demyelinating MHV strain, we found that two central, consecutive prolines are important for cell?cell fusion and pathogenesis. The dihedral fluctuation of the FP was shown to be repressed whenever two consecutive prolines were present, in contrast to the presence of a single proline in the chain. Using this proline-deleted MHV strain, here we investigated whether intracranial injection of this strain can induce optic neuritis by retrograde axonal transport from the brain to the retina through the optic nerve. We observed that the proline-deleted recombinant MHV strain is restricted to the optic nerve, is unable to translocate to the retina, and causes only minimal demyelination and no neuronal death. We conclude that an intact proline dyad in the FP of the recombinant demyelinating MHV strain plays a crucial role in translocation of the virus through axons and subsequent neurodegeneration.	[Rout, Saurav Saswat; Singh, Manmeet; Das Sarma, Jayasri] Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur 741246, India; [Shindler, Kenneth S.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Shindler, Kenneth S.] Univ Penn, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA	Indian Institute of Science Education & Research (IISER) - Kolkata; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Das Sarma, J (corresponding author), Indian Inst Sci Educ & Res Kolkata, Dept Biol Sci, Mohanpur 741246, India.	dassarmaj@iiserkol.ac.in	Sarma, Jayasri Das/AAS-3837-2020; SINGH, MANMEET/HFZ-9743-2022	SINGH, MANMEET/0000-0003-0917-8844; Rout, Saurav Saswat/0000-0002-7086-212X	Indian Institute of Science Education and Research Kolkata fellowship; University Grants Commission fellowship; Department of Biotechnology, Ministry of Science and Technology [BT/PR20922/MED/122/37/2016]	Indian Institute of Science Education and Research Kolkata fellowship; University Grants Commission fellowship(University Grants Commission, India); Department of Biotechnology, Ministry of Science and Technology	This work was supported by an Indian Institute of Science Education and Research Kolkata fellowship (to S. S. R.), a University Grants Commission fellowship (to M. S.), and Department of Biotechnology, Ministry of Science and Technology Grant BT/PR20922/MED/122/37/2016 (to J. D. S.). The authors declare that they have no conflicts of interest with the contents of this article.	CHAMBERS P, 1990, J GEN VIROL, V71, P3075, DOI 10.1099/0022-1317-71-12-3075; Das Sarma J, 2000, J VIROL, V74, P9206, DOI 10.1128/JVI.74.19.9206-9213.2000; Das Sarma J, 2002, J NEUROVIROL, V8, P381, DOI [10.1080/13550280290100815, 10.1080/13550280260422686]; Das Sarma J, 2008, J VIROL, V82, P5519, DOI 10.1128/JVI.01488-07; Das Sarma J, 2009, J NEUROSCI, V29, P10272, DOI 10.1523/JNEUROSCI.1975-09.2009; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Kaufman G, 2014, VIRUS RES, V189, P177, DOI 10.1016/j.virusres.2014.05.023; Khan RS, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-3; LAVI E, 1986, LAB ANIM SCI, V36, P130; McGavern DB, 1999, J NEUROSCI RES, V58, P492, DOI 10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P; PERLMAN S, 1990, J EXP MED, V172, P1127, DOI 10.1084/jem.172.4.1127; Santos AM, 2008, J COMP NEUROL, V506, P224, DOI 10.1002/cne.21538; Shindler KS, 2008, J VIROL, V82, P8882, DOI 10.1128/JVI.00920-08; Shindler KS, 2011, J NEUROPATH EXP NEUR, V70, P470, DOI 10.1097/NEN.0b013e31821da499; Singh M, 2019, J BIOL CHEM, V294, P8064, DOI 10.1074/jbc.RA118.004418; Singh M, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00311	17	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6926	6935		10.1074/jbc.RA119.011918	http://dx.doi.org/10.1074/jbc.RA119.011918			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32249210	Green Published, hybrid			2022-12-28	WOS:000536212600011
J	Yamaguchi, I; Yoshimura, SH; Katoh, H				Yamaguchi, Itsuki; Yoshimura, Shige H.; Katoh, Hironori			High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid transport; cell death; cancer biology; cell biology; lysosome	UBIQUITIN-PROTEASOME SYSTEM; PROTEIN-DEGRADATION; CONTACT INHIBITION; HIPPO PATHWAY; CANCER; ANTIPORTER; MTOR; METABOLISM; PHOSPHORYLATION; GROWTH	The cystine/glutamate transporter system xc? consists of the light-chain subunit xCT (SLC7A11) and the heavy-chain subunit CD98 (4F2hc or SLC3A2) and exchanges extracellular cystine for intracellular glutamate at the plasma membrane. The imported cystine is reduced to cysteine and used for synthesis of GSH, one of the most important antioxidants in cancer cells. Because cancer cells have increased levels of reactive oxygen species, xCT, responsible for cystine?glutamate exchange, is overexpressed in many cancers, including glioblastoma. However, under glucose-limited conditions, xCT overexpression induces reactive oxygen species accumulation and cell death. Here we report that cell survival under glucose deprivation depends on cell density. We found that high cell density (HD) down-regulates xCT levels and increases cell viability under glucose deprivation. We also found that growth of glioblastoma cells at HD inactivates mTOR and that treatment of cells grown at low density with the mTOR inhibitor Torin 1 down-regulates xCT and inhibits glucose deprivation-induced cell death. The lysosome inhibitor bafilomycin A1 suppressed xCT down-regulation in HD-cultured glioblastoma cells and in Torin 1?treated cells grown at low density. Additionally, bafilomycin A1 exposure or ectopic xCT expression restored glucose deprivation?induced cell death at HD. These results suggest that HD inactivates mTOR and promotes lysosomal degradation of xCT, leading to improved glioblastoma cell viability under glucose-limited conditions. Our findings provide evidence that control of xCT protein expression via lysosomal degradation is an important mechanism for metabolic adaptation in glioblastoma cells.	[Yamaguchi, Itsuki; Katoh, Hironori] Kyoto Univ, Lab Mol Neurobiol, Grad Sch Biostudies, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan; [Yoshimura, Shige H.] Kyoto Univ, Lab Plasma Membrane & Nucl Signaling, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Katoh, H (corresponding author), Kyoto Univ, Lab Mol Neurobiol, Grad Sch Biostudies, Sakyo Ku, Yoshidakonoe Cho, Kyoto 6068501, Japan.	hirokato@pharm.kyoto-u.ac.jp	Yoshimura, Shige H./AAF-5463-2019	Yoshimura, Shige H./0000-0001-6033-1301; Katoh, Hironori/0000-0002-8191-8117	Japan Society for the Promotion of Science [18K06215]; Princess Takamatsu Cancer Research Fund [18-25006]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Princess Takamatsu Cancer Research Fund	This work was supported in part by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science 18K06215 and Princess Takamatsu Cancer Research Fund Grant 18-25006. The authors declare that they have no conflicts of interest with the contents of this article.	Angeli JPF, 2019, NAT REV CANCER, V19, P405, DOI 10.1038/s41568-019-0149-1; Brown CW, 2018, J BIOL CHEM, V293, P12741, DOI 10.1074/jbc.RA118.003017; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; Dikic I, 2017, ANNU REV BIOCHEM, V86, P193, DOI 10.1146/annurev-biochem-061516-044908; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Galadari S, 2017, FREE RADICAL BIO MED, V104, P144, DOI 10.1016/j.freeradbiomed.2017.01.004; Goji T, 2017, J BIOL CHEM, V292, P19721, DOI 10.1074/jbc.M117.814392; Gu DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103015; Gu YC, 2017, MOL CELL, V67, P128, DOI 10.1016/j.molcel.2017.05.030; Gujral TS, 2017, P NATL ACAD SCI USA, V114, pE3729, DOI 10.1073/pnas.1703096114; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassannia B, 2019, CANCER CELL, V35, P830, DOI 10.1016/j.ccell.2019.04.002; Hay N, 2016, NAT REV CANCER, V16, P635, DOI 10.1038/nrc.2016.77; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Ji CH, 2017, MOL CELLS, V40, P441, DOI 10.14348/molcells.2017.0115; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; KOBAYASHI H, 1992, CANCER CHEMOTH PHARM, V31, P6, DOI 10.1007/BF00695987; Koppula P, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0288-x; Koppula P, 2017, J BIOL CHEM, V292, P14240, DOI 10.1074/jbc.M117.798405; Lagunas-Martinez A, 2017, APOPTOSIS, V22, P27, DOI 10.1007/s10495-016-1299-1; Lamming DW, 2019, TRAFFIC, V20, P27, DOI 10.1111/tra.12617; Lawrence RE, 2019, NAT CELL BIOL, V21, P133, DOI 10.1038/s41556-018-0244-7; Leontieva OV, 2014, P NATL ACAD SCI USA, V111, P8832, DOI 10.1073/pnas.1405723111; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Lien EC, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aao6604; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Liu T, 2019, CANCER RES, V79, P1913, DOI 10.1158/0008-5472.CAN-18-3037; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Mossmann D, 2018, NAT REV CANCER, V18, P744, DOI 10.1038/s41568-018-0074-8; Mousavi SA, 2001, BBA-BIOMEMBRANES, V1510, P243, DOI 10.1016/S0005-2736(00)00354-0; Pavel M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05388-x; Puertollano Rosa, 2014, F1000Prime Rep, V6, P52, DOI 10.12703/P6-52; Qiao LY, 2009, NEUROSCI LETT, V456, P15, DOI 10.1016/j.neulet.2009.03.085; Reuven N, 2013, CELL DEATH DIFFER, V20, P1330, DOI 10.1038/cdd.2013.83; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rousseau A, 2016, NATURE, V536, P184, DOI 10.1038/nature18943; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shin CS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15074; Song XX, 2018, CURR BIOL, V28, P2388, DOI 10.1016/j.cub.2018.05.094; Takeuchi S, 2013, NEUROSURGERY, V72, P33, DOI 10.1227/NEU.0b013e318276b2de; Teramoto K, 2019, CELL SIGNAL, V62, DOI 10.1016/j.cellsig.2019.05.014; Trajkovic K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211727; Tsuchihashi K, 2016, CANCER RES, V76, P2954, DOI 10.1158/0008-5472.CAN-15-2121; Wang XJ, 2013, AUTOPHAGY, V9, P1500, DOI 10.4161/auto.25573; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wenz C, 2019, ARCH TOXICOL, V93, P1265, DOI 10.1007/s00204-019-02413-w; Westhoff MA, 2008, ONCOGENE, V27, P5169, DOI 10.1038/onc.2008.148; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112	57	18	18	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6936	6945		10.1074/jbc.RA119.012213	http://dx.doi.org/10.1074/jbc.RA119.012213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32265299	Green Published, hybrid			2022-12-28	WOS:000536212600012
J	Bradley, MC; Yang, KT; Fernandez-del-Rio, L; Ngo, J; Ayer, A; Tsui, HS; Novales, NA; Stocker, R; Shirihai, OS; Barros, MH; Clarke, CF				Bradley, Michelle C.; Yang, Krista; Fernandez-del-Rio, Lucia; Ngo, Jennifer; Ayer, Anita; Tsui, Hui S.; Novales, Noelle Alexa; Stocker, Roland; Shirihai, Orian S.; Barros, Mario H.; Clarke, Catherine F.			COQ11 deletion mitigates respiratory deficiency caused by mutations in the gene encoding the coenzyme Q chaperone protein Coq10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquinone; mitochondrial metabolism; Saccharomyces cerevisiae; lipid; yeast; coenzyme Q; CoQ synthome; Coq10; Coq11	SACCHAROMYCES-CEREVISIAE; C-METHYLTRANSFERASE; ELECTRON-TRANSPORT; YEAST; MITOCHONDRIA; POLYPEPTIDE; COMPLEX; KINASE; MECHANISMS; SUPPLEMENTATION	Coenzyme Q (Q(n)) is a vital lipid component of the electron transport chain that functions in cellular energy metabolism and as a membrane antioxidant. In the yeast Saccharomyces cerevisiae, coq1?coq9 deletion mutants are respiratory-incompetent, sensitive to lipid peroxidation stress, and unable to synthesize Q(6). The yeast coq10 deletion mutant is also respiratory-deficient and sensitive to lipid peroxidation, yet it continues to produce Q(6) at an impaired rate. Thus, Coq10 is required for the function of Q(6) in respiration and as an antioxidant and is believed to chaperone Q(6) from its site of synthesis to the respiratory complexes. In several fungi, Coq10 is encoded as a fusion polypeptide with Coq11, a recently identified protein of unknown function required for efficient Q(6) biosynthesis. Because ?fused? proteins are often involved in similar biochemical pathways, here we examined the putative functional relationship between Coq10 and Coq11 in yeast. We used plate growth and Seahorse assays and LC-MS/MS analysis to show that COQ11 deletion rescues respiratory deficiency, sensitivity to lipid peroxidation, and decreased Q(6) biosynthesis of the coq10? mutant. Additionally, immunoblotting indicated that yeast coq11? mutants accumulate increased amounts of certain Coq polypeptides and display a stabilized CoQ synthome. These effects suggest that Coq11 modulates Q(6) biosynthesis and that its absence increases mitochondrial Q(6) content in the coq10?coq11? double mutant. This augmented mitochondrial Q(6) content counteracts the respiratory deficiency and lipid peroxidation sensitivity phenotypes of the coq10? mutant. This study further clarifies the intricate connection between Q(6) biosynthesis, trafficking, and function in mitochondrial metabolism.	[Bradley, Michelle C.; Yang, Krista; Fernandez-del-Rio, Lucia; Ngo, Jennifer; Tsui, Hui S.; Novales, Noelle Alexa; Clarke, Catherine F.] Univ Calif Los Angeles, Dept Chem & Biochem, Inst Mol Biol, Los Angeles, CA 90095 USA; [Ngo, Jennifer; Shirihai, Orian S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol & Med, Los Angeles, CA 90095 USA; [Ayer, Anita; Stocker, Roland] Victor Chang Cardiac Res Inst, Vasc Biol Div, Sydney, NSW 2010, Australia; [Ayer, Anita; Stocker, Roland] Univ New South Wales Med, St Vincents Clin Sch, Sydney, NSW 2050, Australia; [Barros, Mario H.] Univ Sao Paulo, Dept Microbiol, BR-05508900 Sao Paulo, Brazil	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Universidade de Sao Paulo	Clarke, CF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Inst Mol Biol, Los Angeles, CA 90095 USA.	cathy@chem.ucla.edu	del Rio, Lucia Fernandez/AAV-8233-2021; Stocker, Roland/AAV-4489-2021; Novales, Noelle Alexa/AAV-2010-2020; Barros, Mario H/B-8118-2012; Barros, Mario/Q-6358-2019	del Rio, Lucia Fernandez/0000-0001-5657-2700; Barros, Mario/0000-0003-2977-9815; Novales, Noelle Alexa/0000-0002-4903-2738; Ngo, Jennifer/0000-0002-5829-6866; Ayer, Anita/0000-0002-7073-2835	National Science Foundation [MCB-1330803]; National Institutes of Health [T32GM007185]; Ruth L. Kirschstein National Service; Whitcome Individual Predoctoral Fellowship; UCLA Summer Undergraduate Research Fellowship, Department of Chemistry and Biochemistry; Fundacao de Amparo a Pesquisa de Sao Paulo-FAPESP [2013/09482-8, 2013/07937-8]; Gates Millennium Scholars Fellowship; Eugene V. Cota Robles Fellowship	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitcome Individual Predoctoral Fellowship; UCLA Summer Undergraduate Research Fellowship, Department of Chemistry and Biochemistry; Fundacao de Amparo a Pesquisa de Sao Paulo-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Gates Millennium Scholars Fellowship; Eugene V. Cota Robles Fellowship	This work was supported by National Science Foundation Grant MCB-1330803 (to C. F. C.), National Institutes of Health Grant T32GM007185 (to H. S. T. and M. C. B.) Ruth L. Kirschstein National Service (to M. C. B. and H. S. T.), the Whitcome Individual Predoctoral Fellowship (to M. C. B.), UCLA Summer Undergraduate Research Fellowship, Department of Chemistry and Biochemistry (to K. Y.), Fundacao de Amparo a Pesquisa de Sao Paulo-FAPESP 2013/09482-8 and 2013/07937-8 (to M. H. B.), Gates Millennium Scholars Fellowship (to J. N.), and the Eugene V. Cota Robles Fellowship (to J. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alcazar-Fabra M, 2018, ESSAYS BIOCHEM, V62, P377, DOI 10.1042/EBC20170107; Allan CM, 2015, J BIOL CHEM, V290, P7517, DOI 10.1074/jbc.M114.633131; Allan CM, 2013, BBA-MOL CELL BIOL L, V1831, P776, DOI 10.1016/j.bbalip.2012.12.007; Awad AM, 2018, ESSAYS BIOCHEM, V62, P361, DOI 10.1042/EBC20170106; Barkovich RJ, 1997, J BIOL CHEM, V272, P9182; Barros MH, 2017, MOL BIOL CELL, V28, P1426, DOI 10.1091/mbc.E16-11-0775; Barros MH, 2005, J BIOL CHEM, V280, P42627, DOI 10.1074/jbc.M510768200; Brachmann CB, 1998, YEAST, V14, P115; CHEN WJ, 1987, CELL, V49, P651, DOI 10.1016/0092-8674(87)90541-1; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Cui TZ, 2009, FEBS J, V276, P748, DOI 10.1111/j.1742-4658.2008.06821.x; Desbats MA, 2015, J INHERIT METAB DIS, V38, P145, DOI 10.1007/s10545-014-9749-9; Eisenberg-Bord Michal, 2019, Contact (Thousand Oaks), V2, p2515256418825409, DOI 10.1177/2515256418825409; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Fontanesi F, 2013, IUBMB LIFE, V65, P397, DOI 10.1002/iub.1156; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gonzalez-Hunt Claudia P, 2016, Curr Protoc Toxicol, V67, DOI 10.1002/0471140856.tx2011s67; Guaras A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009; Guo X, 2017, CELL REP, V18, P307, DOI 10.1016/j.celrep.2016.12.049; He CWH, 2014, BBA-MOL CELL BIOL L, V1841, P630, DOI 10.1016/j.bbalip.2013.12.017; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Hill S, 2012, FREE RADICAL BIO MED, V53, P893, DOI 10.1016/j.freeradbiomed.2012.06.004; Hill S, 2011, FREE RADICAL BIO MED, V50, P130, DOI 10.1016/j.freeradbiomed.2010.10.690; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Kawamukai M, 2016, BIOSCI BIOTECH BIOCH, V80, P23, DOI 10.1080/09168451.2015.1065172; Kehrein K, 2015, ONCOTARGET, V6, P16806, DOI 10.18632/oncotarget.4783; Kopec J, 2011, ACTA CRYSTALLOGR F, V67, P1184, DOI 10.1107/S174430911102923X; Marbois B, 2005, J BIOL CHEM, V280, P20231, DOI 10.1074/jbc.M501315200; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Montini G, 2008, NEW ENGL J MED, V358, P2849, DOI 10.1056/NEJMc0800582; Murley A, 2016, MOL CELL, V61, P648, DOI 10.1016/j.molcel.2016.01.031; Nguyen TPT, 2014, BBA-MOL CELL BIOL L, V1841, P1628, DOI 10.1016/j.bbalip.2014.08.007; OHASHI A, 1982, J BIOL CHEM, V257, P3042; Okada K, 1996, BBA-LIPID LIPID MET, V1302, P217, DOI 10.1016/0005-2760(96)00064-1; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Perocchi F, 2006, PLOS GENET, V2, P1612, DOI 10.1371/journal.pgen.0020170; PRYOR WA, 1990, FREE RADICAL BIO MED, V8, P541, DOI 10.1016/0891-5849(90)90153-A; READING DS, 1989, NATURE, V337, P655, DOI 10.1038/337655a0; Reidenbach AG, 2018, CELL CHEM BIOL, V25, P154, DOI 10.1016/j.chembiol.2017.11.001; Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159; Santos-Ocana C, 2002, J BIOL CHEM, V277, P10973, DOI 10.1074/jbc.M112222200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; Shen Y, 2005, PROTEINS, V58, P747, DOI 10.1002/prot.20365; SIKORSKI RS, 1989, GENETICS, V122, P19; Stefely JA, 2017, TRENDS BIOCHEM SCI, V42, P824, DOI 10.1016/j.tibs.2017.06.008; Stefely JA, 2015, MOL CELL, V57, P83, DOI 10.1016/j.molcel.2014.11.002; Stoldt S, 2018, NAT CELL BIOL, V20, P528, DOI 10.1038/s41556-018-0090-7; Subramanian K, 2019, J CELL BIOL, V218, P1352, DOI 10.1083/jcb.201808044; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Tran UC, 2006, J BIOL CHEM, V281, P16401, DOI 10.1074/jbc.M513267200; Tsui HS, 2019, J LIPID RES, V60, P1293, DOI 10.1194/jlr.M093534; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; van den Bosch BJC, 2012, J MED GENET, V49, P10, DOI 10.1136/jmedgenet-2011-100466; Vogtle FN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00359-0; Wang Y, 2019, TRENDS ENDOCRIN MET, V30, P929, DOI 10.1016/j.tem.2019.08.009; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905	71	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6023	6042		10.1074/jbc.RA119.012420	http://dx.doi.org/10.1074/jbc.RA119.012420			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32205446	Green Published, hybrid			2022-12-28	WOS:000531417300015
J	Zweifel, ME; Courtemanche, N				Zweifel, Mark E.; Courtemanche, Naomi			Competition for delivery of profilin?actin to barbed ends limits the rate of formin-mediated actin filament elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						formin; actin; profilin; fluorescence; microscopy; polyproline tract	FH1 DOMAIN; NUCLEATION; POLYMERIZATION; MECHANISM; PROLINE; MODEL; DROSOPHILA; PROTEINS; MONOMERS; COMPLEX	Formins direct the elongation of unbranched actin filaments by binding their barbed ends and processively stepping onto incoming actin monomers to incorporate them into the filament. Binding of profilin to actin monomers creates profilin?actin complexes, which then bind polyproline tracts located in formin homology 1 (FH1) domains. Diffusion of these natively disordered domains enables direct delivery of profilin?actin to the barbed end, speeding the rate of filament elongation. In this study, we investigated the mechanism of coordinated actin delivery from the multiple polyproline tracts in formin FH1 domains. We found that each polyproline tract can efficiently mediate polymerization, but that all tracts do not generate the same rate of elongation. In WT FH1 domains, the multiple polyproline tracts compete to deliver profilin?actin to the barbed end. This competition ultimately limits the rate of formin-mediated elongation. We propose that intrinsic properties of the filament-binding FH2 domain tune the efficiency of FH1-mediated elongation by directly regulating the rate of monomer incorporation at the barbed end. A strong correlation between competitive FH1-mediated profilin?actin delivery and FH2-regulated gating of the barbed end effectively limits the elongation rate, thereby obviating the need for evolutionary optimization of FH1 domain sequences.	[Zweifel, Mark E.; Courtemanche, Naomi] Univ Minnesota, Dept Genet Cell Biol & Dev, 6-130 MCB,420 Washington Ave SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Courtemanche, N (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 6-130 MCB,420 Washington Ave SE, Minneapolis, MN 55455 USA.	ncourtem@umn.edu		Courtemanche, Naomi/0000-0003-4374-4782	National Institutes of Health [GM122787, AR007612]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Research Grant GM122787 (to N. C.) and National Institutes of Health Training Grant AR007612 (to M. E. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja R, 2007, CELL, V131, P337, DOI 10.1016/j.cell.2007.08.030; An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Aydin F, 2018, ELIFE, V7, DOI 10.7554/eLife.37342; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Bruhmann S, 2017, P NATL ACAD SCI USA, V114, pE5815, DOI 10.1073/pnas.1703145114; Bryant D, 2017, CYTOSKELETON, V74, P29, DOI 10.1002/cm.21344; Byrnes AE, 2017, J CELL BIOL, V216, P1641, DOI 10.1083/jcb.201610090; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Courtemanche Naomi, 2018, Biophys Rev, V10, P1553, DOI 10.1007/s12551-018-0468-6; Courtemanche N, 2013, P NATL ACAD SCI USA, V110, P9752, DOI 10.1073/pnas.1308257110; Courtemanche N, 2012, J BIOL CHEM, V287, P7812, DOI 10.1074/jbc.M111.322958; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Geyer EA, 2018, ELIFE, V7, DOI [10.7554/eLife.34574, 10.7554/elife.34574]; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Horan BG, 2018, FEBS LETT, V592, P1804, DOI 10.1002/1873-3468.13088; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Kursula P, 2008, J MOL BIOL, V375, P270, DOI 10.1016/j.jmb.2007.10.050; Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; Michelot A, 2005, PLANT CELL, V17, P2296, DOI 10.1105/tpc.105.030908; Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621; Neidt EM, 2008, J BIOL CHEM, V283, P23872, DOI 10.1074/jbc.M803734200; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Patel AA, 2018, J BIOL CHEM, V293, P532, DOI 10.1074/jbc.M117.800888; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Petrella EC, 1996, BIOCHEMISTRY-US, V35, P16535, DOI 10.1021/bi961498d; Pring M, 2003, BIOCHEMISTRY-US, V42, P486, DOI 10.1021/bi026520j; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Pruyne D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164067; Quinlan ME, 2005, NATURE, V433, P382, DOI 10.1038/nature03241; Ramabhadran V, 2012, J BIOL CHEM, V287, P34234, DOI 10.1074/jbc.M112.365122; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Scott BJ, 2011, MOL BIOL CELL, V22, P3826, DOI 10.1091/mbc.E11-06-0492; Sherer LA, 2018, J BIOL CHEM, V293, P17917, DOI 10.1074/jbc.RA118.004845; Slep KC, 2009, BIOCHEM SOC T, V37, P1002, DOI 10.1042/BST0371002; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Vavylonis D, 2006, MOL CELL, V21, P455, DOI 10.1016/j.molcel.2006.01.016; Vinson VK, 1998, BIOCHEMISTRY-US, V37, P10871, DOI 10.1021/bi980093l; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Winkelman JD, 2014, P NATL ACAD SCI USA, V111, P4121, DOI 10.1073/pnas.1322093111; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zhao C, 2014, FEBS LETT, V588, P2288, DOI 10.1016/j.febslet.2014.05.016; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057; Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852	51	9	9	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4513	4525		10.1074/jbc.RA119.012000	http://dx.doi.org/10.1074/jbc.RA119.012000			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32075907	Green Published, hybrid			2022-12-28	WOS:000524499700013
J	Kabra, A; Rumpa, E; Li, Y				Kabra, Ashish; Rumpa, Efsita; Li Ying			Modulation of conformational equilibrium by phosphorylation underlies the activation of deubiquitinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); deubiquitylation (deubiquitination); protein conformation; post-translational modification (PTM); enzyme kinetics; conformational dynamics; deubiquitinase A (DUBA); enzyme activation; protein homeostasis	CHEMICAL-SHIFTS; EXCHANGE RATES; UBIQUITIN; MOTIONS; SPECIFICITY; MECHANISMS; SOFTWARE; ENZYMES; SYSTEM; FAMILY	Deubiquitinases deconjugate ubiquitin modifications from target proteins and are involved in many cellular processes in eukaryotes. The functions of deubiquitinases are regulated by post-translational modifications, mainly phosphorylation and ubiquitination. Post-translational modifications can result in subtle changes in structural and dynamic properties, which are difficult to identify but functionally important. In this work, we used NMR spectroscopy to characterize the conformational properties of the human deubiquitinase A (DUBA), a negative regulator of type I interferon. DUBA activity is regulated by phosphorylation at a single serine residue, Ser-177. We found that the catalytic rate constant of DUBA is enhanced by phosphorylation. By comparing NMR and enzyme kinetics data among different forms of DUBA with low and high activities, we concluded that a two-state equilibrium that was present only in phosphorylated DUBA is important for DUBA activity. Our results highlight the importance of defining conformational dynamics in understanding the mechanism of DUBA activation.	[Kabra, Ashish; Rumpa, Efsita; Li Ying] Univ Louisville, Dept Chem, 2320 South Brook St, Louisville, KY 40208 USA	University of Louisville	Li, Y (corresponding author), Univ Louisville, Dept Chem, 2320 South Brook St, Louisville, KY 40208 USA.	ying.li.1@louisville.edu	Kabra, Ashish/AGV-0844-2022; Li, Ying/D-1758-2011; Kabra, Ashish/ABD-2125-2020	Kabra, Ashish/0000-0002-5291-5398; Li, Ying/0000-0001-7678-9405; Kabra, Ashish/0000-0002-5291-5398	National Institutes of Health [R15GM123391]; University of Louisville	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Louisville	This work was supported by National Institutes of Health Grant R15GM123391 (to Y. L.) and by startup funds from University of Louisville. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahlner A, 2013, J BIOMOL NMR, V56, P191, DOI 10.1007/s10858-013-9737-7; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; BICKNELL R, 1985, BIOCHEM J, V231, P83, DOI 10.1042/bj2310083; Bienkiewicz EA, 1999, J BIOMOL NMR, V15, P203, DOI 10.1023/A:1008375029746; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Coleman KE, 2018, MOL CELL, V70, P1, DOI 10.1016/j.molcel.2018.03.022; de Vivo A, 2019, NUCLEIC ACIDS RES, V47, P729, DOI 10.1093/nar/gky1219; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Findeisen M, 2007, MAGN RESON CHEM, V45, P175, DOI 10.1002/mrc.1941; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Goddard T. D., 2004, SPARKY 3 NMR ASSIGNM; Gonzalez-Navajas JM, 2010, J EXP MED, V207, P2799, DOI 10.1084/jem.20101326; Harrigan JA, 2018, NAT REV DRUG DISCOV, V17, P57, DOI 10.1038/nrd.2017.152; HOFFMANN R, 1994, INT J PEPT PROT RES, V44, P193; Huang OW, 2012, NAT STRUCT MOL BIOL, V19, P171, DOI 10.1038/nsmb.2206; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Kabra A, 2019, BIOMOL NMR ASSIGN, V13, P37, DOI 10.1007/s12104-018-9847-y; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kumar P, 2012, J BIOL CHEM, V287, P17050, DOI 10.1074/jbc.M111.316661; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Leznicki P, 2017, J CELL SCI, V130, P1997, DOI 10.1242/jcs.201855; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Li Y, 2013, P NATL ACAD SCI USA, V110, P16462, DOI 10.1073/pnas.1314303110; Loria JP, 2008, ACCOUNTS CHEM RES, V41, P214, DOI 10.1021/ar700132n; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Mevissen TET, 2016, NATURE, V538, P402, DOI 10.1038/nature19836; Neu A, 2015, NAT CHEM BIOL, V11, P697, DOI [10.1038/nchembio.1866, 10.1038/NCHEMBIO.1866]; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rutz S, 2015, NATURE, V518, P417, DOI 10.1038/nature13979; Sahtoe DD, 2015, TRENDS BIOCHEM SCI, V40, P456, DOI 10.1016/j.tibs.2015.05.002; Saleh- T, 2017, NAT STRUCT MOL BIOL, V24, P893, DOI 10.1038/nsmb.3470; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; VOGEL HJ, 1982, BIOCHEMISTRY-US, V21, P5825, DOI 10.1021/bi00266a016; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Zhao Y, 2018, MOL CELL, V69, P505, DOI 10.1016/j.molcel.2018.01.009; Zhu Guang, 2004, Methods Mol Biol, V278, P57	47	3	3	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 20	2020	295	12					3945	3951		10.1074/jbc.AC119.010808	http://dx.doi.org/10.1074/jbc.AC119.010808			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9AB	32071088	Green Published, hybrid			2022-12-28	WOS:000527704400019
J	Melick, CH; Meng, DL; Jewell, JL				Melick, Chase H.; Meng, Delong; Jewell, Jenna L.			A-kinase anchoring protein 8L interacts with mTORC1 and promotes cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR complex (mTORC); mTORC1; protein synthesis; cell biology; cell proliferation; protein kinase A (PKA); A-kinase anchoring protein (AKAP); cell size; mRNA translation; nutrient sensing; scaffolding protein; AKAP8L; anabolic pathway; cAMP signaling	MESSENGER-RNA TRANSLATION; AKAP SIGNALING COMPLEXES; REGULATORY SUBUNIT; PHOSPHOPROTEOMIC ANALYSIS; CATALYTIC SUBUNIT; NUCLEAR-PROTEIN; HELICASE-A; INITIATION; PATHWAY; HA95	mTOR complex 1 (mTORC1) senses nutrients to mediate anabolic processes within the cell. Exactly how mTORC1 promotes cell growth remains unclear. Here, we identified a novel mTORC1-interacting protein called protein kinase A anchoring protein 8L (AKAP8L). Using biochemical assays, we found that the N-terminal region of AKAP8L binds to mTORC1 in the cytoplasm. Importantly, loss of AKAP8L decreased mTORC1-mediated processes such as translation, cell growth, and cell proliferation. AKAPs anchor protein kinase A (PKA) through PKA regulatory subunits, and we show that AKAP8L can anchor PKA through regulatory subunit I?. Reintroducing full-length AKAP8L into cells restored mTORC1-regulated processes, whereas reintroduction of AKAP8L missing the N-terminal region that confers the interaction with mTORC1 did not. Our results suggest a multifaceted role for AKAPs in the cell. We conclude that mTORC1 appears to regulate cell growth, perhaps in part through AKAP8L.	[Melick, Chase H.; Meng, Delong; Jewell, Jenna L.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd,Rm NA5-508A, Dallas, TX 75390 USA; [Melick, Chase H.; Meng, Delong; Jewell, Jenna L.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Melick, Chase H.; Meng, Delong; Jewell, Jenna L.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jewell, JL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd,Rm NA5-508A, Dallas, TX 75390 USA.	Jenna.Jewell@UTSouthwestern.edu		Meng, Delong/0000-0001-5183-4564; Melick, Chase/0000-0003-3977-9886; Jewell, Jenna/0000-0002-8021-9453	Cancer Prevention Research Institute of Texas (CPRIT) Scholar Recruitment of First-Time, Tenure-Track Faculty Member Grant [RR150032]; Cancer Prevention Research Institute of Texas (CPRIT) High-Impact/High-Risk Research Award [RP160713]; Welch Foundation [I-1927-20170325]; 2017 UT Southwestern President's Research Council Distinguished Researcher Award; American Cancer Society Institutional Research Grant [ACS-IRG-17-174-13]; National Institutes of Health [R01GM129097-01, T32GM008203]	Cancer Prevention Research Institute of Texas (CPRIT) Scholar Recruitment of First-Time, Tenure-Track Faculty Member Grant; Cancer Prevention Research Institute of Texas (CPRIT) High-Impact/High-Risk Research Award; Welch Foundation(The Welch Foundation); 2017 UT Southwestern President's Research Council Distinguished Researcher Award; American Cancer Society Institutional Research Grant(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Cancer Prevention Research Institute of Texas (CPRIT) Scholar Recruitment of First-Time, Tenure-Track Faculty Member Grant RR150032; Cancer Prevention Research Institute of Texas (CPRIT) High-Impact/High-Risk Research Award RP160713; Welch Foundation Grant I-1927-20170325; the 2017 UT Southwestern President's Research Council Distinguished Researcher Award; American Cancer Society Institutional Research Grant ACS-IRG-17-174-13; and National Institutes of Health Grants R01GM129097-01 (to J. L. J.) and T32GM008203 (to C. H. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; BARONI MD, 1989, MOL CELL BIOL, V9, P2715, DOI 10.1128/MCB.9.6.2715; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; COGHLAN VM, 1994, J BIOL CHEM, V269, P7658; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Eide T, 1998, EXP CELL RES, V238, P305, DOI 10.1006/excr.1997.3855; Esseltine JL, 2013, TRENDS PHARMACOL SCI, V34, P648, DOI 10.1016/j.tips.2013.10.005; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fonseca BD, 2015, J BIOL CHEM, V290, P15996, DOI 10.1074/jbc.M114.621730; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Gutzkow KB, 2003, CELL SIGNAL, V15, P871, DOI 10.1016/S0898-6568(03)00038-X; Han I, 2002, MOL CELL BIOL, V22, P2136, DOI 10.1128/MCB.22.7.2136-2146.2002; Hanlon CD, 2015, J CELL SCI, V128, P3533, DOI 10.1242/jcs.175158; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hong S, 2017, ELIFE, V6, DOI 10.7554/eLife.25237; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; JAHNSEN T, 1986, J BIOL CHEM, V261, P6637; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Jewell JL, 2019, ELIFE, V8, DOI 10.7554/eLife.43038; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; JOACHIM S, 1990, EUR J CELL BIOL, V51, P76; Kapiloff MS, 2014, J GEN PHYSIOL, V143, P9, DOI 10.1085/jgp.201311020; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KOYAMA S, 1993, CELL, V72, P945, DOI 10.1016/0092-8674(93)90582-B; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Lopez IP, 2013, MOL CELL BIOL, V33, P2903, DOI 10.1128/MCB.00031-13; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malbon CC, 2004, BIOCHEM J, V379, P1, DOI 10.1042/BJ20031648; Martins S, 2003, J CELL BIOL, V160, P177, DOI 10.1083/jcb.200210026; Martins SB, 2000, J CELL SCI, V113, P3703; Mavrakis M, 2006, HUM MOL GENET, V15, P2962, DOI 10.1093/hmg/ddl239; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Nandagopal N, 2015, TRANSLATION, V3, DOI 10.4161/21690731.2014.983402; NIGG EA, 1985, CELL, V41, P1039, DOI 10.1016/S0092-8674(85)80084-2; Orstavik S, 2000, BIOL CELL, V92, P27, DOI 10.1016/S0248-4900(00)88761-4; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pavlos NJ, 2017, TRENDS ENDOCRIN MET, V28, P213, DOI 10.1016/j.tem.2016.10.007; Philippe L, 2018, NUCLEIC ACIDS RES, V46, P1457, DOI 10.1093/nar/gkx1237; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Rinaldi L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.241; Roux PP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012252; RUBIN CS, 1972, J BIOL CHEM, V247, P6135; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; SALVATORI S, 1990, BIOCHEM J, V267, P679, DOI 10.1042/bj2670679; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SARKAR D, 1984, J BIOL CHEM, V259, P9840; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; TOKIWA G, 1994, NATURE, V371, P342, DOI 10.1038/371342a0; Westberg C, 2000, J BIOL CHEM, V275, P21396, DOI 10.1074/jbc.M909887199; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yang JP, 2001, J BIOL CHEM, V276, P30694, DOI 10.1074/jbc.M102809200; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang YY, 2017, J PROTEOME RES, V16, P2825, DOI 10.1021/acs.jproteome.7b00140; Zhu XZ, 2017, JOVE-J VIS EXP, DOI 10.3791/55218	74	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8096	8105		10.1074/jbc.AC120.012595	http://dx.doi.org/10.1074/jbc.AC120.012595			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32312749	Green Published, hybrid			2022-12-28	WOS:000540935400021
J	Radka, CD; Frank, MW; Yao, JW; Seetharaman, J; Miller, DJ; Rock, CO				Radka, Christopher D.; Frank, Matthew W.; Yao, Jiangwei; Seetharaman, Jayaraman; Miller, Darcie J.; Rock, Charles O.			The genome of a Bacteroidetes inhabitant of the human gut encodes a structurally distinct enoyl-acyl carrier protein reductase (FabI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; fatty acid synthase (FAS); microbiome; acyl carrier protein (ACP); crystal structure; Bacteroidetes; FabI; enoyl-acyl carrier protein reductase; fatty acid biosynthesis; Alistipes finegoldii; structural biology; gut microbiome; water channel; NADH binding	FATTY-ACID SYNTHESIS; IN-VITRO ACTIVITY; ACP-REDUCTASE; CRYSTAL-STRUCTURE; SUBSTRATE RECOGNITION; ANTIBACTERIAL AGENT; ISONIAZID TARGET; BINDING MODE; TRICLOSAN; INHIBITION	Enoyl-acyl carrier protein reductase (FabI) catalyzes a rate-controlling step in bacterial fatty-acid synthesis and is a target for antibacterial drug development. A phylogenetic analysis shows that FabIs fall into four divergent clades. Members of clades 1?3 have been structurally and biochemically characterized, but the fourth clade, found in members of phylum Bacteroidetes, is uncharacterized. Here, we identified the unique structure and conformational changes that distinguish clade 4 FabIs. Alistipes finegoldii is a prototypical Bacteroidetes inhabitant of the gut microbiome. We found that A. finegoldii FabI (AfFabI) displays cooperative kinetics and uses NADH as a cofactor, and its crystal structure at 1.72 ? resolution showed that it adopts a Rossmann fold as do other characterized FabIs. It also disclosed a carboxyl-terminal extension that forms a helix?helix interaction that links the protomers as a unique feature of AfFabI. An AfFabI?NADH crystal structure at 1.86 ? resolution revealed that this feature undergoes a large conformational change to participate in covering the NADH-binding pocket and establishing the water channels that connect the active site to the central water well. Progressive deletion of these interactions led to catalytically compromised proteins that fail to bind NADH. This unique conformational change imparted a distinct shape to the AfFabI active site that renders it refractory to a FabI drug that targets clade 1 and 3 pathogens. We conclude that the clade 4 FabI, found in the Bacteroidetes inhabitants of the gut, have several structural features and conformational transitions that distinguish them from other bacterial FabIs.	[Radka, Christopher D.; Frank, Matthew W.; Yao, Jiangwei; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Seetharaman, Jayaraman; Miller, Darcie J.] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA; [Yao, Jiangwei] Gen Dynam Informat Technol, 2 Corp Blvd NE, Atlanta, GA 30329 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Radka, Christopher D./AGX-1090-2022; Rock, Charles/N-2256-2018	Radka, Christopher D./0000-0002-6037-7710; Frank, Matthew/0000-0002-4914-1440; Yao, Jiangwei/0000-0001-7088-3468; JAYARAMAN, SEETHARAMAN/0000-0003-3942-9640; Rock, Charles/0000-0001-8648-4189	NIGMS, National Institutes of Health [GM034496]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by NIGMS, National Institutes of Health Grant GM034496 (to C. O. R.), Cancer Center Support Grant CA21765, and the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAKER ME, 1995, BIOCHEM J, V309, P1029, DOI 10.1042/bj3091029; Belluti F, 2013, J MED CHEM, V56, P7516, DOI 10.1021/jm400637m; BERGLER H, 1992, J GEN MICROBIOL, V138, P2093, DOI 10.1099/00221287-138-10-2093; Chen L., 2007, SE COLLABORATORY STR, p2P91; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; DeLano W.L, PYMOL MOL GRAPHICS S; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLOCCO MM, 1994, J MOL BIOL, V235, P709, DOI 10.1006/jmbi.1994.1022; Francino MP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01543; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Hafkin B, 2016, ANTIMICROB AGENTS CH, V60, P1695, DOI 10.1128/AAC.01741-15; Hartkoorn RC, 2012, EMBO MOL MED, V4, P1032, DOI 10.1002/emmm.201201689; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Hevener KE, 2018, ACTA CRYSTALLOGR F, V74, P105, DOI 10.1107/S2053230X18000262; Hirschbeck MW, 2012, STRUCTURE, V20, P89, DOI 10.1016/j.str.2011.07.019; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; Jackowski S, 2002, ANTIMICROB AGENTS CH, V46, P1246, DOI 10.1128/AAC.46.5.1246-1252.2002; Johnson EL, 2017, J MOL MED, V95, P1, DOI 10.1007/s00109-016-1492-2; Jordan C. A., 2015, CRYSTAL STRUCTURE E, p5CFZ; Jordan CA, 2015, ACTA CRYSTALLOGR F, V71, P1521, DOI 10.1107/S2053230X15022098; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaplan N, 2013, J CHEMOTHERAPY, V25, P18, DOI 10.1179/1973947812Y.0000000063; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; Karlowsky JA, 2009, ANTIMICROB AGENTS CH, V53, P3544, DOI 10.1128/AAC.00400-09; Keeney KM, 2014, ANNU REV MICROBIOL, V68, P217, DOI 10.1146/annurev-micro-091313-103456; Kim HT, 2017, BIOCHEM BIOPH RES CO, V493, P28, DOI 10.1016/j.bbrc.2017.09.084; Kim KH, 2011, J MOL BIOL, V406, P403, DOI 10.1016/j.jmb.2010.12.003; Kim SJ, 2010, BIOCHEM BIOPH RES CO, V400, P517, DOI 10.1016/j.bbrc.2010.08.083; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Luckner SR, 2010, J BIOL CHEM, V285, P14330, DOI 10.1074/jbc.M109.090373; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; Marrakchi H, 2002, J BIOL CHEM, V277, P44809, DOI 10.1074/jbc.M208920200; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mehboob S, 2012, J MED CHEM, V55, P5933, DOI 10.1021/jm300489v; Menetrey A, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01669-18; Muench SP, 2007, ACTA CRYSTALLOGR D, V63, P328, DOI 10.1107/S0907444906053625; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parikh S, 1999, BIOCHEMISTRY-US, V38, P13623, DOI 10.1021/bi990529c; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Perozzo R, 2002, J BIOL CHEM, V277, P13106, DOI 10.1074/jbc.M112000200; Pidugu LS, 2004, J MOL BIOL, V343, P147, DOI 10.1016/j.jmb.2004.08.033; Pojer F., 2012, MYCOBACTERIUM TUBERC, p4DRE; Priyadarshi A, 2010, PROTEINS, V78, P480, DOI 10.1002/prot.22581; Qiu XY, 1999, PROTEIN SCI, V8, P2529, DOI 10.1110/ps.8.11.2529; Radka CD, 2020, MOL MICROBIOL, V113, P807, DOI 10.1111/mmi.14445; Radka CD, 2017, ACTA CRYSTALLOGR D, V73, P921, DOI 10.1107/S2059798317015236; RAFFERTY JB, 1995, STRUCTURE, V3, P927, DOI 10.1016/S0969-2126(01)00227-1; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Saito J, 2008, PROTEIN SCI, V17, P691, DOI 10.1110/ps.073288808; Schiebel J, 2015, BIOCHEMISTRY-US, V54, P1943, DOI 10.1021/bi5014358; Schiebel J, 2012, STRUCTURE, V20, P802, DOI 10.1016/j.str.2012.03.013; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P., 2015, BASIC PRINCIPLES ANA; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Subramanya H., 2013, CRYSTAL STRUCTURE CO, p4JQC; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Ward WHJ, 1999, BIOCHEMISTRY-US, V38, P12514, DOI 10.1021/bi9907779; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wright ES, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0749-z; Yao J., 2014, CRYSTAL STRUCTURE CH, p4Q9N; Yao JW, 2017, BBA-MOL CELL BIOL L, V1862, P1300, DOI 10.1016/j.bbalip.2016.09.014; Yao JW, 2016, ANTIMICROB AGENTS CH, V60, P4264, DOI 10.1128/AAC.00535-16; Yao JW, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a027045; Yao JW, 2016, J BIOL CHEM, V291, P171, DOI 10.1074/jbc.M115.699462; Yao JW, 2014, J BIOL CHEM, V289, P22365, DOI 10.1074/jbc.M114.584185; Yao JW, 2013, J BIOL CHEM, V288, P36261, DOI 10.1074/jbc.M113.512905; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zhao HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126420; Zhao Huaying, 2013, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2012s71; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	83	4	4	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7635	7652		10.1074/jbc.RA120.013336	http://dx.doi.org/10.1074/jbc.RA120.013336			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32317282	hybrid, Green Published			2022-12-28	WOS:000538038900007
J	Sheppard, D; Berry, JL; Denise, R; Rocha, EPC; Matthews, S; Pelicic, V				Sheppard, Devon; Berry, Jamie-Lee; Denise, Remi; Rocha, Eduardo P. C.; Matthews, Steve; Pelicic, Vladimir			The major subunit of widespread competence pili exhibits a novel and conserved type IV pilin fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA transformation; protein structure; type IV pili; nuclear magnetic resonance (NMR); phylogenetics; DNA uptake; Streptococcus sanguinis; type IV filaments; type IV pilin	PSEUDOMONAS-AERUGINOSA; DNA-BINDING; PROTEIN; TRANSFORMATION; NEISSERIA; ALIGNMENT; SOFTWARE; SEQUENCE; COMGC	Type IV filaments (T4F), which are helical assemblies of type IV pilins, constitute a superfamily of filamentous nanomachines virtually ubiquitous in prokaryotes that mediate a wide variety of functions. The competence (Com) pilus is a widespread T4F, mediating DNA uptake (the first step in natural transformation) in bacteria with one membrane (monoderms), an important mechanism of horizontal gene transfer. Here, we report the results of genomic, phylogenetic, and structural analyses of ComGC, the major pilin subunit of Com pili. By performing a global comparative analysis, we show that Com pili genes are virtually ubiquitous in Bacilli, a major monoderm class of Firmicutes. This also revealed that ComGC displays extensive sequence conservation, defining a monophyletic group among type IV pilins. We further report ComGC solution structures from two naturally competent human pathogens, Streptococcus sanguinis (ComGC(SS)) and Streptococcus pneumoniae (ComGC(SP)), revealing that this pilin displays extensive structural conservation. Strikingly, ComGC(SS) and ComGC(SP) exhibit a novel type IV pilin fold that is purely helical. Results from homology modeling analyses suggest that the unusual structure of ComGC is compatible with helical filament assembly. Because ComGC displays such a widespread distribution, these results have implications for hundreds of monoderm species.	[Sheppard, Devon; Berry, Jamie-Lee; Pelicic, Vladimir] Imperial Coll London, Med Res Council, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Denise, Remi; Rocha, Eduardo P. C.] CNRS, UMR3525, Inst Pasteur, Microbial Evolutionary Genom, F-75015 Paris, France; [Denise, Remi] Sorbonne Univ, Coll Doctoral, F-75005 Paris, France; [Matthews, Steve] Imperial Coll London, Ctr Struct Biol, London SW7 2AZ, England	Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Imperial College London; University of London; Institute of Cancer Research - UK	Pelicic, V (corresponding author), Imperial Coll London, Med Res Council, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England.	v.pelicic@imperial.ac.uk	Rocha, Eduardo/B-7009-2009; Pelicic, Vladimir/ABD-3102-2021; Pelicic, Vladimir/N-3755-2017; Denise, Remi/AAQ-9468-2020	Rocha, Eduardo/0000-0001-7704-822X; Pelicic, Vladimir/0000-0002-9456-4995; Pelicic, Vladimir/0000-0002-9456-4995; Denise, Remi/0000-0003-2277-689X	Medical Research Council [MR/P022197/1, 2449/2016]; INCEPTION project [PIA/ANR-16-CONV-0005]; MRC [MR/P028225/1, MR/P022197/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); INCEPTION project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant MR/P022197/1 (to V. P.), Doctoral School Complexite du vivant-ED515 contract number 2449/2016 (to R. D.), and INCEPTION project PIA/ANR-16-CONV-0005 (to E. P. C. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Abby SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110726; ALBANO M, 1989, J BACTERIOL, V171, P5386, DOI 10.1128/jb.171.10.5386-5404.1989; Berry JL, 2019, J BIOL CHEM, V294, P6796, DOI 10.1074/jbc.RA118.006917; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Chen I, 2006, J BIOL CHEM, V281, P21720, DOI 10.1074/jbc.M604071200; CHUNG YS, 1995, MOL MICROBIOL, V15, P543, DOI 10.1111/j.1365-2958.1995.tb02267.x; Chung YS, 1998, MOL MICROBIOL, V29, P905, DOI 10.1046/j.1365-2958.1998.00989.x; Chung YS, 1998, J BACTERIOL, V180, P41, DOI 10.1128/JB.180.1.41-45.1998; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denise R, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000390; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Dress AWM, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-7; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dubnau D, 2019, ANNU REV GENET, V53, P217, DOI 10.1146/annurev-genet-112618-043641; Ellison CK, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay2591; Ellison CK, 2018, NAT MICROBIOL, V3, P773, DOI 10.1038/s41564-018-0174-y; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forest KT, 1999, MOL MICROBIOL, V31, P743, DOI 10.1046/j.1365-2958.1999.01184.x; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Gurung I, 2016, MOL MICROBIOL, V99, P380, DOI 10.1111/mmi.13237; Imam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028919; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kolappan S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13015; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; LaPointe CF, 2000, J BIOL CHEM, V275, P1502, DOI 10.1074/jbc.275.2.1502; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurenceau R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003473; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lopez-Castilla A, 2017, NAT MICROBIOL, V2, P1686, DOI 10.1038/s41564-017-0041-2; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; MOHAN S, 1989, J BACTERIOL, V171, P6043, DOI 10.1128/jb.171.11.6043-6051.1989; Muschiol S, 2017, J BIOL CHEM, V292, P14134, DOI 10.1074/jbc.M117.787671; Orekhov VY, 2011, PROG NUCL MAG RES SP, V59, P271, DOI 10.1016/j.pnmrs.2011.02.002; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pelicic V, 2019, MOL MICROBIOL, V112, P1674, DOI 10.1111/mmi.14397; Reardon PN, 2013, J BIOL CHEM, V288, P29260, DOI 10.1074/jbc.M113.498527; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Wang FB, 2017, STRUCTURE, V25, P1423, DOI 10.1016/j.str.2017.07.016; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427	51	6	6	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6594	6604		10.1074/jbc.RA120.013316	http://dx.doi.org/10.1074/jbc.RA120.013316			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32273343	hybrid, Green Published			2022-12-28	WOS:000537685000028
J	Song, JY; Lee, HY; Yang, HW; Song, JJ; Lagarias, JC; Park, YI				Song, Ji-Young; Lee, Ha Yong; Yang, Hee Wook; Song, Ji-Joon; Lagarias, J. Clark; Park, Youn-Il			Spectral and photochemical diversity of tandem cysteine cyanobacterial phytochromes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; plant; algae; photosynthesis; photoreceptor; Color sensing; dual cysteine phytochromes; phycocyanobilin; protochromism; violet and blue light photoreceptors	CHROMOPHORE CONTENT; HISTIDINE KINASES; CRYSTAL-STRUCTURE; DOMAIN; PHOTOCONVERSION; REVEALS; BACTERIOPHYTOCHROME; PHYCOVIOLOBILIN; MODULE; DIVERSIFICATION	The atypical trichromatic cyanobacterial phytochrome NpTP1 from Nostoc punctiforme ATCC 29133 is a linear tetrapyrrole (bilin)-binding photoreceptor protein that possesses tandem-cysteine residues responsible for shifting its light-sensing maximum to the violet spectral region. Using bioinformatics and phylogenetic analyses, here we established that tandem-cysteine cyanobacterial phytochromes (TCCPs) compose a well-supported monophyletic phytochrome lineage distinct from prototypical red/far-red cyanobacterial phytochromes. To investigate the light-sensing diversity of this family, we compared the spectroscopic properties of NpTP1 (here renamed NpTCCP) with those of three phylogenetically diverged TCCPs identified in the draft genomes of Tolypothrix sp. PCC7910, Scytonema sp. PCC10023, and Gloeocapsa sp. PCC7513. Recombinant photosensory core modules of ToTCCP, ScTCCP, and GlTCCP exhibited violet-blue?absorbing dark-states consistent with dual thioether-linked phycocyanobilin (PCB) chromophores. Photoexcitation generated singly-linked photoproduct mixtures with variable ratios of yellow-orange and red-absorbing species. The photoproduct ratio was strongly influenced by pH and by mutagenesis of TCCP- and phytochrome-specific signature residues. Our experiments support the conclusion that both photoproduct species possess protonated 15E bilin chromophores, but differ in the ionization state of the noncanonical ?second? cysteine sulfhydryl group. We found that the ionization state of this and other residues influences subsequent conformational change and downstream signal transmission. We also show that tandem-cysteine phytochromes present in eukaryotes possess similar amino acid substitutions within their chromophore-binding pocket, which tune their spectral properties in an analogous fashion. Taken together, our findings provide a roadmap for tailoring the wavelength specificity of plant phytochromes to optimize plant performance in diverse natural and artificial light environments.	[Song, Ji-Young; Lee, Ha Yong; Yang, Hee Wook; Park, Youn-Il] Chungnam Natl Univ, Dept Biol Sci, Daejeon 34134, South Korea; [Song, Ji-Joon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea; [Song, Ji-Joon] Korea Adv Inst Sci & Technol, KI BioCentury, Daejeon 34141, South Korea; [Lagarias, J. Clark] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Chungnam National University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California Davis	Park, YI (corresponding author), Chungnam Natl Univ, Dept Biol Sci, Daejeon 34134, South Korea.; Lagarias, JC (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	jclagarias@ucdavis.edu; yipark@cnu.ac.kr	Lagarias, John Clark/L-3139-2013; Song, Ji-Joon/C-1721-2011	Lagarias, John Clark/0000-0002-2093-0403; Park, Youn-Il/0000-0003-2912-2821; Song, Ji-Young/0000-0003-3964-1094; Song, Ji-Joon/0000-0001-7120-6311	Next-Generation BioGreen 21 Program, Rural Development Administration [PJ013118]; KIST Open Research Program [2E27512-17-122]; Ministry of Oceans and Fisheries Grant, Korea [20180430]; National Institutes of Health [R01 GM068552]; United States Department of Agriculture National Institute of Food and Agriculture Hatch project [CA-D*-MCB-4126-H]; Chemical Sciences, Geosciences, and the Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy [DE-FG02-09ER16117]	Next-Generation BioGreen 21 Program, Rural Development Administration; KIST Open Research Program; Ministry of Oceans and Fisheries Grant, Korea; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture National Institute of Food and Agriculture Hatch project; Chemical Sciences, Geosciences, and the Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy(United States Department of Energy (DOE))	This work was supported by Next-Generation BioGreen 21 Program, Rural Development Administration Grant PJ013118, KIST Open Research Program Grant 2E27512-17-122, the Collaborative Genome Program funded by Ministry of Oceans and Fisheries Grant 20180430, Korea (to Y.-I. P.), and National Institutes of Health Grant R01 GM068552, United States Department of Agriculture National Institute of Food and Agriculture Hatch project number CA-D*-MCB-4126-H, and Chemical Sciences, Geosciences, and the Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy Grant DE-FG02-09ER16117 (to J. C. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders K, 2013, J BIOL CHEM, V288, P35714, DOI 10.1074/jbc.M113.510461; [Anonymous], [No title captured]; [Anonymous], [No title captured]; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; Biswas A, 2011, J BIOL CHEM, V286, P35509, DOI 10.1074/jbc.M111.284281; BRANDLMEIER T, 1981, Z NATURFORSCH C, V36, P431; Buhl E, 2018, J PHYS CHEM LETT, V9, P7180, DOI 10.1021/acs.jpclett.8b03382; Buhrke D, 2020, BIOCHEMISTRY-US, V59, P509, DOI 10.1021/acs.biochem.9b00931; Burgie ES, 2020, P NATL ACAD SCI USA, V117, P300, DOI 10.1073/pnas.1912041116; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Burgie ES, 2013, STRUCTURE, V21, P88, DOI 10.1016/j.str.2012.11.001; Cho SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40576; Cho SM, 2015, J BIOL CHEM, V290, P28502, DOI 10.1074/jbc.M115.669150; Cornilescu CC, 2014, J BIOL CHEM, V289, P3055, DOI 10.1074/jbc.M113.531053; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Enomoto G, 2012, BIOCHEMISTRY-US, V51, P3050, DOI 10.1021/bi300020u; Escobar FV, 2017, J PHYS CHEM B, V121, P47, DOI 10.1021/acs.jpcb.6b09600; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Fischer AJ, 2005, BIOCHEMISTRY-US, V44, P15203, DOI 10.1021/bi051633z; Fortunato AE, 2016, PLANT CELL, V28, P616, DOI 10.1105/tpc.15.00928; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Giraud E, 2002, NATURE, V417, P202, DOI 10.1038/417202a; GLAZER AN, 1973, J BIOL CHEM, V248, P659; Hasegawa M, 2018, J BIOL CHEM, V293, P1713, DOI 10.1074/jbc.M117.816553; Hirose Y, 2013, P NATL ACAD SCI USA, V110, P4974, DOI 10.1073/pnas.1302909110; Ishizuka T, 2007, PLANT CELL PHYSIOL, V48, P1385, DOI 10.1093/pcp/pcm106; Ishizuka T, 2011, BIOCHEMISTRY-US, V50, P953, DOI 10.1021/bi101626t; Jorissen HJMM, 2002, PHOTOCHEM PHOTOBIOL, V75, P554, DOI 10.1562/0031-8655(2002)075<0554:PWNBCT>2.0.CO;2; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Kim PW, 2014, BIOCHEMISTRY-US, V53, P4601, DOI 10.1021/bi5005359; Kim PW, 2014, BIOCHEMISTRY-US, V53, P2818, DOI 10.1021/bi500108s; Kirpich JS, 2018, J PHYS CHEM LETT, V9, P3454, DOI 10.1021/acs.jpclett.8b01133; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li FW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8852; Lim S, 2018, P NATL ACAD SCI USA, V115, P4387, DOI 10.1073/pnas.1720682115; Narikawa R, 2014, BIOCHEMISTRY-US, V53, P5051, DOI 10.1021/bi500376b; Narikawa R, 2013, P NATL ACAD SCI USA, V110, P918, DOI 10.1073/pnas.1212098110; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2020, NEW PHYTOL, V225, P2283, DOI 10.1111/nph.16240; Rockwell NC, 2017, CURR OPIN PLANT BIOL, V37, P87, DOI 10.1016/j.pbi.2017.04.003; Rockwell NC, 2014, P NATL ACAD SCI USA, V111, P3871, DOI 10.1073/pnas.1401871111; Rockwell NC, 2012, BIOCHEMISTRY-US, V51, P1449, DOI 10.1021/bi201783j; Rockwell NC, 2011, P NATL ACAD SCI USA, V108, P11854, DOI 10.1073/pnas.1107844108; Rockwell NC, 2010, CHEMPHYSCHEM, V11, P1172, DOI 10.1002/cphc.200900894; Sato T, 2019, J BIOL CHEM, V294, P18909, DOI 10.1074/jbc.RA119.010384; Schirrmeister BE, 2013, P NATL ACAD SCI USA, V110, P1791, DOI 10.1073/pnas.1209927110; Schmidt A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07392-7; Shang LX, 2010, BIOCHEMISTRY-US, V49, P6070, DOI 10.1021/bi100756x; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Song JY, 2011, P NATL ACAD SCI USA, V108, P10780, DOI 10.1073/pnas.1104242108; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Takala H, 2014, NATURE, V509, P245, DOI 10.1038/nature13310; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Zhang JR, 2013, PLANT PHYSIOL, V161, P1445, DOI 10.1104/pp.112.208892; Zhao KH, 2012, HANDB PORPHYR SCI, V22, P1	64	5	5	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6754	6766		10.1074/jbc.RA120.012950	http://dx.doi.org/10.1074/jbc.RA120.012950			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32184354	hybrid, Green Published			2022-12-28	WOS:000537685000039
J	Basu, A; Shields, KE; Yap, MNF				Basu, Arnab; Shields, Kathryn E.; Yap, Mee-Ngan F.			The hibernating 100S complex is a target of ribosome-recycling factor and elongation factor G in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribosome; Staphylococcus aureus (S; aureus); GTPase; translation elongation factor; translation regulation; 100S ribosome; bacterial persistence; elongation factor G (EF-G); hibernation; ribosome-recycling factor (RRF)	PROMOTING FACTOR; ESCHERICHIA-COLI; EF-G; PSEUDOMONAS-AERUGINOSA; PROTEIN-SYNTHESIS; EXPRESSION; RRF; TRANSLATION; INITIATION; STABILITY	The formation of translationally inactive 70S dimers (called 100S ribosomes) by hibernation-promoting factor is a widespread survival strategy among bacteria. Ribosome dimerization is thought to be reversible, with the dissociation of the 100S complexes enabling ribosome recycling for participation in new rounds of translation. The precise pathway of 100S ribosome recycling has been unclear. We previously found that the heat-shock GTPase HflX in the human pathogen Staphylococcus aureus is a minor disassembly factor. Cells lacking hflX do not accumulate 100S ribosomes unless they are subjected to heat exposure, suggesting the existence of an alternative pathway during nonstressed conditions. Here, we provide biochemical and genetic evidence that two essential translation factors, ribosome-recycling factor (RRF) and GTPase elongation factor G (EF-G), synergistically split 100S ribosomes in a GTP-dependent but tRNA translocation-independent manner. We found that although HflX and the RRF/EF-G pair are functionally interchangeable, HflX is expressed at low levels and is dispensable under normal growth conditions. The bacterial RRF/EF-G pair was previously known to target only the post-termination 70S complexes; our results reveal a new role in the reversal of ribosome hibernation that is intimately linked to bacterial pathogenesis, persister formation, stress responses, and ribosome integrity.	[Basu, Arnab; Shields, Kathryn E.; Yap, Mee-Ngan F.] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Yap, Mee-Ngan F.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Saint Louis University; Northwestern University; Feinberg School of Medicine	Yap, MNF (corresponding author), St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA.; Yap, MNF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	frances.yap@northwestern.edu		Yap, Mee-Ngan F./0000-0003-4213-4050; Basu, Arnab/0000-0002-8048-8733	National Institutes of Health [GM121359]; Department of Defense Award [W81XWH-18-1-0122]; Northwestern University Faculty Start-up fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Award(United States Department of Defense); Northwestern University Faculty Start-up fund	This work was supported by National Institutes of Health Grant GM121359 (to M.-N. Y.), Department of Defense Award W81XWH-18-1-0122 (to M.-N. Y.), and the Northwestern University Faculty Start-up fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akanuma G, 2016, MICROBIOL-SGM, V162, P448, DOI 10.1099/mic.0.000234; Akiyama T, 2017, P NATL ACAD SCI USA, V114, P3204, DOI 10.1073/pnas.1700695114; Basu A, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00426-18; Basu A, 2017, P NATL ACAD SCI USA, V114, pE8165, DOI 10.1073/pnas.1709588114; Basu A, 2016, NUCLEIC ACIDS RES, V44, P4881, DOI 10.1093/nar/gkw180; Beckert B, 2018, NAT MICROBIOL, V3, P1115, DOI 10.1038/s41564-018-0237-0; Beckert B, 2017, EMBO J, V36, P2061, DOI 10.15252/embj.201696189; Boerema AP, 2018, NAT PLANTS, V4, P212, DOI 10.1038/s41477-018-0129-6; BRUCKNER R, 1992, GENE, V122, P187, DOI 10.1016/0378-1119(92)90048-T; Burroughs AM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081981; Caldas T, 2000, J BIOL CHEM, V275, P855, DOI 10.1074/jbc.275.2.855; Cerasi M, 2014, METALLOMICS, V6, P845, DOI 10.1039/c3mt00352c; Chen J, 2014, PLASMID, V76, P1, DOI 10.1016/j.plasmid.2014.08.001; Chen YW, 2017, NUCLEIC ACIDS RES, V45, P10168, DOI 10.1093/nar/gkx694; Coatham ML, 2016, NUCLEIC ACIDS RES, V44, P1952, DOI 10.1093/nar/gkv1524; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Davis AR, 2014, P NATL ACAD SCI USA, V111, P15379, DOI 10.1073/pnas.1410356111; Dey S, 2018, J CELL BIOL, V217, P2519, DOI 10.1083/jcb.201711131; Dzyubak E, 2016, ANTIMICROB AGENTS CH, V60, P7178, DOI 10.1128/AAC.01806-16; Feaga HA, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00009-20; Franken LE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00718-x; Fu Z, 2016, STRUCTURE, V24, P2092, DOI 10.1016/j.str.2016.09.014; Fuller JR, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00019; Gohara DW, 2018, CURR GENET, V64, P753, DOI 10.1007/s00294-017-0796-2; Hirokawa G, 2004, MOL MICROBIOL, V54, P1011, DOI 10.1111/j.1365-2958.2004.04324.x; Hirokawa G, 2008, NUCLEIC ACIDS RES, V36, P6676, DOI 10.1093/nar/gkn647; Hood RD, 2016, P NATL ACAD SCI USA, V113, pE4867, DOI 10.1073/pnas.1524915113; Iwakura N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177972; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; Keiler KC, 2015, NAT REV MICROBIOL, V13, P285, DOI 10.1038/nrmicro3438; Khusainov I, 2017, EMBO J, V36, P2073, DOI 10.15252/embj.201696105; Kline BC, 2015, J BACTERIOL, V197, P581, DOI 10.1128/JB.02223-14; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Li YL, 2018, P NATL ACAD SCI USA, V115, P8191, DOI 10.1073/pnas.1804555115; Matzov D, 2019, FEBS J, V286, P3558, DOI 10.1111/febs.14968; Matzov D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00753-8; Mckay SL, 2015, ANTIMICROB AGENTS CH, V59, P6992, DOI 10.1128/AAC.01532-15; Medina LMP, 2019, MOL CELL PROTEOMICS, V18, P892, DOI 10.1074/mcp.RA118.001138; Michalik S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10059-w; Mohammad F, 2019, ELIFE, V8, DOI 10.7554/eLife.42591; Mohr D, 2000, EMBO J, V19, P3458, DOI 10.1093/emboj/19.13.3458; Moormeier DE, 2013, APPL ENVIRON MICROB, V79, P3413, DOI 10.1128/AEM.00395-13; Orelle C, 2015, NATURE, V524, P119, DOI 10.1038/nature14862; Polikanov YS, 2012, SCIENCE, V336, P915, DOI 10.1126/science.1218538; Prabhakar A, 2017, CELL REP, V20, P161, DOI 10.1016/j.celrep.2017.06.028; Prossliner T, 2018, ANNU REV GENET, V52, P321, DOI 10.1146/annurev-genet-120215-035130; Puri P, 2014, MOL MICROBIOL, V91, P394, DOI 10.1111/mmi.12468; Qin B, 2016, J MOL BIOL, V428, P3577, DOI 10.1016/j.jmb.2016.05.019; Raj VS, 2005, RNA, V11, P275, DOI 10.1261/rna.7201805; Rodnina MV, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032664; Savelsbergh A, 2000, J MOL BIOL, V300, P951, DOI 10.1006/jmbi.2000.3886; Shcherbakova K, 2015, GENES CELLS, V20, P789, DOI 10.1111/gtc.12273; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Trauner A, 2012, J BIOL CHEM, V287, P24053, DOI 10.1074/jbc.M112.364851; Trosch R, 2019, BIOL CHEM, V400, P879, DOI 10.1515/hsz-2018-0436; Ueta M, 2008, J BIOCHEM, V143, P425, DOI 10.1093/jb/mvm243; Ueta M, 2013, GENES CELLS, V18, P554, DOI 10.1111/gtc.12057; Ueta M, 2010, GENES CELLS, V15, P43, DOI 10.1111/j.1365-2443.2009.01364.x; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Yamami T, 2005, MOL MICROBIOL, V55, P150, DOI 10.1111/j.1365-2958.2004.04387.x; Yamamoto H, 2016, P NATL ACAD SCI USA, V113, pE1180, DOI 10.1073/pnas.1524554113; Yoshida H, 2014, WIRES RNA, V5, P723, DOI 10.1002/wrna.1242; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016; Zhang LQ, 2006, ARCH BIOCHEM BIOPHYS, V450, P191, DOI 10.1016/j.abb.2006.03.029; Zhang YQ, 2015, NAT STRUCT MOL BIOL, V22, P906, DOI 10.1038/nsmb.3103; Zhou DJ, 2020, NAT STRUCT MOL BIOL, V27, P25, DOI 10.1038/s41594-019-0350-7	66	7	8	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6053	6063		10.1074/jbc.RA119.012307	http://dx.doi.org/10.1074/jbc.RA119.012307			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32209660	hybrid, Green Published			2022-12-28	WOS:000531417300017
J	Sevrieva, IR; Brandmeier, B; Ponnam, S; Gautel, M; Irving, M; Campbell, KS; Sun, YB; Kampourakis, T				Sevrieva, Ivanka R.; Brandmeier, Birgit; Ponnam, Saraswathi; Gautel, Mathias; Irving, Malcom; Campbell, Kenneth S.; Sun, Yin-Biao; Kampourakis, Thomas			Cardiac myosin regulatory light chain kinase modulates cardiac contractility by phosphorylating both myosin regulatory light chain and troponin I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiomyocyte; posttranslational modification (PTM); myosin; troponin; contractile protein; calcium signalling; cardiac muscle regulation; cardiac myosin light chain kinase; heart function; troponin I phosphorylation	HUMAN HEART; CONSTITUTIVE PHOSPHORYLATION; VENTRICULAR MYOCARDIUM; MUSCLE; DEPHOSPHORYLATION; KINETICS; AFFINITY; STRETCH	Heart muscle contractility and performance are controlled by posttranslational modifications of sarcomeric proteins. Although myosin regulatory light chain (RLC) phosphorylation has been studied extensively in vitro and in vivo, the precise role of cardiac myosin light chain kinase (cMLCK), the primary kinase acting upon RLC, in the regulation of cardiomyocyte contractility remains poorly understood. In this study, using recombinantly expressed and purified proteins, various analytical methods, in vitro and in situ kinase assays, and mechanical measurements in isolated ventricular trabeculae, we demonstrate that human cMLCK is not a dedicated kinase for RLC but can phosphorylate other sarcomeric proteins with well-characterized regulatory functions. We show that cMLCK specifically monophosphorylates Ser(23) of human cardiac troponin I (cTnI) in isolation and in the trimeric troponin complex in vitro and in situ in the native environment of the muscle myofilament lattice. Moreover, we observed that human cMLCK phosphorylates rodent cTnI to a much smaller extent in vitro and in situ, suggesting species-specific adaptation of cMLCK. Although cMLCK treatment of ventricular trabeculae exchanged with rat or human troponin increased their cross-bridge kinetics, the increase in sensitivity of myofilaments to calcium was significantly blunted by human TnI, suggesting that human cTnI phosphorylation by cMLCK modifies the functional consequences of RLC phosphorylation. We propose that cMLCK-mediated phosphorylation of TnI is functionally significant and represents a critical signaling pathway that coordinates the regulatory states of thick and thin filaments in both physiological and potentially pathophysiological conditions of the heart.	[Sevrieva, Ivanka R.; Brandmeier, Birgit; Ponnam, Saraswathi; Gautel, Mathias; Irving, Malcom; Sun, Yin-Biao; Kampourakis, Thomas] Kings Coll London, Randall Ctr Cell & Mol Biophys, London SE1 1UL, England; [Sevrieva, Ivanka R.; Brandmeier, Birgit; Ponnam, Saraswathi; Gautel, Mathias; Irving, Malcom; Sun, Yin-Biao; Kampourakis, Thomas] Kings Coll London, British Heart Fdn, Ctr Res Excellence, London SE1 1UL, England; [Campbell, Kenneth S.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA	University of London; King's College London; University of London; King's College London; University College London; University of Kentucky	Kampourakis, T (corresponding author), Kings Coll London, Randall Ctr Cell & Mol Biophys, London SE1 1UL, England.; Kampourakis, T (corresponding author), Kings Coll London, British Heart Fdn, Ctr Res Excellence, London SE1 1UL, England.	thomas.kampourakis@kcl.ac.uk	; Sun, Yin-Biao/F-9988-2018	Ponnam, Saraswathi/0000-0002-5592-3684; Kampourakis, Thomas/0000-0002-8269-1567; Sun, Yin-Biao/0000-0002-4992-8198; Sevrieva, Ivanka/0000-0001-8471-6484	British Heart Foundation [FS/16/3/31887, FS/15/1/31071]; British Heart Foundation Chair of Molecular Cardiology [CH/08/001]	British Heart Foundation(British Heart Foundation); British Heart Foundation Chair of Molecular Cardiology	This study was supported by British Heart Foundation Basic Science Intermediate Fellowship FS/16/3/31887 (to T. K.), Senior Basic Science Fellowship FS/15/1/31071 (to Y.-B. S.), and British Heart Foundation Chair of Molecular Cardiology CH/08/001 (to M. G. and B. B.) The authors declare that they have no conflicts of interest with the contents of this article.	Al Madhoun AS, 2011, EMBO J, V30, P2477, DOI 10.1038/emboj.2011.153; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Bunch TA, 2018, J MOL CELL CARDIOL, V125, P140, DOI 10.1016/j.yjmcc.2018.10.009; Chan JY, 2008, CIRC RES, V102, P571, DOI 10.1161/CIRCRESAHA.107.161687; Chang AN, 2015, J BIOL CHEM, V290, P10703, DOI 10.1074/jbc.M115.642165; Chung JH, 2018, J MOL CELL CARDIOL, V121, P81, DOI 10.1016/j.yjmcc.2018.07.005; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Ding PG, 2010, J BIOL CHEM, V285, P40819, DOI 10.1074/jbc.M110.160499; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; HERRING BP, 1992, J BIOL CHEM, V267, P25945; Hodatsu A, 2019, ESC HEART FAIL, V6, P406, DOI 10.1002/ehf2.12410; Huang J, 2008, J BIOL CHEM, V283, P19748, DOI 10.1074/jbc.M802605200; IKEBE M, 1994, J BIOL CHEM, V269, P28173; Isobe K, 2020, AM J PHYSIOL-RENAL, V318, pF600, DOI 10.1152/ajprenal.00431.2019; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kampourakis T, 2018, J PHYSIOL-LONDON, V596, P31, DOI 10.1113/JP275050; Kampourakis T, 2016, P NATL ACAD SCI USA, V113, pE3039, DOI 10.1073/pnas.1602776113; Kampourakis T, 2015, J MOL CELL CARDIOL, V85, P199, DOI 10.1016/j.yjmcc.2015.06.002; Keane NE, 1997, EUR J BIOCHEM, V248, P329, DOI 10.1111/j.1432-1033.1997.00329.x; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Kockskamper J, 2008, PROG BIOPHYS MOL BIO, V97, P250, DOI 10.1016/j.pbiomolbio.2008.02.026; Martin-Garrido A, 2018, J BIOL CHEM, V293, P8588, DOI 10.1074/jbc.RA117.001292; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Messer AE, 2009, PROTEOM CLIN APPL, V3, P1371, DOI 10.1002/prca.200900071; Monasky MM, 2010, J MOL CELL CARDIOL, V48, P1023, DOI 10.1016/j.yjmcc.2010.03.004; Perino A, 2012, CIRC RES, V111, P482, DOI 10.1161/CIRCRESAHA.111.262899; Pulcastro HC, 2016, ARCH BIOCHEM BIOPHYS, V601, P56, DOI 10.1016/j.abb.2015.12.014; Riise J, 2008, CARDIOVASC RES, V80, P407, DOI 10.1093/cvr/cvn216; Saad NS, 2018, LIFE SCI, V215, P119, DOI 10.1016/j.lfs.2018.10.065; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Scruggs SB, 2011, ARCH BIOCHEM BIOPHYS, V510, P129, DOI 10.1016/j.abb.2011.02.013; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134; Solaro RJ, 2013, CIRC RES, V112, P355, DOI 10.1161/CIRCRESAHA.112.268672; Sun YB, 2009, J PHYSIOL-LONDON, V587, P155, DOI 10.1113/jphysiol.2008.164707; Tobita T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17769-1; van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5; Varian KD, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/290971; Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202; Yuan CC, 2015, P NATL ACAD SCI USA, V112, pE4138, DOI 10.1073/pnas.1505819112; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773; ZHI G, 1994, J BIOL CHEM, V269, P24723	44	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4398	4410		10.1074/jbc.RA119.011945	http://dx.doi.org/10.1074/jbc.RA119.011945			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32086378	Green Published, hybrid			2022-12-28	WOS:000524499700004
J	Fila, T; Trazzi, S; Crochemore, C; Bartesaghi, R; Ciani, E				Fila, Tatiana; Trazzi, Stefania; Crochemore, Christophe; Bartesaghi, Renata; Ciani, Elisabetta			Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation (vol 284, pg 15325, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Fila T, 2009, J BIOL CHEM, V284, P15325, DOI 10.1074/jbc.M109.002329	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 13	2020	295	11					3746	3746		10.1074/jbc.AAC120.013005	http://dx.doi.org/10.1074/jbc.AAC120.013005			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LF9IB	32169856	hybrid, Green Published			2022-12-28	WOS:000527725300029
J	Ciani, E; Guidi, S; Della Valle, G; Perini, G; Bartesaghi, R; Contestabile, A				Ciani, Elisabetta; Guidi, Sandra; Della Valle, Giuliano; Perini, Giovanni; Bartesaghi, Renata; Contestabile, Antonio			RETRACTION: Withdrawal: Nitric oxide protects neuroblastoma cells from apoptosis induced by serum deprivation through cAMP-response element-binding protein (CREB) activation (Retraction of Vol 277, Pg 49896, 2002)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Retraction													Ciani, Elisabetta/AAL-6462-2020					Ciani E, 2002, J BIOL CHEM, V277, P49896, DOI 10.1074/jbc.M206177200	1	1	1	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3391	3391		10.1074/jbc.W120.012955	http://dx.doi.org/10.1074/jbc.W120.012955			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32144154	hybrid, Green Published			2022-12-28	WOS:000519597300045
J	Harbig, A; Mernberger, M; Bittel, L; Pleschka, S; Schughart, K; Steinmetzer, T; Stiewe, T; Nist, A; Bottcher-Friebertshauser, E				Harbig, Anne; Mernberger, Marco; Bittel, Linda; Pleschka, Stephan; Schughart, Klaus; Steinmetzer, Torsten; Stiewe, Thorsten; Nist, Andrea; Boettcher-Friebertshaeuser, Eva			Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						infectious disease; serine protease; trypsin; virus; mouse; airway proteases; hemagglutinin; influenza virus; cleavage; protease gene expression; TMPRSS2; TMPRSS4; hepsin; prostasin; trypsin-like protease; host-pathogen interactions; mouse lung proteases	TRANSMEMBRANE SERINE-PROTEASE; PROTEOLYTIC ACTIVATION; CLEAVAGE ACTIVATION; HEMAGGLUTININ; TMPRSS2; MATRIPTASE; HAT; IDENTIFICATION; PATHOGENICITY; REPLICATION	Cleavage of influenza virus hemagglutinin (HA) by host proteases is essential for virus infectivity. HA of most influenza A and B (IAV/IBV) viruses is cleaved at a monobasic motif by trypsin-like proteases. Previous studies have reported that transmembrane serine protease 2 (TMPRSS2) is essential for activation of H7N9 and H1N1pdm IAV in mice but that H3N2 IAV and IBV activation is independent of TMPRSS2 and carried out by as-yet-undetermined protease(s). Here, to identify additional H3 IAV- and IBV-activating proteases, we used RNA-Seq to investigate the protease repertoire of murine lower airway tissues, primary type II alveolar epithelial cells (AECIIs), and the mouse lung cell line MLE-15. Among 13 candidates identified, TMPRSS4, TMPRSS13, hepsin, and prostasin activated H3 and IBV HAin vitro. IBV activation and replication was reduced in AECIIs fromTmprss2/Tmprss4-deficient mice compared with WT or Tmprss2-deficient mice, indicating that murine TMPRSS4 is involved in IBV activation. Multicycle replication of H3N2 IAV and IBV in AECIIs ofTmprss2/Tmprss4-deficient mice varied in sensitivity to protease inhibitors, indicating that different, but overlapping, sets of murine proteases facilitate H3 and IBV HA cleavages. Interestingly, human hepsin and prostasin orthologs did not activate H3, but they did activate IBV HAin vitro. Our results indicate that TMPRSS4 is an IBV-activating protease in murine AECIIs and suggest that TMPRSS13, hepsin, and prostasin cleave H3 and IBV HA in mice. They further show that hepsin and prostasin orthologs might contribute to the differences observed in TMPRSS2-independent activation of H3 in murine and human airways.	[Harbig, Anne; Bittel, Linda; Boettcher-Friebertshaeuser, Eva] Philipps Univ, Inst Virol, D-35043 Marburg, Germany; [Mernberger, Marco; Stiewe, Thorsten] Philipps Univ, Inst Mol Oncol, German Ctr Lung Res, D-35043 Marburg, Germany; [Steinmetzer, Torsten] Philipps Univ, Inst Pharmaceut Chem, D-35043 Marburg, Germany; [Stiewe, Thorsten; Nist, Andrea] Philipps Univ, Genom Core Facil, D-35043 Marburg, Germany; [Pleschka, Stephan] Justus Liebig Univ, Inst Med Virol, D-35390 Giessen, Germany; [Schughart, Klaus] Helmholtz Ctr Infect Res, Dept Infect Genet, D-38124 Braunschweig, Germany; [Schughart, Klaus] Univ Vet Med Hannover, D-30559 Hannover, Germany; [Schughart, Klaus] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Justus Liebig University Giessen; Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation; University of Tennessee System; University of Tennessee Health Science Center	Bottcher-Friebertshauser, E (corresponding author), Philipps Univ Marburg, Inst Virol, Hans Meerwein Str 2, D-35043 Marburg, Germany.	friebertshaeuser@staff.uni-marburg.de	Pleschka, Stephan/HGU-9354-2022; Böttcher-Friebertshäuser, Eva/D-6266-2012	Stiewe, Thorsten/0000-0003-0134-7826; Pleschka, Stephan/0000-0002-7372-7089	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through the collaborative research center [SFB 1021]; Von-Behring Rontgen Stiftung; LOEWE Center DRUID; Helmholtz-Association (Program Infection and Immunity); German Ministry for Education and Research (BMBF)	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through the collaborative research center(German Research Foundation (DFG)); Von-Behring Rontgen Stiftung; LOEWE Center DRUID; Helmholtz-Association (Program Infection and Immunity)(Helmholtz Association); German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through the collaborative research center SFB 1021 (to E. B.-F. and S. P.), by the Von-Behring Rontgen Stiftung (to E. B.-F.), by the LOEWE Center DRUID (to E. B.-F. and T. S.), by intramural grants from the Helmholtz-Association (Program Infection and Immunity) (to K. S.), and by the German Ministry for Education and Research (BMBF)funded German Center for Infectious Diseases (DZIF) partner site Giessen (to S. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Baron J, 2013, J VIROL, V87, P1811, DOI 10.1128/JVI.02320-12; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Beaulieu A, 2013, J VIROL, V87, P4237, DOI 10.1128/JVI.03005-12; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Bottcher-Friebertshauser E, 2014, CURR TOP MICROBIOL, V385, P3, DOI 10.1007/82_2014_384; Bottcher-Friebertshauser E, 2012, VACCINE, V30, P7374, DOI 10.1016/j.vaccine.2012.10.001; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Bottcher-Friebertshauser E., 2018, ACTIVATION VIRUSES H, P153; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Guenet JL, 2005, GENOME RES, V15, P1729, DOI 10.1101/gr.3728305; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hamilton BS, 2013, J BIOL CHEM, V288, P17399, DOI 10.1074/jbc.M112.440362; Hamilton BS, 2012, J VIROL, V86, P10579, DOI 10.1128/JVI.00306-12; Hammami M, 2012, MEDCHEMCOMM, V3, P807, DOI 10.1039/c2md20074k; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Keppner A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135224; Kido Hiroshi, 2008, J Mol Genet Med, V3, P167; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Koutsakos M, 2016, FUTURE MICROBIOL, V11, P119, DOI 10.2217/fmb.15.120; Kuhn N, 2016, J VIROL, V90, P4298, DOI 10.1128/JVI.02693-15; Lambertz RLO, 2019, J GEN VIROL, V100, P1073, DOI 10.1099/jgv.0.001274; Laporte M, 2020, J VIROL, V94, DOI 10.1128/JVI.01430-19; Leu CH, 2015, ANTIMICROB AGENTS CH, V59, P5619, DOI 10.1128/AAC.00065-15; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Limburg H, 2019, J VIROL, V93, DOI 10.1128/JVI.00649-19; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu YH, 2015, ANTIVIR RES, V120, P89, DOI 10.1016/j.antiviral.2015.05.006; Madsen DH, 2014, BIOCHEM J, V461, P487, DOI 10.1042/BJ20140337; Magnen M, 2018, BIOL CHEM, V399, P1053, DOI 10.1515/hsz-2017-0340; Massucci MT, 2004, BIOMETALS, V17, P249, DOI 10.1023/B:BIOM.0000027700.90780.45; Meyer D, 2013, BIOCHEM J, V452, P331, DOI 10.1042/BJ20130101; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; OVCHARENKO AV, 1994, ANTIVIR RES, V23, P107, DOI 10.1016/0166-3542(94)90038-8; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Peters DE, 2014, J BIOL CHEM, V289, P14740, DOI 10.1074/jbc.M113.541318; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Sakai K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29430; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; SCHEIBLAUER H, 1992, J INFECT DIS, V166, P783, DOI 10.1093/infdis/166.4.783; Sisay MT, 2010, J MED CHEM, V53, P5523, DOI 10.1021/jm100183e; Stech J, 2005, NAT MED, V11, P683, DOI 10.1038/nm1256; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Szabo R, 2016, DEVELOPMENT, V143, P2818, DOI 10.1242/dev.137968; Tanabe LM, 2017, FEBS J, V284, P1421, DOI 10.1111/febs.13971; Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wong GW, 2001, J BIOL CHEM, V276, P49169, DOI 10.1074/jbc.M108677200; Yoon SW, 2014, CURR TOP MICROBIOL, V385, P359, DOI 10.1007/82_2014_396; Zhirnov OP, 2011, ANTIVIR RES, V92, P27, DOI 10.1016/j.antiviral.2011.07.014; Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14	55	13	15	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11388	11407		10.1074/jbc.RA120.012635	http://dx.doi.org/10.1074/jbc.RA120.012635			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32303635	Green Published, hybrid			2022-12-28	WOS:000563922500002
J	Kim, HJ; Lee, H; Lee, Y; Choi, I; Ko, Y; Lee, S; Jang, S				Kim, Hyung Jun; Lee, Hyunjung; Lee, Yunmi; Choi, Inhee; Ko, Yoonae; Lee, Sangchul; Jang, Soojin			The ThiL enzyme is a valid antibacterial target essential for both thiamine biosynthesis and salvage pathways inPseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thiamine; thiamine monophosphate kinase; bacterial metabolism; bacterial pathogenesis; Pseudomonas aeruginosa; infection; antibacterial target; PaThiL; virulence; drug target	RESISTANT PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; MONOPHOSPHATE KINASE; MUTANT; GENES; PYROPHOSPHOKINASE; PLASMID; DISEASE; DESIGN	Thiamine pyrophosphate (TPP) is an essential cofactor for various pivotal cellular processes in all living organisms, including bacteria. Thiamine biosynthesis occurs in bacteria but not in humans; therefore, the enzymes in this pathway are attractive targets for antibiotic development. Among these enzymes, thiamine monophosphate kinase (ThiL) catalyzes the final step of this pathway, phosphorylating thiamine monophosphate to produce TPP. Here, we extensively investigated ThiL inPseudomonas aeruginosa, a major pathogen responsible for hospital-acquired infections. We demonstrate thatthiLdeletion abolishes not only thiamine biosynthesis but also thiamine salvage capability and results in growth defects of the ?thiLstrain even in the presence of thiamine derivatives, except for TPP. Most importantly, the pathogenesis of the ?thiLstrain was markedly attenuated, compared with that of WT cells, with lower inflammatory cytokine induction and 10(3)?10(4)-fold decreased bacterial loads in anin vivoinfection model in which the intracellular TPP level was in the submicromolar range. To validateP. aeruginosaThiL (PaThiL) as a drug target, we further characterized its biochemical properties, determining aV(max)of 4.0 ? 0.2 nmol?min(?1)andK(m)values of 111 ? 8 and 8.0 ? 3.5 ?mfor ATP and thiamine monophosphate, respectively. Anin vitrosmall-molecule screening assay identified PaThiL inhibitors including WAY213613, a noncompetitive inhibitor with aK(i)value of 13.4 ? 2.3 ?mand potential antibacterial activity againstP. aeruginosa. These comprehensive biological and biochemical results indicate that PaThiL represents a potential drug target for the development of an augmented repertoire of antibiotics againstP. aeruginosa.	[Kim, Hyung Jun; Lee, Hyunjung; Lee, Yunmi; Jang, Soojin] Inst Pasteur Korea, Discovery Biol Dept, Antibacterial Resistance Lab, Seongnam Si, Gyeonggi Do, South Korea; [Choi, Inhee; Ko, Yoonae; Lee, Sangchul] Inst Pasteur Korea, Translat Res Dept, Med Chem, Seongnam Si, Gyeonggi Do, South Korea	Institut Pasteur Korea; Institut Pasteur Korea	Jang, S (corresponding author), Inst Pasteur Korea, Discovery Biol Dept, Antibacterial Resistance Lab, Seongnam Si, Gyeonggi Do, South Korea.	soojin.jang@ip-korea.org			National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2017M3A9G6068246]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (Grant NRF-2017M3A9G6068246), as well as Gyeonggi-do.	de Andrade JAA, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-11; Barbier F, 2010, M S-MED SCI, V26, P960, DOI 10.1051/medsci/20102611960; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; Botelho J, 2019, DRUG RESIST UPDATE, V44, P26, DOI 10.1016/j.drup.2019.07.002; Branski LK, 2009, SURG INFECT, V10, P389, DOI 10.1089/sur.2009.024; Bunik VI, 2013, FEBS J, V280, P6412, DOI 10.1111/febs.12512; Chatzinikolaou I, 2000, ARCH INTERN MED, V160, P501, DOI 10.1001/archinte.160.4.501; Cho JH, 2013, BIOCHIMIE, V95, P1411, DOI 10.1016/j.biochi.2013.03.007; Choi J, 2018, INT J CHRONIC OBSTR, V13, P3077, DOI 10.2147/COPD.S173759; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Cruz MC, 2002, EMBO J, V21, P546, DOI 10.1093/emboj/21.4.546; Dhir S, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00207; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Fernandes M, 2016, GRAEF ARCH CLIN EXP, V254, P315, DOI 10.1007/s00417-015-3208-7; Filloux A, 2014, METHODS MOL BIOL, V1149, P1, DOI 10.1007/978-1-4939-0473-0; Frank RAW, 2007, CELL MOL LIFE SCI, V64, P892, DOI 10.1007/s00018-007-6423-5; Gangolf M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013616; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Gigliobianco T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-148; Glasser NR, 2017, J BIOL CHEM, V292, P5593, DOI 10.1074/jbc.M116.772848; IMAMURA N, 1982, J BACTERIOL, V151, P708, DOI 10.1128/JB.151.2.708-717.1982; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Karunakaran R, 2006, J BACTERIOL, V188, P6661, DOI 10.1128/JB.00641-06; Khare G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022441; Krucinska J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53301-3; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; Leonardi R, 2004, J BIOL CHEM, V279, P17054, DOI 10.1074/jbc.M312714200; Lunse CE, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00053; Lunse CE, 2014, INT J MED MICROBIOL, V304, P79, DOI 10.1016/j.ijmm.2013.09.002; Manfredi R, 2000, EUR J EPIDEMIOL, V16, P111, DOI 10.1023/A:1007626410724; McCulloch KM, 2008, BIOCHEMISTRY-US, V47, P3810, DOI 10.1021/bi800041h; Melnick J, 2004, J BACTERIOL, V186, P3660, DOI 10.1128/JB.186.11.3660-3662.2004; NAKAYAMA H, 1972, J BACTERIOL, V112, P1118, DOI 10.1128/JB.112.3.1118-1126.1972; NISHINO H, 1972, J BIOCHEM-TOKYO, V72, P1093, DOI 10.1093/oxfordjournals.jbchem.a129996; NOSAKA K, 1993, J BIOL CHEM, V268, P17440; Odum EP, 2012, NIGER J CLIN PRACT, V15, P442, DOI 10.4103/1119-3077.104522; Parkins MD, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00019-18; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Ruiz-Garbajosa P, 2017, REV ESP QUIM, V30, P8; Schweizer HP, 2001, CURR OPIN BIOTECH, V12, P439, DOI 10.1016/S0958-1669(00)00242-1; Settembre E, 2003, CURR OPIN STRUC BIOL, V13, P739, DOI 10.1016/j.sbi.2003.10.006; Singleton Charles K., 2001, Current Molecular Medicine (Hilversum), V1, P197, DOI 10.2174/1566524013363870; Sullivan AH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40558-x; Suzuki K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180279; Swier LJYM, 2015, CHEMBIOCHEM, V16, P819, DOI 10.1002/cbic.201402673; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/S1473-3099(17)30753-3, 10.1016/s1473-3099(17)30753-3]; Tylicki A, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171148; Wang JR, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-18; Webb E, 1997, J BIOL CHEM, V272, P15702, DOI 10.1074/jbc.272.25.15702; Wilson R, 2016, RESP MED, V117, P179, DOI 10.1016/j.rmed.2016.06.007	54	3	3	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2020	295	29					10081	10091		10.1074/jbc.RA120.013295	http://dx.doi.org/10.1074/jbc.RA120.013295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MR1DY	32404369	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000553333300027
J	Molina, M; Moulis, C; Monties, N; Guieysse, D; Morel, S; Cioci, G; Remaud-Simeon, M				Molina, Manon; Moulis, Claire; Monties, Nelly; Guieysse, David; Morel, Sandrine; Cioci, Gianluca; Remaud-Simeon, Magali			A specific oligosaccharide-binding site in the alternansucrase catalytic domain mediates alternan elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glucansucrase; alternan; biosourced; polysaccharide; GH70; polymerase; sugar-binding pockets; surface-binding site; processivity; alternansucrase; enzyme catalysis; enzyme mechanism; carbohydrate structure; biotechnology; dextran; green chemistry	CARBOHYDRATE-ACTIVE ENZYMES; MOLAR-MASS DEXTRAN; BRANCHING SUCRASE; GLUCANSUCRASE; SUCROSE	Microbial ?-glucans produced by GH70 (glycoside hydrolase family 70) glucansucrases are gaining importance because of the mild conditions for their synthesis from sucrose, their biodegradability, and their current and anticipated applications that largely depend on their molar mass. Focusing on the alternansucrase (ASR) fromLeuconostoc citreumNRRL B-1355, a well-known glucansucrase catalyzing the synthesis of both high- and low-molar-mass alternans, we searched for structural traits in ASR that could be involved in the control of alternan elongation. The resolution of five crystal structures of a truncated ASR version (ASR?2) in complex with different gluco-oligosaccharides pinpointed key residues in binding sites located in the A and V domains of ASR. Biochemical characterization of three single mutants and three double mutants targeting the sugar-binding pockets identified in domain V revealed an involvement of this domain in alternan binding and elongation. More strikingly, we found an oligosaccharide-binding site at the surface of domain A, distant from the catalytic site and not previously identified in other glucansucrases. We named this site surface-binding site (SBS) A1. Among the residues lining the SBS-A1 site, two (Gln(700)and Tyr(717)) promoted alternan elongation. Their substitution to alanine decreased high-molar-mass alternan yield by a third, without significantly impacting enzyme stability or specificity. We propose that the SBS-A1 site is unique to alternansucrase and appears to be designed to bind alternating structures, acting as a mediator between the catalytic site and the sugar-binding pockets of domain V and contributing to a processive elongation of alternan chains.	[Molina, Manon; Moulis, Claire; Monties, Nelly; Guieysse, David; Morel, Sandrine; Cioci, Gianluca; Remaud-Simeon, Magali] Univ Toulouse, Toulouse Biotechnol Inst TBI, CNRS, INRAE,INSA, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); INRAE; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite de Toulouse; Institut National des Sciences Appliquees de Toulouse	Cioci, G; Remaud-Simeon, M (corresponding author), Univ Toulouse, Toulouse Biotechnol Inst TBI, CNRS, INRAE,INSA, Toulouse, France.	cioci@insa-toulouse.fr; remaud@insa-toulouse.fr		MOULIS, Claire/0000-0002-1937-9052; GUIEYSSE, David/0000-0002-8802-4968; Molina, Manon/0000-0002-6323-8185				Albenne C, 2006, PROTEIN-STRUCT FUNCT, V66, P118, DOI DOI 10.1002/prot.21083; BIELY P, 1994, EUR J BIOCHEM, V226, P633, DOI 10.1111/j.1432-1033.1994.tb20090.x; Bounaix MS, 2010, INT J FOOD MICROBIOL, V144, P1, DOI 10.1016/j.ijfoodmicro.2010.05.026; Brison Y, 2016, J BIOL CHEM, V291, P7527, DOI 10.1074/jbc.M115.688796; Brison Y, 2012, J BIOL CHEM, V287, P7915, DOI 10.1074/jbc.M111.305078; Charoenwongpaiboon T, 2019, RSC ADV, V9, P4370, DOI 10.1039/c8ra10263e; Claverie M, 2020, J BIOL CHEM, V295, P5602, DOI 10.1074/jbc.RA119.011995; Claverie M, 2019, BIOCHEMISTRY-US, V58, P2853, DOI 10.1021/acs.biochem.9b00373; Claverie M, 2017, ACS CATAL, V7, P7106, DOI 10.1021/acscatal.7b02182; Cockburn D, 2014, BIOLOGIA, V69, P705, DOI 10.2478/s11756-014-0373-9; Cockburn D, 2013, SPR CARB CH, V39, P204, DOI 10.1039/9781849737173-00204; COTE GL, 1982, CARBOHYD RES, V101, P57, DOI 10.1016/S0008-6215(00)80795-8; Cote GL, 2003, ACS SYM SER, V849, P76; COTE GL, 1992, CARBOHYD POLYM, V19, P249, DOI 10.1016/0144-8617(92)90077-4; Cote GL, 2006, CARBOHYD RES, V341, P2066, DOI 10.1016/j.carres.2006.04.044; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuyvers S, 2012, CRIT REV BIOTECHNOL, V32, P93, DOI 10.3109/07388551.2011.561537; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dennes T. J., 2015, U.S. Patent, Patent No. [9,957,334, 9957334]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freitas F, 2011, TRENDS BIOTECHNOL, V29, P388, DOI 10.1016/j.tibtech.2011.03.008; Hernandez-Hernandez O, 2011, J AGR FOOD CHEM, V59, P10901, DOI 10.1021/jf202466s; Holt SM, 2005, LETT APPL MICROBIOL, V40, P385, DOI 10.1111/j.1472-765X.2005.01681.x; Hudson KL, 2015, J AM CHEM SOC, V137, P15152, DOI 10.1021/jacs.5b08424; Irague R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077837; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; Joucla G, 2006, FEBS LETT, V580, P763, DOI 10.1016/j.febslet.2006.01.001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Leathers TD, 2009, BIOTECHNOL LETT, V31, P289, DOI 10.1007/s10529-008-9866-3; Leemhuis H, 2013, J BIOTECHNOL, V163, P250, DOI 10.1016/j.jbiotec.2012.06.037; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Meng XF, 2017, FOOD CHEM, V217, P81, DOI 10.1016/j.foodchem.2016.08.087; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Molina M, 2019, ACS CATAL, V9, P2222, DOI 10.1021/acscatal.8b04510; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moscovici M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01012; Moulis C, 2006, J BIOL CHEM, V281, P31254, DOI 10.1074/jbc.M604850200; Moulis C, 2016, CELL MOL LIFE SCI, V73, P2661, DOI 10.1007/s00018-016-2244-8; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nivedha AK, 2016, J CHEM THEORY COMPUT, V12, P892, DOI 10.1021/acs.jctc.5b00834; Paullin J. L., 2013, U.S. Patent, Patent No. [9,139,718, 9139718]; Pijning T, 2012, ACTA CRYSTALLOGR F, V68, P1448, DOI 10.1107/S1744309112044168; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sanz ML, 2005, J AGR FOOD CHEM, V53, P5911, DOI 10.1021/jf050344e; Skov LK, 2002, J BIOL CHEM, V277, P47741, DOI 10.1074/jbc.M207860200; Soetaert W, 1995, PROGR BIOTECHNOL, V10, P351, DOI 10.1016/S0921-0423(06)80116-4; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Wangpaiboon K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26721-w; Wilkens C, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01652; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	54	4	4	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9474	9489		10.1074/jbc.RA120.013028	http://dx.doi.org/10.1074/jbc.RA120.013028			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32409580	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000552758600017
J	Nelson, AC; Turbyville, TJ; Dharmaiah, S; Rigby, M; Yang, RD; Wang, TY; Columbus, J; Stephens, R; Taylor, T; Sciacca, D; Onsongo, G; Sarver, A; Subramanian, S; Nissley, DV; Simanshu, DK; Lou, E				Nelson, Andrew C.; Turbyville, Thomas J.; Dharmaiah, Srisathiyanarayanan; Rigby, Megan; Yang, Rendong; Wang, Ting-You; Columbus, John; Stephens, Robert; Taylor, Troy; Sciacca, Drew; Onsongo, Getiria; Sarver, Anne; Subramanian, Subbaya; Nissley, Dwight, V; Simanshu, Dhirendra K.; Lou, Emil			RASinternal tandem duplication disrupts GTPase-activating protein (GAP) binding to activate oncogenic signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RAS protein; colon cancer; structural biology; protein structure; oncogene; bedside-to-bench analysis; exome sequencing; personalized medicine; switch II domain; tandem duplication	CANCER-RELATED ANALYSIS; MUTATIONS; RAS; VARIANTS; PLATFORM; BREAST; CSMD1; KRAS	The oncogene RAS is one of the most widely studied proteins in cancer biology, and mutant active RAS is a driver in many types of solid tumors and hematological malignancies. Yet the biological effects of differentRASmutations and the tissue-specific clinical implications are complex and nuanced. Here, we identified an internal tandem duplication (ITD) in the switch II domain of NRAS from a patient with extremely aggressive colorectal carcinoma. Results of whole-exome DNA sequencing of primary and metastatic tumors indicated that this mutation was present in all analyzed metastases and excluded the presence of any other clear oncogenic driver mutations. Biochemical analysis revealed increased interaction of the RAS ITD with Raf proto-oncogene Ser/Thr kinase (RAF), leading to increased phosphorylation of downstream MAPK/ERK kinase (MEK)/extracellular signal?regulated kinase (ERK). The ITD prevented interaction with neurofibromin 1 (NF1)?GTPase?activating protein (GAP), providing a mechanism for sustained activity of the RAS ITD protein. We present the first crystal structures of NRAS and KRAS ITD at 1.65?1.75 ? resolution, respectively, providing insight into the physical interactions of this class of RAS variants with its regulatory and effector proteins. Our in-depth bedside-to-bench analysis uncovers the molecular mechanism underlying a case of highly aggressive colorectal cancer and illustrates the importance of robust biochemical and biophysical approaches in the implementation of individualized medicine.	[Nelson, Andrew C.; Sciacca, Drew; Onsongo, Getiria] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Turbyville, Thomas J.; Dharmaiah, Srisathiyanarayanan; Rigby, Megan; Columbus, John; Stephens, Robert; Taylor, Troy; Nissley, Dwight, V; Simanshu, Dhirendra K.] Leidos Biomed Res Inc, NCI RAS Initiat, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Yang, Rendong; Wang, Ting-You] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Sarver, Anne; Subramanian, Subbaya] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [Lou, Emil] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Nelson, AC (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.; Simanshu, DK (corresponding author), Leidos Biomed Res Inc, NCI RAS Initiat, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA.; Lou, E (corresponding author), Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA.	nels2055@umn.edu; dhirendra.simanshu@nih.gov; emil-lou@umn.edu	WANG, TINGYOU/ADF-9723-2022; yang, rendong/I-5552-2014	WANG, TINGYOU/0000-0003-4354-3198; yang, rendong/0000-0002-9512-2240; Dharmaiah, Srisathiyanarayanan/0000-0001-7630-3962; Simanshu, Dhirendra/0000-0002-9717-4618; Nelson, Andrew/0000-0002-4741-0010	Department of Laboratory Medicine and Pathology, University of Minnesota; Eastern Star Scholars, University of Minnesota Masonic Cancer Center; American Cancer Society Clinical Scientist Development Grant [CSDG-18-139-01-CSM]; Mezin-Koats Colon Cancer Research Award; Randy Shaver Cancer Research and Community Fund; Litman Family Fund for Cancer Research; Central Society for Clinical and Translational Research Early Career Development Award; American Cancer Society [118198-IRG-58-001-52-IRG94]; Minnesota Masonic Charities; Minnesota Medical Foundation/University of Minnesota Foundation; Masonic Cancer Center, University of Minnesota; Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota; National Institutes of Health Clinical and Translational Science KL2 Scholar Award [8UL1TR000114]; National Cancer Institute, NIH Contract [HHSN261200800001E]	Department of Laboratory Medicine and Pathology, University of Minnesota(University of Minnesota System); Eastern Star Scholars, University of Minnesota Masonic Cancer Center; American Cancer Society Clinical Scientist Development Grant(American Cancer Society); Mezin-Koats Colon Cancer Research Award; Randy Shaver Cancer Research and Community Fund; Litman Family Fund for Cancer Research; Central Society for Clinical and Translational Research Early Career Development Award; American Cancer Society(American Cancer Society); Minnesota Masonic Charities; Minnesota Medical Foundation/University of Minnesota Foundation; Masonic Cancer Center, University of Minnesota(University of Minnesota System); Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota; National Institutes of Health Clinical and Translational Science KL2 Scholar Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH Contract	This research was supported in part by contributions from the patient's parents, and research funding from the Department of Laboratory Medicine and Pathology, University of Minnesota (to A. C. N.); Eastern Star Scholars, University of Minnesota Masonic Cancer Center (to A. C. N.); American Cancer Society Clinical Scientist Development Grant CSDG-18-139-01-CSM (to A. C. N.); the Mezin-Koats Colon Cancer Research Award (to E. L.); The Randy Shaver Cancer Research and Community Fund (to E. L.); the Litman Family Fund for Cancer Research; a Central Society for Clinical and Translational Research Early Career Development Award (to E. L.); Institutional Research Grant 118198-IRG-58-001-52-IRG94 from the American Cancer Society (to E. L.); Minnesota Masonic Charities; Minnesota Medical Foundation/University of Minnesota Foundation (to E. L.); the Masonic Cancer Center and Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota (to E. L.); and the National Institutes of Health Clinical and Translational Science KL2 Scholar Award 8UL1TR000114 (to E. L.). This project was funded in whole or in part with federal funds from the National Cancer Institute, NIH Contract HHSN261200800001E. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, and the mention of trade names, commercial products, or organizations does not imply endorsement by the U.S. Government.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agamasu C, 2019, BIOPHYS J, V116, P1049, DOI 10.1016/j.bpj.2019.02.004; Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Dharmaiah S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46846-w; Douville C, 2013, BIOINFORMATICS, V29, P647, DOI 10.1093/bioinformatics/btt017; Eijkelenboom A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44584-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escudero-Esparza A, 2016, ONCOTARGET, V7, P76920, DOI 10.18632/oncotarget.12729; Farrell CL, 2008, CANCER BIOL THER, V7, P609, DOI 10.4161/cbt.7.4.5623; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Guedes JG, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-169; Henzler C, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.05.07; Hsu HC, 2016, ONCOTARGET, V7, P22257, DOI 10.18632/oncotarget.8076; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kamal M, 2017, ONCOL REP, V38, P283, DOI 10.3892/or.2017.5656; Kopra K, 2020, ANAL CHEM, V92, P4971, DOI 10.1021/acs.analchem.9b05126; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li MM, 2017, J MOL DIAGN, V19, P4, DOI 10.1016/j.jmoldx.2016.10.002; Ma CQ, 2009, CANCER BIOL THER, V8, P907, DOI 10.4161/cbt.8.10.8132; Machleidt T, 2015, ACS CHEM BIOL, V10, P1797, DOI 10.1021/acschembio.5b00143; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; Masica DL, 2017, CANCER RES, V77, pE35, DOI 10.1158/0008-5472.CAN-17-0338; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Rabara D, 2019, P NATL ACAD SCI USA, V116, P22122, DOI 10.1073/pnas.1908353116; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Riihimaki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29765; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Shull AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058731; Shutes A, 2006, METHOD ENZYMOL, V407, P9, DOI 10.1016/S0076-6879(05)07002-3; Taylor T, 2017, METHODS MOL BIOL, V1586, P65, DOI 10.1007/978-1-4939-6887-9_5; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Wall VE, 2014, METHODS MOL BIOL, V1116, P193, DOI 10.1007/978-1-62703-764-8_14; Weinstock MT, 2016, NAT METHODS, V13, P849, DOI 10.1038/nmeth.3970; White Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10647; Wojcik P, 2008, POL J PATHOL, V59, P93; Xie QG, 2011, METHODS MOL BIOL, V680, P3, DOI 10.1007/978-1-60761-901-7_1; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yang RD, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0251-2	50	3	3	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9335	9348		10.1074/jbc.RA119.011080	http://dx.doi.org/10.1074/jbc.RA119.011080			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32393580	hybrid, Green Published			2022-12-28	WOS:000552758600007
J	Schaffer, JE				Schaffer, Jean E.			Death by lipids: The role of small nucleolar RNAs in metabolic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						lipotoxicity; noncoding RNA; snoRNAs; diabetes complications; genetic screens; RNA; diabetes; fatty acid; triacylglycerol; noncoding RNAs	ENDOPLASMIC-RETICULUM STRESS; PALMITATE-INDUCED APOPTOSIS; FATTY-ACID; OXIDATIVE STRESS; CELL-DYSFUNCTION; MOUSE MODEL; HEART; ACCUMULATION; PROTECTS; SNORNAS	Excess fatty acid accumulation in nonadipose tissues leads to cell dysfunction and cell death that is linked to the pathogenesis of inherited and acquired human diseases. Study of this process, known as lipotoxicity, has provided new insights into the regulation of lipid homeostasis and has revealed new molecular pathways involved in lipid-induced cellular stress. The discovery that disruption of specific small nucleolar RNAs protects against fatty acid?induced cell death and remodels metabolismin vivoopens new opportunities for understanding how nutrient signals influence cellular and systemic metabolic homeostasis through RNA biology.	[Schaffer, Jean E.] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Schaffer, JE (corresponding author), Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02115 USA.	jean.schaffer@joslin.harvard.edu			National Institutes of Health [R01 DK064989, R01 DK108357, DP1 DK119141]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R01 DK064989, R01 DK108357, and DP1 DK119141 (to J. E. S.). The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Anderson EJ, 2009, J AM COLL CARDIOL, V54, P1891, DOI 10.1016/j.jacc.2009.07.031; Atzorn V, 2004, MOL CELL BIOL, V24, P1769, DOI 10.1128/MCB.24.4.1769-1778.2004; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Bouchard-Bourelle P, 2020, NUCLEIC ACIDS RES, V48, pD220, DOI 10.1093/nar/gkz884; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Brookheart RT, 2009, J BIOL CHEM, V284, P7446, DOI 10.1074/jbc.M806209200; Burnett LC, 2017, HUM MOL GENET, V26, P4606, DOI 10.1093/hmg/ddx342; Cacicedo JM, 2005, DIABETES, V54, P1838, DOI 10.2337/diabetes.54.6.1838; Caputa G, 2016, CELL DEATH DIFFER, V23, P347, DOI 10.1038/cdd.2015.105; CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Cnop M, 2001, DIABETES, V50, P1771, DOI 10.2337/diabetes.50.8.1771; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; d'Orval BC, 2001, NUCLEIC ACIDS RES, V29, P4518, DOI 10.1093/nar/29.22.4518; Dai Q, 2017, NAT METHODS, V14, P695, DOI 10.1038/nmeth.4294; DIMAURO S, 1973, SCIENCE, V182, P929, DOI 10.1126/science.182.4115.929; Elezaby A, 2015, J MOL CELL CARDIOL, V79, P275, DOI 10.1016/j.yjmcc.2014.12.001; Ertunc ME, 2016, J LIPID RES, V57, P2099, DOI 10.1194/jlr.R066514; Hauck AK, 2016, J LIPID RES, V57, P1976, DOI 10.1194/jlr.R066597; Hirsova P, 2016, J LIPID RES, V57, P1758, DOI 10.1194/jlr.R066357; Holley CL, 2015, J BIOL CHEM, V290, P11741, DOI 10.1074/jbc.M115.637413; James O, 1999, LANCET, V353, P1634, DOI 10.1016/S0140-6736(99)00163-4; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Kehr S, 2011, BIOINFORMATICS, V27, P279, DOI 10.1093/bioinformatics/btq642; Kienesberger PC, 2013, CARDIOVASC RES, V99, P442, DOI 10.1093/cvr/cvt124; Kim JI, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00210-19; King TH, 2003, MOL CELL, V11, P425, DOI 10.1016/S1097-2765(03)00040-6; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Kuramoto K, 2012, J BIOL CHEM, V287, P23852, DOI 10.1074/jbc.M111.328708; Lancaster GI, 2018, CELL METAB, V27, P1096, DOI 10.1016/j.cmet.2018.03.014; Lee JY, 2016, J CLIN INVEST, V126, P4616, DOI 10.1172/JCI88069; Lee Y, 2004, P NATL ACAD SCI USA, V101, P13624, DOI 10.1073/pnas.0405499101; Li MW, 2017, J BIOL CHEM, V292, P20228, DOI 10.1074/jbc.M117.818146; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu L, 2009, J BIOL CHEM, V284, P36312, DOI 10.1074/jbc.M109.049817; Ljubkovic M, 2019, DIABETES, V68, P1924, DOI 10.2337/db19-0423; McMahon M, 2019, ELIFE, V8, DOI 10.7554/eLife.48847; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Nicoloso M, 1996, J MOL BIOL, V260, P178, DOI 10.1006/jmbi.1996.0391; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okugawa Y, 2017, GUT, V66, P107, DOI 10.1136/gutjnl-2015-309359; Ostrander DB, 2001, J BIOL CHEM, V276, P38061; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Piccolis M, 2019, MOL CELL, V74, P32, DOI 10.1016/j.molcel.2019.01.036; Polex-Wolf J, 2018, J CLIN INVEST, V128, P960, DOI 10.1172/JCI97007; Pulinilkunnil T, 2013, DIABETES, V62, P1464, DOI 10.2337/db12-0927; Rimer JM, 2018, J BIOL CHEM, V293, P13284, DOI 10.1074/jbc.RA118.003410; Scruggs BS, 2012, MOL CELL BIOL, V32, P4092, DOI 10.1128/MCB.00022-12; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Sharma S, 2017, PLOS GENET, V13, DOI [10.1371/journal.pgen.1006804, 10.1371/journal.pgen.1007019]; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Siprashvili Z, 2016, NAT GENET, V48, P53, DOI 10.1038/ng.3452; STANLEY CA, 1983, PEDIATR RES, V17, P877, DOI 10.1203/00006450-198311000-00008; Tsushima K, 2018, CIRC RES, V122, P58, DOI 10.1161/CIRCRESAHA.117.311307; Valm AM, 2017, NATURE, V546, P162, DOI 10.1038/nature22369; Weber MJ, 2006, PLOS GENET, V2, P1984, DOI 10.1371/journal.pgen.0020205; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Youssef OA, 2015, P NATL ACAD SCI USA, V112, P5023, DOI 10.1073/pnas.1424044112; Zhou FB, 2017, NAT CELL BIOL, V19, P844, DOI 10.1038/ncb3563; Zhu XG, 2019, MOL CELL, V74, P45, DOI 10.1016/j.molcel.2019.01.037	70	7	7	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8628	8635		10.1074/jbc.AW120.011105	http://dx.doi.org/10.1074/jbc.AW120.011105			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32393576	Green Published, hybrid			2022-12-28	WOS:000546986500026
J	Shi, D; Zhao, SJ; Zuo, MQ; Zhang, JJ; Hou, WY; Dong, MQ; Cao, QH; Lou, HQ				Shi, Di; Zhao, Shuaijun; Zuo, Mei-Qing; Zhang, Jingjing; Hou, Wenya; Dong, Meng-Qiu; Cao, Qinhong; Lou, Huiqiang			The acetyltransferase Eco1 elicits cohesin dimerization during S phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; acetylation; DNA replication; dimerization; acetyltransferase; chromatid cohesion; cohesin; double ring model; Eco1; self-interaction; protein acetylation	SISTER-CHROMATID COHESION; CHROMOSOME STRUCTURE; DNA-REPLICATION; ESTABLISHMENT; COMPLEX; PROTEINS; ACETYLATION; DEPENDS; ROLES; ARMS	Cohesin is a DNA-associated protein complex that forms a tripartite ring controlling sister chromatid cohesion, chromosome segregation and organization, DNA replication, and gene expression. Sister chromatid cohesion is established by the protein acetyltransferase Eco1, which acetylates two conserved lysine residues on the cohesin subunit Smc3 and thereby ensures correct chromatid separation in yeast (Saccharomyces cerevisiae) and other eukaryotes. However, the consequence of Eco1-catalyzed cohesin acetylation is unknown, and the exact nature of the cohesive state of chromatids remains controversial. Here, we show that self-interactions of the cohesin subunits Scc1/Rad21 and Scc3 occur in a DNA replication?coupled manner in both yeast and human cells. Using cross-linking MS-based and in vivo disulfide cross-linking analyses of purified cohesin, we show that a subpopulation of cohesin may exist as dimers. Importantly, upon temperature-sensitive and auxin-induced degron-mediated Eco1 depletion, the cohesin-cohesin interactions became significantly compromised, whereas deleting either the deacetylase Hos1 or the Eco1 antagonist Wpl1/Rad61 increased cohesin dimer levels by ?20%. These results indicate that cohesin dimerizes in the S phase and monomerizes in mitosis, processes that are controlled by Eco1, Wpl1, and Hos1 in the sister chromatid cohesion-dissolution cycle. These findings suggest that cohesin dimerization is controlled by the cohesion cycle and support the notion that a double-ring cohesin model operates in sister chromatid cohesion.	[Shi, Di; Zhao, Shuaijun; Zhang, Jingjing; Hou, Wenya; Cao, Qinhong; Lou, Huiqiang] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, 2 Yuan Ming Yuan West Rd, Beijing 100193, Peoples R China; [Shi, Di; Zhao, Shuaijun; Zhang, Jingjing; Hou, Wenya; Cao, Qinhong; Lou, Huiqiang] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Biol Sci, 2 Yuan Ming Yuan West Rd, Beijing 100193, Peoples R China; [Zuo, Mei-Qing; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China	China Agricultural University; China Agricultural University; National Institute of Biological Sciences, Beijing	Lou, HQ (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.; Lou, HQ (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100193, Peoples R China.	lou@cau.edu.cn	Lou, Huiqiang/B-6287-2012	Lou, Huiqiang/0000-0003-4465-6186; Dong, Meng-Qiu/0000-0002-6094-1182	National Natural Science Foundation of China [31630005, 31770084, 31771382]; National Basic Research Program (973 Program) of China [2014CB849801]; Program for Extramural Scientists of the State Key Laboratory of Agrobiotechnology Grant [2018SKLAB6-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program) of China(National Basic Research Program of China); Program for Extramural Scientists of the State Key Laboratory of Agrobiotechnology Grant	This work was supported by the National Natural Science Foundation of China Grants 31630005, 31770084, and 31771382; National Basic Research Program (973 Program) of China Grant 2014CB849801; and Program for Extramural Scientists of the State Key Laboratory of Agrobiotechnology Grant 2018SKLAB6-5. The authors declare that they have no conflicts of interest with the contents of this article.	Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Cattoglio C, 2019, ELIFE, V8, DOI 10.7554/eLife.40164; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Eng T, 2015, MOL BIOL CELL, V26, P4224, DOI 10.1091/mbc.E15-06-0331; Feytout A, 2011, MOL CELL BIOL, V31, P1771, DOI 10.1128/MCB.01284-10; Gligoris T, 2016, TRENDS CELL BIOL, V26, P680, DOI 10.1016/j.tcb.2016.04.002; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hansen AS, 2017, ELIFE, V6, DOI 10.7554/eLife.25776; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hirano T, 2017, GENES CELLS, V22, P934, DOI 10.1111/gtc.12539; Holzmann J, 2019, ELIFE, V8, DOI 10.7554/eLife.46269; Holzmann J, 2011, J PROTEOME RES, V10, P780, DOI 10.1021/pr100927x; in 't Veld PJH, 2014, SCIENCE, V346, P968, DOI 10.1126/science.1256904; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Kim Y, 2019, SCIENCE, V366, P1345, DOI 10.1126/science.aaz4475; Kulemzina I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002856; Li Y, 2018, ELIFE, V7, DOI 10.7554/eLife.38356; Liu L, 2020, CELL MOL LIFE SCI, V77, P3041, DOI 10.1007/s00018-019-03333-9; Makrantoni V, 2018, CURR BIOL, V28, pR688, DOI 10.1016/j.cub.2018.05.019; Maradeo ME, 2010, FEBS LETT, V584, P4037, DOI 10.1016/j.febslet.2010.08.020; Mohan C, 2018, ELIFE, V7, DOI 10.7554/eLife.36654; Morales C, 2018, CURR OPIN CELL BIOL, V52, P51, DOI 10.1016/j.ceb.2018.01.010; Murayama Y, 2018, CELL, V172, P465, DOI 10.1016/j.cell.2017.12.021; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Peters JM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011130; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Quan Y, 2015, CELL REP, V13, P2576, DOI 10.1016/j.celrep.2015.11.018; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Skibbens RV, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006337; Skibbens RV, 2009, CURR BIOL, V19, pR1126, DOI 10.1016/j.cub.2009.10.067; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Srinivasan M, 2018, CELL, V173, P1508, DOI 10.1016/j.cell.2018.04.015; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Uhlmann F, 2009, EMBO REP, V10, P1095, DOI 10.1038/embor.2009.207; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Wang XD, 2017, SCIENCE, V355, P524, DOI 10.1126/science.aai8982; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	51	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7554	7565		10.1074/jbc.RA120.013102	http://dx.doi.org/10.1074/jbc.RA120.013102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32312753	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000538038900001
J	van den Bos, E; Ambrosy, B; Horsthemke, M; Walbaum, S; Bachg, AC; Wettschureck, N; Innamorati, G; Wilkie, TM; Hanley, PJ				van den Bos, Esther; Ambrosy, Benjamin; Horsthemke, Markus; Walbaum, Stefan; Bachg, Anne C.; Wettschureck, Nina; Innamorati, Giulio; Wilkie, Thomas M.; Hanley, Peter J.			Knockout mouse models reveal the contributions of G protein subunits to complement C5a receptor?mediated chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium imaging; cell motility; chemotaxis; complement system; G protein-coupled receptor (GPCR); G protein; gene knockout; complement C5a; immune system; macrophage	MACROPHAGE-MIGRATION; BLOOD-PRESSURE; CELL; INHIBITION; MOTILITY; RELEASE; G-ALPHA(I2); DEFECTS; P2Y(2)	G protein?coupled receptor signaling is required for the navigation of immune cells along chemoattractant gradients. However, chemoattractant receptors may couple to more than one type of heterotrimeric G protein, each of which consists of a G?, G?, and G? subunit, making it difficult to delineate the critical signaling pathways. Here, we used knockout mouse models and time-lapse microscopy to elucidate G? and G? subunits contributing to complement C5a receptor-mediated chemotaxis. Complement C5a-mediated chemokinesis and chemotaxis were almost completely abolished in macrophages lacking Gnai2 (encoding G?(i2)), consistent with a reduced leukocyte recruitment previously observed in Gnai2(?/?) mice, whereas cells lacking Gnai3 (G?(i3)) exhibited only a slight decrease in cell velocity. Surprisingly, C5a-induced Ca2+ transients and lamellipodial membrane spreading were persistent in Gnai2(?/?) macrophages. Macrophages lacking both Gnaq (G?(q)) and Gna11 (G?(11)) or both Gna12 (G?(12)) and Gna13 (G?(13)) had essentially normal chemotaxis, Ca2+ signaling, and cell spreading, except Gna12/Gna13-deficient macrophages had increased cell velocity and elongated trailing ends. Moreover, Gnaq/Gna11-deficient cells did not respond to purinergic receptor P2Y(2) stimulation. Genetic deletion of Gna15 (G?(15)) virtually abolished C5a-induced Ca2+ transients, but chemotaxis and cell spreading were preserved. Homozygous Gnb1 (G?(1)) deletion was lethal, but mice lacking Gnb2 (G?(2)) were viable. Gnb2(?/?) macrophages exhibited robust Ca2+ transients and cell spreading, albeit decreased cell velocity and impaired chemotaxis. In summary, complement C5a-mediated chemotaxis requires G?(i2) and G?(2), but not Ca2+ signaling, and membrane protrusive activity is promoted by G proteins that deplete phosphatidylinositol 4,5-bisphosphate.	[van den Bos, Esther; Ambrosy, Benjamin; Horsthemke, Markus; Walbaum, Stefan; Bachg, Anne C.; Hanley, Peter J.] Westfalische Wilhelms Univ Munster, Inst Mol Zellbiol, Munster, Germany; [Wettschureck, Nina] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Bad Nauheim, Germany; [Innamorati, Giulio] Univ Verona, Dept Surg Sci Dent Gynecol & Pediat, Verona, Italy; [Wilkie, Thomas M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, Dallas, TX 75390 USA	University of Munster; Max Planck Society; University of Verona; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hanley, PJ (corresponding author), Westfalische Wilhelms Univ Munster, Inst Mol Zellbiol, Munster, Germany.	hanley@uni-muenster.de	Innamorati, Giulio/AAR-6314-2020; Innamorati, Giulio/GVU-1941-2022	Innamorati, Giulio/0000-0003-0123-8777; 	Deutsche Forschungsgemeinschaft (DFG) [HA 3271/3-2]; NCI, National Institutes of Health [CA192381]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant HA 3271/3-2 (to P. J. H.). T. M. W. is supported by NCI, National Institutes of Health, Grant CA192381. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arai H, 1996, J BIOL CHEM, V271, P21814, DOI 10.1074/jbc.271.36.21814; Artemenko Y, 2014, CELL MOL LIFE SCI, V71, P3711, DOI 10.1007/s00018-014-1638-8; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Bzymek R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25016; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Collins SR, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156027; Das J, 2014, CHEM REV, V114, P12108, DOI 10.1021/cr300481j; Davignon I, 2000, MOL CELL BIOL, V20, P797, DOI 10.1128/MCB.20.3.797-804.2000; del Rey A, 2006, J BIOL CHEM, V281, P35147, DOI 10.1074/jbc.M607713200; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Grimm M, 2016, ARTERIOSCL THROM VAS, V36, P37, DOI 10.1161/ATVBAHA.115.306066; Hanley PJ, 2010, P NATL ACAD SCI USA, V107, P12145, DOI 10.1073/pnas.0911986107; Horsthemke M, 2018, JOVE-J VIS EXP, DOI 10.3791/57566; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Hwang JI, 2004, P NATL ACAD SCI USA, V101, P488, DOI 10.1073/pnas.0307549100; Hwang JI, 2005, P NATL ACAD SCI USA, V102, P9493, DOI 10.1073/pnas.0503503102; Isfort K, 2011, J BIOL CHEM, V286, P44776, DOI 10.1074/jbc.M111.289793; Jiang MS, 2002, METHOD ENZYMOL, V344, P277; Kehrl JH, 2016, BIOCHEM PHARMACOL, V114, P40, DOI 10.1016/j.bcp.2016.04.005; Konigs V, 2014, J BIOL CHEM, V289, P30772, DOI 10.1074/jbc.M114.563270; Kronlage M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000588; Kuang YN, 1996, J BIOL CHEM, V271, P3975; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Leber T., 1888, FORTSCHR MED, V6, P460; Li XX, 2019, J IMMUNOL, V202, P3339, DOI 10.4049/jimmunol.1900371; Li XG, 2018, P NATL ACAD SCI USA, V115, pE9125, DOI 10.1073/pnas.1809039115; Linden J, 2019, ANNU REV IMMUNOL, V37, P325, DOI 10.1146/annurev-immunol-051116-052406; Mangmool S, 2011, TOXINS, V3, P884, DOI 10.3390/toxins3070884; Meade B D, 1985, Dev Biol Stand, V61, P63; MEADE BD, 1984, INFECT IMMUN, V45, P718, DOI 10.1128/IAI.45.3.718-725.1984; Okae H, 2010, DEV DYNAM, V239, P1089, DOI 10.1002/dvdy.22256; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; van den Bos E, 2020, JOVE-J VIS EXP, DOI 10.3791/60750; Wang SP, 2016, J CLIN INVEST, V126, P4527, DOI 10.1172/JCI87343; Wang SP, 2015, J CLIN INVEST, V125, P3077, DOI 10.1172/JCI81067; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Wiege K, 2012, J IMMUNOL, V189, P980, DOI 10.4049/jimmunol.1200891; Xiong YA, 2010, P NATL ACAD SCI USA, V107, P17079, DOI 10.1073/pnas.1011271107; Zarbock A, 2007, BLOOD, V110, P3773, DOI 10.1182/blood-2007-06-094565; Zengel P, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-21	47	6	6	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7726	7742		10.1074/jbc.RA119.011984	http://dx.doi.org/10.1074/jbc.RA119.011984			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32332099	hybrid, Green Published			2022-12-28	WOS:000538038900013
J	Mamounis, KJ; Yukl, ET; Davidson, VL				Mamounis, Kyle J.; Yukl, Erik T.; Davidson, Victor L.			Roles of active-site residues in catalysis, substrate binding, cooperativity, and the reaction mechanism of the quinoprotein glycine oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; enzyme mechanism; enzyme kinetics; cooperativity; structure-function; quinone; oxidase; site-directed mutagenesis; acid-base chemistry; cysteine tryptophylquinone; GoxA; LodA-like protein	TRYPTOPHYLQUINONE; BIOGENESIS; ENZYME; GOXA	The quinoprotein glycine oxidase from the marine bacterium Pseudoalteromonas luteoviolacea (PlGoxA) uses a protein-derived cysteine tryptophylquinone (CTQ) cofactor to catalyze conversion of glycine to glyoxylate and ammonia. This homotetrameric enzyme exhibits strong cooperativity toward glycine binding. It is a good model for studying enzyme kinetics and cooperativity, specifically for being able to separate those aspects of protein function through directed mutagenesis. Variant proteins were generated with mutations in four active-site residues, Phe-316, His-583, Tyr-766, and His-767. Structures for glycine-soaked crystals were obtained for each. Different mutations had differential effects on k(cat) and K-0.5 for catalysis, K-0.5 for substrate binding, and the Hill coefficients describing the steady-state kinetics or substrate binding. Phe-316 and Tyr-766 variants retained catalytic activity, albeit with altered kinetics and cooperativity. Substitutions of His-583 revealed that it is essential for glycine binding, and the structure of H583C PlGoxA had no active-site glycine present in glycine-soaked crystals. The structure of H767A PlGoxA revealed a previously undetected reaction intermediate, a carbinolamine product-reduced CTQ adduct, and exhibited only negligible activity. The results of these experiments, as well as those with the native enzyme and previous variants, enabled construction of a detailed mechanism for the reductive half-reaction of glycine oxidation. This proposed mechanism includes three discrete reaction intermediates that are covalently bound to CTQ during the reaction, two of which have now been structurally characterized by X-ray crystallography.	[Mamounis, Kyle J.; Davidson, Victor L.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA; [Yukl, Erik T.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	State University System of Florida; University of Central Florida; New Mexico State University	Davidson, VL (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	victor.davidson@ucf.edu		Davidson, Victor/0000-0002-1966-7302; Mamounis, Kyle/0000-0002-5489-0198	National Institutes of Health NIGMS Award [R35GM130173]	National Institutes of Health NIGMS Award	This work was supported by National Institutes of Health NIGMS Award R35GM130173 (to V. L. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreo-Vidal A, 2018, BIOCHEMISTRY-US, V57, P1155, DOI 10.1021/acs.biochem.8b00009; Avalos D, 2019, BIOCHEMISTRY-US, V58, P706, DOI 10.1021/acs.biochem.8b01145; Brazeau BJ, 2004, ARCH BIOCHEM BIOPHYS, V428, P22, DOI 10.1016/j.abb.2004.03.034; Campillo-Brocal JC, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1455-y; Campillo-Brocal JC, 2013, MICROBIOLOGYOPEN, V2, P684, DOI 10.1002/mbo3.107; Davidson VL, 2018, BIOCHEMISTRY-US, V57, P3115, DOI 10.1021/acs.biochem.8b00123; Davidson VL, 2003, J AM CHEM SOC, V125, P3224, DOI 10.1021/ja0297133; EDSALL JT, 1980, FED PROC, V39, P226; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Jones LH, 2005, J BIOL CHEM, V280, P17392, DOI 10.1074/jbc.M500943200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klinman JP, 2014, CHEM REV, V114, P4343, DOI 10.1021/cr400475g; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Lucas-Elio P, 2005, BBA-GEN SUBJECTS, V1721, P193, DOI 10.1016/j.bbagen.2004.11.002; Ma ZX, 2019, BIOCHEMISTRY-US, V58, P2243, DOI 10.1021/acs.biochem.9b00104; Mamounis KJ, 2019, J BIOL CHEM, V294, P17463, DOI 10.1074/jbc.RA119.011255; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Okazaki S, 2013, J BIOCHEM, V154, P233, DOI 10.1093/jb/mvt070; Sehanobish E, 2016, J BIOL CHEM, V291, P23199, DOI 10.1074/jbc.M116.741835; Sehanobish E, 2016, BIOCHEMISTRY-US, V55, P2305, DOI 10.1021/acs.biochem.6b00274; Sehanobish E, 2015, ARCH BIOCHEM BIOPHYS, V579, P26, DOI 10.1016/j.abb.2015.05.013; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	26	1	1	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6472	6481		10.1074/jbc.RA120.013198	http://dx.doi.org/10.1074/jbc.RA120.013198			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32234764	hybrid, Green Published			2022-12-28	WOS:000537685000018
J	Rosana, ARR; Whitford, DS; Migur, A; Steglich, C; Kujat-Choy, SL; Hess, WR; Owttrim, GW				Rosana, Albert Remus R.; Whitford, Denise S.; Migur, Anzhela; Steglich, Claudia; Kujat-Choy, Sonya L.; Hess, Wolfgang R.; Owttrim, George W.			RNA helicase?regulated processing of the Synechocystis rimO?crhR operon results in differential cistron expression and accumulation of two sRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; post-transcriptional regulation; RNA processing; RNA helicase; stress response; cold-stress response; differential operon cistron expression; rimO?crhR dicistronic RNA; small noncoding regulatory RNA; Synechocystis CrhR RNA helicase	DEAD-BOX PROTEINS; MESSENGER-RNA; ESCHERICHIA-COLI; ANABAENA-VARIABILIS; GENE-EXPRESSION; HELICASE; TRANSCRIPTION; CLEAVAGE; ENZYME; STABILIZATION	The arrangement of functionally-related genes in operons is a fundamental element of how genetic information is organized in prokaryotes. This organization ensures coordinated gene expression by co-transcription. Often, however, alternative genetic responses to specific stress conditions demand the discoordination of operon expression. During cold temperature stress, accumulation of the gene encoding the sole Asp?Glu?Ala?Asp (DEAD)-box RNA helicase in Synechocystis sp. PCC 6803, crhR (slr0083), increases 15-fold. Here, we show that crhR is expressed from a dicistronic operon with the methylthiotransferase rimO/miaB (slr0082) gene, followed by rapid processing of the operon transcript into two monocistronic mRNAs. This cleavage event is required for and results in destabilization of the rimO transcript. Results from secondary structure modeling and analysis of RNase E cleavage of the rimO?crhR transcript in vitro suggested that CrhR plays a role in enhancing the rate of the processing in an auto-regulatory manner. Moreover, two putative small RNAs are generated from additional processing, degradation, or both of the rimO transcript. These results suggest a role for the bacterial RNA helicase CrhR in RNase E-dependent mRNA processing in Synechocystis and expand the known range of organisms possessing small RNAs derived from processing of mRNA transcripts.	[Rosana, Albert Remus R.; Whitford, Denise S.; Kujat-Choy, Sonya L.; Owttrim, George W.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Migur, Anzhela; Steglich, Claudia; Hess, Wolfgang R.] Univ Freiburg, Fac Biol, Schanzlestr 1, D-79104 Freiburg, Germany; [Hess, Wolfgang R.] Univ Freiburg, Freiburg Inst Adv Studies, Albertstr 19, D-79104 Freiburg, Germany	University of Alberta; University of Freiburg; University of Freiburg	Owttrim, GW (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	gowttrim@ualberta.ca	Whitford, Denise S./L-7126-2015; Rosana, Albert Remus/AAL-3288-2020	Whitford, Denise S./0000-0001-7551-4805; Rosana, Albert Remus/0000-0001-7847-7763; Hess, Wolfgang/0000-0002-5340-3423	Natural Sciences and Engineering Research Council of Canada (NSERC) [171319]; Baden-Wuerttemberg Foundation [BWST_NCRNA_008]; Federal Ministry of Education and Research (BMBF) Program RNAProNet Grant [031L0164B]; Deutsche Forschungsgemeinschaft (DFG) [STE 1119/4-2]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Baden-Wuerttemberg Foundation; Federal Ministry of Education and Research (BMBF) Program RNAProNet Grant(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant 171319 (to G. W. O.), Baden-Wuerttemberg Foundation Grant BWST_NCRNA_008 (to W. R. H.), Federal Ministry of Education and Research (BMBF) Program RNAProNet Grant 031L0164B (to W. R. H.), and Deutsche Forschungsgemeinschaft (DFG) Grant STE 1119/4-2 (to C. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Anton BP, 2008, P NATL ACAD SCI USA, V105, P1826, DOI 10.1073/pnas.0708608105; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Behler J, 2018, NAT MICROBIOL, V3, P367, DOI 10.1038/s41564-017-0103-5; Cam K, 1996, NUCLEIC ACIDS RES, V24, P3065, DOI 10.1093/nar/24.15.3065; Cameron JC, 2015, PHOTOSYNTH RES, V126, P171, DOI 10.1007/s11120-015-0076-2; Chamot D, 2000, J BACTERIOL, V182, P1251, DOI 10.1128/JB.182.5.1251-1256.2000; Chamot D, 2005, J BIOL CHEM, V280, P2036, DOI 10.1074/jbc.M409700200; Chamot D, 1999, J BACTERIOL, V181, P1728, DOI 10.1128/JB.181.6.1728-1732.1999; Chao YJ, 2017, MOL CELL, V65, P39, DOI 10.1016/j.molcel.2016.11.002; Chao YJ, 2012, EMBO J, V31, P4005, DOI 10.1038/emboj.2012.229; Charollais J, 2004, NUCLEIC ACIDS RES, V32, P2751, DOI 10.1093/nar/gkh603; Charollais J, 2003, MOL MICROBIOL, V48, P1253, DOI 10.1046/j.1365-2958.2003.03513.x; Conlon EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052137; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; Dar D, 2018, MBIO, V9, DOI 10.1128/mBio.01730-18; Dar D, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007354; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Even S, 2005, NUCLEIC ACIDS RES, V33, P2141, DOI 10.1093/nar/gki505; Gao HC, 2006, J BACTERIOL, V188, P4560, DOI 10.1128/JB.01908-05; Gaubig LC, 2011, MICROBIOL-SGM, V157, P66, DOI 10.1099/mic.0.043802-0; Georg J, 2019, RNA BIOL, V16, P1205, DOI 10.1080/15476286.2019.1621622; Greene J M, 2001, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0406s45; Gulati A, 2001, J BIOSCIENCE, V26, P193, DOI 10.1007/BF02703643; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Horie Y, 2007, MOL GENET GENOMICS, V278, P331, DOI 10.1007/s00438-007-0254-9; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Imamura S, 2009, GENE REGUL SYST BIO, V3, P65; Iost I, 2013, BBA-GENE REGUL MECH, V1829, P866, DOI 10.1016/j.bbagrm.2013.01.012; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jager S, 2004, NUCLEIC ACIDS RES, V32, P386, DOI 10.1093/nar/gkh174; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Kaneko T, 1996, DNA Res, V3, P185, DOI 10.1093/dnares/3.3.185; Klahn S, 2015, P NATL ACAD SCI USA, V112, pE6243, DOI 10.1073/pnas.1508412112; Koo JT, 2004, MOL MICROBIOL, V52, P1813, DOI 10.1111/j.1365-2958.2004.04099.x; Kopf M, 2014, DNA RES, V21, P527, DOI 10.1093/dnares/dsu018; Kujat SL, 2000, PLANT PHYSIOL, V124, P703, DOI 10.1104/pp.124.2.703; Laing E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r46; LEE SJ, 1994, MOL MICROBIOL, V11, P833, DOI 10.1111/j.1365-2958.1994.tb00361.x; Lim HN, 2011, P NATL ACAD SCI USA, V108, P10626, DOI 10.1073/pnas.1105692108; Linder P, 2009, TRENDS PLANT SCI, V14, P344, DOI 10.1016/j.tplants.2009.03.007; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu J, 1999, INT J BIOCHEM CELL B, V31, P215, DOI 10.1016/S1357-2725(98)00142-3; Memon D, 2013, ANTON LEEUW INT J G, V103, P331, DOI 10.1007/s10482-012-9813-0; Mikami K, 2002, MOL MICROBIOL, V46, P905, DOI 10.1046/j.1365-2958.2002.03202.x; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Mohanty BK, 2010, NUCLEIC ACIDS RES, V38, P597, DOI 10.1093/nar/gkp997; Mossey P, 2013, PLASMID, V69, P72, DOI 10.1016/j.plasmid.2012.09.002; Nickel M, 2004, MOL GENET GENOMICS, V272, P98, DOI 10.1007/s00438-004-1038-0; Owttrim GW, 2013, RNA BIOL, V10, P96, DOI 10.4161/rna.22638; Owttrim GW, 2012, METHOD ENZYMOL, V511, P385, DOI 10.1016/B978-0-12-396546-2.00018-8; Papenfort K, 2013, CELL, V153, P426, DOI 10.1016/j.cell.2013.03.003; Pei GS, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0743-y; Pierrel F, 2004, J BIOL CHEM, V279, P47555, DOI 10.1074/jbc.M408562200; Polidoros AN, 2006, BIOTECHNIQUES, V41, P35, DOI 10.2144/000112205; Pratte BS, 2015, J BACTERIOL, V197, P1408, DOI 10.1128/JB.02609-14; Pratte BS, 2014, J BACTERIOL, V196, P3609, DOI 10.1128/JB.02045-14; Pratte BS, 2013, MOL MICROBIOL, V88, P413, DOI 10.1111/mmi.12197; Price MN, 2006, PLOS GENET, V2, P859, DOI 10.1371/journal.pgen.0020096; Prud'homme-Genereux A, 2004, MOL MICROBIOL, V54, P1409, DOI 10.1111/j.1365-2958.2004.04360.x; Qi QG, 2005, APPL ENVIRON MICROB, V71, P5678, DOI 10.1128/AEM.71.10.5678-5684.2005; Ritter SPA, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2019.129462; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rosana ARR, 2016, J BACTERIOL, V198, P2089, DOI 10.1128/JB.00267-16; Rosana ARR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048683; Rosana ARR, 2012, PLANT CELL PHYSIOL, V53, P646, DOI 10.1093/pcp/pcs020; SATO N, 1995, NUCLEIC ACIDS RES, V23, P2161; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sinetova MA, 2016, BBA-GEN SUBJECTS, V1860, P2391, DOI 10.1016/j.bbagen.2016.07.006; Smolke CD, 2000, APPL ENVIRON MICROB, V66, P5399, DOI 10.1128/AEM.66.12.5399-5405.2000; Suzuki I, 2001, MOL MICROBIOL, V40, P235, DOI 10.1046/j.1365-2958.2001.02379.x; Suzuki I, 2000, EMBO J, V19, P1327, DOI 10.1093/emboj/19.6.1327; Tarassova OS, 2014, J BACTERIOL, V196, P1560, DOI 10.1128/JB.01362-13; Ungerer JL, 2010, J BACTERIOL, V192, P3311, DOI 10.1128/JB.00278-10; Wang X, 2015, P NATL ACAD SCI USA, V112, P7581, DOI 10.1073/pnas.1424683112; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	76	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6372	6386		10.1074/jbc.RA120.013148	http://dx.doi.org/10.1074/jbc.RA120.013148			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32209657	Green Published, hybrid			2022-12-28	WOS:000537685000011
J	Wu, R; Fang, JL; Liu, MC; A, J; Liu, JM; Chen, WX; Li, J; Ma, G; Zhang, ZQ; Zhang, BT; Fu, LY; Dong, JT				Wu, Rui; Fang, Jiali; Liu, Mingcheng; A, Jun; Liu, Jinming; Chen, Wenxuan; Li, Juan; Ma, Gui; Zhang, Zhiqian; Zhang, Baotong; Fu, Liya; Dong, Jin-Tang			SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						SUMOylation; posttranslational modification (PTM); proliferation; protein stability; UBC9; zinc finger homeobox 3 (ZFHX3); protein inhibitor of activated STAT2 (PIAS2); SUMO-specific peptidase 1 (SENP1); cell proliferation; cancer; transcription factor; SUMO-conjugating enzyme UBC9; SUMO1-activating enzyme subunit 1 (SAE1)	NUCLEAR-LOCALIZATION; SUMO; ATBF1; UBIQUITIN; PROTEIN; DELETION; DIFFERENTIATION; DEGRADATION; MECHANISMS; BINDING	SUMOylation is a posttranslational modification (PTM) at a lysine residue and is crucial for the proper functions of many proteins, particularly of transcription factors, in various biological processes. Zinc finger homeobox 3 (ZFHX3), also known as AT motif-binding factor 1 (ATBF1), is a large transcription factor that is active in multiple pathological processes, including atrial fibrillation and carcinogenesis, and in circadian regulation and development. We have previously demonstrated that ZFHX3 is SUMOylated at three or more lysine residues. Here, we investigated which enzymes regulate ZFHX3 SUMOylation and whether SUMOylation modulates ZFHX3 stability and function. We found that SUMO1, SUMO2, and SUMO3 each are conjugated to ZFHX3. Multiple lysine residues in ZFHX3 were SUMOylated, but Lys-2806 was the major SUMOylation site, and we also found that it is highly conserved among ZFHX3 orthologs from different animal species. Using molecular analyses, we identified the enzymes that mediate ZFHX3 SUMOylation; these included SUMO1-activating enzyme subunit 1 (SAE1), an E1-activating enzyme; SUMO-conjugating enzyme UBC9 (UBC9), an E2-conjugating enzyme; and protein inhibitor of activated STAT2 (PIAS2), an E3 ligase. Multiple analyses established that both SUMO-specific peptidase 1 (SENP1) and SENP2 deSUMOylate ZFHX3. SUMOylation at Lys-2806 enhanced ZFHX3 stability by interfering with its ubiquitination and proteasomal degradation. Functionally, Lys-2806 SUMOylation enabled ZFHX3-mediated cell proliferation and xenograft tumor growth of the MDA-MB-231 breast cancer cell line. These findings reveal the enzymes involved in, and the functional consequences of, ZFHX3 SUMOylation, insights that may help shed light on ZFHX3's roles in various cellular and pathophysiological processes.	[Wu, Rui; Fang, Jiali; Liu, Jinming; Ma, Gui; Fu, Liya] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China; [Liu, Mingcheng; A, Jun; Chen, Wenxuan; Li, Juan; Zhang, Zhiqian; Dong, Jin-Tang] Southern Univ Sci & Technol, Sch Med, Shenzhen 518055, Guangdong, Peoples R China; [Zhang, Baotong] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Emory Winship Canc Inst, Atlanta, GA 30322 USA	Nankai University; Southern University of Science & Technology; Emory University	Dong, JT (corresponding author), Southern Univ Sci & Technol, Sch Med, Shenzhen 518055, Guangdong, Peoples R China.	dongjt@sustech.edu.cn	Zhang, Baotong/H-3482-2019; Zhang, Zhiqian/P-7746-2018	Zhang, Baotong/0000-0002-6586-4016; Zhang, Zhiqian/0000-0003-1226-4807	National Natural Science Foundation of China (NSFC) [81472464, 31871466]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC) Grants 81472464 and 31871466. The authors declare that they have no conflicts of interest with the contents of this article.	Aillet F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051672; Barry R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05321-2; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Berry FB, 2001, J BIOL CHEM, V276, P25057, DOI 10.1074/jbc.M010378200; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Chen CH, 2013, CANCER RES, V73, P3951, DOI 10.1158/0008-5472.CAN-12-4360; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng WL, 2019, ACTA PHYSIOL, V227, DOI 10.1111/apha.13322; Creton S, 2010, CELL, V143, P848, DOI 10.1016/j.cell.2010.11.026; Dong XY, 2012, BIOCHEM J, V444, P581, DOI 10.1042/BJ20111890; Dong XY, 2011, J BIOL CHEM, V286, P13879, DOI 10.1074/jbc.M110.187849; Dong XY, 2010, J BIOL CHEM, V285, P32801, DOI 10.1074/jbc.M110.128330; Du JX, 2008, J BIOL CHEM, V283, P31991, DOI 10.1074/jbc.M803612200; Du YZ, 2018, NUCLEIC ACIDS RES, V46, P5195, DOI 10.1093/nar/gky156; Eckermann K, 2013, NEUROMOL MED, V15, P737, DOI 10.1007/s12017-013-8259-5; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gong LM, 1997, J BIOL CHEM, V272, P28198, DOI 10.1074/jbc.272.45.28198; Harder Z, 2004, CURR BIOL, V14, P340, DOI 10.1016/j.cub.2004.02.004; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Henley JM, 2014, PHYSIOL REV, V94, P1249, DOI 10.1152/physrev.00008.2014; Hu QX, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0138-y; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jalal D, 2017, NUCLEIC ACIDS RES, V45, P2242, DOI 10.1093/nar/gkw1369; Ji Z, 2007, ONCOGENE, V26, P395, DOI 10.1038/sj.onc.1209789; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kataoka H, 2017, MOL MED REP, V16, P3095, DOI 10.3892/mmr.2017.7016; Kawaguchi M, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2845-5; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Li M, 2017, BIOCHEM BIOPH RES CO, V490, P492, DOI 10.1016/j.bbrc.2017.06.068; Li M, 2013, BIOCHEM BIOPH RES CO, V430, P358, DOI 10.1016/j.bbrc.2012.11.009; Li R, 2013, CANCER RES, V73, P5742, DOI 10.1158/0008-5472.CAN-13-0538; Lumpkin RJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01271-3; Luo HB, 2014, P NATL ACAD SCI USA, V111, P16586, DOI 10.1073/pnas.1417548111; Ma G, 2019, J GENET GENOMICS, V46, P119, DOI 10.1016/j.jgg.2019.03.003; Mabuchi M, 2010, BIOCHEM BIOPH RES CO, V398, P321, DOI 10.1016/j.bbrc.2010.06.090; Nishida T, 2011, BIOCHEM BIOPH RES CO, V406, P285, DOI 10.1016/j.bbrc.2011.02.034; Nojiri S, 2004, BIOCHEM BIOPH RES CO, V314, P97, DOI 10.1016/j.bbrc.2003.12.054; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Parsons MJ, 2015, CELL, V162, P607, DOI 10.1016/j.cell.2015.06.060; Ran Y, 2011, J MOL CELL BIOL, V3, P283, DOI 10.1093/jmcb/mjr020; Seeler JS, 2017, NAT REV CANCER, V17, P184, DOI 10.1038/nrc.2016.143; Shimada K, 2008, BONE, V42, P886, DOI 10.1016/j.bone.2008.01.009; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Sun XD, 2005, NAT GENET, V37, P407, DOI 10.1038/ng1528; Sun XD, 2015, J GENET GENOMICS, V42, P373, DOI 10.1016/j.jgg.2015.06.004; Sun XD, 2014, NEOPLASIA, V16, P377, DOI 10.1016/j.neo.2014.05.001; Sun XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092746; Sun XD, 2013, HEAD NECK-J SCI SPEC, V35, P1007, DOI 10.1002/hed.23077; Sun XD, 2012, GENESIS, V50, P819, DOI 10.1002/dvg.22041; Wang TS, 2019, MOL CELL, V75, P823, DOI 10.1016/j.molcel.2019.06.008; Yang SH, 2005, EMBO J, V24, P2161, DOI 10.1038/sj.emboj.7600690; YASUDA H, 1994, MOL CELL BIOL, V14, P1395, DOI 10.1128/MCB.14.2.1395; Zhao D, 2016, J BIOL CHEM, V291, P12809, DOI 10.1074/jbc.M116.719377	57	10	10	4	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6741	6753		10.1074/jbc.RA119.012338	http://dx.doi.org/10.1074/jbc.RA119.012338			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32249212	hybrid, Green Published			2022-12-28	WOS:000537685000038
J	Neill, T; Chen, CG; Buraschi, S; Iozzo, RV				Neill, Thomas; Chen, Carolyn G.; Buraschi, Simone; Iozzo, Renato V.			Catabolic degradation of endothelial VEGFA via autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						angiogenesis; autophagy; endothelial cell; proteoglycan; cell signaling; AICAR; AMPK; HUVEC; Peg3; VEGFR2	GROWTH-FACTOR RECEPTOR; BREAST-CARCINOMA CELLS; IMPRINTED GENE PEG3; REGULATES AUTOPHAGY; TUMOR ANGIOGENESIS; IN-VITRO; DECORIN; CANCER; ENDOREPELLIN; INHIBITION	Extracellular matrix-evoked angiostasis and autophagy within the tumor microenvironment represent two critical, but unconnected, functions of the small leucine-rich proteoglycan, decorin. Acting as a partial agonist of vascular endothelial growth factor 2 (VEGFR2), soluble decorin signals via the energy sensing protein, AMP-activated protein kinase (AMPK), in the autophagic degradation of intracellular vascular endothelial growth factor A (VEGFA). Here, we discovered that soluble decorin evokes intracellular catabolism of endothelial VEGFA that is mechanistically independent of mTOR, but requires an autophagic regulator, paternally expressed gene 3 (PEG3). We found that administration of autophagic inhibitors such as chloroquine or bafilomycin A1, or depletion of autophagy-related 5 (ATG5), results in accumulation of intracellular VEGFA, indicating that VEGFA is a basal autophagic substrate. Mechanistically, decorin increased the VEGFA clearance rate by augmenting autophagic flux, a process that required RAB24 member RAS oncogene family (RAB24), a small GTPase that facilitates the disposal of autophagic compartments. We validated these findings by demonstrating the physiological relevance of this process in vivo. Mice starved for 48 h exhibited a sharp decrease in overall cardiac and aortic VEGFA that could be blocked by systemic chloroquine treatment. Thus, our findings reveal a unified mechanism for the metabolic control of endothelial VEGFA for autophagic clearance in response to decorin and canonical pro-autophagic stimuli. We posit that the VEGFR2/AMPK/PEG3 axis integrates the anti-angiogenic and pro-autophagic bioactivities of decorin as the molecular basis for tumorigenic suppression. These results support future therapeutic use of decorin as a next-generation protein therapy to combat cancer.	Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Sidney Kimmel Med Coll, Canc Cell Biol & Signaling Program, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Neill, T (corresponding author), Thomas Jefferson Univ, 1020 Locust St,Suite 336G Jefferson Alumni Hall, Philadelphia, PA 19107 USA.; Iozzo, RV (corresponding author), Thomas Jefferson Univ, 1020 Locust St,Suite 336 Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	thomas.neill@jefferson.edu; renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020	Buraschi, Simone/0000-0002-4233-7627; Chen, Carolyn/0000-0003-4933-6544	National Institutes of Health [RO1 CA39481, RO1 CA47282, T32 AR052273]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants RO1 CA39481 and RO1 CA47282 (to R. V. I.) and T32 AR052273 (to C. G. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Apte RS, 2019, CELL, V176, P1248, DOI 10.1016/j.cell.2019.01.021; Ban HS, 2010, CANCER LETT, V296, P17, DOI 10.1016/j.canlet.2010.03.010; Bi XL, 2008, CARCINOGENESIS, V29, P1435, DOI 10.1093/carcin/bgn141; Bi XL, 2012, CARCINOGENESIS, V33, P326, DOI 10.1093/carcin/bgr293; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chen C, 2019, METHODS MOL BIOL, V1952, P157, DOI 10.1007/978-1-4939-9133-4_14; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Dodd KM, 2015, ONCOGENE, V34, P2239, DOI 10.1038/onc.2014.164; Douglass S, 2015, CONNECT TISSUE RES, V56, P381, DOI 10.3109/03008207.2015.1045297; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Ferrara N, 2016, NAT REV DRUG DISCOV, V15, P385, DOI 10.1038/nrd.2015.17; Fong TAT, 1999, CANCER RES, V59, P99; Francipane MG, 2013, ONCOTARGET, V4, P1948, DOI 10.18632/oncotarget.1310; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Garantziotis S, 2019, MATRIX BIOL, V78-79, P1, DOI 10.1016/j.matbio.2019.02.002; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goldoni S, 2008, AM J PATHOL, V173, P844, DOI 10.2353/ajpath.2008.080275; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Goyal A, 2016, J BIOL CHEM, V291, P19245, DOI 10.1074/jbc.M116.740266; Goyal A, 2014, MATRIX BIOL, V34, P46, DOI 10.1016/j.matbio.2013.12.011; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Gubbiotti MA, 2020, SEMIN CANCER BIOL, V62, P1, DOI 10.1016/j.semcancer.2019.05.003; Gubbiotti MA, 2018, J BIOL CHEM, V293, P16940, DOI 10.1074/jbc.RA118.004563; Gubbiotti MA, 2016, MATRIX BIOL, V55, P7, DOI 10.1016/j.matbio.2016.09.009; Gubbiotti MA, 2015, MATRIX BIOL, V48, P6, DOI 10.1016/j.matbio.2015.10.002; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gurney MA, 2015, METHODS MOL BIOL, V1219, P187, DOI 10.1007/978-1-4939-1661-0_14; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Iozzo RV, 2018, MATRIX BIOL, V71-72, P1, DOI 10.1016/j.matbio.2018.03.023; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jarvelainen H, 2015, MATRIX BIOL, V43, P15, DOI 10.1016/j.matbio.2015.01.023; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Jin LJ, 2014, BREAST CANCER RES TR, V146, P41, DOI 10.1007/s10549-014-2978-7; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Karamanos Nikos K, 2019, Matrix Biol, V75-76, P1, DOI 10.1016/j.matbio.2018.08.007; Karamanos NK, 2018, CHEM REV, V118, P9152, DOI 10.1021/acs.chemrev.8b00354; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kim J, 2013, AUTOPHAGY, V9, P1110, DOI 10.4161/auto.24877; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2011, AUTOPHAGY, V7, P1, DOI 10.4161/auto.7.1.14130; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Kuhajda FP, 2008, INT J OBESITY, V32, pS36, DOI 10.1038/ijo.2008.121; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu Qingsong, 2009, Drug Discov Today Ther Strateg, V6, P47; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mendel DB, 2000, CLIN CANCER RES, V6, P4848; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Mongiat M, 2019, BIOCHEM SOC T, V47, P1543, DOI 10.1042/BST20190653; Moore BR, 2011, ANTIMICROB AGENTS CH, V55, P3899, DOI 10.1128/AAC.00067-11; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Moulis M, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6020014; Neill T, 2017, J BIOL CHEM, V292, P16211, DOI 10.1074/jbc.M116.769950; Neill T, 2016, ADV DRUG DELIVER REV, V97, P174, DOI 10.1016/j.addr.2015.10.016; Neill T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975645; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Neill T, 2014, AM J PATHOL, V184, P2146, DOI 10.1016/j.ajpath.2014.05.010; Neill T, 2014, J BIOL CHEM, V289, P4952, DOI 10.1074/jbc.M113.512566; Neill T, 2013, AUTOPHAGY, V9, P1626, DOI 10.4161/auto.25881; Neill T, 2013, FEBS J, V280, P2353, DOI 10.1111/febs.12148; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Nye MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056325; Orillion A, 2018, CLIN CANCER RES, V24, P6383, DOI 10.1158/1078-0432.CCR-18-0980; Patel S, 1998, J BIOL CHEM, V273, P3121, DOI 10.1074/jbc.273.6.3121; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Ricard-Blum S, 2019, MATRIX BIOL, V75-76, P170, DOI 10.1016/j.matbio.2017.11.005; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rimsa V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069538; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Saleh AD, 2013, CELL CYCLE, V12, P1955, DOI 10.4161/cc.25016; Schaefer L, 2014, MATRIX BIOL, V35, P1, DOI 10.1016/j.matbio.2014.05.001; Simone BA, 2016, CELL CYCLE, V15, P2265, DOI 10.1080/15384101.2016.1160982; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Stjepanovic G, 2017, MOL CELL, V67, P528, DOI 10.1016/j.molcel.2017.07.003; Theocharis AD, 2015, BBA-REV CANCER, V1855, P276, DOI 10.1016/j.bbcan.2015.03.006; Torres A, 2017, J BIOL CHEM, V292, P5055, DOI 10.1074/jbc.M116.753632; Vigetti D, 2018, J BIOL CHEM, V293, P16951, DOI 10.1074/jbc.H118.006101; Xu W, 2015, GENE THER, V22, P247, DOI 10.1038/gt.2014.110; Yang F, 2013, J BIOL CHEM, V288, P6552, DOI 10.1074/jbc.M112.418335; Yang YF, 2015, HUM GENE THER, V26, P813, DOI 10.1089/hum.2015.098; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yla-Anttila Paivi, 2018, Small GTPases, V9, P57, DOI 10.1080/21541248.2017.1317699; Yla-Anttila P, 2015, AUTOPHAGY, V11, P1833, DOI 10.1080/15548627.2015.1086522; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	113	17	18	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					6064	6079		10.1074/jbc.RA120.012593	http://dx.doi.org/10.1074/jbc.RA120.012593			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32209654	Green Published, hybrid			2022-12-28	WOS:000531417300018
J	Scott, HL; Buckner, N; Fernandez-Albert, F; Pedone, E; Postiglione, L; Shi, GY; Allen, N; Wong, LF; Magini, L; Marucci, L; O'Sullivan, GA; Cole, S; Powell, J; Maycox, P; Uney, JB				Scott, Helen L.; Buckner, Nicola; Fernandez-Albert, Francesc; Pedone, Elisa; Postiglione, Lorena; Shi, Gongyu; Allen, Nicholas; Wong, Liang-Fong; Magini, Lorenzo; Marucci, Lucia; O'Sullivan, Gregory A.; Cole, Sarah; Powell, Justin; Maycox, Peter; Uney, James B.			A dual druggable genome-wide siRNA and compound library screening approach identifies modulators of parkin recruitment to mitochondria (vol 295, pg 3285, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Fernandez-Albert, Francesc/0000-0001-5561-0701				Scott HL, 2020, J BIOL CHEM, V295, P3285, DOI 10.1074/jbc.RA119.009699	1	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2020	295	17					5835	5835		10.1074/jbc.AAC120.013668	http://dx.doi.org/10.1074/jbc.AAC120.013668			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LJ7SQ	32332132	hybrid, Green Published			2022-12-28	WOS:000530361700024
J	Dou, ML; Yao, Y; Ma, L; Wang, XY; Shi, XE; Yang, GS; Li, X				Dou Mingle; Yao Ying; Ma, Lu; Wang Xiaoyu; Shi Xin'e; Yang Gongshe; Li Xiao			The long noncoding RNA MyHC IIA/X-AS contributes to skeletal muscle myogenesis and maintains the fast fiber phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						long noncoding RNA (long ncRNA; lncRNA); myogenesis; muscle physiology; microRNA (miRNA); skeletal muscle; lncRNA; muscle fiber type; MyHC; myogenesis	CULTURE; GENES; FOXO1	Mammalian skeletal muscles comprise different types of muscle fibers, and this muscle fiber heterogeneity is generally characterized by the expression of myosin heavy chain (MyHC) isoforms. A switch in MyHC expression leads to muscle fiber?type transition under various physiological and pathological conditions, but the underlying regulator coordinating the switch of MyHC expression remains largely unknown. Experiments reported in this study revealed the presence of a skeletal muscle?specific antisense transcript generated from the intergenic region between porcine MyHC IIa and IIx and is referred to here as MyHC IIA/X-AS. We found that MyHC IIA/X-AS is identified as a long noncoding RNA (lncRNA) that is strictly expressed in skeletal muscles and is predominantly distributed in the cytoplasm. Genetic analysis disclosed that MyHC IIA/X-AS stimulates cell cycle exit of skeletal satellite cells and their fusion into myotubes. Moreover, we observed that MyHC IIA/X-AS is more enriched in fast-twitch muscle and represses slow-type gene expression and thereby maintains the fast phenotype. Furthermore, we found that MyHC IIA/X-AS acts as a competing endogenous RNA that sponges microRNA-130b (miR-130b) and thereby maintains MyHC IIx expression and the fast fiber type. We also noted that miR-130b was proved to down-regulate MyHC IIx by directly targeting its 3?-UTR. Together, the results of our study uncovered a novel pathway, which revealed that lncRNA derived from the skeletal MyHC cluster could modulate local MyHC expression in trans, highlighting the role of lncRNAs in muscle fiber?type switching.	[Dou Mingle; Yao Ying; Ma, Lu; Wang Xiaoyu; Shi Xin'e; Yang Gongshe; Li Xiao] Northwest A&F Univ, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Li, X (corresponding author), Northwest A&F Univ, Key Lab Anim Genet Breeding & Reprod Shaanxi Prov, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	nice.lixiao@gmail.com		Wang, Xiaoyu/0000-0002-0861-0204; Li, Xiao/0000-0002-6630-0503	National Natural Science Foundation [31501925]; National Key Research and Development Program of China [2018YFD0500402]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by National Natural Science Foundation Grant 31501925 and National Key Research and Development Program of China Grant 2018YFD0500402.The authors declare that they have no conflicts of interest with the contents of this article.	Carter CS, 2019, GEROSCIENCE, V41, P297, DOI 10.1007/s11357-019-00077-z; Costa N. da, 2005, Archiv fur Tierzucht, V48, P32; Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y; Haddad F, 2008, AM J PHYSIOL-HEART C, V294, pH29, DOI 10.1152/ajpheart.01125.2007; Kamei Y, 2004, J BIOL CHEM, V279, P41114, DOI 10.1074/jbc.M400674200; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Li BJ, 2015, ASIAN AUSTRAL J ANIM, V28, P1171, DOI 10.5713/ajas.14.0848; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Pandorf CE, 2006, J BIOL CHEM, V281, P38330, DOI 10.1074/jbc.M607249200; Pattanakuhar S, 2017, OBES RES CLIN PRACT, V11, P112, DOI 10.1016/j.orcp.2016.09.012; Ponsuksili S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-533; Reiser PJ, 2019, ARCH BIOCHEM BIOPHYS, V662, P129, DOI 10.1016/j.abb.2018.12.009; Rinaldi C, 2008, AM J PHYSIOL-REG I, V295, pR208, DOI 10.1152/ajpregu.00134.2008; Sakakibara I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004386; Schiaffino S, 2018, FEBS J, V285, P3688, DOI 10.1111/febs.14502; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Siengdee P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127850; Sun YM, 2003, J MUSCLE RES CELL M, V24, P561, DOI 10.1023/B:JURE.0000009895.03111.b3; Talbot J, 2016, WIRES DEV BIOL, V5, P518, DOI 10.1002/wdev.230; Tang Q, 2018, CELL PHYSIOL BIOCHEM, V47, P893, DOI 10.1159/000490131; Xu M, 2017, ONCOTARGET, V8, P10662, DOI 10.18632/oncotarget.12891; Xue J, 2017, BIOTECHNOL LETT, V39, P1611, DOI 10.1007/s10529-017-2400-8; Yang JJ, 2017, CELL TISSUE BANK, V18, P513, DOI 10.1007/s10561-017-9614-9; Zhu M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14718	24	9	9	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4937	4949		10.1074/jbc.RA119.010498	http://dx.doi.org/10.1074/jbc.RA119.010498			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32152230	hybrid, Green Published			2022-12-28	WOS:000526887000017
J	Gorisse, L; Li, ZG; Wagner, CD; Worthylake, DK; Zappacosta, F; Hedman, AC; Annan, RS; Sacks, DB				Gorisse, Laetitia; Li, Zhigang; Wagner, Craig D.; Worthylake, David K.; Zappacosta, Francesca; Hedman, Andrew C.; Annan, Roland S.; Sacks, David B.			Ubiquitination of the scaffold protein IQGAP1 diminishes its interaction with and activation of the Rho GTPase CDC42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						scaffold protein; ubiquitylation (ubiquitination); CDC42; cell signaling; Ras-related C3 botulinum toxin substrate 1 (Rac1); GAP-related domain; IQGAP1; small GTPase	RAC1; BINDING; IDENTIFICATION; CALMODULIN; PROMOTES; ADHESION; DOMAIN; PHOSPHORYLATION; CONJUGATION; PROTEASOME	IQ motif-containing GTPase-activating protein 1 (IQGAP1) is a scaffold protein that interacts with numerous binding partners and thereby regulates fundamental biological processes. The functions of IQGAP1 are modulated by several mechanisms, including protein binding, self-association, subcellular localization, and phosphorylation. Proteome-wide screens have indicated that IQGAP1 is ubiquitinated, but the possible effects of this post-translational modification on its function are unknown. Here we characterized and evaluated the function of IQGAP1 ubiquitination. Using MS-based analysis in HEK293 cells, we identified six lysine residues (Lys-556, -1155, -1230, -1465, -1475, and -1528) as ubiquitination sites in IQGAP1. To elucidate the biological consequences of IQGAP1 ubiquitination, we converted each of these lysines to arginine and found that replacing two of these residues, Lys-1155 and Lys-1230, in the GAP-related domain of IQGAP1 (termed IQGAP1 GRD-2K) reduces its ubiquitination. Moreover, IQGAP1 GRD-2K bound a significantly greater proportion of the two Rho GTPases cell division cycle 42 (CDC42) and Rac family small GTPase 1 (RAC1) than did WT IQGAP1. Consistent with this observation, reconstitution of IQGAP1-null cells with IQGAP1 GRD-2K significantly increased the amount of active CDC42 and enhanced cell migration significantly more than WT IQGAP1. Our results reveal that ubiquitination of the CDC42 regulator IQGAP1 alters its ability to bind to and activate this GTPase, leading to physiological effects. Collectively, these findings expand our view of the role of ubiquitination in cell signaling and provide additional insight into CDC42 regulation.	[Gorisse, Laetitia; Li, Zhigang; Hedman, Andrew C.; Sacks, David B.] NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA; [Wagner, Craig D.; Zappacosta, Francesca; Annan, Roland S.] GlaxoSmithKline, Discovery Analyt, Collegeville, PA 19426 USA; [Worthylake, David K.] Louisiana State Univ Hlth Sci, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	National Institutes of Health (NIH) - USA; GlaxoSmithKline; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Sacks, DB (corresponding author), 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA.	david.sacks2@nih.gov		Sacks, David/0000-0003-3100-0735	National Institutes of Health Intramural Research Program	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Bardwell AJ, 2017, J BIOL CHEM, V292, P8750, DOI 10.1074/jbc.M116.767087; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Brown MD, 2007, J BIOL CHEM, V282, P30265, DOI 10.1074/jbc.M702537200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Cerikan B, 2016, DEV CELL, V39, P28, DOI 10.1016/j.devcel.2016.08.020; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Choi S, 2016, NAT CELL BIOL, V18, P1324, DOI 10.1038/ncb3441; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kurella VB, 2009, J BIOL CHEM, V284, P14857, DOI 10.1074/jbc.M808974200; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; LeCour L, 2016, STRUCTURE, V24, P1499, DOI 10.1016/j.str.2016.06.016; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Liang ZW, 2017, CANCER LETT, V411, P90, DOI 10.1016/j.canlet.2017.09.046; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Liu L, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00370; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; Mateer SC, 2003, CELL MOTIL CYTOSKEL, V55, P147, DOI 10.1002/cm.10118; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Nouri K, 2016, J BIOL CHEM, V291, P26364, DOI 10.1074/jbc.M116.752121; Oshikawa K, 2012, J PROTEOME RES, V11, P796, DOI 10.1021/pr200668y; Osman MA, 2010, THESCIENTIFICWORLDJO, V10, P944, DOI 10.1100/tsw.2010.85; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Ozdemir ES, 2018, J BIOL CHEM, V293, P3685, DOI 10.1074/jbc.RA117.001596; Pan CW, 2017, EMBO J, V36, P995, DOI 10.15252/embj.201695534; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Sayedyahossein S, 2016, J BIOL CHEM, V291, P19261, DOI 10.1074/jbc.M116.732529; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shin D, 2017, ELIFE, V6, DOI 10.7554/eLife.29154; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sinha S, 2008, CELL SIGNAL, V20, P1927, DOI 10.1016/j.cellsig.2008.05.002; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Tu S, 2001, J BIOL CHEM, V276, P19656, DOI 10.1074/jbc.M009838200; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Vetterkind S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09434-4; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999	70	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4822	4835		10.1074/jbc.RA119.011491	http://dx.doi.org/10.1074/jbc.RA119.011491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32094223	Green Published, hybrid			2022-12-28	WOS:000526887000007
J	Alogaili, F; Chinnarasu, S; Jaeschke, A; Kranias, EG; Hui, DY				Alogaili, Fawzi; Chinnarasu, Sivaprakasam; Jaeschke, Anja; Kranias, Evangelia G.; Hui, David Y.			Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						liver metabolism; pyruvate dehydrogenase complex (PDC); calcium; bile acid; inositol trisphosphate receptor (InsP3R)	FATTY LIVER-DISEASE; Y GASTRIC BYPASS; GLUCOSE-HOMEOSTASIS; ACID SYNTHESIS; RECEPTOR; PROTEIN; RETICULUM; OVEREXPRESSION; CHOLESTEROL; DYSFUNCTION	Increasing hepatic mitochondrial activity through pyruvate dehydrogenase and elevating enterohepatic bile acid recirculation are promising new approaches for metabolic disease therapy, but neither approach alone can completely ameliorate disease phenotype in high-fat diet?fed mice. This study showed that diet-induced hepatosteatosis, hyperlipidemia, and insulin resistance can be completely prevented in mice with liver-specific HCLS1-associated protein X-1 (HAX-1) inactivation. Mechanistically, we showed that HAX-1 interacts with inositol 1,4,5-trisphosphate receptor-1 (InsP3R1) in the liver, and its absence reduces InsP3R1 levels, thereby improving endoplasmic reticulum?mitochondria calcium homeostasis to prevent excess calcium overload and mitochondrial dysfunction. As a result, HAX-1 ablation activates pyruvate dehydrogenase and increases mitochondria utilization of glucose and fatty acids to prevent hepatosteatosis, hyperlipidemia, and insulin resistance. In contrast to the reduction of InsP3R1 levels, hepatic HAX-1 deficiency increases bile salt exporter protein levels, thereby promoting enterohepatic bile acid recirculation, leading to activation of bile acid?responsive genes in the intestinal ileum to augment insulin sensitivity and of cholesterol transport genes in the liver to suppress hyperlipidemia. The dual mechanisms of increased mitochondrial respiration and enterohepatic bile acid recirculation due to improvement of endoplasmic reticulum?mitochondria calcium homeostasis with hepatic HAX-1 inactivation suggest that this may be a potential therapeutic target for metabolic disease intervention.	[Alogaili, Fawzi; Chinnarasu, Sivaprakasam; Jaeschke, Anja; Hui, David Y.] Univ Cincinnati, Metab Dis Res Ctr, Dept Pathol & Lab Med, Coll Med, Cincinnati, OH 45237 USA; [Alogaili, Fawzi; Kranias, Evangelia G.] Univ Cincinnati, Dept Pharmacol & Syst Physiol, Coll Med, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Hui, DY (corresponding author), Univ Cincinnati, Dept Pathol, Coll Med, 2120 E Galbraith Rd, Cincinnati, OH 45237 USA.	huidy@ucmail.uc.edu	Chinnarasu, Sivaprakasam/AAU-4373-2020	COJANDARAJ, Dr LOUIS/0000-0002-5264-6546; ALOGAILI, FAWZI/0000-0003-3702-7138	National Institutes of Health [RO1 DK074932]; Higher Committee for Education Development in Iraq	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Higher Committee for Education Development in Iraq	This work was supported by National Institutes of Health Grant RO1 DK074932 (to D. Y. H.). This work was also supported by a scholarship from the Higher Committee for Education Development in Iraq (to F. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad NN, 2013, INT J OBESITY, V37, P1553, DOI 10.1038/ijo.2013.38; Ahmadian M, 2010, INT J BIOCHEM CELL B, V42, P555, DOI 10.1016/j.biocel.2009.12.009; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Arruda AP, 2015, CELL METAB, V22, P381, DOI 10.1016/j.cmet.2015.06.010; Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Bain SC, 2008, EXPERT OPIN DRUG SAF, V7, P643, DOI 10.1517/14740330802432003 ; Bidwell PA, 2018, J MOL CELL CARDIOL, V114, P220, DOI 10.1016/j.yjmcc.2017.11.014; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Chen SJ, 2013, HUM GENE THER CL DEV, V24, P154, DOI 10.1089/humc.2013.082; Day CP, 2011, CLIN MED, V11, P176, DOI 10.7861/clinmedicine.11-2-176; Delea TE, 2003, DIABETES CARE, V26, P2983, DOI 10.2337/diacare.26.11.2983; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Egnatchik RA, 2014, MOL METAB, V3, P544, DOI 10.1016/j.molmet.2014.05.004; Fadeel B, 2009, BBA-GEN SUBJECTS, V1790, P1139, DOI 10.1016/j.bbagen.2009.06.004; Feriod CN, 2017, HEPATOL COMMUN, V1, P23, DOI 10.1002/hep4.1012; Feriod CN, 2014, AM J PHYSIOL-ENDOC M, V307, pE1057, DOI 10.1152/ajpendo.00236.2014; Figge A, 2004, J BIOL CHEM, V279, P2790, DOI 10.1074/jbc.M307363200; Go Y, 2016, DIABETES, V65, P2876, DOI 10.2337/db16-0223; Goh GBB, 2015, BBA CLIN, V3, P141, DOI 10.1016/j.bbacli.2014.09.001; Hamlin AN, 2016, J BIOL CHEM, V291, P16610, DOI 10.1074/jbc.M116.717744; Han J, 2010, J BIOL CHEM, V285, P22461, DOI 10.1074/jbc.M109.086587; Henkel AS, 2013, AM J PHYSIOL-GASTR L, V304, pG221, DOI 10.1152/ajpgi.00322.2012; Hippe A, 2006, GENE, V379, P116, DOI 10.1016/j.gene.2006.04.027; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Kaushal S, 2014, N AM J MED SCI, V6, P107, DOI 10.4103/1947-2714.128471; Khan AU, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10339-5; Kneeman JM, 2012, THER ADV GASTROENTER, V5, P199, DOI 10.1177/1756283X11430859; Kohli R, 2013, J CLIN ENDOCR METAB, V98, pE708, DOI 10.1210/jc.2012-3736; Krishnan KC, 2018, CELL SYST, V6, P103, DOI 10.1016/j.cels.2017.12.006; Kruglov EA, 2011, HEPATOLOGY, V54, P1790, DOI 10.1002/hep.24548; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; Lam CK, 2013, CIRC RES, V112, P79, DOI 10.1161/CIRCRESAHA.112.279935; Li TG, 2011, HEPATOLOGY, V53, P996, DOI 10.1002/hep.24107; MEIER PJ, 1990, METHOD ENZYMOL, V192, P534; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; Myronovych A, 2014, OBESITY, V22, P390, DOI 10.1002/oby.20548; Nakatani H, 2009, METABOLISM, V58, P1400, DOI 10.1016/j.metabol.2009.05.006; Ortiz DF, 2004, J BIOL CHEM, V279, P32761, DOI 10.1074/jbc.M404337200; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; Pandak WM, 2002, J BIOL CHEM, V277, P48158, DOI 10.1074/jbc.M205244200; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Polonsky KS, 2008, NAT CLIN PRACT ENDOC, V4, P421, DOI 10.1038/ncpendmet0889; Rieusset J, 2017, BBA-MOL CELL RES, V1864, P865, DOI 10.1016/j.bbamcr.2017.01.001; Schumacher JD, 2017, TOXICOL APPL PHARM, V330, P1, DOI 10.1016/j.taap.2017.06.023; Simmen T, 2011, EXPERT OPIN THER TAR, V15, P741, DOI 10.1517/14728222.2011.561787; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; Triplitt C, 2007, J MANAGE CARE PHARM, V13, pS2; Vafiadaki E, 2009, MOL BIOL CELL, V20, P306, DOI 10.1091/mbc.E08-06-0587; Wang HH, 2010, EUR J CLIN INVEST, V40, P541, DOI 10.1111/j.1365-2362.2010.02300.x; Wang YG, 2012, NATURE, V485, P128, DOI 10.1038/nature10988; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Wu CY, 2018, MOL METAB, V12, P12, DOI 10.1016/j.molmet.2018.03.014; Yap SV, 2010, J MOL CELL CARDIOL, V48, P1266, DOI 10.1016/j.yjmcc.2009.10.028; Zhao W, 2009, P NATL ACAD SCI USA, V106, P20776, DOI 10.1073/pnas.0906998106	60	6	6	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4631	4646		10.1074/jbc.RA119.012361	http://dx.doi.org/10.1074/jbc.RA119.012361			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32079675	Green Published, hybrid			2022-12-28	WOS:000524499700022
J	Dustin, ML; Zenclussen, AC				Dustin, Michael L.; Zenclussen, Ana C.			A checkpoint cliffhanger at the dawn of placental mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The PD-1 ligands PD-L1 and PD-L2 are commonly expressed on the surface of cells, where they regulate immune system activation. However, the specific role played by each ligand has been unclear. Using site-directed mutagenesis, surface plasmon resonance, and crystallography, Philips et al. explore the distinct features of PD-L2 and identify a specific evolutionary event linked to its appearance. This work provides a deeper understanding of how the immune system adapted to mammalian placental gestation and could be an important consideration in the development of new immune checkpoint therapies.	[Dustin, Michael L.] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England; [Zenclussen, Ana C.] Otto von Guericke Univ, Expt Obstet & Gynecol, D-39106 Magdeburg, Germany	University of Oxford; Otto von Guericke University	Dustin, ML (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England.; Zenclussen, AC (corresponding author), Otto von Guericke Univ, Expt Obstet & Gynecol, D-39106 Magdeburg, Germany.	Michael.dustin@kennedy.ox.ac.uk; ana.zenclussen@med.ovgu.de	Dustin, Michael/AAM-4611-2020; Zenclussen, Ana/AAE-8760-2020	Zenclussen, Ana/0000-0003-3544-4552; Dustin, Michael/0000-0003-4983-6389				Flies AS, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00581; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64; Nie XX, 2018, CELL MOL IMMUNOL, V15, P888, DOI 10.1038/cmi.2017.17; Petroff MG, 2010, AM J REPROD IMMUNOL, V63, P506, DOI 10.1111/j.1600-0897.2010.00841.x; Philips EA, 2020, J BIOL CHEM, V295, P4372, DOI 10.1074/jbc.AC119.011747; Schumacher A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02896; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Zhang Y, 2006, P NATL ACAD SCI USA, V103, P11695, DOI 10.1073/pnas.0601347103	10	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4381	4382		10.1074/jbc.H120.013307	http://dx.doi.org/10.1074/jbc.H120.013307			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32245902	hybrid, Green Published			2022-12-28	WOS:000524499700002
J	Peng, FX; Zhou, Y; Wang, J; Guo, BQ; Wei, Y; Deng, H; Wu, ZH; Zhang, C; Shi, KT; Li, Y; Wang, X; Shore, P; Zhao, SS; Deng, WS				Peng, Feixia; Zhou, Ying; Wang, Juan; Guo, Baoqiang; Wei, Yun; Deng, Huan; Wu, Zihui; Zhang, Cheng; Shi, Kaituo; Li, Yuan; Wang, Xin; Shore, Paul; Zhao, Shasha; Deng, Wensheng			The transcription factor Sp1 modulates RNA polymerase III gene transcription by controlling BRF1 and GTF3C2 expression in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						specificity protein 1 (Sp1); RNA polymerase III; transcription; filamin; cancer; TFIIB-related factor 1 (BRF1); gene transcription; TFIIB-related factor 1 (BRF1); filamin A (FLNA)	O-GLYCOSYLATION; I-RECEPTOR; CANCER; PHOSPHORYLATION; INHIBITION; PROTEIN; MITHRAMYCIN; ACTIVATION; FILAMIN; P300	Specificity protein 1 (Sp1) is an important transcription factor implicated in numerous cellular processes. However, whether Sp1 is involved in the regulation of RNA polymerase III (Pol III)-directed gene transcription in human cells remains unknown. Here, we first show that filamin A (FLNA) represses Sp1 expression as well as expression of TFIIB-related factor 1 (BRF1) and general transcription factor III C subunit 2 (GTF3C2) in HeLa, 293T, and SaOS2 cell lines stably expressing FLNA-silencing shRNAs. Both BRF1 promoter 4 (BRF1P4) and GTF3C2 promoter 2 (GTF3C2P2) contain putative Sp1-binding sites, suggesting that Sp1 affects Pol III gene transcription by regulating BRF1 and GTF3C2 expression. We demonstrate that Sp1 knockdown inhibits Pol III gene transcription, BRF1 and GTF3C2 expression, and the proliferation of 293T and HeLa cells, whereas Sp1 overexpression enhances these activities. We obtained a comparable result in a cell line in which both FLNA and Sp1 were depleted. These results indicate that Sp1 is involved in the regulation of Pol III gene transcription independently of FLNA expression. Reporter gene assays showed that alteration of Sp1 expression affects BRF1P4 and GTF3C2P2 activation, suggesting that Sp1 modulates Pol III?mediated gene transcription by controlling BRF1 and GTF3C2 gene expression. Further analysis revealed that Sp1 interacts with and thereby promotes the occupancies of TATA box?binding protein, TFIIA?, and p300 at both BRF1P4 and GTF3C2P2. These findings indicate that Sp1 controls Pol III?directed transcription and shed light on how Sp1 regulates cancer cell proliferation.	[Peng, Feixia; Zhou, Ying; Wang, Juan; Wei, Yun; Deng, Huan; Wu, Zihui; Zhang, Cheng; Shi, Kaituo; Li, Yuan; Zhao, Shasha; Deng, Wensheng] Wuhan Univ Sci & Technol, Coll Life Sci & Hlth, Wuhan 430065, Peoples R China; [Guo, Baoqiang] Manchester Metropolitan Univ, Fac Sci & Engn, Ctr Biosci, Manchester M1 5GD, Lancs, England; [Wang, Xin; Shore, Paul] Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PL, Lancs, England	Wuhan University of Science & Technology; Manchester Metropolitan University; University of Manchester	Zhao, SS; Deng, WS (corresponding author), Wuhan Univ Sci & Technol, Coll Life Sci & Hlth, Wuhan 430065, Peoples R China.; Shore, P (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PL, Lancs, England.	Paul.Shore@manchester.ac.uk; zhaoshasha@wust.edu.cn; dengwensheng@wust.edu.cn		Shore, Paul/0000-0002-1832-5976	Natural Science Foundation of China [31271395, 31671357]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China Projects 31271395 and 31671357 (to W. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramovitch S, 2003, FEBS LETT, V541, P149, DOI 10.1016/S0014-5793(03)00315-6; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Cabarcas S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-47; Choi J, 2017, P NATL ACAD SCI USA, V114, P13691, DOI 10.1073/pnas.1719592115; Chu SJ, 2012, GENE, V508, P1, DOI 10.1016/j.gene.2012.07.022; Deng WS, 2012, P NATL ACAD SCI USA, V109, P1524, DOI 10.1073/pnas.1107879109; Derenzini M, 2017, ACTA HISTOCHEM, V119, P190, DOI 10.1016/j.acthis.2017.01.009; Dieci G, 2013, BBA-GENE REGUL MECH, V1829, P296, DOI 10.1016/j.bbagrm.2012.09.010; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grewal SS, 2015, BBA-GENE REGUL MECH, V1849, P898, DOI 10.1016/j.bbagrm.2014.12.005; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Holmqvist PH, 2013, TRANSCR-AUSTIN, V4, P18, DOI 10.4161/trns.22601; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Jiang YX, 2004, CLIN EXP METASTAS, V21, P755, DOI 10.1007/s10585-005-1198-2; Kim HS, 2009, J BIOL CHEM, V284, P15475, DOI 10.1074/jbc.M808734200; Lei Junxia, 2017, Liver Res, V1, P112, DOI 10.1016/j.livres.2017.08.005; LESCURE A, 1992, J MOL BIOL, V228, P387, DOI 10.1016/0022-2836(92)90828-8; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Luster TA, 2000, MOL REPROD DEV, V57, P4, DOI 10.1002/1098-2795(200009)57:1<4::AID-MRD3>3.0.CO;2-I; Majumdar G, 2006, J BIOL CHEM, V281, P3642, DOI 10.1074/jbc.M511223200; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Mauger E, 2004, BIOCHEM SOC T, V32, P976, DOI 10.1042/BST0320976; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Ohlsson C, 1998, ENDOCRINOLOGY, V139, P1101, DOI 10.1210/en.139.3.1101; Park JL, 2017, EPIGENOMICS-UK, V9, P171, DOI 10.2217/epi-2016-0108; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; Salvatori L, 2003, ONCOGENE, V22, P4875, DOI 10.1038/sj.onc.1206784; Sankpal UT, 2012, CURR MED CHEM, V19, P3779; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; Sriskanthadevan-Pirahas S, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007202; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Torigoe T, 2003, NUCLEIC ACIDS RES, V31, P4523, DOI 10.1093/nar/gkg487; Turowski TW, 2016, BIOCHEM SOC T, V44, P1367, DOI 10.1042/BST20160062; Vizcaino C, 2015, PHARMACOL THERAPEUT, V152, P111, DOI 10.1016/j.pharmthera.2015.05.008; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wang J, 2016, J BIOL CHEM, V291, P25239, DOI 10.1074/jbc.M116.735886; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang YT, 2011, J MOL BIOL, V414, P1, DOI 10.1016/j.jmb.2011.09.027; White RJ, 2004, ONCOGENE, V23, P3208, DOI 10.1038/sj.onc.1207547; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Yuan P, 2007, CANCER-AM CANCER SOC, V110, P2682, DOI 10.1002/cncr.23092; Zhong Q, 2016, ONCOTARGET, V7, P6243, DOI 10.18632/oncotarget.6668	47	7	7	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4617	4630		10.1074/jbc.RA119.011555	http://dx.doi.org/10.1074/jbc.RA119.011555			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32115405	hybrid, Green Published			2022-12-28	WOS:000524499700021
J	Spiegel, S				Spiegel, Sarah			Sphingosine-1-phosphate: From insipid lipid to a key regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						sphingosine 1-phosphate (S1P); sphingosine kinase (SphK); sphingolipid; S1PR; sphingolipid metabolites	PROTEIN-COUPLED RECEPTOR; PHOSPHATIDIC-ACID LEVELS; PROGRAMMED CELL-DEATH; SPHINGOSINE 1-PHOSPHATE; CHOLERA-TOXIN; B-SUBUNIT; FLUORESCENT GANGLIOSIDES; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; KINASE	It is a great honor to be asked to write a ?Reflections? article by one of the true icons of biochemistry, Herb Tabor. I felt humbled, especially since it follows many written by biochemists I admire and whose contributions have shaped major advances in biochemistry and molecular biology in the last century. Here I present my personal reflections on my adventure with the bioactive sphingolipid metabolite sphingosine-1-phosphate intertwined with those of my family life as a wife, mother, and grandmother. These reflections brought back many memories of events in my early career that played significant roles in determining the path I have taken for more than 40 years and that brought much fun and satisfaction into my life. It has been an exciting journey so far, with many surprises along the way, that still continues.	[Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA.; Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA.	sarah.spiegel@vcuhealth.org		Spiegel, Sarah/0000-0003-0751-2634	National Institutes of Health [R01GM043880]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01GM043880 (to S. S.). The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; BARTON NW, 1990, P NATL ACAD SCI USA, V87, P1913, DOI 10.1073/pnas.87.5.1913; Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123; BUCKLEY NE, 1990, EXP CELL RES, V189, P13, DOI 10.1016/0014-4827(90)90250-E; Comi G, 2017, J NEUROL, V264, P2436, DOI 10.1007/s00415-017-8642-5; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cuvillier O, 1998, J BIOL CHEM, V273, P2910, DOI 10.1074/jbc.273.5.2910; DESAI NN, 1992, J BIOL CHEM, V267, P23122; DIXON SJ, 1987, J CELL BIOL, V105, P1153, DOI 10.1083/jcb.105.3.1153; Donoviel MS, 2015, FASEB J, V29, P5018, DOI 10.1096/fj.15-274936; Edsall LC, 1997, J NEUROSCI, V17, P6952; Edsall LC, 1999, ANAL BIOCHEM, V272, P80, DOI 10.1006/abio.1999.4157; GOODEMOTE KA, 1995, J BIOL CHEM, V270, P10272, DOI 10.1074/jbc.270.17.10272; Grenald SA, 2017, PAIN, V158, P1733, DOI 10.1097/j.pain.0000000000000965; Hait NC, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.16; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; HLA T, 1990, J BIOL CHEM, V265, P9308; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kleuser B, 1998, CANCER RES, V58, P1817; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Maczis MA, 2018, J LIPID RES, V59, P2297, DOI 10.1194/jlr.M085191; Malek RL, 2001, J BIOL CHEM, V276, P5692, DOI 10.1074/jbc.M003964200; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Milstien S, 2006, CANCER CELL, V9, P148, DOI 10.1016/j.ccr.2006.02.025; Nagahashi M, 2018, CANCER RES, V78, P1713, DOI 10.1158/0008-5472.CAN-17-1423; Nagahashi M, 2013, FASEB J, V27, P1001, DOI 10.1096/fj.12-219618; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 2003, J BIOL CHEM, V278, P46452, DOI 10.1074/jbc.M308749200; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Price MM, 2013, J ALLERGY CLIN IMMUN, V131, P501, DOI 10.1016/j.jaci.2012.07.014; REBOIS RV, 1983, P NATL ACAD SCI-BIOL, V80, P1275, DOI 10.1073/pnas.80.5.1275; Rosenfeldt HM, 2001, FASEB J, V15, P2649, DOI 10.1096/fj.01-0523com; Singh Sandeep K., 2020, Advances in Biological Regulation, V75, P100670, DOI 10.1016/j.jbior.2019.100670; SPIEGEL S, 1989, J BIOL CHEM, V264, P6766; SPIEGEL S, 1989, J BIOL CHEM, V264, P16512; SPIEGEL S, 1985, J CELL BIOL, V100, P721, DOI 10.1083/jcb.100.3.721; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; SPIEGEL S, 1987, P NATL ACAD SCI USA, V84, P141, DOI 10.1073/pnas.84.1.141; SPIEGEL S, 1984, J CELL BIOL, V99, P699, DOI 10.1083/jcb.99.2.699; SPIEGEL S, 1990, J CELL BIOCHEM, V42, P143, DOI 10.1002/jcb.240420305; SPIEGEL S, 1979, P NATL ACAD SCI USA, V76, P5277, DOI 10.1073/pnas.76.10.5277; SPIEGEL S, 1985, SCIENCE, V230, P1285, DOI 10.1126/science.2999979; SPIEGEL S, 1984, J CELL BIOL, V99, P1575, DOI 10.1083/jcb.99.5.1575; SPIEGEL S, 1986, J CELL BIOL, V102, P1898, DOI 10.1083/jcb.102.5.1898; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Stockstill K, 2018, J EXP MED, V215, P1301, DOI 10.1084/jem.20170584; STOFFEL W, 1970, H-S Z PHYSIOL CHEM, V351, P1041, DOI 10.1515/bchm2.1970.351.2.1041; STOFFEL W, 1970, H-S Z PHYSIOL CHEM, V351, P635, DOI 10.1515/bchm2.1970.351.1.635; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Thudichum J.L.W., 1884, TREATISE CHEM CONSTI; Toman RE, 2004, J CELL BIOL, V166, P381, DOI 10.1083/jcb.200402016; Van Brocklyn JR, 2000, BLOOD, V95, P2624; Van Brocklyn JR, 1999, J BIOL CHEM, V274, P4626, DOI 10.1074/jbc.274.8.4626; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; van der Weyden L, 2017, NATURE, V541, P233, DOI 10.1038/nature20792; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; ZHANG H, 1990, J BIOL CHEM, V265, P76; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; ZHANG H, 1990, J BIOL CHEM, V265, P21309	83	9	9	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3371	3384		10.1074/jbc.X120.012838	http://dx.doi.org/10.1074/jbc.X120.012838			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32144147	Green Published, hybrid			2022-12-28	WOS:000519597300038
J	Choi, MS; Graves, MJ; Matoo, S; Storad, ZA; Idris, RAE; Weck, ML; Smith, ZB; Tyska, MJ; Crawley, SW				Choi, Myoung Soo; Graves, Maura J.; Matoo, Samaneh; Storad, Zachary A.; Idris, Rawnag A. El Sheikh; Weck, Meredith L.; Smith, Zachary B.; Tyska, Matthew J.; Crawley, Scott W.			The small EF-hand protein CALML4 functions as a critical myosin light chain within the intermicrovillar adhesion complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; epithelial cell; intestinal epithelium; actin; calmodulin (CaM); cadherin; brush border; calmodulin-like protein 4 (CALML4); intermicrovillar adhesion complex (IMAC); Usher syndrome; intestine; protrusion; enterocyte	I USHER-SYNDROME; BRUSH-BORDER; INFANTILE HYPERINSULINISM; CONTIGUOUS GENE; VIIA GENE; DOMAIN; MUTATIONS; DEAFNESS; LOCALIZATION; ENTEROPATHY	Specialized transporting and sensory epithelial cells employ homologous protocadherin-based adhesion complexes to remodel their apical membrane protrusions into organized functional arrays. Within the intestine, the nutrient-transporting enterocytes utilize the intermicrovillar adhesion complex (IMAC) to assemble their apical microvilli into an ordered brush border. The IMAC bears remarkable homology to the Usher complex, whose disruption results in the sensory disorder type 1 Usher syndrome (USH1). However, the entire complement of proteins that comprise both the IMAC and Usher complex are not yet fully elucidated. Using a protein isolation strategy to recover the IMAC, we have identified the small EF-hand protein calmodulin-like protein 4 (CALML4) as an IMAC component. Consistent with this finding, we show that CALML4 exhibits marked enrichment at the distal tips of enterocyte microvilli, the site of IMAC function, and is a direct binding partner of the IMAC component myosin-7b. Moreover, distal tip enrichment of CALML4 is strictly dependent upon its association with myosin-7b, with CALML4 acting as a light chain for this myosin. We further show that genetic disruption of CALML4 within enterocytes results in brush border assembly defects that mirror the loss of other IMAC components and that CALML4 can also associate with the Usher complex component myosin-7a. Our study further defines the molecular composition and protein-protein interaction network of the IMAC and Usher complex and may also shed light on the etiology of the sensory disorder USH1H.	[Choi, Myoung Soo; Graves, Maura J.; Matoo, Samaneh; Storad, Zachary A.; Idris, Rawnag A. El Sheikh; Crawley, Scott W.] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [Weck, Meredith L.; Smith, Zachary B.; Tyska, Matthew J.] Vanderbilt Univ, Dept Cell & Dev Biol, Sch Med, Nashville, TN 37240 USA	University System of Ohio; University of Toledo; Vanderbilt University	Crawley, SW (corresponding author), Univ Toledo, Coll Nat Sci & Math, 2801 W Bancroft St, Toledo, OH 43606 USA.	william.crawley@utoledo.edu		Crawley, Scott William/0000-0002-4121-5353	National Science Foundation NOA-AGEP fellowship; FYSRE University of Toledo scholarship; URSCAP University of Toledo scholarship; National Institutes of Health [R15GM131382, DK075555, DK095811]; University of Toledo	National Science Foundation NOA-AGEP fellowship; FYSRE University of Toledo scholarship; URSCAP University of Toledo scholarship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Toledo	This work was supported by a National Science Foundation NOA-AGEP fellowship (to M. J. G.), FYSRE and URSCAP University of Toledo scholarships (to Z. A. S. and R. A. E.), University of Toledo start-up funds, and National Institutes of Health Grants R15GM131382 (to S. W. C.) and DK075555 and DK095811 (to M. J. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adato A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899; Ahmed ZM, 2009, CLIN GENET, V75, P86, DOI 10.1111/j.1399-0004.2008.01038.x; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Barr-Gillespie PG, 2015, MOL BIOL CELL, V26, P2727, DOI 10.1091/mbc.E14-04-0940; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Chaib H, 1997, HUM MOL GENET, V6, P27, DOI 10.1093/hmg/6.1.27; Crawley SW, 2016, DEV CELL, V36, P190, DOI 10.1016/j.devcel.2015.12.022; Crawley SW, 2014, J CELL BIOL, V207, P441, DOI 10.1083/jcb.201407015; Crawley SW, 2014, CELL, V157, P433, DOI 10.1016/j.cell.2014.01.067; Haithcock J, 2011, J BIOL CHEM, V286, P8819, DOI 10.1074/jbc.M110.163592; Heissler Sarah M, 2014, Bioarchitecture, V4, P169, DOI 10.1080/19490992.2015.1054092; Henn A, 2005, J BIOL CHEM, V280, P39665, DOI 10.1074/jbc.M507667200; Hussain K, 2004, J PEDIATR ENDOCR MET, V17, P1613; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Jaiganesh A, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029280; Jaworek TJ, 2012, J HUM GENET, V57, P633, DOI 10.1038/jhg.2012.79; Lentz J, 2016, GENEREVIEWS; Li JC, 2017, P NATL ACAD SCI USA, V114, pE3776, DOI 10.1073/pnas.1702251114; Marjoram RJ, 2016, METHODS, V94, P19, DOI 10.1016/j.ymeth.2015.09.025; McConnell RE, 2011, AM J PHYSIOL-GASTR L, V300, pG914, DOI 10.1152/ajpgi.00005.2011; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; MILLER D, 1961, ANAL BIOCHEM, V2, P284, DOI 10.1016/S0003-2697(61)80014-6; Morgan CP, 2016, ELIFE, V5, DOI 10.7554/eLife.18312; Pan LF, 2012, PHYSIOLOGY, V27, P25, DOI 10.1152/physiol.00037.2011; Pangrsic T, 2015, P NATL ACAD SCI USA, V112, pE1028, DOI 10.1073/pnas.1416424112; PETERSON MD, 1993, J CELL SCI, V105, P445; Postema MM, 2018, CURR BIOL, V28, P2876, DOI 10.1016/j.cub.2018.07.022; Sahly I, 2012, J CELL BIOL, V199, P381, DOI 10.1083/jcb.201202012; Sakai T, 2015, J BIOL CHEM, V290, P17587, DOI 10.1074/jbc.M114.599365; Sauvanet C, 2015, ANNU REV CELL DEV BI, V31, P593, DOI 10.1146/annurev-cellbio-100814-125234; Schietroma C, 2017, J CELL BIOL, V216, P1849, DOI 10.1083/jcb.201612030; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weck ML, 2016, CURR BIOL, V26, P2717, DOI 10.1016/j.cub.2016.08.014; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Yang Y, 2005, J BIOL CHEM, V280, P32061, DOI 10.1074/jbc.M506765200; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Yu IM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15864	43	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9281	9296		10.1074/jbc.RA120.012820	http://dx.doi.org/10.1074/jbc.RA120.012820			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32209652	Green Published, hybrid			2022-12-28	WOS:000552758600002
J	Junkova, P; Pleskot, R; Prchal, J; Sys, J; Ruml, T				Junkova, Petra; Pleskot, Roman; Prchal, Jan; Sys, Jakub; Ruml, Tomas			Differences and commonalities in plasma membrane recruitment of the two morphogenetically distinct retroviruses HIV-1 and MMTV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1; mouse mammary tumor virus (MMTV); matrix protein; covalent labeling?mass spectrometry; coarse-grained molecular dynamics; Gag polyprotein; particle assembly; viral replication; retrovirus; membrane binding; mass spectrometry (MS); molecular dynamics; retrovirus; lipid?protein interaction; human immunodeficiency virus (HIV)	VIRUS MATRIX PROTEIN; PFIZER MONKEY VIRUS; COARSE-GRAINED SIMULATIONS; AMINO-ACID SUBSTITUTIONS; GAG PROTEIN; BINDING DOMAIN; TUMOR-VIRUSES; BASIC REGION; FORCE-FIELD; ENVELOPE	Retroviral Gag polyproteins are targeted to the inner leaflet of the plasma membrane through their N-terminal matrix (MA) domain. Because retroviruses of different morphogenetic types assemble their immature particles in distinct regions of the host cell, the mechanism of MA-mediated plasma membrane targeting differs among distinct retroviral morphogenetic types. Here, we focused on possible mechanistic differences of the MA-mediated plasma membrane targeting of the B-type mouse mammary tumor virus (MMTV) and C-type HIV-1, which assemble in the cytoplasm and at the plasma membrane, respectively. Molecular dynamics simulations, together with surface mapping, indicated that, similarly to HIV-1, MMTV uses a myristic switch to anchor the MA to the membrane and electrostatically interacts with phosphatidylinositol 4,5-bisphosphate to stabilize MA orientation. We observed that the affinity of MMTV MA to the membrane is lower than that of HIV-1 MA, possibly related to their different topologies and the number of basic residues in the highly basic MA region. The latter probably reflects the requirement of C-type retroviruses for tighter membrane binding, essential for assembly, unlike for D/B-type retroviruses, which assemble in the cytoplasm. A comparison of the membrane topology of the HIV-1 MA, using the surface-mapping method and molecular dynamics simulations, revealed that the residues at the HIV-1 MA C terminus help stabilize protein?protein interactions within the HIV-1 MA lattice at the plasma membrane. In summary, HIV-1 and MMTV share common features such as membrane binding of the MA via hydrophobic interactions and exhibit several differences, including lower membrane affinity of MMTV MA.	[Junkova, Petra; Prchal, Jan; Sys, Jakub; Ruml, Tomas] Univ Chem & Technol, Dept Biochem & Microbiol, Prague, Czech Republic; [Junkova, Petra] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic; [Pleskot, Roman] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Pleskot, Roman] VIB Ctr Plant Syst Biol, Ghent, Belgium	University of Chemistry & Technology, Prague; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Ruml, T (corresponding author), Univ Chem & Technol, Dept Biochem & Microbiol, Prague, Czech Republic.	tomas.ruml@vscht.cz	Prchal, Jan/H-9756-2014; Pleskot, Roman/F-7774-2014	Prchal, Jan/0000-0002-3398-5059; Pleskot, Roman/0000-0003-0436-9748	Czech Science Foundation [GA17-24281S]; European Regional Development Fund Project "ChemBioDrug" Grant [CZ.02.1.01/0.0/0.0/16_ 019/0000729]	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund Project "ChemBioDrug" Grant	This work was supported by Czech Science Foundation Grant GA17-24281S (to T. R.) and by European Regional Development Fund Project "ChemBioDrug" Grant CZ.02.1.01/0.0/0.0/16_ 019/0000729 (to P. J.).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Alfadhli A, 2007, J VIROL, V81, P1472, DOI 10.1128/JVI.02122-06; Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERNHARD W, 1958, CANCER RES, V18, P491; BERNHARD W, 1960, CANCER RES, V20, P712; Brandano L, 2012, J VIROL, V86, P2347, DOI 10.1128/JVI.06047-11; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Burniston MT, 1999, J VIROL, V73, P8527, DOI 10.1128/JVI.73.10.8527-8540.1999; Charlier L, 2014, BIOPHYS J, V106, P577, DOI 10.1016/j.bpj.2013.12.019; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Choi G, 1999, J VIROL, V73, P5431, DOI 10.1128/JVI.73.7.5431-5437.1999; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Dalton AK, 2005, J VIROL, V79, P6227, DOI 10.1128/JVI.79.10.6227-6238.2005; Datta SAK, 2007, J MOL BIOL, V365, P799, DOI 10.1016/j.jmb.2006.10.072; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Dick RA, 2012, P NATL ACAD SCI USA, V109, P18761, DOI 10.1073/pnas.1209408109; Dolezal M, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-015-0235-8; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; ERDIE CR, 1990, J VIROL, V64, P5204, DOI 10.1128/JVI.64.10.5204-5208.1990; Fernandes F, 2011, TRAFFIC, V12, P438, DOI 10.1111/j.1600-0854.2010.01153.x; FINE D, 1978, CANCER RES, V38, P3123; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Gaines CR, 2018, J MOL BIOL, V430, P2113, DOI 10.1016/j.jmb.2018.04.042; GELDERBLOM HR, 1989, ARCH VIROL, V106, P1, DOI 10.1007/BF01311033; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; Hearps AC, 2008, BIOCHEMISTRY-US, V47, P2199, DOI 10.1021/bi701360j; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNTER E, 1990, CURR TOP MICROBIOL, V157, P187; Ingolfsson HI, 2014, J AM CHEM SOC, V136, P14554, DOI 10.1021/ja507832e; Inlora J, 2014, MBIO, V5, DOI 10.1128/mBio.02202-14; Inlora J, 2011, J VIROL, V85, P3802, DOI 10.1128/JVI.02383-10; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Junkova P, 2016, PROTEINS, V84, P1717, DOI 10.1002/prot.25156; Kiernan RE, 1998, J VIROL, V72, P4116, DOI 10.1128/JVI.72.5.4116-4126.1998; Kroupa T, 2016, J MOL BIOL, V428, P4708, DOI 10.1016/j.jmb.2016.10.010; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Lindwasser OW, 2002, P NATL ACAD SCI USA, V99, P13037, DOI 10.1073/pnas.212409999; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; Lochrie MA, 1997, NUCLEIC ACIDS RES, V25, P2902, DOI 10.1093/nar/25.14.2902; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Mendoza VL, 2009, MASS SPECTROM REV, V28, P785, DOI 10.1002/mas.20203; Mercredi PY, 2016, J MOL BIOL, V428, P1637, DOI 10.1016/j.jmb.2016.03.005; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Murphy RE, 2019, J BIOL CHEM, V294, P18600, DOI 10.1074/jbc.RA119.010997; Nadaraia-Hoke S, 2013, J VIROL, V87, P3609, DOI 10.1128/JVI.03059-12; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 1997, J VIROL, V71, P4409, DOI 10.1128/JVI.71.6.4409-4418.1997; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Ott DE, 2005, J VIROL, V79, P13839, DOI 10.1128/JVI.79.22.13839-13847.2005; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Prchal J, 2012, J MOL BIOL, V423, P427, DOI 10.1016/j.jmb.2012.07.021; Prchal J, 2011, PROTEIN EXPRES PURIF, V79, P122, DOI 10.1016/j.pep.2011.05.010; Provitera P, 2000, J MOL BIOL, V296, P887, DOI 10.1006/jmbi.1999.3482; Qi YF, 2015, J CHEM THEORY COMPUT, V11, P4486, DOI 10.1021/acs.jctc.5b00513; Ramalingam D, 2011, J VIROL, V85, P305, DOI 10.1128/JVI.02626-09; RHEE SS, 1991, EMBO J, V10, P535, DOI 10.1002/j.1460-2075.1991.tb07980.x; RHEE SS, 1990, CELL, V63, P77, DOI 10.1016/0092-8674(90)90289-Q; RHEE SS, 1987, J VIROL, V61, P1045, DOI 10.1128/JVI.61.4.1045-1053.1987; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Sanford B, 2014, VIROLOGY, V468, P293, DOI 10.1016/j.virol.2014.08.017; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Stansell E, 2007, J VIROL, V81, P8977, DOI 10.1128/JVI.00657-07; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tedbury PR, 2016, P NATL ACAD SCI USA, V113, pE182, DOI 10.1073/pnas.1516618113; Tedbury PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003739; Thornhill D, 2019, J VIROL, V93, DOI 10.1128/JVI.00756-19; Valentine KG, 2010, STRUCTURE, V18, P9, DOI 10.1016/j.str.2009.11.010; Vlach J, 2008, P NATL ACAD SCI USA, V105, P10565, DOI 10.1073/pnas.0801765105; Vlach J, 2018, J BIOL CHEM, V293, P18828, DOI 10.1074/jbc.RA118.003944; Vlach J, 2014, J BIOL CHEM, V289, P8697, DOI 10.1074/jbc.M113.543694; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Vlach J, 2009, J MOL BIOL, V390, P967, DOI 10.1016/j.jmb.2009.05.063; Watanabe SM, 2018, J BIOL CHEM, V293, P18841, DOI 10.1074/jbc.RA118.003947; Yandrapalli N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39332; Yasuda J, 2000, VIROLOGY, V268, P533, DOI 10.1006/viro.1999.0179; Zhang GZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131515; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	86	3	3	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8819	8833		10.1074/jbc.RA119.011991	http://dx.doi.org/10.1074/jbc.RA119.011991			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32385109	Green Published, hybrid			2022-12-28	WOS:000546296800017
J	Miyazaki, T; Park, EY				Miyazaki, Takatsugu; Park, Enoch Y.			Structure?function analysis of silkworm sucrose hydrolase uncovers the mechanism of substrate specificity in GH13 subfamily 17exo-?-glucosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; crystal structure; enzyme kinetics; sucrose; carbohydrate metabolism; phylogenetic; glycoside hydrolase family 13 subfamily 17 (GH13_17); BmSUH; BmSUC1; Bombyx mori; conformational change; enzyme mechanism; inhibitor; substrate specificity; phylogenetics	ALPHA-GLUCOSIDASE-I; CRYSTAL-STRUCTURE; STRUCTURAL-ANALYSIS; TREHALOSE SYNTHASE; MOLECULAR-CLONING; PRODUCT SPECIFICITY; CATALYTIC MECHANISM; BOMBYX-MORI; AMYLASE; ENZYME	The domestic silkwormBombyx moriexpresses two sucrose-hydrolyzing enzymes, BmSUH and BmSUC1, belonging to glycoside hydrolase family 13 subfamily 17 (GH13_17) and GH32, respectively. BmSUH has little activity on maltooligosaccharides, whereas other insect GH13_17 ?-glucosidases are active on sucrose and maltooligosaccharides. Little is currently known about the structural mechanisms and substrate specificity of GH13_17 enzymes. In this study, we examined the crystal structures of BmSUH without ligands; in complexes with substrates, products, and inhibitors; and complexed with its covalent intermediate at 1.60?1.85 ? resolutions. These structures revealed that the conformations of amino acid residues around subsite ?1 are notably different at each step of the hydrolytic reaction. Such changes have not been previously reported among GH13 enzymes, includingexo- andendo-acting hydrolases, such as ?-glucosidases and ?-amylases. Amino acid residues at subsite +1 are not conserved in BmSUH and other GH13_17 ?-glucosidases, but subsite ?1 residues are absolutely conserved. Substitutions in three subsite +1 residues, Gln(191), Tyr(251), and Glu(440), decreased sucrose hydrolysis and increased maltase activity of BmSUH, indicating that these residues are key for determining its substrate specificity. These results provide detailed insights into structure?function relationships in GH13 enzymes and into the molecular evolution of insect GH13_17 ?-glucosidases.	[Miyazaki, Takatsugu; Park, Enoch Y.] Shizuoka Univ, Res Inst Green Sci & Technol, Green Chem Res Div, Shizuoka, Japan	Shizuoka University	Miyazaki, T (corresponding author), Shizuoka Univ, Res Inst Green Sci & Technol, Green Chem Res Div, Shizuoka, Japan.	miyazaki.takatsugu@shizuoka.ac.jp	Miyazaki, Takatsugu/M-1498-2016	Miyazaki, Takatsugu/0000-0003-1809-0641	Japan Society for the Promotion of Science KAKENHI [19K15748]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 19K15748 (to T. M.).	Alonso-Gil S, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00269; Auiewiriyanukul W, 2018, FEBS LETT, V592, P2268, DOI 10.1002/1873-3468.13126; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Brzozowski AM, 1997, BIOCHEMISTRY-US, V36, P10837, DOI 10.1021/bi970539i; Caner S, 2013, GLYCOBIOLOGY, V23, P1075, DOI 10.1093/glycob/cwt044; Caputo AT, 2016, P NATL ACAD SCI USA, V113, pE4630, DOI 10.1073/pnas.1604463113; Champion E, 2009, ACTA CRYSTALLOGR D, V65, P1309, DOI 10.1107/S0907444909040311; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dai X, 2019, INSECT MOL BIOL, V28, P862, DOI 10.1111/imb.12603; Daimon T, 2008, J BIOL CHEM, V283, P15271, DOI 10.1074/jbc.M709350200; do Nascimento NA, 2017, INSECT BIOCHEM MOLEC, V81, P62, DOI 10.1016/j.ibmb.2016.12.009; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gabrisko M, 2013, J MOL EVOL, V76, P129, DOI 10.1007/s00239-013-9545-4; Gabrisko M, 2011, J MOL EVOL, V72, P104, DOI 10.1007/s00239-010-9406-3; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Guerin F, 2012, J BIOL CHEM, V287, P6642, DOI 10.1074/jbc.M111.322917; Hobbs JK, 2013, ACS CHEM BIOL, V8, P2388, DOI 10.1021/cb4005029; Holm L, 2019, BIOINFORMATICS, V35, P5326, DOI 10.1093/bioinformatics/btz536; Hondoh H, 2008, J MOL BIOL, V378, P913, DOI 10.1016/j.jmb.2008.03.016; Ito K, 2011, J MOL BIOL, V408, P177, DOI 10.1016/j.jmb.2011.02.028; JAMES AA, 1989, GENE, V75, P73, DOI 10.1016/0378-1119(89)90384-3; Jensen MH, 2004, BIOCHEMISTRY-US, V43, P3104, DOI 10.1021/bi0357762; Ji XM, 2005, J MOL EVOL, V60, P615, DOI 10.1007/s00239-004-0242-1; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kim HS, 2004, J BACTERIOL, V186, P411, DOI 10.1128/JB.186.2.411-418.2004; Kim MJ, 1999, ARCH BIOCHEM BIOPHYS, V371, P277, DOI 10.1006/abbi.1999.1423; Kimura A, 2004, CARBOHYD RES, V339, P1035, DOI 10.1016/j.carres.2003.10.035; Kobayashi M, 2015, FEBS LETT, V589, P484, DOI 10.1016/j.febslet.2015.01.005; Konno K, 2006, P NATL ACAD SCI USA, V103, P1337, DOI 10.1073/pnas.0506944103; Koropatkin NM, 2010, STRUCTURE, V18, P200, DOI 10.1016/j.str.2009.12.010; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lammens W, 2009, J EXP BOT, V60, P727, DOI 10.1093/jxb/ern333; Larsbrink J, 2012, J BIOL CHEM, V287, P43288, DOI 10.1074/jbc.M112.416511; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li CM, 2005, BIOCHEMISTRY-US, V44, P3347, DOI 10.1021/bi048334e; Li XT, 2017, SCI REP-UK, V7, DOI 10.1038/srep45787; Light SH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.202; Lin MG, 2016, ACTA CRYSTALLOGR D, V72, P59, DOI 10.1107/S2059798315020756; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; MATSUURA Y, 1984, J BIOCHEM-TOKYO, V95, P697, DOI 10.1093/oxfordjournals.jbchem.a134659; Mirza O, 2006, J BIOL CHEM, V281, P35576, DOI 10.1074/jbc.M605611200; Miyazaki T, 2019, INSECT BIOCHEM MOLEC, V115, DOI 10.1016/j.ibmb.2019.103254; Miyazaki T, 2016, J STRUCT BIOL, V196, P479, DOI 10.1016/j.jsb.2016.09.015; Moller MS, 2012, J BACTERIOL, V194, P4249, DOI 10.1128/JB.00622-12; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ngiwsara L, 2012, BIOSCI BIOTECH BIOCH, V76, P1967, DOI 10.1271/bbb.120473; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1703, DOI 10.1271/bbb.70125; Ohashi K, 1996, BIOCHEM BIOPH RES CO, V221, P380, DOI 10.1006/bbrc.1996.0604; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palcic MM, 1999, GLYCOCONJUGATE J, V16, P351, DOI 10.1023/A:1007096011392; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ravaud S, 2007, J BIOL CHEM, V282, P28126, DOI 10.1074/jbc.M704515200; Ravaud S, 2009, FEBS LETT, V583, P1964, DOI 10.1016/j.febslet.2009.05.002; Reid SJ, 2005, APPL MICROBIOL BIOT, V67, P312, DOI 10.1007/s00253-004-1885-y; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roy R, 2013, ACS CHEM BIOL, V8, P2245, DOI 10.1021/cb400508k; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sharma M, 2019, INT J BIOL MACROMOL, V140, P1315, DOI 10.1016/j.ijbiomac.2019.08.126; Shen X, 2015, ACTA CRYSTALLOGR D, V71, P1382, DOI 10.1107/S139900471500721X; Shirai T, 2008, PROTEINS, V73, P126, DOI 10.1002/prot.22044; SIERKS MR, 1990, PROTEIN ENG, V3, P193, DOI 10.1093/protein/3.3.193; SILVERSTEIN R, 1967, J BIOL CHEM, V242, P1338; Sim L, 2014, J BIOL CHEM, V289, P22991, DOI 10.1074/jbc.M114.565044; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Skov LK, 2001, J BIOL CHEM, V276, P25273, DOI 10.1074/jbc.M010998200; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Strobl S, 1998, J MOL BIOL, V278, P617, DOI 10.1006/jmbi.1998.1667; Suthangkornkul R, 2015, PROTEIN EXPRES PURIF, V110, P145, DOI 10.1016/j.pep.2015.02.018; Syson K, 2014, BIOCHEMISTRY-US, V53, P2494, DOI 10.1021/bi500183c; Tagami T, 2013, J BIOL CHEM, V288, P19296, DOI 10.1074/jbc.M113.465211; Uitdehaag JCM, 1999, NAT STRUCT BIOL, V6, P432, DOI 10.1038/8235; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vujicic-Zagar A, 2010, P NATL ACAD SCI USA, V107, P21406, DOI 10.1073/pnas.1007531107; Wang HB, 2015, INSECT BIOCHEM MOLEC, V61, P46, DOI 10.1016/j.ibmb.2015.04.005; Wang JQ, 2017, J AGR FOOD CHEM, V65, P7726, DOI 10.1021/acs.jafc.7b02732; Wang YL, 2014, ACTA CRYSTALLOGR D, V70, P3144, DOI 10.1107/S1399004714022500; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; Wongchawalit J, 2006, BIOSCI BIOTECH BIOCH, V70, P2889, DOI 10.1271/bbb.60302; Woo EJ, 2008, J BIOL CHEM, V283, P28641, DOI 10.1074/jbc.M802560200; Xie J, 2016, J BIOL CHEM, V291, P25667, DOI 10.1074/jbc.M116.759290; Xu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074788; Yamamoto K, 2010, FEBS J, V277, P4205, DOI 10.1111/j.1742-4658.2010.07810.x; Zhang DH, 2003, J BIOL CHEM, V278, P35428, DOI 10.1074/jbc.M302616200; Zhang R, 2009, BIOCHEMISTRY-US, V48, P10752, DOI 10.1021/bi901400p; Zheng LB, 1995, EXP PARASITOL, V81, P272, DOI 10.1006/expr.1995.1118	89	5	5	3	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8784	8797		10.1074/jbc.RA120.013595	http://dx.doi.org/10.1074/jbc.RA120.013595			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32381508	Green Published, hybrid			2022-12-28	WOS:000546296800014
J	Jeffreys, LN; Pacholarz, KJ; Johannissen, LO; Girvan, HM; Barran, PE; Voice, MW; Munro, AW				Jeffreys, Laura N.; Pacholarz, Kamila J.; Johannissen, Linus O.; Girvan, Hazel M.; Barran, Perdita E.; Voice, Michael W.; Munro, Andrew W.			Characterization of the structure and interactions of P450 BM3 using hybrid mass spectrometry approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; dimerization; enzyme catalysis; enzyme structure; flavoprotein; fusion protein; mass spectrometry (MS); reductase; structural biology; collision induced unfolding (CIU); cytochrome P450 BM3; domain interactions; hydrogen-deuterium exchange mass spectrometry (HDX-MS); native ion mobility mass spectrometry (IM-MS); protein dynamics; protein solvent accessibility; monooxygenase; solution structure	HYDROGEN-DEUTERIUM EXCHANGE; ELECTRON-TRANSFER; CYTOCHROME-P450 ENZYMES; LIGAND-BINDING; HEME DOMAINS; DYNAMICS; SITE; HYDROXYLATION; PURIFICATION; STABILITY	The cytochrome P450 monooxygenase P450 BM3 (BM3) is a biotechnologically important and versatile enzyme capable of producing important compounds such as the medical drugs pravastatin and artemether, and the steroid hormone testosterone. BM3 is a natural fusion enzyme comprising two major domains: a cytochrome P450 (heme-binding) catalytic domain and a NADPH-cytochrome P450 reductase (CPR) domain containing FAD and FMN cofactors in distinct domains of the CPR. A crystal structure of full-length BM3 enzyme is not available in its monomeric or catalytically active dimeric state. In this study, we provide detailed insights into the protein-protein interactions that occur between domains in the BM3 enzyme and characterize molecular interactions within the BM3 dimer by using several hybrid mass spectrometry (MS) techniques, namely native ion mobility MS (IM-MS), collision-induced unfolding (CIU), and hydrogen-deuterium exchange MS (HDX-MS). These methods enable us to probe the structure, stoichiometry, and domain interactions in the ?240 kDa BM3 dimeric complex. We obtained high-sequence coverage (88?99%) in the HDX-MS experiments for full-length BM3 and its component domains in both the ligand-free and ligand-bound states. We identified important protein interaction sites, in addition to sites corresponding to heme-CPR domain interactions at the dimeric interface. These findings bring us closer to understanding the structure and catalytic mechanism of P450 BM3.	[Jeffreys, Laura N.; Johannissen, Linus O.; Girvan, Hazel M.; Barran, Perdita E.; Munro, Andrew W.] Univ Manchester, Manchester Inst Biotechnol, Sch Nat Sci, Dept Chem, 131 Princess St, Manchester M1 7DN, Lancs, England; [Jeffreys, Laura N.; Johannissen, Linus O.; Girvan, Hazel M.; Barran, Perdita E.; Munro, Andrew W.] Univ Manchester, Manchester Synthet Biol Res Ctr Fine & Special Ch, 131 Princess St, Manchester M1 7DN, Lancs, England; [Pacholarz, Kamila J.; Barran, Perdita E.] Univ Manchester, Michael Barber Ctr Collaborat Mass Spectrometry, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England; [Voice, Michael W.] Cypex Ltd, 6 Tom McDonald Ave, Dundee DD241NH, Scotland	University of Manchester; University of Manchester; University of Manchester	Munro, AW (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Sch Nat Sci, Dept Chem, 131 Princess St, Manchester M1 7DN, Lancs, England.	andrew.munro@manchester.ac.uk	Barran, Perdita/AAY-6303-2021; Jeffreys, Laura/GVU-4604-2022	Jeffreys, Laura/0000-0002-0607-6116; Girvan, Hazel/0000-0003-2299-8644; Barran, Perdita/0000-0002-7720-586X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L017253/1]; Cypex Ltd.; BBSRC Responsive Mode Grant [BB/K001884/1]; BBSRC [BB/R009961/1, BB/K001884/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cypex Ltd.; BBSRC Responsive Mode Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/L017253/1 for a CASE PhD Studentship with Cypex Ltd. (to L. N. J.), and by BBSRC Responsive Mode Grant BB/K001884/1) (to A. W. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson KW, 2016, J BIOL CHEM, V291, P11876, DOI 10.1074/jbc.M116.723577; Behan RK, 2006, J AM CHEM SOC, V128, P11471, DOI 10.1021/ja062428p; BODDUPALLI SS, 1992, J BIOL CHEM, V267, P10375; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; Butler CF, 2013, J BIOL CHEM, V288, P25387, DOI 10.1074/jbc.M113.479717; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Darimont D, 2018, BIOELECTROCHEMISTRY, V119, P119, DOI 10.1016/j.bioelechem.2017.08.009; Dodhia VR, 2006, J BIOL INORG CHEM, V11, P903, DOI 10.1007/s00775-006-0144-3; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Girvan HM, 2016, CURR OPIN CHEM BIOL, V31, P136, DOI 10.1016/j.cbpa.2016.02.018; Girvan HM, 2011, ARCH BIOCHEM BIOPHYS, V507, P75, DOI 10.1016/j.abb.2010.09.014; Govindaraj S, 1996, PROTEIN SCI, V5, P1389, DOI 10.1002/pro.5560050717; Gricman L, 2016, CHEMISTRYSELECT, V1, P1243, DOI 10.1002/slct.201600369; Gustafsson MCU, 2004, BIOCHEMISTRY-US, V43, P5474, DOI 10.1021/bi035904m; Hamuro Y, 2008, J INORG BIOCHEM, V102, P364, DOI 10.1016/j.jinorgbio.2007.10.001; Joyce MG, 2012, FEBS J, V279, P1694, DOI 10.1111/j.1742-4658.2012.08544.x; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kitazume T, 2007, BIOCHEMISTRY-US, V46, P11892, DOI 10.1021/bi701031r; Larriba C, 2013, J COMPUT PHYS, V251, P344, DOI 10.1016/j.jcp.2013.05.038; Larriba C, 2013, J PHYS CHEM A, V117, P3887, DOI 10.1021/jp312432z; LI HY, 1991, J BIOL CHEM, V266, P11909; Liao WL, 2009, BIOCHEMISTRY-US, V48, P4150, DOI 10.1021/bi900168m; Liu YL, 2018, J RAMAN SPECTROSC, V49, P287, DOI 10.1002/jrs.5278; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Meinhold P, 2005, CHEMBIOCHEM, V6, P1765, DOI 10.1002/cbic.200500261; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Migas LG, 2018, INT J MASS SPECTROM, V427, P20, DOI 10.1016/j.ijms.2017.08.014; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; MIURA Y, 1975, BIOCHIM BIOPHYS ACTA, V388, P305, DOI 10.1016/0005-2760(75)90089-2; Munro AW, 1996, BBA-PROTEIN STRUCT M, V1296, P127, DOI 10.1016/0167-4838(96)00061-1; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Neeli R, 2005, FEBS LETT, V579, P5582, DOI 10.1016/j.febslet.2005.09.023; Noble MA, 1999, BIOCHEM J, V339, P371, DOI 10.1042/0264-6021:3390371; Pacholarz KJ, 2017, STRUCTURE, V25, P730, DOI 10.1016/j.str.2017.03.005; Pacholarz KJ, 2014, ANGEW CHEM INT EDIT, V53, P7765, DOI 10.1002/anie.201402863; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Treuheit NA, 2016, BIOCHEMISTRY-US, V55, P1058, DOI 10.1021/acs.biochem.5b01313; Verma R, 2014, BIOPOLYMERS, V101, P197, DOI 10.1002/bip.22301; Wilderman PR, 2010, J BIOL CHEM, V285, P38602, DOI 10.1074/jbc.M110.180646; Xia CW, 2018, BIOCHEMISTRY-US, V57, P945, DOI 10.1021/acs.biochem.7b01102; Zhang HM, 2018, J BIOL CHEM, V293, P7727, DOI 10.1074/jbc.RA117.000600	44	3	3	8	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7595	7607		10.1074/jbc.RA119.011630	http://dx.doi.org/10.1074/jbc.RA119.011630			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32303637	Green Published, hybrid			2022-12-28	WOS:000538038900004
J	Sarsour, EH; Son, JM; Kalen, AL; Xiao, WS; Du, J; Alexander, MS; O'Leary, BR; Cullen, JJ; Goswami, PC				Sarsour, Ehab H.; Son, Jyung Mean; Kalen, Amanda L.; Xiao, Wusheng; Du, Juan; Alexander, Matthew S.; O'Leary, Brianne R.; Cullen, Joseph J.; Goswami, Prabhat C.			Arachidonate 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid contribute to stromal aging-induced progression of pancreatic cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; aging; arachidonic acid (AA) (ARA); pancreatic cancer; fibroblast; stromal cell; cell proliferation	REPLICATIVE LIFE-SPAN; CELL-PROLIFERATION; LIPID-METABOLISM; FIBROBLASTS; INHIBITION; 15-LIPOXYGENASE-2; EXPRESSION; IMBALANCE	The incidence of pancreatic cancer increases with age, suggesting that chronological aging is a significant risk factor for this disease. Fibroblasts are the major nonmalignant cell type in the stroma of human pancreatic ductal adenocarcinoma (PDAC). In this study, we investigated whether the chronological aging of normal human fibroblasts (NHFs), a previously underappreciated area in pancreatic cancer research, influences the progression and therapeutic outcomes of PDAC. Results from experiments with murine xenografts and 2D and 3D co-cultures of NHFs and PDAC cells revealed that older NHFs stimulate proliferation of and confer resistance to radiation therapy of PDAC. MS-based metabolite analysis indicated that older NHFs have significantly increased arachidonic acid 12-lipoxygenase (ALOX12) expression and elevated levels of its mitogenic metabolite, 12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid (12-(S)-HETE) compared with their younger counterparts. In co-cultures with older rather than with younger NHFs, PDAC cells exhibited increases in mitogen-activated protein kinase signaling and cellular metabolism, as well as a lower oxidation state that correlated with their enhanced proliferation and resistance to radiation therapy. Expression of ALOX12 was found to be significantly lower in PDAC cell lines and tumor biopsies, suggesting that PDAC cells rely on a stromal supply of mitogens for their proliferative needs. Pharmacological (hydroxytyrosol) and molecular (siRNA) interventions of ALOX12 in older NHFs suppressed their ability to stimulate proliferation of PDAC cells. We conclude that chronological aging of NHFs contributes to PDAC progression and that ALOX12 and 12-(S)-HETE may be potential stromal targets for interventions that seek to halt progression and improve therapy outcomes.	[Sarsour, Ehab H.] Kansas City Univ Med & Biosci, Coll Osteopath Med, Dept Basic Sci, Kansas City, MO 64106 USA; [Son, Jyung Mean] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Kalen, Amanda L.; Goswami, Prabhat C.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Du, Juan; Alexander, Matthew S.; O'Leary, Brianne R.; Cullen, Joseph J.] Univ Iowa, Dept Surg, Iowa City, IA 52242 USA; [Xiao, Wusheng] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Xiao, Wusheng] Harvard Med Sch, Boston, MA 02115 USA	Kansas City University of Medicine & Biosciences; University of Southern California; University of Iowa; University of Iowa; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Goswami, PC (corresponding author), Univ Iowa, Free Rad & Radiat Biol Div, Dept Radiat Oncol, Iowa City, IA 52242 USA.	prabhat-goswami@uiowa.edu	Xiao, Wusheng/GLU-8346-2022; Son, Jyung Mean Mean/AAW-4712-2021	Xiao, Wusheng/0000-0002-0256-8746; Goswami, Prabhat/0000-0002-5700-2096; Cullen, Joseph/0000-0002-2222-1328; Sarsour, Ehab/0000-0002-9384-5509	National Institute of Health NCI [P30CA086862]	National Institute of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Eric Taylor, Director of the University of Iowa Metabolomics Core Facility and his team Dr. Lynn Teesh, Dr. Adam Rauckhorst, and Alvin Pewa for their help with MS, and Gareth Smith for editorial assistance. Flow Cytometry, Central Microscopy, and Radiation and Free Radical Research Core facilities were supported by National Institute of Health NCI P30CA086862.	Silva LBAR, 2019, FOOD RES INT, V125, DOI 10.1016/j.foodres.2019.108646; Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Brouwers B, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0871-0; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Corbet C, 2017, CURR OPIN CLIN NUTR, V20, P254, DOI 10.1097/MCO.0000000000000381; Ding XZ, 2001, INT J CANCER, V94, P630, DOI 10.1002/ijc.1527.abs; Du J, 2015, CANCER RES, V75, P3314, DOI 10.1158/0008-5472.CAN-14-1707; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Fang H, 2013, CANCER RES, V73, P4965, DOI 10.1158/0008-5472.CAN-13-0661; Flaberg E, 2011, INT J CANCER, V128, P2793, DOI 10.1002/ijc.25612; Gotoh Y, 2002, CELL PROLIFERAT, V35, P221, DOI 10.1046/j.1365-2184.2002.00241.x; Guo YD, 2011, J BIOL CHEM, V286, P33832, DOI 10.1074/jbc.M110.216564; Hartel M, 2004, WORLD J SURG, V28, P818, DOI 10.1007/s00268-004-7147-4; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Kadaba R, 2013, J PATHOL, V230, P107, DOI 10.1002/path.4172; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kanikarla-Marie P, 2018, CANCER METAST REV, V37, P439, DOI 10.1007/s10555-018-9755-8; Krtolica A, 2003, Adv Gerontol, V11, P109; Long J, 2018, AM J CANCER RES, V8, P778; de Souza PAL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101087; Lunardi S, 2014, CANCER LETT, V343, P147, DOI 10.1016/j.canlet.2013.09.039; Maskell DL, 2003, FEMS YEAST RES, V3, P201, DOI 10.1016/S1567-1356(02)00199-X; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Petroni A, 1997, THROMB RES, V87, P315, DOI 10.1016/S0049-3848(97)00133-3; PETRONI A, 1995, THROMB RES, V78, P151, DOI 10.1016/0049-3848(95)00043-7; Polymenis M, 2012, CELL CYCLE, V11, P3531, DOI 10.4161/cc.22041; Postnikoff SDL, 2014, METHODS MOL BIOL, V1163, P223, DOI 10.1007/978-1-4939-0799-1_17; Santos CN, 2018, CURR PHARM DESIGN, V24, P2137, DOI 10.2174/1381612824666180608102344; Sarsour EH, 2005, J BIOL CHEM, V280, P18033, DOI 10.1074/jbc.M501939200; Sarsour EH, 2008, AGING CELL, V7, P405, DOI 10.1111/j.1474-9726.2008.00384.x; Sarsour EH, 2014, AGE, V36, P1213, DOI 10.1007/s11357-014-9645-0; Sarsour EH, 2012, CANCER RES, V72, P3807, DOI 10.1158/0008-5472.CAN-11-1063; Sarsour EH, 2010, MITOCHONDRION, V10, P342, DOI 10.1016/j.mito.2010.02.004; SETTY BNY, 1987, J BIOL CHEM, V262, P17613; Shureiqi I, 1999, CARCINOGENESIS, V20, P1985, DOI 10.1093/carcin/20.10.1985; Son JM, 2017, AGING CELL, V16, P1136, DOI 10.1111/acel.12649; STOKER MGP, 1966, J CELL SCI, V1, P297; Stoykova GE, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112626; Subbarayan V, 2005, NEOPLASIA, V7, P280, DOI 10.1593/neo.04457; Sunami Y., 2017, CANCERS BASEL, V10; Tang DG, 2007, PROSTAG OTH LIPID M, V82, P135, DOI 10.1016/j.prostaglandins.2006.05.022; Waghray M, 2013, CURR OPIN GASTROEN, V29, P537, DOI 10.1097/MOG.0b013e328363affe; Wang D, 2006, GUT, V55, P115, DOI 10.1136/gut.2004.047100; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang HP, 2003, FREE RADICAL RES, V37, P621, DOI 10.1080/1071576031000088283; Yachida S, 2013, ONCOGENE, V32, P5253, DOI 10.1038/onc.2013.29; Yip D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002093.pub3; Zhang PY, 2015, CELL BIOCHEM BIOPHYS, V73, P649, DOI 10.1007/s12013-015-0558-z	49	6	6	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					6946	6957		10.1074/jbc.RA120.012798	http://dx.doi.org/10.1074/jbc.RA120.012798			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32265301	hybrid, Green Published			2022-12-28	WOS:000536212600013
J	Yoon, J; Cho, Y; Kim, KY; Yoon, MJ; Lee, HS; Jeon, SD; Cho, Y; Kim, C; Kim, MG				Yoon, Joobyoung; Cho, Youngkyung; Kim, Ki Yeon; Yoon, Min Ji; Lee, Hyo Seon; Jeon, Sangjun Davie; Cho, Yongcheol; Kim, Chungho; Kim, Moon Gyo			A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase C?II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						serine protease; shedding; PKC; c-Jun N-terminal kinase (JNK); cell invasion; breast cancer; bioinformatics; cell biology; cell invasion; ectodomain shedding; JNK; protein kinase C ?; Prss14; epithin	SERINE-PROTEASE; PROSTATE-CANCER; MATRIPTASE; FILAMIN; EPITHIN; JNK; CARCINOGENESIS; SUPPRESSES; ACTIVATION; EXPRESSION	Serine protease 14 (Prss14)/epithin is a transmembrane serine protease that plays essential roles in tumor progression and metastasis and therefore is a promising target for managing cancer. Prss14/epithin shedding may underlie its activity in cancer and worsen outcomes; accordingly, a detailed understanding of the molecular mechanisms in Prss14/epithin shedding may inform the design of future cancer therapies. On the basis of our previous observation that an activator of PKC, phorbol 12-myristate 13-acetate (PMA), induces Prss14/epithin shedding, here we further investigated the intracellular signaling pathway involved in this process. While using mitogen-activated protein kinase inhibitors to investigate possible effectors of downstream PKC signaling, we unexpectedly found that an inhibitor of c-Jun N-terminal kinase (JNK), SP600125, induces Prss14/epithin shedding even in the absence of PMA. SP600125-induced shedding, like that stimulated by PMA, was mediated by tumor necrosis factor-??converting enzyme. In contrast, a JNK activator, anisomycin, partially abolished the effects of SP600125 on Prss14/epithin shedding. Moreover, the results from loss-of-function experiments with specific inhibitors, short hairpin RNA?mediated knockdown, and overexpression of dominant-negative PKC?II variants indicated that PKC?II is a major player in JNK inhibition? and PMA-mediated Prss14/epithin shedding. SP600125 increased phosphorylation of PKC?II and tumor necrosis factor-??converting enzyme and induced their translocation into the plasma membrane. Finally, in vitro cell invasion experiments and bioinformatics analysis of data in The Cancer Genome Atlas breast cancer database revealed that JNK and PKC?II are important for Prss14/epithin-mediated cancer progression. These results provide important information regarding strategies against tumor metastasis.	[Yoon, Joobyoung; Cho, Youngkyung; Lee, Hyo Seon] Seoul Natl Univ, Sch Biol Sci, Seoul 08826, South Korea; [Cho, Youngkyung; Yoon, Min Ji; Cho, Yongcheol; Kim, Chungho] Korea Univ, Dept Life Sci, Seoul 02841, South Korea; [Kim, Ki Yeon; Jeon, Sangjun Davie; Kim, Moon Gyo] Inha Univ, Dept Biol Sci, Inharo 100, Incheon 22212, South Korea; [Yoon, Joobyoung] Dongwha Pharm, Res Inst, Yongin, South Korea	Seoul National University (SNU); Korea University; Inha University	Kim, MG (corresponding author), Inha Univ, Dept Biol Sci, Inharo 100, Incheon 22212, South Korea.	mgkim@inha.ac.kr		Cho, Youngkyung/0000-0002-8677-6162	Inha University; National Research Foundation of Korea - Korean government (Ministry of Education, Science and Technology) [2017R1A2B4008109]	Inha University; National Research Foundation of Korea - Korean government (Ministry of Education, Science and Technology)	This work was supported by an Inha University research grant and by a National Research Foundation of Korea grant funded by the Korean government (Ministry of Education, Science and Technology) (2017R1A2B4008109 to M. G. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Boon RA, 2010, BLOOD, V115, P2533, DOI 10.1182/blood-2009-06-228726; Bubici C, 2014, BRIT J PHARMACOL, V171, P24, DOI 10.1111/bph.12432; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Cho EG, 2005, BIOCHEM BIOPH RES CO, V327, P328, DOI 10.1016/j.bbrc.2004.12.014; Cho Y, 2017, BIOCHEM BIOPH RES CO, V490, P997, DOI 10.1016/j.bbrc.2017.06.153; Chou FP, 2013, AM J PATHOL, V183, P1306, DOI 10.1016/j.ajpath.2013.06.024; Chu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092244; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; FAVARON M, 1990, P NATL ACAD SCI USA, V87, P1983, DOI 10.1073/pnas.87.5.1983; Galkin AV, 2004, PROSTATE, V61, P228, DOI 10.1002/pros.20094; Ha SY, 2014, VIRCHOWS ARCH, V464, P19, DOI 10.1007/s00428-013-1504-3; Hazzalin CA, 1998, MOL CELL BIOL, V18, P1844, DOI 10.1128/MCB.18.4.1844; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kim C, 2005, EMBO REP, V6, P1045, DOI 10.1038/sj.embor.7400534; Kim C, 2011, BLOOD, V117, P1415, DOI 10.1182/blood-2010-03-275289; Kim H, 2010, EXP CELL RES, V316, P1829, DOI 10.1016/j.yexcr.2010.02.007; Kim KY, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1373-y; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kim SB, 2010, MOL CELLS, V29, P617, DOI 10.1007/s10059-010-0077-0; Kim S, 2016, ONCOTARGET, V7, P34643, DOI 10.18632/oncotarget.9155; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Lee HS, 2014, BIOCHEM BIOPH RES CO, V452, P1084, DOI 10.1016/j.bbrc.2014.09.055; Lee HS, 2010, BIOCHEM BIOPH RES CO, V395, P553, DOI 10.1016/j.bbrc.2010.04.065; Lemjabbar-Alaoui H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017489; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Sales KU, 2015, ONCOGENE, V34, P4664, DOI 10.1038/onc.2014.391; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Tigges U, 2003, J BIOL CHEM, V278, P23561, DOI 10.1074/jbc.M302302200; Tsai CH, 2014, ONCOGENE, V33, P4643, DOI 10.1038/onc.2013.412; Tseng CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183507; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wu SR, 2010, AM J PATHOL, V177, P3145, DOI 10.2353/ajpath.2010.100228; Yang C, 2007, EXP CELL RES, V313, P1240, DOI 10.1016/j.yexcr.2007.01.011; Yoon JB, 2003, J BIOL CHEM, V278, P15319, DOI 10.1074/jbc.M212520200; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zoratti GL, 2016, ONCOTARGET, V7, P58162, DOI 10.18632/oncotarget.11262; Zoratti GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7776	41	3	3	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2020	295	20					7168	7177		10.1074/jbc.RA119.011206	http://dx.doi.org/10.1074/jbc.RA119.011206			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LS2IH	32241917	Green Published, hybrid			2022-12-28	WOS:000536212600030
J	Jin, CM; Zhu, XB; Wu, H; Wang, YQ; Hu, X				Jin, Chengmeng; Zhu, Xiaobing; Wu, Hao; Wang, Yuqi; Hu, Xun			Perturbation of phosphoglycerate kinase 1 (PGK1) only marginally affects glycolysis in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycolysis; serine; lactic acid; cancer; Warburg effect; cellular metabolism; energy homeostasis; PGK1 forward reaction kinetics; phosphoglycerate kinase	AEROBIC GLYCOLYSIS; METABOLISM; P53; M2; INHIBITION; EXPRESSION; THERMODYNAMICS; METHYLGLYOXAL; CONTRIBUTES; MECHANISM	Phosphoglycerate kinase 1 (PGK1) plays important roles in glycolysis, yet its forward reaction kinetics are unknown, and its role especially in regulating cancer cell glycolysis is unclear. Here, we developed an enzyme assay to measure the kinetic parameters of the PGK1-catalyzed forward reaction. The K-m values for 1,3-bisphosphoglyceric acid (1,3-BPG, the forward reaction substrate) were 4.36 ?m (yeast PGK1) and 6.86 ?m (human PKG1). The K-m values for 3-phosphoglycerate (3-PG, the reverse reaction substrate and a serine precursor) were 146 ?m (yeast PGK1) and 186 ?m (human PGK1). The V-max of the forward reaction was about 3.5- and 5.8-fold higher than that of the reverse reaction for the human and yeast enzymes, respectively. Consistently, the intracellular steady-state concentrations of 3-PG were between 180 and 550 ?m in cancer cells, providing a basis for glycolysis to shuttle 3-PG to the serine synthesis pathway. Using siRNA-mediated PGK1-specific knockdown in five cancer cell lines derived from different tissues, along with titration of PGK1 in a cell-free glycolysis system, we found that the perturbation of PGK1 had no effect or only marginal effects on the glucose consumption and lactate generation. The PGK1 knockdown increased the concentrations of fructose 1,6-bisphosphate, dihydroxyacetone phosphate, glyceraldehyde 3-phosphate, and 1,3-BPG in nearly equal proportions, controlled by the kinetic and thermodynamic states of glycolysis. We conclude that perturbation of PGK1 in cancer cells insignificantly affects the conversion of glucose to lactate in glycolysis.	[Jin, Chengmeng; Zhu, Xiaobing; Wu, Hao; Wang, Yuqi; Hu, Xun] Zhejiang Univ, Sch Med, Affiliated Hosp 2,Zhejiang Prov Key Lab Mol Biol, Canc Inst,Key Lab Canc Intervent & Prevent,China, Hangzhou 310000, Peoples R China	Zhejiang University	Hu, X (corresponding author), 88 Jiefang Rd, Hangzhou 310000, Peoples R China.	huxun@zju.edu.cn			National Basic Research Program of China (973 Program) [2013CB911303]; National Natural Science Foundation of China [81470126]; Zhejiang Provincial Department of Sciences and Technologies [2018C03009]; Fundamental Research Funds for the Central Universities Grants [2017XZZX001-01, 2019FZJD009]; National Ministry of Education, China	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Department of Sciences and Technologies; Fundamental Research Funds for the Central Universities Grants; National Ministry of Education, China(Ministry of Education, China)	This work was supported in part by National Basic Research Program of China (973 Program) Grant 2013CB911303, National Natural Science Foundation of China Project Grant 81470126 and Key Project Grant 2018C03009 funded by Zhejiang Provincial Department of Sciences and Technologies, and Fundamental Research Funds for the Central Universities Grants 2017XZZX001-01 and 2019FZJD009, National Ministry of Education, China (to X. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad SS, 2013, INT J ONCOL, V43, P586, DOI 10.3892/ijo.2013.1971; Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Ai JZ, 2011, CELL PHYSIOL BIOCHEM, V27, P207, DOI 10.1159/000327946; Alberty Robert A, 2006, Methods Biochem Anal, V48, P1; Altman BJ, 2016, NAT REV CANCER, V16, P619, DOI 10.1038/nrc.2016.71; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Berg KCG, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0691-y; Blanco R, 2009, HUM MUTAT, V30, P1199, DOI 10.1002/humu.21028; Bollong MJ, 2018, NATURE, V562, P600, DOI 10.1038/s41586-018-0622-0; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cascone T, 2018, CELL METAB, V27, P977, DOI 10.1016/j.cmet.2018.02.024; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen XP, 2015, NAT CHEM BIOL, V11, P19, DOI 10.1038/nchembio.1657; Chiarelli LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032065; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Dang CV, 1999, MOL CELL BIOL, V19, P1; DeWaal D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02733-4; DONNOVAN L, 1975, THERMOCHIM ACTA, V11, P151, DOI 10.1016/0040-6031(75)80018-9; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan J, 2015, ACS CHEM BIOL, V10, P510, DOI 10.1021/cb500683c; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Giachelli CM, 2003, J AM SOC NEPHROL, V14, pS300, DOI 10.1097/01.ASN.0000081663.52165.66; Gibon Y, 1997, ANAL BIOCHEM, V251, P153, DOI 10.1006/abio.1997.2283; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; HOPPESEYLER F, 1993, J VIROL, V67, P3111, DOI 10.1128/JVI.67.6.3111-3117.1993; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hu HG, 2017, HEPATOLOGY, V65, P515, DOI 10.1002/hep.28887; Hwang TL, 2006, PROTEOMICS, V6, P2259, DOI 10.1002/pmic.200500345; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; KACSER H, 1995, BIOCHEM SOC T, V23, P341, DOI 10.1042/bst0230341; KELETI T, 1972, BIOCHIM BIOPHYS ACTA, V268, P285, DOI 10.1016/0005-2744(72)90323-3; Kress S, 1998, J CANCER RES CLIN, V124, P315, DOI 10.1007/s004320050175; Li Xin, 2011, Database (Oxford), V2011, pbar005, DOI 10.1093/database/bar005; Li XJ, 2018, MOL CELL, V72, P650, DOI 10.1016/j.molcel.2018.09.007; Li XJ, 2016, MOL CELL, V61, P705, DOI 10.1016/j.molcel.2016.02.009; Liberti MV, 2017, CELL METAB, V26, P648, DOI 10.1016/j.cmet.2017.08.017; Locasale Jason W, 2018, Curr Opin Syst Biol, V8, P32, DOI 10.1016/j.coisb.2017.11.005; Lu S, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0336-6; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mendez E, 2008, BIOCHEM MOL BIOL EDU, V36, P116, DOI 10.1002/bmb.20157; Nakazawa MS, 2016, NAT REV CANCER, V16, P663, DOI 10.1038/nrc.2016.84; Passonneau J.V., 1993, ENZYMATIC ANAL PRACT; REKHARSKY MV, 1981, THERMOCHIM ACTA, V46, P89, DOI 10.1016/0040-6031(81)80234-1; RICHARD JP, 1993, BIOCHEM SOC T, V21, P549, DOI 10.1042/bst0210549; Shashni B, 2013, J DRUG TARGET, V21, P161, DOI 10.3109/1061186X.2012.736998; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Shipanova IN, 1997, ARCH BIOCHEM BIOPHYS, V344, P29, DOI 10.1006/abbi.1997.0195; Tanner LB, 2018, CELL SYST, V7, P49, DOI 10.1016/j.cels.2018.06.003; Varga A, 2009, FEBS LETT, V583, P3660, DOI 10.1016/j.febslet.2009.10.048; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Xie JS, 2016, J BIOL CHEM, V291, P8987, DOI 10.1074/jbc.M115.704825; Xie JS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04927; YAGINUMA Y, 1991, CANCER RES, V51, P6506; Yan H, 2012, CNS NEUROSCI THER, V18, P729, DOI 10.1111/j.1755-5949.2012.00353.x; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08759-0; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Ying MF, 2019, J BIOL CHEM, V294, P9615, DOI 10.1074/jbc.RA119.007841; Yuan JY, 2018, DNA CELL BIOL, V37, P574, DOI 10.1089/dna.2018.4188; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhang W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08277-3; Zhang YJ, 2018, MOL CELL, V71, P201, DOI 10.1016/j.molcel.2018.06.023; Zhao YJ, 2018, TRANSL CANCER RES, V7, P231, DOI 10.21037/tcr.2018.02.14; Zhong XY, 2018, CELL REP, V24, P3207, DOI 10.1016/j.celrep.2018.08.066; Zieker D, 2010, INT J CANCER, V126, P1513, DOI 10.1002/ijc.24835	72	10	10	3	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6425	6446		10.1074/jbc.RA119.012312	http://dx.doi.org/10.1074/jbc.RA119.012312			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32217690	Green Published, hybrid			2022-12-28	WOS:000537685000015
J	Liu, K; Jin, HW; Zhou, B				Liu, Kuo; Jin, Hengwei; Zhou, Bin			Genetic lineage tracing with multiple DNA recombinases: A user's guide for conducting more precise cell fate mapping studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						development; gene mapping; gene expression; genetics; stem cell; Cre-loxP; Dre-rox; dual recombination; genetic recombination; lineage trace; site-specific DNA recombinase; cell fate mapping; organ regeneration; tissue regeneration; reporter gene	LABEL-RETAINING CELLS; NEURAL CREST CELLS; STEM-CELLS; IN-VIVO; LIVER PROGENITORS; MOSAIC ANALYSIS; DOUBLE MARKERS; HEPATOCYTES; ORIGIN; LUNG	Site-specific recombinases, such as Cre, are a widely used tool for genetic lineage tracing in the fields of developmental biology, neural science, stem cell biology, and regenerative medicine. However, nonspecific cell labeling by some genetic Cre tools remains a technical limitation of this recombination system, which has resulted in data misinterpretation and led to many controversies in the scientific community. In the past decade, to enhance the specificity and precision of genetic targeting, researchers have used two or more orthogonal recombinases simultaneously for labeling cell lineages. Here, we review the history of cell-tracing strategies and then elaborate on the working principle and application of a recently developed dual genetic lineage-tracing approach for cell fate studies. We place an emphasis on discussing the technical strengths and caveats of different methods, with the goal to develop more specific and efficient tracing technologies for cell fate mapping. Our review also provides several examples for how to use different types of DNA recombinase?mediated lineage-tracing strategies to improve the resolution of the cell fate mapping in order to probe and explore cell fate?related biological phenomena in the life sciences.	[Liu, Kuo; Jin, Hengwei; Zhou, Bin] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol Ce, Shanghai 200031, Peoples R China; [Liu, Kuo; Zhou, Bin] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Zhou, B (corresponding author), 320 Yueyang Rd,Life Sci Res Bldg A-2112, Shanghai 200031, Peoples R China.	zhoubin@sibs.ac.cn		Zhou, Bin/0000-0001-5278-5522	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) [XDA16010507, XDB19000000]; National Science Foundation of China [31730112, 31625019, 91849202, 81761138040]	Strategic Priority Research Program of the Chinese Academy of Sciences (CAS); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) Grants XDA16010507 and XDB19000000 and National Science Foundation of China Grants 31730112, 31625019, 91849202, and 81761138040. The authors declare that they have no conflicts of interest with the contents of this article.	Alcolea MP, 2013, NAT REV CANCER, V13, P161, DOI 10.1038/nrc3460; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; [Anonymous], 2008, STEMBOOK; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; BALAKIER H, 1982, DEV BIOL, V90, P352, DOI 10.1016/0012-1606(82)90384-0; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Blanpain C, 2013, NAT REV MOL CELL BIO, V14, P489, DOI 10.1038/nrm3625; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Buckingham ME, 2011, DEV CELL, V21, P394, DOI 10.1016/j.devcel.2011.07.019; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Engleka KA, 2012, CIRC RES, V110, P922, DOI 10.1161/CIRCRESAHA.112.266510; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Han XM, 2019, STEM CELL REP, V12, P624, DOI 10.1016/j.stemcr.2019.01.010; He LJ, 2017, NAT MED, V23, P1488, DOI 10.1038/nm.4437; Henner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077672; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004286; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; Itasaki N, 1999, NAT CELL BIOL, V1, pE203, DOI 10.1038/70231; Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Joseph C, 2013, CELL STEM CELL, V13, P520, DOI 10.1016/j.stem.2013.10.010; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Lincoln J, 2004, DEV DYNAM, V230, P239, DOI 10.1002/dvdy.20051; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Liu K, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-019-0132-8; Liu K, 2020, J BIOL CHEM, V295, P690, DOI 10.1074/jbc.RA119.011349; Liu K, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.167775; Liu QZ, 2019, NAT GENET, V51, P728, DOI 10.1038/s41588-019-0346-6; Liu QZ, 2016, CELL RES, V26, P119, DOI 10.1038/cr.2015.143; Liu QZ, 2015, NAT MED, V21, P866, DOI 10.1038/nm.3888; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; METZGER D, 1995, J BIOL CHEM, V270, P9535, DOI 10.1074/jbc.270.16.9535; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nakamura T, 2006, CIRC RES, V98, P1547, DOI 10.1161/01.RES.0000227505.19472.69; O'Rourke KP, 2017, NAT BIOTECHNOL, V35, P577, DOI 10.1038/nbt.3837; Pu WJ, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.183830; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Roper J, 2017, NAT BIOTECHNOL, V35, P569, DOI 10.1038/nbt.3836; ROSENQUIST GC, 1981, DEV BIOL, V87, P201, DOI 10.1016/0012-1606(81)90143-3; Salwig I, 2019, EMBO J, V38, DOI 10.15252/embj.2019102099; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Sereti KI, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02891-z; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suzuki E, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1280; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Tian XY, 2015, CIRC RES, V116, P515, DOI 10.1161/CIRCRESAHA.116.305097; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang Y, 2017, J BIOL CHEM, V292, P8594, DOI 10.1074/jbc.M117.782029; WEISBLAT DA, 1978, SCIENCE, V202, P1295, DOI 10.1126/science.725606; Welniak LA, 2007, ANNU REV IMMUNOL, V25, P139, DOI 10.1146/annurev.immunol.25.022106.141606; Yamamoto M, 2009, GENESIS, V47, P107, DOI 10.1002/dvg.20474; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Zhang H, 2016, NAT GENET, V48, P537, DOI 10.1038/ng.3536; Zhao H, 2019, CURR OPIN CELL BIOL, V61, P101, DOI 10.1016/j.ceb.2019.07.004; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	77	22	23	3	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6413	6424		10.1074/jbc.REV120.011631	http://dx.doi.org/10.1074/jbc.REV120.011631			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32213599	hybrid, Green Published			2022-12-28	WOS:000537685000014
J	Yadav, PK; Vitvitsky, V; Carballal, S; Seravalli, J; Banerjee, R				Yadav, Pramod Kumar; Vitvitsky, Victor; Carballal, Sebastian; Seravalli, Javier; Banerjee, Ruma			Thioredoxin regulates human mercaptopyruvate sulfurtransferase at physiologically-relevant concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen sulfide; thioredoxin; allosteric regulation; enzyme kinetics; oxidation-reduction (redox)	3-MERCAPTOPYRUVATE SULFUR-TRANSFERASE; MERCAPTOLACTATE-CYSTEINE DISULFIDE; MAMMALIAN THIOREDOXIN; SULFIDE OXIDATION; ACTIVE-SITE; RAT-LIVER; H2S; ANTIOXIDANT; ACID; CHROMATOGRAPHY	3-Mercaptopyruvate sulfur transferase (MPST) catalyzes the desulfuration of 3-mercaptopyruvate (3-MP) and transfers sulfane sulfur from an enzyme-bound persulfide intermediate to thiophilic acceptors such as thioredoxin and cysteine. Hydrogen sulfide (H2S), a signaling molecule implicated in many physiological processes, can be released from the persulfide product of the MPST reaction. Two splice variants of MPST, differing by 20 amino acids at the N terminus, give rise to the cytosolic MPST1 and mitochondrial MPST2 isoforms. Here, we characterized the poorly-studied MPST1 variant and demonstrated that substitutions in its Ser?His?Asp triad, proposed to serve a general acid?base role, minimally affect catalytic activity. We estimated the 3-MP concentration in murine liver, kidney, and brain tissues, finding that it ranges from 0.4 ?mol?kg(?1) in brain to 1.4 ?mol?kg(?1) in kidney. We also show that N-acetylcysteine, a widely-used antioxidant, is a poor substrate for MPST and is unlikely to function as a thiophilic acceptor. Thioredoxin exhibits substrate inhibition, increasing the K-M for 3-MP ?15-fold compared with other sulfur acceptors. Kinetic simulations at physiologically-relevant substrate concentrations predicted that the proportion of sulfur transfer to thioredoxin increases ?3.5-fold as its concentration decreases from 10 to 1 ?m, whereas the total MPST reaction rate increases ?7-fold. The simulations also predicted that cysteine is a quantitatively-significant sulfane sulfur acceptor, revealing MPST's potential to generate low-molecular-weight persulfides. We conclude that the MPST1 and MPST2 isoforms are kinetically indistinguishable and that thioredoxin modulates the MPST-catalyzed reaction in a physiologically-relevant concentration range.	[Yadav, Pramod Kumar; Vitvitsky, Victor; Carballal, Sebastian; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Carballal, Sebastian] Univ Republica, Fac Med, Dept Bioquim, Montevideo 11800, Uruguay; [Carballal, Sebastian] Univ Republica, Ctr Invest Biomed CEINBIO, Montevideo 11800, Uruguay; [Seravalli, Javier] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Seravalli, Javier] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Michigan System; University of Michigan; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Banerjee, R (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010; Vitvitsky, Victor/ABA-2967-2021	Yadav, Pramod K./0000-0003-0026-1684; Vitvitsky, Victor/0000-0001-6251-6115	National Institutes of Health [HL58984]; American Heart Association [14POST18760003]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported in part by National Institutes of Health Grant HL58984 and American Heart Association Grant 14POST18760003 (to P. K. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alphey MS, 2003, J BIOL CHEM, V278, P48219, DOI 10.1074/jbc.M307187200; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; CRAWHALL JC, 1969, AM J DIS CHILD, V117, P71, DOI 10.1001/archpedi.1969.02100030073008; CRAWHALL JC, 1968, SCIENCE, V160, P419, DOI 10.1126/science.160.3826.419; DEMARQUOY J, 1991, EXPERIENTIA, V47, P497, DOI 10.1007/BF01959954; Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011; FAHEY RC, 1981, ANAL BIOCHEM, V111, P357, DOI 10.1016/0003-2697(81)90573-X; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; Frasdorf B, 2014, J BIOL CHEM, V289, P34543, DOI 10.1074/jbc.M114.605733; Fridovich I., 2007, REDOX BIOCH, P49, DOI [10.1002/9780470177334.ch3, DOI 10.1002/9780470177334.CH3]; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Hanaoka K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40227; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Huang GT, 2016, J PHYS CHEM B, V120, P4608, DOI 10.1021/acs.jpcb.6b03387; HUBER HE, 1987, J BIOL CHEM, V262, P16224; JARABAK R, 1978, ARCH BIOCHEM BIOPHYS, V185, P458, DOI 10.1016/0003-9861(78)90189-3; Jeney V, 2009, FREE RADICAL BIO MED, V46, P616, DOI 10.1016/j.freeradbiomed.2008.11.018; Kabil O, 2014, ANNU REV NUTR, V34, P171, DOI 10.1146/annurev-nutr-071813-105654; Kabil O, 2011, ANTIOXID REDOX SIGN, V15, P363, DOI 10.1089/ars.2010.3781; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; KATAOKA H, 1993, J CHROMATOGR-BIOMED, V615, P197, DOI 10.1016/0378-4347(93)80333-Y; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Kwon DY, 2013, PLANTA MED, V79, P997, DOI 10.1055/s-0032-1328704; Levitt MD, 2011, ANTIOXID REDOX SIGN, V15, P373, DOI 10.1089/ars.2010.3525; Libiad M, 2018, J BIOL CHEM, V293, P2675, DOI 10.1074/jbc.RA117.000826; Libiad M, 2015, J BIOL CHEM, V290, P23579, DOI 10.1074/jbc.M115.675694; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; Motl N, 2017, J BIOL CHEM, V292, P14026, DOI 10.1074/jbc.M117.790170; Nagahara N, 2005, J BIOL CHEM, V280, P34569, DOI 10.1074/jbc.M505643200; Nagahara N, 1996, J BIOL CHEM, V271, P27395, DOI 10.1074/jbc.271.44.27395; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nagahara N, 2007, J BIOL CHEM, V282, P1561, DOI 10.1074/jbc.M605931200; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; Porter CM, 2012, BIOORG CHEM, V43, P44, DOI 10.1016/j.bioorg.2011.11.001; Roman HB, 2013, ANTIOXID REDOX SIGN, V19, P1321, DOI 10.1089/ars.2012.5010; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Stutelberg MW, 2014, J CHROMATOGR B, V949, P94, DOI 10.1016/j.jchromb.2014.01.006; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Turanov AA, 2010, METHOD ENZYMOL, V474, P245, DOI 10.1016/S0076-6879(10)74014-3; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Vitvitsky V, 2015, J BIOL CHEM, V290, P8310, DOI 10.1074/jbc.M115.639831; Vitvitsky V, 2013, MECH AGEING DEV, V134, P321, DOI 10.1016/j.mad.2013.05.004; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Westrop GD, 2009, J BIOL CHEM, V284, P33485, DOI 10.1074/jbc.M109.054320; Williams RAM, 2003, J BIOL CHEM, V278, P1480, DOI 10.1074/jbc.M209395200; WLODEK L, 1982, ACTA BIOCHIM POL, V29, P121; Yadav PK, 2019, J BIOL CHEM, V294, P11011, DOI 10.1074/jbc.RA119.009047; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177; Zivanovic J, 2020, CELL METAB, V31, P207, DOI 10.1016/j.cmet.2019.12.001; Zuhra K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080828	55	24	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6299	6311		10.1074/jbc.RA120.012616	http://dx.doi.org/10.1074/jbc.RA120.012616			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32179647	hybrid, Green Published			2022-12-28	WOS:000537685000006
J	Goydel, RS; Weber, J; Peng, HY; Qi, JP; Soden, J; Freeth, J; Park, H; Rader, C				Goydel, Rebecca S.; Weber, Justus; Peng, Haiyong; Qi, Junpeng; Soden, Jo; Freeth, Jim; Park, HaJeung; Rader, Christoph			Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody engineering; antigen; epitope mapping; X-ray crystallography; cancer therapy; affinity maturation; kringle domain; receptor tyrosine kinase (RTK) ROR2	COMPLEMENTARITY-DETERMINING REGIONS; TYROSINE KINASE GENES; PHAGE DISPLAY; RECEPTOR; EXPRESSION; GENERATION; FAMILY; DOMAIN; CRYSTALLOGRAPHY; SOFTWARE	Antibodies are widely used as cancer therapeutics, but their current use is limited by the low number of antigens restricted to cancer cells. A receptor tyrosine kinase, receptor tyrosine kinase-like orphan receptor 2 (ROR2), is normally expressed only during embryogenesis and is tightly down-regulated in postnatal healthy tissues. However, it is up-regulated in a diverse set of hematologic and solid malignancies, thus ROR2 represents a candidate antigen for antibody-based cancer therapy. Here we describe the affinity maturation and humanization of a rabbit mAb that binds human and mouse ROR2 but not human ROR1 or other human cell-surface antigens. Co-crystallization of the parental rabbit mAb in complex with the human ROR2 kringle domain (hROR2-Kr) guided affinity maturation by heavy-chain complementarity-determining region 3 (HCDR3)-focused mutagenesis and selection. The affinity-matured rabbit mAb was then humanized by complementarity-determining region (CDR) grafting and framework fine tuning and again co-crystallized with hROR2-Kr. We show that the affinity-matured and humanized mAb retains strong affinity and specificity to ROR2 and, following conversion to a T cell?engaging bispecific antibody, has potent cytotoxicity toward ROR2-expressing cells. We anticipate that this humanized affinity-matured mAb will find application for antibody-based cancer therapy of ROR2-expressing neoplasms.	[Goydel, Rebecca S.; Weber, Justus; Peng, Haiyong; Qi, Junpeng; Rader, Christoph] Scripps Res Inst, Dept Immunol & Microbiol, 130 Scripps Way 2C1, Jupiter, FL 33458 USA; [Soden, Jo; Freeth, Jim] Scripps Res Inst, Xray Crystallog Core, Jupiter, FL 33458 USA; [Park, HaJeung] Retrogenix Ltd, Chinley SK23 6FJ, High Peak, England; [Weber, Justus] Univ Klinikum Wurzburg, Med Klin & Poliklin 2, Versbacher Str 5, D-97078 Wurzburg, Germany	Scripps Research Institute; Scripps Research Institute; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg	Rader, C (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, 130 Scripps Way 2C1, Jupiter, FL 33458 USA.	crader@scripps.edu	Qi, Junpeng/AAH-5525-2020	Weber, Justus/0000-0002-4919-952X; Rader, Christoph/0000-0001-9955-3454	National Institutes of Health [R01 CA174844, R01 CA181258, R01 CA204484, R21 CA229961]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by National Institutes of Health Grants R01 CA174844, R01 CA181258, R01 CA204484, and R21 CA229961 (to C. R.). This is manuscript no. 29916 from The Scripps Research Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Al-Shawi R, 2001, DEV GENES EVOL, V211, P161, DOI 10.1007/s004270100140; Almagro JC, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01751; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Balakrishnan A, 2017, CLIN CANCER RES, V23, P3061, DOI 10.1158/1078-0432.CCR-16-2083; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davda J, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0586-0; Debebe Z, 2015, PHARMACOL THERAPEUT, V150, P143, DOI 10.1016/j.pharmthera.2015.01.010; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Edris B, 2012, J PATHOL, V227, P223, DOI 10.1002/path.3986; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forrester WC, 2002, CELL MOL LIFE SCI, V59, P83, DOI 10.1007/s00018-002-8407-9; Freeth J, 2020, SLAS DISCOV, V25, P223, DOI 10.1177/2472555219897567; Frenquelli M, 2020, LEUKEMIA, V34, P257, DOI 10.1038/s41375-019-0486-9; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hellmann I, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02490; Henry C, 2015, J CANCER RES CLIN, V141, P243, DOI 10.1007/s00432-014-1824-y; Hristodorov D, 2013, MOL BIOTECHNOL, V53, P326, DOI 10.1007/s12033-012-9531-x; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Jones TD, 2016, MABS-AUSTIN, V8, P1, DOI 10.1080/19420862.2015.1114320; Lee CH, 2010, P NATL ACAD SCI USA, V107, P9567, DOI 10.1073/pnas.1001541107; Ma SSQ, 2017, VIRCHOWS ARCH, V470, P99, DOI 10.1007/s00428-016-2019-5; Mage RG, 2019, DEV COMP IMMUNOL, V92, P99, DOI 10.1016/j.dci.2018.10.003; MASIAKOWSKI P, 1992, J BIOL CHEM, V267, P26181; Matsuda T, 2001, MECH DEVELOP, V105, P153, DOI 10.1016/S0925-4773(01)00383-5; McConnell AD, 2014, MABS-AUSTIN, V6, P1274, DOI 10.4161/mabs.29680; Menzen T, 2014, J PHARM SCI-US, V103, P445, DOI 10.1002/jps.23827; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2005, J BIOL CHEM, V280, P13593, DOI 10.1074/jbc.M500768200; Peng H, 2017, J MOL BIOL, V429, P2954, DOI 10.1016/j.jmb.2017.08.003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qi JP, 2018, P NATL ACAD SCI USA, V115, pE5467, DOI 10.1073/pnas.1719905115; QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029; Rader C, 2000, J BIOL CHEM, V275, P13668, DOI 10.1074/jbc.275.18.13668; Rader Christoph, 2009, V525, P101, DOI 10.1007/978-1-59745-554-1_5; Rebagay G, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00034; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Robinson HR, 2018, BLOOD, V132, P521, DOI 10.1182/blood-2018-02-830992; Stahl SJ, 2010, J MOL BIOL, V397, P697, DOI 10.1016/j.jmb.2010.01.061; Stricker S, 2017, CURR TOP DEV BIOL, V123, P105, DOI 10.1016/bs.ctdb.2016.09.003; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang M, 2010, J STRUCT BIOL, V169, P349, DOI 10.1016/j.jsb.2009.09.011; Weber J, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.23; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Zhang YF, 2017, MABS-AUSTIN, V9, P419, DOI 10.1080/19420862.2017.1289302; ZHU ZP, 1995, INT J CANCER, V62, P319, DOI 10.1002/ijc.2910620315	54	16	15	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2020	295	18					5995	6006		10.1074/jbc.RA120.012791	http://dx.doi.org/10.1074/jbc.RA120.012791			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LL2WK	32193207	hybrid, Green Published			2022-12-28	WOS:000531417300013
J	Gordon, CJ; Tchesnokov, EP; Feng, JY; Porter, DP; Gotte, M				Gordon, Calvin J.; Tchesnokov, Egor P.; Feng, Joy Y.; Porter, Danielle P.; Gotte, Matthias			The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plus-stranded RNA virus; viral polymerase; drug development; enzyme inhibitor; nucleoside; nucleotide analog; coronavirus; positive-sense RNA virus; Ebola virus (EBOV); Middle East respiratory syndrome coronavirus (MERS?CoV); SARS?CoV-2; remdesivir; antiviral drug; RNA chain termination; RNA-dependent RNA polymerase (RdRp); viral replicase	EBOLA-VIRUS; GS-5734; REPLICATION; EXCISION	Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing the outbreak of severe acute respiratory syndrome?coronavirus 2 (CoV-2). Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including severe acute respiratory syndrome?CoV and Middle East respiratory syndrome (MERS?CoV). RDV is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps). Here, we co-expressed the MERS?CoV nonstructural proteins nsp5, nsp7, nsp8, and nsp12 (RdRp) in insect cells as a part a polyprotein to study the mechanism of inhibition of MERS?CoV RdRp by RDV. We initially demonstrated that nsp8 and nsp12 form an active complex. The triphosphate form of the inhibitor (RDV-TP) competes with its natural counterpart ATP. Of note, the selectivity value for RDV-TP obtained here with a steady-state approach suggests that it is more efficiently incorporated than ATP and two other nucleotide analogs. Once incorporated at position i, the inhibitor caused RNA synthesis arrest at position i + 3. Hence, the likely mechanism of action is delayed RNA chain termination. The additional three nucleotides may protect the inhibitor from excision by the viral 3??5? exonuclease activity. Together, these results help to explain the high potency of RDV against RNA viruses in cell-based assays.	[Gordon, Calvin J.; Tchesnokov, Egor P.; Gotte, Matthias] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada; [Gotte, Matthias] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB T6G 2E1, Canada; [Feng, Joy Y.; Porter, Danielle P.] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	University of Alberta; University of Alberta; Gilead Sciences	Gotte, M (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada.	gotte@ualberta.ca		Gordon, Calvin/0000-0002-8259-6201	Canadian Institutes of Health Research [159507]; Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR-One Health Consortium; Gilead Sciences	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR-One Health Consortium; Gilead Sciences(Gilead Sciences)	This study was supported by Canadian Institutes of Health Research Grant 159507 (to M. G.) and a grant from the Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR-One Health Consortium (to M. G.). M. G. has previously received funding from Gilead Sciences in support for the study of EBOV RdRp inhibition by RDV.	Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18; Arabi YM, 2020, TRIALS, V21, DOI 10.1186/s13063-019-3846-x; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14; de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117; Deval J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004995; Dulin D, 2017, CELL REP, V21, P1063, DOI 10.1016/j.celrep.2017.10.005; Ferron F, 2018, P NATL ACAD SCI USA, V115, pE162, DOI 10.1073/pnas.1718806115; Imbert I, 2006, EMBO J, V25, P4933, DOI 10.1038/sj.emboj.7601368; Jordan PC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006889; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395; Muhlberger E, 1999, J VIROL, V73, P2333; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Noton SL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002980; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Siegel D, 2017, J MED CHEM, V60, P1648, DOI 10.1021/acs.jmedchem.6b01594; Subissi L, 2014, P NATL ACAD SCI USA, V111, pE3900, DOI 10.1073/pnas.1323705111; Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326; Tchesnokov EP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22328-3; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180	26	469	485	6	104	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4773	4779		10.1074/jbc.AC120.013056	http://dx.doi.org/10.1074/jbc.AC120.013056			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32094225	hybrid, Green Published			2022-12-28	WOS:000526887000002
J	Tremblay, JR; Lopez, K; Ku, HT				Tremblay, Jacob R.; Lopez, Kassandra; Ku, Hsun Teresa			A GLIS3?CD133?WNT-signaling axis regulates the self-renewal of adult murine pancreatic progenitor-like cells in colonies and organoids (vol 294, pg 16634, 2019)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Ku, Hsun/0000-0001-5662-9893				Tremblay JR, 2019, J BIOL CHEM, V294, P16634, DOI 10.1074/jbc.RA118.002818	1	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5175	5175		10.1074/jbc.AAC120.013439	http://dx.doi.org/10.1074/jbc.AAC120.013439			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32277066	hybrid, Green Published			2022-12-28	WOS:000526887000035
J	Du, H; Wang, PC; Wu, J; He, XM; Wang, YS				Du, Hua; Wang, Pengcheng; Wu, Jun; He, Xiaomei; Wang, Yinsheng			The roles of polymerases ? and ? in replicative bypass of O-6- and N-2-alkyl-2?-deoxyguanosine lesions in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; DNA replication; MS; mutagenesis; mutagenesis mechanism; DNA alkylation; polymerase ?; polymerase ?	TRANSLESION DNA-SYNTHESIS; ERROR-FREE BYPASS; SOMATIC HYPERMUTATION; THYMINE GLYCOL; POL-ZETA; DAMAGE; O-6-ALKYLGUANINE; REPAIR; THETA; ETA	Exogenous and endogenous chemicals can react with DNA to produce DNA lesions that may block DNA replication. Not much is known about the roles of polymerase (Pol) ? and Pol ? in translesion synthesis (TLS) in cells. Here we examined the functions of these two polymerases in bypassing major-groove O-6-alkyl-2?-deoxyguanosine (O-6-alkyl-dG) and minor-groove N-2-alkyl-dG lesions in human cells, where the alkyl groups are ethyl, n-butyl (nBu), and, for O-6-alkyl-dG, pyridyloxobutyl. We found that Pol ? and Pol ? promote TLS across major-groove O-6-alkyl-dG lesions. O-6-alkyl-dG lesions mainly induced G?A mutations that were modulated by the two TLS polymerases and the structures of the alkyl groups. Simultaneous ablation of Pol ? and Pol ? resulted in diminished mutation frequencies for all three O-6-alkyl-dG lesions. Depletion of Pol ? alone reduced mutations only for O-6-nBu-dG, and sole loss of Pol ? attenuated the mutation rates for O-6-nBu-dG and O-6-pyridyloxobutyl-dG. Replication across the two N-2-alkyl-dG lesions was error-free, and Pol ? and Pol ? were dispensable for their replicative bypass. Together, our results provide critical knowledge about the involvement of Pol ? and Pol ? in bypassing alkylated guanine lesions in human cells.	[Du, Hua; Wang, Pengcheng; Wu, Jun; He, Xiaomei; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wang, Yin/HCI-9352-2022		National Institutes of Health [R01 ES029749]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01 ES029749 (to Y. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Arana ME, 2008, NUCLEIC ACIDS RES, V36, P3847, DOI 10.1093/nar/gkn310; Arana ME, 2007, DNA REPAIR, V6, P213, DOI 10.1016/j.dnarep.2006.09.012; Bauer NC, 2015, NUCLEIC ACIDS RES, V43, P10083, DOI 10.1093/nar/gkv1136; Burns JA, 2010, NUCLEIC ACIDS RES, V38, P8178, DOI 10.1093/nar/gkq706; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Du H, 2019, J BIOL CHEM, V294, P11144, DOI 10.1074/jbc.RA119.009054; Du H, 2018, J BIOL CHEM, V293, P11100, DOI 10.1074/jbc.RA118.003477; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Gowda ASP, 2016, CHEM RES TOXICOL, V29, P1894, DOI 10.1021/acs.chemrestox.6b00318; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Hendel A, 2008, DNA REPAIR, V7, P1636, DOI 10.1016/j.dnarep.2008.06.008; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; JANSEN JG, 1995, CANCER RES, V55, P1875; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Li ZQ, 2002, MUTAT RES-FUND MOL M, V510, P71, DOI 10.1016/S0027-5107(02)00253-1; Liu S, 2015, CHEM SOC REV, V44, P7829, DOI 10.1039/c5cs00316d; Masuda K, 2005, P NATL ACAD SCI USA, V102, P13986, DOI 10.1073/pnas.0505636102; Masuda K, 2007, J BIOL CHEM, V282, P17387, DOI 10.1074/jbc.M611849200; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Ohashi E, 2000, GENE DEV, V14, P1589; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; PARTHASARATHY R, 1986, CARCINOGENESIS, V7, P221, DOI 10.1093/carcin/7.2.221; Pauly GT, 2002, CHEM RES TOXICOL, V15, P165, DOI 10.1021/tx0101245; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; Seki M, 2008, DNA REPAIR, V7, P119, DOI 10.1016/j.dnarep.2007.08.005; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; SWANN PF, 1990, MUTAT RES, V233, P81, DOI 10.1016/0027-5107(90)90153-U; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Tamae D, 2011, BIOCHEMISTRY-US, V50, P2321, DOI 10.1021/bi101933p; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wu J, 2019, ACS CHEM BIOL, V14, P1708, DOI 10.1021/acschembio.9b00129; Wu J, 2018, J BIOL CHEM, V293, P8638, DOI 10.1074/jbc.RA118.003133; Wu J, 2016, NUCLEIC ACIDS RES, V44, P9256, DOI 10.1093/nar/gkw662; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Yang W, 2018, ANNU REV BIOCHEM, V87, P239, DOI 10.1146/annurev-biochem-062917-012405; Yoon JH, 2019, CELL, V176, P1295, DOI 10.1016/j.cell.2019.01.023; Yoon JH, 2014, J BIOL CHEM, V289, P13177, DOI 10.1074/jbc.M114.556977; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b; Ziv O, 2009, P NATL ACAD SCI USA, V106, P11552, DOI 10.1073/pnas.0812548106	55	6	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4556	4562		10.1074/jbc.RA120.012830	http://dx.doi.org/10.1074/jbc.RA120.012830			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32098870	Green Published, hybrid			2022-12-28	WOS:000524499700016
J	Yarawsky, AE; Johns, SL; Schuck, P; Herr, AB				Yarawsky, Alexander E.; Johns, Stefanie L.; Schuck, Peter; Herr, Andrew B.			The biofilm adhesion protein Aap from Staphylococcus epidermidis forms zinc-dependent amyloid fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; analytical ultracentrifugation; bacterial pathogenesis; biofilm; biophysics; circular dichroism (CD); confocal microscopy; fibril; infection; spectroscopy	ACCUMULATION-ASSOCIATED PROTEIN; SEDIMENTATION-VELOCITY ANALYSIS; ANALYTICAL ULTRACENTRIFUGATION; INTERCELLULAR-ADHESION; SHAPE-DISTRIBUTIONS; CIRCULAR-DICHROISM; SELF-ASSOCIATION; FIBRILS; BINDING; PEPTIDE	The skin-colonizing commensal bacterium Staphylococcus epidermidis is a leading cause of hospital-acquired and device-related infections. Its pathogenicity in humans is largely due to its propensity to form biofilms, surface-adherent bacterial accumulations that are remarkably resistant to chemical and physical stresses. Accumulation-associated protein (Aap) from S. epidermidis has been shown to be necessary and sufficient for mature biofilm formation and catheter infection. Aap contains up to 17 tandem B-repeat domains, capable of zinc-dependent assembly into twisted, rope-like intercellular filaments in the biofilm. Using microscopic and biophysical techniques, we show here that Aap B-repeat constructs assemble further into zinc-dependent functional amyloid fibers. We observed such amyloid fibers by confocal microscopy during both early and late stages of S. epidermidis biofilm formation, and we confirmed that extracellular fibrils from these biofilms contain Aap. Unlike what has been observed for amyloidogenic biofilm proteins from other bacteria, which typically use chaperones or initiator proteins to initiate amyloid assembly, our findings indicate that Aap from S. epidermidis requires Zn2+ as a catalyst that drives amyloid fiber formation, similar to many mammalian amyloid-forming proteins that require metals for assembly. This work provides detailed insights into S. epidermidis biofilm formation and architecture that improve our understanding of persistent staphylococcal infections.	[Yarawsky, Alexander E.; Johns, Stefanie L.] Univ Cincinnati, Coll Med, Grad Program Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Yarawsky, Alexander E.; Herr, Andrew B.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Herr, Andrew B.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Schuck, Peter] Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Bioengn, NIH, Bethesda, MD 20814 USA; [Johns, Stefanie L.] Enable Inject Inc, Cincinnati, OH 45241 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Herr, AB (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA.; Herr, AB (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.; Herr, AB (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.	andrew.herr@cchmc.org	Schuck, Peter/AAA-6888-2020; Herr, Andrew/R-3049-2019	Schuck, Peter/0000-0002-8859-6966; Herr, Andrew/0000-0002-3598-3399; Yarawsky, Alexander/0000-0002-5973-5058	National Institutes of Health NIGMS [R01 GM094363]; NIAID [U19 AI070235]; Cincinnati Children's Hospital Research Foundation; National Institutes of Health Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cincinnati Children's Hospital Research Foundation; National Institutes of Health Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering	This work was supported by National Institutes of Health NIGMS Grant R01 GM094363 (to A. B. H.) and NIAID Grant U19 AI070235 (to A. B. H.), by Cincinnati Children's Hospital Research Foundation (to A. B. H.), and in part by the National Institutes of Health Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering (to P. S.). A. B. H. serves as a Scientific Advisory Board member for Hoth Therapeutics, Inc., holds equity in Hoth Therapeutics and Chelexa BioSciences, LLC, and was a co-inventor on three patents broadly related to the subject matter of this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Andersen CB, 2010, J MOL BIOL, V397, P932, DOI 10.1016/j.jmb.2010.02.012; Banner MA, 2007, J BACTERIOL, V189, P2793, DOI 10.1128/JB.00952-06; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Binger KJ, 2008, J MOL BIOL, V376, P1116, DOI 10.1016/j.jmb.2007.12.055; Blancas-Mejia LM, 2015, J BIOL CHEM, V290, P4953, DOI 10.1074/jbc.M114.615401; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Calabrese MF, 2008, NAT STRUCT MOL BIOL, V15, P965, DOI 10.1038/nsmb.1483; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chaton CT, 2017, PROTEIN SCI, V26, P1964, DOI 10.1002/pro.3232; Chaton CT, 2015, METHOD ENZYMOL, V562, P187, DOI 10.1016/bs.mie.2015.04.004; Chi LLP, 2011, METHODS MOL BIOL, V752, P179, DOI 10.1007/978-1-60327-223-0_12; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Conrady DG, 2013, P NATL ACAD SCI USA, V110, pE202, DOI 10.1073/pnas.1208134110; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Decker R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004735; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2009, METHOD ENZYMOL, V454, P87, DOI 10.1016/S0076-6879(08)03804-4; Dong JJ, 2006, J AM CHEM SOC, V128, P3540, DOI 10.1021/ja055973j; Dueholm MS, 2015, J BIOL CHEM, V290, P20590, DOI 10.1074/jbc.M115.654780; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Eakin CM, 2002, BIOCHEMISTRY-US, V41, P10646, DOI 10.1021/bi025944a; Edgeworth JA, 2010, P NATL ACAD SCI USA, V107, P14402, DOI 10.1073/pnas.1004036107; Faller P, 2009, CHEMBIOCHEM, V10, P2837, DOI 10.1002/cbic.200900321; Fedunova D, 2013, GEN PHYSIOL BIOPHYS, V32, P215, DOI 10.4149/gpb_2013020; Fey PD, 2010, CURR OPIN MICROBIOL, V13, P610, DOI 10.1016/j.mib.2010.09.007; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Formosa-Dague C, 2016, P NATL ACAD SCI USA, V113, P410, DOI 10.1073/pnas.1519265113; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Geoghegan JA, 2010, J BACTERIOL, V192, P5663, DOI 10.1128/JB.00628-10; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gruszka DT, 2012, P NATL ACAD SCI USA, V109, pE1011, DOI 10.1073/pnas.1119456109; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Herr AB, 2011, METHOD ENZYMOL, P101, DOI 10.1016/B978-0-12-381268-1.00005-7; Howie AJ, 2009, MICRON, V40, P285, DOI 10.1016/j.micron.2008.10.002; Hussain M, 1997, INFECT IMMUN, V65, P519, DOI 10.1128/IAI.65.2.519-524.1997; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jabbouri S, 2010, FEMS IMMUNOL MED MIC, V59, P280, DOI 10.1111/j.1574-695X.2010.00695.x; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x; Kristian SA, 2008, J INFECT DIS, V197, P1028, DOI 10.1086/528992; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lembre P, 2014, PROTEIN PEPTIDE LETT, V21, P75; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Liu C, 2011, J AM CHEM SOC, V133, P6736, DOI 10.1021/ja200222n; Macchi F, 2012, INT J MOL SCI, V13, P3801, DOI 10.3390/ijms13033801; Macintosh RL, 2009, J BACTERIOL, V191, P7007, DOI 10.1128/JB.00764-09; Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881; MacRaild CA, 2003, BIOPHYS J, V84, P2562, DOI 10.1016/S0006-3495(03)75061-9; Morris K, 2010, CHEM SOC REV, V39, P3445, DOI 10.1039/b919453n; Nagel-Steger L, 2010, EUR BIOPHYS J BIOPHY, V39, P415, DOI 10.1007/s00249-009-0416-2; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Navarro S, 2016, EUR J MED CHEM, V121, P785, DOI 10.1016/j.ejmech.2015.10.044; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Paharik AE, 2017, MOL MICROBIOL, V103, P860, DOI 10.1111/mmi.13594; Pedersen JS, 2008, PROTEIN SCI, V17, P2, DOI 10.1110/ps.073127808; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Ryan TM, 2010, J MOL BIOL, V399, P731, DOI 10.1016/j.jmb.2010.04.042; Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schaeffer CR, 2015, INFECT IMMUN, V83, P214, DOI 10.1128/IAI.02177-14; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Shelton CL, 2017, BIOCHEM J, V474, P427, DOI 10.1042/BCJ20160675; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; Smith DP, 2010, P NATL ACAD SCI USA, V107, P6794, DOI 10.1073/pnas.0913046107; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Taglialegna A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005711; Talmard C, 2009, J BIOL INORG CHEM, V14, P449, DOI 10.1007/s00775-008-0461-9; Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Uckay I, 2009, ANN MED, V41, P109, DOI 10.1080/07853890802337045; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; VASSAR PS, 1959, ARCH PATHOL, V68, P487; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Wang Y, 2018, J BIOL CHEM, V293, P14296, DOI 10.1074/jbc.RA118.002448; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107; Yarawsky AE, 2017, J MOL BIOL, V429, P261, DOI 10.1016/j.jmb.2016.11.017; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106; Zhao Ran, 2016, Biophys Rev, V8, P445, DOI 10.1007/s12551-016-0233-7	102	21	21	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4411	4427		10.1074/jbc.RA119.010874	http://dx.doi.org/10.1074/jbc.RA119.010874			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32102851	hybrid, Green Published			2022-12-28	WOS:000524499700005
J	Cougot, D; Wu, YF; Cairo, S; Caramel, J; Renard, CA; Levy, L; Buendia, MA; Neuveut, C				Cougot, Delphine; Wu, Yuanfei; Cairo, Stefano; Caramel, Julie; Renard, Claire-Angelique; Levy, Laurence; Buendia, Marie Annick; Neuveut, Christine			The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription (vol 282, pg 4277, 2007)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction																		Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200	1	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2888	2888		10.1074/jbc.AAC120.012898	http://dx.doi.org/10.1074/jbc.AAC120.012898			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	32111723	hybrid, Green Published			2022-12-28	WOS:000519969100031
